PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Seifert, EL; Gal, A; Acoba, MG; Li, QP; Anderson-Pullinger, L; Golenar, T; Moffat, C; Sondheimer, N; Claypool, SM; Hajnoczky, G				Seifert, Erin L.; Gal, Aniko; Acoba, Michelle G.; Li, Qipei; Anderson-Pullinger, Lauren; Golenar, Tunde; Moffat, Cynthia; Sondheimer, Neal; Claypool, Steven M.; Hajnoczky, Gyorgy			Natural and Induced Mitochondrial Phosphate Carrier Loss DIFFERENTIAL DEPENDENCE OF MITOCHONDRIAL METABOLISM AND DYNAMICS AND CELL SURVIVAL ON THE EXTENT OF DEPLETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; RAT-LIVER MITOCHONDRIA; ATP SYNTHASOME; YEAST MITOCHONDRIA; P-I; FUSION; DEFICIENCY; EXPRESSION; MYOPATHY; CARDIOMYOPATHY	The relevance of mitochondrial phosphate carrier (PiC), encoded by SLC25A3, in bioenergetics is well accepted. However, little is known about the mechanisms mediating the cellular impairments induced by pathological SLC25A3 variants. To this end, we investigated the pathogenicity of a novel compound heterozygous mutation in SLC25A3. First, each variant was modeled in yeast, revealing that substituting GSSAS for QIP within the fifth matrix loop is incompatible with survival on non-fermentable substrate, whereas the L200W variant is functionally neutral. Next, using skin fibroblasts from an individual expressing these variants and HeLa cells with varying degrees of PiC depletion, PiC loss of similar to 60% was still compatible with uncompromised maximal oxidative phosphorylation (oxphos), whereas lower maximal oxphos was evident at similar to 85% PiC depletion. Furthermore, intact mutant fibroblasts displayed suppressed mitochondrial bioenergetics consistent with a lower substrate availability rather than phosphate limitation. This was accompanied by slowed proliferation in glucose-replete medium; however, proliferation ceased when only mitochondrial substrate was provided. Both mutant fibroblasts and HeLa cells with 60% PiC loss showed a less interconnected mitochondrial network and a mitochondrial fusion defect that is not explained by altered abundance of OPA1 or MFN1/2 or relative amount of different OPA1 forms. Altogether these results indicate that PiC depletion may need to be profound (>85%) to substantially affect maximal oxphos and that pathogenesis associated with PiC depletion or loss of function may be independent of phosphate limitation when ATP requirements are not high.	[Seifert, Erin L.; Gal, Aniko; Li, Qipei; Anderson-Pullinger, Lauren; Golenar, Tunde; Moffat, Cynthia; Hajnoczky, Gyorgy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr Imaging Res & Diagnost, Philadelphia, PA 19107 USA; [Acoba, Michelle G.; Claypool, Steven M.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Sondheimer, Neal] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Sondheimer, Neal] Univ Toronto, Dept Paediat, Toronto, ON M5G 1X8, Canada	Jefferson University; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Seifert, EL; Hajnoczky, G (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr Imaging Res & Diagnost, Philadelphia, PA 19107 USA.	erin.seifert@jefferson.edu; gyorgy.hajnoczky@jefferson.edu	Sondheimer, Neal/X-7846-2019; Acoba, Michelle Grace/S-4973-2016	Acoba, Michelle Grace/0000-0002-0768-069X; Claypool, Steven/0000-0001-5316-1623; Sondheimer, Neal/0000-0001-9982-5712	United Mitochondrial Disease Foundation [14-145R]; National Institutes of Health [R01HL108882]; Hungarian-American Enterprise Scholarship Fund international research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051526] Funding Source: NIH RePORTER	United Mitochondrial Disease Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian-American Enterprise Scholarship Fund international research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by United Mitochondrial Disease Foundation Grant 14-145R (to E. L. S.) and National Institutes of Health Grant R01HL108882 (to S. M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a Hungarian-American Enterprise Scholarship Fund international research fellowship.	Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; Baricault L, 2007, EXP CELL RES, V313, P3800, DOI 10.1016/j.yexcr.2007.08.008; Bhoj EJ, 2015, JIMD REP, V19, P59, DOI 10.1007/8904_2014_364; Burelle Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120767; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Claypool SM, 2002, J BIOL CHEM, V277, P28038, DOI 10.1074/jbc.M202367200; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Cotticelli MG, 2015, J BIOMOL SCREEN, V20, P1084, DOI 10.1177/1087057115600433; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; DOLCE V, 1994, J BIOL CHEM, V269, P10451; Dolce V, 1996, FEBS LETT, V399, P95, DOI 10.1016/S0014-5793(96)01294-X; Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Guillery O, 2008, NEUROMUSCULAR DISORD, V18, P319, DOI 10.1016/j.nmd.2007.12.008; Gutierrez-Aguilar M, 2014, J MOL CELL CARDIOL, V72, P316, DOI 10.1016/j.yjmcc.2014.04.008; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUCKRIEDE A, 1995, VIRCHOWS ARCH, V427, P159; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Kwong JQ, 2014, CELL DEATH DIFFER, V21, P1209, DOI 10.1038/cdd.2014.36; LIGETI E, 1985, BIOCHEMISTRY-US, V24, P4423, DOI 10.1021/bi00337a025; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; MACCECCHINI ML, 1979, P NATL ACAD SCI USA, V76, P343, DOI 10.1073/pnas.76.1.343; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Moffat C, 2014, J LIPID RES, V55, P2458, DOI 10.1194/jlr.M046961; Nuskova H, 2015, BIOCHEM BIOPH RES CO, V464, P787, DOI 10.1016/j.bbrc.2015.07.034; PALMIERI F, 1971, EUR J BIOCHEM, V22, P66, DOI 10.1111/j.1432-1033.1971.tb01515.x; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; RIEZMAN H, 1983, EMBO J, V2, P1105, DOI 10.1002/j.1460-2075.1983.tb01553.x; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240; Seifert EL, 2015, BIOCHEM BIOPH RES CO, V464, P369, DOI 10.1016/j.bbrc.2015.06.031; Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006; Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447; Zara V, 1996, MOL CELL BIOL, V16, P6524	38	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26126	26137		10.1074/jbc.M116.744714	http://dx.doi.org/10.1074/jbc.M116.744714			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27780865	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000390345200030
J	Hsu, TY; Shih, HM; Wang, YC; Lin, LC; He, GY; Chen, CY; Kao, CH; Chen, CH; Chen, WK; Yang, TY				Hsu, Tai-Yi; Shih, Hong-Mo; Wang, Yu-Chiao; Lin, Leng-Chieh; He, Guan-Yi; Chen, Chih-Yu; Kao, Chia-Hung; Chen, Chao-Hsien; Chen, Wei-Kung; Yang, Tse-Yen			Effect of Alcoholic Intoxication on the Risk of Inflammatory Bowel Disease: A Nationwide Retrospective Cohort Study	PLOS ONE			English	Article							ULCERATIVE-COLITIS; INTESTINAL PERMEABILITY; CROHNS-DISEASE; SMOKING-HABITS; CONSUMPTION; POPULATION; RECURRENCE; SYMPTOMS; AGE	Purpose This study investigated whether alcoholic intoxication (AI) increases the risk of inflammatory bowel disease (IBD) by using a population-based database in Taiwan. Methods This retrospective matched-cohort study included 57 611 inpatients with new-onset AI (AI cohort) and 230 444 randomly selected controls (non-AI cohort). Each patient was monitored for 10 years to individually identify those who were subsequently diagnosed with Crohn disease (CD) and ulcerative colitis (UC) during the follow-up period. Cox proportional hazard regression analysis was conducted to determine the risk of IBD in patients with AI compared with controls without AI. Results The incidence rate of IBD during the 10-year follow-up period was 2.69 per 1 000 person-years and 0.49 per 1 000 person-years in the AI and non-AI cohorts, respectively. After adjustment for age, sex, and comorbidity, the AI cohort exhibited a 3.17-fold increased risk of IBD compared with the non-AI cohort (hazard ratio [HR] = 3.17, 95% confidence interval [CI] = 2.19-4.58). Compared with the non-AI cohort, the HRs of CD and UC were 4.40 and 2.33 for the AI cohort, respectively. After stratification for the severity of AI according to the duration of hospital stay, the adjusted HRs exhibited a significant correlation with the severity; the HRs of IBD were 1.76, 6.83, and 19.9 for patients with mild, moderate, and severe AI, respectively (p for the trend <.0001). Conclusion The risk of IBD was higher in patients with AI and increased with the length of hospital stay.	[Hsu, Tai-Yi; Shih, Hong-Mo; Chen, Chih-Yu; Chen, Wei-Kung] China Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Hsu, Tai-Yi; Shih, Hong-Mo; Wang, Yu-Chiao; Chen, Chih-Yu; Chen, Wei-Kung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Wang, Yu-Chiao] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Leng-Chieh] Chang Gung Mem Hosp, Dept Emergency Med, Chiayi, Taiwan; [Lin, Leng-Chieh] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [He, Guan-Yi] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [He, Guan-Yi] Natl Taiwan Univ Hosp, Dept Dermatol, Yunlin Branch, Touliu, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan; [Chen, Chao-Hsien; Yang, Tse-Yen] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Yang, Tse-Yen] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; National Taiwan University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Yang, TY (corresponding author), China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.; Yang, TY (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	yang_t_y@yahoo.com.tw	yang, zhe yan/C-4259-2015; , ChihYu/J-3855-2013	yang, zhe yan/0000-0002-3165-132X; Shih, Hong-Mo/0000-0001-7732-3594; , ChihYu/0000-0001-9986-8413	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan for providing the service of statistical analysis, which is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan.	Aldhous MC, 2007, AM J GASTROENTEROL, V102, P589, DOI 10.1111/j.1572-0241.2007.01065.x; BATEL P, 1995, ADDICTION, V90, P977, DOI 10.1111/j.1360-0443.1995.tb03507.x; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Boyko EJ, 1989, AM J GASTROENTEROL, P84; Chang H.Y., 2011, REPORT NATL HLTH INT; Cohen AB, 2013, DIGEST DIS SCI, V58, P1322, DOI 10.1007/s10620-012-2373-3; COTTONE M, 1994, GASTROENTEROLOGY, V106, P643, DOI 10.1016/0016-5085(94)90697-1; DIFRANZA JR, 1990, J STUD ALCOHOL, V51, P130, DOI 10.15288/jsa.1990.51.130; Gronbaek L, 2015, CLIN GASTROENTEROL H, V13, P2017, DOI 10.1016/j.cgh.2015.05.032; Han DY, 2010, MUTAT RES-FUND MOL M, V690, P116, DOI 10.1016/j.mrfmmm.2009.09.002; Hey H, 2007, SCAND J GASTROENTERO, V42, P968, DOI 10.1080/00365520701452241; Higashi A, 1991, Nihon Eiseigaku Zasshi, V45, P1035; Higuchi LM, 2012, AM J GASTROENTEROL, V107, P1399, DOI 10.1038/ajg.2012.196; Hoie O, 2007, AM J GASTROENTEROL, V102, P1692, DOI 10.1111/j.1572-0241.2007.01265.x; Jiang L, 2007, J CLIN GASTROENTEROL, V41, P280, DOI 10.1097/01.mcg.0000225644.75651.f1; Jowett SL, 2004, GUT, V53, P1479, DOI 10.1136/gut.2003.024828; KESHAVARZIAN A, 1994, AM J GASTROENTEROL, V89, P2205; KHORUTS A, 1991, HEPATOLOGY, V13, P267, DOI 10.1016/0270-9139(91)92439-F; Kurata JH, 1994, J CLIN GASTROENTEROL, V19; LIEBER CS, 1995, NEW ENGL J MED, V333, P1058, DOI 10.1056/NEJM199510193331607; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; NAKAMURA Y, 1994, AM J EPIDEMIOL, V140, P902, DOI 10.1093/oxfordjournals.aje.a117178; Octoratou M, 2012, MED-SURG J, V116, P40; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Patel M, 1996, ALCOHOL CLIN EXP RES, V20, P275, DOI 10.1111/j.1530-0277.1996.tb01640.x; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Reid MC, 1999, ARCH INTERN MED, V159, P1681, DOI 10.1001/archinte.159.15.1681; Shah VO, 2010, NAT PROD RES, V24, P1177, DOI 10.1080/14786410903112680; Swanson GR, 2011, DIGESTION, V84, P238, DOI 10.1159/000329403; Swanson GR, 2010, ALCOHOL, V44, P223, DOI 10.1016/j.alcohol.2009.10.019; Wyatt J, 1997, AM J GASTROENTEROL, V92, P1891; Yeh CC, 2013, MAYO CLIN PROC, V88, P1091, DOI 10.1016/j.mayocp.2013.06.024; Zutshi M, 2007, INT J COLORECTAL DIS, V22, P1437, DOI 10.1007/s00384-007-0332-9	34	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165411	10.1371/journal.pone.0165411	http://dx.doi.org/10.1371/journal.pone.0165411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802288	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200022
J	Mayerhofer, H; Sautron, E; Rolland, N; Catty, P; Seigneurin-Berny, D; Pebay-Peyroula, E; Ravaud, S				Mayerhofer, Hubert; Sautron, Emeline; Rolland, Norbert; Catty, Patrice; Seigneurin-Berny, Daphne; Pebay-Peyroula, Eva; Ravaud, Stephanie			Structural Insights into the Nucleotide-Binding Domains of the P-1B-type ATPases HMA6 and HMA8 from Arabidopsis thaliana	PLOS ONE			English	Article							COPPER-TRANSPORTING ATPASE; P-TYPE ATPASE; WILSON-DISEASE PROTEIN; N-DOMAIN; CHLOROPLAST ENVELOPE; X-RAY; CRYSTALLIZATION; HOMEOSTASIS; FEATURES; H1069Q	Copper is a crucial ion in cells, but needs to be closely controlled due to its toxic potential and ability to catalyse the formation of radicals. In chloroplasts, an important step for the proper functioning of the photosynthetic electron transfer chain is the delivery of copper to plastocyanin in the thylakoid lumen. The main route for copper transport to the thylakoid lumen is driven by two P-IB-type ATPases, Heavy Metal ATPase 6 (HMA6) and HMA8, located in the inner membrane of the chloroplast envelope and in the thylakoid membrane, respectively. Here, the crystal structures of the nucleotide binding domain of HMA6 and HMA8 from Arabidopsis thaliana are reported at 1.5 angstrom and 1.75 angstrom resolution, respectively, providing the first structural information on plants Cu+- ATPases. The structures reveal a compact domain, with two short helices on both sides of a twisted beta-sheet. A double mutant, aiding in the crystallization, provides a new crystal contact, but also avoids an internal clash highlighting the benefits of construct modifications. Finally, the histidine in the HP motif of the isolated domains, unable to bind ATP, shows a side chain conformation distinct from nucleotide bound structures.	[Mayerhofer, Hubert; Pebay-Peyroula, Eva; Ravaud, Stephanie] Univ Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France; [Sautron, Emeline; Rolland, Norbert; Seigneurin-Berny, Daphne] Univ Grenoble Alpes, CEA, CNRS, LPCV,Inst Biosci & Biotechnol Grenoble BIG,INRA, Grenoble, France; [Catty, Patrice] Univ Grenoble Alpes, CEA, CNRS, LCBM,BIG,INRA, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Ravaud, S (corresponding author), Univ Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.	Stephanie.Ravaud@ibs.fr	ROLLAND, Norbert/B-4405-2012; SEIGNEURIN-BERNY, Daphne/C-8412-2017	ROLLAND, Norbert/0000-0003-1959-6636; SEIGNEURIN-BERNY, Daphne/0000-0002-7436-9885	European Community's Seventh Framework Programme FP7 [HEALTH-F4-2007-201924]; Grenoble Alliance for Integrated Structural Cell Biology GRAL [ANR-10-LABX-49-01]; Institut Universitaire de France; French Centre National de la Recherche Scientifique; University Grenoble Alpes; EDICT Consortium	European Community's Seventh Framework Programme FP7; Grenoble Alliance for Integrated Structural Cell Biology GRAL; Institut Universitaire de France; French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Grenoble Alpes; EDICT Consortium	HM was supported by two post-doc fellowships, first from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no. HEALTH-F4-2007-201924, EDICT Consortium and then from the Grenoble Alliance for Integrated Structural Cell Biology GRAL (ANR-10-LABX-49-01). EPP was Supported by the Institut Universitaire de France. SR was supported by a chair from the French Centre National de la Recherche Scientifique and from the University Grenoble Alpes. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2009, PLANTA, V229, P767, DOI 10.1007/s00425-008-0869-z; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Abu-Abed M, 2004, BIOCHEM J, V379, P235, DOI 10.1042/BJ20040168; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Banci L, 2010, J BIOL CHEM, V285, P2537, DOI 10.1074/jbc.M109.054262; Bramkamp M, 2004, BIOCHEMISTRY-US, V43, P12289, DOI 10.1021/bi048727d; Catty P, 2011, J BIOL CHEM, V286, P36188, DOI 10.1074/jbc.M111.241034; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dimasi N, 2007, ACTA CRYSTALLOGR F, V63, P204, DOI 10.1107/S1744309107004903; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Haupt M, 2006, J BIOL CHEM, V281, P9641, DOI 10.1074/jbc.M508290200; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Jayakanthan S, 2012, BIOSCIENCE REP, V32, P443, DOI 10.1042/BSR20120048; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kieselbach T, 2000, FEBS LETT, V480, P271, DOI 10.1016/S0014-5793(00)01890-1; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Liu LL, 2009, ACTA CRYSTALLOGR F, V65, P621, DOI 10.1107/S1744309109017023; Lubben M, 2007, J MOL BIOL, V369, P368, DOI 10.1016/j.jmb.2007.03.029; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng D, 2015, BIOMOL NMR ASSIGN, V9, P129, DOI 10.1007/s12104-014-9558-y; Morgan CT, 2004, J BIOL CHEM, V279, P36363, DOI 10.1074/jbc.M404553200; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; POST RL, 1972, J BIOL CHEM, V247, P6530; Puig S, 2007, PLANT CELL ENVIRON, V30, P271, DOI 10.1111/j.1365-3040.2007.01642.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodriguez-Granillo A, 2008, J MOL BIOL, V383, P1097, DOI 10.1016/j.jmb.2008.07.065; Sautron E, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150065; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; STITT M, 1982, PLANT PHYSIOL, V70, P971, DOI 10.1104/pp.70.4.971; Tapken W, 2012, J BIOL CHEM, V287, P18544, DOI 10.1074/jbc.M111.318204; Tsivkovskii R, 2003, J BIOL CHEM, V278, P13302, DOI 10.1074/jbc.M300034200; Tsuda T, 2009, EMBO J, V28, P1782, DOI 10.1038/emboj.2009.143; Walden H, 2010, ACTA CRYSTALLOGR D, V66, P352, DOI 10.1107/S0907444909038207; Wang KT, 2014, NATURE, V514, P518, DOI 10.1038/nature13618; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	45	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165666	10.1371/journal.pone.0165666	http://dx.doi.org/10.1371/journal.pone.0165666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802305	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200035
J	Tsai, KJ; Sze, CI; Lin, YC; Lin, YJ; Hsieh, TH; Lin, CH				Tsai, Kuen-Jer; Sze, Chun-I; Lin, Yung-Chieh; Lin, Yuh-Jyh; Hsieh, Ting-Hui; Lin, Chyi-Her			A Single Postnatal Dose of Dexamethasone Enhances Memory of Rat Pups Later in Life	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; FACTOR-KAPPA-B; NMDA RECEPTOR; LONG-TERM; PRETERM INFANTS; BRONCHOPULMONARY DYSPLASIA; TYROSINE PHOSPHORYLATION; POSTSYNAPTIC DENSITY; SYNAPTIC PLASTICITY; DENTATE GYRUS	Postnatal dexamethasone (Dex) therapy is associated with adverse neurodevelopmental outcomes, which might be related to its timing of administration. We used time-dated pregnant Wistar albino rats, whose litters were divided into experimental (Dex) and control groups intraperitoneally administered one dose of Dex (0.5 mg/kg) or normal saline (NS), respectively, at either day 1 (P1) or 7 (P7). The magnitude of the contextual freezing response and performance on the Morris water maze were significantly higher in the Dex-P7 group than in those of the other groups at P56. Dendritic spine density, membranous expression of the N-methyl-D-aspartate receptor (NMDAR) subunit NR2A/2B, and postsynaptic density-95 (PSD-95) were significantly higher in the Dex-P7 group than in the other groups. Furthermore, cytosolic expression of nuclear factor kappa B (NF-kappa B) and phosphatidylinositol 3-kinase (PI3K) was significantly higher in the Dex group than in NS group. Moreover, Dex administration at P7 increased cell proliferation, neuronal differentiation, and the survival of newly born neurons in the dentate gyrus. These results suggest Dex at P7 enhances the acquisition of contextual fear and spatial memory later in life due to the modulation of the newly born neurons, increase in dendritic spine number, and NMDAR expression.	[Tsai, Kuen-Jer] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan, Taiwan; [Tsai, Kuen-Jer] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Ctr Clin Med, Tainan, Taiwan; [Sze, Chun-I] Natl Cheng Kung Univ, Dept Pathol & Cell Biol & Anat, Coll Med, Tainan, Taiwan; [Lin, Yung-Chieh; Lin, Yuh-Jyh; Hsieh, Ting-Hui; Lin, Chyi-Her] Natl Cheng Kung Univ, Dept Pediat, Coll Med, Tainan, Taiwan; [Lin, Yung-Chieh; Lin, Yuh-Jyh; Hsieh, Ting-Hui; Lin, Chyi-Her] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Pediat, Coll Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Lin, CH (corresponding author), Natl Cheng Kung Univ, Dept Pediat, Coll Med, Tainan, Taiwan.		Tsai, Kuen-Jer/AAZ-2714-2021; Lin, Yuh Jyh/AAK-4314-2020; Tsai, Kuen-Jer/B-9393-2009	Tsai, Kuen-Jer/0000-0002-2170-9735; Tsai, Kuen-Jer/0000-0002-2170-9735; Lin, Yung-Chieh/0000-0002-7698-8428	Taiwan Ministry of Science and Technology [MOST 104-2314-B-006-092]; NCKU Academic Summit Program [D100-35001]	Taiwan Ministry of Science and Technology; NCKU Academic Summit Program	The study was financially supported by the grant MOST 104-2314-B-006-092 from Taiwan Ministry of Science and Technology, and NCKU Academic Summit Program (D100-35001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi-Obe M, 2000, LANCET, V356, P1162, DOI 10.1016/S0140-6736(00)02761-6; Albu S, 2015, AM J OTOLARYNG, V36, P205, DOI 10.1016/j.amjoto.2014.10.032; Barbazanges A, 1996, J NEUROSCI, V16, P7783; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chrousos GP, 2009, NEUROIMMUNOMODULAT, V16, P272, DOI 10.1159/000216185; DIEZ JA, 1976, ENDOCRINOLOGY, V98, P1434, DOI 10.1210/endo-98-6-1434; Doyle LW, 2010, NEONATOLOGY, V98, P217, DOI 10.1159/000286210; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; FAUSER A, 1993, EUR J PEDIATR, V152, P354, DOI 10.1007/BF01956753; Gaissmaier RE, 1999, J PEDIATR-US, V134, P701, DOI 10.1016/S0022-3476(99)70284-2; Hafezi-Moghadam A, 2002, NAT MED, V8, P473, DOI 10.1038/nm0502-473; Hagberg H, 1997, ACTA PAEDIATR, V86, P85; Halasz I, 1997, DEV BRAIN RES, V100, P198, DOI 10.1016/S0165-3806(97)00033-3; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; Halliday HL, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001145, 10.1002/14651858.CD001145]; Hunt CA, 1996, J NEUROSCI, V16, P1380; Iwamoto T, 2004, J NEUROCHEM, V89, P100, DOI 10.1046/j.1471-4159.2003.02293.x; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Limbourg FP, 2002, J CLIN INVEST, V110, P1729, DOI 10.1172/JCI200215481; Lin HJ, 2006, ANN NEUROL, V59, P939, DOI 10.1002/ana.20885; MASSARO D, 1986, AM J PHYSIOL, V251, pR218, DOI 10.1152/ajpregu.1986.251.2.R218; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Modi N, 2001, PEDIATR RES, V50, P581, DOI 10.1203/00006450-200111000-00008; Murphy BP, 2001, PEDIATRICS, V107, P217, DOI 10.1542/peds.107.2.217; Onland W, 2009, PEDIATRICS, V123, P367, DOI 10.1542/peds.2008-0016; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Pham K, 2005, NEUROSCIENCE, V130, P17, DOI 10.1016/j.neuroscience.2004.09.015; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Sandi C, 1998, NEURAL PLAST, V6, P41, DOI 10.1155/NP.1998.41; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; SCHOENFELD NM, 1980, NEUROENDOCRINOLOGY, V31, P101, DOI 10.1159/000123058; Shinwell ES, 2000, ARCH DIS CHILD-FETAL, V83, pF177, DOI 10.1136/fn.83.3.F177; Stark AR, 2001, NEW ENGL J MED, V344, P95, DOI 10.1056/NEJM200101113440203; Sze CI, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/628094; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Vazdarjanova A, 1998, P NATL ACAD SCI USA, V95, P15003, DOI 10.1073/pnas.95.25.15003; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wang YY, 2010, RES J BIOTECHNOL, V5, P5; Warris LT, 2016, J CLIN ONCOL, V34, P2287, DOI 10.1200/JCO.2015.66.0761; Watterberg KL, 2010, PEDIATRICS, V126, P800, DOI 10.1542/peds.2010-1534; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286; Yeh TF, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.5.e7; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903	55	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165752	10.1371/journal.pone.0165752	http://dx.doi.org/10.1371/journal.pone.0165752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798707	Green Submitted, Green Published, gold			2022-12-26	WOS:000386711100061
J	Wang, H; Huai, RT; Yang, JQ; Li, YC				Wang, Hui; Huai, Ruituo; Yang, Junqing; Li, Yanchun			Modification of Hypoxic Respiratory Response by Protein Tyrosine Kinase in Brainstem Ventral Respiratory Neuron Group	PLOS ONE			English	Article							GLUTAMATE RECEPTORS; PHOSPHORYLATION; GLUR1; RAT; HIPPOCAMPUS; GENERATION	Protein tyrosine kinase (PTK) mediated the tyrosine phosphorylation modification of neuronal receptors and ion channels. Whether such modification resulted in changes of physiological functions was not sufficiently studied. In this study we examined whether the hypoxic respiratory response D which is the enhancement of breathing in hypoxic environment could be affected by the inhibition of PTK at brainstem ventral respiratory neuron column (VRC). Experiments were performed on urethane anesthetized adult rabbits. Phrenic nerve discharge was recorded as the central respiratory motor output. Hypoxic respiratory response was produced by ventilating the rabbit with 10% O2-balance 90% N2 for 5 minutes. The responses of phrenic nerve discharge to hypoxia were observed before and after microinjecting PTK inhibitor genistein, AMPA receptor antagonist CNQX, or inactive PTK inhibitor analogue daidzein at the region of ambiguus nucleus (NA) at levels 0-2 mm rostral to obex where the inspiratory subgroup of VRC were recorded. Results were as follows: 1. the hypoxic respiratory response was significantly attenuated after microinjection of genistein and/or CNQX, and no additive effect (i.e., further attenuation of hypoxic respiratory response) was observed when genistein and CNQX were microinjected one after another at the same injection site. Microinjection of daidzein had no effect on hypoxic respiratory response. 2. Fluorescent immunostaining showed that hypoxia significantly increased the number of phosphotyrosine immunopositive neurons in areas surrounding NA and most of these neurons were also immunopositive to glutamate AMPA receptor subunit GluR1. These results suggested that PTK played an important role in regulating the hypoxic respiratory response, possibly through the tyrosine phosphorylation modification of glutamate AMPA receptors on the respiratory neurons of ventral respiratory neuron column.	[Wang, Hui; Huai, Ruituo; Yang, Junqing] Shandong Univ Sci & Technol, Shandong Prov Key Lab Robot & Intelligent Technol, Qingdao, Shandong, Peoples R China; [Li, Yanchun] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA	Shandong University of Science & Technology; Drexel University	Li, YC (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA.	sduchun@163.com	li, yan/GTI-4638-2022		Natural Science Foundation of Shandong Province [ZR2013CQ017]; National Natural Science Foundation of China [61203370, 61305129]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	HW received a research grant funded by Natural Science Foundation of Shandong Province (ZR2013CQ017). JY and RH received support from the National Natural Science Foundation of China (61203370 & 61305129) respectively.	Angelis D, 2014, NEUROCHEM RES, V39, P2118, DOI 10.1007/s11064-014-1404-1; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; CATARSI S, 1993, NATURE, V363, P353, DOI 10.1038/363353a0; Dingledine R, 1999, PHARMACOL REV, V51, P7; FUNK GD, 1993, J NEUROPHYSIOL, V70, P1497, DOI 10.1152/jn.1993.70.4.1497; Ge Q, 1998, J PHYSIOL-LONDON, V509, P255, DOI 10.1111/j.1469-7793.1998.255bo.x; Hawes B E, 2001, Curr Protoc Pharmacol, VChapter 3, DOI 10.1002/0471141755.ph0305s05; Hunter T, 1989, CURR OPIN CELL BIOL, V1, P1168, DOI 10.1016/S0955-0674(89)80068-7; Kim GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088962; Kunibe I, 2003, BRAIN RES, V978, P83, DOI 10.1016/S0006-8993(03)02770-7; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Li Yan-Chun, 2005, Shengli Xuebao, V57, P395; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Pamenter ME, 2014, J PHYSIOL-LONDON, V592, P1839, DOI 10.1113/jphysiol.2013.268706; Rojas A, 2013, MOL PHARMACOL, V83, P746, DOI 10.1124/mol.112.083352; Shao XM, 2001, J NEUROPHYSIOL, V85, P2461, DOI 10.1152/jn.2001.85.6.2461; Song G, 2012, BRAIN STRUCT FUNCT, V217, P835, DOI 10.1007/s00429-012-0384-7; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Zhang F, 2013, STROKE, V44, P170, DOI 10.1161/STROKEAHA.112.667253	20	0	0	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165895	10.1371/journal.pone.0165895	http://dx.doi.org/10.1371/journal.pone.0165895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798679	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100072
J	Orrock, JL; Connolly, BM				Orrock, John L.; Connolly, Brian M.			Changes in Trap Temperature as a Method to Determine Timing of Capture of Small Mammals	PLOS ONE			English	Article							TEMPORAL ACTIVITY; PEROMYSCUS; MOUSE; TIME; MICE	Patterns of animal activity provide important insight into hypotheses in animal behavior, physiological ecology, behavioral ecology, as well as population and community ecology. Understanding patterns of animal activity in field settings is often complicated by the need for expensive equipment and time-intensive methods that limit data collection. Because animals must be active to be detected, the timing of detection (e.g., the timing of capture) may be a useful proxy for estimation of activity time. In this paper, we describe a new method for determining timing of capture for small mammals. In our method, two small temperature loggers are positioned in each trap so that one logger registers the internal temperature of a live-trap at set intervals while the other logger simultaneously records external trap temperature. We illustrate the utility of this technique using field data from live-trapping of deer mice, Peromyscus maniculatus, one of the most ubiquitous, widely distributed small mammals in North America. Traps with animals inside registered consistent increases in internal trap temperature, creating a clear, characteristic temperature deviation between the two data loggers that can determine trap entry time within a very narrow time window (e.g., 10 minutes). We also present pilot data to demonstrate the usefulness of the method for two other small-mammal species. This new method is relatively inexpensive, robust to field conditions, and does not require modification of traps or wiring of new devices. It can be deployed as part of common live-trapping methods, making it possible to assay the timing of capture for a large number of animals in many different ecological contexts. In addition to quantifying timing of capture, this approach may also collect meaningful temperature data and provide insight into the thermal costs of animal activity and relationships between environmental conditions and the time of an animal's capture.	[Orrock, John L.; Connolly, Brian M.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Orrock, JL (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	jorrock@wisc.edu	Connolly, Brian/H-9896-2019		National Science Foundation [DEB-1439550]; University of Wisconsin; NSF [DEB-1439550]; UW Vilas Associates Fellowship award; Direct For Biological Sciences [1439550] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Wisconsin; NSF(National Science Foundation (NSF)); UW Vilas Associates Fellowship award; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation DEB-1439550 (www.nsf.gov) and by a Vilas Associates award from the University of Wisconsin (https://research.wisc.edu/resfunding/vilasassoc/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NSF DEB-1439550 and a UW Vilas Associates Fellowship award to JLO.	Anthony NM, 2005, WILDLIFE SOC B, V33, P1018, DOI 10.2193/0091-7648(2005)33[1018:CEOLAS]2.0.CO;2; BARRY RE, 1989, J MAMMAL, V70, P660, DOI 10.2307/1381446; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; BRUSEO JA, 1995, J MAMMAL, V76, P78, DOI 10.2307/1382316; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; CONLEY KE, 1986, J EXP BIOL, V126, P249; Connolly BM, 2014, ECOLOGY, V95, P1759, DOI 10.1890/13-1774.1; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; DANIELSON BJ, 1987, J MAMMAL, V68, P160, DOI 10.2307/1381066; DeCoursey PJ, 2000, J COMP PHYSIOL A, V186, P169, DOI 10.1007/s003590050017; Ferreira MS, 2016, MAMMALIA, V80, P117, DOI 10.1515/mammalia-2014-0131; FOX BJ, 1978, J WILDLIFE MANAGE, V42, P672, DOI 10.2307/3800842; Halle S, 2000, ECOL STU AN, V141, P285; Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112; Harper SJ, 1996, J MAMMAL, V77, P364, DOI 10.2307/1382809; Henke SE, 2003, WILDLIFE SOC B, V31, P762; King JA, 1968, BIOL PEROMYSCUS RODE; LYNCH GR, 1976, PHYSIOL ZOOL, V49, P191, DOI 10.1086/physzool.49.2.30152539; Naya DE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1629; Orrock JL, 2004, OECOLOGIA, V140, P662, DOI 10.1007/s00442-004-1613-4; Orrock JL, 2011, AM NAT, V177, P691, DOI 10.1086/659632; Orrock JL, 2010, OIKOS, V119, P101, DOI 10.1111/j.1600-0706.2009.17831.x; Pearson DE, 2008, ECOL APPL, V18, P321, DOI 10.1890/07-0766.1; RAND PW, 1993, J MED ENTOMOL, V30, P614, DOI 10.1093/jmedent/30.3.614; Rehmeier RL, 2006, J MAMMAL, V87, P628, DOI 10.1644/05-MAMM-A-220R2.1; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; SNYDER D P, 1982, Mammalian Species, P1, DOI 10.2307/3503819; Stephens RB, 2014, AM MIDL NAT, V171, P139, DOI 10.1674/0003-0031-171.1.139; Stoddart D.M., 1979, ECOLOGY SMALL MAMMAL; Sutherland DR, 2010, J WILDLIFE MANAGE, V74, P906, DOI 10.2193/2009-217	31	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165710	10.1371/journal.pone.0165710	http://dx.doi.org/10.1371/journal.pone.0165710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792770	gold, Green Published, Green Submitted			2022-12-26	WOS:000389537000046
J	Otalora-Ardila, A; Herrera, LG; Flores-Martinez, JJ; Welch, KC				Otalora-Ardila, Aida; Herrera M., L. Gerardo; Juan Flores-Martinez, Jose; Welch, Kenneth C., Jr.			Metabolic Cost of the Activation of Immune Response in the Fish-Eating Myotis (Myotis vivesi): The Effects of Inflammation and the Acute Phase Response	PLOS ONE			English	Article							MITE SPINTURNIX-MYOTI; TRADE-OFFS; BODY-TEMPERATURE; ENERGETIC COSTS; HOUSE SPARROWS; IMMUNOLOGY; CHALLENGE; ECOLOGY; TORPOR; FEVER	Inflammation and activation of the acute phase response (APR) are energetically demanding processes that protect against pathogens. Phytohaemagglutinin (PHA) and lipopolysaccharide (LPS) are antigens commonly used to stimulate inflammation and the APR, respectively. We tested the hypothesis that the APR after an LPS challenge was energetically more costly than the inflammatory response after a PHA challenge in the fish-eating Myotis bat (Myotis vivesi). We measured resting metabolic rate (RMR) after bats were administered PHA and LPS. We also measured skin temperature (Tskin) after the LPS challenge and skin swelling after the PHA challenge. Injection of PHA elicited swelling that lasted for several days but changes in RMR and body mass were not significant. LPS injection produced a significant increase in Tskin and in RMR, and significant body mass loss. RMR after LPS injection increased by 140-185% and the total cost of the response was 6.50 kJ. Inflammation was an energetically low-cost process but the APR entailed a significant energetic investment. Examination of APR in other bats suggests that the way in which bats deal with infections might not be uniform.	[Otalora-Ardila, Aida] Univ Nacl Autonoma Mexico, Inst Biol, Posgrad Ciencias Biol, Mexico City, DF, Mexico; [Herrera M., L. Gerardo] Univ Nacl Autonoma Mexico, Inst Biol, Estn Biol Chamela, San Patricio, Jalisco, Mexico; [Juan Flores-Martinez, Jose] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Lab Sistemas Informac Geog, Mexico City, DF, Mexico; [Welch, Kenneth C., Jr.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Toronto; University Toronto Scarborough	Herrera, LG (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Estn Biol Chamela, San Patricio, Jalisco, Mexico.	gherrera@ib.unam.mx	Otálora, Aída/AAE-7280-2019; Welch, Kenneth C./F-1276-2011	Otálora, Aída/0000-0002-0020-7509; Welch, Kenneth C./0000-0002-3283-6510; Herrera Montalvo, Luis Gerardo/0000-0001-9348-5040	Direccion General de Asuntos del Personal Academic [PAPIIT] [IN202113]; Natural Sciences and Engineering Research Council of Canada [386466]; National Council of Science and Technology (CONACyT); Posgrado en Ciencias Biologicas UNAM	Direccion General de Asuntos del Personal Academic [PAPIIT]; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Posgrado en Ciencias Biologicas UNAM(Universidad Nacional Autonoma de Mexico)	Funding for this research was provided by Direccion General de Asuntos del Personal Academic [PAPIIT # IN202113] to LGHM, and by a Natural Sciences and Engineering Research Council of Canada Discovery Grant [# 386466] to K.C.W. AOA acknowledges the scholarship and financial support provided by the National Council of Science and Technology (CONACyT), and Posgrado en Ciencias Biologicas UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LC, 2009, J COMP PHYSIOL B, V179, P315, DOI 10.1007/s00360-008-0315-3; BANET M, 1981, EXPERIENTIA, V37, P1302, DOI 10.1007/BF01948375; Barclay RMR, 1996, J MAMMAL, V77, P1102, DOI 10.2307/1382791; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Baze MM, 2011, J EXP BIOL, V214, P3255, DOI 10.1242/jeb.054544; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Boughton RK, 2007, J EXP ZOOL PART A, V307A, P479, DOI 10.1002/jez.402; Boughton RK, 2011, FUNCT ECOL, V25, P81, DOI 10.1111/j.1365-2435.2010.01817.x; Brook CE, 2015, TRENDS MICROBIOL, V23, P172, DOI 10.1016/j.tim.2014.12.004; Buehler DM, 2010, INTEGR COMP BIOL, V50, P346, DOI 10.1093/icb/icq055; Burness G, 2010, J EXP BIOL, V213, P1386, DOI 10.1242/jeb.027011; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Canale CI, 2011, FUNCT ECOL, V25, P557, DOI 10.1111/j.1365-2435.2010.01815.x; CARPENTER RE, 1968, COMP BIOCHEM PHYSIOL, V24, P951, DOI 10.1016/0010-406X(68)90807-4; Christe P, 2000, ECOL LETT, V3, P207; Demas Gregory, 2011, P259; Derting TL, 2003, PHYSIOL BIOCHEM ZOOL, V76, P744, DOI 10.1086/375662; Flores J, 2005, CULT CRIT, P187; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; Hasselquist D, 2012, ANIM BEHAV, V83, P1303, DOI 10.1016/j.anbehav.2012.03.025; Hegemann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036358; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; King MO, 2013, J EXP BIOL, V216, P2097, DOI 10.1242/jeb.079574; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; KLUGER MJ, 1986, YALE J BIOL MED, V59, P89; Lee KA, 2005, OECOLOGIA, V145, P244, DOI 10.1007/s00442-005-0113-5; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; MacDonald L, 2012, PHYSIOL BEHAV, V107, P762, DOI 10.1016/j.physbeh.2012.06.009; Marais M, 2011, J THERM BIOL, V36, P116, DOI 10.1016/j.jtherbio.2010.12.004; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Merlo JL, 2014, COMP BIOCHEM PHYS A, V175, P90, DOI 10.1016/j.cbpa.2014.05.021; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Nilsson JA, 2007, J AVIAN BIOL, V38, P488, DOI 10.1111/j.2007.0908-8857.03919.x; Owen-Ashley NT, 2007, J ORNITHOL, V148, pS583, DOI 10.1007/s10336-007-0197-2; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez A, 2014, J EXP ZOOL PART A, V321, P376, DOI 10.1002/jez.1868; Schneeberger K, 2013, J EXP BIOL, V216, P4514, DOI 10.1242/jeb.090837; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Skold-Chiriac S, 2014, PHYSIOL BIOCHEM ZOOL, V87, P288, DOI 10.1086/674789; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; StatSoft Inc., 2004, STAT VERS 7 COMP PRO; Stockmaier S, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0576; Viljoen H, 2011, J ZOOL, V285, P222, DOI 10.1111/j.1469-7998.2011.00833.x; Welch KC, 2015, J EXP BIOL, V218, P1180, DOI 10.1242/jeb.115964; Williams JB, 2009, ARDEA, V97, P120, DOI 10.5253/078.097.0115; Zeileis A, 2005, J STAT SOFTW, V14, P1, DOI [10.18637/jss.v014.i06, DOI 10.18637/JSS.V014.I06]; Zhang Zhiqiang, 2011, Acta Theriologica Sinica, V31, P284	51	27	27	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0164938	10.1371/journal.pone.0164938	http://dx.doi.org/10.1371/journal.pone.0164938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792729	Green Published, Green Submitted, gold			2022-12-26	WOS:000389537000012
J	dos Santos, TR; Faria, GDM; Guerreiro, BM; dal Pietro, NHPD; Lopes, WDZ; da Silva, HM; Garcia, JL; Luvizotto, MCR; Bresciani, KDS; da Costa, AJ				dos Santos, Thais Rabelo; Magalhaes Faria, Gabriela da Silva; Guerreiro, Bruna Martins; Pereira da Silva dal Pietro, Nathalia Helena; Zanetti Lopes, Welber Daniel; da Silva, Helenara Machado; Garcia, Joao Luis; Rui Luvizotto, Maria Cecilia; Saraiva Bresciani, Katia Denise; da Costa, Alvimar Jose			Congenital Toxoplasmosis in Chronically Infected and Subsequently Challenged Ewes	PLOS ONE			English	Article							OVINE ABORTION; TRANSPLACENTAL TRANSMISSION; VERTICAL TRANSMISSION; GONDII; SHEEP; TISSUES; CATTLE; BIOASSAY; SEMEN; MICE	This experiment studied congenital transmission in sheep experimentally infected with oocysts of Toxoplasma gondii and reinfected at one of three stages of pregnancy. Twenty ewes were experimentally infected with T. gondii strain ME49 (day 0). After the T. gondii infection became chronic (IFAT <= 512), the ewes were allocated with rams for coverage. After the diagnosis of pregnancy, these ewes were allocated into four experimental groups (n = 5): I-reinfected with T. gondii on the 40(th) day of gestation (DG); II-reinfected on DG 80; III-reinfected on DG 120; and IV-saline solution on DG 120 (not reinfected). Five ewes (IFAT< 64) were kept as negative controls (uninfected, group V), therefore in groups I-III were infected prior to pregnancy and re-infected during pregnancy, group IV was only infected prior to pregnancy, and group V was not infected. Parasitism by T. gondii was investigated (histopathology, immunohistochemistry, mouse bioassay and PCR) in mothers and lambs tissue. All ewes produced lambs serologically positive for T. gondii. The results of the mouse bioassay, immunohistochemistry and PCR assays revealed the presence of T. gondii in all 20 sheep and their lambs. The congenital transmission of T. gondii was associated with fetal loss and abnormalities in persistently infected sheep and in ewes infected and subsequently reinfected by this protozoan. Therefore, congenital T. gondii infection was common when ewes were chronically infected prior to pregnancy, with or without reinfection during at various stages of gestation.	[dos Santos, Thais Rabelo] Rondonia Fed Univ UNIR, Dept Vet Med, Ave Norte Sul 7300, BR-76940000 Rolim De Moura, RO, Brazil; [Magalhaes Faria, Gabriela da Silva; Guerreiro, Bruna Martins; Pereira da Silva dal Pietro, Nathalia Helena; Zanetti Lopes, Welber Daniel; da Silva, Helenara Machado; da Costa, Alvimar Jose] UNESP Jaboticabal, Dept Anim Pathol, CPPAR, FCAV, Access Rd,Prof Paul Donato Castellane S-N, BR-14884900 Jaboticabal, SP, Brazil; [Garcia, Joao Luis] Univ Estadual Londrina, Dept Vet Prevent Med, Londrina, SP, Brazil; [Rui Luvizotto, Maria Cecilia] UNESP, FMVA, Dept Clin Surg & Anim Reprod, Aracatuba, SP, Brazil; [Saraiva Bresciani, Katia Denise] UNESP, FMVA, Dept Prod & Anim Hlth, Aracatuba, SP, Brazil	Universidade Federal de Rondonia; Universidade Estadual de Londrina; Universidade Estadual Paulista; Universidade Estadual Paulista	dos Santos, TR (corresponding author), Rondonia Fed Univ UNIR, Dept Vet Med, Ave Norte Sul 7300, BR-76940000 Rolim De Moura, RO, Brazil.	rabelo.vet@hotmail.com	Garcia, Joao Luis/Y-8864-2019; Garcia, João Luis/X-4279-2019; Luis, João/AAE-9252-2019; dos Santos Doni, Thais Rabelo/E-3391-2012; Doni, Thais Rabelo Santos/O-2973-2019	Garcia, Joao Luis/0000-0002-5736-7511; Garcia, João Luis/0000-0003-1826-7582; dos Santos Doni, Thais Rabelo/0000-0002-8300-0473; Doni, Thais Rabelo Santos/0000-0002-8300-0473	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/06173-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2009/06173-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton L, 1988, GIG SANIT, V9, P6; Arantes TP, 2009, EXP PARASITOL, V123, P190, DOI 10.1016/j.exppara.2009.07.003; AVMA, 2007, NOT GUID EUTH; BEVERLEY JK, 1971, VET REC, V88, P174, DOI 10.1136/vr.88.7.174; Bresciani KDS, 2009, PARASITOL RES, V104, P1213, DOI 10.1007/s00436-008-1317-5; Buxton D, 2006, SMALL RUMINANT RES, V62, P43, DOI 10.1016/j.smallrumres.2005.07.037; Buxton D, 2007, VET PARASITOL, V149, P25, DOI 10.1016/j.vetpar.2007.07.003; CamargO M. E., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P117; COLE JR, 1973, APPL MICROBIOL, V25, P976, DOI 10.1128/AEM.25.6.976-980.1973; CONRAD PA, 1993, J VET DIAGN INVEST, V5, P572, DOI 10.1177/104063879300500412; COSTA AJ, 1977, J PARASITOL, V63, P212, DOI 10.2307/3280042; da Silva AV, 2001, VET PARASITOL, V97, P191, DOI 10.1016/S0304-4017(01)00404-6; DEROEVER.H, 1969, TROP GEOGR MED, V21, P443; DESMONTS G, 1974, B NEW YORK ACAD MED, V50, P146; DUBEY J P, 1984, International Goat and Sheep Research, V2, P93; Dubey JP, 2009, VET PARASITOL, V163, P1, DOI 10.1016/j.vetpar.2009.02.026; Dubey J.P., 1988, P1; DUBEY JP, 1993, AM J VET RES, V54, P270; DUBEY JP, 1980, J PARASITOL, V66, P111, DOI 10.2307/3280600; Dubey JP, 1998, VET PARASITOL, V74, P75, DOI 10.1016/S0304-4017(97)00135-0; Duncanson P, 2001, INT J PARASITOL, V31, P1699, DOI 10.1016/S0020-7519(01)00282-X; Edwards JF, 2013, VET PARASITOL, V192, P129, DOI 10.1016/j.vetpar.2012.09.037; Ellis JT, 1998, INT J PARASITOL, V28, P1053, DOI 10.1016/S0020-7519(98)00096-4; Esteban-Redondo I, 1999, VET PARASITOL, V86, P155, DOI 10.1016/S0304-4017(99)00138-7; Esteban-Redondo I, 1998, INT J PARASITOL, V28, P1459, DOI 10.1016/S0020-7519(98)00116-7; Freyre A, 2012, VET PARASITOL, V183, P359, DOI 10.1016/j.vetpar.2011.07.039; Freyre A, 1999, J PARASITOL, V85, P746, DOI 10.2307/3285756; Fuentes I, 1996, J CLIN MICROBIOL, V34, P2368, DOI 10.1128/JCM.34.10.2368-2371.1996; Garcia JL, 2006, EXP PARASITOL, V113, P100, DOI 10.1016/j.exppara.2005.12.011; GUESDON JL, 1979, J HISTOCHEM CYTOCHEM, V27, P1131, DOI 10.1177/27.8.90074; Hartley W. J., 1961, New Zealand Veterinary Journal, V9, P1, DOI 10.1080/00480169.1961.33404; Hide G, 2009, PARASITOLOGY, V136, P1877, DOI 10.1017/S0031182009990941; Innes EA, 2009, PARASITOLOGY, V136, P1887, DOI 10.1017/S0031182009991636; Kodjikian L, 2004, PEDIATR INFECT DIS J, V23, P4; Lopes WDZ, 2011, PARASITOL RES, V109, P405, DOI 10.1007/s00436-011-2268-9; Lopes Welber Daniel Zanetti, 2009, J Parasitol Res, V2009, DOI 10.1155/2009/602803; Maia MS, 1998, MANUAL INSEMINACAO A; MILLER JK, 1982, VET REC, V111, P124, DOI 10.1136/vr.111.6.124; Montoya A, 2009, VET PARASITOL, V160, P159, DOI 10.1016/j.vetpar.2008.10.029; Morley EK, 2008, PARASITOLOGY, V135, P169, DOI 10.1017/S0031182007003721; Morley EK, 2005, PARASITOLOGY, V131, P181, DOI 10.1017/S0031182005007614; Moura AB, 2007, PESQUI VET BRASIL, V27, P430, DOI 10.1590/S0100-736X2007001000008; MUNDAY BL, 1972, RES VET SCI, V13, P100; Rassouli M, 2011, PARASITOLOGY, V138, P691, DOI 10.1017/S0031182011000205; Rodger SM, 2006, VET REC, V159, P768; Sabin AB, 1941, J AMER MED ASSOC, V116, P801, DOI 10.1001/jama.1941.02820090001001; Scarpelli L, 2009, PESQUI VET BRASIL, V29, P59, DOI 10.1590/S0100-736X2009000100009; SHARMA S P, 1974, Indian Journal of Animal Sciences, V44, P214; STEUBER S, 1995, DEUT TIERARZTL WOCH, V102, P91; Tsutsui VS, 2007, ARQ BRAS MED VET ZOO, V59, P30, DOI 10.1590/S0102-09352007000100006; WATSON WA, 1971, VET REC, V88, P42, DOI 10.1136/vr.88.2.42; WHITLOCK H. V., 1950, JOUR HELMINTHOL, V24, P47, DOI 10.1017/S0022149X00019106; Williams RH, 2005, PARASITOLOGY, V130, P301, DOI 10.1017/S0031182004006614; Lopes WDZ, 2013, VET PARASITOL, V195, P47, DOI 10.1016/j.vetpar.2012.12.056	54	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165124	10.1371/journal.pone.0165124	http://dx.doi.org/10.1371/journal.pone.0165124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788185	gold, Green Published, Green Submitted			2022-12-26	WOS:000389604900046
J	Ochi, S; Tsubokura, M; Kato, S; Iwamoto, S; Ogata, S; Morita, T; Hori, A; Oikawa, T; Kikuchi, A; Watanabe, Z; Kanazawa, Y; Kumakawa, H; Kuma, Y; Kumakura, T; Inomata, Y; Kami, M; Shineha, R; Saito, Y				Ochi, Sae; Tsubokura, Masaharu; Kato, Shigeaki; Iwamoto, Shuichi; Ogata, Shinichi; Morita, Tomohiro; Hori, Arinobu; Oikawa, Tomoyoshi; Kikuchi, Antoku; Watanabe, Zenjiro; Kanazawa, Yukio; Kumakawa, Hiromi; Kuma, Yoshinobu; Kumakura, Tetsuo; Inomata, Yoshimitsu; Kami, Masahiro; Shineha, Ryuzaburo; Saito, Yasutoshi			Hospital Staff Shortage after the 2011 Triple Disaster in Fukushima, Japan-An Earthquake, Tsunamis, and Nuclear Power Plant Accident: A Case of the Soso District	PLOS ONE			English	Article							WILLINGNESS	Introduction In 2011, Fukushima was struck by a triple disaster: an earthquake, tsunamis, and a nuclear accident. In the aftermath, there was much fear among hospital staff members about radiation exposure and many staff members failed to report to work. Objectives One objective is to measure this shortage in hospital staff and another is to compare the difference in recovery by hospital types and by categories of hospital staff. Design The monthly records of the number of staff members from May 2011 to September 2012 were extracted anonymously from the records of 7 local hospitals in the Soso district in Fukushima. Change in the number of staff was analyzed. Results Staff shortages at hospitals reached a maximum within one month after the disaster (47% reported to work). The shortage of clerks was the most severe (38% reported to work), followed by nurses (48% reported to work). The shortages remained even 18 months after the disaster. Conclusion After a disaster in which the damage to hospital functions surpasses the structural damage, massive support of human resources in the acute phase and a smaller volume of support in the mid-term phase appear to be required, particularly for non-medical staff.	[Ochi, Sae; Tsubokura, Masaharu; Morita, Tomohiro] Soma Cent Hosp, Dept Internal Med, Fukushima, Japan; [Kato, Shigeaki] Soma Cent Hosp, Dept Radiat Protect, Fukushima, Japan; [Iwamoto, Shuichi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gen Internal Med, Hiroshima, Japan; [Ogata, Shinichi] Soso Publ Hlth Inst, Fukushima, Japan; [Hori, Arinobu; Kumakura, Tetsuo] Hibarigaoka Hosp, Dept Psychol, Fukushima, Japan; [Oikawa, Tomoyoshi; Kanazawa, Yukio] Minamisoma Municipal Gen Hosp, Fukushima, Japan; [Kikuchi, Antoku] Onoda Hosp, Fukushima, Japan; [Watanabe, Zenjiro] Kashima Kosei Hosp, Fukushima, Japan; [Kumakawa, Hiromi] Publ Soma Gen Hosp, Fukushima, Japan; [Kuma, Yoshinobu] Publ Soma Gen Hosp, Dept Urol, Fukushima, Japan; [Inomata, Yoshimitsu] Ohmachi Hosp, Fukushima, Japan; [Kami, Masahiro] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Shineha, Ryuzaburo] Soma Cent Hosp, Fukushima, Japan; [Saito, Yasutoshi] Hirata Cent Hosp, Fukushima, Japan	Hiroshima University; University of Tokyo	Ochi, S (corresponding author), Soma Cent Hosp, Dept Internal Med, Fukushima, Japan.	ochisae1024@gmail.com	Ochi, Sae/Y-4753-2018; Tsubokura, Masaharu/D-7300-2017; Tsubokura, Masaharu/AAV-4364-2021	Ochi, Sae/0000-0003-4133-3170; Tsubokura, Masaharu/0000-0001-8027-202X; Tsubokura, Masaharu/0000-0001-8027-202X				Akabayashi A, 2012, CAMB Q HEALTHC ETHIC, V21, P392, DOI 10.1017/S0963180112000126; Barnett DJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-164; Harasawa K, 2012, LANCET, V379, P2240, DOI 10.1016/S0140-6736(12)60978-7; Hayden EC, 2014, NATURE, V514, P15, DOI 10.1038/514015a; Kanazawa Y., 2011, SURG FRONTIER, V18, P39; Kodama Y, 2014, DISASTER MED PUBLIC, V8, P471, DOI 10.1017/dmp.2014.112; Koido YKH, 2011, HOKEN IRYO KAGAKU, V60, P7; MAXWELL C, 1982, AM J PUBLIC HEALTH, V72, P275, DOI 10.2105/AJPH.72.3.275; Ochi S, 2014, PREHOSP DISASTER MED, V29, P245, DOI 10.1017/S1049023X14000521; Ozaki A, 2016, QJM-INT J MED, V109, P353, DOI 10.1093/qjmed/hcw035; Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086; Rubin GJ, 2012, BIOSECUR BIOTERROR, V10, P383, DOI 10.1089/bsp.2012.0043; Sawano T, 2016, J OCCUP HEALTH, V58, P320, DOI 10.1539/joh.15-0292-CS; UNDRR, 2015, SEND FRAM DIS RISK R	14	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164952	10.1371/journal.pone.0164952	http://dx.doi.org/10.1371/journal.pone.0164952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VY	27788170	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900035
J	Puccetti, MV; Fischer, MA; Arrate, MP; Boyd, KL; Duszynski, RJ; Betous, R; Cortez, D; Eischen, CM				Puccetti, M. V.; Fischer, M. A.; Arrate, M. P.; Boyd, K. L.; Duszynski, R. J.; Betous, R.; Cortez, D.; Eischen, C. M.			Defective replication stress response inhibits lymphomagenesis and impairs lymphocyte reconstitution	ONCOGENE			English	Article							ONCOGENE-INDUCED SENESCENCE; IMMUNO-OSSEOUS DYSPLASIA; HEMATOPOIETIC STEM-CELLS; DNA-DAMAGE RESPONSE; SMARCAL1; APOPTOSIS; EXPRESSION; MUTATIONS; HALLMARK; REPAIR	DNA replication stress promotes genome instability in cancer. However, the contribution of the replication stress response to the development of malignancies remains unresolved. The DNA replication stress response protein SMARCAL1 stabilizes DNA replication forks and prevents replication fork collapse, a cause of DNA breaks and apoptosis. While the fork regression/remodeling functions of SMARCAL1 have been investigated, its in vivo functions in replication stress and cancer are unclear. Using a gamma radiation (IR)-induced replication stress T-cell lymphoma mouse model, we observed a significant inhibition of lymphomagenesis in mice lacking one or both alleles of Smarcal1. Notably, a quarter of the Smarcal1-deficient mice did not develop tumors. Moreover, hematopoietic stem/progenitor cells (HSPCs) and developing thymocytes in Smarcal1-deficient mice showed increased DNA damage and apoptosis during the proliferation burst following IR and an impaired ability to repopulate the thymus after IR. Additionally, mice lacking Smarcal1 showed significant HSPC defects when challenged to respond to other replication stress stimuli. Thus, our data reveal the critical function of the DNA replication stress response and, specifically, Smarcal1 in hematopoietic cell survival and tumor development. Our results also provide important insight into the immunodeficiency observed in individuals with mutations in SMARCAL1 by suggesting that it is an HSPC defect.	[Puccetti, M. V.; Fischer, M. A.; Arrate, M. P.; Boyd, K. L.; Duszynski, R. J.; Eischen, C. M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Puccetti, M. V.; Eischen, C. M.] Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Betous, R.; Cortez, D.] Vanderbilt Univ, Dept Biochem, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Jefferson University; Vanderbilt University	Eischen, CM (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, 233S 10th St Bluemle Life Sci Bldg, Philadelphia, PA 19107 USA.	christine.eischen@jefferson.edu	Bétous, Rémy/ABF-4789-2020; Bétous, Rémy/P-2355-2014	Bétous, Rémy/0000-0003-0518-1763; 	Ann Melly Scholarship [F30CA189433, T32GM007347, R01CA160432]; NCI Cancer Center Support Grants [P30CA068485, P30CA056036]; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA160432, F30CA189433, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	Ann Melly Scholarship; NCI Cancer Center Support Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Dr Cornelius Boerkoel for providing the Smarcal1<SUP>+/triangle</SUP> mice, Carol Bansbach for technical assistance with Figure 1b, Catherine Alford for technical assistance with flow cytometry, the Bioimaging Shared Resource of the Sidney Kimmel Cancer Center, and Dr Sandy Zinkel, Dr Scott Hiebert, and members of the Eischen lab for helpful discussions. This work was supported by F30CA189433 (MVP), T32GM007347 (MVP), Ann Melly Scholarship (MVP), R01CA160432 (CME and DC), and NCI Cancer Center Support Grants P30CA068485 and P30CA056036.	Adams PD, 2015, CELL STEM CELL, V16, P601, DOI 10.1016/j.stem.2015.05.002; Alt JR, 2005, J BIOL CHEM, V280, P18771, DOI 10.1074/jbc.M413387200; Alvarez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9548; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Baradaran-Heravi A, 2012, HUM MOL GENET, V21, P2572, DOI 10.1093/hmg/dds083; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Bouska A, 2008, MOL CELL BIOL, V28, P4862, DOI 10.1128/MCB.01584-07; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheshier SH, 2007, STEM CELLS DEV, V16, P707, DOI 10.1089/scd.2007.0017; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KAPLAN HS, 1952, J NATL CANCER I, V13, P185; Keka IS, 2015, NUCLEIC ACIDS RES, V43, P6359, DOI 10.1093/nar/gkv621; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kominami R, 2006, CANCER SCI, V97, P575, DOI 10.1111/j.1349-7006.2006.00218.x; Labi V, 2010, GENE DEV, V24, P1602, DOI 10.1101/gad.1940210; Macheret M, 2015, ANNU REV PATHOL-MECH, V10, P425, DOI 10.1146/annurev-pathol-012414-040424; Michalak EM, 2010, GENE DEV, V24, P1608, DOI 10.1101/gad.1940110; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; Postow L, 2009, J BIOL CHEM, V284, P35951, DOI 10.1074/jbc.M109.048330; Sanyal M, 2015, CLIN IMMUNOL, V161, P355, DOI 10.1016/j.clim.2015.10.005; SPRANGER J, 1991, J PEDIATR-US, V119, P64, DOI 10.1016/S0022-3476(05)81040-6; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	39	14	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 4	2017	36	18					2553	2564		10.1038/onc.2016.408	http://dx.doi.org/10.1038/onc.2016.408			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET9AN	27797382	Green Accepted			2022-12-26	WOS:000400597300006
J	Bracher, S; Schmidt, CC; Dittmer, SI; Jung, H				Bracher, Susanne; Schmidt, Claudia C.; Dittmer, Sophie I.; Jung, Heinrich			Core Transmembrane Domain 6 Plays a Pivotal Role in the Transport Cycle of the Sodium/Proline Symporter PutP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-BINDING SITES; ESCHERICHIA-COLI; NA+/PROLINE TRANSPORTER; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; LIGAND-BINDING; OUTWARD-OPEN; LOOP 4; MECHANISM; NA+	Crystal structures of transporters with a LeuT-type structural fold assign core transmembrane domain 6 (TM6') a central role in substrate binding and translocation. Here, the function of TM6' in the sodium/proline symporter PutP, a member of the solute/sodium symporter family, was investigated. A complete scan of TM6' identified eight amino acids as particularly important for PutP function. Of these residues, Tyr-248, His-253, and Arg-257 impact sodium binding, whereas Arg-257 and Ala-260 may participate in interactions leading to closure of the inner gate. Furthermore, the previous suggestion of an involvement of Trp-244, Tyr-248, and Pro-252 in proline binding is further supported. In addition, substitution of Gly-245, Gly-247, and Gly250 affects the amount of PutP in the membrane. A Cys accessibility analysis suggests an involvement of the inner half of TM6' in the formation of a hydrophilic pathway that is open to the inside in the absence of ligands and closed in the presence of sodium and proline. In conclusion, the results demonstrate that TM6' plays a central role in substrate binding and release on the inner side of the membrane also in PutP and extend the knowledge on functionally relevant amino acids in transporters with a LeuT-type structural fold.	[Bracher, Susanne; Schmidt, Claudia C.; Dittmer, Sophie I.; Jung, Heinrich] Ludwig Maximilians Univ Munchen, Dept Biol 1, Div Microbiol, D-82152 Martinsried, Germany	University of Munich	Jung, H (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 1, Div Microbiol, D-82152 Martinsried, Germany.	hjung@lmu.de	Jung, Heinrich/K-3790-2014	Jung, Heinrich/0000-0002-5450-3063; Schmidt, Claudia/0000-0002-7642-7081	Deutsche Forschungsgemeinschaft [JU 333/4-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Project JU 333/4-2. The authors declare that they have no conflicts of interest with the contents of this article.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Bracher S, 2016, J BIOL CHEM, V291, P4998, DOI 10.1074/jbc.M115.675306; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Hilger D, 2008, J BIOL CHEM, V283, P4921, DOI 10.1074/jbc.M706741200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jung H, 1998, J BIOL CHEM, V273, P26400, DOI 10.1074/jbc.273.41.26400; Jung H, 1998, BIOCHEMISTRY-US, V37, P11083, DOI 10.1021/bi980684b; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Jung H, 2012, FRONT BIOSCI-LANDMRK, V17, P745, DOI 10.2741/3955; Khafizov K, 2012, P NATL ACAD SCI USA, V109, pE3035, DOI 10.1073/pnas.1209039109; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Li Z, 2015, J BIOL CHEM, V290, P127, DOI 10.1074/jbc.M114.584383; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Olkhova E, 2011, J MOL BIOL, V406, P59, DOI 10.1016/j.jmb.2010.11.045; Penmatsa A, 2014, J PHYSIOL-LONDON, V592, P863, DOI 10.1113/jphysiol.2013.259051; Perez C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5231; Perez C, 2013, BIOL CHEM, V394, P641, DOI 10.1515/hsz-2012-0336; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirch T, 2003, J BIOL CHEM, V278, P42942, DOI 10.1074/jbc.M308253200; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; Portulano C, 2014, ENDOCR REV, V35, P106, DOI 10.1210/er.2012-1036; Quick M, 1996, EUR J BIOCHEM, V239, P732, DOI 10.1111/j.1432-1033.1996.0732u.x; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Quick M, 2015, VITAM HORM, V98, P63, DOI 10.1016/bs.vh.2014.12.003; Raba M, 2008, J MOL BIOL, V382, P884, DOI 10.1016/j.jmb.2008.07.070; Raba M, 2014, STRUCTURE, V22, P769, DOI 10.1016/j.str.2014.03.011; REIZER J, 1994, BBA-REV BIOMEMBRANES, V1197, P133, DOI 10.1016/0304-4157(94)90003-5; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STALMACH ME, 1983, J BACTERIOL, V156, P481, DOI 10.1128/JB.156.2.481-486.1983; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yamato I., 1993, ALKALI CATION TRANSP, P53; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	47	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26208	26215		10.1074/jbc.M116.753103	http://dx.doi.org/10.1074/jbc.M116.753103			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27793991	Green Published, hybrid			2022-12-26	WOS:000390345200036
J	Candeloro, L; Savini, L; Conte, A				Candeloro, Luca; Savini, Lara; Conte, Annamaria			A New Weighted Degree Centrality Measure: The Application in an Animal Disease Epidemic	PLOS ONE			English	Article							NETWORK ANALYSIS; STRENGTH	In recent years researchers have investigated a growing number of weighted heterogeneous networks, where connections are not merely binary entities, but are proportional to the intensity or capacity of the connections among the various elements. Different degree centrality measures have been proposed for this kind of networks. In this work we propose weighted degree and strength centrality measures (WDC and WSC). Using a reducing factor we correct classical centrality measures (CD) to account for tie weights distribution. The bigger the departure from equal weights distribution, the greater the reduction. These measures are applied to a real network of Italian livestock movements as an example. A simulation model has been developed to predict disease spread into Italian regions according to animal movements and animal population density. Model's results, expressed as infected regions and number of times a region gets infected, were related to weighted and classical degree centrality measures. WDC and WSC were shown to be more efficient in predicting node's risk and vulnerability. The proposed measures and their application in an animal network could be used to support surveillance and infection control strategy plans.	[Candeloro, Luca; Savini, Lara; Conte, Annamaria] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Stat & GIS Dept, Teramo, Italy	IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Candeloro, L (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Stat & GIS Dept, Teramo, Italy.	l.candeloro@izs.it	Conte, Annamaria/H-5869-2016; Candeloro, Luca/ABA-6009-2021; Savini, Lara LS/C-2851-2018	Conte, Annamaria/0000-0001-6975-2698; Candeloro, Luca/0000-0001-8475-3787; Savini, Lara LS/0000-0001-6175-7793				Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Buttner K, 2013, PREV VET MED, V110, P418, DOI 10.1016/j.prevetmed.2013.01.008; Campbell E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01905; Chen S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04472; Cormen Thomas H., 2009, INTRO ALGORITHMS; Freeman L., 2004, DEV SOCIAL NETWORK A; FREEMAN LC, 1991, SOC NETWORKS, V13, P141, DOI 10.1016/0378-8733(91)90017-N; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Karlberg M, 1997, SOC NETWORKS, V19, P325, DOI 10.1016/S0378-8733(97)00001-4; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Leinhardt S., 1977, SOCIAL NETWORKS DEV, pxiii; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nieminen U.J., 1973, SOC SCI RES, V2, P371, DOI [10.1016/0049-089X(73)90010-0, DOI 10.1016/0049-089X(73)90010-0]; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Scott J., 2000, SOCIAL STRUCTURE, V2nd; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Yang S, 2001, SOC NETWORKS, V23, P285, DOI 10.1016/S0378-8733(01)00043-0	22	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165781	10.1371/journal.pone.0165781	http://dx.doi.org/10.1371/journal.pone.0165781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802327	Green Submitted, Green Published, gold			2022-12-26	WOS:000386714200053
J	Lobel, U; Forkert, ND; Schmitt, P; Dohrmann, T; Schroeder, M; Magnus, T; Kluge, S; Weiler-Normann, C; Bi, XM; Fiehler, J; Sedlacik, J				Loebel, Ulrike; Forkert, Nils Daniel; Schmitt, Peter; Dohrmann, Torsten; Schroeder, Maria; Magnus, Tim; Kluge, Stefan; Weiler-Normann, Christina; Bi, Xiaoming; Fiehler, Jens; Sedlacik, Jan			Cerebral Hemodynamics in Patients with Hemolytic Uremic Syndrome Assessed by Susceptibility Weighted Imaging and Four-Dimensional Non-Contrast MR Angiography	PLOS ONE			English	Article							ESCHERICHIA-COLI; CARBON-DIOXIDE; BLOOD-FLOW; 4D MRA; CHILDREN; 3D; QUANTIFICATION; ENHANCEMENT; INFECTION; PROPOFOL	Background and Purpose Conventional magnetic resonance imaging (MRI) of patients with hemolytic uremic syndrome (HUS) and neurological symptoms performed during an epidemic outbreak of Escherichia coli O104:H4 in Northern Europe has previously shown pathological changes in only approximately 50% of patients. In contrast, susceptibility-weighted imaging (SWI) revealed a loss of venous contrast in a large number of patients. We hypothesized that this observation may be due to an increase in cerebral blood flow (CBF) and aimed to identify a plausible cause. Materials and Methods Baseline 1.5T MRI scans of 36 patients (female, 26; male, 10; mean age, 38.2 +/- 19.3 years) were evaluated. Venous contrast was rated on standard SWI minimum intensity projections. A prototype four-dimensional (time resolved) magnetic resonance angiography (4D MRA) assessed cerebral hemodynamics by global time-to-peak (TTP), as a surrogate marker for CBF. Clinical parameters studied were hemoglobin, hematocrit, creatinine, urea levels, blood pressure, heart rate, and end-tidal CO2. Results SWI venous contrast was abnormally low in 33 of 36 patients. TTP ranged from 3.7 to 10.2 frames (mean, 7.9 +/- 1.4). Hemoglobin at the time of MRI (n = 35) was decreased in all patients (range, 5.0 to 12.6 g/dL; mean, 8.2 +/- 1.4); hematocrit (n = 33) was abnormally low in all but a single patient (range, 14.3 to 37.2%; mean, 23.7 +/- 4.2). Creatinine was abnormally high in 30 of 36 patients (83%) (range, 0.8 to 9.7; mean, 3.7 +/- 2.2). SWI venous contrast correlated significantly with hemoglobin (r = 0.52, P = 0.0015), hematocrit (r = 0.65, P < 0.001), and TTP (r = 0.35, P = 0.036). No correlation of SWI with blood pressure, heart rate, end-tidal CO2, creatinine, and urea level was observed. Findings suggest that the loss of venous contrast is related to an increase in CBF secondary to severe anemia related to HUS. SWI contrast of patients with pathological conventional MRI findings was significantly lower compared to patients with normal MRI (mean SWI score, 1.41 and 2.05, respectively; P = 0.04). In patients with abnormal conventional MRI, mean TTP (7.45), mean hemoglobin (7.65), and mean hematocrit (22.0) were lower compared to patients with normal conventional MRI scans (mean TTP = 8.28, mean hemoglobin = 8.63, mean hematocrit = 25.23). Conclusion In contrast to conventional MRI, almost all patients showed pathological changes in cerebral hemodynamics assessed by SWI and 4D MRA. Loss of venous contrast on SWI is most likely the result of an increase in CBF and may be related to the acute onset of anemia. Future studies will be needed to assess a possible therapeutic effect of blood transfusions in patients with HUS and neurological symptoms.	[Loebel, Ulrike; Fiehler, Jens; Sedlacik, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Forkert, Nils Daniel] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Forkert, Nils Daniel] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Schmitt, Peter] Siemens Hlth Care, Erlangen, Germany; [Dohrmann, Torsten; Schroeder, Maria; Kluge, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care, Hamburg, Germany; [Magnus, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Weiler-Normann, Christina] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Hamburg, Germany; [Weiler-Normann, Christina] Univ Med Ctr Hamburg Eppendorf, Martin Zeitz Ctr Rare Dis, Hamburg, Germany; [Bi, Xiaoming] Siemens Healthcare, Los Angeles, CA USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Calgary; University of Calgary; Siemens AG; Siemens Germany; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Siemens AG	Lobel, U (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	u.loebel@uke.de	Forkert, Nils Daniel/K-6273-2012	Forkert, Nils Daniel/0000-0003-2556-3224	Siemens Healthcare	Siemens Healthcare(Siemens AG)	For Xiaoming Bi and Peter Schmitt: The funder (Siemens Healthcare) provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhoum S, 2015, J CEREBR BLOOD F MET, V35, P1616, DOI 10.1038/jcbfm.2015.96; Bauer A, 2014, PEDIATR NEPHROL, V29, P1607, DOI 10.1007/s00467-014-2803-x; Bi XM, 2010, MAGN RESON MED, V63, P835, DOI 10.1002/mrm.22220; Braune SA, 2013, CRIT CARE MED, V41, P1702, DOI 10.1097/CCM.0b013e31828a24a8; Dhar R, 2009, STROKE, V40, P3039, DOI 10.1161/STROKEAHA.109.556159; Fan AP, 2015, NEUROIMAGE, V104, P146, DOI 10.1016/j.neuroimage.2014.09.068; Forkert ND, 2011, METHOD INFORM MED, V50, P74, DOI 10.3414/ME10-02-0003; Forkert ND, 2013, MAGN RESON IMAGING, V31, P262, DOI 10.1016/j.mri.2012.07.008; Forkert ND, 2012, J MAGN RESON IMAGING, V36, P443, DOI 10.1002/jmri.23652; Forkert ND, 2011, MAGN RESON MED, V65, P289, DOI 10.1002/mrm.22583; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; GALLO GE, 1995, PEDIATR NEPHROL, V9, P117, DOI 10.1007/BF00858990; Ge YL, 2009, J MAGN RESON IMAGING, V29, P1190, DOI 10.1002/jmri.21758; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Hagel C, 2015, BRAIN PATHOL, V25, P146, DOI 10.1111/bpa.12166; Harreld JH, 2013, NEURORADIOLOGY, V55, P1049, DOI 10.1007/s00234-013-1187-0; Karsli C, 2003, ANESTH ANALG, V97, P694, DOI 10.1213/01.ANE.0000074235.81165.AF; Kuroda M, 2015, NEUROCHEM INT, V85-86, P24, DOI 10.1016/j.neuint.2015.04.003; Kuwabara Y, 2002, KIDNEY INT, V61, P564, DOI 10.1046/j.1523-1755.2002.00142.x; Lobel U, 2014, CLIN NEURORADIOL, V24, P111, DOI 10.1007/s00062-013-0231-0; Loos S, 2012, CLIN INFECT DIS, V55, P753, DOI 10.1093/cid/cis531; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; Mandler JM, 2002, BRAIN DAM B, P315, DOI 10.1016/B978-012693019-1/50015-0; Morimoto Y, 2001, J NEUROSURG ANESTH, V13, P33, DOI 10.1097/00008506-200101000-00006; Navarro-Garcia F, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0008-2013; Page AV, 2013, J INFECT DIS, V208, P929, DOI 10.1093/infdis/jit268; Sedlacik J, 2010, AM J NEURORADIOL, V31, P901, DOI 10.3174/ajnr.A1960; Shimizu M, 2017, CLIN EXP NEPHROL, V21, P76, DOI 10.1007/s10157-016-1254-z; Shimizu M, 2014, CYTOKINE, V66, P1, DOI 10.1016/j.cyto.2013.12.005; Shiraishi M, 2008, J NEUROIMMUNOL, V196, P147, DOI 10.1016/j.jneuroim.2008.02.012; Ullrich S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055278; Winchell AM, 2014, AM J NEURORADIOL, V35, P1016, DOI 10.3174/ajnr.A3794	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0164863	10.1371/journal.pone.0164863	http://dx.doi.org/10.1371/journal.pone.0164863			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802295	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200011
J	Niebuhr, CN; Poulin, R; Tompkins, DM				Niebuhr, Chris N.; Poulin, Robert; Tompkins, Daniel M.			Is Avian Malaria Playing a Role in Native Bird Declines in New Zealand? Testing Hypotheses along an Elevational Gradient	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; APAPANE HIMATIONE-SANGUINEA; PARASITES PLASMODIUM SPP.; EVOLUTIONARY RELATIONSHIPS; MOHOUA-OCHROCEPHALA; FOREST BIRDS; DIVERSITY; BLOOD; PATHOGENICITY; PREVALENCE	The mosquito-borne disease avian malaria (Plasmodium spp.) has impacted both captive populations and wild individuals of native New Zealand bird species. However, whether or not it is a cause of concern to their wild populations is still unclear. In Hawaii, the disease has been a major factor in the population declines of some native forest bird species, often limiting their elevational distribution due to an inverse relationship between force of infection and elevation. While studies have investigated latitudinal patterns of infection in New Zealand, elevational patterns are unexplored. To address this, a survey was conducted in Nelson Lakes National Park, a site experiencing native bird declines in which disease has been suggested as playing a role, to investigate whether there is a similar inverse relationship in New Zealand. Results from blood samples (n = 436) collected over three seasons across a broad elevational range (650-1400 m) support there being such a relationship. In addition, an overall higher prevalence in non-native (14.1%) versus native birds (1.7%) may indicate differential impacts on these two groups, while particularly high prevalence in non-native Turdus spp. supports previous suggestions that they are key reservoir hosts for the disease. Overall, these findings add weight to the hypothesis that avian malaria is playing a role in ongoing declines of native New Zealand birds.	[Niebuhr, Chris N.; Poulin, Robert] Univ Otago, Dept Zool, Dunedin, New Zealand; [Tompkins, Daniel M.] Landcare Res, Dunedin, New Zealand	University of Otago; Landcare Research - New Zealand	Niebuhr, CN (corresponding author), Univ Otago, Dept Zool, Dunedin, New Zealand.	chris.niebuhr@postgrad.otago.ac.nz	Poulin, Robert/C-3117-2008; Poulin, Robert/GQO-8936-2022	Poulin, Robert/0000-0003-1390-1206; Poulin, Robert/0000-0003-1390-1206; Niebuhr, Chris/0000-0002-8892-3605	University of Otago Doctoral Scholarship; University of Otago Postgraduate Publishing Bursary; New Zealand Department of Conservation	University of Otago Doctoral Scholarship; University of Otago Postgraduate Publishing Bursary; New Zealand Department of Conservation	CNN was supported by a University of Otago Doctoral Scholarship and a University of Otago Postgraduate Publishing Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to the New Zealand Department of Conservation and the staff of Nelson Lakes National Park for their support and assistance, especially Jenny Long, John Henderson, and Nik Joice. Additional thanks are necessary for Clare Cross and Kevin Drew for their assistance in the field and Isa Blasco-Costa for her guidance in the laboratory.	Ahumada JA, 2004, J MED ENTOMOL, V41, P1157, DOI 10.1603/0022-2585-41.6.1157; Alley MR, 2008, NEW ZEAL VET J, V56, P247, DOI 10.1080/00480169.2008.36842; Alley MRM, 2012, KOKAKO, V19, P11; Atkinson CT, 2010, J AVIAN BIOL, V41, P357, DOI 10.1111/j.1600-048X.2009.04915.x; Atkinson CT, 2009, J AVIAN MED SURG, V23, P53, DOI 10.1647/2008-059.1; Atkinson CT, 1995, PARASITOLOGY, V111, pS59, DOI 10.1017/S003118200007582X; Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; Atkinson CT, 2001, CONDOR, V103, P209, DOI 10.1650/0010-5422(2001)103[0209:PSRADO]2.0.CO;2; Baillie SM, 2011, PARASITOLOGY, V138, P1843, DOI 10.1017/S0031182011001491; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; BELKIN J N, 1968, Contributions of the American Entomological Institute, V3, P1; Bensch S, 2007, J ANIM ECOL, V76, P112, DOI 10.1111/j.1365-2656.2006.01176.x; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Castro I, 2011, J WILDLIFE DIS, V47, P860, DOI 10.7589/0090-3558-47.4.860; Crump JA, 2001, EMERG INFECT DIS, V7, P767; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DAWSON D G, 1978, Notornis, V25, P257; Derraik JGB, 2008, J ROY SOC NEW ZEAL, V38, P237, DOI 10.1080/03014220809510558; Elliott GP, 2010, BIOL CONSERV, V143, P2119, DOI 10.1016/j.biocon.2010.05.022; Ewen JG, 2012, ECOL LETT, V15, P1112, DOI 10.1111/j.1461-0248.2012.01833.x; GREENWOOD PJ, 1976, J ANIM ECOL, V45, P887, DOI 10.2307/3587; Grimaldi WW, 2015, POLAR BIOL, V38, P591, DOI 10.1007/s00300-014-1632-5; Harper G, 2014, ROTOITI NATURE RECOV; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2011, J WILDLIFE DIS, V47, P849, DOI 10.7589/0090-3558-47.4.849; HOLDAWAY RN, 1990, NEW ZEAL J ZOOL, V17, P309, DOI 10.1080/03014223.1990.10422938; Howe L, 2012, PARASITOL RES, V110, P913, DOI 10.1007/s00436-011-2577-z; Ishtiaq F, 2006, P ROY SOC B-BIOL SCI, V273, P587, DOI 10.1098/rspb.2005.3313; Jahn P, 2013, NOTORNIS, V60, P201; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; Lowry R., 2004, VASSARSTATS WEBSITE; McCallum H, 2005, CONSERV BIOL, V19, P1421, DOI 10.1111/j.1523-1739.2005.00217.x; Moller AP, 2007, ECOLOGY, V88, P871, DOI 10.1890/06-0747; Niebuhr CN, 2016, PARASITOL RES, V115, P3905, DOI 10.1007/s00436-016-5157-4; Niebuhr CN, 2016, THESIS; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; Schoener ER, 2014, NEW ZEAL VET J, V62, P189, DOI 10.1080/00480169.2013.871195; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Sijbranda DC, 2016, N Z J ECOL, V40, P72; Sturrock HJW, 2008, NEW ZEAL J ECOL, V32, P98; Tompkins DM, 2006, ECOL STU AN, V186, P67; Tompkins DM, 2006, J ROY SOC NEW ZEAL, V36, P51, DOI 10.1080/03014223.2006.9517799; Tompkins DM, 2015, TRENDS PARASITOL, V31, P149, DOI 10.1016/j.pt.2015.01.007; Tompkins DM, 2011, BIOL CONSERV, V144, P668, DOI 10.1016/j.biocon.2010.09.027; Valkinas G., 2005, AVIAN MALARIA PARASI; Williams RB, 2005, AVIAN PATHOL, V34, P29, DOI 10.1080/03079450400025430; Yorinks N, 2000, AUK, V117, P731, DOI 10.1642/0004-8038(2000)117[0731:EOMOAB]2.0.CO;2	50	25	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165918	10.1371/journal.pone.0165918	http://dx.doi.org/10.1371/journal.pone.0165918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802326	Green Submitted, gold, Green Published			2022-12-26	WOS:000386714200068
J	Guo, JZ; Zhao, W; Zhan, SY; Li, L; Zhong, T; Wang, LJ; Dong, Y; Zhang, HP				Guo, Jiazhong; Zhao, Wei; Zhan, Siyuan; Li, Li; Zhong, Tao; Wang, Linjie; Dong, Yao; Zhang, Hongping			Identification and Expression Profiling of miRNAome in Goat longissimus dorsi Muscle from Prenatal Stages to a Neonatal Stage	PLOS ONE			English	Article							SKELETAL-MUSCLE; DIFFERENTIAL EXPRESSION; MICRORNAS; TRANSCRIPTOME; PROLIFERATION; MUTATION; CLUSTER	Skeletal muscle development is a complex biological process regulated by numerous genes and non-coding RNAs, such as microRNAs (miRNAs). In the current study, we made use of the deep sequencing data from Jianzhou Da'er goat longissimus dorsi sampled on days 45, 60, and 105 of gestation, as well as day three after birth to identify miRNAs that regulate goat skeletal myogenesis, and examine their temporal expression profiles. A total of 410 known goat miRNAs, 752 miRNA homologs and 88 novel miRNAs were identified across four stages. Besides three myomiRs, the abundance of 17 miRNAs, including chi-miR-424, chi-miR-542-3p and chi-miR-136-5p was more than 10,000 reads per million mapped reads (RPM), on average. Furthermore, 50 miRNAs with more than 100 RPM clustered at the imprinted DLK1-DIO3 locus on chromosome 21 and showed similar expression patterns, indicating that these miRNAs played important roles in skeletal myogenesis of goats. Based on pairwise comparisons, 221 differentially expressed (DE), known miRNAs were identified across four stages. GO and KEGG analyses of the genes targeted by the DE miRNAs revealed the significantly enriched processes and pathways to be consistent with temporal changes of skeletal muscle development across all sampled stages. However, follow-up experimental studies were required to explore functions of these miRNAs and targets underlying skeletal myogenesis.	[Guo, Jiazhong; Zhao, Wei; Zhan, Siyuan; Li, Li; Zhong, Tao; Wang, Linjie; Dong, Yao; Zhang, Hongping] Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu 611130, Peoples R China	Sichuan Agricultural University	Zhang, HP (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu 611130, Peoples R China.		Li, Li/T-4353-2017; ZHAN, SIYUAN/M-6948-2019	Li, Li/0000-0003-2459-3499; ZHAN, SIYUAN/0000-0003-3449-9682; Guo, Jiazhong/0000-0001-9773-2280	Sichuan Province Science and Technology Support Program (Science & Technology Department of Sichuan Province), China [2014NZ0077, 2015NZ0112, 16ZC2849]	Sichuan Province Science and Technology Support Program (Science & Technology Department of Sichuan Province), China	This work was supported by Sichuan Province Science and Technology Support Program (Science & Technology Department of Sichuan Province), China (2014NZ0077, 2015NZ0112 and 16ZC2849). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif M, 2012, CIRC RES, V110, P638, DOI 10.1161/CIRCRESAHA.111.247437; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Du M, 2010, J ANIM SCI, V88, pE51, DOI 10.2527/jas.2009-2311; Du M, 2010, BIOL REPROD, V82, P4, DOI 10.1095/biolreprod.109.077099; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gao YQ, 2015, P NATL ACAD SCI USA, V112, P13627, DOI 10.1073/pnas.1511448112; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kim JY, 2014, AGING-US, V6, P524, DOI 10.18632/aging.100677; Kozomara A., 2010, NUCLEIC ACIDS RES; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krawczynski K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2172-2; Krist B, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/281756; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052388; Liu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050001; Ma JD, 2015, INT J MOL SCI, V16, P9635, DOI 10.3390/ijms16059635; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Mercken EM, 2013, AGING-US, V5, P692, DOI 10.18632/aging.100598; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Poy MN, 2009, P NATL ACAD SCI, V106; Qin LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072418; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Tam S., 2015, BRIEFINGS IN BIOINFO; Wojcicka A, 2014, INT J BIOCHEM CELL B, V53, P208, DOI 10.1016/j.biocel.2014.05.020; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yuan C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-511; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zuo JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124873	51	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165764	10.1371/journal.pone.0165764	http://dx.doi.org/10.1371/journal.pone.0165764			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798673	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100063
J	Urban, AE; Quick, EO; Miller, KP; Krcmery, J; Simon, HG				Urban, Alexander E.; Quick, Erin O.; Miller, Kaylie P.; Krcmery, Jennifer; Simon, Hans-Georg			Pdlim7 Regulates Arf6-Dependent Actin Dynamics and Is Required for Platelet-Mediated Thrombosis in Mice	PLOS ONE			English	Article							PDZ-LIM PROTEIN; STRESS FIBER FORMATION; HEART DEVELOPMENT; DOMAIN PROTEIN; ALPHA-ACTININ; F-ACTIN; SUBCELLULAR-LOCALIZATION; P21-ACTIVATED KINASE; INTEGRIN ACTIVATION; BINDING-PROTEIN	Upon vessel injury, platelets become activated and rapidly reorganize their actin cytoskeleton to adhere to the site of endothelial damage, triggering the formation of a fibrin-rich plug to prevent further blood loss. Inactivation of Pdlim7 provides the new perspective that regulation of actin cytoskeletal changes in platelets is dependent on the encoded PDZ-LIM protein. Loss-of-function of Pdlim7 triggers hypercoagulopathy and causes significant perinatal lethality in mice. Our in vivo and in vitro studies reveal that Pdlim7 is dynamically distributed along actin fibers, and lack of Pdlim7 leads to a marked inability to rearrange the actin cytoskeleton. Specifically, the absence of Pdlim7 prevents platelets from bundling actin fibers into a concentric ring that defines the round spread shape of activated platelets. Similarly, in mouse embryonic fibroblasts, loss of Pdlim7 abolishes the formation of stress fibers needed to adopt the typical elongated fibroblast shape. In addition to revealing a fundamental cell biological role in actin cytoskeletal organization, we also demonstrate a function of Pdlim7 in regulating the cycling between the GTP/GDP-bound states of Arf6. The small GTPase Arf6 is an essential factor required for actin dynamics, cytoskeletal rearrangements, and platelet activation. Consistent with our findings of significantly elevated initial F-actin ratios and subsequent morphological aberrations, loss of Pdlim7 causes a shift in balance towards an increased Arf6-GTP level in resting platelets. These findings identify a new Pdlim7-Arf6 axis controlling actin dynamics and implicate Pdlim7 as a primary endogenous regulator of platelet-dependent hemostasis.	[Simon, Hans-Georg] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; Stanley Manne Childrens Res Inst, Chicago, IL USA	Northwestern University; Feinberg School of Medicine	Simon, HG (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.	hgsimon@northwestern.edu			National Heart, Lung, and Blood institute [F31HL090031]; Children's Research Fund; Lurie Children's Hospital Research Center Pilot Grant; Family of Michael P. Polsky; Stanley Manne Children's Research Institute pilot grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL090031] Funding Source: NIH RePORTER	National Heart, Lung, and Blood institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Children's Research Fund; Lurie Children's Hospital Research Center Pilot Grant; Family of Michael P. Polsky; Stanley Manne Children's Research Institute pilot grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood institute (Grant F31HL090031), the Children's Research Fund (To J. Krcmery), the Lurie Children's Hospital Research Center Pilot Grant, and The Family of Michael P. Polsky (to HG Simon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Claudia Guzman, Brandon Holtrup, and Devin Midura for expert technical assistance. We are grateful to Dr. Gilbert White II for sharing materials, analysis tools as well as expertise on platelet biology, and to Dr. Shannon Odelberg for advice on Arfo methodology. Drs. John Crispino, and Hau Kwaan for inspiring discussions. Finally, we would like to thank Drs. Michael Kluppel and Shannon Odelberg for constructive criticism and reading of the manuscript. We also thank Joshua Z. Rappoport, Constadina Arvanitis, and David Kirchenbuchler from The Center for Advanced Microscopy and Nikon Imaging Center for assistance with SIM super-resolution microscopy, live-cell TIRF-SIM imaging and analysis of data. We also thank the Stanley Manne Children's Research Institute Microscope facility and William Goossens for continued support with imaging and data analysis. This work was supported by the National Heart, Lung, and Blood Institute Grant F31HL090031 and the Children's Research Fund (to J. Krcmery), and Stanley Manne Children's Research Institute pilot grant and The Family of Michael P. Polsky (to H.-G. Simon).	Akbar H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022117; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bauer K, 2000, BLOOD, V96, P4236; Bearer EL, 2002, INT REV CYTOL, V217, P137; Bimber B, 2007, DEV BIOL, V302, P230, DOI 10.1016/j.ydbio.2006.09.023; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Calaminus SDJ, 2007, J THROMB HAEMOST, V5, P535, DOI 10.1111/j.1538-7836.2007.02377.x; Camarata T, 2006, J CELL BIOL, V174, P339, DOI 10.1083/jcb.200511109; Camarata T, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-104; Camarata T, 2010, DEV BIOL, V337, P233, DOI 10.1016/j.ydbio.2009.10.039; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Estevez B, 2013, BLOOD, V121, P4586, DOI 10.1182/blood-2012-12-470765; FOX JEB, 1993, THROMB HAEMOSTASIS, V70, P884; Fox JEB, 2001, THROMB HAEMOSTASIS, V86, P198; Freshney R.I, 2010, CULTURE ANIMAL CELLS, Vsixth, P732; Grossmann AH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003398; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Gupta S, 2012, CIRC RES, V111, P1410, DOI 10.1161/CIRCRESAHA.112.264754; Hartwig JH, 1999, THROMB HAEMOSTASIS, V82, P392; Huang YJ, 2016, BLOOD, V127, P1459, DOI [10.1182/blood-2015-05648550, 10.1182/blood-2015-05-648550]; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; KARLSSON R, 1984, J CELL PHYSIOL, V121, P96, DOI 10.1002/jcp.1041210113; Krause A, 2004, DEV BIOL, V273, P106, DOI 10.1016/j.ydbio.2004.05.024; Krcmery J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080809; Krcmery J, 2010, BIOESSAYS, V32, P100, DOI 10.1002/bies.200900148; Kulisz A, 2008, MOL CELL BIOL, V28, P1553, DOI 10.1128/MCB.00935-07; Lemieux MG, 2014, CYTOSKELETON, V71, P157, DOI 10.1002/cm.21160; Li Z, 2002, BLOOD, V99, P4466, DOI 10.1182/blood.V99.12.4466; Lodish H, 2000, MOL CELL BIOL; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Miyazaki K, 2012, EXP CELL RES, V318, P1716, DOI 10.1016/j.yexcr.2012.05.006; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; NACHMIAS VT, 1991, CELL MOTIL CYTOSKEL, V20, P190, DOI 10.1002/cm.970200303; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Ott EB, 2008, DEV DYNAM, V237, P3940, DOI 10.1002/dvdy.21807; Pandey D, 2006, BLOOD, V107, P575, DOI 10.1182/blood-2004-11-4377; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; Pomies P, 1999, J BIOL CHEM, V274, P29242, DOI 10.1074/jbc.274.41.29242; Poulter NS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8254; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Schachtner H, 2012, EUR J CELL BIOL, V91, P923, DOI 10.1016/j.ejcb.2012.04.002; Suzuki-Inoue K, 2001, BLOOD, V98, P3708, DOI 10.1182/blood.V98.13.3708; Takubo T, 1998, BIOTECH HISTOCHEM, V73, P310, DOI 10.3109/10520299809141124; Tamura N, 2007, BIOCHEM BIOPH RES CO, V364, P589, DOI 10.1016/j.bbrc.2007.10.064; Tanaka-Okamoto M, 2009, CANCER SCI, V100, P608, DOI 10.1111/j.1349-7006.2009.01091.x; Torrado M, 2004, INVEST OPHTH VIS SCI, V45, P3955, DOI 10.1167/iovs.04-0721; Vallenius T, 2004, EXP CELL RES, V293, P117, DOI 10.1016/j.yexcr.2003.09.004; van der Meer DLM, 2006, DEV BIOL, V299, P356, DOI 10.1016/j.ydbio.2006.07.032; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	59	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0164042	10.1371/journal.pone.0164042	http://dx.doi.org/10.1371/journal.pone.0164042			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792740	Green Published, gold, Green Submitted			2022-12-26	WOS:000389537000004
J	Ogoina, D; Oyeyemi, AS; Ayah, O; Onabor, AA; Midia, A; Olomo, WT; Kunle-Olowu, OE				Ogoina, Dimie; Oyeyemi, Abisoye Sunday; Ayah, Okubusa; Onabor, Austin A.; Midia, Adugo; Olomo, Wisdom Tudou; Kunle-Olowu, Onyaye E.			Preparation and Response to the 2014 Ebola Virus Disease Epidemic in Nigeria-The Experience of a Tertiary Hospital in Nigeria	PLOS ONE			English	Article							PREPAREDNESS; LESSONS; OUTBREAK; HEALTH; COMMUNITY	Introduction The 2014 Ebola Virus Disease (EVD) outbreak elicited global attention and challenged health systems around the world, Nigeria inclusive. We hereby report the preparation and response to the outbreak by a tertiary teaching hospital in Bayelsa State, Nigeria. Method Between 4th August and 31st October 2014, we conducted a mixed cross sectional and qualitative study to ascertain the EVD-related fear, myths and misconceptions among healthcare workers (HCWs), and to evaluate the plans, activities and challenges faced by the hospital during the outbreak. Data was collected using a self-administered questionnaire as well as by documented observations during the outbreak. HCWs were asked to rate their fear of EVD from 1 (no fear) to 10 (highest fear). Results Out of 189 respondents, majority (> 75%) reported uncertainty about the myth that EVD can be prevented by drinking salt water or eating Garcinia kola, while 82% of respondents believed that EVD can be prevented by avoiding crowded places. About 40% of respondents expressed fear ratings of EVD of >= 7 out of 10. In response to the outbreak, the hospital established an EVD response team, organised EVD-sensitization and training programmes and commenced routine EVD surveillance activities. An EVD-isolation ward was constructed from an existing ward, a field incinerator was designed, hand sanitizers were produced locally and personal protective equipment were procured. No case of EVD was reported in the hospital, although three false alarms caused panic. Some HCWs adopted overly protective and avoidance behaviours, but these behaviours were abandoned after the outbreak was declared over. Conclusion Our results suggest that the fear, myth and misconceptions were common among HCW during the outbreak. The EVD outbreak, however, helped to strengthen gaps in infection control and emergency preparedness in the hospital. Strategies to allay fear are required to contain future outbreaks of EVD in Nigeria hospitals.	[Ogoina, Dimie] Niger Delta Univ, Niger Delta Univ Teaching Hosp, Dept Internal Med, Yenagoa, Bayelsa State, Nigeria; [Oyeyemi, Abisoye Sunday] Niger Delta Univ, Niger Delta Univ Teaching Hosp, Dept Community Med, Yenagoa, Bayelsa State, Nigeria; [Ayah, Okubusa; Olomo, Wisdom Tudou] Niger Delta Univ Teaching Hosp, Dept Nursing Serv, Okolobiri, Bayelsa State, Nigeria; [Onabor, Austin A.; Midia, Adugo] Niger Delta Univ Teaching Hosp, Dept Pharm, Okolobiri, Bayelsa State, Nigeria; [Kunle-Olowu, Onyaye E.] Niger Delta Univ, Niger Delta Univ Teaching Hosp, Dept Paediat, Yenagoa, Bayelsa State, Nigeria		Ogoina, D (corresponding author), Niger Delta Univ, Niger Delta Univ Teaching Hosp, Dept Internal Med, Yenagoa, Bayelsa State, Nigeria.	dimieogoina@gmail.com	Ogoina, Dimie/H-4091-2019	Ogoina, Dimie/0000-0002-2098-6300				Adongo PB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149627; Aliyu A, 2014, VANGUARD NEWS; Asuzu MC, 2015, J PUBLIC HEALTH POL, V36, P251, DOI 10.1057/jphp.2015.2; Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859; de Jong MD, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.48.20980; De Roo A, 1998, TROP MED INT HEALTH, V3, P883; Eziukwu A, 2014, PREM TIMES; Fasina FO, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.40.20920; Federal Ministry of Health N, 2014, EB RES HEALTHW; Federal Ministry of Health Nigeria, 2014, STAT EB VIR DIS NIG; Federal Ministry of Health Nigeria, 2014, INF CONTR SCREEN EB; Federal Ministry of Health Nigeria, 2014, LEAD MULT TEAMW KEY; Hall RCW, 2008, GEN HOSP PSYCHIAT, V30, P446, DOI 10.1016/j.genhosppsych.2008.05.003; Kpanake L, 2016, J PUBLIC HEALTH POL, V37, P160, DOI 10.1057/jphp.2016.1; Martin TCS, 2015, J HOSP INFECT, V91, P11, DOI 10.1016/j.jhin.2015.04.021; Morgan DJ, 2015, INFECT CONT HOSP EP, V36, P627, DOI 10.1017/ice.2015.61; Murdock H., 2014, VOICE AM NEWS; Narasimhulu DM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv192; Obinna C, 2015, VANGUARD NEWS; Ogoina D, 2016, INT HEALTH, V8, P5, DOI 10.1093/inthealth/ihv065; Oladimeji AM, 2015, TROP MED INT HEALTH, V20, P1162, DOI 10.1111/tmi.12528; Olowookere SA, 2015, J TROP MED-US, V2015, DOI 10.1155/2015/431317; Olugasa BO, 2015, PAN AFR MED J, V22, DOI 10.11694/pamj.supp.2015.22.1.6673; Polgreen PM, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv087; Rowell A, 2014, REGULATING FEAR CASE, V198, P1; Sarti Aimee J, 2015, CMAJ Open, V3, pE198, DOI 10.9778/cmajo.20150025; Schram J, 2014, NEW YORK POST; Schultz CH, 2015, DISASTER MED PUBLIC, V9, P558, DOI 10.1017/dmp.2015.111; Shuaib F, 2014, MMWR-MORBID MORTAL W, V63, P867; Tartari E, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0061-8; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179; Turtle L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120013; Van Damme W, 2000, TROP MED INT HEALTH, V5, P511; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2000, GUID COLL CLIN SPEC; WHO, 2016, LIB GUIN STEP COORD; WHO, 2014, STAND OP PROC CONTR; Wong CH, 2016, DISASTER MED PUBLIC, V10, P662, DOI 10.1017/dmp.2016.2; World Health Organization, 2014, CONS EB VIR DIS PREP; World Health Organization, 2014, HIGH LEV M BUILD RES	40	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165271	10.1371/journal.pone.0165271	http://dx.doi.org/10.1371/journal.pone.0165271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788191	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900053
J	Pearce, P; Brownbill, P; Janacek, J; Jirkovska, M; Kubinova, L; Chernyavsky, IL; Jensen, OE				Pearce, Philip; Brownbill, Paul; Janacek, Jiri; Jirkovska, Marie; Kubinova, Lucie; Chernyavsky, Igor L.; Jensen, Oliver E.			Image-Based Modeling of Blood Flow and Oxygen Transfer in Feto-Placental Capillaries	PLOS ONE			English	Article							HUMAN PLACENTAL VILLI; TERM INFANTS; TRANSPORT; MATURATION; MORPHOLOGY	During pregnancy, oxygen diffuses from maternal to fetal blood through villous trees in the placenta. In this paper, we simulate blood flow and oxygen transfer in feto-placental capillaries by converting three-dimensional representations of villous and capillary surfaces, reconstructed from confocal laser scanning microscopy, to finite-element meshes, and calculating values of vascular flow resistance and total oxygen transfer. The relationship between the total oxygen transfer rate and the pressure drop through the capillary is shown to be captured across a wide range of pressure drops by physical scaling laws and an upper bound on the oxygen transfer rate. A regression equation is introduced that can be used to estimate the oxygen transfer in a capillary using the vascular resistance. Two techniques for quantifying the effects of statistical variability, experimental uncertainty and pathological placental structure on the calculated properties are then introduced. First, scaling arguments are used to quantify the sensitivity of the model to uncertainties in the geometry and the parameters. Second, the effects of localized dilations in fetal capillaries are investigated using an idealized axisymmetric model, to quantify the possible effect of pathological placental structure on oxygen transfer. The model predicts how, for a fixed pressure drop through a capillary, oxygen transfer is maximized by an optimal width of the dilation. The results could explain the prevalence of fetal hypoxia in cases of delayed villous maturation, a pathology characterized by a lack of the vasculo-syncytial membranes often seen in conjunction with localized capillary dilations.	[Pearce, Philip; Chernyavsky, Igor L.; Jensen, Oliver E.] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England; [Brownbill, Paul] Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Brownbill, Paul] Cent Manchester Univ Hosp NHS Fdn Trust, Maternal & Fetal Hlth Res Ctr, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Janacek, Jiri; Kubinova, Lucie] Acad Sci Czech Republ, Inst Physiol, Dept Biomath, Vvi, Prague, Czech Republic; [Jirkovska, Marie] Charles Univ Prague, Inst Histol & Embryol, Fac Med 1, Albertov 4, CZ-12801 Prague 2, Czech Republic	University of Manchester; University of Manchester; University of Manchester; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague	Pearce, P (corresponding author), Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England.	ppearce@mit.edu	Jensen, Oliver/B-5880-2008; Jirkovská, Marie/P-2219-2017; Kubinova, Lucie/B-6803-2012; Janacek, Jiri/B-7932-2012; Pearce, Philip/S-3481-2016; Brownbill, Paul/I-2412-2015	Jensen, Oliver/0000-0003-0172-6578; Jirkovská, Marie/0000-0003-3902-4758; Kubinova, Lucie/0000-0002-2977-8460; Janacek, Jiri/0000-0003-0286-4999; Pearce, Philip/0000-0001-5788-3826; Chernyavsky, Igor L./0000-0003-0284-9318; Brownbill, Paul/0000-0002-8328-7072	Engineering and Physical Sciences Research Council (EPSRC) Doctoral Prize Fellowship [EP/L504877/1]; EPSRC [EP/K037145/1]; Medical Research Council (MRC) [MR/N011538/1]; Czech Academy of Sciences [RVO: 67985823]; Charles University in Prague [PRVOUK P25/LF1/2]; EPSRC Mathematical Sciences Platform [EP/101912X/1]; Engineering and Physical Sciences Research Council [EP/K037145/1] Funding Source: researchfish; Medical Research Council [MR/N011538/1] Funding Source: researchfish; EPSRC [EP/I01912X/1] Funding Source: UKRI; MRC [MR/N011538/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC) Doctoral Prize Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Czech Academy of Sciences(Czech Academy of Sciences); Charles University in Prague; EPSRC Mathematical Sciences Platform(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	P.P. was supported by an Engineering and Physical Sciences Research Council (EPSRC) Doctoral Prize Fellowship (EP/L504877/1). O.E.J. was supported by EPSRC, grant EP/K037145/1. I. L.C. was supported by Medical Research Council (MRC), grant MR/N011538/1. J.J. and L.K. were supported by the Czech Academy of Sciences (RVO: 67985823). M.J. was supported by the project PRVOUK P25/LF1/2 of Charles University in Prague. This work was supported by the EPSRC Mathematical Sciences Platform, Grant EP/101912X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Adnani M, 2015, PEDIATR DEVEL PATHOL, V18, P375, DOI 10.2350/12-02-1604-OA.1; Amestoy PR, 2001, SIAM J MATRIX ANAL A, V23, P15, DOI 10.1137/S0895479899358194; Banerjee RK, 2008, J BIOMECH, V41, P475, DOI 10.1016/j.jbiomech.2007.09.011; Beard DA, 2001, ANN BIOMED ENG, V29, P298, DOI 10.1114/1.1359450; Benirschke K., 2006, PATHOLOGY HUMAN PLAC, DOI [10.1007/b137920, DOI 10.1007/B137920]; Brownbill P, 2006, PLACENTA, V27, P560, DOI 10.1016/j.placenta.2005.08.002; Burton GJ, 1996, PLACENTA, V17, P49, DOI 10.1016/S0143-4004(05)80643-5; Carter AM, 2000, PLACENTA, V21, pS31, DOI 10.1053/plac.1999.0513; Chernyavsky IL, 2010, PLACENTA, V31, P44, DOI 10.1016/j.placenta.2009.11.003; Chernyavsky IL, 2011, PHILOS T R SOC A, V369, P4162, DOI 10.1098/rsta.2011.0170; Clark AR, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2014.0078; Cussler E.L., 1997, DIFFUSION MASS TRANS; Espinoza J, 2001, PLACENTA, V22, P606, DOI 10.1053/plac.2001.0696; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Gill JS, 2011, J THEOR BIOL, V291, P33, DOI 10.1016/j.jtbi.2011.09.008; Haase AS, 2015, J FLUID MECH, V764, DOI 10.1017/jfm.2014.733; Harteman JC, 2013, J PEDIATR-US, V163, P968, DOI 10.1016/j.jpeds.2013.06.010; Heinrich J.C., 1999, S COMP PHYS; Higgins JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000288; Higgins M, 2011, PEDIATR DEVEL PATHOL, V14, P273, DOI 10.2350/10-07-0872-OA.1; JACKSON MR, 1988, PLACENTA, V9, P1, DOI 10.1016/0143-4004(88)90067-7; Jirkovska M, 2008, PLACENTA, V29, P892, DOI 10.1016/j.placenta.2008.07.004; Jirkovska M, 2002, J VASC RES, V39, P268, DOI 10.1159/000063692; Jones A. S., 1975, Journal of the Australian Mathematical Society, Series B (Applied Mathematics), V19, P146, DOI 10.1017/S0334270000001041; KARIMU AL, 1994, BRIT J OBSTET GYNAEC, V101, P57, DOI 10.1111/j.1471-0528.1994.tb13011.x; Karimu AL, 1994, PLACENTA, V15, P541, DOI [10.1016/S0143-4004(05)80372-8, DOI 10.1016/S0143-4004(05)80372-8]; KASINGER W, 1981, SCAND J CLIN LAB INV, V41, P701, DOI 10.3109/00365518109090518; Kato Y, 2014, 2014 IEEE INT C IM S; Kesmarky G, 2008, CLIN HEMORHEOL MICRO, V39, P243, DOI 10.3233/CH-2008-1088; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Krampl E, 2000, ULTRASOUND OBST GYN, V16, P9, DOI 10.1046/j.1469-0705.2000.00156.x; Lecarpentier E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147262; Marieb EN, 2007, HUMAN ANATOMY PHYSL; MAYHEW TM, 1988, PLACENTA, V9, P565, DOI 10.1016/0143-4004(88)90001-X; Mayhew TM, 2006, PLACENTA, V27, pS17, DOI 10.1016/j.placenta.2005.11.006; MAYHEW TM, 1994, PLACENTA, V15, P837, DOI 10.1016/S0143-4004(05)80185-7; Mayo RP, 2016, PLACENTA, V43, P54, DOI 10.1016/j.placenta.2016.05.001; Mills A.F., 1999, HEAT TRANSFER; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; Pudney C, 1998, COMPUT VIS IMAGE UND, V72, P404, DOI 10.1006/cviu.1998.0680; Rannacher R, 2000, ADV MATH FLUID MECH, P191; Redline RW, 2008, PEDIATR DEVEL PATHOL, V11, P456, DOI 10.2350/08-05-0468.1; Redline RW., 2012, DIAGN HISTOPATHOL, V18, P189, DOI [10.1016/j.mpdhp.2012.02.002, DOI 10.1016/J.MPDHP.2012.02.002]; Rivera RGH, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.188101; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Sapoval B, 2002, P NATL ACAD SCI USA, V99, P10411, DOI 10.1073/pnas.122352499; Schneider H, 1996, PLACENTA, V17, P15, DOI 10.1016/S0143-4004(05)80639-3; Serov AS, 2016, J APPL PHYSIOL, V120, P17, DOI 10.1152/japplphysiol.00543.2015; Serov AS, 2015, J THEOR BIOL, V368, P133, DOI 10.1016/j.jtbi.2014.12.016; Serov AS, 2015, J THEOR BIOL, V364, P383, DOI 10.1016/j.jtbi.2014.09.022; Stallmach T, 2001, OBSTET GYNECOL, V97, P505, DOI 10.1016/S0029-7844(00)01208-4; Treacy A, 2013, PEDIATR DEVEL PATHOL, V16, P63, DOI 10.2350/12-06-1218-OA.1; Wright S, 1999, NUMERICAL OPTIMIZATI, V35, P7; YAMAGUCHI K, 1985, J APPL PHYSIOL, V58, P1215, DOI 10.1152/jappl.1985.58.4.1215; Yampolsky M, 2008, PLACENTA, V29, P790, DOI 10.1016/j.placenta.2008.06.005	56	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165369	10.1371/journal.pone.0165369	http://dx.doi.org/10.1371/journal.pone.0165369			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788214	gold, Green Published, Green Submitted			2022-12-26	WOS:000389604900069
J	Purzycka-Bohdan, D; Szczerkowska-Dobosz, A; Zablotna, M; Wierzbicka, J; Piotrowska, A; Zmijewski, MA; Nedoszytko, B; Nowicki, R				Purzycka-Bohdan, Dorota; Szczerkowska-Dobosz, Aneta; Zablotna, Monika; Wierzbicka, Justyna; Piotrowska, Anna; Zmijewski, Michal A.; Nedoszytko, Boguslaw; Nowicki, Roman			Assessment of Interleukin 16 Serum Levels and Skin Expression in Psoriasis Patients in Correlation with Clinical Severity of the Disease	PLoS One			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; IL-16 GENE POLYMORPHISMS; ATOPIC-DERMATITIS; CIRCULATING INTERLEUKIN-16; PROLIFERATION; INFILTRATION; PATHOGENESIS; ASSOCIATION; INJECTION; THERAPY	Interleukin 16 (IL-16) has been described as a significant cytokine involved in the recruitment of CD4+ cells during inflammation; however, its potential role in psoriasis has not been defined. Our aim was to investigate the IL-16 serum levels and IL-16 mRNA skin expression in psoriasis patients in correlation with disease severity and mRNA skin expression for CD4. Moreover, the IL-16 skin localization was assessed and the -295 T/C IL-16 polymorphism was analyzed. For this exploratory, observational, and cross-sectional study, 97 unrelated patients with chronic plaque type psoriasis and 104 healthy controls were enrolled. IL-16 serum levels were significantly increased in patients compared with controls (P = 0.000022) and positively correlated with Psoriasis Area and Severity Index (r = 0.34, P = 0.0007), Body Surface Area (r = 0.34, P = 0.01) and were significantly higher in individuals with moderate to severe psoriasis (P = 0.0029). There was no significant correlation between IL-16 serum levels and Dermatology Quality of Life Index and no differences in genotype and allele frequencies for -295 T/C IL-16 polymorphism. The expression of IL-16 (mRNA and protein) was elevated in the margin of psoriatic skin while statistically significant increase in IL-16 immunoreactivity, but not in mRNA level, was observed within plaques. Furthermore, the IL-16 mRNA levels within psoriatic lesions positively correlated with the levels of CD4 mRNA, but not with Psoriasis Area and Severity Index. In conclusion, our data revealed an association between circulating IL-16 and severity of psoriasis which indicates that this cytokine could serve as a potential marker of disease activity. However, further investigations are required.	[Purzycka-Bohdan, Dorota; Szczerkowska-Dobosz, Aneta; Zablotna, Monika; Nedoszytko, Boguslaw; Nowicki, Roman] Med Univ Gdansk, Dept Dermatol Venereol & Allergol, Gdansk, Poland; [Wierzbicka, Justyna; Piotrowska, Anna; Zmijewski, Michal A.] Med Univ Gdansk, Dept Histol, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Szczerkowska-Dobosz, A (corresponding author), Med Univ Gdansk, Dept Dermatol Venereol & Allergol, Gdansk, Poland.	adobosz@gumed.edu.pl	Szczerkowska-Dobosz, Aneta/AAA-1535-2020; Piotrowska, Anna/R-6088-2018; Nowicki, Roman J./U-3148-2018; Nedoszytko, Boguslaw/AAY-5079-2020	Szczerkowska-Dobosz, Aneta/0000-0003-4040-0116; Piotrowska, Anna/0000-0002-2672-0474; Nowicki, Roman J./0000-0003-4768-1387; Zmijewski, Michal/0000-0003-2206-3531; Nedoszytko, Boguslaw/0000-0002-6286-0693; , Dorota/0000-0003-2804-0437				Azimzadeh P, 2011, J GASTROINTEST LIVER, V20, P371; Blaschke V, 1999, J INVEST DERMATOL, V113, P658, DOI 10.1046/j.1523-1747.1999.00717.x; Cai YH, 2012, CELL MOL IMMUNOL, V9, P302, DOI 10.1038/cmi.2012.15; Center DM, 2004, J IMMUNOL, V172, P1654, DOI 10.4049/jimmunol.172.3.1654; Chupp GL, 1998, J IMMUNOL, V161, P3114; CRUIKSHANK W, 1982, J IMMUNOL, V128, P2569; Cruikshank WW, 2000, J LEUKOCYTE BIOL, V67, P757, DOI 10.1002/jlb.67.6.757; Frezzolini A, 2004, CLIN EXP IMMUNOL, V137, P595, DOI 10.1111/j.1365-2249.2004.02570.x; Frezzolini A, 2002, ALLERGY, V57, P815, DOI 10.1034/j.1398-9995.2002.23687.x; Laberge S, 1998, J ALLERGY CLIN IMMUN, V102, P645, DOI 10.1016/S0091-6749(98)70282-9; Lee S, 1998, BRIT J RHEUMATOL, V37, P1334; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Masuda K, 2003, ACTA DERM-VENEREOL, V83, P249, DOI 10.1080/00015550310016472; Nagy G, 2011, INT ARCH ALLERGY IMM, V156, P69, DOI 10.1159/000321959; Nakayama EE, 2000, GENES IMMUN, V1, P293, DOI 10.1038/sj.gene.6363672; Nickoloff BJ, 1999, AM J PATHOL, V155, P145, DOI 10.1016/S0002-9440(10)65109-7; PRINZ JC, 1994, EUR J IMMUNOL, V24, P593, DOI 10.1002/eji.1830240315; Rasmy H, 2011, ARCH MED SCI, V7, P713, DOI 10.5114/aoms.2011.24144; Richmond J, 2014, J CELL PHYSIOL, V229, P139, DOI 10.1002/jcp.24441; Richmond J, 2011, J CLIN IMMUNOL, V31, P39, DOI 10.1007/s10875-010-9464-8; Romani Sara, 2014, Hepat Res Treat, V2014, P790753, DOI 10.1155/2014/790753; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Skundric DS, 2005, J NEUROSCI RES, V79, P680, DOI 10.1002/jnr.20377; Tamaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068893; Wagner CL, 2013, ANN RHEUM DIS, V72, P83, DOI 10.1136/annrheumdis-2012-201697; Wilson KC, 2005, CELL IMMUNOL, V237, P17, DOI 10.1016/j.cellimm.2005.09.003; WroneSmith T, 1996, J CLIN INVEST, V98, P1878, DOI 10.1172/JCI118989; Xue H, 2009, CLIN CHIM ACTA, V403, P223, DOI 10.1016/j.cca.2009.03.016; Zak KP, 2007, LIK SPRAVA, V5-6, P46; Zheng HY, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15016556	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165577	10.1371/journal.pone.0165577	http://dx.doi.org/10.1371/journal.pone.0165577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788245	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900111
J	Spackman, E; Cardona, C; Munoz-Aguayo, J; Fleming, S				Spackman, Erica; Cardona, Carol; Munoz-Aguayo, Jeannette; Fleming, Susan			Successes and Short Comings in Four Years of an International External Quality Assurance Program for Animal Influenza Surveillance	PLoS One			English	Article							LINKED-IMMUNOSORBENT-ASSAY; VIRUS; PROFICIENCY; ANTIBODIES; DIAGNOSIS	The US National institutes of Health-Centers of Excellence for Influenza Research and Surveillance is a research consortium that funds numerous labs worldwide to conduct influenza A surveillance in diverse animal species. There is no harmonization of testing procedures among these labs; therefore an external quality assurance (EQA) program was implemented to evaluate testing accuracy among labs in the program in 2012. Accurate detection of novel influenza A variants is crucial because of the broad host range and potentially high virulence of the virus in diverse species. Two molecular detection sample sets and 2 serology sample sets (one with avian origin isolates, and one with mammalian origin isolates each) were made available at approximately six month intervals. Participating labs tested the material in accordance with their own protocols. During a five year period a total of 41 labs from 23 countries ordered a total of 132 avian molecular, 121 mammalian molecular and 90 serology sample sets. Testing was completed by 111 individuals. Detection of type A influenza by RT-PCR was reliable with a pass rate (80% or greater agreement with expected results) of 86.6% for avian and 86.2% for mammalian origin isolates. However, identification of subtype by RT-PCR was relatively poor with 54.1% and 75.9% accuracy for avian and mammalian influenza isolates respectively. Serological testing had an overall pass rate of 86.9% and 22/23 labs used commercial ELISA kits. Based on the results of this EQA program six labs modified their procedures to improve accuracy and one lab identified an unknown equipment problem. These data represent the successful implementation of an international EQA program for an infectious disease; insights into the logistics and test design are also discussed.	[Spackman, Erica] ARS, Exot & Emerging Avian Viral Dis Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30605 USA; [Cardona, Carol; Munoz-Aguayo, Jeannette; Fleming, Susan] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities	Spackman, E (corresponding author), ARS, Exot & Emerging Avian Viral Dis Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30605 USA.	Erica.Spackman@ars.usda.gov		Spackman, Erica/0000-0002-4935-2360	US Department of Agriculture, ARS CRIS Project [6040-32000-063-00D]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [AAI12004-001-00001]; Minnesota Center for Excellence in Influenza Research and Surveillance [HHSN266200700007]	US Department of Agriculture, ARS CRIS Project; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Minnesota Center for Excellence in Influenza Research and Surveillance	Support was provided by US Department of Agriculture, ARS CRIS Project 6040-32000-063-00D and by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, under IAA No. AAI12004-001-00001 and the Minnesota Center for Excellence in Influenza Research and Surveillance HHSN266200700007. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support was provided by US Department of Agriculture, ARS CRIS Project 6040-32000063-00D and by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, under IAA No. AAI12004-001-00001 and the Minnesota Center for Excellence in Influenza Research and Surveillance HHSN266200700007. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	[Anonymous], 2009, CDC PROT REALT RTPCR; Brown JD, 2009, CLIN VACCINE IMMUNOL, V16, P824, DOI 10.1128/CVI.00084-09; Ciacci-Zanella JR, 2010, J VET DIAGN INVEST, V22, P3, DOI 10.1177/104063871002200102; Dufour-Zavala L., 2008, LAB MANUAL ISOLATION, P204; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Gao RB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-67; Jenson TA, 2014, METHODS MOL BIOL, V1161, P141, DOI 10.1007/978-1-4939-0758-8_13; Pedersen Janice C., 2008, V436, P53, DOI 10.1007/978-1-59745-279-3_8; Popowich MD, 2012, J CLIN VIROL, V54, P245, DOI 10.1016/j.jcv.2012.04.001; Root JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102513; Slomka MJ, 2009, INFLUENZA OTHER RESP, V3, P151, DOI 10.1111/j.1750-2659.2009.00083.x; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2005, J VET DIAGN INVEST, V17, P76, DOI 10.1177/104063870501700117; Stang Heather L, 2013, Clin Microbiol Newsl, V35, P145, DOI 10.1016/j.clinmicnews.2013.08.007; Stelzer-Braid S, 2008, EMERG INFECT DIS, V14, P1126, DOI 10.3201/eid1407.071098; Wiegers AL, 2004, J VET DIAGN INVEST, V16, P255, DOI 10.1177/104063870401600401	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164261	10.1371/journal.pone.0164261	http://dx.doi.org/10.1371/journal.pone.0164261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788155	gold, Green Published, Green Submitted			2022-12-26	WOS:000389604900015
J	Farina, S; Guala, I; Oliva, S; Piazzi, L; da Silva, RP; Ceccherelli, G				Farina, Simone; Guala, Ivan; Oliva, Silvia; Piazzi, Luigi; da Silva, Rodrigo Pires; Ceccherelli, Giulia			The Seagrass Effect Turned Upside Down Changes the Prospective of Sea Urchin Survival and Landscape Implications	PLOS ONE			English	Article							PARACENTROTUS-LIVIDUS; PREDATION RISK; PATCH SIZE; HABITAT COMPLEXITY; FISH PREDATORS; RECRUITMENT; ABUNDANCE; PREFERENCES; POPULATIONS; PROTECTION	Habitat structure plays an important mediating role in predator-prey interactions. However the effects are strongly dependent on regional predator pools, which can drive predation risk in habitats with very similar structure in opposite directions. In the Mediterranean Sea predation on juvenile sea urchins is commonly known to be regulated by seagrass structure. In this study we test whether the possibility for juvenile Paracentrotus lividus to be predated changes in relation to the fragmentation of the seagrass Posidonia oceanica (four habitat classes: continuous, low-fragmentation, high-fragmentation and rocks), and to the spatial arrangement of such habitat classes at a landscape scale. Sea urchin predation risk was measured in a 20-day field experiment on tethered individuals placed in three square areas 35x35 m(2) in size. Variability of both landscape and habitat structural attributes was assessed at the sampling grain 5x5 m(2). Predation risk changed among landscapes, as it was lower where more 'rocks', and thus less seagrass, were present. The higher risk was found in the 'continuous' P. oceanica rather than in the low-fragmentation, high-fragmentation and rock habitats (p-values = 0.0149, 0.00008, and 0.0001, respectively). Therefore, the expectation that juvenile P. lividus survival would have been higher in the 'continuous' seagrass habitat, which would have served as shelter from high fish predation pressure, was not met. Predation risk changed across habitats due to different success between attack types: benthic attacks (mostly from whelks) were overall much more effective than those due to fish activity, the former type being associated with the 'continuous' seagrass habitat. Fish predation on juvenile sea urchins on rocks and 'high-fragmentation' habitat was less likely than benthic predation in the 'continuous' seagrass, with the low seagrass patch complexity increasing benthic activity. Future research should be aimed at investigating, derived from the complex indirect interactions among species, how top-down control in marine reserves can modify seagrass habitat effects.	[Farina, Simone; Guala, Ivan; da Silva, Rodrigo Pires] IMC Int Marine Ctr, I-09170 Oristano, Italy; [Oliva, Silvia; Piazzi, Luigi; Ceccherelli, Giulia] Univ Sassari, Sci Nat & Environm Resources, Via Piandanna 4, I-07100 Sassari, Italy	University of Sassari	Farina, S (corresponding author), IMC Int Marine Ctr, I-09170 Oristano, Italy.	s.farina@fondazioneimc.it	Farina, Simone/ABF-4876-2021; Farina, Simone/AAB-9308-2021; Oliva, Silvia/F-5493-2013	Farina, Simone/0000-0003-0169-8044; Oliva, Silvia/0000-0001-9035-0538; Silva, Rodrigo/0000-0002-1590-8236; guala, ivan/0000-0003-4712-1435; Ceccherelli, Giulia/0000-0002-9832-9677	Regione Autonoma della Sardegna [L/7 CRP49692]	Regione Autonoma della Sardegna(Regione Sardegna)	This research was financed by a Regione Autonoma della Sardegna (L/7 CRP49692) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financed by a Regione Autonoma della Sardegna (L/7 CRP49692) grant. We are grateful to spatial analysis expertAitana Oltra (Movement Ecology Lab, CEAB-CSIC) for her valuable advice regarding to the experimental design. We would also like to thank Matteo Spanu for his help in the field and the staff of Tavolara Punta Coda Cavallo Marine Protected Area for the logistic assistance, work authorizations and for providing us the bioticmap to carry out this study (S1 File).	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; ARONSON RB, 1995, MAR ECOL PROG SER, V121, P307, DOI 10.3354/meps121307; Atwood TC, 2009, J WILDLIFE MANAGE, V73, P876, DOI 10.2193/2008-325; Bartholomew A, 2000, MAR ECOL PROG SER, V206, P45, DOI 10.3354/meps206045; Boada J, 2015, BIOL CONSERV, V191, P67, DOI 10.1016/j.biocon.2015.06.017; Bonaviri C, 2009, MAR ECOL PROG SER, V382, P129, DOI 10.3354/meps07976; Bostrom C, 2006, ESTUAR COAST SHELF S, V68, P383, DOI 10.1016/j.ecss.2006.01.026; Brown JS, 1999, EVOL ECOL RES, V1, P49; Buia M, 2000, BIOL MAR MEDIT, V7, P203; CARPENTER RC, 1984, MAR BIOL, V82, P101, DOI 10.1007/BF00392768; Ceccherelli G, 2009, ESTUAR COAST SHELF S, V81, P59, DOI 10.1016/j.ecss.2008.10.007; Crawley MJ, 2012, R BOOK, DOI [10.1002/9781118448908, DOI 10.1002/9781118448908]; Creel S, 2015, ECOL SOC AM, V86, P3387, DOI 10.1890/05-0032; de Boer WF, 2007, HYDROBIOLOGIA, V591, P5, DOI 10.1007/s10750-007-0780-9; Farina S, 2015, SCALE DEPENDENT FACT; Farina S, 2014, OIKOS, V123, P1311, DOI 10.1111/oik.01382; Farina S, 2009, MAR ECOL PROG SER, V377, P131, DOI 10.3354/meps07692; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Fox J., 2002, R S PLUS COMPANION A; Gacia E, 2009, BOT MAR, V52, P439, DOI 10.1515/BOT.2009.054; Gorman AM, 2009, J EXP MAR BIOL ECOL, V371, P1, DOI 10.1016/j.jembe.2008.12.008; Guidetti P, 2005, MAR ENVIRON RES, V59, P333, DOI 10.1016/j.marenvres.2004.05.008; Guidetti P, 2004, HELGOLAND MAR RES, V58, P110, DOI 10.1007/s10152-004-0176-4; Guidetti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091841; Hauser A, 2006, MAR ECOL PROG SER, V325, P93, DOI 10.3354/meps325093; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Hereu B, 2005, MAR BIOL, V146, P293, DOI 10.1007/s00227-004-1439-y; Hereu B, 2008, ECOLOGY, V89, P3423, DOI 10.1890/07-0613.1; Hernandez L, 2005, WILDLIFE BIOL, V11, P215, DOI 10.2981/0909-6396(2005)11[215:FITLOF]2.0.CO;2; Hoese FJ, 2006, BEHAVIOUR, V143, P763, DOI 10.1163/156853906777791333; Horinouchi M, 2013, MAR ECOL PROG SER, V488, P255, DOI 10.3354/meps10396; Hovel KA, 2001, ECOLOGY, V82, P1814; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Kerfoot W. C., 1987, PREDATION DIRECT IND; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Laurel BJ, 2003, MAR ECOL PROG SER, V251, P245, DOI 10.3354/meps251245; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; Martin CW, 2010, OECOLOGIA, V162, P893, DOI 10.1007/s00442-010-1564-x; Martinez-Crego B, 2008, MAR ECOL PROG SER, V361, P93, DOI 10.3354/meps07358; McCarigal K, 1995, PNWGTR351 FOR SERV; MCCLANAHAN TR, 1989, J EXP MAR BIOL ECOL, V126, P77, DOI 10.1016/0022-0981(89)90125-1; McClanahan TR, 1997, ECOL MODEL, V104, P145, DOI 10.1016/S0304-3800(97)00121-X; McClanahan TR, 1998, J EXP MAR BIOL ECOL, V221, P231, DOI 10.1016/S0022-0981(97)00130-5; MCCOLLIN D, 1993, GLOBAL ECOL BIOGEOGR, V3, P48, DOI 10.2307/2997459; McGinley M., 2009, ENCY EARTH; MCINTYRE NE, 1995, LANDSCAPE ECOL, V10, P85, DOI 10.1007/BF00153826; Oliva S, 2016, MAR ENVIRON RES, V117, P13, DOI 10.1016/j.marenvres.2016.02.013; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; Pages JF, 2012, FUNCT ECOL, V26, P1015, DOI 10.1111/j.1365-2435.2012.02038.x; Papadimitriou S, 2005, ORG GEOCHEM, V36, P949, DOI 10.1016/j.orggeochem.2004.12.002; Peharda M, 2006, MAR BIOL, V148, P1011, DOI 10.1007/s00227-005-0148-5; Pinna S, 2013, MAR ECOL PROG SER, V485, P47, DOI 10.3354/meps10326; Pinna S, 2012, MAR ECOL PROG SER, V445, P173, DOI 10.3354/meps09457; Planes S, 2006, EMPAFISH, V1, P158; Prado P, 2007, MAR ECOL PROG SER, V340, P63, DOI 10.3354/meps340063; Prado P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035170; Rawlins AD, 2011, Q J MECH APPL MATH, V64, P47, DOI 10.1093/qjmam/hbq022; Richardson CA, 2004, J EXP MAR BIOL ECOL, V299, P1, DOI 10.1016/j.jembe.2003.08.012; Rieucau G, 2009, BEHAV ECOL SOCIOBIOL, V63, P891, DOI 10.1007/s00265-009-0732-7; Rutledge D, 2003, TECHNOLOGY; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 1996, MAR ECOL PROG SER, V140, P71, DOI 10.3354/meps140071; Sala E, 1997, MAR BIOL, V129, P531, DOI 10.1007/s002270050194; Schmidt K, 2015, MAMMAL RES, V60, P275, DOI 10.1007/s13364-015-0229-x; Tanaka Y, 2006, BOT MAR, V49, P365, DOI 10.1515/BOT.2006.047; Therneau T. M., 1999, TECHNICAL REPORT; Tomas F, 2004, MAR ECOL PROG SER, V282, P173, DOI 10.3354/meps282173; Venerables W, 2010, NOTES R PROGRAMMING; Wicks EC, 2009, MAR ECOL PROG SER, V378, P71, DOI 10.3354/meps07885; Zuur AF, 2009, USE R, P1, DOI 10.1007/978-0-387-93837-0	73	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164294	10.1371/journal.pone.0164294	http://dx.doi.org/10.1371/journal.pone.0164294			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783684	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800034
J	Feng, CX; Hu, JQ; Liu, C; Liu, SL; Liao, GY; Song, LJ; Zeng, XY				Feng, Chunxiang; Hu, Jinqian; Liu, Chang; Liu, Shiliang; Liao, Guiying; Song, Linjie; Zeng, Xiaoyong			Association of 17-beta Estradiol with Adipose-Derived Stem Cells: New Strategy to Produce Functional Myogenic Differentiated Cells with a Nano-Scaffold for Tissue Engineering	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; STRESS URINARY-INCONTINENCE; STROMAL CELLS; BONE-MARROW; IN-VIVO; ADIPOGENIC DIFFERENTIATION; MOLECULAR REGULATION; ESTROGEN; RAT; PROLIFERATION	The increased incidence of stress urinary incontinence (SUI) in postmenopausal women has been proposed to be associated with a reduction in the level of 17-beta estradiol (E2). E2 has also been shown to enhance the multi-differentiation ability of adipose-derived stem cells (ASCs) in vitro. However, studies on the potential value of E2 for tissue engineering in SUI treatment are rare. In the present study, we successfully fabricated myogenically differentiated ASCs (MD-ASCs), which were seeded onto a Poly(L-lactide)/Poly(e-caprolactone) electrospinning nano-scaffold, and incorporated E2 into the system, with the aim of improving the proliferation and myogenic differentiation of ASCs. ASCs were collected from the inguinal subcutaneous fat of rats. The proliferation and myogenic differentiation of ASCs, as well as the nano-scaffold biocompatibility of MD-ASCs, with or without E2 supplementation, were investigated. We demonstrated that E2 incorporation enhanced the proliferation of ASCs in vitro, and the most optimal concentration was 10(-9) M. E2 also led to modulation of the MD-ASCs phenotype toward a concentrated type with smooth muscle-inductive medium. The expression of early (alpha-smooth muscle actin), mid (calponin), and late-stage (myosin heavy chain) contractile markers in MD-ASCs was enhanced by E2 during the different differentiation stages. Furthermore, the nano-scaffold was biocompatible with MD-ASCs, and cell proliferation was significantly enhanced by E2. Taken together, these results demonstrate that E2 can enhance the proliferation and myogenic differentiation of ASCs and can be used to construct a biocompatible cell/nano-scaffold. These scaffolds with desirable differentiation cells show promising applications for tissue engineering.	[Feng, Chunxiang; Hu, Jinqian; Liu, Chang; Liu, Shiliang; Zeng, Xiaoyong] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Urol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Liao, Guiying; Song, Linjie] China Univ Geosci Wuhan, Sch Mat Sci & Chem Engn, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; China University of Geosciences	Zeng, XY (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Urol, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	tjhhust@126.com			National Natural Science Foundation of China [81270851, 31570988]; Innovation Foundation of Huazhong University of Science and Technology [0118540191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Foundation of Huazhong University of Science and Technology	This study was supported by a grant from the National Natural Science Foundation of China (Project Nos. 81270851 and 31570988), and the Innovation Foundation of Huazhong University of Science and Technology (Project No. 0118540191) (https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list).; This study was supported by a grant from the National Natural Science Foundation of China (Project Nos. 81270851 and 31570988), and the Innovation Foundation of Huazhong University of Science and Technology (Project No. 0118540191).	Auld KL, 2012, J MOL ENDOCRINOL, V48, P177, DOI 10.1530/JME-11-0140; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Chen L, 2012, CELLS TISSUES ORGANS, V196, P13, DOI 10.1159/000330796; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071265; Cody JD, 2012, COCHRANE DB SYST REV, V10, pD1405; Cooke PS, 2004, EXP BIOL MED, V229, P1127, DOI 10.1177/153537020422901107; Dang ZC, 2004, J BONE MINER RES, V19, P853, DOI 10.1359/JBMR.040120; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; DiSilvio L, 2006, INJURY, V37, pS33, DOI 10.1016/j.injury.2006.08.022; Dooley Y, 2008, J UROLOGY, V179, P656, DOI 10.1016/j.juro.2007.09.081; Ferraro GA, 2013, J CELL BIOCHEM, V114, P1039, DOI 10.1002/jcb.24443; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; Fleischmann N, 2002, J UROLOGY, V168, P1265, DOI 10.1016/S0022-5347(05)64637-X; Fu Q, 2010, UROLOGY, V75, P718, DOI 10.1016/j.urology.2009.10.003; Gierloff M, 2014, J PLAST RECONSTR AES, V67, P1427, DOI 10.1016/j.bjps.2014.05.042; Guo T, 2014, CELL PHYSIOL BIOCHEM, V33, P681, DOI 10.1159/000358644; Hashimoto TR, 1999, UROLOGY, V53, P642, DOI 10.1016/S0090-4295(98)00528-7; Heim M, 2004, ENDOCRINOLOGY, V145, P848, DOI 10.1210/en.2003-1014; Hilborn J, 2012, J TISSUE ENG REGEN M, V1, P110; Hong L, 2006, TISSUE ENG, V12, P2747, DOI 10.1089/ten.2006.12.2747; Hong L, 2011, STEM CELLS DEV, V20, P925, DOI 10.1089/scd.2010.0125; Huang JI, 2005, J ORTHOP RES, V23, P1383, DOI 10.1016/j.orthres.2005.03.018; Kim IL, 2013, BIOMATERIALS, V34, P5571, DOI 10.1016/j.biomaterials.2013.04.004; Li HJ, 2007, P NATL ACAD SCI USA, V104, P4065, DOI 10.1073/pnas.0611639104; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; Liang CC, 2013, TAIWAN J OBSTET GYNE, V52, P335, DOI 10.1016/j.tjog.2012.11.003; Lin GT, 2010, CYTOTHERAPY, V12, P88, DOI 10.3109/14653240903350265; Luo S, 2013, TOHOKU J EXP MED, V231, P101, DOI 10.1620/tjem.231.101; McCullen SD, 2007, INT J NANOMED, V2, P253; Merkle VM, 2015, ACTA BIOMATER, V27, P77, DOI 10.1016/j.actbio.2015.08.044; Owens GK, 1997, AGENT ACTION SUPPL, V48, P3; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Rajalin AM, 2010, BIOCHEM BIOPH RES CO, V396, P477, DOI 10.1016/j.bbrc.2010.04.120; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; Ryan AJ, 2015, BIOMATERIALS, V73, P296, DOI 10.1016/j.biomaterials.2015.09.003; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Shi LB, 2014, BIOMATERIALS, V35, P1519, DOI 10.1016/j.biomaterials.2013.11.025; Sreejayan Nair, 2007, V139, P283; Suguita M., 2000, Clinical and Experimental Obstetrics and Gynecology, V27, P176; Talwar RM, 2006, J ORAL MAXIL SURG, V64, P600, DOI 10.1016/j.joms.2005.12.006; Thom DH, 2010, J UROLOGY, V184, P1394, DOI 10.1016/j.juro.2010.05.095; Wu XJ, 2016, INT J NANOMED, V11, P389, DOI 10.2147/IJN.S88803; Wu Y, 2015, ATHEROSCLEROSIS, V240, P453, DOI 10.1016/j.atherosclerosis.2015.04.008; Yamamoto T, 2010, INT J UROL, V17, P75, DOI 10.1111/j.1442-2042.2009.02429.x; Zhang N, 2014, STEM CELL REV REP, V10, P600, DOI 10.1007/s12015-014-9508-1; Zhang R, 2012, STEM CELLS, V30, P481, DOI 10.1002/stem.1023; Zhao WM, 2011, EUR UROL, V59, P155, DOI 10.1016/j.eururo.2010.10.038; Zhu Q, 2001, J UROLOGY, V166, P1136, DOI 10.1016/S0022-5347(05)65935-6	50	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164918	10.1371/journal.pone.0164918	http://dx.doi.org/10.1371/journal.pone.0164918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783699	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800051
J	Meir-Gruber, L; Manor, Y; Gefen-Halevi, S; Hindiyeh, MY; Mileguir, F; Azar, R; Smollan, G; Belausov, N; Rahav, G; Shamiss, A; Mendelson, E; Keller, N				Meir-Gruber, Lital; Manor, Yossi; Gefen-Halevi, Shiraz; Hindiyeh, Musa Y.; Mileguir, Fernando; Azar, Roberto; Smollan, Gill; Belausov, Natasha; Rahav, Galia; Shamiss, Ari; Mendelson, Ella; Keller, Nathan			Population Screening Using Sewage Reveals Pan-Resistant Bacteria in Hospital and Community Samples	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; BETA-LACTAMASE; ENTEROBACTERIACEAE; CARBAPENEMASE; OUTBREAK; STRAINS; EPIDEMIOLOGY; PREVALENCE; EMERGENCE; INFECTION	The presence of pan-resistant bacteria worldwide possesses a threat to global health. It is difficult to evaluate the extent of carriage of resistant bacteria in the population. Sewage sampling is a possible way to monitor populations. We evaluated the presence of pan-resistant bacteria in Israeli sewage collected from all over Israel, by modifying the pour plate method for heterotrophic plate count technique using commercial selective agar plates. This method enables convenient and fast sewage sampling and detection. We found that sewage in Israel contains multiple pan-resistant bacteria including carbapenemase resistant Enterobacteriacae carrying bla(KPC) and bla(NDM-1), MRSA and VRE. bla(KPC) carrying Klebsiella pneumonia and Enterobacter cloacae were the most common Enterobacteriacae drug resistant bacteria found in the sewage locations we sampled. Klebsiella pneumonia, Enterobacter spp., Escherichia coli and Citrobacter spp. were the 4 main CRE isolated from Israeli sewage and also from clinical samples in our clinical microbiology laboratory. Hospitals and Community sewage had similar percentage of positive samplings for bla(KPC) and bla(NDM-1). VRE was found to be more abundant in sewage in Israel than MRSA but there were more locations positive for MRSA and VRE bacteria in Hospital sewage than in the Community. Therefore, our upgrade of the pour plate method for heterotrophic plate count technique using commercial selective agar plates can be a useful tool for routine screening and monitoring of the population for pan-resistant bacteria using sewage.	[Meir-Gruber, Lital; Gefen-Halevi, Shiraz; Smollan, Gill; Belausov, Natasha; Keller, Nathan] Chaim Sheba Med Ctr, Microbiol Lab, Tel Hashomer, Israel; [Manor, Yossi; Hindiyeh, Musa Y.; Mileguir, Fernando; Azar, Roberto; Mendelson, Ella] Minist Hlth, Chaim Sheba Med Ctr, Publ Hlth Serv, Cent Virol Lab, Tel Hashomer, Israel; [Meir-Gruber, Lital; Hindiyeh, Musa Y.; Rahav, Galia; Mendelson, Ella] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Shamiss, Ari] Chaim Sheba Med Ctr, Tel Hashomer, Israel; [Keller, Nathan] Chaim Sheba Med Ctr, Infect Dis Unit, Tel Hashomer, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Gefen-Halevi, S (corresponding author), Chaim Sheba Med Ctr, Microbiol Lab, Tel Hashomer, Israel.	Shiraz.halevi@shena.health.gov.il						Adler A, 2014, J ANTIMICROB CHEMOTH, V69, P1211, DOI 10.1093/jac/dkt505; [Anonymous], 2011, 21 INFORMATIONAL SUP, V31; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; Benenson S, 2012, J ANTIMICROB CHEMOTH, V67, P1651, DOI 10.1093/jac/dks115; Borer A, 2012, AM J INFECT CONTROL, V40, P421, DOI 10.1016/j.ajic.2011.05.022; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x; Cattoir V, 2013, J ANTIMICROB CHEMOTH, V68, P731, DOI 10.1093/jac/dks469; da Costa PM, 2013, INT J ENV RES PUB HE, V10, P278, DOI 10.3390/ijerph10010278; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Dukic VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052722; Espinal P, 2011, ANTIMICROB AGENTS CH, V55, P5396, DOI 10.1128/AAC.00679-11; Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004; Garcia LS, 2010, CLIN MICROBIOLOGY PR; Gefen-Halevi S, 2013, J CLIN MICROBIOL, V51, P1642, DOI 10.1128/JCM.00381-13; Greenberg A, 2005, STANDARD METHODS EXA, P9; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Heuer H, 2002, FEMS MICROBIOL ECOL, V42, P289, DOI 10.1111/j.1574-6941.2002.tb01019.x; Hindiyeh M, 2008, J CLIN MICROBIOL, V46, P2879, DOI 10.1128/JCM.00661-08; Klare I, 1995, MICROB DRUG RESIST, V1, P265, DOI 10.1089/mdr.1995.1.265; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Lachish T, 2012, INT J ANTIMICROB AG, V40, P566, DOI 10.1016/j.ijantimicag.2012.07.011; Leavitt A, 2007, ANTIMICROB AGENTS CH, V51, P3026, DOI 10.1128/AAC.00299-07; Manor Y, 2014, EUROSURVEILLANCE, V19, P31, DOI 10.2807/1560-7917.ES2014.19.7.20710; Mathai D, 2015, MICROB DRUG RESIST, V21, P59, DOI 10.1089/mdr.2014.0031; Nilsson Oskar, 2012, Infect Ecol Epidemiol, V2, DOI 10.3402/iee.v2i0.16959; Nordmann P, 2014, CLIN MICROBIOL INFEC, V20, P821, DOI 10.1111/1469-0691.12719; Nordmann P, 2014, MED MALADIES INFECT, V44, P51, DOI 10.1016/j.medmal.2013.11.007; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Pr M, 2011, MANUAL CLIN MICROBIO; Samra Z, 2007, INT J ANTIMICROB AG, V30, P525, DOI 10.1016/j.ijantimicag.2007.07.024; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Schwaber MJ, 2014, CLIN INFECT DIS, V58, P697, DOI 10.1093/cid/cit795; Schwaber MJ, 2011, CLIN INFECT DIS, V52, P848, DOI 10.1093/cid/cir025; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Zhang XZ, 2012, DIAGN MICR INFEC DIS, V73, P204, DOI 10.1016/j.diagmicrobio.2012.02.007	40	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164873	10.1371/journal.pone.0164873	http://dx.doi.org/10.1371/journal.pone.0164873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780222	Green Submitted, Green Published, gold			2022-12-26	WOS:000389046900021
J	Shang, WJ; Shen, YF; Gao, SL; Feng, GW; Feng, YH; Wang, ZG; Zhang, XB				Shang, Wenjun; Shen, Yuefeng; Gao, Shilin; Feng, Guiwen; Feng, Yonghua; Wang, Zhigang; Zhang, Xiaobai			Comparison of HLA-A, -B and-DRB1 Loci Polymorphism between Kidney Transplants of Uremia Patients and Healthy Individuals in Central China	PLOS ONE			English	Article							STAGE RENAL-DISEASE; POPULATION; FREQUENCIES; TAIWAN; GENE	Chronic kidney disease is becoming a global public health problem, which will usually cause uremia at the end stage of chronic kidney failure. So far, kidney transplant is the most effective and proper therapy for uremia, however, the short supply of matched donor kidney has been a persistent bottleneck for transplantation. HLA matching of HLA-A, -B and -DRB1 loci is very important for the allocation of kidney transplants. In this study, we investigated genotypes of HLA-A, -B and -DRB1 loci based on 1,464 uremia patients and 10,000 unrelated healthy individuals in Henan province of China, and compared the frequency distribution of these HLA alleles and corresponding haplotypes between patient and healthy groups. We detected 23 HLA-A, 49 HLA-B and 17 HLA-DRB1 alleles in total. The predominant alleles of HLA-A, -B and -DRB1 loci in patients are the same as those in healthy group. The seven most frequent alleles account for about 87%, 50%, and 77% at HLA-A, -B and -DRB1 loci, respectively. The haplotypes (combinations of HLA-A, -B, and -DRB1) with significantly different frequency between patients and controls mostly account for less than 1%. Overall, this suggests that HLA matching is not a potential difficulty for kidney transplant of uremia patients. However, three of the top seven frequent HLA-DRB1 alleles have a significantly different distribution in patients and controls, while only one alleles for HLA-B and zero for HLA-A loci. These HLA-DRB1 alleles may be closely associated with uremia. This study sheds new lights on the composition and difference of HLA genotypes in uremia patients and healthy populations in Central China that can serve as a guide to HLA matching for kidney transplants and a resource for HLA typing-related studies.	[Shang, Wenjun; Gao, Shilin; Feng, Guiwen; Feng, Yonghua; Wang, Zhigang] Zhengzhou Univ, Affiliated Hosp 1, Dept Kidney Transplantat, Zhengzhou, Henan, Peoples R China; [Shen, Yuefeng; Zhang, Xiaobai] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai, Peoples R China	Zhengzhou University; Tongji University	Wang, ZG (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Kidney Transplantat, Zhengzhou, Henan, Peoples R China.; Zhang, XB (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai, Peoples R China.	zhigang2012@126.com; zhangxb@tongji.edu.cn			National Natural Science Foundation of China [U1304810, 31200952]; China central colleges and universities basic research-specific cross discipline grant [1501219096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China central colleges and universities basic research-specific cross discipline grant	This work was supported by the National Natural Science Foundation of China (U1304810, 31200952), and the China central colleges and universities basic research-specific cross discipline grant (1501219096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Chang YW, 1997, HUM IMMUNOL, V56, P125, DOI 10.1016/S0198-8859(97)00108-0; Crispim JC, 2008, TRANSPL P, V40, P1333, DOI 10.1016/j.transproceed.2008.02.086; El-Gezawy Ebtesam M, 2011, Egypt J Immunol, V18, P13; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FREEDMAN BI, 1994, AM J KIDNEY DIS, V23, P797, DOI 10.1016/S0272-6386(12)80132-6; Karahan GE, 2009, RENAL FAILURE, V31, P44, DOI 10.1080/08860220802546297; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; MYTILINEOS J, 1993, TRANSPLANTATION, V55, P778, DOI 10.1097/00007890-199304000-00018; Nguyen HD, 2013, EVOLUTION HLA MATCHI, DOI [10.5772/54747, DOI 10.5772/54747]; Papasteriades C, 1997, DIS MARKERS, V13, P117; Shaw CK, 1999, TISSUE ANTIGENS, V53, P51, DOI 10.1034/j.1399-0039.1999.530106.x; Shen CM, 2008, CROAT MED J, V49, P476, DOI 10.3325/cmj.2008.4.476; Spriewald BM, 2005, ANN RHEUM DIS, V64, P457, DOI 10.1136/ard.2004.025809; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Vitetta L, 2013, MOL NUTR FOOD RES, V57, P824, DOI 10.1002/mnfr.201200714; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Zhang Hong-bo, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P464; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	20	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165426	10.1371/journal.pone.0165426	http://dx.doi.org/10.1371/journal.pone.0165426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780235	Green Published, gold, Green Submitted			2022-12-26	WOS:000389046900055
J	Yang, CJ; Wu, LN; Cai, WF; Zhu, WW; Shen, Q; Li, ZJ; Fang, Y				Yang, Caijun; Wu, Lina; Cai, Wenfang; Zhu, Wenwen; Shen, Qian; Li, Zongjie; Fang, Yu			Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study	PLOS ONE			English	Article							IMPACT; MEDICINES	Objective Drug shortages were a complex global problem. The aim of this study was to analyze, characterize, and assess the drug shortages, and identify possible solutions in Shaanxi Province, western China. Methods A qualitative methodological approach was conducted during May-June 2015 and December 2015-January 2016. Semi-structured interviews were performed to gather information from representatives of hospital pharmacists, wholesalers, pharmaceutical producers, and local health authorities. Results Thirty participants took part in the study. Eight traditional Chinese medicines and 87 types of biologicals and chemicals were reported to be in short supply. Most were essential medicines. Five main determinants of drug shortages were detected: too low prices, too low market demands, Good Manufacturing Practice (GMP) issues, materials issues, and approval issues for imported drugs. Five different solutions were proposed by the participants: 1) let the market decide the drug price; 2) establish an information platform; 3) establish a reserve system; 4) enhance the communication among the three parties in the supply chain; and 5) improve hospital inventory management. Conclusions Western China was currently experiencing a serious drug shortage. Numerous reasons for the shortage were identified. Most drug shortages in China were currently because of "too low prices." To solve this problem, all of the stakeholders, especially the government, needed to participate in managing the drug shortages.	[Yang, Caijun; Wu, Lina; Cai, Wenfang; Zhu, Wenwen; Shen, Qian; Li, Zongjie; Fang, Yu] Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian, Peoples R China; [Yang, Caijun; Wu, Lina; Cai, Wenfang; Zhu, Wenwen; Shen, Qian; Li, Zongjie; Fang, Yu] Xi An Jiao Tong Univ, Ctr Drug Safety & Policy Res, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Fang, Y (corresponding author), Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian, Peoples R China.; Fang, Y (corresponding author), Xi An Jiao Tong Univ, Ctr Drug Safety & Policy Res, Xian, Peoples R China.	yufang@mail.xjtu.edu.cn			National Natural Science Foundation of China [71503197, 71473192]; China Medical Board Open Competition Research Program [14-196]; "Young Talent Support Plan" of Xian Jiaotong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Medical Board Open Competition Research Program; "Young Talent Support Plan" of Xian Jiaotong University	This work is supported by National Natural Science Foundation of China (71503197 and 71473192) the China Medical Board Open Competition Research Program (14-196), and the "Young Talent Support Plan" of Xian Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHP Expert Panel on Drug Product Shortages, 2009, Am J Health Syst Pharm, V66, P1399, DOI 10.2146/ajhp090026; Baumer AM, 2004, AM J HEALTH-SYST PH, V61, P2015, DOI 10.1093/ajhp/61.19.2015; Beerten E, 2011, ANN PHARM BELGES, V15, P11; Bogaert P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125691; Butler D, 2013, NATURE, V504, P15, DOI 10.1038/504015a; Canadian Medical Association (CMA), 2011, EPANEL SURV SUMM GEN; Canadian Pharmacists Association (CPA), 2010, CAN DRUG SHORT SURV; Casassus B, 2015, LANCET, V385, P1279, DOI 10.1016/S0140-6736(15)60667-5; Chabner BA, 2011, NEW ENGL J MED, V365, P2147, DOI 10.1056/NEJMp1112633; Dill S, 2014, EUR J CLIN PHARMACOL, V70, P1405, DOI 10.1007/s00228-014-1747-1; Ding, 2015, J TRADITIONAL CHINES, V23, P99; Dylst P, 2013, APPL HEALTH ECON HEA, V11, P437, DOI 10.1007/s40258-013-0043-z; Fang L., 2015, CHINESE HLTH SERVICE, V8, P610; Fang Y, 2013, LANCET GLOB HEALTH, V1, pE227, DOI 10.1016/S2214-109X(13)70072-X; Generics and Biosimilarrs Initiative, 2012, UK DRUG SHORT AR FAR; Gong SW, 2010, CHIN J HOSP ADM, V26, P126; Gray A, 2012, B WORLD HEALTH ORGAN, V90, P158, DOI 10.2471/BLT.11.101303; Gu JL, 2013, SOFT SCI HLTH, V27, P325; Haninger K, 2011, EC ANAL CAUSES DRUG; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, P1811, DOI 10.2146/ajhp110210; Kaiser J, 2011, SCIENCE, V332, P523, DOI 10.1126/science.332.6029.523; Kaposy C, 2014, J BIOETHIC INQ, V11, P1; Kux L, 2011, PUBL WORKSH REQ COMM; Kweder SL, 2013, CLIN PHARMACOL THER, V93, P245, DOI 10.1038/clpt.2012.235; Liu B., 2007, CHINA PHARM, V18, P2481, DOI [10.1360/jos180001, DOI 10.1360/JOS180001]; [刘敏豪 Liu Minhao], 2012, [中国药房, China Pharmacy], V23, P673; Liu XK, 2013, J N PHARM, V10, P88; Meng QY, 2005, HEALTH POLICY PLANN, V20, P185, DOI 10.1093/heapol/czi018; National Development and Reform Commission. (NDRC), 2014, NOT IMPR MAN LOW PRI; National Health and Family Planning Commission of the People's Republic of China, 2013, NAT ESS MED LIST; Pauwels K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119322; Pauwels K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-438; Printz C, 2012, CANCER-AM CANCER SOC, V118, P289, DOI 10.1002/cncr.27386; Rosoff PM, 2012, AM J BIOETHICS, V12, P1, DOI 10.1080/15265161.2011.634483; Schweitzer SO, 2013, AM J PUBLIC HEALTH, V103, pE10, DOI 10.2105/AJPH.2013.301239; Tang S., 2015, CHINESE GEN PRACTICE, V18, P243; Tucker ME, 2012, BRIT MED J, V345, P900; US Food and Drug Administration, 2011, REV FDAS APPR MED PR; Ventola C Lee, 2011, P T, V36, P740; Wang YG., 2005, DECISION INFORM FINA, V12, P36; WHO, 1988, DEV IMPL NAT DRUG PO; WHO, 2012, W AR HLTH IN; Woodcock J, 2013, CLIN PHARMACOL THER, V93, P170, DOI 10.1038/clpt.2012.220; World Health Organisation, 2001, WHO TECHN REP SER; Zeng WJ, 2014, J COMP EFFECT RES, V3, P371, DOI [10.2217/CER.14.28, 10.2217/cer.14.28]	45	31	34	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165183	10.1371/journal.pone.0165183	http://dx.doi.org/10.1371/journal.pone.0165183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780218	gold, Green Published, Green Submitted			2022-12-26	WOS:000389046900034
J	Costanzo, G; Pino, S; Timperio, AM; Sponer, JE; Sponer, J; Novakova, O; Sedo, O; Zdrahal, Z; Di Mauro, E				Costanzo, Giovanna; Pino, Samanta; Timperio, Anna Maria; Sponer, Judit E.; Sponer, Jiri; Novakova, Olga; Sedo, Ondrej; Zdrahal, Zbynek; Di Mauro, Ernesto			Non-Enzymatic Oligomerization of 3 ', 5 ' Cyclic AMP	PLOS ONE			English	Article							TEMPLATE-DIRECTED SYNTHESIS; NUCLEOSIDE PHOSPHORYLATION; MONTMORILLONITE CATALYSIS; MOLECULAR-STRUCTURE; RIBOZYME ACTIVITY; RNA; OLIGONUCLEOTIDES; POLYMERIZATION; GMP; DNA	Recent studies illustrate that short oligonucleotide sequences can be easily produced from nucleotide precursors in a template-free non-enzymatic way under dehydrating conditions, i.e. using essentially dry materials. Here we report that 3',5' cyclic AMP may also serve as a substrate of the reaction, which proceeds under moderate conditions yet with a lower efficiency than the previously reported oligomerization of 3',5' cyclic GMP. Optimally the oligomerization requires (i) a temperature of 80 degrees C, (ii) a neutral to alkaline environment and (iii) a time on the order of weeks. Differences in the yield and required reaction conditions of the oligomerizations utilizing 3', 5' cGMP and cAMP are discussed in terms of the crystal structures of the compounds. Polymerization of 3',5' cyclic nucleotides, whose paramount relevance in a prebiotic chemistry context has been widely accepted for decades, supports the possibility that the origin of extant genetic materials might have followed a direct uninterrupted path since its very beginning, starting from non-elaborately pre-activated monomer compounds and simple reactions.	[Costanzo, Giovanna] CNR, Ist Biol & Patol Mol, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Pino, Samanta] Sapienza Univ Roma, Dipartimento Biol & Biotecnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Timperio, Anna Maria] La Tuscia Univ, Dept Ecol & Biol, I-01100 Viterbo, Italy; [Sponer, Judit E.; Sponer, Jiri; Novakova, Olga] Acad Sci Czech Republic, Inst Biophys, Kralovopolska 135, CZ-61265 Brno, Czech Republic; [Sponer, Judit E.; Sponer, Jiri; Sedo, Ondrej; Zdrahal, Zbynek] Masaryk Univ, CEITEC Cent European Inst Technol, Kamenice 5, CZ-62500 Brno, Czech Republic; [Di Mauro, Ernesto] Sapienza Univ Roma, Dipartimento Biol Biotecnol Charles Darwin, Fdn Cenci Bolognetti, Ist Pasteur Italia, Ple Aldo Moro 5, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Tuscia University; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno; Fondazione Cenci Bolognetti; Sapienza University Rome	Sponer, JE (corresponding author), Acad Sci Czech Republic, Inst Biophys, Kralovopolska 135, CZ-61265 Brno, Czech Republic.; Sponer, JE (corresponding author), Masaryk Univ, CEITEC Cent European Inst Technol, Kamenice 5, CZ-62500 Brno, Czech Republic.; Di Mauro, E (corresponding author), Sapienza Univ Roma, Dipartimento Biol Biotecnol Charles Darwin, Fdn Cenci Bolognetti, Ist Pasteur Italia, Ple Aldo Moro 5, I-00185 Rome, Italy.	judit@ncbr.muni.cz; ernesto.dimauro@uniroma1.it	novakova, olga/H-1938-2014; Zdrahal, Zbynek/D-9491-2012; Šedo, Ondrej/D-9868-2012; Sponer, Jiri/D-9467-2012	Novakova, Olga/0000-0001-8653-4836; Sponer, Jiri/0000-0001-6558-6186; Zdrahal, Zbynek/0000-0003-3044-5548	Italian Space Agency (ASI) project "Esobiologia e Ambienti estremi: dalla chimica delle Molecola alla Biologia degli estremofili" [2014-026-R.0 (CUP: F 92114000030005)]; Ministry of Education, Youth and Sports of the Czech Republic [CEITEC 2020 (LQ1601)]; Grant Agency of the Czech Republic [14-12010S]; Proteomics Core Facility of CEITEC under CIISB project [LM2015043]; Ministry of Education, Youth and Sports of the Czech Republic; CSF [P206/12/G151]	Italian Space Agency (ASI) project "Esobiologia e Ambienti estremi: dalla chimica delle Molecola alla Biologia degli estremofili"; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Proteomics Core Facility of CEITEC under CIISB project; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); CSF	This work is supported by the Italian Space Agency (ASI) project "Esobiologia e Ambienti estremi: dalla chimica delle Molecola alla Biologia degli estremofili" Number 2014-026-R.0 (CUP: F 92114000030005); by the Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601); and by the Grant Agency of the Czech Republic, grant number 14-12010S. The MS part of work was carried out with the support of Proteomics Core Facility of CEITEC under CIISB project, ID number LM2015043, funded by the Ministry of Education, Youth and Sports of the Czech Republic. OS and ZZ thanks for support of CSF (project P206/12/G151).	Atkins J. F., 2011, RNA WORLDS LIFES ORI; Attwater J, 2013, NAT CHEM, V5, P1011, DOI [10.1038/nchem.1781, 10.1038/NCHEM.1781]; Burcar BT, 2013, ORIGINS LIFE EVOL B, V43, P247, DOI 10.1007/s11084-013-9334-5; CHWANG AK, 1974, ACTA CRYSTALLOGR B, V30, P1233, DOI 10.1107/S0567740874004602; Costanzo G, 2007, J BIOL CHEM, V282, P16729, DOI 10.1074/jbc.M611346200; Costanzo G, 2012, CHEMBIOCHEM, V13, P999, DOI 10.1002/cbic.201200068; Costanzo G, 2009, J BIOL CHEM, V284, P33206, DOI 10.1074/jbc.M109.041905; Cozens C, 2012, P NATL ACAD SCI USA, V109, P8067, DOI 10.1073/pnas.1120964109; Deck C, 2011, NAT CHEM, V3, P603, DOI [10.1038/NCHEM.1086, 10.1038/nchem.1086]; Dickson KS, 2000, J BIOL CHEM, V275, P15828, DOI 10.1074/jbc.M910044199; Egetenmeyer S, 2011, CHEM-EUR J, V17, P11813, DOI 10.1002/chem.201101828; Ferris JP, 2002, ORIGINS LIFE EVOL B, V32, P311, DOI 10.1023/A:1020543312109; Gull M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17198; Huang WH, 2006, J AM CHEM SOC, V128, P8914, DOI 10.1021/ja061782k; JARVINEN P, 1991, J ORG CHEM, V56, P5396, DOI 10.1021/jo00018a037; Kaiser A, 2012, ANGEW CHEM INT EDIT, V51, P8299, DOI 10.1002/anie.201203859; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; MILLS DR, 1975, P NATL ACAD SCI USA, V72, P4252, DOI 10.1073/pnas.72.11.4252; Morasch M, 2014, CHEMBIOCHEM, V15, P879, DOI 10.1002/cbic.201300773; Mutschler H, 2015, NAT CHEM, V7, P502, DOI [10.1038/NCHEM.2251, 10.1038/nchem.2251]; Orgel LE, 2004, CRIT REV BIOCHEM MOL, P39; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; Pino S, 2013, ENTROPY-SWITZ, V15, P5362, DOI 10.3390/e15125362; RUDOLPH SA, 1971, J BIOL CHEM, V246, P1271; Saladino R, 2006, J BIOL CHEM, V281, P5790, DOI 10.1074/jbc.M512545200; Saladino R, 2015, P NATL ACAD SCI USA, V112, pE2746, DOI 10.1073/pnas.1422225112; SCHOFFSTALL AM, 1976, ORIGINS LIFE EVOL B, V7, P399, DOI 10.1007/BF00927935; Schrum JP, 2009, J AM CHEM SOC, V131, P14560, DOI 10.1021/ja906557v; Soukup GA, 1999, TRENDS BIOTECHNOL, V17, P469, DOI 10.1016/S0167-7799(99)01383-9; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sponer JE, 2015, J PHYS CHEM B, V119, P2979, DOI 10.1021/acs.jpcb.5b00601; Taran O, 2010, J SYST CHEM, V1, P1; USHER DA, 1976, SCIENCE, V192, P53, DOI 10.1126/science.1257755; VARUGHESE KI, 1982, J AM CHEM SOC, V104, P3398, DOI 10.1021/ja00376a026; VERLANDER MS, 1973, J MOL EVOL, V2, P303, DOI 10.1007/BF01654098; WU T, 1992, J AM CHEM SOC, V114, P7963, DOI 10.1021/ja00047a001	36	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165723	10.1371/journal.pone.0165723	http://dx.doi.org/10.1371/journal.pone.0165723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802310	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200045
J	Chen, DY; Lin, CH; Chen, YM; Chen, HH				Chen, Der-Yuan; Lin, Ching-Heng; Chen, Yi-Ming; Chen, Hsin-Hua			Risk of Atrial Fibrillation or Flutter Associated with Periodontitis: A Nationwide, Population-Based, Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SYSTEMIC INFLAMMATION MARKERS; ACUTE MYOCARDIAL-INFARCTION; CHRONIC KIDNEY-DISEASE; CARDIAC-SURGERY; PREVALENCE; ARRHYTHMIAS; RECURRENCE; PSORIASIS; PATHOPHYSIOLOGY	Objective To investigate the risk of atrial fibrillation or atrial flutter in patients with periodontitis (PD) in comparison with individuals without PD. Methods We used the 1999-2010 Taiwanese National Health Insurance Research Database to identify cases of PD in the year 2000 matching (1: 1) with persons without PD during 1999-2000 according to sex and individual age as the control group. Using Cox proportional regression analysis adjusting for potential confounders, including age, sex, and comorbidities at baseline, and average annual number of ambulatory visits and dental scaling frequency during the follow-up period, we estimated hazard ratios (HRs) with 95% confidence intervals (CIs) to examine the risk of atrial fibrillation or flutter in PD patients in comparison with the control group. Subgroup analyses according to age, gender, or comorbidities were conducted to study the robustness of the association and investigate possible interaction effects. Results We enrolled 393,745 patients with PD and 393,745 non-PD individuals. The incidence rates of atrial fibrillation or flutter were 200 per 10 5 years among the PD group and 181 per 10 5 years in the non-PD group (incidence rate ratio, 1.10; 95% CI, 1.06-1.14). After adjusting for potential confounders, we found an increased risk of atrial fibrillation or flutter in the PD group compared with the non-PD group (HR, 1.31; 95% CI, 1.25-1.36). The greater risk of atrial fibrillation or flutter in the PD group remained significant across all disease subgroups except hyperthyroidism and sleep apnea. Conclusion The present study results indicate an increased risk of atrial fibrillation or flutter in patients with PD. Lack of individual information about alcohol consumption, obesity, and tobacco use was a major limitation.	[Chen, Der-Yuan; Lin, Ching-Heng; Chen, Yi-Ming; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Chen, Hsin-Hua] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan.; Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan.	shc5555@hotmail.com	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065				Ahlehoff O, 2012, EUR HEART J, V33, P2054, DOI 10.1093/eurheartj/ehr285; Al-Zaiti SS, 2014, HEART LUNG, V44, P59, DOI 10.1016/j.hrtlng.2014.10.005; Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Bacani AK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/809514; Bang CN, 2014, J HYPERTENS, V32, P667, DOI 10.1097/HJH.0000000000000078; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; CAMERON A, 1988, AM J CARDIOL, V61, P714, DOI 10.1016/0002-9149(88)91053-3; Chao TF, 2013, INT J CARDIOL, V168, P1360, DOI 10.1016/j.ijcard.2012.12.011; Chen SJ, 2013, INT J CARDIOL, V168, P2300, DOI 10.1016/j.ijcard.2013.01.192; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; Conen D, 2009, CIRCULATION, V119, P2146, DOI 10.1161/CIRCULATIONAHA.108.830042; Crenshaw BS, 1997, J AM COLL CARDIOL, V30, P406, DOI 10.1016/S0735-1097(97)00194-0; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; Dernellis J, 2004, EUR HEART J, V25, P1100, DOI 10.1016/j.ehj.2004.04.025; Dublin S, 2010, J GEN INTERN MED, V25, P853, DOI 10.1007/s11606-010-1340-y; Eldar M, 1998, CIRCULATION, V97, P965; Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350; Fein AS, 2013, J AM COLL CARDIOL, V62, P300, DOI 10.1016/j.jacc.2013.03.052; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Frost L, 2005, INT J CARDIOL, V103, P78, DOI 10.1016/j.ijcard.2004.08.024; Frost L, 2004, ARCH INTERN MED, V164, P1675, DOI 10.1001/archinte.164.15.1675; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Galea R, 2014, TEX HEART I J, V41, P461, DOI 10.14503/THIJ-13-3466; Gami AS, 2004, CIRCULATION, V110, P364, DOI 10.1161/01.CIR.0000136587.68725.8E; Giannopoulos G, 2014, MED CHEM, V10, P663, DOI 10.2174/1573406410666140318110100; Greve AM, 2013, INT J CARDIOL, V166, P72, DOI 10.1016/j.ijcard.2011.09.064; Guo YT, 2015, CHEST, V147, P109, DOI 10.1378/chest.14-0321; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hayashi T, 2013, EUROPACE, V15, P1777, DOI 10.1093/europace/eut158; Ho KM, 2009, CIRCULATION, V119, P1853, DOI 10.1161/CIRCULATIONAHA.108.848218; Holm-Pedersen P, 2005, J AM GERIATR SOC, V53, P430, DOI 10.1111/j.1532-5415.2005.53160.x; Hu YF, 2015, NAT REV CARDIOL, V12, P230, DOI 10.1038/nrcardio.2015.2; Ishii Y, 2005, CIRCULATION, V111, P2881, DOI 10.1161/CIRCULATIONAHA.104.475194; Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054; Kallergis EM, 2008, HEART, V94, P200, DOI 10.1136/hrt.2006.108688; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Kim EJ, 2014, AM HEART J, V167, P123, DOI 10.1016/j.ahj.2013.10.012; Lindhardsen J, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1257; Liu T, 2008, AM J CARDIOL, V102, P647, DOI 10.1016/j.amjcard.2008.06.031; Liu T, 2007, J AM COLL CARDIOL, V49, P1642, DOI 10.1016/j.jacc.2006.12.042; Loos BG, 2005, J PERIODONTOL, V76, P2106, DOI 10.1902/jop.2005.76.11-S.2106; Maisel WH, 2003, AM J CARDIOL, V91, p2D, DOI 10.1016/S0002-9149(02)03373-8; Marcus GM, 2008, HEART RHYTHM, V5, P215, DOI 10.1016/j.hrthm.2007.10.007; Marott SCW, 2010, J AM COLL CARDIOL, V56, P789, DOI 10.1016/j.jacc.2010.02.066; Martinez-Comendador J, 2016, THORAC CARDIOV SURG, V64, P427, DOI 10.1055/s-0035-1555753; Nadeem M, 2009, SADJ, V64, P470; Nibali L, 2007, J CLIN PERIODONTOL, V34, P931, DOI 10.1111/j.1600-051X.2007.01133.x; Nucifora G, 2011, INT J CARDIOVAS IMAG, V27, P777, DOI 10.1007/s10554-010-9725-x; Ohlmeier C, 2013, EUROPACE, V15, P1436, DOI 10.1093/europace/eut048; Ohsawa M, 2005, J EPIDEMIOLOGY JAPAN, V15; Pejcic A, 2011, EUR J CLIN MICROBIOL, V30, P407, DOI 10.1007/s10096-010-1101-1; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Pink C, 2015, J CLIN PERIODONTOL, V42, P988, DOI 10.1111/jcpe.12473; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Sekine Y, 2001, CHEST, V120, P1783, DOI 10.1378/chest.120.6.1783; Selmer C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7895; Shi D, 2008, J PERIODONTOL, V79, P2340, DOI [10.1902/jop.2008.080192, 10.1902/jop.2008.080192 ]; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stortecky S, 2013, CIRC-CARDIOVASC INTE, V6, P77, DOI 10.1161/CIRCINTERVENTIONS.112.000124; Watanabe H, 2009, AM HEART J, V158, P629, DOI 10.1016/j.ahj.2009.06.031; Wazni O, 2005, HEART, V91, P1303, DOI 10.1136/hrt.2004.038661; Wilke T, 2013, EUROPACE, V15, P486, DOI 10.1093/europace/eus333; Yu GA, 2010, J ELECTROCARDIOL, V43, P359, DOI 10.1016/j.jelectrocard.2009.12.002	68	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165601	10.1371/journal.pone.0165601	http://dx.doi.org/10.1371/journal.pone.0165601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798703	Green Submitted, Green Published, gold			2022-12-26	WOS:000386711100048
J	Karna, SLR; D'Arpa, P; Chen, T; Qian, LW; Fourcaudot, AB; Yamane, K; Chen, P; Abercrombie, JJ; You, T; Leung, KP				Karna, S. L. Rajasekhar; D'Arpa, Peter; Chen, Tsute; Qian, Li-Wu; Fourcaudot, Andrea B.; Yamane, Kazuyoshi; Chen, Ping; Abercrombie, Johnathan J.; You, Tao; Leung, Kai P.			RNA-Seq Transcriptomic Responses of FullThickness Dermal Excision Wounds to Pseudomonas aeruginosa Acute and Biofilm Infection	PLOS ONE			English	Article							GENE-EXPRESSION; SIGMA-FACTOR; IN-VITRO; ACTIVATION; MODEL; PVDS; REGULATORS; VIRULENCE; BODIES; REPAIR	Pseudomonas aeruginosa infections of wounds in clinical settings are major complications whose outcomes are influenced by host responses that are not completely understood. Herein we evaluated transcriptomic changes of wounds as they counter P. aeruginosa infection D first active infection, and then chronic biofilm infection. We used the dermal fullthickness, rabbit ear excisional wound model. We studied the wound response: towards acute infection at 2, 6, and 24 hrs after inoculating 10(6) bacteria into day-3 wounds; and, towards more chronic biofilm infection of wounds similarly infected for 24 hrs but then treated with topical antibiotic to coerce biofilm growth and evaluated at day 5 and 9 postinfection. The wounds were analyzed for bacterial counts, expression of P. aeruginosa virulence and biofilm-synthesis genes, biofilm morphology, infiltrating immune cells, re-epithelialization, and genome-wide gene expression (RNA-Seq transcriptome). This analysis revealed that 2 hrs after bacterial inoculation into day-3 wounds, the down-regulated genes (infected vs. non-infected) of the wound edge were nearly all non-coding RNAs (ncRNAs), comprised of snoRNA, miRNA, and RNU6 pseudogenes, and their down-regulation preceded a general down-regulation of skin-enriched coding gene expression. As the active infection intensified, ncRNAs remained overrepresented among down-regulated genes; however, at 6 and 24 hrs they changed to a different set, which overlapped between these times, and excluded RNU6 pseudogenes but included snRNA components of the major and minor spliceosomes. Additionally, the raw counts of multiple types of differentiallyexpressed ncRNAs increased on post-wounding day 3 in control wounds, but infection suppressed this increase. After 5 and 9 days, these ncRNA counts in control wounds decreased, whereas they increased in the infected, healing-impaired wounds. These data suggest a sequential and coordinated change in the levels of transcripts of multiple major classes of ncRNAs in wound cells transitioning from inflammation to the proliferation phase of healing.	[Karna, S. L. Rajasekhar; Qian, Li-Wu; Fourcaudot, Andrea B.; Yamane, Kazuyoshi; Chen, Ping; Abercrombie, Johnathan J.; You, Tao; Leung, Kai P.] US Army Inst Surg Res, Dent & Craniofacial Trauma Res & Tissue Regenerat, Jbsa Ft Sam Houston, TX USA; [D'Arpa, Peter] US Army Ctr Environm Hlth Res, Ft Detrick, MD USA; [D'Arpa, Peter] Geneva Fdn, Tacoma, WA USA; [Chen, Tsute] Forsyth Inst, Cambridge, MA USA	United States Department of Defense; United States Army; Harvard University; Forsyth Institute	Leung, KP (corresponding author), US Army Inst Surg Res, Dent & Craniofacial Trauma Res & Tissue Regenerat, Jbsa Ft Sam Houston, TX USA.	kai.p.leung.civ@mail.mil	Chen, Tsute/ABC-2676-2020; Karna, Sai Lakshmi Rajasekhar/AAG-6587-2019	Karna, Sai Lakshmi Rajasekhar/0000-0002-1876-7117; D'Arpa, Peter/0000-0002-0562-0263	US Army Medical Research and Materiel Command; Combat Casualty Care Research Directorate; Naval Medical Research Center's Advanced Medical Development program [MIPR N3239815MHX040]; Research Associateship Program from the National Research Council; U. S. Army Research Laboratory; U.S. Army Research Office [W911NF1310376]	US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Combat Casualty Care Research Directorate; Naval Medical Research Center's Advanced Medical Development program; Research Associateship Program from the National Research Council; U. S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office	This work was supported in part by the US Army Medical Research and Materiel Command, Combat Casualty Care Research Directorate and the Naval Medical Research Center's Advanced Medical Development program (MIPR N3239815MHX040) (KPL)and the Research Associateship Program from the National Research Council (SLRK). P. D'Arpa is supported by the U. S. Army Research Laboratory and the U.S. Army Research Office under contract/grant number W911NF1310376 to The Geneva Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN ST, 1990, ANN PLAS SURG, V24, P17, DOI 10.1097/00000637-199001000-00004; Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1; Bratkovic T, 2014, BBA-GENE REGUL MECH, V1839, P438, DOI 10.1016/j.bbagrm.2014.04.009; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Choi KM, 2010, GASTROENTEROLOGY, V138, P2399, DOI 10.1053/j.gastro.2010.02.014; CHU L, 1991, GENE, V107, P1, DOI 10.1016/0378-1119(91)90290-R; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eulalio A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017296; FIELD CK, 1994, AM J SURG, V167, pS2, DOI 10.1016/0002-9610(94)90002-7; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Galiano RD, 1996, J CLIN INVEST, V98, P2462, DOI 10.1172/JCI119064; Gurianova V, 2015, CELL BIOCHEM FUNCT, V33, P509, DOI 10.1002/cbf.3151; Gurjala AN, 2011, WOUND REPAIR REGEN, V19, P400, DOI 10.1111/j.1524-475X.2011.00690.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P6110, DOI 10.1128/AEM.01421-13; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Leoni L, 2000, J BACTERIOL, V182, P1481, DOI 10.1128/JB.182.6.1481-1491.2000; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Leung KP, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-20; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marguerat S, 2008, BIOCHEM SOC T, V36, P1091, DOI 10.1042/BST0361091; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Nabzdyk LP, 2013, J VASC SURG, V58, P766, DOI 10.1016/j.jvs.2012.11.095; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Ochsner UA, 1996, MOL MICROBIOL, V21, P1019, DOI 10.1046/j.1365-2958.1996.481425.x; Percival SL, 2014, WOUND REPAIR REGEN, V22, P174, DOI 10.1111/wrr.12125; Pirnay JP, 2000, CRIT CARE, V4, P255, DOI 10.1186/cc702; Qian LW, 2016, WOUND REPAIR REGEN, V24, P26, DOI 10.1111/wrr.12381; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Remminghorst U, 2006, APPL ENVIRON MICROB, V72, P298, DOI 10.1128/AEM.72.1.298-305.2006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seth AK, 2012, J AM COLL SURGEONS, V215, P388, DOI 10.1016/j.jamcollsurg.2012.05.028; Sharpe JR, 2009, BRIT J DERMATOL, V161, P671, DOI 10.1111/j.1365-2133.2009.09168.x; Takeo K, 2009, AM J PHYSIOL-CELL PH, V297, pC330, DOI 10.1152/ajpcell.00009.2009; Team RC, 2015, R LANG ENV STAT COMP; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Tsalikis J, 2015, J BIOL CHEM, V290, P20904, DOI 10.1074/jbc.M115.659466; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; Vasil ML, 1998, J BACTERIOL, V180, P6784, DOI 10.1128/JB.180.24.6784-6788.1998; Wan LL, 2008, MOL CELL, V31, P244, DOI 10.1016/j.molcel.2008.06.004; Wang HLV, 2016, WIRES RNA, V7, P356, DOI 10.1002/wrna.1340; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Youssef OA, 2015, P NATL ACAD SCI USA, V112, P5023, DOI 10.1073/pnas.1424044112	51	9	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165312	10.1371/journal.pone.0165312	http://dx.doi.org/10.1371/journal.pone.0165312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792773	gold, Green Published, Green Submitted			2022-12-26	WOS:000389537000017
J	Chandran, UR; Medvedeva, OP; Barmada, MM; Blood, PD; Chakka, A; Luthra, S; Ferreira, A; Wong, KF; Lee, AV; Zhang, Z; Budden, R; Scott, JR; Berndt, A; Berg, JM; Jacobson, RS				Chandran, Uma R.; Medvedeva, Olga P.; Barmada, M. Michael; Blood, Philip D.; Chakka, Anish; Luthra, Soumya; Ferreira, Antonio; Wong, Kim F.; Lee, Adrian V.; Zhang, Zhihui; Budden, Robert; Scott, J. Ray; Berndt, Annerose; Berg, Jeremy M.; Jacobson, Rebecca S.			TCGA Expedition: A Data Acquisition and Management System for TCGA Data	PLOS ONE			English	Article							SIGNATURE	Background The Cancer Genome Atlas Project (TCGA) is a National Cancer Institute effort to profile at least 500 cases of 20 different tumor types using genomic platforms and to make these data, both raw and processed, available to all researchers. TCGA data are currently over 1.2 Petabyte in size and include whole genome sequence (WGS), whole exome sequence, methylation, RNA expression, proteomic, and clinical datasets. Publicly accessible TCGA data are released through public portals, but many challenges exist in navigating and using data obtained from these sites. We developed TCGA Expedition to support the research community focused on computational methods for cancer research. Data obtained, versioned, and archived using TCGA Expedition supports command line access at high-performance computing facilities as well as some functionality with third party tools. For a subset of TCGA data collected at University of Pittsburgh, we also re-associate TCGA data with de-identified data from the electronic health records. Here we describe the software as well as the architecture of our repository, methods for loading of TCGA data to multiple platforms, and security and regulatory controls that conform to federal best practices. Results TCGA Expedition software consists of a set of scripts written in Bash, Python and Java that download, extract, harmonize, version and store all TCGA data and metadata. The software generates a versioned, participant-and sample-centered, local TCGA data directory with metadata structures that directly reference the local data files as well as the original data files. The software supports flexible searches of the data via a web portal, user-centric data tracking tools, and data provenance tools. Using this software, we created a collaborative repository, the Pittsburgh Genome Resource Repository (PGRR) that enabled investigators at our institution to work with all TCGA data formats, and to interrogate these data with analysis pipelines, and associated tools. WGS data are especially challenging for individual investigators to use, due to issues with downloading, storage, and processing; having locally accessible WGS BAM files has proven invaluable. Conclusion Our open-source, freely available TCGA Expedition software can be used to create a local collaborative infrastructure for acquiring, managing, and analyzing TCGA data and other large public datasets.	[Chandran, Uma R.; Medvedeva, Olga P.; Barmada, M. Michael; Chakka, Anish; Luthra, Soumya; Jacobson, Rebecca S.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15260 USA; [Chandran, Uma R.; Chakka, Anish; Luthra, Soumya; Lee, Adrian V.; Jacobson, Rebecca S.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA; [Barmada, M. Michael] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15260 USA; [Barmada, M. Michael; Ferreira, Antonio; Wong, Kim F.] Univ Pittsburgh, Ctr Simulat & Modeling, Pittsburgh, PA USA; [Blood, Philip D.; Zhang, Zhihui; Budden, Robert; Scott, J. Ray] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA; [Lee, Adrian V.] Univ Pittsburgh, Dept Pharmacol & Cell Biol, Pittsburgh, PA USA; [Lee, Adrian V.] Magee Womens Res Inst, Pittsburgh, PA USA; [Barmada, M. Michael; Berndt, Annerose] UPMC Corp Serv, Pittsburgh, PA USA; [Berg, Jeremy M.; Jacobson, Rebecca S.] Univ Pittsburgh, Inst Precis Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jacobson, RS (corresponding author), Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15260 USA.; Jacobson, RS (corresponding author), Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA.; Jacobson, RS (corresponding author), Univ Pittsburgh, Inst Precis Med, Pittsburgh, PA 15260 USA.	rebeccaj@pitt.edu	Berg, Jeremy/GRY-6706-2022	Berg, Jeremy/0000-0002-2444-8139; Chakka, Anish Bhaswanth/0000-0002-1095-1817; Ferreira, Antonio/0000-0002-6581-6233; Lee, Adrian/0000-0001-9917-514X; Berg, Jeremy/0000-0003-3022-0963	Institute for Precision Medicine at the University of Pittsburgh; University of Pittsburgh Cancer Institute; National Cancer Institute [P30CA047904]; National Science Foundation CC*IIE award [144064]; National Science Foundation at the Pittsburgh Supercomputing Center (PSC) [ACI-1261721]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	Institute for Precision Medicine at the University of Pittsburgh; University of Pittsburgh Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation CC*IIE award(National Science Foundation (NSF)); National Science Foundation at the Pittsburgh Supercomputing Center (PSC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge support from the Institute for Precision Medicine at the University of Pittsburgh and the University of Pittsburgh Cancer Institute. The project used the UPCI Tissue and Research Pathology Services that is supported in part by award P30CA047904 from the National Cancer Institute (https://na01.safelinks.protection.outlook.com/?url=www.cancer.gov&data=01%7C01%7Crebeccaj%40pitt.edu%7Cf6b178379b3b481e214008d3f8e68cb2%7C9ef9f489e0a04eeb87cc3a526112fd0d%7C1&sdata=XmoeftTTF9W%2B%2BFuUmIFfSthqmb%2B2QpBFd%2FvAzjjler4%3D&reserved=0). Upgrades to the Pitt networking infrastructure to support the collaboration were funded through National Science Foundation CC* IIE award #144064. This work used the Data Exacell, which is supported by National Science Foundation award number ACI-1261721, at the Pittsburgh Supercomputing Center (PSC). Additionally, this project used the UPCI Cancer Bioinformatics Services, which is supported in part by the National Cancer Institute award P30CA047904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the help of technical staff at Pittsburgh Supercomputing Center, the Simulation and Modeling Center and the Department of Biomedical Informatics at the University of Pittsburgh. We thank Jared Yanovich, formerly at PSC and now at Google, for assistance with SLASH2 development and implementation. We also thank Sean Sweeney, and Brian Pasquini at the Pitt Computing Services and Systems Development (CSSD). Security for their help in ensuring that we meet the dbGAP security best practices, and Brian Stengel (CSSD) for his assistance with Science DMZ integration. Finally, we are indebted to Michelle Kienholz for her expert editorial assistance. We gratefully acknowledge support from the Institute for Precision Medicine at the University of Pittsburgh and the University of Pittsburgh Cancer Institute. The project used the UPCI Tissue and Research Pathology Services that is supported in part by award P30CA047904. Upgrades to the Pitt networking infrastructure to support the collaboration were funded through NSF CC*IIE award #144064. This work used the Data Exacell, which is supported by National Science Foundation award number ACI-1261721, at the Pittsburgh Supercomputing Center (PSC). Additionally, this project used the UPCI Cancer Bioinformatics Services, which is supported in part by the National Cancer Institute award P30CA047904.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Cooper GF, 2015, J AM MED INFORM ASSN, V22, P1132, DOI 10.1093/jamia/ocv059; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hamilton MP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3730; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li XL, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-159; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; Mardis ER, 2013, ANNU REV ANAL CHEM, V6, P287, DOI 10.1146/annurev-anchem-062012-092628; Nowoczynski P, 2012, P 1 C EXTR SCI ENG D, P1; Robbins DE, 2013, BIOINFORMATICS, V29, P1333, DOI 10.1093/bioinformatics/btt141; Scheufele Elisabeth, 2014, AMIA Jt Summits Transl Sci Proc, V2014, P96; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Volinia S, 2013, P NATL ACAD SCI USA, V110, P7413, DOI 10.1073/pnas.1304977110; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Weisenberger DJ, 2014, J CLIN INVEST, V124, P17, DOI 10.1172/JCI69740	24	44	45	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165395	10.1371/journal.pone.0165395	http://dx.doi.org/10.1371/journal.pone.0165395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788220	gold, Green Submitted, Green Published			2022-12-26	WOS:000389604900075
J	Tian, XB; Jiang, JM; Wang, JD; Zhang, SC				Tian, Xiaobing; Jiang, Jingmei; Wang, Jiedong; Zhang, Shucheng			Improved Fecundity in Northern China: A Secular Trend from 1980 to 2003	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; TIME-TO-PREGNANCY; SEMEN QUALITY; REGIONAL DIFFERENCES; REPRODUCTIVE HEALTH; HUMAN-FERTILITY; WAITING TIME; DECLINE; INFERTILITY; BRITAIN	Objective This study aimed to assess the trend of human fecundity over time in China. Methods This retrospective study was conducted in Tongliao, China. Couples who were married during the time period between January 1, 1981 and December 31, 2003 were considered eligible for this study. A total of 27,413 individuals provided valid information via house-tohouse interviews. The 12-month cumulative pregnancy rate (CPR) and annual percentage change were used as the outcome measurements. Results There was a significant increase in the CPR over the five successive time groups. A break point in 1988 divided the entire study period into two distinct segments: 1981-1988, during which the CPR increased from 72.2% to 84.2%, and 1988-2003, during which the CPR increased from 84.2% to 87.2%. Conclusions The findings were unlikely to be the result of biases, and could not be explained by increased medical treatment for infertility and changes in the prevalence of sexually transmitted diseases. Dramatic societal and behavioral changes due to the unique family planning policy and economic reform policies in China might have been the plausible reason for the results.	[Tian, Xiaobing] North Sichuan Med Coll, Nanchong, Sichuan, Peoples R China; [Jiang, Jingmei] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Inst Basic Med Sci,Dept Epidemiol & Stat, Beijing, Peoples R China; [Wang, Jiedong; Zhang, Shucheng] Natl Res Inst Populat & Family Planning, Beijing, Peoples R China	North Sichuan Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Zhang, SC (corresponding author), Natl Res Inst Populat & Family Planning, Beijing, Peoples R China.	nsmcxb@263.net			Ministry of Science and Technology of China [2006FY230400]; Education bureau of Sichuan province [12ZA048]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Education bureau of Sichuan province	The project was supported by: 1) the Ministry of Science and Technology of China (Project No: 2006FY230400), http://www.most.gov.cn/. Jiedong Wang recieved the funding. 2) Education bureau of Sichuan province (Project No: 12ZA048). http://www.scedu.net/. Xiaobing Tian recieved the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akre O, 1999, FERTIL STERIL, V71, P1066, DOI 10.1016/S0015-0282(99)00115-6; AUGER J, 1995, NEW ENGL J MED, V332, P281, DOI 10.1056/NEJM199502023320501; Bilian X, 1996, ADV CONTRACEPT, V12, P257, DOI 10.1007/BF01849327; Borges E, 2015, INT BRAZ J UROL, V41, P757, DOI 10.1590/S1677-5538.IBJU.2014.0186; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; De Geyter C, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14087; Dyer SJ, 2009, HUM REPROD, V24, P2379, DOI 10.1093/humrep/dep219; HANDWERKER L, 1995, CAMB Q HEALTHC ETHIC, V4, P355, DOI 10.1017/S0963180100006101; Hemminki Elina, 2005, Reprod Health, V2, P5, DOI 10.1186/1742-4755-2-5; Hitchcock CL, 2009, FERTIL STERIL, V92, pE47, DOI 10.1016/j.fertnstert.2009.06.036; Jensen TK, 2005, HUM REPROD, V20, P955, DOI 10.1093/humrep/deh723; Jin XY, 2005, SOC BIOL, V52, P18; Jin X, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/179098; Joffe M, 2000, LANCET, V355, P1961, DOI 10.1016/S0140-6736(00)02328-X; Joffe M, 2005, AM J EPIDEMIOL, V162, P115, DOI 10.1093/aje/kwi172; Joffe M, 1996, LANCET, V347, P1519, DOI 10.1016/S0140-6736(96)90673-X; JOFFE M, 1993, FERTIL STERIL, V60, P99; Joffe M, 2007, BMJ-BRIT MED J, V334, P524, DOI 10.1136/bmj.39097.508426.BE; Jorgensen N, 2001, HUM REPROD, V16, P1012, DOI 10.1093/humrep/16.5.1012; Key J, 2009, AM J EPIDEMIOL, V169, P285, DOI 10.1093/aje/kwn302; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kupka MS, 2016, HUM REPROD, V31, P233, DOI 10.1093/humrep/dev319; Nordkap L, 2012, MOL CELL ENDOCRINOL, V355, P221, DOI 10.1016/j.mce.2011.05.048; Olsen J, 2003, AM J EPIDEMIOL, V157, P94, DOI 10.1093/aje/kwf178; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Radin RG, 2015, PAEDIATR PERINAT EP, V29, P576, DOI 10.1111/ppe.12245; Sallmen M, 2005, EPIDEMIOLOGY, V16, P494, DOI 10.1097/01.ede.0000165391.65690.e1; Scheike TH, 2008, EPIDEMIOLOGY, V19, P191, DOI 10.1097/EDE.0b013e31816334ad; Stephen EH, 2006, FERTIL STERIL, V86, P516, DOI 10.1016/j.fertnstert.2006.02.129; Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055; Tuntiseranee P, 1998, HUM REPROD, V13, P471, DOI 10.1093/humrep/13.2.471; Zhang LH, 1999, CHINESE MED J-PEKING, V112, P968	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165097	10.1371/journal.pone.0165097	http://dx.doi.org/10.1371/journal.pone.0165097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788188	Green Submitted, gold, Green Published			2022-12-26	WOS:000389604900043
J	Sommerlandt, FMJ; Spaethe, J; Rossler, W; Dyer, AG				Sommerlandt, Frank M. J.; Spaethe, Johannes; Roessler, Wolfgang; Dyer, Adrian G.			Does Fine Color Discrimination Learning in Free-Flying Honeybees Change Mushroom-Body Calyx Neuroarchitecture?	PLOS ONE			English	Article							ANTERIOR OPTIC TUBERCLE; APIS-MELLIFERA; INSECT BRAIN; BOMBUS-IMPATIENS; MINI-BRAIN; BEE BRAIN; PUPAL DEVELOPMENT; VISUAL-ATTENTION; MEMORY TRACE; BODIES	Honeybees learn color information of rewarding flowers and recall these memories in future decisions. For fine color discrimination, bees require differential conditioning with a concurrent presentation of target and distractor stimuli to form a long-term memory. Here we investigated whether the long-term storage of color information shapes the neural network of microglomeruli in the mushroom body calyces and if this depends on the type of conditioning. Free-flying honeybees were individually trained to a pair of perceptually similar colors in either absolute conditioning towards one of the colors or in differential conditioning with both colors. Subsequently, bees of either conditioning groups were tested in non-rewarded discrimination tests with the two colors. Only bees trained with differential conditioning preferred the previously learned color, whereas bees of the absolute conditioning group, and a stimuli-naive group, chose randomly among color stimuli. All bees were then kept individually for three days in the dark to allow for complete long-term memory formation. Whole-mount immunostaining was subsequently used to quantify variation of microglomeruli number and density in the mushroom-body lip and collar. We found no significant differences among groups in neuropil volumes and total microglomeruli numbers, but learning performance was negatively correlated with microglomeruli density in the absolute conditioning group. Based on these findings we aim to promote future research approaches combining behaviorally relevant color learning tests in honeybees under free-flight conditions with neuroimaging analysis; we also discuss possible limitations of this approach.	[Sommerlandt, Frank M. J.; Spaethe, Johannes; Roessler, Wolfgang] Univ Wurrzburg, Dept Behav Physiol & Sociobiol, Biozentrum, Wurzburg, Germany; [Dyer, Adrian G.] RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia	University of Wurzburg; Royal Melbourne Institute of Technology (RMIT)	Sommerlandt, FMJ (corresponding author), Univ Wurrzburg, Dept Behav Physiol & Sociobiol, Biozentrum, Wurzburg, Germany.	frank.sommerlandt@uni-wuerzburg.de	Rössler, Wolfgang/E-9526-2019	Rössler, Wolfgang/0000-0002-5195-8214; Spaethe, Johannes/0000-0002-0734-2869	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; Free State of Bavaria (Elitenetzwerk Bayern); Australian Research Council [DP0987989]; German Research Foundation; University of Wurzburg	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; Free State of Bavaria (Elitenetzwerk Bayern); Australian Research Council(Australian Research Council); German Research Foundation(German Research Foundation (DFG)); University of Wurzburg	FMJS was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg. This work was further supported by a PhD research scholarship offered by the Free State of Bavaria (Elitenetzwerk Bayern) to FMJS, and an Australian Research Council grant DP0987989 to AGD, JS and WR. This publication was funded by the German Research Foundation and the University of Wurzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel R, 2001, J COMP NEUROL, V437, P363, DOI 10.1002/cne.1289; Avargues-Weber A, 2014, J COMP PHYSIOL A, V200, P449, DOI 10.1007/s00359-014-0909-z; Avargues-Weber A, 2011, ANNU REV ENTOMOL, V56, P423, DOI 10.1146/annurev-ento-120709-144855; Avargues-Weber A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015370; Barth FG, 1985, INSECTS AND FLOWERS; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171, DOI 10.1007/BF00188925; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; DAUMER K, 1956, Z VERGL PHYSIOL, V38, P413; de Ibarra NH, 2014, J COMP PHYSIOL A, V200, P411, DOI 10.1007/s00359-014-0915-1; Dobrin SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037666; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; DUKAS R, 1994, ANIM BEHAV, V48, P1007, DOI 10.1006/anbe.1994.1333; Dyer AG, 2014, ECOL MODEL, V277, P119, DOI 10.1016/j.ecolmodel.2014.01.009; Dyer Adrian G., 2014, Insects, V5, P629, DOI 10.3390/insects5030629; Dyer AG, 2014, J COMP PHYSIOL A, V200, P409, DOI 10.1007/s00359-014-0913-3; Dyer AG, 2011, P ROY SOC B-BIOL SCI, V278, P952, DOI 10.1098/rspb.2010.2412; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; Dyer AG, 2005, J COMP PHYSIOL A, V191, P547, DOI 10.1007/s00359-005-0622-z; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; Ehmer B, 2002, J COMP NEUROL, V451, P362, DOI 10.1002/cne.10355; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Falibene A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00084; Ganeshina O, 2001, J COMP NEUROL, V437, P335, DOI 10.1002/cne.1287; Giurfa M, 2004, NATURWISSENSCHAFTEN, V91, P228, DOI 10.1007/s00114-004-0530-z; Giurfa M, 2003, BEE WORLD, V84, P5, DOI 10.1080/0005772X.2003.11099566; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Groh C, 2006, BRAIN BEHAV EVOLUT, V68, P1, DOI 10.1159/000092309; Groh C, 2012, J COMP NEUROL, V520, P3509, DOI 10.1002/cne.23102; Groh C, 2011, ARTHROPOD STRUCT DEV, V40, P358, DOI 10.1016/j.asd.2010.12.002; Gronenberg W, 2001, J COMP NEUROL, V435, P474, DOI 10.1002/cne.1045; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Hill PSM, 1997, ANIM BEHAV, V54, P615, DOI 10.1006/anbe.1996.0467; Hourcade B, 2010, J NEUROSCI, V30, P6461, DOI 10.1523/JNEUROSCI.0841-10.2010; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Jernigan CM, 2014, J EXP BIOL, V217, P337, DOI 10.1242/jeb.091355; Jersakova J, 2006, BIOL REV, V81, P219, DOI 10.1017/S1464793105006986; Kirschner S, 2006, J COMP NEUROL, V499, P933, DOI 10.1002/cne.21158; Kremer MC, 2010, CURR BIOL, V20, P1938, DOI 10.1016/j.cub.2010.09.060; Krofczik S, 2008, DEV NEUROBIOL, V68, P1007, DOI 10.1002/dneu.20640; Lichtenstein L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134248; Maleszka J, 2009, J COMP PHYSIOL A, V195, P733, DOI 10.1007/s00359-009-0449-0; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; MENZEL R, 1967, Z VERGL PHYSIOL, V56, P22, DOI 10.1007/BF00333562; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Morawetz L, 2013, J COMP PHYSIOL A, V199, P817, DOI 10.1007/s00359-013-0843-5; Morawetz L, 2012, J EXP BIOL, V215, P2515, DOI 10.1242/jeb.066399; Mota T, 2013, J NEUROSCI, V33, P4, DOI 10.1523/JNEUROSCI.1412-12.2013; Mota T, 2011, J NEUROSCI, V31, P11443, DOI 10.1523/JNEUROSCI.0995-11.2011; Muenz TS, 2015, DEV NEUROBIOL, V75, P1368, DOI 10.1002/dneu.22290; Muller H, 2012, ENTOMOL GEN, V34, P1; NEUMEYER C, 1981, J COMP PHYSIOL, V144, P543, DOI 10.1007/BF01326839; Niggebrugge C, 2009, J EXP BIOL, V212, P1344, DOI 10.1242/jeb.021881; Paulk AC, 2008, ARTHROPOD STRUCT DEV, V37, P443, DOI 10.1016/j.asd.2008.03.002; Paulk AC, 2008, J NEUROSCI, V28, P6319, DOI 10.1523/JNEUROSCI.1196-08.2008; Paulk AC, 2009, J NEUROSCI, V29, P9987, DOI 10.1523/JNEUROSCI.1325-09.2009; Paulk AC, 2009, J COMP NEUROL, V513, P441, DOI 10.1002/cne.21993; Proctor MCF, 1972, THE POLLINATION OF F; Reinhard J, 2004, J EXP BIOL, V207, P4371, DOI 10.1242/jeb.01306; Riveros AJ, 2012, ANIM COGN, V15, P1183, DOI 10.1007/s10071-012-0542-6; Rossler W., 2012, HONEYBEE NEUROBIOLOG, P141, DOI [DOI 10.1007/978-94-007-2099-2, 10.1007/978-94-007-2099-2]; Scheiner R, 2003, APIDOLOGIE, V34, P67, DOI 10.1051/apido:2002050; Scholl C, 2014, DEV NEUROBIOL, V74, P1141, DOI 10.1002/dneu.22195; Spaethe J, 2006, J EXP BIOL, V209, P987, DOI 10.1242/jeb.02124; Spaethe J, 2014, J COMP PHYSIOL A, V200, P485, DOI 10.1007/s00359-014-0886-2; Stieb SM, 2012, DEV NEUROBIOL, V72, P729, DOI 10.1002/dneu.20982; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; von Frisch K., 1965, TANZSPRACHE ORIENTIE, DOI [10.1007/978-3-642-94916-6, DOI 10.1007/978-3-642-94916-6]; von Frisch K, 1914, FARBENSINN FORMENSIN, DOI [10.5962/bhl.title.11736, DOI 10.5962/BHL.TITLE.11736]; Von Helverson O., 1972, Journal Comp Physiol, V80, P439; WITTHOFT W., 1967, Z MORPHOL TIERE, V61, P160, DOI 10.1007/BF00298776; Wustenberg D, 1998, EUR J NEUROSCI, V10, P2742, DOI 10.1046/j.1460-9568.1998.t01-1-00319.x; Yilmaz A, 2016, DEV NEUROBIOL, V76, P1041, DOI 10.1002/dneu.22374; Zentall TR, 2000, J GEN PSYCHOL, V127, P45, DOI 10.1080/00221300009598570	82	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164386	10.1371/journal.pone.0164386	http://dx.doi.org/10.1371/journal.pone.0164386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VE	27783640	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800037
J	Dieker, J; Berden, JH; Bakker, M; Briand, JP; Muller, S; Voll, R; Sjowall, C; Herrmann, M; Hilbrands, LB; van der Vlag, J				Dieker, Jurgen; Berden, Jo H.; Bakker, Marinka; Briand, Jean-Paul; Muller, Sylviane; Voll, Reinhard; Sjowall, Christopher; Herrmann, Martin; Hilbrands, Luuk B.; van der Vlag, Johan			Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis	PLOS ONE			English	Article							ANTINUCLEOSOME ANTIBODIES; ANTI-CHROMATIN; ERYTHEMATOSUS; CYCLOPHOSPHAMIDE; APOPTOSIS; CELL; AZATHIOPRINE/METHYLPREDNISOLONE; AUTOIMMUNITY; NUCLEOSOME; BIOMARKERS	Persistent exposure of the immune system to death cell debris leads to autoantibodies against chromatin in patients with systemic lupus erythematosus (SLE). Deposition of antichromatin/ chromatin complexes can instigate inflammation in multiple organs including the kidney. Previously we identified specific cell death-associated histone modifications as targets of autoantibodies in SLE. In this study we addressed, in a large cohort of SLE patients and controls, the question whether plasma reactivities with specific histone peptides associated with serology and clinical features. Plasma from SLE patients with and without lupus nephritis, disease controls, and healthy controls, were tested in ELISA with histone H4 peptide acetylated at lysines 8, 12 and 16 (H4p(ac)), H2B peptide acetylated at lysine 12 (H2Bp(ac)), H3 peptide trimethylated at lysine 27 (H3p(me)), and their unmodified equivalents. SLE patients displayed a higher reactivity with the modified equivalent of each peptide. Reactivity with H4p(ac) showed both a high sensitivity (89%) and specificity (91%) for SLE, while H2Bp(ac) exhibited a high specificity (96%) but lower sensitivity (69%). Reactivity with H3p(me) appeared not specific for SLE. Anti-H4p(ac) and anti-H2Bp(ac) reactivity demonstrated a high correlation with disease activity. Moreover, patients reacting with multiple modified histone peptides exhibited higher SLEDAI and lower C3 levels. SLE patients with renal involvement showed higher reactivity with H2B/H2Bp(ac) and a more pronounced reactivity with the modified equivalent of H3p(me) and H2Bp(ac). In conclusion, reactivity with H4p(ac) and H2Bp(ac) is specific for SLE patients and correlates with disease activity, whereas reactivity with H2Bp(ac) is in particular associated with lupus nephritis.	[Dieker, Jurgen; Berden, Jo H.; Bakker, Marinka; Hilbrands, Luuk B.; van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Nephrol, Nijmegen, Netherlands; [Briand, Jean-Paul; Muller, Sylviane] CNRS, Immunopathol & Chim Therapeut, Lab Excellence MEDALIS, Inst Biol Mol & Cellulaire, Strasbourg, France; [Voll, Reinhard] Univ Med Ctr Freiburg, Dept Rheumatol & Clin Immunol, Freiburg, Germany; [Voll, Reinhard] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Sjowall, Christopher] Linkoping Univ, Dept Clin & Expt Med, Rheumatol AIR, Linkoping, Sweden; [Herrmann, Martin] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Dept Internal Med 3, Erlangen, Germany	Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Freiburg; University of Freiburg; Linkoping University; University of Erlangen Nuremberg	van der Vlag, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Nephrol, Nijmegen, Netherlands.	johan.vandervlag@radboudumc.nl	Herrmann, Martin/A-9597-2013; Sjöwall, Christopher/C-9678-2009; herrmann, martin/AAT-9836-2020; Hilbrands, Luuk/B-4921-2011; Van der Vlag, Johan/E-4636-2010	Herrmann, Martin/0000-0002-0258-2484; Sjöwall, Christopher/0000-0003-0900-2048; Hilbrands, Luuk/0000-0002-4935-9765; Van der Vlag, Johan/0000-0001-7843-5918	Dutch Arthritis Association [09-1-308]; German Research Society (DFG) [SFB643-TP-B5]; K & R Wucherpfennig-Stifting; French Centre National de la Recherche Scientifique; Laboratory of Excellence Medalis, Initiative of Excellence (IdEx), Strasbourg University [ANR-10-LABX-0034]	Dutch Arthritis Association; German Research Society (DFG)(German Research Foundation (DFG)); K & R Wucherpfennig-Stifting; French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Laboratory of Excellence Medalis, Initiative of Excellence (IdEx), Strasbourg University	JD was financially supported by a grant from the Dutch Arthritis Association (http://www.reumafonds.nl; grant 09-1-308; JvdV). MH was supported by the German Research Society (http://www.dfg.de; DFG; SFB643-TP-B5) and by the K & R Wucherpfennig-Stifting. SM and JPB were financially supported by the French Centre National de la Recherche Scientifique and the Laboratory of Excellence Medalis (https://medalis.unistra.fr; ANR-10-LABX-0034), Initiative of Excellence (IdEx), Strasbourg University.	Arends S, 2014, NETH J MED, V72, P481; Beyer C, 2010, NAT REV RHEUMATOL, V6, P21, DOI 10.1038/nrrheum.2009.229; Bigler C, 2008, AM J KIDNEY DIS, V51, P624, DOI 10.1053/j.ajkd.2007.10.041; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bouts YM, 2012, AUTOIMMUNITY, V45, P597, DOI 10.3109/08916934.2012.719953; Bruns A, 2000, ARTHRITIS RHEUM-US, V43, P2307, DOI 10.1002/1529-0131(200010)43:10<2307::AID-ANR19>3.0.CO;2-J; Chong BF, 2012, J INVEST DERMATOL, V132, P2770, DOI 10.1038/jid.2012.207; Compagno M, 2013, SCAND J RHEUMATOL, V42, P311, DOI 10.3109/03009742.2013.765032; Cornillet M, 2014, ANN RHEUM DIS, V73, P1246, DOI 10.1136/annrheumdis-2012-202868; Datta SK, 2003, ANN NY ACAD SCI, V987, P79, DOI 10.1111/j.1749-6632.2003.tb06035.x; Dieker J, 2016, ARTHRITIS RHEUMATOL, V68, P462, DOI 10.1002/art.39417; Dieker JW, 2007, ARTHRITIS RHEUM-US, V56, P1921, DOI 10.1002/art.22646; Dieker JWC, 2002, LUPUS, V11, P856, DOI 10.1191/0961203302lu307rr; Dixit K, 2011, HUM IMMUNOL, V72, P219, DOI 10.1016/j.humimm.2010.12.004; Doyle HA, 2013, AUTOIMMUNITY, V46, P6, DOI 10.3109/08916934.2012.710859; Fournel S, 2003, CURR PROTEIN PEPT SC, V4, P261, DOI 10.2174/1389203033487126; Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58; Gladman DD, 2000, J RHEUMATOL, V29, P288, DOI DOI 10.3899/JRHEUM.110550; Grootscholten C, 2006, KIDNEY INT, V70, P732, DOI 10.1038/sj.ki.5001630; Grootscholten C, 2007, ANN RHEUM DIS, V66, P693, DOI 10.1136/ard.2006.065425; Guo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068520; Heidenreich U, 2009, LUPUS, V18, P1276, DOI 10.1177/0961203309345753; Hoffmann MH, 2010, J AUTOIMMUN, V34, pJ178, DOI 10.1016/j.jaut.2009.11.013; Lacotte S, 2010, J IMMUNOL, V184, P3937, DOI 10.4049/jimmunol.0902595; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Linnik MD, 2005, ARTHRITIS RHEUM, V52, P1129, DOI 10.1002/art.20980; Lolli F, 2005, P NATL ACAD SCI USA, V102, P10273, DOI 10.1073/pnas.0503178102; Mok CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/638413; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Ng KP, 2006, ARTHRIT RHEUM-ARTHR, V55, P900, DOI 10.1002/art.22356; Pan N, 2014, LUPUS, V23, P293, DOI 10.1177/0961203313515763; Papini AM, 2009, J PEPT SCI, V15, P621, DOI 10.1002/psc.1166; Petri MA, 2013, ARTHRITIS RHEUM-US, V65, P2143, DOI 10.1002/art.37995; Pieterse E, 2015, CLIN EXP IMMUNOL, V179, P68, DOI 10.1111/cei.12359; Pratesi F, 2014, ANN RHEUM DIS, V73, P1414, DOI 10.1136/annrheumdis-2012-202765; Price JV, 2012, NAT MED, V18, P1434, DOI 10.1038/nm.2913; Rekvig OP, 2014, ARTHRITIS RHEUMATOL, V66, P1061, DOI 10.1002/art.38365; Seredkina N, 2013, MOL MED, V19, P161, DOI 10.2119/molmed.2013.00010; Stinton LM, 2007, LUPUS, V16, P394, DOI 10.1177/0961203307078391; Stummvoll GH, 2009, ANN RHEUM DIS, V68, P110, DOI 10.1136/ard.2007.082032; Sui MS, 2013, J CLIN IMMUNOL, V33, P378, DOI 10.1007/s10875-012-9825-6; Sun XY, 2008, J CLIN LAB ANAL, V22, P271, DOI 10.1002/jcla.20248; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; van Bavel CC, 2011, ANN RHEUM DIS, V70, P201, DOI 10.1136/ard.2010.129320; van Bavel CC, 2010, MOL IMMUNOL, V48, P248, DOI 10.1016/j.molimm.2010.08.003; van Bavel CC, 2009, MOL IMMUNOL, V47, P511, DOI 10.1016/j.molimm.2009.08.009; van der Vlag J, 2011, SEMIN NEPHROL, V31, P376, DOI 10.1016/j.semnephrol.2011.06.009; van Venrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391, DOI 10.1038/nrrheum.2011.76; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071043	49	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165373	10.1371/journal.pone.0165373	http://dx.doi.org/10.1371/journal.pone.0165373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780265	Green Published, gold			2022-12-26	WOS:000389046900050
J	Johnson, RC; Ellis, MW; Schlett, CD; Millar, EV; LaBreck, PT; Mor, D; Elassal, EM; Lanier, JB; Redden, CL; Cui, TY; Teneza-Mora, N; Bishop, DK; Hall, ER; Bishop-Lilly, KA; Merrell, DS				Johnson, Ryan C.; Ellis, Michael W.; Schlett, Carey D.; Millar, Eugene V.; LaBreck, Patrick T.; Mor, Deepika; Elassal, Emad M.; Lanier, Jeffrey B.; Redden, Cassie L.; Cui, Tianyuan; Teneza-Mora, Nimfa; Bishop, Danett K.; Hall, Eric R.; Bishop-Lilly, Kimberly A.; Merrell, D. Scott			Bacterial Etiology and Risk Factors Associated with Cellulitis and Purulent Skin Abscesses in Military Trainees	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; RESISTANT STAPHYLOCOCCUS-AUREUS; RANDOMIZED CONTROLLED-TRIAL; EMERGENCY-DEPARTMENT; HOUSEHOLD CONTACTS; COLONIZATION; ERYSIPELAS; DIAGNOSIS; CULTURES; MICROBIOLOGY	Military trainees are at high risk for skin and soft-tissue infections (SSTIs). Although Staphylococcus aureus is associated with purulent SSTI, it is unclear to what degree this pathogen causes nonpurulent cellulitis. To inform effective prevention strategies and to provide novel insights into SSTI pathogenesis, we aimed to determine the etiology of SSTI in this population. We conducted a prospective observational study in US Army Infantry trainees with SSTI (cutaneous abscesses and cellulitis) from July 2012 through December 2014. We used standard microbiology, serology, and high-throughput sequencing to determine the etiology of SSTI. Furthermore, we compared purported risk factors as well as anatomic site colonization for S. aureus. Among 201 SSTI cases evaluated for SSTI risk factors, cellulitis was associated with lower extremity blisters (P = 0.01) and abscess was associated with methicillin-resistant S. aureus (MRSA) colonization (P<0.001). Among the 22 tested cellulitis cases that were part of the microbiome analysis, only 1 leading edge aspirate was culturable (Coagulase- negative Staphylococcus). Microbiome evaluation of aspirate specimens demonstrated that Rhodanobacter terrae was the most abundant species (66.8% average abundance), while abscesses were dominated by S. aureus (92.9% average abundance). Although abscesses and cellulitis share the spectrum of clinical SSTI, the bacterial etiologies as determined by current technology appear distinct. Furthermore, the presence of atypical bacteria within cellulitis aspirates may indicate novel mechanisms of cellulitis pathogenesis.	[Johnson, Ryan C.; LaBreck, Patrick T.; Merrell, D. Scott] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Ellis, Michael W.] Univ Toledo, Med Ctr, 2801 W Bancroft St, Toledo, OH 43606 USA; [Schlett, Carey D.; Millar, Eugene V.; Mor, Deepika; Elassal, Emad M.; Cui, Tianyuan; Teneza-Mora, Nimfa] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Lanier, Jeffrey B.] Martin Army Community Hosp, Ft Benning, GA USA; [Redden, Cassie L.; Bishop-Lilly, Kimberly A.] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Redden, Cassie L.; Bishop-Lilly, Kimberly A.] Naval Med Res Ctr, Biol Def Res Directorate, Frederick, MD USA; [Bishop, Danett K.; Hall, Eric R.] Naval Med Res Ctr, Wound Infect Dept, Infect Dis Directorate, Silver Spring, MD USA; [Merrell, D. Scott] Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; University System of Ohio; University of Toledo; Uniformed Services University of the Health Sciences - USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Naval Medical Research Center (NMRC); Naval Medical Research Center (NMRC); Uniformed Services University of the Health Sciences - USA	Merrell, DS (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.; Merrell, DS (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA.	douglas.merrell@usuhs.edu		Johnson, Ryan/0000-0002-2114-2951	US Department of Defense Program [HT9404-12-1-0019]; Department of Defense Global Emerging Infections Surveillance and Response System (GEIS) [HU0001-10-1-0018]; Military Infectious Diseases Research Program (MIDRP) [HT9404-12-1-0012]; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]	US Department of Defense Program; Department of Defense Global Emerging Infections Surveillance and Response System (GEIS); Military Infectious Diseases Research Program (MIDRP); National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Primary support for this work was provided by a US Department of Defense Program Project Grant (HT9404-12-1-0019 to DSM, MWE, and ERH). Additional support for this work was provided by the Department of Defense Global Emerging Infections Surveillance and Response System (GEIS;HU0001-10-1-0018 to MWE) and the Military Infectious Diseases Research Program (MIDRP; HT9404-12-1-0012 to M.W.E). The protocol was executed by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences, and funded in part by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter Agency Agreement [Y1-AI-5072]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht VS, 2015, J CLIN MICROBIOL, V53, P3478, DOI 10.1128/JCM.01371-15; Bergkvist PI, 1997, SCAND J INFECT DIS, V29, P377, DOI 10.3109/00365549709011834; Campbell KM, 2004, J CLIN MICROBIOL, V42, P4050, DOI 10.1128/JCM.42.9.4050-4053.2004; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crisp JG, 2015, CLIN INFECT DIS, V61, P1679, DOI 10.1093/cid/civ655; Dall L, 2005, CUTIS, V75, P177; Dupuy A, 1999, BRIT MED J, V318, P1591, DOI 10.1136/bmj.318.7198.1591; DUVANEL T, 1989, ARCH INTERN MED, V149, P293, DOI 10.1001/archinte.149.2.293; Edelsberg J, 2009, EMERG INFECT DIS, V15, P1516, DOI 10.3201/eid1509.081228; Elliott D, 2000, AM J SURG, V179, P361, DOI 10.1016/S0002-9610(00)00360-3; Ellis MW, 2007, ANTIMICROB AGENTS CH, V51, P3591, DOI 10.1128/AAC.01086-06; Ellis MW, 2014, CLIN INFECT DIS, V58, P1540, DOI 10.1093/cid/ciu166; Ellis MW, 2014, J CLIN MICROBIOL, V52, P344, DOI 10.1128/JCM.02455-13; Ellis MW, 2009, J CLIN MICROBIOL, V47, P940, DOI 10.1128/JCM.02352-08; Fritz SA, 2012, ARCH PEDIAT ADOL MED, V166, P551, DOI 10.1001/archpediatrics.2011.900; Gunderson CG, 2011, AM J MED, V124, P1113, DOI 10.1016/j.amjmed.2011.06.028; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; HOOK EW, 1986, ARCH INTERN MED, V146, P295, DOI 10.1001/archinte.146.2.295; Jeng A, 2010, MEDICINE, V89, P217, DOI 10.1097/MD.0b013e3181e8d635; Johnson RC, 2015, INFECT IMMUN, V83, P802, DOI 10.1128/IAI.02664-14; LAWLOR MT, 1992, CLIN INFECT DIS, V14, P247, DOI 10.1093/clinids/14.1.247; LEPPARD BJ, 1985, BRIT J DERMATOL, V112, P559, DOI 10.1111/j.1365-2133.1985.tb15264.x; MARTINEZLOPEZ LE, 1993, MIL MED, V158, P433, DOI 10.1093/milmed/158.7.433; MCHENRY CR, 1995, ANN SURG, V221, P558, DOI 10.1097/00000658-199505000-00013; Miller LG, 2012, CLIN INFECT DIS, V54, P1523, DOI 10.1093/cid/cis213; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nakatsuji T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2441; NEWELL PM, 1988, J CLIN MICROBIOL, V26, P401, DOI 10.1128/JCM.26.3.401-404.1988; Pallin DJ, 2008, ANN EMERG MED, V51, P291, DOI 10.1016/j.annemergmed.2007.12.004; Perl B, 1999, CLIN INFECT DIS, V29, P1483, DOI 10.1086/313525; Rajan S, 2012, CLEV CLIN J MED, V79, P57, DOI 10.3949/ccjm.79a.11044; Semel JD, 1996, CLIN INFECT DIS, V23, P1162, DOI 10.1093/clinids/23.5.1162; Simonen SME, 2006, EPIDEMIOL INFECT, V134, P293, DOI 10.1017/S095026880500484X; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Swartz MN, 2004, NEW ENGL J MED, V350, P904, DOI 10.1056/NEJMcp031807; Tognetti L, 2012, J EUR ACAD DERMATOL, V26, P931, DOI 10.1111/j.1468-3083.2011.04416.x; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Wylie FP, 2011, CLIN PEDIATR, V50, P503, DOI 10.1177/0009922810394652; Zinderman CE, 2004, EMERG INFECT DIS, V10, P941, DOI 10.3201/eid1005.030604	41	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165491	10.1371/journal.pone.0165491	http://dx.doi.org/10.1371/journal.pone.0165491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780238	gold, Green Submitted, Green Published			2022-12-26	WOS:000389046900059
J	Usseglio, P; Friedlander, AM; Koike, H; Zimmerhackel, J; Schuhbauer, A; Eddy, T; Salinas-De-Leon, P				Usseglio, Paolo; Friedlander, Alan M.; Koike, Haruko; Zimmerhackel, Johanna; Schuhbauer, Anna; Eddy, Tyler; Salinas-de-Leon, Pelayo			So Long and Thanks for All the Fish: Overexploitation of the Regionally Endemic Galapagos Grouper Mycteroperca olfax (Jenyns, 1840)	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; FISHERIES MANAGEMENT; CONSERVATION; COMMUNITIES; MATURITY; GROWTH; CATCH; SIZE; TIME; AGE	The regionally endemic Galapagos Grouper, locally known as bacalao, is one of the most highly prized finfish species within the Galapagos Marine Reserve (GMR). Concerns of overfishing, coupled with a lack of fishing regulations aimed at this species raises concerns about the current population health. We assessed changes in population health over a 30-year period using three simple indicators: (1) percentage of fish below reproductive size (Lm); (2) percentage of fish within the optimum length interval (Lopt); and (3) percentage of mega-spawners in the catch. Over the assessed period, none of the indicators reached values associated with healthy populations, with all indicators declining over time. Furthermore, the most recent landings data show that the vast majority of the bacalao caught (95.7%,) were below L-m, the number of fish within the Lopt interval was extremely low (4.7%), and there were virtually no mega-spawners (0.2%). Bacalao fully recruit to the fishery 15 cm below the size at which 50% of the population matures. The Spawning Potential Ratio is currently 5% of potential unfished fecundity, strongly suggesting severe overfishing. Our results suggest the need for bacalao-specific management regulations that should include minimum (65 cm TL) and maximum (78 cm TL) landing sizes, slot limits (64-78 cm TL), as well as a closed season during spawning from October to January. It is recognized that these regulations are harsh and will certainly have negative impacts on the livelihoods of fishers in the short term, however, continued inaction will likely result in a collapse of this economically and culturally valuable species. Alternative sources of income should be developed in parallel with the establishment of fishing regulations to limit the socio-economic disruption to the fishing community during the transition to a more sustainable management regime.	[Usseglio, Paolo; Friedlander, Alan M.; Koike, Haruko] Univ Hawaii, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Usseglio, Paolo] Fdn In Nova Castilla la Mancha, Madrid, Spain; [Friedlander, Alan M.] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Zimmerhackel, Johanna; Schuhbauer, Anna; Salinas-de-Leon, Pelayo] Charles Darwin Res Fdn, Dept Marine Sci, Santa Cruz, Galapagos Islan, Ecuador; [Schuhbauer, Anna] Univ British Columbia, Vancouver, BC, Canada; [Eddy, Tyler] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	University of Hawaii System; National Geographic Society; University of British Columbia; Dalhousie University	Usseglio, P (corresponding author), Univ Hawaii, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA.; Usseglio, P (corresponding author), Fdn In Nova Castilla la Mancha, Madrid, Spain.	pusseglio@in-nova.org	Eddy, Tyler/ABE-7092-2021; Usseglio, Paolo/S-7252-2017	Eddy, Tyler/0000-0002-2833-9407; Usseglio, Paolo/0000-0002-8622-0164; Zimmerhackel, Johanna Sophie/0000-0002-8663-835X	Fisheries Ecology Research Lab at the University of Hawaii; Lindblad Expeditions-National Geographic Joint Fund for Conservation and Research; Galapagos Conservation Trust; Mohammed Species Conservation Fund; Disney Worldwide Conservation Fund; Helmsley Charitable Trust	Fisheries Ecology Research Lab at the University of Hawaii; Lindblad Expeditions-National Geographic Joint Fund for Conservation and Research; Galapagos Conservation Trust; Mohammed Species Conservation Fund; Disney Worldwide Conservation Fund; Helmsley Charitable Trust	Travel costs to Galapagos and analysis equipment were self-funded, additional support for processing materials and equipment was provided by the Fisheries Ecology Research Lab at the University of Hawaii. This research was partly supported by grants from the Lindblad Expeditions-National Geographic Joint Fund for Conservation and Research, The Galapagos Conservation Trust, The Mohammed Species Conservation Fund, The Disney Worldwide Conservation Fund and The Helmsley Charitable Trust, awarded to Dr. Pelayo Salinas-de-Leon.; We thank Jorge Baque, Lena Heel, and the staff at the CDF, and park rangers for help in fieldwork and sample processing. We are grateful to the artisanal fishers of Galapagos for their help and support during this project, especially "Don Gabino" and Marco Bailon. We are very grateful to the Rolf Blomberg Archive (Quito, Ecuador) and the Hancock Foundation Archives (Los Angeles, US) for access to their historical collections. Thanks to John Woram, Paige Berube, Juliano Palacios, Miguel Gomez and Alexandra Witman for their assistance in the search of historical Galapagos photographs, and Professor Hany Farid for his technical assistance with the measurement of historical photographs. Lastly, we would like to thank four anonymous reviewers whose comments greatly improved this manuscript.	Afonso P, 2011, BIOL CONSERV, V144, P2739, DOI 10.1016/j.biocon.2011.07.028; Armsworth PR, 2001, CAN J FISH AQUAT SCI, V58, P568, DOI 10.1139/cjfas-58-3-568; Banks SJ., 2002, RESERVA MARINA GAL P, P22; Bannerot S., 1987, P561; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beamish RJ, 2006, PROG OCEANOGR, V68, P289, DOI 10.1016/j.pocean.2006.02.005; Beets J, 1999, ENVIRON BIOL FISH, V55, P91, DOI 10.1023/A:1007404421518; Bertoncini AA, 2008, IUCN RED LIST THREAT; Beverton RJH, 1956, RAPP P V REUN CIEM, V140; Bucaram SJ, 2014, MAR POLICY, V43, P80, DOI 10.1016/j.marpol.2013.05.005; Bucaram SJ, 2013, OCEAN COAST MANAGE, V78, P88, DOI 10.1016/j.ocecoaman.2013.03.001; Burbano DV, 2014, SOC ECOL INTERACT GA, P227, DOI 10.1007/978-3-319-02769-2_11; Castrejon M., 2011, COMANEJO PESQUERO RE; Castrejon M, 2014, SOC ECOL INTERACT GA, P159, DOI 10.1007/978-3-319-02769-2_8; Castrejon M, 2013, MAR POLICY, V38, P235, DOI 10.1016/j.marpol.2012.05.040; CHAPMAN DG, 1960, BIOMETRICS, V16, P354, DOI 10.2307/2527687; CLARK C, 1973, J FISH RES BOARD CAN, V30, P1629, DOI 10.1139/f73-262; Clark WG, 2002, N AM J FISH MANAGE, V22, P251, DOI 10.1577/1548-8675(2002)022<0251:FRTYL>2.0.CO;2; Coello S, 1993, REV CIENCIAS MAR LIM, V3, P115; Coello S., 1989, REVISTA PACIFICO SUR, P705; Depczynski M, 2006, ECOLOGY, V87, P3119, DOI 10.1890/0012-9658(2006)87[3119:EPAIIV]2.0.CO;2; Diekert FK, 2012, ENVIRON RESOUR ECON, V52, P549, DOI 10.1007/s10640-012-9542-x; Edgar GJ, 2004, ENVIRON CONSERV, V31, P212, DOI 10.1017/S0376892904001584; Edgar GJ, 2004, J BIOGEOGR, V31, P1107, DOI 10.1111/j.1365-2699.2004.01055.x; Finchum R, 2002, THESIS; Froese R, 2004, FISH FISH, V5, P86, DOI 10.1111/j.1467-2979.2004.00144.x; Froese R, 2000, J FISH BIOL, V56, P758, DOI 10.1111/j.1095-8649.2000.tb00870.x; Gaillard JM, 2005, AM NAT, V166, P119, DOI 10.1086/430330; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Goodyear C. Philip, 1993, Canadian Special Publication of Fisheries and Aquatic Sciences, V120, P67; Haedrich RL, 1997, FISH RES, V31, P229, DOI 10.1016/S0165-7836(97)00023-4; Halekoh U, 2014, J STAT SOFTW, V59, P1; HARRIS MP, 1969, J ZOOL, V159, P145; Hearn A, 2008, OCEAN COAST MANAGE, V51, P567, DOI 10.1016/j.ocecoaman.2008.06.009; Heemstra P.C., 1993, FAO SPECIES CATALOGU, V16; Heppell SS, 2006, ECOL APPL, V16, P238, DOI 10.1890/04-1113; Heylings P., 2002, RESERVA MARINA GAL P, P10; Hixon MA, 2014, ICES J MAR SCI, V71, P2171, DOI 10.1093/icesjms/fst200; Hoenig J.M., 1983, ICES CM, V500, P23; Hordyk A, 2015, ICES J MAR SCI, V72, P217, DOI 10.1093/icesjms/fsu004; Hordyk A, 2015, ICES J MAR SCI, V72, P204, DOI 10.1093/icesjms/fst235; Huntsman Gene R., 1994, North American Journal of Fisheries Management, V14, P41, DOI 10.1577/1548-8675(1994)014<0041:SOTIOF>2.3.CO;2; INEC, 2011, PROYECC POBL; Johnson M.K., 2006, TR2006579; Koenig C.C., 1996, ICLARM C P, V48, P307; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; McIntyre TM, 2003, CAN J FISH AQUAT SCI, V60, P1111, DOI 10.1139/F03-090; Mikhail E. M., 2001, INTRO MODERN PHOTOGR; Molina L, 2003, PESCA BLANCA PESQUER, P103; Murillo JC, 2002, RESERVA MARINA GALAP, P176; Murillo JC, 2001, PESCA ARTESANAL GALA, P55; Nicolaides F, 2002, RESERVA MARINA GALAP, P146; Ogle DH, 2015, FSA FISHENES STOCK A; Pauly D, 1990, NAGA ICLARM Q, V13, P2; Prince J, 2015, ICES J MAR SCI, V72, P194, DOI 10.1093/icesjms/fsu011; Pulvenis F, 2012, TOPICS FACT SHEETS; R Core Team, 2021, R LANGUAGE ENV STAT; Reck GK, 1983, THESIS; Rodriguez W, 1984, I NACL PESCA B TECNI, V6, P3; Salinas-de-Leon P, 2015, J FISH BIOL, V87, P179, DOI 10.1111/jfb.12703; Schiller L, 2015, AQUAT CONSERV, V25, P431, DOI 10.1002/aqc.2458; Scott B, 1999, CAN J FISH AQUAT SCI, V56, P1882, DOI 10.1139/cjfas-56-10-1882; Shepherd SA, 2004, ENVIRON CONSERV, V31, P102, DOI 10.1017/S0376892903001188; Slama CC., 1980, MANUAL PHOTOGRAMMETR, V4th edn; Smith MW, 2012, N AM J FISH MANAGE, V32, P956, DOI 10.1080/02755947.2012.711270; THOMPSON R, 1978, J FISH BIOL, V12, P115, DOI 10.1111/j.1095-8649.1978.tb04158.x; Toral-Granda MV, 2005, POPULATION DENSITY F, P91; Trippel EA, 1998, T AM FISH SOC, V127, P339, DOI 10.1577/1548-8659(1998)127&lt;0339:ESAVAS&gt;2.0.CO;2; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628; Usseglio P., 2015, THESIS; Usseglio P, 2015, PEERJ, V3, DOI 10.7717/peerj.1270; Usseglio P, 2014, SOC ECOL INTERACT GA, P187, DOI 10.1007/978-3-319-02769-2_9; Viteri C, 2007, OCEAN COAST MANAGE, V50, P253, DOI 10.1016/j.ocecoaman.2006.05.002; von Gagern A, 2009, THESIS; Walters Carl, 2010, Open Fish Science Journal, V3, P52; Zhou SJ, 2012, CAN J FISH AQUAT SCI, V69, P1292, DOI 10.1139/F2012-060; Zimmerhackel JS, 2015, PEERJ, V3, DOI 10.7717/peerj.995; Zwanenburg KCT, 2000, ICES J MAR SCI, V57, P503, DOI 10.1006/jmsc.2000.0744	78	21	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165167	10.1371/journal.pone.0165167	http://dx.doi.org/10.1371/journal.pone.0165167			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780213	Green Published, gold, Green Submitted			2022-12-26	WOS:000389046900033
J	Owais, A; Schwartz, B; Kleinbaum, DG; Suchdev, PS; Faruque, ASG; Das, SK; Stein, AD				Owais, Aatekah; Schwartz, Benjamin; Kleinbaum, David G.; Suchdev, Parminder S.; Faruque, A. S. G.; Das, Sumon K.; Stein, Aryeh D.			Minimum Acceptable Diet at 9 Months but Not Exclusive Breastfeeding at 3 Months or Timely Complementary Feeding Initiation Is Predictive of Infant Growth in Rural Bangladesh	PLOS ONE			English	Article							CHILD UNDERNUTRITION; LOW-INCOME; INTERVENTIONS; ASSOCIATION; INDICATORS; MORBIDITY; ATTITUDES; PROGRAMS; DIARRHEA; WORKS	The association between suboptimal infant feeding practices and growth faltering is well-established. However, most of this evidence comes from cross-sectional studies. To prospectively assess the association between suboptimal infant feeding practices and growth faltering, we interviewed pregnant women at 28-32 weeks' gestation and followed-up their offspring at postnatal months 3, 9, 16 and 24 months in rural Bangladesh. Using maternal recall over the past 24 hours, exclusive breastfeeding (EBF) status at 3 months, age at complementary feeding (CF) initiation, and receipt of minimum acceptable diet (MAD; as defined by WHO) at 9 months were assessed. Infant length and weight measurements were used to produce length-for-age (LAZ) and weight-for-length (WLZ) z-scores at each follow-up. Generalized estimating equations were used to estimate associations of LAZ and WLZ with infant feeding practices. All models were adjusted for baseline SES, infant sex, maternal height, age, literacy and parity. Follow-up was completed by 2189, 2074, 1969 and 1885 mother-child dyads at 3, 9, 16 and 24 months, respectively. Stunting prevalence increased from 28% to 57% between infant age 3 and 24 months. EBF at 3 months and age at CF initiation were not associated with linear infant growth, but receipt of MAD at 9 months was. By age 24 months, infants receiving MAD had attained a higher LAZ compared to infants who did not receive MAD (adjusted beta = 0.25, 95% CI: 0.13-0.37). Although prevalence of stunting was already high at age 3 months, ensuring infants receive a diverse, high quality diet from 6 months onwards may reduce rates of stunting in the second year of life.	[Owais, Aatekah] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Owais, Aatekah] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA; [Schwartz, Benjamin] Los Angeles Cty Dept Publ Hlth, Los Angeles, CA USA; [Kleinbaum, David G.; Stein, Aryeh D.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Suchdev, Parminder S.; Stein, Aryeh D.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Faruque, A. S. G.; Das, Sumon K.] Int Ctr Diarrhea Dis Res, Dhaka, Bangladesh	Emory University; Rollins School Public Health; Emory University; Los Angeles County Department of Public Health; Emory University; Emory University; International Centre for Diarrhoeal Disease Research (ICDDR)	Stein, AD (corresponding author), Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA.; Stein, AD (corresponding author), Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	aryeh.stein@emory.edu	Suchdev, Parmi S/K-4851-2012; Das, Sumon Kumar/T-6384-2019; Das, Sumon Kumar/AAD-1551-2019	Stein, Aryeh/0000-0003-1138-6458; Owais, Aatekah/0000-0002-9148-843X	CARE USA; icddr,b; Laney Graduate School, Emory University, Atlanta, GA; FOGARTY INTERNATIONAL CENTER [D43TW007585] Funding Source: NIH RePORTER	CARE USA; icddr,b; Laney Graduate School, Emory University, Atlanta, GA; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by grants from CARE USA to Emory University and icddr,b. AO was supported by funds from Laney Graduate School, Emory University, Atlanta, GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker J, 2013, FOOD NUTR BULL, V34, pS226, DOI 10.1177/15648265130343S208; Bangladesh Demographic and Health Survey, 2014, BANGL DEM HLTH SURV; Bangladesh Demographic and Health Survey, 2011, BANGL DEM HLTH SURV; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Cai XD, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-12; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Jones AD, 2014, MATERN CHILD NUTR, V10, P1, DOI 10.1111/mcn.12070; Khan J, 2015, MATERN CHILD HLTH J, V19, P468, DOI 10.1007/s10995-014-1526-8; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Lutter CK, 2013, MATERN CHILD NUTR, V9, P101, DOI 10.1111/mcn.12087; Mallard SR, 2014, J NUTR, V144, P1818, DOI 10.3945/jn.114.199547; Marriott BP, 2012, MATERN CHILD NUTR, V8, P354, DOI 10.1111/j.1740-8709.2011.00380.x; Mohsena M, 2010, PUBLIC HEALTH NUTR, V13, P1498, DOI 10.1017/S1368980010001758; Onyango AW, 2014, PUBLIC HEALTH NUTR, V17, P1975, DOI 10.1017/S1368980013002401; Owais A, 2016, PUBLIC HEALTH NUTR, V19, P1875, DOI 10.1017/S1368980015003195; Richard SA, 2013, AM J EPIDEMIOL, V178, P1129, DOI 10.1093/aje/kwt094; Senarath U, 2012, MATERN CHILD NUTR, V8, P89, DOI 10.1111/j.1740-8709.2011.00370.x; Susiloretni KA, 2015, MATERN CHILD HLTH J, V19, P1515, DOI 10.1007/s10995-014-1656-z; Thomas JS, 2015, MATERN CHILD HLTH J, V19, P49, DOI 10.1007/s10995-014-1494-z; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WHO, JOB AID WEIGH MEAS C; WHO, 2006, WHO CHILD GROWTH STA; Yu EA, 2015, PUBLIC HEALTH NUTR, V18, P679, DOI 10.1017/S1368980014000937	29	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165128	10.1371/journal.pone.0165128	http://dx.doi.org/10.1371/journal.pone.0165128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776161	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200042
J	Myers, CL; Li, FKK; Koo, BM; El-Halfawy, OM; French, S; Gross, CA; Strynadka, NCJ; Brown, ED				Myers, Cullen L.; Li, Franco K. K.; Koo, Byoung-Mo; El-Halfawy, Omar M.; French, Shawn; Gross, Carol A.; Strynadka, Natalie C. J.; Brown, Eric D.			Identification of Two Phosphate Starvation-induced Wall Teichoic Acid Hydrolases Provides First Insights into the Degradative Pathway of a Key Bacterial Cell Wall Component	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE GDPD; BACILLUS-SUBTILIS CELLS; GRAM-POSITIVE BACTERIA; L-ALANINE AMIDASE; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRANSCRIPTIONAL ANALYSIS; TEICHURONIC ACID; ACTIVE-SITE	The cell wall of most Gram-positive bacteria contains equal amounts of peptidoglycan and the phosphate-rich glycopolymer wall teichoic acid (WTA). During phosphate-limited growth of the Gram-positive model organism Bacillus subtilis 168, WTA is lost from the cell wall in a response mediated by the PhoPR two-component system, which regulates genes involved in phosphate conservation and acquisition. It has been thought that WTA provides a phosphate source to sustain growth during starvation conditions; however, WTA degradative pathways have not been described for this or any condition of bacterial growth. Here, we uncover roles for the Bacillus subtilis PhoP regulon genes glpQ and phoD as encoding secreted phosphodiesterases that function in WTA metabolism during phosphate starvation. Unlike the parent 168 strain, Delta glpQ or Delta phoD mutants retained WTA and ceased growth upon phosphate limitation. Characterization of GlpQ and PhoD enzymatic activities, in addition to X-ray crystal structures of GlpQ, revealed distinct mechanisms of WTA depolymerization for the two enzymes; GlpQ catalyzes exolytic cleavage of individual monomer units, and PhoD catalyzes endo-hydrolysis at nonspecific sites throughout the polymer. The combination of these activities appears requisite for the utilization of WTA as a phosphate reserve. Phenotypic characterization of the Delta glpQ and Delta phoD mutants revealed altered cell morphologies and effects on autolytic activity and antibiotic susceptibilities that, unexpectedly, also occurred in phosphate-replete conditions. Our findings offer novel insight into the B. subtilis phosphate starvation response and implicate WTA hydrolase activity as a determinant of functional properties of the Gram-positive cell envelope.	[Myers, Cullen L.; El-Halfawy, Omar M.; French, Shawn; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Myers, Cullen L.; El-Halfawy, Omar M.; French, Shawn; Brown, Eric D.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Li, Franco K. K.; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z3, Canada; [Li, Franco K. K.; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Koo, Byoung-Mo; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [El-Halfawy, Omar M.] Univ Alexandria, Fac Pharm, Dept Microbiol & Immunol, Alexandria 21521, Egypt	McMaster University; McMaster University; University of British Columbia; University of British Columbia; University of California System; University of California San Francisco; Egyptian Knowledge Bank (EKB); Alexandria University	Brown, ED (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	ebrown@mcmaster.ca	El-Halfawy, Omar/AAE-2491-2020	El-Halfawy, Omar/0000-0003-2829-5851; Li, Franco/0000-0001-7318-9754; Koo, Byoung-Mo/0000-0003-1001-6367; Myers, Cullen/0000-0002-5789-2260	Canadian Institutes of Health Research Foundation [FRN-143215]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Canadian Institutes of Health Research; Howard Hughes Medical Institute; Canada Foundation for Innovation; British Columbia; National Institutes of Health [R01 GM102790, R35 GM118061]	Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Canadian Institutes of Health Research Foundation Grant FRN-143215, a Natural Sciences and Engineering Research Council of Canada Discovery Grant (to E. D. B.), the Canada Research Chairs Program (to E. D. B. and N. C. J. S.), the Canadian Institutes of Health Research, the Howard Hughes Medical Institute International Scholar Program, Canada Foundation for Innovation, British Columbia Knowledge Development Fund, and National Institutes of Health Grants R01 GM102790 and R35 GM118061 (to C. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allenby NEE, 2005, J BACTERIOL, V187, P8063, DOI 10.1128/JB.187.23.8063-8080.2005; Allenby NEE, 2004, MICROBIOL-SGM, V150, P2619, DOI 10.1099/mic.0.27126-0; Allison SE, 2011, J BIOL CHEM, V286, P23708, DOI 10.1074/jbc.M111.241265; Antelmann H, 2000, J BACTERIOL, V182, P4478, DOI 10.1128/JB.182.16.4478-4490.2000; Bhavsar AP, 2004, J BACTERIOL, V186, P7865, DOI 10.1128/JB.186.23.7865-7873.2004; Bhavsar AP, 2001, APPL ENVIRON MICROB, V67, P403, DOI 10.1128/AEM.67.1.403-410.2001; Bisicchia P, 2010, MOL MICROBIOL, V75, P972, DOI 10.1111/j.1365-2958.2009.07036.x; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Botella E, 2014, MOL MICROBIOL, V94, P1242, DOI 10.1111/mmi.12833; Botella E, 2011, MICROBIOL-SGM, V157, P2470, DOI 10.1099/mic.0.049205-0; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Chan YGY, 2013, J BACTERIOL, V195, P4650, DOI 10.1128/JB.00544-13; Cutting S., 1990, MOL BIOL METHODS BAC; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; D'Elia MA, 2009, CHEM BIOL, V16, P548, DOI 10.1016/j.chembiol.2009.04.009; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Eder S, 1996, MICROBIOL-SGM, V142, P2041, DOI 10.1099/13500872-142-8-2041; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farha MA, 2013, ACS CHEM BIOL, V8, P226, DOI 10.1021/cb300413m; GRANT WD, 1979, J BACTERIOL, V137, P35, DOI 10.1128/JB.137.1.35-43.1979; HERBOLD DR, 1975, J BIOL CHEM, V250, P7231; Hulett F. M, 2002, BACILLUS SUBTILIS IT, P193, DOI [10.1128/9781555817992.ch15, DOI 10.1128/9781555817992.CH15]; HULETT FM, 1994, J BACTERIOL, V176, P1348, DOI 10.1128/jb.176.5.1348-1358.1994; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; JENKINSON HF, 1983, J GEN MICROBIOL, V129, P1945; Kasahara J, 2016, J BACTERIOL, V198, P1585, DOI 10.1128/JB.00003-16; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; KUSSER W, 1983, J BACTERIOL, V155, P302, DOI 10.1128/JB.155.1.302-310.1983; Lee SH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7364; LINDSAY B, 1976, J BACTERIOL, V127, P803, DOI 10.1128/JB.127.2.803-811.1976; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maria JPS, 2014, P NATL ACAD SCI USA, V111, P12510, DOI 10.1073/pnas.1404099111; MAUCK J, 1971, J BIOL CHEM, V246, P1820; MIN H, 1986, ANAL BIOCHEM, V155, P275, DOI 10.1016/0003-2697(86)90437-9; Muller JP, 1999, FEMS MICROBIOL LETT, V180, P287; MUNSON RS, 1993, J BACTERIOL, V175, P4569, DOI 10.1128/JB.175.14.4569-4571.1993; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nicholson W. L, 1991, MOL BIOL METHODS BAC, P391; Ohshima N, 2008, J BACTERIOL, V190, P1219, DOI 10.1128/JB.01223-07; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Pragai Z, 2004, J BACTERIOL, V186, P1182, DOI 10.1128/JB.186.4.1182-1190.2004; Reith J, 2011, APPL MICROBIOL BIOT, V92, P1, DOI 10.1007/s00253-011-3486-x; Rodriguez F, 2014, J BIOL CHEM, V289, P30889, DOI 10.1074/jbc.M114.604892; Sambrook J, 2012, MOL CLONING, V4; Santelli E, 2004, PROTEINS, V56, P167, DOI 10.1002/prot.20120; Schenk G, 2013, COORDIN CHEM REV, V257, P473, DOI 10.1016/j.ccr.2012.03.020; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sewell EWC, 2014, J ANTIBIOT, V67, P43, DOI 10.1038/ja.2013.100; Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921; Soldo B, 1999, MOL MICROBIOL, V31, P795, DOI 10.1046/j.1365-2958.1999.01218.x; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; TOMMASSEN J, 1991, MOL GEN GENET, V226, P321, DOI 10.1007/BF00273621; VELLANOWETH RL, 1992, MOL MICROBIOL, V6, P1105, DOI 10.1111/j.1365-2958.1992.tb01548.x; Vuitika L, 2016, BBA-MOL CELL BIOL L, V1861, P970, DOI 10.1016/j.bbalip.2016.05.009; Wecke J, 1997, MICROBIOL-UK, V143, P2953, DOI 10.1099/00221287-143-9-2953; Winstel V, 2015, MBIO, V6, DOI 10.1128/mBio.00632-15; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; WISE EM, 1972, P NATL ACAD SCI USA, V69, P233, DOI 10.1073/pnas.69.1.233; Xiang Y, 2009, MOL CELL, V34, P375, DOI 10.1016/j.molcel.2009.04.009; Yamamoto H, 2003, J BACTERIOL, V185, P6666, DOI 10.1128/JB.185.22.6666-6677.2003	65	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26066	26082		10.1074/jbc.M116.760447	http://dx.doi.org/10.1074/jbc.M116.760447			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27780866	hybrid, Green Published			2022-12-26	WOS:000390345200026
J	Gleyzer, N; Scarpulla, RC				Gleyzer, Natalie; Scarpulla, Richard C.			Concerted Action of PGC-1-related Coactivator (PRC) and c-MYC in the Stress Response to Mitochondrial Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; metabolism; mitochondria; signaling; stress	ALLOSTERIC AKT INHIBITOR; PHOSPHORYLATION; TRANSCRIPTION; EXPRESSION; RESPIRATION; ACTIVATION; TRANSFORMATION; DEGRADATION; INTEGRATION; BIOGENESIS	PGC-1-related coactivator (PRC) has a dual function in growth-regulated mitochondrial biogenesis and as a sensor of metabolic stress. PRC induction by mitochondrial inhibitors, intracellular ROS, or topoisomerase I inhibition orchestrates an inflammatory program associated with the adaptation to cellular stress. Activation of this program is accompanied by the coordinate expression of c-MYC, which is linked kinetically to that of PRC in response to multiple stress inducers. Here, we show that the c-MYC inhibitor 10058-F4 blocks the induction of c-MYC, PRC, and representative PRC-dependent stress genes by the respiratory chain uncoupler, carbonyl cyanide m-chlorophenyl hydrazine (CCCP). This result, confirmed by the suppression of PRC induction by c-MYC siRNA silencing, demonstrates a requirement for c-MYC in orchestrating the stress program. PRC steady-state expression was markedly increased upon mutation of two GSK-3 serine phosphorylation sites within the carboxyl-terminal domain. The negative control of PRC expression by GSK-3 was consistent with the phosphor-inactivation of GSK-3 by CCCP and by the induction of PRC by the GSK-3 inhibitor AZD2858. Unlike PRC, which was induced post-translationally through increased protein half-life, c-MYC was induced predominantly at the mRNA level. Moreover, suppression of Akt activation by the Akt inhibitor MK-2206 blocked the CCCP induction of PRC, c-MYC, and representative PRC stress genes, demonstrating a requirement for Akt signaling. MK-2206 also inhibited the phosphor-inactivation of GSK-3 by CCCP, a result consistent with the ability of Akt to phosphorylate, and thereby suppress GSK-3 activity. Thus, PRC and c-MYC can act in concert through Akt-GSK-3 signaling to reprogram gene expression in response to mitochondrial stress.	[Gleyzer, Natalie; Scarpulla, Richard C.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 East Chicago Ave, Chicago, IL 60611 USA	Northwestern University	Scarpulla, RC (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 East Chicago Ave, Chicago, IL 60611 USA.	rsc248@northwestern.edu			National Institutes of General Medical Sciences [GM 32525]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM032525, R01GM032525] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of General Medical Sciences Grant GM 32525. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Campaner S, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-6; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Dey S, 2013, AUTOPHAGY, V9, P612, DOI 10.4161/auto.23486; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Flick K, 2012, SEMIN CELL DEV BIOL, V23, P515, DOI 10.1016/j.semcdb.2012.01.019; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Gleyzer N, 2013, J BIOL CHEM, V288, P8004, DOI 10.1074/jbc.M112.426841; Gleyzer N, 2011, J BIOL CHEM, V286, P39715, DOI 10.1074/jbc.M111.291575; Gohil VM, 2013, J BIOL CHEM, V288, P35387, DOI 10.1074/jbc.M113.489237; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Gugneja S, 1997, J BIOL CHEM, V272, P18732, DOI 10.1074/jbc.272.30.18732; Guha M, 2010, MOL BIOL CELL, V21, P3578, DOI 10.1091/mbc.E10-03-0192; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; He X, 2012, DEV DYNAM, V241, P975, DOI 10.1002/dvdy.23769; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hudis C, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3577; Idan C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14756; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111/j.1476-5381.2009.00331.x; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marsell R, 2012, BONE, V50, P619, DOI 10.1016/j.bone.2011.11.007; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Molife LR, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-1; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rohban S, 2015, BBA-GENE REGUL MECH, V1849, P517, DOI 10.1016/j.bbagrm.2014.04.008; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Scarpulla RC, 2012, BBA-GENE REGUL MECH, V1819, P1088, DOI 10.1016/j.bbagrm.2011.10.011; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200; Wang H, 1997, BBA-GENE STRUCT EXPR, V1352, P325, DOI 10.1016/S0167-4781(97)00035-3; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Whitfield JR, 2012, CELL MOL LIFE SCI, V69, P931, DOI 10.1007/s00018-011-0860-x; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Yoon JC, 2014, P NATL ACAD SCI USA, V111, P3781, DOI 10.1073/pnas.1400705111	59	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25529	25541		10.1074/jbc.M116.719682	http://dx.doi.org/10.1074/jbc.M116.719682			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27789709	Green Published, hybrid			2022-12-26	WOS:000390095300021
J	Lander, N; Chiurillo, MA; Storey, M; Vercesi, AE; Docampo, R				Lander, Noelia; Chiurillo, Miguel A.; Storey, Melissa; Vercesi, Anibal E.; Docampo, Roberto			CRISPR/Cas9-mediated endogenous C-terminal Tagging of Trypanosoma cruzi Genes Reveals the Acidocalcisome Localization of the Inositol 1,4,5-Trisphosphate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; inositol 1; 4; 5-trisphosphate (IP3); mitochondria; Trypanosoma cruzi; vacuolar acidification; acidocalcisome; flagellum	SECRETORY GRANULES; CA-2+ TRANSPORT; CA2+; BRUCEI; EXPRESSION; MEMBRANE; RELEASE; PROTEIN; GROWTH; PYROPHOSPHATASE	Methods for genetic manipulation of Trypanosoma cruzi, the etiologic agent of Chagas disease, have been highly inefficient, and no endogenous tagging of genes has been reported to date. We report here the use of the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated gene 9) system for endogenously tagging genes in this parasite. The utility of the method was established by tagging genes encoding proteins of known localization such as TcFCaBP (flagellar calcium binding protein) and TcVP1 (vacuolar proton pyrophosphatase), and two proteins of undefined or disputed localization, the TcMCU (mitochondrial calcium uniporter) and TcIP3R (inositol 1,4,5-trisphosphate receptor). We confirmed the flagellar and acidocalcisome localization of TcFCaBP and TcVP1 by co-localization with antibodies to the flagellum and acidocalcisomes, respectively. As expected, TcMCU was co-localized with the voltage-dependent anion channel to the mitochondria. However, in contrast to previous reports and our own results using overexpressed TcIP3R, endogenously tagged TcIP3R showed co-localization with antibodies against VP1 to acidocalcisomes. These results are also in agreement with our previous reports on the localization of this channel to acidocalcisomes of Trypanosoma brucei and suggest that caution should be exercised when overexpression of tagged genes is done to localize proteins in T. cruzi.	[Lander, Noelia; Chiurillo, Miguel A.; Vercesi, Anibal E.; Docampo, Roberto] Univ Estadual Campinas, Dept Patol Clin, Fac Ciencias Med, BR-13083 Campinas, SP, Brazil; [Storey, Melissa; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Storey, Melissa; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	Universidade Estadual de Campinas; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lander, N; Docampo, R (corresponding author), Univ Estadual Campinas, Dept Patol Clin, Fac Ciencias Med, BR-13083 Campinas, SP, Brazil.; Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.; Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	noelia@uga.edu; rdocampo@uga.edu	Vercesi, Aníbal E/C-8767-2012; Docampo, Roberto/X-9424-2019	Docampo, Roberto/0000-0003-4229-8784; Vercesi, Anibal Eugenio/0000-0001-6671-7125; Chiurillo, Miguel A./0000-0002-5581-9027; Lander, Noelia/0000-0003-2178-381X	Sao Paulo Research Foundation [2013/ 50624-0, 2014/08995-4, 2014/13148-9]; National Institutes of Health [AI107663]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI107663, R01AI107663] Funding Source: NIH RePORTER	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Sao Paulo Research Foundation Grant 2013/ 50624-0, and National Institutes of Health Grant AI107663, and Sao Paulo Research Foundation Postdoctoral Fellowships 2014/08995-4 (to N. L.) and 2014/13148-9 (to M. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez J, 2012, CELL CALCIUM, V51, P331, DOI 10.1016/j.ceca.2011.12.002; Alzayady KJ, 2015, MOL BIOL EVOL, V32, P2236, DOI 10.1093/molbev/msv098; BANGS JD, 1993, J CELL SCI, V105, P1101; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BLONDEL O, 1994, P NATL ACAD SCI USA, V91, P7777, DOI 10.1073/pnas.91.16.7777; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; DOCAMPO R, 1989, J BIOL CHEM, V264, P108; DOCAMPO R, 1989, ARCH BIOCHEM BIOPHYS, V272, P122, DOI 10.1016/0003-9861(89)90202-6; Docampo R, 2015, CELL CALCIUM, V57, P194, DOI 10.1016/j.ceca.2014.10.015; Docampo R, 2014, MOL BIOCHEM PARASIT, V196, P108, DOI 10.1016/j.molbiopara.2014.09.001; Docampo R, 2012, TRENDS PARASITOL, V28, P31, DOI 10.1016/j.pt.2011.10.007; Docampo R, 2011, ESSAYS BIOCHEM, V51, P1, DOI [10.1042/BSE0510001, 10.1042/bse0510001]; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; ENGMAN DM, 1989, J BIOL CHEM, V264, P18627; Gerasimenko OV, 1996, CELL, V84, P473, DOI 10.1016/S0092-8674(00)81292-1; Hashimoto M, 2013, MOL MICROBIOL, V87, P1133, DOI 10.1111/mmi.12155; Huang GZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004555; Huang GZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3865; Huang GZ, 2013, P NATL ACAD SCI USA, V110, P1887, DOI 10.1073/pnas.1216955110; Ladenburger EM, 2006, J CELL SCI, V119, P3705, DOI 10.1242/jcs.03075; Lander N, 2016, J EUKARYOT MICROBIOL, V63, P679, DOI 10.1111/jeu.12338; Lander N, 2015, MBIO, V6, DOI 10.1128/mBio.01012-15; Lander N, 2013, J BIOL CHEM, V288, P34205, DOI 10.1074/jbc.M113.518993; Lander N, 2010, INFECT IMMUN, V78, P231, DOI 10.1128/IAI.00780-09; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Lu HG, 1998, MOL CELL BIOL, V18, P2309, DOI 10.1128/MCB.18.4.2309; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Peng D, 2015, MBIO, V6, DOI 10.1128/mBio.02097-14; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Quesada I, 2001, BIOPHYS J, V80, P2133, DOI 10.1016/S0006-3495(01)76186-3; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Singha UK, 2009, EUKARYOT CELL, V8, P1418, DOI 10.1128/EC.00132-09; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Yoo SH, 2010, FASEB J, V24, P653, DOI 10.1096/fj.09-132456; YOO SH, 1994, J BIOL CHEM, V269, P12001; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096908; Zhang WG, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/765362	43	54	54	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25505	25515		10.1074/jbc.M116.749655	http://dx.doi.org/10.1074/jbc.M116.749655			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27793988	Green Published, hybrid			2022-12-26	WOS:000390095300019
J	Arena, SL; Davis, JL; Grant, JW; Madigan, ML				Arena, Sara L.; Davis, Julian L.; Grant, J. Wallace; Madigan, Michael L.			Tripping Elicits Earlier and Larger Deviations in Linear Head Acceleration Compared to Slipping	PLOS ONE			English	Article							LOCOMOTOR TASKS; HUMAN WALKING; OLDER-ADULTS; RECOVERY; BODY; STABILITY; PATTERNS; BALANCE; PELVIS; SLIPS	Slipping and tripping contribute to a large number of falls and fall-related injuries. While the vestibular system is known to contribute to balance and fall prevention, it is unclear whether it contributes to detecting slip or trip onset. Therefore, the purpose of this study was to investigate the effects of slipping and tripping on head acceleration during walking. This information would help determine whether individuals with vestibular dysfunction are likely to be at a greater risk of falls due to slipping or tripping, and would inform the potential development of assistive devices providing augmented sensory feedback for vestibular dysfunction. Twelve young men were exposed to an unexpected slip or trip. Head acceleration was measured and transformed to an approximate location of the vestibular system. Peak linear acceleration in anterior, posterior, rightward, leftward, superior, and inferior directions were compared between slipping, tripping, and walking. Compared to walking, peak accelerations were up to 4.68 m/s(2) higher after slipping, and up to 10.64 m/s(2) higher after tripping. Head acceleration first deviated from walking 100-150 ms after slip onset and 0-50ms after trip onset. The temporal characteristics of head acceleration support a possible contribution of the vestibular system to detecting trip onset, but not slip onset. Head acceleration after slipping and tripping also appeared to be sufficiently large to contribute to the balance recovery response.	[Arena, Sara L.] High Point Univ, Dept Exercise Sci, High Point, NC 27268 USA; [Davis, Julian L.] Univ Southern Indiana, Dept Engn, Evansville, IN USA; [Grant, J. Wallace] Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA; [Madigan, Michael L.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA	Virginia Polytechnic Institute & State University; Texas A&M University System; Texas A&M University College Station	Arena, SL (corresponding author), High Point Univ, Dept Exercise Sci, High Point, NC 27268 USA.	sarena@highpoint.edu		Davis, Julian/0000-0003-4109-3904; Madigan, Michael/0000-0002-4299-3851	National Institute for Occupational Safety and Health [R01OH009880]	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was funded from a National Institute for Occupational Safety and Health grant (R01OH009880) awarded to Michael Madigan.	Agrawal Y, 2009, ARCH INTERN MED, V169, P938, DOI 10.1001/archinternmed.2009.66; Amandus H, 2012, HUM FACTORS, V54, P387, DOI 10.1177/0018720811403140; Beeman SM, 2011, ANN BIOMED ENG, V39, P2998, DOI 10.1007/s10439-011-0379-1; Bell J, 2010, SLIP TRIP FALL PREVE; BENSON AJ, 1986, AVIAT SPACE ENVIR MD, V57, P1088; Bent LR, 2005, EXERC SPORT SCI REV, V33, P107, DOI 10.1097/00003677-200507000-00002; Bent LR, 2004, WHEN IS VESTIBULAR I, P1269; Beringer DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096525; Beschorner K. E., 2013, IIE T OCCUPATIONAL E, V1, P31, DOI [10.1080/21577323.2012.660904, DOI 10.1080/21577323.2012.660904]; BRANDT T, 1988, INT CONGR SER, V812, P127; Centers for Disease Control and Prevention, 2021, 10 LEAD CAUS DEATH U; Cham R, 2002, GAIT POSTURE, V15, P159, DOI 10.1016/S0966-6362(01)00150-3; Cham R, 2001, J BIOMECH, V34, P1439, DOI 10.1016/S0021-9290(01)00116-6; Chambers AJ, 2007, GAIT POSTURE, V25, P565, DOI 10.1016/j.gaitpost.2006.06.007; Chandler RF., 1975, INVESTIGATION INERTI; Choi S, 2015, ANN REHABIL MED-ARM, V39, P897, DOI 10.5535/arm.2015.39.6.897; Courtney TK, 2001, ERGONOMICS, V44, P1118, DOI 10.1080/00140130110085538; Day BL, 2005, CURR BIOL, V15, pR583, DOI 10.1016/j.cub.2005.07.053; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; ENG JJ, 1994, EXP BRAIN RES, V102, P339; Herdman SJ, 2000, AM J OTOL, V21, P847; HLAVACKA F, 1995, NEUROSCI LETT, V189, P9, DOI 10.1016/0304-3940(95)11436-Z; HORAK FB, 1994, EXP BRAIN RES, V100, P93; Hughes GB, 2007, CLIN OTOLOGY, Vxvi; Kavanagh JJ, 2004, GAIT POSTURE, V20, P291, DOI 10.1016/j.gaitpost.2003.10.004; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Leavy B, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0036-x; Lipscomb HJ, 2006, APPL ERGON, V37, P267, DOI 10.1016/j.apergo.2005.07.008; Marigold DS, 2003, J NEUROPHYSIOL, V89, P1727, DOI 10.1152/jn.00683.2002; Marigold DS, 2002, J NEUROPHYSIOL, V88, P339, DOI 10.1152/jn.00691.2001; Menz HB, 2003, GAIT POSTURE, V18, P35, DOI 10.1016/S0966-6362(02)00159-5; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Meriam JL, 2002, ENG MECH DYNAMICS; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pijnappels M, 2005, J BIOMECH, V38, P627, DOI 10.1016/j.jbiomech.2004.03.029; POZZO T, 1990, EXP BRAIN RES, V82, P97; POZZO T, 1995, EXP BRAIN RES, V106, P327; Rivera ARV, 2012, J EXP ZOOL PART A, V317A, P467, DOI 10.1002/jez.1739; Safety LMRIf, 2014, LIB MUT WORKPL SAF I; Tang PF, 1998, EXP BRAIN RES, V119, P141, DOI 10.1007/s002210050327; Troy KL, 2006, GAIT POSTURE, V24, P441, DOI 10.1016/j.gaitpost.2005.09.009; Wright RL, 2015, GAIT POSTURE, V41, P164, DOI 10.1016/j.gaitpost.2014.09.025	44	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165670	10.1371/journal.pone.0165670	http://dx.doi.org/10.1371/journal.pone.0165670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802298	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200037
J	Tiveron, AP; Rosalen, PL; Franchin, M; Lacerda, RCC; Bueno-Silva, B; Benso, B; Denny, C; Ikegaki, M; de Alencar, SM				Tiveron, Ana Paula; Rosalen, Pedro Luiz; Franchin, Marcelo; Coelho Lacerda, Risia Cristina; Bueno-Silva, Bruno; Benso, Bruna; Denny, Carina; Ikegaki, Masaharu; de Alencar, Severino Matias			Chemical Characterization and Antioxidant, Antimicrobial, and Anti-Inflammatory Activities of South Brazilian Organic Propolis	PLOS ONE			English	Article							PHENOLIC COMPOSITION; RED PROPOLIS; IN-VITRO; CYTOKINE PRODUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN; ESSENTIAL OILS; ANTIBACTERIAL; ACCUMULATION; GEOPROPOLIS	South Brazilian organic propolis (OP), which has never been studied before, was assessed and its chemical composition, scavenging potential of reactive oxygen species, antimicrobial and anti-inflammatory activities are herein presented. Based on the chemical profile obtained using HPLC, OP was grouped into seven variants (OP1-OP7) and all of them exhibited high scavenging activity, mainly against superoxide and hypochlorous acid species. OP1, OP2, and OP3 had the smallest minimal inhibitory concentration (MIC) against Gram-positive bacteria Streptococcus mutans, Streptococcus oralis, and Streptococcus aureus (12.5-100 mu g/mL). OP1, OP2, OP3, and OP4 were more effective against Pseudomonas aeruginosa (Gram-negative), with MIC values ranging from 100 to 200 mu g/mL. OP6 showed anti-inflammatory activity by decreasing NF-kappa B activation and TNF-alpha release in RAW 264.7 macrophages, and expressing the NF-kappa B-luciferase reporter stable gene. Therefore, south Brazilian OP can be considered an excellent source of bioactive compounds with great potential of application in the pharmaceutical and food industry.	[Tiveron, Ana Paula; Coelho Lacerda, Risia Cristina; de Alencar, Severino Matias] Univ Sao Paulo, Dept Agri Food Ind Food & Nutr, Luiz de Queiroz Coll Agr, Ave Padua Dias 11, BR-13418900 Piracicaba, SP, Brazil; [Rosalen, Pedro Luiz; Franchin, Marcelo; Bueno-Silva, Bruno; Benso, Bruna; Denny, Carina] Univ Campinas UNICAMP, Dept Physiol Sci, Piracicaba Dent Sch, Ave Limeira 901,CP 52, BR-13414903 Piracicaba, SP, Brazil; [Ikegaki, Masaharu] Univ Fed Alfenas, Sch Pharmaceut Sci, Rua Gabriel Monteiro da Silva 714, BR-37130000 Alfenas, MG, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Alfenas	de Alencar, SM (corresponding author), Univ Sao Paulo, Dept Agri Food Ind Food & Nutr, Luiz de Queiroz Coll Agr, Ave Padua Dias 11, BR-13418900 Piracicaba, SP, Brazil.	smalencar@usp.br	Ikegaki, Masaharu/R-2540-2019; Bueno-Silva, Bruno/J-3097-2012; Alencar, Severino Matias/B-7743-2012; Benso, Bruna/L-1010-2015; Franchin, Marcelo/M-7636-2017; Rosalen, Pedro Luiz/I-3718-2012	Bueno-Silva, Bruno/0000-0003-3275-5910; Alencar, Severino Matias/0000-0002-6637-7973; Benso, Bruna/0000-0002-4425-5174; Franchin, Marcelo/0000-0001-5613-2756; Rosalen, Pedro Luiz/0000-0003-0812-4027; Ikegaki, Masaharu/0000-0003-0688-1518; Lacerda, Risia/0000-0002-3410-0443	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo [2010/52679-9, 2011/50651-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [472848/2011-9]	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Grant #2010/52679-9 - Fundacao do Amparo a Pesquisa do Estado de Sao Paulo - http://www.bv.fapesp.br/pt/bolsas/130453/caracterizacao-e-identificaco-de-compostos-com-atividade-antioxidante-de-propolis-orgenica-brasileir/ - APT. Grant # 2011/50651-2 Fundacao do Amparo a Pesquisa do Estado de Sao Paulo - http://bvs.fapesp.br/pt/auxilios/45149/composicao-quimica-e-atividade-antioxidante-de-um-novo-tipo-de-propolis-brasileira-produzida-por-abe/ - SMA. Grant # 472848/2011-9 Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - http://www.cnpq.br - SMA.	Abreu P, 2006, LIFE SCI, V78, P1578, DOI 10.1016/j.lfs.2005.07.037; Al-Duais M, 2009, EUR FOOD RES TECHNOL, V228, P813, DOI 10.1007/s00217-008-0994-8; Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; [Anonymous], 1991, J Antimicrob Chemother, V27 Suppl D, P1; Aziz M, 2018, CRIT REV FOOD SCI, V58, P486, DOI 10.1080/10408398.2016.1194256; Bankova V, 1999, FITOTERAPIA, V70, P190, DOI [10.1016/S0367-326X(98)00045-8, 10.1016/S0367-326X(98)00044-6]; Banskota AH, 2001, PHYTOTHER RES, V15, P561, DOI 10.1002/ptr.1029; Becker EM, 2004, EUR FOOD RES TECHNOL, V219, P561, DOI 10.1007/s00217-004-1012-4; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Brown L, 2015, NAT REV MICROBIOL, V13, P620, DOI 10.1038/nrmicro3480; Bueno-Silva B, 2013, BIOFOULING, V29, P1233, DOI 10.1080/08927014.2013.834050; Bueno-Silva B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144954; Bueno-Silva B, 2013, J AGR FOOD CHEM, V61, P4546, DOI 10.1021/jf305468f; Bufalo MC, 2013, J ETHNOPHARMACOL, V149, P84, DOI 10.1016/j.jep.2013.06.004; Oldoni TLC, 2015, J BRAZIL CHEM SOC, V26, P2054, DOI 10.5935/0103-5053.20150186; Duarte MCT, 2007, J ETHNOPHARMACOL, V111, P197, DOI 10.1016/j.jep.2006.11.034; Galvao LCD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/751435; Demiirkol G., 2013, Scientific Works. Series C. Veterinary Medicine, V59, P14; Duarte S, 2006, ARCH ORAL BIOL, V51, P15, DOI 10.1016/j.archoralbio.2005.06.002; Erdem M, 2016, ARCH INSECT BIOCHEM, V93, P202, DOI 10.1002/arch.21352; Franchin M, 2016, J NAT PROD, V79, P1828, DOI 10.1021/acs.jnatprod.6b00263; Franchin M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/907041; Franchin M, 2012, J ETHNOPHARMACOL, V143, P709, DOI 10.1016/j.jep.2012.07.040; Freires IA, 2016, EUR J MED CHEM, V110, P267, DOI 10.1016/j.ejmech.2016.01.033; Furletti VF, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/985832; Gomes A, 2007, BIOORGAN MED CHEM, V15, P6027, DOI 10.1016/j.bmc.2007.06.046; Gulcin I, 2012, ARCH TOXICOL, V86, P345, DOI 10.1007/s00204-011-0774-2; Hayacibara MF, 2005, J ETHNOPHARMACOL, V101, P110, DOI 10.1016/j.jep.2005.04.001; Jananie R. K., 2011, Journal of Chemical and Pharmaceutical Research, V3, P647; Kiwa BCS OKO-Garantie GmbH, ORG CERT; Koleva II, 2001, ANAL CHEM, V73, P3373, DOI 10.1021/ac0013610; Koo H, 2000, CURR MICROBIOL, V41, P192, DOI 10.1007/s0028400101170; Koo H, 2003, J ANTIMICROB CHEMOTH, V52, P782, DOI 10.1093/jac/dkg449; Kotsinas A, 2012, CANCER LETT, V327, P97, DOI 10.1016/j.canlet.2011.12.009; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Liu XB, 2016, FREE RADICAL BIO MED, V91, P25, DOI 10.1016/j.freeradbiomed.2015.12.001; Magalhaes LM, 2008, ANAL CHIM ACTA, V613, P1, DOI 10.1016/j.aca.2008.02.047; Marcucci MC, 2001, J ETHNOPHARMACOL, V74, P105, DOI 10.1016/S0378-8741(00)00326-3; Mattos-Graner RO, 2001, INFECT IMMUN, V69, P6931, DOI 10.1128/IAI.69.11.6931-6941.2001; Melo PS, 2015, FOOD CHEM, V181, P160, DOI 10.1016/j.foodchem.2015.02.087; Moraes-De-Souza RA, 2008, CIENC TECNOL ALIMENT, V6, P41, DOI 10.1080/11358120809487626; Oldoni TLC, 2011, SEP PURIF TECHNOL, V77, P208, DOI 10.1016/j.seppur.2010.12.007; Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b; Park YongKun, 2000, Honeybee Science, V21, P85; Paulino N, 2006, PLANTA MED, V72, P899, DOI 10.1055/s-2006-947185; Cabral ISR, 2009, QUIM NOVA, V32, P1523, DOI 10.1590/S0100-40422009000600031; Ribeiro DR, 2015, BASIC CLIN PHARMACOL, V117, P85, DOI 10.1111/bcpt.12374; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Silva RL, 2015, J NAT PROD, V78, P241, DOI 10.1021/np500796f; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Szliszka E, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/735176; Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w	52	71	72	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165588	10.1371/journal.pone.0165588	http://dx.doi.org/10.1371/journal.pone.0165588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802316	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200029
J	Gabbett, TJ				Gabbett, Tim J.			Influence of Fatigue on Tackling Ability in Rugby League Players: Role of Muscular Strength, Endurance, and Aerobic Qualities	PLOS ONE			English	Article							PERFORMANCE; INJURY	This study investigated the influence of repeated high-intensity effort exercise on tackling ability in rugby league players, and determined the relationship between physical qualities and tackling ability under fatigued conditions in these athletes. Eleven semi-professional rugby league players underwent measurements of speed (10 m and 40 m sprint), upper-body strength (4 repetition maximum [RM] bench press and weighted chin-up), upper-body muscular endurance (body mass maximum repetition chin-up, body mass maximum repetition dips), lower-body strength (4RM squat), and estimated maximal aerobic power (multi-stage fitness test). Tackling ability was assessed using a standardized one-on-one tackling test, before, during, and following four bouts of repeated high-intensity effort (RHIE) exercise. The relationship between physical qualities and fatigue-induced decrements in tackling ability were determined using Pearson product moment correlation coefficients. Each cycle of the RHIE protocol induced progressive reductions in tackling ability. A moderate reduction (Effect Size = similar to-1.17 +/- 0.60, -34.1 +/- 24.3%) in tackling ability occurred after the fourth cycle of the RHIE protocol. Players with greater relative lower-body strength (i.e. 4RM squat/kg) had the best tackling ability under fatigued conditions (r = 0.72, p = 0.013). There were no significant relationships between tackling ability under fatigued conditions and any other physical quality. These findings suggest that lower-body strength protects against fatigue-induced decrements in tackling ability. The development of lower-body strength should be a priority to facilitate the development of robust tackling skills that are maintained under fatigue.	[Gabbett, Tim J.] Gabbett Performance Solut, Brisbane, Qld, Australia		Gabbett, TJ (corresponding author), Gabbett Performance Solut, Brisbane, Qld, Australia.	tim@gabbettperformance.com.au						Austin D, 2011, J STRENGTH COND RES, V25, P1659, DOI 10.1519/JSC.0b013e3181da781c; Cohen J.E., 1988, STAT POWER ANAL BEHA; Gabbett T, 2009, INT J SPORTS SCI COA, V4, P521, DOI 10.1260/174795409790291402; Gabbett TJ, 2015, INT J SPORT PHYSIOL, V10, P718, DOI 10.1123/ijspp.2014-0127; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P3259, DOI 10.1519/JSC.0b013e31828d6219; Gabbett TJ, 2012, J SCI MED SPORT, V15, P80, DOI 10.1016/j.jsams.2011.07.004; Gabbett TJ, 2012, J STRENGTH COND RES, V26, P121, DOI 10.1519/JSC.0b013e31821e4c60; Gabbett TJ, 2011, J SCI MED SPORT, V14, P210, DOI 10.1016/j.jsams.2011.01.002; Gabbett TJ, 2011, J STRENGTH COND RES, V25, P72, DOI 10.1519/JSC.0b013e3181ff506f; Gabbett TJ, 2010, J STRENGTH COND RES, V24, P2989, DOI 10.1519/JSC.0b013e3181f00d22; Gabbett TJ, 2009, J STRENGTH COND RES, V23, P540, DOI 10.1519/JSC.0b013e31818efe8b; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P625, DOI 10.1519/JSC.0b013e3181635a6a; Gabbett TJ, 2005, J SPORT SCI, V23, P961, DOI 10.1080/02640410400023381; Hendricks S, 2014, EUR J SPORT SCI, V14, P753, DOI 10.1080/17461391.2014.905982; Hendricks S, 2014, J SPORT SCI MED, V13, P557; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Johnston RD, 2015, J SCI MED SPORT, V18, P209, DOI 10.1016/j.jsams.2014.01.009; King DA, 2011, J SPORT MED PHYS FIT, V51, P435; King D, 2012, RES SPORTS MED, V20, P86, DOI 10.1080/15438627.2012.660824; Ramsbottom R, 1988, Br J Sports Med, V22, P141; Speranza M, 2015, J STRENGTH IN PRESS; Speranza MJA, 2015, INT J SPORT PHYSIOL, V10, P754, DOI 10.1123/ijspp.2015-0044; Speranza MJA, 2015, J STRENGTH COND RES, V29, P2071, DOI 10.1519/JSC.0000000000000897; Wilson GJ, 1994, APPL ANATOMY BIOMECH, P110	24	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0163161	10.1371/journal.pone.0163161	http://dx.doi.org/10.1371/journal.pone.0163161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798634	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000386711100002
J	Gaziova, I; Jackson, D; Boor, PJ; Carter, D; Cruz-Monserrate, Z; Elferink, CJ; Joshi, AD; Kaphalia, B; Logsdon, CD; de Castro, KP; Soong, L; Tao, XR; Qiu, SM; Elferink, LA				Gaziova, Ivana; Jackson, Daniel; Boor, Paul J.; Carter, Dwayne; Cruz-Monserrate, Zobeida; Elferink, Cornelis J.; Joshi, Aditya D.; Kaphalia, Bhupendra; Logsdon, Craig D.; de Castro, Karen Pereira; Soong, Lynn; Tao, Xinrong; Qiu, Suimin; Elferink, Lisa A.			The MET Receptor Tyrosine Kinase Confers Repair of Murine Pancreatic Acinar Cells following Acute and Chronic Injury	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; SIGNALING PATHWAY; C-MET; INFLAMMATION; REGULATOR; XBP-1; MICE	Acinar cells represent the primary target in necroinflammatory diseases of the pancreas, including pancreatitis. The signaling pathways guiding acinar cell repair and regeneration following injury remain poorly understood. The purpose of this study was to determine the importance of Hepatocyte Growth Factor Receptor/MET signaling as an intrinsic repair mechanism for acinar cells following acute damage and chronic alcohol-associated injury. Here, we generated mice with targeted deletion of MET in adult acinar cells (MET-/-). Acute and repetitive pancreatic injury was induced in MET-/- and control mice with cerulein, and chronic injury by feeding mice Lieber-DeCarli diets containing alcohol with or without enhancement of repetitive pancreatic injury. We examined the exocrine pancreas of these mice histologically for acinar death, edema, inflammation and collagen deposition and changes in the transcriptional program. We show that MET expression is relatively low in normal adult pancreas. However, MET levels were elevated in ductal and acinar cells in human pancreatitis specimens, consistent with a role for MET in an adaptive repair mechanism. We report that genetic deletion of MET in adult murine acinar cells was linked to increased acinar cell death, chronic inflammation and delayed recovery (regeneration) of pancreatic exocrine tissue. Notably, increased pancreatic collagen deposition was detected in MET knockout mice following repetitive injury as well alcohol-associated injury. Finally, we identified specific alterations of the pancreatic transcriptome associated with MET signaling during injury, involved in tissue repair, inflammation and endoplasmic reticulum stress. Together, these data demonstrate the importance of MET signaling for acinar repair and regeneration, a novel finding that could attenuate the symptomology of pancreatic injury.	[Gaziova, Ivana; Tao, Xinrong; Elferink, Lisa A.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Boor, Paul J.; Kaphalia, Bhupendra; Qiu, Suimin] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Jackson, Daniel; Carter, Dwayne; Elferink, Cornelis J.; Joshi, Aditya D.; de Castro, Karen Pereira] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Soong, Lynn] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Cruz-Monserrate, Zobeida] Ohio State Univ, Div Gastroenterol Hepatol & Nutr, Wexner Med Ctr, Columbus, OH 43210 USA; [Logsdon, Craig D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center	Elferink, LA (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	lisa.elferink@utmb.edu		Cruz-Monserrate, Zobeida/0000-0003-0849-655X	National Institute on Alcohol Abuse and Alcoholism [R21AA0249001, R01DK052067]; National Institute on Environmental Health Sciences [R21ES024607, R01ES026874, 5P30ES006676, U19ES020676, 5F31ES023305]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK102514, R01DK052067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676, R01ES026874, R21ES024607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA024290] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institute on Alcohol Abuse and Alcoholism, Award Number R21AA0249001, Recipient Lisa A. Elferink; National Institute on Environmental Health Sciences, Award Number R21ES024607, Recipient Cornelis J. Elferink; National Institute on Environmental Health Sciences, Award Number R01ES026874, Recipient Cornelis J. Elferink; National Institute on Environmental Health Sciences, Award Number 5P30ES006676, Cornelis J. Elferink; National Institute on Environmental Health Sciences, Award Number U19ES020676, Cornelis J. Elferink; National Institute on Environmental Health Sciences, Award Number 5F31ES023305, Recipient Daniel Jackson; and National Institute on Alcohol Abuse and Alcoholism, Award Number R01DK052067, Recipient Craig D. Logsdon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte MV, 2010, J GASTROEN HEPATOL, V25, P1816, DOI 10.1111/j.1440-1746.2010.06445.x; Baek JH, 2012, J IMMUNOL, V189, P1699, DOI 10.4049/jimmunol.1200729; Bigatto V, 2015, MOL ONCOL, V9, P377, DOI 10.1016/j.molonc.2014.09.002; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Dai CS, 2005, AM J PATHOL, V167, P429, DOI 10.1016/S0002-9440(10)62987-2; Dai JY, 2009, J CELL BIOCHEM, V107, P1222, DOI 10.1002/jcb.22226; Denham W, 1997, GASTROENTEROLOGY, V113, P1741, DOI 10.1053/gast.1997.v113.pm9352880; di Magliano MP, 2013, GASTROENTEROLOGY, V144, pE1, DOI 10.1053/j.gastro.2012.11.018; Folias AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102125; Galimi F, 2001, J IMMUNOL, V166, P1241, DOI 10.4049/jimmunol.166.2.1241; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Habtezion A, 2015, CURR OPIN GASTROEN, V31, P395, DOI 10.1097/MOG.0000000000000195; Huang HJ, 2013, GASTROENTEROLOGY, V144, P202, DOI 10.1053/j.gastro.2012.09.059; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Ji BA, 2008, GENESIS, V46, P390, DOI 10.1002/dvg.20411; Kaphalia L, 2014, TOXICOL APPL PHARM, V277, P109, DOI 10.1016/j.taap.2014.02.018; Kubisch Constanze H, 2008, Expert Rev Gastroenterol Hepatol, V2, P249, DOI 10.1586/17474124.2.2.249; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; Li C, 2011, GASTROENTEROLOGY; Li N, 2007, J BIOL CHEM, V282, P16764, DOI 10.1074/jbc.M610835200; Liou GY, 2013, J CELL BIOL, V202, P563, DOI 10.1083/jcb.201301001; Lugea A, 2011, GASTROENTEROLOGY, V140, P987, DOI 10.1053/j.gastro.2010.11.038; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Matsuno M, 1997, RES COMMUN MOL PATH, V97, P25; Mews P, 2002, GUT, V50, P535, DOI 10.1136/gut.50.4.535; Molnarfi N, 2015, AUTOIMMUN REV, V14, P293, DOI 10.1016/j.autrev.2014.11.013; Murtaugh LC, 2015, ANNU REV PHYSIOL, V77, P229, DOI 10.1146/annurev-physiol-021014-071727; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pandol SJ, 2010, DIGEST DIS, V28, P776, DOI 10.1159/000327212; Perides G, 2005, GUT, V54, P1461, DOI 10.1136/gut.2004.062919; Sah RP, 2014, J BIOL CHEM, V289, P27551, DOI 10.1074/jbc.M113.528174; Sah RP, 2013, CURR OPIN GASTROEN, V29, P523, DOI 10.1097/MOG.0b013e328363e399; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Tao X, 2014, ORAL ONCOL, V50, P104, DOI 10.1016/j.oraloncology.2013.10.014; Tirosh B, 2006, J BIOL CHEM, V281, P5852, DOI 10.1074/jbc.M509061200; Ueda T, 1996, PANCREAS, V12, P76, DOI 10.1097/00006676-199601000-00010; vanderVoort R, 1997, J EXP MED, V185, P2121, DOI 10.1084/jem.185.12.2121; Xue J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8158; Zheng L, 2013, GASTROENTEROLOGY, V144, P1230, DOI 10.1053/j.gastro.2012.12.042; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	46	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165485	10.1371/journal.pone.0165485	http://dx.doi.org/10.1371/journal.pone.0165485			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798657	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100039
J	Kalra, A; Edula, JR; Gupta, PK; Pandey, AK; Chauhan, VS				Kalra, Aakanksha; Edula, Jyotheeswara Reddy; Gupta, Puneet Kumar; Pandey, Alok Kumar; Chauhan, Virander S.			Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-3(11) and MSP-1(19): PfAMSP-Fu(35)	PLOS ONE			English	Article							MALARIA VACCINE CANDIDATE; PROTEIN; IMMUNOGENICITY; ANTIBODIES; IDENTIFICATION; COMBINATION; INFECTION; COMPLEX	Development of fusion chimeras as potential vaccine candidates is considered as an attractive strategy to generate effective immune responses to more than one antigen using a single construct. Here, we described the design, production, purification and antigenicity of a fusion chimera (PfAMSP-Fu(35)), comprised of immunologically relevant regions of three vaccine target malaria antigens, PfAARP, PfMSP-3 and PfMSP-1. The recombinant PfAMSP-Fu35 is expressed as a soluble protein and purified to homogeneity with ease at a yield of similar to 7 mg L-1. Conformational integrity of the C-terminal fragment of PfMSP-1, PfMSP-119 was retained in the fusion chimera as shown by ELISA with conformation sensitive monoclonal antibodies. High titre antibodies were raised to the fusion protein and to all the three individual components in mice and rabbits upon immunization with fusion chimera in two different adjuvant formulations. The sera against PfAMSP-Fu(35) recognized native parasite proteins corresponding to the three components of the fusion chimera. As shown by invasion inhibition assay and antibody mediated cellular inhibition assay, antibodies purified from the PfAMSP-Fu(35) immunized serum successfully and efficiently inhibited parasite invasion in P. falciparum 3D7 in vitro both directly and in monocyte dependent manner. However, the invasion inhibitory activity of anti-AMSP-Fu(35) antibody is not significantly enhanced as expected as compared to a previously described two component fusion chimera, MSP-Fu(24). Therefore, it may not be of much merit to consider AMSP-Fu(35) as a vaccine candidate for preclinical development.	[Kalra, Aakanksha; Edula, Jyotheeswara Reddy; Gupta, Puneet Kumar; Pandey, Alok Kumar; Chauhan, Virander S.] Int Ctr Genet Engn & Biotechnol, Malaria Res Grp, New Delhi, India; [Edula, Jyotheeswara Reddy] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 5650871, Japan	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Osaka University	Chauhan, VS (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Res Grp, Aruna Asaf Ali Marg, New Delhi, India.	virander@icgeb.res.in	Chauhan, Virander S./K-5276-2019; Pandey, Alok Kumar/ABD-9897-2021	reddy, jyotheeswara/0000-0003-4467-5766	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (CSIR); Indian Council for Medical Research (ICMR)	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council for Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	We thank the Department of Biotechnology, Government of India, for supporting this work through a project grant for malaria vaccine development. We also thank Council of Scientific and Industrial Research (CSIR) for providing a senior research fellowship to Aakanksha Kalra. We also thank Indian Council for Medical Research (ICMR) for providing a senior research fellowship to Puneet Kumar Gupta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, WHO REPORT 2015; Bang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028165; Belard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022525; Bousema JT, 2007, PARASITE IMMUNOL, V29, P309, DOI 10.1111/j.1365-3024.2007.00948.x; Campo JJ, 2014, VACCINE, V32, P2209, DOI 10.1016/j.vaccine.2014.02.042; Cheng C, 2015, VACCINE, V33, P7344, DOI 10.1016/j.vaccine.2015.10.023; Dodoo D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-108; Drew DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051023; Gupta PK, 2014, CLIN VACCINE IMMUNOL, V21, P886, DOI 10.1128/CVI.00179-14; Hoffman SL, 2015, AM J PREV MED, V49, pS319, DOI 10.1016/j.amepre.2015.09.011; James S, 2006, CHEMBIOCHEM, V7, P1943, DOI 10.1002/cbic.200600357; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Kalra A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1510-4; Mazumdar S, 2010, BIOPROC BIOSYST ENG, V33, P719, DOI 10.1007/s00449-009-0394-x; Mazumdar S, 2010, INFECT IMMUN, V78, P872, DOI 10.1128/IAI.00427-09; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Mohapatra PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105562; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; Mutabingwa TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005138; OEUVRAY C, 1994, BLOOD, V84, P1594; Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373; Pan WQ, 2004, J IMMUNOL, V172, P6167, DOI 10.4049/jimmunol.172.10.6167; Pandey AK, 2013, INFECT IMMUN, V81, P441, DOI 10.1128/IAI.01107-12; Radfar A, 2009, NAT PROTOC, V4, P1899, DOI 10.1038/nprot.2009.198; Reddy KS, 2015, P NATL ACAD SCI USA, V112, P1179, DOI 10.1073/pnas.1415466112; Reddy KS, 2014, INFECT IMMUN, V82, P152, DOI 10.1128/IAI.00970-13; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Singh B, 2012, INFECT IMMUN, V80, P1491, DOI 10.1128/IAI.05980-11; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Srinivasan P, 2014, P NATL ACAD SCI USA, V111, P10311, DOI 10.1073/pnas.1409928111; Tamborrini M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-359; Theisen M, 2014, VACCINE, V32, P2623, DOI 10.1016/j.vaccine.2014.03.020; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Vant Wout M, 2012, CHANGES, V29, P997, DOI [10.1016/j.biotechadv.2011.08.021.Secreted, DOI 10.1016/J.BIOTECHADV.2011.08.021.SECRETED]; Wickramarachchi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001732; Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636	39	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165720	10.1371/journal.pone.0165720	http://dx.doi.org/10.1371/journal.pone.0165720			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798691	gold, Green Submitted, Green Published			2022-12-26	WOS:000386711100057
J	Bensoussan, S; Cornil, M; Meunier-Salaun, MC; Tallet, C				Bensoussan, Sandy; Cornil, Maude; Meunier-Salaun, Marie-Christine; Tallet, Celine			Piglets Learn to Use Combined Human-Given Visual and Auditory Signals to Find a Hidden Reward in an Object Choice Task	PLOS ONE			English	Article							PIGS SUS-SCROFA; CUES; ELEPHANTS; BEHAVIOR; DISCRIMINATION; GESTURES; GOATS	Although animals rarely use only one sense to communicate, few studies have investigated the use of combinations of different signals between animals and humans. This study assessed for the first time the spontaneous reactions of piglets to human pointing gestures and voice in an object-choice task with a reward. Piglets (Sus scrofa domestica) mainly use auditory signals-individually or in combination with other signals D to communicate with their conspecifics. Their wide hearing range (42 Hz to 40.5 kHz) fits the range of human vocalisations (40 Hz to 1.5 kHz), which may induce sensitivity to the human voice. However, only their ability to use visual signals from humans, especially pointing gestures, has been assessed to date. The current study investigated the effects of signal type (visual, auditory and combined visual and auditory) and piglet experience on the piglets' ability to locate a hidden food reward over successive tests. Piglets did not find the hidden reward at first presentation, regardless of the signal type given. However, they subsequently learned to use a combination of auditory and visual signals (human voice and static or dynamic pointing gestures) to successfully locate the reward in later tests. This learning process may result either from repeated presentations of the combination of static gestures and auditory signals over successive tests, or from transitioning from static to dynamic pointing gestures, again over successive tests. Furthermore, piglets increased their chance of locating the reward either if they did not go straight to a bowl after entering the test area or if they stared at the experimenter before visiting it. Piglets were not able to use the voice direction alone, indicating that a combination of signals (pointing and voice direction) is necessary. Improving our communication with animals requires adapting to their individual sensitivity to human-given signals.	[Bensoussan, Sandy; Cornil, Maude; Meunier-Salaun, Marie-Christine; Tallet, Celine] INRA, PEGASE, Agrocampus Ouest, St Gilles, France	INRAE; Institut Agro; Agrocampus Ouest	Tallet, C (corresponding author), INRA, PEGASE, Agrocampus Ouest, St Gilles, France.	celine.tallet-saighi@inra.fr		bensoussan, sandy/0000-0003-3948-034X; tallet, celine/0000-0002-1899-9233	 [30000937]		This work was supported by Grant number 30000937 to SB, www.bretagne.bzh/jcms/TH071112_5041/fr/le-conse@regional-http://www.rennes.inra.fr/, grant funding for student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnetta B., 2000, ANIMAL COGNITION, V3, P107, DOI [10.1007/s100710000070, DOI 10.1007/S100710000070, DOI 10.1177/0963721416667718]; Albiach-Serrano A, 2012, APPL ANIM BEHAV SCI, V141, P25, DOI 10.1016/j.applanim.2012.07.005; [Anonymous], 2014, R LANG ENV STAT COMP; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Byrnit JT, 2009, ANIM COGN, V12, P401, DOI 10.1007/s10071-008-0200-1; Call J, 2000, ANIM COGN, V3, P23, DOI 10.1007/s100710050047; Collin S, 2016, JOURN RECH PORC 2 3; Croney CC, 2003, APPL ANIM BEHAV SCI, V83, P303, DOI 10.1016/S0168-1591(03)00128-X; Davis H, 1998, BEHAV PROCESS, V43, P27, DOI 10.1016/S0376-6357(97)00082-X; FRASER D, 1995, APPL ANIM BEHAV SCI, V44, P139, DOI 10.1016/0168-1591(95)00610-5; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; Giuffra E, 2000, GENETICS, V154, P1785; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2009.06.031; Hauser MD., 1996, SYNOPSIS ARGUMENT EV, P1; HEFFNER RS, 1990, HEARING RES, V48, P231, DOI 10.1016/0378-5955(90)90063-U; HEMSWORTH PH, 1986, APPL ANIM BEHAV SCI, V15, P45, DOI 10.1016/0168-1591(86)90021-3; Hernadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043267; HINDE RA, 1976, J CHILD PSYCHOL PSYC, V17, P1, DOI 10.1111/j.1469-7610.1976.tb00370.x; Jensen P., 2002, ETHOLOGY DOMESTIC AN; KALMUS H., 1955, BRIT JOUR ANIMAL BEHAVIOUR, V3, P25, DOI 10.1016/S0950-5601(55)80072-X; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; Kirchner J, 2012, J ANIM SCI, V90, P5013, DOI 10.2527/jas.2011-4478; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Martin-Malivel J, 2001, ANIM LEARN BEHAV, V29, P10, DOI 10.3758/BF03192812; McComb K, 2014, P NATL ACAD SCI USA, V111, P5433, DOI 10.1073/pnas.1321543111; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Nawroth C, 2015, ANIM COGN, V18, P757, DOI 10.1007/s10071-015-0842-8; Nawroth C, 2013, ARCH TIERZUCHT, V56, P861, DOI 10.7482/0003-9438-56-086; Nawroth C, 2014, ANIM COGN, V17, P701, DOI 10.1007/s10071-013-0702-3; Nawroth C, 2013, BEHAV PROCESS, V96, P53, DOI 10.1016/j.beproc.2013.03.002; NICOL CJ, 1994, APPL ANIM BEHAV SCI, V40, P31, DOI 10.1016/0168-1591(94)90085-X; Pack AA, 2004, J COMP PSYCHOL, V118, P160, DOI 10.1037/0735-7036.118.2.160; Pinheiro J, R PACKAGE VERSION; Plotnik JM, 2014, ANIM BEHAV, V88, P91, DOI 10.1016/j.anbehav.2013.11.011; Plotnik JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061174; PODBERSCEK AL, 1991, APPL ANIM BEHAV SCI, V31, P119, DOI 10.1016/0168-1591(91)90159-U; Proops L, 2010, ANIM BEHAV, V79, P1205, DOI 10.1016/j.anbehav.2010.02.015; Rossano F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3201; Rushen J, 1999, APPL ANIM BEHAV SCI, V65, P285, DOI 10.1016/S0168-1591(99)00089-1; Rybarczyk P, 2001, APPL ANIM BEHAV SCI, V74, P175, DOI 10.1016/S0168-1591(01)00162-9; Scheumann M, 2004, ANIM COGN, V7, P224, DOI 10.1007/s10071-004-0216-0; Schonfield Jeremy, 2003, INDIA CHINA AUSTR TR, P15; Schusterman Ronald J., 1992, P334; SEABROOK MF, 1992, FARM ANIMALS AND THE ENVIRONMENT, P111; Shreve KRV, 2015, ANIM COGN, V18, P1195, DOI 10.1007/s10071-015-0897-6; Signoret J. P., 1975, The behaviour of domestic animals,, P295; Smet AF, 2014, ANIM COGN, V17, P1365, DOI 10.1007/s10071-014-0772-x; Tallet C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071841; Tanida H, 1998, APPL ANIM BEHAV SCI, V56, P149, DOI 10.1016/S0168-1591(97)00095-6; Titze IR, 2000, PRINCIPLES VOICE PRO, P185; Tornick JK, 2011, ANIM COGN, V14, P117, DOI 10.1007/s10071-010-0349-2; Udell MAR, 2008, J COMP PSYCHOL, V122, P84, DOI 10.1037/0735-7036.122.1.84; Uexkull Jakob von, 2001, SEMIOTICA, V134, P107, DOI [10.1515/semi.2001.017, DOI 10.1515/SEMI.2001.017]; Waiblinger S, 2006, APPL ANIM BEHAV SCI, V101, P185, DOI 10.1016/j.applanim.2006.02.001; Weaver W., 1949, RECENT CONTRIBUTIONS, P12; Wilson EO, 1980, COMMUNICATION BASIC, P90	59	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0164988	10.1371/journal.pone.0164988	http://dx.doi.org/10.1371/journal.pone.0164988			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3YA	27792731	gold, Green Published, Green Submitted			2022-12-26	WOS:000389537000014
J	Kamino, K; Kondo, Y				Kamino, Keita; Kondo, Yohei			Rescaling of Spatio-Temporal Sensing in Eukaryotic Chemotaxis	PLOS ONE			English	Article							FOLD-CHANGE DETECTION; COVALENT MODIFICATION; BACTERIAL CHEMOTAXIS; SIGNALING PATHWAYS; ESCHERICHIA-COLI; CELL-MOVEMENT; LEADING-EDGE; LIVING CELLS; ADAPTATION; MECHANISMS	Eukaryotic cells respond to a chemoattractant gradient by forming intracellular gradients of signaling molecules that reflect the extracellular chemical gradient D an ability called directional sensing. Quantitative experiments have revealed two characteristic input-output relations of the system: First, in a static chemoattractant gradient, the shapes of the intracellular gradients of the signaling molecules are determined by the relative steepness, rather than the absolute concentration, of the chemoattractant gradient along the cell body. Second, upon a spatially homogeneous temporal increase in the input stimulus, the intracellular signaling molecules are transiently activated such that the response magnitudes are dependent on fold changes of the stimulus, not on absolute levels. However, the underlying mechanism that endows the system with these response properties remains elusive. Here, by adopting a widely used modeling framework of directional sensing, local excitation and global inhibition (LEGI), we propose a hypothesis that the two rescaling behaviors stem from a single design principle, namely, invariance of the governing equations to a scale transformation of the input level. Analyses of the LEGI-based model reveal that the invariance can be divided into two parts, each of which is responsible for the respective response properties. Our hypothesis leads to an experimentally testable prediction that a system with the invariance detects relative steepness even in dynamic gradient stimuli as well as in static gradients. Furthermore, we show that the relation between the response properties and the scale invariance is general in that it can be implemented by models with different network topologies.	[Kamino, Keita] FOM Inst AMOLF, Amsterdam, Netherlands; [Kondo, Yohei] Kyoto Univ, Grad Sch Informat, Kyoto, Japan	AMOLF; Kyoto University	Kamino, K (corresponding author), FOM Inst AMOLF, Amsterdam, Netherlands.; Kondo, Y (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.	k.kamino@amolf.nl; ykondo@sys.i.kyoto-u.ac.jp	Kamino, Keita/AAW-6824-2020; Kamino, Keita/HHZ-7180-2022	Kamino, Keita/0000-0003-1645-6398; Kondo, Yohei/0000-0002-2801-4522	Paul G. Allen Family Foundation; Foundation for Fundamental Research on Matter (FOM) part of the Netherlands Organisation for Scientific Research (NWO); Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living Systems) from Japan Agency for Medical Research and Development (AMED); JSPS KAKENHI Grant [26840077]	Paul G. Allen Family Foundation; Foundation for Fundamental Research on Matter (FOM) part of the Netherlands Organisation for Scientific Research (NWO); Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living Systems) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by The Paul G. Allen Family Foundation and the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organisation for Scientific Research (NWO) (to K. K.) and the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living Systems) from Japan Agency for Medical Research and Development (AMED) and JSPS KAKENHI Grant Number 26840077. (to Y. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003781; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Dormann D, 2003, CURR OPIN GENET DEV, V13, P358, DOI 10.1016/S0959-437X(03)00087-X; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Iglesias PA, 2009, WIRES SYST BIOL MED, V1, P247, DOI 10.1002/wsbm.13; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Lazova MD, 2011, RESPONSE RESCALING B, DOI [10.1073/pnas.1108608108/-/DCSupplemental, DOI 10.1073/PNAS.1108608108/-/DCSUPPLEMENTAL.WWW.PNAS.0RG/CGI/D0I/10.1073/PNAS.1108608108]; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Levine H, 2006, P NATL ACAD SCI USA, V103, P9761, DOI 10.1073/pnas.0601302103; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Nakajima A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6367; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Schneider IC, 2006, CELL CYCLE, V5, P1130, DOI 10.4161/cc.5.11.2770; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Skataric M, 2015, IET SYST BIOL, V9, P1, DOI 10.1049/iet-syb.2014.0006; Skataric M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002748; Skoge M, 2014, P NATL ACAD SCI USA, V111, P14448, DOI 10.1073/pnas.1412197111; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Takeda K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002413; Tu YH, 2013, ANNU REV BIOPHYS, V42, P337, DOI 10.1146/annurev-biophys-083012-130358; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wang CJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002449; Weeks G, 2003, CELL SIGNAL, V15, P901, DOI 10.1016/S0898-6568(03)00073-1; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Xu X, 2007, J CELL BIOL, V178, P141, DOI 10.1083/jcb.200611096	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0164674	10.1371/journal.pone.0164674	http://dx.doi.org/10.1371/journal.pone.0164674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792738	Green Published, gold, Green Submitted			2022-12-26	WOS:000389537000010
J	Citro, V; Pena-Garcia, J; den-Haan, H; Perez-Sanchez, H; Del Prete, R; Liguori, L; Cimmaruta, C; Lukas, J; Cubellis, MV; Andreotti, G				Citro, Valentina; Pena-Garcia, Jorge; den-Haan, Helena; Perez-Sanchez, Horacio; Del Prete, Rosita; Liguori, Ludovica; Cimmaruta, Chiara; Lukas, Jan; Cubellis, Maria Vittoria; Andreotti, Giuseppina			Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease	PLOS ONE			English	Article							THERMAL SHIFT ASSAYS; PROTEIN STABILITY; ENZYME REPLACEMENT; MOLECULAR-BASIS; ETHYL SULFIDE; MUTATIONS; 2,6-DITHIOPURINE; PREDICTION; MUTAGENESIS; INCREASES	Personalized therapies are required for Fabry disease due to its large phenotypic spectrum and numerous different genotypes. In principle, missense mutations that do not affect the active site could be rescued with pharmacological chaperones. At present pharmacological chaperones for Fabry disease bind the active site and couple a stabilizing effect, which is required, to an inhibitory effect, which is deleterious. By in silico docking we identified an allosteric hot-spot for ligand binding where a drug-like compound, 2,6-dithiopurine, binds preferentially. 2,6-dithiopurine stabilizes lysosomal alpha-galactosidase in vitro and rescues a mutant that is not responsive to a mono-therapy with previously described pharmacological chaperones, 1-deoxygalactonojirimycin and galactose in a cell based assay.	[Citro, Valentina; Del Prete, Rosita; Liguori, Ludovica; Cimmaruta, Chiara; Cubellis, Maria Vittoria] Univ Naples Federico II, Dipartimento Biol, I-80126 Naples, Italy; [Pena-Garcia, Jorge; den-Haan, Helena; Perez-Sanchez, Horacio] Univ Catolica San Antonio Murcia UCAM, Bioinformat & High Performance Comp Res Grp BIO H, Dept Comp Engn, Murcia, Spain; [Liguori, Ludovica; Cimmaruta, Chiara; Andreotti, Giuseppina] CNR, Ist Chim Biomol, I-80078 Pozzuoli, Italy; [Lukas, Jan] Med Univ Rostock, Albrecht Kossel Inst Neuroregenerat, Rostock, Germany	University of Naples Federico II; Universidad Catolica de Murcia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); University of Rostock	Cubellis, MV (corresponding author), Univ Naples Federico II, Dipartimento Biol, I-80126 Naples, Italy.; Perez-Sanchez, H (corresponding author), Univ Catolica San Antonio Murcia UCAM, Bioinformat & High Performance Comp Res Grp BIO H, Dept Comp Engn, Murcia, Spain.	hperez@ucam.edu; cubellis@unina.it	ANDREOTTI, GIUSEPPINA/AAX-8952-2020; Pérez-Sánchez, Horacio/O-5017-2016	ANDREOTTI, GIUSEPPINA/0000-0002-1594-0156; Pérez-Sánchez, Horacio/0000-0003-4468-7898; cubellis, maria vittoria/0000-0001-6147-6553; Citro, Valentina/0000-0002-0289-404X; Del Prete, Rosita/0000-0003-4214-1568; Liguori, Ludovica/0000-0002-8480-0501; Cimmaruta, Chiara/0000-0001-7586-6659	Telethon - Italy [GGP12108]; Fundacion Seneca del Centro de Coordinacion de la Investigacion de la Region de Murcia [18946/JLI/13]; NLHPC [ECM-02]	Telethon - Italy(Fondazione Telethon); Fundacion Seneca del Centro de Coordinacion de la Investigacion de la Region de Murcia(Fundacion Seneca); NLHPC	Funding was provided by Telethon - Italy (Grant no. GGP12108). This work was partially supported by the Fundacion Seneca del Centro de Coordinacion de la Investigacion de la Region de Murcia under Project 18946/JLI/13. Powered@NLHPC: This research was partially supported by the supercomputing infrastructure of the NLHPC (ECM-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andreotti G, 2015, DRUG TEST ANAL, V7, P831, DOI 10.1002/dta.1798; Andreotti G, 2013, MOL GENET GENOM MED, V1, P32, DOI 10.1002/mgg3.3; Andreotti G, 2014, BBA-GEN SUBJECTS, V1840, P1214, DOI 10.1016/j.bbagen.2013.12.018; Andreotti G, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-66; Andreotti G, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-36; Ashton-Prolla P, 2000, J INVEST MED, V48, P227; Beck M, 2015, MOL GENET METAB REP, V3, P21, DOI 10.1016/j.ymgmr.2015.02.002; Bendikov-Bar I, 2013, BLOOD CELL MOL DIS, V50, P141, DOI 10.1016/j.bcmd.2012.10.007; Benjamin ER, 2009, J INHERIT METAB DIS, V32, P424, DOI 10.1007/s10545-009-1077-0; Boulware S, 2012, TOXICOL APPL PHARM, V263, P203, DOI 10.1016/j.taap.2012.06.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cammisa M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-111; Cammisa M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S9; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Cubellis MV, 2015, BIOCHIMIE, V113, P54, DOI 10.1016/j.biochi.2015.03.018; Cubellis MV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S8; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Germain DP, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-91; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Giugliani R, 2013, MOL GENET METAB, V109, P86, DOI 10.1016/j.ymgme.2013.01.009; Guce AI, 2011, CHEM BIOL, V18, P1521, DOI 10.1016/j.chembiol.2011.10.012; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Ishii S, 2007, BIOCHEM J, V406, P285, DOI 10.1042/BJ20070479; Ishii S, 2009, J PHARMACOL EXP THER, V328, P723, DOI 10.1124/jpet.108.149054; Jenkinson SF, 2011, ORG LETT, V13, P4064, DOI 10.1021/ol201552q; Khanna R, 2010, FEBS J, V277, P1618, DOI 10.1111/j.1742-4658.2010.07588.x; Kim MS, 2009, PROTEIN SCI, V18, P1051, DOI 10.1002/pro.115; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lukas J, 2016, HUM MUTAT, V37, P43, DOI 10.1002/humu.22910; Lukas J, 2015, MOL THER, V23, P456, DOI 10.1038/mt.2014.224; Lukas J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003632; Mele BH, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0273-2; OKUMIYA T, 1995, BIOCHEM BIOPH RES CO, V214, P1219, DOI 10.1006/bbrc.1995.2416; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Park JY, 2009, EXP MOL MED, V41, P1, DOI 10.3858/emm.2009.41.1.001; Powell KL, 2010, CHEM RES TOXICOL, V23, P497, DOI 10.1021/tx9001918; QING WG, 1995, DRUG METAB DISPOS, V23, P854; Rombach SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-29; Shimotori M, 2008, HUM MUTAT, V29, P331, DOI 10.1002/humu.9520; Shin SH, 2008, PHARMACOGENET GENOM, V18, P773, DOI 10.1097/FPC.0b013e32830500f4; Sirrs S, 2016, JIMD REP, V27, P85, DOI 10.1007/8904_2015_435; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Stroganov OV, 2008, J CHEM INF MODEL, V48, P2371, DOI 10.1021/ci800166p; Tsukimura T, 2011, MOL GENET METAB, V103, P26, DOI 10.1016/j.ymgme.2011.01.013; Vega MC, 2003, CURR OPIN CHEM BIOL, V7, P694, DOI 10.1016/j.cbpa.2003.10.004; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Wu XY, 2011, HUM MUTAT, V32, P965, DOI 10.1002/humu.21530; Yan X, 2013, J CHEM INF MODEL, V53, P1967, DOI 10.1021/ci300601q; Yu Y, 2014, ACS CHEM BIOL, V9, P1460, DOI 10.1021/cb500143h	51	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165463	10.1371/journal.pone.0165463	http://dx.doi.org/10.1371/journal.pone.0165463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788225	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900089
J	Egger, F; Meyer, T; Hecksteden, A				Egger, Florian; Meyer, Tim; Hecksteden, Anne			Interindividual Variation in the Relationship of Different Intensity Markers-A Challenge for Targeted Training Prescriptions	PLOS ONE			English	Article							LACTATE STEADY-STATE; THRESHOLD	Purpose Training intensities are frequently prescribed as relative workloads based on a single reference value (e.g. maximum oxygen uptake). However, exercise-induced physical strain is multifaceted and large interindividual variability in intensity markers has been reported for constant load exercise with standardized relative intensity. This questions the accuracy of (univariate) relative intensities in targeting specific training stimuli. The present trial aims to investigate interindividual variability in the relationship of strain indicators using interpolated performance curves derived from constant load tests at different workloads. This approach enables the prediction of other indicators based on a chosen reference and subsequent comparison of predictive accuracy between group-based and individualized regression models. Methods 15 competitive cyclists completed a stepwise incremental cycling test followed by 5 constant load tests with the same absolute workloads as in the stepwise incremental test. The highest of theses workloads which yielded a lactate (BLa) steady state was repeated enabling estimation of intraindividual variability. From constant load tests, the courses of BLa relative to the respective reference value (e.g. % VO2peak) were interpolated by polynomial regression. Variability between individual regression curves was analyzed by mixed modeling. Predictive accuracy was estimated as the sum of squared differences between predicted and observed values. Results The proportion of total variation in the course of BLa relative to the respective reference parameter accounted for by subject identity ranged between 36 and 51%. A significant increase in predictive accuracy was observed for VO2peak and HRmax, respectively, as predicting parameters. Conclusion These results are in support of a multivariable, individualized approach to intensity prescriptions when aiming at accurately targeted perturbations of homeostasis.	[Egger, Florian; Meyer, Tim; Hecksteden, Anne] Univ Saarland, Inst Sports & Prevent Med, Saarbrucken, Germany	Saarland University	Egger, F (corresponding author), Univ Saarland, Inst Sports & Prevent Med, Saarbrucken, Germany.	florianegger86@gmail.com	Egger, Florian/K-8409-2019					Beneke R, 2003, EUR J APPL PHYSIOL, V89, P95, DOI 10.1007/s00421-002-0783-1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Dekerle J, 2003, EUR J APPL PHYSIOL, V89, P281, DOI 10.1007/s00421-002-0786-y; Faude O, 2009, SPORTS MED, V39, P469, DOI 10.2165/00007256-200939060-00003; Hecksteden A, 2015, J APPL PHYSIOL, V118, P1450, DOI 10.1152/japplphysiol.00714.2014; Mann T, 2013, SPORTS MED, V43, P613, DOI 10.1007/s40279-013-0045-x; Meyer T, 1999, MED SCI SPORT EXER, V31, P1342, DOI 10.1097/00005768-199909000-00017; Scharhag-Rosenberger F, 2010, J SCI MED SPORT, V13, P74, DOI 10.1016/j.jsams.2008.12.626; Senn Stephen, 2011, Stat Methods Med Res, V20, P657, DOI 10.1177/0962280210379174; STEGMANN H, 1981, INT J SPORTS MED, V2, P160, DOI 10.1055/s-2008-1034604	11	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165010	10.1371/journal.pone.0165010	http://dx.doi.org/10.1371/journal.pone.0165010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788182	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900038
J	Giacon, TR; Vanderlei, FM; Christofaro, DGD; Vanderlei, LCM				Giacon, Thais Roque; Vanderlei, Franciele Marques; Destro Christofaro, Diego Giulliano; Marques Vanderlei, Luiz Carlos			Impact of Diabetes Type 1 in Children on Autonomic Modulation at Rest and in Response to the Active Orthostatic Test	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RATE MONITOR; NEUROPATHY; TIME	Introduction Cardiovascular autonomic neuropathy is one of the most common complications of diabetes mellitus type 1 (DM1), of which one of the first subclinical manifestations is changes in heart rate variability (HRV). Thus, analysis of HRV associated with the autonomic active orthostatic test is important in this population. Objectives To analyze the autonomic modulation responses induced by the implementation of the active orthostatic test, in children with DM1, and study the autonomic modulation by means of HRV indices. Method Data of 35 children were analyzed, of both sexes, aged between 7 and 15 years, who were divided into two groups: Diabetic (n = 16) and Control (n = 19). The following variables were collected initially: weight, height, body fat percentage, heart rate, blood pressure and casual blood glucose. Subsequently, for analysis of autonomic modulation, the beat-to-beat heart rate was captured by a heart rate monitor in the supine position for 30 minutes and after 10 minutes standing during performance of the active orthostatic test. HRV indices were calculated in the time and frequency domains. For data analysis, covariance analysis was used to compare groups and ANOVA for repeated measures to compare the effects of the active orthostatic test. These data were adjusted for age, sex, ethnicity, body fat percentage and casual blood glucose, with a 5% significance level. Results The results suggested that diabetic children at rest present a decrease in SDNN (50.4 vs. 75.2), rMSSD (38.7 vs 57.6) and LF [ms(2)] (693.6 vs 1874.6). During the active orthostatic test the children in both groups demonstrated a reduction in SDNN, RMSSD and LF [ms(2)] compared to the resting position, and this response was less pronounced in the diabetic group. Conclusion We conclude that regardless of age, sex, ethnicity, body fat percentage and casual blood glucose, performing the active orthostatic test promoted increased sympathetic modulation and reduced parasympathetic modulation in both groups, and this response was less pronounced in diabetic children, who presented reduced overall variability and parasympathetic modulation.	[Giacon, Thais Roque] UNESP, FCT, Programa Pos Grad Fisioterapia, Presidente Prudente, SP, Brazil; [Vanderlei, Franciele Marques; Marques Vanderlei, Luiz Carlos] UNESP, FCT, Dept Fisioterapia, Presidente Prudente, SP, Brazil; [Destro Christofaro, Diego Giulliano] UNESP, FCT, Dept Educ Fis, Presidente Prudente, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Giacon, TR (corresponding author), UNESP, FCT, Programa Pos Grad Fisioterapia, Presidente Prudente, SP, Brazil.	thaisgiacon@hotmail.com	Christofaro, Diego Giulliano Destro/C-3312-2014; Vanderlei, Luiz Carlos Marques/C-7704-2012; Vanderlei, Franciele M/G-7464-2014; de Abreu, Luiz Carlos/B-7873-2012; Vanderlei, Franciele/GQA-4595-2022	Christofaro, Diego Giulliano Destro/0000-0001-9917-9992; Vanderlei, Luiz Carlos Marques/0000-0002-1891-3153; de Abreu, Luiz Carlos/0000-0002-7618-2109; Vanderlei, Franciele/0000-0001-5792-6072; Giacon, Thais Roque/0000-0002-8307-6830	Support Foundation for Research of Sao Paulo State (FAPESP) [2013/19055-0]	Support Foundation for Research of Sao Paulo State (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA))	The study was funded by the Support Foundation for Research of Sao Paulo State (FAPESP; Case Number: 2013/19055-0).	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Alves RL, 2012, J HUM GROWTH DEV, V22, P321; [Anonymous], 2014, DIRETRIZES SOC BRASI; Associacao Brasileira para o Estudo da Obesidade e da Sindrome Metabolica, 2009, SOC SIN MET, P1; Balcioglu AS, 2015, WORLD J DIABETES, V6, P80, DOI 10.4239/wjd.v6.i1.80; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Chen SR, 2008, CHILD NERV SYST, V24, P741, DOI 10.1007/s00381-007-0499-y; Chen SR, 2007, J FORMOS MED ASSOC, V106, P935, DOI 10.1016/S0929-6646(08)60064-9; Chessa M, 2002, HERZ, V27, P785, DOI 10.1007/s00059-002-2340-4; de Castro C L, 1992, Arq Bras Cardiol, V59, P75; Dimitropoulos G, 2014, WORLD J DIABETES, V5, P17, DOI 10.4239/wjd.v5.i1.17; Diretriz, 2010, 6 DIRETRIZ HIPERTENS; Dutra SGV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077092; Eyre ELJ, 2014, AUTON NEUROSCI-BASIC, V186, P8, DOI 10.1016/j.autneu.2014.09.019; Foss-Freitas MC, 2008, ARQ BRAS ENDROCRINOL, V52; Gamelin FX, 2006, MED SCI SPORT EXER, V38, P887, DOI 10.1249/01.mss.0000218135.79476.9c; Gardim Camila Balsamo, 2014, Rev. paul. pediatr., V32, P279, DOI 10.1590/0103-0582201432215513; Godoy M, 2005, ARQ CIENC SAUDE, V12, P167; Porto LGG, 2009, PACE, V32, P43, DOI 10.1111/j.1540-8159.2009.02175.x; Hill LK, 2015, PSYCHOSOM MED, V77, P16, DOI 10.1097/PSY.0000000000000133; Javorka M, 2008, CLIN PHYSIOL FUNCT I, V28, P326, DOI 10.1111/j.1475-097X.2008.00813.x; Kardelen F, 2006, PEDIATR DIABETES, V7, P45, DOI 10.1111/j.1399-543X.2006.00141.x; Lucini D, 2009, HYPERTENSION, V54, P987, DOI 10.1161/HYPERTENSIONAHA.109.140103; LUKASKI HC, 1987, AM J CLIN NUTR, V46, P537, DOI 10.1093/ajcn/46.4.537; Maraes VRFS, 2010, REV ANDAL DERECHO DE, V3, P33; Vanderlei LCM, 2009, REV BRAS CIR CARDIOV, V24, P205, DOI 10.1590/S0102-76382009000200018; Tannus LRM, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00191; Moura-Tonello SCG, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-13; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Ozgur S, 2014, CARDIOL YOUNG, V24, P872, DOI 10.1017/S1047951113001224; Patterson C, 2014, DIABETES RES CLIN PR, V103, P161, DOI 10.1016/j.diabres.2013.11.005; Ribeiro Antonio Luiz P., 2004, Arq. Bras. Cardiol., V83, P35, DOI 10.1590/S0066-782X2004001300004; Rodriguez-Colon S, 2014, CLIN AUTON RES, V24, P265, DOI 10.1007/s10286-014-0257-7; Vanderlei LCM, 2008, BRAZ J MED BIOL RES, V41, P854, DOI 10.1590/S0100-879X2008005000039	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164375	10.1371/journal.pone.0164375	http://dx.doi.org/10.1371/journal.pone.0164375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788152	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900018
J	Guzman, C; Conaco, C				Guzman, Christine; Conaco, Cecilia			Gene Expression Dynamics Accompanying the Sponge Thermal Stress Response	PLOS ONE			English	Article							CORAL MONTASTRAEA-FAVEOLATA; RNA-SEQ DATA; INTERACTION NETWORKS; ANIMAL COMPLEXITY; ANEMONIA-VIRIDIS; OXIDATIVE STRESS; REFERENCE GENOME; MARINE SPONGES; CLIMATE-CHANGE; LIFE-CYCLE	Marine sponges are important members of coral reef ecosystems. Thus, their responses to changes in ocean chemistry and environmental conditions, particularly to higher seawater temperatures, will have potential impacts on the future of these reefs. To better understand the sponge thermal stress response, we investigated gene expression dynamics in the shallow water sponge, Haliclona tubifera (order Haplosclerida, class Demospongiae), subjected to elevated temperature. Using high-throughput transcriptome sequencing, we show that these conditions result in the activation of various processes that interact to maintain cellular homeostasis. Short-term thermal stress resulted in the induction of heat shock proteins, antioxidants, and genes involved in signal transduction and innate immunity pathways. Prolonged exposure to thermal stress affected the expression of genes involved in cellular damage repair, apoptosis, signaling and transcription. Interestingly, exposure to sublethal temperatures may improve the ability of the sponge to mitigate cellular damage under more extreme stress conditions. These insights into the potential mechanisms of adaptation and resilience of sponges contribute to a better understanding of sponge conservation status and the prediction of ecosystem trajectories under future climate conditions.	[Guzman, Christine; Conaco, Cecilia] Univ Philippines, Coll Sci, Inst Marine Sci, Quezon City, Philippines; [Guzman, Christine] Okinawa Inst Sci & Technol Grad Univ, 1919-1 Tancha, Onna Son, Okinawa 9040495, Japan	University of the Philippines System; University of the Philippines Diliman; Okinawa Institute of Science & Technology Graduate University	Conaco, C (corresponding author), Univ Philippines, Coll Sci, Inst Marine Sci, Quezon City, Philippines.	cconaco@msi.upd.edu.ph	Guzman, Christine/M-9355-2016	Guzman, Christine/0000-0001-9024-1198; Conaco, Cecilia/0000-0002-3594-2810	University of the Philippines System PhD Recruitment Grant [OVPAA-BPhD-2012-04]; L'Oreal-UNESCO For Women in Science National Fellowship	University of the Philippines System PhD Recruitment Grant; L'Oreal-UNESCO For Women in Science National Fellowship	This study was funded by the University of the Philippines System PhD Recruitment Grant (OVPAA-BPhD-2012-04) and a L'Oreal-UNESCO For Women in Science National Fellowship to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2016, SCIENCE, V352, P338, DOI 10.1126/science.aac7125; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Basu M, 2015, 3 BIOTECH, V5, P1021, DOI 10.1007/s13205-015-0306-5; Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bell JJ, 2015, CONSERV BIOL, V29, P42, DOI 10.1111/cobi.12447; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Collins WJ, 2013, ATMOS CHEM PHYS, V13, P2471, DOI 10.5194/acp-13-2471-2013; Conaco C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-209; Conaco C, 2012, P NATL ACAD SCI USA, V109, P10612, DOI 10.1073/pnas.1201890109; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Duckworth AR, 2013, MAR BIOL, V160, P27, DOI 10.1007/s00227-012-2053-z; Duckworth AR, 2012, MAR ECOL PROG SER, V462, P67, DOI 10.3354/meps09853; Dunn CW, 2015, TRENDS ECOL EVOL, V30, P282, DOI 10.1016/j.tree.2015.03.003; Elliott GR, 2010, J EXP BIOL, V213, P1477; Ellwanger K, 2007, J COMP PHYSIOL A, V193, P1, DOI 10.1007/s00359-006-0165-y; Erwin PM, 2012, APPL ENVIRON MICROB, V78, P7358, DOI 10.1128/AEM.02035-12; Fan L, 2013, ISME J, V7, P991, DOI 10.1038/ismej.2012.165; Gaiti F, 2015, MOL BIOL EVOL, V32, P2367, DOI 10.1093/molbev/msv117; Garren M, 2016, ISME J, V10, P1363, DOI 10.1038/ismej.2015.216; Gold DA, 2016, P NATL ACAD SCI USA, V113, P2684, DOI 10.1073/pnas.1512614113; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grottoli AG, 2014, GLOBAL CHANGE BIOL, V20, P3823, DOI 10.1111/gcb.12658; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Guzman C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18774; Hemmrich G, 2008, BIOESSAYS, V30, P1010, DOI 10.1002/bies.20813; Kelmo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076441; Kenkel CD, 2013, MOL ECOL, V22, P4322, DOI 10.1111/mec.12390; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leal MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030580; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lopez-Legentil S, 2008, MOL ECOL, V17, P1840, DOI 10.1111/j.1365-294X.2008.03667.x; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Moya A, 2012, MOL ECOL, V21, P1158, DOI 10.1111/j.1365-294X.2012.05458.x; Pita L, 2013, FEMS MICROBIOL ECOL, V86, P268, DOI 10.1111/1574-6941.12159; Puill-Stephan E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039099; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHEFFIELD WP, 1990, J BIOL CHEM, V265, P11069; Simister R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052220; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tout J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00432; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Vidal-Dupiol J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058652; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Webster N, 2013, MOL ECOL, V22, P1854, DOI 10.1111/mec.12213; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Weir D M, 1989, FEMS Microbiol Immunol, V1, P331; Whalan S, 2008, CORAL REEFS, V27, P783, DOI 10.1007/s00338-008-0400-9; Yu HY, 2003, TRENDS GENET, V19, P422, DOI 10.1016/S0168-9525(03)00175-6; Zhao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046244	63	22	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165368	10.1371/journal.pone.0165368	http://dx.doi.org/10.1371/journal.pone.0165368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788197	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900068
J	Thompson, LR; Zeng, QL; Chisholm, SW				Thompson, Luke R.; Zeng, Qinglu; Chisholm, Sallie W.			Gene Expression Patterns during Light and Dark Infection of Prochlorococcus by Cyanophage	PLoS One			English	Article							FERREDOXIN-NADP REDUCTASE; PHOTOSYSTEM-I; RNA-SEQ; PHOTOSYNTHESIS GENES; MARINE VIRUSES; DIFFERENTIAL EXPRESSION; CYANOBACTERIUM; SYNECHOCOCCUS; GENOME; SEQUENCE	Cyanophage infecting the marine cyanobacteria Prochlorococcus and Synechococcus require light and host photosystem activity for optimal reproduction. Many cyanophages encode multiple photosynthetic electron transport (PET) proteins, which are presumed to maintain electron flow and produce ATP and NADPH for nucleotide biosynthesis and phage genome replication. However, evidence suggests phage augment NADPH production via the pentose phosphate pathway (PPP), thus calling into question the need for NADPH production by PET. Genes implicated in cyclic PET have since been identified in cyanophage genomes. It remains an open question which mode of PET, cyclic or linear, predominates in infected cyanobacteria, and thus whether the balance is towards producing ATP or NADPH. We sequenced transcriptomes of a cyanophage (P-HM2) and its host (Prochlorococcus MED4) throughout infection in the light or in the dark, and analyzed these data in the context of phage replication and metabolite measurements. Infection was robust in the light, but phage were not produced in the dark. Host gene transcripts encoding highlight inducible proteins and two terminal oxidases (plastoquinol terminal oxidase and cytochrome coxidase) implicated in protecting the photosynthetic membrane from light stress were the most enriched in light but not dark infection. Among the most diminished transcripts in both light and dark infection was ferredoxin NADP(+) reductase (FNR), which uses the electron acceptor NADP(+) to generate NADPH in linear photosynthesis. The phage gene for CP12, which putatively inhibits the Calvin cycle enzyme that receives NADPH from FNR, was highly expressed in light infection. Therefore, both PET production of NADPH and its consumption by carbon fixation are putatively repressed during phage infection in light. Transcriptomic evidence is thus consistent with cyclic photophosphorylation using oxygen as the terminal electron acceptor as the dominant mode of PET under infection, with ATP from PET and NADPH from the PPP producing the energy and reducing equivalents for phage nucleotide biosynthesis and replication.	[Thompson, Luke R.; Chisholm, Sallie W.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Zeng, Qinglu; Chisholm, Sallie W.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Thompson, Luke R.] NOAA, Southwest Fisheries Sci Ctr, La Jolla, CA 92037 USA; [Zeng, Qinglu] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Oceanic Atmospheric Admin (NOAA) - USA; Hong Kong University of Science & Technology	Thompson, LR; Chisholm, SW (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Chisholm, SW (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Thompson, LR (corresponding author), NOAA, Southwest Fisheries Sci Ctr, La Jolla, CA 92037 USA.	luket@alum.mit.edu; chisholm@mit.edu	Thompson, Luke R./Z-3344-2019	Thompson, Luke R./0000-0002-3911-1280; Zeng, Qinglu/0000-0002-5616-7155; Chisholm, Sallie/0000-0003-1480-2445	Gordon and Betty Moore Foundation [GBMF495]; National Science Foundation [OCE-1153588, DBI-0424599]; NIH Pre-Doctoral Training Grant [T32GM007287]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); NIH Pre-Doctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the Gordon and Betty Moore Foundation through Grant GBMF495 to S.W.C., by the National Science Foundation through Grants OCE-1153588 and DBI-0424599 to S.W.C., and by NIH Pre-Doctoral Training Grant T32GM007287 to L.R.T.	Alperovitch-Lavy A, 2011, ENVIRON MICROBIOL, V13, P24, DOI 10.1111/j.1462-2920.2010.02304.x; AMLA DV, 1987, ARCH MICROBIOL, V148, P321, DOI 10.1007/BF00456711; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersson B, 2004, PHOTODAMAGE D1 PROTE, P377, DOI [10.1007/0-306-48148-0_22, DOI 10.1007/0-306-48148-0_22]; Bagby SC, 2015, ISME J, V9, P2232, DOI 10.1038/ismej.2015.36; Bailey S, 2004, RES MICROBIOL, V155, P720, DOI 10.1016/j.resmic.2004.06.002; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P827, DOI 10.1111/j.1462-2920.2005.00969.x; Cooley JW, 2001, J BACTERIOL, V183, P4251, DOI 10.1128/JB.183.14.4251-4258.2001; Curien G, 2016, PLANT CELL PHYSIOL, V57, P1354, DOI 10.1093/pcp/pcw048; Doron S, 2016, ISME J, V10, P1437, DOI 10.1038/ismej.2015.210; Enav H, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-9; FORTI G, 1984, FEBS LETT, V166, P81, DOI 10.1016/0014-5793(84)80049-6; Frois-Moniz K., 2014, HOST VIRUS INTERACTI; Giannoukos G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r23; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Hernandez-Arriaga AM, 2009, NUCLEIC ACIDS RES, V37, P4799, DOI 10.1093/nar/gkp503; Jia Y, 2010, FEMS MICROBIOL LETT, V310, P120, DOI 10.1111/j.1574-6968.2010.02054.x; Kao CC, 2005, APPL ENVIRON MICROB, V71, P4276, DOI 10.1128/AEM.71.8.4276-4279.2005; KAUFMAN L, 2005, WILEY SERIES PROBABI; Kelly L, 2013, ISME J, V7, P1827, DOI 10.1038/ismej.2013.58; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lea-Smith DJ, 2013, PLANT PHYSIOL, V162, P484, DOI 10.1104/pp.112.210260; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin XQ, 2016, ENVIRON MICROBIOL, V18, P450, DOI 10.1111/1462-2920.13104; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; MACKENZIE JJ, 1972, VIROLOGY, V49, P517, DOI 10.1016/0042-6822(72)90503-X; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Mekhalfi M, 2014, NEW PHYTOL; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Negi SS, 2008, J STRUCT BIOL, V161, P18, DOI 10.1016/j.jsb.2007.08.016; Ni TC, 2016, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00123; Philosof A, 2011, ISME J, V5, P1568, DOI 10.1038/ismej.2011.43; Pope WH, 2007, J MOL BIOL, V368, P966, DOI 10.1016/j.jmb.2007.02.046; Puxty RJ, 2016, CURR BIOL, V26, P1585, DOI 10.1016/j.cub.2016.04.036; Puxty RJ, 2014, PHOTOSYN RES; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; SHERMAN LA, 1976, VIROLOGY, V71, P1, DOI 10.1016/0042-6822(76)90089-1; Steglich C, 2006, J BACTERIOL, V188, P7796, DOI 10.1128/JB.01097-06; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Thompson AW, 2011, ISME J, V5, P1580, DOI 10.1038/ismej.2011.49; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; Typas A, 2015, NAT REV MICROBIOL, V13, P559, DOI 10.1038/nrmicro3508; VERMAAS WFJ, 1994, FEBS LETT, V337, P103, DOI 10.1016/0014-5793(94)80638-1; Waldbauer JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043432; Wilde A, 2001, BIOCHEM J, V357, P211, DOI 10.1042/0264-6021:3570211; Yi H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr617; Zeng QL, 2012, CURR BIOL, V22, P124, DOI 10.1016/j.cub.2011.11.055; Zheng XM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S13-S7; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	62	24	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165375	10.1371/journal.pone.0165375	http://dx.doi.org/10.1371/journal.pone.0165375			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788196	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900071
J	Dubois, JD; Cantin, V; Piche, M; Descarreaux, M				Dubois, Jean-Daniel; Cantin, Vincent; Piche, Mathieu; Descarreaux, Martin			Physiological and Psychological Predictors of Short-Term Disability in Workers with a History of Low Back Pain: A Longitudinal Study	PLOS ONE			English	Article							FEAR-AVOIDANCE MODEL; FRENCH VERSION; SCREENING TOOL; QUESTIONNAIRE; VALIDATION; TRUNK; ASSOCIATION; ADAPTATION; MODULATION; MECHANISMS	Despite an elusive pathophysiology, common characteristics are often observed in individuals with chronic low back pain (LBP). These include psychological symptoms, altered pain perception, altered pain modulation and altered muscle activation. These factors have been explored as possible determinants of disability, either separately or in cross-sectional studies, but were never assessed in a single longitudinal study. Therefore, the objective was to determine the relative contribution of psychological and neurophysiological factors to future disability in individuals with past LBP. The study included two experimental sessions (baseline and six months later) to assess cutaneous heat pain and pain tolerance thresholds, pain inhibition, as well as trunk muscle activation. Both sessions included the completion of validated questionnaires to determine clinical pain, disability, pain catastrophizing, fear-avoidance beliefs and pain vigilance. One hundred workers with a history of LBP and 19 healthy individuals took part in the first experimental session. The second experimental session was exclusively conducted on workers with a history of LBP (77/100). Correlation analyses between initial measures and disability at six months were conducted, and measures significantly associated with disability were used in multiple regression analyses. A first regression analysis showed that psychological symptoms contributed unique variance to future disability (R-2 = 0.093, p = .009). To control for the fluctuating nature of LBP, a hierarchical regression was conducted while controlling for clinical pain at six months (R-2 = 0.213, p < .001) where pain inhibition contributed unique variance in the second step of the regression (R2 change = 0.094, p = .005). These results indicate that pain inhibition processes may constitute potential targets for treatment to alleviate future disability in individuals with past or present LBP. Then again, the link between psychological symptoms and pain inhibition needs to be clarified as both of these factors are linked together and influence disability in their own way.	[Dubois, Jean-Daniel] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ, Canada; [Cantin, Vincent; Descarreaux, Martin] Univ Quebec Trois Rivieres, Dept Sci Act Phys, Trois Rivieres, PQ, Canada; [Piche, Mathieu] Univ Quebec Trois Rivieres, Dept Chiroprat, Trois Rivieres, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres	Dubois, JD (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ, Canada.; Descarreaux, M (corresponding author), Univ Quebec Trois Rivieres, Dept Sci Act Phys, Trois Rivieres, PQ, Canada.	Jean-Daniel.dubois@uqtr.ca; Martin.descarreaux@uqtr.ca		Descarreaux, Martin/0000-0002-3545-5860	Institut de Recherche Robert-Sauve en Sante et en Securite du Travail	Institut de Recherche Robert-Sauve en Sante et en Securite du Travail	This study was supported by a research grant from the Institut de Recherche Robert-Sauve en Sante et en Securite du Travail (2012-0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Asmundson GJ, 2004, UNDERSTANDING TREATI, V3-24; Axen I, 2013, BEST PRACT RES CL RH, V27, P601, DOI 10.1016/j.berh.2013.10.004; Bean DJ, 2014, CLIN J PAIN, V30, P647, DOI 10.1097/AJP.0000000000000007; Bellingham GA, 2010, REGION ANESTH PAIN M, V35, P294, DOI 10.1097/AAP.0b013e3181df2645; Boersma K, 2005, BEHAV RES THER, V43, P1495, DOI 10.1016/j.brat.2004.11.006; Bruyere O, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-12; Chaory K, 2004, SPINE, V29, P908, DOI 10.1097/00007632-200404150-00018; Colloca CJ, 2005, J MANIP PHYSIOL THER, V28, P623, DOI 10.1016/j.jmpt.2005.08.005; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; d'Errico A, 2013, J OCCUP HEALTH, V55, P276, DOI 10.1539/joh.12-0261-OA; D'hooge R, 2013, J ELECTROMYOGR KINES, V23, P173, DOI 10.1016/j.jelekin.2012.09.003; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Desrochers G, 2009, CLIN J PAIN, V25, P520, DOI 10.1097/AJP.0b013e31819976e3; Diers M, 2007, J CLIN NEUROPHYSIOL, V24, P76, DOI 10.1097/01.wnp.0000241093.00844.0e; Dubois JD, 2014, J ELECTROMYOGR KINES, V24, P550, DOI 10.1016/j.jelekin.2014.04.012; Dubois JD, 2011, J ELECTROMYOGR KINES, V21, P774, DOI 10.1016/j.jelekin.2011.05.004; French DJ, 2005, CAN J BEHAV SCI, V37, P181, DOI 10.1037/h0087255; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; Hodges PW, 2013, EUR J PAIN, V17, P1138, DOI 10.1002/j.1532-2149.2013.00286.x; Hodges PW, 2011, J ELECTROMYOGR KINES, V21, P220, DOI 10.1016/j.jelekin.2011.01.002; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hubscher M, 2014, CLIN J PAIN, V30, P886, DOI 10.1097/AJP.0000000000000045; Julien N, 2005, PAIN, V114, P295, DOI 10.1016/j.pain.2004.12.032; Lambeek LC, 2011, SPINE, V36, P1050, DOI 10.1097/BRS.0b013e3181e70488; Lariviere C, 2002, J ELECTROMYOGR KINES, V12, P91, DOI 10.1016/S1050-6411(02)00011-1; Le Bars D., 2008, SENSES COMPREHENSIVE, P763; LeResche L, 2013, J PAIN, V14, P1663, DOI 10.1016/j.jpain.2013.08.008; MacDonald D, 2009, PAIN, V142, P183, DOI 10.1016/j.pain.2008.12.002; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P35; Mannion AF, 2009, J OCCUP ENVIRON MED, V51, P1256, DOI 10.1097/JOM.0b013e3181beac69; McCracken LM, 1997, BEHAV THER, V28, P271, DOI 10.1016/S0005-7894(97)80047-0; McGorry RW, 2000, SPINE, V25, P834, DOI 10.1097/00007632-200004010-00012; Meeus M, 2010, J REHABIL MED, V42, P884, DOI [10.2340/16501977-0595, 10.2340/16501977.0595]; Nahman-Averbuch H, 2016, PAIN PRACT, V16, P38, DOI 10.1111/papr.12256; O'Neill S, 2014, CLIN J PAIN, V30, P831, DOI 10.1097/AJP.0000000000000042; O'Neill S, 2011, EUR SPINE J, V20, P2120, DOI 10.1007/s00586-011-1796-4; Peters ML, 2005, PAIN, V113, P45, DOI 10.1016/j.pain.2004.09.033; Phillips K, 2011, BEST PRACT RES CL RH, V25, P141, DOI 10.1016/j.berh.2011.02.005; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Puta C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058885; RAINVILLE P, 1992, SOMATOSENS MOT RES, V9, P265, DOI 10.3109/08990229209144776; Rej S, 2014, PAIN MED, V15, P1154, DOI 10.1111/pme.12456; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Roussel NA, 2013, CLIN J PAIN, V29, P625, DOI 10.1097/AJP.0b013e31826f9a71; Roussel P., 1996, ECONOMICA; Schliessbach J, 2013, EUR J PAIN, V17, P1502, DOI 10.1002/j.1532-2149.2013.00332.x; Scholich SL, 2012, DISABIL REHABIL, V34, P1993, DOI 10.3109/09638288.2012.667187; Severeijns R, 2001, CLIN J PAIN, V17, P165, DOI 10.1097/00002508-200106000-00009; Skljarevski V, 2010, J PAIN, V11, P1282, DOI 10.1016/j.jpain.2010.03.002; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; TRIANO JJ, 1987, SPINE, V12, P561, DOI 10.1097/00007632-198707000-00010; Van Damme S, 2002, PAIN, V100, P111, DOI 10.1016/S0304-3959(02)00290-7; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Weiss D.J., 1967, MINN STUD VOCAT REHA; Wideman TH, 2013, PAIN, V154, P2262, DOI 10.1016/j.pain.2013.06.005; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2015, PAIN, V156, pS24, DOI 10.1097/01.j.pain.0000460343.46847.58; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021; Young AE, 2011, PAIN, V152, P204, DOI 10.1016/j.pain.2010.10.033; Zerkak D., 2013, Annals of Physical and Rehabilitation Medicine, V56, P613, DOI 10.1016/j.rehab.2013.08.006	63	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165478	10.1371/journal.pone.0165478	http://dx.doi.org/10.1371/journal.pone.0165478			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VE	27783666	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800077
J	Mogil, LS; Becker, NA; Maher, J				Mogil, Lauren S.; Becker, Nicole A.; Maher, James, III			Supercoiling Effects on Short-Range DNA Looping in E-coli	PLOS ONE			English	Article							IN-VIVO; LAC REPRESSOR; TRANSCRIPTIONAL RESPONSE; PROMOTER REPRESSION; PHYSICAL-PROPERTIES; SUPERHELICAL TURNS; LENGTH DEPENDENCE; OPERATORS; PROTEIN; MUTATIONS	DNA-protein loops can be essential for gene regulation. The Escherichia coli lactose (lac) operon is controlled by DNA-protein loops that have been studied for decades. Here we adapt this model to test the hypothesis that negative superhelical strain facilitates the formation of short-range (6-8 DNA turns) repression loops in E. coli. The natural negative superhelicity of E. coli DNA is regulated by the interplay of gyrase and topoisomerase enzymes, adding or removing negative supercoils, respectively. Here, we measured quantitatively DNA looping in three different E. coli strains characterized by different levels of global supercoiling: wild type, gyrase mutant (gyrB226), and topoisomerase mutant (Delta topA10). DNA looping in each strain was measured by assaying repression of the endogenous lac operon, and repression of ten reporter constructs with DNA loop sizes between 70-85 base pairs. Our data are most simply interpreted as supporting the hypothesis that negative supercoiling facilitates gene repression by small DNA-protein loops in living bacteria.	[Mogil, Lauren S.; Becker, Nicole A.; Maher, James, III] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA; [Mogil, Lauren S.] Mayo Clin, Coll Med, Biochem & Mol Biol Track, Mayo Grad Sch, 200 First St SW, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Maher, J (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	maher@mayo.edu			Mayo Foundation, Mayo Graduate School; NIH Grant [GM75965]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075965] Funding Source: NIH RePORTER	Mayo Foundation, Mayo Graduate School; NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Mayo Foundation, Mayo Graduate School, and NIH Grant GM75965.	Abu Mraheil M, 2013, PHARMAZIE, V68, P541, DOI 10.1691/ph.2013.6520; Anderson M, 2009, MOL BIOL CELL, V20, P4131, DOI 10.1091/mbc.E09-05-0359; Bagel S, 1999, ANTIMICROB AGENTS CH, V43, P868, DOI 10.1128/AAC.43.4.868; Becker NA, 2005, J MOL BIOL, V349, P716, DOI 10.1016/j.jmb.2005.04.035; Becker NA, 2008, NUCLEIC ACIDS RES, V36, P4009, DOI 10.1093/nar/gkn353; Becker NA, 2007, NUCLEIC ACIDS RES, V35, P3988, DOI 10.1093/nar/gkm419; Becker NA, 2014, NUCLEIC ACIDS RES, V42, P5495, DOI 10.1093/nar/gku180; Becker NA, 2013, NUCLEIC ACIDS RES, V41, P156, DOI 10.1093/nar/gks1011; BELLOMY GR, 1988, BIOCHEMISTRY-US, V27, P3900, DOI 10.1021/bi00411a002; Bond LM, 2010, NUCLEIC ACIDS RES, V38, P8072, DOI 10.1093/nar/gkq755; BOROWIEC JA, 1987, J MOL BIOL, V195, P89, DOI 10.1016/0022-2836(87)90329-9; BOROWIEC JA, 1985, J MOL BIOL, V184, P587, DOI 10.1016/0022-2836(85)90305-5; BOROWIEC JA, 1987, J MOL BIOL, V196, P101, DOI 10.1016/0022-2836(87)90513-4; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Deng S, 2005, MOL MICROBIOL, V57, P1511, DOI 10.1111/j.1365-2958.2005.04796.x; DRLICA K, 1992, MOL MICROBIOL, V6, P425, DOI 10.1111/j.1365-2958.1992.tb01486.x; EISMANN ER, 1990, J MOL BIOL, V213, P763, DOI 10.1016/S0022-2836(05)80262-1; Fulcrand G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19243; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; Higgins NP, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.PLAS-0036-2014; Johnson S, 2012, NUCLEIC ACIDS RES, V40, P7728, DOI 10.1093/nar/gks473; Kahn JD, 2006, BIOPHYSICAL REV LETT; KELLER W, 1975, P NATL ACAD SCI USA, V72, P4876, DOI 10.1073/pnas.72.12.4876; KRAMER H, 1988, EMBO J, V7, P547, DOI 10.1002/j.1460-2075.1988.tb02844.x; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; LAW SM, 1993, J MOL BIOL, V230, P161, DOI 10.1006/jmbi.1993.1133; Le TT, 2014, NUCLEIC ACIDS RES, V42, P10786, DOI 10.1093/nar/gku735; Leng FF, 2011, P NATL ACAD SCI USA, V108, P19973, DOI 10.1073/pnas.1109854108; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; MATTHEWS KS, 1992, MICROBIOL REV, V56, P123, DOI 10.1128/MMBR.56.1.123-136.1992; MOSSING MC, 1986, SCIENCE, V233, P889, DOI 10.1126/science.3090685; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Napierala M, 2005, J BIOL CHEM, V280, P37366, DOI 10.1074/jbc.M508065200; Norregaard K, 2013, P NATL ACAD SCI USA, V110, P17386, DOI 10.1073/pnas.1215907110; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Peters JP, 2011, METHOD ENZYMOL, P287, DOI 10.1016/B978-0-12-381268-1.00012-4; Preisler A, 2006, J ANTIMICROB CHEMOTH, V57, P430, DOI 10.1093/jac/dki475; Priest DG, 2014, P NATL ACAD SCI USA, V111, P349, DOI 10.1073/pnas.1317817111; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; Rovinskiy N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002845; Saiz L, 2005, P NATL ACAD SCI USA, V102, P17642, DOI 10.1073/pnas.0505693102; Saiz L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000355; Saiz L, 2008, NUCLEIC ACIDS RES, V36, P726, DOI 10.1093/nar/gkm1034; Saiz L, 2006, CURR OPIN STRUC BIOL, V16, P344, DOI 10.1016/j.sbi.2006.05.008; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; Seol Y, 2007, BIOPHYS J, V93, P4360, DOI 10.1529/biophysj.107.112995; SHEN LL, 1989, J BIOL CHEM, V264, P2973; STERNGLANZ R, 1981, P NATL ACAD SCI-BIOL, V78, P2747, DOI 10.1073/pnas.78.5.2747; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; Whipple FW, 1998, NUCLEIC ACIDS RES, V26, P3700, DOI 10.1093/nar/26.16.3700; Willenbrock H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-252; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zechiedrich EL, 2000, J BIOL CHEM, V275, P8103, DOI 10.1074/jbc.275.11.8103; ZUBAY G, 1972, P NATL ACAD SCI USA, V69, P1100, DOI 10.1073/pnas.69.5.1100	61	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165306	10.1371/journal.pone.0165306	http://dx.doi.org/10.1371/journal.pone.0165306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783696	Green Submitted, gold, Green Published			2022-12-26	WOS:000389602800068
J	Thomas, A; Miller, A; Roughan, J; Malik, A; Haylor, K; Sandersen, C; Flecknell, P; Leach, M				Thomas, Aurelie; Miller, Amy; Roughan, Johnny; Malik, Aneesa; Haylor, Katherine; Sandersen, Charlotte; Flecknell, Paul; Leach, Matthew			Efficacy of Intrathecal Morphine in a Model of Surgical Pain in Rats	PLOS ONE			English	Article							POSTOPERATIVE PAIN; ANIMAL-MODELS; FACIAL EXPRESSIONS; LABORATORY MOUSE; GRIMACE SCALE; DOSE-RESPONSE; BUPRENORPHINE; ANALGESIA; BEHAVIOR; LAPAROTOMY	Concerns over interactions between analgesics and experimental outcomes are a major reason for withholding opioids from rats undergoing surgical procedures. Only a fraction of morphine injected intravenously reaches receptors responsible for analgesia in the central nervous system. Intrathecal administration of morphine may represent a way to provide rats with analgesia while minimizing the amount of morphine injected. This study aimed to assess whether morphine injected intrathecally via direct lumbar puncture provides sufficient analgesia to rats exposed to acute surgical pain (caudal laparotomy). In an initial blinded, randomised study, pain-free rats received morphine subcutaneously (MSC, 3mg kg-1, N = 6), intrathecally (MIT, 0.2mg.kg-1, N = 6); NaCl subcutaneously (NSC, N = 6) or intrathecally (NIT, N = 6). Previously validated pain behaviours, activity and Rat Grimace Scale (RGS) scores were recorded at baseline, 1, 2, 4 and 8h post-injection. Morphine-treated rats had similar behaviours to NaCl rats, but their RGS scores were significantly different over time and between treatments. In a second blinded study, rats (N = 28) were randomly allocated to one of the following four treatments (N = 7): MSC, 3mg.kg-1, surgery; MIT, 0.2mg.kg-1, surgery; NIT, surgery; NSC, sham surgery. Composite Pain Behaviours (CPB) and RGS were recorded as previously. CPB in MIT and MSC groups were not significantly different to NSC group. MSC and MIT rats displayed significantly lower RGS scores than NIT rats at 1 and 8h postoperatively. RGS scores for MIT and MSC rats were not significantly different at 1, 2, and 8h postoperatively. Intraclass correlation value amongst operators involved in RGS scoring (N = 9) was 0.913 for total RGS score. Intrathecal morphine was mostly indistinguishable from its subcutaneous counterpart, providing pain relief lasting up to 8 hours in a rat model of surgical pain. Further studies are warranted to clarify the relevance of the rat grimace scale for assessing pain in rats that have received opioid analgesics.	[Thomas, Aurelie; Roughan, Johnny; Flecknell, Paul] Newcastle Univ, Inst Neurosci, Comparat Biol Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Miller, Amy; Leach, Matthew] Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne, Tyne & Wear, England; [Malik, Aneesa] Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Haylor, Katherine] Newcastle Univ, Sch Biomed Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Sandersen, Charlotte] Univ Liege, Fac Med Vet, Clin Vet Univ, Liege, Belgium	Newcastle University - UK; Newcastle University - UK; University of Edinburgh; Newcastle University - UK; University of Liege	Thomas, A (corresponding author), Newcastle Univ, Inst Neurosci, Comparat Biol Ctr, Newcastle Upon Tyne, Tyne & Wear, England.	aurelie.thomas@me.com	Roughan, John Vincent/AAF-3586-2021	Roughan, John Vincent/0000-0002-0031-3918; Flecknell, Paul/0000-0002-1075-1129; Sandersen, charlotte/0000-0002-3404-2757				Abaza R, 2006, J UROLOGY, V175, P2317, DOI 10.1016/S0022-5347(06)00257-6; Afsharimani B, 2015, BRIT J PHARMACOL, V172, P251, DOI 10.1111/bph.12589; Al-Hashimi M, 2013, BRIT J ANAESTH, V111, P80, DOI 10.1093/bja/aet153; BABBINI M, 1972, BRIT J PHARMACOL, V46, P213, DOI 10.1111/j.1476-5381.1972.tb06866.x; Bara M, 2014, CRIT CARE, V18, DOI 10.1186/cc13694; Barash PG, 2011, CLIN ANESTHESIA; Bratcher NA, 2015, J AM ASSOC LAB ANIM, V54, P133; Brennan TJ, 1997, ANESTHESIOLOGY, V87, P1517, DOI 10.1097/00000542-199712000-00031; Buerkle H, 1996, ANESTHESIOLOGY, V84, P94, DOI 10.1097/00000542-199601000-00012; Burden N, 2015, J AM ASSOC LAB ANIM, V54, P198; Buvanendran A, 2008, ANESTH ANALG, V107, P300, DOI 10.1213/ane.0b013e3181732f21; Cicero TJ, 2006, J PHARMACOL EXP THER, V279, P767; Clark JA, 1997, LAB ANIM SCI, V47, P300; Collaert N., 2016, IEEE SOI 3D SUBTHRES, P1, DOI DOI 10.1109/S3S.2016.7804409; Coulter CA, 2009, LAB ANIM-UK, V43, P232, DOI 10.1258/la.2008.008021; Craig MM, 2015, BEHAV NEUROSCI, V129, P643, DOI 10.1037/bne0000081; De Rantere D, 2016, EUR J PAIN, V20, P417, DOI 10.1002/ejp.742; Dornelas Conceição Aparecida, 2006, Acta Cir. Bras., V21, P38, DOI 10.1590/S0102-86502006000100009; Economic Commission for Europe of the United Nations, 2010, REGULATION NO 112; Emery MJ, 2016, ANESTHESIOLOGY, V1; Fairbanks CA, 2003, ADV DRUG DELIVER REV, V55, P1007, DOI 10.1016/S0169-409X(03)00101-7; Flecknell P, 2015, PREANESTHESIA ANESTH; Flecknell P, 2015, LAB ANIMAL ANAESTHES; FLECKNELL PA, 1984, LAB ANIM, V18, P147, DOI 10.1258/002367784780891226; Flecknell PA, 2007, REFINEMENT ANIMAL US, P1; Ganesh A, 2007, ANESTH ANALG, V104, P271, DOI 10.1213/01.ane.0000252418.05394.28; Girgin NK, 2008, J CLIN ANESTH, V20, P180, DOI 10.1016/j.jclinane.2007.07.010; Grace PM, 2016, P NATL ACAD SCI USA, V113, pE3441, DOI 10.1073/pnas.1602070113; Graham ML, 2015, EUR J PHARMACOL, V759, P19, DOI 10.1016/j.ejphar.2015.03.040; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Gueye PN, 2002, TOXICOL SCI, V65, P107, DOI 10.1093/toxsci/65.1.107; Hanninen L, 2009, BEHAV RES METHODS, V41, P472, DOI 10.3758/BRM.41.2.472; Hawkins P, 2006, ANIMAL TECHNOLOGY; Home Office, 2015, ANN STAT SCI PROC LI, P1, DOI DOI 10.1016/J.FSIGEN.2013.09.005; IWAMOTO K, 1977, J PHARMACOL EXP THER, V200, P236; JACOBSON L, 1990, PAIN, V43, P141, DOI 10.1016/0304-3959(90)91066-R; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2010, LAB ANIM-UK, V44, P59, DOI 10.1258/la.2009.007160; Liao LN, 2014, EUR J ORAL SCI, V122, P121, DOI 10.1111/eos.12110; Lilley E, 2015, SHOCK, V43, P304, DOI 10.1097/SHK.0000000000000318; Mager DE, 2009, DRUG METAB PHARMACOK, V24, P16, DOI 10.2133/dmpk.24.16; Mamet J, 2014, PAIN, V155, P322, DOI 10.1016/j.pain.2013.10.015; Martin TJ, 2005, PAIN, V113, P376, DOI 10.1016/j.pain.2004.11.017; Martin TJ, 2004, ANESTHESIOLOGY, V101, P191, DOI 10.1097/00000542-200407000-00030; Massa H, 2012, TOXICOL SCI, V130, P168, DOI 10.1093/toxsci/kfs234; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Miller A, 2015, APPL ANIM BEHAV SCI, V172, P58, DOI 10.1016/j.applanim.2015.08.038; Ohtani M, 1997, J PHARMACOL EXP THER, V281, P428; Oliver V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097882; Papathanasiou T, 2016, PHASCI ELSEVIER B, V82, P97; Papathanasiou T, 2016, PHARM RES PHARM 0705, P1, DOI [10.1007/s11095-015-1770-7, DOI 10.1007/S11095-015-1770-7]; Pettersen VLA, 2009, ANESTH ANALG, V109, P1312, DOI 10.1213/ane.0b013e3181b16ff5; Prado WA, 2003, J NEUROSCI METH, V129, P33, DOI 10.1016/S0165-0270(03)00197-3; Rathmell JP, 2005, ANESTH ANALG, V101, pS30, DOI 10.1213/01.ANE.0000177101.99398.22; Roughan JV, 2016, EUR J PAIN, V20, P231, DOI 10.1002/ejp.712; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Roughan JV, 2002, LAB ANIM-UK, V36, P322, DOI 10.1258/002367702320162423; Roughan JV, 2000, RES VET SCI, V69, P283, DOI 10.1053/rvsc.2000.0430; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Russell WMS., 1959, MED J AUSTRALIA; Saleh AS, 1985, LONG TERM PAIN TREAT; Schaap MWH, 2012, LAB ANIM-UK, V46, P287, DOI 10.1258/la.2012.012058; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Stoelting PK, 2007, BASICS OF ANESTHESIA; Stoelting R.K., 2012, PHARM PHYSL ANESTHET; Stokes EL, 2009, LAB ANIM-UK, V43, P149, DOI 10.1258/la.2008.008020; Suzuki T, 1984, Yakubutsu Seishin Kodo, V4, P149; Thomas AS, 2015, FALSE TITLE, V403, P1, DOI 10.1163/9789401212076; Tranquilli W J, 2013, LUMB JONES VET ANEST; TUNG AS, 1982, BRAIN RES, V247, P75, DOI 10.1016/0006-8993(82)91029-0; Waite ME, 2015, J AM ASSOC LAB ANIM, V54, P420; WALLENSTEIN MC, 1983, EUR J PHARMACOL, V90, P65, DOI 10.1016/0014-2999(83)90214-5; WALLENSTEIN MC, 1981, AM J PHYSIOL, V241, pR130, DOI 10.1152/ajpregu.1981.241.3.R130; Whiteside GT, 2004, BRIT J PHARMACOL, V141, P85, DOI 10.1038/sj.bjp.0705568; Wiesenfeld-Hallin Zsuzsanna, 2005, Gend Med, V2, P137, DOI 10.1016/S1550-8579(05)80042-7; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080; WOOLF CJ, 1981, BRAIN RES, V209, P491, DOI 10.1016/0006-8993(81)90176-1; Wright-Williams SL, 2007, PAIN, V130, P108, DOI 10.1016/j.pain.2006.11.003; YAKSH TL, 1981, PAIN, V11, P293, DOI 10.1016/0304-3959(81)90633-3; YAKSH TL, 1976, SCIENCE, V192, P1357, DOI 10.1126/science.1273597; Yaksh TL, 1977, SURVEY ANESTHESIOLOG, V21, P122, DOI [10.1097/00132586-197704000-00009, DOI 10.1097/00132586-197704000-00009]; Zahn PK, 1997, ANESTHESIOLOGY, V86, P1066, DOI 10.1097/00000542-199705000-00010	84	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0163909	10.1371/journal.pone.0163909	http://dx.doi.org/10.1371/journal.pone.0163909			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783629	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800020
J	Vacca, I; Del Tordello, E; Gasperini, G; Pezzicoli, A; Di Fede, M; Paccani, SR; Marchi, S; Mubaiwa, TD; Hartley-Tassell, LE; Jennings, MP; Seib, KL; Masignani, V; Pizza, M; Serruto, D; Arico, B; Delany, I				Vacca, Irene; Del Tordello, Elena; Gasperini, Gianmarco; Pezzicoli, Alfredo; Di Fede, Martina; Paccani, Silvia Rossi; Marchi, Sara; Mubaiwa, Tsisti D.; Hartley-Tassell, Lauren E.; Jennings, Michael P.; Seib, Kate L.; Masignani, Vega; Pizza, Mariagrazia; Serruto, Davide; Arico, Beatrice; Delany, Isabel			Neisserial Heparin Binding Antigen (NHBA) Contributes to the Adhesion of Neisseria meningitidis to Human Epithelial Cells	PLOS ONE			English	Article							SEROGROUP-B MENINGOCOCCUS; MULTICOMPONENT VACCINE; PROTEIN; GLYCOCONJUGATE; RECEPTORS; CANDIDATE; ADHERENCE; CONTACT; DOMAIN; GENES	Neisserial Heparin Binding Antigen (NHBA) is a surface-exposed lipoprotein ubiquitously expressed by Neisseria meningitidis strains and an antigen of the Bexsero (R) vaccine. NHBA binds heparin through a conserved Arg-rich region that is the target of two proteases, the meningococcal NalP and human lactoferrin (hLf). In this work, in vitro studies showed that recombinant NHBA protein was able to bind epithelial cells and mutations of the Arg-rich tract abrogated this binding. All N-terminal and C-terminal fragments generated by NalP or hLf cleavage, regardless of the presence or absence of the Arg-rich region, did not bind to cells, indicating that a correct positioning of the Arg-rich region within the full length protein is crucial. Moreover, binding was abolished when cells were treated with heparinase III, suggesting that this interaction is mediated by heparan sulfate proteoglycans (HSPGs). N. meningitidis nhba knockout strains showed a significant reduction in adhesion to epithelial cells with respect to isogenic wild-type strains and adhesion of the wild-type strain was inhibited by anti-NHBA antibodies in a dose-dependent manner. Overall, the results demonstrate that NHBA contributes to meningococcal adhesion to epithelial cells through binding to HSPGs and suggest a possible role of anti-Bexsero (R) antibodies in the prevention of colonization.	[Vacca, Irene; Del Tordello, Elena; Gasperini, Gianmarco; Pezzicoli, Alfredo; Di Fede, Martina; Paccani, Silvia Rossi; Marchi, Sara; Masignani, Vega; Pizza, Mariagrazia; Serruto, Davide; Arico, Beatrice; Delany, Isabel] GSK Vaccines, Siena, Italy; [Mubaiwa, Tsisti D.; Hartley-Tassell, Lauren E.; Jennings, Michael P.; Seib, Kate L.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Vacca, Irene] Univ Leicester, Leicester, Leics, England	GlaxoSmithKline; Griffith University; University of Leicester	Delany, I (corresponding author), GSK Vaccines, Siena, Italy.	isabel.x.delany@gsk.com	Seib, Kate L/B-4670-2015; Jennings, Michael P/G-4822-2013	Seib, Kate L/0000-0002-7094-3528; Jennings, Michael P/0000-0002-1027-4684; mubaiwa, T/0000-0003-4453-9211	GSK Vaccines; University of Bologna; Siena; Australian National Health and Medical Research Council [1099278, 1045235, 1071659]	GSK Vaccines; University of Bologna; Siena; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	GSK Vaccines, (formerly Novartis Vaccines) who developed the Bexsero vaccine, provided support in the form of salaries for EDT, AP, SRP, SM, VM, MP, DS, BA, and ID. IV, GG and MDF, have received a GSK graduate fellowship from the University of Bologna (first two) and Siena (third). KLS and MPJ were supported by the Australian National Health and Medical Research Council (project grant 1099278 and Career Development Fellowship 1045235 to KLS; program grant 1071659 to MPJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We would like to thank Claudia Facciotti and Eva Grassi for technical support in protein purification, Nicolai V. Bovin (Shemyakin Institute) for providing array glycans and Christopher J. Day (Institute for Glycomics) for support with glycan array analysis. KLS and MPJ were supported by the Australian National Health and Medical Research Council (Project Grant 1099278 and Career Development Fellowship 1045235 to KLS; Program Grant 1071659 to MPJ). Irene Vacca, Gianmarco Gasperini and Martina di Fede are recipients of GSK fellowships from the PhD program of the University of Bologna and Siena, respectively.	Arenas J, 2013, MOL MICROBIOL, V87, P254, DOI 10.1111/mmi.12097; Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; Bambini S, 2009, VACCINE, V27, P2794, DOI 10.1016/j.vaccine.2009.02.098; Barrile R, 2015, CELL MICROBIOL, V17, P1365, DOI 10.1111/cmi.12439; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Carbonnelle E, 2009, VACCINE, V27, pB78, DOI 10.1016/j.vaccine.2009.04.069; Casellato A, 2014, CELL MICROBIOL, V16, P925, DOI 10.1111/cmi.12250; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Day CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004927; de Vries FP, 1998, MOL MICROBIOL, V27, P1203, DOI 10.1046/j.1365-2958.1998.00763.x; Deghmane AE, 2002, MOL MICROBIOL, V43, P1555, DOI 10.1046/j.1365-2958.2002.02838.x; Deghmane AE, 2003, INFECT IMMUN, V71, P2897, DOI 10.1128/IAI.71.5.2897-2901.2003; Del Tordello E, 2014, P NATL ACAD SCI USA, V111, P427, DOI 10.1073/pnas.1321556111; Derkaoui M, 2016, MOL MICROBIOL, V100, P788, DOI 10.1111/mmi.13349; Esposito V, 2011, J BIOL CHEM, V286, P41767, DOI 10.1074/jbc.M111.289314; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuliani MM, 2010, VACCINE, V28, P5023, DOI 10.1016/j.vaccine.2010.05.014; HANNAH JH, 1994, INFECT IMMUN, V62, P5010, DOI 10.1128/IAI.62.11.5010-5019.1994; Hauck CR, 2003, CURR OPIN MICROBIOL, V6, P43, DOI 10.1016/S1369-5274(03)00004-3; Hung MC, 2013, MBIO, V4, DOI 10.1128/mBio.00041-13; Jacobsson S, 2006, VACCINE, V24, P2161, DOI 10.1016/j.vaccine.2005.11.006; Lecuyer H, 2012, INFECT IMMUN, V80, P175, DOI 10.1128/IAI.05837-11; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Muzzi A, 2013, MBIO, V4, DOI 10.1128/mBio.00163-13; Oldfield NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069746; Read RC, 2014, LANCET, V384, P2123, DOI 10.1016/S0140-6736(14)60842-4; Rostand KS, 1997, INFECT IMMUN, V65, P1; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; Serruto D, 2003, MOL MICROBIOL, V48, P323, DOI 10.1046/j.1365-2958.2003.03420.x; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; Sutherland TC, 2010, INFECT IMMUN, V78, P3832, DOI 10.1128/IAI.01377-09; Turner DPJ, 2006, INFECT IMMUN, V74, P2957, DOI 10.1128/IAI.74.5.2957-2964.2006; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097	36	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0162878	10.1371/journal.pone.0162878	http://dx.doi.org/10.1371/journal.pone.0162878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780200	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900001
J	Gerarduzzi, C; de Polo, A; Liu, XS; El Kharbili, M; Little, JB; Yuan, ZM				Gerarduzzi, Casimiro; de Polo, Anna; Liu, Xue-Song; El Kharbili, Manale; Little, John B.; Yuan, Zhi-Min			Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex IMPLICATION OF A NOVEL MDMX SER-314 PHOSPHOSITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; ERBB4 ISOFORM; LIGASE ACTIVITY; EXPRESSION; MDM2; DOMAIN; PROLIFERATION; DEGRADATION; CARCINOMA; SURVIVAL	Deregulated receptor tyrosine kinase (RTK) signaling is frequently associated with tumorigenesis and therapy resistance, but its underlying mechanisms still need to be elucidated. In this study, we have shown that the RTK human epidermal growth factor receptor 4 (Her4, also known as Erbb4) can inhibit the tumor suppressor p53 by regulating MDMX-mouse double minute 2 homolog (MDM2) complex stability. Upon activation by either overexpression of a constitutively active vector or ligand binding (Neuregulin-1), Her4 was able to stabilize the MDMX-MDM2 complex, resulting in suppression of p53 transcriptional activity, as shown by p53-responsive element-driven luciferase assay and mRNA levels of p53 target genes. Using a phospho-proteomics approach, we functionally identified a novel Her4-induced posttranslational modification on MDMX at Ser-314, a putative phosphorylation site for the CDK4/6 kinase. Remarkably, inhibition of Ser-314 phosphorylation either with Ser-to-Ala substitution or with a specific inhibitor of CDK4/6 kinase blocked Her4-induced stabilization of MDMX-MDM2 and rescued p53 activity. Our study offers insights into the mechanisms of deregulated RTK-induced carcinogenesis and provides the basis for the use of inhibitors targeting RTK-mediated signals for p53 restoration.	[Gerarduzzi, Casimiro; de Polo, Anna; Liu, Xue-Song; El Kharbili, Manale; Little, John B.; Yuan, Zhi-Min] Harvard TH Chan Sch Publ Hlth, John B Little Ctr Radiat Sci, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Yuan, ZM (corresponding author), Harvard TH Chan Sch Publ Hlth, John B Little Ctr Radiat Sci, Boston, MA 02115 USA.	zyuan@hsph.harvard.edu		de Polo, Anna/0000-0002-5607-8048; Gerarduzzi, Casimiro/0000-0001-7098-1455	Morningside Foundation; Zhu fund; NCI, National Institutes of Health [R01CA085679, RO1CA167814, RO1CA183074]	Morningside Foundation; Zhu fund; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Morningside Foundation, the Zhu fund, and NCI, National Institutes of Health Grants R01CA085679, RO1CA167814, and RO1CA183074. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Barnes NLP, 2005, CLIN CANCER RES, V11, P2163, DOI 10.1158/1078-0432.CCR-04-1633; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Feng SM, 2007, MOL ENDOCRINOL, V21, P1861, DOI 10.1210/me.2006-0101; Forslund A, 2008, MOL CANCER RES, V6, P205, DOI 10.1158/1541-7786.MCR-07-0239; Fujiwara S, 2014, ONCOTARGET, V5, P3919, DOI 10.18632/oncotarget.2002; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Gilkes DM, 2008, MOL CELL BIOL, V28, P1999, DOI 10.1128/MCB.01633-07; Gu JJ, 2001, ONCOGENE, V20, P3519, DOI 10.1038/sj.onc.1204454; Haskins JW, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac5124; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Ito M, 2011, CLIN CANCER RES, V17, P416, DOI 10.1158/1078-0432.CCR-10-2050; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lopez-Pajares V, 2008, J BIOL CHEM, V283, P13707, DOI 10.1074/jbc.M710030200; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Mejia-Guerrero S, 2010, GENE CHROMOSOME CANC, V49, P518, DOI 10.1002/gcc.20761; Mohd N., 2014, INT J EDUC RES, V2, P2; Myklebust MP, 2012, BRIT J CANCER, V107, P1684, DOI 10.1038/bjc.2012.463; Nakamura Y, 2013, PROSTATE, V73, P590, DOI 10.1002/pros.22599; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Okazaki S, 2016, BIOCHEM BIOPH RES CO, V470, P239, DOI 10.1016/j.bbrc.2016.01.045; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Pentassuglia L, 2016, AM J PHYSIOL-ENDOC M, V310, pE782, DOI 10.1152/ajpendo.00259.2015; Portier BP, 2013, ONCOTARGET, V4, P1662, DOI 10.18632/oncotarget.1232; Sassen A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1843; Shadfan M, 2012, TRANSL CANCER RES, V1, P88, DOI 10.3978/j.issn.2218-676X.2012.04.02; Shibagaki I, 1995, CLIN CANCER RES, V1, P769; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Suo Z, 2002, J PATHOL, V196, P17, DOI 10.1002/path.1003; Thor AD, 2009, AM J PATHOL, V175, P1802, DOI 10.2353/ajpath.2009.090204; Tovey SM, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1394; Tovey SM, 2004, BREAST CANCER RES, V6, pR246, DOI 10.1186/bcr783; Veikkolainen V, 2011, CELL CYCLE, V10, P2647, DOI 10.4161/cc.10.16.17194; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020	45	11	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25937	25949		10.1074/jbc.M116.752303	http://dx.doi.org/10.1074/jbc.M116.752303			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27777309	Green Published, hybrid			2022-12-26	WOS:000390345200016
J	Murakami, M; Nakatani, J; Oki, T				Murakami, Michio; Nakatani, Jun; Oki, Taikan			Evaluation of Risk Perception and Risk-Comparison Information Regarding Dietary Radionuclides after the 2011 Fukushima Nuclear Power Plant Accident	PLOS ONE			English	Article							HEALTH MANAGEMENT SURVEY; PSYCHOLOGICAL DISTRESS; COMMUNICATION; MORTALITY; JAPAN; REPRESENTATION; EARTHQUAKE; DISASTER; COHORT	In the wake of the 2011 Fukushima Daiichi Nuclear Power Station accident, to facilitate evidence-based risk communication we need to understand radiation risk perception and the effectiveness of risk-comparison information. We measured and characterized perceptions of dread risks and unknown risks regarding dietary radionuclides in residents of Fukushima, Tokyo, and Osaka to identify the primary factors among location, evacuation experience, gender, age, employment status, absence/presence of spouse, children and grandchildren, educational background, humanities/science courses, smoking habits, and various types of trustworthy information sources. We then evaluated the effects of these factors and risk-comparison information on multiple outcomes, including subjective and objective understanding, perceived magnitude of risk, perceived accuracy of information, backlash against information, and risk acceptance. We also assessed how risk-comparison information affected these multiple outcomes for people with high risk perception. Online questionnaires were completed by people (n = 9249) aged from 20 to 69 years in the three prefectures approximately 5 years after the accident. We gave each participant one of 15 combinations of numerical risk data and risk-comparison information, including information on standards, smoking-associated risk, and cancer risk, in accordance with Covello's guidelines. Dread-risk perception among Fukushima residents with no experience of evacuation was much lower than that in Osaka residents, whereas evacuees had strikingly higher dread-risk perception, irrespective of whether their evacuation had been compulsory or voluntary. We identified location (distance from the nuclear power station), evacuation experience, and trust of central government as primary factors. Location (including evacuation experience) and trust of central government were significantly associated with the multiple outcomes above. Only information on "cancer risk from radiation and smoking risk" enhanced both subjective and objective understanding without diminishing trust in all participants and in the high dread-risk perception group; use of other risk-comparison information could lead the public to overestimate risk.	[Murakami, Michio] Fukushima Med Univ, Dept Hlth Risk Commun, Sch Med, 1 Hikarigaoka, Fukushima 9601295, Japan; [Nakatani, Jun] Univ Tokyo, Dept Urban Engn, Grad Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan; [Oki, Taikan] Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan	Fukushima Medical University; University of Tokyo; University of Tokyo	Murakami, M (corresponding author), Fukushima Med Univ, Dept Hlth Risk Commun, Sch Med, 1 Hikarigaoka, Fukushima 9601295, Japan.	michio@fmu.ac.jp	Oki, Taikan/E-5778-2010; Nakatani, Jun/H-7864-2019	Oki, Taikan/0000-0003-4067-4678; Nakatani, Jun/0000-0002-8085-5089	"Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency	"Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency	This study was supported by a "Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency, http://www.jst.go.jp/kisoken/crest/en/index.html. MM, JN, and TO receive the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, SIGMA MENTAL ILLNESS; Apter AJ, 2008, J GEN INTERN MED, V23, P2117, DOI 10.1007/s11606-008-0803-x; Boholm A., 1998, J RISK RES, V1, P135, DOI [10.1080/136698798377231, DOI 10.1080/136698798377231]; Consumer Affairs Agency Government of Japan, 2016, FUH HIG NIK SHOH IS; Covello V.T., 1988, RISK COMMUNICATION R; FAO/WHO, 2011, JOINT FAO WHO PUBL W, P63; FISCHHOFF B, 1978, J EXP PSYCHOL HUMAN, V4, P330, DOI 10.1037/0096-1523.4.2.330; Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; Hino Y, 2016, TOHOKU J EXP MED, V239, P333, DOI 10.1620/tjem.239.333; Hommerich C, 2012, INT J JPN SOCIOL, V21, P46, DOI 10.1111/j.1475-6781.2012.01169.x; ICRP, 1959, ICRP PUBL; ICRP (International Commission on Radiological Protection), 2007, ANN ICRP, V37; Ikeda K, 2015, SINSAI KARA MIERU JO; Inoue M, 2004, PREV MED, V38, P516, DOI 10.1016/j.ypmed.2003.11.026; Johnson BB, 2003, RISK ANAL, V23, P767, DOI 10.1111/1539-6924.00354; Joint FAO WHO Expert Committee on Food Additives, 2011, FAO JECFA MON, V8; Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X; Kahneman D., 2011, THINKING FAST SLOW; KLEINHESSELINK RR, 1991, J CROSS CULT PSYCHOL, V22, P11, DOI 10.1177/0022022191221004; Mattisson C, 2015, J AFFECT DISORDERS, V178, P98, DOI 10.1016/j.jad.2015.02.028; Murakami M, 2016, RADIAT PROT DOSIM, V171, P156, DOI 10.1093/rpd/ncw211; Murakami M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112791, 10.1]; National Institute of Radiological Sciences, 1965, RAD SURV DAT JAP; National Research Council, 1987, IMPR RISK COMM; National Research Council Of The National Academies, 2005, ASS SCI INF RAD EXP, DOI 10.17226/11279; Nuclear Safety Research Association, 2011, SINB SEIK KANK HOUSH; Oguri T, 2012, FOOD CHEM TOXICOL, V50, P2663, DOI 10.1016/j.fct.2012.05.010; Oka T, 2014, JPN J RISK ANAL, V24, P101; Oki S, 2012, INT J DISAST RISK RE, V2, P37, DOI 10.1016/j.ijdrr.2012.07.002; Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Pratt LA, 2009, ANN EPIDEMIOL, V19, P202, DOI 10.1016/j.annepidem.2008.12.005; ROTH E, 1990, RISK ANAL, V10, P375, DOI 10.1111/j.1539-6924.1990.tb00520.x; Sato A., 2015, FUKUSHIMA GLOBAL COM; Science Council of Japan Daiichibu Fukushima Genpatsu saigai gono kagaku to shakai no arikata wotou bunkakai, 2014, KAG TO SHAK NO YOR K; Slovic P, 2000, LAW HUMAN BEHAV, V24, P271, DOI 10.1023/A:1005595519944; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; STARR C, 1969, SCIENCE, V165, P1232, DOI 10.1126/science.165.3899.1232; Steinhardt J, 2015, RISK ANAL, V35, P1423, DOI 10.1111/risa.12368; Suzuki Y, 2015, B WORLD HEALTH ORGAN, V93, P598, DOI 10.2471/BLT.14.146498; Thaler R.H., 2021, NUDGE FINAL EDITION; Tsubokura M, 2015, HEALTH PHYS, V108, P39, DOI 10.1097/HP.0000000000000167; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, SOURC EFF RISKS ION; United Nations Scientific Committee on the Effects of Atomic Radiation, 2011, UNSCEAR 2008 REP, VII; Visschers VHM, 2013, RISK ANAL, V33, P333, DOI 10.1111/j.1539-6924.2012.01861.x; Yamagishi K, 1997, APPL COGNITIVE PSYCH, V11, P495, DOI 10.1002/(SICI)1099-0720(199712)11:6<495::AID-ACP481>3.0.CO;2-J	46	34	34	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165594	10.1371/journal.pone.0165594	http://dx.doi.org/10.1371/journal.pone.0165594			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6CX	27802304	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200030
J	Aiello, KA; Alter, O				Aiello, Katherine A.; Alter, Orly			Platform-Independent Genome-Wide Pattern of DNA Copy-Number Alterations Predicting Astrocytoma Survival and Response to Treatment Revealed by the GSVD Formulated as a Comparative Spectral Decomposition	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; OVARIAN-CANCER; GLIOBLASTOMA; GENE; EXPRESSION; PART; P53	We use the generalized singular value decomposition (GSVD), formulated as a comparative spectral decomposition, to model patient-matched grades III and II, i.e., lower-grade astrocytoma (LGA) brain tumor and normal DNA copy-number profiles. A genome-wide tumor-exclusive pattern of DNA copy-number alterations (CNAs) is revealed, encompassed in that previously uncovered in glioblastoma (GBM), i.e., grade IV astrocytoma, where GBM-specific CNAs encode for enhanced opportunities for transformation and proliferation via growth and developmental signaling pathways in GBM relative to LGA. The GSVD separates the LGA pattern from other sources of biological and experimental variation, common to both, or exclusive to one of the tumor and normal datasets. We find, first, and computationally validate, that the LGA pattern is correlated with a patient's survival and response to treatment. Second, the GBM pattern identifies among the LGA patients a subtype, statistically indistinguishable from that among the GBM patients, where the CNA genotype is correlated with an approximately one-year survival phenotype. Third, cross-platform classification of the Affymetrix-measured LGA and GBM profiles by using the Agilent-derived GBM pattern shows that the GBM pattern is a platform-independent predictor of astrocytoma outcome. Statistically, the pattern is a better predictor (corresponding to greater median survival time difference, proportional hazard ratio, and concordance index) than the patient's age and the tumor's grade, which are the best indicators of astrocytoma currently in clinical use, and laboratory tests. The pattern is also statistically independent of these indicators, and, combined with either one, is an even better predictor of astrocytoma outcome. Recurring DNA CNAs have been observed in astrocytoma tumors' genomes for decades, however, copy-number subtypes that are predictive of patients' outcomes were not identified before. This is despite the growing number of datasets recording different aspects of the disease, and due to an existing fundamental need for mathematical frameworks that can simultaneously find similarities and dissimilarities across the datasets. This illustrates the ability of comparative spectral decompositions to find what other methods miss.	[Aiello, Katherine A.; Alter, Orly] Univ Utah, Sci Comp & Imaging Inst, Salt Lake City, UT 84112 USA; [Aiello, Katherine A.; Alter, Orly] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Alter, Orly] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Alter, Orly] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Alter, O (corresponding author), Univ Utah, Sci Comp & Imaging Inst, Salt Lake City, UT 84112 USA.; Alter, O (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.; Alter, O (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.; Alter, O (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	orly@sci.utah.edu		Alter, Orly/0000-0002-0418-1078	National Cancer Institute (NCI) U01 Grant [CA-202144]; Utah Science, Technology, and Research (USTAR) Initiative; National Center for Advancing Translational Sciences (NCATS) UL1 Grant [TR-001067]; NATIONAL CANCER INSTITUTE [U01CA202144] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001067] Funding Source: NIH RePORTER	National Cancer Institute (NCI) U01 Grant; Utah Science, Technology, and Research (USTAR) Initiative; National Center for Advancing Translational Sciences (NCATS) UL1 Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by National Cancer Institute (NCI) U01 Grant CA-202144, http://physics.cancer.gov/network/ UniversityofUtah.aspx, and the Utah Science, Technology, and Research (USTAR) Initiative (to OA). This research was also supported by National Center for Advancing Translational Sciences (NCATS) UL1 Grant TR-001067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar E, 2015, P IEEE, V103, P1602, DOI 10.1109/JPROC.2015.2438719; Alter O, 2004, P NATL ACAD SCI USA, V101, P16577, DOI 10.1073/pnas.0406767101; Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Alter O, 2004, MIAM NAT BIOT WINT S, V15; Bady P, 2012, ACTA NEUROPATHOL, V124, P547, DOI 10.1007/s00401-012-1016-2; BAI ZJ, 1993, SIAM J SCI COMPUT, V14, P1464, DOI 10.1137/0914085; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger JA, 2006, IEEE ACM T COMPUT BI, V3, P2, DOI 10.1109/TCBB.2006.10; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collins FS, 2013, NEW ENGL J MED, V369, P2369, DOI 10.1056/NEJMp1314561; COX DR, 1972, J R STAT SOC B, V34, P187; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; DAUMASDUPORT C, 1988, CANCER-AM CANCER SOC, V62, P2152, DOI 10.1002/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T; De Clercq W, 2006, IEEE T BIO-MED ENG, V53, P2583, DOI 10.1109/TBME.2006.879459; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Etemadmoghadam D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015498; Fischer U, 2008, MOL CANCER RES, V6, P576, DOI 10.1158/1541-7786.MCR-07-0283; Friedland S, 2005, SIAM J MATRIX ANAL A, V27, P434, DOI 10.1137/S0895479804439791; Golub G. H., 2012, MATRIX COMPUTATIONS; Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Harries M, 2002, LANCET ONCOL, V3, P529, DOI 10.1016/S1470-2045(02)00846-X; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Heim S, 2014, J PATHOL, V234, P138, DOI 10.1002/path.4406; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Horn R., 2012, MATRIX ANAL, DOI [10.1017/CBO9781139020411, DOI 10.1017/CBO9781139020411, 10.1017/cbo9781139020411]; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030098; Mischel PS, 2004, NAT REV NEUROSCI, V5, P782, DOI 10.1038/nrn1518; Misra A, 2005, CLIN CANCER RES, V11, P2907, DOI 10.1158/1078-0432.CCR-04-0708; NETSKY MG, 1950, J NEUROSURG, V7, P261, DOI 10.3171/jns.1950.7.3.0261; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Omberg L, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.70; PAIGE CC, 1981, SIAM J NUMER ANAL, V18, P398, DOI 10.1137/0718026; Ponnapalli S. P., 2006, WORKSH ALG MOD MASS; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; Prisco MG, 2012, HUM PATHOL, V43, P282, DOI 10.1016/j.humpath.2011.05.002; Purow B, 2009, NAT REV NEUROL, V5, P419, DOI 10.1038/nrneurol.2009.96; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Sankaranarayanan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121396; Schreiber AW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-335; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sun Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003406; Tomescu OA, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S2-S4; Turner KM, 2015, P NATL ACAD SCI USA, V112, P3421, DOI 10.1073/pnas.1414573112; van Veelen MLC, 1998, J NEUROL NEUROSUR PS, V64, P581, DOI 10.1136/jnnp.64.5.581; VANLOAN C, 1985, NUMER MATH, V46, P479, DOI 10.1007/BF01389653; VANLOAN CF, 1976, SIAM J NUMER ANAL, V13, P76, DOI 10.1137/0713009; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wiltshire RN, 2000, NEURO-ONCOLOGY, V2, P164, DOI 10.1093/neuonc/2.3.164; Xiao XL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004006; Xiao XL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-72	70	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0164546	10.1371/journal.pone.0164546	http://dx.doi.org/10.1371/journal.pone.0164546			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798635	Green Submitted, gold, Green Published			2022-12-26	WOS:000386711100010
J	Madi, H; Lukic, J; Vasiljevic, Z; Biocanin, M; Kojic, M; Jovcic, B; Lozo, J				Madi, Haowa; Lukic, Jovanka; Vasiljevic, Zorica; Biocanin, Marjan; Kojic, Milan; Jovcic, Branko; Lozo, Jelena			Genotypic and Phenotypic Characterization of Stenotrophomonas maltophilia Strains from a Pediatric Tertiary Care Hospital in Serbia	PLOS ONE			English	Article							OPPORTUNISTIC PATHOGEN; ANTIBIOTIC-RESISTANCE; BIOFILM FORMATION; VIRULENCE; GENES; SUSCEPTIBILITY; INFECTION; ADHERENCE; MOTILITY	Background Stenotrophomonas maltophilia is an environmental bacterium and an opportunistic pathogen usually associated with healthcare-associated infections, which has recently been recognized as a globally multi-drug resistant organism. The aim of this study was genotyping and physiological characterization of Stenotrophomonas maltophilia isolated in a large, tertiary care pediatric hospital in Belgrade, Serbia, hosting the national reference cystic fibrosis (CF) center for pediatric and adult patients. Methods We characterized 42 strains of cystic fibrosis (CF) and 46 strains of non-cystic fibrosis (non-CF) origin isolated from 2013 to 2015 in order to investigate their genetic relatedness and phenotypic traits. Genotyping was performed using sequencing of 16S rRNA gene, Pulse Field Gel Electrophoresis (PFGE) and Multi locus sequencing typing (MLST) analysis. Sensitivity to five relevant antimicrobial agents was determined, namely trimethoprim/sulfamethoxazole (TMP/SMX), chloramphenicol, ciprofloxacin, levofloxacin and tetracycline. Surface characteristics, motility, biofilm formation and adhesion to mucin were tested in all strains. Statistical approach was used to determine correlations between obtained results. Results Most of the isolates were not genetically related. Six new sequence types were determined. Strains were uniformly sensitive to all tested antimicrobial agents. The majority of isolates (89.8%) were able to form biofilm with almost equal representation in both CF and non-CF strains. Swimming motility was observed in all strains, while none of them exhibited swarming motility. Among strains able to adhere to mucin, no differences between CF and non-CF isolates were observed. Conclusions High genetic diversity among isolates implies the absence of clonal spread within the hospital. Positive correlation between motility, biofilm formation and adhesion to mucin was demonstrated. Biofilm formation and motility were more pronounced among non-CF than CF isolates.	[Madi, Haowa; Lukic, Jovanka; Biocanin, Marjan; Kojic, Milan; Jovcic, Branko; Lozo, Jelena] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Vasiljevic, Zorica] Inst Mother & Child Hlth Care Serbia Dr Vukan Cup, Belgrade, Serbia; [Jovcic, Branko; Lozo, Jelena] Univ Belgrade, Fac Biol, Belgrade, Serbia	University of Belgrade; University of Belgrade	Lozo, J (corresponding author), Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia.; Lozo, J (corresponding author), Univ Belgrade, Fac Biol, Belgrade, Serbia.	jlozo@bio.bg.ac.rs	Lukic, Jovanka/HHS-0787-2022; Vasiljevic, Zorica V/J-8389-2016; Lozo, Jelena/R-7354-2018; Lukic, Jovanka/AAU-9006-2020; Kojic, Milan/I-4528-2019	Lukic, Jovanka/0000-0002-4959-2057; Vasiljevic, Zorica V/0000-0002-8864-1325; Lozo, Jelena/0000-0001-9888-5270; Kojic, Milan/0000-0001-5645-750X; Jovcic, Branko/0000-0002-9500-3786	Ministry of Education, Science and Technological Development of the Republic of Serbia [173019]	Ministry of Education, Science and Technological Development of the Republic of Serbia	The Ministry of Education, Science and Technological Development of the Republic of Serbia, Grant No. 173019 supported this work. The funder had no role in study design, data collection and analysis, decision to publish and or preparation of the manuscript.	Abbott IJ, 2011, EXPERT REV ANTI-INFE, V9, P471, DOI [10.1586/eri.11.24, 10.1586/ERI.11.24]; Balcazar JL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01216; Begovic J, 2010, CENT EUR J BIOL, V5, P103, DOI 10.2478/s11535-009-0078-1; Berrazeg M., 2014, EURO SURVEILL, V19; Brooke JS, 2014, EXPERT REV ANTI-INFE, V12, P1, DOI 10.1586/14787210.2014.864553; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; CLSI, 2015, M100S25 CLSI, V35; de Oliveira-Garcia D, 2003, CELL MICROBIOL, V5, P625, DOI 10.1046/j.1462-5822.2003.00306.x; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Di Bonaventura G, 2010, INFECT IMMUN, V78, P2466, DOI 10.1128/IAI.01391-09; Falagas ME, 2009, EUR J CLIN MICROBIOL, V28, P719, DOI 10.1007/s10096-009-0709-5; Fouhy Y, 2007, J BACTERIOL, V189, P4964, DOI 10.1128/JB.00310-07; Garcia CA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00926; Garcia de Viedma D, 1999, INFECT CONT HOSP EP, V20, P816, DOI 10.1086/501590; Hart CA, 2002, BRIT MED BULL, V61, P81, DOI 10.1093/bmb/61.1.81; Hu LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157693; Huang TP, 2006, J BACTERIOL, V188, P3116, DOI 10.1128/JB.188.8.3116-3120.2006; Jovcic B, 2011, ANTIMICROB AGENTS CH, V55, P3929, DOI 10.1128/AAC.00226-11; Juhasz E, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/s12941-014-0058-9; Kaiser S, 2009, J BACTERIOL, V191, P2934, DOI 10.1128/JB.00892-08; Lin YT, 2015, ANTIMICROB AGENTS CH, V59, P4067, DOI 10.1128/AAC.00372-15; Masgala Aikaterini, 2010, Central European Journal of Public Health, V18, P119; McKay GA, 2003, INFECT IMMUN, V71, P3068, DOI 10.1128/IAI.71.6.3068-3075.2003; Munoz-Provencio D, 2009, ARCH MICROBIOL, V191, P153, DOI 10.1007/s00203-008-0436-9; Novovic K, 2016, MICROB DRUG RESIST, V22, P707, DOI 10.1089/mdr.2015.0264; Pompilio A, 2008, FEMS MICROBIOL LETT, V287, P41, DOI 10.1111/j.1574-6968.2008.01292.x; Pompilio- A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00951; Pompilio A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-159; Rutter WC, 2016, MICROB DRUG RESIST; Samonis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037375; Sanchez MB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00658; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Toleman MA, 2007, EMERG INFECT DIS, V13, P559, DOI 10.3201/eid1304.061378; Valdezate S, 2004, J CLIN MICROBIOL, V42, P693, DOI 10.1128/JCM.42.2.693-699.2003; Zgair AK, 2011, J MED MICROBIOL, V60, P1032, DOI 10.1099/jmm.0.026377-0; Zheng L, 2016, APPL ENVIRON MICROB, V82, P2444, DOI 10.1128/AEM.03951-15	36	25	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165660	10.1371/journal.pone.0165660	http://dx.doi.org/10.1371/journal.pone.0165660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798695	gold, Green Submitted, Green Published			2022-12-26	WOS:000386711100052
J	Kinzner, MC; Tratter, M; Bachli, G; Kirchmair, M; Kaufmann, R; Arthofer, W; Schlick-Steiner, BC; Steiner, FM				Kinzner, Martin-Carl; Tratter, Magdalena; Bachli, Gerhard; Kirchmair, Martin; Kaufmann, Ruediger; Arthofer, Wolfgang; Schlick-Steiner, Birgit C.; Steiner, Florian M.			Oviposition Substrate of the Mountain Fly Drosophila nigrosparsa (Diptera: Drosophilidae)	PLOS ONE			English	Article							CLIMATE-CHANGE; COMPETITION; BEHAVIOR; ECOLOGY; PREFERENCE; RANGE; FUNGI	The survival of insect larvae often depends on the mother's choice of oviposition substrate, and thus, this choice is an essential part of an insect species' ecology. Especially species with narrow substrate preferences may suffer from changes in substrate availability triggered by, for example, climate change. Recent climate warming is affecting species directly (e.g., physiology) but also indirectly (e.g., biological interactions) leading to mismatching phenologies and distributions. However, the preferred oviposition substrate is still unknown for many drosophilid species, especially for those at higher elevations. In this study, we investigated the oviposition-substrate preference of the montane-alpine fly Drosophila nigrosparsa in rearing and multiple-choice experiments using natural substrates in the laboratory. Insect emergence from field-collected substrates was tested. More than 650 insects were reared from natural substrates, among them 152 drosophilids but no individual of D. nigrosparsa. In the multiple-choice experiments, D. nigrosparsa preferred ovipositing on mushrooms (> 93% of eggs); additionally, a few eggs were laid on berries but none on other substrates such as cow faeces, rotten plant material, and soil. The flies laid 24 times more eggs per day when mushrooms were included in the substrates than when they were excluded. We infer that D. nigrosparsa is a mushroom breeder with some variation in oviposition choice. The flies favoured some mushrooms over others, but they were not specialised on a single fungal taxon. Although it is unclear if and how climate change will affect D. nigrosparsa, our results indicate that this species will not be threatened by oviposition-substrate limitations in the near future because of the broad altitudinal distribution of the mushrooms considered here, even if the flies will have to shift upwards to withstand increasing temperatures.	[Kinzner, Martin-Carl; Tratter, Magdalena; Kaufmann, Ruediger; Arthofer, Wolfgang; Schlick-Steiner, Birgit C.; Steiner, Florian M.] Univ Innsbruck, Inst Ecol, Innsbruck, Austria; [Bachli, Gerhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Kirchmair, Martin] Univ Innsbruck, Inst Microbiol, Innsbruck, Austria	University of Innsbruck; University of Zurich; University of Innsbruck	Kinzner, MC (corresponding author), Univ Innsbruck, Inst Ecol, Innsbruck, Austria.	kinzner@gmail.com		Kinzner, Martin-Carl/0000-0001-5195-4048; Schlick-Steiner, Birgit/0000-0003-4026-5778; Bachli, Gerhard/0000-0002-8402-176X; Steiner, Florian M./0000-0003-2414-4650	University of Innsbruck; Austrian Science Fund (FWF) [P23949]; Austrian Science Fund (FWF) [P 23949] Funding Source: researchfish	University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by the University of Innsbruck and the Austrian Science Fund (FWF, http://www.fwf.ac.at/) under grant P23949 awarded to FMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthofer W, 2015, MOL ECOL RESOUR, V15, P228, DOI 10.1111/1755-0998.12340; Ashburner M., 2004, DROSOPHILA LAB HDB; Bachli G, 1985, DIPTERA DROSOPHILIDA; BEGON M, 1975, OECOLOGIA, V20, P255, DOI 10.1007/BF00347477; Boddy L, 2014, FUNGAL ECOL, V10, P20, DOI 10.1016/j.funeco.2013.10.006; Buntgen U, 2013, GLOBAL CHANGE BIOL, V19, P2785, DOI 10.1111/gcb.12263; BURLA H, 1991, Z ZOOL SYST EVOL, V29, P97; BURLA H, 1968, Vierteljahrsschrift der Naturforschenden Gesellschaft in Zuerich, V113, P311; Carson H.L., 1971, ECOLOGY DROSOPHILA B; CARSON HL, 1951, ECOLOGY, V32, P317, DOI 10.2307/1930422; Cornelissen T, 2011, NEOTROP ENTOMOL, V40, P155, DOI 10.1590/S1519-566X2011000200001; GRIMALDI D, 1984, ECOLOGY, V65, P1113, DOI 10.2307/1938319; HEED WB, 1965, SCIENCE, V149, P758, DOI 10.1126/science.149.3685.758; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hoffmeister TS, 2001, EVOL ECOL RES, V3, P37; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Kernaghan G, 2001, ECOGRAPHY, V24, P181, DOI 10.1034/j.1600-0587.2001.240208.x; KIMURA M T, 1977, Kontyu, V45, P571; Knudsen H, 2008, FUNGA NORDICA AGARIC; Korner C, 2003, ALPINE PLANT LIFE FU, V2e; Lakovaara S, 1969, DROSOPH INF SERV, V128; Law GR, 1997, ENTOMOLOGIST; LoPresti EF, 2016, B ECOL SOC AM, V97, P305, DOI [10.1002/bes2.1239, DOI 10.1002/BES2.1239]; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Markow TA, 2015, ELIFE, V4, DOI 10.7554/eLife.06793; Mayhew PJ, 2001, TRENDS ECOL EVOL, V16, P165, DOI 10.1016/S0169-5347(00)02099-1; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Merrill RM, 2008, J ANIM ECOL, V77, P145, DOI 10.1111/j.1365-2656.2007.01303.x; Mitchell JC, 2014, HERPETOL CONSERV BIO, V9, P495; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Putman A.I., 2013, MOL ECOL RESOUR, V13, P966, DOI DOI 10.1111/1755-0998.12140; R Core Team, 2021, R LANGUAGE ENV STAT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Schweiger O, 2012, GLOBAL ECOL BIOGEOGR, V21, P88, DOI 10.1111/j.1466-8238.2010.00607.x; SHORROCKS B, 1984, NATURE, V310, P310, DOI 10.1038/310310a0; SHORROCKS B, 1979, J ANIM ECOL, V48, P899, DOI 10.2307/4202; SHORROCKS B, 1977, OECOLOGIA, V26, P335, DOI 10.1007/BF00345533; Shorrocks B., 1982, Genetics and Biology of Drosophila, V3b, P385; Steiner FM, 2010, ANT ECOLOGY, P177; Sullivan W., 2000, DROSOPHILA PROTOCOLS; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Tschinkel WR, 2011, MYRMECOL NEWS, V14, P49	50	10	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165743	10.1371/journal.pone.0165743	http://dx.doi.org/10.1371/journal.pone.0165743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788257	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900121
J	Nguyen, HD; Hong, KS; Shin, YI				Nguyen, Hoang-Dung; Hong, Keum-Shik; Shin, Yong-Il			Bundled-Optode Method in Functional Near-Infrared Spectroscopy	PLOS ONE			English	Article							HEMODYNAMIC-RESPONSE; MOTOR CORTEX; OPTICAL-PROPERTIES; BRAIN ACTIVATION; OXYGEN-SATURATION; AUDITORY-CORTEX; TISSUE; RESOLUTION; SOMATOTOPY; MODEL	In this paper, a theory for detection of the absolute concentrations of oxy-hemoglobin (HbO) and deoxy-hemoglobin (HbR) from hemodynamic responses using a bundledoptode configuration in functional near-infrared spectroscopy (fNIRS) is proposed. The proposed method is then applied to the identification of two fingers (i.e., little and thumb) during their flexion and extension. This experiment involves a continuous-wave-type dual-wavelength (760 and 830 nm) fNIRS and five healthy male subjects. The active brain locations of two finger movements are identified based on the analysis of the t- and p-values of the averaged HbOs, which are quite distinctive. Our experimental results, furthermore, revealed that the hemodynamic responses of two-finger movements are different: The mean, peak, and time-to-peak of little finger movements are higher than those of thumb movements. It is noteworthy that the developed method can be extended to 3-dimensional fNIRS imaging.	[Nguyen, Hoang-Dung; Hong, Keum-Shik] Pusan Natl Univ, Dept Cognomech Engn, 2 Busandaehak Ro, Busan 46241, South Korea; [Hong, Keum-Shik] Pusan Natl Univ, Sch Mech Engn, 2 Busandaehak Ro, Busan 46241, South Korea; [Shin, Yong-Il] Pusan Natl Univ, Sch Med, Dept Rehabil Med, 20 Geumo Ro, Yangsan Si 50612, Gyeongsangnam D, South Korea; [Shin, Yong-Il] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, 20 Geumo Ro, Yangsan Si 50612, Gyeongsangnam D, South Korea	Pusan National University; Pusan National University; Pusan National University; Pusan National University; Pusan National University Hospital	Hong, KS (corresponding author), Pusan Natl Univ, Dept Cognomech Engn, 2 Busandaehak Ro, Busan 46241, South Korea.; Hong, KS (corresponding author), Pusan Natl Univ, Sch Mech Engn, 2 Busandaehak Ro, Busan 46241, South Korea.	kshong@pusan.ac.kr	Hong, Keum-Shik/B-9911-2013	Hong, Keum-Shik/0000-0002-8528-4457	Mid-Career Researcher Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [NRF-2014R1A2A1A10049727]; Convergence Technology Development Program for Bionic Arm through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [2016M3C1B2912986]	Mid-Career Researcher Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea; Convergence Technology Development Program for Bionic Arm through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea	This research was supported by the Mid-Career Researcher Program (grant no. NRF-2014R1A2A1A10049727) and the Convergence Technology Development Program for Bionic Arm (grant no. 2016M3C1B2912986) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Aqil M, 2012, NEUROIMAGE, V63, P553, DOI 10.1016/j.neuroimage.2012.07.006; Barker JW, 2014, BIOMED OPT EXPRESS, V5, P4300, DOI 10.1364/BOE.5.004300; Beisteiner R, 2001, NEUROIMAGE, V13, P1016, DOI 10.1006/nimg.2000.0737; Bhutta MR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00709; Bhutta MR, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4865124; Boas DA, 2004, OPT LETT, V29, P1506, DOI 10.1364/OL.29.001506; Cui X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015474; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; Dechent P, 2003, HUM BRAIN MAPP, V18, P272, DOI 10.1002/hbm.10084; Dehaes M, 2011, BIOMED OPT EXPRESS, V2, P552, DOI 10.1364/BOE.2.000552; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Diedrichsen J, 2013, CEREB CORTEX, V23, P1362, DOI 10.1093/cercor/bhs120; Dura-Bernal S, 2015, FRONT NEUROROBOTICS, V9, DOI 10.3389/fnbot.2015.00013; Everdell NL, 2013, MED ENG PHYS, V35, P1692, DOI 10.1016/j.medengphy.2013.04.011; FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777; Gagnon L, 2012, NEUROIMAGE, V59, P2518, DOI 10.1016/j.neuroimage.2011.08.095; Habermehl C, 2012, NEUROIMAGE, V59, P3201, DOI 10.1016/j.neuroimage.2011.11.062; Haeussinger FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026377; Hallacoglu B, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.081406; Nguyen HD, 2016, BIOMED OPT EXPRESS, V7, P3491, DOI 10.1364/BOE.7.003491; Hong KS, 2016, INT J NEURAL SYST, V26, DOI 10.1142/S012906571650012X; Hong KS, 2016, HEARING RES, V333, P157, DOI 10.1016/j.heares.2016.01.009; Hong KS, 2015, NEUROSCI LETT, V587, P87, DOI 10.1016/j.neulet.2014.12.029; Hong KS, 2014, BIOMED OPT EXPRESS, V5, P1778, DOI 10.1364/BOE.5.001778; Hoshi Y, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804911; Hotson G, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026017; Hu XS, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026012; Hu XS, 2011, NEUROSCI LETT, V504, P115, DOI 10.1016/j.neulet.2011.09.011; Hu XS, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-82; Jasdzewski G, 2003, NEUROIMAGE, V20, P479, DOI 10.1016/S1053-8119(03)00311-2; Kamran MA, 2014, NEUROSCI LETT, V580, P130, DOI 10.1016/j.neulet.2014.07.058; Kamran MA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056002; Kek KJ, 2008, OPT EXPRESS, V16, P18173, DOI 10.1364/OE.16.018173; Khan MJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00244; Khan MJ, 2015, BIOMED OPT EXPRESS, V6, P4063, DOI 10.1364/BOE.6.004063; Kleinschmidt A, 1997, EUR J NEUROSCI, V9, P2178, DOI 10.1111/j.1460-9568.1997.tb01384.x; Kocaturk M, 2015, FRONT NEUROROBOTICS, V9, DOI 10.3389/fnbot.2015.00008; Laughner JI, 2012, AM J PHYSIOL-HEART C, V303, pH753, DOI 10.1152/ajpheart.00404.2012; Leung TS, 2006, PHYS MED BIOL, V51, P703, DOI 10.1088/0031-9155/51/3/015; Matcher SJ, 1997, APPL OPTICS, V36, P386, DOI 10.1364/AO.36.000386; Meier JD, 2008, J NEUROPHYSIOL, V100, P1800, DOI 10.1152/jn.90531.2008; Naseer Noman, 2015, Front Hum Neurosci, V9, P3, DOI 10.3389/fnhum.2015.00003; Naseer N, 2015, J NEAR INFRARED SPEC, V23, P23, DOI 10.1255/jnirs.1145; Naseer N, 2014, EXP BRAIN RES, V232, P555, DOI 10.1007/s00221-013-3764-1; Naseer N, 2013, NEUROSCI LETT, V553, P84, DOI 10.1016/j.neulet.2013.08.021; Ntziachristos V, 1999, REV SCI INSTRUM, V70, P193, DOI 10.1063/1.1149565; Olman CA, 2012, HUM BRAIN MAPP, V33, P1594, DOI 10.1002/hbm.21310; Penfield W, 1950, CEREBRAL CORTEX MAN; Rao SM, 1996, J CEREBR BLOOD F MET, V16, P1250, DOI 10.1097/00004647-199611000-00020; Saager RB, 2011, NEUROIMAGE, V55, P1679, DOI 10.1016/j.neuroimage.2011.01.043; Santosa H, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00418; Santosa H, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4812785; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; Scholkmann F, 2014, PHYSIOL MEAS, V35, P717, DOI 10.1088/0967-3334/35/4/717; Shah ASM, 2014, ASIA MODEL SYMP AMS, P187, DOI 10.1109/AMS.2014.44; Strangman GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066319; Suzuki H, 2011, ADV MATER RES-SWITZ, V222, P309, DOI 10.4028/www.scientific.net/AMR.222.309; Suzuki S, 1999, P SOC PHOTO-OPT INS, V3597, P582, DOI 10.1117/12.356862; Taga G, 2007, NEUROIMAGE, V38, P452, DOI 10.1016/j.neuroimage.2007.07.050; Tam ND, 2014, J BIOMED ENG MED IMA, V1, P18, DOI [10.14738/jbemi.12.146, DOI 10.14738/JBEMI.12.146]; Teng YC, 2008, PROG NAT SCI-MATER, V18, P1083, DOI 10.1016/j.pnsc.2008.01.035; Tidoni E, 2014, FRONT NEUROROBOTICS, V8, DOI 10.3389/fnbot.2014.00020; Tuchin VV, 1997, USP FIZ NAUK+, V167, P517, DOI 10.1070/PU1997v040n05ABEH000236; Urgen BA, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00019; Valipour A, 2002, EUR RESPIR J, V20, P444, DOI 10.1183/09031936.02.00265702; Ward LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125012; Welvaert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077089; Yamada T, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275469; Yue GH, 2000, BRAIN RES, V856, P291, DOI 10.1016/S0006-8993(99)02385-9	71	59	59	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165146	10.1371/journal.pone.0165146	http://dx.doi.org/10.1371/journal.pone.0165146			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788178	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900048
J	Norahmad, NA; Razak, MRMA; Abdullah, NR; Sastu, UR; Imwong, M; Muniandy, PK; Saat, MNF; Muhammad, A; Jelip, J; Tikuson, M; Yusof, N; Rundi, C; Mudin, RN; Mohamed, AFS				Norahmad, Nor Azrina; Razak, Mohd Ridzuan Mohd Abd; Abdullah, Noor Rain; Sastu, Umi Rubiah; Imwong, Mallika; Muniandy, Prem Kumar; Saat, Muhammad Nor Farhan; Muhammad, Amirrudin; Jelip, Jenarun; Tikuson, Moizin; Yusof, Norsalleh; Rundi, Christina; Mudin, Rose Nani; Mohamed, Ami Fazlin Syed			Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia	PLOS ONE			English	Article							LEVEL CHLOROQUINE RESISTANCE; SULFADOXINE-PYRIMETHAMINE; DIHYDROFOLATE-REDUCTASE; DIHYDROPTEROATE SYNTHASE; TREATMENT RESPONSE; POINT MUTATIONS; PFMDR1 GENE; DHPS GENES; PFCRT; MEFLOQUINE	Chloroquine (CQ) and fansidar (sulphadoxine-pyrimethamine, SP) were widely used for treatment of Plasmodium falciparum for several decades in Malaysia prior to the introduction of Artemisinin-based Combination Therapy (ACT) in 2008. Our previous study in Kalabakan, located in south-east coast of Sabah showed a high prevalence of resistance to CQ and SP, suggesting the use of the treatment may no longer be effective in the area. This study aimed to provide a baseline data of antimalarial drug resistant markers on P. falciparum isolates in Kota Marudu located in the north-east coast of Sabah. Mutations on genes associated with CQ (pfcrtand pfmdrl) and SP (pfdhps and pfdhfr) were assessed by PCR amplification and restriction fragment length polymorphism. Mutations on the kelch13 marker (K13) associated with artemisinin resistance were determined by DNA sequencing technique. The assessment of pfmdrl copy number variation associated with mefloquine resistant was done by real-time PCR technique. A low prevalence (6.9%) was indicated for both pfcrt K76T and pfmdrl N86Y mutations. All P. falciparum isolates harboured the pfdhps A437G mutation. Prevalence of pfdhfr gene mutations, S108N and 1164L, were 100% and 10.3%, respectively. Combining the different resistant markers, only two isolates were conferred to have CQ and SP treatment failure markers as they contained mutant alleles of pfcrtand pfmdrl together with quintuple pfdhps/pfdhfr mutation (combination of pfdhps A437G+A581G and pfdhfrC59R +S108N+I164L). All P. falciparum isolates carried single copy number of pfmdrl and wild type K13 marker. This study has demonstrated a low prevalence of CQ and SP resistance alleles in the study area. Continuous monitoring of antimalarial drug efficacy is warranted and the findings provide information for policy makers in ensuring a proper malaria control.	[Norahmad, Nor Azrina; Razak, Mohd Ridzuan Mohd Abd; Abdullah, Noor Rain; Sastu, Umi Rubiah; Muniandy, Prem Kumar; Saat, Muhammad Nor Farhan; Muhammad, Amirrudin; Mohamed, Ami Fazlin Syed] Inst Med Res, Herbal Med Res Ctr, Kuala Lumpur, Malaysia; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Jelip, Jenarun] Sabah State Hlth Dept, Sabah Vector Borne Dis Control Programme, Kota Kinabalu, Sabah, Malaysia; [Tikuson, Moizin; Yusof, Norsalleh; Rundi, Christina] Sabah Dist Hlth Off Kota Marudu, Kota Kinabalu, Sabah, Malaysia; [Mudin, Rose Nani] Fed Govt Adm Ctr, Vector Borne Dis Sect, Dis Control Div, Minist Hlth, Putrajaya, Malaysia	Kementerian Kesihatan Malaysia; Mahidol University; Kementerian Kesihatan Malaysia	Norahmad, NA (corresponding author), Inst Med Res, Herbal Med Res Ctr, Kuala Lumpur, Malaysia.	azrina@imr.gov.my	Imwong, Mallika/ABE-6493-2020; Mohd Abd Razak, Mohd Ridzuan/GXZ-7049-2022	Syed Mohamed, Ami Fazlin/0000-0003-2747-951X; Mohd Abd Razak, Mohd Ridzuan/0000-0002-9589-5892	National Institute of Health, Ministry of Health Malaysia	National Institute of Health, Ministry of Health Malaysia(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The source of funding is National Institute of Health, Ministry of Health Malaysia. The sponsor's role is to provide funding for the research only. It is the requirement of the sponsor (funder) that findings from the study should be published.; The authors would like to thank the Director General of Health Malaysia for the permission to publish this paper. We also thank the Director for the Institute for Medical Research (IMR), Kuala Lumpur for her critical review and support in publishing this paper; all the volunteers participating in this study; the officers and staffs of Kota Marudu and Kalabakan Health District Department for their efforts in helping us reaching to the study sites and recruiting the volunteers; and Dr Mallika's lab staffs for their consultation in genotyping and interpretation of data. This study was supported by the National Institute of Health, Ministry of Health Malaysia.	Abd Razak MRM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152415; Abdullah NR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-198; Alam MT, 2011, J INFECT DIS, V203, P220, DOI 10.1093/infdis/jiq038; Anthony TG, 2005, J INFECT DIS, V191, P1558, DOI 10.1086/429338; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Atroosh WM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-251; Babiker HA, 2001, J INFECT DIS, V183, P1535, DOI 10.1086/320195; BARNES DA, 1992, EMBO J, V11, P3067, DOI 10.1002/j.1460-2075.1992.tb05378.x; Basuki S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-135; Centre HI, 2014, MALAYSIA, P1511; Chen NH, 2003, ANTIMICROB AGENTS CH, V47, P3500, DOI 10.1128/AAC.47.11.3500-3505.2003; Cox-Singh J, 2003, INT J PARASITOL, V33, P1545, DOI 10.1016/S0020-7519(03)00199-1; Department of Statistics M, 2011, POP DISTR BAS DEM CH; Division VBDSDC, 2014, MAN GUID MAL MAL; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; Escalante AA, 2015, AM J TROP MED HYG, V93, P79, DOI 10.4269/ajtmh.15-0005; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Hakim SL, 1996, T ROY SOC TROP MED H, V90, P294, DOI 10.1016/S0035-9203(96)90258-8; Imwong M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17412; Jelinek T, 1998, TROP MED INT HEALTH, V3, P605, DOI 10.1046/j.1365-3156.1998.00280.x; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Lau TY, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-445; Maguire JD, 2001, ANN TROP MED PARASIT, V95, P559, DOI 10.1080/00034980120092516; Mendez F, 2002, AM J EPIDEMIOL, V156, P230, DOI 10.1093/aje/kwf030; MONTGOMERY R., 1963, TRANS ROY SOC TROP MED HYG, V57, P409, DOI 10.1016/0035-9203(63)90073-7; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Norahmad NA, 2011, SE ASIAN J TROP MED, V42, P1322; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; PEEL SA, 1994, AM J TROP MED HYG, V51, P648, DOI 10.4269/ajtmh.1994.51.648; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Rundi C, 2011, 3 ANN M AS PAC MAL E; Rungsihirunrat K, 2009, ACTA TROP, V109, P37, DOI 10.1016/j.actatropica.2008.09.011; Setthaudom C, 2011, AM J TROP MED HYG, V85, P606, DOI 10.4269/ajtmh.2011.11-0108; Shorthouse DP, 2010, SIMPLEMAPPR ONLINE T; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Tan Lii Lian, 2014, ScientificWorldJournal, V2014, P935846, DOI 10.1155/2014/935846; Tinto H, 2003, INFECT GENET EVOL, V3, P287, DOI 10.1016/j.meegid.2003.08.002; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0; Vector Borne Disease Control Sector M, 2014, MAL FILAR TECHN M; Wernsdorfer WH, 2003, CURR OPIN INFECT DIS, V16, P553, DOI 10.1097/00001432-200312000-00007; WHO, 2015, WORLD MAL REP 2015	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165515	10.1371/journal.pone.0165515	http://dx.doi.org/10.1371/journal.pone.0165515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788228	gold, Green Published, Green Submitted			2022-12-26	WOS:000389604900100
J	Goglin, SE; Farzaneh-Far, R; Epel, ES; Lin, J; Blackburn, EH; Whooley, MA				Goglin, Sarah E.; Farzaneh-Far, Ramin; Epel, Elissa S.; Lin, Jue; Blackburn, Elizabeth H.; Whooley, Mary A.			Change in Leukocyte Telomere Length Predicts Mortality in Patients with Stable Coronary Heart Disease from the Heart and Soul Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; QUANTITATIVE PCR; ARTERY-DISEASE; IN-VIVO; RISK; TETRAHYMENA; SENESCENCE; ASSOCIATION; AGE	Background Short telomere length independently predicts mortality in patients with coronary heart disease. Whether 5-year change in telomere length predicts subsequent mortality in patients with coronary heart disease has not been evaluated. Methods In a prospective cohort study of 608 individuals with stable coronary artery disease, we measured leukocyte telomere length at baseline and after five years of follow-up. We divided the sample into tertiles of telomere change: shortened, maintained or lengthened. We used Cox survival models to evaluate 5-year change in telomere length as a predictor of mortality. Results During an average of 4.2 years follow-up, there were 149 deaths. Change in telomere length was inversely predictive of all-cause mortality. Using the continuous variable of telomere length change, each standard deviation (325 base pair) greater increase in telomere length was associated with a 24% reduction in mortality (HR 0.76, 95% CI 0.61-0.94; p = 0.01), adjusted for age, sex, waist to hip ratio, exercise capacity, LV ejection fraction, serum creatinine, and year 5 telomere length. Mortality occurred in 39% (79/203) of patients who experienced telomere shortening, 22% (45/203) of patients whose telomere length was maintained, and 12% (25/202) of patients who experienced telomere lengthening (p<0.001). As compared with patients whose telomere length was maintained, those who experienced telomere lengthening were 56% less likely to die (HR 0.44, 95% CI, 0.23-0.87). Conclusions In patients with coronary heart disease, an increase in leukocyte telomere length over 5 years is associated with decreased mortality.	[Goglin, Sarah E.; Whooley, Mary A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Farzaneh-Far, Ramin; Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Lin, Jue] UCSF, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Blackburn, Elizabeth H.; Whooley, Mary A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Whooley, MA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Whooley, MA (corresponding author), Vet Affairs Med Ctr, San Francisco, CA 94121 USA.	Mary.whooley@ucsf.edu		Whooley, Mary/0000-0002-5943-0078	Department of Veteran Affairs (Epidemiology Merit Review Program),Washington, DC; National Heart, Lung, and Blood Institute, Bethesda, Maryland [R01HL-079235]; Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program), Princeton, New Jersey; American Federation for Aging Research (Paul Beeson Faculty Scholars in Aging Research Program), New York, New York; American Heart Association	Department of Veteran Affairs (Epidemiology Merit Review Program),Washington, DC; National Heart, Lung, and Blood Institute, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program), Princeton, New Jersey; American Federation for Aging Research (Paul Beeson Faculty Scholars in Aging Research Program), New York, New York; American Heart Association(American Heart Association)	The Heart and Soul Study was funded by the Department of Veteran Affairs (Epidemiology Merit Review Program),Washington, DC; grant R01HL-079235 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland; the Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program), Princeton, New Jersey; and the American Federation for Aging Research (Paul Beeson Faculty Scholars in Aging Research Program), New York, New York. The telomere measurements were supported by an American Heart Association Fellowship-to-Faculty grant to Dr. Farzaneh-Far. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Aviv A, 2002, J MOL MED, V80, P689, DOI 10.1007/s00109-002-0377-8; Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; D'Mello MJJ, 2015, CIRC-CARDIOVASC GENE, V8, P82, DOI 10.1161/CIRCGENETICS.113.000485; Edo MD, 2005, CARDIOVASC RES, V66, P213, DOI 10.1016/j.cardiores.2004.09.007; Effros RB, 2004, ANN NY ACAD SCI, V1019, P123, DOI 10.1196/annals.1297.022; Epel ES, 2009, AGING-US, V1, P81; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Lan Q, 2009, CLIN CANCER RES, V15, P7429, DOI 10.1158/1078-0432.CCR-09-0845; Lin Y, 2015, CLIN SCI, V128, P367, DOI 10.1042/CS20140481; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Muezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003; Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8; Serrano AL, 2004, CIRC RES, V94, P575, DOI 10.1161/01.RES.0000122141.18795.9C; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Weng NP, 1997, P NATL ACAD SCI USA, V94, P10827, DOI 10.1073/pnas.94.20.10827; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0	33	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0160748	10.1371/journal.pone.0160748	http://dx.doi.org/10.1371/journal.pone.0160748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783614	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800007
J	Kawai, N; He, HS				Kawai, Nobuyuki; He, Hongshen			Breaking Snake Camouflage: Humans Detect Snakes More Accurately than Other Animals under Less Discernible Visual Conditions	PLOS ONE			English	Article							YOUNG-CHILDREN; RECOGNITION; ATTENTION; STIMULI; GRASS; FEAR; PREPAREDNESS; EVOLUTION; PULVINAR; EMOTION	Humans and non-human primates are extremely sensitive to snakes as exemplified by their ability to detect pictures of snakes more quickly than those of other animals. These findings are consistent with the Snake Detection Theory, which hypothesizes that as predators, snakes were a major source of evolutionary selection that favored expansion of the visual system of primates for rapid snake detection. Many snakes use camouflage to conceal themselves from both prey and their own predators, making it very challenging to detect them. If snakes have acted as a selective pressure on primate visual systems, they should be more easily detected than other animals under difficult visual conditions. Here we tested whether humans discerned images of snakes more accurately than those of non-threatening animals (e.g., birds, cats, or fish) under conditions of less perceptual information by presenting a series of degraded images with the Random Image Structure Evolution technique (interpolation of random noise). We find that participants recognize mosaic images of snakes, which were regarded as functionally equivalent to camouflage, more accurately than those of other animals under dissolved conditions. The present study supports the Snake Detection Theory by showing that humans have a visual system that accurately recognizes snakes under less discernible visual conditions.	[Kawai, Nobuyuki; He, Hongshen] Nagoya Univ, Grad Sch Informat Sci, Dept Cognit Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan	Nagoya University	Kawai, N (corresponding author), Nagoya Univ, Grad Sch Informat Sci, Dept Cognit Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	kawai@is.nagoya-u.ac.jp	Kawai, Nobuyuki/M-4902-2014	Kawai, Nobuyuki/0000-0003-0372-1703	Japan Society for the Promotion of Science [25285199, 16H02058]; Grants-in-Aid for Scientific Research [16H02058, 25285199] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	his work was supported by the Japan Society for the Promotion of Science (25285199, 16H02058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COOK EW, 1986, J ABNORM PSYCHOL, V95, P195, DOI 10.1037/0021-843X.95.3.195; Coss RG, 2000, BEHAVIOUR, V137, P315, DOI 10.1163/156853900502105; Coss RG, 2003, EVOLUTIONARY AESTHETICS, P69; Darwin C., 1872, EXPRESS EMOT MAN, DOI DOI 10.1037/10001-000; Etting SF, 2014, ETHOLOGY, V120, P1177, DOI 10.1111/eth.12293; Greene HW, 1997, SNAKES EVOLUTION MYS; Hayakawa S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00080; He HS, 2014, NEUROREPORT, V25, P1049, DOI 10.1097/WNR.0000000000000227; Isbell LA, PRIMATES IN PRESS, DOI [10.1007/s10329-016-0562-y, DOI 10.1007/S10329-016-0562-Y]; Isbell LA, 2009, WHY WE SEE SO WELL; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Kawai N, 2016, J COMP PSYCHOL; Kawai N, 2016, ANIM COGN, V19, P655, DOI 10.1007/s10071-015-0949-y; Lobue V, 2008, PSYCHOL SCI, V19, P284, DOI 10.1111/j.1467-9280.2008.02081.x; Lobue V, 2013, DEV REV, V33, P285, DOI 10.1016/j.dr.2013.07.005; LoBue V, 2011, VIS COGN, V19, P129, DOI 10.1080/13506285.2010.522216; LoBue V, 2010, J EXP CHILD PSYCHOL, V107, P59, DOI 10.1016/j.jecp.2010.04.005; Masataka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015122; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Ohman A, 2007, P NATL ACAD SCI USA, V104, P16396, DOI 10.1073/pnas.0707885104; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Ohman A, 2012, J COGN PSYCHOL, V24, P17, DOI 10.1080/20445911.2011.629603; Pollak SD, 2002, DEV PSYCHOL, V38, P784, DOI 10.1037/0012-1649.38.5.784; Sadr J, 2004, COGNITIVE SCI, V28, P259, DOI 10.1016/j.cogsci.2004.09.003; Shibasaki M, 2011, COGN STUD, V18, P158, DOI DOI 10.11225/JCSS.18.158S; Shibasaki M, 2009, J COMP PSYCHOL, V123, P131, DOI 10.1037/a0015095; Soares SC, 2013, PSYCH J, V2, P11, DOI 10.1002/pchj.18; Soares SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114724; Soares SC, 2009, BEHAV RES THER, V47, P1032, DOI 10.1016/j.brat.2009.07.022; Soares SC, 2012, EVOL PSYCHOL-US, V10, P187, DOI 10.1177/147470491201000202; Vidal N, 2002, J TOXICOL-TOXIN REV, V21, P21, DOI 10.1081/TXR-120004740; Villeneuve MY, 2005, NEUROIMAGE, V28, P474, DOI 10.1016/j.neuroimage.2005.06.015; Wolfe JM, 2001, PERCEPT PSYCHOPHYS, V63, P381, DOI 10.3758/BF03194406	35	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164342	10.1371/journal.pone.0164342	http://dx.doi.org/10.1371/journal.pone.0164342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VE	27783686	gold, Green Published, Green Submitted			2022-12-26	WOS:000389602800035
J	Argenta, A; Satish, L; Gallo, P; Liu, F; Kathju, S				Argenta, Anne; Satish, Latha; Gallo, Phillip; Liu, Fang; Kathju, Sandeep			Local Application of Probiotic Bacteria Prophylaxes against Sepsis and Death Resulting from Burn Wound Infection	PLOS ONE			English	Article							LACTOBACILLUS-PLANTARUM; PSEUDOMONAS-AERUGINOSA; SILVER SULFADIAZINE; POTENTIAL USE; IN-VITRO; SUPERNATANTS; THERAPY; PATIENT; MECHANISMS; BIOFILMS	Objective To determine if local prophylactic application of probiotic bacteria to burn wounds will prevent death in a mouse model of burn wound sepsis. Background Infection remains the most common complication after burn injury and can result in sepsis and death, despite the use of topical and systemic antibiotics. Pseudomonas aeruginosa is a frequently implicated pathogen. Local application of probiotics directly to burn wounds is an attractive novel intervention that avoids the pitfalls of standard antibiotic therapies. Methods A burn-sepsis model was established using a sub-eschar injection of bioluminescent P. aeruginosa; infection was tracked using a charge-coupled camera. Full-thickness burn injuries were placed on the dorsums of adult mice; the injured sites were then treated with vehicle (burn wound control), probiotics (Lactobacillus plantarum only), pathogenic bacteria (Pseudomonas aeruginosa only), or probiotics plus pathogen (Lactobacillus plus Pseudomonas). Animals were monitored until death/moribundity or for one week, then sacrificed. Harvested tissues were subjected to imaging and molecular assays. Results Control and probiotic-only animals showed no mortality (100% survival) at one week. Pseudomonas-only animals showed > 90% mortality within 40 hours of infection. In contrast, animals treated with probiotics plus Pseudomonas showed less than 10% mortality. Use of bioluminescent Pseudomonas bacteria demonstrated that probiotic therapy inhibited septicemic accumulation of the pathogen in remote organs. In addition, probiotic therapy successfully suppressed the infection-dependent induction of TNF-alpha and interleukins 6 and 10 in the liver. Conclusions Local probiotic therapy shows great potential as a valuable adjunct in the management of complicated burn injury.	[Argenta, Anne; Satish, Latha; Gallo, Phillip; Liu, Fang; Kathju, Sandeep] Univ Pittsburgh, Med Ctr, Dept Plast Surg, Pittsburgh, PA 15260 USA; [Satish, Latha; Kathju, Sandeep] McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kathju, S (corresponding author), Univ Pittsburgh, Med Ctr, Dept Plast Surg, Pittsburgh, PA 15260 USA.; Kathju, S (corresponding author), McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.	kathjus@upmc.edu	Latha, Satish/AAH-4977-2019	Latha, Satish/0000-0003-0154-7094	Armed Forces Institute of Regenerative Medicine [W81XWH-08-2-003]; National Cancer Institute [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	Armed Forces Institute of Regenerative Medicine; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant from the Armed Forces Institute of Regenerative Medicine (W81XWH-08-2-003). This project made use of University of Pittsburgh Cancer Institute facilities that were supported in part by National Cancer Institute award P30CA047904.	Alhede M, 2014, ADV APPL MICROBIOL, V86, P1, DOI 10.1016/B978-0-12-800262-9.00001-9; Bang RL, 2002, BURNS, V28, P746, DOI 10.1016/S0305-4179(02)00183-3; Brachkova MI, 2012, AAPS PHARMSCITECH, V13, P357, DOI 10.1208/s12249-012-9753-z; Branski LK, 2009, SURG INFECT, V10, P389, DOI 10.1089/sur.2009.024; Chaby G, 2005, ANN DERMATOL VENER, V132, P891, DOI 10.1016/S0151-9638(05)79509-0; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Cook G, 2000, INT J ANTIMICROB AG, V13, P169, DOI 10.1016/S0924-8579(99)00120-X; Cutting Keith, 2007, Int Wound J, V4, P177, DOI 10.1111/j.1742-481X.2007.00338.x; D'Avignon LC, 2010, BURNS, V36, P773, DOI 10.1016/j.burns.2009.11.007; De Groote MA, 2005, PEDIATR INFECT DIS J, V24, P278, DOI 10.1097/01.inf.0000154588.79356.e6; de LeBlanc AD, 2010, INT J FOOD MICROBIOL, V138, P223, DOI 10.1016/j.ijfoodmicro.2010.01.020; Earley ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129996; FOX CL, 1968, ARCH SURG-CHICAGO, V96, P184; Fujita K, 1981, BMJ-BRIT MED J, V18, P219; Gomez R, 2009, J AM COLL SURGEONS, V208, P348, DOI 10.1016/j.jamcollsurg.2008.11.012; Gouriet F, 2012, EUR J CLIN MICROBIOL, V31, P2469, DOI 10.1007/s10096-012-1599-5; Hall-Stoodley L, 2012, FEMS IMMUNOL MED MIC, V65, P127, DOI 10.1111/j.1574-695X.2012.00968.x; Kennedy P, 2010, BURNS, V36, P49, DOI 10.1016/j.burns.2009.02.017; Kohler GA, 2012, INFECT DIS OBSTET GY, V2012; Koren L, 2007, BURNS, V33, P594, DOI 10.1016/j.burns.2006.09.007; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Lee HS, 2008, INT IMMUNOPHARMACOL, V8, P574, DOI 10.1016/j.intimp.2008.01.009; Liu YJ, 2011, IEEE SYS MAN CYBERN, P2011, DOI 10.1109/ICSMC.2011.6083967; Matsumoto T, 2008, J APPL MICROBIOL, V104, P672, DOI 10.1111/j.1365-2672.2007.03593.x; Medina M, 2008, MICROBIOL IMMUNOL, V52, P399, DOI 10.1111/j.1348-0421.2008.00050.x; Mehta A, 2013, BONE MARROW TRANSPL, V48, P461, DOI 10.1038/bmt.2012.153; Moore J E, 2002, Commun Dis Public Health, V5, P23; Morgan SD, 2009, UROL RES, V37, P89, DOI 10.1007/s00240-009-0176-6; Moriarty TF, 2007, BRIT J BIOMED SCI, V64, P101, DOI 10.1080/09674845.2007.11732766; Peral MC, 2009, INT WOUND J, V6, P73, DOI 10.1111/j.1742-481X.2008.00577.x; Puertollano E, 2009, J APPL MICROBIOL, V106, P1194, DOI 10.1111/j.1365-2672.2008.04086.x; Ramos AN, 2010, INT IMMUNOPHARMACOL, V10, P247, DOI 10.1016/j.intimp.2009.11.007; Ramos AN, 2012, WOUND REPAIR REGEN, V20, P552, DOI 10.1111/j.1524-475X.2012.00798.x; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; Ryssel H, 2010, WOUND REPAIR REGEN, V18, P439, DOI 10.1111/j.1524-475X.2010.00610.x; Satish L, 2010, CELL STRESS CHAPERON, V15, P819, DOI 10.1007/s12192-010-0190-1; Satish L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010063; Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Trop M, 2006, J TRAUMA, V60, P648, DOI 10.1097/01.ta.0000208126.22089.b6; Vahabnezhad E, 2013, J CLIN GASTROENTEROL, V47, P437, DOI 10.1097/MCG.0b013e318279abf0; Valdez JC, 2005, CLIN MICROBIOL INFEC, V11, P472, DOI 10.1111/j.1469-0691.2005.01142.x; Williams FN, 2009, CRIT CARE, V13, DOI 10.1186/cc8170	43	42	44	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165294	10.1371/journal.pone.0165294	http://dx.doi.org/10.1371/journal.pone.0165294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780258	Green Submitted, gold, Green Published			2022-12-26	WOS:000389046900043
J	Kim, SH; Lee, EJ; Han, JC; Sohn, SW; Rhee, T; Kee, C				Kim, Seung Hoon; Lee, Eun Jung; Han, Jong Chul; Sohn, Sae Woon; Rhee, Taekkwan; Kee, Changwon			The Effect of Diurnal Fluctuation in Intraocular Pressure on the Evaluation of Risk Factors of Progression in Normal Tension Glaucoma	PLOS ONE			English	Article							OCULAR HYPERTENSION; TRIAL	Purpose To investigate whether diurnal fluctuation in intraocular pressure (IOP) can influence the result of the correlations between IOP-related factors and progression of normal tension glaucoma (NTG). Methods Glaucoma progression was defined as visual field (VF) progression and changes in the optic disc and/or retinal nerve fiber layer (RNFL). Two different methods were used to evaluate the impact of the diurnal fluctuation in IOP. 'Conventional method' used in previous studies included all IOP measurements during the follow up time. 'Time adjusted method' was used to adjust diurnal fluctuation in IOP with the preferred time. Mean IOP, long term IOP fluctuation and the difference between the lowest and highest IOP were calculated using both methods. Cox regression analyses were performed to evaluate the association between IOP-related factors and NTG progression. Results One hundred and forty eyes of 140 patients with NTG were included in this study. 41% (58 of 140 eyes) of eyes underwent NTG progression. Long term IOP variation calculated by conventional method was not a significant risk factor for NTG progression (hazard ratio [HR], 0.311; 95% confidence interval[CI], 0.056-1.717; P= 0.180). Long term IOP variation calculated by time adjusted method, however, was related to progression, with an HR of 5.260 (95% CI,1.191-23.232; P = 0.029). Conclusion Although having the same IOP-related factors, if diurnal fluctuation is included, different results may be found on the relationship between IOP-related factors and NTG progression. Based on our results, diurnal fluctuation in IOP should be considered when IOP-related factors are studied in the future.	[Kim, Seung Hoon; Lee, Eun Jung; Han, Jong Chul; Sohn, Sae Woon; Rhee, Taekkwan; Kee, Changwon] Sungkyunkwan Univ, Sch Med, Dept Ophthalmol, Samsung Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kee, C (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Ophthalmol, Samsung Med Ctr, Seoul, South Korea.	ckee@skku.edu		Kim, Seung Hoon/0000-0002-7704-6213; Kee, Changwon/0000-0002-7419-0316				Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Arnalich-Montiel F, 2009, GRAEF ARCH CLIN EXP, V247, P391, DOI 10.1007/s00417-008-0986-1; Bagga H, 2009, CURR OPIN OPHTHALMOL, V20, P79, DOI 10.1097/ICU.0b013e32831eef4f; Bengtsson B, 2007, OPHTHALMOLOGY, V114, P205, DOI 10.1016/j.ophtha.2006.07.060; DAVID R, 1992, BRIT J OPHTHALMOL, V76, P280, DOI 10.1136/bjo.76.5.280; DEVIVERO C, 1994, EYE, V8, P521, DOI 10.1038/eye.1994.129; Fogagnolo P, 2009, INVEST OPHTH VIS SCI, V50, P2209, DOI 10.1167/iovs.08-2889; Fukuchi T, 2013, J GLAUCOMA, V22, P689, DOI 10.1097/IJG.0b013e318264b779; GIUFFRE G, 1995, ACTA OPHTHALMOL SCAN, V73, P222; Hasegawa K, 2006, JPN J OPHTHALMOL, V50, P449, DOI 10.1007/s10384-006-0343-z; Hughes E, 2003, J GLAUCOMA, V12, P232, DOI 10.1097/00061198-200306000-00009; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim Yong-Kyu, 2010, Korean J Ophthalmol, V24, P23, DOI 10.3341/kjo.2010.24.1.23; KITAZAWA Y, 1975, AM J OPHTHALMOL, V79, P557, DOI 10.1016/0002-9394(75)90792-8; Lee PP, 2007, AM J OPHTHALMOL, V144, P901, DOI 10.1016/j.ajo.2007.07.040; Leidl MC, 2014, BRIT J OPHTHALMOL, V98, P1315, DOI 10.1136/bjophthalmol-2013-303980; Leske MC, 1999, OPHTHALMOLOGY, V106, P2144, DOI 10.1016/S0161-6420(99)90497-9; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Medeiros FA, 2008, OPHTHALMOLOGY, V115, P934, DOI 10.1016/j.ophtha.2007.08.012; Musch DC, 2011, OPHTHALMOLOGY, V118, P1766, DOI 10.1016/j.ophtha.2011.01.047; Naito T, 2015, CLIN OPHTHALMOL, V9, P1373, DOI 10.2147/OPTH.S86450; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Sihota R., 2005, Indian Journal of Ophthalmology, V53, P243; Sit Arthur J., 2009, Molecular & Cellular Biomechanics, V6, P57; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wilensky J T, 1991, Trans Am Ophthalmol Soc, V89, P757; Xi Xiao Rong, 1996, JPMA (Journal of the Pakistan Medical Association), V46, P171; YAMAGAMI J, 1993, OPHTHALMOLOGY, V100, P643	28	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164876	10.1371/journal.pone.0164876	http://dx.doi.org/10.1371/journal.pone.0164876			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776182	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200024
J	Pan, XY; Zhao, W; Wang, CY; Lin, J; Zeng, XY; Ren, RX; Wang, K; Xun, TR; Shai, Y; Liu, SW				Pan, Xiao-Yan; Zhao, Wei; Wang, Chun-Yan; Lin, Jian; Zeng, Xiao-Yun; Ren, Ru-Xia; Wang, Keng; Xun, Tian-Rong; Shai, Yechiel; Liu, Shu-Wen			Heat Shock Protein 90 Facilitates Latent HIV Reactivation through Maintaining the Function of Positive Transcriptional Elongation Factor b (p-TEFb) under Proteasome Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; GENE-EXPRESSION; REPLICATION; INFECTION	The persistence of HIV in resting memory CD4(+) T cells at a latent state is considered as the major barrier on the path to achieve a cure for HIV. Proteasome inhibitors (PIs) were previously reported as latency reversing agents (LRAs) but the mechanism underlying this function is yet unclear. Here we demonstrate that PIs reactivate latent HIV ex vivo without global T cell activation, and may facilitate host innate immune responses. Mechanistically, latent HIV reactivation induced by PIs is mediated by heat shock factor 1 (HSF1) via the recruitment of the heat shock protein (HSP) 90-positive transcriptional elongation factor b (p-TEFb) complex. Specifically, HSP90 downstream HSF1 gives positive feedback to the reactivation process through binding to cyclin-dependent kinase 9 (CDK9) and preventing it from undergoing degradation by the proteasome. Overall, these findings suggest proteasome inhibitors as potential latency reversing agents. In addition, HSF1/HSP90 involved in HIV transcription elongation, may serve as therapeutic targets in HIV eradication.	[Pan, Xiao-Yan; Zhao, Wei; Lin, Jian; Zeng, Xiao-Yun; Ren, Ru-Xia; Wang, Keng; Xun, Tian-Rong; Liu, Shu-Wen] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab Drug Screening, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Chun-Yan] Southern Med Univ, Nanfang Hosp, Dept Clin Lab, Guangzhou 510515, Guangdong, Peoples R China; [Shai, Yechiel] Weizmann Inst Sci, Dept Biochem, IL-76100 Rehovot, Israel; [Liu, Shu-Wen] Southern Med Univ, Guangdong Prov Inst Nephrol, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Weizmann Institute of Science; Southern Medical University - China	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biochem, IL-76100 Rehovot, Israel.; Liu, SW (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.	Yechiel.Shai@weizmann.ac.il; liusw@smu.edu.cn	Pan, Xiaoyan/AAN-1582-2020	Liu, Shuwen/0000-0001-6346-5006	Natural Science Foundation of China [31370781]; National SAMP;T Key Special Foundation [2014ZX09509001-004]; Natural Science Foundation of Guangdong Province [S2011020005207]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National SAMP;T Key Special Foundation; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by Natural Science Foundation of China Grant 31370781, National S&T Key Special Foundation Grant 2014ZX09509001-004, and Natural Science Foundation of Guangdong Province Grant S2011020005207 (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson I, 2014, P NATL ACAD SCI USA, V111, pE1528, DOI 10.1073/pnas.1320178111; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; Borsa M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0298-0; Bruner KM, 2015, TRENDS MICROBIOL, V23, P192, DOI 10.1016/j.tim.2015.01.013; Budhiraja S, 2013, FUTURE VIROL, V8, P649, DOI [10.2217/fvl.13.52, 10.2217/FVL.13.52]; Chan JKL, 2011, CURR OPIN HIV AIDS, V6, P12, DOI 10.1097/COH.0b013e32834124fd; Chen IY, 2015, TRENDS MICROBIOL, V23, P55, DOI 10.1016/j.tim.2014.09.007; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Egger L, 2007, CELL DEATH DIFFER, V14, P1172, DOI 10.1038/sj.cdd.4402125; Hsu HT, 2014, J IMMUNOL, V192, P4957, DOI 10.4049/jimmunol.1300631; Itzen F, 2014, NUCLEIC ACIDS RES, V42, P7577, DOI 10.1093/nar/gku449; Jiang GC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005066; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Joshi P, 2016, J BIOL CHEM, V291, P10332, DOI 10.1074/jbc.M116.717538; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Kumar M, 2005, J BIOL CHEM, V280, P40041, DOI 10.1074/jbc.M508904200; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Miller LK, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-120; Mitchell S, 2016, WIRES SYST BIOL MED, V8, P227, DOI 10.1002/wsbm.1331; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Olesen R, 2015, J VIROL, V89, P10176, DOI 10.1128/JVI.01484-15; Pan XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26294; Rawat P, 2011, NUCLEIC ACIDS RES, V39, P5879, DOI 10.1093/nar/gkr198; Roesch F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002792; Scherz-Shouval R, 2014, CELL, V158, P564, DOI 10.1016/j.cell.2014.05.045; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Sreedhar AS, 2004, BBA-PROTEINS PROTEOM, V1697, P233, DOI 10.1016/j.bbapap.2003.11.027; Wheeler DS, 2003, BIOCHEM BIOPH RES CO, V301, P54, DOI 10.1016/S0006-291X(02)02986-8; Yang HC, 2009, P NATL ACAD SCI USA, V106, P6321, DOI 10.1073/pnas.0809536106; Yoon YJ, 2011, J BIOL CHEM, V286, P1737, DOI 10.1074/jbc.M110.179440	35	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26177	26187		10.1074/jbc.M116.743906	http://dx.doi.org/10.1074/jbc.M116.743906			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27799305	hybrid, Green Published			2022-12-26	WOS:000390345200034
J	Dubey, A; Copeland, PR				Dubey, Aditi; Copeland, Paul R.			The Selenocysteine-Specific Elongation Factor Contains Unique Sequences That Are Required for Both Nuclear Export and Selenocysteine Incorporation	PLOS ONE			English	Article							MESSENGER-RNA; LEPTOMYCIN-B; SELENOPROTEIN EXPRESSION; FISSION YEAST; PROTEIN; BINDING; CRM1; LOCALIZATION; COMPLEXES; SECISBP2	Selenocysteine (Sec) is a critical residue in at least 25 human proteins that are essential for antioxidant defense and redox signaling in cells. Sec is inserted into proteins cotranslationally by the recoding of an in-frame UGA termination codon to a Sec codon. In eukaryotes, this recoding event requires several specialized factors, including a dedicated, Sec-specific elongation factor called eEFSec, which binds Sec-tRNA(Sec) with high specificity and delivers it to the ribosome for selenoprotein production. Unlike most translation factors, including the canonical elongation factor eEF1A, eEFSec readily localizes to the nucleus of mammalian cells and shuttles between the cytoplasmic and nuclear compartments. The functional significance of eEFSec's nuclear localization has remained unclear. In this study, we have examined the subcellular localization of eEFSec in the context of altered Sec incorporation to demonstrate that reduced selenoprotein production does not correlate with changes in the nuclear localization of eEFSec. In addition, we identify several novel sequences of the protein that are essential for localization as well as Sec insertion activity, and show that eEFSec utilizes CRM1-mediated nuclear export pathway. Our findings argue for two distinct pools of eEFSec in the cell, where the cytoplasmic pool participates in Sec incorporation and the nuclear pool may be involved in an as yet unknown function.	[Dubey, Aditi; Copeland, Paul R.] Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Dubey, Aditi] NYU, Dept Basic Sci & Craniofacial Biol, New York, NY USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; New York University	Copeland, PR (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	paul.copeland@rutgers.edu		Copeland, Paul/0000-0003-3343-0587; Dubey, Aditi/0000-0003-0162-7334	National Institutes of Health [GM070773]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077073] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health GM070773 (PRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Cherfils J, 2011, NAT CHEM BIOL, V7, P493, DOI 10.1038/nchembio.608; Chung J, 2012, J CELL SCI, V125, P2684, DOI 10.1242/jcs.099267; Copeland PR, 1999, J BIOL CHEM, V274, P25447, DOI 10.1074/jbc.274.36.25447; de Jesus LA, 2006, MOL CELL BIOL, V26, P1795, DOI 10.1128/MCB.26.5.1795-1805.2006; Donovan J, 2008, J BIOL CHEM, V283, P35129, DOI 10.1074/jbc.M806008200; Dubey A, 2015, DIVERSITY SELENIUM F, P31; Fletcher JE, 2000, RNA, V6, P1573, DOI 10.1017/S1355838200000625; Fletcher JE, 2001, RNA, V7, P1442; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gonzalez-Flores JN, 2012, J BIOL CHEM, V287, P38936, DOI 10.1074/jbc.M112.415463; Gupta N, 2013, J MOL BIOL, V425, P2415, DOI 10.1016/j.jmb.2013.04.016; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; NISHI K, 1994, J BIOL CHEM, V269, P6320; Papp LV, 2006, MOL CELL BIOL, V26, P4895, DOI 10.1128/MCB.02284-05; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seeher S, 2014, FREE RADICAL BIO MED, V75, pS9, DOI 10.1016/j.freeradbiomed.2014.10.849; Seeher S, 2014, ANTIOXID REDOX SIGN, V21, P835, DOI 10.1089/ars.2013.5358; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shetty SP, 2014, J BIOL CHEM, V289, P25317, DOI 10.1074/jbc.M114.590430; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Sunde RA, 2011, ADV NUTR, V2, P138, DOI 10.3945/an.110.000240; Touat-Hamici Z, 2014, J BIOL CHEM, V289, P14750, DOI 10.1074/jbc.M114.551994; Watanabe M, 1999, GENES CELLS, V4, P291, DOI 10.1046/j.1365-2443.1999.00259.x; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Zavacki AM, 2003, MOL CELL, V11, P773, DOI 10.1016/S1097-2765(03)00064-9	34	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165642	10.1371/journal.pone.0165642	http://dx.doi.org/10.1371/journal.pone.0165642			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802322	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200032
J	Chen, HL; Zhou, MQ; Tian, W; Meng, KX; He, HF				Chen, Hai-long; Zhou, Mei-qi; Tian, Wei; Meng, Ke-xin; He, Hai-fei			Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database	PLOS ONE			English	Article							TUMOR CHARACTERISTICS; SURVIVAL; WOMEN; FEATURES; STATISTICS; COHORT	Background Age is an important risk factor for breast cancer, but data regarding whether patient age at diagnosis is related to breast cancer survival are conflicting. This population-based study evaluated the effect of age on breast cancer prognosis and identified outcome-related factors. Patients and Methods We searched the Surveillance, Epidemiology, and End Results (SEER) database and enrolled female primary non-metastatic cases. Patients were subdivided into seven groups, and analyses of the associations between age and overall survival (OS) and breast cancer-specific survival (BCSS) were carried out using the Kaplan-Meier method and Cox regression model, respectively. We also assessed differences in survival among three specific age groups, using the ages of 30 and 50 years as cut-offs. Stratified analyses regarding race, histology, grade, stage and hormone receptor status were also carried out. Results A total of 133,057 female patients diagnosed with breast cancer from 2004 to 2008 were included in the current study (6.4% < 40 years), Women aged 40 to 49 years and 60 to 69 years exhibited significantly better OS and BCSS, respectively (log-rank, p<0.001), than their counterparts in other groups. Middle-aged women exhibited distinctly better OS (log-rank, p<0.001) and BCSS (log-rank, p<0.001) than their counterparts in the other two age groups. Following adjustments for potential confounding factors, middle-age at breast cancer diagnosis was shown to be an independent predictor of favourable outcomes in terms of OS, but not BCSS (for OS, HR, 0.92; 95% CI, 0.87-0.98; p = 0.007; for BCSS, HR, 0.94; 95% CI, 0.80-1.01; p = 0.075, using the young group as reference). Stratified analysis showed that middle-age was significantly associated with increased survival, except among patients with stage III disease, and that elderly women faced worse prognoses than younger patients. Conclusion Our results indicate that younger breast cancer patients exhibit more aggressive disease than older patients. Middle-aged patients exhibit better OS and BCSS than young and elderly patients but exhibit BCSS rates similar to those of young patients after adjustments for confounders. Stratified analysis demonstrated that middle-aged patients exhibited better survival than young patients, with the exception of patients with stage III disease. An age of 60 years or more was a significant independent predictor of a poor prognosis.	[Chen, Hai-long; Meng, Ke-xin] Zhejiang Prov Peoples Hosp, Dept Gen Surg, Hangzhou, Zhejiang, Peoples R China; [Zhou, Mei-qi; Tian, Wei; He, Hai-fei] Zhejiang Univ, Dept Surg Oncol, Affiliated Hosp 2, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang University	Chen, HL (corresponding author), Zhejiang Prov Peoples Hosp, Dept Gen Surg, Hangzhou, Zhejiang, Peoples R China.	enhail@126.com						Ali AMG, 2011, BRIT J CANCER, V104, P564, DOI 10.1038/bjc.2011.14; Alieldin NH, 2014, J EGYPT NATL CANCER, V26, P23, DOI 10.1016/j.jnci.2013.08.005; Balabram D, 2015, CAD SAUDE PUBLICA, V31, P1732, DOI 10.1590/0102-311X00114214; Bouchardy C, 2007, BRIT J CANCER, V96, P1743, DOI 10.1038/sj.bjc.6603783; Brandt J, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-014-0429-x; Cluze C, 2009, BREAST CANCER RES TR, V117, P121, DOI 10.1007/s10549-008-0222-z; CROWE JP, 1994, ARCH SURG-CHICAGO, V129, P483; Cvetanovic A, 2015, J BUON, V20, P1407; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dobi A, 2011, PATHOL ONCOL RES, V17, P425, DOI 10.1007/s12253-010-9305-3; Fernandopulle SM, 2006, PATHOLOGY, V38, P219, DOI 10.1080/00313020600699268; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Gnerlich JL, 2009, J AM COLL SURGEONS, V208, P341, DOI 10.1016/j.jamcollsurg.2008.12.001; Ibrahim A, 2014, Gulf J Oncolog, V1, P76; Ikpat O F R, 2002, East Afr Med J, V79, P651; Jain M, 1997, BREAST CANCER RES TR, V42, P43, DOI 10.1023/A:1005798124538; Kataoka A, 2014, BREAST CANCER-TOKYO, V21, P643, DOI 10.1007/s12282-013-0466-2; Maggard MA, 2003, J SURG RES, V113, P109, DOI 10.1016/S0022-4804(03)00179-3; Roder DM, 2012, ANZ J SURG, V82, P524, DOI 10.1111/j.1445-2197.2012.06114.x; Schonberg MA, 2010, J CLIN ONCOL, V28, P2038, DOI 10.1200/JCO.2009.25.9796; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vostakolaei FA, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/517976; Wei XQ, 2013, ASIAN PAC J CANCER P, V14, P5949, DOI 10.7314/APJCP.2013.14.10.5949; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885	24	65	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165409	10.1371/journal.pone.0165409	http://dx.doi.org/10.1371/journal.pone.0165409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798652	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100035
J	Vasiev, B				Vasiev, Bakhtier			Modelling Chemotactic Motion of Cells in Biological Tissues	PLOS ONE			English	Article							DICTYOSTELIUM-DISCOIDEUM AGGREGATION; DEVELOPMENTAL BIOLOGY; PRIMITIVE STREAK; MIGRATION; GASTRULATION; MORPHOGENESIS; SIMULATION; PATTERNS; GRADIENT; EMBRYO	Developmental processes in biology are underlined by proliferation, differentiation and migration of cells. The latter two are interlinked since cellular differentiation is governed by the dynamics of morphogens which, in turn, is affected by the movement of cells. Mutual effects of morphogenetic and cell movement patterns are enhanced when the movement is due to chemotactic response of cells to the morphogens. In this study we introduce a mathematical model to analyse how this interplay can result in a steady movement of cells in a tissue and associated formation of travelling waves in a concentration field of morphogen. Using the model we have identified four chemotactic scenarios for migration of single cell or homogeneous group of cells in a tissue. Such a migration can take place if moving cells are (1) repelled by a chemical produced by themselves or (2) attracted by a chemical produced by the surrounding cells in a tissue. Furthermore, the group of cells can also move if cells in surrounding tissue are (3) repelled by a chemical produced by moving cells or (4) attracted by a chemical produced by surrounding cells themselves. The proposed mechanisms can underlie migration of cells during embryonic development as well as spread of metastatic cells.	[Vasiev, Bakhtier] Univ Liverpool, Dept Math Sci, Liverpool, Merseyside, England	University of Liverpool	Vasiev, B (corresponding author), Univ Liverpool, Dept Math Sci, Liverpool, Merseyside, England.	bnvasiev@liverpool.ac.uk	Vasiev, Bakhtier/D-8006-2011	Vasiev, Bakhtier/0000-0002-3452-7885	BBSRC [BB/K002430/1]; Biotechnology and Biological Sciences Research Council [BB/K002430/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC; URL: http://www.bbsrc.ac.uk/. Grant number: BB/K002430/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvarova RF, 1999, CURR OPIN GENET DEV, V9, P411, DOI 10.1016/S0959-437X(99)80062-8; Baker RE, 2007, MATH BIOSCI, V209, P30, DOI 10.1016/j.mbs.2007.01.006; Chuai M, 2012, CURR GENOMICS, V13, P267, DOI 10.2174/138920212800793357; Chuai M, 2009, CURR OPIN GENET DEV, V19, P343, DOI 10.1016/j.gde.2009.06.007; Cui C, 2005, DEV BIOL, V284, P37, DOI 10.1016/j.ydbio.2005.04.021; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Dormann D, 2002, J BIOL PHYS, V28, P765, DOI 10.1023/A:1021259326918; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; GRIMA R, 2005, PHYS REV LETT, V95, P4; Grimm O, 2010, DEVELOPMENT, V137, P2253, DOI 10.1242/dev.032409; Harrison NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022700; Huang S, 2005, CELL MOTIL CYTOSKEL, V61, P201, DOI 10.1002/cm.20077; KELLER EF, 1971, J THEOR BIOL, V30, P235, DOI 10.1016/0022-5193(71)90051-8; MCCARTHY JB, 1983, J CELL BIOL, V97, P772, DOI 10.1083/jcb.97.3.772; Merks RMH, 2005, PHYSICA A, V352, P113, DOI 10.1016/j.physa.2004.12.028; Michelin S, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4810749; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; ODELL GM, 1986, PHILOS T R SOC B, V312, P487, DOI 10.1098/rstb.1986.0016; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Savill NJ, 1997, J THEOR BIOL, V184, P229, DOI 10.1006/jtbi.1996.0237; Sengupta A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031122; STERN CD, 2004, GASTRULATION CELLS E, P219; Vasiev B, 2003, J THEOR BIOL, V223, P347, DOI 10.1016/S0022-5193(03)00103-6; Vasiev B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010571; VASIEV BN, 1994, PHYS REV LETT, V73, P3173, DOI 10.1103/PhysRevLett.73.3173; Vasieva O, 2013, REPRODUCTION, V145, pR175, DOI 10.1530/REP-12-0081; VASIEVA OO, 1994, J THEOR BIOL, V171, P361, DOI 10.1006/jtbi.1994.1240; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Walther A, 2013, CHEM REV, V113, P5194, DOI 10.1021/cr300089t; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3	32	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165570	10.1371/journal.pone.0165570	http://dx.doi.org/10.1371/journal.pone.0165570			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798687	Green Published, gold			2022-12-26	WOS:000386711100046
J	Zhou, N				Zhou, Ning			Monopolar Detection Thresholds Predict Spatial Selectivity of Neural Excitation in Cochlear Implants: Implications for Speech Recognition	PLOS ONE			English	Article							AUDITORY-NERVE; ELECTRODE CONFIGURATION; RESPONSE PROPERTIES; MASKING; NOISE; STIMULATION; PERCEPTION; HEARING; USERS; SITE	The objectives of the study were to (1) investigate the potential of using monopolar psychophysical detection thresholds for estimating spatial selectivity of neural excitation with cochlear implants and to (2) examine the effect of site removal on speech recognition based on the threshold measure. Detection thresholds were measured in Cochlear Nucleus (R) device users using monopolar stimulation for pulse trains that were of (a) low rate and long duration, (b) high rate and short duration, and (c) high rate and long duration. Spatial selectivity of neural excitation was estimated by a forward-masking paradigm, where the probe threshold elevation in the presence of a forward masker was measured as a function of masker-probe separation. The strength of the correlation between the monopolar thresholds and the slopes of the masking patterns systematically reduced as neural response of the threshold stimulus involved interpulse interactions (refractoriness and sub-threshold adaptation), and spike-rate adaptation. Detection threshold for the low-rate stimulus most strongly correlated with the spread of forward masking patterns and the correlation reduced for long and high rate pulse trains. The low-rate thresholds were then measured for all electrodes across the array for each subject. Subsequently, speech recognition was tested with experimental maps that deactivated five stimulation sites with the highest thresholds and five randomly chosen ones. Performance with deactivating the high-threshold sites was better than performance with the subjects' clinical map used every day with all electrodes active, in both quiet and background noise. Performance with random deactivation was on average poorer than that with the clinical map but the difference was not significant. These results suggested that the monopolar low-rate thresholds are related to the spatial neural excitation patterns in cochlear implant users and can be used to select sites for more optimal speech recognition performance.	[Zhou, Ning] East Carolina Univ, Dept Commun Sci & Disorders, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Zhou, N (corresponding author), East Carolina Univ, Dept Commun Sci & Disorders, Greenville, NC 27858 USA.	zhoun@ecu.edu			Emerging Research Grant from Hearing Health Foundation; NIH NIDCD Grant [R03 DC014771-01A1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC014771] Funding Source: NIH RePORTER	Emerging Research Grant from Hearing Health Foundation; NIH NIDCD Grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Emerging Research Grant from Hearing Health Foundation and NIH NIDCD Grant R03 DC014771-01A1 (http://hearinghealthfoundation.org/; https://www.nidcd.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierer JA, 2011, EAR HEARING, V32, P436, DOI 10.1097/AUD.0b013e3181ff33ab; Bierer JA, 2010, EAR HEARING, V31, P247, DOI 10.1097/AUD.0b013e3181c7daf4; Boex C, 2003, J ACOUST SOC AM, V114, P2058, DOI 10.1121/1.1610452; Boothroyd A, 1986, A SENTENCE TEST OF S; Boulet J, 2015, JARO-J ASSOC RES OTO, V17, P1; Cartee LA, 2000, HEARING RES, V146, P143, DOI 10.1016/S0378-5955(00)00109-X; Cartee LA, 2006, HEARING RES, V215, P10, DOI 10.1016/j.heares.2006.02.012; Chatterjee M, 1998, J ACOUST SOC AM, V103, P2565, DOI 10.1121/1.422777; Cohen LT, 2009, HEARING RES, V248, P1, DOI 10.1016/j.heares.2008.11.007; Dingemanse JG, 2006, EAR HEARING, V27, P645, DOI 10.1097/01.aud.0000246683.29611.1b; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P180, DOI 10.1007/s10162-005-5061-6; Garadat SN, 2013, AUDIOL NEURO-OTOL, V18, P247, DOI 10.1159/000351302; Garofolo JS, 1993, TIMIT ACOUSTIC PHONE; Hughes ML, 2008, EAR HEARING, V29, P435, DOI 10.1097/AUD.0b013e31816a0d3d; Hughes ML, 2012, HEARING RES, V285, P46, DOI 10.1016/j.heares.2012.01.010; KILLIAN MJP, 1994, HEARING RES, V81, P66, DOI 10.1016/0378-5955(94)90154-6; Kwon BJ, 2006, J ACOUST SOC AM, V119, P2994, DOI 10.1121/1.2184128; Labadie RF, 2016, OTOL NEUROTOL, V37, P137, DOI 10.1097/MAO.0000000000000926; Long CJ, 2014, JARO-J ASSOC RES OTO, V15, P293, DOI 10.1007/s10162-013-0437-5; McKay CM, 2013, JARO-J ASSOC RES OTO, V14, P879, DOI 10.1007/s10162-013-0417-9; McKay CM, 2012, J ACOUST SOC AM, V131, P2209, DOI 10.1121/1.3683248; Middlebrooks JC, 2004, J ACOUST SOC AM, V116, P452, DOI 10.1121/1.1760795; Miller CA, 2001, JARO-J ASSOC RES OTO, V2, P216, DOI 10.1007/s101620010083; Miller CA, 2011, JARO-J ASSOC RES OTO, V12, P219, DOI 10.1007/s10162-010-0249-9; Nadol JB, 1997, OTOLARYNG HEAD NECK, V117, P220, DOI 10.1016/S0194-5998(97)70178-5; Nelson DA, 2011, J ACOUST SOC AM, V129, P3916, DOI 10.1121/1.3583503; Noble JH, 2016, OTOL NEUROTOL, V37, pE63, DOI 10.1097/MAO.0000000000000909; Pfingst BE, 2004, AUDIOL NEURO-OTOL, V9, P341, DOI 10.1159/000081283; Pfingst BE, 2001, JARO-J ASSOC RES OTO, V2, P87, DOI 10.1007/s101620010065; Srinivasan AG, 2013, HEARING RES, V299, P29, DOI 10.1016/j.heares.2013.02.004; STYPULKOWSKI PH, 1984, HEARING RES, V14, P205, DOI 10.1016/0378-5955(84)90051-0; Tang Q, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046029; Wilson BS, 1997, AM J OTOL, V18, pS30; Woo J, 2010, JARO-J ASSOC RES OTO, V11, P283, DOI 10.1007/s10162-009-0199-2; Zhang F, 2007, JARO-J ASSOC RES OTO, V8, P356, DOI 10.1007/s10162-007-0086-7; Zhou N, 2016, J ACOUST SOC AM, V140, P1537, DOI 10.1121/1.4962230; Zhou N, 2012, J ACOUST SOC AM, V132, P994, DOI 10.1121/1.4730907; ZHOU RZ, 1995, HEARING RES, V88, P98, DOI 10.1016/0378-5955(95)00105-D	39	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165476	10.1371/journal.pone.0165476	http://dx.doi.org/10.1371/journal.pone.0165476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798658	Green Submitted, gold, Green Published			2022-12-26	WOS:000386711100038
J	Chacon-Cabrera, A; Lund-Palau, H; Gea, J; Barreiro, E				Chacon-Cabrera, Alba; Lund-Palau, Helena; Gea, Joaquim; Barreiro, Esther			Time-Course of Muscle Mass Loss, Damage, and Proteolysis in Gastrocnemius following Unloading and Reloading: Implications in Chronic Diseases	PLOS ONE			English	Article							SKELETAL TROPONIN-I; OXIDATIVE STRESS; UBIQUITIN-PROTEASOME; PROTEIN-SYNTHESIS; CANCER CACHEXIA; DISUSE; ATROPHY; MITOCHONDRIAL; MORTALITY; AUTOPHAGY	Background Disuse muscle atrophy is a major comorbidity in patients with chronic diseases including cancer. We sought to explore the kinetics of molecular mechanisms shown to be involved in muscle mass loss throughout time in a mouse model of disuse muscle atrophy and recovery following immobilization. Methods Body and muscle weights, grip strength, muscle phenotype (fiber type composition and morphometry and muscle structural alterations), proteolysis, contractile proteins, systemic troponin I, and mitochondrial content were assessed in gastrocnemius of mice exposed to periods (1, 2, 3, 7, 15 and 30 days) of non-invasive hindlimb immobilization (plastic splint, I cohorts) and in those exposed to reloading for different time-points (1, 3, 7, 15, and 30 days, R cohorts) following a seven-day period of immobilization. Groups of control animals were also used. Results Compared to non-exposed controls, muscle weight, limb strength, slow-and fast-twitch cross-sectional areas, mtDNA/ nDNA, and myosin content were decreased in mice of I cohorts, whereas tyrosine release, ubiquitin-proteasome activity, muscle injury and systemic troponin I levels were increased. Gastrocnemius reloading following splint removal improved muscle mass loss, strength, fiber atrophy, injury, myosin content, and mtDNA/ nDNA, while reducing ubiquitin-proteasome activity and proteolysis. Conclusions A consistent program of molecular and cellular events leading to reduced gastrocnemius muscle mass and mitochondrial content and reduced strength, enhanced proteolysis, and injury, was seen in this non-invasive mouse model of disuse muscle atrophy. Unloading of the muscle following removal of the splint significantly improved the alterations seen during unloading, characterized by a specific kinetic profile of molecular events involved in muscle regeneration. These findings have implications in patients with chronic diseases including cancer in whom physical activity may be severely compromised.	[Chacon-Cabrera, Alba; Lund-Palau, Helena; Gea, Joaquim; Barreiro, Esther] Univ Pompeu Fabra, Hlth & Expt Sci Dept CEXS, Muscle Wasting & Cachexia Chron Resp Dis & Lung C, IMIM Hosp del Mar,Pulmonol Dept, Parc Salut Mar,PRBB,C Dr Aiguader 88, E-08003 Barcelona, Spain; [Chacon-Cabrera, Alba; Gea, Joaquim; Barreiro, Esther] ISCIII, Ctr Invest Red Enfermedades Resp CIBERES, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Barreiro, E (corresponding author), Univ Pompeu Fabra, Hlth & Expt Sci Dept CEXS, Muscle Wasting & Cachexia Chron Resp Dis & Lung C, IMIM Hosp del Mar,Pulmonol Dept, Parc Salut Mar,PRBB,C Dr Aiguader 88, E-08003 Barcelona, Spain.; Barreiro, E (corresponding author), ISCIII, Ctr Invest Red Enfermedades Resp CIBERES, Barcelona, Spain.	ebarreiro@imim.es			CIBERES from the Instituto de Salud Carlos III [PI14/00713, SAF-2014-54371-R]; SEPAR from Spanish Respiratory Society; Catalan Foundation of Pneumology (FUCAP)	CIBERES from the Instituto de Salud Carlos III; SEPAR from Spanish Respiratory Society; Catalan Foundation of Pneumology (FUCAP)	This study has been supported by the following Spanish agencies: CIBERES, PI14/00713 (FEDER), and SAF-2014-54371-R (FEDER) from the Instituto de Salud Carlos III (http://www.isciii.es/); SEPAR 2013 and SEPAR 2016 from Spanish Respiratory Society (SEPAR, http://www.separ.es/); and Catalan Foundation of Pneumology (FUCAP, http://www.ccfundacions.cat/fundacions/fundacio-catalana-de-pneumologia-fucap), FUCAP 2016. The funders had had no role in the study design, data analyses or manuscript writing.	Adams GR, 2003, J APPL PHYSIOL, V95, P2185, DOI 10.1152/japplphysiol.00346.2003; Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Anker SD, 2002, INT J CARDIOL, V85, P51, DOI 10.1016/S0167-5273(02)00233-4; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Argiles JM, 1996, TRENDS PHARMACOL SCI, V17, P223, DOI 10.1016/0165-6147(96)10021-3; Barreiro E, 2010, J ANIM PHYSIOL AN N, V94, pE393, DOI 10.1111/j.1439-0396.2010.01027.x; Barreiro E, 2015, ARCH BRONCONEUMOL, V51, P384, DOI 10.1016/j.arbres.2015.04.011; Barreiro E, 2016, J CELL PHYSIOL, V231, P1495, DOI 10.1002/jcp.25241; Callahan DM, 2015, AM J PHYSIOL-CELL PH, V308, pC932, DOI 10.1152/ajpcell.00014.2015; Chacon-Cabrera A, 2015, BBA-GEN SUBJECTS, V1850, P2530, DOI 10.1016/j.bbagen.2015.09.020; Chacon-Cabrera A, 2014, J CELL PHYSIOL, V229, P1660, DOI 10.1002/jcp.24611; Chapman DW, 2013, J SCI MED SPORT, V16, P82, DOI 10.1016/j.jsams.2012.05.006; Fontes-Oliveira CC, 2013, BBA-GEN SUBJECTS, V1830, P2770, DOI 10.1016/j.bbagen.2012.11.009; Dirks ML, 2014, J NUTR, V144, P1196, DOI 10.3945/jn.114.194217; Erwann S, 2014, FREE RADICAL BIO MED, V75, pS28, DOI 10.1016/j.freeradbiomed.2014.10.754; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211; Fermoselle C, 2011, ARCH BRONCONEUMOL, V47, P590, DOI 10.1016/j.arbres.2011.07.008; Foster GE, 2012, EUR J APPL PHYSIOL, V112, P3547, DOI 10.1007/s00421-012-2337-5; FURUNO K, 1990, J BIOL CHEM, V265, P8550; Hvid LG, 2014, EXP GERONTOL, V52, P1, DOI 10.1016/j.exger.2014.01.012; Itai Y, 2004, ACTA PHYSIOL SCAND, V181, P217, DOI 10.1111/j.1365-201X.2004.01271.x; Kang CH, 2016, FREE RADICAL BIO MED, V93, P32, DOI 10.1016/j.freeradbiomed.2015.12.032; Kang C, 2013, J APPL PHYSIOL, V115, P1618, DOI 10.1152/japplphysiol.01354.2012; Lang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038910; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Magne H, 2011, J PHYSIOL-LONDON, V589, P511, DOI 10.1113/jphysiol.2010.201707; Maltais Francois, 2014, Am J Respir Crit Care Med, V189, pe15, DOI 10.1164/rccm.201402-0373ST; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marin-Corral J, 2009, EUR RESPIR J, V33, P1309, DOI 10.1183/09031936.00072008; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; Mele A, 2016, SCI REP-UK, V6, DOI 10.1038/srep20061; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Muscaritoli M, 2006, EUR J CANCER, V42, P31, DOI 10.1016/j.ejca.2005.07.026; Pellegrino MA, 2011, J PHYSIOL-LONDON, V589, P2147, DOI 10.1113/jphysiol.2010.203232; Powers SK, 2012, CURR OPIN CLIN NUTR, V15, P240, DOI 10.1097/MCO.0b013e328352b4c2; Puig-Vilanova E, 2015, CLIN SCI, V128, P905, DOI 10.1042/CS20140428; Puig-Vilanova E, 2015, FREE RADICAL BIO MED, V79, P91, DOI 10.1016/j.freeradbiomed.2014.11.006; Puig-Vilanova E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111514; Puig-Vilanova E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102296; Remels AH, 2007, EUR RESPIR J, V30, P245, DOI 10.1183/09031936.00144106; Simpson JA, 2005, CLIN CHEM, V51, P966, DOI 10.1373/clinchem.2004.042671; Smith HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094356; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; TISCHLER ME, 1982, J BIOL CHEM, V257, P1613; van Hees HWH, 2008, AM J PHYSIOL-LUNG C, V294, pL1260, DOI 10.1152/ajplung.00035.2008; Vargas R, 2008, ALCOHOL CLIN EXP RES, V32, P128, DOI 10.1111/j.1530-0277.2007.00548.x; Vassallo JD, 2009, TOXICOL SCI, V111, P402, DOI 10.1093/toxsci/kfp166; Wall BT, 2016, AM J PHYSIOL-ENDOC M, V310, pE137, DOI 10.1152/ajpendo.00227.2015	51	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0164951	10.1371/journal.pone.0164951	http://dx.doi.org/10.1371/journal.pone.0164951			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792730	Green Published, gold			2022-12-26	WOS:000389537000013
J	Liang, H; Zhang, AY; Gu, YX; You, YH; Zhang, JZ; Zhang, MJ				Liang, Hao; Zhang, Aiyu; Gu, Yixin; You, Yuanhai; Zhang, Jianzhong; Zhang, Maojun			Genetic Characteristics and Multiple-PCR Development for Capsular Identification of Specific Serotypes of Campylobacter jejuni	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; GENOME SEQUENCE; POLYSACCHARIDE; VIRULENCE; REVEALS; GENERATION; INFECTION; DYNAMICS; OUTBREAK; STRAINS	The polysaccharide capsule (CPS) of Campylobacter jejuni is a virulence factor linked to cell surface carbohydrate diversity which mainly determines the serotypes. Thirty-four CPS gene cluster structures have been published and some of them can be distinguished by multiple-PCR. Penner serotypes HS1/44c, HS2, HS4c, HS19, HS23/36c and HS41 are markers for Guillain-Barre A syndrome (GBS). The capsules may contribute to GBS susceptibility. Analysis of 18 CPS loci revealed high gene content diversity and a mosaic nature of the capsule loci, which are possibly due to gene gain/loss events, and demonstrated a high degree of conservation of genes within serotypes/serotype complexes. A method of multiple-PCR was developed to distinguish five specific serotypes and three GBS-related serotypes. Primers specific for each capsule type were designed on the basis of paralogs or a unique DNA region of the CPS locus. The multiple-PCR can distinguish the eight serotypes in two PCRs with sensitivity and specificity of 100% using 227 strains of known Penner type. The multiple-PCR method will help to distinguish serotypes simply and rapidly.	[Liang, Hao; Zhang, Aiyu; Gu, Yixin; You, Yuanhai; Zhang, Jianzhong; Zhang, Maojun] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zhang, MJ (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	zhangmaojun@icdc.cn	Zhang, Jianzhong/AAM-6179-2021	Zhang, Jianzhong/0000-0001-7056-8206	Major State Basic Research Development Program [2013CB127204]; General Program of National Natural Science Foundation of China [81271789]	Major State Basic Research Development Program(National Basic Research Program of China); General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major State Basic Research Development Program (2013CB127204), and the General Program of National Natural Science Foundation of China (81271789).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASPINALL GO, 1992, CARBOHYD RES, V231, P13, DOI 10.1016/0008-6215(92)84003-B; Chen YH, 2008, CARBOHYD RES, V343, P1034, DOI 10.1016/j.carres.2008.02.024; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Garrigan C, 2014, DIAGN MICR INFEC DIS, V80, P204, DOI 10.1016/j.diagmicrobio.2014.08.002; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Guerry P, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00007; Heikema AP, 2015, CLIN MICROBIOLOGY IN; Islam Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007257; Jackson BR, 2014, EPIDEMIOL INFECT, V142, P1089, DOI 10.1017/S0950268813001908; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Kunin V, 2003, GENOME RES, V13, P1589, DOI 10.1101/gr.1092603; Kuroki S, 1993, ANN NEUROLOGY, V33; Lastovica AJ, 1997, J INFECT DIS, V176, pS139, DOI 10.1086/513796; Lefebure T, 2010, GENOME BIOL EVOL, V2, P646, DOI 10.1093/gbe/evq048; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; McNally DJ, 2007, J BIOL CHEM, V282, P28566, DOI 10.1074/jbc.M704413200; Monteiro MA, 2009, INFECT IMMUN, V77, P1128, DOI 10.1128/IAI.01056-08; Nobuhiro Y, 2004, P NATL ACAD SCI USA, V101, P11404, DOI [10.1073/pnas.0402391101, DOI 10.1073/PNAS.0402391101]; Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Poly F, 2011, J CLIN MICROBIOL, V49, P1750, DOI 10.1128/JCM.02348-10; Richards VP, 2013, INFECT GENET EVOL, V14, P200, DOI 10.1016/j.meegid.2012.12.010; Rychlik Wojciech, 2007, V402, P35; Singh VK, 1998, BIOTECHNIQUES, V24, P318, DOI 10.2144/98242pf02; Wong A, 2015, MOL MICROBIOL, V96, P1136, DOI 10.1111/mmi.12995; Zhang MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015060; Zhang MJ, 2010, FOODBORNE PATHOG DIS, V7, P913, DOI 10.1089/fpd.2009.0493	33	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165159	10.1371/journal.pone.0165159	http://dx.doi.org/10.1371/journal.pone.0165159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788180	Green Submitted, gold, Green Published			2022-12-26	WOS:000389604900049
J	Rice, MB; Rossi, LG; Apa, AD				Rice, Mindy B.; Rossi, Liza G.; Apa, Anthony D.			Seasonal Habitat Use by Greater Sage-Grouse (Centrocercus urophasianus) on a Landscape with Low Density Oil and Gas Development	PLOS ONE			English	Article							RESOURCE SELECTION FUNCTIONS; SPECIES-DISTRIBUTION MODELS; BROOD-REARING HABITAT; ENERGY DEVELOPMENT; CONSERVATION; IMPACTS; DESIGN; FEMALE	Fragmentation of the sagebrush (Artemisia spp.) ecosystem has led to concern about a variety of sagebrush obligates including the greater sage-grouse (Centrocercus urophasianus). Given the increase of energy development within greater sage-grouse habitats, mapping seasonal habitats in pre-development populations is critical. The North Park population in Colorado is one of the largest and most stable in the state and provides a unique case study for investigating resource selection at a relatively low level of energy development compared to other populations both within and outside the state. We used locations from 117 radio-marked female greater sage-grouse in North Park, Colorado to develop seasonal resource selection models. We then added energy development variables to the base models at both a landscape and local scale to determine if energy variables improved the fit of the seasonal models. The base models for breeding and winter resource selection predicted greater use in large expanses of sagebrush whereas the base summer model predicted greater use along the edge of riparian areas. Energy development variables did not improve the winter or the summer models at either scale of analysis, but distance to oil/gas roads slightly improved model fit at both scales in the breeding season, albeit in opposite ways. At the landscape scale, greater sage-grouse were closer to oil/gas roads whereas they were further from oil/gas roads at the local scale during the breeding season. Although we found limited effects from low level energy development in the breeding season, the scale of analysis can influence the interpretation of effects. The lack of strong effects from energy development may be indicative that energy development at current levels are not impacting greater sage-grouse in North Park. Our baseline seasonal resource selection maps can be used for conservation to help identify ways of minimizing the effects of energy development.	[Rice, Mindy B.] Colorado Pk & Wildlife, Avian Res, Ft Collins, CO 80526 USA; [Rossi, Liza G.] Colorado Pk & Wildlife, Terr Sect, Steamboat Springs, CO USA; [Apa, Anthony D.] Colorado Pk & Wildlife, Avian Res, Grand Junction, CO USA		Rice, MB (corresponding author), Colorado Pk & Wildlife, Avian Res, Ft Collins, CO 80526 USA.	rice1min@gmail.com			Colorado Parks and Wildlife; Arapaho National Wildlife Refuge	Colorado Parks and Wildlife; Arapaho National Wildlife Refuge	We would like to thank Colorado Parks and Wildlife and Arapaho National Wildlife Refuge for funding this study.; We would like to thank Colorado Parks and Wildlife and Arapaho National Wildlife Refuge for funding this study as well as the Area 10 staff who assisted in the field and with input on model development. A huge thanks goes to Gemara Gifford who helped create the energy development variables. We thank all the technicians who assisted on this project as well as the landowners who allowed access to their properties including K. Crowder and the North Park greater sage-grouse working group. We also thank R. Conrey and H. Johnson and anonymous reviewers for comments on earlier drafts of this manuscript.	Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Aldridge CL, 2012, J WILDLIFE MANAGE, V76, P391, DOI 10.1002/jwmg.268; Anderson D. R., 2008, MODEL BASED INFERENC; Atamian MT, 2010, J WILDLIFE MANAGE, V74, P1533, DOI 10.2193/2009-226; Bergquist E, 2007, ENVIRON MONIT ASSESS, V128, P381, DOI 10.1007/s10661-006-9321-7; Blomberg EJ, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00304.1; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Braun CE, 2002, TRANS N AM WILDL NAT, V67, P337; Bureau of Land Management (BLM), 2015, NW COL GREAT SAG GRO; Bureau of Land Management (BLM), 2009, REAS FOR DEV 2008 20; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Colorado Greater Sage-grouse Steering Committee, 2008, COL GREAT SAG GROUS; Connelly JW, 2011, STUD AVIAN BIOL, P549; Connelly JW, 2011, STUD AVIAN BIOL, P69; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Davies KW, 2011, BIOL CONSERV, V144, P2573, DOI 10.1016/j.biocon.2011.07.016; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Doherty KE, 2010, J WILDLIFE MANAGE, V74, P1544, DOI 10.2193/2009-043; DRUT MS, 1994, J RANGE MANAGE, V47, P90, DOI 10.2307/4002848; DUNN PO, 1986, J WILDLIFE MANAGE, V50, P228, DOI 10.2307/3801903; Dzialak MR, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00315.1; Fedy BC, 2014, WILDLIFE MONOGR, V190, P1, DOI 10.1002/wmon.1014; Fischer RA, 1996, CONDOR, V98, P868, DOI 10.2307/1369875; GIESEN K M, 1982, Wildlife Society Bulletin, V10, P224; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Hausleitner D., 2003, THESIS; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; Hollaran MJ, 2005, THESIS; Holloran MJ, 2015, J WILDLIFE MANAGE, V79, P630, DOI 10.1002/jwmg.877; Johnson CJ, 2008, ECOL MODEL, V213, P143, DOI 10.1016/j.ecolmodel.2007.11.013; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; Kirol CP, 2015, ECOL APPL, V25, P968, DOI 10.1890/13-1152.1; KLEBENOW DA, 1968, J RANGE MANAGE, V21, P80, DOI 10.2307/3896359; KLOTT JH, 1990, J WILDLIFE MANAGE, V54, P84, DOI 10.2307/3808905; Lyon AG, 2003, WILDLIFE SOC B, V31, P486; MANIER D. J., 2013, 20131098 US GEOL SUR; Manly B.F.J., 2002, RESOURCE SELECTION A; McAlpine CA, 2008, J APPL ECOL, V45, P558, DOI 10.1111/j.1365-2664.2007.01431.x; Naugle DE, 2011, STUD AVIAN BIOL, P489; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Patterson R.L., 1952, SAGE GROUSE WYOMING; R Core Team, 2021, R LANGUAGE ENV STAT; Remington T. E., 1991, THORNE ECOLOGICAL I, V5, P128; Rice MB, 2013, J WILDLIFE MANAGE, V77, P821, DOI 10.1002/jwmg.496; Savage DE, 1969, W39R9 NEV DIV WILDL; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schroeder MA, 2004, CONDOR, V106, P363, DOI 10.1650/7425; Smith KT, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00238; Stokland JN, 2011, ECOL MODEL, V222, P1800, DOI 10.1016/j.ecolmodel.2011.02.025; Sveum CM, 1998, GREAT BASIN NAT, V58, P344; Tack J. D., 2009, THESIS; Taylor RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071256; Tedrow L, FINAL REPORT ASSESSI, P105; U.S. Fish and Wildlife Service, FED REG, V80, P59857; WAKKINEN WL, 1992, WILDLIFE SOC B, V20, P425; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Walker BL, 2016, J WILDLIFE MANAGE, V80, P63, DOI 10.1002/jwmg.962; Wiens TS, 2008, ECOL MODEL, V212, P244, DOI 10.1016/j.ecolmodel.2007.10.005	61	3	3	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165399	10.1371/journal.pone.0165399	http://dx.doi.org/10.1371/journal.pone.0165399			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788202	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900076
J	Sicko, RJ; Browne, ML; Rigler, SL; Druschel, CM; Liu, G; Fan, RZ; Romitti, PA; Caggana, M; Kay, DM; Brody, LC; Mills, JL				Sicko, Robert J.; Browne, Marilyn L.; Rigler, Shannon L.; Druschel, Charlotte M.; Liu, Gang; Fan, Ruzong; Romitti, Paul A.; Caggana, Michele; Kay, Denise M.; Brody, Lawrence C.; Mills, James L.			Genetic Variants in Isolated Ebstein Anomaly Implicated in Myocardial Development Pathways	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; COPY-NUMBER VARIATION; MYOSIN HEAVY-CHAIN; TRICUSPID-VALVE; HUMAN GENOME; DE-NOVO; DILATED CARDIOMYOPATHY; SEPTAL-DEFECT; DELETION; MALFORMATION	Ebstein anomaly ( EA) is a rare heart defect in which the tricuspid valve is malformed and displaced. The tricuspid valve abnormalities can lead to backflow of blood from the right ventricle to the right atrium, preventing proper circulation of blood to the lungs. Although the etiology of EA is largely unresolved, increased prevalence of EA in those with a family history of congenital heart disease suggests EA has a genetic component. Copy number variants (CNVs) are a major source of genetic variation and have been implicated in a range of congenital heart defect phenotypes. We performed a systematic, genome-wide search for CNVs in 47 isolated EA cases using genotyping microarrays. In addition, we used a custom HaloPlex panel to sequence three known EA genes and 47 candidate EA genes. We identified 35 candidate CNVs in 24 (51%) EA cases. Rare sequence variants in genes associated with cardiomyopathy were identified in 11 (23%) EA cases. Two CNVs near the transcriptional repressor HEY1, a member of the NOTCH signaling pathway, were identified in three unrelated cases. All other candidate CNVs were each identified in a single case. At least 11 of 35 candidate CNVs include genes involved in myocardial development or function, including multiple genes in the BMP signaling pathway. We identified enrichment of gene sets involved in histone modification and cardiomyocyte differentiation, supporting the involvement of the developing myocardium in the etiology of EA. Gene set enrichment analysis also identified ribosomal RNA processing, a potentially novel pathway of altered cardiac development in EA. Our results suggest an altered myocardial program may contribute to abnormal tricuspid valve development in EA. Future studies should investigate abnormal differentiation of cardiomyocytes as a potential etiological factor in EA.	[Sicko, Robert J.; Caggana, Michele; Kay, Denise M.] New York State Dept Hlth, Wadsworth Ctr, Div Genet, Albany, NY USA; [Browne, Marilyn L.; Druschel, Charlotte M.; Liu, Gang] New York State Dept Hlth, Congenital Malformat Registry, Albany, NY USA; [Browne, Marilyn L.; Druschel, Charlotte M.] SUNY Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, Rensselaer, NY USA; [Rigler, Shannon L.; Fan, Ruzong; Mills, James L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Rigler, Shannon L.] Walter Reed Natl Mil Med Ctr, Dept Neonatol, Bethesda, MD USA; [Romitti, Paul A.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA USA; [Brody, Lawrence C.] NHGRI, Med Genom & Metab Genet Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Albany; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Walter Reed National Military Medical Center; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Mills, JL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	jamesmills@nih.gov		Liu, Gang/0000-0003-1928-2047; Kay, Denise/0000-0002-9928-2698; Mills, James/0000-0003-4496-332X; Browne, Marilyn/0000-0002-1872-2787; Romitti, Paul/0000-0001-5393-9984; Sicko, Robert/0000-0001-7521-9742	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [HHSN2752011000011, HHSN27500005, N01-DK-73431]; National Human Genome Research Institute; Wellcome Trust; National Center on Birth Defects and Developmental Disabilities [U01DD001035] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000167] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); National Center on Birth Defects and Developmental Disabilities(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (contracts HHSN2752011000011 and HHSN27500005; NICHD contract N01-DK-73431) and the National Human Genome Research Institute. Funding for the DECIPHER project was provided by the Wellcome Trust.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andelfinger G, 2003, J MED GENET, V40, P320, DOI 10.1136/jmg.40.5.320; [Anonymous], 2014, INFINIUM GENOTYPING; Azhar M, 2010, INT J BIOL SCI, V6, P546; Bae KB, 2011, TRANSGENIC RES, V20, P1019, DOI 10.1007/s11248-010-9476-4; Baekvad-hansen M, 2006, DELINEATION 2 2 MB M, V433, P427; Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Bainbridge MN, 2015, CIRC-CARDIOVASC GENE, V8, P544, DOI 10.1161/CIRCGENETICS.115.001026; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929; Begay RL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002645; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Beppu H, 2009, DEV BIOL, V331, P167, DOI 10.1016/j.ydbio.2009.04.032; Bettahi H, 2002, J BIOL CHEM, V277, P48282, DOI 10.1074/jbc.M209599200; Bettinelli AL, 2013, AM J MED GENET A, V161, P3187, DOI 10.1002/ajmg.a.36182; Boghossian NS, 2016, AM J MED GENET A, V170, P622, DOI 10.1002/ajmg.a.37493; Bragin E, 2014, NUCLEIC ACIDS RES, V42, pD993, DOI 10.1093/nar/gkt937; Budde BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001362; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Christensen AH, 2010, J MED GENET, V47, P736, DOI 10.1136/jmg.2010.077891; CORREAVILLASENOR A, 1994, TERATOLOGY, V50, P137, DOI 10.1002/tera.1420500208; Desai AA, 2012, AM J RESP CRIT CARE, V186, P359, DOI 10.1164/rccm.201201-0057OC; Digilio MC, 2011, AM J MED GENET A, V155A, P2196, DOI 10.1002/ajmg.a.34131; Egorova IF, ARKH PATOL, V77, P3; Favire L, 1999, PRENATAL DIAG, V19, P49; Fesslova V, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/368067; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forrester MB, 2004, PAEDIATR PERINAT EP, V18, P415, DOI 10.1111/j.1365-3016.2004.00594.x; Fost CHA, 2005, SWISS MED WKLY, V135, P269; Frank D, 2007, CIRCULATION, V116, P2587, DOI 10.1161/CIRCULATIONAHA.107.711317; Gaussin V, 2005, CIRC RES, V97, P219, DOI 10.1161/01.RES.0000177862.85474.63; Ghosh TK, 2014, J CARDIOVASC DEV DIS, V1, P134, DOI 10.3390/jcdd1010134; Giglio S, 2000, CIRCULATION, V102, P432; Gioli-Pereira L, 2010, INT J CARDIOL, V138, P261, DOI 10.1016/j.ijcard.2008.08.035; Guillory AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074784; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; HUTCHINSON R, 1992, J MED GENET, V29, P407, DOI 10.1136/jmg.29.6.407; Isserlin Ruth, 2014, F1000Res, V3, P141, DOI 10.12688/f1000research.4536.1; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kathiriya IS, 2004, J BIOL CHEM, V279, P54937, DOI 10.1074/jbc.M409879200; Keith JD, 1958, HEART DIS INFANCY CH; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kohler S, 2014, J MED GENET, V51, P766, DOI 10.1136/jmedgenet-2014-102633; Laitenberger G, 2008, PEDIATR CARDIOL, V29, P1104, DOI 10.1007/s00246-007-9150-7; Lander J., 2014, CURR GENET MED REP, V2, P168, DOI DOI 10.1007/S40142-014-0049-3; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Leite Maria de Fatima M P, 2004, Arq Bras Cardiol, V82, P390; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin CJ, 2012, DEVELOPMENT, V139, P3277, DOI 10.1242/dev.063495; Lupo PJ, 2011, AM J MED GENET A, V155A, P1007, DOI 10.1002/ajmg.a.33883; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Miller MS, 2005, AM J MED GENET A, V139A, P141, DOI 10.1002/ajmg.a.30921; Nakagawa M, 1999, CLIN GENET, V55, P383; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; O'Connor Rachel, 2011, Case Rep Genet, V2011, P898706, DOI 10.1155/2011/898706; Oxenius A, 2013, CARDIOL YOUNG, V23, P27, DOI 10.1017/S1047951112000224; Paez MT, 2008, AM J MED GENET A, V146A, P1158, DOI 10.1002/ajmg.a.32205; Postma AV, 2011, CIRC-CARDIOVASC GENE, V4, P43, DOI 10.1161/CIRCGENETICS.110.957985; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; Razeghi P, 2006, FASEB J, V20, P1090, DOI 10.1096/fj.06-5718com; Rigler SL, 2015, GENET MED, V17, P348, DOI 10.1038/gim.2014.112; Saavedra-Matiz CA, 2013, CLIN CHEM, V59, P1045, DOI 10.1373/clinchem.2012.198945; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Sekhobo JP, 2001, PUBLIC HEALTH REP, V116, P296, DOI 10.1016/S0033-3549(04)50051-1; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Sinkovec M, 2005, INT J CARDIOL, V102, P297, DOI 10.1016/j.ijcard.2004.05.033; Smedley D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat025; Song ZZ, 2010, INT J CARDIOL, V143, pE30, DOI 10.1016/j.ijcard.2008.12.024; Southard AE, 2012, PEDIATRICS, V129, P755, DOI 10.1542/peds.2011-2337; Stefanovic S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4680; Stefanovic S, 2009, J CELL BIOL, V186, P665, DOI 10.1083/jcb.200901040; Trost D, 1999, DEUT MED WOCHENSCHR, V124, P3, DOI 10.1055/s-2008-1062601; van Trier DC, 2013, EUR J MED GENET, V56, P426, DOI 10.1016/j.ejmg.2013.05.002; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Wain KE, 2012, J GENET COUNS, V21, P631, DOI 10.1007/s10897-012-9507-9; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Warburton D, 2014, HUM GENET, V133, P11, DOI 10.1007/s00439-013-1353-9; Wyszynski DF, 2010, CONGENITAL HEART DEF; Yatsenko SA, 2004, CLIN GENET, V66, P128, DOI 10.1111/j.1399-0004.2004.00290.x; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013; ZUBERBUHLER JR, 1979, J THORAC CARDIOV SUR, V77, P202	89	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165174	10.1371/journal.pone.0165174	http://dx.doi.org/10.1371/journal.pone.0165174			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788187	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900051
J	Verduin, WM; Van Den Helder, R; Doodeman, HJ; Struijf, E; Houdijk, APJ				Verduin, W. M.; Van Den Helder, R.; Doodeman, H. J.; Struijf, E.; Houdijk, A. P. J.			Dexa Body Composition Assessment in 10-11 Year Healthy Children	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; VISCERAL ADIPOSE-TISSUE; COMPUTED-TOMOGRAPHY; OBESE CHILDREN; ABDOMINAL FAT; PREPUBERTAL CHILDREN; CARDIOVASCULAR RISK; METABOLIC SYNDROME; SEX-DIFFERENCES; ADOLESCENTS	Introduction Obesity is a growing health problem associated with metabolic derangements and cardiovascular disease. Accumulating evidence links the accumulation of visceral adipose tissue (VAT) to these obesity related health risks in adults. Childhood obesity is associated with a lifetime risk of cardiovascular disease and poses a serious challenge to future health care. In children, there is much less data on the prevalence and gender differences of visceral obesity than in adults. This study aims to provide reference values for VAT in children 10 -11 years of age. Methods In a cross-sectional study performed in the north western part of theNetherlands, healthy children of 10 -11 years of age, were recruited from primary schools. Anthropometric data consisting of height, weight, waist circumference (WC) and BMI were measured. Body composition was measured using DXA, providing measures for bone mineral content, total fat mass (TFM), lean body mass (LBM) and VAT. Results 217 children were eligible for this study. Girls appeared to have a greater TFM (31.4% vs 27.5% of total body weight (TBW); P <.01) but lower VAT (0.3% vs 0.5% of TBW; P <.01) than boys, whereas boys had higher LBM (65.4% vs 69.3% TBW; P <.01). Median VAT area (cm 2) was 41.1 for boys and 22.4 for girls (P <.01). Moderate to strong correlations were found for WC and BMI with VAT (boys: r =.664 and r =.630; Girls r =.699 and r =.546 respectively all P <.001). Discussion This study shows gender specific differences in VAT percentiles in healthy non-obese 10 -11 year old children as measured by DXA that may serve as reference values in children. Independent of BMI and WC, girls tend to have more TFM but less VAT and LBM than boys.	[Verduin, W. M.; Van Den Helder, R.; Houdijk, A. P. J.] North West Clin, Dept Surg, Alkmaar, Netherlands; [Verduin, W. M.; Van Den Helder, R.; Doodeman, H. J.; Houdijk, A. P. J.] North West Clin, Foreest Med Sch, Alkmaar, Netherlands; [Struijf, E.] Municipal Publ Hlth Care Org Hollands Noorden, Alkmaar, Netherlands		Houdijk, APJ (corresponding author), North West Clin, Dept Surg, Alkmaar, Netherlands.; Houdijk, APJ (corresponding author), North West Clin, Foreest Med Sch, Alkmaar, Netherlands.	A.P.J.Houdijk@nwz.nl		Verduin, Wouter/0000-0002-1039-2277	European Fund for Regional Development	European Fund for Regional Development(European Commission)	This study was supported by the European Fund for Regional Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2017, J APPL RES INTELLECT, V30, P696, DOI 10.1111/jar.12263; Albanese CV, 2003, J CLIN DENSITOM, V6, P75, DOI 10.1385/JCD:6:2:75; Asayama K, 2005, PEDIATR INT, V47, P498, DOI 10.1111/j.1442-200x.2005.02117.x; Bauer J, 2012, PEDIATR RES, V72, P420, DOI 10.1038/pr.2012.100; Benfield LL, 2008, INT J OBESITY, V32, P91, DOI 10.1038/sj.ijo.0803780; Brug J, 2012, PLOS ONE, V7; Casavalle PL, 2014, PEDIATR ENDOCR REV P, V12, P213; Choi YJ, 2015, J CLIN DENSITOM, V18, P192, DOI 10.1016/j.jocd.2015.02.001; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Druet C, 2008, HORM RES, V70, P22, DOI 10.1159/000129674; Flechtner-Mors M, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/370753; Goran MI, 1999, AM J CLIN NUTR, V70, p149S; Goran MI, 1997, AM J CLIN NUTR, V65, P1703, DOI 10.1093/ajcn/65.6.1703; Gower BA, 1999, DIABETES, V48, P1515, DOI 10.2337/diabetes.48.8.1515; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Huang TTK, 2001, OBES RES, V9, P283, DOI 10.1038/oby.2001.35; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Kiess W, 2011, BUNDESGESUNDHEITSBLA, V54, P527, DOI 10.1007/s00103-011-1265-6; Kist-van-Holthe JE, 2012, JGZ RICHTLIJN OVERGE; Lee SJ, 2008, OBESITY, V16, P1066, DOI 10.1038/oby.2008.13; Lobstein T, 2015, LANCET, V385, P2510, DOI 10.1016/S0140-6736(14)61746-3; Matsuzawa Y, 2011, J ATHEROSCLEROSIS TH, V18; Micklesfield LK, 2012, OBESITY, V20, P1109, DOI 10.1038/oby.2011.367; Nederland G., 2009, PROT WERKW OP ORG JE; Niemirska A, 2013, HYPERTENSION, V62, P782, DOI 10.1161/HYPERTENSIONAHA.113.01292; Owens S, 1998, J PEDIATR-US, V133, P41, DOI 10.1016/S0022-3476(98)70175-1; Raghuveer G, 2010, AM J CLIN NUTR, V91, p1514S, DOI 10.3945/ajcn.2010.28701D; Satake E, 2010, J PEDIATR ENDOCR MET, V23, P5; Shen W, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-17; Silver HJ, 2010, DIABETES METAB SYNDR, V3, P337, DOI [10.2147/DMSO.S9454, 10.2147/DMSOTT.S9454]; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Staiano AE, 2013, OBESITY, V21, P1251, DOI 10.1002/oby.20210; Staiano AE, 2012, INT J OBESITY, V36, P1261, DOI 10.1038/ijo.2012.95; Statistiek CBvd, 2004, GEZ MED CONS NAAR GG; von Schnurbein J, 2011, HORM RES PAEDIAT, V75, P412, DOI 10.1159/000324110; Weiss R, 2005, J CLIN ENDOCR METAB, V90, P3731, DOI 10.1210/jc.2004-2305; Xia Y, 2014, J CLIN DENSITOM, V17, P78, DOI 10.1016/j.jocd.2013.03.007	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165275	10.1371/journal.pone.0165275	http://dx.doi.org/10.1371/journal.pone.0165275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788168	gold, Green Published, Green Submitted			2022-12-26	WOS:000389604900054
J	Silk, JB; Seyfarth, RM; Cheney, DL				Silk, Joan B.; Seyfarth, Robert M.; Cheney, Dorothy L.			Strategic Use of Affiliative Vocalizations by Wild Female Baboons	PLOS ONE			English	Article							SOCIAL RELATIONSHIPS; GRUNT VOCALIZATIONS; MOREMI RESERVE; URSINUS	Although vocal production in non-human primates is highly constrained, individuals appear to have some control over whether to call or remain silent. We investigated how contextual factors affect the production of grunts given by wild female chacma baboons, Papio ursinus, during social interactions. Females grunted as they approached other adult females 28% of the time. Supporting previous research, females were much more likely to grunt to mothers with young infants than to females without infants. Grunts also significantly increased the likelihood of affiliative interactions among all partners. Notably, however, grunts did not simply mirror existing social bonds. Instead, they appeared to perform a very different function: namely, to serve as signals of benign intent between partners whose relationship is not necessarily close or predictable. Females were less likely to grunt to their mothers or adult daughters D-the individuals with whom they shared the closest and least aggressive bonds D-than to other females. In contrast, patterns of grunting between sisters were similar to those between nonkin, perhaps reflecting sisters' more ambivalent relationships. Females grunted at higher rates to lower-ranking, than to higher-ranking, females, supporting the hypothesis that grunts do not simply signal the signaler's level of arousal or anxiety about receiving aggression, but instead function as signals of benign intent. Taken together, results suggest that the grunts given by female baboons serve to reduce uncertainty about the likely outcome of an interaction between partners whose relationship is not predictably affiliative. Despite their limited vocal repertoire, baboons appear to be skilled at modifying call production in different social contexts and for different audiences.	[Silk, Joan B.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Seyfarth, Robert M.] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA; [Cheney, Dorothy L.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Arizona State University; Arizona State University-Tempe; University of Pennsylvania; University of Pennsylvania	Silk, JB (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	joansilk@gmail.com	Seyfarth, Robert/AAX-9474-2020		National Science Foundation [9213586]; National Institutes of Health [HD-29433, MH62249]; Leakey Foundation; National Geographic Society; University of Pennsylvania; Arizona State University	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leakey Foundation; National Geographic Society(National Geographic Society); University of Pennsylvania; Arizona State University	National Science Foundation (9213586) (JBS), National Institutes of Health (HD-29433, MH62249) (DLC, RMS), The Leakey Foundation (DLC, RMS), The National Geographic Society (DLC, RMS), The University of Pennsylvania (DLC, RMS), and Arizona State University (JBS).	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Altmann J., 1980, BABOON MOTHERS INFAN; Arlet M, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0711; BAUERS KA, 1993, ETHOLOGY, V94, P147; Boinski S, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P421; Cheney DL, 1997, ANIM BEHAV, V54, P409, DOI 10.1006/anbe.1996.0438; Cheney DL, 2004, INT J PRIMATOL, V25, P401, DOI 10.1023/B:IJOP.0000019159.75573.13; CHENEY DL, 1995, ANIM BEHAV, V50, P249, DOI 10.1006/anbe.1995.0237; Cheney DL, 1996, ANIM BEHAV, V52, P507, DOI 10.1006/anbe.1996.0193; Cheney DL, 2007, BABOON METAPHYSICS, DOI [10.7208/chicago/9780226102429.001.0001, DOI 10.7208/CHICAGO/9780226102429.]; Egnor SER, 2007, J COMP PHYSIOL A, V193, P477, DOI 10.1007/s00359-006-0205-7; Engh AL, 2006, ANIM BEHAV, V71, P381, DOI 10.1016/j.anbehav.2005.05.009; Fischer J, 2011, INT J PRIMATOL, V32, P1279, DOI 10.1007/s10764-011-9542-7; Frank RE, 2009, BEHAVIOUR, V146, P889, DOI 10.1163/156853908X396656; Hammerschmidt K., 2008, EVOLUTION COMMUNICAT, P93; Herbinger I, 2009, ANIM BEHAV, V78, P1389, DOI 10.1016/j.anbehav.2009.09.010; Kulahci IG, 2015, ANIM BEHAV, V110, P179, DOI 10.1016/j.anbehav.2015.09.016; Marler P, 1983, ADV STUDY MAMMALIAN, P343; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Rendall D, 1999, ANIM BEHAV, V57, P583, DOI 10.1006/anbe.1998.1031; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Seyfarth RM, 2016, ANIM BEHAV IN PRESS, DOI 10.1016/j.anbehav.2016.05.020; Seyfarth RM, 2012, P NATL ACAD SCI USA, V109, P16980, DOI 10.1073/pnas.1210780109; Silk JB, 1996, ANIM BEHAV, V52, P259, DOI 10.1006/anbe.1996.0171; Silk JB, 2000, ANIM BEHAV, V59, P423, DOI 10.1006/anbe.1999.1312; Silk JB, 2003, ETHOLOGY, V109, P627, DOI 10.1046/j.1439-0310.2003.00907.x; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522; Silk J, 2013, EVOL ANTHROPOL, V22, P213, DOI 10.1002/evan.21367; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Silk JB, 2012, ANIM BEHAV, V83, P1511, DOI 10.1016/j.anbehav.2012.03.028; Silk JB, 2010, BEHAV ECOL SOCIOBIOL, V64, P1733, DOI 10.1007/s00265-010-0986-0; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Smith W.J., 1977, BEHAV COMMUNICATING; Takahashi DY, 2015, SCIENCE, V349, P734, DOI 10.1126/science.aab1058; Teixeira de Cunha Rogerio Grassetto, 2009, P341, DOI 10.1007/978-0-387-78705-3_13; Whitham JC, 2007, ETHOLOGY, V113, P862, DOI 10.1111/j.1439-0310.2007.01381.x	36	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0163978	10.1371/journal.pone.0163978	http://dx.doi.org/10.1371/journal.pone.0163978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783705	gold, Green Published			2022-12-26	WOS:000389602800021
J	Tabrizi, JS; Sadeghi-Bazargani, H; Farahbakhsh, M; Nikniaz, L; Nikniaz, Z				Tabrizi, Jafar Sadegh; Sadeghi-Bazargani, Homayoun; Farahbakhsh, Mostafa; Nikniaz, Leila; Nikniaz, Zeinab			Prevalence and Associated Factors of Prehypertension and Hypertension in Iranian Population: The Lifestyle Promotion Project (LPP)	PLOS ONE			English	Article							TO-HEIGHT RATIO; RISK-FACTORS; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; MONGOLIAN POPULATION; WAIST CIRCUMFERENCE; ADULT-POPULATION; INNER-MONGOLIA; SCREENING TOOL; GLOBAL BURDEN	Background This population-based study aimed at investigating the prevalence and associated factors of prehypertension/hypertension in Iran. Methods and Findings The data (n = 2818) for this study were collected in 2015 as a part of the major Lifestyle Promotion Project (LPP) conducted in East Azerbaijan (urban and regional parts). The data for socio-demographic status, dietary information, and physical activity and anxiety levels were collected through validated questionnaires. Then, physical examination including systolic and diastolic blood pressure (SBP, DBP), body mass index (BMI) and conicity index was performed. First-morning spot urine (SU) sample was collected to assume salt intake. The One-way ANOVA, logistic regression, chi-square test and independent t-test were used for statistical analysis. The prevalence of prehypertension, stage I and stage II hypertension, and overall hypertension was 47.3%, 13.6%, 5.45% and 22.6% respectively. The mean systolic (p = 0.004) and diastolic (p< 0.001) blood pressure in men were significantly higher than women. Results of logistic regression analysis showed that in both sexes, family history of hypertension, obesity, abdominal obesity, anxiety and having high levels of sodium intake were associated with high blood pressure (p< 0.05). Additionally, 45.8% of the hypertensive patients were aware of their disease, 10.0% of the aware patients, and 44.5% of everyone with high blood pressure were receiving antihypertensive medication. Conclusions Our data showed that prehypertension/hypertension is a major health problem in Iran. Focusing on identifying risk factors to hypertension, regular drug intake, good nutrition, physical activity, and changing lifestyles of patients with hypertension are essential.	[Tabrizi, Jafar Sadegh] Tabriz Univ Med Sci, Fac Management & Med Informat, Tabriz Hlth Serv Management Res Ctr, Tabriz, Iran; [Sadeghi-Bazargani, Homayoun] Tabriz Univ Med Sci, Fac Hlth, Dept Stat & Epidemiol, Rd & Traff Injury Res Ctr, Tabriz, Iran; [Farahbakhsh, Mostafa] Tabriz Univ Med Sci, Res Ctr Psychiat & Behav Sci, Tabriz, Iran; [Nikniaz, Leila] Tabriz Univ Med Sci, Tabriz Hlth Serv Management Res Ctr, Tabriz, Iran; [Nikniaz, Zeinab] Tabriz Univ Med Sci, Liver & Gastrointestinal Dis Res Ctr, Tabriz, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Nikniaz, L (corresponding author), Tabriz Univ Med Sci, Tabriz Hlth Serv Management Res Ctr, Tabriz, Iran.	nikniazleila@gmail.com	Nikniaz, Leila/M-5747-2017; Farahbakhsh, Mostafa/F-3748-2018; Sadeghi-Bazargani, Homayoun/M-5522-2017; nikniaz, zeinab/L-5912-2017; tabrizi, jafarsadegh/L-5036-2017	Nikniaz, Leila/0000-0003-2951-936X; nikniaz, zeinab/0000-0001-6522-1048; tabrizi, jafarsadegh/0000-0002-1458-8672	East Azarbaijan Provincial Health Center; Tabriz Health Services Management Research Center at Tabriz University of Medical Sciences; Eastern Azarbaijan Governor General	East Azarbaijan Provincial Health Center; Tabriz Health Services Management Research Center at Tabriz University of Medical Sciences; Eastern Azarbaijan Governor General	This work was supported by the following sources of funding: East Azarbaijan Provincial Health Center; Tabriz Health Services Management Research Center at Tabriz University of Medical Sciences; Eastern Azarbaijan Governor General.; The authors wish to thank the East Azarbaijan Provincial Health Center, Tabriz Health Services Management Research Center at Tabriz University of Medical Sciences and Eastern Azarbaijan Governor General for financial support.	Abdollahy A, 2007, J GORGAN U MED SCI, V8, P37; Ahmadi A, 2014, INT J EPIDEMIOLOGIC, V1, P3; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Azizi F, 2002, J HUM HYPERTENS, V16, P305, DOI 10.1038/sj.jhh.1001399; Bovet P, 2002, INT J EPIDEMIOL, V31, P240, DOI 10.1093/ije/31.1.240; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Cheraghian B, 2014, MED J ISLAMIC REPUBL, V28, P67; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Deaton C, 2011, J CARDIOVASC NURS, V26, pS5, DOI 10.1097/JCN.0b013e318213efcf; Drenjancevic-Peric I, 2011, KIDNEY BLOOD PRESS R, V34, P1, DOI 10.1159/000320387; Efstratopoulos AD, 2006, AM J HYPERTENS, V19, P53, DOI 10.1016/j.amjhyper.2005.07.011; Erem C, 2009, J PUBLIC HEALTH-UK, V31, P47, DOI 10.1093/pubmed/fdn078; Gulen M., 1994, BMJ-BRIT MED J, V308, P60; Gupta AK, 2010, HYPERTENS RES, V33, P905, DOI 10.1038/hr.2010.91; He FJ, 2013, EFFECT LONGER TERM M; Hildrum B, 2008, BRIT J PSYCHIAT, V193, P108, DOI 10.1192/bjp.bp.107.045013; Janghorbani M, 2008, J HYPERTENS, V26, P419, DOI 10.1097/HJH.0b013e3282f2d34d; Jenkins Sandra, 2005, J Pediatr Nurs, V20, P258, DOI 10.1016/j.pedn.2005.02.014; Jonas BS, 2000, PSYCHOSOM MED, V62, P188, DOI 10.1097/00006842-200003000-00006; Kaplan N., 1998, CLIN HYPERTENTION; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lee JH, 2006, PUBLIC HEALTH NURS, V23, P314, DOI 10.1111/j.1525-1446.2006.00567.x; Li HM, 2008, CIRC J, V72, P1666, DOI 10.1253/circj.CJ-08-0138; Liszka HA, 2005, ANN FAM MED, V3, P294, DOI 10.1370/afm.312; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Motlagh SFZ, 2015, INT J HYPERTENS, V2015, DOI 10.1155/2015/897070; Mufunda T, 2000, J HUM HYPERTENS, V14, P65, DOI 10.1038/sj.jhh.1000886; Murray CJ L., 1996, GLOBAL BURDEN DIS IN, V2; Noorbala AA, 2004, BRIT J PSYCHIAT, V184, P70, DOI 10.1192/bjp.184.1.70; Park SH, 2009, CIRC J, V73, P1643, DOI 10.1253/circj.CJ-09-0161; Peymani P, 2012, IR IRAN INT CARDIOVA, V6, P40; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Rhee MY, 2014, NUTRIENTS, V6, P2360, DOI 10.3390/nu6062360; Rywik SL, 1998, ANN EPIDEMIOL, V8, P3, DOI 10.1016/S1047-2797(97)00177-4; Sadeghi M, 2004, Med J Malaysia, V59, P460; Shinn EH, 2001, AM J HYPERTENS, V14, P660, DOI 10.1016/S0895-7061(01)01304-8; SOMOVA LI, 1995, J HYPERTENS, V13, P193; Sun ZQ, 2007, CIRC J, V71, P550, DOI 10.1253/circj.71.550; Tabrizi J., 2016, DEPICTION HLTH, V7, P1; Tu K, 2008, CAN MED ASSOC J, V178, P1429, DOI 10.1503/cmaj.071283; Vasheghani-Farahani Ali, 2011, Asian J Sports Med, V2, P106; Who J, 2003, WHO TECH REP SER, V916; World Health Organization, 2016, GLOB BRIEF HYP SIL K; Yan LJL, 2003, JAMA-J AM MED ASSOC, V290, P2138, DOI 10.1001/jama.290.16.2138; Zametkin AJ, 2004, FOCUS; Zhang MZ, 2009, CIRC J, V73, P1437, DOI 10.1253/circj.CJ-09-0101	48	54	56	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165264	10.1371/journal.pone.0165264	http://dx.doi.org/10.1371/journal.pone.0165264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783691	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800066
J	Franceschini, M; Massimiani, MP; Paravati, S; Agosti, M				Franceschini, Marco; Massimiani, Maria Pia; Paravati, Stefano; Agosti, Maurizio			Return to Work: A Cut-Off of FIM Gain with Montebello Rehabilitation Factor Score in Order to Identify Predictive Factors in Subjects with Acquired Brain Injury	PLOS ONE			English	Article							LIFE; EMPLOYMENT; STROKE	Return to work (RTW) for people with acquired brain injury (ABI) represents a main objective of rehabilitation: this work presents a strong correlation between personal well-being and quality of life. The aim of this study is to investigate the prognostic factors that can predict RTW after ABI (traumatic or non-traumatic aetiology) in patients without disorders of consciousness (e.g. coma, vegetative or minimally conscious state) at the beginning of their admission to rehabilitation. At the end of a 6-month follow-up after discharge, data were successfully collected in 69 patients. The rehabilitation effectiveness (functional Recovery) between admission and discharge was assessed by Functional Independent Measure (FIM) gain, through the Montebello Rehabilitation Factor Score (MRFS), which was obtained as follows: (discharge FIM D admission FIM)/(Maximum possible FIM D Admission FIM) x 100. The cut-off value (criterion) deriving from MRFS, which helped identify RTW patients, resulted inn.659 (sn 88.9%; sp 52.4%). Considering the Mini Mental State Examination (MMSE) and the MRFS data, the multivariable binary logistic regression analysis presented 62.96% of correct RTW classification cases, 80.95% of non-RTW leading to an overall satisfactory predictability of 73.91%. The results of the present study suggest that occupational therapy intervention could modify cut-off in patients with an MFRS close to target at the end of an in-hospital rehabilitative program thus developing their capabilities and consequently surpassing cut-off itself.	[Franceschini, Marco] IRCCS San Raffaele Pisana, Rome, Italy; [Franceschini, Marco] San Raffaele Univ, Rome, Italy; [Massimiani, Maria Pia] San Raffaele Portuense, Rome, Italy; [Paravati, Stefano] Tor Vergata Univ, Dept Phys Med & Rehabil, Rome, Italy; [Agosti, Maurizio] Univ Hosp Parma, Parma, Italy	IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; University of Rome Tor Vergata; University of Parma; University Hospital of Parma	Franceschini, M (corresponding author), IRCCS San Raffaele Pisana, Rome, Italy.; Franceschini, M (corresponding author), San Raffaele Univ, Rome, Italy.	marco.franceschini@sanraffaele.it		Franceschini, Marco/0000-0002-2131-1583; Agosti, Maurizio/0000-0003-2365-3488	Italian Health Ministry [RFPS 2008-2-1137641]	Italian Health Ministry(Ministry of Health, Italy)	Italian Health Ministry funded this project (project no RFPS 2008-2-1137641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; Biering K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049268; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Denti L, 2008, EUR J PHYS REHAB MED, V44, P3; Drubach DA, 1994, J NEUROL REHABIL, V8, P92; Franceschini M, 2012, SPINAL CORD, V50, P238, DOI 10.1038/sc.2011.131; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Koh GCH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003483; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; O'Neill JH, 2004, ARCH PHYS MED REHAB, V85, pS68, DOI 10.1016/j.apmr.2003.08.114; SCHAFER H, 1989, STAT MED, V8, P1381, DOI 10.1002/sim.4780081110; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; ZWEIG MH, 1993, CLIN CHEM, V39, P561	25	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165165	10.1371/journal.pone.0165165	http://dx.doi.org/10.1371/journal.pone.0165165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED7LQ	27780215	Green Submitted, Green Published, gold			2022-12-26	WOS:000389046900032
J	Pan, CW; Chen, MH; Chou, LS; Lin, HJ				Pan, Ching-Wen; Chen, Meng-Hsien; Chou, Lien-Siang; Lin, Hsing-Juh			The Trophic Significance of the Indo-Pacific Humpback Dolphin, Sousa chinensis, in Western Taiwan	PLOS ONE			English	Article							PHYTOPLANKTON BIOMASS; MODEL; HABITAT; LAGOON; RIVER; PRODUCTIVITY; PATTERNS; GROWTH; CARBON; RATES	Indo-Pacific humpback dolphins (Sousa chinensis) have attracted considerable attention due to their critically endangered status and related conservation issues, but their trophic relationships and ecological significance in coastal ecosystems are poorly understood. For instance, this species is noticeably more abundant in the Xin-Huwei River Estuary (Ex) of Western Taiwan than in the nearby Zhuoshui River Estuary (Ez), though it is unclear why the distribution shows such partitioning. To explore this topic, we conducted field surveys seasonally for two years from 2012 to 2013 and constructed Ecopath models of Ex, Ez, and an offshore site (Dm) to compare energy flow within the food webs. Model comparisons showed that the availability of food resources was the main factor influencing the biomass of Indo-Pacific humpback dolphins. Specifically, its more frequent occurrence in Ex can be attributed to greater phytoplankton production and greater biomasses of macroinverte-brates and prey fish than in the other two areas. An increase in fishing activity might decrease the food availability and, consequently, the biomass of the dolphins. Although the decline in the dolphin population would increase the biomass of some prey fish species, local fishermen might not necessarily benefit from the decline due to the concurrent decrease of highly valued crabs and shrimp. Collectively, our work suggests that the Indo-Pacific humpback dolphin is a keystone species in tropical coastal waters of Taiwan, and thereby exhibit a disproportional large ecological impact given their relatively low abundance.	[Pan, Ching-Wen; Lin, Hsing-Juh] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Pan, Ching-Wen; Lin, Hsing-Juh] Natl Chung Hsing Univ, Res Ctr Global Change Biol, Taichung 402, Taiwan; [Chen, Meng-Hsien] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung 804, Taiwan; [Chen, Meng-Hsien] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Kaohsiung 804, Taiwan; [Chen, Meng-Hsien] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan; [Chou, Lien-Siang] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 106, Taiwan; [Lin, Hsing-Juh] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	National Chung Hsing University; National Chung Hsing University; National Sun Yat Sen University; National Sun Yat Sen University; Kaohsiung Medical University; National Taiwan University; Academia Sinica - Taiwan	Lin, HJ (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan.; Lin, HJ (corresponding author), Natl Chung Hsing Univ, Res Ctr Global Change Biol, Taichung 402, Taiwan.; Lin, HJ (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	hjlin@dragon.nchu.edu.tw		Lin, Hsing-Juh/0000-0001-8322-7195	Formosa Plastic Group	Formosa Plastic Group	We received funding from the Formosa Plastic Group. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHASSAN JM, 1987, J TOXICOL-TOXIN REV, V6, P1, DOI 10.3109/15569548709053860; Barros Nelio B., 2004, Aquatic Mammals, V30, P179, DOI 10.1578/AM.30.1.2004.179; Brey T., 1999, Naga, V22, P24; Chang HY, 2012, FRESHWATER BIOL, V57, P1839, DOI 10.1111/j.1365-2427.2012.02843.x; Christensen V., 2005, ECOPATH ECOSIM USERS; Cloern JE, 2014, BIOGEOSCIENCES, V11, P2477, DOI 10.5194/bg-11-2477-2014; Cloern James E., 1999, Aquatic Ecology, V33, P3, DOI 10.1023/A:1009952125558; CLOERN JE, 1987, CONT SHELF RES, V7, P1367, DOI 10.1016/0278-4343(87)90042-2; Cloern JE, 2002, LIMNOL OCEANOGR, V47, P713, DOI 10.4319/lo.2002.47.3.0713; Duan LJ, 2009, ECOL MODEL, V220, P2802, DOI 10.1016/j.ecolmodel.2009.07.016; Field JG., 1989, NETWORK ANAL MARINE, P3; Funtowicz S. O., 1990, UNCERTAINTY QUALITY; Gameiro C, 2011, HYDROBIOLOGIA, V669, P249, DOI 10.1007/s10750-011-0695-3; Guenette S, 2006, CAN J FISH AQUAT SCI, V63, P2495, DOI 10.1139/F06-136; Hirst AG, 2003, LIMNOL OCEANOGR, V48, P1988, DOI 10.4319/lo.2003.48.5.1988; Hirst AG, 2003, ADV MAR BIOL, V44, P1, DOI 10.1016/S0065-2881(03)44002-9; Hoeinghaus DJ, 2007, ECOSYSTEMS, V10, P1019, DOI 10.1007/s10021-007-9075-2; HOENIG JM, 1983, FISH B-NOAA, V81, P898; Hung K, 2008, THESIS; Jefferson Thomas A., 2001, Mammalian Species, V655, P1, DOI 10.1644/1545-1410(2001)655<0001:SC>2.0.CO;2; Karczmarski L, 2000, MAR MAMMAL SCI, V16, P65, DOI 10.1111/j.1748-7692.2000.tb00904.x; Kay J. J., 1989, NETWORK ANAL MARINE, P15, DOI DOI 10.1007/978-3-642-75017-5_2; Ko M.-C., 2011, THESIS; KUO D, 2011, FISH CENT RES REP, V19, P97; Lee LH, 2011, MAR ECOL PROG SER, V441, P33, DOI 10.3354/meps09362; Libralato S, 2006, ECOL MODEL, V195, P153, DOI 10.1016/j.ecolmodel.2005.11.029; Lin HJ, 1999, ESTUAR COAST SHELF S, V48, P575, DOI 10.1006/ecss.1998.0457; Lin HJ, 2007, MAR POLLUT BULL, V54, P1789, DOI 10.1016/j.marpolbul.2007.07.008; Lin HJ, 2006, MAR ENVIRON RES, V62, P61, DOI 10.1016/j.marenvres.2006.03.003; Lin HJ, 2012, AQUAT BIOL, V17, P269, DOI 10.3354/ab00481; Lin TH, 2015, ESTUAR COAST, V38, P1376, DOI 10.1007/s12237-014-9886-2; Lin TH, 2013, MAR BIOL, V160, P1353, DOI 10.1007/s00227-013-2187-7; Meyercordt J, 1999, AQUAT MICROB ECOL, V20, P273, DOI 10.3354/ame020273; Monaco ME, 1997, MAR ECOL PROG SER, V161, P239, DOI 10.3354/meps161239; Morissette L., 2007, THESIS U BRIT COLUMB; Okey TA, 2004, ECOL MODEL, V172, P383, DOI 10.1016/j.ecolmodel.2003.09.019; Opitz S., 1996, TROPHIC INTERACTIONS; Pan CW, 2016, CONT SHELF RES, V118, P88, DOI 10.1016/j.csr.2016.02.015; Parra GJ, 2006, J ANIM ECOL, V75, P862, DOI 10.1111/j.1365-2656.2006.01104.x; Parsons ECM, 1998, SCI TOTAL ENVIRON, V214, P175, DOI 10.1016/S0048-9697(98)00063-1; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; REDFIELD AC, 1958, AM SCI, V46, P205; Reeves RR, 2008, IUCN RED LIST THREAT, V2008; RIDDLE MJ, 1990, MAR BIOL, V104, P109, DOI 10.1007/BF01313164; Ross PS, 2010, AQUAT CONSERV, V20, P685, DOI 10.1002/aqc.1141; Testa J.M., 2012, ESTUARINE ECOLOGY, P381; THOMAS L., 2006, DISTANCE 5 0 RELEASE; Trites Andrew W., 1997, Journal of Northwest Atlantic Fishery Science, V22, P173; ULANOWICZ R E, 1990, Coenoses, V5, P7; Wang JY, 2007, MAMMALIA, V71, P157, DOI 10.1515/MAMM.2007.032; Wang JY, 2008, MAMMALIA, V72, P302, DOI 10.1515/MAMM.2008.030	51	6	6	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165283	10.1371/journal.pone.0165283	http://dx.doi.org/10.1371/journal.pone.0165283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780252	Green Submitted, Green Published, gold			2022-12-26	WOS:000389046900040
J	Yamao, M; Aoki, K; Yukinawa, N; Ishii, S; Matsuda, M; Naoki, H				Yamao, Masataka; Aoki, Kazuhiro; Yukinawa, Naoto; Ishii, Shin; Matsuda, Michiyuki; Naoki, Honda			Two New FRET Imaging Measures: Linearly Proportional to and Highly Contrasting the Fraction of Active Molecules	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; LIVING CELLS; FLUORESCENCE MICROSCOPY; SINGLE-MOLECULE; FEEDBACK LOOPS; PROTEIN; BIOSENSORS; PROBES; NEURITOGENESIS; ACTIVATION	We developed two new FRET imaging measures for intramolecular FRET biosensors, called linearly proportional (LP) and highly contrasting (HC) measures, which can be easily calculated by the fluorescence intensities of donor and acceptor as a ratio between their weighted sums. As an alternative to the conventional ratiometric measure, which non-linearly depends on the fraction of active molecule, we first developed the LP measure, which is linearly proportional to the fraction of active molecules. The LP measure inherently unmixes bleed-through signals and is robust against fluorescence noise. By extending the LP measure, we furthermore designed the HC measure, which provides highly contrasting images of the molecular activity, more than the ratiometric measure. In addition to their advantages, these measures are insensitive to the biosensor expression level, which is a fundamental property of the ratiometric measure. Using artificial data and FRET imaging data, we showed that the LP measure effectively represents the fraction of active molecules and that the HC measure improves visual interpretability by providing high contrast images of molecular activity. Therefore, the LP and HC measures allow us to gain more quantitative and qualitative insights from FRET imaging than the ratiometric measure.	[Yamao, Masataka] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara, Japan; [Aoki, Kazuhiro] Natl Inst Basic Biol, Okazaki, Aichi, Japan; [Yukinawa, Naoto] Okinawa Inst Sci & Technol Grad Univ, Kunigami, Okinawa, Japan; [Ishii, Shin; Matsuda, Michiyuki; Naoki, Honda] Kyoto Univ, Imaging Platform Spatiotemporal Informat, Sakyo Ku, Kyoto, Japan; [Ishii, Shin] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan; [Matsuda, Michiyuki; Naoki, Honda] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto, Japan	Nara Institute of Science & Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okinawa Institute of Science & Technology Graduate University; Kyoto University; Kyoto University; Kyoto University	Naoki, H (corresponding author), Kyoto Univ, Imaging Platform Spatiotemporal Informat, Sakyo Ku, Kyoto, Japan.; Naoki, H (corresponding author), Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto, Japan.	n-honda@sys.i.kyoto-u.ac.jp	Naoki, Honda/N-5674-2017; Aoki, Kazuhiro/I-5483-2019; Naoki, Honda/AAW-6284-2020	Naoki, Honda/0000-0001-6816-9126; Aoki, Kazuhiro/0000-0001-7263-1555; Naoki, Honda/0000-0001-6816-9126; Ishii, Shin/0000-0001-9385-8230; Matsuda, Michiyuki/0000-0002-5876-9969	Ministry of Education, Culture, Sports, Science (MEXT); Japan Agency for Medical Research and development (AMED), Japan; Grants-in-Aid for Scientific Research [26290053] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and development (AMED), Japan(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) (H. N., K. A., M. M. and S. I.)from the Ministry of Education, Culture, Sports, Science (MEXT) and Japan Agency for Medical Research and development (AMED), Japan. URL: http://www.amed.go.jp/. Grant number: none. The Strategic Research Program for Brain Sciences (M. Y., H. N., N.Y. and S. I.) from the Ministry of Education, Culture, Sports, Science (MEXT) and Japan Agency for Medical Research and development (AMED), Japan. URL: http://www.nips.ac.jp/srpbs/. Grant number: none.	Ahmed S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134708; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Aoki K, 2012, CANCER SCI, V103, P614, DOI 10.1111/j.1349-7006.2011.02196.x; Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Birtwistle MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027823; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Deniz AA, 2001, ANNU REV PHYS CHEM, V52, P233, DOI 10.1146/annurev.physchem.52.1.233; Fruhwirth GO, 2011, CHEMPHYSCHEM, V12, P442, DOI 10.1002/cphc.201000866; Fujita Y, 2014, FEBS J, V281, P3177, DOI 10.1111/febs.12852; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Hiratsuka T, 2015, ELIFE, V4, DOI 10.7554/eLife.05178; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; KRISHNAMURTHI V, 1995, APPL OPTICS, V34, P6633, DOI 10.1364/AO.34.006633; Kunida K, 2012, J CELL SCI, V125, P2381, DOI 10.1242/jcs.096859; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Michelson A.A., 1995, STUDIES OPTICS; Miyawaki A, 2015, MOL CELL, V58, P632, DOI 10.1016/j.molcel.2015.03.002; Nagy P, 2005, CYTOM PART A, V67A, P86, DOI 10.1002/cyto.a.20164; Nagy P, 2016, CYTOM PART A, V89A, P376, DOI 10.1002/cyto.a.22828; Nakamura T, 2008, BRAIN CELL BIOL, V36, P19, DOI 10.1007/s11068-008-9028-5; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; Salonikidis PS, 2008, BIOPHYS J, V95, P5412, DOI 10.1529/biophysj.107.125666; Sample V, 2014, J CELL SCI, V127, P1151, DOI 10.1242/jcs.099994; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Tao W, 2015, AM J PHYSIOL-CELL PH, V309, pC724, DOI 10.1152/ajpcell.00182.2015; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsukada Y, 2016, J NEUROSCI, V36, P2571, DOI 10.1523/JNEUROSCI.2837-15.2016; Tsukada Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000223; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Woehler A, 2010, BIOPHYS J, V99, P2344, DOI 10.1016/j.bpj.2010.07.053; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yamao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17527; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zeug A, 2012, BIOPHYS J, V103, P1821, DOI 10.1016/j.bpj.2012.09.031	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164254	10.1371/journal.pone.0164254	http://dx.doi.org/10.1371/journal.pone.0164254			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780260	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900010
J	George, SK; Abolbashari, M; Jackson, JD; Aboushwareb, T; Atalal, A; Yoo, JJ				George, Sunil K.; Abolbashari, Mehran; Jackson, John D.; Aboushwareb, Tamer; Atalal, Anthony; Yoo, James J.			Potential Use of Autologous Renal Cells from Diseased Kidneys for the Treatment of Renal Failure	PLoS One			English	Article							PROXIMAL TUBULE CELLS; ERYTHROPOIETIN-PRODUCING CELLS; EPITHELIAL-CELLS; OXIDATIVE STRESS; PROGENITOR CELLS; TIGHT JUNCTIONS; STEM-CELLS; IN-VITRO; THERAPY; PROLIFERATION	Chronic kidney disease (CKD) occurs when certain conditions cause the kidneys to gradually lose function. For patients with CKD, renal transplantation is the only treatment option that restores kidney function. In this study, we evaluated primary renal cells obtained from diseased kidneys to determine whether their normal phenotypic and functional characteristics are retained, and could be used for cell therapy. Primary renal cells isolated from both normal kidneys (NK) and diseased kidneys (CKD) showed similar phenotypic characteristics and growth kinetics. The expression levels of renal tubular cell markers, Aquaporin-1 and E-Cadherin, and podocyte-specific markers, WT-1 and Nephrin, were similar in both NK and CKD kidney derived cells. Using fluorescence-activated cell sorting (FACS), specific renal cell populations were identified and included proximal tubular cells (83.1% from NK and 80.3% from CKD kidneys); distal tubular cells (11.03% from NK and 10.9% from CKD kidneys); and podocytes (1.91% from NK and 1.78% from CKD kidneys). Ultra-structural analysis using scanning electron microscopy (SEM) revealed microvilli on the apical surface of cultured cells from NK and CKD samples. Moreover, transmission electron microscopy (TEM) analysis showed a similar organization of tight junctions, desmosomes, and other intracellular structures. The Na+ uptake characteristics of NK and CKD derived renal cells were also similar (24.4 mmol/L and 25 mmol/L, respectively) and no significant differences were observed in the protein uptake and transport characteristics of these two cell isolates. These results show that primary renal cells derived from diseased kidneys such as CKD have similar structural and functional characteristics to their counterparts from a normal healthy kidney (NK) when grown in vitro. This study suggests that cells derived from diseased kidney may be used as an autologous cell source for renal cell therapy, particularly in patients with CKD or end-stage renal disease (ESRD).	[George, Sunil K.; Jackson, John D.; Atalal, Anthony; Yoo, James J.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Abolbashari, Mehran] Texas Tech Univ, Paul L Foster Sch Med, El Paso, TX 79905 USA; [Aboushwareb, Tamer] Allergen Med Affairs, RSS Urol Mid Atlantic, POB 19534, Irvine, CA 92623 USA	Wake Forest University; Texas Tech University System; Texas Tech University	Yoo, JJ (corresponding author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jyoo@wakehealth.edu	Yoo, James J./L-4850-2017		Tengion Inc.; Wake Forest Institute for Regenerative Medicine	Tengion Inc.; Wake Forest Institute for Regenerative Medicine	This study was supported by Tengion Inc. through a sponsored research agreement, and Wake Forest Institute for Regenerative Medicine. In addition to supporting the study financially, Tengion Inc. was involved in the discussion of the study design and progress. There was no additional external funding received for this study.	Abolbashari M, 2016, ACTA BIOMATER, V29, P52, DOI 10.1016/j.actbio.2015.11.026; Aboushwareb T, 2008, WORLD J UROL, V26, P295, DOI 10.1007/s00345-008-0301-0; Atala A, 2004, AM J TRANSPLANT, V4, P58, DOI 10.1111/j.1600-6135.2004.0346.x; Baer PC, 2006, CELLS TISSUES ORGANS, V184, P16, DOI 10.1159/000096947; Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Chung HC, 2015, KOREAN J UROL, V56, P412, DOI 10.4111/kju.2015.56.6.412; Souza Clarissa Vasconcellos de, 2012, Rev. Bras. Hematol. Hemoter., V34, P345, DOI 10.5581/1516-8484.20120090; Denker BM, 2011, J AM SOC NEPHROL, V22, P622, DOI 10.1681/ASN.2010090922; DETRISAC CJ, 1984, KIDNEY INT, V25, P383, DOI 10.1038/ki.1984.28; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Gekle M, 2005, ANNU REV PHYSIOL, V67, P573, DOI 10.1146/annurev.physiol.67.031103.154845; George SK, 2011, AGING CELL, V10, P584, DOI 10.1111/j.1474-9726.2011.00686.x; Guimaraes-Souza NK, 2012, NEPHROL DIAL TRANSPL, V27, P3082, DOI 10.1093/ndt/gfr785; Hajhosseiny R, 2013, INT J CLIN PRACT, V67, P14, DOI 10.1111/j.1742-1241.2012.02954.x; Hryciw DH, 2012, CELL PHYSIOL BIOCHEM, V30, P1215, DOI 10.1159/000343313; Hugo C, 1998, KIDNEY INT, V54, P1934, DOI 10.1046/j.1523-1755.1998.00195.x; Jamiolkowski Ryan M., 2012, Yale Journal of Biology and Medicine, V85, P37; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Lanza RP, 2002, NAT BIOTECHNOL, V20, P689, DOI 10.1038/nbt703; NKUDIC, 2012, NAT KIDN UR DIS INF; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Oliver JA, 2004, CURR OPIN NEPHROL HY, V13, P17, DOI 10.1097/00041552-200401000-00003; Pavenstadt H, 2000, AM J PHYSIOL-RENAL, V278, pF173, DOI 10.1152/ajprenal.2000.278.2.F173; Phillips AO, 2002, HISTOL HISTOPATHOL, V17, P247, DOI 10.14670/HH-17.247; Presnell SC, 2011, TISSUE ENG PART C-ME, V17, P261, DOI [10.1089/ten.tec.2010.0399, 10.1089/ten.TEC.2010.0399]; Prevention: CfDCa, 2014, NAT CHRON KIDN DIS F; Reilly RF, 2007, STRUCTURAL FUNCTIONA; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Sabahi R, 2006, DRUGS, V66, P1933, DOI 10.2165/00003495-200666150-00004; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Sakakima M, 2008, NEPHRON EXP NEPHROL, V109, pE57, DOI 10.1159/000142100; Sasaki S, 2004, HYPERTENSION, V43, P286, DOI 10.1161/01.HYP.0000112421.18551.1e; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shimada IS, 2011, J CELL BIOCHEM, V112, P374, DOI 10.1002/jcb.22963; Smeets B, 2013, J PATHOL, V229, P645, DOI 10.1002/path.4125; Souma T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00167; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Tallheden T, 2005, ARTHRITIS RES THER, V7, pR560, DOI 10.1186/ar1709; Thomas R, 2008, PRIMARY CARE, V35, P329, DOI 10.1016/j.pop.2008.01.008; Vincent AS, 2004, KIDNEY INT, V65, P393, DOI 10.1111/j.1523-1755.2004.00391.x; Westover AJ, 2012, J TISSUE ENG REGEN M, V6, P589, DOI 10.1002/term.471; Yamaleyeva LM, 2012, STEM CELL TRANSL MED, V1, P373, DOI 10.5966/sctm.2011-0048; Yang M, 2011, ADV CHRONIC KIDNEY D, V18, P400, DOI 10.1053/j.ackd.2011.10.001; Zhai XY, 2000, KIDNEY INT, V58, P1523, DOI 10.1046/j.1523-1755.2000.00314.x; Zhao SA, 2009, REPROD SCI, V16, P970, DOI 10.1177/1933719109338630	48	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164997	10.1371/journal.pone.0164997	http://dx.doi.org/10.1371/journal.pone.0164997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776163	gold, Green Submitted, Green Published			2022-12-26	WOS:000389009200033
J	Li, YF; Adur, MK; Kannan, A; Davila, J; Zhao, YC; Nowak, RA; Bagchi, MK; Bagchi, IC; Li, QX				Li, Yanfen; Adur, Malavika K.; Kannan, Athilakshmi; Davila, Juanmahel; Zhao, Yuechao; Nowak, Romana A.; Bagchi, Milan K.; Bagchi, Indrani C.; Li, Quanxi			Progesterone Alleviates Endometriosis via Inhibition of Uterine Cell Proliferation, Inflammation and Angiogenesis in an Immunocompetent Mouse Model	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; DNA METHYLATION; GENE-EXPRESSION; LESION ESTABLISHMENT; IMMUNOPHILIN FKBP52; ECTOPIC ENDOMETRIUM; BABOON MODEL; PR-B; PATHOGENESIS; ESTRADIOL	Endometriosis, defined as growth of the endometrial cells outside the uterus, is an inflammatory disorder that is associated with chronic pelvic pain and infertility in women of childbearing age. Although the estrogen-dependence of endometriosis is well known, the role of progesterone in development of this disease remains poorly understood. In this study, we developed a disease model in which endometriosis was induced in the peritoneal cavities of immunocompetent female mice, and maintained with exogenous estrogen. The endometriosis- like lesions that were identified at a variety of ectopic locations exhibited abundant blood supply and extensive adhesions. Histological examination revealed that these lesions had a well-organized endometrial architecture and fibrotic response, resembling those recovered from clinical patients. In addition, an extensive proliferation, inflammatory response, and loss of estrogen receptor alpha (ERa) and progesterone receptor (PR) expression were also observed in these lesions. Interestingly, administration of progesterone before, but not after, lesion induction suppressed lesion expansion and maintained ERa and PR expressions. These progesterone-pretreated lesions exhibited attenuation in KI67, CD31, and pro-inflammatory cytokine expression as well as macrophage infiltration, indicating that progesterone ameliorates endometriosis progression by inhibiting cell proliferation, inflammation and neovascularization. Our studies further showed that suppression of global DNA methylation by application of DNA methyltransferase inhibitor to female mice bearing ectopic lesions restrained lesion expansion and restored ERa and PR expression in eutopic endometrium and ectopic lesions. These results indicate that epigenetic regulation of target gene expression via DNA methylation contributes, at least in part, to progesterone resistance in endometriosis.	[Li, Yanfen; Kannan, Athilakshmi; Davila, Juanmahel; Bagchi, Indrani C.; Li, Quanxi] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61801 USA; [Adur, Malavika K.; Nowak, Romana A.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Zhao, Yuechao; Bagchi, Milan K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA; [Li, Yanfen] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Adur, Malavika K.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Iowa State University	Li, QX (corresponding author), Univ Illinois, Dept Comparat Biosci, Urbana, IL 61801 USA.	quanxili@illinois.edu		Li, Yanfen/0000-0002-9465-7147	National Institute of Environmental Health Science [R21 ES024198]; National Institute of Child Health and Human Development [U54 HD 055787, U54 HD40093]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024198] Funding Source: NIH RePORTER	National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was supported by R21 ES024198, http://www.niehs.nih.gov/, National Institute of Environmental Health Science, QL. The funder had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The work was also supported by U54 HD 055787, https://www.nichd.nih.gov/Pages/index.aspx, National Institute of Child Health and Human Development. MKB and ICB. The funder had a role in study design, data collection and analysis. The work was also supported by U54 HD40093, https://www.nichd.nih.gov/Pages/index.aspx, National Institute of Child Health and Human Development. RAN. The funder had a role in study design, data collection and analysis, decision to publish.	Acien P, 2007, FERTIL STERIL, V88, P32, DOI 10.1016/j.fertnstert.2006.11.188; Afshar Y, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104497; Aghajanova L, 2009, ENDOCRINOLOGY, V150, P3863, DOI 10.1210/en.2009-0008; Andersson KL, 2014, HUM REPROD, V29, P1906, DOI 10.1093/humrep/deu161; Attia GR, 2000, J CLIN ENDOCR METAB, V85, P2897, DOI 10.1210/jc.85.8.2897; Bacci M, 2009, AM J PATHOL, V175, P547, DOI 10.2353/ajpath.2009.081011; BERGQVIST A, 1993, FERTIL STERIL, V60, P63; Borghese B, 2010, MOL ENDOCRINOL, V24, P1872, DOI 10.1210/me.2010-0160; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Bruner-Tran K L, 2013, Minerva Ginecol, V65, P199; Bulun SE, 2006, MOL CELL ENDOCRINOL, V248, P94, DOI 10.1016/j.mce.2005.11.041; Bulun SE, 2012, SEMIN REPROD MED, V30, P39, DOI 10.1055/s-0031-1299596; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029; Burns KA, 2012, ENDOCRINOLOGY, V153, P3960, DOI 10.1210/en.2012-1294; CONNEELY OM, 1989, J BIOL CHEM, V264, P14062; Cooke PS, 1997, P NATL ACAD SCI USA, V94, P6535, DOI 10.1073/pnas.94.12.6535; Delvoux B, 2009, J CLIN ENDOCR METAB, V94, P876, DOI 10.1210/jc.2008-2218; DIZEREGA GS, 1980, FERTIL STERIL, V33, P649; Dunselman GAJ, 2014, HUM REPROD, V29, P400, DOI 10.1093/humrep/det457; Dyson MT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004158; Fang ZJ, 2004, FERTIL STERIL, V82, P673, DOI 10.1016/j.fertnstert.2004.01.048; Fazleabas AT, 2010, SEMIN REPROD MED, V28, P75, DOI 10.1055/s-0029-1242997; Ferrero S, 2014, ANN NY ACAD SCI, V1317, P17, DOI 10.1111/nyas.12411; Foran E, 2010, MOL CANCER RES, V8, P471, DOI 10.1158/1541-7786.MCR-09-0496; Fuhrich DG, 2013, ANAL QUANT CYTOL, V35, P210; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Guo SW, 2009, MOL HUM REPROD, V15, P587, DOI 10.1093/molehr/gap064; Hadfield R, 1996, HUM REPROD, V11, P878; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Han SJ, 2015, CELL, V163, P960, DOI 10.1016/j.cell.2015.10.034; Harris HA, 2005, HUM REPROD, V20, P936, DOI 10.1093/humrep/deh711; Hayashi A, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-31; Heard ME, 2014, ENDOCRINOLOGY, V155, P1532, DOI 10.1210/en.2013-1947; Hirota Y, 2008, AM J PATHOL, V173, P1747, DOI 10.2353/ajpath.2008.080527; Hughes GC, 2014, NAT REV RHEUMATOL, V10, P740, DOI 10.1038/nrrheum.2014.144; Izawa Masao, 2013, Front Biosci (Elite Ed), V5, P900; Jackson KS, 2007, REPROD SCI, V14, P137, DOI 10.1177/1933719106298409; Jones LA, 2008, IMMUNOLOGY, V125, P59, DOI 10.1111/j.1365-2567.2008.02820.x; Kaponis Apostolos, 2012, Front Biosci (Schol Ed), V4, P1213; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Khin Sann Sanda, 2011, Cancers (Basel), V3, P982, DOI 10.3390/cancers3010982; Kim TH, 2014, ENDOCRINOLOGY, V155, P1921, DOI 10.1210/en.2013-1951; Kitawaki J, 2002, J STEROID BIOCHEM, V83, P149, DOI 10.1016/S0960-0760(02)00260-1; Lee B, 2009, BIOL REPROD, V80, P79, DOI 10.1095/biolreprod.108.070391; Li QX, 2016, ENDOCRINOLOGY, V157, P1764, DOI 10.1210/en.2015-2031; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Lousse Jean-Christophe, 2012, Front Biosci (Elite Ed), V4, P23; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Meyer JL, 2014, INT J MOL MED, V33, P897, DOI 10.3892/ijmm.2014.1637; Moradi M, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-123; Mounsey AL, 2006, AM FAM PHYSICIAN, V74, P594; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Naqvi H, 2014, REPROD SCI, V21, P1237, DOI 10.1177/1933719114532841; Nasu K, 2011, J OBSTET GYNAECOL RE, V37, P683, DOI 10.1111/j.1447-0756.2011.01663.x; Pawar S, 2014, MOL ENDOCRINOL, V28, P1408, DOI 10.1210/me.2014-1074; Pisetsky DS, 2011, CLIN VACCINE IMMUNOL, V18, P1420, DOI 10.1128/CVI.05110-11; PRENTICE A, 1992, HUM REPROD, V7, P1318, DOI 10.1093/oxfordjournals.humrep.a137848; Schweppe K-W., 2012, EXPERT REV OBSTET GY, V7, P141; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Slack A, 1999, EUR J BIOCHEM, V264, P191, DOI 10.1046/j.1432-1327.1999.00603.x; Tangen IL, 2014, EUR J CANCER, V50, P3003, DOI 10.1016/j.ejca.2014.09.003; van Kaam KJAF, 2008, HUM REPROD, V23, P2692, DOI 10.1093/humrep/den153; Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255; Wang XL, 2009, MOL IMMUNOL, V46, P2413, DOI 10.1016/j.molimm.2009.04.014; Wu Y, 2005, AM J OBSTET GYNECOL, V193, P371, DOI 10.1016/j.ajog.2005.01.034; Wu Y, 2008, FERTIL STERIL, V90, P234, DOI 10.1016/j.fertnstert.2007.06.008; Wu Y, 2006, EPIGENETICS-US, V1, P106, DOI 10.4161/epi.1.2.2766; Xia DR, 2012, NAT MED, V18, P224, DOI 10.1038/nm.2608; Xue Q, 2007, BIOL REPROD, V77, P681, DOI 10.1095/biolreprod.107.061804; Yamagata Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083612; Yasmin R, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/201703; Zhao YC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010626; Zhao YC, 2014, MOL ENDOCRINOL, V28, P1934, DOI 10.1210/me.2014-1080; Zheng QM, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0092-2	75	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165347	10.1371/journal.pone.0165347	http://dx.doi.org/10.1371/journal.pone.0165347			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776183	Green Submitted, Green Published, gold			2022-12-26	WOS:000389009200057
J	Cheng, B; Meng, YW; Cui, YB; Li, CF; Tao, F; Yin, HJ; Yang, CY; Xu, P				Cheng, Bin; Meng, Yiwei; Cui, Yanbing; Li, Chunfang; Tao, Fei; Yin, Huijia; Yang, Chunyu; Xu, Ping			Alkaline Response of a Halotolerant Alkaliphilic Halomonas Strain and Functional Diversity of Its Na+ (K+)/H+ Antiporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CATION/PROTON ANTIPORTERS; VIBRIO-PARAHAEMOLYTICUS; ALKALIMONAS-AMYLOLYTICA; BACILLUS-SUBTILIS; BLACK LIQUOR; GENE; CLONING; EXPRESSION; SYSTEM	Halomonas sp. Y2 is a halotolerant alkaliphilic strain from Na+-rich pulp mill wastewater with high alkalinity (pH > 11.0). Transcriptome analysis of this isolate revealed this strain may use various transport systems for pH homeostasis. In particular, the genes encoding four putative Na+/H+ antiporters were differentially expressed upon acidic or alkaline conditions. Further evidence, from heterologous expression and mutant studies, suggested that Halomonas sp. Y2 employs its Na+/H+ antiporters in a labor division way to deal with saline and alkaline environments. Ha-NhaD2 displayed robust Na+(Li+) resistance and high transport activities in Escherichia coli; a Delta Ha-nhaD2 mutant exhibited growth inhibition at high Na+(Li+) concentrations at pH values of 6.2, 8.0, and 10.0, suggesting its physiological role in osmotic homeostasis. In contrast, Ha-NhaD1 showed much weaker activities in ion exporting and pH homeostasis. Ha-Mrp displayed a combination of properties similar to those of Mrp transporters from some Bacillus alkaliphiles and neutrophiles. This conferred obvious Na+(Li+, K+) resistance in E. coli-deficient strains, as those ion transport spectra of some neutrophil Mrp antiporters. Conversely, similar to the Bacillus alkaliphiles, Ha-Mrp showed central roles in the pH homeostasis of Halomonas sp. Y2. An Ha-mrp-disrupted mutant was seriously inhibited by high concentrations of Na+(Li+, K+) but only under alkaline conditions. Ha-NhaP was determined to be a K+/H+ antiporter and shown to confer strong K+ resistance both at acidic and alkaline stresses.	[Cheng, Bin; Meng, Yiwei; Cui, Yanbing; Li, Chunfang; Yin, Huijia; Yang, Chunyu; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Tao, Fei; Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Tao, Fei; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China	Shandong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, CY (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	ycy21th@sdu.edu.cn	Liu, Wenjun/L-5256-2016	Liu, Wenjun/0000-0001-9380-2990; Xu, Ping/0000-0002-4418-9680	National Natural Science Foundation of China [31370153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 31370153. The authors declare that they have no conflicts of interest with the contents of this article.	Banciu HL, 2015, CURR OPIN MICROBIOL, V25, P73, DOI 10.1016/j.mib.2015.05.003; Chanroj S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00025; Dzioba J, 2002, MOL CELL BIOCHEM, V229, P119, DOI 10.1023/A:1017932829927; EPSTEIN W, 1993, BIOCHEM SOC T, V21, P1006, DOI 10.1042/bst0211006; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Grant WD, 2011, EXTREMOPHILES HDB, P27, DOI DOI 10.1007/978-4-431-53898-1_3; HAMAMOTO T, 1994, MOL MICROBIOL, V14, P939, DOI 10.1111/j.1365-2958.1994.tb01329.x; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; Huang GL, 2007, BIORESOURCE TECHNOL, V98, P2829, DOI 10.1016/j.biortech.2006.09.029; Ito M, 2001, FEBS LETT, V496, P117, DOI 10.1016/S0014-5793(01)02417-6; Ito M, 2000, J BACTERIOL, V182, P5663, DOI 10.1128/JB.182.20.5663-5670.2000; Janto B, 2011, ENVIRON MICROBIOL, V13, P3289, DOI 10.1111/j.1462-2920.2011.02591.x; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Krulwich TA, 2009, MOL MICROBIOL, V74, P257, DOI 10.1111/j.1365-2958.2009.06842.x; Kurz Matthias, 2006, Saline Syst, V2, P10, DOI 10.1186/1746-1448-2-10; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu J, 2005, J BACTERIOL, V187, P7589, DOI 10.1128/JB.187.22.7589-7595.2005; Meng L, 2014, EXTREMOPHILES, V18, P963, DOI 10.1007/s00792-014-0666-5; Mesbah NM, 2009, MOL MICROBIOL, V74, P270, DOI 10.1111/j.1365-2958.2009.06845.x; Nozaki K, 1998, BBA-BIOMEMBRANES, V1369, P213, DOI 10.1016/S0005-2736(97)00223-X; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; PINNER E, 1992, J BIOL CHEM, V267, P11064; Putnoky P, 1998, MOL MICROBIOL, V28, P1091, DOI 10.1046/j.1365-2958.1998.00868.x; Radchenko MV, 2006, MOL MICROBIOL, V59, P651, DOI 10.1111/j.1365-2958.2005.04966.x; Resch CT, 2010, BIOCHEMISTRY-US, V49, P2520, DOI 10.1021/bi902173y; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Stolyar S, 2007, J BACTERIOL, V189, P8944, DOI 10.1128/JB.00284-07; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Takami H., 2011, EXTREMOPHILES HDB, P184; Wei Y, 2007, MICROBIOL-SGM, V153, P2168, DOI 10.1099/mic.0.2007/007450-0; Wilks JC, 2009, APPL ENVIRON MICROB, V75, P981, DOI 10.1128/AEM.01652-08; Yang CY, 2010, BIORESOURCE TECHNOL, V101, P6778, DOI 10.1016/j.biortech.2010.03.108; Yang CY, 2010, BIORESOURCE TECHNOL, V101, P1737, DOI 10.1016/j.biortech.2009.09.092; Yang LF, 2006, FEMS MICROBIOL LETT, V255, P89, DOI 10.1111/j.1574-6968.2005.00055.x; Zou YJ, 2008, J MICROBIOL, V46, P415, DOI 10.1007/s12275-008-0009-2	42	30	34	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26056	26065		10.1074/jbc.M116.751016	http://dx.doi.org/10.1074/jbc.M116.751016			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27777302	Green Published, hybrid			2022-12-26	WOS:000390345200025
J	Lertkiatmongkol, P; Paddock, C; Newman, DK; Zhu, JQ; Thomas, MJ; Newman, PJ				Lertkiatmongkol, Panida; Paddock, Cathy; Newman, Debra K.; Zhu, Jieqing; Thomas, Michael J.; Newman, Peter J.			The Role of Sialylated Glycans in Human Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1)-mediated Trans Homophilic Interactions and Endothelial Cell Barrier Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOSYLATION; BINDING SPECIFICITIES; HEMOPHILIC BINDING; INFLUENZA-VIRUSES; PECAM-1; ACID; INFLAMMATION; DOMAINS; SIALOADHESIN; MIGRATION	Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1) is a major component of the endothelial cell intercellular junction. Previous studies have shown that PECAM-1 homophilic interactions, mediated by amino-terminal immunoglobulin homology domain 1, contribute to maintenance of the vascular permeability barrier and to its re-establishment following inflammatory or thrombotic insult. PECAM-1 glycans account for similar to 30% of its molecular mass, and the newly solved crystal structure of human PECAM-1 immunoglobulin homology domain 1 reveals that a glycan emanating from the asparagine residue at position 25 (Asn-25) is located within the trans homophilic-binding interface, suggesting a role for an Asn-25-associated glycan in PECAM-1 homophilic interactions. In support of this possibility, unbiased molecular docking studies revealed that negatively charged alpha 2,3 sialic acid moieties bind tightly to a groove within the PECAM-1 homophilic interface in an orientation that favors the formation of an electrostatic bridge with positively charged Lys-89, mutation of which has been shown previously to disrupt PECAM-1-mediated homophilic binding. To verify the contribution of the Asn-25 glycan to endothelial barrier function, we generated an N25Q mutant form of PECAM-1 that is not glycosylated at this position and examined its ability to contribute to vascular integrity in endothelial cell-like REN cells. Confocal microscopy showed that although N25Q PECAM-1 concentrates normally at cell-cell junctions, the ability of this mutant form of PECAM-1 to support re-establishment of a permeability barrier following disruption with thrombin was significantly compromised. Taken together, these data suggest that a sialic acid-containing glycan emanating from Asn-25 reinforces dynamic endothelial cell-cell interactions by stabilizing the PECAM-1 homophilic binding interface.	[Lertkiatmongkol, Panida; Paddock, Cathy; Newman, Debra K.; Zhu, Jieqing; Newman, Peter J.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53201 USA; [Lertkiatmongkol, Panida; Newman, Debra K.; Thomas, Michael J.; Newman, Peter J.] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA; [Zhu, Jieqing] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Newman, Peter J.] Med Coll Wisconsin, Dept Cell Biol, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Newman, PJ (corresponding author), BloodCtr Wisconsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	peter.newman@bcw.edu			NHLBI, National Institutes of Health [HL-40926]; Midwest Affiliate of the American Heart Association [16PRE30400012]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Midwest Affiliate of the American Heart Association(American Heart Association)	This work was supported by Grant HL-40926 from the NHLBI, National Institutes of Health (to P. J. N.) and Predoctoral Fellowship Award 16PRE30400012 (to P. L.) from the Midwest Affiliate of the American Heart Association. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe Y, 1999, J IMMUNOL, V163, P2867; ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Bird IN, 1999, J CELL SCI, V112, P1989; Carvalho S, 2016, ONCOGENE, V35, P1619, DOI 10.1038/onc.2015.225; Cioffi DL, 2012, AM J PHYSIOL-LUNG C, V302, pL1067, DOI 10.1152/ajplung.00190.2011; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Collins BE, 1997, J BIOL CHEM, V272, P16889, DOI 10.1074/jbc.272.27.16889; CUNNINGHAM BA, 1983, P NATL ACAD SCI-BIOL, V80, P3116, DOI 10.1073/pnas.80.10.3116; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Farooq MM, 2001, J VASC SURG, V34, P555, DOI 10.1067/mva.2001.115813; FERRERO E, 1995, FEBS LETT, V374, P323, DOI 10.1016/0014-5793(95)01110-Z; Gao CJ, 2003, BLOOD, V102, P169, DOI 10.1182/blood-2003-01-0003; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kaufman DA, 2004, BIOCHEM BIOPH RES CO, V320, P1076, DOI 10.1016/j.bbrc.2004.06.055; Kitazume S, 2014, J BIOL CHEM, V289, P27604, DOI 10.1074/jbc.M114.563585; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; Maas M, 2005, AM J PHYSIOL-HEART C, V288, pH159, DOI 10.1152/ajpheart.00500.2004; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; MCEVER RP, 1991, THROMB HAEMOSTASIS, V65, P223; Mei H, 2014, J BIOL CHEM, V289, P20836, DOI 10.1074/jbc.M114.557454; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Newman PJ, 1999, J CLIN INVEST, V103, P5, DOI 10.1172/JCI5928; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Newton JP, 1999, BIOCHEM BIOPH RES CO, V261, P283, DOI 10.1006/bbrc.1999.1018; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Nourshargh S, 2006, J LEUKOCYTE BIOL, V80, P714, DOI 10.1189/jlb.1105645; O'Brien CD, 2004, AM J PHYSIOL-CELL PH, V287, pC1103, DOI 10.1152/ajpcell.00573.2003; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Paddock C, 2016, BLOOD, V127, P1052, DOI 10.1182/blood-2015-07-660092; POWELL LD, 1994, J BIOL CHEM, V269, P10628; Privratsky JR, 2011, J CELL SCI, V124, P1477, DOI 10.1242/jcs.082271; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Rombouts Y, 2016, GLYCOCONJUGATE J, V33, P457, DOI 10.1007/s10719-015-9648-9; Sabri S, 1995, BIOCHEM CELL BIOL, V73, P411, DOI 10.1139/o95-048; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott DW, 2015, MOL BIOL CELL, V26, P3205, DOI 10.1091/mbc.E14-12-1604; Scott DW, 2013, AM J PHYSIOL-CELL PH, V305, pC228, DOI 10.1152/ajpcell.00116.2013; Scott DW, 2013, GLYCOBIOLOGY, V23, P622, DOI 10.1093/glycob/cwt014; Shi WX, 1996, J BIOL CHEM, V271, P15130, DOI 10.1074/jbc.271.25.15130; SMYTHE WR, 1994, CANCER RES, V54, P2055; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Sun J, 2000, J CELL SCI, V113, P1459; Sun J, 1996, J BIOL CHEM, V271, P18561, DOI 10.1074/jbc.271.31.18561; Sun QH, 1996, J BIOL CHEM, V271, P11090, DOI 10.1074/jbc.271.19.11090; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068; Zhao HB, 2008, J CELL BIOCHEM, V104, P162, DOI 10.1002/jcb.21608	61	21	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26216	26225		10.1074/jbc.M116.756502	http://dx.doi.org/10.1074/jbc.M116.756502			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27793989	Green Published, hybrid			2022-12-26	WOS:000390345200037
J	Huda, F; Fan, YP; Suzuki, M; Konno, A; Matsuzaki, Y; Takahashi, N; Chan, JKY; Hirai, H				Huda, Fathul; Fan, Yiping; Suzuki, Mamiko; Konno, Ayumu; Matsuzaki, Yasunori; Takahashi, Nobutaka; Chan, Jerry K. Y.; Hirai, Hirokazu			Fusion of Human Fetal Mesenchymal Stem Cells with "Degenerating" Cerebellar Neurons in Spinocerebellar Ataxia Type 1 Model Mice	PLOS ONE			English	Article							PURKINJE NEURONS; MOUSE MODEL; MUSCLE DIFFERENTIATION; NEURODEGENERATION; TRANSPLANTATION; EXPRESSION; TRANSDIFFERENTIATION; HETEROKARYONS; INDUCTION; VECTORS	Mesenchymal stem cells (MSCs) migrate to damaged tissues, where they participate in tissue repair. Human fetal MSCs (hfMSCs), compared with adult MSCs, have higher proliferation rates, a greater differentiation capacity and longer telomeres with reduced senescence. Therefore, transplantation of quality controlled hfMSCs is a promising therapeutic intervention. Previous studies have shown that intravenous or intracortical injections of MSCs result in the emergence of binucleated cerebellar Purkinje cells (PCs) containing an MSC-derived marker protein in mice, thus suggesting a fusion event. However, transdiffer-entiation of MSCs into PCs or transfer of a marker protein from an MSC to a PC cannot be ruled out. In this study, we unequivocally demonstrated the fusion of hfMSCs with murine PCs through a tetracycline-regulated (Tet-off) system with or without a Cre-dependent genetic inversion switch (flip-excision; FLEx). In the FLEx-Tet system, we performed intracerebellar injection of viral vectors expressing tetracycline transactivator (tTA) and Cre recombinase into either non-symptomatic (4-week-old) or clearly symptomatic (6-8-month-old) spinocerebellar ataxia type 1 (SCA1) mice. Then, the mice received an injection of 50,000 genetically engineered hfMSCs that expressed GFP only in the presence of Cre recombinase and tTA. We observed a significant emergence of GFP-expressing PCs and interneurons in symptomatic, but not non-symptomatic, SCA1 mice 2 weeks after the MSC injection. These results, together with the results obtained using age-matched wild-type mice, led us to conclude that hfMSCs have the potential to preferentially fuse with degenerating PCs and interneurons but not with healthy neurons.	[Huda, Fathul; Suzuki, Mamiko; Konno, Ayumu; Matsuzaki, Yasunori; Takahashi, Nobutaka; Hirai, Hirokazu] Gunma Univ, Grad Sch Med, Dept Neurophysiol & Neural Repair, Maebashi, Gunma 3718511, Japan; [Huda, Fathul] Padjadjaran State Univ, Div Physiol, Dept Anat Physiol & Cell Biol, Fac Med, Bandung 40161, Indonesia; [Fan, Yiping; Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore 229899, Singapore; [Fan, Yiping; Chan, Jerry K. Y.] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore 119228, Singapore; [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore	Gunma University; Universitas Padjadjaran; KK Women's & Children's Hospital; National University of Singapore; National University of Singapore	Hirai, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Neurophysiol & Neural Repair, Maebashi, Gunma 3718511, Japan.	hirai@gunma-u.ac.jp	Huda, Fathul/AAQ-3267-2020; Hirai, Hirokazu/ABP-1143-2022; Huda, Fathul/H-7431-2016; Konno, Ayumu/J-1667-2017	Huda, Fathul/0000-0002-4818-1862; Huda, Fathul/0000-0002-4818-1862; Konno, Ayumu/0000-0001-9382-396X; Hirai, Hirokazu/0000-0002-0721-4293	KAKENHI [26111701]; Naito Foundation; Gunma University Initiative for Advanced Research (GIAR); Ministry of Education, Science, Sports and Culture of Japan (MEXT) [110049]; National Medical Research Council, Singapore [NMRC/CSA/043/2012]; Funding Program for Next Generation World Leading Researchers [L5021]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Naito Foundation(Naito Memorial Foundation); Gunma University Initiative for Advanced Research (GIAR); Ministry of Education, Science, Sports and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Medical Research Council, Singapore(National Medical Research Council, Singapore); Funding Program for Next Generation World Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Funding Program for Next Generation World Leading Researchers (L5021), Grant-in-Aid for Scientific Research on Innovative Areas ("Brain Environment") (KAKENHI, Grant Number 26111701), the Naito Foundation, Gunma University Initiative for Advanced Research (GIAR) to H. Hirai and postgraduate scholarship (No. 110049) to F. Huda from the Ministry of Education, Science, Sports and Culture of Japan (MEXT). JKYC received salary support from the National Medical Research Council, Singapore (NMRC/CSA/043/2012).	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Asumda FZ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-44; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; Bae JS, 2005, HUM GENE THER, V16, P1006, DOI 10.1089/hum.2005.16.1006; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chan J, 2007, STEM CELLS, V25, P875, DOI 10.1634/stemcells.2006-0694; Chan J, 2006, STEM CELLS, V24, P1879, DOI 10.1634/stemcells.2005-0564; Chen KA, 2011, MOL CELL NEUROSCI, V47, P61, DOI 10.1016/j.mcn.2011.03.003; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Espejel S, 2009, ANN NEUROL, V66, P100, DOI 10.1002/ana.21670; Gahan PB, 2010, CELL BIOCHEM FUNCT, V28, P529, DOI 10.1002/cbf.1690; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gotherstrom C, 2014, STEM CELL TRANSL MED, V3, P255, DOI 10.5966/sctm.2013-0090; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Huda F, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.32; Inamura N, 2012, GENESIS, V50, P424, DOI 10.1002/dvg.20808; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Johnson TV, 2014, BRAIN, V137, P503, DOI 10.1093/brain/awt292; Jones J, 2010, NEUROBIOL DIS, V40, P415, DOI 10.1016/j.nbd.2010.07.001; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kasparov S, 2004, PROG BIOPHYS MOL BIO, V84, P251, DOI 10.1016/j.pbiomolbio.2003.11.011; Kemp K, 2011, NEUROPATH APPL NEURO, V37, P166, DOI 10.1111/j.1365-2990.2010.01122.x; Kemp K, 2012, BRAIN, V135, P2962, DOI 10.1093/brain/aws226; Kemp K, 2010, J NEUROCHEM, V114, P1569, DOI 10.1111/j.1471-4159.2009.06553.x; Kennea NL, 2009, CELL CYCLE, V8, P1069, DOI 10.4161/cc.8.7.8121; Krabbe C, 2005, APMIS, V113, P831, DOI 10.1111/j.1600-0463.2005.apm_3061.x; Krampera Mauro, 2007, Blood Transfus, V5, P120, DOI 10.2450/2007.0029-07; Lee ESM, 2009, STEM CELLS, V27, P1921, DOI 10.1002/stem.112; Liu Y, 2003, J CELL BIOCHEM, V88, P29, DOI 10.1002/jcb.10281; Magrassi L, 2007, J NEUROSCI, V27, P9885, DOI 10.1523/JNEUROSCI.2539-07.2007; Matsuura S, 2014, CEREBELLUM, V13, P323, DOI 10.1007/s12311-013-0536-1; Matsuzaki Y, 2014, J NEUROSCI METH, V223, P133, DOI 10.1016/j.jneumeth.2013.12.004; Menicanin D, 2009, STEM CELL REV REP, V5, P36, DOI 10.1007/s12015-009-9056-2; Mieda T, 2015, JOURNAL OF NEUROSCIE; Miyake K, 2012, J NIPPON MED SCH, V79, P394, DOI 10.1272/jnms.79.394; Nakamura K, 2015, CEREBELLUM, V14, P165, DOI 10.1007/s12311-014-0604-1; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Saunders A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00047; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Taran R, 2014, J BIOSCIENCES, V39, P157, DOI 10.1007/s12038-013-9409-5; Torashima T, 2006, BRAIN RES, V1082, P11, DOI 10.1016/j.brainres.2006.01.104; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004; Uesaka N, 2014, SCIENCE, V344, P1020, DOI 10.1126/science.1252514; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Wislet-Gendebien S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/601560; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456; ZOGHBI HY, 1995, SEMIN CELL BIOL, V6, P29, DOI 10.1016/1043-4682(95)90012-8	58	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0164202	10.1371/journal.pone.0164202	http://dx.doi.org/10.1371/journal.pone.0164202			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802273	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200006
J	Vidy, A; Maisonnasse, P; Da Costa, B; Delmas, B; Chevalier, C; Le Goffic, R				Vidy, Aurore; Maisonnasse, Pauline; Da Costa, Bruno; Delmas, Bernard; Chevalier, Christophe; Le Goffic, Ronan			The Influenza Virus Protein PB1-F2 Increases Viral Pathogenesis through Neutrophil Recruitment and NK Cells Inhibition	PLOS ONE			English	Article							LUNG INJURY; HEMAGGLUTININS; RECOGNITION; ACTIVATION; EXPRESSION; BACTERIAL; MEMBRANE; INNATE	The influenza A virus (IAV) PB1-F2 protein is a virulence factor contributing to the pathogenesis observed during IAV infections in mammals. In this study, using a mouse model, we compared the host response associated with PB1-F2 with an early transcriptomic signature that was previously associated with neutrophils and consecutively fatal IAV infections. This allowed us to show that PB1-F2 is partly involved in neutrophil-related mechanisms leading to death. Using neutropenic mice, we confirmed that the harmful effect of PB1-F2 is due to an excessive inflammation mediated by an increased neutrophil mobilization. We identified the downstream effects of this PB1-F2-exacerbated neutrophil recruitment. PB1-F2 had no impact on the lymphocyte recruitment in the airways at day 8 pi. However, functional genomics analysis and flow cytometry in broncho-alveolar lavages at 4 days pi revealed that PB1-F2 induced a NK cells deficiency. Thus, our results identify PB1-F2 as an important immune disruptive factor during the IAV infection.	[Vidy, Aurore; Maisonnasse, Pauline; Da Costa, Bruno; Delmas, Bernard; Chevalier, Christophe; Le Goffic, Ronan] Univ Paris Saclay, INRA, VIM, F-78350 Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Le Goffic, R (corresponding author), Univ Paris Saclay, INRA, VIM, F-78350 Jouy En Josas, France.	ronan.legoffic@jouy.inra.fr	Chevalier, Christophe/C-2575-2009; Chevalier, Christophe/AAK-4461-2020; LE GOFFIC, Ronan/B-7649-2008; Chevalier, Christophe/AAW-5560-2020; LE GOFFIC, Ronan/M-3099-2019	Chevalier, Christophe/0000-0003-3231-9027; LE GOFFIC, Ronan/0000-0002-2012-0064; LE GOFFIC, Ronan/0000-0002-2012-0064; Maisonnasse, Pauline/0000-0002-0555-207X	Bourse de la Fondation pour la Recherche Medicale [SPF20111223376]	Bourse de la Fondation pour la Recherche Medicale	AV is a recipient of a "Bourse de la Fondation pour la Recherche Medicale" (Grant number: SPF20111223376). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Barberis I, 2016, J Prev Med Hyg, V57, pE41; Bradley LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002641; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chevalier C, 2016, J BIOL CHEM, V291, P9060, DOI 10.1074/jbc.M115.710533; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; Costantini C, 2010, INT IMMUNOL, V22, P827, DOI 10.1093/intimm/dxq434; Da Costa B, 2015, J VIROL, V89, P6376, DOI 10.1128/JVI.00589-15; Dallegri F, 1997, INFLAMM RES, V46, P382, DOI 10.1007/s000110050208; GADEK JE, 1992, AM J MED, V92, pS27, DOI 10.1016/0002-9343(92)90604-A; Galani IE, 2015, J LEUKOCYTE BIOL, V98, P557, DOI 10.1189/jlb.4VMR1114-555R; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Guo HL, 2011, J LEUKOCYTE BIOL, V89, P189, DOI 10.1189/jlb.0610319; Henkel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011112; Hufford MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047659; Jaeger BN, 2012, J EXP MED, V209, P565, DOI 10.1084/jem.20111908; Joseph C, 2013, INFLUENZA OTHER RESP, V7, P105, DOI 10.1111/irv.12089; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Lee SH, 2007, TRENDS IMMUNOL, V28, P252, DOI 10.1016/j.it.2007.04.001; Leymarie O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057894; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; Meyer L, 2016, J VIROL, V90, P3684, DOI 10.1128/JVI.03101-15; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Pommerenke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041169; Sakai S, 2000, J VIROL, V74, P2472, DOI 10.1128/JVI.74.5.2472-2476.2000; Si-Tahar M, 2009, CLIN EXP IMMUNOL, V156, P194, DOI 10.1111/j.1365-2249.2009.03893.x; Sporri R, 2008, J IMMUNOL, V181, P7121, DOI 10.4049/jimmunol.181.10.7121; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; Stohr K, 2003, BRIT MED J, V326, P1223, DOI 10.1136/bmj.326.7401.1223; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Vidic J, 2016, J BIOL CHEM, V291, P739, DOI 10.1074/jbc.M115.652917; Warren HS, 1999, IMMUNOL CELL BIOL, V77, P64, DOI 10.1046/j.1440-1711.1999.00790.x; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zhou K, 2016, J IMMUNOL, V31, P9	47	29	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165361	10.1371/journal.pone.0165361	http://dx.doi.org/10.1371/journal.pone.0165361			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798704	gold, Green Published, Green Submitted			2022-12-26	WOS:000386711100029
J	French, SL; Paramitha, AC; Moon, MJ; Dickins, RA; Hamilton, JR				French, Shauna L.; Paramitha, Antonia C.; Moon, Mitchell J.; Dickins, Ross A.; Hamilton, Justin R.			Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets	PLOS ONE			English	Article							THROMBIN-RECEPTOR; ANTAGONIST; MICE; GENERATION; PROTECTION; VORAPAXAR; GENE	Anti-platelet drugs are the mainstay of pharmacotherapy for heart attack and stroke prevention, yet improvements are continually sought. Thrombin is the most potent activator of platelets and targeting platelet thrombin receptors (protease-activated receptors; PARs) is an emerging anti-thrombotic approach. Humans express two PARs on their platelets-PAR1 and PAR4. The first PAR1 antagonist was recently approved for clinical use and PAR4 antagonists are in early clinical development. However, pre-clinical studies examining platelet PAR function are challenging because the platelets of non-primates do not accurately reflect the PAR expression profile of human platelets. Mice, for example, express Par3 and Par4. To address this limitation, we aimed to develop a genetically modified mouse that would express the same repertoire of platelet PARs as humans. Here, human PAR1 preceded by a lox-stop-lox was knocked into the mouse Par3 locus, and then expressed in a platelet-specific manner (hPAR1-KI mice). Despite correct targeting and the predicted loss of Par3 expression and function in platelets from hPAR1-KI mice, no PAR1 expression or function was detected. Specifically, PAR1 was not detected on the platelet surface nor internally by flow cytometry nor in whole cell lysates by Western blot, while a PAR1-activating peptide failed to induce platelet activation assessed by either aggregation or surface P-selectin expression. Platelets from hPAR1-KI mice did display significantly diminished responsiveness to thrombin stimulation in both assays, consistent with a Par3-/-phenotype. In contrast to the observations in hPAR1-KI mouse platelets, the PAR1 construct used here was successfully expressed in HEK293T cells. Together, these data suggest ectopic PAR1 expression is not tolerated in mouse platelets and indicate a different approach is required to develop a small animal model for the purpose of any future preclinical testing of PAR antagonists as anti-platelet drugs.	[French, Shauna L.; Paramitha, Antonia C.; Moon, Mitchell J.; Dickins, Ross A.; Hamilton, Justin R.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia	Monash University	Hamilton, JR (corresponding author), Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia.	Justin.Hamilton@monash.edu	Dickins, Ross A/K-2852-2012	Dickins, Ross A/0000-0003-4112-5304; Paramitha, Antonia Christa/0000-0002-2664-8628; Moon, Mitchell/0000-0001-9345-5001	National Health & Medical Research Council of Australia [104729]; Australian Research Council [130100540]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by a grant to JRH from the National Health & Medical Research Council of Australia (1047295) and a Future Fellowship from the Australian Research Council (130100540). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank AMREP AS staff for animal care and members of the AMREP flow cytometry core facility for technical assistance and advice. The authors also thank Assoc Professors Philip Thompson, Elizabeth Gardiner and Robert Andrews for generously providing key reagents, and L. R. B. Cooper for valuable contributions. This work was supported by grants to JRH from the National Health & Medical Research Council of Australia. JRH is a Future Fellow of the Australian Research Council.	Andrade-Gordon P, 2001, J PHARMACOL EXP THER, V298, P34; Arachiche A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097724; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; CONNOLLY TM, 1994, THROMB HAEMOSTASIS, V72, P627; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Derian CK, 2003, J PHARMACOL EXP THER, V304, P855, DOI 10.1124/jpet.102.042663; French SL, 2015, BLOOD REV, V29, P179, DOI 10.1016/j.blre.2014.10.006; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Hamilton JR, 2004, J THROMB HAEMOST, V2, P1429, DOI 10.1111/j.1538-7836.2004.00783.x; Holinstat M, 2016, CLIN PHARMACOL THER, V99, P72, DOI 10.1002/cpt.282; Ismat FA, 2016, STROKE, V47; Kahn ML, 1998, J BIOL CHEM, V273, P23290, DOI 10.1074/jbc.273.36.23290; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Khan TA, 2005, ANN THORAC SURG, V79, P1545, DOI 10.1016/j.athoracsur.2004.11.006; Lee H, 2012, BRIT J PHARMACOL, V166, P2188, DOI 10.1111/j.1476-5381.2012.01944.x; Lee H, 2013, THROMB HAEMOSTASIS, V109, P164, DOI [10.1160/TH12-06-0389, 10.1116/TH12-06-0389]; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Mountford JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7535; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Pawlinski R, 2007, CIRCULATION, V116, P2298, DOI 10.1161/CIRCULATIONAHA.107.692764; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; TORDAI A, 1995, BIOCHEM BIOPH RES CO, V206, P857, DOI 10.1006/bbrc.1995.1122; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Vandendries ER, 2007, P NATL ACAD SCI USA, V104, P288, DOI 10.1073/pnas.0610188104; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Weiss EJ, 2002, BLOOD, V100, P3240, DOI 10.1182/blood-2002-05-1470; Yin YJ, 2006, CANCER RES, V66, P5224, DOI 10.1158/0008-5472.CAN-05-4234; Zampatis DE, 2012, FEBS LETT, V586, P2351, DOI 10.1016/j.febslet.2012.05.042	30	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165565	10.1371/journal.pone.0165565	http://dx.doi.org/10.1371/journal.pone.0165565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788223	Green Submitted, gold, Green Published			2022-12-26	WOS:000389604900109
J	Jing, C; Ma, C; Zhang, J; Jing, S; Jiang, X; Yang, Y; Zhao, Z				Jing, Chenjuan; Ma, Changqing; Zhang, Juan; Jing, Shujuan; Jiang, Xiaobing; Yang, Yazhou; Zhao, Zhengyang			Effect of Debagging Time on Pigment Patterns in the Peel and Sugar and Organic Acid Contents in the Pulp of `Golden Delicious' and `Qinguan' Apple Fruit at Mid and Late Stages of Development	PLOS ONE			English	Article							SUCROSE-SPECIFIC INDUCTION; ANTHOCYANIN BIOSYNTHESIS; PHENOLIC-COMPOUNDS; COLOR DEVELOPMENT; DOMESTICA BORKH.; RED APPLES; L. FRUIT; QUALITY; EXPRESSION; CULTIVARS	This study examined the effect of debagging time on color and flavor / taste compounds in the non-red apple cultivar `Golden Delicious' and red cultivar `Qinguan' at mid and late stages of fruit development. Debagging briefly improved the red color in both cultivars, the peel of `Golden Delicious' presenting pale-pink hue. However, rapid anthocyanin accumulation occurred in apple peel at a specific time (after 179 days after flowering (DAF) in `Qinguan') and was unaltered by debagging time in the red cultivar `Qinguan'. Furthermore, untimely debagging had a detrimental effect on the content of anthocyanin. All sugars increased and organic acids decreased in apple pulp at mid to late stages of development. Bagging treatment reduced the content of most sugars and organic acids, as well as, the overall total. However, glucose and citric acid contents were higher in bagged fruit than non-bagged fruit; the maximum occurred in T7 treatment that was no-debagging at DAF 159 / 196 (`Golden delicious' / `Qinguan'), i.e., 24.35 and 0.07 mg g(-1) FW in `Golden delicious', and 38.86 and 0.06 mg g(-1) FW in `Qinguan', respectively. In a word, bagging treatment can alter the pattern of peel color development in apple fruit; however, it remains difficult to alter the timing of rapid anthocyanin accumulation as it is regulated solely by development. Moreover, bagging treatment reduced the total accumulation of sugars and organic acids, and even the over total in pulp, but increased the glucose and citric acid contents in apple pulp.	[Jing, Chenjuan; Ma, Changqing; Zhang, Juan; Jiang, Xiaobing; Yang, Yazhou; Zhao, Zhengyang] Northwest A&F Univ, Dept Hort, Yangling, Shaanxi, Peoples R China; [Jing, Chenjuan; Ma, Changqing; Zhang, Juan; Jiang, Xiaobing; Yang, Yazhou; Zhao, Zhengyang] Shaanxi Res Ctr Apple Engn & Technol, Yangling, Shaanxi, Peoples R China; [Jing, Shujuan; Zhao, Zhengyang] Northwest A&F Univ, Apple Expt Farm, Baishui, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zhao, Z (corresponding author), Northwest A&F Univ, Dept Hort, Yangling, Shaanxi, Peoples R China.; Zhao, Z (corresponding author), Shaanxi Res Ctr Apple Engn & Technol, Yangling, Shaanxi, Peoples R China.; Zhao, Z (corresponding author), Northwest A&F Univ, Apple Expt Farm, Baishui, Shaanxi, Peoples R China.	zhaozy@nwsuaf.edu.cn	景, 娟 C/C-7797-2012		National Natural Science Foundation of China [31471845]; Earmarked Fund for Modern Agro-industry Technology Research System of China [CARS-28]; National Sci-Tech Support Plan [2014BAD16B06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-industry Technology Research System of China; National Sci-Tech Support Plan	This research was supported by three sources of funding and Zhengyang Zhao received the funding: National Natural Science Foundation of China (No. 31471845, http;//www.nsfc.gov.cn), the Earmarked Fund for Modern Agro-industry Technology Research System of China (No. CARS-28, http://119.253.58.231) and National Sci-Tech Support Plan (No. 2014BAD16B06, http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Ban Y, 2009, PLANTA, V230, P871, DOI 10.1007/s00425-009-0993-4; BRITSCH L, 1993, EUR J BIOCHEM, V217, P745, DOI 10.1111/j.1432-1033.1993.tb18301.x; Chen CS, 2012, SCI HORTIC-AMSTERDAM, V142, P68, DOI 10.1016/j.scienta.2012.05.001; Chen C, 2016, POSTHARVEST BIOL TEC, V111, P126, DOI 10.1016/j.postharvbio.2015.08.005; Chen M, 2012, SCI HORTIC-AMSTERDAM, V147, P118, DOI 10.1016/j.scienta.2012.09.011; Das PK, 2012, MOL CELLS, V34, P501, DOI 10.1007/s10059-012-0151-x; de Oliveira AF, 2015, MOLECULES, V20, P2061, DOI 10.3390/molecules20022061; Dong Y, 2015, PROTOPLASMA, V252, P165, DOI 10.1007/s00709-014-0665-5; Ekici L, 2014, FOOD ANAL METHOD, V7, P1328, DOI 10.1007/s12161-013-9753-y; Feng FJ, 2014, SCI HORTIC-AMSTERDAM, V165, P123, DOI 10.1016/j.scienta.2013.11.008; Fitzenberger E, 2014, PLANT FOOD HUM NUTR, V69, P78, DOI 10.1007/s11130-013-0399-0; Galant AL, 2015, FOOD CHEM, V188, P149, DOI 10.1016/j.foodchem.2015.04.071; Gao JJ, 2011, PLANT CELL TISS ORG, V106, P235, DOI 10.1007/s11240-010-9912-4; Hara M, 2003, PLANT SCI, V164, P259, DOI 10.1016/S0168-9452(02)00408-9; Hecke K, 2006, EUR J CLIN NUTR, V60, P1136, DOI 10.1038/sj.ejcn.1602430; Hong Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1428-1; Huang CH, 2009, SCI HORTIC-AMSTERDAM, V121, P149, DOI 10.1016/j.scienta.2009.01.031; Iglesias I, 2008, SCI HORTIC-AMSTERDAM, V119, P32, DOI 10.1016/j.scienta.2008.07.004; Jeong SW, 2010, PLANT PHYSIOL, V154, P1514, DOI 10.1104/pp.110.161869; Ju ZG, 1998, SCI HORTIC-AMSTERDAM, V77, P155, DOI 10.1016/S0304-4238(98)00161-7; LANCASTER JE, 1992, CRIT REV PLANT SCI, V10, P487, DOI 10.1080/07352689209382324; Li MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033055; Liu T, 2015, SCI HORTIC-AMSTERDAM, V184, P142, DOI 10.1016/j.scienta.2015.01.003; Liu YL, 2013, EUR FOOD RES TECHNOL, V236, P329, DOI 10.1007/s00217-012-1896-3; Liu YL, 2013, MOLECULES, V18, P1549, DOI 10.3390/molecules18021549; Lopez-Bucio J, 2000, PLANT SCI, V160, P1, DOI 10.1016/S0168-9452(00)00347-2; Ma BQ, 2015, FOOD CHEM, V172, P86, DOI 10.1016/j.foodchem.2014.09.032; Marles MAS, 2003, PHYTOCHEMISTRY, V64, P367, DOI 10.1016/S0031-9422(03)00377-7; MCGUIRE RG, 1992, HORTSCIENCE, V27, P1254, DOI 10.21273/HORTSCI.27.12.1254; MORIGUCHI T, 1990, J AM SOC HORTIC SCI, V115, P278, DOI 10.21273/JASHS.115.2.278; NORO S, 1989, J JPN SOC HORTIC SCI, V58, P17, DOI 10.2503/jjshs.58.17; O'Hara LE, 2013, MOL PLANT, V6, P261, DOI 10.1093/mp/sss120; Palapol Y, 2009, POSTHARVEST BIOL TEC, V51, P349, DOI 10.1016/j.postharvbio.2008.08.003; Park SH, 2011, J FOOD SCI, V76, pM293, DOI 10.1111/j.1750-3841.2011.02205.x; PERRING MA, 1974, QUAL PLANT, V23, P379, DOI 10.1007/BF01095426; Piovan Anna, 2007, Phytochemistry Reviews, V6, P235, DOI 10.1007/s11101-006-9052-y; Rahman SME, 2011, FOOD MICROBIOL, V28, P484, DOI 10.1016/j.fm.2010.10.006; REIF HJ, 1985, MOL GEN GENET, V199, P208, DOI 10.1007/BF00330261; SAURE MC, 1990, SCI HORTIC-AMSTERDAM, V42, P181, DOI 10.1016/0304-4238(90)90082-P; Sharma RR, 2014, J HORTIC SCI BIOTECH, V89, P101, DOI 10.1080/14620316.2014.11513055; Sharma RR, 2013, DELICIOUS AGR SCI, V04, DOI [10.4236/as.2013.49059, DOI 10.4236/AS.2013.49059]; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Sun S, 2014, SCI HORTIC-AMSTERDAM, V168, P161, DOI 10.1016/j.scienta.2014.01.031; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Treutter D, 2001, PLANT GROWTH REGUL, V34, P71, DOI 10.1023/A:1013378702940; Usenik V, 2009, FOOD CHEM, V114, P529, DOI 10.1016/j.foodchem.2008.09.083; Van den Ende W, 2014, ENVIRON EXP BOT, V108, P4, DOI 10.1016/j.envexpbot.2013.09.017; Wang HQ, 2000, POSTHARVEST BIOL TEC, V19, P123, DOI 10.1016/S0925-5214(00)00089-2; Wu JH, 2007, FOOD CHEM, V103, P88, DOI 10.1016/j.foodchem.2006.07.030; Xie L, 2013, PLANT GROWTH REGUL, V69, P295, DOI 10.1007/s10725-012-9772-5; Zhang KM, 2013, PLANT BIOLOGY, V15, P991, DOI 10.1111/j.1438-8677.2012.00721.x; Zhang YZ, 2010, FOOD CHEM, V123, P1013, DOI 10.1016/j.foodchem.2010.05.053; Zhao JH, 2015, FOOD CHEM, V173, P718, DOI 10.1016/j.foodchem.2014.10.082	57	7	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165050	10.1371/journal.pone.0165050	http://dx.doi.org/10.1371/journal.pone.0165050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788164	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900039
J	Park, JY; Park, S; Lee, SH; Lee, MG; Park, YB; Oh, KC; Lee, JM; Kim, DI; Seo, KH; Shin, KC; Yoo, KH; Ko, Y; Jang, SH; Jung, KS; Hwang, YI				Park, Ji Young; Park, Sunghoon; Lee, Sun Hwa; Lee, Myung Goo; Park, Yong Bum; Oh, Kil Chan; Lee, Jae-Myung; Kim, Do Il; Seo, Ki-Hyun; Shin, Kyeong-Cheol; Yoo, Kwang Ha; Ko, Yongchun; Jang, Seung Hun; Jung, Ki-Suck; Hwang, Yong Il			Microorganisms Causing Community-Acquired Acute Bronchitis: The Role of Bacterial Infection	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; OBSTRUCTIVE PULMONARY-DISEASE; PLACEBO-CONTROLLED TRIAL; GENERAL-PRACTICE; PRIMARY-CARE; ANTIBIOTIC-TREATMENT; RHINOVIRUS INFECTION; PNEUMONIA; ETIOLOGY; ADULTS	Background Although acute bronchitis is quite common, there is relatively limited information regarding the microorganisms that are involved in this illness. Methods We performed a prospective study of acute bronchitis at 31 hospitals and clinics in Korea from July 2011 to June 2012. Sputum specimens were collected for polymerase chain reaction (PCR) and culture of microorganisms. Results Of the 811 enrolled patients, 291 had acceptable sputum specimens that were included for analysis of the etiologic distribution. With multiplex PCR testing, viruses were identified in 36.1% (105/291), most commonly rhinovirus (25.8%) and coronavirus (3.8%). Typical bacteria were isolated in 126/291 (43.3%) patients. Among these patients Haemophilus influenzae (n = 39) and Streptococcus pneumoniae (n = 30) were isolated most commonly; atypical bacteria were identified in 44 (15.1%) patients. Bacteria-only, virus-only, and mixed infections (bacteria plus virus) accounted for 36.7% (98/291), 17.2% (50/291), and 18.9% (55/291) of infections, respectively. In particular, 52.4% of patients with viral infection had a concurrent bacterial infection, and rhinovirus was the most common virus in mixed infections (40/55). Additionally, infections with typical bacteria were more common in patients with chronic lung disease (p = 0.029), and typical bacterial infections showed a trend towards a higher prevalence with older age (p = 0.001). Conclusions Bacteria were associated with almost half of community-acquired acute bronchitis cases. Additional studies are required to further illuminate the role of bacteria and to identify patient groups most likely to benefit from antibiotic treatment.	[Park, Ji Young; Park, Sunghoon; Jang, Seung Hun; Jung, Ki-Suck; Hwang, Yong Il] Hallym Univ, Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med, Anyang, South Korea; [Lee, Sun Hwa] Seegene Med Fdn, Seoul, South Korea; [Lee, Myung Goo] Chuncheon Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med, Chunchon, South Korea; [Park, Yong Bum] Kangdong Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med, Seoul, South Korea; [Oh, Kil Chan] Myeongmun Clin Internal Med, Yongin, South Korea; [Lee, Jae-Myung] Leejaemyung Clin Internal Med, Anyang, South Korea; [Kim, Do Il] Rapha Clin Otolaryngol, Anyang, South Korea; [Seo, Ki-Hyun] Soonchunhyang Univ Hosp, Div Pulm & Crit Care Med, Cheonan, South Korea; [Shin, Kyeong-Cheol] Yeungnam Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Daegu, South Korea; [Yoo, Kwang Ha] Konkuk Univ Hosp, Div Pulm Allergy & Crit Care Med, Seoul, South Korea; [Ko, Yongchun] Gwangju Christian Hosp, Div Pulm Med, Gwangju, South Korea	Hallym University; Soonchunhyang University; Soonchunhyang University Hospital; Yeungnam University; Konkuk University; Konkuk University Medical Center	Hwang, YI (corresponding author), Hallym Univ, Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med, Anyang, South Korea.	hyicyk@gmail.com	Jung, Ki-Suck/AAN-2473-2021; HWANG, YONG IL/AAU-7121-2021	HWANG, YONG IL/0000-0002-3502-5211; Park, Ji Young/0000-0002-6533-4656; Park, Yong Bum/0000-0002-5814-6104	Korea Centers of Disease Control and Prevention (KCDC) [2011-E46003-00, 2012-E46003-00]	Korea Centers of Disease Control and Prevention (KCDC)	This study was supported by a grant from the Korea Centers of Disease Control and Prevention (KCDC; 2011 and 2012 Academic Research Funds, 2011-E46003-00 and 2012-E46003-00) to K-SJ. The sponsor had no role in the design of the study, the collection and analysis of the data, or the preparation of the manuscript.	Ahn JG, 2012, KOREAN J PEDIAT INFE, V19, P71; Allegra L, 2005, RESP MED, V99, P742, DOI 10.1016/j.rmed.2004.10.020; Braman SS, 2006, CHEST, V129, p95S, DOI 10.1378/chest.129.1_suppl.95S; Capelastegui A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-134; Creer DD, 2006, THORAX, V61, P75, DOI 10.1136/thx.2004.027441; Diederen BMW, 2007, EUR RESPIR J, V30, P240, DOI 10.1183/09031936.00012707; Evans AT, 2002, LANCET, V359, P1648, DOI 10.1016/S0140-6736(02)08597-5; Freymuth F, 2004, REV MAL RESPIR, V21, P35, DOI 10.1016/S0761-8425(04)71233-4; Garcha DS, 2012, THORAX, V67, P1075, DOI 10.1136/thoraxjnl-2012-201924; Gonzales R, 2001, ANN INTERN MED, V134, P521, DOI 10.7326/0003-4819-134-6-200103200-00021; Graffelman AW, 2004, BRIT J GEN PRACT, V54, P15; Gutierrez F, 2005, CLIN MICROBIOL INFEC, V11, P788, DOI 10.1111/j.1469-0691.2005.01226.x; HENRY D, 1995, ANTIMICROB AGENTS CH, V39, P2528, DOI 10.1128/AAC.39.11.2528; Holm A, 2007, BRIT J GEN PRACT, V57, P547; Hopstaken RM, 2005, J ANTIMICROB CHEMOTH, V56, P941, DOI 10.1093/jac/dki330; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Jonsson JS, 1997, SCAND J PRIM HEALTH, V15, P156, DOI 10.3109/02813439709018507; Kaiser L, 1996, LANCET, V347, P1507, DOI 10.1016/S0140-6736(96)90670-4; Lieberman D, 2002, DIAGN MICR INFEC DIS, V42, P21, DOI 10.1016/S0732-8893(01)00324-8; Lindsay DSJ, 2004, J MED MICROBIOL, V53, P183, DOI 10.1099/jmm.0.05464-0; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; Llor C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5762; Macfarlane J, 1997, BRIT MED J, V315, P1206, DOI 10.1136/bmj.315.7117.1206; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; MACFARLANE JT, 1993, LANCET, V341, P511, DOI 10.1016/0140-6736(93)90275-L; Mohan A, 2010, RESPIROLOGY, V15, P536, DOI 10.1111/j.1440-1843.2010.01722.x; Mosser AG, 2005, AM J RESP CRIT CARE, V171, P645, DOI 10.1164/rccm.200407-970OC; MURRAY PR, 1975, MAYO CLIN PROC, V50, P339; Nduba VN, 2008, THORAX, V63, P999, DOI 10.1136/thx.2008.097311; Nelson S, 1997, J CLIN MICROBIOL, V35, P117, DOI 10.1128/JCM.35.1.117-120.1997; Park S, 2015, J KOREAN MED SCI, V30, P1446, DOI 10.3346/jkms.2015.30.10.1446; Park S, 2014, J KOREAN MED SCI, V29, P1232, DOI 10.3346/jkms.2014.29.9.1232; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Seki M, 2007, INTERNAL MED, V46, P953, DOI 10.2169/internalmedicine.46.6364; Seymour ML, 2002, J INFECT DIS, V185, P540, DOI 10.1086/338570; Smith SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000245.pub3; Sohn JW, 2006, J KOREAN MED SCI, V21, P602, DOI 10.3346/jkms.2006.21.4.602; Wang J, 2014, JAMA INTERN MED, V174, P1914, DOI 10.1001/jamainternmed.2014.5214; Wenzel RP, 2006, NEW ENGL J MED, V355, P2125, DOI 10.1056/NEJMcp061493; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x; World Health Organization, 2009, PAND INFL PREP RESP; YP C, 2010, INFECT CHEMOTHER, V42, P397	45	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165553	10.1371/journal.pone.0165553	http://dx.doi.org/10.1371/journal.pone.0165553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788254	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900107
J	Simons, RRL; Horigan, V; Gale, P; Kosmider, RD; Breed, AC; Snary, EL				Simons, Robin R. L.; Horigan, Verity; Gale, Paul; Kosmider, Rowena D.; Breed, Andrew C.; Snary, Emma L.			A Generic Quantitative Risk Assessment Framework for the Entry of Bat-Borne Zoonotic Viruses into the European Union	PLoS One			English	Article							NIPAH-VIRUS; FLYING-FOXES; EBOLA-VIRUS; TRANSMISSION; BANGLADESH; MALAYSIA; INFECTION; INDIA; EPIDEMIC; OUTBREAK	Bat-borne viruses have been linked to a number of zoonotic diseases; in 2014 there have been human cases of Nipah virus (NIV) in Bangladesh and Ebola virus in West and Central Africa. Here we describe a model designed to provide initial quantitative predictions of the risk of entry of such viruses to European Union (EU) Member States (MSs) through four routes: human travel, legal trade (e.g. fruit and animal products), live animal movements and illegal importation of bushmeat. The model utilises available datasets to assess the movement via these routes between individual countries of the world and EU MSs. These data are combined with virus specific data to assess the relative risk of entry between EU MSs. As a case study, the model was parameterised for NiV. Scenario analyses showed that the selection of exporting countries with NiV and potentially contaminated trade products were essential to the accuracy of all model outputs. Uncertainty analyses of other model parameters identified that the model expected number of years to an introduction event within the EU was highly susceptible to the prevalence of NiV in bats. The relative rankings of the MSs and routes, however, were more robust. The UK, the Netherlands and Germany were consistently the most likely points of entry and the ranking of most MSs varied by no more than three places (maximum variation five places). Legal trade was consistently the most likely route of entry, only falling below human travel when the estimate of the prevalence of NiV in bats was particularly low. Any model-based calculation is dependent on the data available to feed into the model and there are distinct gaps in our knowledge, particularly in regard to various pathogen/virus as well as host/bat characteristics. However, the strengths of this model lie in the provision of relative comparisons of risk among routes and MSs. The potential for expansion of the model to include other routes and viruses and the possibility of rapid parameterisation demonstrates its potential for use in an outbreak situation.	[Simons, Robin R. L.; Horigan, Verity; Gale, Paul; Kosmider, Rowena D.; Breed, Andrew C.; Snary, Emma L.] APHA, Dept Epidemiol Sci, Addlestone KT15 3NB, Surrey, England		Simons, RRL (corresponding author), APHA, Dept Epidemiol Sci, Addlestone KT15 3NB, Surrey, England.	robin.simons@apha.gsi.gov.uk	Breed, Andrew C/A-5682-2011; Snary, Emma/C-7932-2011; Simons, Robin/C-7272-2011	Breed, Andrew C/0000-0002-3439-9510; Simons, Robin/0000-0002-9202-0265	European Commission Seventh Framework Programme under ANTIGONE (Global Onset of Novel Epidemics) [278976]; UK Department for Environment, Food and Rural Affairs (Defra) [SE4213]	European Commission Seventh Framework Programme under ANTIGONE (Global Onset of Novel Epidemics); UK Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the European Commission Seventh Framework Programme (http://ec.europa.eu/research/fp7/index_en.cfm), under ANTIGONE (Global Onset of Novel Epidemics) with project number 278976. Additional matched funding was provided by the UK Department for Environment, Food and Rural Affairs (Defra; https://www.gov.uk/government/organisations/department-for-environment-food-rural-affairs) under project SE4213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; Arankalle VA, 2011, EMERG INFECT DIS, V17, P907, DOI 10.3201/eid1705.100968; Bair-Brake H, 2014, ZOONOSES PUBLIC HLTH, V61, P97, DOI 10.1111/zph.12050; Breed AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061316; CAC, 2014, REC TRNDS GROWTH UK; Chaber AL, 2010, CONSERV LETT, V3, P317, DOI 10.1111/j.1755-263X.2010.00121.x; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Clayton BA, 2012, EMERG INFECT DIS, V18, P1983, DOI 10.3201/eid1812.120875; Cutler SJ, 2010, EMERG INFECT DIS, V16, P1, DOI 10.3201/eid1601.081467; de Vos C, 2015, 11CVI0168 CENTR VET; de Wit E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004001; Defra, 2015, EX AN DIS RISK PATHW; ECDC, 2014, RAP RISK ASS OUTBR E; ECDC, 2014, UPD RAP RISK ASS SEV; EFSA, 2014, EFSA J, V12, P3884; EUROPHYT, 2014, EUR UN NOT SYST PLAN; Eurostat, 2014, STAT DAT 2014; Falk H, 2013, REV SCI TECH OIE, V32, P727; FaoStat, 2014, TRAD DAT 2014; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; Geisbert TW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008929; Geisbert TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010690; Goddard AD, 2012, RISK ANAL, V32, P1769, DOI 10.1111/j.1539-6924.2012.01804.x; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147; IEDCR, 2014, NIP SIT 2014; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Jones RD, 2005, RISK ANAL, V25, P533, DOI 10.1111/j.1539-6924.2005.00613.x; Kelly L, 2013, TRANSBOUND EMERG DIS, V60, P360, DOI 10.1111/j.1865-1682.2012.01355.x; Khan SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042689; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237; Memish ZA, 2013, EMERGING INFECT DIS, V19; Middleton DJ, 2002, J COMP PATHOL, V126, P124, DOI 10.1053/jcpa.2001.0532; Mills JN, 2009, EMERG INFECT DIS, V15, P950, DOI 10.3201/eid1506.080453; Nahar N, 2014, GLOBAL HLTH PROMOTIO; Nkoghe D, 2011, J INFECT DIS, V204, pS768, DOI 10.1093/infdis/jir344; OIE, 2004, HDB IMP RISK AN AN A; PHE, 2014, RISK ASS EB OUTBR W; Rahman MA, 2012, VECTOR-BORNE ZOONOT, V12, P65, DOI 10.1089/vbz.2011.0656; Rahman SA, 2010, EMERG INFECT DIS, V16, P1990, DOI 10.3201/eid1612.091790; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Saez AM, 2015, EMBO MOL MED, V7, P17, DOI 10.15252/emmm.201404792; Scanlan JC, 2014, EC HLTH, DOI [10.1007/s10393-014-0920-4, DOI 10.1007/S10393-014-0920-4]; Shirai J, 2007, JARQ-JPN AGR RES Q, V41, P69, DOI 10.6090/jarq.41.69; Simons RRL, 2014, VIRUSES-BASEL, V6, P2084, DOI 10.3390/v6052084; Snary EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027918; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; Weingartl HM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00811; WHO, 2014, EB VIR DIS OUTBR W A; WHO, 2014, CAS MARB HAEM FEV IM; World Health Organization, 2014, WHO RISK ASS HUM INF; Yadav PD, 2012, AM J TROP MED HYG, V87, P576, DOI 10.4269/ajtmh.2012.11-0416	59	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165383	10.1371/journal.pone.0165383	http://dx.doi.org/10.1371/journal.pone.0165383			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788234	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900072
J	Ujisawa, T; Ohta, A; Uda-Yagi, M; Kuhara, A				Ujisawa, Tomoyo; Ohta, Akane; Uda-Yagi, Misato; Kuhara, Atsushi			Diverse Regulation of Temperature Sensation by Trimeric G-Protein Signaling in Caenorhabditis elegans	PLOS ONE			English	Article							SENSITIVE ADENYLATE-CYCLASE; NUCLEOTIDE-GATED CHANNEL; OLFACTORY RECEPTOR-CELLS; C-ELEGANS; SENSORY NEURON; CALCIUM; LIGHT; THERMOSENSATION; DISCRIMINATION; CONDUCTANCE	Temperature sensation by the nervous system is essential for life and proliferation of animals. The molecular-physiological mechanisms underlying temperature signaling have not been fully elucidated. We show here that diverse regulatory machinery underlies temperature sensation through trimeric G-protein signaling in the nematode Caenorhabditis elegans. Molecular-genetic studies demonstrated that cold tolerance is regulated by additive functions of three Ga proteins in a temperature-sensing neuron, ASJ, which is also known to be a light-sensing neuron. Optical recording of calcium concentration in ASJ upon temperature-changes demonstrated that three Ga proteins act in different aspects of temperature signaling. Calcium concentration changes in ASJ upon temperature change were unexpectedly decreased in a mutant defective in phosphodiesterase, which is well known as a negative regulator of calcium increase. Together, these data demonstrate commonalities and differences in the molecular components concerned with light and temperature signaling in a single sensory neuron.	[Ujisawa, Tomoyo; Ohta, Akane; Kuhara, Atsushi] Konan Univ, Lab Mol & Cellular Regulat, Grad Sch Nat Sci, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan; [Ohta, Akane; Kuhara, Atsushi] Konan Univ, Lab Mol & Cellular Regulat, Fac Sci & Engn, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan; [Ujisawa, Tomoyo; Ohta, Akane; Uda-Yagi, Misato; Kuhara, Atsushi] Konan Univ, Inst Integrat Neurobiol, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan	Konan University; Konan University; Konan University	Ohta, A; Kuhara, A (corresponding author), Konan Univ, Lab Mol & Cellular Regulat, Grad Sch Nat Sci, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan.; Ohta, A; Kuhara, A (corresponding author), Konan Univ, Lab Mol & Cellular Regulat, Fac Sci & Engn, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan.; Ohta, A; Kuhara, A (corresponding author), Konan Univ, Inst Integrat Neurobiol, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan.	aohta@center.konan-u.ac.jp; kuhara@center.konan-u.ac.jp	Kuhara, Atsushi/S-5855-2018; Cote, Rick H/G-3363-2013	Kuhara, Atsushi/0000-0003-2994-8658; Cote, Rick H/0000-0002-1573-6526	Naito Foundation; Uehara Memorial Foundation; Cosmetology Research Foundation; Hirao Taro Foundation of KONAN GAKUEN for Academic Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [15H04404, 26640018, 15H05928]; Kato Memorial Bioscience Foundation; Shiseido Female Researcher Science Grant; Japan Science Society; JSPS KAKENHI; Nakatani Foundation; Takeda Science Foundation;  [15K18579];  [16J00123];  [15J04977]; Grants-in-Aid for Scientific Research [15H04404] Funding Source: KAKEN	Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Cosmetology Research Foundation; Hirao Taro Foundation of KONAN GAKUEN for Academic Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kato Memorial Bioscience Foundation; Shiseido Female Researcher Science Grant(Shiseido Company, Limited); Japan Science Society; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nakatani Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AK was supported by the Naito Foundation, the Uehara Memorial Foundation, the Cosmetology Research Foundation, the Hirao Taro Foundation of KONAN GAKUEN for Academic Research, a JSPS KAKENHI Grant-in-Aid for Scientific Research (B) (15H04404) and Grant-in-Aid for Challenging Exploratory Research (26640018), and a Grant-in-Aid for Scientific Research on Innovative Areas, Thermal Biology (15H05928), from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. AO was supported by the Kato Memorial Bioscience Foundation, the Shiseido Female Researcher Science Grant, the Japan Science Society, JSPS KAKENHI, a Grant-in-Aid for Young Scientists (B) (15K18579), and a Grant-in-Aid for JSPS Fellows PD (16J00123), Japan. TU was supported by a Grant-in-Aid for JSPS Fellows DC (15J04977), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank I. Mori, X.Z.S. Xu, J. Alcedo, S. Mitani, Y. lino for sharing DNA constructs and strains; National Bioresource Project (Japan) and the Caenorhabditis Genetic Center for strains; T. Ishiwari and K. Kanai for supporting molecular genetic experiments or setting up experimental systems; and members of the Kuhara Laboratory for comments on this work and stimulating discussion. A.K. was supported by the Naito Foundation; the Nakatani Foundation; the Uehara Memorial Foundation; the Cosmetology Research Foundation; the Hirao Taro Foundation of KONAN GAKUEN for Academic Research; a JSPS KAKENHI Grant-in-Aid for Scientific Research (B) (15H04404) and Grant-in-Aid for Challenging Exploratory Research (26640018); and a Grant-in-Aid for Scientific Research on Innovative Areas (Thermal Biology, 15H05928 and Memory dynamism, 26115525) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. A.O. was supported by the Takeda Science Foundation; the Kato Memorial Bioscience Foundation; the Shiseido Female Researcher Science Grant; the Japan Science Society; JSPS KAKENHI; a Grant-in-Aid for Young Scientists (B) (15K18579); and a Grant-in-Aid for JSPS Fellows PD (16J00123), Japan. T.U. was supported by a Grant-in-Aid for JSPS Fellows DC (15J04977), Japan.	Aoki I, 2015, CURR OPIN NEUROBIOL, V34, P117, DOI 10.1016/j.conb.2015.03.011; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kuhara A, 2008, SCIENCE, V320, P803, DOI 10.1126/science.1148922; Kuhara A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1352; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Lockery SR, 2009, NAT NEUROSCI, V12, P377, DOI 10.1038/nn0409-377; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Ohta A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5412; Ohta A, 2013, NEUROSCI RES, V76, P119, DOI 10.1016/j.neures.2013.03.008; Okahata M, 2016, J COMP PHYSL B; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; Sonoda S, 2016, CELL REP, V16, P56, DOI 10.1016/j.celrep.2016.05.078; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Takeishi A, 2016, NEURON, V90, P235, DOI 10.1016/j.neuron.2016.03.002; Ujisawa T., 2014, PROTOCOL EXCHANGE; Wang D, 2013, J GEN PHYSIOL, V142, P437, DOI 10.1085/jgp.201310959; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165518	10.1371/journal.pone.0165518	http://dx.doi.org/10.1371/journal.pone.0165518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788246	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900101
J	Deng, T; Zhang, XS; Kim, C; Zhang, JW; Zhang, DG; Volis, S				Deng, Tao; Zhang, Xiao-Shuang; Kim, Changkyun; Zhang, Jian-Wen; Zhang, Dai-Gui; Volis, Sergei			Mazus sunhangii (Mazaceae), a New Species Discovered in Central China Appears to Be Highly Endangered	PLOS ONE			English	Article							SCROPHULARIACEAE; FLORA	Mazus sunhangii, a new species of Mazaceae from central China is described and illustrated based on evidence from morphology and molecular phylogeny. This new species is morphologically similar to M. puchellus and M. omeiensis but differs in erect habit, inflorescence position, leaf pattern and corolla color. Phylogenetic analysis based on four chloroplast DNA regions (rbcL, rps16, trnL-F, and psbA-trnH) identified the new species as the independent lineage sister to the other East Asian Mazus species. The new species is known only from a single location in Mt. Shennongjia area in northwest Hubei province, at the elevation of 760 m. The species grows on the limestone cliff, and, because a tourist arterial highway is located along this cliff, its habitat can be easily disturbed or destroyed. We propose that the only known species location is recognized as critical habitat (i.e., as the habitat required to ensure the persistence of a species) and the species listed as Critically Endangered based on the International Union for Conservation of Nature Red List Categories and Criteria B2a.	[Deng, Tao; Zhang, Xiao-Shuang; Kim, Changkyun; Zhang, Jian-Wen; Zhang, Dai-Gui; Volis, Sergei] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Deng, Tao; Zhang, Xiao-Shuang; Zhang, Dai-Gui] Jishou Univ, Key Lab Plant Resources Conservat & Utilizat, Jishou, Hunan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Jishou University	Zhang, DG (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China.; Zhang, DG (corresponding author), Jishou Univ, Key Lab Plant Resources Conservat & Utilizat, Jishou, Hunan, Peoples R China.	zdg634278@126.com	, wenzi/ABB-4126-2021; Volis, Sergei/GLU-5848-2022; ZHANG, Jianwen/AAG-7743-2020	ZHANG, Jianwen/0000-0002-4735-168X	West Light Foundation of The Chinese Academy of Sciences; Major Program of National Natural Science Foundation of China [31590823]; Traditional Chinese Medicine Public Health Special Project [[2011]76, 201207002]	West Light Foundation of The Chinese Academy of Sciences(Chinese Academy of Sciences); Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Traditional Chinese Medicine Public Health Special Project	This study was supported by West Light Foundation of The Chinese Academy of Sciences (to T. Deng), Major Program of National Natural Science Foundation of China (31590823 to Hang Sun) and Traditional Chinese Medicine Public Health Special Project ([2011]76, 201207002 to D.-G. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by West Light Foundation of The Chinese Academy of Sciences (to T. Deng), Major Program of National Natural Science Foundation of China (31590823 to H. Sun) and Traditional Chinese Medicine Public Health Special Project ([2011]76, 201207002 to D.-G. Zhang). We are grateful to L. Wang for the line drawings and X.-J. Li for collecting materials of Mazsu omeiensis.	Barker WR, 1991, ASPECTS TASMANIAN BO, P85, DOI [10.26749/rstpp.124.2.85, DOI 10.26749/RSTPP.124.2.85]; Beardsley PM, 2002, AM J BOT, V89, P1093, DOI 10.3732/ajb.89.7.1093; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Deng T, 2013, TAXON, V62, P89, DOI 10.1002/tax.621008; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gao Q, 2009, BOT STUD, V50, P251; Heenan PB, 1996, NEW ZEAL J BOT, V34, P33; Heenan PB, 1997, NEW ZEAL J BOT, V35, P437, DOI 10.1080/0028825X.1987.10410168; HONG DY, 1998, FLORA CHINA, P1; Hsieh TH, 2000, REVISION MAZUS LOUR, V45, p131 ; HU SY, 1980, J ARNOLD ARBORETUM, V61, P41, DOI 10.5962/bhl.part.8539; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Li HL, 1954, GENUS MAZUS SCROPHUL, V8, p29 , DOI [10.2307/2804908, DOI 10.2307/2804908]; Loureiro JD, 1790, FLORA COCHINCHINENSI, V2, P385; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Qian M., 1987, WUYI SCI J, V7, P263; Reveal James L., 2011, Kew Bulletin, V66, P5, DOI 10.1007/s12225-011-9259-y; Schaferhoff B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-352; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Xie Z, 2003, BIODIVERS CONSERV, V12, P65, DOI 10.1023/A:1021200525430; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058	23	5	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0163581	10.1371/journal.pone.0163581	http://dx.doi.org/10.1371/journal.pone.0163581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783628	Green Submitted, Green Published, gold			2022-12-26	WOS:000389602800017
J	Koyama, Y; Andoh, T; Kamiya, Y; Miyazaki, T; Maruyama, K; Kariya, T; Goto, T				Koyama, Yukihide; Andoh, Tomio; Kamiya, Yoshinori; Miyazaki, Tomoyuki; Maruyama, Koichi; Kariya, Takayuki; Goto, Takahisa			Bumetanide, an Inhibitor of NKCC1 (Na-K-2Cl Cotransporter Isoform 1), Enhances Propofol-Induced Loss of Righting Reflex but Not Its Immobilizing Actions in Neonatal Rats	PLOS ONE			English	Article							CATION-CHLORIDE COTRANSPORTERS; NEURONAL DEVELOPMENT; SEIZURES; GABA; ANESTHESIA; SLEEP; EXPRESSION; PLASTICITY; MIDAZOLAM; GLUTAMATE	Gamma-aminobutyric acid (GABA) has been shown to induce excitation on immature neurons due to increased expression of Na+-K+-2Cl-co-transporter isoform 1 (NKCC1), and the transition of GABAergic signaling from excitatory to inhibitory occurs before birth in the rat spinal cord and spreads rostrally according to the developmental changes in cationchloride co-transporter expression. We previously showed that midazolam activates the hippocampal CA3 area and induces less sedation in neonatal rats compared with adolescent rats in an NKCC1-dependent manner. In the present study, we tested the hypothesis that propofol-induced loss of righting reflex (LORR) but not immobilizing actions are modulated by NKCC1-dependent mechanisms and reduced in neonatal rats compared with adolescent rats. We estimated neuronal activity in the cortex, hippocampus and thalamus after propofol administration with or without bumetanide, an NKCC1 inhibitor, by immunostaining of phosphorylated cyclic adenosine monophosphate-response element binding protein (pCREB). We studied effects of bumetanide on propofol-induced LORR and immobilizing actions in postnatal day 7 and 28 (P7 and P28) rats. The pCREB expression in the cortex (P = 0.001) and hippocampus (P = 0.01) was significantly greater in the rats receiving propofol only than in the rats receiving propofol plus bumetanide at P 7. Propofol-induced LORR or immobilizing effects did not differ significantly between P7 and P28. Bumetanide significantly enhanced propofol-induced LORR (P = 0.031) but not immobilization in P7 rats. These results are partially consistent with our hypothesis. They suggest that propofol may activate the rostral but not caudal central nervous system dependently on NKCC1, and these differential actions may underlie the different properties of sedative and immobilizing actions observed in neonatal rats.	[Koyama, Yukihide; Andoh, Tomio; Miyazaki, Tomoyuki; Kariya, Takayuki; Goto, Takahisa] Yokohama City Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Yokohama, Kanagawa, Japan; [Koyama, Yukihide; Andoh, Tomio; Maruyama, Koichi] Teikyo Univ, Mizonokuchi Hosp, Sch Med, Dept Anesthesiol, Kawasaki, Kanagawa, Japan; [Kamiya, Yoshinori] Niigata Univ, Grad Sch Med, Dept Anesthesiol, Niigata, Japan	Yokohama City University; Teikyo University; Niigata University	Koyama, Y (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Yokohama, Kanagawa, Japan.; Koyama, Y (corresponding author), Teikyo Univ, Mizonokuchi Hosp, Sch Med, Dept Anesthesiol, Kawasaki, Kanagawa, Japan.	yukihidekoyama1008@gmail.com; yukihidekoyama1008@gmail.com	Koyama, Yukihide/AAP-9006-2021		Ministry of Education, Culture, Sports, Science and Technology, Japan [25861389]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (No. 25861389 to T.K.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, https://kaken.nii.ac.jp/d/p/25861389.ja.html.	Andrada J, 2012, ANESTH ANALG, V114, P661, DOI 10.1213/ANE.0b013e3182405228; Baker R, 2014, J NEUROSCI, V34, P13326, DOI 10.1523/JNEUROSCI.1519-14.2014; Beloozerova IN, 2005, J NEUROPHYSIOL, V93, P1831, DOI 10.1152/jn.00577.2004; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Cacheaux LP, 2005, J PHARMACOL EXP THER, V315, P517, DOI 10.1124/jpet.105.091801; Cleary RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057148; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; CONNELL J, 1989, ARCH DIS CHILD-FETAL, V64, P459, DOI 10.1136/adc.64.4_Spec_No.459; Deliagina TG, 2006, PHYSIOLOGY, V21, P216, DOI 10.1152/physiol.00001.2006; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Edwards DA, 2010, ANESTHESIOLOGY, V112, P567, DOI 10.1097/ALN.0b013e3181cf9138; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Glykys J, 2009, NEURON, V63, P657, DOI 10.1016/j.neuron.2009.08.022; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Jugovac I, 2006, ANESTHESIOLOGY, V105, P764, DOI 10.1097/00000542-200610000-00023; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; Kirmse K, 2010, J NEUROSCI, V30, P16002, DOI 10.1523/JNEUROSCI.2534-10.2010; Koch SC, 2008, ANESTHESIOLOGY, V108, P122, DOI 10.1097/01.anes.0000296079.45446.15; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Koyama Y, 2013, ANESTHESIOLOGY, V119, P1096, DOI 10.1097/ALN.0b013e31829e4b05; Kubo K, 2009, J PHARMACOL EXP THER, V329, P592, DOI 10.1124/jpet.109.151456; Kungys G, 2009, ANESTH ANALG, V108, P1531, DOI 10.1213/ane.0b013e31819d9308; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; Ma JY, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0004.2002; Musienko PE, 2008, BEHAV BRAIN RES, V190, P124, DOI 10.1016/j.bbr.2008.02.011; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Puskarjov M, 2014, EPILEPSIA, V55, P806, DOI 10.1111/epi.12620; Puskarjov N., 2015, CEREB CORTE IN PRESS; QUASHA AL, 1980, ANESTHESIOLOGY, V53, P315, DOI 10.1097/00000542-198010000-00008; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Scher MS, 2003, PEDIATR NEUROL, V28, P277, DOI 10.1016/S0887-8994(02)00621-5; Sipila ST, 2006, J PHYSIOL-LONDON, V573, P765, DOI 10.1113/jphysiol.2006.107086; Sonner JM, 2003, ANESTH ANALG, V96, P706, DOI [10.1213/01.ANE.0000048821.23225.3A, 10.1213/01.ANE.0000048821.232253]; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Wang S, 2015, NEUROSCIENCE, V286, P203, DOI 10.1016/j.neuroscience.2014.11.031; Westphalen RI, 2003, J PHARMACOL EXP THER, V304, P1188, DOI 10.1124/jpet.102.044685; Yu DS, 2013, NEUROSCI LETT, V534, P41, DOI 10.1016/j.neulet.2012.12.033	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164125	10.1371/journal.pone.0164125	http://dx.doi.org/10.1371/journal.pone.0164125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783647	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800026
J	Bateni, SB; Meyers, FJ; Bold, RJ; Canter, RJ				Bateni, Sarah B.; Meyers, Frederick J.; Bold, Richard J.; Canter, Robert J.			Increased Rates of Prolonged Length of Stay, Readmissions, and Discharge to Care Facilities among Postoperative Patients with Disseminated Malignancy: Implications for Clinical Practice	PLOS ONE			English	Article							COLORECTAL-CANCER-SURGERY; BOWEL OBSTRUCTION; LIVER METASTASES; QUALITY; LIFE; MORTALITY; OUTCOMES; END; RESECTION; CARCINOMATOSIS	Background The impact of surgery on end of life care for patients with disseminated malignancy (DMa) is incompletely characterized. The purpose of this study was to evaluate postoperative outcomes impacting quality of care among DMa patients, specifically prolonged length of hospital stay, readmission, and disposition. Methods The American College of Surgeons National Surgical Quality Improvement Program (ACSNSQIP) database was queried for years 2011-2012. DMa patients were matched to nonDMa patients with comparable clinical characteristics and operation types. Primary hepatic operations were excluded, leaving a final cohort of 17,972 DMa patients. The primary outcomes were analyzed using multivariate Cox regression models. Results DMa patients represented 2.1% of all ACS-NSQIP procedures during the study period. The most frequent operations were bowel resections (25.3%). Compared to non-DMa matched controls, DMa patients had higher rates of postoperative overall morbidity (24.4% vs. 18.7%, p<0.001), serious morbidity (14.9% vs. 12.0%, p<0.001), mortality (7.6% vs. 2.5%, p<0.001), prolonged length of stay (32.2% vs. 19.8%, p<0.001), readmission (15.7% vs. 9.6%, p<0.001), and discharges to facilities (16.2% vs. 12.9%, p<0.001). Subgroup analyses of patients by procedure type showed similar results. Importantly, DMa patients who did not experience any postoperative complication experienced significantly higher rates of prolonged length of stay (23.0% vs. 11.8%, p<0.001), readmissions (10.0% vs. 5.2%, p<0.001), discharges to a facility (13.2% vs. 9.5%, p<0.001), and 30-day mortality (4.7% vs. 0.8%, p<0.001) compared to matched non-DMa patients. Conclusion Surgical interventions among DMa patients are associated with poorer postoperative outcomes including greater postoperative complications, prolonged length of hospital stay, readmissions, disposition to facilities, and death compared to non- DMa patients. These data reinforce the importance of clarifying goals of care for DMa patients, especially when acute changes in health status potentially requiring surgery occur.	[Bateni, Sarah B.; Bold, Richard J.; Canter, Robert J.] Univ Calif Sacramento, Davis Med Ctr, Dept Surg, Div Surg Oncol, Sacramento, CA 95819 USA; [Meyers, Frederick J.] Univ Calif Sacramento, Davis Med Ctr, Dept Internal Med, Hematol Oncol, Sacramento, CA USA	California State University System; California State University Sacramento; California State University System; California State University Sacramento	Bateni, SB; Canter, RJ (corresponding author), Univ Calif Sacramento, Davis Med Ctr, Dept Surg, Div Surg Oncol, Sacramento, CA 95819 USA.	sbbateni@ucdavis.edu; rjcanter@ucdavis.edu						Adam R, 2006, ANN SURG, V244, P524, DOI 10.1097/01.sla.0000239036.46827.5f; Al-Refaie WB, 2011, ANN SURG, V253, P947, DOI 10.1097/SLA.0b013e318216f56e; Al-Refaie WB, 2010, ANN SURG, V251, P311, DOI 10.1097/SLA.0b013e3181b6b04c; Alese OB, 2015, CANCER-AM CANCER SOC, V121, P1772, DOI 10.1002/cncr.29297; Aloia TA, 2006, ARCH SURG-CHICAGO, V141, P460, DOI 10.1001/archsurg.141.5.460; American College of Surgeons, 2013, US GUID 2012 ACS NSQ; Bateni SB, 2015, J SURG RES, V197, P118, DOI 10.1016/j.jss.2015.03.063; Blair SL, 2001, ANN SURG ONCOL, V8, P632, DOI 10.1007/s10434-001-0632-1; Collins TC, 1999, ANN SURG, V230, P251, DOI 10.1097/00000658-199908000-00016; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Feuer DJ, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002764; Francescutti V, 2013, ANN SURG ONCOL, V20, P707, DOI 10.1245/s10434-012-2662-2; Gregg JR, 2011, J UROLOGY, V185, P90, DOI 10.1016/j.juro.2010.09.021; Henry JC, 2012, SURGERY, V152, P747, DOI 10.1016/j.surg.2012.07.009; Hui D, 2014, CANCER-AM CANCER SOC, V120, P1743, DOI 10.1002/cncr.28628; McCahill LE, 2003, ANN SURG ONCOL, V10, P654, DOI 10.1245/ASO.2003.06.011; Miner TJ, 2004, ANN SURG, V240, P719, DOI 10.1097/01.sla.0000141707.09312.dd; Olson TJP, 2014, JAMA SURG, V149, P383, DOI 10.1001/jamasurg.2013.4059; Reisinger KW, 2015, ANN SURG, V261, P345, DOI 10.1097/SLA.0000000000000628; Shiloach M, 2010, J AM COLL SURGEONS, V210, P6, DOI 10.1016/j.jamcollsurg.2009.09.031; Tomlinson JS, 2007, J CLIN ONCOL, V25, P4575, DOI 10.1200/JCO.2007.11.0833; TOWNSEND J, 1990, BRIT MED J, V301, P415, DOI 10.1136/bmj.301.6749.415; Tseng WH, 2011, ANN SURG, V254, P333, DOI 10.1097/SLA.0b013e31822513ed; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863; Zhang BH, 2012, ARCH INTERN MED, V172, P1133, DOI 10.1001/archinternmed.2012.2364	27	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165315	10.1371/journal.pone.0165315	http://dx.doi.org/10.1371/journal.pone.0165315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780274	Green Published, gold, Green Submitted			2022-12-26	WOS:000389046900045
J	de Andrade, LRB; Neto, RF; Granato, ISC; Sant'Ana, GC; Morais, PPP; Borem, A				Braatz de Andrade, Luciano Rogerio; Fritsche Neto, Roberto; Correia Granato, Italo Stefanine; Sant'Ana, Gustavo Cesar; Pinho Morais, Pedro Patric; Borem, Aluizio			Genetic Vulnerability and the Relationship of Commercial Germplasms of Maize in Brazil with the Nested Association Mapping Parents	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; POPULATION-STRUCTURE; INBRED LINES; DIVERSITY; PROGRAM	A few breeding companies dominate the maize (Zea mays L.) hybrid market in Brazil: Monsanto (R) (35%), DuPont Pioneer (R) (30%), Dow Agrosciences (R) (15%), Syngenta (R) (10%) and Helix Sementes (4%). Therefore, it is important to monitor the genetic diversity in commercial germplasms as breeding practices, registration and marketing of new cultivars can lead to a significant reduction of the genetic diversity. Reduced genetic variation may lead to crop vulnerabilities, food insecurity and limited genetic gains following selection. The aim of this study was to evaluate the genetic vulnerability risk by examining the relationship between the commercial Brazilian maize germplasms and the Nested Association Mapping (NAM) Parents. For this purpose, we used the commercial hybrids with the largest market share in Brazil and the NAM parents. The hybrids were genotyped for 768 single nucleotide polymorphisms (SNPs), using the Illumina Goldengate (R) platform. The NAM parent genomic data, comprising 1,536 SNPs for each line, were obtained from the Panzea data bank. The population structure, genetic diversity and the correlation between allele frequencies were analyzed. Based on the estimated effective population size and genetic variability, it was found that there is a low risk of genetic vulnerability in the commercial Brazilian maize germplasms. However, the genetic diversity is lower than those found in the NAM parents. Furthermore, the Brazilian germplasms presented no close relations with most NAM parents, except B73. This indicates that B73, or its heterotic group (Iowa Stiff Stalk Synthetic), contributed to the development of the commercial Brazilian germplasms.	[Braatz de Andrade, Luciano Rogerio; Pinho Morais, Pedro Patric; Borem, Aluizio] Univ Fed Vicosa, Plants Sci Dept, Vicosa, MG, Brazil; [Fritsche Neto, Roberto; Correia Granato, Italo Stefanine] Univ Sao Paulo, Dept Genet, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil; [Sant'Ana, Gustavo Cesar] Ctr Cooperat Int Rech Agron Dev, Syst Biol, Montpellier, Languedoc Rouss, France	Universidade Federal de Vicosa; Universidade de Sao Paulo; CIRAD	Neto, RF (corresponding author), Univ Sao Paulo, Dept Genet, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil.	roberto.neto@usp.br	Granato, Italo/F-2516-2014; Fritsche-Neto, Roberto/B-2256-2013; Braatz de Andrade, Luciano Rogério/M-1689-2014	Granato, Italo/0000-0003-2093-6810; Fritsche-Neto, Roberto/0000-0003-4310-0047; Braatz de Andrade, Luciano Rogério/0000-0003-4752-1164	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); DuPont Pioneer; Santa Helena Sementes; Dow Agrosciences; Biomatrix; Agromen Tecnologia; Syngenta; Helix Sementes; Dekalb	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); DuPont Pioneer; Santa Helena Sementes; Dow Agrosciences; Biomatrix; Agromen Tecnologia; Syngenta(Syngenta); Helix Sementes; Dekalb	Support was provided by: 1) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [http://www.fapesp.br/] (to RFN); 2) Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [http://www.fapemig.brfpt.br/] (to AB); 3) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [http://cnpq.br/] (to RFN GCS PPPM); 4) Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [http://www.capes.gov.br/] (to LRBA ISCG RFN AB); 5) DuPont Pioneer [http://www.pioneersementes.com.br/] (to RFN); 6) Santa Helena Sementes [http://www.shsementes.com.br/pt/] (to RFN); 7) Dow Agrosciences [http://www.dowagro.com/pt-br/brasil] (to RFN); 8) Biomatrix [http://www.biomatrix.com.br/pt/index.php] (to RFN); 9) Agromen Tecnologia [http:/www. agromen.com.br/0 (to RFN); 10) Syngenta [http://www3.syngenta.com.country/br/pt/Pages/home.aspx] (to RFN); 11) Helix Sementes; and 12) Dekalb. Funders 1 and 2 gave financial support to the laboratory. Funders 3 and 4 funded the graduate students LRBA, ISCG, PPPM and GCS. The funders 5, 6, 7, 8, 9 and 10 provided their hybrid seeds. Funder 5 had also conducted the genotyping of the Hybrids by GoldenGate Plataform, in USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank DuPont Pioneer Company for their assistance in conducting the genotyping. We also thank Helix Sementes, Dekalb, Dow Agrosciences, Dupont Pioneer and Syngenta, for providing their hybrid seeds for this research.	Bernardo R., 2010, BREEDING QUANTITATIV, V2; Brown AH, 2010, INDICATORS GENETIC D; Romay MC, 2011, CROP SCI, V51, P1016, DOI 10.2135/cropsci2010.06.0365; Cruz JC, 2013, QUATROCENTAS SESSENT; de Resende MDV, 2014, ESTATISTICA MATEMATI; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Galvão João Carlos Cardoso, 2014, Rev. Ceres, V61, P819, DOI 10.1590/0034-737x201461000007; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Guo YM, 2014, J HERED, V105, P555, DOI 10.1093/jhered/esu021; Knueppel S, 2015, HAPESTXXR MULTILOCUS; Le Clerc V, 2005, THEOR APPL GENET, V110, P294, DOI 10.1007/s00122-004-1834-2; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu KJ, 2003, GENETICS, V165, P2117; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Mikel MA, 2006, CROP SCI, V46, P1193, DOI 10.2135/cropsci2005.10-0371; Monaco MK, 2014, NUCL ACIDS RES, V42; Murray J., 1910, REPORTS SCI EXPEDITI, P17; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nelson PT, 2008, CROP SCI, V48, P1673, DOI 10.2135/cropsci2008.02.0092; Oyekunle M, 2015, FIELD CROP RES, V170, P55, DOI 10.1016/j.fcr.2014.10.005; Parentoni SN, 2013, CROP BREED APPL BIOT, V13, P9, DOI 10.1590/S1984-70332013000100002; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2016, R FDN STAT COMP; Reif JC, 2005, THEOR APPL GENET, V111, P838, DOI 10.1007/s00122-005-0004-5; Schwender H., 2013, scrime: Analysis of High-Dimensional Categorical Data such as SNP Data; Sebbenn Alexandre Magno, 2005, Rev. Árvore, V29, P1, DOI 10.1590/S0100-67622005000100001; Semagn K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-113; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Williams TR, 2000, MAYDICA, V45, P163; Wu X, 2014, THEOR APPL GENET, V127, P621, DOI 10.1007/s00122-013-2246-y; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7	36	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0163739	10.1371/journal.pone.0163739	http://dx.doi.org/10.1371/journal.pone.0163739			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780247	Green Submitted, Green Published, gold			2022-12-26	WOS:000389046900006
J	Cai, Y; Li, XW; Wang, RM; Yang, Q; Li, P; Hu, H				Cai, Yong; Li, Xiwen; Wang, Runmiao; Yang, Qing; Li, Peng; Hu, Hao			Quality Traceability System of Traditional Chinese Medicine Based on Two Dimensional Barcode Using Mobile Intelligent Technology	PLOS ONE			English	Article							FINGERPRINT; EXTRACTION; DNA	Currently, the chemical fingerprint comparison and analysis is mainly based on professional equipment and software, it's expensive and inconvenient. This study aims to integrate QR (Quick Response) code with quality data and mobile intelligent technology to develop a convenient query terminal for tracing quality in the whole industrial chain of TCM (traditional Chinese medicine). Three herbal medicines were randomly selected and their chemical two-dimensional barcode (2D) barcodes fingerprints were constructed. Smart-phone application (APP) based on Android system was developed to read initial data of 2D chemical barcodes, and compared multiple fingerprints from different batches of same species or different species. It was demonstrated that there were no significant differences between original and scanned TCM chemical fingerprints. Meanwhile, different TCM chemical fingerprint QR codes could be rendered in the same coordinate and showed the differences very intuitively. To be able to distinguish the variations of chemical fingerprint more directly, linear interpolation angle cosine similarity algorithm (LIACSA) was proposed to get similarity ratio. This study showed that QR codes can be used as an effective information carrier to transfer quality data. Smartphone application can rapidly read quality information in QR codes and convert data into TCM chemical fingerprints.	[Cai, Yong; Wang, Runmiao; Li, Peng; Hu, Hao] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Cai, Yong] Beijing Normal Univ, Informat Technol Coll, Zhuhai Campus, Zhuhai, Peoples R China; [Li, Xiwen] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Yang, Qing] Sichuan Univ, State Key Lab Hydraul & Mt River Engn, Chengdu, Peoples R China	University of Macau; Beijing Normal University; Beijing Normal University Zhuhai; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Sichuan University	Hu, H (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.	haohu@umac.mo	HU, Hao/H-7813-2018; xiwen, li/W-1990-2019	HU, Hao/0000-0001-9441-106X; 	University of Macau [MYRG2016-00055-ICMS-QRCM]; Hong Kong, Macao & Taiwan Science and Technology Cooperation Project [2015DFM30030]; ICMM [ZZ2014029]; Open Foundation of State Key Laboratory of Hydraulics and Mountain River Engineering, Sichuan University [SKHL1419]	University of Macau; Hong Kong, Macao & Taiwan Science and Technology Cooperation Project; ICMM; Open Foundation of State Key Laboratory of Hydraulics and Mountain River Engineering, Sichuan University	This research was supported by the funding of University of Macau (MYRG2016-00055-ICMS-QRCM), Hong Kong, Macao & Taiwan Science and Technology Cooperation Project (2015DFM30030), ICMM basic research funding (ZZ2014029), and Open Foundation of State Key Laboratory of Hydraulics and Mountain River Engineering, Sichuan University (SKHL1419).	Cai Y, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/251304; Chen XJ, 2007, J CHROMATOGR A, V1163, P96, DOI 10.1016/j.chroma.2007.06.020; Clarke J, 2016, JMIR MENT HEALTH, V3, DOI 10.2196/mental.4656; de Jongh T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007459.pub2; Dickinson JE, 2014, CURR ISSUES TOUR, V17, P84, DOI 10.1080/13683500.2012.718323; Dongare T, 2014, INT J EMERGING RES M, V3, P13; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Gao HM, 2013, APPL MECH MATER, V321-324, P3056, DOI 10.4028/www.scientific.net/AMM.321-324.3056; Gao J, 2009, THIRD INTERNATIONAL CONFERENCE ON MULTIMEDIA AND UBIQUITOUS ENGINEERING (MUE 2009), P320, DOI 10.1109/MUE.2009.62; Gao LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150947; Jiang Y, 2009, J CHROMATOGR A, V1216, P2156, DOI 10.1016/j.chroma.2008.04.040; Kong WJ, 2009, PHYTOMEDICINE, V16, P950, DOI 10.1016/j.phymed.2009.03.016; Kratz S, 2006, PERGAMES, V151; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Liang YZ, 2010, J SEP SCI, V33, P410, DOI 10.1002/jssc.200900653; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035146; Martincic CJ., 2016, INFORM SYSTEMS ED J, V14, P14; Moreno-Munoz A, 2016, RENEW SUST ENERG REV, V53, P1611, DOI 10.1016/j.rser.2015.09.077; Peng L., 2006, TELECOMMUNICATIONS S, V22, P36; Ruan GH, 2007, J CHROMATOGR B, V850, P241, DOI 10.1016/j.jchromb.2006.11.036; Seino K, 2004, OCEANS '04 MTS/IEEE TECHNO-OCEAN '04, VOLS 1- 2, CONFERENCE PROCEEDINGS, VOLS. 1-4, P476; Tang DQ, 2010, ANAL BIOANAL CHEM, V396, P3087, DOI 10.1007/s00216-010-3536-8; Wang D, 2016, J TRAVEL RES, V55, P52, DOI 10.1177/0047287514535847; Wang D, 2012, J TRAVEL RES, V51, P371, DOI 10.1177/0047287511426341; Wenping Du, 2016, Materials Science Forum, V836-837, P283, DOI 10.4028/www.scientific.net/MSF.836-837.283; Yang Jun, 2013, Zhongguo Yi Liao Qi Xie Za Zhi, V37, P18; Yetisen AK, 2014, LAB CHIP, V14, P833, DOI 10.1039/c3lc51235e; Zhang JL, 2005, J PHARMACEUT BIOMED, V36, P1029, DOI 10.1016/j.jpba.2004.09.009	28	5	7	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165263	10.1371/journal.pone.0165263	http://dx.doi.org/10.1371/journal.pone.0165263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780256	Green Submitted, gold, Green Published			2022-12-26	WOS:000389046900039
J	Sole-Casals, J; Pena, KLD; Caiafa, CF				Sole-Casals, Jordi; Lopez-de-Ipina Pena, Karmele; Caiafa, Cesar F.			Inverting Monotonic Nonlinearities by Entropy Maximization	PLOS ONE			English	Article							WIENER; IDENTIFICATION; INVERSION	This paper proposes a new method for blind inversion of a monotonic nonlinear map applied to a sum of random variables. Such kinds of mixtures of random variables are found in source separation and Wiener system inversion problems, for example. The importance of our proposed method is based on the fact that it permits to decouple the estimation of the nonlinear part (nonlinear compensation) from the estimation of the linear one (source separation matrix or deconvolution filter), which can be solved by applying any convenient linear algorithm. Our new nonlinear compensation algorithm, the MaxEnt algorithm, generalizes the idea of Gaussianization of the observation by maximizing its entropy instead. We developed two versions of our algorithm based either in a polynomial or a neural network parameterization of the nonlinear function. We provide a sufficient condition on the nonlinear function and the probability distribution that gives a guarantee for the MaxEnt method to succeed compensating the distortion. Through an extensive set of simulations, MaxEnt is compared with existing algorithms for blind approximation of nonlinear maps. Experiments show that MaxEnt is able to successfully compensate monotonic distortions outperforming other methods in terms of the obtained Signal to Noise Ratio in many important cases, for example when the number of variables in a mixture is small. Besides its ability for compensating nonlinearities, MaxEnt is very robust, i.e. showing small variability in the results.	[Sole-Casals, Jordi] Cent Univ Catalonia, Univ Vic, Univ Sci Tech, Data & Signal Proc Res Grp, Vic, Catalonia, Spain; [Lopez-de-Ipina Pena, Karmele] Univ Basque Country, Syst Engn & Automat Dept, EleKin Res Grp, Euskal Herriko Unibertsitatea, Donostia San Sebastian, Spain; [Caiafa, Cesar F.] CCT La Plata, IAR, CONICET, Buenos Aires, DF, Argentina	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); University of Basque Country; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Sole-Casals, J (corresponding author), Cent Univ Catalonia, Univ Vic, Univ Sci Tech, Data & Signal Proc Res Grp, Vic, Catalonia, Spain.	jordi.sole@uvic.cat	Solé-Casals, Jordi/GRX-7991-2022; Caiafa, Cesar/A-6045-2010; Solé-Casals, Jordi/B-7754-2008; López-de-Ipiña, Karmele/K-4379-2013	Caiafa, Cesar/0000-0001-5437-6095; Solé-Casals, Jordi/0000-0002-6534-1979; López-de-Ipiña, Karmele/0000-0003-0742-0932	University of Vic - Central University of Catalonia [R0947]; ANPCyT, Argentina [PICT 2012 -1519]; CONICET, Argentina [PIP 114-201101-00021]	University of Vic - Central University of Catalonia; ANPCyT, Argentina(ANPCyT); CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work has been partly funded by the University of Vic - Central University of Catalonia under the grant R0947 to JSC and grants from ANPCyT - PICT 2012 -1519 and CONICET - PIP 114-201101-00021, Argentina, to CFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been partly funded by the University of Vic - Central University of Catalonia under the grant R0947 and grants from ANPCyT - PICT 2012-1519 and CONICET - PIP 114-201101-00021, Argentina. The authors would like to acknowledge Prof. Christian Jutten (GIPSA Lab, Grenoble, France) for his discussions and guidance across this research work. The authors thank reviewers for providing deep and useful comments on the first version of the manuscript.	Astola JT, 2008, IEEE T INSTRUM MEAS, V57, P1949, DOI 10.1109/TIM.2008.917192; Bai EW, 2007, P AMER CONTR CONF, P2404; Bai E-W, 2002, IFAC P, V35, P97; Bai EW, 2009, AUTOMATICA, V45, P736, DOI 10.1016/j.automatica.2008.09.023; Bai Er-Wei, IEEE T SIGNAL PROCES, V53, P2315; Cardoso JF, 1999, NEURAL COMPUT, V11, P157, DOI 10.1162/089976699300016863; Chi CY, 2006, BLIND EQUALIZATION S; Haykin S., 2009, NEURAL NETWORKS LEAR; Huang DL, 2006, IEEE T SIGNAL PROCES, V54, P4343, DOI 10.1109/TSP.2006.881183; HUNTER IW, 1986, BIOL CYBERN, V55, P135; Nikias C. L., 1993, HIGHER ORDER SPECTRA; Sano A, 2002, SICE 2002: PROCEEDINGS OF THE 41ST SICE ANNUAL CONFERENCE, VOLS 1-5, P1521, DOI 10.1109/SICE.2002.1196533; Sole J, 2002, NEUROCOMPUTING, V48, P339, DOI 10.1016/S0925-2312(01)00651-8; Sole-Casals J, 2005, SIGNAL PROCESS, V85, P1780, DOI 10.1016/j.sigpro.2004.11.030; Taleb A, 2001, IEEE T SIGNAL PROCES, V49, P917, DOI 10.1109/78.917796; Taleb A, 1999, IEEE T SIGNAL PROCES, V47, P2807, DOI 10.1109/78.790661; Ziehe A, 2003, P 4 INT S IND COMP A, P269	17	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165288	10.1371/journal.pone.0165288	http://dx.doi.org/10.1371/journal.pone.0165288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780261	Green Published, gold, Green Submitted			2022-12-26	WOS:000389046900042
J	Flores, BN; Dulchaysky, ME; Krans, A; Sawaya, MR; Paulson, HL; Todd, PK; Barmada, SJ; Ivanova, MI				Flores, Brittany N.; Dulchaysky, Mark E.; Krans, Amy; Sawaya, Michael R.; Paulson, Henry L.; Todd, Peter K.; Barmada, Sami J.; Ivanova, Magdalena I.			Distinct C9orf72-Associated Dipeptide Repeat Structures Correlate with Neuronal Toxicity	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; C9ORF72 HEXANUCLEOTIDE REPEAT; NUCLEAR-RNA FOCI; GGGGCC REPEAT; ALPHA-SYNUCLEIN; PROTEIN; AGGREGATION; EXPANSION; TRANSLATION; NEURODEGENERATION	Hexanucleotide repeat expansions in C9orf72 are the most common inherited cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The expansions elicit toxicity in part through repeat-associated non-AUG (RAN) translation of the intronic (GGGGCC)(n) sequence into dipeptide repeat-containing proteins (DPRs). Little is known, however, about the structural characteristics and aggregation propensities of the dipeptide units comprising DPRs. To address this question, we synthesized dipeptide units corresponding to the three sense-strand RAN translation products, analyzed their structures by circular dichroism, electron microscopy and dye binding assays, and assessed their relative toxicity when applied to primary cortical neurons. Short, glycine-arginine (GR) 3 dipeptides formed spherical aggregates and selectively reduced neuronal survival compared to glycine- alanine (GA) 3 and glycine-proline (GP) 3 dipeptides. Doubling peptide length had little effect on the structure of GR or GP peptides, but (GA) 6 peptides formed beta-sheet rich aggregates that bound thioflavin T and Congo red yet lacked the typical fibrillar morphology of amyloids. Aging of (GA) 6 dipeptides increased their beta-sheet content and enhanced their toxicity when applied to neurons. We also observed that the relative toxicity of each tested dipeptide was proportional to peptide internalization. Our results demonstrate that different C9orf72-related dipeptides exhibit distinct structural properties that correlate with their relative toxicity.	[Flores, Brittany N.; Paulson, Henry L.; Todd, Peter K.; Barmada, Sami J.] Univ Michigan, Cellular & Mol Biol Grad Program, Ann Arbor, MI 48109 USA; [Dulchaysky, Mark E.; Krans, Amy; Paulson, Henry L.; Todd, Peter K.; Barmada, Sami J.; Ivanova, Magdalena I.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA USA; [Paulson, Henry L.; Todd, Peter K.; Barmada, Sami J.] Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA; [Todd, Peter K.] Vet Affairs Med Ctr, Ann Arbor, MI USA; [Ivanova, Magdalena I.] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Michigan System; University of Michigan	Barmada, SJ (corresponding author), Univ Michigan, Cellular & Mol Biol Grad Program, Ann Arbor, MI 48109 USA.; Barmada, SJ; Ivanova, MI (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.; Barmada, SJ (corresponding author), Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA.; Ivanova, MI (corresponding author), Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA.	sbarmada@mec.umich.edu; mivanova@umich.edu	Todd, Peter/AAH-2463-2020	Todd, Peter/0000-0003-4781-6376; Sawaya, Michael/0000-0003-0874-9043; Dulchavsky, Mark/0000-0002-5253-8924; Barmada, Sami/0000-0002-9604-968X	University of Michigan Protein Folding Diseases Initiative; National Institute of Health (NIH) [K08NS072233, 1R01NS097542-01]; NIH [T32-GM007315, R01NS086810, R01NS099280]; Department of Veterans Affairs (BLRD) [11216X001841, 1016X003231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099280, K08NS072233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG053760] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003231] Funding Source: NIH RePORTER	University of Michigan Protein Folding Diseases Initiative; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs (BLRD)(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the University of Michigan Protein Folding Diseases Initiative to MII, HLP, and SJB; the National Institute of Health (NIH) K08NS072233, 1R01NS097542-01 to SJB; NIH T32-GM007315 to BNF; and NIH R01NS086810 and NIH R01NS099280 to PKT. This work also received support from the Department of Veterans Affairs (BLRD 11216X001841, 1016X003231) to PKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Barmada SJ, 2015, P NATL ACAD SCI USA, V112, P7821, DOI 10.1073/pnas.1509744112; Barmada SJ, 2014, NAT CHEM BIOL, V10, P677, DOI 10.1038/nchembio.1563; Boeynaems S, 2016, SCI REP, V6, P1; Chang YJ, 2016, J BIOL CHEM, V291, P4903, DOI 10.1074/jbc.M115.694273; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P627, DOI 10.1002/bip.1976.360150403; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Di Scala C, 2014, J NEUROCHEM, V128, P186, DOI 10.1111/jnc.12390; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Gendron TF, 2015, ACTA NEUROPATHOL, V130, P559, DOI 10.1007/s00401-015-1474-4; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Gendron TF, 2013, EXPERT OPIN THER TAR, V17, P991, DOI 10.1517/14728222.2013.818659; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Kanekura K, 2016, HUM MOL GENET, V25, P1803, DOI 10.1093/hmg/ddw052; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Khan BK, 2012, J NEUROL NEUROSUR PS, V83, P358, DOI 10.1136/jnnp-2011-301883; Klunk WE, 1999, ANAL BIOCHEM, V266, P66, DOI 10.1006/abio.1998.2933; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Mackenzie IRA, 2015, ACTA NEUROPATHOL, V130, P845, DOI 10.1007/s00401-015-1476-2; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; May S, 2014, ACTA NEUROPATHOL, V128, P485, DOI 10.1007/s00401-014-1329-4; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Rucker AL, 2002, PROTEIN SCI, V11, P980, DOI 10.1110/ps.4550102; Saelices L, 2015, J BIOL CHEM, V290, P28932, DOI 10.1074/jbc.M115.659912; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serpell LC, 1999, METHOD ENZYMOL, V309, P526; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Su ZM, 2014, NEURON, V83, P1043, DOI 10.1016/j.neuron.2014.07.041; Tao ZT, 2015, HUM MOL GENET, V24, P2426, DOI 10.1093/hmg/ddv005; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Tiwari MK, 2015, J ALZHEIMERS DIS, V47, P215, DOI 10.3233/JAD-150046; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Tran H, 2015, NEURON, V87, P1207, DOI 10.1016/j.neuron.2015.09.015; van der Zee J, 2013, HUM MUTAT, V34, P363, DOI 10.1002/humu.22244; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Yamakawa M, 2015, HUM MOL GENET, V24, P1630, DOI 10.1093/hmg/ddu576; Yang DJ, 2015, ACTA NEUROPATHOL, V130, P525, DOI 10.1007/s00401-015-1448-6; Zanuy D, 2004, STRUCTURE, V12, P439, DOI 10.1016/j.str.2004.02.002; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	55	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165084	10.1371/journal.pone.0165084	http://dx.doi.org/10.1371/journal.pone.0165084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776165	gold, Green Submitted, Green Published			2022-12-26	WOS:000389009200039
J	Li, A; Gong, SZ; Johnson, KA				Li, An; Gong, Shanzhong; Johnson, Kenneth A.			Rate-limiting Pyrophosphate Release by HIV Reverse Transcriptase Improves Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MITOCHONDRIAL-DNA POLYMERASE; REAL-TIME MEASUREMENT; RNA-POLYMERASE; MUTATION-RATE; NUCLEOTIDE INCORPORATION; CONFORMATIONAL-CHANGE; TERNARY COMPLEXES; 3TC RESISTANCE; KINETIC-DATA	Previous measurements of the rates of polymerization and pyrophosphate release with DNA templates showed that pyrophosphate (PPi) dissociation was fast after nucleotide incorporation so that it did not contribute to enzyme specificity (k(cat)/K-m). Here, kinetic parameters governing nucleotide incorporation and PPi release were determined using an RNA template. Compared with a DNA template of the same sequence, the rate of chemistry increased by up to 10-fold (250 versus 24 s(-1)), whereas the rate of PPi release decreased to approximately 58 s(-1) so that PPi release became the rate-limiting step. During processive nucleotide incorporation, the first nucleotide (TTP) was incorporated at a fast rate (152 s(-1)), whereas the rates of incorporation of remaining nucleotides (CGTCG) were much slower with an average rate of 24 s(-1), suggesting that sequential incorporation events were limited by the relatively slow PPi release step. The accompanying paper shows that slow PPi release allows polymerization and RNase H to occur at comparable rates. Although PPi release is the rate-determining step, it is not the specificity-determining step for correct incorporation based on our current estimates of the rate of reversal of the chemistry step (3 s(-1)). In contrast, during misin-corporation, PPi release became extremely slow, which we estimated to be similar to 0.002 s(-1). These studies establish the mechanistic basis for DNA polymerase fidelity during reverse transcription and provide a free energy profile. We correct previous underestimates of discrimination by including the slow PPi release step. Our current estimate of 2.4 x 10(6) is >20-fold greater than estimated previously.	[Li, An; Gong, Shanzhong; Johnson, Kenneth A.] Univ Texas Austin, Inst Cell & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), 2500 Speedway MBB3-122, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			National Institutes of Health [R01 GM084741]; Welch Foundation [F-1604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM084741. This work was also supported by a grant from the Welch Foundation (F-1604). K. A. J. is the president of KinTek Corp., which provided the AutoSF-200x stopped flow and RQF-3 quench-flow instruments and KinTek Explorer software used in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; Avidan O, 2002, EUR J BIOCHEM, V269, P859, DOI 10.1046/j.0014-2956.2001.02719.x; BAKHANASHVILI M, 1993, BIOCHEMISTRY-US, V32, P7559, DOI 10.1021/bi00080a030; Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182; Boutabout M, 2001, NUCLEIC ACIDS RES, V29, P2217, DOI 10.1093/nar/29.11.2217; BOYER JC, 1992, P NATL ACAD SCI USA, V89, P6919, DOI 10.1073/pnas.89.15.6919; Boyer PL, 2000, J VIROL, V74, P6494, DOI 10.1128/JVI.74.14.6494-6500.2000; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Da LT, 2012, J AM CHEM SOC, V134, P2399, DOI 10.1021/ja210656k; Das K, 2016, ACS CHEM BIOL, V11, P2158, DOI 10.1021/acschembio.6b00187; Das K, 2014, NUCLEIC ACIDS RES, V42, P8125, DOI 10.1093/nar/gku487; Das K, 2012, NAT STRUCT MOL BIOL, V19, P253, DOI 10.1038/nsmb.2223; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Genna V, 2016, NUCLEIC ACIDS RES, V44, P2827, DOI 10.1093/nar/gkw128; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2008, ANAL BIOCHEM, V372, P125, DOI 10.1016/j.ab.2007.08.004; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; Havlir DV, 1996, ANN INTERN MED, V124, P984, DOI 10.7326/0003-4819-124-11-199606010-00006; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JI JP, 1994, VIROLOGY, V199, P323, DOI 10.1006/viro.1994.1130; JI JP, 1992, BIOCHEMISTRY-US, V31, P954, DOI 10.1021/bi00119a002; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Johnson RS, 2011, J MOL BIOL, V412, P849, DOI 10.1016/j.jmb.2011.05.023; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Kantor R, 2004, AIDS, V18, P1503, DOI 10.1097/01.aids.0000131358.29586.6b; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kellinger MW, 2011, BIOCHEMISTRY-US, V50, P5008, DOI 10.1021/bi200204m; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kirmizialtin S, 2015, J PHYS CHEM B, V119, P11513, DOI 10.1021/acs.jpcb.5b05467; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200; Li A, 2016, J BIOL CHEM, V291, P26566, DOI 10.1074/jbc.M116.753160; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Malinen AM, 2012, NUCLEIC ACIDS RES, V40, P7442, DOI 10.1093/nar/gks383; Mansky LM, 1996, AIDS RES HUM RETROV, V12, P307, DOI 10.1089/aid.1996.12.307; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; MITSUYA H, 1990, SCIENCE, V249, P1533, DOI 10.1126/science.1699273; Morin JA, 2015, NUCLEIC ACIDS RES, V43, P3643, DOI 10.1093/nar/gkv204; NOWAK M, 1990, NATURE, V347, P522, DOI 10.1038/347522a0; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Rezende LF, 1998, NUCLEIC ACIDS RES, V26, P3066, DOI 10.1093/nar/26.12.3066; ROBERTS JD, 1989, MOL CELL BIOL, V9, P469, DOI 10.1128/MCB.9.2.469; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5	59	17	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26554	26565		10.1074/jbc.M116.753152	http://dx.doi.org/10.1074/jbc.M116.753152			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27777304	Green Published, hybrid			2022-12-26	WOS:000391568200027
J	Alekhina, O; Marchese, A				Alekhina, Olga; Marchese, Adriano			beta-Arrestin1 and Signal-transducing Adaptor Molecule 1 (STAM1) Cooperate to Promote Focal Adhesion Kinase Autophosphorylation and Chemotaxis via the Chemokine Receptor CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; BREAST-CANCER; BETA-ARRESTIN; CXCR4-MEDIATED CHEMOTAXIS; LYSOSOMAL DEGRADATION; LIGASE AIP4; ACTIVATION; EXPRESSION; COMPLEX; PHOSPHORYLATION	The chemokine receptor CXCR4 and its chemokine ligand CXCL12 mediate directed cell migration during organogenesis, immune responses, and metastatic disease. However, the mechanisms governing CXCL12/CXCR4-dependent chemotaxis remain poorly understood. Here, we show that the beta-arrestin1.signal-transducing adaptor molecule 1 (STAM1) complex, initially identified to govern lysosomal trafficking of CXCR4, also mediates CXCR4-dependent chemotaxis. Expression of mini-gene fragments from beta-arrestin1 or STAM1, known to disrupt the beta-arrestin1.STAM1 complex, and RNAi against beta-arrestin1 or STAM1, attenuates CXCL12-induced chemotaxis. The beta-arrestin1.STAM1 complex is necessary for promoting autophosphorylation of focal adhesion kinase (FAK). FAK is necessary for CXCL12-induced chemotaxis and associates with and localizes with beta-arrestin1 and STAM1 in a CXCL12-dependent manner. Our data reveal previously unknown roles in CXCR4-dependent chemotaxis for beta-arrestin1 and STAM1, which we propose act in concert to regulate FAK signaling. The beta-arrestin1.STAM1 complex is a promising target for blocking CXCR4-promoted FAK autophosphorylation and chemotaxis.	[Alekhina, Olga; Marchese, Adriano] Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd,BSB 355, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Marchese, A (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd,BSB 355, Milwaukee, WI 53226 USA.	amarchese@mcw.edu			National Institutes of Health [GM106727, GM106727-S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM106727 and GM106727-S1 (to A. M.). The authors declare the following patent (US8691188B2): Methods of Utilizing the Arrestin-2/STAM-1 Complex as a Therapeutic Target (to A. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2001, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb0901s00, DOI 10.1002/0471143030.CB0901S00]; Anthony DF, 2011, MOL CELL BIOL, V31, P1066, DOI 10.1128/MCB.00883-10; Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Brami-Cherrier K, 2014, EMBO J, V33, P356, DOI 10.1002/embj.201386399; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Cleghorn WM, 2015, MOL BIOL CELL, V26, P622, DOI 10.1091/mbc.E14-02-0740; DeFea KA, 2013, PROG MOL BIOL TRANSL, V118, P205, DOI 10.1016/B978-0-12-394440-5.00008-5; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; Dillenburg-Pilla P, 2015, FASEB J, V29, P1056, DOI 10.1096/fj.14-260083; Fernandis AZ, 2004, ONCOGENE, V23, P157, DOI 10.1038/sj.onc.1206910; Fischer T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004069; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Galet C, 2008, CELL SIGNAL, V20, P1822, DOI 10.1016/j.cellsig.2008.06.005; Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769; Gurevich VV, 2015, CRIT REV BIOCHEM MOL, V50, P440, DOI 10.3109/10409238.2015.1067185; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Holleman J, 2014, MOL BIOL CELL, V25, P1892, DOI 10.1091/mbc.E13-10-0612; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jung O, 2012, J CELL SCI, V125, P5960, DOI 10.1242/jcs.100586; Kennedy JE, 2015, PROG MOL BIOL TRANSL, V132, P15, DOI 10.1016/bs.pmbts.2015.02.005; Le Y, 2005, J IMMUNOL, V174, P2582, DOI 10.4049/jimmunol.174.5.2582; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Lohi O, 1998, FEBS LETT, V436, P419, DOI 10.1016/S0014-5793(98)01171-5; Ma XJ, 2014, J BIOL CHEM, V289, P13638, DOI 10.1074/jbc.M113.511360; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2016, METHOD ENZYMOL, V570, P281, DOI 10.1016/bs.mie.2015.10.004; Marchese A, 2014, CURR OPIN CELL BIOL, V27, P72, DOI 10.1016/j.ceb.2013.11.011; Meng D, 2009, J BIOL CHEM, V284, P11425, DOI 10.1074/jbc.M806395200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Paradis JS, 2015, P NATL ACAD SCI USA, V112, pE5160, DOI 10.1073/pnas.1508836112; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peng SB, 2005, MOL CANCER RES, V3, P227; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Ryu CH, 2010, BIOCHEM BIOPH RES CO, V398, P105, DOI 10.1016/j.bbrc.2010.06.043; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Sengupta R, 2012, CANCER RES, V72, P122, DOI 10.1158/0008-5472.CAN-11-1701; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tavernier-Tardy E, 2009, LEUKEMIA RES, V33, P764, DOI 10.1016/j.leukres.2008.10.014; Verma R, 2015, J BIOL CHEM, V290, P6810, DOI 10.1074/jbc.M114.606699; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhang JP, 2007, INT J GYNECOL CANCER, V17, P478, DOI 10.1111/j.1525-1438.2007.00786.x; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	68	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26083	26097		10.1074/jbc.M116.757138	http://dx.doi.org/10.1074/jbc.M116.757138			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27789711	Green Published, hybrid			2022-12-26	WOS:000390345200027
J	Sheweita, SA; El-Hosseiny, LS; Nashashibi, MA				Sheweita, Salah A.; El-Hosseiny, Lobna S.; Nashashibi, Munther A.			Protective Effects of Essential Oils as Natural Antioxidants against Hepatotoxicity Induced by Cyclophosphamide in Mice	PLOS ONE			English	Article							DRUG-METABOLIZING-ENZYMES; OXIDATIVE STRESS; INDUCED GENOTOXICITY; GLUTATHIONE; DAMAGE; TRANSFERASE; ACTIVATION; QUERCETIN; INDUCTION; REDUCTASE	Clinical application of cyclophosphamide (CP) as an anticancer drug is often limited due to its toxicity. CP is metabolized mainly in the liver by cytochrome P450 system into acrolein which is the proximate toxic metabolite. Many different natural antioxidants were found to alleviate the toxic effects of various toxic agents via different mechanisms. Therefore, the present study aimed at investigating the role of essential oils extracted from fennel, cumin and clove as natural antioxidants in the alleviation of hepatotoxicity induced by CP through assessment of hepatotoxicity biomarkers (AST, ALT, ALP), histopathology of liver tissues as well as other biochemical parameters involved in the metabolism of CP. The data of the present study showed that treatment of male mice with cyclophosphamide (2.5 mg/Kg BW) as repeated dose for 28 consecutive days was found to induce hepatotoxicity through the elevation in the activities of AST, ALT, and ALP. Combined administration of any of these oils with CP to mice partially normalized the altered hepatic biochemical markers caused by CP, whereas administration of fennel, clove or cumin essential oils alone couldn't change liver function indices. Moreover, CP caused histological changes in livers of mice including swelling and dilation in sinusoidal space, inflammation in portal tract and hepatocytes, as well as, hyperplasia in Kuppfer cells. However, co-administration of any of the essential oils with CP alleviated to some extent the changes caused by CP but not as the normal liver. CP was also found to induce free radical levels (measured as thiobarbituric acid reactive substances) and inhibited the activities of superoxide dismutase, glutathione reductase, and catalase as well as activities and protein expressions of both (GST pi) and glutathione peroxidase. Essential oils restored changes in activities of antioxidant enzymes (SOD, CAT, GR, GST, and GPx) caused by CP to their normal levels compared to control group. In addition, treatment of mice with CP was found to induce the protein expression of CYP 3A4, 2B1/2, 2C6, 2C23. Moreover, the present study showed that essential oils reduced the expression of CYPs 2E1, 3A4 but could not restore the expression of CYP 2C6 and 2C23 compared to CP-treated mice. Interestingly, pretreatment of mice with essential oil of clove was found to restore activities of DMN-dI, AHH, and ECOD which were induced by CP to their normal control levels. It is concluded that EOs showed a marked hepatoprotective effect against hepatotoxicity induced by CP. In addition, co-administration of CP with any of these oils might be used as a new strategy for cancer treatment to alleviate the hepatotoxicity induced by CP.	[Sheweita, Salah A.; Nashashibi, Munther A.] Univ Alexandria, Inst Grad Studies & Res, Dept Biotechnol, Alexandria, Egypt; [El-Hosseiny, Lobna S.] Univ Alexandria, Inst Grad Studies & Res, Dept Environm Studies, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	Sheweita, SA (corresponding author), Univ Alexandria, Inst Grad Studies & Res, Dept Biotechnol, Alexandria, Egypt.	ssheweita@yahoo.com	Sheweita, Salah A/AFU-1622-2022	Sheweita, Salah A/0000-0001-8113-4403; El-Hosseiny, Lobna/0000-0001-9770-7835				Aboul-Ela El, 2014, J CELL BIOL, V2, P18; Abozid MM, 2013, INT J CHEM TECH RES, V5, P1470; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; ARIYOSHI T, 1975, XENOBIOTICA, V5, P33, DOI 10.3109/00498257509056091; AUSTIN CA, 1988, BIOCHEM PHARMACOL, V37, P2223, DOI 10.1016/0006-2952(88)90585-0; Badgujar SB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/842674; Barakat L. A. A., 2011, Journal of Applied Sciences Research, P1368; Barouki R, 2007, FEBS LETT, V581, P749, DOI [10.1016/j.febslet.2007.01.044, DOI 10.1016/J.FEBSLET.2007.01.044]; Baskaran Y, 2010, TOXICOLOGY, V268, P204, DOI 10.1016/j.tox.2009.12.018; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bhattacharya A, 2003, J AM COLL NUTR, V22, P388, DOI 10.1080/07315724.2003.10719322; Chakraborty P, 2009, CANCER CHEMOTH PHARM, V64, P971, DOI 10.1007/s00280-009-0950-8; Chang TKH, 1997, CANCER RES, V57, P1946; CHIU DTY, 1976, BIOCHIM BIOPHYS ACTA, V445, P558, DOI 10.1016/0005-2744(76)90110-8; Conklin DJ, 2009, J PHARMACOL EXP THER, V331, P456, DOI 10.1124/jpet.109.156513; Cortes-Rojas Diego Francisco, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P90, DOI 10.1016/S2221-1691(14)60215-X; David M., 1983, METHOD ENZYMAT AN, P358; De-Oliveira ACAX, 1997, TOXICOLOGY, V124, P135, DOI 10.1016/S0300-483X(97)00144-3; Dhanalakshmi GS, 2003, NUTR CANCER, V47, P171, DOI 10.1207/s15327914nc4702_10; Drury AR., 1980, CARLETONS HISTOLOGIC, V5; Emadi A, 2009, NAT REV CLIN ONCOL, V6, P638, DOI 10.1038/nrclinonc.2009.146; Gnanasekaran Sadhana, 2015, J Exp Ther Oncol, V11, P51; GOPALAN P, 1993, CARCINOGENESIS, V14, P1469, DOI 10.1093/carcin/14.7.1469; GREENLEE WF, 1978, J PHARMACOL EXP THER, V205, P596; Gupta AK, 2006, AM J PHARM TOXICOL, V1, P17, DOI [DOI 10.3844/AJPTSP.2006.17.20, 10.3844/ajptsp.2006.17.20]; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Han EH, 2007, FEBS LETT, V581, P749, DOI 10.1016/j.febslet.2007.01.044; Huang HC, 2015, INT J MOL SCI, V16, P10470, DOI 10.3390/ijms160510470; IARC, 2012, IARC MON A, V100A; Johri R K, 2011, Pharmacogn Rev, V5, P63, DOI 10.4103/0973-7847.79101; Kalmes M, 2012, J TOXICOL ENV HEAL A, V75, P478, DOI 10.1080/15287394.2012.674916; Kaurinovic B, 2010, MOLECULES, V15, P5943, DOI 10.3390/molecules15095943; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maor Y, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/815105; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Misharina TA, 2008, APPL BIOCHEM MICRO+, V44, P438, DOI 10.1134/S0003683808040182; MISRA HP, 1972, J BIOL CHEM, V247, P3170; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; Moignet A, 2014, LEUKEMIA, V28, P1134, DOI 10.1038/leu.2013.359; Mostafa M, 1992, RAMAZZINI NEWSLETTER, V2, P15; MURRAY GI, 1987, BRIT J CANCER, V55, P605, DOI 10.1038/bjc.1987.123; Musonda CA, 1998, CARCINOGENESIS, V19, P1583, DOI 10.1093/carcin/19.9.1583; Muzio G, 1999, FREE RADICAL BIO MED, V26, P1314, DOI 10.1016/S0891-5849(98)00329-3; Myers CR, 2009, TOXICOLOGY, V257, P95, DOI 10.1016/j.tox.2008.12.013; Nadeem M., 2012, PAK J FOOD SCI, V22, P101; Nithya N., 2012, Journal of Pharmacology and Toxicology, V7, P38, DOI 10.3923/jpt.2012.38.45; Rabeh N. M., 2014, Pakistan Journal of Nutrition, V13, P303; Rayan D., 1978, METHOD ENZYMOL, V752, P118; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Saleh MA, 2010, ETHNIC DIS, V20, P78; Shanmugarajan TS, 2008, J PHARM TOXICOL, V3, P363, DOI DOI 10.3923/JPT.2008.363.372; Sheweita SA, 2000, CURR DRUG METAB, V1, P107, DOI 10.2174/1389200003339117; Sheweita SA, 2003, CURR DRUG METAB, V4, P45, DOI 10.2174/1389200033336919; Singh S, 2015, INDIAN J EXP BIOL, V53, P647; TAPPEL A. L., 1959, ARCH BIOCHEM AND BIOPHYS, V80, P333, DOI 10.1016/0003-9861(59)90259-0; Tripathi P, 2013, DRUG CHEM TOXICOL, V36, P396, DOI 10.3109/01480545.2012.749271; Tripathi P, 2013, DRUG CHEM TOXICOL, V36, P35, DOI 10.3109/01480545.2011.648328; Tsai-Turton M, 2007, TOXICOL SCI, V98, P216, DOI 10.1093/toxsci/kfm087; VENKATESAN N, 1968, LIFE SCI PT 1 PHYSI, V7, P1111, DOI 10.1016/0024-3205(68)90217-8; Vieira PM, 2012, J MED FOOD, V15, P563, DOI 10.1089/jmf.2011.0270; Wahlang B, 2015, Adv Pharmacol, V74, P1, DOI 10.1016/bs.apha.2015.04.004; WILLIAMS CH, 1962, J BIOL CHEM, V237, P587; Xie HJ, 2003, PHARMACOGENOMICS J, V3, P53, DOI 10.1038/sj.tpj.6500157; Zarei M, 2013, FOOD CHEM TOXICOL, V57, P179, DOI 10.1016/j.fct.2013.03.028; Zhang YLMCQ, 2005, TOXICOL SCI, V88, P545, DOI 10.1093/toxsci/kfi333; Zhou SF, 2007, CURR DRUG METAB, V8, P526; Zhu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep17536	68	48	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165667	10.1371/journal.pone.0165667	http://dx.doi.org/10.1371/journal.pone.0165667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802299	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200036
J	Walter, RFH; Werner, R; Vollbrecht, C; Hager, T; Flom, E; Christoph, DC; Schmeller, J; Schmid, KW; Wohlschlaeger, J; Mairinger, FD				Walter, Robert Fred Henry; Werner, Robert; Vollbrecht, Claudia; Hager, Thomas; Flom, Elena; Christoph, Daniel Christian; Schmeller, Jan; Schmid, Kurt Werner; Wohlschlaeger, Jeremias; Mairinger, Fabian Dominik			ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter Technology	PLOS ONE			English	Article							EXPRESSION ANALYSIS; RNA EXPRESSION; TUMORS; TISSUE; SAMPLES; MARKER	Background Neuroendocrine lung cancer (NELC) represents 25% of all lung cancer cases and large patient collectives exist as formalin-fixed, paraffin-embedded (FFPE) tissue only. FFPE is controversially discussed as source for molecular biological analyses and reference genes for NELC are poorly establishes. Material and methods Forty-three representative FFPE-specimens were used for mRNA expression analysis using the digital nCounter technology (NanoString). Based on recent literature, a total of 91 mRNA targets were investigated as potential tumor markers or reference genes. The geNorm, NormFinder algorithms and coefficient of correlation were used to identify the most stable reference genes. Statistical analysis was performed by using the R programming environment (version 3.1.1) Results RNA integrity (RIN) ranged from 1.8 to 2.6 and concentrations from 34 to 2,109 ng/mu l. However, the nCounter technology gave evaluable results for all samples tested. ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP were identified as constantly expressed genes with high stability (M-) values according to geNorm, NormFinder and coefficients of correlation. Conclusion FFPE-derived mRNA is suitable for molecular biological investigations via the nCounter technology, although it is highly degraded. ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP are potent reference genes in neuroendocrine tumors of the lung.	[Walter, Robert Fred Henry; Flom, Elena] Univ Duisburg Essen, Univ Hosp Essen, West German Lung Ctr, Ruhrlandklin, Essen, Germany; [Walter, Robert Fred Henry; Hager, Thomas; Schmeller, Jan; Schmid, Kurt Werner; Wohlschlaeger, Jeremias; Mairinger, Fabian Dominik] Univ Duisburg Essen, Univ Hosp Essen, Inst Pathol, Essen, Germany; [Werner, Robert] Helios Klinikum Emil von Behring, Inst Pathol, Berlin, Germany; [Vollbrecht, Claudia] German Canc Consortium DKTK, Partnersite Berlin, Berlin, Germany; [Vollbrecht, Claudia] Charite, Inst Pathol, Berlin, Germany; [Vollbrecht, Claudia] German Canc Res Ctr, Heidelberg, Germany; [Christoph, Daniel Christian] Univ Duisburg Essen, Univ Hosp Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany; [Wohlschlaeger, Jeremias] Ev Luth Diakonissenkrankenhaus Flensburg, Inst Pathol, Flensburg, Germany	University of Duisburg Essen; University of Duisburg Essen; Helios Kliniken; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen	Walter, RFH (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, West German Lung Ctr, Ruhrlandklin, Essen, Germany.; Walter, RFH (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Pathol, Essen, Germany.	robert.walter@ruhrlandklinik.uk-essen.de		Schmeller, Jan/0000-0002-2012-2350; Walter, Robert/0000-0003-3725-7064; Mairinger, Fabian/0000-0003-1067-0051; Vollbrecht, Claudia/0000-0002-0861-001X	Institute of Pathology and Ruhrlandklinik	Institute of Pathology and Ruhrlandklinik	The study was financed by the Institute of Pathology and Ruhrlandklinik.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Beaume M, 2011, J MICROBIOL METH, V84, P327, DOI 10.1016/j.mimet.2010.12.025; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dhakal B, 2016, F1000RES, V5; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Joerger M, 2010, CURR DRUG TARGETS, V11, P37, DOI 10.2174/138945010790030974; Kalmar A, 2013, METHODS, V59, pS16, DOI 10.1016/j.ymeth.2012.09.011; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Li RN, 2013, LIFE SCI, V92, P747, DOI 10.1016/j.lfs.2013.02.014; Mairinger FD, 2014, J CANCER, V5, P465, DOI 10.7150/jca.9235; Mairinger FD, 2014, MODERN PATHOL, V27, P1632, DOI 10.1038/modpathol.2014.74; Mairinger FD, 2014, J CANCER, V5, P646, DOI 10.7150/jca.9955; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Rekhtman N, 2010, ARCH PATHOL LAB MED, V134, P1628, DOI 10.1043/2009-0583-RAR.1; Sobin LH., 2003, INT UNION CANC UICC, V7, DOI [10.1002/0471463752, DOI 10.1002/0471463752]; Travis WD., 2004, TRAVIS WB WHO CLASSI; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vollbrecht C, 2015, BRIT J CANCER, V113, P1704, DOI 10.1038/bjc.2015.397; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Walter R. F. H., 2016, ONCOTARGET; Walter RFH, 2015, ONCOTARGET, V6, P24690, DOI 10.18632/oncotarget.3992; Walter RFH, 2015, FUTURE ONCOL, V11, P1027, DOI 10.2217/fon.15.18; Walter RFH, 2013, PATHOL RES PRACT, V209, P784, DOI 10.1016/j.prp.2013.09.007	23	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165181	10.1371/journal.pone.0165181	http://dx.doi.org/10.1371/journal.pone.0165181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802291	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200019
J	Feldmeier, S; Schefczyk, L; Wagner, N; Heinemann, G; Veith, M; Lotters, S				Feldmeier, Stephan; Schefczyk, Lukas; Wagner, Norman; Heinemann, Guenther; Veith, Michael; Loetters, Stefan			Exploring the Distribution of the Spreading Lethal Salamander Chytrid Fungus in Its Invasive Range in Europe - A Macroecological Approach	PLOS ONE			English	Article							SPECIES DISTRIBUTION; BATRACHOCHYTRIUM-SALAMANDRIVORANS; SAMPLE-SIZE; CLIMATE; PERFORMANCE; MODELS; ABSENCES; MAXENT; CHYTRIDIOMYCOSIS; BIODIVERSITY	The chytrid fungus Batrachochytrium salamandrivorans (Bsal) is a dangerous pathogen to salamanders and newts. Apparently native to Asia, it has recently been detected in Western Europe where it is expected to spread and to have dramatic effects on naive hosts. Since 2010, Bsal has led to some catastrophic population declines of urodeles in the Netherlands and Belgium. More recently, it has been discovered in additional, more distant sites including sites in Germany. With the purpose to contribute to a better understanding of Bsal, we modelled its potential distribution in its invasive European range to gain insights about the factors driving this distribution. We computed Bsal Maxent models for two predictor sets, which represent different temporal resolutions, using three different background extents to account for different invasion stage scenarios. Beside 'classical' bioclimate, we employed weather data, which allowed us to emphasize predictors in accordance with the known pathogen's biology. The most important predictors as well as spatial predictions varied between invasion scenarios and predictor sets. The most reasonable model was based on weather data and the scenario of a recent pathogen introduction. It identified temperature predictors, which represent optimal growing conditions and heat limiting conditions, as the most explaining drivers of the current distribution. This model also predicted large areas in the study region as suitable for Bsal. The other models predicted considerably less, but shared some areas which we interpreted as most likely high risk zones. Our results indicate that growth relevant temperatures measured under laboratory conditions might also be relevant on a macroecological scale, if predictors with a high temporal resolution and relevance are used. Additionally, the conditions in our study area support the possibility of a further Bsal spread, especially when considering that our models might tend to underestimate the potential distribution of Bsal.	[Feldmeier, Stephan; Wagner, Norman; Veith, Michael; Loetters, Stefan] Univ Trier, Dept Biogeog, Trier, Germany; [Schefczyk, Lukas; Heinemann, Guenther] Univ Trier, Dept Environm Meteorol, Trier, Germany	Universitat Trier; Universitat Trier	Lotters, S (corresponding author), Univ Trier, Dept Biogeog, Trier, Germany.	loetters@uni-trier.de	Wagner, Norman/AFR-9091-2022	Wagner, Norman/0000-0001-9565-619X; Feldmeier, Stephan/0000-0002-6756-6995	Trier Centre for Sustainable Systems (TriCSS); Deutsche Gesellschaft fur Herpetologie and Terrarienkunde (DGHT); Nikolaus Koch Stiftung; Stiftung Artenschutr; Verband der Zoologischen Garten; Zoo Landau	Trier Centre for Sustainable Systems (TriCSS); Deutsche Gesellschaft fur Herpetologie and Terrarienkunde (DGHT); Nikolaus Koch Stiftung; Stiftung Artenschutr; Verband der Zoologischen Garten; Zoo Landau	S.F. and L.S. are funded by the Trier Centre for Sustainable Systems (TriCSS). Our Bsal research benefits from funds by the Deutsche Gesellschaft fur Herpetologie and Terrarienkunde (DGHT), Nikolaus Koch Stiftung, Stiftung Artenschutr, Verband der Zoologischen Garten and Zoo Landau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, J BIOGEOGR, V30, P591, DOI 10.1046/j.1365-2699.2003.00867.x; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; [Anonymous], 2011, ECOLOGICAL NICHES GE; [Anonymous], 2010, MAPPING SPECIES DIST; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bateman BL, 2012, ECOGRAPHY, V35, P306, DOI 10.1111/j.1600-0587.2011.06871.x; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Blooi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11788; Blooi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08037; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Cunningham AA, 2015, VET REC, V176, P468, DOI 10.1136/vr.h2264; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Goverse E, 2015, RENDS AANTALLEN NEM, V26, P12; Gray MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005251; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gutjahr O, 2016, METEOROL Z, V25, P543, DOI 10.1127/metz/2016/0638; Hanberry BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044486; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans R.J., DISMO SPECIES DISTRI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, RASTER GEOGRAPHIC DA; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Langwig KE, 2015, FRONT ECOL ENVIRON, V13, P195, DOI 10.1890/140241; Latinne A, 2015, J BIOGEOGR, V42, P1714, DOI 10.1111/jbi.12528; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pohlert T., PAIRWISE MULTIPLE CO; R Core Team, 2013, R LANG ENV STAT COMP; Rahbek C, 2007, NATURE, V447, P652, DOI 10.1038/nature05889; Rasztovits E, 2014, ANN FOREST SCI, V71, P201, DOI 10.1007/s13595-013-0346-0; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Reside AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013569; Richgels KLD, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150616; Rockel B, 2008, METEOROL Z, V17, P347, DOI 10.1127/0941-2948/2008/0309; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Roedder Dennis, 2009, Diversity, V1, P52; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Sabino-Pinto J, 2015, AMPHIBIA-REPTILIA, V36, P411, DOI 10.1163/15685381-00003008; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Senay SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071218; Shcheglovitova M, 2013, ECOL MODEL, V269, P9, DOI 10.1016/j.ecolmodel.2013.08.011; Sillero N, 2014, AMPHIBIA-REPTILIA, V35, P1, DOI 10.1163/15685381-00002935; Smith KG, 2009, ECOL LETT, V12, P1069, DOI 10.1111/j.1461-0248.2009.01363.x; Spitzen-van der Sluijs A, 2016, EMERG INFECT DIS, V22, P1286, DOI 10.3201/eid2207.160109; Stuart S. N., 2008, THREATENED AMPHIBIAN; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x; van Proosdij ASJ, 2016, ECOGRAPHY, V39, P542, DOI 10.1111/ecog.01509; Van Rooij P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0266-0; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warton D, 2013, J ANIM ECOL, V82, P1125, DOI 10.1111/1365-2656.12071; Watling JI, 2015, ECOL MODEL, V309, P48, DOI 10.1016/j.ecolmodel.2015.03.017; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Yap TA, 2015, SCIENCE, V349, P481, DOI 10.1126/science.aab1052; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	79	22	23	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165682	10.1371/journal.pone.0165682	http://dx.doi.org/10.1371/journal.pone.0165682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798698	Green Submitted, gold, Green Published			2022-12-26	WOS:000386711100054
J	Chua, SK; Shyu, KG; Lin, YF; Lo, HM; Wang, BW; Chang, H; Lien, LM				Chua, Su-Kiat; Shyu, Kou-Gi; Lin, Yuh-Feng; Lo, Huey-Ming; Wang, Bao-Wei; Chang, Hang; Lien, Li-Ming			Tumor Necrosis Factor-Alpha and the ERK Pathway Drive Chemerin Expression in Response to Hypoxia in Cultured Human Coronary Artery Endothelial Cells	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEART-FAILURE; ADIPOKINES; OBESITY; ANGIOGENESIS; HYPERTROPHY; STRESS	Background Chemerin, a novel adipokine, plays a role in the inflammation status of vascular endothelial cells. Hypoxia causes endothelial-cell proliferation, migration, and angiogenesis. This study was aimed at evaluating the protein and mRNA expression of chemerin after exposure of human coronary artery endothelial cells (HCAECs) to hypoxia. Methods and Results Cultured HCAECs underwent hypoxia for different time points. Chemerin protein levels increased after 4 h of hypoxia at 2.5% O-2, with a peak of expression of tumor necrosis factor-alpha (TNF-alpha) at 1 h. Both hypoxia and exogenously added TNF-alpha during normoxia stimulated chemerin expression, whereas an ERK inhibitor (PD98059), ERK small interfering RNA (siRNA), or an anti-TNF-alpha antibody attenuated the chemerin upregulation induced by hypoxia. A gel shift assay indicated that hypoxia induced an increase in DNA-protein binding between the chemerin promoter and transcription factor SP1. A luciferase assay confirmed an increase in transcriptional activity of SP1 on the chemerin promoter during hypoxia. Hypoxia significantly increased the tube formation and migration of HCAECs, whereas PD98059, the anti-TNF-alpha antibody, and chemerin siRNA each attenuated these effects. Conclusion Hypoxia activates chemerin expression in cultured HCAECs. Hypoxia-induced chemerin expression is mediated by TNF-alpha and at least in part by the ERK pathway. Chemerin increases early processes of angiogenesis by HCAECs after hypoxic treatment.	[Chua, Su-Kiat; Lin, Yuh-Feng] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chua, Su-Kiat; Shyu, Kou-Gi; Lo, Huey-Ming] Shin Kong Wu Ho Su Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Lin, Yuh-Feng] Taipei Med Univ, Shuang Ho Hosp, Div Nephrol, Dept Med, New Taipei, Taiwan; [Wang, Bao-Wei] Shin Kong Wu Ho Su Mem Hosp, Cent Lab, Taipei, Taiwan; [Chang, Hang] Shin Kong Wu Ho Su Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Chang, Hang] Taipei Med Univ, Inst Injury Prevent & Control, Coll Publ Hlth, Taipei, Taiwan; [Lien, Li-Ming] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Lien, Li-Ming] Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan	Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; Shuang Ho Hospital; Shin Kong Wu Ho Su Memorial Hospital; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital	Chang, H (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Dept Emergency Med, Taipei, Taiwan.; Chang, H (corresponding author), Taipei Med Univ, Inst Injury Prevent & Control, Coll Publ Hlth, Taipei, Taiwan.; Lien, LM (corresponding author), Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan.; Lien, LM (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan.	baowei@ms22.hinet.net; M002177@ms.skh.org.tw			National Science Council, Taiwan; Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	This work was supported by The National Science Council, Taiwan, and Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.	Ben-Yosef Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1321, DOI 10.1152/ajpcell.00079.2005; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Chamberland JP, 2013, EUR J ENDOCRINOL, V169, P453, DOI 10.1530/EJE-13-0098; Gao XY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-87; Herenius MMJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057802; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Kim D, 2016, J BIOL CHEM, V291, P16271, DOI 10.1074/jbc.M116.715797; Lehr S, 2012, PROTEOM CLIN APPL, V6, P91, DOI 10.1002/prca.201100052; Li XT, 2012, CORONARY ARTERY DIS, V23, P412, DOI 10.1097/MCA.0b013e3283576a60; Lin LY, 2014, CARDIOVASC DIABETOL, V13, DOI [10.1186/s12933-014-0111-1, 10.1186/s12933-014-0145-4]; Lin XH, 2012, CLIN LAB, V58, P539; Molica F, 2015, THROMB HAEMOSTASIS, V113, P553, DOI 10.1160/TH14-06-0513; Nakamura K, 2014, J CARDIOL, V63, P250, DOI 10.1016/j.jjcc.2013.11.006; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Saffitz JE, 2004, CIRC RES, V94, P585, DOI 10.1161/01.RES.0000121575.34653.50; Sanchez A, 2012, J ALZHEIMERS DIS, V32, P587, DOI 10.3233/JAD-2012-120829; Shen WG, 2007, CELL BIOL TOXICOL, V23, P323, DOI 10.1007/s10565-006-0157-2; Shyu KG, 2012, EUR J CLIN INVEST, V42, P17, DOI 10.1111/j.1365-2362.2011.02549.x; Tsutamoto T, 2007, EUR HEART J, V28, P1723, DOI 10.1093/eurheartj/ehm154; de Voorde J, 2013, METABOLISM, V62, P1513, DOI 10.1016/j.metabol.2013.06.004; Wang BW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084188; Wang BW, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-27; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yamawaki H, 2011, BIOL PHARM BULL, V34, P307, DOI 10.1248/bpb.34.307; Zhang O, 2015, CLIN CHIM ACTA, V448, P27, DOI 10.1016/j.cca.2015.05.018	25	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165613	10.1371/journal.pone.0165613	http://dx.doi.org/10.1371/journal.pone.0165613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792771	Green Published, gold, Green Submitted			2022-12-26	WOS:000389537000038
J	Stefanowicz-Hajduk, J; Sparzak-Stefanowska, B; Krauze-Baranowska, M; Ochocka, JR				Stefanowicz-Hajduk, Justyna; Sparzak-Stefanowska, Barbara; Krauze-Baranowska, Miroslawa; Ochocka, J. Renata			Securinine from Phyllanthus glaucus Induces Cell Cycle Arrest and Apoptosis in Human Cervical Cancer HeLa Cells	PLOS ONE			English	Article							CYTOTOXIC LIGNAN; EXPRESSION; DEATH; VIROSECURININE; ALKALOIDS; GROWTH; BCL-2; BETA	Background The Securinega-type alkaloids occur in plants belonging to Euphorbiaceae family. One of the most widely distributed alkaloid of this group is securinine, which was identified next to allosecurinine in Phyllanthus glaucus (leafflower). Recently, some Securinega-type alkaloids have paid attention to its antiproliferative potency towards different cancer cells. However, the cytotoxic properties of allosecurinine have not yet been evaluated. Methods The cytotoxicity of the extract, alkaloid fraction obtained from P. glaucus, isolated securinine and allosecurinine against HeLa cells was evaluated by real-time xCELLigence system and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptosis was detected by annexin V and 7-amino-actinomycin (7-AAD) staining and confirmed with fluorescent Hoechst 33342 dye. The assessment of mitochondrial membrane potential (MMP), reactive oxygen species (ROS) generation, the level of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2), caspase-3/7 activity and cell cycle analysis were measured by flow cytometry. The enzymatic activity of caspase-9 was assessed by a luminometric assay. The expression of apoptosis associated genes was analyzed by realtime PCR. Results The experimental data revealed that securinine and the alkaloid fraction were significantly potent on HeLa cells growth inhibition with IC50 values of 7.02 +/- 0.52 mu g/ml (32.3 mu M) and 25.46 +/- 1.79 mu g/ml, respectively. The activity of allosecurinine and Phyllanthus extract were much lower. Furthermore, our study showed that the most active securinine induced apoptosis in a dose-dependent manner in the tested cells, increased the percentage of ROS positive cells and depolarized cells as well as stimulated the activity of ERK1/2, caspase-9 and -3/7. Securinine also induced cell cycle arrest in S phase. Real-time PCR analysis showed high expression of TNFRSF genes in the cells stimulated with securinine. Conclusions Securinine induces apoptosis and activates cell cycle checkpoints in HeLa cells which is associated with oxidative stress. The results indicate that the mitochondrial pathway is involved in the programmed cell death.	[Stefanowicz-Hajduk, Justyna; Ochocka, J. Renata] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland; [Sparzak-Stefanowska, Barbara; Krauze-Baranowska, Miroslawa] Med Univ Gdansk, Dept Pharmacognosy Med Plant Garden, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Stefanowicz-Hajduk, J (corresponding author), Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland.	justynastef@gumed.edu.pl		Krauze-Baranowska, Miroslawa/0000-0002-0344-7401; Sparzak-Stefanowska, Barbara/0000-0001-9658-0553	(NCN) National Science Centre grant [DEC-2012/05/N/NZ/00957]; Ministry of Science and Higher Education of the Republic of Poland under the Leading National Research Centre (KNOW) program	(NCN) National Science Centre grant; Ministry of Science and Higher Education of the Republic of Poland under the Leading National Research Centre (KNOW) program	The project was financed by a (NCN) National Science Centre grant (DEC-2012/05/N/NZ/00957). This project was supported by the Ministry of Science and Higher Education of the Republic of Poland, from the qualit-promoting subsidy, under the Leading National Research Centre (KNOW) program for the years 2012-2017.	Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; BEUTLER JA, 1985, BRAIN RES, V330, P135, DOI 10.1016/0006-8993(85)90014-9; Blaser H, 2016, TRENDS CELL BIOL, V26, P249, DOI 10.1016/j.tcb.2015.12.002; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Calixto JB, 1998, MED RES REV, V18, P225, DOI 10.1002/(SICI)1098-1128(199807)18:4&lt;225::AID-MED2&gt;3.0.CO;2-X; Chen CR, 2012, PHARMAZIE, V67, P351, DOI 10.1691/ph.2012.1634; GUPTA K, 2011, PLOS ONE, V6; Han SW, 2014, ONCOL REP, V31, P2245, DOI 10.3892/or.2014.3101; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Kao SJ, 2017, ENVIRON TOXICOL, V32, P1426, DOI 10.1002/tox.22336; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kustermann S, 2013, TOXICOL IN VITRO, V27, P1589, DOI 10.1016/j.tiv.2012.08.019; Lee S A, 2011, PLOS ONE, V6; Li MD, 2014, PHARMAZIE, V69, P217, DOI 10.1691/ph.2014.3802; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Ma CG, 2014, TOXICOL REP, V1, P114, DOI 10.1016/j.toxrep.2014.04.008; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Pu H, 2001, Zhong Yao Cai, V24, P278; Rana S, 2010, FASEB J, V24, P2126, DOI 10.1096/fj.09-148999; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Shin D, 2015, CELL PHYSIOL BIOCHEM, V36, P1151, DOI 10.1159/000430286; Singh A. K., 2007, Mycobiology, V35, P62, DOI 10.4489/MYCO.2007.35.2.062; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sparzak B, 2008, JPC-J PLANAR CHROMAT, V21, P103, DOI 10.1556/JPC.21.2008.2.5; Sparzak B, 2015, MOLECULES, V20, P7915, DOI 10.3390/molecules20057915; Sparzak B, 2015, PHYTOCHEM LETT, V11, P353, DOI 10.1016/j.phytol.2014.10.013; Sparzak B, 2009, J AOAC INT, V92, P1343; Stefanowicz-Hajduk J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135993; Tang YQ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012644, 10.1371/journal.pone.0015631]; Xia YH, 2011, FITOTERAPIA, V82, P1258, DOI 10.1016/j.fitote.2011.08.015; Yu S, 2016, NAT PROD RES, V30, P419, DOI 10.1080/14786419.2015.1023198; Yuan W, 2007, NAT PROD RES, V21, P234, DOI 10.1080/14786410701189781; Zhang G, 2014, MOL MED REP, V10, P2365, DOI 10.3892/mmr.2014.2531; Zhang W., 2011, J CHIN PHARM SCI, V20, P203; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	39	16	16	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165372	10.1371/journal.pone.0165372	http://dx.doi.org/10.1371/journal.pone.0165372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792748	Green Published, gold, Green Submitted			2022-12-26	WOS:000389537000019
J	Wenzel, MA; Almeida, I; Blankertz, B				Wenzel, Markus A.; Almeida, Ines; Blankertz, Benjamin			Is Neural Activity Detected by ERP-Based Brain-Computer Interfaces Task Specific?	PLOS ONE			English	Article							VISUAL-SEARCH; P300; P3A; MEG	Objective Brain-computer interfaces (BCIs) that are based on event-related potentials (ERPs) can estimate to which stimulus a user pays particular attention. In typical BCIs, the user silently counts the selected stimulus (which is repeatedly presented among other stimuli) in order to focus the attention. The stimulus of interest is then inferred from the electroencephalogram (EEG). Detecting attention allocation implicitly could be also beneficial for human-computer interaction (HCI), because it would allow software to adapt to the user's interest. However, a counting task would be inappropriate for the envisaged implicit application in HCI. Therefore, the question was addressed if the detectable neural activity is specific for silent counting, or if it can be evoked also by other tasks that direct the attention to certain stimuli. Approach Thirteen people performed a silent counting, an arithmetic and a memory task. The tasks required the subjects to pay particular attention to target stimuli of a random color. The stimulus presentation was the same in all three tasks, which allowed a direct comparison of the experimental conditions. Results Classifiers that were trained to detect the targets in one task, according to patterns present in the EEG signal, could detect targets in all other tasks (irrespective of some task-related differences in the EEG). Significance The neural activity detected by the classifiers is not strictly task specific but can be generalized over tasks and is presumably a result of the attention allocation or of the augmented workload. The results may hold promise for the transfer of classification algorithms from BCI research to implicit relevance detection in HCI.	[Wenzel, Markus A.; Blankertz, Benjamin] Tech Univ Berlin, Neurotechnol Grp, Berlin, Germany; [Almeida, Ines] Univ Lisbon, Fac Ciencias, Lisbon, Portugal	Technical University of Berlin; Universidade de Lisboa	Wenzel, MA (corresponding author), Tech Univ Berlin, Neurotechnol Grp, Berlin, Germany.	markus.wenzel@tu-berlin.de		Blankertz, Benjamin/0000-0002-2437-4846	European Union [611570]; Bundesministerium fur Bildung und Forschung [01GQ0850]	European Union(European Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013; http://cordis.europa.eu/fp7/) under grant agreement no 611570. The work of BB was additionally funded by the Bundesministerium fur Bildung und Forschung (https://www.bmbf.de/) under contract 01GQ0850. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acqualagna L, 2013, CLIN NEUROPHYSIOL, V124, P901, DOI 10.1016/j.clinph.2012.12.050; An XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111070; Barral Oswald, 2015, P INT C INTELLIGENT, P389, DOI [10.1145/2678025.2701389, DOI 10.1145/2678025.2701389]; Bennington JY, 1999, INT J PSYCHOPHYSIOL, V34, P171, DOI 10.1016/S0167-8760(99)00070-7; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Brouwer AM, 2013, J VISION, V13, DOI 10.1167/13.3.17; Brouwer AM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00019; Cole MJ, 2011, INTERACT COMPUT, V23, P346, DOI 10.1016/j.intcom.2011.04.007; Cole MJ, 2011, SIGIR 2011 WORKSH EN; Dalmaijer E, 2014, PEER J PREPRINTS; Debener S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16743; Efron B., 1979, BOOTSTRAP METHODS AN, V7; Eugster MJA, 2014, SIGIR'14: PROCEEDINGS OF THE 37TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P425, DOI 10.1145/2600428.2609594; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fazli S, 2011, NEUROIMAGE, V56, P2100, DOI 10.1016/j.neuroimage.2011.03.061; Fazli S, 2009, NEURAL NETWORKS, V22, P1305, DOI 10.1016/j.neunet.2009.06.003; Finke A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146848; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Golenia Jan-Eike, 2015, Symbiotic Interaction. 4th International Workshop, Symbiotic 2015. Proceedings: LNCS 9359, P81, DOI 10.1007/978-3-319-24917-9_8; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Grozea C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025008; Guger C, 2012, FRONT NEUROSCI, V6, P1, DOI DOI 10.3389/FNINS.2012.00060; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Gwizdka J, 2011, ICMI 2011 WORKSH INF; Hajimirza SN, 2012, IEEE T MULTIMEDIA, V14, P805, DOI 10.1109/TMM.2012.2186792; Hardoon DR, 2010, P 2010 S EYE TRACK R, P291, DOI DOI 10.1145/1743666.1743734; Jayaram V, 2016, IEEE COMPUT INTELL M, V11, P20, DOI 10.1109/MCI.2015.2501545; Jeon YW, 2001, CLIN NEUROPHYSIOL, V112, P2202, DOI 10.1016/S1388-2457(01)00663-0; Kanoh S, 2008, IEEE ENG MED BIO, P642, DOI 10.1109/IEMBS.2008.4649234; Kaunitz LN, 2014, NEUROIMAGE, V89, P297, DOI 10.1016/j.neuroimage.2013.12.006; Kauppi JP, 2015, NEUROIMAGE, V112, P288, DOI 10.1016/j.neuroimage.2014.12.079; Kindermans PJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035005; Koyamada S., 2015, ARXIV PREPRINT ARXIV; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Liu Y, 2011, CLIN NEUROPHYSIOL, V122, P1127, DOI 10.1016/j.clinph.2010.10.049; Looney David, 2014, BRAINCOMPUTER INTERF, P41, DOI [10.1007/978-3-642-54707-2_5, DOI 10.1007/978-3-642-54707-2_5]; Lu SJ, 2009, IEEE T NEUR SYS REH, V17, P135, DOI 10.1109/TNSRE.2009.2015197; Manyakov NV, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/519868; McKinney W., 2010, 9 PYTHON SCI C, V445, P51; McKinney W., 2011, PANDAS FDN PYTHON LI, P9; Nikulin VV, 2010, CLIN NEUROPHYSIOL, V121, P1007, DOI 10.1016/j.clinph.2010.02.008; Oliveira FTP, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2209; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Proulx M, 2011, P 2011 ACM WORKSH SO, P27, DOI DOI 10.1145/2072627.2072636; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schreuder M, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00112; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; SILVER NC, 1987, J APPL PSYCHOL, V72, P146, DOI 10.1037/0021-9010.72.1.146; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Treder MS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066003; Uscumlic M, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016015; Waskom M, 2015, SEABORN V0 6 0 JUNE; Wenzel Markus A., 2015, Symbiotic Interaction. 4th International Workshop, Symbiotic 2015. Proceedings: LNCS 9359, P172, DOI 10.1007/978-3-319-24917-9_19; Wenzel MA, 2016, FRONT NEUROSCI-SWITZ, V10, DOI [10.3389/fnins.2016.00023, 10.3389/fnins.7016.00023]; Zander TO, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025005; Zander TO, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00053	62	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165556	10.1371/journal.pone.0165556	http://dx.doi.org/10.1371/journal.pone.0165556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792781	Green Published, gold, Green Submitted			2022-12-26	WOS:000389537000029
J	May, JP; Hysi, E; Wirtzfeld, LA; Undzys, E; Li, SD; Kolios, MC				May, Jonathan P.; Hysi, Eno; Wirtzfeld, Lauren A.; Undzys, Elijus; Li, Shyh-Dar; Kolios, Michael C.			Photoacoustic Imaging of Cancer Treatment Response: Early Detection of Therapeutic Effect from Thermosensitive Liposomes	PLoS One			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INTENSITY FOCUSED ULTRASOUND; DRUG-DELIVERY; SENSITIVE LIPOSOMES; BLOOD OXYGENATION; IN-VIVO; HODGKINS LYMPHOMA; TUMOR; HYPERTHERMIA; BREAST	Imaging methods capable of indicating the potential for success of an individualized treatment course, during or immediately following the treatment, could improve therapeutic outcomes. Temperature Sensitive Liposomes (TSLs) provide an effective way to deliver chemotherapeutics to a localized tumoral area heated to mild-hyperthermia (HT). The high drug levels reached in the tumor vasculature lead to increased tumor regression via the cascade of events during and immediately following treatment. For a TSL carrying doxorubicin (DOX) these include the rapid and intense exposure of endothelial cells to high drug concentrations, hemorrhage, blood coagulation and vascular shutdown. In this study, ultrasound-guided photoacoustic imaging was used to probe the changes to tumors following treatment with the TSL, HaT-DOX (Heat activated cytoToxic). Levels of oxygen saturation (sO(2)) were studied in a longitudinal manner, from 30 min pre-treatment to 7 days post-treatment. The efficacious treatments of HT-HaT-DOX were shown to induce a significant drop in sO(2) (>10%) as early as 30 min post-treatment that led to tumor regression (in 90% of cases); HT-Saline and non-efficacious HT-HaT-DOX (10% of cases) treatments did not show any significant change in sO(2) at these timepoints. The changes in sO(2) were further corroborated with histological data, using the vascular and perfusion markers CD31 and FITC-lectin. These results allowed us to further surmise a plausible mechanism of the cellular events taking place in the TSL treated tumor regions over the first 24 hours post-treatment. The potential for using photoacoustic imaging to measure tumor sO(2) as a surrogate prognostic marker for predicting therapeutic outcome with a TSL treatment is demonstrated.	[May, Jonathan P.; Undzys, Elijus; Li, Shyh-Dar] Ontario Inst Canc Res, Drug Discovery Program, Drug Discovery & Formulat Grp, Toronto, ON, Canada; [Hysi, Eno; Wirtzfeld, Lauren A.; Kolios, Michael C.] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Hysi, Eno; Wirtzfeld, Lauren A.; Kolios, Michael C.] St Michaels Hosp, Inst Biomed Engn Sci & Technol, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [May, Jonathan P.; Li, Shyh-Dar] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of British Columbia	Li, SD (corresponding author), Ontario Inst Canc Res, Drug Discovery Program, Drug Discovery & Formulat Grp, Toronto, ON, Canada.; Kolios, MC (corresponding author), Ryerson Univ, Dept Phys, Toronto, ON, Canada.; Kolios, MC (corresponding author), St Michaels Hosp, Inst Biomed Engn Sci & Technol, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.; Li, SD (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.	shyh-dar.li@ubc.ca; mkolios@ryerson.ca	May, Jonathan P/AAA-1894-2020; Kolios, Michael C./F-1767-2010; May, Jonathan/T-4546-2017	May, Jonathan P/0000-0003-1651-130X; Kolios, Michael C./0000-0002-9994-8293; May, Jonathan/0000-0003-1651-130X; Li, Shyh-Dar/0000-0002-1763-2667	Natural Sciences and Engineering Research Council of Canada (NSERC); CIHR; Vanier Canada Graduate Scholarship - NSERC; Prostate Foundation Young Investigator Award; CIHR New Investigator Award; Ontario Institute for Cancer Research; Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Vanier Canada Graduate Scholarship - NSERC; Prostate Foundation Young Investigator Award; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	MCK is funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) and CIHR. EH is supported by a Vanier Canada Graduate Scholarship funded by NSERC. SDL is supported by the Prostate Foundation Young Investigator Award and the CIHR New Investigator Award. Ontario Institute for Cancer Research and Canadian Institutes of Health Research (CIHR) are acknowledged for the funding support to the Li lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TJ, 2012, PHOTONS PLUS ULTRASO, V2012, P8223; Andresen TL, 2010, MOL MEMBR BIOL, V27, P353, DOI 10.3109/09687688.2010.515950; Beanes Steven R., 2003, Expert Reviews in Molecular Medicine, V5, P1, DOI 10.1017/S1462399403005817; Beard P, 2011, INTERFACE FOCUS, V1, P602, DOI 10.1098/rsfs.2011.0028; Bernsen MR, 2015, EUR J NUCL MED MOL I, V42, P579, DOI 10.1007/s00259-014-2980-7; Chen Q, 2004, MOL CANCER THER, V3, P1311; Cox B, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061202; de Smet M, 2011, J CONTROL RELEASE, V150, P102, DOI 10.1016/j.jconrel.2010.10.036; Emelianov SY, 2009, PHYS TODAY, V62, P34, DOI 10.1063/1.3141939; Esenaliev RO, 2002, APPL OPTICS, V41, P4722, DOI 10.1364/AO.41.004722; Furth C, 2009, J CLIN ONCOL, V27, P4385, DOI 10.1200/JCO.2008.19.7814; Gerling M, 2014, THERANOSTICS, V4, P604, DOI 10.7150/thno.7996; Grull H, 2012, J CONTROL RELEASE, V161, P317, DOI 10.1016/j.jconrel.2012.04.041; Hafez IM, 2004, METHOD ENZYMOL, V387, P113; Hysi E, 2014, PROBING DIFFERENT BI; Kim CK, 2014, EUR RADIOL, V24, P1514, DOI 10.1007/s00330-014-3167-0; Kneidl B, 2014, INT J NANOMED, V9, P4387, DOI 10.2147/IJN.S49297; Kruger RA, 2010, MED PHYS, V37, P6096, DOI 10.1118/1.3497677; Landon C.D., 2011, OPEN NANOMEDICINE J, V3, P38, DOI [DOI 10.2174/1875933501103010038, 10.2174/1875933501103010038]; Li CH, 2009, PHYS MED BIOL, V54, pR59, DOI 10.1088/0031-9155/54/19/R01; Linnik IV, 2014, MAGN RESON MED, V71, P1854, DOI 10.1002/mrm.24826; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Luke GP, 2014, CANCER RES, V74, P5397, DOI 10.1158/0008-5472.CAN-14-0796; Maeda H, 2011, ADV DRUG DELIVER REV, V63, P129, DOI 10.1016/j.addr.2010.05.001; Mallidi S, 2015, THERANOSTICS, V5, P289, DOI 10.7150/thno.10155; Mallidi S, 2011, TRENDS BIOTECHNOL, V29, P213, DOI 10.1016/j.tibtech.2011.01.006; Manzoor AA, 2012, CANCER RES, V72, P5566, DOI 10.1158/0008-5472.CAN-12-1683; May JP, 2013, EXPERT OPIN DRUG DEL, V10, P511, DOI 10.1517/17425247.2013.758631; Mikhaeel NG, 2005, ANN ONCOL, V16, P1514, DOI 10.1093/annonc/mdi272; Needham D, 2000, CANCER RES, V60, P1197; Negussie AH, 2011, INT J HYPERTHER, V27, P140, DOI 10.3109/02656736.2010.528140; O'Connor JPB, 2009, INT J RADIAT ONCOL, V75, P1209, DOI 10.1016/j.ijrobp.2008.12.040; Park S, 2015, CHEM COMMUN, V51, P9343, DOI 10.1039/c5cc03003j; Ponce AM, 2006, INT J HYPERTHER, V22, P205, DOI 10.1080/02656730600582956; Punglia RS, 2007, NEW ENGL J MED, V357, P1052; Rich LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21237; Rich LJ, 2015, RADIOLOGY, V275, P110, DOI 10.1148/radiol.14140654; Roblyer D, 2011, P NATL ACAD SCI USA, V108, P14626, DOI 10.1073/pnas.1013103108; Sadeghi-Naini A, 2014, ONCOTARGET, V5, P3497, DOI 10.18632/oncotarget.1950; Ta T, 2014, J CONTROL RELEASE, V194, P71, DOI 10.1016/j.jconrel.2014.08.013; Tagami T, 2012, J CONTROL RELEASE, V161, P142, DOI 10.1016/j.jconrel.2012.03.023; Tagami T, 2011, J CONTROL RELEASE, V154, P290, DOI 10.1016/j.jconrel.2011.05.020; Tagami T, 2011, BIOMATERIALS, V32, P6570, DOI 10.1016/j.biomaterials.2011.05.029; Tagami T, 2011, J CONTROL RELEASE, V152, P303, DOI 10.1016/j.jconrel.2011.02.009; Terasawa T, 2009, J CLIN ONCOL, V27, P1906, DOI 10.1200/JCO.2008.16.0861; Thrall JH, 2004, RADIOLOGY, V231, P613, DOI 10.1148/radiol.2313040323; Tirkes T, 2013, RADIOGRAPHICS, V33, P1323, DOI 10.1148/rg.335125214; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang XD, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2192804; Wilson KE, 2014, THERANOSTICS, V4, P1062, DOI 10.7150/thno.9922; Yao JJ, 2014, PHOTOACOUSTICS, V2, P87, DOI 10.1016/j.pacs.2014.04.002; Yoon TJ, 2013, WORLD J GASTRO ENDOS, V5, P534, DOI 10.4253/wjge.v5.i11.534; Zhao BS, 2009, J NUCL MED, V50, P239, DOI 10.2967/jnumed.108.056655	53	26	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165345	10.1371/journal.pone.0165345	http://dx.doi.org/10.1371/journal.pone.0165345			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788199	Green Published, gold, Green Accepted			2022-12-26	WOS:000389604900066
J	Vranckx, LS; Demeulemeester, J; Debyser, Z; Gijsbers, R				Vranckx, Lenard S.; Demeulemeester, Jonas; Debyser, Zeger; Gijsbers, Rik			Towards a Safer, More Randomized Lentiviral Vector Integration Profile Exploring Artificial LEDGF Chimeras	PLOS ONE			English	Article							LEUKEMIA-VIRUS INTEGRATION; HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC GRANULOMATOUS-DISEASE; TRANSCRIPTION START SITES; GENE-THERAPY; HUMAN GENOME; FOAMY VIRUS; HUMAN-CELLS; HEMATOPOIETIC-CELLS; HIV-1 INTEGRASE	The capacity to integrate transgenes into the host cell genome makes retroviral vectors an interesting tool for gene therapy. Although stable insertion resulted in successful correction of several monogenic disorders, it also accounts for insertional mutagenesis, a major setback in otherwise successful clinical gene therapy trials due to leukemia development in a subset of treated patients. Despite improvements in vector design, their use is still not risk-free. Lentiviral vector (LV) integration is directed into active transcription units by LEDGF/ p75, a host-cell protein co-opted by the viral integrase. We engineered LEDGF/p75-based hybrid tethers in an effort to elicit a more random integration pattern to increase biosafety, and potentially reduce proto-oncogene activation. We therefore truncated LEDGF/p75 by deleting the N-terminal chromatin-reading PWWP-domain, and replaced this domain with alternative pan-chromatin binding peptides. Expression of these LEDGF-hybrids in LEDGF-depleted cells efficiently rescued LV transduction and resulted in LV integrations that distributed more randomly throughout the host-cell genome. In addition, when considering safe harbor criteria, LV integration sites for these LEDGF-hybrids distributed more safely compared to LEDGF/p75-mediated integration in wild-type cells. This approach should be broadly applicable to introduce therapeutic or suicide genes for cell therapy, such as patient-specific iPS cells.	[Vranckx, Lenard S.; Demeulemeester, Jonas; Debyser, Zeger; Gijsbers, Rik] Katholieke Univ Leuven, Lab Mol Virol & Drug Discovery, Leuven, Belgium; [Gijsbers, Rik] Katholieke Univ Leuven, Lab Viral Vector Technol & Gene Therapy, Leuven, Belgium; [Gijsbers, Rik] Katholieke Univ Leuven, Leuven Viral Vector Core, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Gijsbers, R (corresponding author), Katholieke Univ Leuven, Lab Mol Virol & Drug Discovery, Leuven, Belgium.; Gijsbers, R (corresponding author), Katholieke Univ Leuven, Lab Viral Vector Technol & Gene Therapy, Leuven, Belgium.; Gijsbers, R (corresponding author), Katholieke Univ Leuven, Leuven Viral Vector Core, Leuven, Belgium.	Rik.Gijsbers@med.kuleuven.be	Demeulemeester, Jonas/J-6130-2014	Demeulemeester, Jonas/0000-0002-2660-2478	Flemish Fund for Scientific Research (FWO); FWO; KU Leuven Research Council (OT); KU Leuven IDO program; Belgian IAP Belvir [IDO/12/008, ZKB9996 SB/0881057, FWO ZKC0523, ZKC3378]	Flemish Fund for Scientific Research (FWO)(FWO); FWO(FWO); KU Leuven Research Council (OT); KU Leuven IDO program; Belgian IAP Belvir	L.V. is a doctoral fellow supported by the Flemish Fund for Scientific Research (FWO; Fonds voor Wetenschappelijk Onderzoek). Research at KU Leuven received financial support from the FWO, the KU Leuven Research Council (OT), the KU Leuven IDO program and the Belgian IAP Belvir (IDO/12/008, ZKB9996 SB/0881057 and FWO ZKC0523, ZKC3378).; We are grateful to Jan De Rijck and Dominique Van Looveren for critical reading and to Pau lien Van de Velde for her technical assistance. Viral vector production was performed at the Leuven Viral Vector Core. L.V. is a doctoral fellow supported by the Flemish Fund for Scientific Research (FWO; Fonds voor Wetenschappelijk Onderzoek). Research at KU Leuven received financial support from the FWO, the KU Leuven Research Council (OT), the KU Leuven IDO program and the Belgian IAP Belvir (IDO/12/008, ZKB9996 SB/0881057 and FWO ZKC0523, ZKC3378).	Antoniou MN, 2013, HUM GENE THER, V24, P363, DOI 10.1089/hum.2013.062; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartholomeeusen K, 2007, J MOL BIOL, V372, P407, DOI 10.1016/j.jmb.2007.06.090; Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cesana D, 2014, MOL THER, V22, P774, DOI 10.1038/mt.2014.3; Cesana D, 2012, J CLIN INVEST, V122, P1667, DOI 10.1172/JCI62189; Chatziandreou I, 2011, EXP HEMATOL, V39, P643, DOI 10.1016/j.exphem.2011.03.003; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; De Ravin SS, 2014, J VIROL, V88, P4504, DOI 10.1128/JVI.00011-14; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; De Rijck J, 2010, NUCLEIC ACIDS RES, V38, P6135, DOI 10.1093/nar/gkq410; Debyser Z, 2015, TRENDS BIOCHEM SCI, V40, P108, DOI 10.1016/j.tibs.2014.12.001; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Emery DW, 2011, HUM GENE THER, V22, P761, DOI 10.1089/hum.2010.233; Ferris AL, 2010, P NATL ACAD SCI USA, V107, P3135, DOI 10.1073/pnas.0914142107; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Gijsbers R, 2011, J BIOL CHEM, V286, P41812, DOI 10.1074/jbc.M111.255711; Gijsbers R, 2010, MOL THER, V18, P552, DOI 10.1038/mt.2010.36; Gupta SS, 2013, J VIROL, V87, P12721, DOI 10.1128/JVI.01942-13; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Hughes S, 2010, J BIOL CHEM, V285, P541, DOI 10.1074/jbc.M109.036491; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Kaufmann KB, 2013, MOL THER, V21, P648, DOI 10.1038/mt.2012.249; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kustikova OS, 2009, MOL THER, V17, P1537, DOI 10.1038/mt.2009.134; LaFave MC, 2014, NUCLEIC ACIDS RES, V42, P4257, DOI 10.1093/nar/gkt1399; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; Maetzig T, 2011, VIRUSES-BASEL, V3, P677, DOI 10.3390/v3060677; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Moldt B, 2011, MOL THER, V19, P1499, DOI 10.1038/mt.2011.47; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Mussolino C, 2013, NAT BIOTECHNOL, V31, P208, DOI 10.1038/nbt.2527; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Newrzela S, 2008, BLOOD, V112, P2278, DOI 10.1182/blood-2007-12-128751; Nowrouzi A, 2006, J GEN VIROL, V87, P1339, DOI 10.1099/vir.0.81554-0; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Osorio L, 2014, J BIOTECHNOL, V169, P71, DOI 10.1016/j.jbiotec.2013.11.004; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Rothe M, 2014, CURR GENE THER, V14, P429, DOI 10.2174/1566523214666140918110905; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Sekhar V, 2012, J VIROL, V86, P10047, DOI 10.1128/JVI.01140-12; Sekhar V, 2010, J VIROL, V84, P543, DOI 10.1128/JVI.01908-09; Sharma A, 2013, P NATL ACAD SCI USA, V110, P12036, DOI 10.1073/pnas.1307157110; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Silvers RM, 2010, HUM GENE THER, V21, P337, DOI 10.1089/hum.2009.134; Staunstrup NH, 2009, MOL THER, V17, P1205, DOI 10.1038/mt.2009.10; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Stevens SW, 1996, J VIROL, V70, P6459, DOI 10.1128/JVI.70.9.6459-6462.1996; Suerth JD, 2012, MOL THER, V20, P1022, DOI 10.1038/mt.2011.309; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tobaly-Tapiero J, 2008, TRAFFIC, V9, P1717, DOI 10.1111/j.1600-0854.2008.00792.x; Trobridge GD, 2006, P NATL ACAD SCI USA, V103, P1498, DOI 10.1073/pnas.0510046103; Trono D, 2012, J CLIN INVEST, V122, P1600, DOI 10.1172/JCI63066; Tsutsui KM, 2011, NUCLEIC ACIDS RES, V39, P5067, DOI 10.1093/nar/gkr088; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; van Nuland R, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-12; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vets S, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.4; Vosa L, 2012, J VIROL, V86, P348, DOI 10.1128/JVI.05606-11; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Wang H, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00307; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5	88	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164167	10.1371/journal.pone.0164167	http://dx.doi.org/10.1371/journal.pone.0164167			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788138	gold, Green Published, Green Submitted			2022-12-26	WOS:000389604900013
J	Wang, HB; Zheng, SF; Liu, MD; Jia, CX; Wang, SL; Wang, X; Xue, S; Guo, YL				Wang, Haibin; Zheng, Shengfa; Liu, Maodong; Jia, Changxin; Wang, Shilei; Wang, Xue; Xue, Sha; Guo, Yunliang			The Effect of Propofol on Mitochondrial Fission during Oxygen-Glucose Deprivation and Reperfusion Injury in Rat Hippocampal Neurons	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; FOCAL CEREBRAL-ISCHEMIA; PROGRAMMED CELL-DEATH; ISCHEMIA/REPERFUSION INJURY; PERMEABILITY TRANSITION; CALCIUM-TRANSPORT; GLUTAMATE-RECEPTOR; BRAIN-INJURY; INHIBITION; DRP1	The neuroprotective role of propofol in transient global and focal cerebral ischemia reperfusion (I/R) animal model has recently been highlighted. However, no studies have conducted to explore the relationship between mitochondrial fission/fusion and I/R injury under the intervention of propofol. Moreover, neuroprotective mechanism of propofol is yet unclear. Culturing primary hippocampal cells were subjected to oxygen-glucose deprivation and re-oxygenation (OGD/R) model, as a model of cerebral I/R in vitro. Methods CCK-8 assay was used to test the effect of propofol on cell viability. We examined the effect of propofol on mitochondrial ultrastructure and mitochondrial fission evoked by OGD/R with transmission electron microscopy and immunofluorescence assay. To investigate possible neuroprotective mechanisms, the authors then examined whether propofol could inhibit calcium-overload, calcineurin (CaN) activation and the phosphorylation of dynamin-related protein 1 (Drp1) during the period of OGD/R, as well as the combination of Drp1-ser 637 and fission 1 (Fis1) protein by immunofluorescence assay, ELISA and double-labeling immunofluorescence analysis. Finally, the expression of Drp1-ser 637 and Fis1, apoptosis inducing factor (AIF) and cytochrome C (Cyt C) were detected by western blot. When added in culture media during OGD period, propofol (0.1 mu M-50 mu M) could alleviate neurons injury and protect mitochondrial ultrastructure, meanwhile inhibit mitochondrial fission. Furthermore, the concentration of intracellular free Ca2+, CaN activition and the phosphorylation of Drp1-ser637 were suppressed, as well as the translocation and combination of Drp1-ser 637 and Fis1. The authors also found that the expression of Cyt C, AIF, Drp1-ser637 and Fis1 were down-regulated. Notably, high dose of propofol (100 mu M-200 mu M) were confirmed to decrease the survival of neurons based on results of cell viability. Propofol could inhibit mitochondrial fission and mitochondrial apoptotic pathway evoked by OGD/R in rat hippocampal neurons, which may be via depressing calcium-overload.	[Wang, Haibin; Liu, Maodong; Jia, Changxin; Wang, Shilei; Wang, Xue; Xue, Sha] Qingdao Univ, Affiliated Hosp, Dept Anesthesiol, Qingdao, Shandong, Peoples R China; [Zheng, Shengfa] Qingdao Univ, Inst Cerebrovasc Dis, Affiliated Hosp, Qingdao, Shandong, Peoples R China; [Guo, Yunliang] Peoples Hosp Rizhao, Dept Anesthesiol, Rizhao, Shandong, Peoples R China	Qingdao University; Qingdao University	Wang, SL (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Anesthesiol, Qingdao, Shandong, Peoples R China.	wshlei@aliyun.com			National Natural Science Foundation of China, Beijing, China [81371448]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China (81371448), Beijing, China.	Adembri C, 2006, ANESTHESIOLOGY, V104, P80, DOI 10.1097/00000542-200601000-00014; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bayona NA, 2004, ANESTHESIOLOGY, V100, P1151, DOI 10.1097/00000542-200405000-00017; Buggy DJ, 2000, ANESTHESIOLOGY, V92, P1067, DOI 10.1097/00000542-200004000-00025; Cai JS, 2011, NEUROCHEM RES, V36, P1724, DOI 10.1007/s11064-011-0487-1; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; CHANG KSK, 1993, ANESTH ANALG, V76, P24; Chen HC, 2004, CURR TOP DEV BIOL, V59, P119, DOI 10.1016/S0070-2153(04)59005-1; Chen RM, 2013, SURGERY, V154, P58, DOI 10.1016/j.surg.2013.02.003; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Deryabina YI, 2004, BIOCHEMISTRY-MOSCOW+, V69, P91, DOI 10.1023/B:BIRY.0000016357.17251.7b; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Feiner JR, 2005, ANESTH ANALG, V100, P215, DOI 10.1213/01.ANE.0000142129.17005.73; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Garrido M J, 1994, Rev Esp Anestesiol Reanim, V41, P308; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hannon JD, 2002, ANESTHESIOLOGY, V96, P1457, DOI 10.1097/00000542-200206000-00027; Ito H, 1999, ACTA ANAESTH SCAND, V43, P153, DOI 10.1034/j.1399-6576.1999.430206.x; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kristal BS, 1997, J NEUROCHEM, V69, P524; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Kucuk A, 2014, BRATISL MED J, V115, P680, DOI 10.4149/BLL_2014_132; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Li J, 2014, NEUROPHARMACOLOGY, V77, P358, DOI 10.1016/j.neuropharm.2013.08.029; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043810; Liang N, 2014, J NEURAL TRANSM, V121, P593, DOI 10.1007/s00702-014-1166-6; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; Liu Q, 2012, ACTA PHARMACOL SIN, V33, P1495, DOI 10.1038/aps.2012.86; Liu WT, 2012, BRAIN RES, V1456, P94, DOI 10.1016/j.brainres.2012.03.038; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Miyamae M, 1996, AM J PHYSIOL-HEART C, V271, pH2145, DOI 10.1152/ajpheart.1996.271.5.H2145; Molina CA, 2009, CEREBROVASC DIS, V27, P162, DOI 10.1159/000200455; Murphy PG, 1996, BRIT J ANAESTH, V76, P536, DOI 10.1093/bja/76.4.536; ORSER BA, 1995, BRIT J PHARMACOL, V116, P1761, DOI 10.1111/j.1476-5381.1995.tb16660.x; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Regula KA, 2005, J MOL CELL CARDIOL, V38, P3, DOI 10.1016/j.yjmcc.2004.11.003; Shibata M, 2002, BRAIN RES, V942, P1, DOI 10.1016/S0006-8993(02)02474-5; Si YN, 2014, EUR REV MED PHARMACO, V18, P1843; Sobrado M, 2003, NEUROSCIENCE, V118, P107, DOI 10.1016/S0306-4522(02)00912-0; STEPHAN H, 1987, ANAESTHESIST, V36, P60; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; SZTARK F, 1995, FEBS LETT, V368, P101, DOI 10.1016/0014-5793(95)00610-L; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Tsuchiya M, 2001, AM J RESP CRIT CARE, V163, P26, DOI 10.1164/ajrccm.163.1.9911120; VANHEMELRIJCK J, 1990, ANESTH ANALG, V71, P49; Velly LJ, 2003, ANESTHESIOLOGY, V99, P368, DOI 10.1097/00000542-200308000-00018; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Wang HY, 2009, BRAIN RES, V1297, P177, DOI 10.1016/j.brainres.2009.08.054; Wang JY, 2014, J STROKE CEREBROVASC, V23, P1491, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.021; YAMAKURA T, 1995, NEUROSCI LETT, V188, P187, DOI 10.1016/0304-3940(95)11431-U; Young Y, 1997, EUR J ANAESTH, V14, P320, DOI 10.1046/j.1365-2346.1997.00130.x; Yu SJ, 2005, BIOL PHARM BULL, V28, P1016, DOI 10.1248/bpb.28.1016; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yue ZY, 2015, BRAIN RES, V1594, P108, DOI 10.1016/j.brainres.2014.10.016; Zhang DX, 2014, BRAIN INJURY, V28, P1758, DOI 10.3109/02699052.2014.947624; Zhang N, 2013, NEUROSCI LETT, V535, P104, DOI 10.1016/j.neulet.2012.12.049	60	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165052	10.1371/journal.pone.0165052	http://dx.doi.org/10.1371/journal.pone.0165052			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788177	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900040
J	Wittmann, A; Grimm, MOW; Scherthan, H; Horsch, M; Beckers, J; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Ford, SJ; Burton, NC; Razansky, D; Trumbach, D; Aichler, M; Walch, AK; Calzada-Wack, J; Neff, F; Wurst, W; Hartmann, T; Floss, T				Wittmann, Anke; Grimm, Marcus O. W.; Scherthan, Harry; Horsch, Marion; Beckers, Johannes; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Ford, Steven J.; Burton, Neal C.; Razansky, Daniel; Trumbach, Dietrich; Aichler, Michaela; Walch, Axel Karl; Calzada-Wack, Julia; Neff, Frauke; Wurst, Wolfgang; Hartmann, Tobias; Floss, Thomas			Sphingomyelin Synthase 1 Is Essential for Male Fertility in Mice	PLoS One			English	Article							POLYUNSATURATED FATTY-ACIDS; DOUBLE-STRAND BREAKS; LONG-CHAIN; GERM-CELLS; MAMMALIAN SPERMATOGENESIS; CHROMOSOME INACTIVATION; LYSINE-9 METHYLATION; MASS-SPECTROMETRY; DEFICIENT MICE; SERTOLI-CELLS	Sphingolipids and the derived gangliosides have critical functions in spermatogenesis, thus mutations in genes involved in sphingolipid biogenesis are often associated with male infertility. We have generated a transgenic mouse line carrying an insertion in the sphingomyelin synthase gene Sms1, the enzyme which generates sphingomyelin species in the Golgi apparatus. We describe the spermatogenesis defect of Sms1(-/-) mice, which is characterized by sloughing of spermatocytes and spermatids, causing progressive infertility of male homozygotes. Lipid profiling revealed a reduction in several long chain unsaturated phosphatidylcholins, lysophosphatidylcholins and sphingolipids in the testes of mutants. Multi-Spectral Optoacoustic Tomography indicated blood-testis barrier dysfunction. A supplementary diet of the essential omega-3 docosahexaenoic acid and eicosapentaenoic acid diminished germ cell sloughing from the seminiferous epithelium and restored spermatogenesis and fertility in 50% of previously infertile mutants. Our findings indicate that SMS1 has a wider than anticipated role in testis polyunsaturated fatty acid homeostasis and for male fertility.	[Wittmann, Anke; Trumbach, Dietrich; Wurst, Wolfgang; Floss, Thomas] Helmholtz Zentrum Munchen, Inst Dev Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Grimm, Marcus O. W.; Hartmann, Tobias] Univ Saarland, Expt Neurol, D-66424 Homburg, Germany; [Scherthan, Harry] Bundeswehr Verb Univ Ulm, Inst Radiobiol, D-80937 Munich, Germany; [Horsch, Marion; Beckers, Johannes; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Mouse Clin, Inst Expt Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Aichler, Michaela; Walch, Axel Karl] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, Inst Pathol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Calzada-Wack, Julia; Neff, Frauke] Helmholtz Zentrum Munchen, German Mouse Clin, Inst Pathol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe; Wurst, Wolfgang; Floss, Thomas] Tech Univ Munich, Co Helmholtz Zentrum Munchen, Munich, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, Site Munich,Schillerstr 44, D-80336 Munich, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany; [Ford, Steven J.; Burton, Neal C.; Razansky, Daniel] Helmholtz Zentrum Munchen, Inst Biol & Med Imaging, D-85764 Neuherberg, Germany; [Ford, Steven J.; Burton, Neal C.; Razansky, Daniel] Tech Univ Munich, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Saarland University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Floss, T (corresponding author), Helmholtz Zentrum Munchen, Inst Dev Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.; Floss, T (corresponding author), Tech Univ Munich, Co Helmholtz Zentrum Munchen, Munich, Germany.	tfloss@helmholtz-muenchen.de	Walch, Axel/B-4554-2012; Beckers, Johannes/K-7237-2012; Grimm, Marcus O. W./F-8134-2011; Hartmann, Tobias/AAB-8297-2022; Aichler, Michaela/B-5356-2014; de Angelis, Martin Hrabe/F-5531-2012; Gailus-Durner, Valerie/M-7337-2014; Razansky, Daniel/B-8590-2015	Walch, Axel/0000-0001-5578-4023; Beckers, Johannes/0000-0001-7874-3822; Grimm, Marcus O. W./0000-0002-4160-6506; de Angelis, Martin Hrabe/0000-0002-7898-2353; Wurst, Wolfgang/0000-0003-4422-7410; Calzada, Julia/0000-0003-0816-9305; Hartmann, Tobias/0000-0001-7481-6430; Razansky, Daniel/0000-0001-8676-0964	KNDD2 [FKZ 01 GI 1005D]; NGFNplus [01GS08133, 01GS0850, PNA-01GS08129-5]; Federal Ministry for Education and Research (BMBF) grant [01GS0850, 01GS08174]; German Federal Ministry of Education and Research (BMBF); BMBF [01KX1012]; EU [EUMODIC LSHG-2006-037188]; National Genome Research Network [NGFN 01GR]; EFRE/Kowi [C/4-EFRE-11/2008/KA]; DFG priority program sphingolipids	KNDD2; NGFNplus; Federal Ministry for Education and Research (BMBF) grant(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); EU(European Commission); National Genome Research Network; EFRE/Kowi; DFG priority program sphingolipids(German Research Foundation (DFG))	This work was funded by the KNDD2 grants FKZ 01 GI 1005D to T.F. This work was also funded by the program for medical genome research with financial support from the NGFNplus grant "Funktionelle Tiermodelle fur die Kandidatengene der Alzheimerschen Erkrankung" (01GS08133), the Federal Ministry for Education and Research (BMBF) grant "Charakterisierung genetischer Mausmodelle furr die Parkinsonsche Erkrankung" under the support code 01GS08174, the grant "Verhalten" 01GS0850, furthermore by the Helmholtz Alliance "Mental Health in an Ageing Society" (HELMA) (HA215). This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The GMC was supported by NGFNplus (01GS0850) and Infrafrontier (01KX1012) grants from the BMBF and the EU (EUMODIC LSHG-2006-037188). This work was supported by grants to JB from the National Genome Research Network (NGFN 01GR). This work was supported by grants the NGFNplus grant PNA-01GS08129-5 and EFRE/Kowi funding on basis of grant C/4-EFRE-11/2008/KA to TH and by the DFG priority program sphingolipids to TH and MOWG.	ARSCOTT GH, 1965, J NUTR, V87, P63, DOI 10.1093/jn/87.1.63; Butler A, 2002, AM J PATHOL, V161, P1061, DOI 10.1016/S0002-9440(10)64267-8; Carette D, 2010, DEV BIOL, V346, P54, DOI 10.1016/j.ydbio.2010.07.014; Cross NL, 2000, BIOL REPROD, V63, P1129, DOI 10.1095/biolreprod63.4.1129; Dergunova LV, 2013, MOL BIOL REP; Dong LL, 2012, INT IMMUNOL, V24, P327, DOI 10.1093/intimm/dxs008; Fan J, 2006, MOL REPROD DEV, V73, P1284, DOI 10.1002/mrd.20559; Fujimoto H, 2000, J BIOL CHEM, V275, P22623, DOI 10.1074/jbc.C000200200; Furland NE, 2007, J BIOL CHEM, V282, P18141, DOI 10.1074/jbc.M700708200; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Grimm MOW, 2011, J CHROMATOGR A, V1218, P7713, DOI 10.1016/j.chroma.2011.07.073; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Gu M, 1997, ANAL BIOCHEM, V244, P347, DOI 10.1006/abio.1996.9915; Gulliver CE, 2012, ANIM REPROD SCI, V131, P9, DOI 10.1016/j.anireprosci.2012.02.002; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P409, DOI 10.1002/jemt.20786; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; JECKEL D, 1990, FEBS LETT, V261, P155, DOI 10.1016/0014-5793(90)80659-7; Jensen TK, 2013, AM J CLIN NUTR, V97, P411, DOI 10.3945/ajcn.112.042432; Khalil AM, 2006, CYTOGENET GENOME RES, V112, P11, DOI 10.1159/000087508; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; KRUGER RA, 1995, MED PHYS, V22, P1605, DOI 10.1118/1.597429; Kubler K, 2011, EUR J IMMUNOL, V41, P3028, DOI 10.1002/eji.201141555; Laufer J, 2007, PHYS MED BIOL, V52, P141, DOI 10.1088/0031-9155/52/1/010; Lee NPY, 2007, J ENDOCRINOL, V192, P17, DOI 10.1677/JOE-06-0002; Lenzi A, 1996, HUM REPROD UPDATE, V2, P246, DOI 10.1093/humupd/2.3.246; Li Y, 2013, ARTERIOSCLER THROMB; Li ZQ, 2012, ARTERIOSCL THROM VAS, V32, P1577, DOI 10.1161/ATVBAHA.112.251538; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Lu MH, 2012, J PHYSIOL-LONDON, V590, P4029, DOI 10.1113/jphysiol.2012.235846; Lucki Natasha C., 2008, V49, P387, DOI 10.1007/978-1-4020-8831-5_15; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mermoud JE, 2002, CURR BIOL, V12, P247, DOI 10.1016/S0960-9822(02)00660-7; Mital P, 2011, BIOL REPROD, V84, P851, DOI 10.1095/biolreprod.110.087452; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Oresti GM, 2010, J LIPID RES, V51, P2909, DOI 10.1194/jlr.M006429; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Rabionet M, 2008, J BIOL CHEM, V283, P13357, DOI 10.1074/jbc.M800870200; Rabionet M, 2015, HUM MOL GENET, V24, P4792, DOI 10.1093/hmg/ddv204; Razansky D, 2007, OPT LETT, V32, P2891, DOI 10.1364/OL.32.002891; Razansky D, 2011, NAT PROTOC, V6, P1121, DOI 10.1038/nprot.2011.351; RISLEY MS, 1992, J CELL SCI, V103, P81; ROBINSON BS, 1992, J BIOL CHEM, V267, P1746; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; Rozhkova AV, 2011, GENE, V481, P65, DOI 10.1016/j.gene.2011.04.010; Sandhoff R, 2010, FEBS LETT, V584, P1907, DOI 10.1016/j.febslet.2009.12.032; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Subathra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023644; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; Trasler J, 1998, ENDOCRINOLOGY, V139, P3280, DOI 10.1210/en.139.7.3280; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Villani M, 2008, BIOCHEM J, V414, P31, DOI 10.1042/BJ20071240; Yan L, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-33; Yang Z, 2005, GENE, V363, P123, DOI 10.1016/j.gene.2005.07.036; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Yeang C, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-89; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zadravec D, 2011, J LIPID RES, V52, P245, DOI 10.1194/jlr.M011346	69	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164298	10.1371/journal.pone.0164298	http://dx.doi.org/10.1371/journal.pone.0164298			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788151	gold, Green Submitted, Green Published			2022-12-26	WOS:000389604900016
J	Yang, C; Ye, J; Li, XM; Gao, XX; Zhang, KF; Luo, L; Ding, JP; Zhang, YH; Li, YS; Cao, HG; Ling, YH; Zhang, XR; Liu, Y; Fang, FG				Yang, Chen; Ye, Jing; Li, Xiumei; Gao, Xiaoxiao; Zhang, Kaifa; Luo, Lei; Ding, Jianping; Zhang, Yunhai; Li, Yunsheng; Cao, Hongguo; Ling, Yinghui; Zhang, Xiaorong; Liu, Ya; Fang, Fugui			DNA Methylation Patterns in the Hypothalamus of Female Pubertal Goats	PLOS ONE			English	Article							CENTRAL PRECOCIOUS PUBERTY; CPG ISLANDS; GENE; PROMOTER; MKRN3; RNA; AGE; DIFFERENTIATION; IDENTIFICATION; DEMETHYLATION	Female pubertal development is tightly controlled by complex mechanisms, including neuroendocrine and epigenetic regulatory pathways. Specific gene expression patterns can be influenced by DNA methylation changes in the hypothalamus, which can in turn regulate timing of puberty onset. In order to understand the relationship between DNA methylation changes and gene expression patterns in the hypothalamus of pubertal goats, wholegenome bisulfite sequencing and RNA-sequencing analyses were carried out. There was a decline in DNA methylation levels in the hypothalamus during puberty and 268 differentially methylated regions (DMR) in the genome, with differential patterns in different gene regions. There were 1049 genes identified with distinct expression patterns. High levels of DNA methylation were detected in promoters, introns and 3'-untranslated regions (UTRs). Levels of methylation decreased gradually from promoters to 5'-UTRs and increased from 5'-UTRs to introns. Methylation density analysis demonstrated that methylation level variation was consistent with the density in the promoter, exon, intron, 5'-UTRs and 3'-UTRs. Analyses of CpG island (CGI) sites showed that the enriched gene contents were gene bodies, intergenic regions and introns, and these CGI sites were hypermethylated. Our study demonstrated that DNA methylation changes may influence gene expression profiles in the hypothalamus of goats during the onset of puberty, which may provide new insights into the mechanisms involved in pubertal onset.	[Yang, Chen; Ye, Jing; Li, Xiumei; Gao, Xiaoxiao; Zhang, Kaifa; Luo, Lei; Ding, Jianping; Zhang, Yunhai; Li, Yunsheng; Cao, Hongguo; Ling, Yinghui; Zhang, Xiaorong; Liu, Ya; Fang, Fugui] Anhui Agr Univ, Anhui Prov Lab Anim Genet Resources Protect & Bre, Coll Anim Sci & Technol, 130 Changjiang West Rd, Hefei 230036, Anhui, Peoples R China; [Yang, Chen; Ye, Jing; Li, Xiumei; Gao, Xiaoxiao; Zhang, Kaifa; Luo, Lei; Ding, Jianping; Zhang, Yunhai; Li, Yunsheng; Cao, Hongguo; Ling, Yinghui; Zhang, Xiaorong; Liu, Ya; Fang, Fugui] Anhui Prov Lab Local Livestock & Poultry Genet Re, 130 Changjiang West Rd, Hefei 230036, Anhui, Peoples R China; [Yang, Chen; Ye, Jing; Li, Xiumei; Gao, Xiaoxiao; Zhang, Kaifa; Luo, Lei; Ding, Jianping; Zhang, Yunhai; Li, Yunsheng; Cao, Hongguo; Ling, Yinghui; Zhang, Xiaorong; Liu, Ya; Fang, Fugui] Anhui Agr Univ, Coll Anim Sci & Technol, Dept Anim Vet Sci, 130 Changjiang West Rd, Hefei 230036, Anhui, Peoples R China	Anhui Agricultural University; Anhui Agricultural University	Fang, FG (corresponding author), Anhui Agr Univ, Anhui Prov Lab Anim Genet Resources Protect & Bre, Coll Anim Sci & Technol, 130 Changjiang West Rd, Hefei 230036, Anhui, Peoples R China.; Fang, FG (corresponding author), Anhui Prov Lab Local Livestock & Poultry Genet Re, 130 Changjiang West Rd, Hefei 230036, Anhui, Peoples R China.; Fang, FG (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Dept Anim Vet Sci, 130 Changjiang West Rd, Hefei 230036, Anhui, Peoples R China.	fgfang@163.com	liu, ya/AAI-1890-2020; Zhang, Yunhai/O-4453-2014; li, xiu/GXV-1745-2022	Zhang, Yunhai/0000-0001-9721-5910; 	National Natural Science Foundation of China [31472096, 31301934]; National Transgenenic New Species Breeding Program of China [2014ZX08008-005-004]; Anhui Provincial Natural Science Foundation [1508085MC54]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenenic New Species Breeding Program of China; Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	The National Natural Science Foundation of China [grant number 31472096], the National Transgenenic New Species Breeding Program of China [grant number 2014ZX08008-005-004], the National Natural Science Foundation of China [grant number 31301934], and the Anhui Provincial Natural Science Foundation [grant number 1508085MC54].	Abreu AP, 2015, J MOL ENDOCRINOL, V54, pR131, DOI 10.1530/JME-14-0315; Abreu AP, 2013, NEW ENGL J MED, V368, P2467, DOI 10.1056/NEJMoa1302160; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Cortes ME, 2015, J PEDIATR ADOL GYNEC, V28, P286, DOI 10.1016/j.jpag.2014.09.017; Dantas A, 2016, ARQ BRAS MED VET ZOO, V68, P22, DOI 10.1590/1678-4162-8278; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Vries L, 2014, HUM REPROD, V29, P2838, DOI 10.1093/humrep/deu256; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dong WH, 2015, GENE, V573, P70, DOI 10.1016/j.gene.2015.07.026; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Fan SC, 2009, BIOCHEM BIOPH RES CO, V383, P421, DOI 10.1016/j.bbrc.2009.04.023; Gkountela S, 2015, CELL, V161, P1425, DOI 10.1016/j.cell.2015.05.012; Grandone A, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0056-8; Hu MH, 2015, ENDOCRINOLOGY, V156, P2619, DOI 10.1210/en.2014-1655; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kansakoski J, 2015, PEDIATR RES, V78, P709, DOI 10.1038/pr.2015.159; Kurian Joseph R, 2013, Front Endocrinol (Lausanne), V4, P61, DOI 10.3389/fendo.2013.00061; Kurian JR, 2010, ENDOCRINOLOGY, V151, P5359, DOI 10.1210/en.2010-0555; Lokk K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r54; Lomniczi A, 2015, FRONT NEUROENDOCRIN, V36, P90, DOI 10.1016/j.yfrne.2014.08.003; Luan X, 2007, NEUROENDOCRINOLOGY, V86, P77, DOI 10.1159/000107511; Macedo DB, 2014, J CLIN ENDOCR METAB, V99, pE1097, DOI 10.1210/jc.2013-3126; Mancini-DiNardo D, 2003, HUM MOL GENET, V12, P283, DOI 10.1093/hmg/ddg024; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mazaheri A, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.156839; Nabel CS, 2011, SCIENCE, V333, P1229, DOI 10.1126/science.1211917; Nagaraju GP, 2013, CANCER LETT, V328, P10, DOI 10.1016/j.canlet.2012.08.028; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Sahin K, 2014, BIOMED REP, V2, P574, DOI 10.3892/br.2014.266; Si Yf, 2016, GENE, V575, P321, DOI 10.1016/j.gene.2015.09.006; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Smith JT, 2006, J NEUROSCI, V26, P6687, DOI 10.1523/JNEUROSCI.1618-06.2006; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Stueve TR, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-78; Teles MG, 2015, NEW ENGL J MED, V358, P709; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wyatt AK, 2013, GENET EPIGENETICS, V5, P51, DOI 10.4137/GEG.S12897; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	41	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165327	10.1371/journal.pone.0165327	http://dx.doi.org/10.1371/journal.pone.0165327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788248	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900063
J	Zittermann, A; Ernst, JB; Pilz, S; Dreier, J; Kuhn, J; Knabbe, C; Gummert, JF; Morshuis, M; Milting, H				Zittermann, Armin; Ernst, Jana B.; Pilz, Stefan; Dreier, Jens; Kuhn, Joachim; Knabbe, Cornelius; Gummert, Jan F.; Morshuis, Michiel; Milting, Hendrik			Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device	PLoS One			English	Article							VITAMIN-D-RECEPTOR; GROWTH-FACTOR 23; DILATED CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; CARDIAC-HYPERTROPHY; METABOLISM; 1,25-DIHYDROXYVITAMIN-D; MORTALITY; METAANALYSIS; DEFICIENCY	Background Calcium and phosphate are central for myocardial contractility and energy metabolism, and low levels of the calciotropic hormone 1,25-dihydroxyvitamin D (1,25(OH)(2)D), as well as high levels of the phosphaturic hormone fibroblast growth factor (FGF)-23, are independently associated with poor clinical outcome in heart failure (HF) patients. We therefore aimed to investigate the postoperative time course of the aforementioned hormones in HF patients supported with a left-ventricular assist device (LVAD) implant. Methods For the present study, stored biobank plasma samples of 69 patients, collected before LVAD implantation (t0) and 12 days (t1), 30 days (t2), 83 days (t3), and 300 days (t4) post-intervention, were used to measure circulating FGF-23, parathyroid hormone (PTH), 25-hydroxyvitamin D (25OHD), 1,25(OH)(2)D, and kidney function. Results Most patients were male and had baseline INTERMACS levels and cardiac index values <= 3 and <= 2.7 L/min/m(2), respectively. There were significant time effects on estimated glomerular filtration rate (eGFR), FGF-23 and 1,25(OH)(2)D, but not on PTH or 25OHD. Notably, eGFR values increased and FGF-23 levels decreased only transiently, whereas 1,25 (OH)(2)D increased continuously until t4. The rise in 1,25(OH)(2)D was largely influenced by those patients who survived the first post-implant year, and was not seen in non-survivors. Variations in 1,25(OH)(2)D levels could only partly be explained by eGFR values or FGF-23, 25OHD, and PTH levels (multiple R-2 = 0.305; P<0.001). Conclusions The present study indicates that LVAD implantation has only transient effects on circulating FGF-23 levels, but is associated with a continuous increase in circulating 1,25(OH)(2)D levels, especially in survivors.	[Zittermann, Armin; Ernst, Jana B.; Gummert, Jan F.; Morshuis, Michiel] Ruhr Univ Bochum, Clin Thorac & Cardiovasc Surg, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany; [Pilz, Stefan] Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria; [Dreier, Jens; Kuhn, Joachim; Knabbe, Cornelius] Ruhr Univ Bochum, Heart & Diabet Ctr NRW, Inst Lab & Transfus Med, Bad Oeynhausen, Germany; [Milting, Hendrik] Ruhr Univ Bochum, Erich & Hanna Klessmann Inst Cardiovasc Res & Dev, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany	Ruhr University Bochum; Medical University of Graz; Ruhr University Bochum; Ruhr University Bochum	Zittermann, A (corresponding author), Ruhr Univ Bochum, Clin Thorac & Cardiovasc Surg, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany.	azittermann@hdz-nrw.de		Pilz, Stefan/0000-0002-7959-1311				BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Borgermann J, 2012, CRIT CARE MED, V40, P2073, DOI 10.1097/CCM.0b013e31824e8c42; Cabiati M, 2012, PEPTIDES, V36, P192, DOI 10.1016/j.peptides.2012.05.018; Chen S, 2008, HYPERTENSION, V52, P1106, DOI 10.1161/HYPERTENSIONAHA.108.119602; Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680; DEBOLAND AR, 1994, CELL SIGNAL, V6, P717, DOI 10.1016/0898-6568(94)00042-5; Fischer TH, 2014, EUR J HEART FAIL, V16, P1292, DOI 10.1002/ejhf.163; Ford JA, 2014, AM J CLIN NUTR, V100, P746, DOI 10.3945/ajcn.113.082602; Gruson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135427; HOCHHAUSER E, 1989, ANGIOLOGY, V40, P300, DOI 10.1177/000331978904000410; Khan RS, 2012, CIRC-HEART FAIL, V5, P340, DOI 10.1161/CIRCHEARTFAILURE.111.964031; Koller L, 2015, CIRC-HEART FAIL, V8, P1059, DOI 10.1161/CIRCHEARTFAILURE.115.002341; Milting H, 2008, J HEART LUNG TRANSPL, V27, P589, DOI 10.1016/j.healun.2008.02.018; Molony DA, 2011, ADV CHRONIC KIDNEY D, V18, P120, DOI 10.1053/j.ackd.2011.02.004; NEUBAUER S, 1992, CIRCULATION, V86, P1810, DOI 10.1161/01.CIR.86.6.1810; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Richter M., 2012, J CLIN EXP CARDIOL, DOI [10.4172/2155-9880.S9-003, DOI 10.4172/2155-9880.S9-003]; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Scialla JJ, 2014, NAT REV NEPHROL, V10, P268, DOI 10.1038/nrneph.2014.49; SIMPSON RU, 1988, CELL CALCIUM, V9, P285, DOI 10.1016/0143-4160(88)90009-7; Slaughter MS, 2011, CURR OPIN CARDIOL, V26, P232, DOI 10.1097/HCO.0b013e328345aff4; Tromp TR, 2015, HEART FAIL REV, V20, P519, DOI 10.1007/s10741-015-9481-z; Weitzel LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060292; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Zittermann A, 2016, EUR J NUTR, V55, P305, DOI 10.1007/s00394-015-0847-8; Zittermann A, 2003, J AM COLL CARDIOL, V41, P105, DOI 10.1016/S0735-1097(02)02624-4; Zittermann A, 2008, EUR J HEART FAIL, V10, P321, DOI 10.1016/j.ejheart.2008.01.013; Zittermann A, 2015, CLIN CHEM, V61, P1484, DOI 10.1373/clinchem.2015.244913; Zittermann A, 2015, J CLIN ENDOCR METAB, V100, P72, DOI 10.1210/jc.2014-3013; Zittermann A, 2011, SCAND CARDIOVASC J, V45, P342, DOI 10.3109/14017431.2011.611250; Zittermann A, 2009, TRANSPLANTATION, V87, P118, DOI 10.1097/TP.0b013e31818c2708	32	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164459	10.1371/journal.pone.0164459	http://dx.doi.org/10.1371/journal.pone.0164459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788150	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900022
J	Lah, L; Trense, D; Benke, H; Berggren, P; Gunnlaugsson, P; Lockyer, C; Ozturk, A; Ozturk, B; Pawliczka, I; Roos, A; Siebert, U; Skora, K; Vikingsson, G; Tiedemann, R				Lah, Ljerka; Trense, Daronja; Benke, Harald; Berggren, Per; Gunnlaugsson, Porvaldur; Lockyer, Christina; Ozturk, Ayaka; Ozturk, Bayram; Pawliczka, Iwona; Roos, Anna; Siebert, Ursula; Skora, Krzysztof; Vikingsson, Gisli; Tiedemann, Ralph			Spatially Explicit Analysis of Genome-Wide SNPs Detects Subtle Population Structure in a Mobile Marine Mammal, the Harbor Porpoise	PLOS ONE			English	Article							ATLANTIC HUMPBACK WHALES; MULTILOCUS GENOTYPE DATA; BALTIC SEA; PHOCOENA-PHOCOENA; GENETIC-STRUCTURE; KILLER WHALE; MORPHOMETRIC COMPARISONS; SKAGERRAK SEAS; CONSERVATION; WATERS	The population structure of the highly mobile marine mammal, the harbor porpoise (Phocoena phocoena), in the Atlantic shelf waters follows a pattern of significant isolation-by-distance. The population structure of harbor porpoises from the Baltic Sea, which is connected with the North Sea through a series of basins separated by shallow underwater ridges, however, is more complex. Here, we investigated the population differentiation of harbor porpoises in European Seas with a special focus on the Baltic Sea and adjacent waters, using a population genomics approach. We used 2872 single nucleotide polymor-phisms (SNPs), derived from double digest restriction-site associated DNA sequencing (ddRAD-seq), as well as 13 microsatellite loci and mitochondrial haplotypes for the same set of individuals. Spatial principal components analysis (sPCA), and Bayesian clustering on a subset of SNPs suggest three main groupings at the level of all studied regions: the Black Sea, the North Atlantic, and the Baltic Sea. Furthermore, we observed a distinct separation of the North Sea harbor porpoises from the Baltic Sea populations, and identified splits between porpoise populations within the Baltic Sea. We observed a notable distinction between the Belt Sea and the Inner Baltic Sea sub-regions. Improved delineation of harbor porpoise population assignments for the Baltic based on genomic evidence is important for conservation management of this endangered cetacean in threatened habitats, particularly in the Baltic Sea proper. In addition, we show that SNPs outperform microsatellite markers and demonstrate the utility of RAD-tags from a relatively small, opportunistically sampled cetacean sample set for population diversity and divergence analysis.	[Lah, Ljerka; Trense, Daronja; Tiedemann, Ralph] Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Potsdam, Germany; [Benke, Harald] Deutsch Meeresmuseum, Stralsund, Germany; [Berggren, Per] Newcastle Univ, Sch Marine Sci & Technol, Dove Marine Lab, Cullercoats, North Shields, England; [Gunnlaugsson, Porvaldur; Vikingsson, Gisli] Marine Res Inst, Reykjavik, Iceland; [Lockyer, Christina] North Atlantic Marine Mammal Commiss, Tromso, Norway; [Ozturk, Ayaka; Ozturk, Bayram] Istanbul Univ, Fac Fisheries, Dept Marine Biol, Istanbul, Turkey; [Pawliczka, Iwona; Skora, Krzysztof] Univ Gdansk, Hel Marine Stn, Hel, Poland; [Roos, Anna] Swedish Museum Nat Hist, Stockholm, Sweden; [Siebert, Ursula] Univ Vet Med, Hannover Fdn, Inst Terr & Aquat Wildlife Res ITAW, Busum, Germany	University of Potsdam; Newcastle University - UK; Marine & Freshwater Research Institute (MFRI); Istanbul University; Fahrenheit Universities; University of Gdansk; Swedish Museum of Natural History	Tiedemann, R (corresponding author), Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Potsdam, Germany.	tiedeman@uni-potsdam.de	Amaha Ozturk, Ayaka/AAB-8197-2022; Ozturk, Ayaka Amaha/ABI-4939-2020; Ozturk, Ayaka Amaha/AAD-6380-2020; Öztürk, Bayram/AAD-6228-2020	Öztürk, Bayram/0000-0001-7844-2448; Pawliczka, Iwona/0000-0001-9235-9456; Vikingsson, Gisli/0000-0002-4501-193X; Tiedemann, Ralph/0000-0002-2604-6336	University of Potsdam; Bundesamt fur Naturschutz	University of Potsdam; Bundesamt fur Naturschutz	This work was supported by University of Potsdam and Bundesamt fur Naturschutz.; We acknowledge financial support from the Bundesamt fur Naturschutz and the University of Potsdam. We thank Tomaz Skrbinsek (Biotechnical Faculty, University of Ljubljana) for help with sPCA and ArcGIS, and the Unit of Evolutionary Adaptive Genomics at the University of Potsdam (Prof. Michael Hofreiter) for access to the Agilent TapeStation Instrument. Rebecca Nagel kindly assisted with data handling. The sampling in Schleswig-Holstein, Germany was partly funded by the Ministry of Energy, Agriculture Environment, and Rural Affairs of Schleswig-Holstein.	Aaris-Sorensen K, 2010, MAR MAMMAL SCI, V26, P253, DOI 10.1111/j.1748-7692.2009.00356.x; Amaral AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031482; Andrews K., 2014, PRIMATES AND CETACEA; ASCOBANS, 2009, ASCOBANS CONSERVATIO; ASCOBANS, 2012, ASCOBANS CONSERVATIO; ASCOBANS, 2002, ASCOBANS RECOVERY PL; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Benke H, 2014, MAR ECOL PROG SER, V495, P275, DOI 10.3354/meps10538; Berggren P, 2002, BIOL CONSERV, V103, P313, DOI 10.1016/S0006-3207(01)00142-2; Berggren P, 2004, PAP IWC SC 5 SM INT; Borjesson P, 2003, MAR MAMMAL SCI, V19, P38, DOI 10.1111/j.1748-7692.2003.tb01091.x; Borjesson P, 1997, CAN J ZOOL, V75, P280, DOI 10.1139/z97-035; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; De Luna CJ, 2012, J EVOLUTION BIOL, V25, P674, DOI 10.1111/j.1420-9101.2012.02461.x; DeFaveri J, 2013, MOL ECOL RESOUR, V13, P377, DOI 10.1111/1755-0998.12071; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans PGH, 2014, J MAR BIOL ASSOC UK, V94, P1073, DOI 10.1017/S0025315414000848; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Fontaine MC, 2014, MOL ECOL, V23, P3306, DOI 10.1111/mec.12817; Fontaine MC, 2010, P ROY SOC B-BIOL SCI, V277, P2829, DOI 10.1098/rspb.2010.0412; Garke C, 2012, ANIM GENET, V43, P419, DOI 10.1111/j.1365-2052.2011.02284.x; Galatius A, 2012, J MAR BIOL ASSOC UK, V92, P1669, DOI 10.1017/S0025315412000513; Gallus Anja, 2012, Endangered Species Research, V18, P265, DOI 10.3354/esr00448; Gillespie D., 2005, Journal of Cetacean Research and Management, V7, P51; Haasl RJ, 2011, HEREDITY, V106, P158, DOI 10.1038/hdy.2010.21; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hammond PS, 2013, BIOL CONSERV, V164, P107, DOI 10.1016/j.biocon.2013.04.010; HAMMOND PS, 2008, IUCN 2008 IUCN RED L; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hiby L, 1996, 1995 BALTIC NORTH SE; Hoelzel AR, 2007, MOL BIOL EVOL, V24, P1407, DOI 10.1093/molbev/msm063; Hoelzel A. Rus, 2009, V17, P294; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; HOLM S, 1979, SCAND J STAT, V6, P65; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jackson JA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3222; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Johannesson K, 2011, AMBIO, V40, P179, DOI 10.1007/s13280-010-0129-x; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Louis M, 2014, MOL ECOL, V23, P857, DOI 10.1111/mec.12653; MacKenzie BR, 2002, CAN J FISH AQUAT SCI, V59, P173, DOI 10.1139/F01-201; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Merwade VM, 2005, J HYDROL ENG, V10, P243, DOI 10.1061/(ASCE)1084-0699(2005)10:3(243); Morin PA, 2015, MOL ECOL, V24, P3964, DOI 10.1111/mec.13284; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; Moura AE, 2013, J EVOLUTION BIOL, V26, P63, DOI 10.1111/jeb.12032; Moura AE, 2014, MOL ECOL, V23, P5179, DOI 10.1111/mec.12929; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Palme A, 2008, ORYX, V42, P305, DOI 10.1017/S0030605308006960; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; PALSBOLL PJ, 1995, MAR ECOL PROG SER, V116, P1, DOI 10.3354/meps116001; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pritchard JK, 2000, GENETICS, V155, P945; Rheinheimer G., 1996, MEERESKUNDE DER OSTS; Rosel PE, 2009, MOL ECOL, V18, P5030, DOI 10.1111/j.1365-294X.2009.04413.x; Rosel PE, 2003, CONSERV GENET, V4, P647, DOI 10.1023/A:1025666212967; Scheidat M., 2008, Endangered Species Research, V5, P215, DOI 10.3354/esr00161; Senn H, 2013, MOL ECOL, V22, P3141, DOI 10.1111/mec.12242; Skora K.E., 2003, NAMMCO Scientific Publications, V5, P303; Sommer RS, 2008, BOREAS, V37, P458, DOI 10.1111/j.1502-3885.2008.00034.x; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Stevick PT, 2006, J ZOOL, V270, P244, DOI 10.1111/j.1469-7998.2006.00128.x; Stopar K, 2010, MOL PHYLOGENET EVOL, V57, P417, DOI 10.1016/j.ympev.2010.07.004; Sveegaard S, 2015, GLOB ECOL CONSERV, V3, P839, DOI 10.1016/j.gecco.2015.04.002; Sveegaard S, 2012, MAR ECOL PROG SER, V468, P245, DOI 10.3354/meps09959; Sveegaard S, 2011, MAR MAMMAL SCI, V27, P230, DOI 10.1111/j.1748-7692.2010.00379.x; Tiedemann R, 1996, Z SAUGETIERKD, V61, P104; Verfuss UK, 2007, J MAR BIOL ASSOC UK, V87, P165, DOI 10.1017/S0025315407054938; Verissimo A, 2012, MAR FRESHWATER RES, V63, P505, DOI 10.1071/MF11237; Viquerat S, 2014, MAR BIOL, V161, P745, DOI 10.1007/s00227-013-2374-6; Viricel A, 2014, MOL ECOL, V23, P5018, DOI 10.1111/mec.12923; Viricel A, 2014, MOL ECOL RESOUR, V14, P597, DOI 10.1111/1755-0998.12206; Wang JY, 1997, MAR BIOL, V127, P531, DOI 10.1007/s002270050042; Wennerstrom L, 2013, BIODIVERS CONSERV, V22, P3045, DOI 10.1007/s10531-013-0570-9; Wiemann A, 2010, CONSERV GENET, V11, P195, DOI 10.1007/s10592-009-0023-x; Wright AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055553; Zettler ML, 2007, MAR POLLUT BULL, V55, P258, DOI 10.1016/j.marpolbul.2006.08.024; Zillen L, 2008, EARTH-SCI REV, V91, P77, DOI 10.1016/j.earscirev.2008.10.001	89	35	36	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0162792	10.1371/journal.pone.0162792	http://dx.doi.org/10.1371/journal.pone.0162792			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783621	gold, Green Published			2022-12-26	WOS:000389602800012
J	Yuan, GL; Sheng, Z; Liu, WJ				Yuan, Gonglin; Sheng, Zhou; Liu, Wenjie			The Modified HZ Conjugate Gradient Algorithm for Large-Scale Nonsmooth Optimization	PLOS ONE			English	Article							LINE SEARCH METHODS; CONVERGENCE ANALYSIS; DESCENT	In this paper, the Hager and Zhang (HZ) conjugate gradient (CG) method and the modified HZ (MHZ) CG method are presented for large-scale nonsmooth convex minimization. Under some mild conditions, convergent results of the proposed methods are established. Numerical results show that the presented methods can be better efficiency for large-scale nonsmooth problems, and several problems are tested (with the maximum dimensions to 100,000 variables).	[Yuan, Gonglin; Sheng, Zhou] Guangxi Univ, Coll Math & Informat Sci, Guangxi Coll & Univ Key Lab Math & Its Applicat, Nanning 530004, Guangxi, Peoples R China; [Yuan, Gonglin] Guangzhou Univ, Coll Math & Informat Sci, Guangzhou 510006, Guangdong, Peoples R China; [Liu, Wenjie] Nanjing Univ Informat Sci & Technol, Sch Comp & Software, Nanjing 210044, Jiangsu, Peoples R China; [Liu, Wenjie] Nanjing Univ Informat Sci & Technol, Jiangsu Engn Ctr Network Monitoring, Nanjing 210044, Jiangsu, Peoples R China	Guangxi University; Guangzhou University; Nanjing University of Information Science & Technology; Nanjing University of Information Science & Technology	Sheng, Z (corresponding author), Guangxi Univ, Coll Math & Informat Sci, Guangxi Coll & Univ Key Lab Math & Its Applicat, Nanning 530004, Guangxi, Peoples R China.	szhou03@live.com	Yuan, Gonglin/HGE-6598-2022	Yuan, Gonglin/0000-0003-2667-5834	Guangxi Science Fund for Distinguished Young Scholars [2015GXNSFGA139001]; National Natural Science Foundation of China [11261006, 11661009, 61232016, U1405254]; PAPD	Guangxi Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PAPD	This work is supported by the Guangxi Science Fund for Distinguished Young Scholars (Grant No. 2015GXNSFGA139001), National Natural Science Foundation of China (Grant No. 11261006 and 11661009), National Natural Science Foundation of China (No. 61232016), National Natural Science Foundation of China (No. U1405254), and PAPD issue of Jiangsu advantages discipline.; The authors would like to thank the referees for their valuable comments which greatly improve this paper. This work was supported by the Guangxi Science Fund for Distinguished Young Scholars (Grant No. 2015GXNSFGA139001), the National Natural Science Foundation of China (Grant No. 11261006 and 11661009), National Natural Science Foundation of China No. 61232016, National Natural Science Foundation of China No. U1405254, and PAPD issue of Jiangsu advantages discipline.	[Anonymous], REPORTS DEP MATH I B; [Anonymous], 1989, HDB OPERATIONS RES M, DOI [10.1016/s0927-0507(89)01008-x, DOI 10.1016/S0927-0507(89)01008-X]; BONNANS JF, 1995, MATH PROGRAM, V68, P15, DOI 10.1007/BF01585756; CALAMAI PH, 1987, MATH PROGRAM, V39, P93, DOI 10.1007/BF02592073; CORREA R, 1993, MATH PROGRAM, V62, P261, DOI 10.1007/BF01585170; Dolan ED, 2002, MATH PROGRAM, V91, P201, DOI 10.1007/s101070100263; Fu Z., 2015, ENABLING PERSONALIZE; Fu ZJ, 2016, IEEE T INF FOREN SEC, V11, P2706, DOI 10.1109/TIFS.2016.2596138; FUKUSHIMA M, 1984, MATH PROGRAM, V30, P163, DOI 10.1007/BF02591883; Gu B, 2016, STRUCTURAL MINIMAX P; Gu B, 2016, ROBUST REGULARIZATIO; Gu B, 2015, IEEE T NEUR NET LEAR, V26, P1403, DOI 10.1109/TNNLS.2014.2342533; Haarala M, 2004, OPTIM METHOD SOFTW, V19, P673, DOI 10.1080/10556780410001689225; Hager WW, 2006, ACM T MATH SOFTWARE, V32, P113, DOI 10.1145/1132973.1132979; Hager WW, 2005, SIAM J OPTIMIZ, V16, P170, DOI 10.1137/030601880; Hiriart-Urruty JB., 1993, CONVEX ANAL MINIMIZA, DOI [10.1007/978-3-662-06409-2, DOI 10.1007/978-3-662-06409-2]; Karmitsa N, 2012, OPTIM METHOD SOFTW, V27, P131, DOI 10.1080/10556788.2010.526116; Li J, 2015, IEEE T INF FOREN SEC, V10, P507, DOI 10.1109/TIFS.2014.2381872; Makela M.M, 2003, REPORTS DEP MATH I B; Neittaanm?ki, 1992, NONSMOOTH OPTIMIZATI; Pan ZQ, 2016, IEEE T BROADCAST, V62, P675, DOI 10.1109/TBC.2016.2580920; Pan ZQ, 2015, IEEE T BROADCAST, V61, P166, DOI 10.1109/TBC.2015.2419824; QI LQ, 1993, MATH OPER RES, V18, P227, DOI 10.1287/moor.18.1.227; Shi ZJ, 2004, APPL MATH COMPUT, V157, P393, DOI 10.1016/j.amc.2003.08.058; Xia ZH, 2016, IEEE T INF FOREN SEC, V11, P2594, DOI 10.1109/TIFS.2016.2590944; Xia ZH, 2016, IEEE T PARALL DISTR, V27, P340, DOI 10.1109/TPDS.2015.2401003; Xia ZH, 2016, MULTIMED TOOLS APPL, V75, P1947, DOI 10.1007/s11042-014-2381-8; Yuan CS, 2016, CHINA COMMUN, V13, P60, DOI 10.1109/CC.2016.7559076; Yuan GL, 2008, ACTA MATH SIN, V24, P35, DOI 10.1007/s10114-007-1012-y; Yuan GL, 2016, J OPTIMIZ THEORY APP, V168, P129, DOI 10.1007/s10957-015-0781-1; Yuan GL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140071; Yuan GL, 2015, J COMPUT APPL MATH, V286, P186, DOI 10.1016/j.cam.2015.03.014; Yuan GL, 2014, J COMPUT APPL MATH, V255, P86, DOI 10.1016/j.cam.2013.04.032; Yuan GL, 2009, OPTIM LETT, V3, P11, DOI 10.1007/s11590-008-0086-5; Yuan GL, 2010, COMPUT OPTIM APPL, V47, P237, DOI 10.1007/s10589-008-9219-0; Yuan GL, 2009, J COMPUT APPL MATH, V233, P519, DOI 10.1016/j.cam.2009.08.001; Yuan GL, 2009, J COMPUT APPL MATH, V230, P44, DOI 10.1016/j.cam.2008.10.062; Yuan GL, 2009, J KOREAN STAT SOC, V38, P29, DOI 10.1016/j.jkss.2008.05.004; Yuan GL, 2009, ANN OPER RES, V166, P73, DOI 10.1007/s10479-008-0420-4; Zhou ZL, 2017, IEEE T INF FOREN SEC, V12, P48, DOI 10.1109/TIFS.2016.2601065	40	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164289	10.1371/journal.pone.0164289	http://dx.doi.org/10.1371/journal.pone.0164289			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780245	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900011
J	Ilyicheva, T; Durymanov, A; Susloparov, I; Kolosova, N; Goncharova, N; Svyatchenko, S; Petrova, O; Bondar, A; Mikheev, V; Ryzhikov, A				Ilyicheva, T.; Durymanov, A.; Susloparov, I.; Kolosova, N.; Goncharova, N.; Svyatchenko, S.; Petrova, O.; Bondar, A.; Mikheev, V.; Ryzhikov, A.			Fatal Cases of Seasonal Influenza in Russia in 2015-2016	PLoS One			English	Article							RECEPTOR-BINDING; HEMAGGLUTININ; VIRUS; A(H1N1)PDM09; VARIANTS; ASIA	The influenza epidemic in 2015-2016 in Russia is characterized by a sharp increase of influenza cases (beginning from the second week of 2016) with increased fatalities. Influenza was confirmed in 20 fatal cases registered among children (0-10 years), in 5 cases among pregnant women, and in 173 cases among elderly people (60 years and older). Two hundred and ninety nine people died from influenza were patients with some chronic problems. The overwhelming majority among the deceased (more than 98%) were not vaccinated against influenza. We isolated 109 influenza A(H1N1) pdm09 and one A(H3N2) virus strains from 501 autopsy material samples. The antigenic features of the strains were similar to the vaccine strains. A phylogenic analysis of hemagglutinin revealed that influenza A (H1N1) pdm09 virus strains belonged to 6B genetic group that had two main dominant subgroups during the 2015-2016 season. In Russia strains of the first group predominated. We registered an increased proportion of strains with D222G mutation in receptor-binding site. A herd immunity analysis carried out immediately prior to the epidemic showed that 34.4% blood sera samples collected in different regions of Russia were positive to A/California/ 07/09(H1N1) pdm09. We came to a conclusion that public awareness enhancement is necessary to reduce unreasonable refusals of vaccination.	[Ilyicheva, T.; Durymanov, A.; Susloparov, I.; Kolosova, N.; Goncharova, N.; Svyatchenko, S.; Petrova, O.; Mikheev, V.; Ryzhikov, A.] Vector State Res Ctr Virol & Biotechnol, Novosibirsk, Russia; [Ilyicheva, T.] Novosibirsk State Univ, Novosibirsk, Russia; [Bondar, A.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Genom Core Facil, Novosibirsk, Russia	State Research Center of Virology & Biotechnology VECTOR; Novosibirsk State University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Ilyicheva, T (corresponding author), Vector State Res Ctr Virol & Biotechnol, Novosibirsk, Russia.; Ilyicheva, T (corresponding author), Novosibirsk State Univ, Novosibirsk, Russia.	ilyichev@mail.ru	Kolosova, Natalia/AAH-6399-2020; Ilyicheva, Tatyana N./B-1327-2012; Bondar, Alexander/AAA-7087-2020	Kolosova, Natalia/0000-0001-8865-8592; Ilyicheva, Tatyana N./0000-0002-2354-7688; Bondar, Alexander/0000-0001-9181-0487; Susloparov, Ivan/0000-0002-9718-7339	Russian Science Foundation [15-15-00047]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Grant #15-15-00047, Russian Science Foundation, http://rscf.ru, to TI NK NG SS OP. The funders made it able to obtain a number of reagents, to pay for carrying out several sequences and HI test with sera of immunized human, for analyzing data and to cover publication fees.	[Anonymous], 2016, END INFL ARVI EP SEA; [Anonymous], 2016, INFL CHAR SUMM EUR M; Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; Casalegno JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104009; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Goka EA, 2014, ARCH VIROL, V159, P3167, DOI 10.1007/s00705-014-2179-z; Hurt A., 2009, FLUOROMETRIC NEURAMI; Ilyicheva T, 2013, INFECT GENET EVOL, V20, P177, DOI 10.1016/j.meegid.2013.08.025; Ilyicheva T, 2011, INFECT GENET EVOL, V11, P2107, DOI 10.1016/j.meegid.2011.05.002; Ilyicheva T, 2016, J MED VIROL, V88, P35, DOI 10.1002/jmv.24301; Imai H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001106; Kubysheva N, 2014, COPD, V11, P639, DOI 10.3109/15412555.2014.898042; Lvov D. K., 2010, Voprosy Virusologii, V55, P15; Marchenko VY, 2016, ARCH VIROL, V161, P1645, DOI 10.1007/s00705-016-2800-4; Maurer-Stroh Sebastian, 2010, PLoS Curr, V2, pRRN1162; Memoli MJ, 2012, VIROLOGY, V428, P21, DOI 10.1016/j.virol.2012.02.018; Nguyen HKL, 2015, INFLUENZA OTHER RESP, V9, P216, DOI 10.1111/irv.12323; Radomski JP, 2014, MOL PHYLOGENET EVOL, V70, P29, DOI 10.1016/j.ympev.2013.08.020; Tjon-Kon-Fat R, 2016, INFLUENZA OTHER RESP, V10, P236, DOI 10.1111/irv.12381	20	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165332	10.1371/journal.pone.0165332	http://dx.doi.org/10.1371/journal.pone.0165332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776172	gold, Green Published, Green Submitted			2022-12-26	WOS:000389009200054
J	Fjeld, K; Beer, S; Johnstone, M; Zimmer, C; Mossner, J; Ruffert, C; Krehan, M; Zapf, C; Njolstad, PR; Johansson, S; Bugert, P; Miyajima, F; Liloglou, T; Brown, LJ; Winn, SA; Davies, K; Latawiec, D; Gunson, BK; Criddle, DN; Pirmohamed, M; Grutzmann, R; Michl, P; Greenhalf, W; Molven, A; Sutton, R; Rosendahl, J				Fjeld, Karianne; Beer, Sebastian; Johnstone, Marianne; Zimmer, Constantin; Moessner, Joachim; Ruffert, Claudia; Krehan, Mario; Zapf, Christian; Njolstad, Pal Rasmus; Johansson, Stefan; Bugert, Peter; Miyajima, Fabio; Liloglou, Triantafillos; Brown, Laura J.; Winn, Simon A.; Davies, Kelly; Latawiec, Diane; Gunson, Bridget K.; Criddle, David N.; Pirmohamed, Munir; Gruetzmann, Robert; Michl, Patrick; Greenhalf, William; Molven, Anders; Sutton, Robert; Rosendahl, Jonas			Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic Pancreatitis	PLOS ONE			English	Article							SALT-STIMULATED LIPASE; ACID ETHYL-ESTER; HEREDITARY PANCREATITIS; VARIANTS; ASSOCIATION; MUTATIONS; RISK; POLYMORPHISM; DYSFUNCTION; INHIBITOR	Background Carboxyl-ester lipase (CEL) contributes to fatty acid ethyl ester metabolism, which is implicated in alcoholic pancreatitis. The CEL gene harbours a variable number of tandem repeats (VNTR) region in exon 11. Variation in this VNTR has been linked to monogenic pancreatic disease, while conflicting results were reported for chronic pancreatitis (CP). Here, we aimed to investigate a potential association of CEL VNTR lengths with alcoholic CP. Methods Overall, 395 alcoholic CP patients, 218 patients with alcoholic liver cirrhosis (ALC) serving as controls with a comparable amount of alcohol consumed, and 327 healthy controls from Germany and the United Kingdom (UK) were analysed by determination of fragment lengths by capillary electrophoresis. Allele frequencies and genotypes of different VNTR categories were compared between the groups. Results Twelve repeats were overrepresented in UK ACP patients (P = 0.04) compared to controls, whereas twelve repeats were enriched in German ALC compared to alcoholic CP patients (P = 0.03). Frequencies of CEL VNTR lengths of 14 and 15 repeats differed between German ALC patients and healthy controls (P = 0.03 and 0.008, respectively). However, in the genotype and pooled analysis of VNTR lengths no statistical significant association was depicted. Additionally, the 16-16 genotype as well as 16 repeats were more frequent in UK ALC than in alcoholic CP patients (P = 0.034 and 0.02, respectively). In all other calculations, including pooled German and UK data, allele frequencies and genotype distributions did not differ significantly between patients and controls or between alcoholic CP and ALC. Conclusions We did not obtain evidence that CEL VNTR lengths are associated with alcoholic CP. However, our results suggest that CEL VNTR lengths might associate with ALC, a finding that needs to be clarified in larger cohorts.	[Fjeld, Karianne; Njolstad, Pal Rasmus; Johansson, Stefan; Molven, Anders] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, Bergen, Norway; [Fjeld, Karianne; Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, Bergen, Norway; [Beer, Sebastian; Zimmer, Constantin; Moessner, Joachim; Krehan, Mario; Zapf, Christian] Univ Leipzig, Div Gastroenterol & Rheumatol, Dept Internal Med Neurol & Dermatol, Leipzig, Germany; [Johnstone, Marianne; Brown, Laura J.; Winn, Simon A.; Davies, Kelly; Latawiec, Diane; Greenhalf, William; Sutton, Robert] Univ Liverpool, Royal Liverpool Univ Hosp, Inst Translat Med, NIHR Liverpool Pancreas Biomed Res Unit, Liverpool, Merseyside, England; [Ruffert, Claudia; Michl, Patrick; Rosendahl, Jonas] Univ Halle Wittenberg, Dept Internal Med 1, Halle, Germany; [Njolstad, Pal Rasmus] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Bugert, Peter] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, German Red Cross Blood Serv Baden Wurttemberg Hes, Mannheim, Germany; [Miyajima, Fabio; Pirmohamed, Munir] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England; [Liloglou, Triantafillos] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England; [Gunson, Bridget K.] Queen Elizabeth Hosp, NIHR Birmingham Liver Biomed Res Unit, Birmingham, W Midlands, England; [Gunson, Bridget K.] Univ Birmingham, Birmingham, W Midlands, England; [Criddle, David N.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England; [Gruetzmann, Robert] Univ Erlangen Nurnberg, Dept Surg, Erlangen, Germany; [Molven, Anders] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Leipzig University; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Martin Luther University Halle Wittenberg; University of Bergen; Haukeland University Hospital; Ruprecht Karls University Heidelberg; University of Liverpool; University of Liverpool; University of Birmingham; University of Birmingham; University of Liverpool; University of Erlangen Nuremberg; University of Bergen; University of Bergen; Haukeland University Hospital	Rosendahl, J (corresponding author), Univ Halle Wittenberg, Dept Internal Med 1, Halle, Germany.	jonas.rosendahl@uk-halle.de	Pirmohamed, Munir/H-6004-2011; Miyajima, Fabio/K-6587-2012; Johansson, Stefan/C-4394-2011; Greenhalf, William/A-2680-2013; Fjeld, Karianne/Q-7122-2018; Michl, Patrick/AAG-3987-2021; Michl, Patrick/HDN-4172-2022; Hollyman, Marianne/J-8362-2016	Pirmohamed, Munir/0000-0002-7534-7266; Miyajima, Fabio/0000-0002-1347-4825; Johansson, Stefan/0000-0002-2298-7008; Fjeld, Karianne/0000-0003-0441-1475; Hollyman, Marianne/0000-0002-5972-0454	Deutsche Forschungsgemeinschaft [RO 3929/1-1, RO 3939/2-1]; Colora Stiftung gGmbH; KG Jebsen Foundation; Regional Health Authority of Western Norway; Norwegian Research Council; Royal College of Surgeons of England; National Institute for Health Research; Cancer Research UK [16812] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10064, NF-SI-0515-10084] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Colora Stiftung gGmbH; KG Jebsen Foundation; Regional Health Authority of Western Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission); Royal College of Surgeons of England; National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Deutsche Forschungsgemeinschaft RO 3929/1-1 & RO 3939/2-1, by a grant of the Colora Stiftung gGmbH (to J.R.), by grants from the KG Jebsen Foundation, Regional Health Authority of Western Norway and Norwegian Research Council (to A.M. and P.R.N), by the Royal College of Surgeons of England and Biomedical Research Unit funding scheme from the National Institute for Health Research. M.J. was supported by a Fellowship from the Royal College of Surgeons of England. Robert Sutton is an NIHR Senior Investigator. No sources of funding have influenced the study in any regard.	Aparisi L, 2008, WORLD J GASTROENTERO, V14, P6171, DOI 10.3748/wjg.14.6171; Bengtsson-Ellmark SH, 2004, EUR J HUM GENET, V12, P627, DOI 10.1038/sj.ejhg.5201204; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Buchner AM, 2001, AM J GASTROENTEROL, V96, P2231, DOI 10.1111/j.1572-0241.2001.03941.x; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Fjeld K, 2015, NAT GENET, V47, P518, DOI 10.1038/ng.3249; Forsmark CE, 2008, CLIN GASTROENTEROL H, V6, P1291, DOI 10.1016/j.cgh.2008.08.008; Higuchi S, 2002, J HUM GENET, V47, P213, DOI 10.1007/s100380200027; Huang W, 2014, GUT, V63, P1313, DOI 10.1136/gutjnl-2012-304058; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; Lombardo D, 2001, BBA-MOL CELL BIOL L, V1533, P1, DOI 10.1016/S1388-1981(01)00130-5; Miyasaka K, 2005, PANCREAS, V30, pE87, DOI 10.1097/01.mpa.0000160960.21580.mL; Nakamura Y, 2004, J GASTROENTEROL, V39, P879, DOI 10.1007/s00535-004-1405-y; Pace A, 2009, CLIN GASTROENTEROL H, V7, P1241, DOI 10.1016/j.cgh.2009.06.010; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Ragvin A, 2013, PANCREATOLOGY, V13, P29, DOI 10.1016/j.pan.2012.12.059; RENNER IG, 1984, DIGEST DIS SCI, V29, P593, DOI 10.1007/BF01347290; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; SINGER MV, 1985, GASTROENTEROLOGY, V89, P683, DOI 10.1016/0016-5085(85)90468-8; Stromqvist M, 1997, ARCH BIOCHEM BIOPHYS, V347, P30, DOI 10.1006/abbi.1997.0307; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; TSUJITA T, 1994, EUR J BIOCHEM, V224, P57, DOI 10.1111/j.1432-1033.1994.tb19994.x; Whitcomb DC, 2012, NAT GENET, V44, P1349, DOI 10.1038/ng.2466; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165567	10.1371/journal.pone.0165567	http://dx.doi.org/10.1371/journal.pone.0165567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802312	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200027
J	Ang, GY; Yu, CY; Subramaniam, V; Khalid, MIHA; Aziz, TATA; James, RJ; Ahmad, A; Rahman, TA; Nor, FM; Ismail, AI; Isa, KM; Salleh, H; Teh, LK; Salleh, MZ				Ang, Geik Yong; Yu, Choo Yee; Subramaniam, Vinothini; Khalid, Mohd Ikhmal Hanif Abdul; Aziz, Tuan Azlin Tuan Abdu; James, Richard Johari; Ahmad, Aminuddin; Rahman, Thuhairah Abdul; Nor, Fadzilah Mohd; Ismail, Adzrool Idzwan; Isa, Kamarudzaman Md.; Salleh, Hood; Teh, Lay Kek; Salleh, Mohd Zaki			Detection of CYP2C19 Genetic Variants in Malaysian Orang Asli from Massively Parallel Sequencing Data	PLOS ONE			English	Article							CLOPIDOGREL-TREATED PATIENTS; CYP2C19-ASTERISK-17 ALLELE; CYTOCHROME-P450 ENZYMES; OMEPRAZOLE METABOLISM; PLATELET-AGGREGATION; POLYMORPHISMS; PHARMACOGENETICS; ANTIDEPRESSANTS; GENOTYPES; IDENTIFICATION	The human cytochrome P450 (CYP) is a superfamily of enzymes that have been a focus in research for decades due to their prominent role in drug metabolism. CYP2C is one of the major subfamilies which metabolize more than 10% of all clinically used drugs. In the context of CYP2C19, several key genetic variations that alter the enzyme's activity have been identified and catalogued in the CYP allele nomenclature database. In this study, we investigated the presence of well-established variants as well as novel polymorphisms in the CYP2C19 gene of 62 Orang Asli from the Peninsular Malaysia. A total of 449 genetic variants were detected including 70 novel polymorphisms; 417 SNPs were located in introns, 23 in upstream, 7 in exons, and 2 in downstream regions. Five alleles and seven genotypes were inferred based on the polymorphisms that were found. Null alleles that were observed include CYP2C19*3 (6.5%), *2 (5.7%) and *35 (2.4%) whereas allele with increased function *17 was detected at a frequency of 4.8%. The normal metabolizer genotype was the most predominant (66.1%), followed by intermediate metabolizer (19.4%), rapid metabolizer (9.7%) and poor metabolizer (4.8%) genotypes. Findings from this study provide further insights into the CYP2C19 genetic profile of the Orang Asli as previously unreported variant alleles were detected through the use of massively parallel sequencing technology platform. The systematic and comprehensive analysis of CYP2C19 will allow uncharacterized variants that are present in the Orang Asli to be included in the genotyping panel in the future.	[Ang, Geik Yong; Yu, Choo Yee; Subramaniam, Vinothini; Khalid, Mohd Ikhmal Hanif Abdul; Aziz, Tuan Azlin Tuan Abdu; James, Richard Johari; Ismail, Adzrool Idzwan; Isa, Kamarudzaman Md.; Teh, Lay Kek; Salleh, Mohd Zaki] Univ Teknol MARA Selangor UiTM, Integrat Pharmacogen Inst iPROMISE, Puncak Alam, Selangor, Malaysia; [James, Richard Johari; Teh, Lay Kek; Salleh, Mohd Zaki] Univ Teknol MARA Selangor UiTM, Fac Pharm, Puncak Alam, Selangor, Malaysia; [Ahmad, Aminuddin; Rahman, Thuhairah Abdul; Nor, Fadzilah Mohd] Univ Teknol MARA Selangor UiTM, Fac Med, Puncak Alam, Selangor, Malaysia; [Ismail, Adzrool Idzwan] Univ Utara Malaysia, Coll Arts & Sci, Sintok, Kedah, Malaysia; [Isa, Kamarudzaman Md.] Univ Selangor, Fac Commun & Media, Shah Alam, Malaysia; [Salleh, Hood] Univ Kebangsaan Malaysia, Inst Alam Sekitar & Pembangunan LESTARI, Bangi, Selangor, Malaysia	Universiti Utara Malaysia; Universiti Kebangsaan Malaysia	Teh, LK; Salleh, MZ (corresponding author), Univ Teknol MARA Selangor UiTM, Integrat Pharmacogen Inst iPROMISE, Puncak Alam, Selangor, Malaysia.; Teh, LK; Salleh, MZ (corresponding author), Univ Teknol MARA Selangor UiTM, Fac Pharm, Puncak Alam, Selangor, Malaysia.	tehlaykek@gmail.com; zakisalleh.mzs@gmail.com	Salleh, Mohd Zaki/ABD-4784-2020; Teh, Lay Kek/AAV-2790-2020; JOHARI JAMES, RICHARD MUHAMMAD/A-4557-2016; Abdul Rahman, Thuhairah Hasrah/ABA-5874-2021; Teh, Lay Kek/ABH-6209-2020; YU, CHOO YEE/G-2033-2015; Ang, Geik Yong/AAH-9471-2020; James, Richard Muhammad Johari/ABE-3781-2020; Salleh, Mohd Zaki/D-3287-2009	JOHARI JAMES, RICHARD MUHAMMAD/0000-0003-4138-615X; YU, CHOO YEE/0000-0002-8453-5023; Ang, Geik Yong/0000-0003-0509-6518; James, Richard Muhammad Johari/0000-0003-4138-615X; ABDUL RAHMAN, THUHAIRAH/0000-0003-2779-1765; abdul khalid, mohd ikhmal hanif/0000-0003-1833-8854; Teh, Lay Kek/0000-0002-2830-4263	Ministry of Higher Education Malaysia [600-RMI/LRGS 5/3 (1/2011)-1]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	The project is funded by Ministry of Higher Education Malaysia [600-RMI/LRGS 5/3 (1/2011)-1]. The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andrews S., 2010, FASTQC QUALITY CONTR; Baldwin RM, 2008, BRIT J CLIN PHARMACO, V65, P767, DOI 10.1111/j.1365-2125.2008.03104.x; Barak Y, 2011, PROG NEURO-PSYCHOPH, V35, P1744, DOI 10.1016/j.pnpbp.2011.06.007; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blaisdell J, 2002, PHARMACOGENETICS, V12, P703, DOI 10.1097/00008571-200212000-00004; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Caudle K. E., 2016, GENET MED; Cavallari Larisa H, 2012, J Pharm Pract, V25, P413, DOI 10.1177/0897190012448311; Chaudhry AS, 2015, DRUG METAB DISPOS, V43, P1226, DOI 10.1124/dmd.115.064428; Collet JP, 2011, JACC-CARDIOVASC INTE, V4, P392, DOI 10.1016/j.jcin.2011.03.002; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Frere C, 2009, J THROMB HAEMOST, V7, P1409, DOI 10.1111/j.1538-7836.2009.03500.x; Furuta T, 1998, ANN INTERN MED, V129, P1027, DOI 10.7326/0003-4819-129-12-199812150-00006; Grasmader K, 2004, EUR J CLIN PHARMACOL, V60, P329, DOI 10.1007/s00228-004-0766-8; Hicks JK, 2015, CLIN PHARMACOL THER, V98, P127, DOI 10.1002/cpt.147; Hicks JK, 2013, CLIN PHARMACOL THER, V93, P402, DOI 10.1038/clpt.2013.2; Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124; Hodgson K, 2014, J PSYCHOPHARMACOL, V28, P133, DOI 10.1177/0269881113512041; Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z; Ingelman-Sundberg Magnus, 2005, Toxicol Appl Pharmacol, V207, P52; Klose TS, 1999, J BIOCHEM MOL TOXIC, V13, P289, DOI 10.1002/(SICI)1099-0461(1999)13:6<289::AID-JBT1>3.0.CO;2-N; Lapple F, 2003, PHARMACOGENETICS, V13, P565, DOI 10.1097/01.fpc.0000054122.14659.1e; Lee CR, 2002, PHARMACOGENETICS, V12, P251, DOI 10.1097/00008571-200204000-00010; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malaysian Adverse Drug Reaction Advisory Committee, ANNUAL REPORT FOR 20; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; NurWaliyuddin HZA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141536; Rudberg I, 2008, CLIN PHARMACOL THER, V83, P322, DOI 10.1038/sj.clpt.6100291; Sansone Randy A, 2008, Psychiatry (Edgmont), V5, P16; Scott SA, 2013, CLIN PHARMACOL THER, V94, P317, DOI 10.1038/clpt.2013.105; Scott SA, 2012, PHARMACOGENET GENOM, V22, P159, DOI 10.1097/FPC.0b013e32834d4962; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; The indigenous world, 2015, THE INDIGENOUS WORLD, P271; Tiong WN, 2012, HEART, V98, pE270, DOI 10.1136/heartjnl-2012-302920v.4; Wang SM, 2009, J HUM GENET, V54, P372, DOI 10.1038/jhg.2009.41; Wijnen PAHM, 2007, ALIMENT PHARM THER, V26, P211, DOI 10.1111/j.1365-2036.2007.03490.x; Wolf CR, 2000, BRIT MED J, V320, P987, DOI 10.1136/bmj.320.7240.987; Yang YS, 2004, BRIT J CLIN PHARMACO, V58, P332, DOI 10.1111/j.1365-2125.2004.02144.x; Yusoff NM, 2015, J PHARMACOGENOMICS P, V6; Zainuddin Z, 2015, GENETIC AND DENTAL P	49	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0164169	10.1371/journal.pone.0164169	http://dx.doi.org/10.1371/journal.pone.0164169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798644	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100005
J	Fu, G; Shen, ZX				Fu, Gang; Shen, Zhen Xi			Environmental Humidity Regulates Effects of Experimental Warming on Vegetation Index and Biomass Production in an Alpine Meadow of the Northern Tibet	PLOS ONE			English	Article							SOIL RESPIRATION; SHORT-TERM; SPECIES COMPOSITION; CONIFEROUS FOREST; CLIMATIC FACTORS; ABIES-FAXONIANA; WESTERN SICHUAN; PLANT-GROWTH; CARBON-CYCLE; ECOSYSTEM	Uncertainty about responses of vegetation index, aboveground biomass (AGB) and gross primary production (GPP) limits our ability to predict how climatic warming will influence plant growth in alpine regions. A field warming experiment was conducted in an alpine meadow at a low (4313 m), mid-(4513 m) and high elevation (4693 m) in the Northern Tibet since May 2010. Growing season vapor pressure deficit (VPD), soil temperature (T-s) and air temperature (T-a) decreased with increasing elevation, while growing season precipitation, soil moisture (SM), normalized difference vegetation index (NDVI), soil adjusted vegetation index (SAVI), AGB and GPP increased with increasing elevation. The growing season Ta, T-s and VPD in 2015 was greater than that in 2014, while the growing season precipitation, SM, NDVI, SAVI, AGB and GPP in 2015 was lower than that in 2014, respectively. Compared to the mean air temperature and precipitation during the growing season in 1963-2015, it was a warmer and wetter year in 2014 and a warmer and drier year in 2015. Experimental warming increased growing season T-s, T-a, VPD, but decreased growing season SM in 2014-2015 at all the three elevations. Experimental warming only reduced growing season NDVI, SAVI, AGB and GPP at the low elevation in 2015. Growing season NDVI, SAVI, AGB and GPP increased with increasing SM and precipitation, but decreased with increasing VPD, indicating vegetation index and biomass production increased with environmental humidity. The VPD explained more variation of growing season NDVI, SAVI, AGB and GPP compared to T-s, T-a and SM at all the three elevations. Therefore, environmental humidity regulated the effect of experimental warming on vegetation index and biomass production in alpine meadows on the Tibetan Plateau.	[Fu, Gang; Shen, Zhen Xi] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Lhasa Plateau Ecosyst Res Stn, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Shen, ZX (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Lhasa Plateau Ecosyst Res Stn, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China.	shenzx@igsnrr.ac.cn	Fu, Gang/AAA-5041-2022	Fu, Gang/0000-0002-6055-8730	National Natural Science Foundation of China [31600432, 41171084]; Chinese Academy of Science Western Light Talents Program; Natural Science Foundation of Tibet Autonomous Region; Science and Technology Plan Projects of Tibet Autonomous Region; National Science and Technology Plan Project of China [2014BAD146006, 2013BAC04601, 2011BAC09603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science Western Light Talents Program; Natural Science Foundation of Tibet Autonomous Region; Science and Technology Plan Projects of Tibet Autonomous Region; National Science and Technology Plan Project of China	This work was funded by the National Natural Science Foundation of China (No. 31600432, 41171084), Chinese Academy of Science Western Light Talents Program (Response of livestock carrying capability to climatic change and grazing in the alpine meadow of Northern Tibetan Plateau), the Natural Science Foundation of Tibet Autonomous Region (Response of species richness and above-ground biomass to warming in the alpine meadow of Tibet), the Science and Technology Plan Projects of Tibet Autonomous Region (Forage Grass Industry) and the National Science and Technology Plan Project of China (Nos. 2014BAD146006, 2013BAC04601, 2011BAC09603).	Boelman NT, 2003, OECOLOGIA, V135, P414, DOI 10.1007/s00442-003-1198-3; [陈骥 Chen Ji], 2014, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V28, P127; Dagg J, 2010, CAN J REMOTE SENS, V36, pS111, DOI 10.5589/m10-019; Fu G., 2013, BIOGEOSCI DISCUSS, V10, P13015; Fu G, 2016, J PLANT GROWTH REGUL; Fu G, 2015, J MT SCI-ENGL, V12, P935, DOI 10.1007/s11629-014-3035-z; Fu G, 2015, J PLANT GROWTH REGUL, V34, P57, DOI 10.1007/s00344-014-9442-0; Fu G, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.073505; Fu G, 2012, CAN J REMOTE SENS, V38, P157, DOI 10.5589/m12-023; Ganjurjav H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132044; Gianelle D, 2009, INT J REMOTE SENS, V30, P435, DOI 10.1080/01431160802314855; Han C, 2009, PLANT GROWTH REGUL, V58, P153, DOI 10.1007/s10725-009-9363-2; Hu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075503; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jiang J, 2015, ECOL RES, V30, P3, DOI 10.1007/s11284-014-1199-1; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Klein JA, 2007, ECOL APPL, V17, P541, DOI 10.1890/05-0685; La Puma IP, 2007, REMOTE SENS ENVIRON, V109, P225, DOI 10.1016/j.rse.2007.01.001; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Li GY, 2011, J APPL ECOL, V48, P659, DOI 10.1111/j.1365-2664.2011.01965.x; Li N, 2011, SOIL BIOL BIOCHEM, V43, P942, DOI 10.1016/j.soilbio.2011.01.009; [李娜 Li Na], 2011, [生态学报, Acta Ecologica Sinica], V31, P895; Lin DL, 2010, NEW PHYTOL, V188, P187, DOI 10.1111/j.1469-8137.2010.03347.x; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; [刘光生 Liu Guangsheng], 2015, [冰川冻土, Journal of Glaciology and Geocryology], V37, P668; [刘琳 LIU Lin], 2011, [草业科学, Pratacultural Science], V28, P1405; Liu Wei, 2010, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V30, P995; Liu WJ, 2012, ENV RES LETT, V7; Lu M, 2013, ECOLOGY, V94, P726, DOI 10.1890/12-0279.1; Lu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059054; Ma KM, 2004, LAND DEGRAD DEV, V15, P75, DOI 10.1002/ldr.584; Nagy Z, 2007, AGR ECOSYST ENVIRON, V121, P21, DOI 10.1016/j.agee.2006.12.003; Pan Xin-Lin, 2008, Yingyong Shengtai Xuebao, V19, P1637; Peng DL, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004060; Peng F, 2015, ECOL ENG, V84, P653, DOI 10.1016/j.ecoleng.2015.09.069; Peng F, 2015, ARCT ANTARCT ALP RES, V47, P359, DOI 10.1657/AAAR0014-018; Peng P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102265; Piao SL, 2011, AGR FOREST METEOROL, V151, P1599, DOI 10.1016/j.agrformet.2011.06.016; Qin Y, 2015, COLD REG SCI TECHNOL, V115, P77, DOI 10.1016/j.coldregions.2015.03.012; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Sharp ED, 2013, GLOBAL CHANGE BIOL, V19, P1780, DOI 10.1111/gcb.12149; Shen ZX, 2014, REMOTE SENS-BASEL, V6, P6765, DOI 10.3390/rs6086765; Shi Fu-Sun, 2010, Chinese Journal of Plant Ecology, V34, P488, DOI 10.3773/j.issn.1005-264x.2010.05.002; Shi Fu-Sun, 2008, Bulletin of Botanical Research, V28, P730; Sun J, 2015, ENVIRON MONIT ASSESS, V188, P1; Sun J, 2013, REMOTE SENS-BASEL, V5, P1894, DOI 10.3390/rs5041894; Wang SH, 2015, POL J ECOL, V63, P424, DOI 10.3161/15052249PJE2015.63.3.012; Wang SP, 2012, ECOLOGY, V93, P2365, DOI 10.1890/11-1408.1; Wang XX, 2014, SOIL BIOL BIOCHEM, V76, P140, DOI 10.1016/j.soilbio.2014.05.014; Wang Z, 2013, J VEG SCI, V24, P189, DOI 10.1111/j.1654-1103.2012.01442.x; Wu JS, 2014, ALPINE BOT, V124, P13, DOI 10.1007/s00035-014-0125-z; Wu ZT, 2011, ECOSYSTEMS, V14, P1066, DOI 10.1007/s10021-011-9464-4; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xiong JB, 2014, FEMS MICROBIOL ECOL, V89, P281, DOI 10.1111/1574-6941.12289; Xu ZF, 2012, ENVIRON EXP BOT, V77, P1, DOI 10.1016/j.envexpbot.2011.10.011; Yang Yue-juan, 2015, Shengtaixue Zazhi, V34, P781; Yi SH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045403; Yin HJ, 2008, ECOL RES, V23, P459, DOI 10.1007/s11284-007-0404-x; Yin Hua-Jun, 2008, Zhiwu Shengtai Xuebao, V32, P1072, DOI 10.3773/j.issn.1005-264x.2008.05.012; Yu CQ, 2014, SCI WORLD J, DOI 10.1155/2014/152576; [余欣超 Yu Xinchao], 2015, [科学通报, Chinese Science Bulletin], V60, P379; Zhang GL, 2013, P NATL ACAD SCI USA, V110, P4309, DOI 10.1073/pnas.1210423110; Zhang XZ, 2015, APPL SOIL ECOL, V87, P32, DOI 10.1016/j.apsoil.2014.11.012; Zhang Y, 2015, RANGELAND J, V37, P57, DOI 10.1071/RJ14080; [赵艳艳 Zhao Yanyan], 2015, [草地学报, Acta Agrestia Sinica], V23, P665	65	14	16	16	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165643	10.1371/journal.pone.0165643	http://dx.doi.org/10.1371/journal.pone.0165643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798690	Green Submitted, Green Published, gold			2022-12-26	WOS:000386711100051
J	Lin, J; Hiraoka, K; Watanabe, T; Kuo, T; Shinozaki, Y; Takatori, A; Koshikawa, N; Chandran, A; Otsuki, J; Sugiyama, H; Horton, P; Nagase, H				Lin, Jason; Hiraoka, Kiriko; Watanabe, Takayoshi; Kuo, Tony; Shinozaki, Yoshinao; Takatori, Atsushi; Koshikawa, Nobuko; Chandran, Anandhakumar; Otsuki, Joe; Sugiyama, Hiroshi; Horton, Paul; Nagase, Hiroki			Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome	PLOS ONE			English	Article							DNA-SEQUENCING DATA; MINOR-GROOVE; GENE; DESIGN; ANNOTATION; DISCOVERY; FRAMEWORK; FIBROBLASTS; INHIBITION; MOLECULES	Pyrrole-imidazole polyamides are versatile DNA minor groove binders and attractive therapeutic options against oncological targets, especially upon functionalization with an alkylating agent such as seco-CBI. These molecules also provide an alternative for oncogenes deemed "undruggable" at the protein level, where the absence of solvent-accessible pockets or structural crevices prevent the formation of protein-inhibitor ligands; nevertheless, the genome-wide effect of pyrrole-imidazole polyamide binding remain largely unclear to-date. Here we propose a next-generation sequencing-based workflow combined with whole genome expression arrays to address such issue using a candidate anti-cancer alkylating agent, KR12, against codon 12 mutant KRAS. Biotinylating KR12 enables the means to identify its genome-wide effects in living cells and possible biological implications via a coupled workflow of enrichment-based sequencing and expression microarrays. The subsequent computational pathway and expression analyses allow the identification of its genomic binding sites, as well as a route to explore a polyamide's possible genome-wide effects. Among the 3,343 KR12 binding sites identified in the human LS180 colorectal cancer genome, the reduction of KR12-bound gene expressions was also observed. Additionally, the coupled microarray-sequencing analysis also revealed some insights about the effect of local chromatin structure on pyrrole-imidazole polyamide, which had not been fully understood to-date. A comparative analysis with KR12 in a different human colorectal cancer genome SW480 also showed agreeable agreements of KR12 binding affecting gene expressions. Combination of these analyses thus suggested the possibility of applying this approach to other pyrrole-imidazole polyamides to reveal further biological details about the effect of polyamide binding in a genome.	[Lin, Jason; Hiraoka, Kiriko; Watanabe, Takayoshi; Shinozaki, Yoshinao; Takatori, Atsushi; Koshikawa, Nobuko; Nagase, Hiroki] Chiba Canc Ctr, Res Inst, Canc Genet Lab, Chuo Ku, Chiba, Japan; [Kuo, Tony; Horton, Paul] Natl Inst Adv Ind Sci & Technol, Artificial Intelligence Res Ctr, Koto Ku, Tokyo, Japan; [Shinozaki, Yoshinao; Otsuki, Joe] Nihon Univ, Dept Mat & Appl Chem, Chiyoda Ku, Tokyo, Japan; [Chandran, Anandhakumar; Sugiyama, Hiroshi] Kyoto Univ, Dept Chem, Sakyo Ku, Kyoto, Japan	Chiba Cancer Center; National Institute of Advanced Industrial Science & Technology (AIST); Nihon University; Kyoto University	Nagase, H (corresponding author), Chiba Canc Ctr, Res Inst, Canc Genet Lab, Chuo Ku, Chiba, Japan.	hnagase@chiba-cc.jp	Sugiyama, Hiroshi/C-7687-2011	Sugiyama, Hiroshi/0000-0001-8923-5946; Nagase, Hiroki/0000-0002-3992-5399	KIBAN-B fund from MEXT, Japan [26290060]; Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT); Grants-in-Aid for Scientific Research [15K05486, 25112001] Funding Source: KAKEN	KIBAN-B fund from MEXT, Japan; Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KIBAN-B fund (26290060) from MEXT, Japan and the Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) (to HN).	Anandhakumar C, 2014, CHEMBIOCHEM, V15, P2647, DOI 10.1002/cbic.201402497; Baek S, 2012, METHODS MOL BIOL, V833, P433, DOI 10.1007/978-1-61779-477-3_26; Broad Institute, PIC TOOLS, DOI [10.1038/ng.806, DOI 10.1038/NG.806]; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chandran A, 2016, NUCLEIC ACIDS RES, V44, P4014, DOI 10.1093/nar/gkw283; Chang AY, 2000, J AM CHEM SOC, V122, P4856, DOI 10.1021/ja994345x; Chen M, 2010, MOL THER, V18, P519, DOI 10.1038/mt.2009.263; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dervan PB, 2003, CURR OPIN STRUC BIOL, V13, P284, DOI 10.1016/S0959-440X(03)00081-2; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Erwin GS, 2014, ANGEW CHEM INT EDIT, V53, P10124, DOI 10.1002/anie.201405497; Frith MC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1212; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hargrove AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143161; Hiraoka K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7706; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jespersen C, 2012, BIOORG MED CHEM LETT, V22, P4068, DOI 10.1016/j.bmcl.2012.04.090; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kang JS, 2014, J AM CHEM SOC, V136, P3687, DOI 10.1021/ja500211z; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Koohy H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096303; Lajiness JP, 2011, J ORG CHEM, V76, P583, DOI 10.1021/jo102136w; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ledford H, 2015, NATURE, V520, P278, DOI 10.1038/520278a; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maeshima K, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/6/064116; Makley LN, 2013, CHEM BIOL DRUG DES, V81, P22, DOI 10.1111/cbdd.12066; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meier JL, 2012, J AM CHEM SOC, V134, P17814, DOI 10.1021/ja308888c; Mishra R, 2015, CANCER SCI, V106, P421, DOI 10.1111/cas.12610; Obinata D, 2014, CANCER SCI, V105, P1272, DOI 10.1111/cas.12493; Pandian GN, 2014, ACS CHEM BIOL, V9, P2729, DOI 10.1021/cb500724t; Pandian GN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00544; Polavarapu A, 2012, J ORG CHEM, V77, P5914, DOI 10.1021/jo300351g; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rashid NU, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r67; Raskatov JA, 2012, P NATL ACAD SCI USA, V109, P1023, DOI 10.1073/pnas.1118506109; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Shukla S, 2014, NEOPLASIA, V16, P115, DOI 10.1593/neo.14184; Syed J, 2015, CHEMBIOCHEM, V16, P1497, DOI 10.1002/cbic.201500140; Taylor RD, 2015, CHEM-EUR J, V21, P14996, DOI 10.1002/chem.201501870; Tenenbaum D, 2016, KEGGREST 1 12 2 CLIE; ThermoFisher Scientific, ION AMPLISEQ COMPR C; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wilks C, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau093; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165581	10.1371/journal.pone.0165581	http://dx.doi.org/10.1371/journal.pone.0165581			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798693	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100047
J	Kosoy, R; Agashe, C; Grishin, A; Leung, DY; Wood, RA; Sicherer, SH; Jones, SM; Burks, AW; Davidson, WF; Lindblad, RW; Dawson, P; Merad, M; Kidd, BA; Dudley, JT; Sampson, HA; Berin, MC				Kosoy, Roman; Agashe, Charuta; Grishin, Alexander; Leung, Donald Y.; Wood, Robert A.; Sicherer, Scott H.; Jones, Stacie M.; Burks, A. Wesley; Davidson, Wendy F.; Lindblad, Robert W.; Dawson, Peter; Merad, Miriam; Kidd, Brian A.; Dudley, Joel T.; Sampson, Hugh A.; Berin, M. Cecilia			Transcriptional Profiling of Egg Allergy and Relationship to Disease Phenotype	PLOS ONE			English	Article							REGULATORY T-CELLS; COWS MILK ALLERGY; FC-EPSILON-RI; PLASMACYTOID DENDRITIC CELLS; FOOD ALLERGY; PEANUT ALLERGY; CHILDREN; RESPONSES; RECEPTOR; TOLERANCE	Background Egg allergy is one of the most common food allergies of childhood. There is a lack of information on the immunologic basis of egg allergy beyond the role of IgE. Objective To use transcriptional profiling as a novel approach to uncover immunologic processes associated with different phenotypes of egg allergy. Methods Peripheral blood mononuclear cells (PBMCs) were obtained from egg-allergic children who were defined as reactive (BER) or tolerant (BET) to baked egg, and from food allergic controls (AC) who were egg non-allergic. PBMCs were stimulated with egg white protein. Gene transcription was measured by microarray after 24 h, and cytokine secretion by multiplex assay after 5 days. Results The transcriptional response of PBMCs to egg protein differed between BER and BET versus AC subjects. Compared to the AC group, the BER group displayed increased expression of genes associated with allergic inflammation as well as corresponding increased secretion of IL-5, IL-9 and TNF-alpha. A similar pattern was observed for the BET group. Further similarities in gene expression patterns between BER and BET groups, as well as some important differences, were revealed using a novel Immune Annotation resource developed for this project. This approach identified several novel processes not previously associated with egg allergy, including positive associations with TLR4-stimulated myeloid cells and activated NK cells, and negative associations with an induced Treg signature. Further pathway analysis of differentially expressed genes comparing BER to BET subjects showed significant enrichment of IFN-alpha and IFN-gamma response genes, as well as genes associated with virally-infected DCs. Conclusions Transcriptional profiling identified several novel pathways and processes that differed when comparing the response to egg allergen in BET, BER, and AC groups. We conclude that this approach is a useful hypothesis- generating mechanism to identify novel immune processes associated with allergy and tolerance to forms of egg.	[Kosoy, Roman; Kidd, Brian A.; Dudley, Joel T.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Agashe, Charuta; Grishin, Alexander; Sicherer, Scott H.; Sampson, Hugh A.; Berin, M. Cecilia] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Leung, Donald Y.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Wood, Robert A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Jones, Stacie M.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Jones, Stacie M.] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA; [Burks, A. Wesley] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Davidson, Wendy F.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lindblad, Robert W.; Dawson, Peter] EMMES Corp, Rockville, MD USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Jewish Health; Johns Hopkins University; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emmes Corporation; Icahn School of Medicine at Mount Sinai	Berin, MC (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA.	cecilia.berin@mssm.edu	Agashe, Charuta/AAF-3847-2020; Agashe, Charuta/AFP-8581-2022	Agashe, Charuta/0000-0001-8820-8655; Kidd, Brian/0000-0003-2110-1145; berin, cecilia/0000-0002-9051-9249	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [U19A1066738, U01A1066560, U01A1044236]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 TR000154, UL1 TR000067, UL1 TR000039, UL1 TR000083, UL1 TR000424]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023515] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) grants U19A1066738 and U01A1066560, and a supplement to U01A1044236. The project was also supported by grant numbers UL1 TR000154 (National Jewish), UL1 TR000067 (Mount Sinai), UL1 TR000039 (Arkansas), UL1 TR000083 (North Carolina), and UL1 TR000424 (Johns Hopkins) from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH).; We acknowledge the Human Immune Monitoring Center, and the Genomics Core Facility at the Icahn School of Medicine at Mount Sinai for their contribution. We thank the physicians and staff of the Jaffe Food Allergy Institute for their assistance in recruiting atopic controls, and the physicians, research coordinators, and laboratory staff at the 5 CoFAR study sites for their contributions. This work was supported in part through the computational resources and staff expertise provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai.	Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Brough HA, 2014, J ALLERGY CLIN IMMUN, V134, P1329, DOI 10.1016/j.jaci.2014.06.032; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chen CY, 2015, IMMUNITY, V43, P788, DOI 10.1016/j.immuni.2015.08.020; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Frischmeyer-Guerrerio PA, 2011, CLIN EXP ALLERGY, V41, P61, DOI 10.1111/j.1365-2222.2010.03606.x; Gill MA, 2010, J IMMUNOL, V184, P5999, DOI 10.4049/jimmunol.0901194; Herre J, 2013, J IMMUNOL, V191, P1529, DOI 10.4049/jimmunol.1300284; Jaervinen KM, 2007, ALLERGY, V62, P758, DOI 10.1111/j.1398-9995.2007.01332.x; Karlsson MR, 2004, J EXP MED, V199, P1679, DOI 10.1084/jem.20032121; Kidd BA, 2016, NAT BIOTECHNOL, V34, P47, DOI 10.1038/nbt.3367; Kim JS, 2011, J ALLERGY CLIN IMMUN, V128, P125, DOI 10.1016/j.jaci.2011.04.036; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lemon-Mule H, 2008, J ALLERGY CLIN IMMUN, V122, P977, DOI 10.1016/j.jaci.2008.09.007; Leonard SA, 2012, J ALLERGY CLIN IMMUN, V130, P473, DOI 10.1016/j.jaci.2012.06.006; Maurer D, 1996, J IMMUNOL, V157, P607; Nowak-Wegrzyn A, 2008, J ALLERGY CLIN IMMUN, V122, P342, DOI 10.1016/j.jaci.2008.05.043; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Osterfeld H, 2010, J ALLERGY CLIN IMMUN, V125, P469, DOI 10.1016/j.jaci.2009.09.054; Prussin C, 2009, J ALLERGY CLIN IMMUN, V124, P1326, DOI 10.1016/j.jaci.2009.09.048; Qamar N, 2015, CLIN EXP ALLERGY, V45, P1663, DOI 10.1111/cea.12570; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Schroeder JT, 2005, J IMMUNOL, V175, P5724, DOI 10.4049/jimmunol.175.9.5724; Shreffler WG, 2009, J ALLERGY CLIN IMMUN, V123, P43, DOI [10.1016/j.jaci.2008.09.051, 10.1016/j.jaci.2008.12.1128]; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Zhang YX, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad4322	33	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0163831	10.1371/journal.pone.0163831	http://dx.doi.org/10.1371/journal.pone.0163831			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788149	gold, Green Published, Green Submitted			2022-12-26	WOS:000389604900010
J	McGlashan, J; Johnstone, M; Creighton, D; de la Haye, K; Allender, S				McGlashan, Jaimie; Johnstone, Michael; Creighton, Doug; de la Haye, Kayla; Allender, Steven			Quantifying a Systems Map: Network Analysis of a Childhood Obesity Causal Loop Diagram	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PUBLIC-HEALTH; SMALL-WORLD; DYNAMICS	Causal loop diagrams developed by groups capture a shared understanding of complex problems and provide a visual tool to guide interventions. This paper explores the application of network analytic methods as a new way to gain quantitative insight into the structure of an obesity causal loop diagram to inform intervention design. Identification of the structural features of causal loop diagrams is likely to provide new insights into the emergent properties of complex systems and analysing central drivers has the potential to identify leverage points. The results found the structure of the obesity causal loop diagram to resemble commonly observed empirical networks known for efficient spread of information. Known drivers of obesity were found to be the most central variables along with others unique to obesity prevention in the community. While causal loop diagrams are often specific to single communities, the analytic methods provide means to contrast and compare multiple causal loop diagrams for complex problems.	[McGlashan, Jaimie; Allender, Steven] Deakin Univ, Global Obes Ctr, Geelong, Vic, Australia; [McGlashan, Jaimie; Johnstone, Michael; Creighton, Doug] Deakin Univ, Inst Intelligent Syst Res & Innovat, Geelong, Vic, Australia; [de la Haye, Kayla] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA USA	Deakin University; Deakin University; University of Southern California	McGlashan, J (corresponding author), Deakin Univ, Global Obes Ctr, Geelong, Vic, Australia.; McGlashan, J (corresponding author), Deakin Univ, Inst Intelligent Syst Res & Innovat, Geelong, Vic, Australia.	jaimie.mcglashan@deakin.edu.au	Allender, Steven/G-9881-2011	Allender, Steven/0000-0002-4842-3294	Australian National Health and Medical Research Council/Australian National Heart Foundation Career Development Fellowship [APP1045836]; US National Institutes of Health "Systems Science to Guide Whole-of-Community Childhood Obesity Interventions" [1R01HL115485-01A1]; NHMRC Centre for Research Excellence in Obesity Policy and Food Systems [APP1041020]; Western Health Alliance; Global Obesity Centre; Institute for Intelligent Systems Research and Innovation at Deakin University, Geelong, Australia	Australian National Health and Medical Research Council/Australian National Heart Foundation Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health "Systems Science to Guide Whole-of-Community Childhood Obesity Interventions"(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC Centre for Research Excellence in Obesity Policy and Food Systems(National Health and Medical Research Council (NHMRC) of Australia); Western Health Alliance; Global Obesity Centre; Institute for Intelligent Systems Research and Innovation at Deakin University, Geelong, Australia	SA is supported by funding from an Australian National Health and Medical Research Council/Australian National Heart Foundation Career Development Fellowship (APP1045836). He is also a researcher on the US National Institutes of Health grant titled, "Systems Science to Guide Whole-of-Community Childhood Obesity Interventions" (1R01HL115485-01A1) and within a NHMRC Centre for Research Excellence in Obesity Policy and Food Systems (APP1041020). This work is part of the WHO STOPS childhood obesity trial (APP1114118) and funding from the Western Health Alliance 2014-2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Global Obesity Centre and Institute for Intelligent Systems Research and Innovation at Deakin University, Geelong, Australia.	Abidin NZ, 2014, APPL MATH SCI, V8, P3283, DOI [10.12988/ams.2014.43247, DOI 10.12988/AMS.2014.43247]; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Allender S, 2006, HEALTH EDUC RES, V21, P826, DOI 10.1093/her/cyl063; Allender S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129683; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Bie RF, 2017, NEUROCOMPUTING, V220, P67, DOI 10.1016/j.neucom.2016.06.074; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Chami GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103500; Chor D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127382; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; de la Haye K, 2011, J ADOLESCENT HEALTH, V49, P421, DOI 10.1016/j.jadohealth.2011.02.008; de la Haye K, 2011, SOC SCI MED, V73, P719, DOI 10.1016/j.socscimed.2011.06.023; Finegood DT, 2010, OBESITY, V18, pS13, DOI 10.1038/oby.2009.426; Frewen PA, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.20656; HAMMOND R. A., 2009, PREVENTING CHRONIC D, V6; Hein O, 2006, WIRTSCHAFTSINF, V48, P267, DOI 10.1007/s11576-006-0058-2; Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059; Hovmand P.S., 2013, COMMUNITY BASED SYST, V2014th, DOI [10.1007/978-1-4614-8763-0, DOI 10.1007/978-1-4614-8763-0]; Ison R, 2010, SYSTEMS PRACTICE: HOW TO ACT IN A CLIMATE-CHANGE WORLD, P303, DOI 10.1007/978-1-84996-125-7_13; Jagannadham J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146759; Jiang Y, 2017, IEEE T IND INFORM, V13, P1900, DOI 10.1109/TII.2016.2573762; Johnstone M, 2015, 21ST INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2015), P1848; King L, 2011, OBES REV, V12, P329, DOI 10.1111/j.1467-789X.2010.00798.x; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Mabry PL, 2013, HEALTH EDUC BEHAV, V40, p9S, DOI 10.1177/1090198113503469; Marks J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145344; McNally RJ, 2015, CLIN PSYCHOL SCI, V3, P836, DOI 10.1177/2167702614553230; Meadows D, 1999, WORLD, P1; Montastier E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004047; Nahum-Shani I, 2018, ANN BEHAV MED, V52, P446, DOI 10.1007/s12160-016-9830-8; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Onnela JPJP, 2014, SCIENCE, V343, P1325, DOI 10.1126/science.1251746; Robinaugh DJ, 2014, J ABNORM PSYCHOL, V123, P510, DOI 10.1037/abn0000002; Salvy SJ, 2012, PHYSIOL BEHAV, V106, P369, DOI 10.1016/j.physbeh.2012.03.022; Saxe GN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151174; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Telesford QK, 2011, BRAIN CONNECT, V1, P367, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; Topirceanu A, 2014, EUR NETW INT C; Torres NV, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00354; Valente TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131712; Vandenbroeck P, 2007, FORESIGHT TACKLING O; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang YG, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-17; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	51	46	46	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165459	10.1371/journal.pone.0165459	http://dx.doi.org/10.1371/journal.pone.0165459			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VY	27788224	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900087
J	Rocha, AR; Silva, R; Villegas, A; Sanchez-Guzman, JM; Ramos, JA; Masero, JA				Rocha, Afonso R.; Silva, Rita; Villegas, Auxiliadora; Sanchez-Guzman, Juan M.; Ramos, Jaime A.; Masero, Jose A.			Physiological, Morphological and Behavioural Responses of Self-Feeding Precocial Chicks Copying with Contrasting Levels of Water Salinity during Development	PLoS One			English	Article							BASAL METABOLIC-RATE; AMERICAN AVOCET; SURFACE-TENSION; SHOREBIRDS; GROWTH; ENVIRONMENTS; BIRDS; PERFORMANCE; ADAPTATIONS; TRANSPORT	Combined physiological and behavioural responses to salt loads during development have rarely been studied in air-breathing vertebrates able to inhabit hypersaline habitats, but they may be of particular importance in understanding, for example, the differences among species in patterns of habitat use or ontogenetic diet switches. Here, we compared the physiological and behavioural responses of self-feeding precocial chicks developed in contrasting levels of water salinity. The model species was the Black-winged Stilt (Himantopus himantopus) a precocial shorebird that breeds in a range of habitats from freshwater to hypersaline wetlands. Specifically, we compared resting metabolic rate (RMR), heat shock proteins (Hsp70), plasma ions, hematocrit, body mass, body size, growth rate and head shaking behaviour of captive-reared Black-winged Stilt fledglings developed under fresh (0 parts per thousand), saline (20 parts per thousand), and hypersaline (60 parts per thousand) water. Contrary to expectations, none of the physiological and morphological variables measured differed significantly among treatments. Likewise, the RMR of wild and captive-reared fledglings was similar. Surprisingly, the saltgland mass of wild fledglings from freshwater and those from hypersaline habitats was also similar. However, head-shaking, a behavioural response associated to minimize salt intake and to expel the secretions of salt glands, differed according to salinity source: head-shaking rate increased with increasing salinity. The results of this study support the key role of behavioural osmoregulation in avoiding salt stress during development.	[Rocha, Afonso R.; Silva, Rita; Ramos, Jaime A.] Univ Coimbra, Dept Life Sci, MARE Marine & Environm Sci Ctr, P-3000456 Coimbra, Portugal; [Villegas, Auxiliadora; Sanchez-Guzman, Juan M.; Masero, Jose A.] Univ Extremadura, Dept Anat Cell Biol & Zool, Ave Elvas S-N, E-06071 Badajoz, Spain	Universidade de Coimbra; Universidad de Extremadura	Rocha, AR (corresponding author), Univ Coimbra, Dept Life Sci, MARE Marine & Environm Sci Ctr, P-3000456 Coimbra, Portugal.	afonso.rocha@gmail.com	Ramos, Jaime/B-6616-2018; SANCHEZ, JUAN MANUEL/M-1889-2014; Masero, Jose A./A-9478-2008; Rocha, Afonso Duarte dos Reis/P-1749-2019; Auxiliadora, Villegas/E-5468-2012; Auxiliadora, Villegas/M-7212-2019; Masero, Jose A./P-3418-2019	Ramos, Jaime/0000-0002-9533-987X; Masero, Jose A./0000-0001-5318-4833; Rocha, Afonso Duarte dos Reis/0000-0002-6222-2552; Auxiliadora, Villegas/0000-0001-7906-5613; Auxiliadora, Villegas/0000-0001-7906-5613; Masero, Jose A./0000-0001-5318-4833; Sanchez Guzman, Juan Manuel/0000-0002-0484-6308	Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH / BD / 74228 / 2010]; Fundacao para a Ciencia e Tecnologia [UID/MAR/04292/2013]; Spanish Ministry of Science and Innovation [CGL2011-27485]; Junta of Extremadura; FEDER funds [GR15080]	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta of Extremadura; FEDER funds(European Commission)	AR received the support given by Fundacao para a Ciencia e Tecnologia (Portugal, SFRH / BD / 74228 / 2010), Fundacao para a Ciencia e Tecnologia (UID/MAR/04292/2013), Spanish Ministry of Science and Innovation (CGL2011-27485), and Junta of Extremadura and FEDER funds (GR15080).; We thank the Salinas do Samouco Foundation for allowing us to use their facilities. We are grateful to F. Martinho for the analyses of saltglands and the use of the laboratory, and to Jessica Hey for correcting the English. We would also like to thank Editor, two anonymous reviewers and Jorge S. Gutierrez who significantly improved the manuscript. A.R. acknowledges the support given by 'Fundacao para a Ciencia e Tecnologia' (Portugal, SFRH / BD / 74228 / 2010) and through the strategic project UID/MAR/04292/2013 granted to MARE. Finally, project CGL2011-27485 (Spanish Ministry of Science and Innovation) and GR15080 (Junta of Extremadura and FEDER funds) provided funding for the study.	Bai YC, 2015, AQUACULTURE, V437, P297, DOI 10.1016/j.aquaculture.2014.12.020; Bentley P.J., 2002, ENDOCRINES OSMOREGUL; Cramp S., 1983, BIRDS W PALEARCTIC; DUNSON WA, 1981, J HERPETOL, V15, P163, DOI 10.2307/1563376; Estrella SM, 2007, AUK, V124, P1244, DOI 10.1642/0004-8038(2007)124[1244:SPFAOS]2.0.CO;2; Estrella SM, 2007, J EXP BIOL, V210, P3757, DOI 10.1242/jeb.007690; Fellows Brian, 2013, Wader Study Group Bulletin, V120, P208; Gutierrez JS, 2015, OECOLOGIA, V178, P1077, DOI 10.1007/s00442-015-3308-4; Gutierrez JS, 2014, ARDEOLA, V61, P233, DOI 10.13157/arla.61.2.2014.233; Gutierrez JS, 2012, FUNCT ECOL, V26, P236, DOI 10.1111/j.1365-2435.2011.01929.x; Gutierrez JS, 2011, J EXP BIOL, V214, P829, DOI 10.1242/jeb.048223; Hannam KM, 2003, WATERBIRDS, V26, P119, DOI 10.1675/1524-4695(2003)026[0119:IOSOGA]2.0.CO;2; Krijgsveld KL, 2012, J ORNITHOL, V153, P1203, DOI 10.1007/s10336-012-0851-1; Kvist A, 2001, FUNCT ECOL, V15, P465, DOI 10.1046/j.0269-8463.2001.00549.x; Lindstrom A, 2003, CONDOR, V105, P420, DOI 10.1650/7222; MAHONEY SA, 1985, CONDOR, V87, P389, DOI 10.2307/1367221; MAHONEY SA, 1985, CONDOR, V87, P520, DOI 10.2307/1367950; Martins YS, 2014, GEN COMP ENDOCR, V202, P50, DOI 10.1016/j.ygcen.2014.03.047; Masero JA, 2002, BIRD STUDY, V49, P304, DOI 10.1080/00063650209461280; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; Nakkrasae LI, 2016, AQUAC RES, V47, P3109, DOI 10.1111/are.12761; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Peaker M, 1975, SALT GALNDS BIRDS RE; Pierce RJ, 1996, HDB BIRD WORLD, P332; Reed JM, 1999, WILSON BULL, V111, P478; Rocha AD, 2016, J AVIAN BIOL, V47, P824, DOI 10.1111/jav.00883; Ronning B, 2007, J EVOLUTION BIOL, V20, P1815, DOI 10.1111/j.1420-9101.2007.01384.x; Rubega M.A., 1996, INT WADER STUDIES, V9, P45; Rubega MA, 2004, J AVIAN BIOL, V35, P13, DOI 10.1111/j.0908-8857.2004.03126.x; Rubega MA, 1997, IBIS, V139, P488, DOI 10.1111/j.1474-919X.1997.tb04663.x; Sabat P, 2000, REV CHIL HIST NAT, V73, P401; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; STAALAND H, 1967, COMP BIOCHEM PHYSIOL, V23, P933, DOI 10.1016/0010-406X(67)90354-4; Verkuil Y, 2003, ARDEA, V91, P71	34	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165364	10.1371/journal.pone.0165364	http://dx.doi.org/10.1371/journal.pone.0165364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788200	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900067
J	Sartarelli, M				Sartarelli, Marcello			Handedness, Earnings, Ability and Personality. Evidence from the Lab	PLOS ONE			English	Article							MANUAL SORTING TASK; CORPUS-CALLOSUM; BEHAVIORAL-INHIBITION; HAND PREFERENCE; BRAIN STRUCTURE; SEX; PERFORMANCE; MORPHOLOGY; ASYMMETRY; MEN	Evidence showing that on average left-handed (L), who are 10% in a population, tend to earn less than others is solely based on survey data. This paper is the first to test the relationship between handedness and earnings experimentally and also to assess whether the mechanism underlying it is predominantly cognitive or psychological. Data on 432 undergraduate students show that L do not obtain significantly different payoffs, a proxy for earnings, in a stylised labour market with multiple principals and agents. Similarly, scores in the Cognitive Reflection Test are not significantly different. Data on personality, measured using the Big Five test, show, instead, that L are significantly more agreeable and L females more extroverted. In addition, earnings significantly vary with personality only for L, increasing with extraversion and decreasing with neuroticism. Overall, our results fail to reject the null hypothesis that earnings do not differ by handedness and suggest differences in personality as a novel mechanism to rationalise L's behaviour.	[Sartarelli, Marcello] Univ Alicante, Dept Fundamentos Anal Econ, Alicante, Spain	Universitat d'Alacant	Sartarelli, M (corresponding author), Univ Alicante, Dept Fundamentos Anal Econ, Alicante, Spain.	marcello.sartarelli@ua.es		Sartarelli, Marcello/0000-0002-9733-0916	Spanish Ministerio de Economiia y Competitividad [ECO2015-65820-P, ECO2013-43119]; Universidad de Alicante [GRE 13-04]	Spanish Ministerio de Economiia y Competitividad; Universidad de Alicante	This work was supported by Spanish Ministerio de Economiia y Competitividad (ECO2015-65820-P and ECO2013-43119) and Universidad de Alicante (GRE 13-04).	Annett M, 2009, BRIT J PSYCHOL, V100, P491, DOI 10.1348/000712608X357867; Armour JAL, 2014, HEREDITY, V112, P221, DOI 10.1038/hdy.2013.93; Branas-Garza P, 2015, 68049 U LIB MUN, P68049; Brandler WM, 2014, TRENDS MOL MED, V20, P83, DOI 10.1016/j.molmed.2013.10.008; Brandler WM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003751; Brookshire G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036036; Cabrales A, 2010, AM ECON REV, V100, P2261, DOI 10.1257/aer.100.5.2261; Casasanto D, 2012, COGNITIVE SCI, V36, P359, DOI 10.1111/j.1551-6709.2011.01199.x; COREN S, 1995, AM J PSYCHOL, V108, P311, DOI 10.2307/1422892; Cueva C, 2016, J BEHAV EXP ECON, V64, P81, DOI 10.1016/j.socec.2015.09.002; Denny K, 2007, J HUM RESOUR, V42, P353; DRIESEN NR, 1995, PSYCHOBIOLOGY, V23, P240; Faurie C, 2006, LATERALITY, V11, P57, DOI 10.1080/13576500500294620; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Frosch C, 2015, P 4 EUR C COGN SCI 1, P633; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Goodman J, 2014, J ECON PERSPECT, V28, P193, DOI 10.1257/jep.28.4.193; Greiner B., 2004, ONLINE RECRUITMENT S, P10; HABIB M, 1991, BRAIN COGNITION, V16, P41, DOI 10.1016/0278-2626(91)90084-L; Hardie SM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00134; HARDYCK C, 1977, PSYCHOL BULL, V84, P385, DOI 10.1037/0033-2909.84.3.385; HARDYCK C, 1976, CORTEX, V12, P266, DOI 10.1016/S0010-9452(76)80008-1; Hepper PG, 2005, NEUROPSYCHOLOGIA, V43, P313, DOI 10.1016/j.neuropsychologia.2004.08.009; HINES M, 1992, BEHAV NEUROSCI, V106, P3, DOI 10.1037/0735-7044.106.1.3; John O, 1991, BIG 5 INVENTORY VERS; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; Johnston DW, 2007, 2752 IZA, P2752; Johnston DW, 2010, 4774 IZA, P4774; MCMANUS C, 2002, RIGHT HAND LEFT HAND; McManus IC, 2013, ANN NY ACAD SCI, V1288, P48, DOI 10.1111/nyas.12102; McManus IC, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P37, DOI 10.1017/CBO9780511576744.004; MCMANUS IC, 1991, PSYCHOL BULL, V110, P237, DOI 10.1037/0033-2909.110.2.237; MCMANUS IC, 1983, J BIOSOC SCI, V15, P289, DOI 10.1017/S0021932000014632; Medland SE, 2009, NEUROPSYCHOLOGIA, V47, P330, DOI 10.1016/j.neuropsychologia.2008.09.005; Perelle IB, 2005, BEHAV GENET, V35, P343, DOI 10.1007/s10519-005-3226-z; PERELLE IB, 1983, BEHAV SCI, V28, P284, DOI 10.1002/bs.3830280405; Porac C, 1981, LATERAL PREFERENCES; Prichard E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00009; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Ruebeck CS, 2007, LATERALITY, V12, P101, DOI 10.1080/13576500600992297; Sartarelli M., 2016, LVIE WORKING PAPER S; Vuoksimaa E, 2009, NEUROPSYCHOLOGIA, V47, P1294, DOI 10.1016/j.neuropsychologia.2009.01.007; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; WITELSON SF, 1991, BRAIN RES, V545, P175, DOI 10.1016/0006-8993(91)91284-8; WITELSON SF, 1991, NEUROPSYCHOLOGIA, V29, P327, DOI 10.1016/0028-3932(91)90046-B; Wright L, 2004, LATERALITY, V9, P133, DOI 10.1080/13576500244000265; Wright L, 2015, FRONT PSYCHOL, V58, P6; Wright L, 2013, PERS INDIV DIFFER, V54, P903, DOI 10.1016/j.paid.2013.01.005; Wright L, 2012, LATERALITY, V17, P629, DOI 10.1080/1357650X.2011.615126; Wright L, 2011, LATERALITY, V16, P753, DOI 10.1080/1357650X.2010.521752; Wright L, 2009, PERS INDIV DIFFER, V46, P20, DOI 10.1016/j.paid.2008.08.019	53	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164412	10.1371/journal.pone.0164412	http://dx.doi.org/10.1371/journal.pone.0164412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VY	27788156	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900019
J	Smeyne, RJ; Breckenridge, CB; Beck, M; Jiao, Y; Butt, MT; Wolf, JC; Zadory, D; Minnema, DJ; Sturgess, NC; Travis, KZ; Cook, AR; Smith, LL; Botham, PA				Smeyne, Richard Jay; Breckenridge, Charles B.; Beck, Melissa; Jiao, Yun; Butt, Mark T.; Wolf, Jeffrey C.; Zadory, Dan; Minnema, Daniel J.; Sturgess, Nicholas C.; Travis, Kim Z.; Cook, Andrew R.; Smith, Lewis L.; Botham, Philip A.			Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; PARKINSONS-DISEASE; LIPID-PEROXIDATION; HERBICIDE PARAQUAT; TOXICITY; ACTIVATION; DEGENERATION; EXPRESSION; MECHANISM; NEUROTOXICITY	The neurotoxicity of paraquat dichloride (PQ) was assessed in two inbred strains of 9- or 16-week old male C57BL/6 mice housed in two different laboratories and compared to the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). PQ was administered by intraperitoneal injections; either once (20 mg/kg) or twice (10 mg/kg) weekly for 3 weeks, while MPTP-HCl was injected 4 times on a single day (20 mg/kg/dose). Brains were collected 8, 16, 24, 48, 96 or 168 hours after the last PQ treatment, and 48 or 168 hours after MPTP treatment. Dopamine neurons in the substantia nigra pars compacta (SNpc) were identified by antibodies to tyrosine hydroxylase (TH+) and microglia were identified using Iba-1 immunoreactivity. The total number of TH+ neurons and the number of resting and activated microglia in the SNpc at 168 hours after the last dose were estimated using model-or design-based stereology, with investigators blinded to treatment. In a further analysis, a pathologist, also blinded to treatment, evaluated the SNpc and/or striatum for loss of TH+ neurons (SNpc) or terminals (striatum), cell death (as indicated by amino cupric silver uptake, TUNEL and/or caspase 3 staining) and neuroinflammation (as indicated by Iba-1 and/or GFAP staining). PQ, administered either once or twice weekly to 9- or 16-week old mice from two suppliers, had no effect on the number of TH+ neurons or microglia in the SNpc, as assessed by two groups, each blinded to treatment, using different stereological methods. PQ did not induce neuronal cell loss or degeneration in the SNpc or striatum. Additionally, there was no evidence of apoptosis, microgliosis or astrogliosis. In MPTP-treated mice, the number of TH+ neurons in the SNpc was significantly decreased and the number of activated microglia increased. Histopathological assessment found degenerating neurons/terminals in the SNpc and striatum but no evidence of apoptotic cell death. MPTP activated microglia in the SNpc and increased the number of astrocytes in the SNpc and striatum.	[Smeyne, Richard Jay; Jiao, Yun] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Breckenridge, Charles B.; Minnema, Daniel J.] Syngenta Crop Protect LLC, POB 18300, Greensboro, NC 27419 USA; [Beck, Melissa] WIL Res Labs LLC, Ashland, OH 44805 USA; [Butt, Mark T.] Tox Path Specialists LLC, 8747 Chestnut Grove Rd, Frederick, MD 21701 USA; [Wolf, Jeffrey C.; Zadory, Dan] Expt Pathol Labs Inc, 45600 Terminal Dr, Sterling, VA 20166 USA; [Sturgess, Nicholas C.; Travis, Kim Z.; Cook, Andrew R.; Botham, Philip A.] Syngenta Ltd, Jealotts Hill Int Res Ctr, Bracknell RG42 6EY, Berks, England; [Smith, Lewis L.] Univ Leicester, Univ Rd, Leicester LE1 7RH, Leics, England; [Smeyne, Richard Jay] Thomas Jefferson Univ, Dept Neurosci, BLSB 208,233 South 10th St, Philadelphia, PA 19107 USA; [Beck, Melissa] Cedarville Univ, Cedarville, OH 45314 USA	St Jude Children's Research Hospital; Syngenta; Syngenta; University of Leicester; Jefferson University; Cedarville University	Smeyne, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.; Smeyne, RJ (corresponding author), Thomas Jefferson Univ, Dept Neurosci, BLSB 208,233 South 10th St, Philadelphia, PA 19107 USA.	richard.smeyne@jefferson.edu	Beck, Melissa/GQA-6895-2022	Smeyne, Richard/0000-0002-8459-5472	Syngenta Crop Protection LLC; ALSAC	Syngenta Crop Protection LLC(Syngenta); ALSAC(American Lebanese Syrian Associated Charities (ALSAC))	This work was funded by Syngenta Crop Protection LLC (CBB, MTB, MB, JCW, DZ, DJM, NCS, KZT, ARC, LLS and PAB) and ALSAC (RJS and YJ). The funder provided support in the form of salaries for authors CBB and DJM. Syngenta Limited provided support in the form of salaries for authors NCS, KZT, ARC and PAB. Support for authors in the form of salaries was provided by WIL Research Laboratories LLC (MB), Tox Path Specialists LLC (MTB) and Experimental Pathology Laboratories Inc (JCW & DZ). LLS received support in the form of consultancy fees provided by Syngenta Limited. RJS and YJ conducted studies and evaluations at SJCRH under contract to Syngenta Crop Protection LLC. The specific roles of these authors are articulated in the 'author contributions' section.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Bonneh-Barkay D, 2005, MOL BRAIN RES, V134, P52, DOI 10.1016/j.molbrainres.2004.11.005; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Breckenridge CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151841; Breckenridge CB, 2013, NEUROTOXICOLOGY, V37, P1, DOI 10.1016/j.neuro.2013.03.005; Brooks AI, 1999, BRAIN RES, V823, P1, DOI 10.1016/S0006-8993(98)01192-5; BUS JS, 1976, ENVIRON HEALTH PERSP, V16, P139, DOI 10.2307/3428594; Chen L, 2012, NEUROBIOL AGING, V33, DOI DOI 10.1016/J.NEUR0BI0LAGING.2011.01.008; Chen Y, 2007, J PHARMACOL EXP THER, V322, P695, DOI 10.1124/jpet.107.123554; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Corasaniti M T, 1991, Funct Neurol, V6, P385; Drozdzik M, 2003, PHARMACOGENETICS, V13, P259, DOI 10.1097/01.fpc.0000054087.48725.dg; Fernagut PO, 2007, SYNAPSE, V61, P991, DOI 10.1002/syn.20456; Firestone JA, 2010, AM J IND MED, V53, P217, DOI 10.1002/ajim.20788; Foster AJ, 2004, TOXICOLOGY, V202, P131; FUKUSHIMA T, 1994, EXP TOXICOL PATHOL, V46, P437, DOI 10.1016/S0940-2993(11)80056-4; Gao HM, 2011, PROG NEUROBIOL, V94, P1, DOI 10.1016/j.pneurobio.2011.03.005; GARRETT WT, 1991, NEUROSCI LETT, V128, P137, DOI 10.1016/0304-3940(91)90778-R; Gatto NM, 2009, ENVIRON HEALTH PERSP, V117, P1912, DOI 10.1289/ehp.0900852; Goldman SM, 2014, ANNU REV PHARMACOL, V54, P141, DOI 10.1146/annurev-pharmtox-011613-135937; Goldman SM, 2005, NEUROLOGY, V65, P1430, DOI 10.1212/01.wnl.0000180361.74060.70; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; He Z, 2009, CURR NEUROVASC RES, V6, P54, DOI 10.2174/156720209787466055; Jackson-Lewis V, 2015, MOVEMENT DISORDERS: GENETICS AND MODELS, 2ND EDITION, P287, DOI 10.1016/B978-0-12-405195-9.00017-2; Jiao Y, 2015, J PARKINSON DIS, V5, P389, DOI 10.3233/JPD-140424; Jiao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029447; Jones BC, 2014, J BIOCHEM MOL TOXIC, V28, P191, DOI 10.1002/jbt.21552; Jones BC, 2013, NEUROTOXICOLOGY, V38, P23, DOI 10.1016/j.neuro.2013.05.010; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Kamel F, 2014, PARKINSONISM RELAT D, V20, P82, DOI 10.1016/j.parkreldis.2013.09.023; KOLLER W, 1990, NEUROLOGY, V40, P1218, DOI 10.1212/WNL.40.8.1218; Lin MK, 2014, GENOME MED, V6, DOI 10.1186/gm566; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Mandel JS, 2012, REGUL TOXICOL PHARM, V62, P385, DOI 10.1016/j.yrtph.2011.10.004; Mangano EN, 2012, NEUROBIOL AGING, V33, P1411, DOI 10.1016/j.neurobiolaging.2011.02.016; McCormack AL, 2003, J NEUROCHEM, V85, P82, DOI 10.1046/j.1471-4159.2003.01621.x; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Miller GW, 2007, TOXICOL SCI, V100, P1, DOI 10.1093/toxsci/kfm223; Minnema DJ, 2014, REGUL TOXICOL PHARM, V68, P250, DOI 10.1016/j.yrtph.2013.12.010; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peng J, 2004, J BIOL CHEM, V279, P32626, DOI 10.1074/jbc.M404596200; PETER B, 1992, BIOCHEM PHARMACOL, V43, P705, DOI 10.1016/0006-2952(92)90234-A; Purisai MG, 2007, NEUROBIOL DIS, V25, P392, DOI 10.1016/j.nbd.2006.10.008; Ramachandiran S, 2007, TOXICOL SCI, V95, P163, DOI 10.1093/toxsci/kfl125; Rappold PM, 2011, P NATL ACAD SCI USA, V108, P20766, DOI 10.1073/pnas.1115141108; Richardson JR, 2005, TOXICOL SCI, V88, P193, DOI 10.1093/toxsci/kfi304; Ritz BR, 2009, ENVIRON HEALTH PERSP, V117, P964, DOI 10.1289/ehp.0800277; Sadasivan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124047; Shimizu K, 2001, BRAIN RES, V906, P135, DOI 10.1016/S0006-8993(01)02577-X; Singh M, 2008, MOL CELL BIOCHEM, V312, P131, DOI 10.1007/s11010-008-9728-2; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; Smeyne M, 2007, P NATL ACAD SCI USA, V104, P1977, DOI 10.1073/pnas.0610978104; SMITH LL, 1985, PHILOS T R SOC B, V311, P647, DOI 10.1098/rstb.1985.0170; Snedecor GW, 1980, STAT METHODS, V7th; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Watson MB, 2013, NEUROSCIENCE, V240, P277, DOI 10.1016/j.neuroscience.2013.03.002; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wen LL, 2007, EXP NEUROL, V205, P270, DOI 10.1016/j.expneurol.2007.02.011; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Woolley D E, 1989, Proc West Pharmacol Soc, V32, P191; Xie R, 2011, J HISTOCHEM CYTOCHEM, V59, P356, DOI 10.1369/0022155411398488; YAMADA K, 1993, EXP TOXICOL PATHOL, V45, P375, DOI 10.1016/S0940-2993(11)80433-1	65	52	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164094	10.1371/journal.pone.0164094	http://dx.doi.org/10.1371/journal.pone.0164094			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788145	gold, Green Published, Green Submitted			2022-12-26	WOS:000389604900012
J	Langsrud, S; Steinhauer, K; Luthje, S; Weber, K; Goroncy-Bermes, P; Holck, AL				Langsrud, Solveig; Steinhauer, Katrin; Luthje, Sonja; Weber, Klaus; Goroncy-Bermes, Peter; Holck, Askild L.			Ethylhexylglycerin Impairs Membrane Integrity and Enhances the Lethal Effect of Phenoxyethanol	PLOS ONE			English	Article							COLI NCTC 5933; DEHYDROGENASE ENZYME-SYSTEMS; ESCHERICHIA-COLI; COSMETIC PRESERVATIVES; BURKHOLDERIA-CEPACIA; 2-PHENOXYETHANOL; RESPIRATION; INHIBITION; OUTBREAK	Preservatives are added to cosmetics to protect the consumers from infections and prevent product spoilage. The concentration of preservatives should be kept as low as possible and this can be achieved by adding potentiating agents. The aim of the study was to investigate the mechanisms behind potentiation of the bactericidal effect of a commonly used preservative, 2-phenoxyethanol (PE), by the potentiating agent ethylhexylglycerin (EHG). Sub-lethal concentrations of EHG (0.075%) and PE (0.675%) in combination led to rapid killing of E. coli (> 5 log reduction of cfu after 30 min), leakage of cellular constituents, disruption of the energy metabolism, morphological deformities of cells and condensation of DNA. Used alone, EHG disrupted the membrane integrity even at low concentrations. In conclusion, sub-lethal concentrations of EHG potentiate the effect of PE through damage of the cell membrane integrity. Thus, adding EHG to PE in a 1: 9 ratio has a similar effect on membrane damage and bacterial viability as doubling the concentration of PE. This study provides insight about the mechanism of action of a strong potentiating agent, EHG, which is commonly used in cosmetics together with PE.	[Langsrud, Solveig; Holck, Askild L.] Nofima Norwegian Inst Food Fisheries & Aquacultur, Osloveien 1, N-1430 As, Norway; [Steinhauer, Katrin; Luthje, Sonja; Weber, Klaus; Goroncy-Bermes, Peter] Schulke & Mayr GmbH, Res & Dev, Robert Koch Str 2, D-22851 Norderstedt, Germany	Nofima	Langsrud, S (corresponding author), Nofima Norwegian Inst Food Fisheries & Aquacultur, Osloveien 1, N-1430 As, Norway.	solveig.langsrud@nofima.no	Langsrud, Solveig/I-1241-2012	Langsrud, Solveig/0000-0001-6415-017X; Steinhauer, Katrin/0000-0002-4218-6152	Schulke & Mayr GmbH, Norderstedt, Germany; Foundation for Research Levy on Agricultural Products (FRLAP) [224921/F40]	Schulke & Mayr GmbH, Norderstedt, Germany; Foundation for Research Levy on Agricultural Products (FRLAP)	This study was funded by Schulke & Mayr GmbH, Norderstedt, Germany and Foundation for Research Levy on Agricultural Products (FRLAP, Grant no. 224921/F40). FRLAP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Schulke & Mayr, through the co-authors participated in planning, interpretation of results and the decision to publish.	Alvarez-Lerma F, 2008, CRIT CARE, V12, DOI 10.1186/cc6778; Beilfuss W, 2005, SOFW-J, V11, P2; Denyer SP, 1995, INT BIODETER BIODEGR, V36, P227, DOI 10.1016/0964-8305(96)00015-7; FITZGERALD KA, 1992, MICROBIOS, V70, P215; GILBERT P, 1976, J PHARM PHARMACOL, V28, pP51; GILBERT P, 1977, MICROBIOS, V19, P17; GILBERT P, 1977, MICROBIOS, V20, P29; GILBERT P, 1977, MICROBIOS, V19, P125; GILBERT P, 1980, MICROBIOS, V28, P7; Harries C, 2016, CONTACT DERMATITIS, V74, P181, DOI 10.1111/cod.12471; Hiom SJ, 2004, DISINFECTION PRESERV; HUGO WB, 1956, J GEN MICROBIOL, V15, P315, DOI 10.1099/00221287-15-2-315; HUGO WB, 1952, J GEN MICROBIOL, V6, P90, DOI 10.1099/00221287-6-1-2-90; Kalchayanand N, 2004, INT J FOOD MICROBIOL, V91, P91, DOI 10.1016/S0168-1605(03)00324-6; Krowka J., 2014, COSM TOIL, V129, P24; Lee E, 2007, CONTACT DERMATITIS, V56, P131, DOI 10.1111/j.1600-0536.2007.01001.x; Lundov MD, 2011, INT J COSMETIC SCI, V33, P190, DOI 10.1111/j.1468-2494.2010.00619.x; Lundov MD, 2013, CONTACT DERMATITIS, V69, P271, DOI 10.1111/cod.12149; Maillard JY, 2002, J APPL MICROBIOL, V92, p16S, DOI 10.1046/j.1365-2672.92.5s1.3.x; Martin M, 2012, ANAESTHESIST, V61, P25, DOI 10.1007/s00101-011-1954-4; ROBINOW C, 1994, MICROBIOL REV, V58, P211, DOI 10.1128/MMBR.58.2.211-232.1994; Scognamiglio J, 2012, FOOD CHEM TOXICOL, V50, pS244, DOI 10.1016/j.fct.2011.10.030; Steinberg D.C., 2010, COSMET TOILETRIES, V125, P46; STEINBERG DC, 2008, COSMET TOILETRIES, V123, P47; Yazar K, 2011, CONTACT DERMATITIS, V64, P265, DOI 10.1111/j.1600-0536.2010.01828.x; ZUSMAN DR, 1973, J BACTERIOL, V115, P1167, DOI 10.1128/JB.115.3.1167-1178.1973	26	13	13	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165228	10.1371/journal.pone.0165228	http://dx.doi.org/10.1371/journal.pone.0165228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783695	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800064
J	Gottardi, R; Hansen, U; Raiteri, R; Loparic, M; Duggelin, M; Mathys, D; Friederich, NF; Bruckner, P; Stolz, M				Gottardi, Riccardo; Hansen, Uwe; Raiteri, Roberto; Loparic, Marko; Duggelin, Marcel; Mathys, Daniel; Friederich, Niklaus F.; Bruckner, Peter; Stolz, Martin			Supramolecular Organization of Collagen Fibrils in Healthy and Osteoarthritic Human Knee and Hip Joint Cartilage	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; HUMAN ARTICULAR-CARTILAGE; MODEL; PROTEOGLYCANS; DECORIN; SYSTEMS; MATRIX; AGE; IX; XI	Cartilage matrix is a composite of discrete, but interacting suprastructures, i.e. cartilage fibers with microfibrillar or network-like aggregates and penetrating extrafibrillar proteoglycan matrix. The biomechanical function of the proteoglycan matrix and the collagen fibers are to absorb compressive and tensional loads, respectively. Here, we are focusing on the suprastructural organization of collagen fibrils and the degradation process of their hierarchical organized fiber architecture studied at high resolution at the authentic location within cartilage. We present electron micrographs of the collagenous cores of such fibers obtained by an improved protocol for scanning electron microscopy (SEM). Articular cartilages are permeated by small prototypic fibrils with a homogeneous diameter of 18 +/- 5 nm that can align in their D-periodic pattern and merge into larger fibers by lateral association. Interestingly, these fibers have tissue-specific organizations in cartilage. They are twisted ropes in superficial regions of knee joints or assemble into parallel aligned cable-like structures in deeper regions of knee joint-or throughout hip joints articular cartilage. These novel observations contribute to an improved understanding of collagen fiber biogenesis, function, and homeostasis in hyaline cartilage.	[Gottardi, Riccardo; Raiteri, Roberto] Univ Genoa, Dept Biophys & Elect Engn, Genoa, Italy; [Hansen, Uwe] Univ Hosp Munster, Inst Expt Musculoskeletal Med, Munster, Germany; [Loparic, Marko; Stolz, Martin] Univ Basel, Biozentrum, Basel, Switzerland; [Duggelin, Marcel; Mathys, Daniel] Univ Basel, Ctr Microscopy, Basel, Switzerland; [Friederich, Niklaus F.] Kantonsspital Bruderholz Basel, Dept Orthopaed Surg & Traumatol, Basel, Switzerland; [Stolz, Martin] Univ Southampton, nCATS, Engn & Environm, Southampton, Hants, England; [Hansen, Uwe; Bruckner, Peter] Univ Munster, Inst Physiol Chem & Pathochem, Munster, Germany; [Gottardi, Riccardo] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Gottardi, Riccardo] Ri MED Fdn, Palermo, Italy	University of Genoa; University of Munster; University of Basel; University of Basel; University of Southampton; University of Munster; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Stolz, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.; Stolz, M (corresponding author), Univ Southampton, nCATS, Engn & Environm, Southampton, Hants, England.	M.Stolz@soton.ac.uk	Gottardi, Riccardo/AAA-5047-2019; Bruckner, Peter/F-4817-2019; Raiteri, Roberto/J-2899-2012	Gottardi, Riccardo/0000-0001-8040-5531; Bruckner, Peter/0000-0002-5566-5611; Stolz, Martin/0000-0002-0732-0811; Raiteri, Roberto/0000-0002-1907-7855	Ri.MED Foundation	Ri.MED Foundation	We are grateful to Dr. Ueli Aebi for using his laboratory at the Biozentrum, University of Basel, for some of the experiments, and the Ri.MED Foundation for support to RG.	Alexander PG, 2014, EXP BIOL MED, V239, P1080, DOI 10.1177/1535370214539232; Antipova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032241; ASPDEN RM, 1981, PROC R SOC SER B-BIO, V212, P299, DOI 10.1098/rspb.1981.0040; Banfield SJ, 1995, CHALLENGES OUR CHANG, V3, DOI [10.1038/375806a0, DOI 10.1038/375806A0]; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; BUCKWALTER JA, 1985, J ORTHOP RES, V3, P251, DOI 10.1002/jor.1100030301; Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465; COOK J, 1964, PROC R SOC LON SER-A, V282, P508, DOI 10.1098/rspa.1964.0248; Creazza G, 1991, SERIES CISM INT CTR, V316, DOI [10.1038/375806a0, DOI 10.1038/375806A0]; Gottardi R, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/37/372501; Hagg R, 1998, J CELL BIOL, V142, P285, DOI 10.1083/jcb.142.1.285; Holmes DF, 2006, P NATL ACAD SCI USA, V103, P17249, DOI 10.1073/pnas.0608417103; Hunziker EB, 1997, MICROSC RES TECHNIQ, V37, P271; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Lin H, 2014, MOL PHARMACEUT, V11, P2203, DOI 10.1021/mp500136b; Lozito TP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt367; Mankin HJ, 1994, ORTHOPAEDIC BASIC SC; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Orgel JPRO, 2011, CONNECT TISSUE RES, V52, P2, DOI 10.3109/03008207.2010.511353; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; OUTERBRIDGE RE, 1975, CLIN ORTHOP RELAT R, P177; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; PETRUSKA JA, 1964, P NATL ACAD SCI USA, V51, P871, DOI 10.1073/pnas.51.5.871; Poole A. Robin, 1999, Frontiers in Bioscience, V4, pd662, DOI 10.2741/Poole; Poole AR, 1996, J ORTHOPAED RES, V14, P681, DOI 10.1002/jor.1100140502; SEGAWA K, 1992, ANAT RECORD, V234, P493, DOI 10.1002/ar.1092340405; Stolz M, 1999, MOL BIOL CELL, V10, p145A; Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; Taffetani M, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4030175	32	34	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0163552	10.1371/journal.pone.0163552	http://dx.doi.org/10.1371/journal.pone.0163552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780246	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000389046900005
J	Aghili, Z; Taheri, S; Zeinabad, HA; Pishkar, L; Saboury, AA; Rahimi, A; Falahati, M				Aghili, Zahra; Taheri, Saba; Zeinabad, Hojjat Alizadeh; Pishkar, Leila; Saboury, Ali Akbar; Rahimi, Arash; Falahati, Mojtaba			Investigating the Interaction of Fe Nanoparticles with Lysozyme by Biophysical and Molecular Docking Studies	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; BOVINE SERUM-ALBUMIN; QUANTUM DOTS; CYTOTOXICITY; FLUORESCENCE; HEMOGLOBIN; COMPLEXES; BINDING	Herein, the interaction of hen egg white lysozyme (HEWL) with iron nanoparticle (Fe NP) was investigated by spectroscopic and docking studies. The zeta potential analysis revealed that addition of Fe NP (6.45 +/- 1.03 mV) to HEWL (8.57 +/- 0.54 mV) can cause to greater charge distribution of nanoparticle-protein system (17.33 +/- 1.84 mV). In addition, dynamic light scattering (DLS) study revealed that addition of Fe NP (92.95 +/- 6.11 nm) to HEWL (2.68 +/- 0.37 nm) increases suspension potential of protein/nanoparticle system (51.17 +/- 3.19 nm). Fluorescence quenching studies reveled that both static and dynamic quenching mechanism occur and hydrogen bond and van der Waals interaction give rise to protein-NP system. Synchronous fluorescence spectroscopy of HEWL in the presence of Fe NP showed that the emission maximum wavelength of tryptophan (Trp) residues undergoes a red-shift. ANS fluorescence data indicated a dramatic exposure of hydrophobic residues to the solvent. The considerable reduction in melting temperature (T(m)) of HEWL after addition of Fe NP determines an unfavorable interaction system. Furthermore circular dichoroism (CD) experiments demonstrated that, the secondary structure of HEWL has not changed with increasing Fe NP concentrations; however, some conformational changes occur in tertiary structure of HEWL. Moreover, protein ligand docking study confirmed that the Fe NP forms hydrogen bond contacts with HEWL.	[Aghili, Zahra; Rahimi, Arash] Islamic Azad Univ, Sci & Res Branch, Dept Biol, Tehran, Iran; [Taheri, Saba] Islamic Azad Univ, Islamshahr Branch, Dept Biol, Islamshahr, Iran; [Zeinabad, Hojjat Alizadeh] Univ Tehran, Dept Elect & Comp Engn, MEMS & NEMS Lab, Tehran, Iran; [Pishkar, Leila] Islamic Azad Univ, Islamshahr Branch, Young Researchers & Elite Club, Islamshahr, Iran; [Saboury, Ali Akbar] Univ Tehran, IBB, Tehran, Iran; [Saboury, Ali Akbar] Univ Tehran, Ctr Excellence Biothermodynam, Tehran, Iran; [Falahati, Mojtaba] IAUPS, Fac Adv Sci & Technol, Dept Nanotechnol, Tehran, Iran	Islamic Azad University; Islamic Azad University; University of Tehran; Islamic Azad University; University of Tehran; University of Tehran	Falahati, M (corresponding author), IAUPS, Fac Adv Sci & Technol, Dept Nanotechnol, Tehran, Iran.	Falahati@ibb.ut.ac.ir	Saboury, Ali Akbar/L-6136-2019; Alizadeh Zeinabad, Hojjat/ABH-2284-2021; Falahati, Mojtaba/AAN-6507-2021; pishkar, leila/AAS-6824-2021	Alizadeh Zeinabad, Hojjat/0000-0003-1575-1803; Rahimi, Arash/0000-0002-4313-7352; Saboury, Ali Akbar/0000-0003-0604-9465				Ali M, 2016, BIOCHIMIE, V123, P117, DOI 10.1016/j.biochi.2016.01.012; Amjad M.S., 2015, ASIAN PAC J TROP DIS, V5, P767, DOI [10.1016/S2222-1808(15)60929-X, DOI 10.1016/S2222-1808(15)60929-X]; Bhogale A, 2014, COLLOID SURFACE B, V113, P276, DOI 10.1016/j.colsurfb.2013.09.021; Bose A, 2016, J LUMIN, V169, P220, DOI 10.1016/j.jlumin.2015.09.018; Dadras A, 2013, J BIOL INORG CHEM, V18, P357, DOI 10.1007/s00775-013-0980-x; Di Bona KR, 2014, REPROD TOXICOL, V50, P36, DOI 10.1016/j.reprotox.2014.09.010; Esfandfar P., 2015, J BIOMOLECU IN PRESS, P1; Ghalandari B, 2015, APPL BIOCHEM BIOTECH, V175, P974, DOI 10.1007/s12010-014-1341-0; Ghalandari B, 2014, J PHOTOCH PHOTOBIO B, V140, P255, DOI 10.1016/j.jphotobiol.2014.08.003; Hola K, 2015, BIOTECHNOL ADV, V33, P1162, DOI 10.1016/j.biotechadv.2015.02.003; Huang S, 2015, J HAZARD MATER, V285, P18, DOI 10.1016/j.jhazmat.2014.11.019; Jafari Azad V, 2016, SCI REP, V21, P29644; Karlsson HL, 2015, HANDBOOK ON THE TOXICOLOGY OF METALS, VOL I & II, 4TH EDITION, P75, DOI 10.1016/B978-0-444-59453-2.00004-4; Kong DY, 2015, SPECTROCHIM ACTA A, V140, P372, DOI 10.1016/j.saa.2015.01.004; Maltas E, 2015, MAT SCI ENG C-MATER, V54, P43, DOI 10.1016/j.msec.2015.05.007; Nasrabadi HT, 2016, ARTIF CELL NANOMED B, V44, P376, DOI 10.3109/21691401.2014.953632; Nowacka O, 2015, J LUMIN, V162, P87, DOI 10.1016/j.jlumin.2015.02.014; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Peng W, 2016, J PHOTOCH PHOTOBIO B, V154, P40, DOI 10.1016/j.jphotobiol.2015.11.010; Pishkar L, 2017, J BIOMOL STRUCT DYN, V35, P603, DOI 10.1080/07391102.2016.1155172; Ponnuvel S, 2015, PROTEIN J, V34, P329, DOI 10.1007/s10930-015-9627-9; Rabbani G, 2014, COLLOID SURFACE B, V123, P96, DOI 10.1016/j.colsurfb.2014.08.035; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Saeidifar M, 2015, J LUMIN, V167, P391, DOI 10.1016/j.jlumin.2015.07.016; Santos MC, 2016, APPL SURF SCI, V367, P26, DOI 10.1016/j.apsusc.2016.01.039; Schrofel A, 2014, ACTA BIOMATER, V10, P4023, DOI 10.1016/j.actbio.2014.05.022; Segall MD, 2002, J PHYS-CONDENS MAT, V14, P2717, DOI 10.1088/0953-8984/14/11/301; Silva AH, 2016, NANOMED-NANOTECHNOL, V12, P909, DOI 10.1016/j.nano.2015.12.371; Sun HY, 2014, SPECTROCHIM ACTA A, V132, P692, DOI 10.1016/j.saa.2014.04.157; Tombacz E, 2015, BIOCHEM BIOPH RES CO, V468, P442, DOI 10.1016/j.bbrc.2015.08.030; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Wang YQ, 2014, J PHOTOCH PHOTOBIO B, V141, P26, DOI 10.1016/j.jphotobiol.2014.08.020; Xue JJ, 2014, SPECTROCHIM ACTA A, V120, P161, DOI 10.1016/j.saa.2013.10.005; Zeinabad HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29644; Zhang HM, 2015, SPECTROCHIM ACTA A, V151, P40, DOI 10.1016/j.saa.2015.06.087; Zolghadri S, 2010, J IRAN CHEM SOC, V7, pS145, DOI 10.1007/BF03246193; Zolghadri S, 2015, TOXICOL IND HEALTH, V31, P721, DOI 10.1177/0748233713483193	37	56	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164878	10.1371/journal.pone.0164878	http://dx.doi.org/10.1371/journal.pone.0164878			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776180	Green Published, gold, Green Submitted			2022-12-26	WOS:000389009200025
J	Miao, F; Shi, Y; Fan, ZF; Jiang, S; Xu, SZ; Lei, TC				Miao, Fang; Shi, Ying; Fan, Zhi-Feng; Jiang, Shan; Xu, Shi-Zhang; Lei, Tie-Chi			Deoxyarbutin Possesses a Potent Skin-Lightening Capacity with No Discernible Cytotoxicity against Melanosomes	PLoS One			English	Article							HYDROQUINONE; SAFETY; TYROSINASE; MECHANISM; EFFICACY; MELASMA	Safe and effective ingredients capable of removing undesired hyperpigmentation from facial skin are urgently needed for both pharmaceutical and cosmetic purposes. Deoxyarbutin (4-[(tetrahydro-2H-pyran-2-yl) oxy] phenol, D-Arb) is a glucoside derivative of hydroquinone. Here, we investigated the toxicity and efficacy of D-Arb at the sub-cellular level (directly on melanosomes) and skin pigmentation using in vivo and in vitro models to compare with its parent compound hydroquinone (1,4-benzenediol, HQ). At first, we examined the ultrastructural changes of melanosomes in hyperpigmented guinea pig skin induced by 308-nm monochromatic excimer light and/or treated with HQ and D-Arb using transmission electron microscopy. The results showed that prominent changes in the melanosomal membrane, such as bulb-like structure and even complete rupture of the outer membranes, were found in the skin after topical application of 5% HQ for 10 days. These changes were barely observed in the skin treated with D-Arb. To further clarify whether membrane toxicity of HQ was a direct result of the compound treatment, we also examinedultrastructural changes of individual melanosomes purified from MNT1 human melanoma cells. Similar observations were obtained from the naked melanosome model in vitro. Finally, we determined the effects of melanosomal fractions exposed to HQ or D-Arb on hydroxyl radical generation in the Fenton reaction utilizing an electron spin resonance assay. D-Arb-treated melanosomesexhibit a moderate hydroxyl radical-scavenging activity, whereas HQ-treated melanosomessignificantly generate more hydroxyl free radicals. This study suggests that D-Arb possesses a potent ability in skin lightening and antioxidation with less melanosome cytotoxicity.	[Miao, Fang; Shi, Ying; Fan, Zhi-Feng; Jiang, Shan; Xu, Shi-Zhang; Lei, Tie-Chi] Wuhan Univ, Dept Dermatol, Renmin Hosp, Wuhan, Peoples R China	Wuhan University	Lei, TC (corresponding author), Wuhan Univ, Dept Dermatol, Renmin Hosp, Wuhan, Peoples R China.	tchlei@whu.eduen	LEI, TIE-CHI/AAE-4276-2020	Lei, Tie-Chi/0000-0003-2304-827X	National Natural Science Foundation of China (NSFC Grant) [81371717, 81573028]	National Natural Science Foundation of China (NSFC Grant)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC Grants 81371717 and 81573028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2007, J INVEST DERMATOL, V127, P751, DOI 10.1038/sj.jid.5700683; Ando H, 2012, J INVEST DERMATOL, V132, P1222, DOI 10.1038/jid.2011.413; Ando Hideya, 2011, Cell Logist, V1, P12, DOI 10.4161/cl.1.1.13638; Boissy RE, 2005, EXP DERMATOL, V14, P601, DOI 10.1111/j.0906-6705.2005.00337.x; Byun JW, 2016, CLIN EXP DERMATOL, V41, P601, DOI 10.1111/ced.12874; Chawla S., 2012, J DRUGS DERMATOL, V11, P28; Degen GH, 2016, REGUL TOXICOL PHARM, V74, P77, DOI 10.1016/j.yrtph.2015.11.007; Desmedt B, 2016, J EUR ACAD DERMATOL, V30, P943, DOI 10.1111/jdv.13595; Dlova NC, 2015, BRIT J DERMATOL, V173, P2, DOI 10.1111/bjd.13556; Draelos ZD, 2007, DERMATOL THER, V20, P308, DOI 10.1111/j.1529-8019.2007.00144.x; Hamed SH, 2006, J COSMET SCI, V57, P291; Hariharan V, 2010, J INVEST DERMATOL, V130, P211, DOI 10.1038/jid.2009.214; Hori I, 2004, PHYTOTHER RES, V18, P475, DOI 10.1002/ptr.1456; Hu ZM, 2009, J DERMATOL SCI, V55, P179, DOI 10.1016/j.jdermsci.2009.06.003; Jiang S, 2010, FREE RADICAL BIO MED, V48, P1144, DOI 10.1016/j.freeradbiomed.2010.01.033; JIMBOW K, 1974, J INVEST DERMATOL, V62, P436, DOI 10.1111/1523-1747.ep12701679; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; Levitt J, 2007, J AM ACAD DERMATOL, V57, P854, DOI 10.1016/j.jaad.2007.02.020; Lu H, 1996, BRIT J DERMATOL, V135, P263, DOI 10.1111/j.1365-2133.1996.tb01157.x; Makin ET, 2013, J DRUGS DERMATOL, V12, pS21; Nicolaidou E, 2014, CLIN DERMATOL, V32, P66, DOI 10.1016/j.clindermatol.2013.05.026; Nordlund JJ, 2006, J EUR ACAD DERMATOL, V20, P781, DOI 10.1111/j.1468-3083.2006.01670.x; Pichardo R, 2009, INT J DERMATOL, V48, P22, DOI 10.1111/j.1365-4632.2009.03778.x; Shankar K, 2014, DERMATOLOGY THER, V4, P165, DOI 10.1007/s13555-014-0064-z; Sheth VM, 2011, J AM ACAD DERMATOL, V65, P699, DOI 10.1016/j.jaad.2011.06.001; Shi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093589; Simmons BJ, 2015, AM J CLIN DERMATOL, V16, P205, DOI 10.1007/s40257-015-0126-8; Watanabe S, 2008, ARCH DERMATOL RES, V300, pS21, DOI 10.1007/s00403-007-0801-6; Westerhof W, 2005, J Cosmet Dermatol, V4, P55, DOI 10.1111/j.1473-2165.2005.40202.x; Yamashita T, 2006, J INVEST DERMATOL, V126, P2281, DOI 10.1038/sj.jid.5700414	30	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165338	10.1371/journal.pone.0165338	http://dx.doi.org/10.1371/journal.pone.0165338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776184	Green Published, gold, Green Submitted			2022-12-26	WOS:000389009200055
J	Torres-Diaz, C; Gallardo-Cerda, J; Lavin, P; Oses, R; Carrasco-Urra, F; Atala, C; Acuna-Rodriguez, IS; Convey, P; Molina-Montenegro, MA				Torres-Diaz, Cristian; Gallardo-Cerda, Jorge; Lavin, Paris; Oses, Romulo; Carrasco-Urra, Fernando; Atala, Cristian; Acuna-Rodriguez, Ian S.; Convey, Peter; Molina-Montenegro, Marco A.			Biological Interactions and Simulated Climate Change Modulates the Ecophysiological Performance of Colobanthus quitensis in the Antarctic Ecosystem	PLOS ONE			English	Article							VASCULAR PLANTS; DESCHAMPSIA-ANTARCTICA; PHENOTYPIC PLASTICITY; GLOBAL CHANGE; WATER-STRESS; RESPONSES; TEMPERATURE; MARITIME; CARYOPHYLLACEAE; POPULATIONS	Most climate and environmental change models predict significant increases in temperature and precipitation by the end of the 21(st) Century, for which the current functional output of certain symbioses may also be altered. In this context we address the following questions: 1) How the expected changes in abiotic factors (temperature, and water) differentially affect the ecophysiological performance of the plant Colobanthus quitensis? and 2) Will this environmental change indirectly affect C. quitensis photochemical performance and biomass accumulation by modifying its association with fungal endophytes? Plants of C. quitensis from King George Island in the South Shetland archipelago (62 degrees 09' S), and Lagotellerie Island in the Antarctic Peninsula (65 degrees 53' S) were put under simulated abiotic conditions in growth chambers following predictive models of global climate change (GCC). The indirect effect of GCC on the interaction between C. quitensis and fungal endophytes was assessed in a field experiment carried out in the Antarctica, in which we eliminated endophytes under contemporary conditions and applied experimental watering to simulate increased precipitation input. We measured four proxies of plant performance. First, we found that warming (+W) significantly increased plant performance, however its effect tended to be less than watering (+W) and combined warming and watering (+T degrees +W). Second, the presence of fungal endophytes improved plant performance, and its effect was significantly decreased under experimental watering. Our results indicate that both biotic and abiotic factors affect ecophysiological performance, and the directions of these influences will change with climate change. Our findings provide valuable information that will help to predict future population spread and evolution through using ecological niche models under different climatic scenarios.	[Torres-Diaz, Cristian; Gallardo-Cerda, Jorge] Univ Bio Bio, Dept Ciencias Basicas, LGB, Chillan, Chile; [Lavin, Paris] Univ Antofagasta, Inst Antofagasta, Lab Complejidad Microbiana & Ecol Func, Antofagasta, Chile; [Oses, Romulo; Molina-Montenegro, Marco A.] Univ Catolica Norte, Fac Ciencias Mar, Ctr Estudios Avanzados Zonas Aridas CEAZA, Coquimbo, Chile; [Carrasco-Urra, Fernando] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Bot, Concepcion, Chile; [Atala, Cristian] Pontificia Univ Catolica Valparaiso, Fac Ciencias, Inst Biol, Lab Anat & Ecol Func Plantas AEF, Valparaiso, Chile; [Acuna-Rodriguez, Ian S.; Molina-Montenegro, Marco A.] Univ Talca, Inst Ciencias Biol, Ctr Ecol Mol & Aplicac Evolut Agroecosistemas CEM, Talca, Chile; [Convey, Peter] British Antarctic Survey, NERC, High Cross, Cambridge, England; [Molina-Montenegro, Marco A.] Univ Talca, Res Program Adaptat Agr Climate Change PIEI A2C2, Talca, Chile	Universidad del Bio-Bio; Universidad de Antofagasta; Universidad Catolica del Norte; Universidad de Concepcion; Pontificia Universidad Catolica de Valparaiso; Universidad de Talca; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Universidad de Talca	Molina-Montenegro, MA (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Ctr Estudios Avanzados Zonas Aridas CEAZA, Coquimbo, Chile.; Molina-Montenegro, MA (corresponding author), Univ Talca, Inst Ciencias Biol, Ctr Ecol Mol & Aplicac Evolut Agroecosistemas CEM, Talca, Chile.; Molina-Montenegro, MA (corresponding author), Univ Talca, Res Program Adaptat Agr Climate Change PIEI A2C2, Talca, Chile.	marco.molina@utalca.cl	Convey, Peter/AAV-5728-2020; Lavin, Paris/AAI-9053-2020	Convey, Peter/0000-0001-8497-9903; Oses-Pedraza, Romulo/0000-0003-2310-3339; Atala, Cristian/0000-0003-1337-9534; Lavin, Paris/0000-0002-8893-526X; Molina-Montenegro, Marco/0000-0001-6801-8942	Chilean Antarctic Institute (INACH) [T-14-08, RT-11-13]; NERC; Natural Environment Research Council [bas0100036] Funding Source: researchfish; NERC [bas0100036] Funding Source: UKRI	Chilean Antarctic Institute (INACH); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Chilean Antarctic Institute (INACH Projects: T-14-08 and RT-11-13). PC is supported by NERC core funding to the British Antarctic Survey's "Biodiversity, Evolution and Adaptation" program. This article contributes to the SCAR biological research programs "Antarctic Thresholds Ecosystem Resilience and Adaptation" (AnT-ERA) and "State of the Antarctic Ecosystem" (AntEco). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful to Carlos Munoz-Ramirez for his valuable field assistance. This work was supported by the Chilean Antarctic Institute (INACH Projects: T-14-08 and RT-11-13). PC is supported by NERC core funding to the British Antarctic Survey's "Biodiversity, Evolution and Adaptation" program. This article contributes to the SCAR biological research programs "Antarctic Thresholds Ecosystem Resilience and Adaptation" (AnT-ERA) and "State of the Antarctic Ecosystem" (AntEco). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Rodriguez IS, 2014, PLANT GENET RESOUR-C, V12, P147, DOI 10.1017/S1479262113000270; Alberdi M, 2002, PHYSIOL PLANTARUM, V115, P479, DOI 10.1034/j.1399-3054.2002.1150401.x; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Beyer L, 2000, ARCT ANTARCT ALP RES, V32, P30, DOI 10.2307/1552407; Bokhorst S, 2007, GLOBAL CHANGE BIOL, V13, P2642, DOI 10.1111/j.1365-2486.2007.01468.x; Cannone N, 2016, CLIMATIC CHANGE, V134, P651, DOI 10.1007/s10584-015-1551-7; Cavieres LA, 2016, PLANT ECOL, V217, P343, DOI 10.1007/s11258-016-0585-x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Convey P, 1996, BIOL REV, V71, P191, DOI 10.1111/j.1469-185X.1996.tb00747.x; Convey P, 2009, ANTARCT SCI, V21, P541, DOI 10.1017/S0954102009990642; Convey P., 2013, ENCY BIODIVERSITY, P179, DOI DOI 10.1016/B978-0-12-384719-5.00264-1; Convey P, 2008, BIOL REV, V83, P103, DOI 10.1111/j.1469-185X.2008.00034.x; Convey P, 2014, ECOL MONOGR, V84, P203, DOI 10.1890/12-2216.1; Convey P, 2011, POLAR RES, V30, DOI 10.3402/polar.v30i0.8929; Convey P, 2011, POLAR BIOL, V34, P1629, DOI 10.1007/s00300-011-1068-0; DERNOEDEN PH, 1991, HORTSCIENCE, V26, P1181, DOI 10.21273/HORTSCI.26.9.1181; File AL, 2012, P ROY SOC B-BIOL SCI, V279, P209, DOI 10.1098/rspb.2011.1995; Flexas J, 2006, NEW PHYTOL, V172, P73, DOI 10.1111/j.1469-8137.2006.01794.x; FOWBERT JA, 1994, ARCTIC ALPINE RES, V26, P290, DOI 10.2307/1551941; Frenot Y, 2005, BIOL REV, V80, P45, DOI 10.1017/S1464793104006542; Gianoli E, 2004, ARCT ANTARCT ALP RES, V36, P484, DOI 10.1657/1523-0430(2004)036[0484:EDIMAC]2.0.CO;2; Giauque H, 2013, AM J BOT, V100, P1435, DOI 10.3732/ajb.1200568; Grace J., 1997, PLANT ECOL, P72; Grobe CW, 1997, ARCTIC ALPINE RES, V29, P217, DOI 10.2307/1552049; Henry GHR, 1997, GLOB CHANGE BIOL, V3, P1, DOI 10.1111/j.1365-2486.1997.gcb132.x; Hill PW, 2011, NAT CLIM CHANGE, V1, P50, DOI [10.1038/nclimate1060, 10.1038/NCLIMATE1060]; Huybrechts P, 2004, GLOBAL PLANET CHANGE, V42, P83, DOI 10.1016/j.gloplacha.2003.11.011; KENNEDY AD, 1993, ARCTIC ALPINE RES, V25, P308, DOI 10.2307/1551914; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; Kopp CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139029; Kopp CW, 2014, J VEG SCI, V25, P135, DOI 10.1111/jvs.12072; Kudo G, 2003, OECOLOGIA, V135, P280, DOI 10.1007/s00442-003-1179-6; Llorens L, 2004, ECOSYSTEMS, V7, P613, DOI 10.1007/s10021-004-0180-1; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Molina-Montenegro MA, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw062; Molina-Montenegro MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076432; Molina-Montenegro MA, 2012, GAYANA BOT, V69, P152, DOI 10.4067/S0717-66432012000100015; Molina-Montenegro MA, 2012, CONSERV BIOL, V26, P717, DOI 10.1111/j.1523-1739.2012.01865.x; Molina-Montenegro MA, 2011, PLANT ECOL DIVERS, V4, P37, DOI 10.1080/17550874.2011.577459; Molina-Montenegro MA, 2011, CIENC INVESTIG AGRAR, V38, P65; MOORE DM, 1970, BR ANTARCT SURV B, V23, P63; Nielsen UN, 2013, ECOL LETT, V16, P409, DOI 10.1111/ele.12058; Pedrol N, 2000, J PLANT PHYSIOL, V157, P383, DOI 10.1016/S0176-1617(00)80023-1; Pointing SB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00692; Potvin C, 1988, FUNCT ECOL, V2, P123, DOI 10.2307/2389472; Rajakaruna N, 2003, INT J PLANT SCI, V164, P371, DOI 10.1086/368395; Redman RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014823; Redman RS, 2001, NEW PHYTOL, V151, P705, DOI 10.1046/j.0028-646x.2001.00210.x; Robinson SA, 2003, GLOBAL CHANGE BIOL, V9, P1681, DOI 10.1046/j.1365-2486.2003.00693.x; Rosa LH, 2009, POLAR BIOL, V32, P161, DOI 10.1007/s00300-008-0515-z; Rosa LH, 2010, FEMS MICROBIOL ECOL, V73, P178, DOI 10.1111/j.1574-6941.2010.00872.x; Sierra-Almeida A, 2007, REV CHIL HIST NAT, V80, P335; Smith J. G., 1996, ADAPTING CLIMATE CHA; Smith RIL, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P234; SMITH RIL, 1994, OECOLOGIA, V99, P322, DOI 10.1007/BF00627745; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Turner J, 2014, POLAR REC, V50, P237, DOI 10.1017/S0032247413000296; Upson R, 2008, ARCT ANTARCT ALP RES, V40, P592, DOI 10.1657/1523-0430(07-057)[UPSON]2.0.CO;2; Upson R, 2007, NEW PHYTOL, V176, P460, DOI 10.1111/j.1469-8137.2007.02178.x; Upson R, 2009, FUNGAL ECOL, V2, P184, DOI 10.1016/j.funeco.2009.02.004; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Welker JM, 2004, GLOBAL CHANGE BIOL, V10, P1981, DOI 10.1111/j.1365-2486.2004.00857.x; Wilbur H. D., 2013, NeoBiota, P21; Xiong FS, 1999, PHYSIOL PLANTARUM, V106, P276, DOI 10.1034/j.1399-3054.1999.106304.x; Xiong FSS, 2000, AM J BOT, V87, P700, DOI 10.2307/2656856	71	23	23	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164844	10.1371/journal.pone.0164844	http://dx.doi.org/10.1371/journal.pone.0164844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776181	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000389009200023
J	Jeon, SJ; Cunha, F; Ma, XJ; Martinez, N; Vieira-Neto, A; Daetz, R; Bicalho, RC; Lima, S; Santos, JEP; Jeong, KC; Galvao, KN				Jeon, Soo Jin; Cunha, Federico; Ma, Xiaojie; Martinez, Natalia; Vieira-Neto, Achilles; Daetz, Rodolfo; Bicalho, Rodrigo C.; Lima, Svetlana; Santos, Jose E. P.; Jeong, K. Casey; Galvao, Klibs N.			]Uterine Microbiota and Immune Parameters Associated with Fever in Dairy Cows with Metritis	PLOS ONE			English	Article							POSTPARTUM UTERINE DISEASE; BACTEROIDES-PYOGENES; NEUTROPHIL FUNCTION; CEFTIOFUR HYDROCHLORIDE; STERILE SUSPENSION; TISSUE-DAMAGE; HOLSTEIN COWS; MILK-YIELD; CAT BITE; INFERTILITY	Objective This study aimed to evaluate bacterial and host factors causing a fever in cows with metritis. For that, we investigated uterine microbiota using a metagenomic sequencing of the 16S rRNA gene (Study 1), and immune response parameters (Study 2) in metritic cows with and without a fever. Principal Findings (Study1) Bacterial communities were similar between the MNoFever and MFever groups based on distance metrics of relative abundance of bacteria. Metritic cows showed a greater prevalence of Bacteroidetes, and Bacteroides and Porphyromonas were the largest contributors to that difference. A comparison of relative abundance at the species level pointed to Bacteroides pyogenes as a fever-related species which was significantly abundant in the MFever than the MNoFever and Healthy groups; however, absolute abundance of Bacteroides pyogenes determined by droplet digital PCR (ddPCR) was similar between MFever and MNoFever groups, but higher than the Healthy group. The same trend was observed in the total number of bacteria. Principal Findings (Study2) The activity of polymorphonuclear leukocyte (PMN) and the production of TNF alpha, PGE(2) metabolite, and PGE(2) were evaluated in serum, before disease onset, at 0 and 3 DPP. Cows in the MNoFever had decreased proportion of PMN undergoing phagocytosis and oxidative burst compared with the MFever. The low PMN activity in the MNoFever was coupled with the low production of TNF alpha, but similar PGE(2) metabolite and circulating PGE(2). Conclusion/Significance Our study is the first to show a similar microbiome between metritic cows with and without a fever, which indicates that the host response may be more important for fever development than the microbiome. Bacteroides pyogenes was identified as an important pathogen for the development of metritis but not fever. The decreased inflammatory response may explain the lack of a febrile response in the MNoFever group.	[Jeon, Soo Jin; Cunha, Federico; Ma, Xiaojie; Daetz, Rodolfo; Galvao, Klibs N.] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA; [Martinez, Natalia; Vieira-Neto, Achilles; Santos, Jose E. P.; Jeong, K. Casey] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Bicalho, Rodrigo C.; Lima, Svetlana] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY USA; [Jeong, K. Casey] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Galvao, Klibs N.] Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Cornell University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Galvao, KN (corresponding author), Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA.; Galvao, KN (corresponding author), Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL USA.	galvaok@ufl.edu	Cunha, Federico/ABF-1860-2021; Martinez-Patino, Natalia/AAB-9445-2021; Santos, José Eduardo P./K-5564-2013; Neto, Achilles Vieira/AEC-4084-2022	Cunha, Federico/0000-0002-8947-7686; Santos, José Eduardo P./0000-0003-3403-1465; Neto, Achilles Vieira/0000-0001-7592-381X; Jeon, Soo Jin/0000-0001-7473-3184	USDA-NIFA-CRIS program [1002880]	USDA-NIFA-CRIS program	This project was supported by the USDA-NIFA-CRIS program (accession number: 1002880).	Alexander CJ, 1997, J CLIN MICROBIOL, V35, P406, DOI 10.1128/JCM.35.2.406-411.1997; BARTLETT PC, 1986, PREV VET MED, V4, P235, DOI 10.1016/0167-5877(86)90026-7; BENNO Y, 1983, SYST APPL MICROBIOL, V4, P396, DOI 10.1016/S0723-2020(83)80024-1; Benzaquen ME, 2007, J DAIRY SCI, V90, P2804, DOI 10.3168/jds.2006-482; Blatteis CM, 2005, PROSTAG OTH LIPID M, V76, P1, DOI 10.1016/j.prostaglandins.2005.01.001; Blatteis CM, 2004, J THERM BIOL, V29, P359, DOI 10.1016/j.jtherbio.2004.08.008; Bromfield JJ, 2015, J ANIM SCI, V93, P2021, DOI 10.2527/jas.2014-8496; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chenault JR, 2004, JAVMA-J AM VET MED A, V224, P1634, DOI 10.2460/javma.2004.224.1634; Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558; Falentin H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00480; Galvao KN, 2012, THERIOGENOLOGY, V77, P356, DOI 10.1016/j.theriogenology.2011.08.008; Giuliodori MJ, 2013, J DAIRY SCI, V96, P3621, DOI 10.3168/jds.2012-5922; Hammon DS, 2006, VET IMMUNOL IMMUNOP, V113, P21, DOI 10.1016/j.vetimm.2006.03.022; Healy LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07060; Herath S, 2009, ENDOCRINOLOGY, V150, P1912, DOI 10.1210/en.2008-1379; HUSSAIN AM, 1989, J VET MED B, V36, P641, DOI 10.1111/j.1439-0450.1989.tb00657.x; Jeon SJ, 2015, APPL ENVIRON MICROB, V81, P6324, DOI 10.1128/AEM.01753-15; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lima FS, 2014, J DAIRY SCI, V97, P5401, DOI 10.3168/jds.2013-7569; Madsen IR, 2011, J CLIN MICROBIOL, V49, P3092, DOI 10.1128/JCM.00250-11; Martinez N, 2014, J DAIRY SCI, V97, P874, DOI 10.3168/jds.2013-7408; Martinez N, 2012, J DAIRY SCI, V95, P7158, DOI 10.3168/jds.2012-5812; McLaughlin CL, 2012, J DAIRY SCI, V95, P4363, DOI 10.3168/jds.2011-5111; Myers RD, 1982, PYRETICS ANTIPYRETIC, P151; Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513; Obita T, 2003, CELL MOL LIFE SCI, V60, P176, DOI 10.1007/s000180300012; Peng Y, 2013, FOLIA MICROBIOL, V58, P593, DOI 10.1007/s12223-013-0238-6; Rajala PJ, 1998, J DAIRY SCI, V81, P3172, DOI 10.3168/jds.S0022-0302(98)75883-7; Ribeiro ES, 2013, J DAIRY SCI, V96, P5682, DOI 10.3168/jds.2012-6335; Sakamoto M, 2010, INT J SYST EVOL MICR, V60, P2984, DOI 10.1099/ijs.0.021154-0; Santos TMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053048; Schukken YH, 2009, J DAIRY SCI, V92, P3091, DOI 10.3168/jds.2008-1557; Sheldon IM, 2009, REPROD DOMEST ANIM, V44, P1, DOI 10.1111/j.1439-0531.2009.01465.x; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Ster C, 2012, J DAIRY SCI, V95, P708, DOI 10.3168/jds.2011-4695; Tavares E, 2005, CLIN DIAGN LAB IMMUN, V12, P1085, DOI 10.1128/CDLI.12.9.1085-1093.2005; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zeisberger E, 1999, J THERM BIOL, V24, P287, DOI 10.1016/S0306-4565(99)00033-9	42	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165740	10.1371/journal.pone.0165740	http://dx.doi.org/10.1371/journal.pone.0165740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802303	Green Submitted, gold, Green Published			2022-12-26	WOS:000386714200048
J	Fazio, L; Logroscino, G; Taurisano, P; Amico, G; Quarto, T; Antonucci, LA; Barulli, MR; Mancini, M; Gelao, B; Ferranti, L; Popolizio, T; Bertolino, A; Blasi, G				Fazio, Leonardo; Logroscino, Giancarlo; Taurisano, Paolo; Amico, Graziella; Quarto, Tiziana; Antonucci, Linda Antonella; Barulli, Maria Rosaria; Mancini, Marina; Gelao, Barbara; Ferranti, Laura; Popolizio, Teresa; Bertolino, Alessandro; Blasi, Giuseppe			Prefrontal Activity and Connectivity with the Basal Ganglia during Performance of Complex Cognitive Tasks Is Associated with Apathy in Healthy Subjects	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FRONTAL-LOBE SYNDROME; WORKING-MEMORY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; NEUROPSYCHIATRIC SYMPTOMS; OLDER-ADULTS; FUNCTIONAL CONNECTIVITY; OLANZAPINE TREATMENT; ATTENTIONAL CONTROL	Objective Convergent evidence indicates that apathy affects cognitive behavior in different neurological and psychiatric conditions. Studies of clinical populations have also suggested the primary involvement of the prefrontal cortex and the basal ganglia in apathy. These brain regions are interconnected at both the structural and functional levels and are deeply involved in cognitive processes, such as working memory and attention. However, it is unclear how apathy modulates brain processing during cognition and whether such a modulation occurs in healthy young subjects. To address this issue, we investigated the link between apathy and prefrontal and basal ganglia function in healthy young individuals. We hypothesized that apathy may be related to sub-optimal activity and connectivity in these brain regions. Methods Three hundred eleven healthy subjects completed an apathy assessment using the Stark-stein's Apathy Scale and underwent fMRI during working memory and attentional performance tasks. Using an ROI approach, we investigated the association of apathy with activity and connectivity in the DLPFC and the basal ganglia. Results Apathy scores correlated positively with prefrontal activity and negatively with prefrontal-basal ganglia connectivity during both working memory and attention tasks. Furthermore, prefrontal activity was inversely related to attentional behavior. Conclusions These results suggest that in healthy young subjects, apathy is a trait associated with inefficient cognitive-related prefrontal activity, i.e., it increases the need for prefrontal resources to process cognitive stimuli. Furthermore, apathy may alter the functional relationship between the prefrontal cortex and the basal ganglia during cognition.	[Fazio, Leonardo; Taurisano, Paolo; Amico, Graziella; Quarto, Tiziana; Antonucci, Linda Antonella; Mancini, Marina; Gelao, Barbara; Bertolino, Alessandro] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, I-70124 Bari, Italy; [Logroscino, Giancarlo; Barulli, Maria Rosaria] Univ Bari Aldo Moro, Dept Basic Med Neurosci & Sense Organs, I-70124 Bari, Italy; [Logroscino, Giancarlo; Barulli, Maria Rosaria] Univ Bari Aldo Moro, Pia Fdn Cardinale G Panico, Dept Clin Res Neurol, I-73039 Lecce, Italy; [Ferranti, Laura] Univ Perugia, Dept Gen & Expt Med, I-06123 Perugia, Italy; [Fazio, Leonardo; Popolizio, Teresa] IRCCS Casa Sollievo Sofferenza, I-71013 San Giovanni Rotondo, Italy; [Bertolino, Alessandro; Blasi, Giuseppe] Bari Univ Hosp, Psychiat Unit, I-70124 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Perugia; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro	Blasi, G (corresponding author), Bari Univ Hosp, Psychiat Unit, I-70124 Bari, Italy.	blasi.seppe@gmail.com	Antonucci, Linda A./P-2339-2018; Taurisano, Paolo/AID-5342-2022; Blasi, Giuseppe/HHS-5404-2022; Taurisano, Paolo/U-1828-2017	Antonucci, Linda A./0000-0002-7919-7402; Taurisano, Paolo/0000-0001-6140-9326; Taurisano, Paolo/0000-0001-6140-9326; Fazio, Leonardo/0000-0003-4000-974X; Blasi, Giuseppe/0000-0003-0878-1131				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Arsalidou M, 2013, HUM BRAIN MAPP, V34, P3031, DOI 10.1002/hbm.22124; Baier B, 2010, J NEUROSCI, V30, P9788, DOI 10.1523/JNEUROSCI.1513-10.2010; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Baudic S, 2006, DEMENT GERIATR COGN, V21, P316, DOI 10.1159/000091523; Bayard S, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/231469; Benoit M, 2004, INT J GERIATR PSYCH, V19, P864, DOI 10.1002/gps.1163; Bentley SM, 2014, MED CLIN N AM, V98, P981, DOI 10.1016/j.mcna.2014.06.013; Bertolino A, 2004, AM J PSYCHIAT, V161, P1798, DOI 10.1176/appi.ajp.161.10.1798; Bertolino A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009348; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Blasi G, 2007, EUR J NEUROSCI, V25, P594, DOI 10.1111/j.1460-9568.2007.05283.x; Blasi G, 2015, NEUROPSYCHOPHARMACOL, V40, P1600, DOI 10.1038/npp.2015.5; Blasi G, 2013, JAMA PSYCHIAT, V70, P921, DOI 10.1001/jamapsychiatry.2013.1378; Blasi G, 2013, AM J PSYCHIAT, V170, P868, DOI 10.1176/appi.ajp.2012.12070908; Blasi G, 2010, CEREB CORTEX, V20, P837, DOI 10.1093/cercor/bhp146; Bonnelle V, 2016, CEREB CORTEX, V26, P807, DOI 10.1093/cercor/bhv247; Bonnelle V, 2015, J PHYSIOL-PARIS, V109, P16, DOI 10.1016/j.jphysparis.2014.04.002; Brodaty H, 2012, J ALZHEIMERS DIS, V31, P411, DOI 10.3233/JAD-2012-120169; Brown RG, 2000, TRENDS NEUROSCI, V23, P412, DOI 10.1016/S0166-2236(00)01626-X; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Clarke DE, 2011, J PSYCHOSOM RES, V70, P73, DOI 10.1016/j.jpsychores.2010.01.012; Clarke DE, 2010, INT PSYCHOGERIATR, V22, P819, DOI 10.1017/S1041610209991402; Craufurd D, 2001, NEUROPSY NEUROPSY BE, V14, P219; Faerden A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-1; First MB, 1996, COMMUNICATION; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Gelao B, 2014, PSYCHOPHARMACOLOGY, V231, P2361, DOI 10.1007/s00213-013-3398-9; GOLDMANRAKIC PS, 1990, PROG BRAIN RES, V85, P325; Grool AM, 2014, NEUROLOGY, V82, P1628, DOI 10.1212/WNL.0000000000000378; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Isella V, 2002, MOVEMENT DISORD, V17, P366, DOI 10.1002/mds.10041; Jarbo K, 2015, J NEUROSCI, V35, P3865, DOI 10.1523/JNEUROSCI.2636-14.2015; Josephs KA, 2011, MOVEMENT DISORD, V26, P493, DOI 10.1002/mds.23471; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Konstantakopoulos G, 2011, SCHIZOPHR RES, V133, P193, DOI 10.1016/j.schres.2011.07.003; Laplane D, 2001, MOVEMENT DISORD, V16, P810, DOI 10.1002/mds.1185; Leentjens AFG, 2008, MOVEMENT DISORD, V23, P2004, DOI 10.1002/mds.22229; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Levy ML, 1998, J NEUROPSYCH CLIN N, V10, P314, DOI 10.1176/jnp.10.3.314; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Levy R, 2012, REV NEUROL-FRANCE, V168, P585, DOI 10.1016/j.neurol.2012.05.003; Levy R, 2006, J NEUROL, V253, P54, DOI 10.1007/s00415-006-7012-5; Lindgren HS, 2013, NEUROPHARMACOLOGY, V71, P148, DOI 10.1016/j.neuropharm.2013.03.034; Litvan I, 1996, NEUROLOGY, V47, P1184, DOI 10.1212/WNL.47.5.1184; Lopez OL, 2001, J NEUROPSYCH CLIN N, V13, P56, DOI 10.1176/appi.neuropsych.13.1.56; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; Marshall GA, 2007, ARCH NEUROL-CHICAGO, V64, P1015, DOI 10.1001/archneur.64.7.1015; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; McPherson S, 2002, J INT NEUROPSYCH SOC, V8, P373, DOI 10.1017/S1355617702813182; MENDEZ MF, 1989, NEUROLOGY, V39, P349, DOI 10.1212/WNL.39.3.349; Middleton FA, 2002, CEREB CORTEX, V12, P926, DOI 10.1093/cercor/12.9.926; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; Okada K, 1997, STROKE, V28, P2437, DOI 10.1161/01.STR.28.12.2437; Okura T, 2010, J AM GERIATR SOC, V58, P330, DOI 10.1111/j.1532-5415.2009.02680.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onoda K, 2011, CEREBROVASC DIS, V31, P6, DOI 10.1159/000319771; Onyike CU, 2007, AM J GERIAT PSYCHIAT, V15, P365, DOI 10.1097/01.JGP.0000235689.42910.0d; Orsini A, 2000, PERCEPT MOTOR SKILL, V90, P1091, DOI 10.2466/PMS.90.3.1091-1100; Paradiso S, 1999, J NEUROL NEUROSUR PS, V67, P664, DOI 10.1136/jnnp.67.5.664; Pardini M, 2016, J AFFECT DISORDERS, V189, P272, DOI 10.1016/j.jad.2015.09.062; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Pluck GC, 2002, J NEUROL NEUROSUR PS, V73, P636, DOI 10.1136/jnnp.73.6.636; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Rasetti R, 2010, NEUROPSYCHOPHARMACOL, V35, P2101, DOI 10.1038/npp.2010.83; Reijnders JSAM, 2010, MOVEMENT DISORD, V25, P2318, DOI 10.1002/mds.23268; Robert G, 2014, J NEUROL NEUROSUR PS, V85, P1153, DOI 10.1136/jnnp-2013-307025; Roth RM, 2004, AM J PSYCHIAT, V161, P157, DOI 10.1176/appi.ajp.161.1.157; Roth RM, 2008, SCHIZOPHR RES, V98, P232, DOI 10.1016/j.schres.2007.08.020; Spalletta G, 2013, HUM BRAIN MAPP, V34, P3193, DOI 10.1002/hbm.22137; Stanton BR, 2013, J NEUROL, V260, P2481, DOI 10.1007/s00415-013-6989-9; Starkstein SE, 2008, J NEUROL NEUROSUR PS, V79, P1088, DOI 10.1136/jnnp.2007.136895; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Starkstein SE, 2005, J NEUROL NEUROSUR PS, V76, P1070, DOI 10.1136/jnnp.2004.052795; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.987.872; STRUB RL, 1989, ARCH NEUROL-CHICAGO, V46, P1024, DOI 10.1001/archneur.1989.00520450096027; Taurisano P, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00235; Varanese S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017846; Yamashita K, 1999, GERONTOLOGY, V45, P279, DOI 10.1159/000022102; Yuen GS, 2014, INT J GERIATR PSYCH, V29, P1116, DOI 10.1002/gps.4171; Zgaljardic DJ, 2007, COGN BEHAV NEUROL, V20, P184, DOI 10.1097/WNN.0b013e318145a6f6	87	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165301	10.1371/journal.pone.0165301	http://dx.doi.org/10.1371/journal.pone.0165301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798669	gold, Green Submitted, Green Published			2022-12-26	WOS:000386711100025
J	Hall, JA; Barrett, G; Phiri, T; Copas, A; Malata, A; Stephenson, J				Hall, Jennifer Anne; Barrett, Geraldine; Phiri, Tambosi; Copas, Andrew; Malata, Address; Stephenson, Judith			Prevalence and Determinants of Unintended Pregnancy in Mchinji District, Malawi; Using a Conceptual Hierarchy to Inform Analysis	PLOS ONE			English	Article							CHILD; INTENTION; OUTCOMES; WEIGHT; INFANT; WOMEN	Background In 2012 there were around 85 million unintended pregnancies globally. Unintended pregnancies unnecessarily expose women to the risks associated with pregnancy, unsafe abortion and childbirth, thereby contributing to maternal mortality and morbidity. Studies have identified a range of potential determinants of unplanned pregnancy but have used varying methodologies, measures of pregnancy intention and analysis techniques. Consequently there are many contradictions in their findings. Identifying women at risk of unplanned pregnancy is important as this information can be used to help with designing and targeting interventions and developing preventative policies. Methods 4,244 pregnant women from Mchinji District, Malawi were interviewed at home between March and December 2013. They were asked about their pregnancy intention using the validated Chichewa version of the London Measure of Unplanned Pregnancy, as well as their socio-demographics and obstetric and psychiatric history. A conceptual hierarchical model of the determinants of pregnancy intention was developed and used to inform the analysis. Multiple random effects linear regression was used to explore the ways in which factors determine pregnancy intention leading to the identification of women at risk of unplanned pregnancies. Results 44.4% of pregnancies were planned. On univariate analyses pregnancy intention was associated with mother and father's age and education, marital status, number of live children, birth interval, socio-economic status, intimate partner violence and previous depression all at p<0.001. Multiple linear regression analysis found that increasing socio-economic status is associated with increasing pregnancy intention but its effect is mediated through other factors in the model. Socio-demographic factors of importance were marital status, which was the factor in the model that had the largest effect on pregnancy intention, partner's age and mother's education level. The effect of mother's education level was mediated by maternal reproductive characteristics. Previous depression, abuse in the last year or sexual abuse, younger age, increasing number of children and short birth intervals were all associated with lower pregnancy intention having controlled for all other factors in the model. This suggests that women in Mchinji District who are either young, unmarried women having their first pregnancy, or older, married women who have completed their desired family size or recently given birth, or women who have experienced depression, abuse in the last year or sexual abuse are at higher risk of unintended pregnancies. Conclusion A simple measure of pregnancy intention with well-established psychometric properties was used to show the distribution of pregnancy planning among women from a poor rural population and to identify those women at higher risk of unintended pregnancy. An analysis informed by a conceptual hierarchical model shed light on the pathways that lead from socio-demographic determinants to pregnancy intention. This information can be used to target family planning services to those most at risk of unplanned pregnancies, particularly women with a history of depression or who are experiencing intimate partner violence.	[Hall, Jennifer Anne; Barrett, Geraldine; Stephenson, Judith] UCL Inst Womens Hlth, Res Dept Reprod Hlth, London, England; [Phiri, Tambosi] MaiMwana Project, Mchinji, Malawi; [Copas, Andrew] UCL Inst Epidemiol & Hlth Care, Dept Infect & Populat Hlth, London, England; [Malata, Address] Univ Malawi, Kamuzu Coll Nursing, Lilongwe, Malawi	University of London; University College London; University of London; University College London; University of Malawi	Hall, JA (corresponding author), UCL Inst Womens Hlth, Res Dept Reprod Hlth, London, England.	jennifer.hall@ucl.ac.uk		Copas, Andrew/0000-0001-8968-5963; Barrett, Geraldine/0000-0002-9738-1051	Wellcome Trust [097268/Z/11/1]; National Institute for Health Research [NF-SI-0513-10099] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a personal research fellowship to JH (097268/Z/11/1) from the Wellcome Trust (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhausen MG, 2014, EUR J CONTRACEP REPR, V19, P57, DOI 10.3109/13625187.2013.851183; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Beguy D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101034; Calvert C, 2013, J FAM PLAN REPROD H, V39, P1, DOI 10.1136/jfprhc-2012-100389; Chilale HK, DEPRESSION MOT UNPUB; Dixit P, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-84; Eggleston E, 1999, INT FAM PLAN PERSPEC, V25, P27, DOI 10.2307/2991899; Eggleston E, 2001, AM J PUBLIC HEALTH, V91, P808, DOI 10.2105/AJPH.91.5.808; Eliason S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-261; Flores M, 2010, CONTRACEPTION, V82, P213, DOI 10.1016/j.contraception.2010.04.138; Fourn L, 1999, Sante, V9, P7; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Hall J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-200; Hamdela B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039074; Ikamari L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-69; Iranfar S, 2009, PAK J MED SCI, V25, P841; ISLAM MM, 2004, J FAM WELF, V0050, P00040; Joyce TJ, 2000, DEMOGRAPHY, V37, P83, DOI 10.2307/2648098; Koenig MA, 2006, POP STUD-J DEMOG, V60, P243, DOI 10.1080/00324720600895819; Kost K, 1998, FAM PLANN PERSPECT, V30, P223, DOI 10.2307/2991608; Lewycka S, 2010, REDUCING MATERNAL NE; Malawi DHS, 2004, MAL DEM HLTH SURV; Malawi DHS, 2010, MAL DEM HLTH SURV; Malawi NSO UNICEF, 2008, MAL MULT IND CLUST S; Marston C, 2003, POP STUD-J DEMOG, V57, P77, DOI 10.1080/0032472032000061749; Melian MM, 2013, REV PANAM SALUD PUBL, V33, P244, DOI 10.1590/S1020-49892013000400002; Poole V L, 2000, Matern Child Health J, V4, P179, DOI 10.1023/A:1009523430135; Rabin RF, 2009, AM J PREV MED, V36, P439, DOI 10.1016/j.amepre.2009.01.024; Rassi A, 2013, AUST NZ J PUBL HEAL, V37, P568, DOI 10.1111/1753-6405.12098; ROSENZWEIG MR, 1993, J HUM RESOUR, V28, P205, DOI 10.2307/146201; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Sedgh G, 2006, INT FAM PLAN PERSPEC, V32, P175, DOI 10.1363/3217506; Shah PS, 2011, MATERN CHILD HLTH J, V15, P205, DOI 10.1007/s10995-009-0546-2; Stewart RC, 2010, SOC PSYCH PSYCH EPID, V45, P551, DOI 10.1007/s00127-009-0094-5; Tebekaw Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-326; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1; WESTOFF CF, 1977, DEMOGRAPHY, V14, P431, DOI 10.2307/2060589; Yeatman S, 2015, MATERN CHILD HLTH J, V19, P1593, DOI 10.1007/s10995-015-1669-2	41	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165621	10.1371/journal.pone.0165621	http://dx.doi.org/10.1371/journal.pone.0165621			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6BX	27798710	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100050
J	Li, T; Hao, XM; Kang, SZ				Li, Tao; Hao, Xinmei; Kang, Shaozhong			Spatial Variability of Grapevine Bud Burst Percentage and Its Association with Soil Properties at Field Scale	PLOS ONE			English	Article							WINEGRAPE PRODUCTION SYSTEMS; UNDERSTANDING VARIABILITY; VINEYARD VARIATION; YIELD; AUTOCORRELATION; VITICULTURE; QUALITY; WATER; WINE	There is a growing interest in precision viticulture with the development of global positioning system and geographical information system technologies. Limited information is available on spatial variation of bud behavior and its possible association with soil properties. The objective of this study was to investigate spatial variability of bud burst percentage and its association with soil properties based on 2-year experiments at a vineyard of arid northwest China. Geostatistical approach was used to describe the spatial variation in bud burst percentage within the vineyard. Partial least square regressions (PLSRs) of bud burst percentage with soil properties were used to evaluate the contribution of soil properties to overall spatial variability in bud burst percentage for the high, medium and low bud burst percentage groups. Within the vineyard, the coefficient of variation (CV) of bud burst percentage was 20% and 15% for 2012 and 2013 respectively. Bud burst percentage within the vineyard showed moderate spatial variability, and the overall spatial pattern of bud burst percentage was similar between the two years. Soil properties alone explained 31% and 37% of the total spatial variation respectively for the low group of 2012 and 2013, and 16% and 24% for the high group of 2012 and 2013 respectively. For the low group, the fraction of variations explained by soil properties was found similar between the two years, while there was substantial difference for the high group. The findings are expected to lay a good foundation for developing remedy measures in the areas with low bud burst percentage, thus in turn improving the overall grape yield and quality.	[Li, Tao; Hao, Xinmei; Kang, Shaozhong] China Agr Univ, Ctr Agr Water Res China, Beijing, Peoples R China; [Li, Tao] Xian Univ Technol, State Key Lab Base Ecohydraul Engn Arid Area, Xian, Shannxi, Peoples R China	China Agricultural University; Xi'an University of Technology	Hao, XM (corresponding author), China Agr Univ, Ctr Agr Water Res China, Beijing, Peoples R China.	haox@cau.edu.cn	kang, Shaozhong/C-5434-2011		Chinese Universities Scientific Fund [2012RC020]; National Natural Science Foundation of China [51321001]; Programme of Introducing Talents of Discipline to Universities [B14002]	Chinese Universities Scientific Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	The project was supported by the Chinese Universities Scientific Fund (No. 2012RC020), the National Natural Science Foundation of China (No. 51321001), and the Programme of Introducing Talents of Discipline to Universities (No. B14002).	Bao S.D., 2000, AGROCHEMICAL ANAL SO, V3rd ed.; Bramley RGV, 2007, J INT SCI VIGNE VIN, V41, P1; Bramley RGV, 2011, AUST J GRAPE WINE R, V17, P217, DOI 10.1111/j.1755-0238.2011.00136.x; Bramley RGV, 2005, AUST J GRAPE WINE R, V11, P33, DOI 10.1111/j.1755-0238.2005.tb00277.x; Bramley RGV, 2004, AUST J GRAPE WINE R, V10, P32, DOI 10.1111/j.1755-0238.2004.tb00006.x; Bramley RGV., 1999, AUST NZ GRAPEGROW WI, V427, P11; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; BURGESS TM, 1980, J SOIL SCI, V31, P315, DOI 10.1111/j.1365-2389.1980.tb02084.x; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Dry P. R., 2000, Australian Journal of Grape and Wine Research, V6, P109, DOI 10.1111/j.1755-0238.2000.tb00168.x; Elgendy R. S. S., 2012, The Journal of American Science, V8, P21; Fu WJ, 2010, SOIL TILL RES, V106, P185, DOI 10.1016/j.still.2009.12.001; Ge F, 2008, J HAZARD MATER, V151, P676, DOI 10.1016/j.jhazmat.2007.06.041; Guilpart N, 2014, EUR J AGRON, V54, P9, DOI 10.1016/j.eja.2013.11.002; Jones TH, 2009, AUST J GRAPE WINE R, V15, P284, DOI 10.1111/j.1755-0238.2009.00061.x; KUBOTA N, 1992, J AM SOC HORTIC SCI, V117, P898, DOI 10.21273/JASHS.117.6.898; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Li T, 2014, SOIL SCI SOC AM J, V78, P598, DOI 10.2136/sssaj2013.07.0269; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; MCQUAKER NR, 1979, ANAL CHEM, V51, P1082, DOI 10.1021/ac50043a071; Morlat R, 2006, PLANT SOIL, V281, P55, DOI 10.1007/s11104-005-3769-z; National Soil Survey Office (NSS), 1995, CHIN SOIL GEN REC; Robertson G.P., 2008, GS GEOSTATISTICS ENV; SAS Institute, 2004, SAS 9 1 3; SKINNER PW, 1987, J AM SOC HORTIC SCI, V112, P449; Steduto P., 2012, CROP YIELD RESPONSE, DOI DOI 10.1016/J.ECOLMODEL.2004.06.005; Tardaguila J, 2011, PRECIS AGRIC, V12, P762, DOI 10.1007/s11119-011-9219-4; Tisseyre B, 2008, J INT SCI VIGNE VIN, V42, P27; Utset A, 1998, GEODERMA, V86, P143, DOI 10.1016/S0016-7061(98)00037-8; van Leeuwen C, 2004, AM J ENOL VITICULT, V55, P207; WALINGA I, 1992, COMMUN SOIL SCI PLAN, V23, P1935, DOI 10.1080/00103629209368715; YUAN TL, 1976, SOIL SCI SOC AM J, V40, P229, DOI 10.2136/sssaj1976.03615995004000020014x	32	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165738	10.1371/journal.pone.0165738	http://dx.doi.org/10.1371/journal.pone.0165738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798692	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100058
J	Thankam, FG; Dilisio, MF; Dietz, NE; Agrawal, DK				Thankam, Finosh G.; Dilisio, Matthew F.; Dietz, Nicholas E.; Agrawal, Devendra K.			TREM-1, HMGB1 and RAGE in the Shoulder Tendon: Dual Mechanisms for Inflammation Based on the Coincidence of Glenohumeral Arthritis	PLOS ONE			English	Article							MYELOID CELLS; VITAMIN-D; RHEUMATOID-ARTHRITIS; RECEPTOR; EXPRESSION; PROTEIN; RESPONSES; TISSUE	Rotator cuff injury (RCI) is a major musculoskeletal disorder in the adult population where inflammation and pain are major contributing factors. Coincidence of other clinical conditions like glenohumeral arthritis aggravates inflammation and delays the healing response. The mechanism and signaling factors underlying the sustenance of inflammation in the rotator cuff joint are largely unknown. The present article aims to elucidate the involvement of inflammatory molecule, TREM-1 (Triggering Receptors Expressed on Myeloid cells-1), and dangerassociated molecular patterns (DAMPs), including high mobility group protein 1 (HMGB-1) and RAGE (receptor for advanced glycation end products), in the setting of RCI with respect to the severity of glenohumeral arthritis. Biceps tendons (15 specimens) from the shoulder and blood (11 samples) from patients with glenohumeral arthritis (Group-1, n = 4) and without glenohumeral arthritis (Group-2, n = 11) after RCI surgery were obtained for the study. Molecular and morphological alterations between the groups were compared using histology, immunofluorescence, RT-PCR and flow cytometry. MRI and histomorphology assessment revealed severe inflammation in Group-1 patients while in Group-2 ECM disorganization was prominent without any hallmarks of inflammation. A significant increase in TREM-1 expression in circulating neutrophils and monocytes was observed. Elevated levels of TREM-1, HMGB-1 and RAGE in Group-1 patients along with CD68 + and CD16 + cells confirmed DAMP-mediated inflammation. Expression of TREM-1 in the tendon of Group-2 patients even in the absence of immune cells presented a new population of TREM-expressing cells that were confirmed by real-time PCR analysis and immunofluorescence. Expression of HMGB-1 and RAGE in the biceps tendon from the shoulder of patients without glenohumeral arthritis implied TREM-1-mediated inflammation without involving immune cells, whereas in patients with glenohumeral arthritis, infiltration and the activation of the immune cells, primarily macrophages, release mediators to induce inflammation. This could be the reason for ECM disorganization without the classical signs of inflammation in patients without glenohumeral arthritis.	[Thankam, Finosh G.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE 68178 USA; [Dilisio, Matthew F.] Creighton Univ, Sch Med, Dept Orthoped Surg, Omaha, NE USA; [Dietz, Nicholas E.] Creighton Univ, Sch Med, Dept Pathol, Omaha, NE USA	Creighton University; Creighton University; Creighton University	Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE 68178 USA.	dkagr@creighton.edu	Agrawal, Devendra/GLR-3925-2022	Agrawal, Devendra/0000-0001-5445-0013	NIH [R01HL112597, R01HL120659]; Creighton University George Haddix President's Grant	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creighton University George Haddix President's Grant	This work was supported by NIH research grants to D.K. Agrawal (R01HL112597 and R01HL120659), and the Creighton University George Haddix President's Grant to M. Dilisio. The content of this review is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal T, 2013, CLIN EXP ALLERGY, V43, P672, DOI 10.1111/cea.12102; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bedi A, 2012, J SHOULDER ELB SURG, V21, P218, DOI 10.1016/j.jse.2011.09.020; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Chen XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115116; Chen Y, 2013, RHEUMATOLOGY, V52, P1739, DOI 10.1093/rheumatology/ket134; Collins CE, 2009, ANN RHEUM DIS, V68, P1768, DOI 10.1136/ard.2008.089557; Dougherty KA, 2016, J INFLAMM RES, V9, P123, DOI 10.2147/JIR.S106206; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Fong G, 2013, J ORTHOP RES, V31, P91, DOI 10.1002/jor.22191; Gupta GK, 2012, EXP MOL PATHOL, V93, P82, DOI 10.1016/j.yexmp.2012.04.006; Hwang KR, 2016, J SHOULDER ELB SURG, V25, P981, DOI 10.1016/j.jse.2015.10.015; Jarvinen M, 1997, SCAND J MED SCI SPOR, V7, P86; Kim TH, 2012, MED HYPOTHESES, V78, P270, DOI 10.1016/j.mehy.2011.10.042; Kuai J, 2009, RHEUMATOLOGY, V48, P1352, DOI 10.1093/rheumatology/kep235; Lee DE, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000391; Li J, 2012, CURR RHEUMATOL REP, V14, P445, DOI 10.1007/s11926-012-0272-4; Magna M, 2014, MOL MED, V20, P138, DOI 10.2119/molmed.2013.00164; Manning CN, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0059-4; Martinotti S, 2015, IMMUNOTARGETS THER, V4, P101, DOI 10.2147/ITT.S58064; Millar NL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7774; Nguyen AH, 2015, CTS-CLIN TRANSL SCI, V8, P441, DOI 10.1111/cts.12308; Palazzo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090633; Pelham CJ, 2014, EXPERT OPIN THER PAT, V24, P1383, DOI 10.1517/13543776.2014.977865; Pelham CJ, 2014, EXPERT REV CLIN IMMU, V10, P243, DOI 10.1586/1744666X.2014.866519; Puddu G, 1976, Am J Sports Med, V4, P145, DOI 10.1177/036354657600400404; Rai V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154802; Rees JD, 2014, BRIT J SPORT MED, V48, P1553, DOI 10.1136/bjsports-2012-091957; Roe K, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00627; Scott A, 2007, ARTHRITIS RHEUM-US, V56, P871, DOI 10.1002/art.22426; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; SIPE JD, 1995, SEMIN ARTHRITIS RHEU, V25, P75, DOI 10.1016/S0049-0172(95)80020-4; Thankam FG, 2016, EXPERT REV CLIN IMMU, V12, P1239, DOI 10.1080/1744666X.2016.1196138; Thankam FG, 2016, MOL CELL BIOCHEM, V417, P17, DOI 10.1007/s11010-016-2710-5; Ubagai T, 2014, INT J MED SCI, V11, P215, DOI 10.7150/ijms.7231; Mora MV, 2015, WORLD J STEM CELLS, V7, P691, DOI 10.4252/wjsc.v7.i4.691; Wang XB, 2015, INT J MOL SCI, V16, P22527, DOI 10.3390/ijms160922527; Wolfe F, 1997, J RHEUMATOL, V24, P1486; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662	41	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165492	10.1371/journal.pone.0165492	http://dx.doi.org/10.1371/journal.pone.0165492			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792788	gold, Green Published, Green Submitted			2022-12-26	WOS:000389537000025
J	Xiong, W; Luo, Y; Wu, L; Liu, F; Liu, HD; Li, JH; Liao, BH; Dong, SH				Xiong, Wei; Luo, Yu; Wu, Lin; Liu, Feng; Liu, Huadong; Li, Jianghua; Liao, Bihong; Dong, Shaohong			Chemerin Stimulates Vascular Smooth Muscle Cell Proliferation and Carotid Neointimal Hyperplasia by Activating Mitogen-Activated Protein Kinase Signaling	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; METABOLIC SYNDROME; ENDOTHELIAL-CELLS; CORONARY-ARTERY; RECEPTOR CCRL2; ELUTING STENTS; EXPRESSION; ATHEROSCLEROSIS; INFLAMMATION; ADIPOKINE	Vascular neointimal hyperplasia and remodeling arising from local inflammation are characteristic pathogeneses of proliferative cardiovascular diseases, such as atherosclerosis and post angioplasty restenosis. The molecular mechanisms behind these pathological processes have not been fully determined. The adipokine chemerin is associated with obesity, metabolism, and control of inflammation. Recently, chemerin has gained increased attention as it was found to play a critical role in the development of cardiovascular diseases. In this study, we investigated the effects of chemerin on the regulation of vascular smooth muscle cells and carotid neointimal formation after angioplasty. We found that circulating chemerin levels increased after carotid balloon injury, and that knockdown of chemerin significantly inhibited the proliferative aspects of vascular smooth muscle cells induced by platelet-derived growth factor-BB and pro-inflammatory chemokines in vitro as well as prohibited carotid neointimal hyperplasia and pro-inflammatory chemokines in vivo after angioplasty. Additionally, inhibition of chemerin down-regulated the expression of several proteins, including phosphorylated p38 mitogen-activated protein kinase, phosphorylated extracellular signal regulated kinase 1/2, nuclear factor-kappa B p65, and proliferation cell nuclear antigen. The novel finding of this study is that chemerin stimulated vascular smooth muscle cells proliferation and carotid intimal hyperplasia through activation of the mitogen-activated protein kinase signaling pathway, which may lead to vascular inflammation and remodeling, and is relevant to proliferative cardiovascular diseases.	[Xiong, Wei; Luo, Yu; Liu, Feng; Liu, Huadong; Li, Jianghua; Liao, Bihong; Dong, Shaohong] Jinan Univ, Shenzhen Peoples Hosp, Dept Cardiol, Clin Med Coll 2, NO 1017,Dongmen North Rd, Shenzhen 518020, Peoples R China; [Wu, Lin] Peking Univ, Hosp 1, Dept Cardiol, 8 Xishiku St, Beijing 100034, Peoples R China	Jinan University; Peking University	Dong, SH (corresponding author), Jinan Univ, Shenzhen Peoples Hosp, Dept Cardiol, Clin Med Coll 2, NO 1017,Dongmen North Rd, Shenzhen 518020, Peoples R China.	dsh266@medmail.com.cn	li, jianghua/GXG-4735-2022		Science Foundation of Shenzhen [jcyj20150403101028192]	Science Foundation of Shenzhen	The study was supported by the Science Foundation of Shenzhen (project number: jcyj20150403101028192).	Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Carlino C, 2012, J CLIN ENDOCR METAB, V97, P3603, DOI 10.1210/jc.2012-1102; Chamberland JP, 2013, EUR J ENDOCRINOL, V169, P453, DOI 10.1530/EJE-13-0098; Cutlip DE, 2002, J AM COLL CARDIOL, V40, P2082, DOI 10.1016/S0735-1097(02)02597-4; Dessein PH, 2014, J RHEUMATOL, V41, P1746, DOI 10.3899/jrheum.140122; Dong BK, 2011, INTERNAL MED, V50, P1093, DOI 10.2169/internalmedicine.50.5025; Dong SH, 2013, MOL MED REP, V8, P407, DOI 10.3892/mmr.2013.1538; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Fredman G, 2010, ARTERIOSCL THROM VAS, V30, P2005, DOI 10.1161/ATVBAHA.110.209908; Gao XY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-87; Garg S, 2013, NAT REV CARDIOL, V10, P248, DOI 10.1038/nrcardio.2013.13; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Hart R, 2010, J IMMUNOL, V185, P3728, DOI 10.4049/jimmunol.0902154; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Kostopoulos CG, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-56; Kunimoto H, 2015, AM J PHYSIOL-HEART C, V309, pH1017, DOI 10.1152/ajpheart.00820.2014; Lin W, 2011, CLIN LAB, V57, P879; Liu HD, 2015, INT J CLIN EXP MED, V8, P13323; Monnier J, 2012, J IMMUNOL, V189, P956, DOI 10.4049/jimmunol.1102871; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Muruganandan S, 2011, J BIOL CHEM, V286, P23982, DOI 10.1074/jbc.M111.220491; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Pachynski RK, 2012, J EXP MED, V209, P1427, DOI 10.1084/jem.20112124; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Shah PK, 2003, CIRCULATION, V107, P2175, DOI 10.1161/01.CIR.0000069943.41206.BD; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Takahashi M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00123; Wang N, 2014, CLIN ORAL INVEST, V18, P997, DOI 10.1007/s00784-013-1046-8; Watts SW, 2013, ARTERIOSCL THROM VAS, V33, P1320, DOI 10.1161/ATVBAHA.113.301476; Weigert J, 2010, CLIN ENDOCRINOL, V72, P342, DOI 10.1111/j.1365-2265.2009.03664.x; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yang HS, 2012, CYTOKINE, V60, P646, DOI 10.1016/j.cyto.2012.07.033; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zhang O, 2015, CLIN CHIM ACTA, V448, P27, DOI 10.1016/j.cca.2015.05.018	37	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165305	10.1371/journal.pone.0165305	http://dx.doi.org/10.1371/journal.pone.0165305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792753	Green Published, Green Submitted, gold			2022-12-26	WOS:000389537000016
J	Ginsburg, AS; Agyemang, CT; Ambler, G; Delarosa, J; Brunette, W; Levari, S; Larson, C; Sundt, M; Newton, S; Borriello, G; Anderson, R				Ginsburg, Amy Sarah; Agyemang, Charlotte Tawiah; Ambler, Gwen; Delarosa, Jaclyn; Brunette, Waylon; Levari, Shahar; Larson, Clarice; Sundt, Mitch; Newton, Sam; Borriello, Gaetano; Anderson, Richard			mPneumonia, an Innovation for Diagnosing and Treating Childhood Pneumonia in Low-Resource Settings: A Feasibility, Usability and Acceptability Study in Ghana	PLOS ONE			English	Article							INTEGRATED MANAGEMENT; ILLNESS IMCI; PULSE OXIMETRY; HEALTH-WORKERS; SOUTH-AFRICA; CARE; CHILDREN; IMPLEMENTATION; TECHNOLOGY; OXYGEN	Pneumonia is the leading cause of infectious disease mortality in children. Currently, health care providers (HCPs) are trained to use World Health Organization Integrated Management of Childhood Illness (IMCI) paper-based protocols and manually assess respiratory rate to diagnose pneumonia in low-resource settings (LRS). However, this approach of relying on clinical signs alone has proven problematic. Hypoxemia, a diagnostic indicator of pneumonia severity associated with an increased risk of death, is not assessed because pulse oximetry is often not available in LRS. To improve HCPs' ability to diagnose, classify, and manage pneumonia and other childhood illnesses, "mPneumonia" was developed. mPneumonia is a mobile health application that integrates a digital version of the IMCI algorithm with a software-based breath counter and a pulse oximeter. A design-stage qualitative pilot study was conducted to assess feasibility, usability, and acceptability of mPneumonia in six health centers and five community-based health planning and services centers in Ghana. Nine health administrators, 30 HCPs, and 30 caregivers were interviewed. Transcribed interview audio recordings were coded and analyzed for common themes. Health administrators reported mPneumonia would be feasible to implement with approval and buy-in from national and regional decision makers. HCPs felt using the mPneumonia application would be feasible to integrate into their work with the potential to improve accurate patient care. They reported it was "easy to use" and provided confidence in diagnosis and treatment recommendations. HCPs and caregivers viewed the pulse oximeter and breath counter favorably. Challenges included electricity requirements for charging and the time needed to complete the application. Some caregivers saw mPneumonia as a sign of modernity, increasing their trust in the care received. Other caregivers were hesitant or confused about the new technology. Overall, this technology was valued by users and is a promising innovation for improving quality of care in frontline health facilities.	[Ginsburg, Amy Sarah] Save Children, Seattle, WA 98134 USA; [Agyemang, Charlotte Tawiah; Newton, Sam] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Ambler, Gwen; Delarosa, Jaclyn] PATH, Seattle, WA USA; [Brunette, Waylon; Levari, Shahar; Larson, Clarice; Sundt, Mitch; Borriello, Gaetano; Anderson, Richard] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA	Save the Children; Kintampo Health Research Centre; University of Washington; University of Washington Seattle	Ginsburg, AS (corresponding author), Save Children, Seattle, WA 98134 USA.	aginsburg@savechildren.org	Brunette, Waylon/ABC-8255-2020	Brunette, Waylon/0000-0001-8254-9440	United Nations Children's Fund	United Nations Children's Fund	The field testing in Ghana was funded by the United Nations Children's Fund (ASG, JD, CTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HM, 2010, HEALTH POLICY, V96, P128, DOI 10.1016/j.healthpol.2010.01.013; DeRenzi B, 2008, E IMCI IMPROVING PED; Duke T, 2010, INT J TUBERC LUNG D, V14, P1362; Duke T, 2009, ANN TROP PAEDIATR, V29, P165, DOI 10.1179/027249309X12467994190011; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Ginsburg AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139625; Ginsburg AS, 2012, J TROP PEDIATRICS, V58, P389, DOI 10.1093/tropej/fmr103; Horwood C, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-62; Kallander K, 2006, T ROY SOC TROP MED H, V100, P956, DOI 10.1016/j.trstmh.2005.11.004; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mitchell M, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-95; Mitchell M, 2012, J HEALTH COMMUN, V17, P118, DOI 10.1080/10810730.2011.649105; Mitchell M, 2012, INT J MED INFORM, V81, P166, DOI 10.1016/j.ijmedinf.2011.11.003; Mitchell M, 2009, INT J HEALTHC TECHNO, V10, P156, DOI 10.1504/IJHTM.2009.025819; Mukanga D, 2011, TROP MED INT HEALTH, V16, P1234, DOI 10.1111/j.1365-3156.2011.02831.x; Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; Shao AF, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0805-4; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNICEF, 2011, SYN ARI TIM RES REP; UNICEF, 2013, STRENGTH PNEUM DIAGN; United Nations Children's Fund (UNICEF), 2013, PNEUM DIAGN CURR OUT; Victora CG, 2006, B WORLD HEALTH ORGAN, V84, P792, DOI 10.2471/BLT.06.030502; Walter ND, 2009, B WORLD HEALTH ORGAN, V87, P99, DOI 10.2471/BLT.08.050740; World Health Organization, 2014, INTEGRATED MANAGEMEN; World Health Organization, 2016, OX THER CHILDR MAN H; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE	27	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165201	10.1371/journal.pone.0165201	http://dx.doi.org/10.1371/journal.pone.0165201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VY	27788179	Green Submitted, gold, Green Published			2022-12-26	WOS:000389604900052
J	Kondo, A; Takahashi, K; Mizuno, T; Kato, A; Hirano, D; Yamamoto, N; Hayashi, H; Koide, S; Takahashi, H; Hasegawa, M; Hiki, Y; Yoshida, S; Miura, K; Yuzawa, Y				Kondo, Ayako; Takahashi, Kazuo; Mizuno, Tomohiro; Kato, Akihiro; Hirano, Daisuke; Yamamoto, Naoki; Hayashi, Hiroki; Koide, Shigehisa; Takahashi, Hiroshi; Hasegawa, Midori; Hiki, Yoshiyuki; Yoshida, Shunji; Miura, Keiji; Yuzawa, Yukio			The Level of IgA Antibodies to Endothelial Cells Correlates with Histological Evidence of Disease Activity in Patients with Lupus Nephritis	PLoS One			English	Article							ANTI-DSDNA ANTIBODIES; CLINICAL-SIGNIFICANCE; ERYTHEMATOSUS; CLASSIFICATION; SLE; GLOMERULONEPHRITIS; AUTOANTIBODIES; ASSOCIATION; ACTIVATION; APOPTOSIS	Anti-endothelial cell antibodies (AECA) are frequently detected in patients with systemic lupus erythematosus (SLE), but their pathological role remains unclear. We recently developed a solubilized cell surface protein capture enzyme-linked immunosorbent assay (CSPELISA) to detect antibodies against membrane proteins involved in autoimmune reactions. In this study, sera from 51 patients with biopsy-proven lupus nephritis (LN), 25 with SLE without renal involvement (non-LN SLE), 42 disease control (DC) subjects, and 80 healthy control (HC) subjects were tested for IgG-and IgA-AECA for human umbilical vein endothelial cells (HUVEC) and human glomerular EC (HGEC) by using CSP-ELISA. IgG-and IgA-AECA titers were significantly higher in LN and non-LN SLE patients than in the DC or HC (P < 0.001) groups. IgG-and IgA-AECA titers for HUVEC corresponded well with those for HGEC. The IgA-AECA level correlated with the SLE disease activity index and with histological evidence of active lesions (cellular proliferations, hyaline thrombi and wire loops, leukocytic infiltration, and fibrinoid necrosis) in LN patients (P < 0.001). The sensitivity of IgA-AECA as a diagnostic test for histological evidence of active lesions in LN patients was 0.92, with a specificity of 0.70. The significant correlation of IgA-AECA with glomerular hypercellularity indicates that IgA-AECA are associated with endothelial damage in LN.	[Kondo, Ayako; Takahashi, Kazuo; Mizuno, Tomohiro; Kato, Akihiro; Hayashi, Hiroki; Koide, Shigehisa; Takahashi, Hiroshi; Hasegawa, Midori; Hiki, Yoshiyuki; Yuzawa, Yukio] Fujita Hlth Univ, Sch Med, Dept Nephrol, Toyoake, Aichi, Japan; [Mizuno, Tomohiro] Meijo Univ, Fac Pharm, Analyt Pharmacol, Nagoya, Aichi, Japan; [Hirano, Daisuke; Yoshida, Shunji] Fujita Hlth Univ, Sch Med, Dept Rheumatol, Toyoake, Aichi, Japan; [Yamamoto, Naoki] Fujita Hlth Univ, Inst Joint Res, Toyoake, Aichi, Japan; [Hiki, Yoshiyuki; Miura, Keiji] Fujita Hlth Univ, Sch Hlth Sci, Toyoake, Aichi, Japan	Fujita Health University; Meijo University; Fujita Health University; Fujita Health University; Fujita Health University	Takahashi, K (corresponding author), Fujita Hlth Univ, Sch Med, Dept Nephrol, Toyoake, Aichi, Japan.; Miura, K (corresponding author), Fujita Hlth Univ, Sch Hlth Sci, Toyoake, Aichi, Japan.	kazuot@fujita-hu.ac.jp; kmiura@fujita-hu.ac.jp	Yamamoto, Naoki/L-2603-2019		JSPS KAKENHI grant [23659312, 24890268, 26860652, 15H05292, 16K09632]; Japan Agency for Medical Research and Development; Takeda Science Foundation; Aichi Jinzou Foundation; Grants-in-Aid for Scientific Research [15H05292] Funding Source: KAKEN	JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Aichi Jinzou Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was funded by the JSPS KAKENHI grant number 23659312, 24890268, 26860652, 15H05292, and 16K09632, by a Grant-in-Aid for Practical Research Project for Renal Diseases, from the Japan Agency for Medical Research and Development, by Takeda Science Foundation, and by Aichi Jinzou Foundation.	AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; Belizna C, 2006, ANN RHEUM DIS, V65, P1545, DOI 10.1136/ard.2005.035295; Belizna C, 1997, SEMIN ARTHRITIS RHEU, V27, P98, DOI 10.1016/S0049-0172(97)80010-8; Bertsias GK, 2012, ANN RHEUM DIS, V71, P1771, DOI 10.1136/annrheumdis-2012-201940; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bordron A, 1998, J CLIN INVEST, V101, P2029, DOI 10.1172/JCI2261; Daha NA, 2011, MOL IMMUNOL, V48, P1656, DOI 10.1016/j.molimm.2011.04.024; Del Papa N, 1999, LUPUS, V8, P423; Domiciano DS, 2009, LUPUS, V18, P1233, DOI 10.1177/0961203309346654; Doria A, 2012, LUPUS, V21, P1492, DOI 10.1177/0961203312462267; Forger F, 2004, LUPUS, V13, P36, DOI 10.1191/0961203304lu485oa; Ghirardello A, 2004, J AUTOIMMUN, V22, P235, DOI 10.1016/j.jaut.2003.12.005; Hernandez NM, 2012, AM J PHYSIOL-RENAL, V302, pF884, DOI 10.1152/ajprenal.00250.2011; Holmen C, 2004, KIDNEY INT, V66, P1049, DOI 10.1111/j.1523-1755.2004.00853.x; Jarius S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-46; Manger K, 2002, ANN RHEUM DIS, V61, P1065, DOI 10.1136/ard.61.12.1065; MILTENBURG AMM, 1993, J RHEUMATOL, V20, P53; Miura K, 2012, J IMMUNOL METHODS, V382, P32, DOI 10.1016/j.jim.2012.05.002; Pisetsky DS, 2012, SCAND J IMMUNOL, V76, P223, DOI 10.1111/j.1365-3083.2012.02728.x; Praprotnik S, 2001, ARTHRITIS RHEUM-US, V44, P1484, DOI 10.1002/1529-0131(200107)44:7<1484::AID-ART269>3.0.CO;2-Q; Rajagopalan S, 2004, BLOOD, V103, P3677, DOI 10.1182/blood-2003-09-3198; Rekvig OP, 2014, SEMIN IMMUNOPATHOL, V36, P301, DOI 10.1007/s00281-014-0428-6; Rovin BH, 2009, CLIN J AM SOC NEPHRO, V4, P1858, DOI 10.2215/CJN.03530509; Sato N, 2011, LUPUS, V20, P1378, DOI 10.1177/0961203311415561; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Thompson T, 2008, ARTHRITIS RHEUM-US, V58, P835, DOI 10.1002/art.23196; Villalta D, 2003, LUPUS, V12, P31, DOI 10.1191/0961203303lu277oa; Villalta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071458; Waldman M, 2005, LUPUS, V14, P19, DOI 10.1191/0961203305lu2054oa; Ward MM, 1999, ARTHRITIS RHEUM, V42, P338, DOI 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Yang YH, 2002, CLIN EXP IMMUNOL, V130, P352, DOI 10.1046/j.1365-2249.2002.01964.x; YAP HK, 1988, CLIN IMMUNOL IMMUNOP, V49, P450, DOI 10.1016/0090-1229(88)90132-8; Youinou P, 2005, IMMUNOBIOLOGY, V210, P789, DOI 10.1016/j.imbio.2005.10.011	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0163085	10.1371/journal.pone.0163085	http://dx.doi.org/10.1371/journal.pone.0163085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788140	Green Submitted, gold, Green Published			2022-12-26	WOS:000389604900004
J	Rao, A; Padhy, D; Sarangi, S; Das, G				Rao, Aparna; Padhy, Debananda; Sarangi, Sarada; Das, Gopinath			Angle Closure Scoring System (ACSS)-A Scoring System for Stratification of Angle Closure Disease	PLoS One			English	Article							PLATEAU IRIS SYNDROME; ULTRASOUND BIOMICROSCOPY; CLINICAL-COURSE; GLAUCOMA; POPULATION; CLASSIFICATION; PROGRESSION; IRIDOTOMY; CHINESE; PHACOEMULSIFICATION	Purpose To evaluate the angle closure scoring system (ACSS) for stratifying primary angle course disease. Methods This observational cross sectional institutional study included patients with primary open angle glaucoma suspects (n = 21) and primary angle closure disease (primary angle closure, PAC, n = 63 and primary angle course glaucoma, PACG, n = 58 (defined by International society of Geographical and Epidemiological Ophthalmology, ISGEO). Two independent examiners blinded to clinical details, graded good quality pre-laser goniophotographs of the patients incorporating quadrants of peripheral anterior synechieae (PAS), non-visibility of posterior trabecular meshwork (PTM) and blotchy pigments (ranging from 1-4 quadrants), iris configuration, angle recess (sum of above depicting ACSS(g)) and lens thickness/axial length ratio (LT/AL), cup disc ratio and baseline intraocular pressure (IOP) to give total score (ACSS(t)). Result There were significant differences in ACSSg scores within the same ISGEO stage of PAC and PACG between eyes that required nil or > 1medicines after laser iridotomy, p<0.001. The ACSSg was associated with need for > 1 medicines in both PAC and PACG eyes, p< 0.001. An ACSSg score> 12 and 14 in PAC (odds ratio = 2.7(95% CI-1.7-5.9) and PACG (Odds ratio = 1.6(95% CI-1.19-2.2) predicted need for single medicines while ACSSg scores > 14 and 19 predicted need for >= 2 medicines in PAC and PACG eyes, respectively. The LT/Al ratio, IOP score or cup disc score did not influence the need for medical treatment independently. Conclusion The ACSS can be a useful clinical adjunct to the ISGEO system to predict need for medicines and prognosticate each stage more accurately.	[Rao, Aparna; Padhy, Debananda; Sarangi, Sarada; Das, Gopinath] LV Prasad Eye Inst, Glaucoma Serv, Bhubaneswar, Orissa, India	L. V. Prasad Eye Institute	Rao, A (corresponding author), LV Prasad Eye Inst, Glaucoma Serv, Bhubaneswar, Orissa, India.	aparna@lvpei.org		rao, Aparna/0000-0001-8120-8740				Alsagoff Z, 2000, OPHTHALMOLOGY, V107, P2300, DOI 10.1016/S0161-6420(00)00385-7; Aung T, 2004, OPHTHALMOLOGY, V111, P1464, DOI 10.1016/j.ophtha.2003.12.061; CHANDLER PA, 1955, ARCH OPHTHALMOL-CHIC, V53, P305, DOI 10.1001/archopht.1955.00930010307001; Chen PP, 2015, OPHTHALMOLOGY, V122, P1294, DOI 10.1016/j.ophtha.2015.03.021; CONGDON N, 1992, SURV OPHTHALMOL, V36, P411, DOI 10.1016/S0039-6257(05)80022-0; Congdon NG, 1997, OPHTHALMOLOGY, V104, P1489, DOI 10.1016/S0161-6420(97)30112-2; Foster PJ, 2004, BRIT J OPHTHALMOL, V88, P486, DOI 10.1136/bjo.2003.020016; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Guzman CP, 2013, INVEST OPHTH VIS SCI, V54, P5281, DOI 10.1167/iovs.13-12285; Kameda T, 2013, GRAEF ARCH CLIN EXP, V251, P825, DOI 10.1007/s00417-012-2091-8; Kim YY, 1997, SURV OPHTHALMOL, V42, P125, DOI 10.1016/S0039-6257(97)00023-4; LOWE R F, 1964, Br J Ophthalmol, V48, P544, DOI 10.1136/bjo.48.10.544; LOWE RF, 1988, AUST NZ J OPHTHALMOL, V16, P245, DOI 10.1111/j.1442-9071.1988.tb01216.x; LOWE RF, 1995, SURV OPHTHALMOL, V40, P163, DOI 10.1016/S0039-6257(95)80006-9; MAPSTONE R, 1974, BRIT J OPHTHALMOL, V58, P46, DOI 10.1136/bjo.58.1.46; Marchini G, 2015, PROG BRAIN RES, V221, P191, DOI 10.1016/bs.pbr.2015.05.001; Nolan WP, 2000, BRIT J OPHTHALMOL, V84, P1255, DOI 10.1136/bjo.84.11.1255; Nongpiur ME, 2013, OPHTHALMOLOGY, V120, P48, DOI 10.1016/j.ophtha.2012.07.005; Nongpiur ME, 2011, CURR OPIN OPHTHALMOL, V22, P96, DOI 10.1097/ICU.0b013e32834372b9; Quek DTL, 2011, AM J OPHTHALMOL, V152, P463, DOI 10.1016/j.ajo.2011.02.023; Rao A, 2015, SEMINOPHTHALMOL, V20, P1; Rao A, 2013, SEMIN OPHTHALMOL, V28, P28, DOI 10.3109/08820538.2012.730099; Rao A, 2013, SEMIN OPHTHALMOL, V28, P4, DOI 10.3109/08820538.2012.702260; SCHEIE HG, 1957, ARCH OPHTHALMOL-CHIC, V58, P510, DOI 10.1001/archopht.1957.00940010526005; Sihota R, 2000, CLIN EXP OPHTHALMOL, V28, P253, DOI 10.1046/j.1442-9071.2000.00324.x; Sihota R, 2005, J GLAUCOMA, V14, P387, DOI 10.1097/01.ijg.0000176934.14229.32; Sihota R, 2011, CURR OPIN OPHTHALMOL, V22, P87, DOI 10.1097/ICU.0b013e328343729f; Sihota R, 2010, J GLAUCOMA, V19, P632, DOI 10.1097/IJG.0b013e3181ca7de9; Speath GL, 1995, T AM OPHTHAL SOC, V93, P337; Tello Celso, 2002, Semin Ophthalmol, V17, P69, DOI 10.1076/soph.17.2.69.14722; Thomas R, 2003, ACTA OPHTHALMOL SCAN, V81, P480, DOI 10.1034/j.1600-0420.2003.00135.x; Trikha S, 2015, CURR OPIN OPHTHALMOL, V26, P128, DOI 10.1097/ICU.0000000000000128; WAND M, 1977, T AM ACAD OPHTHALMOL, V83, P122; Wang YE, 2013, INVEST OPHTH VIS SCI, V54, P3837, DOI 10.1167/iovs.12-11585; WEST RH, 1992, AUST NZ J OPHTHALMOL, V20, P23, DOI 10.1111/j.1442-9071.1992.tb00699.x; Wong HT, 2009, ARCH OPHTHALMOL-CHIC, V127, P256, DOI 10.1001/archophthalmol.2009.22	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0160209	10.1371/journal.pone.0160209	http://dx.doi.org/10.1371/journal.pone.0160209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788183	gold, Green Published, Green Submitted			2022-12-26	WOS:000389604900001
J	Dodge, B; Herbenick, D; Friedman, MR; Schick, V; Fu, TC; Bostwick, W; Bartelt, E; Munoz-Laboy, M; Pletta, D; Reece, M; Sandfort, TGM				Dodge, Brian; Herbenick, Debby; Friedman, M. Reuel; Schick, Vanessa; Fu, Tsung-Chieh (Jane); Bostwick, Wendy; Bartelt, Elizabeth; Munoz-Laboy, Miguel; Pletta, David; Reece, Michael; Sandfort, Theo G. M.			Attitudes toward Bisexual Men and Women among a Nationally Representative Probability Sample of Adults in the United States	PLOS ONE			English	Article							SEXUAL ORIENTATION; BLACK-MEN; HEALTH; EXPERIENCES; PREVALENCE; GAY; PREJUDICE; STIGMA; PERCEPTIONS; DISPARITIES	As bisexual individuals in the United States (U.S.) face significant health disparities, researchers have posited that these differences may be fueled, at least in part, by negative attitudes, prejudice, stigma, and discrimination toward bisexual individuals from heterosexual and gay/lesbian individuals. Previous studies of individual and social attitudes toward bisexual men and women have been conducted almost exclusively with convenience samples, with limited generalizability to the broader U.S. population. Our study provides an assessment of attitudes toward bisexual men and women among a nationally representative probability sample of heterosexual, gay, lesbian, and other-identified adults in the U.S. Data were collected from the 2015 National Survey of Sexual Health and Behavior (NSSHB), via an online questionnaire with a probability sample of adults (18 years and over) from throughout the U.S. We included two modified 5-item versions of the Bisexualities: Indiana Attitudes Scale (BIAS), validated sub-scales that were developed to measure attitudes toward bisexual men and women. Data were analyzed using descriptive statistics, gamma regression, and paired t-tests. Gender, sexual identity, age, race/ethnicity, income, and educational attainment were all significantly associated with participants' attitudes toward bisexual individuals. In terms of responses to individual scale items, participants were most likely to "neither agree nor disagree" with all attitudinal statements. Across sexual identities, self-identified other participants reported the most positive attitudes, while heterosexual male participants reported the least positive attitudes. As in previous research on convenience samples, we found a wide range of demographic characteristics were related with attitudes toward bisexual individuals in our nationally-representative study of heterosexual, gay/lesbian, and other-identified adults in the U.S. In particular, gender emerged as a significant characteristic; female participants' attitudes were more positive than male participants' attitudes, and all participants' attitudes were generally more positive toward bisexual women than bisexual men. While recent population data suggest a marked shift in more positive attitudes toward gay men and lesbian women in the general population of the U.S., the largest proportions of participants in our study reported a relative lack of agreement or disagreement with all affective-evaluative statements in the BIAS scales. Findings document the relative lack of positive attitudes toward bisexual individuals among the general population of adults in the U.S. and highlight the need for developing intervention approaches to promote more positive attitudes toward bisexual individuals, targeted toward not only heterosexual but also gay/lesbian individuals and communities.	[Dodge, Brian; Herbenick, Debby; Fu, Tsung-Chieh (Jane); Bartelt, Elizabeth; Pletta, David; Reece, Michael] Indiana Univ, Ctr Sexual Hlth Promot, Sch Publ Hlth, Bloomington, IN 47405 USA; [Friedman, M. Reuel] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Schick, Vanessa] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Bostwick, Wendy] Univ Illinois, Sch Nursing, Dept Hlth Syst Sci, Chicago, IL 61801 USA; [Munoz-Laboy, Miguel] Temple Univ, Sch Social Work, Philadelphia, PA 19122 USA; [Sandfort, Theo G. M.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA	Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health Science Center Houston; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Columbia University	Dodge, B (corresponding author), Indiana Univ, Ctr Sexual Hlth Promot, Sch Publ Hlth, Bloomington, IN 47405 USA.	bmdodge@indiana.edu	Pletta, David/AAU-3539-2021; Sandfort, Theo/D-1796-2011; Fu, Tsung-chieh/E-6136-2019; Dodge, Brian/H-3123-2013	Pletta, David/0000-0003-0363-153X; Sandfort, Theo/0000-0002-4986-1739; Fu, Tsung-chieh/0000-0003-2118-7225; Bartelt, Elizabeth/0000-0002-5984-3040; Herbenick, Debby/0000-0002-0352-2248; Dodge, Brian/0000-0003-4491-6603	Church & Dwight, Co., Inc.; Indiana University School of Public Health-Bloomington; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	Church & Dwight, Co., Inc.; Indiana University School of Public Health-Bloomington; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for the National Survey of Sexual Health & Behavior (NSSHB) is provided by Church & Dwight, Co., Inc. (Debby Herbenick, Principal Investigator). Additional funding for data collection using the BIAS was awarded by Indiana University School of Public Health-Bloomington (Brian Dodge, Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarie M, 2013, J BISEXUALITY, V13, P191, DOI 10.1080/15299716.2013.780004; Anderson E, 2016, FOCUS SEX RES, P1, DOI 10.1007/978-3-319-29412-4; Anderson E., 2014, 21 CENTURY JOCKS SPO; Anselmi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078990; Baldwin A, 2015, ARCH SEX BEHAV, V44, P2015, DOI 10.1007/s10508-014-0376-1; Barker MRC, 2012, 9781780074146 OP U C; Bartky SL, 1990, FEMININITY DOMINATIO; Biphobia Ochs R., 1996, BISEXUALITY PSYCHOL, P217; Bostwick W, 2014, CULT HEALTH SEX, V16, P488, DOI 10.1080/13691058.2014.889754; Bostwick WB, 2010, AM J PUBLIC HEALTH, V100, P468, DOI 10.2105/AJPH.2008.152942; Brewster ME, 2010, J COUNS PSYCHOL, V57, P451, DOI 10.1037/a0021116; Diamond L. M., 2008, SEXUAL FLUIDITY UNDE; Dodge B, 2014, BISEXUALITIES INDIAN; Dodge B., 2007, BECOMING VISIBLE COU, P28; Dodge B, 2008, ARCH SEX BEHAV, V37, P683, DOI 10.1007/s10508-008-9356-7; Dodge B, 2012, CULT HEALTH SEX, V14, P1095, DOI 10.1080/13691058.2012.721136; Dodge B, 2012, J BISEXUALITY, V12, P223, DOI 10.1080/15299716.2012.674862; Eliason M., 2000, J BISEXUALITY, V1, P137, DOI DOI 10.1300/J159V01N02_05; Eliason MJ, 1997, ARCH SEX BEHAV, V26, P317, DOI 10.1023/A:1024527032040; Flores AR, 2013, PUBLIC SUPPORT MARRI; Freire P., 2014, PEDAGOGY OPPRESSED 3; Friedman M, 2013, 141 APHA ANN M EXP N; Friedman MR, 2014, LGBT HEALTH, V1, P309, DOI 10.1089/lgbt.2014.0005; Friedman MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087139; Friedman MS, 2011, AM J PUBLIC HEALTH, V101, P1481, DOI 10.2105/AJPH.2009.190009; Friedman MR, 2016, ANN M INT AC SEX RES; Friedman MR, ARCH SEXUAL IN PRESS; Gallup, 2015, GAY LESB RIGHTS 2015; Garland R., 1991, MARKETING B, V2, P66, DOI DOI 10.1016/JIHEDUC.2013.06.002; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Hatzenbuehler ML, 2009, PSYCHOL BULL, V135, P707, DOI 10.1037/a0016441; Herbenick D, 2010, J SEX MED, V7, P255, DOI 10.1111/j.1743-6109.2010.02012.x; Herek GM, 2000, CURR DIR PSYCHOL SCI, V9, P19, DOI 10.1111/1467-8721.00051; Herek GM, 2002, J SEX RES, V39, P264, DOI 10.1080/00224490209552150; HEREK GM, 1988, J SEX RES, V25, P451, DOI 10.1080/00224498809551476; Herek GM, 2007, J SOC ISSUES, V63, P905, DOI 10.1111/j.1540-4560.2007.00544.x; Herek GM, 2013, ANNU REV PSYCHOL, V64, P309, DOI 10.1146/annurev-psych-113011-143826; Israel T., 2004, J BISEXUALITY, V4, P117, DOI [10.1300/J159v04n01_09, DOI 10.1300/J159V04N01_09]; Jeffries WL, 2014, AM J PREV MED, V47, P320, DOI 10.1016/j.amepre.2014.05.002; Lerum K, 2009, J SEX RES, V46, P250, DOI 10.1080/00224490903079542; Malebranche DJ, 2008, ARCH SEX BEHAV, V37, P810, DOI 10.1007/s10508-008-9364-7; McCormack M, 2014, SOCIOLOGY, V48, P1207, DOI 10.1177/0038038513518851; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Meyer IH, 2008, AM J PUBLIC HEALTH, V98, P1004, DOI 10.2105/AJPH.2006.096826; Miller M, 2007, BISEXUAL HLTH INTRO; Miller WB, 2016, DEMOGR RES, V34, P203, DOI 10.4054/DemRes.2016.34.7; Mitchell RC, 2015, PSYCHOL SEX, V6, P245, DOI 10.1080/19419899.2014.940372; Mohr JJ, 1999, J COUNS PSYCHOL, V46, P353, DOI 10.1037/0022-0167.46.3.353; Nadler JT, 2015, J GEN PSYCHOL, V142, P71, DOI 10.1080/00221309.2014.994590; Galupo MP, 2014, J BISEXUALITY, V14, P433, DOI 10.1080/15299716.2014.933466; Pew Research Center, 2015, MULT AM; Pew Research Center, 2016, SUPP STEAD SAM SEX M; Pew Research Center, 2013, GLOB DIV HOM 2013; Pratto F, 1997, BRIT J SOC PSYCHOL, V36, P49, DOI 10.1111/j.2044-8309.1997.tb01118.x; Reece M, 2010, J SEX MED, V7, P243, DOI 10.1111/j.1743-6109.2010.02038.x; Roberts TS, 2015, J BISEXUALITY, V15, P554, DOI 10.1080/15299716.2015.1111183; Rust PCR, 2002, ANN REV SEX RES, V13, P180; Rust PCR, 2000, J SOC ISSUES, V56, P205; Savin-Williams RC, 2012, ARCH SEX BEHAV, V41, P103, DOI 10.1007/s10508-012-9913-y; Sidanius J., 2001, SOCIAL DOMINANCE INT; Spalding LR, 1997, PSYCHOL WOMEN QUART, V21, P611, DOI 10.1111/j.1471-6402.1997.tb00134.x; Worthen MGF, 2013, SEX ROLES, V68, P703, DOI 10.1007/s11199-012-0155-1; Yost MR, 2012, ARCH SEX BEHAV, V41, P691, DOI 10.1007/s10508-011-9767-8; Zivony A, 2014, ARCH SEX BEHAV, V43, P1165, DOI 10.1007/s10508-014-0263-9	64	155	156	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164430	10.1371/journal.pone.0164430	http://dx.doi.org/10.1371/journal.pone.0164430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VE	27783644	gold, Green Published, Green Submitted			2022-12-26	WOS:000389602800039
J	Meneguzzi, VC; dos Santos, CB; Leite, GR; Fux, B; Falqueto, A				Meneguzzi, Viviane Coutinho; dos Santos, Claudiney Biral; Leite, Gustavo Rocha; Fux, Blima; Falqueto, Aloisio			Environmental Niche Modelling of Phlebotomine Sand Flies and Cutaneous Leishmaniasis Identifies Lutzomyia intermedia as the Main Vector Species in Southeastern Brazil	PLOS ONE			English	Article							VIANNIA BRAZILIENSIS; DIPTERA PSYCHODIDAE; ENDEMIC AREA; ESPIRITO-SANTO; FAUNA DIPTERA; MATO-GROSSO; STATE; CONSERVATION; PREDICTION; DISPERSAL	Cutaneous leishmaniasis (CL) is caused by a protozoan of the genus Leishmania and is transmitted by sand flies. The state of Espoirito Santo (ES), an endemic area in southeast Brazil, has shown a considerably high prevalence in recent decades. Environmental niche modelling (ENM) is a useful tool for predicting potential disease risk. In this study, ENM was applied to sand fly species and CL cases in ES to identify the principal vector and risk areas of the disease. Sand flies were collected in 466 rural localities between 1997 and 2013 using active and passive capture. Insects were identified to the species level, and the localities were georeferenced. Twenty-one bioclimatic variables were selected from WorldClim. Maxent was used to construct models projecting the potential distribution for five Lutzomyia species and CL cases. ENMTools was used to overlap the species and the CL case models. The Kruskal-Wallis test was performed, adopting a 5% significance level. Approximately 250,000 specimens were captured, belonging to 43 species. The area under the curve (AUC) was considered acceptable for all models. The slope was considered relevant to the construction of the models for all the species identified. The overlay test identified Lutzomyia intermedia as the main vector of CL in southeast Brazil. ENM tools enable an analysis of the association among environmental variables, vector distributions and CL cases, which can be used to support epidemiologic and entomological vigilance actions to control the expansion of CL in vulnerable areas.	[Meneguzzi, Viviane Coutinho; Leite, Gustavo Rocha; Fux, Blima] Univ Fed Espirito Santo, Dept Pathol, Trop Med Unit, Vitoria, ES, Brazil; [dos Santos, Claudiney Biral] Nucleus Entomol & Malacol, Espirito Santo State Hlth Secretariat, Serra, ES, Brazil; [Falqueto, Aloisio] Univ Fed Espirito Santo, Dept Social Med, Trop Med Unit, Vitoria, ES, Brazil; [Fux, Blima] Univ Fed Espirito Santo, Dept Patol, Vitoria, ES, Brazil; [Falqueto, Aloisio] Univ Fed Espirito Santo, Dept Med Trop, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	Meneguzzi, VC (corresponding author), Univ Fed Espirito Santo, Dept Pathol, Trop Med Unit, Vitoria, ES, Brazil.	vmeneguzzi@gmail.com	Fux, Blima/AAO-2941-2020; Leite, Gustavo/H-1292-2012	Leite, Gustavo/0000-0003-4320-3804; Fux, Blima/0000-0002-5038-3551	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES [32/2010]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES, http://www.capes.gov.br, grant number 32/2010 (AF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar GM, 2003, FLEBOTOMINEOS BRASIL; Almeida AS, INT J HLTH GEOGRAPHI, V12, P1; [Anonymous], 1994, CAD SAUDE PUBLICA, V4, P457; Aparicio C, 2004, REV SAUDE PUBL, V38, P511, DOI 10.1590/S0034-89102004000400005; Brasil. Ministerio da Saude (MS). Secretaria de Vigilancia em Saude, 2007, MAN VIG LEISHM TEG A; Chamaille L, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-31; Cupolillo E, 2003, J CLIN MICROBIOL, V41, P3126, DOI 10.1128/JCM.41.7.3126-3132.2003; da Costa SM, 2007, MEM I OSWALDO CRUZ, V102, P149, DOI 10.1590/S0074-02762007005000016; Salomon OD, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/601242; Dantas-Torres F, 2010, REV SOC BRAS MED TRO, V43, P733, DOI 10.1590/S0037-86822010000600028; das Virgens TM, 2008, CAD SAUDE PUBLICA, V24, P2969, DOI 10.1590/S0102-311X2008001200029; de Almeida PS, 2013, MEM I OSWALDO CRUZ, V108, P992, DOI 10.1590/0074-0276130331; de Oliveira Alessandra Gutierrez, 2003, Cad Saude Publica, V19, P933; Dorval MEC, 2009, MEM I OSWALDO CRUZ, V104, P695, DOI 10.1590/S0074-02762009000500005; Dutra GC, 2008, AMBIENCIA, P47; Falqueto A, 2003, MEM I OSWALDO CRUZ, V98, P1003, DOI 10.1590/S0074-02762003000800004; FALQUETO A, 1986, Memorias do Instituto Oswaldo Cruz, V81, P155, DOI 10.1590/S0074-02761986000200004; FALQUETO A, 1991, MEM I OSWALDO CRUZ, V86, P499, DOI 10.1590/S0074-02761991000400030; Falqueto A, THESIS; Feitoza LR, 2001, NATURAL RESOURCES IN; Ferreira AL, 2001, MEM I OSWALDO CRUZ, V96, P1061, DOI 10.1590/S0074-02762001000800006; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Filho SP, 1998, REV SOC BRAS MED TRO, V31, P575; Fischer D, 2011, PROCEDIA ENVIRON SCI, V7, P164, DOI 10.1016/j.proenv.2011.07.029; Forattini O P, 1976, Rev Saude Publica, V10, P31, DOI 10.1590/S0034-89101976000100003; Franco AO, 2011, PARASITOLOGY, V138, P1878, DOI 10.1017/S003118201100148X; Galati EAB, 1996, REV SAUDE PUBL, V30, P115, DOI 10.1590/S0034-89101996000200002; Gonzalez C, 2014, ACTA TROP, V129, P83, DOI 10.1016/j.actatropica.2013.08.014; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Governo do Estado do Espirito Santo (ES). Secretaria de Estado da Economia e Planejamento. Instituto Jones dos Santos Neves, 2011, DIN URB REG EST ESP; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOSMER DW, 2000, WILEY PS TX, P1; Leite GR, 2011, J BIOGEOGR, V38, P651, DOI 10.1111/j.1365-2699.2010.02442.x; Loiola CF, 2007, MEM I OSWALDO CRUZ, V102, P581, DOI 10.1590/S0074-02762007005000050; Martins Flavia, 2002, Revista de Patologia Tropical, V31, P211; Mayo Renata Caporalle, 1998, Revista da Sociedade Brasileira de Medicina Tropical, V31, P339, DOI 10.1590/S0037-86821998000400002; Nieto P, 2006, GEOSPATIAL HEALTH, V1, P115, DOI 10.4081/gh.2006.286; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Phillips S. J., 2016, BRIEF TUTORIAL MAXEN; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinto ID, 2012, BIOTA NEOTROP, V12, P323, DOI 10.1590/S1676-06032012000100025; Rangel EF, 2003, FLEBOTOMINEOS BRASIL, P291; Rangel EF, 1912, MEM I O CRUZ; Rocha LD, 2007, AM J TROP MED HYG, V76, P559, DOI 10.4269/ajtmh.2007.76.559; Roque Andre Luiz R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P251, DOI 10.1016/j.ijppaw.2014.08.004; Sacks David, 2008, P205; Saraiva L, 2012, MEM I OSWALDO CRUZ, V107, P867, DOI 10.1590/S0074-02762012000700005; Sessa PA, 1985, MED TROP, V18, P237; Shimabukuro PHF, 2011, BIOTA NEOTROP, V11, P68; Souza NA, 2002, MEM I OSWALDO CRUZ, V97, P759, DOI 10.1590/S0074-02762002000600001; Tabarelli M, 2005, CONSERV BIOL, V19, P695, DOI 10.1111/j.1523-1739.2005.00694.x; Vieira VP, 2012, AM J TROP MED HYG, V87, P1089, DOI 10.4269/ajtmh.2012.12-0470; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; World Health Organization (WHO), 2015, CAD SAUDE PUBLICA; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	56	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164580	10.1371/journal.pone.0164580	http://dx.doi.org/10.1371/journal.pone.0164580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VE	27783641	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800046
J	Tan, LL; Hoon, SS; Wong, FT				Tan, Lee Ling; Hoon, Shawn S.; Wong, Fong T.			Kinetic Controlled Tag-Catcher Interactions for Directed Covalent Protein Assembly	PLOS ONE			English	Article							SPYTAG-SPYCATCHER CHEMISTRY; GREEN FLUORESCENT PROTEIN; PEPTIDE TAG	Over the last few years, a number of different protein assembly strategies have been developed, greatly expanding the toolbox for controlling macromolecular assembly. One of the most promising developments is a rapid protein ligation approach using a short polypeptide SpyTag and its partner, SpyCatcher derived from Streptococcus pyogenes fibronectin-binding protein, FbaB. To extend this technology, we have engineered and characterized a new Tag-Catcher pair from a related fibronectin-binding protein in Streptococcus dysgalactiae. The polypeptide Tag, named SdyTag, was constructed based on the native Cna protein B-type (CnaB) domain and was found to be highly unreactive to SpyCatcher. SpyCatcher has 320-fold specificity for its native SpyTag compared to SdyTag. Similarly, SdyTag has a 75-fold specificity for its optimized Catcher, named SdyCatcher(DANG) short, compared to SpyCatcher. These Tag-Catcher pairs were used in combination to demonstrate specific sequential assembly of tagged proteins in vitro. We also demonstrated that the in vivo generation of circularized proteins in a Tag-Catcher specific manner where specific Tags can be left unreacted for use in subsequent ligation reactions. From the success of these experiments, we foresee the application of SdyTags and SpyTags, not only, for multiplexed control of protein assembly but also for the construction of novel protein architectures.	[Tan, Lee Ling; Hoon, Shawn S.; Wong, Fong T.] Inst Biomed Sci, Mol Engn Lab, Biopolis Dr, Singapore, Singapore		Wong, FT (corresponding author), Inst Biomed Sci, Mol Engn Lab, Biopolis Dr, Singapore, Singapore.	wongft@bmsi.a-star.edu.sg		Wong, Fong T./0000-0001-6145-5904				Antos JM, 2009, J BIOL CHEM, V284, P16028, DOI 10.1074/jbc.M901752200; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Carter PJ, 2011, EXP CELL RES, V317, P1261, DOI 10.1016/j.yexcr.2011.02.013; Chen AY, 2014, NAT MATER, V13, P515, DOI [10.1038/nmat3912, 10.1038/NMAT3912]; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; DeLano W.L., PYMOL MOL GRAPHICS S; DiMarco RL, 2012, ADV MATER, V24, P3923, DOI 10.1002/adma.201200051; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Fierer JO, 2014, P NATL ACAD SCI USA, V111, pE1176, DOI 10.1073/pnas.1315776111; Foo JL, 2012, BIOTECHNOL ADV, V30, P541, DOI 10.1016/j.biotechadv.2011.09.008; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Iraq News Network (INN), 2015, INN; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; Levary DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018342; Li L, 2014, J MOL BIOL, V426, P309, DOI 10.1016/j.jmb.2013.10.021; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lue RYP, 2004, J AM CHEM SOC, V126, P1055, DOI 10.1021/ja037914g; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schoene C, 2014, ANGEW CHEM INT EDIT, V53, P6101, DOI 10.1002/anie.201402519; Sun F, 2014, P NATL ACAD SCI USA, V111, P11269, DOI 10.1073/pnas.1401291111; Veggiani G, 2016, P NATL ACAD SCI USA, V113, P1202, DOI 10.1073/pnas.1519214113; Yang JY, 2015, I TASSER SERVER NEW; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zhang WB, 2013, J AM CHEM SOC, V135, P13988, DOI 10.1021/ja4076452	28	40	45	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165074	10.1371/journal.pone.0165074	http://dx.doi.org/10.1371/journal.pone.0165074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783674	gold, Green Published, Green Submitted			2022-12-26	WOS:000389602800056
J	Wang, MJ; Yu, TH; Hu, LN; Cheng, Z; Li, M				Wang, Meijiao; Yu, Tinghe; Hu, Lina; Cheng, Zhi; Li, Min			Ubiquitin Carboxy-Terminal HydrolaseL3 Correlates with Human Sperm Count, Motility and Fertilization	PLOS ONE			English	Article							DEUBIQUITINATING ENZYMES; RECIPROCAL MODULATORS; PROTEASOME SYSTEM; CELL APOPTOSIS; DEGRADATION; EXPRESSION; SPERMATOGENESIS; PROTEOLYSIS; INTERACTS; ISOZYMES	Ubiquitin C-terminal hydrolase L3 (UCHL3) belongs to the group of deubiquitinating enzymes and plays a part in apoptosis of germ cells and the differentiation of spermato-cytes into spermatids. However, the exact role of UCHL3 in human spermatogenesis and sperm function remains unknown. Here we examined the level and activity of UCHL3 in spermatozoa from men with asthenozoospermia (A), oligoasthenozoospermia (OA) or nor-mozoospermia (N). Immunofluorescence indicated that UCHL3 was mainly localized in the acrosome and throughout the flagella, and western blotting revealed a lower level in A or OA compared with N (p < 0.05). The catalytic activity of UCHL3 was decreased in spermatozoa from A or OA (p < 0.05, p < 0.001, respectively). The level and activity of UCHL3 were positively correlated with sperm count, concentration and motility. The UCHL3 level was positively correlated with the normal fertilization rate (FR) and percentage of embryos suitable for transfer/cryopreservation of in vitro fertilization (IVF). The UCHL3 activity was also positively correlated with FR, the percentage of embryos suitable for transfer/cryopreservation and high-quality embryos rate of IVF. Aforementioned correlations were not manifested in intra-cytoplasmic sperm injection (ICSI). These findings suggest that UCHL3 may play a role in male infertility.	[Wang, Meijiao] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Physiol, Chengdu, Peoples R China; [Wang, Meijiao; Yu, Tinghe; Hu, Lina] Chongqing Med Univ, Affiliated Hosp 2, Key Med Lab Obstet & Gynecol, Chongqing, Peoples R China; [Hu, Lina; Li, Min] Chongqing Med Univ, Affiliated Hosp 2, Ctr Reprod Med Obstet & Gynecol, Chongqing, Peoples R China; [Cheng, Zhi] Chongqing Med Univ, Sch Basic Med Sci, Chongqing, Peoples R China	Sichuan University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Wang, MJ (corresponding author), Sichuan Univ, West China Sch Preclin & Forens Med, Dept Physiol, Chengdu, Peoples R China.; Wang, MJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Key Med Lab Obstet & Gynecol, Chongqing, Peoples R China.	wangmeijiao1107@163.com		Yu, T/0000-0002-9014-7967	National Natural Science Foundation of China [81300535, 81300463]; Chongqing Natural Science Foundation [cstc2013jcyjA10075, cstc2013jcyjA10086]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This work was funded by grants from the National Natural Science Foundation of China (No. 81300535; 81300463), [http://www.nsfc..gov.cn/] and Chongqing Natural Science Foundation (No. cstc2013jcyjA10075; cstc2013jcyjA10086) [http://www.cstc.gov.cn/].; This work was funded by grants from the National Natural Science Foundation of China (81300535, 81300463) and the Chongqing Natural Science Foundation (cstc2013jcyjA10075, cstc2013jcyjA10086).	Aitken RJ, 1995, REPROD FERT DEVELOP, V7, P659, DOI 10.1071/RD9950659; Amer Soc Reprod Med Collaboration, 2008, FERTIL STERIL, V90, pS74, DOI 10.1016/j.fertnstert.2008.08.092; Baarends WM, 2000, J ENDOCRINOL INVEST, V23, P597, DOI 10.1007/BF03343782; Berruti G, 2005, BIOL REPROD, V72, P14, DOI 10.1095/biolreprod.104.030866; Bose R, 2014, ADV EXP MED BIOL, V759, P181, DOI 10.1007/978-1-4939-0817-2_9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen H, 2011, J ASSIST REPROD GEN, V28, P797, DOI 10.1007/s10815-011-9600-2; Curi SM, 2003, ARCH ANDROLOGY, V49, P343, DOI 10.1080/01485010390219656; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Gnesutta N, 2001, J BIOL CHEM, V276, P39448, DOI 10.1074/jbc.M103454200; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; Haraguchi CM, 2007, J HISTOCHEM CYTOCHEM, V55, P585, DOI 10.1369/jhc.6A7136.2007; Howes L, 2002, J REPROD IMMUNOL, V53, P181, DOI 10.1016/S0165-0378(01)00101-2; Kurihara LJ, 2000, MOL CELL BIOL, V20, P2498, DOI 10.1128/MCB.20.7.2498-2504.2000; Kwon J, 2004, AM J PATHOL, V165, P1367, DOI 10.1016/S0002-9440(10)63394-9; Kwon J, 2004, BIOL REPROD, V71, P515, DOI 10.1095/biolreprod.104.027565; Kwon J, 2007, EXP ANIM TOKYO, V56, P71, DOI 10.1538/expanim.56.71; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Mtango NR, 2012, J CELL PHYSIOL, V227, P1592, DOI 10.1002/jcp.22876; Sano Y, 2006, AM J PATHOL, V169, P132, DOI 10.2353/ajpath.2006.060085; Suresh B, 2015, CELL MOL LIFE SCI, V72, P4711, DOI 10.1007/s00018-015-2030-z; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319; Sutovsky P, 2015, ASIAN J ANDROL, V17, P554, DOI 10.4103/1008-682X.153847; Wang MJ, 2012, ANTIOXID REDOX SIGN, V17, P513, DOI 10.1089/ars.2012.4514; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yi YJ, 2007, BIOL REPROD, V77, P780, DOI 10.1095/biolreprod.107.061275	27	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165198	10.1371/journal.pone.0165198	http://dx.doi.org/10.1371/journal.pone.0165198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780264	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900035
J	Wu, YH; Yen, CJ; Hsiao, JR; Ou, CY; Huang, JS; Wong, TY; Tsai, ST; Huang, CC; Lee, WT; Chen, KC; Fang, SY; Wu, JL; Hsueh, WT; Lin, FC; Yang, MW; Chang, JY; Liao, HC; Wu, SY; Lin, CL; Wang, YH; Weng, YL; Yang, HC; Chen, YS; Chang, JS				Wu, Yuan-Hua; Yen, Chia-Jui; Hsiao, Jenn-Ren; Ou, Chun-Yen; Huang, Jehn-Shyun; Wong, Tung-Yiu; Tsai, Sen-Tien; Huang, Cheng-Chih; Lee, Wei-Ting; Chen, Ken-Chung; Fang, Sheen-Yie; Wu, Jiunn-Liang; Hsueh, Wei-Ting; Lin, Forn-Chia; Yang, Ming-Wei; Chang, Jang-Yang; Liao, Hsiao-Chen; Wu, Shang-Yin; Lin, Chen-Lin; Wang, Yi-Hui; Weng, Ya-Ling; Yang, Han-Chien; Chen, Yu-Shan; Chang, Jeffrey S.			A Comprehensive Analysis on the Association between Tobacco-Free Betel Quid and Risk of Head and Neck Cancer in Taiwanese Men	PLOS ONE			English	Article							ORAL-CANCER; ALCOHOL-DRINKING; SMOKING; CONSUMPTION; INDIA	Objectives Although betel quid (BQ) is an established risk factor of head and neck cancer (HNC), insufficiencies exist in the literature regarding the dose-response, BQ types, HNC sites, and BQ cessation. The current study was conducted to fill these insufficiencies. Materials and Methods A hospital-based case-control study was conducted to evaluate the association between BQ and HNC. In-person interview was conducted to collect data on BQ chewing. The current analysis included 487 men newly diagnosed with HNC and 617 male controls who were frequency-matched to the cases by age. The association between BQ and HNC was assessed using multivariable unconditional logistic regression. Results Ever BQ chewing was associated with an increased HNC risk regardless of the BQ types. A non-linear positive association between BQ and HNC was observed, with a steep rise in HNC risk for the first 5 pack-years or 200,000 minutes of BQ consumption. Every year of BQ cessation was associated with a 2.9% reduction in HNC risk; however, the risk did not reduce to the level of non-BQ chewers even after 20 years of BQ cessation. Eliminating BQ chewing may prevent 51.6% of HNCs, 62.6% of oral cancers, and 41.3% of pharyngeal cancers in Taiwan. Conclusion Our results supported the positive association between BQ and HNC. BQ cessation is effective in reducing HNC risk and should be encouraged. Because BQ cessation may not reduce the HNC risk to the level of non-BQ chewers, it is important to prevent the initiation	[Wu, Yuan-Hua; Hsueh, Wei-Ting; Lin, Forn-Chia; Yang, Ming-Wei] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Radiat Oncol, Tainan, Taiwan; [Yen, Chia-Jui; Chang, Jang-Yang; Wu, Shang-Yin] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med,Div Hematol Oncol, Tainan, Taiwan; [Hsiao, Jenn-Ren; Ou, Chun-Yen; Huang, Cheng-Chih; Lee, Wei-Ting; Fang, Sheen-Yie; Wu, Jiunn-Liang; Liao, Hsiao-Chen; Chen, Yu-Shan] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Otolaryngol, Tainan, Taiwan; [Huang, Jehn-Shyun; Wong, Tung-Yiu; Chen, Ken-Chung] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Stomatol, Tainan, Taiwan; [Chang, Jang-Yang; Wang, Yi-Hui; Weng, Ya-Ling; Yang, Han-Chien; Chang, Jeffrey S.] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Lin, Chen-Lin] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Nursing, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital	Chang, JS (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	jefireychang@nhri.org.tw	Chang, Jeffrey Shu-Ming/AAR-4161-2020	Chang, Jeffrey Shu-Ming/0000-0002-3236-6205; WU, SHANG-YIN/0000-0003-2914-510X	Establishment of Cancer Research System Excellence Program - Ministry of Health and Welfare, Taiwan [MONW105-TDU-B-211-134-004, MOHW105-TDU-B-212-134-013]; National Health Research Institutes [CA-105-SP-01]	Establishment of Cancer Research System Excellence Program - Ministry of Health and Welfare, Taiwan; National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This work was supported by the Establishment of Cancer Research System Excellence Program funded by the Ministry of Health and Welfare, Taiwan (MONW105-TDU-B-211-134-004, MOHW105-TDU-B-212-134-013) and by the National Health Research Institutes (CA-105-SP-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaram P, 2002, INT J CANCER, V98, P440, DOI 10.1002/ijc.10200; Bharali MK, 2014, HUM ECOL RISK ASSESS, V20, P527, DOI 10.1080/10807039.2012.738148; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Gregory M, 2008, COMPUT METH PROG BIO, V92, P109, DOI 10.1016/j.cmpb.2008.05.004; Guha N, 2014, INT J CANCER, V135, P1433, DOI 10.1002/ijc.28643; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Hsu WL, 2014, INT J CANCER, V135, P1480, DOI 10.1002/ijc.28791; Hwang TZ, 2015, INT J CANCER, V137, P395, DOI 10.1002/ijc.29330; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V85, P1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MONOGR EVAL CAR, V100, P1; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Lee CH, 2012, INT J CANCER, V131, pE733, DOI 10.1002/ijc.27401; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Ministry of Health and Welfare Taiwan R.O.C, 2011, ANN CANC REP; MURTI PR, 1985, COMMUNITY DENT ORAL, V13, P340, DOI 10.1111/j.1600-0528.1985.tb00468.x; Muwonge R, 2008, ORAL ONCOL, V44, P446, DOI 10.1016/j.oraloncology.2007.06.002; Prabhu Rachana V, 2014, J Clin Exp Dent, V6, pe569, DOI 10.4317/jced.51318; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Stayner L, 2003, SCAND J WORK ENV HEA, V29, P317, DOI 10.5271/sjweh.737; Znaor A, 2003, INT J CANCER, V105, P681, DOI 10.1002/ijc.11114	21	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164937	10.1371/journal.pone.0164937	http://dx.doi.org/10.1371/journal.pone.0164937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780233	Green Published, gold, Green Submitted			2022-12-26	WOS:000389046900024
J	Bendavit, G; Aboulkassim, T; Hilmi, K; Shah, S; Batist, G				Bendavit, Gabriel; Aboulkassim, Tahar; Hilmi, Khalid; Shah, Sujay; Batist, Gerald			Nrf2 Transcription Factor Can Directly Regulate mTOR: LINKING CYTOPROTECTIVE GENE EXPRESSION TO A MAJOR METABOLIC REGULATOR THAT GENERATES REDOX ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone methylation; mammalian target of rapamycin (mTOR); NF-B (NF-KB); nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); phosphatidylinositol kinase (PI kinase)	NF-KAPPA-B; OXIDATIVE STRESS; BREAST-CANCER; MOLECULAR-MECHANISMS; INFLAMMATORY RESPONSE; SIGNALING PATHWAY; ACTIVATION; METHYLATION; APOPTOSIS; CELLS	Nrf2 is a master transcription factor that regulates a wide variety of cellular proteins by recognizing and binding to antioxidant response elements (AREs) in their gene promoter regions. In this study we show that increasing cellular Nrf2 results in transcriptional activation of the gene for mTOR, which is central to the PI3K signaling pathway. This is the case in cells with normal physiological PI3K. However, in cells with abnormally active PI3K increased cellular Nrf2 levels have no effect on mTOR. ChIP assays results show that increased Nrf2 binding is associated with decreased p65 binding and H3-K27me3 signal (marker of gene repression) as well as increased H3-K4me3 signal (marker of gene activation). However, in cells with PI3K activation, no effect of cellular Nrf2 increase on mTOR transcription was observed. In these cells, increasing Nrf2 levels increases Nrf2 promoter binding marginally, whereas p65 binding and H3-K27me3 mark were significantly increased, and H3-K4me3 signal is reduced. Together, these data show for the first time that Nrf2 directly regulates mTOR transcription when the PI3K pathway is intact, whereas this function is lost when PI3K is activated. We have identified a link between the Nrf2 system of sensing environmental stress and mTOR, which is a key cellular protein in metabolism. Studies in cells with activating mutations in the PI3K pathway suggest that Nrf2 transcriptional regulation of mTOR is related to promoter binding of p65 and of methylation of histone residues permissive of transcription.	[Bendavit, Gabriel; Aboulkassim, Tahar; Hilmi, Khalid; Shah, Sujay; Batist, Gerald] McGill Univ, Lady Davis Inst, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University	Batist, G (corresponding author), McGill Univ, Segal Canc Ctr, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.; Batist, G (corresponding author), McGill Univ, Oncol, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	gerald.batist@mcgill.ca			Canadian Institutes for Health Research (CIHR) [MOP-126073]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research (CIHR) Grant MOP-126073. The authors declare that they have no conflicts of interest with the contents of this article.	Cescon DW, 2015, CLIN CANCER RES, V21, P2499, DOI 10.1158/1078-0432.CCR-14-2206; Chan J, 2014, CURR TREAT OPTION ON, V15, P365, DOI 10.1007/s11864-014-0294-4; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Chuang JI, 2015, FREE RADICAL BIO MED, V89, P274, DOI 10.1016/j.freeradbiomed.2015.08.011; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; George LE, 2012, AM J PHYSIOL-RENAL, V302, pF1440, DOI 10.1152/ajprenal.00006.2012; Guichard SM, 2015, MOL CANCER THER, V14, P2508, DOI 10.1158/1535-7163.MCT-15-0365; Ha KN, 2006, INVEST OPHTH VIS SCI, V47, P2709, DOI 10.1167/iovs.05-1322; Harada S, 2015, J PHARMACOL EXP THER, V355, P353, DOI 10.1124/jpet.115.226431; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Herndon TM, 2005, BIOCHEM BIOPH RES CO, V332, P1133, DOI 10.1016/j.bbrc.2005.05.064; Jin R, 2011, STROKE, V42, P2033, DOI 10.1161/STROKEAHA.110.601369; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Johnston SRD, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv212; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kloo B, 2011, P NATL ACAD SCI USA, V108, P272, DOI 10.1073/pnas.1008969108; Le Page C, 2005, PROSTATE, V65, P306, DOI 10.1002/pros.20291; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Loignon M, 2009, MOL CANCER THER, V8, P2432, DOI 10.1158/1535-7163.MCT-08-1186; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Pan H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/217580; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rao CY, 2015, WORLD J GASTROENTERO, V21, P4555, DOI 10.3748/wjg.v21.i15.4555; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sasaki H, 2012, ONCOL LETT, V4, P1167, DOI 10.3892/ol.2012.938; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen GX, 2009, BIOPHARM DRUG DISPOS, V30, P345, DOI 10.1002/bdd.680; Shibata T, 2010, CANCER RES, V70, P9095, DOI 10.1158/0008-5472.CAN-10-0384; Shin JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096035; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Verma AK, 2015, REDOX BIOL, V6, P80, DOI 10.1016/j.redox.2015.06.020; Vicier C, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3618; Watanabe R, 2011, J NUCL MED, V52, P497, DOI 10.2967/jnumed.111.089623; XIE T, 1995, J BIOL CHEM, V270, P6894, DOI 10.1074/jbc.270.12.6894; Yamadori T, 2012, ONCOGENE, V31, P4768, DOI 10.1038/onc.2011.628; Yoo KH, 2012, INT J BIOL SCI, V8, P59, DOI 10.7150/ijbs.8.59; Yu MA, 2011, CELL SIGNAL, V23, P883, DOI 10.1016/j.cellsig.2011.01.014; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005	53	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25476	25488		10.1074/jbc.M116.760249	http://dx.doi.org/10.1074/jbc.M116.760249			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27784786	Green Published, hybrid			2022-12-26	WOS:000390095300017
J	Ma, FS; Zhang, L; Wang, Y; Lu, RG; Hu, B; Lv, S; Xue, XH; Li, XT; Ling, MY; Fan, SN; Zhang, HL; Yan, XJ				Ma, Fanshu; Zhang, Lei; Wang, Yang; Lu, Rongguang; Hu, Bo; Lv, Shuang; Xue, Xianghong; Li, Xintong; Ling, Mingyu; Fan, Sining; Zhang, Hailing; Yan, Xijun			Development of a Peptide ELISA for the Diagnosis of Aleutian Mink Disease	PLOS ONE			English	Article							SEROLOGICAL RESPONSES; VIRUS; ANTIBODIES; INFECTION; ERADICATION; PROTEINS; PATHOGENICITY; VALIDATION; PREDICTION; EPITOPES	Aleutian disease (AD) is a common immunosuppressive disease in mink farms world-wide. Since the 1980s, counterimmunoelectrophoresis (CIEP) has been the main detection method for infection with the Aleutian Mink Disease Virus (AMDV). In this study, six peptides derived from the AMDV structural protein VP2 were designed, synthesized, and used as ELISA antigens to detect anti-AMDV antibodies in the sera of infected minks. Serum samples were collected from 764 minks in farms from five different provinces, and analyzed by both CIEP (a gold standard) and peptide ELISA. A peptide designated P1 (415 aa-433 aa) exhibited good antigenicity. A novel ELISA was developed using ovalbumin-linked peptide P1 to detect anti-AMDV antibodies in mink sera. The sensitivity and specificity of the peptide ELISA was 98.0% and 97.5%, respectively. Moreover, the ELISA also detected 342 early-stage infected samples (negative by CIEP and positive by PCR), of which 43.6% (149/342) were true positives. These results showed that the peptide ELISA had better sensitivity compared with CIEP, and therefore could be preferable over CIEP for detecting anti-AMDV antibodies in serological screening.	[Ma, Fanshu; Zhang, Lei; Wang, Yang; Lu, Rongguang; Hu, Bo; Lv, Shuang; Xue, Xianghong; Li, Xintong; Ling, Mingyu; Fan, Sining; Zhang, Hailing; Yan, Xijun] Chinese Acad Agr Sci, Inst Special Anim & Plant Sci, Div Infect Dis Special Anim, Changchun, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Special Animal & Plant Sciences, CAAS	Yan, XJ (corresponding author), Chinese Acad Agr Sci, Inst Special Anim & Plant Sci, Div Infect Dis Special Anim, Changchun, Peoples R China.	yanxijun@caas.cn		Ma, Fanshu/0000-0002-5258-9158	Jilin Province Science and Technology Program [20140204074NY]	Jilin Province Science and Technology Program	This study was funded by the Jilin Province Science and Technology Program (20140204074NY). The funder is Zhang Lei, who has taken part in study design, data collection and analysis, and the decision to publish.	AASTED B, 1982, ACTA PATH MICRO IM C, V90, P15; AASTED B, 1986, ACTA VET SCAND, V27, P410; ALEXANDERSEN S, 1985, ELECTROPHORESIS, V6, P535, DOI 10.1002/elps.1150061104; Amat-ur-Rasool H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119854; Andersson AM, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-86; Bloom ME, 1997, J VIROL, V71, P705, DOI 10.1128/JVI.71.1.705-714.1997; Bloom ME, 2001, J VIROL, V75, P11116, DOI 10.1128/JVI.75.22.11116-11127.2001; CHAPMAN MS, 1993, VIROLOGY, V194, P491, DOI 10.1006/viro.1993.1288; Chen X, 2015, J CLIN MICROBIOL, P02625; CHO HJ, 1978, J CLIN MICROBIOL, V7, P18; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Costello F, 1999, SCAND J IMMUNOL, V49, P347; Farid AH, 2012, PREV VET MED, V106, P332, DOI 10.1016/j.prevetmed.2012.03.010; Farid AH, 2015, J VET DIAGN INVEST, V27, P287, DOI 10.1177/1040638715580982; Gorham J R, 1976, Front Biol, V44, P135; Gray DP, 1964, THESIS; Gunnarsson E, 2001, ACTA VET SCAND, P87; HADLOW WJ, 1983, INFECT IMMUN, V41, P1016, DOI 10.1128/IAI.41.3.1016-1023.1983; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Huang QF, 2014, VIROLOGY, V452, P23, DOI 10.1016/j.virol.2014.01.005; Hussain I, 2014, VET MICROBIOL, V173, P50, DOI 10.1016/j.vetmic.2014.07.014; Jensen TH, 2011, J VIROL METHODS, V171, P81, DOI 10.1016/j.jviromet.2010.10.004; Jensen TH, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0214-7; Jensen TH, 2014, VET MICROBIOL, V168, P420, DOI 10.1016/j.vetmic.2013.11.041; Jepsen JR, 2009, EMERG INFECT DIS, V15, P2040, DOI 10.3201/eid1512.090514; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KENYON AJ, 1978, AM J VET RES, V39, P1011; Knuuttila A, 2009, CLIN VACCINE IMMUNOL, V16, P1360, DOI 10.1128/CVI.00148-09; Lang A, 2013, J VIROL METHODS, V193, P667, DOI 10.1016/j.jviromet.2013.07.044; Menezes-Souza D, 2015, APPL MICROBIOL BIOT, V99, P1323, DOI 10.1007/s00253-014-6168-7; Oem Jae Ku, 2005, J Vet Sci, V6, P317; Oie KL, 1996, J VIROL, V70, P852, DOI 10.1128/JVI.70.2.852-861.1996; Oleksiewicz MB, 2005, J VIROL METHODS, V129, P134, DOI 10.1016/j.jviromet.2005.05.017; Pennick KE, 2007, VET PATHOL, V44, P687, DOI 10.1354/vp.44-5-687; Pennick KE, 2005, J VET DIAGN INVEST, V17, P594, DOI 10.1177/104063870501700614; Plagemann PGW, 2006, J VIROL METHODS, V134, P99, DOI 10.1016/j.jviromet.2005.12.003; PORTER DD, 1986, PROG MED VIROL, V33, P42; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Saha Sudipto, 2007, V409, P387, DOI 10.1007/978-1-60327-118-9_29; Soria-Guerra RE, 2015, J BIOMED INFORM, V53, P405, DOI 10.1016/j.jbi.2014.11.003; Soutullo A, 2001, VET MICROBIOL, V79, P111, DOI 10.1016/S0378-1135(00)00352-7; Sun P, 2013, COMPUT MATH METHOD M, V2013, P529; Uttenthal A., 1992, APPL THEORETICAL ELE, V3; Velumani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020737; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang ZJ, 2014, VIRUS RES, V184, P14, DOI 10.1016/j.virusres.2014.02.007; Zhang L, 2013, BINGDUXUEBAO, V11, P102	47	14	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165793	10.1371/journal.pone.0165793	http://dx.doi.org/10.1371/journal.pone.0165793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802320	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200055
J	Prest, EI; Weissbrodt, DG; Hammes, F; van Loosdrecht, MCM; Vrouwenvelder, JS				Prest, E. I.; Weissbrodt, D. G.; Hammes, F.; van Loosdrecht, M. C. M.; Vrouwenvelder, J. S.			Long-Term Bacterial Dynamics in a Full-Scale Drinking Water Distribution System	PLOS ONE			English	Article							ASSIMILABLE ORGANIC-CARBON; ASSESSING BIOLOGICAL STABILITY; FLOW-CYTOMETRY; HETEROTROPHIC BACTERIA; PIPE MATERIALS; BIOMASS; QUALITY; DISINFECTANT; ENUMERATION; VIABILITY	Large seasonal variations in microbial drinking water quality can occur in distribution networks, but are often not taken into account when evaluating results from short- term water sampling campaigns. Temporal dynamics in bacterial community characteristics were investigated during a two- year drinking water monitoring campaign in a full- scale distribution system operating without detectable disinfectant residual. A total of 368 water samples were collected on a biweekly basis at the water treatment plant (WTP) effluent and at one fixed location in the drinking water distribution network (NET). The samples were analysed for heterotrophic plate counts (HPC), Aeromonas plate counts, adenosine- tri- phosphate (ATP) concentrations, and flow cytometric (FCM) total and intact cell counts (TCC, ICC), water temperature, pH, conductivity, total organic carbon (TOC) and assimilable organic carbon (AOC). Multivariate analysis of the large dataset was performed to explore correlative trends between microbial and environmental parameters. The WTP effluent displayed considerable seasonal variations in TCC (from 90 x 10(3) cells mL(-1) in winter time up to 455 x 10(3) cells mL(-1) in summer time) and in bacterial ATP concentrations (< 1-3.6 ng L-1), which were congruent with water temperature variations. These fluctuations were not detected with HPC and Aeromonas counts. The water in the network was predominantly influenced by the characteristics of the WTP effluent. The increase in ICC between the WTP effluent and the network sampling location was small (34 x 10(3) cells mL(-1) on average) compared to seasonal fluctuations in ICC in the WTP effluent. Interestingly, the extent of bacterial growth in the NET was inversely correlated to AOC concentrations in the WTP effluent (Pearson's correlation factor r = - 0.35), and positively correlated with water temperature (r = 0.49). Collecting a large dataset at high frequency over a two year period enabled the characterization of previously undocumented seasonal dynamics in the distribution network. Moreover, high- resolution FCM data enabled prediction of bacterial cell concentrations at specific water temperatures and time of year. The study highlights the need to systematically	[Prest, E. I.; Weissbrodt, D. G.; van Loosdrecht, M. C. M.; Vrouwenvelder, J. S.] Delft Univ Technol, Fac Sci Appl, Dept Biotechnol, Van der Maasweg 9, NL-2629 HZ Delft, Netherlands; [Weissbrodt, D. G.] Aalborg Univ, Ctr Microbial Communities, Dept Chem & Biosci, Fredrik Bajers Vej 7, DK-9220 Aalborg, Denmark; [Hammes, F.] Eawag, Swiss Fed Inst Aquat Sci & Technol, Ueberlandstr 133, CH-8600 Dubendorf, Switzerland; [Vrouwenvelder, J. S.] KAUST, WDRC, Div Biol & Environm Sci & Engn BESE, Thuwal 239556900, Saudi Arabia; [Vrouwenvelder, J. S.] Wetsus, European Ctr Excellence Sustainable Water Technol, Oostergoweg 9, NL-8911 MA Leeuwarden, Netherlands	Delft University of Technology; Aalborg University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); King Abdullah University of Science & Technology	Vrouwenvelder, JS (corresponding author), Delft Univ Technol, Fac Sci Appl, Dept Biotechnol, Van der Maasweg 9, NL-2629 HZ Delft, Netherlands.; Vrouwenvelder, JS (corresponding author), KAUST, WDRC, Div Biol & Environm Sci & Engn BESE, Thuwal 239556900, Saudi Arabia.; Vrouwenvelder, JS (corresponding author), Wetsus, European Ctr Excellence Sustainable Water Technol, Oostergoweg 9, NL-8911 MA Leeuwarden, Netherlands.	J.S.Vrouwenvelder@tudelft.nl	van Loosdrecht, Mark/AAA-9997-2019; van Loosdrecht, Mark C.M./B-2738-2009; Vrouwenvelder, Johannes/AAX-1192-2021; Weissbrodt, David Gregory/A-2101-2017	van Loosdrecht, Mark C.M./0000-0003-0658-4775; Vrouwenvelder, Johannes/0000-0003-2668-2057; Weissbrodt, David Gregory/0000-0002-6313-1652	Evides Waterbedrijf	Evides Waterbedrijf	The presented work was funded by Evides Waterbedrijf, who also contributed to sample collection and part of routine analysis.	Berney M, 2008, WATER RES, V42, P4010, DOI 10.1016/j.watres.2008.07.017; Besmer MD, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00265; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; El-Chakhtoura J, 2015, WATER RES, V74, P180, DOI 10.1016/j.watres.2015.02.015; Escobar IC, 2001, ENVIRON SCI TECHNOL, V35, P3442, DOI 10.1021/es0106669; Fonseca AC, 2001, WATER RES, V35, P3817, DOI 10.1016/S0043-1354(01)00104-X; Francisque A, 2009, WATER RES, V43, P1075, DOI 10.1016/j.watres.2008.11.030; Gagnon GA, 2004, J ENVIRON ENG, V130, P1269, DOI 10.1061/(ASCE)0733-9372(2004)130:11(1269); Hammes FA, 2005, ENVIRON SCI TECHNOL, V39, P3289, DOI 10.1021/es048277c; Hammes F, 2008, WATER RES, V42, P269, DOI 10.1016/j.watres.2007.07.009; Hammes F, 2006, WATER RES, V40, P2275, DOI 10.1016/j.watres.2006.04.029; Hammes F, 2010, WATER RES, V44, P3915, DOI 10.1016/j.watres.2010.04.015; Hammes F, 2010, J WATER SUPPLY RES T, V59, P31, DOI 10.2166/aqua.2010.052; Herzsprung P, 2012, ENVIRON SCI TECHNOL, V46, P5511, DOI 10.1021/es300345c; Hoefel D, 2005, J APPL MICROBIOL, V99, P175, DOI 10.1111/j.1365-2672.2005.02573.x; Hoefel D, 2003, J MICROBIOL METH, V55, P585, DOI 10.1016/S0167-7012(03)00201-X; Hwang C, 2012, APPL ENVIRON MICROB, V78, P7856, DOI 10.1128/AEM.01892-12; Lautenschlager K, 2013, WATER RES, V47, P3015, DOI 10.1016/j.watres.2013.03.002; LECHEVALLIER MW, 1991, APPL ENVIRON MICROB, V57, P857, DOI 10.1128/AEM.57.3.857-862.1991; LeChevallier MW, 1996, APPL ENVIRON MICROB, V62, P2201, DOI 10.1128/AEM.62.7.2201-2211.1996; LECHEVALLIER MW, 1987, APPL ENVIRON MICROB, V53, P2714, DOI 10.1128/AEM.53.12.2714-2724.1987; Ledesma JLJ, 2012, SCI TOTAL ENVIRON, V432, P1, DOI 10.1016/j.scitotenv.2012.05.071; Lenz J, 2010, INT J HYG ENVIR HEAL, V213, P198, DOI 10.1016/j.ijheh.2010.04.006; Lisle J.T., 1998, SAE TECHNICAL PAPERS; Liu G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/595872; Madigan M.T., 2006, BROCK BIOL MICROORGA, P150; Magic-Knezev A, 2004, WATER RES, V38, P3971, DOI 10.1016/j.watres.2004.06.017; MAUL A, 1985, SCI TOTAL ENVIRON, V44, P201, DOI 10.1016/0048-9697(85)90094-4; McCoy ST, 2012, J ENVIRON ENG, V138, P786, DOI 10.1061/(ASCE)EE.1943-7870.0000539; Nescerecka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096354; Niquette P, 2000, WATER RES, V34, P1952, DOI 10.1016/S0043-1354(99)00307-3; Pinto AJ, 2014, MBIO, V5, DOI 10.1128/mBio.01135-14; Polychronopolous M, 2003, WA SCI TECHNOL, V3, P295, DOI 10.2166/ws.2003.0117; Prest EI, 2014, WATER RES, V63, P179, DOI 10.1016/j.watres.2014.06.020; Prest EI, 2013, WATER RES, V47, P7131, DOI 10.1016/j.watres.2013.07.051; Prest EI, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00045; Prevost M, 1998, WATER RES, V32, P1393, DOI 10.1016/S0043-1354(97)00388-6; R Core Team, 2018, R LANG ENV STAT COMP; Ramseier MK, 2011, WATER RES, V45, P2002, DOI 10.1016/j.watres.2010.12.002; Roeselers G., 2015, ENV MICROBI IN PRESS; Van Der Kooij D, 2000, WATER AIR SOIL POLL, V123, P25, DOI 10.1023/A:1005288720291; van der Kooij D, 2001, WA SCI TECHNOL, V1, P39, DOI 10.2166/ws.2001.0052; van der Kooij D., 1985, J FRANCAIS HYDROLOGI, V16, P201, DOI [10.1051/water/19851603201, DOI 10.1051/WATER/19851603201]; van der Wielen PWJJ, 2010, WATER RES, V44, P4860, DOI 10.1016/j.watres.2010.07.016; VANDERKOOIJ D, 1982, J AM WATER WORKS ASS, V74, P540; VANDERKOOIJ D, 1992, J AM WATER WORKS ASS, V84, P57, DOI 10.1002/j.1551-8833.1992.tb07305.x; Vital M, 2012, WATER RES, V46, P4665, DOI 10.1016/j.watres.2012.06.010; Volk C., 1994, Revue des Sciences de l'Eau, V7, P131; Vreeburg JHG, 2004, WA SCI TECHNOL, V4, P431, DOI 10.2166/ws.2004.0135; Wang H, 2014, ENVIRON SCI TECHNOL, V48, P1426, DOI 10.1021/es402636u; Weissbrodt DG, 2014, FEMS MICROBIOL ECOL, V88, P579, DOI 10.1111/1574-6941.12326	51	57	57	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0164445	10.1371/journal.pone.0164445	http://dx.doi.org/10.1371/journal.pone.0164445			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792739	Green Published, gold			2022-12-26	WOS:000389537000008
J	Domagalska-Szopa, M; Szopa, A; Czamara, A				Domagalska-Szopa, Malgorzata; Szopa, Andrzej; Czamara, Andrzej			Dependence of Gait Deviation on Weight-Bearing Asymmetry and Postural Instability in Children with Unilateral Cerebral Palsy	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; STANDING BALANCE; TREADMILL; WALKING; HEMIPLEGIA; INITIATION; PATTERN; INDEX	Postural control deficits have been suggested to be a major component of gait disorders in children with cerebral palsy. The purpose of this study was to investigate the relationship between postural stability and treadmill walking, in children with unilateral cerebral palsy, by defining dependence between the posturographic weight-bearing distribution and center of pressure (CoP) sway during quiet standing with Gillette Gait Index and the 16 distinct gait parameters that composed the Gillette Gait Index. Forty-five children with unilateral cerebral palsy from 7-12 years of age were included in this study. A posturographic procedure and 3-dimensional instrumented gait analysis was developed. In general, across the entire tested group, the significant correlations concerned only the asymmetry of the weight bearing and a few of the distinct gait parameters that compose the Gillette Gait Index; moreover, correlation coefficients were low. The division of subjects into two clinical subgroups: children that exhibited a tendency to overload (1) and to underload (2) the affected body side, modified the results of the explored relationships. Our findings revealed that the difficulties experienced by children with hemiplegia while controlled in a standing position result from tendency to excessively or insufficiently load the affected lower limbs, and thus establishes a direct relationship with inadequate affected peak ankle DF in both stance and swing gait phases. Given the presented relationship between postural instability and deviation of the particular gait parameters in children with unilateral cerebral palsy, a follow-up study will be needed to determine the therapeutic approaches that will be most effective in promoting increased improvement in gait pattern, as well as the static and dynamic balance in standing.	[Domagalska-Szopa, Malgorzata] Med Univ Silesia, Sch Hlth Sci Katowice, Dept Rehabil Med, Katowice, Poland; [Szopa, Andrzej] Med Univ Silesia, Sch Hlth Sci Katowice, Dept Physiotherapy, Katowice, Poland; [Czamara, Andrzej] Coll Physiotherapy Wroclaw, Wroclaw, Poland	Medical University Silesia; Medical University Silesia	Domagalska-Szopa, M (corresponding author), Med Univ Silesia, Sch Hlth Sci Katowice, Dept Rehabil Med, Katowice, Poland.	mdomagalska@sum.edu.pl	Czamara, Andrzej/N-2597-2018	Czamara, Andrzej/0000-0002-2713-5090; Szopa, Andrzej/0000-0002-1765-1622; Domagalska-Szopa, Malgorzata/0000-0001-9086-9970				Altman D.G., 1991, PRACTICAL STATISTIC; [Anonymous], [No title captured]; Celestino ML, 2014, RES DEV DISABIL, V35, P3624, DOI 10.1016/j.ridd.2014.09.002; Cherng RJ, 1999, AM J PHYS MED REHAB, V78, P336, DOI 10.1097/00002060-199907000-00008; Cherng RJ, 2007, AM J PHYS MED REHAB, V86, P548, DOI 10.1097/PHM.0b013e31806dc302; Dodd KJ, 2007, DEV MED CHILD NEUROL, V49, P101, DOI 10.1111/j.1469-8749.2007.00101.x; Domagalska-Szopa M, 2014, THER CLIN RISK MANAG, V10, P113, DOI 10.2147/TCRM.S58186; Domagalska-Szopa M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/462094; Gage J. R., 1991, GAIT ANAL CEREBRAL P; Jung TY, 2016, GAIT POSTURE, V45, P1, DOI 10.1016/j.gaitpost.2015.12.004; Kuypers HGJM., HDB PHYSL NERVOUS SY, P56; Liao HF, 1997, DEV MED CHILD NEUROL, V39, P106, DOI 10.1111/j.1469-8749.1997.tb07392.x; Liao HF, 2003, PERCEPT MOTOR SKILL, V96, P1173, DOI 10.2466/PMS.96.3.1173-1184; Malouin F, 2000, GAIT POSTURE, V11, P239, DOI 10.1016/S0966-6362(00)00051-5; Massaad F, 2004, DEV MED CHILD NEUROL, V46, P674, DOI 10.1017/s0012162204001136; NASHNER LM, 1983, EXP BRAIN RES, V49, P393; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pavao SL, 2014, BRAZ J PHYS THER, V18, P300, DOI 10.1590/bjpt-rbf.2014.0056; Provost Beth, 2007, Pediatr Phys Ther, V19, P2, DOI 10.1097/01.pep.0000249418.25913.a3; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; Romei M, 2004, GAIT POSTURE, V19, P85, DOI 10.1016/S0966-6362(03)00017-1; Rose J, 2002, DEV MED CHILD NEUROL, V44, P58, DOI 10.1017/S0012162201001669; Schutte LM, 2000, GAIT POSTURE, V11, P25, DOI 10.1016/S0966-6362(99)00047-8; Shumway-Cook A., 2011, MOTOR CONTROL TRANSL, V4th; Stackhouse C, 2007, GAIT POSTURE, V26, P301, DOI 10.1016/j.gaitpost.2006.09.076; Szopa A, 2015, RES DEV DISABIL, V39, P67, DOI 10.1016/j.ridd.2015.01.001; Szopa A, 2014, RES DEV DISABIL, V35, P2261, DOI 10.1016/j.ridd.2014.05.020; Tervo RC, 2002, DEV MED CHILD NEUROL, V44, P185, DOI 10.1017/S0012162201001918; van der Krogt MM, 2014, GAIT POSTURE, V40, P587, DOI 10.1016/j.gaitpost.2014.07.003; Wallard L, 2014, GAIT POSTURE, V40, P43, DOI 10.1016/j.gaitpost.2014.02.009; Willoughby KL, 2009, DISABIL REHABIL, V31, P1971, DOI 10.3109/09638280902874204; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Woollacott Marjorie Hines, 2005, Neural Plasticity, V12, P211, DOI 10.1155/NP.2005.211; Woollacott MH, 1996, ACTA PAEDIATR, V85, P58, DOI 10.1111/j.1651-2227.1996.tb14279.x	34	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165583	10.1371/journal.pone.0165583	http://dx.doi.org/10.1371/journal.pone.0165583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VY	27788247	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900112
J	Kim, D; Jeon, H; Ryu, S; Koo, S; Ha, KT; Kim, S				Kim, Dongsoo; Jeon, Hyongjun; Ryu, Sun; Koo, Sungtae; Ha, Ki-Tae; Kim, Seungtae			Proteomic Analysis of the Effect of Korean Red Ginseng in the Striatum of a Parkinson's Disease Mouse Model	PLOS ONE			English	Article							NEUROPROTECTIVE ACTIVITY; CELLS	Recent studies have shown that Korean Red Ginseng (KRG) suppresses dopaminergic neuronal death in the brain of a Parkinson's disease (PD) mouse model, but the mechanism is still elusive. Using a 2-dimensional electrophoresis technique, we investigated whether KRG can restore the changes in protein expressions in the striatum (ST) of 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP)-injected mice. Male C57BL/6 mice (9 weeks old) were injected with 20 mg/kg MPTP intraperitoneally four times at 2-h intervals. KRG (100 mg/kg) was orally administered once a day for 3 days from one hour after the first MPTP injection. Two hours after the third KRG administration a pole test was performed to evaluate motor function, after which the brains were immediately harvested. Survival of dopaminergic neurons in the nigrostriatal pathway and protein expression in the ST were measured by immunohistochemistry and 2-dimensional electrophoresis. KRG suppressed MPTP-induced behavioral dysfunction and neuronal death in the nigrostriatal pathway. Moreover, 30 proteins changed by MPTP and KRG in the ST were identified and shown to be related to glycolysis/gluconeogenesis and neurodegenerative diseases including Alzheimer's disease and PD. KRG has neuroprotective effects against MPTP toxicity and alleviates protein expression profiles related to enhancing energy metabolism in the ST of MPTP-treated mice.	[Kim, Dongsoo; Jeon, Hyongjun; Ryu, Sun; Koo, Sungtae; Ha, Ki-Tae; Kim, Seungtae] Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan, South Korea	Pusan National University	Kim, S (corresponding author), Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan, South Korea.	kimst@pusan.ac.kr	Koo, Sungtae/J-6455-2014	Koo, Sungtae/0000-0001-7773-3905	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2014R1A5A2009936]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. NRF-2014R1A5A2009936). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Garrett E, 2004, Dialogues Clin Neurosci, V6, P259; Bae CH, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/436315, DOI 10.1155/2013/436315]; Cape JL, 2006, TRENDS PLANT SCI, V11, P46, DOI 10.1016/j.tplants.2005.11.007; Chung IM, 2016, J GINSENG RES, V40, P68, DOI 10.1016/j.jgr.2015.05.006; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Gonzalez-Burgos E, 2015, J NEUROIMMUNE PHARM, V10, P14, DOI 10.1007/s11481-014-9569-6; Grunewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571; Hanganu A, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00138; Jun YL, 2015, J GINSENG RES, V39, P148, DOI 10.1016/j.jgr.2014.10.003; Kim ST, 2010, J PHYSIOL SCI, V60, P27, DOI 10.1007/s12576-009-0061-7; Kim YO, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/817096; L'Episcopo F, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-83; Le WD, 2014, NEUROTHERAPEUTICS, V11, P92, DOI 10.1007/s13311-013-0234-1; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Lin WM, 2007, J NEURAL TRANSM-SUPP, P105; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Slemmer JE, 2007, EUR J NEUROSCI, V26, P649, DOI 10.1111/j.1460-9568.2007.05708.x; Thangarajan S, 2014, INT J NEUROSCI, V124, P673, DOI 10.3109/00207454.2013.872642; Wang HK, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-14; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Yeo HB, 2012, J GINSENG RES, V36, P190, DOI 10.5142/jgr.2012.36.2.190	21	16	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164906	10.1371/journal.pone.0164906	http://dx.doi.org/10.1371/journal.pone.0164906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788166	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900034
J	Mizuno, N; Kinoshita, M; Kinoshita, S; Nishida, H; Fujita, M; Kato, K; Murai, K; Nasuda, S				Mizuno, Nobuyuki; Kinoshita, Mika; Kinoshita, Saki; Nishida, Hidetaka; Fujita, Masaya; Kato, Kenji; Murai, Koji; Nasuda, Shuhei			Loss-of-Function Mutations in Three Homoeologous PHYTOCLOCK 1 Genes in Common Wheat Are Associated with the Extra-Early Flowering Phenotype	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; SPRING GROWTH HABIT; CIRCADIAN CLOCK; MOLECULAR CHARACTERIZATION; ALLELIC VARIATION; TETRAPLOID WHEAT; LOW-TEMPERATURE; HEADING TIME; PHOTOPERIOD; VERNALIZATION	Triticum aestivum L. cv 'Chogokuwase' is an extra-early flowering common wheat cultivar that is insensitive to photoperiod conferred by the photoperiod insensitive alleles at the Photoperiod-B1 (Ppd-B1) and Ppd-D1loci, and does not require vernalization for flowering. This reduced vernalization requirement is likely due to the spring habitat allele Vrn-D1 at the VERNALIZATION-D1 locus. Genotypes of the Ppd-1 loci that determine photoperiod sensitivity do not fully explain the insensitivity to photoperiod seen in 'Chogokuwase'. We detected altered expression patterns of clock and clock-output genes including Ppd-1 in 'Chogokuwase' that were similar to those in an einkorn wheat mutant that lacks the clock-gene homologue, wheat PHYTOCLOCK 1 (WPCL1). Presumptive loss-of-function mutations in all WPCL1 homoeologous genes were found in 'Chogokuwase' and 'Geurumil', one of the parental cultivars. Segregation analysis of the two intervarietal F-2 populations revealed that all the examined F-2 plants that headed as early as 'Chogokuwase' had the loss-of-function wpcl1 alleles at all three homoeoloci. Some F-2 plants carrying the wpcl1 alleles at three homoeoloci headed later than 'Chogokuwase', suggesting the presence of other loci influencing heading date. Flowering repressor Vrn-2 was up-regulated in 'Chogokuwase' and 'Geurumil' that had the triple recessive wpcl1 alleles. An elevated transcript abundance of Vrn-2 could explain the observation that 'Geurumil' and some F-2 plants carrying the three recessive wpcl1 homeoealleles headed later than 'Chogokuwase'. In spite of the up-regulation of Vrn-2, 'Chogokuwase' may have headed earlier due to unidentified earliness genes. Our observations indicated that loss-of-function mutations in the clock gene wpcl1 are necessary but are not sufficient to explain the extra-early heading of 'Chogokuwase'.	[Mizuno, Nobuyuki; Nasuda, Shuhei] Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Sakyo Ku, Kyoto, Japan; [Kinoshita, Mika; Kinoshita, Saki; Murai, Koji] Fukui Prefectural Univ, Dept Biosci, Eiheiji, Fukui, Japan; [Nishida, Hidetaka; Kato, Kenji] Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Okayama, Japan; [Fujita, Masaya] NARO, Inst Crop Sci, Tsukuba, Ibaraki, Japan	Kyoto University; Fukui Prefectural University; Okayama University; National Agriculture & Food Research Organization - Japan	Nasuda, S (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Plant Genet, Sakyo Ku, Kyoto, Japan.; Murai, K (corresponding author), Fukui Prefectural Univ, Dept Biosci, Eiheiji, Fukui, Japan.; Kato, K (corresponding author), Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Okayama, Japan.	kenkato@okayama-u.ac.jp; murai@fpu.ac.jp; nasushu@kais.kyoto-u.ac.jp		Nasuda, Shuhei/0000-0002-9019-8692				Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Campoli C, 2013, NEW PHYTOL, V199, P1045, DOI 10.1111/nph.12346; Chen A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003134; Chow BY, 2012, PLANT SIGNAL BEHAV, V7, P170, DOI 10.4161/psb.18766; Danyluk J, 2003, PLANT PHYSIOL, V132, P1849, DOI 10.1104/pp.103.023523; Deng WW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6882; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Distelfeld A, 2009, PLANT PHYSIOL, V149, P245, DOI 10.1104/pp.108.129353; Dubcovsky J, 2006, PLANT MOL BIOL, V60, P469, DOI 10.1007/s11103-005-4814-2; Dubcovsky J, 2005, MOL BREEDING, V15, P395, DOI 10.1007/s11032-005-0084-6; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Gawronski P, 2014, GENETICS, V196, P1253, DOI 10.1534/genetics.113.158444; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Helfer A, 2011, CURR BIOL, V21, P126, DOI 10.1016/j.cub.2010.12.021; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Kato K, 2001, THEOR APPL GENET, V102, P980, DOI 10.1007/s001220000494; KATO K, 1988, JPN J BREED, V38, P172; Kippes N, 2015, P NATL ACAD SCI USA, V112, pE5401, DOI 10.1073/pnas.1514883112; Laurie DA, 1997, PLANT MOL BIOL, V35, P167, DOI 10.1023/A:1005726329248; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mizuno N, 2012, GENES GENET SYST, V87, P357, DOI 10.1266/ggs.87.357; Mizuno N, 2011, PLANT J, V68, P114, DOI 10.1111/j.1365-313X.2011.04667.x; Murai K, 2003, PLANT CELL PHYSIOL, V44, P1255, DOI 10.1093/pcp/pcg171; Nguyen AT, 2013, BREEDING SCI, V63, P374, DOI 10.1270/jsbbs.63.374; Nishida H, 2013, MOL BREEDING, V31, P27, DOI 10.1007/s11032-012-9765-0; Nishiura A, 2014, BREEDING SCI, V64, P213, DOI 10.1270/jsbbs.64.213; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Seki M, 2013, BREEDING SCI, V63, P309, DOI 10.1270/jsbbs.63.309; Seki M, 2011, BREEDING SCI, V61, P405, DOI 10.1270/jsbbs.61.405; Shaw LM, 2012, PLANT J, V71, P71, DOI 10.1111/j.1365-313X.2012.04971.x; Shimada S, 2009, PLANT J, V58, P668, DOI 10.1111/j.1365-313X.2009.03806.x; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Turner AS, 2013, THEOR APPL GENET, V126, P2267, DOI 10.1007/s00122-013-2133-6; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Zakhrabekova S, 2012, P NATL ACAD SCI USA, V109, P4326, DOI 10.1073/pnas.1113009109	44	18	19	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165618	10.1371/journal.pone.0165618	http://dx.doi.org/10.1371/journal.pone.0165618			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788250	Green Submitted, gold, Green Published			2022-12-26	WOS:000389604900115
J	Prager, P; Hollborn, M; Steffen, A; Wiedemann, P; Kohen, L; Bringmann, A				Prager, Philipp; Hollborn, Margrit; Steffen, Anja; Wiedemann, Peter; Kohen, Leon; Bringmann, Andreas			P2Y(1) Receptor Signaling Contributes to High Salt-Induced Priming of the NLRP3 Inflammasome in Retinal Pigment Epithelial Cells	PLoS One			English	Article							ENDOTHELIAL GROWTH-FACTOR; PATHOGENIC T(H)17 CELLS; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; BLOOD-PRESSURE; ARPE-19 CELLS; ACTIVATION; INDUCTION; INHIBITORS; SODIUM	Background Systemic hypertension is a risk factor of age-related macular degeneration (AMD), a chronic inflammatory disease. Acute hypertension is caused by increased extracellular osmolarity after intake of dietary salt (NaCl). We determined in cultured human retinal pigment epithelial (RPE) cells whether high extracellular NaCl alters the gene expression of inflammasome-associated proteins, and whether autocrine/paracrine purinergic (P2) receptor signaling contributes to the NaCI-induced NLRP3 gene expression. Methodology/Principal Findings Hyperosmolarity was induced by the addition of 100 mM NaCl or sucrose to the culture medium. Gene and protein expression levels were determined with real-time RT-PCR and Western blot analysis, respectively. IL-1 beta and IL-18 levels were evaluated with ELISA. Nuclear factor of activated T cell 5 (NFAT5) expression was knocked down with siRNA. High extracellular NaCI induced NLRP3 and pro-IL-1 beta gene expression, while the gene expression of further inflammasome-associated proteins (NLRP1, NLRP2, NLRP6, NLRP7, NLRP12, NLRC4, AIM2, ASC, procaspase-1, pro-IL-18) was not altered or below the detection threshold. The NaCI-induced NLRP3 gene expression was partially dependent on the activities of phospholipase C, IP3 receptors, protein kinase C, the serum and glucocorticoid-regulated kinase, p38 MAPK, ERK1/2, JNK, P13K, and the transcription factors HIF-1 and NFAT5. Pannexin-dependent ATP release and P2Y(1) receptor activation is required for the full induction of NLRP3 gene expression. High NaCI induced a transient increase of the NLRP3 protein level and a moderate NLRP3 inflammasome activation, as indicated by the transient increase of the cytosolic level of mature IL-1 beta. High NaCl also induced secretion of IL-18. Conclusion High extracellular NaCl induces priming of the NLRP3 inflammasome in RPE cells, in part via P2Y(1) receptor signaling. The inflammasome priming effect of NaCl suggests that high intake of dietary salt may promote local retinal inflammation implicated in the development of AMD.	[Prager, Philipp; Hollborn, Margrit; Steffen, Anja; Wiedemann, Peter; Kohen, Leon; Bringmann, Andreas] Univ Leipzig, Dept Ophthalmol, Leipzig, Germany; [Prager, Philipp; Hollborn, Margrit; Steffen, Anja; Wiedemann, Peter; Kohen, Leon; Bringmann, Andreas] Univ Leipzig, Hosp Eye, Leipzig, Germany; [Kohen, Leon] Helios Klinikum Aue, Aue, Germany	Leipzig University; Leipzig University; Helios Kliniken	Bringmann, A (corresponding author), Univ Leipzig, Dept Ophthalmol, Leipzig, Germany.; Bringmann, A (corresponding author), Univ Leipzig, Hosp Eye, Leipzig, Germany.	bria@medizin.uni-leipzig.de			Deutsche Forschungsgemeinschaft [KO 1547/7-1]; Geschwister Freter Stiftung (Hannover, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Geschwister Freter Stiftung (Hannover, Germany)	Supported by grants from the Deutsche Forschungsgemeinschaft (KO 1547/7-1 to L.K.) and the Geschwister Freter Stiftung (Hannover, Germany).	Anderson OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067263; Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bours Martijn Jan Leo, 2011, Front Biosci (Schol Ed), V3, P1443; Brandstetter C, 2015, J MOL MED, V93, P905, DOI 10.1007/s00109-015-1275-1; Chen R, 2014, MOL VIS, V20, P242; Chen SC, 2009, J CLIN INVEST, V119, P1647, DOI 10.1172/JCI35314; Cheung CMG, 2014, J INTERN MED, V276, P140, DOI 10.1111/joim.12227; Cheung Chris Yk, 2013, J Mol Signal, V8, P5, DOI 10.1186/1750-2187-8-5; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Fowler BJ, 2014, SCIENCE, V346, P1000, DOI 10.1126/science.1261754; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; He FJ, 2005, HYPERTENSION, V45, P98, DOI 10.1161/01.HYP.0000149431.79450.a2; Hollborn M, 2015, MOL VIS, V21, P360; Housley GD, 2009, TRENDS NEUROSCI, V32, P128, DOI 10.1016/j.tins.2009.01.001; Ip WKE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7931; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; JUNGER WG, 1994, CIRC SHOCK, V42, P190; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Kerur N, 2013, INVEST OPHTH VIS SCI, V54, P7395, DOI 10.1167/iovs.13-12500; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee K, 2007, J MED CHEM, V50, P1675, DOI 10.1021/jm0610292; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Mohr LKM, 2015, INVEST OPHTH VIS SCI, V56, P6404, DOI 10.1167/iovs.15-16898; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Nicholas SA, 2011, CELL MOL LIFE SCI, V68, P151, DOI 10.1007/s00018-010-0450-3; Nita M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/930671; Piippo N, 2014, BBA-MOL CELL RES, V1843, P3038, DOI 10.1016/j.bbamcr.2014.09.015; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shi GP, 2015, INVEST OPHTH VIS SCI, V56, P1658, DOI 10.1167/iovs.14-14557; SPERDUTO RD, 1986, ARCH OPHTHALMOL-CHIC, V104, P216; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Taylor SRJ, 2008, J IMMUNOL, V180, P300, DOI 10.4049/jimmunol.180.1.300; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; van Leeuwen R, 2003, INVEST OPHTH VIS SCI, V44, P3771, DOI 10.1167/iovs.03-0121; Veltmann M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147312; Woehrle T, 2010, J LEUKOCYTE BIOL, V88, P1181, DOI 10.1189/jlb.0410211; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yi BQ, 2015, TRANSL RES, V166, P103, DOI 10.1016/j.trsl.2014.11.007	49	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165653	10.1371/journal.pone.0165653	http://dx.doi.org/10.1371/journal.pone.0165653			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788256	gold, Green Published, Green Submitted			2022-12-26	WOS:000389604900119
J	Marro, J; Pfefferli, C; Charles, ASD; Bise, T; Jazwinska, A				Marro, Jan; Pfefferli, Catherine; Charles, Anne-Sophie de Preux; Bise, Thomas; Jazwinska, Anna			Collagen XII Contributes to Epicardial and Connective Tissues in the Zebrafish Heart during Ontogenesis and Regeneration	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CARDIAC REGENERATION; FIN REGENERATION; ADULT ZEBRAFISH; EXPRESSION; SUPERFAMILY; CRYOINJURY; MECHANISMS; MUTATIONS; DIVERSITY	Zebrafish heart regeneration depends on cardiac cell proliferation, epicardium activation and transient reparative tissue deposition. The contribution and the regulation of specific collagen types during the regenerative process, however, remain poorly characterized. Here, we identified that the non-fibrillar type XII collagen, which serves as a matrix-bridging component, is expressed in the epicardium of the zebrafish heart, and is boosted after cryoinjury-induced ventricular damage. During heart regeneration, an intense deposition of Collagen XII covers the outer epicardial cap and the interstitial reparative tissue. Analysis of the activated epicardium and fibroblast markers revealed a heterogeneous cellular origin of Collagen XII. Interestingly, this matrix-bridging collagen co-localized with fibrillar type I collagen and several glycoproteins in the post-injury zone, suggesting its role in tissue cohesion. Using SB431542, a selective inhibitor of the TGF-beta receptor, we showed that while the inhibitor treatment did not affect the expression of collagen 12 and collagen 1a2 in the epicardium, it completely suppressed the induction of both genes in the fibrotic tissue. This suggests that distinct mechanisms might regulate collagen expression in the outer heart layer and the inner injury zone. On the basis of this study, we postulate that the TGF-beta signaling pathway induces and coordinates formation of a transient collagenous network that comprises fibril-forming Collagen I and fiber-associated Collagen XII, both of which contribute to the reparative matrix of the regenerating zebrafish heart.	[Marro, Jan; Pfefferli, Catherine; Charles, Anne-Sophie de Preux; Bise, Thomas; Jazwinska, Anna] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland	University of Fribourg	Jazwinska, A (corresponding author), Univ Fribourg, Dept Biol, Chemin Muse 10, CH-1700 Fribourg, Switzerland.	anna.jazwinska@unifr.ch	Jazwinska, Anna/M-8705-2016	Jazwinska, Anna/0000-0003-3881-9284	Swiss National Science Foundation [310030_159995, CRSII3_147675]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation, grant numbers: 310030_159995 and CRSII3_147675.; We thank V. Zimmermann for excellent technical assistance and for fish care, F. Chablais for the specimens and D. Konig and F. Ruggiero for critical reading of the manuscript. We are grateful to F. Ruggiero for antibody against Col XII. This work was supported by the Swiss National Science Foundation, grant numbers: 310030_159995 and CRSII3_147675.	Agarwal P, 2012, J BIOL CHEM, V287, P22549, DOI 10.1074/jbc.M111.335935; Arai K, 2002, MATRIX BIOL, V21, P243, DOI 10.1016/S0945-053X(02)00005-7; Bader HL, 2009, MATRIX BIOL, V28, P32, DOI 10.1016/j.matbio.2008.09.580; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; CHABLAIS F, 2012, JOVE J VIS EXP APR, DOI DOI 10.3791/3666; Chablais F, 2012, DEVELOPMENT, V139, P1921, DOI 10.1242/dev.078543; Chablais F, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-21; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Chiquet M, 2014, INT J BIOCHEM CELL B, V53, P51, DOI 10.1016/j.biocel.2014.04.020; Choi WY, 2012, CURR TOP DEV BIOL, V100, P319, DOI 10.1016/B978-0-12-387786-4.00010-5; Farhat YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051411; Font B, 1996, MATRIX BIOL, V15, P341, DOI 10.1016/S0945-053X(96)90137-7; Gistelinck C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21540; Godwin J, 2014, INT J BIOCHEM CELL B, V56, P47, DOI 10.1016/j.biocel.2014.10.011; Hicks D, 2014, HUM MOL GENET, V23, P2353, DOI 10.1093/hmg/ddt637; Hu N, 2000, ANAT REC, V260, P148, DOI 10.1002/1097-0185(20001001)260:2<148::AID-AR50>3.0.CO;2-X; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Icardo Jose M., 2012, P35; Izu Y, 2011, J CELL BIOL, V193, P1115, DOI 10.1083/jcb.201010010; Jazwinska A, 2007, CURR BIOL, V17, P1390, DOI 10.1016/j.cub.2007.07.019; Jazwinska A, 2016, J PATHOL, V238, P233, DOI 10.1002/path.4644; Jessen JR, 2015, DEV BIOL, V401, P110, DOI 10.1016/j.ydbio.2014.12.022; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; KEENE DR, 1991, J CELL BIOL, V113, P971, DOI 10.1083/jcb.113.4.971; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; Lafontant PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072388; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li AH, 2014, CIRC RES, V114, P916, DOI 10.1161/CIRCRESAHA.114.302819; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; Gonzalez-Rosa JM, 2012, DEV BIOL, V370, P173, DOI 10.1016/j.ydbio.2012.07.007; Gonzalez-Rosa JM, 2011, DEVELOPMENT, V138, P1663, DOI 10.1242/dev.060897; Peacock JD, 2008, DEV DYNAM, V237, P3051, DOI 10.1002/dvdy.21719; Peralta M, 2014, J DEV BIOL, V2, P101, DOI 10.3390/jdb2020101; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Rubin N, 2016, SEMIN CELL DEV BIOL, V58, P34, DOI 10.1016/j.semcdb.2016.04.011; Sallin P, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160012; Sallin P, 2015, DEV BIOL, V399, P27, DOI 10.1016/j.ydbio.2014.12.002; Schnabel K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018503; Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646; Thierry L., 2004, J MOL HISTOL, V35, P803; Uygur A, 2016, DEV CELL, V36, P362, DOI 10.1016/j.devcel.2016.01.018; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; Veit G, 2006, J BIOL CHEM, V281, P27461, DOI 10.1074/jbc.M603147200; WALCHLI C, 1994, J CELL SCI, V107, P669; Wang JH, 2013, DEV BIOL, V382, P427, DOI 10.1016/j.ydbio.2013.08.012; Wilkinson RN, 2014, PROG MOL BIOL TRANSL, V124, P65, DOI 10.1016/B978-0-12-386930-2.00004-5; Wu CC, 2016, DEV CELL, V36, P36, DOI 10.1016/j.devcel.2015.12.010; Young BB, 2002, J CELL BIOCHEM, V87, P208, DOI 10.1002/jcb.10290; Zou YQ, 2014, HUM MOL GENET, V23, P2339, DOI 10.1093/hmg/ddt627	53	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165497	10.1371/journal.pone.0165497	http://dx.doi.org/10.1371/journal.pone.0165497			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783651	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800079
J	Schoenfeld, AK; Lahrsen, E; Alban, S				Schoenfeld, Ann-Kathrin; Lahrsen, Eric; Alban, Susanne			Regulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity Relationships	PLOS ONE			English	Article							HEREDITARY ANGIOEDEMA; DEXTRAN SULFATE; C1-ESTERASE INHIBITOR; PLASMA KALLIKREIN; HEPARIN-BINDING; COAGULATION; PROTEASE; GLYCOSAMINOGLYCANS; PATHWAY; DOMAIN	The serpin C1 inhibitor (C1-INH) is the only regulator of classical complement activation as well as the major regulator of the contact system. Its importance is demonstrated by hereditary angioedema (HAE), a severe disease with potentially life-threatening attacks due to deficiency or dysfunction of C1-INH. C1-INH replacement is the therapy of choice in HAE. In addition, C1-INH showed to have beneficial effects in other diseases characterized by inappropriate complement and contact system activation. Due to some limitations of its clinical application, there is a need for improving the efficacy of therapeutically applied C1-INH or to enhance the activity of endogenous C1-INH. Given the known potentiating effect of heparin on C1-INH, sulfated glycans (SG) may be such candidates. The aim of this study was to characterize suitable SG by evaluating structure-activity relationships. For this, more than 40 structurally distinct SG were examined for their effects on C1-INH, C1s and FXIIa. The SG turned out to potentiate the C1s inhibition by C1-INH without any direct influence on C1s. Their potentiating activity proved to depend on their degree of sulfation, molecular mass as well as glycan structure. In contrast, the SG had no effect on the FXIIa inhibition by C1-INH, but structure-dependently modulated the activity of FXIIa. Among the tested SG, beta-1,3-glucan sulfates with a M-r <= 10 000 were identified as most promising lead candidates for the development of a glycan-based C1-INH amplifier. In conclusion, the obtained information on structural characteristics of SG favoring C1-INH potentiation represent an useful elementary basis for the development of compounds improving the potency of C1-INH in diseases and clinical situations characterized by inappropriate activation of complement and contact system.	[Schoenfeld, Ann-Kathrin; Lahrsen, Eric; Alban, Susanne] Christian Albrechts Univ Kiel, Inst Pharmaceut, Dept Pharmaceut Biol, Kiel, Schleswig Holst, Germany	University of Kiel	Schoenfeld, AK (corresponding author), Christian Albrechts Univ Kiel, Inst Pharmaceut, Dept Pharmaceut Biol, Kiel, Schleswig Holst, Germany.	aschoenfeld@pharmazie.uni-kiel.de		Alban, Susanne/0000-0003-1993-3751	Land Schleswig-Holstein	Land Schleswig-Holstein	We acknowledge financial support by Land Schleswig-Holstein within the funding program Open Access Publikationsfonds.	Alban S, 2008, CURR PHARM DESIGN, V14, P1152, DOI 10.2174/138161208784246135; Alban S, 2012, Handb Exp Pharmacol, P211, DOI 10.1007/978-3-642-23056-1_10; Alban S, 2001, BIOMACROMOLECULES, V2, P354, DOI 10.1021/bm010032u; ALBAN S, 1994, SEMIN THROMB HEMOST, V20, P152, DOI 10.1055/s-2007-1001898; Alban S, 2007, COMMENT MONOGRAPH DA; Alban S, 2009, J INVEST DERMATOL, V129, P1192, DOI 10.1038/jid.2008.358; [Anonymous], 2015, CADTH RAP RESP REP; Begieneman MPV, 2016, J CLIN PATHOL, V69, P1093, DOI 10.1136/jclinpath-2016-203639; Beinrohr L, 2007, J BIOL CHEM, V282, P21100, DOI 10.1074/jbc.M700841200; Borgogna M, 2013, J PHYS CHEM B, V117, P7277, DOI 10.1021/jp4030766; Bowen B, 2001, CLIN IMMUNOL, V98, P157, DOI 10.1006/clim.2000.4947; Caccia S, 2014, PEDIAT ALLER IMM PUL, V27, P159, DOI 10.1089/ped.2014.0425; Caldwell EEO, 1999, ARCH BIOCHEM BIOPHYS, V361, P215, DOI 10.1006/abbi.1998.0996; CAUGHMAN GB, 1982, MOL IMMUNOL, V19, P287, DOI 10.1016/0161-5890(82)90342-X; Cichon S, 2006, AM J HUM GENET, V79, P1098, DOI 10.1086/509899; Citarella F, 2000, THROMB HAEMOSTASIS, V84, P1057; Conway EM, 2015, J THROMB HAEMOST, V13, pS121, DOI 10.1111/jth.12950; Davis AE, 2003, TRANSFUS APHER SCI, V29, P195, DOI 10.1016/j.transci.2003.08.012; Davis AE, 2010, THROMB HAEMOSTASIS, V104, P886, DOI 10.1160/TH10-01-0073; Davis AE, 2008, MOL IMMUNOL, V45, P4057, DOI 10.1016/j.molimm.2008.06.028; Dewald G, 2006, BIOCHEM BIOPH RES CO, V343, P1286, DOI 10.1016/j.bbrc.2006.03.092; EDQM, 2013, EUR PHARM MON DAN SO; Ehrig K, 2015, MAR DRUGS, V13, P76, DOI 10.3390/md13010076; Engel R, 2014, J THROMB HAEMOST, V12, P1513, DOI 10.1111/jth.12663; European Medicines Agency (EMA), RUC CON ALF; GHEBREHIWET B, 1983, J CLIN INVEST, V71, P1450, DOI 10.1172/JCI110898; Gozzo AJ, 2003, BRAZ J MED BIOL RES, V36, P1055, DOI 10.1590/S0100-879X2003000800011; Greve J, 2016, J DTSCH DERMATOL GES, V14, P266, DOI 10.1111/ddg.12856; Grunewald N, 2009, BIOMACROMOLECULES, V10, P2998, DOI 10.1021/bm900501g; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Jiang HX, 2001, J EXP MED, V194, P1609, DOI 10.1084/jem.194.11.1609; Kerr FK, 2008, MOL IMMUNOL, V45, P670, DOI 10.1016/j.molimm.2007.07.008; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Li BZ, 2009, BIOCHEM PHARMACOL, V78, P292, DOI 10.1016/j.bcp.2009.04.012; Liu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09424; Mamidi S, 2017, IMMUNOBIOLOGY, V222, P45, DOI 10.1016/j.imbio.2015.11.008; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Maruyama T, 1998, CARBOHYD RES, V306, P35, DOI 10.1016/S0008-6215(97)10060-X; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; Mauron T, 1998, THROMB HAEMOSTASIS, V80, P82, DOI 10.1055/s-0037-1615143; Melis JPM, 2015, MOL IMMUNOL, V67, P117, DOI 10.1016/j.molimm.2015.01.028; Mulloy Barbara, 2012, Handb Exp Pharmacol, P77, DOI 10.1007/978-3-642-23056-1_5; Murray-Rust TA, 2009, BIOCHEM J, V422, P295, DOI 10.1042/BJ20090198; Petraroli A, 2015, INT ARCH ALLERGY IMM, V166, P259, DOI 10.1159/000381341; PIXLEY RA, 1987, ARCH BIOCHEM BIOPHYS, V256, P490, DOI 10.1016/0003-9861(87)90606-0; Poppelaars F, 2016, CLIN EXP IMMUNOL, V184, P378, DOI 10.1111/cei.12777; Rajabi M, 2012, BBA-GEN SUBJECTS, V1820, P56, DOI 10.1016/j.bbagen.2011.10.008; Rasmussen ER, 2016, ANN ALLERG ASTHMA IM, V116, P476, DOI 10.1016/j.anai.2016.03.008; RENT R, 1976, CLIN EXP IMMUNOL, V23, P264; Rossi V, 2010, J IMMUNOL, V184, P4982, DOI 10.4049/jimmunol.0902016; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; Schmaier AH, 2016, J THROMB HAEMOST, V14, P28, DOI 10.1111/jth.13194; SILVERBERG M, 1987, BIOCHEM J, V248, P715, DOI 10.1042/bj2480715; SIM RB, 1979, FEBS LETT, V97, P111, DOI 10.1016/0014-5793(79)80063-0; Singer M, 2011, CRIT CARE, V15, DOI 10.1186/cc9304; TANKERSLEY DL, 1983, BLOOD, V62, P448; Tissot B, 2003, BBA-PROTEINS PROTEOM, V1651, P5, DOI 10.1016/S1570-9639(03)00230-9; Videm V, 1999, J THORAC CARDIOV SUR, V117, P803, DOI 10.1016/S0022-5223(99)70302-8; Wat JM, 2014, BLOOD, V123, P768, DOI 10.1182/blood-2013-07-515726; Wijeyewickrema LC, 2016, BLOOD, V128, P1766, DOI 10.1182/blood-2016-02-699561; Wuillemin WA, 1996, J BIOL CHEM, V271, P12913, DOI 10.1074/jbc.271.22.12913; Wuillemin WA, 1997, J IMMUNOL, V159, P1953; Yvin J.-C., 2007, Patent No. [EP 1337261-B1, 1337261]; Yvin J. C, 2006, United States, Patent No. [US7008931B2, 7008931]; Zeerleder S, 2016, ANN MED, V48, P256, DOI 10.3109/07853890.2016.1162909; Zhou H, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-184; Zhou ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047296	67	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165493	10.1371/journal.pone.0165493	http://dx.doi.org/10.1371/journal.pone.0165493			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783665	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800078
J	Song, TJ; Cho, SJ; Kim, WJ; Yang, KI; Yun, CH; Chu, MK				Song, Tae-Jin; Cho, Soo-Jin; Kim, Won-Joo; Yang, Kwang Ik; Yun, Chang-Ho; Chu, Min Kyung			Anxiety and Depression in Tension-Type Headache: A Population-Based Study	PLOS ONE			English	Article							PSYCHIATRIC COMORBIDITY; MIGRAINE; IMPACT; EPIDEMIOLOGY; PREVALENCE; OSMOPHOBIA; CLASSIFICATION; DISABILITY; DISORDERS; BURDEN	Although tension-type headache (TTH) is a frequent type of headache disorder and imposes a significant burden, there is scant information about the prevalence and impact of comorbid anxiety and depression among individuals with TTH. We investigated the prevalence and clinical impact of anxiety and depression among patients with TTH in the general population. We recruited Korean participants aged 19-69 years using a two-stage clustered random sampling method. To identify the presence of headache type, anxiety, and depression, we used a semi-structured interview using certain questionnaires. To assess the level of anxiety and depression, we used the Goldberg Anxiety Scale and Patient Health Questionnaire-9, respectively. Among 2,695 participants, 570 people (21.2%) had TTH during previous 1 year. In participants with TTH, the prevalence of anxiety (9.5% vs. 5.3%, p = 0.001) and depression (4.2% vs. 1.8%, p = 0.001) was significantly higher than that of non-headache participants. The prevalence of anxiety among TTH participants with > 15 attacks per month [21.4%, odds ratio (OR): 4.0] and 1-14 attacks per month (13.1%, OR: 2.2) was higher than that in those with < 1 attack per month (6.4%), however this tendency was not observed in participants with depression. Visual Analogue Scale (VAS) score [median 5.0 vs. 4.0, p = 0.010] and Headache Impact Test-6 (HIT-6) score [median 45.5 vs. 42.0, p < 0.001] were significantly higher among those with anxiety. Furthermore, VAS scores [median 5.0 vs. 4.0, p = 0.010] and HIT-6 scores [median 45.5 vs. 42.0, p = 0.027] were also significantly higher among TTH patients with depression than among those without depression. In conclusion, anxiety and depression were more prevalent in participants with TTH than in non-headache participants. These two conditions were associated with an exacerbation of headache symptoms in individuals with TTH.	[Song, Tae-Jin] Ewha Womans Univ, Dept Neurol, Sch Med, Seoul, South Korea; [Song, Tae-Jin] Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Cho, Soo-Jin] Hallym Univ, Dongtan Sacred Heart Hosp, Dept Neurol, Coll Med, Hwaseong, South Korea; [Kim, Won-Joo] Yonsei Univ, Gangnam Severance Hosp, Dept Neurol, Coll Med, Seoul, South Korea; [Yang, Kwang Ik] Soonchunhyang Univ, Coll Med, Cheonan Hosp, Dept Neurol, Cheonan, South Korea; [Yun, Chang-Ho] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Clin Neurosci Ctr, Seongnam, South Korea; [Chu, Min Kyung] Hallym Univ, Coll Med, Dept Neurol, Kangnam Sacred Heart Hosp, Seoul, South Korea	Ewha Womans University; Yonsei University; Yonsei University Health System; Hallym University; Yonsei University; Yonsei University Health System; Soonchunhyang University; Seoul National University (SNU); Hallym University	Chu, MK (corresponding author), Hallym Univ, Coll Med, Dept Neurol, Kangnam Sacred Heart Hosp, Seoul, South Korea.	chumk@hallym.ac.kr		Kim, Won-Joo/0000-0002-5850-010X; Yun, Chang-Ho/0000-0003-2204-8067	Korean Academy of Medical Sciences; grants of Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01057934]	Korean Academy of Medical Sciences; grants of Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This Study was supported by a 2011-Grant from Korean Academy of Medical Sciences. This research was supported by grants of Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A01057934).	Association WM, 2001, WORLD MED ASS DECL H; Beghi E, 2007, NEUROL SCI, V28, pS217, DOI 10.1007/s10072-007-0780-6; Cho SJ, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0554-0; Cho SJ, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-014-0465-9; Choi HS, 2007, KOREAN J FAM MED, V28, P114; De Carlo D, 2012, CEPHALALGIA, V32, P401, DOI 10.1177/0333102412438975; DEBENEDITTIS G, 1992, HEADACHE, V32, P330; Fumal A, 2008, LANCET NEUROL, V7, P70, DOI 10.1016/S1474-4422(07)70325-3; GOBEL H, 1994, CEPHALALGIA, V14, P97, DOI 10.1046/j.1468-2982.1994.1402097.x; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Guidetti V, 1998, CEPHALALGIA, V18, P455, DOI 10.1046/j.1468-2982.1998.1807455.x; Holroyd KA, 2000, HEADACHE, V40, P3, DOI 10.1046/j.1526-4610.2000.00001.x; Kim BK, 2012, J CLIN NEUROL, V8, P204, DOI 10.3988/jcn.2012.8.3.204; Kim JS, 1997, J KOREAN ACAD FAM ME, V18, P1452; Lanteri-Minet M, 2005, PAIN, V118, P319, DOI 10.1016/j.pain.2005.09.010; Lim J, 2001, J KOREAN ACAD FAM ME, V22, P1224; Llop S, 2016, J HEADACHE PAIN, V17, P1, DOI 10.1186/s10194-016-0629-6; Mitsikostas DD, 1999, CEPHALALGIA, V19, P211, DOI 10.1046/j.1468-2982.1999.019004211.x; Murtaza M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005827; Oh K, 2014, BMC NEUROL, V14, DOI [10.1186/s12883-014-0238-4, 10.1186/s12883-014-0244-6]; Patel NV, 2004, NEUROLOGY, V63, P1432, DOI 10.1212/01.WNL.0000142044.22226.54; Peng KP, 2014, HEADACHE, V54, P610, DOI 10.1111/head.12328; PRYSEPHILLIPS W, 1992, CAN J NEUROL SCI, V19, P333, DOI 10.1017/S0317167100041950; Puca F, 1999, CEPHALALGIA, V19, P159, DOI 10.1046/j.1468-2982.1999.1903159.x; Pulvers K, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0330-2; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; Rubin D.B., 2002, STAT ANAL MISSING DA; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silva-Neto RP, 2014, J NEUROL SCI, V339, P118, DOI 10.1016/j.jns.2014.01.040; Song TJ, 2016, CEPHALALGIA; Spierings ELH, 2001, HEADACHE, V41, P554, DOI 10.1046/j.1526-4610.2001.041006554.x; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang YF, 2012, CEPHALALGIA, V32, P1180, DOI 10.1177/0333102412461401; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zebenholzer K, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0603-3	38	37	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165316	10.1371/journal.pone.0165316	http://dx.doi.org/10.1371/journal.pone.0165316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783660	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800069
J	Wan, JC; Hu, SY; Ni, KF; Chang, GF; Sun, XJ; Yu, LL				Wan, Jianchun; Hu, Songyou; Ni, Kefeng; Chang, Guifang; Sun, Xiangjun; Yu, Liangli			Characterisation of Fecal Soap Fatty Acids, Calcium Contents, Bacterial Community and Short-Chain Fatty Acids in Sprague Dawley Rats Fed with Different sn-2 Palmitic Triacylglycerols Diets	PLOS ONE			English	Article							POSITIONAL DISTRIBUTION; MICROBIOTA COMPOSITION; INTESTINAL MICROBIOTA; STOOL COMPOSITION; INFANT FORMULAS; GUT MICROBIOTA; HUMAN-MILK; ABSORPTION; MICE; METABOLISM	The structure of dietary triacylglycerols is thought to influence fatty acid and calcium absorption, as well as intestinal microbiota population of the host. In the present study, we investigated the impact of palmitic acid (PA) esterified at the sn-2 position on absorption of fatty acid and calcium and composition of intestinal microorganisms in rats fed high-fat diets containing either low sn-2 PA (12.1%), medium sn-2 PA (40.4%) or high sn-2 PA (56.3%), respectively. Fecal fatty acid profiles in the soaps were measured by gas chromatography (GC), while fecal calcium concentration was detected by ICP-MS. The fecal microbial composition was assessed using a 16S rRNA high-throughput sequencing technology and fecal short-chain fatty acids were detected by ion chromatograph. Dietary supplementation with a high sn-2 PA fat significantly reduced total fecal contents of fatty acids soap and calcium compared with the medium or low sn-2 PA fat groups. Diet supplementation with sn-2 PA fat did not change the entire profile of the gut microbiota community at phylum level and the difference at genera level also were minimal in the three treatment groups. However, high sn-2 PA fat diet could potentially improve total short-chain fatty acids content in the feces, suggesting that high dietary sn-2 PA fat might have a beneficial effect on host intestinal health.	[Wan, Jianchun; Sun, Xiangjun] Shanghai Jiao Tong Univ, Inst Food & Nutraceut Sci, Sch Agr & Biol, Shanghai, Peoples R China; [Hu, Songyou; Ni, Kefeng; Chang, Guifang] Wilmar Shanghai Biotechnol Res Dev Ctr Co Ltd, Shanghai, Peoples R China; [Yu, Liangli] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA	Shanghai Jiao Tong University; University System of Maryland; University of Maryland College Park	Yu, LL (corresponding author), Shanghai Jiao Tong Univ, Inst Food & Nutraceut Sci, Sch Agr & Biol, Shanghai, Peoples R China.	xjsun@sjtu.edu.cn; lyu5@umd.edu			Wilmar (Shanghai) Biotechnology Research & Development Center Co., Ltd	Wilmar (Shanghai) Biotechnology Research & Development Center Co., Ltd	The study was funded by Wilmar (Shanghai) Biotechnology Research & Development Center Co., Ltd which is the employer of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOCS Official Methods and Recommended Practices of the AOCS, 2013, 391 AOCS; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Blaut Michael, 2012, Handb Exp Pharmacol, P251, DOI 10.1007/978-3-642-24716-3_11; BRINK EJ, 1995, J NUTR, V125, P2379, DOI 10.1093/jn/125.9.2379; Carta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120424; de Wit N, 2012, AM J PHYSL GASTROINT; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Fava F, 2013, INT J OBESITY, V37, P216, DOI 10.1038/ijo.2012.33; Fraher MH, 2012, NAT REV GASTRO HEPAT, V9, P312, DOI 10.1038/nrgastro.2012.44; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Harrish M, 2008, GUT, V57, P1605, DOI [10.1136/gut.2007.133603, DOI 10.1136/GUT.2007.133603]; IUPAC (International Union of Pure and Applied Chemistry), 1979, 2301 IUPAC, V2, P301; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Li YQ, 2010, FOOD RES INT, V43, P739, DOI 10.1016/j.foodres.2009.11.006; LIEN EL, 1994, J PEDIATR-US, V125, pS62, DOI 10.1016/S0022-3476(06)80738-9; Lien EL, 1997, J PEDIATR GASTR NUTR, V25, P167, DOI 10.1097/00005176-199708000-00007; Lucas A, 1997, ARCH DIS CHILD-FETAL, V77, pF178, DOI 10.1136/fn.77.3.F178; Marques TM, 2015, BRIT J NUTR, V113, P728, DOI 10.1017/S0007114514004206; NELSON GM, 1995, J MICROBIOL METH, V22, P293, DOI 10.1016/0167-7012(95)00004-5; Nelson SE, 1998, J AM COLL NUTR, V17, P327, DOI 10.1080/07315724.1998.10718770; OHTA A, 1994, INT J VITAM NUTR RES, V64, P316; Patterson E, 2014, BRIT J NUTR, V111, P1905, DOI 10.1017/S0007114514000117; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; QUINLAN PT, 1995, J PEDIATR GASTR NUTR, V20, P81, DOI 10.1097/00005176-199501000-00014; RENAUD SC, 1995, J NUTR, V125, P229; SMALL DM, 1991, ANNU REV NUTR, V11, P413, DOI 10.1146/annurev.nu.11.070191.002213; TOMARELLI RM, 1968, J NUTR, V95, P583; Wang TY, 2013, EUR J CLIN INVEST, V43, P1203, DOI 10.1111/eci.12161; Wei W, 2015, LWT-FOOD SCI TECHNOL, V60, P1187, DOI 10.1016/j.lwt.2014.09.013; Wu H, 2015, TRENDS ENDOCRIN MET, V26, P758, DOI 10.1016/j.tem.2015.09.011; Xiao L, 2015, NAT BIOTECHNOL, V33, P1103, DOI 10.1038/nbt.3353; Xu X, 1998, J AM OIL CHEM SOC, V75, P1573, DOI 10.1007/s11746-998-0096-6; Yao MJ, 2014, J PEDIATR GASTR NUTR, V59, P440, DOI 10.1097/MPG.0000000000000443; Yaron S, 2013, J PEDIATR GASTR NUTR, V56, P376, DOI 10.1097/MPG.0b013e31827e1ee2; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042529	36	21	22	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164894	10.1371/journal.pone.0164894	http://dx.doi.org/10.1371/journal.pone.0164894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783700	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800050
J	Langhamer, O; Holand, H; Rosenqvist, G				Langhamer, Olivia; Holand, Hakon; Rosenqvist, Gunilla			Effects of an Offshore Wind Farm (OWF) on the Common Shore Crab Carcinus maenas: Tagging Pilot Experiments in the Lillgrund Offshore Wind Farm (Sweden)	PLOS ONE			English	Article							GREEN CRAB; SPATIAL-PATTERNS; ARTIFICIAL REEFS; FISH; ESTUARINE; CRUSTACEA; ABUNDANCE; RECRUITMENT; POPULATIONS; SETTLEMENT	Worldwide growth of offshore renewable energy production will provide marine organisms with new hard substrate for colonization in terms of artificial reefs. The artificial reef effect is important when planning offshore installations since it can create habitat enhancement. Wind power is the most advanced technology within offshore renewable energy sources and there is an urgent need to study its impacts on the marine environment. To test the hypothesis that offshore wind power increases the abundance of reef species relative to a reference area, we conduct an experiment on the model species common shore crab (Carcinus maenas). Overall, 3962 crabs were captured, observed, marked and released in 2011 and 1995 crabs in 2012. Additionally, carapace size, sex distribution, color morphs and body condition was recorded from captured crabs. We observed very low recapture rates at all sites during both years which made evaluating differences in population sizes very difficult. However, we were able to estimate population densities from the capture record for all three sites. There was no obvious artificial reef effect in the Lillgrund wind farm, but a spill-over effect to nearby habitats cannot be excluded. We could not find any effect of the wind farm on either, morphs, sex distribution or condition of the common shore crab. Our study found no evidence that Lillgrund wind farm has a negative effect on populations of the common shore crab. This study provides the first quantitative and experimental data on the common shore crab in relation to offshore wind farms.	[Langhamer, Olivia; Holand, Hakon; Rosenqvist, Gunilla] Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Langhamer, O (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway.	olanghamer@gmail.com		Rosenqvist, Gunilla/0000-0002-6500-020X	Statkraft Ocean Energy Research Program	Statkraft Ocean Energy Research Program	This work was supported by Statkraft Ocean Energy Research Program received by OL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello P, 1997, MAR ECOL PROG SER, V147, P97, DOI 10.3354/meps147097; Amaral V, 2009, ESTUAR COAST SHELF S, V83, P219, DOI 10.1016/j.ecss.2009.03.029; Baeta A, 2005, ESTUAR COAST SHELF S, V65, P43, DOI 10.1016/j.ecss.2005.05.004; Bamber SD, 1997, ESTUAR COAST SHELF S, V44, P195, DOI 10.1006/ecss.1996.0211; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bergstrom L, EFFEKTER HAVSBASERAD; Bergstrom L, FISKUNDERSOKNINGAR V; Bergstrom L, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034012; Bergstrom L, 2013, MAR ECOL PROG SER, V485, P199, DOI 10.3354/meps10344; BOHNSACK JA, 1985, B MAR SCI, V37, P11; BREITBURG DL, 1995, MAR ECOL PROG SER, V125, P45, DOI 10.3354/meps125045; Brostrom G, 2008, J MARINE SYST, V74, P585, DOI 10.1016/j.jmarsys.2008.05.001; COHEN AN, 1995, MAR BIOL, V122, P225; Crothers J. H., 1968, Field Studies, V2, P579; Dafforn KA, 2015, FRONT ECOL ENVIRON, V13, P82, DOI 10.1890/140050; Enderlein P, 2004, J SEA RES, V51, P145, DOI 10.1016/j.seares.2003.05.006; Flach EC, 2003, J SEA RES, V49, P59, DOI 10.1016/S1385-1101(02)00199-5; Floderus A, 2008, EXPERIENCES CONSTRUC; GIBSON RN, 1994, NETH J SEA RES, V32, P191, DOI 10.1016/0077-7579(94)90040-X; Gomes Violante, 1991, Ciencia Biologica Ecology and Systematics, V11, P21; Goransson P, 2002, SARSIA, V87, P263, DOI 10.1080/00364820260400771; Greening Blue Energy, 2010, ID MAN BIOD RISKS OP; Haggarty DR, 2006, FISH RES, V81, P89, DOI 10.1016/j.fishres.2006.05.015; Halpern BS, 2003, ECOL APPL, V13, pS117; Hansen KS, 2012, SMALL SCALE DISTRIBU; Havsmiljoinstitutet, 2014, SJOF KRING SVER DESS; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; JANKE K, 1990, HELGOLANDER MEERESUN, V44, P219, DOI 10.1007/BF02365466; Kangas M., 2000, FISH RES REP FISH W, V121, P1; Kemppainen P, 2005, OECOLOGIA, V143, P402, DOI 10.1007/s00442-004-1819-5; Langhamer O, 2012, SCI WORLD J, DOI 10.1100/2012/386713; Langhamer O, 2009, MAR ENVIRON RES, V68, P151, DOI 10.1016/j.marenvres.2009.06.003; Langhamer O, 2009, ESTUAR COAST SHELF S, V82, P426, DOI 10.1016/j.ecss.2009.02.009; Ledesma FM, 2010, J SEA RES, V63, P213, DOI 10.1016/j.seares.2010.01.002; Liljelind I, 2008, 5859 NAT; Lindkvist T, 2008, ARSRAPPORT HYDROLOGI; Lowe S., 2000, ENCY BIOL INVASIONS; Lowry MB, 2014, FISHERIES MANAG ECOL, V21, P42, DOI 10.1111/fme.12048; MCGAW IJ, 1992, J EXP MAR BIOL ECOL, V155, P145, DOI 10.1016/0022-0981(92)90059-J; MCGAW IJ, 1992, J MAR BIOL ASSOC UK, V72, P599, DOI 10.1017/S0025315400059373; McPherson R, 2002, FISH RES, V54, P209, DOI 10.1016/S0165-7836(00)00303-9; Moen FE, 2004, MARINE FISH INVERTE; Moksnes PO, 2002, J EXP MAR BIOL ECOL, V271, P41, DOI 10.1016/S0022-0981(02)00041-2; Munch-Petersen S, 1982, ABUNDANCE SHORE CRAB, P97; Murray LG, 2010, MAR ECOL PROG SER, V401, P173, DOI 10.3354/meps08415; Petersen JK, 2006, AMBIO, V35, P75, DOI 10.1579/0044-7447(2006)35[75:OWFTTO]2.0.CO;2; Pickering H, 1997, FISH RES, V31, P39, DOI 10.1016/S0165-7836(97)00019-2; PIHL L, 1982, J EXP MAR BIOL ECOL, V57, P273, DOI 10.1016/0022-0981(82)90197-6; Reid D, 2009, J ZOOL, V232, P397; REID DG, 1994, J ZOOL, V232, P397, DOI 10.1111/j.1469-7998.1994.tb01581.x; Reid DG, 1997, ESTUAR COAST SHELF S, V44, P203, DOI 10.1006/ecss.1996.0212; Reubens JT, 2014, HYDROBIOLOGIA, V727, P121, DOI 10.1007/s10750-013-1793-1; Rodrigues S, 2015, RENEW SUST ENERG REV, V49, P1114, DOI 10.1016/j.rser.2015.04.092; ROPES JW, 1969, US FISH WLD S FISH B, V67, P183; Sheehan EV, 2008, J SEA RES, V60, P255, DOI 10.1016/j.seares.2008.09.002; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Stenberg C, 2015, MAR ECOL PROG SER, V528, P257, DOI 10.3354/meps11261; Ungfors A, 2007, FISH RES, V84, P345, DOI 10.1016/j.fishres.2006.11.031; Wale MA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1194; WARMAN CG, 1993, J MAR BIOL ASSOC UK, V73, P355, DOI 10.1017/S0025315400032914; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilhelmsson D, 2008, ESTUAR COAST SHELF S, V79, P459, DOI 10.1016/j.ecss.2008.04.020; Wilhelmsson D, 2006, ICES J MAR SCI, V63, P775, DOI 10.1016/j.icesjms.2006.02.001; Wilhelmsson D, 2014, HUMANIT SEA, P49, DOI 10.1007/978-94-017-8002-5_5; Yamada SB, 2005, BIOL INVASIONS, V7, P309, DOI 10.1007/s10530-004-0877-2	65	16	17	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165096	10.1371/journal.pone.0165096	http://dx.doi.org/10.1371/journal.pone.0165096			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780212	Green Accepted, gold, Green Published			2022-12-26	WOS:000389046900028
J	Wang, ZQ; Liu, Q; Lu, JH; Fan, P; Xie, WD; Qiu, W; Wang, F; Hu, GN; Zhang, Y				Wang, Ziqiang; Liu, Qing; Lu, Jinhua; Fan, Ping; Xie, Weidong; Qiu, Wei; Wang, Fan; Hu, Guangnan; Zhang, Yaou			Serine/Arginine-rich Splicing Factor 2 Modulates Herpes Simplex Virus Type 1 Replication via Regulating Viral Gene Transcriptional Activity and Pre-mRNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; SR PROTEINS; POLYMERASE-II; HIV-1 RNA; SC35; INFECTION; ICP0; DEGRADATION; IMMUNOPRECIPITATION; COMPLEX	Once it enters the host cell, herpes simplex virus type 1 (HSV-1) recruits a series of host cell factors to facilitate its life cycle. Here, we demonstrate that serine/arginine-rich splicing factor 2 (SRSF2), which is an important component of the splicing speckle, mediates HSV-1 replication by regulating viral gene expression at the transcriptional and posttranscriptional levels. Our results indicate that SRSF2 functions as a transcriptional activator by directly binding to infected cell polypeptide 0 (ICP0), infected cell polypeptide 27 (ICP27), and thymidine kinase promoters. Moreover, SRSF2 participates in ICP0 pre-mRNA splicing by recognizing binding sites in ICP0 exon 3. These findings provide insight into the functions of SRSF2 in HSV-1 replication and gene expression.	[Wang, Ziqiang; Liu, Qing; Fan, Ping; Qiu, Wei; Wang, Fan] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Ziqiang; Liu, Qing; Fan, Ping; Xie, Weidong; Qiu, Wei; Wang, Fan; Zhang, Yaou] Tsinghua Univ, Grad Sch Shenzhen, Key Lab Hlth Sci & Technol, Div Life Sci, Shenzhen 518055, Peoples R China; [Lu, Jinhua] Shenzhen South China Pharmaceut Co Ltd, Shenzhen 518055, Peoples R China; [Hu, Guangnan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; University of Massachusetts System; University of Massachusetts Worcester	Zhang, Y (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Key Lab Hlth Sci & Technol, Div Life Sci, Shenzhen 518055, Peoples R China.	zhangyo@sz.tsinghua.edu.cn	liu, qingqing/HHD-0360-2022; Wang, Ziqiang/AAW-5525-2020; Liu, Qing/GWC-9222-2022	wang, ziqiang/0000-0002-4676-3447; Zhang, Yaou/0000-0002-2501-8093	National Natural Science Foundation of China [31371315]; Ministry of Health, China [2012ZX09102301-019]; Basic Research Fund of Shenzhen [JCYJ20150724173156330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health, China; Basic Research Fund of Shenzhen	This work was supported by the National Natural Science Foundation of China (31371315), the Ministry of Health, China (2012ZX09102301-019), and Basic Research Fund of Shenzhen (JCYJ20150724173156330). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Dujaili LJ, 2011, FUTURE MICROBIOL, V6, P877, DOI 10.2217/FMB.11.73; Aslani A, 2002, J BIOL CHEM, V277, P41204, DOI 10.1074/jbc.M208270200; Boe SO, 1998, VIROLOGY, V244, P473, DOI 10.1006/viro.1998.9110; Burge CB, 1999, RNA WORLD, P525; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dai-Ju JQ, 2006, J VIROL, V80, P3567, DOI 10.1128/JVI.80.7.3567-3581.2006; Erkelenz S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0154-8; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; Gu HD, 2007, P NATL ACAD SCI USA, V104, P17134, DOI 10.1073/pnas.0707266104; Gu HD, 2003, P NATL ACAD SCI USA, V100, P8963, DOI 10.1073/pnas.1533420100; Hallay H, 2006, J BIOL CHEM, V281, P37159, DOI 10.1074/jbc.M603864200; Hsia S C, 2013, Br Microbiol Res J, V3, P706; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Jacquenet S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-33; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Kalamvoki M, 2009, P NATL ACAD SCI USA, V106, P14576, DOI 10.1073/pnas.0906905106; Lee HR, 2004, J VIROL, V78, P6527, DOI 10.1128/JVI.78.12.6527-6542.2004; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; McFarlane M, 2015, J VIROL, V89, P5276, DOI 10.1128/JVI.03434-14; OReilly D, 1997, EMBO J, V16, P2420, DOI 10.1093/emboj/16.9.2420; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Paladino P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010428; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Pinnoji RC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-56; QUINLAN MP, 1984, CELL, V36, P857, DOI 10.1016/0092-8674(84)90035-7; RICE SA, 1995, J VIROL, V69, P5550, DOI 10.1128/JVI.69.9.5550-5559.1995; Ropers D, 2004, J BIOL CHEM, V279, P29963, DOI 10.1074/jbc.M404452200; Rowles DL, 2015, PROTEOMICS, V15, P1968, DOI 10.1002/pmic.201500035; SANDRIGOLDIN RM, 1995, J VIROL, V69, P6063, DOI 10.1128/JVI.69.10.6063-6076.1995; Sedlackova L, 2008, J VIROL, V82, P268, DOI 10.1128/JVI.01588-07; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Workenhe ST, 2016, ONCOGENE, V35, P2465, DOI 10.1038/onc.2015.303; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	37	11	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26377	26387		10.1074/jbc.M116.753046	http://dx.doi.org/10.1074/jbc.M116.753046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27784784	Green Published, hybrid			2022-12-26	WOS:000391568200012
J	Chung, SD; Huang, CC; Lin, HC; Tsai, MC; Chen, CH				Chung, Shiu-Dong; Huang, Chung-Chien; Lin, Herng-Ching; Tsai, Ming-Chieh; Chen, Chao-Hung			Increased Risk of Clinically Significant Gallstones following an Appendectomy: A Five-Year Follow-Up Study	PLoS One			English	Article							ACUTE APPENDICITIS; CROHNS-DISEASE; ULCERATIVE-COLITIS; POPULATION-SAMPLE; UNITED-STATES; PREVALENCE; CHOLECYSTECTOMY; EPIDEMIOLOGY; PATHOGENESIS; METAANALYSIS	Although the vermiform appendix is commonly considered a vestigial organ, adverse health consequences after an appendectomy have garnered increasing attention. In this study, we investigated the risks of gallstone occurrence during a 5-year follow-up period after an appendectomy, using a population-based dataset. We used data from the Taiwan Longitudinal Health Insurance Database 2005. The exposed cohort included 4916 patients who underwent an appendectomy. The unexposed cohort was retrieved by randomly selecting 4916 patients matched with the exposed cohort in terms of sex, age, and year. We individually tracked each patient for a 5-year period to identify those who received a diagnosis of gallstones during the follow-up period. Cox proportional hazard regressions were performed for the analysis. During the 5-year follow-up period, the incidence rate per 1000 person-years was 4.71 for patients who had undergone an appendectomy, compared to a rate of 2.59 for patients in the unexposed cohort (p<0.001). Patients who had undergone an appendectomy were independently associated with a 1.79 (95% CI = 1.29-2.48)-fold increased risk of being diagnosed with gallstones during the 5-year follow-up period. We found that among female patients, the adjusted hazard ratio of gallstones was 2.25 (95% CI = 1.41 similar to 3.59) for patients who underwent an appendectomy compared to unexposed patients. However, for male patients, we failed to observe an increased hazard for gallstones among patients who underwent an appendectomy compared to unexposed patients. We found an increased risk of a subsequent gallstone diagnosis within 5 years after an appendectomy.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Taipei, Taiwan; [Chung, Shiu-Dong] Yuan Ze Univ, Grad Program Biomed Informat, Coll Informat, Chungli, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Huang, Chung-Chien; Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Hsinchu Branch, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan; [Chen, Chao-Hung] Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan; [Chen, Chao-Hung] MacKay Mem Hosp, Dept Thorac Surg, Taipei, Taiwan; [Chen, Chao-Hung] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan	Far Eastern Memorial Hospital; Yuan Ze University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Cathay General Hospital; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; National Yang Ming Chiao Tung University	Chen, CH (corresponding author), Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan.; Chen, CH (corresponding author), MacKay Mem Hosp, Dept Thorac Surg, Taipei, Taiwan.; Chen, CH (corresponding author), Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan.	s448@eip.mkc.edu.tw	Huang, CC/AAX-5872-2021	Huang, CC/0000-0003-0818-7175				Al-Omran M, 2003, CAN J SURG, V46, P263; Andersson RE, 2003, GASTROENTEROLOGY, V124, P40, DOI 10.1053/gast.2003.50021; Andersson RE, 2013, WORLD J SURG, V37, P974, DOI 10.1007/s00268-012-1856-x; Attili AF, 1998, HEPATOLOGY, V27, P1492, DOI 10.1002/hep.510270605; Blomqvist P, 1998, J CLIN EPIDEMIOL, V51, P859, DOI 10.1016/S0895-4356(98)00065-1; Bollinger RR, 2007, J THEOR BIOL, V249, P826, DOI 10.1016/j.jtbi.2007.08.032; Buckius MT, 2012, J SURG RES, V175, P185, DOI 10.1016/j.jss.2011.07.017; Burcharth J, 2013, SCAND J SURG, V102, P55, DOI 10.1177/1457496913482248; Chen DW, 2014, J SURG RES, V190, P478, DOI 10.1016/j.jss.2014.04.028; DeSantis A, 1997, HEPATOLOGY, V25, P787, DOI 10.1002/hep.510250401; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Gurusamy KS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005440.pub3; Halldestam I, 2009, BRIT J SURG, V96, P1315, DOI 10.1002/bjs.6687; Hoogerwerf WA, 1999, CURR OPIN GASTROEN, V15, P442, DOI 10.1097/00001574-199909000-00012; Internal Clinical Guidelines Team (UK), 2014, GALLST DIS DIAGN MAN; JORGENSEN T, 1987, AM J EPIDEMIOL, V126, P912, DOI 10.1093/oxfordjournals.aje.a114728; Kaplan GG, 2008, AM J GASTROENTEROL, V103, P2925, DOI 10.1111/j.1572-0241.2008.02118.x; Koutroubakis IE, 2002, INFLAMM BOWEL DIS, V8, P277, DOI 10.1097/00054725-200207000-00007; Koutroubakis IE, 2000, AM J GASTROENTEROL, V95, P171; Lai HW, 2006, J GASTROEN HEPATOL, V21, P1693, DOI 10.1111/j.1440-1746.2006.04426.x; Lapidus A, 1999, AM J GASTROENTEROL, V94, P1261, DOI 10.1111/j.1572-0241.1999.01076.x; Lee Janice Y J, 2015, Practitioner, V259, P15; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Lin KB, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0036-3; MABEE TM, 1976, SURGERY, V79, P460; Njeze Gabriel E, 2013, Niger J Surg, V19, P49, DOI 10.4103/1117-6806.119236; Parente F, 2007, HEPATOLOGY, V45, P1267, DOI 10.1002/hep.21537; Ratanarapee Samrerng, 2010, Journal of the Medical Association of Thailand, V93, P1327; RINK RD, 1981, CIRC SHOCK, V8, P601; Seetahal SA, 2011, AM J SURG, V201, P433, DOI 10.1016/j.amjsurg.2010.10.009; SISSON RG, 1971, AM J SURG, V122, P378, DOI 10.1016/0002-9610(71)90262-5; Stender S, 2013, JAMA INTERN MED, V173, P1222, DOI 10.1001/jamainternmed.2013.6465; TABATA M, 1981, DIGEST DIS SCI, V26, P218, DOI 10.1007/BF01391633; THIJS C, 1990, GASTROENTEROLOGY, V99, P843, DOI 10.1016/0016-5085(90)90978-A; Tsai CJ, 2006, AM J MED, V119, P760, DOI 10.1016/j.amjmed.2006.02.040; VELANOVICH V, 1992, AM SURGEON, V58, P264; Wang Jeffrey K, 2009, Perm J, V13, P50; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Zahid Aliya, 2004, J Coll Physicians Surg Pak, V14, P256; 1992, NIH CONSENS STATEMEN, V10, P1	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165829	10.1371/journal.pone.0165829	http://dx.doi.org/10.1371/journal.pone.0165829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788255	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900123
J	Elfer, KN; Sholl, AB; Wang, M; Tulman, DB; Mandava, H; Lee, BR; Brown, JQ				Elfer, Katherine N.; Sholl, Andrew B.; Wang, Mei; Tulman, David B.; Mandava, H.; Lee, Benjamin R.; Brown, J. Quincy			DRAQ5 and Eosin ('D&E') as an Analog to Hematoxylin and Eosin for Rapid Fluorescence Histology of Fresh Tissues	PLOS ONE			English	Article							MICROSCOPY; CELLULARITY; MARGINS; BLOOD; RNA	Real-time on-site histopathology review of biopsy tissues at the point-of-procedure has great potential for significant clinical value and improved patient care. For instance, on-site review can aid in rapid screening of diagnostic biopsies to reduce false-negative results, or in quantitative assessment of biospecimen quality to increase the efficacy of downstream laboratory and histopathology analysis. However, the only currently available rapid pathology method, frozen section analysis (FSA), is too time-and labor-intensive for use in screening large quantities of biopsy tissues and is too destructive for maximum tissue conservation in multiple small needle core biopsies. In this work we demonstrate the spectrally-compatible combination of the nuclear stain DRAQ5 and the anionic counterstain eosin as a dual-component fluorescent staining analog to hematoxylin and eosin intended for use on fresh, unsectioned tissues. Combined with optical sectioning fluorescence microscopy and pseudo-coloring algorithms, DRAQ5 and eosin ("D&E") enables very fast, non-destructive psuedohistological imaging of tissues at the point-of-acquisition with minimal tissue handling and processing. D&E was validated against H&E on a one-to-one basis on formalin-fixed paraffin-embedded and frozen section tissues of various human organs using standard epi-fluorescence microscopy, demonstrating high fidelity of the staining mechanism as an H&E analog. The method was then applied to fresh, whole 18G renal needle core biopsies and large needle core prostate biospecimen biopsies using fluorescence structured illumination optical sectioning microscopy. We demonstrate the ability to obtain high-resolution histology-like images of unsectioned, fresh tissues similar to subsequent H&E staining of the tissue. The application of D&E does not interfere with subsequent standard-of-care H&E staining and imaging, preserving the integrity of the tissue for thorough downstream analysis. These results indicate that this dual-stain pseudocoloring method could provide a real-time histology-like image at the time of acquisition and valuable objective tissue analysis for the clinician at the time of service.	[Elfer, Katherine N.; Wang, Mei; Tulman, David B.; Brown, J. Quincy] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Sholl, Andrew B.] Tulane Univ, Sch Med, Dept Pathol & Lab Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Mandava, H.; Lee, Benjamin R.] Tulane Univ, Sch Med, Dept Urol, New Orleans, LA 70112 USA; [Lee, Benjamin R.] Univ Arizona Hlth Sci, Dept Surg, Div Urol, Tucson, AZ USA	Tulane University; Tulane University; Tulane University; University of Arizona; University of Arizona Health Sciences	Brown, JQ (corresponding author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.	jqbrown@tulane.edu			National Cancer Institute of the National Institutes of Health [R21 CA159936]; Innovative Molecular Analysis Technologies (IMAT) program of the National Cancer Institute [R33 CM 96457]; Tulane University School of Science and Engineering; National Science Foundation Graduate Research Fellowship Program; National Science Foundation IGERT Fellowship [DGE-1144646]; NATIONAL CANCER INSTITUTE [R33CA196457, R21CA159936] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Innovative Molecular Analysis Technologies (IMAT) program of the National Cancer Institute; Tulane University School of Science and Engineering; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Science Foundation IGERT Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute of the National Institutes of Health (http://www.cancer.gov), grant number R21 CA159936 (JQB), and a grant from the Innovative Molecular Analysis Technologies (IMAT) program (http://innovation.cancer.gov) of the National Cancer Institute, grant number R33 CM 96457 (JQB). The work was also supported by an institutional startup grant from the Tulane University School of Science and Engineering. KNE acknowledges support from the National Science Foundation Graduate Research Fellowship Program (https://www.nsfgrfp.org). DBT acknowledges support from the National Science Foundation IGERT Fellowship (DGE-1144646 to Donald P. Gayer) (http://www.igert.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeytunge S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061227; Bini J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3596742; Bjornsson S, 2008, CYTOM PART B-CLIN CY, V74B, P91, DOI 10.1002/cyto.b.20382; Dobbs J, 2015, BREAST CANCER RES TR, V149, P303, DOI 10.1007/s10549-014-3182-5; Dobbs JL, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.106016; Edward R, 2012, METHOD ENZYMOL, V505, P23, DOI 10.1016/B978-0-12-388448-0.00010-3; Elfer KN, 2015, EUR C BIOM OPT MUN G; Fu HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147006; Fu HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068868; Gareau D, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.066018; Gareau DS, 2012, J SURG RES, V178, P533, DOI 10.1016/j.jss.2012.05.059; Gareau DS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149853; Gareau DS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3130331; Giacomelli MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159337; Karadaglic D, 2008, MICRON, V39, P808, DOI 10.1016/j.micron.2008.01.017; Leigh SY, 2012, OPT LETT, V37, P2430, DOI 10.1364/OL.37.002430; Makhlouf H, 2011, BIOMED OPT EXPRESS, V2, P634, DOI 10.1364/BOE.2.000634; Martin RM, 2005, CYTOM PART A, V67A, P45, DOI 10.1002/cyto.a.20172; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Njoh KL, 2006, CYTOM PART A, V69A, P805, DOI 10.1002/cyto.a.20308; Ragazzi M, 2014, MODERN PATHOL, V27, P460, DOI 10.1038/modpathol.2013.158; Rekhtman N, 2015, ARCH PATHOL LAB MED, V139, P907, DOI 10.5858/arpa.2014-0392-OA; ROBBINS E, 1963, J CELL BIOL, V18, P237, DOI 10.1083/jcb.18.2.237; Saldua MA, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016006; SARNAT HB, 1986, CAN J NEUROL SCI, V13, P31, DOI 10.1017/S0317167100035769; SARNAT HB, 1987, CAN J NEUROL SCI, V14, P224; Schlichenmeyer TC, 2014, BIOMED OPT EXPRESS, V5, P366, DOI 10.1364/BOE.5.000366; Smith Paul J, 2004, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0725s28; Smith PJ, 1999, J IMMUNOL METHODS, V229, P131, DOI 10.1016/S0022-1759(99)00116-7; Snuderl M, 2013, BRAIN PATHOL, V23, P73, DOI 10.1111/j.1750-3639.2012.00626.x; Tao YK, 2014, P NATL ACAD SCI USA, V111, P15304, DOI 10.1073/pnas.1416955111; Truong LD, 2005, ARCH PATHOL LAB MED, V129, P1585; Wang M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27419; Wang M, 2015, CANCER RES, V75, P4032, DOI 10.1158/0008-5472.CAN-14-3806; Wang M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.16; Warth A, 2010, PATHOL ONCOL RES, V16, P119, DOI 10.1007/s12253-009-9201-x	36	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165530	10.1371/journal.pone.0165530	http://dx.doi.org/10.1371/journal.pone.0165530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788264	gold, Green Submitted, Green Published			2022-12-26	WOS:000389604900104
J	Shimizu, J; Okazaki, S; Nagoya, S; Takahashi, N; Kanaya, K; Mizuo, K; Hyodoh, H; Watanabe, S; Yamashita, T				Shimizu, Junya; Okazaki, Shunichiro; Nagoya, Satoshi; Takahashi, Nobuyuki; Kanaya, Kumiko; Mizuo, Keisuke; Hyodoh, Hideki; Watanabe, Satoshi; Yamashita, Toshihiko			Susceptibility of Males, but Not Females to Developing Femoral Head Osteonecrosis in Response to Alcohol Consumption	PLoS One			English	Article							NONTRAUMATIC OSTEONECROSIS; IDIOPATHIC OSTEONECROSIS; LIVER-DISEASE; PERMEABILITY; PATHOGENESIS; SYSTEM; MODEL; BONE; RATS	Background We previously reported that ethanol-containing liquid diet feeding induces osteonecrosis of the femoral head in male rats. Also, it was reported that a large amount of consumed ethanol and a long-term history of drinking were risk factors for osteonecrosis of the femoral head, and that the frequency of alcohol-induced osteonecrosis of the femoral head in males was much greater than in females. The higher incidence of alcohol-induced osteonecrosis of the femoral head could be due to either higher prevalence of alcohol drinking in males or due to their potential higher sensitivity to alcohol. The aim of the study is to investigate the influence of alcohol consumption and drinking period on the development of osteonecrosis of the femoral head in rats of both sex. Methods All the experimental male rats were allocated to the male one-month ethanol drinking group (M1). Female rats were randomly divided into the female one- to five-months ethanol drinking groups (F1-5). All rats were fed a Lieber-DeCarli liquid diet containing 5% ethanol for one to five months. Results One-month feeding with the ethanol-containing liquid diet resulted in the development of osteonecrosis of the femoral head in seven of twenty in the M1 group, but none in the F1 group, although the mean intake of ethanol per body weight in the M1 group was significantly lower than that in the F1 group. Furthermore, long drinking periods with a large amount of ethanol intake in the F2-5 groups did not induce osteonecrosis of the femoral head. Conclusion The present study shows that lower alcohol consumption over short periods of time that were sufficient to induce osteonecrosis of the femoral head in males had no effect on females. Even with greater alcohol consumption and longer duration, females did not develop osteonecrosis of the femoral head. Therefore, unknown factors related to sex must be responsible for the development of this condition.	[Shimizu, Junya; Takahashi, Nobuyuki; Kanaya, Kumiko; Yamashita, Toshihiko] Sapporo Med Univ, Sch Med, Dept Orthoped Surg, Sapporo, Hokkaido, Japan; [Shimizu, Junya; Okazaki, Shunichiro; Takahashi, Nobuyuki; Mizuo, Keisuke; Hyodoh, Hideki; Watanabe, Satoshi] Sapporo Med Univ, Sch Med, Dept Legal Med, Sapporo, Hokkaido, Japan; [Okazaki, Shunichiro; Nagoya, Satoshi] Sapporo Med Univ, Dept Musculoskeletal Biomech & Surg Dev, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Okazaki, S (corresponding author), Sapporo Med Univ, Sch Med, Dept Legal Med, Sapporo, Hokkaido, Japan.; Okazaki, S (corresponding author), Sapporo Med Univ, Dept Musculoskeletal Biomech & Surg Dev, Sapporo, Hokkaido, Japan.	oka@sapmed.ac.jp			Japan Society for the Promotion of Science [25861330]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Grants-in-Aid for Young Scientists (B) (S.O., 25861330) from the Japan Society for the Promotion of Science.	ABELES M, 1978, ARCH INTERN MED, V138, P750, DOI 10.1001/archinte.138.5.750; Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; BODE C, 1991, ANN NY ACAD SCI, V625, P837, DOI 10.1111/j.1749-6632.1991.tb33931.x; Brandon-Warner E, 2012, ALCOHOL CLIN EXP RES, V36, P641, DOI 10.1111/j.1530-0277.2011.01660.x; Fukushima W, 2010, CLIN ORTHOP RELAT R, V468, P2715, DOI 10.1007/s11999-010-1292-x; Hashimoto JG, 2008, NEUROPSYCHOPHARMACOL, V33, P1084, DOI 10.1038/sj.npp.1301494; HIROTA Y, 1993, AM J EPIDEMIOL, V137, P530, DOI 10.1093/oxfordjournals.aje.a116706; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; LIEBER CS, 1989, HEPATOLOGY, V10, P501, DOI 10.1002/hep.1840100417; Okazaki S, 2009, RHEUMATOLOGY, V48, P227, DOI 10.1093/rheumatology/ken462; Okazaki S, 2016, J ORTHOP RES, V34, P342, DOI 10.1002/jor.23008; Okazaki S, 2015, LAB INVEST, V95, P92, DOI 10.1038/labinvest.2014.134; Okazaki S, 2013, INT J EXP PATHOL, V94, P312, DOI 10.1111/iep.12035; Okazaki S, 2013, RHEUMATOL INT, V33, P51, DOI 10.1007/s00296-011-2295-y; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Takahashi S, 2015, J EPIDEMIOL, V25, P437, DOI 10.2188/jea.JE20140162; Tateda K, 2012, LAB INVEST, V92, P1318, DOI 10.1038/labinvest.2012.89; Wang YS, 2008, CLIN ORTHOP RELAT R, V466, P1059, DOI 10.1007/s11999-008-0178-7; Yamamoto T, 1997, ARTHRITIS RHEUM, V40, P2055, DOI 10.1002/art.1780401119	19	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165490	10.1371/journal.pone.0165490	http://dx.doi.org/10.1371/journal.pone.0165490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788269	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900095
J	Rimini, D; Molinari, F; Liboni, W; Balbo, M; Daro, R; Viotti, E; Fernandez, I				Rimini, Daniele; Molinari, Filippo; Liboni, William; Balbo, Marina; Daro, Roberta; Viotti, Erika; Fernandez, Isabel			Effect of Ocular Movements during Eye Movement Desensitization and Reprocessing (EMDR) Therapy: A Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							CEREBRAL BLOOD-FLOW; STRESS; BRAIN; OSCILLATIONS; LIGHT	Introduction Eye Movement Desensitization and Reprocessing (EMDR) is a psychotherapeutic treatment resolving emotional distress caused by traumatic events. With EMDR, information processing is facilitated by eye movements (EM) during the recall of a traumatic memory (RECALL). The aim of this study is to investigate the effects of ocular movements of EMDR on the hemodynamics of the prefrontal cortex (PFC). Material and Methods Two groups were recruited: a trial group (wEM) received a complete EMDR treatment, whereas a control group (woEM) received a therapy without EM. PFC hemodynamics was monitored by near-infrared spectroscopy during RECALL and during focusing on the worst image of the trauma (pre-RECALL). The parameters of oxy-(oxy-Hb), and deoxy-hemoglobin (deoxy-Hb) were acquired and analyzed in time domain, by calculating the slope within pre-RECALL and RECALL periods, and in the frequency domain, by calculating the mean power of oxy-Hb and deoxy-Hb in the very-low frequency (VLF, 20-40 mHz) and low frequency (LF, 40-140 mHz) bandwidths. We compared pre-RECALL with RECALL periods within subjects, and pre-RECALL and RECALL parameters of wEM with the corresponding of woEM. Results An effect of group on mean slope of oxy-Hb and deoxy-Hb in pre-RECALL and oxy-Hb in RECALL periods was observed. wEM showed a lower percentage of positive angular coefficients during pre-RECALL with respect to RECALL, on the opposite of woEM. In the frequency domain, wEM had significant difference in oxy-Hb and deoxy-Hb LF of left hemisphere, whereas woEM showed no difference. Discussion and Conclusion We observed the effect of EM on PFC oxygenation during EMDR, since wEM subjects showed a mean increase of oxy-Hb during RECALL and a decrease during pre-RECALL, as opposed to woEM. Frequency analysis evidenced a reduction of activity of sympathetic nervous system in wEM group during pre-RECALL. Our outcomes revealed a different hemodynamics induced by eye movements in wEM with respect to woEM group.	[Rimini, Daniele; Molinari, Filippo] Politecn Torino, Dept Elect & Telecommun, Biolab, Turin, Italy; [Liboni, William] Un Passo Insieme ONLUS Fdn, Turin, Italy; [Balbo, Marina; Daro, Roberta; Viotti, Erika; Fernandez, Isabel] EMDR Italy Assoc, Bovisio Masciago, MB, Italy	Polytechnic University of Turin	Rimini, D (corresponding author), Politecn Torino, Dept Elect & Telecommun, Biolab, Turin, Italy.	daniele.rimini@polito.it	Rimini, Daniele/GRY-0486-2022; Rimini, Daniele/H-3948-2018	Rimini, Daniele/0000-0001-7170-7052	EMDR Italy Association	EMDR Italy Association	The study was partly granted by the EMDR Italy Association.	DEROGATIS LR, 1977, BRIT J SOC CLIN PSYC, V16, P347, DOI 10.1111/j.2044-8260.1977.tb00241.x; DUNCAN A, 1995, PHYS MED BIOL, V40, P295, DOI 10.1088/0031-9155/40/2/007; Elwell CE, 2011, PHILOS T R SOC A, V369, P4355, DOI 10.1098/rsta.2011.0303; Engelhard IM, 2010, BEHAV RES THER, V48, P442, DOI 10.1016/j.brat.2010.01.003; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Gsell W, 2000, J CHEM NEUROANAT, V20, P215, DOI 10.1016/S0891-0618(00)00095-8; Gunter RW, 2009, J EMDR PRACT RES, V3, P161, DOI 10.1891/1933-3196.3.3.161; Herkt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106350; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Lee CW, 2013, J BEHAV THER EXP PSY, V44, P231, DOI 10.1016/j.jbtep.2012.11.001; Leon-Carrion J, 2008, BEHAV BRAIN RES, V193, P248, DOI 10.1016/j.bbr.2008.06.013; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maggioni E, 2015, NEUROIMAGE, V108, P410, DOI 10.1016/j.neuroimage.2014.12.074; Molinari F, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/459213; Mullinger KJ, 2014, NEUROIMAGE, V94, P263, DOI 10.1016/j.neuroimage.2014.02.029; Ni TO, 2009, NEUROSCI RES, V65, P375, DOI 10.1016/j.neures.2009.08.014; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Oh DH, 2007, J EMDR PRACT RES, V1, P24, DOI 10.1891/1933-3196.1.1.24; Owen-Reece H, 1999, BRIT J ANAESTH, V82, P418, DOI 10.1093/bja/82.3.418; Pagani M, 2007, NUCL MED COMMUN, V28, P757, DOI 10.1097/MNM.0b013e3282742035; Pagani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045753; Sakatani K, 1998, STROKE, V29, P1299, DOI 10.1161/01.STR.29.7.1299; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Schubert SJ, 2011, J ANXIETY DISORD, V25, P1, DOI 10.1016/j.janxdis.2010.06.024; Shapiro F, 2007, J EMDR PRACT RES, V1, P68, DOI 10.1891/1933-3196.1.2.68; Shapiro Francine, 2002, ENCY PSYCHOTHERAPY, P777, DOI 10.1002/9780470479216.corpsy0337; Sliwka U, 2001, HEADACHE, V41, P157, DOI 10.1046/j.1526-4610.2001.041002157.x; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Van Haren RM, 2013, J SURG RES, V184, P526, DOI 10.1016/j.jss.2013.03.090; World Health Organization, 2013, GUID MAN COND SPEC R; Zarghi A, 2013, BASIC CLIN NEUROSCI, V4, P97	32	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164379	10.1371/journal.pone.0164379	http://dx.doi.org/10.1371/journal.pone.0164379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VE	27783688	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800036
J	Someya, A; Ikegami, T; Sakamoto, K; Nagaoka, I				Someya, Akimasa; Ikegami, Takako; Sakamoto, Koji; Nagaoka, Isao			Glucosamine Downregulates the IL-1 beta-Induced Expression of Proinflammatory Cytokine Genes in Human Synovial MH7A Cells by O-GlcNAc Modification-Dependent and - Independent Mechanisms	PLOS ONE			English	Article							NF-KAPPA-B; OCCURRING AMINO MONOSACCHARIDE; KNEE OSTEOARTHRITIS; C-REL; ACTIVATION; SULFATE; GLCNACYLATION; INFLAMMATION; CHONDROCYTES; LPS	Osteoarthritis (OA) is one of the major joint diseases, and the synovial inflammation is involved in the pathogenesis and progression of OA. Glucosamine (GlcN) is widely used as a dietary supplement for OA, and is expected to exert the antiinflammatory action in OA. However, the detailed mechanism for the antiinflammatory action of GlcN remains poorly understood. In this study, to elucidate the molecular mechanism involved in the GlcN-medicated regulation of synovial cell activation, we comprehensively analyzed the effect of GlcN on the gene expression using a human synovial cell line MH7A by DNA microarray. The results indicated that GlcN significantly downregulates the expression of 187 genes (<= 1/1.5-fold) and upregulates the expression of 194 genes (>= 1.5-fold) in IL-1 beta-stimulated MH7A cells. Interestingly, pathway analysis indicated that among the 10 pathways into which the GlcN-regulated genes are categorized, the 4 pathways are immune-related. Furthermore, GlcN suppressed the expression of proinflammatory cytokine genes (such as IL-6, IL-8, IL-24 and TNF-alpha genes). In addition, GlcN-mediated O-GlcNAc modification was involved in the downregulation of TNF-a and IL-8 genes but not IL-6 and IL-24 genes, based on the effects of alloxan, an O-GlcNAc transferase inhibitor. Thus, GlcN likely exerts an antiinflammatroy action in OA by suppressing the expression of proinflammatory cytokine genes in synovial MH7A cells by O-GlcNAc modification-dependent and -independent mechanisms.	[Someya, Akimasa; Nagaoka, Isao] Juntendo Univ, Grad Sch Med, Dept Host Def & Biochem Res, Bunkyo Ku, Tokyo 1138421, Japan; [Ikegami, Takako] Juntendo Univ, Grad Sch Med, Res Support Ctr, Lab Mol & Biochem Res,Bunkyo Ku, Tokyo 1138421, Japan; [Sakamoto, Koji] Koyo Chem Co Ltd, Taito Ku, Tokyo 1100005, Japan	Juntendo University; Juntendo University	Someya, A (corresponding author), Juntendo Univ, Grad Sch Med, Dept Host Def & Biochem Res, Bunkyo Ku, Tokyo 1138421, Japan.	someya@juntendo.ac.jp			Japan Society for the Promotion of Science [23592232]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid (Grant number 23592232: https://www.jsps.go.jp/j-grantsinaid/index.html) for Scientific Research from Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. K. Miyazawa (Kissei Pharmaceutical Co., Ltd., Nagano, Japan) for the establishment of MH7A cells. This work was supported by Grant-in-Aid (Grant number 23592232) for Scientific Research from Japan Society for the Promotion of Science.	Baudoin L, 2015, FRONT ENDOCRINOL, V5, DOI [10.3389/fendo.2014.00235, 10.3389/fendo.2016.00235]; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; d'Abusco AS, 2007, CLIN EXP RHEUMATOL, V25, P847; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Feng X., 2013, DISCRETE DYN NAT SOC, V2013, P1, DOI DOI 10.1155/2013/160123; Gouze JN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2082; Han SK, 2006, RHEUMATOL INT, V26, P972, DOI 10.1007/s00296-006-0109-4; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Haywood L, 2003, ARTHRITIS RHEUM, V48, P2173, DOI 10.1002/art.11094; Henrotin Yves, 2013, BMC Res Notes, V6, P115, DOI 10.1186/1756-0500-6-115; Henrotin Y, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3657; Hua J, 2007, INFLAMM RES, V56, P432, DOI 10.1007/s00011-007-7020-7; Hua J, 2002, J LEUKOCYTE BIOL, V71, P632; Hwang SY, 2013, BRIT J PHARMACOL, V169, P1551, DOI 10.1111/bph.12223; Ju YH, 2008, INT J MOL MED, V22, P657, DOI 10.3892/ijmm_00000069; Ju YH, 2008, INT J MOL MED, V22, P809, DOI 10.3892/ijmm_00000089; Kapoor M, 2012, J RHEUMATOL, V39, P635, DOI 10.3899/jrheum.110621; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Kim JA, 2011, INFLAMM RES, V60, P1131, DOI 10.1007/s00011-011-0377-7; Kumari S, 2013, IMMUNITY, V39, P899, DOI 10.1016/j.immuni.2013.10.009; Kwak TK, 2010, J BIOL CHEM, V285, P36021, DOI 10.1074/jbc.M110.129601; Largo R, 2003, OSTEOARTHR CARTILAGE, V11, P290, DOI 10.1016/S1063-4584(03)00028-1; Li Y, 2014, CARBOHYD POLYM, V99, P568, DOI 10.1016/j.carbpol.2013.08.082; Liu CJ, 2006, J BIOL CHEM, V281, P15800, DOI 10.1074/jbc.M513433200; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; Liu SZ, 2011, MOL IMMUNOL, V48, P895, DOI 10.1016/j.molimm.2010.12.018; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Miyazawa K, 1998, J BIOCHEM-TOKYO, V124, P1153, DOI 10.1093/oxfordjournals.jbchem.a022233; Pavelka K, 2002, ARCH INTERN MED, V162, P2113, DOI 10.1001/archinte.162.18.2113; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; Reginster JY, 2012, RHEUMATOL INT, V32, P2959, DOI 10.1007/s00296-012-2416-2; Salazar J, 2014, ARTHRITIS, DOI 10.1155/2014/432463; So JS, 2011, LIFE SCI, V88, P358, DOI 10.1016/j.lfs.2010.12.013; Suh HN, 2014, J CELL PHYSIOL, V229, P1557, DOI 10.1002/jcp.24599; Towheed TE, 2003, ARTHRIT RHEUM-ARTHR, V49, P601, DOI 10.1002/art.11183; Uitterlinden EJ, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-120; Uldry M, 2002, FEBS LETT, V524, P199, DOI 10.1016/S0014-5793(02)03058-2; Valvason C, 2008, RHEUMATOLOGY, V47, P31, DOI 10.1093/rheumatology/kem289; Vangsness CT, 2011, BULL HOSP JT DIS, V69, P122; Waldner MJ, 2012, INT J BIOL SCI, V8, P1248, DOI 10.7150/ijbs.4614; Xing DQ, 2008, AM J PHYSIOL-HEART C, V295, pH335, DOI 10.1152/ajpheart.01259.2007; Xing DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024021; Yomogida S, 2008, INT J MOL MED, V22, P317, DOI 10.3892/ijmm_00000025; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zhang ES, 2013, CLIN RHEUMATOL, V32, P797, DOI 10.1007/s10067-013-2171-0; Zhang Q, 2015, OSTEOARTHR CARTILAGE, V23, P2259, DOI 10.1016/j.joca.2015.06.014; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhu Y, 2013, OSTEOARTHR CARTILAGE, V21, P1627, DOI 10.1016/j.joca.2013.07.017	50	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165158	10.1371/journal.pone.0165158	http://dx.doi.org/10.1371/journal.pone.0165158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776166	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200044
J	Li, H; Sineshchekov, OA; Wu, G; Spudich, JL				Li, Hai; Sineshchekov, Oleg A.; Wu, Gang; Spudich, John L.			In Vitro Activity of a Purified Natural Anion Channelrhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; electron paramagnetic resonance (EPR); lipid vesicle; membrane reconstitution; photoreceptor; LUV; flash photolysis; retinal protein; chloride channel	GATED CATION CHANNEL; CHLORIDE CHANNEL; PROTON PUMP; LIGHT; BACTERIORHODOPSIN; RECONSTITUTION; LIPOSOMES; PROTEORHODOPSIN; PROTEOLIPOSOMES; HALORHODOPSIN	Natural anion channelrhodopsins (ACRs) recently discovered in cryptophyte algae are the most active rhodopsin channels known. They are of interest both because of their unique natural function of light-gated chloride conductance and because of their unprecedented efficiency of membrane hyperpolarization for optogenetic neuron silencing. Light-induced currents of ACRs have been studied in HEK cells and neurons, but light-gated channel conductance of ACRs in vitro has not been demonstrated. Here we report light-induced chloride channel activity of a purified ACR protein reconstituted in large unilamellar vesicles (LUVs). EPR measurements establish that the channels are inserted uniformly inside-out with their cytoplasmic surface facing the medium of the LUV suspension. We show by time-resolved flash spectroscopy that the photochemical reaction cycle of a functional purified ACR from Guillardia theta (GtACR1) in LUVs exhibits similar spectral shifts, indicating similar photocycle intermediates as GtACR1 in detergent micelles. Furthermore, the photocycle rate is dependent on electric potential generated by chloride gradients in the LUVs in the same manner as in voltage-clamped animal cells. We confirm with this system that, in contrast to cation-conducting channelrhodopsins, opening of the channel occurs prior to deprotonation of the Schiff base. However, the photointermediate transitions in the LUVs exhibit faster kinetics. The ACR-incorporated LUVs provide a purified defined system amenable to EPR, optical and vibrational spectroscopy, and fluorescence resonance energy transfer measurements of structural changes of ACRs with the molecules in a demonstrably functional state.	[Li, Hai; Sineshchekov, Oleg A.; Wu, Gang; Spudich, John L.] Univ Texas Hlth Sci Ctr, McGovern Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; [Wu, Gang] Univ Texas Hlth Sci Ctr, McGovern Med Sch, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Spudich, JL (corresponding author), Univ Texas, Dept Biochem & Mol Biol, McGovern Med Sch, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	john.l.spudich@uth.tmc.edu			National Institutes of Health [R01GM027750]; Robert A. Welch Foundation [AU-0009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM027750 (to J. L. S.) and Endowed Chair Number AU-0009 from the Robert A. Welch Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; BOGOMOLNI RA, 1984, P NATL ACAD SCI-BIOL, V81, P5408, DOI 10.1073/pnas.81.17.5408; Bruun S, 2011, FEBS LETT, V585, P3998, DOI 10.1016/j.febslet.2011.11.007; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Dioumaev AK, 2003, BIOCHEMISTRY-US, V42, P6582, DOI 10.1021/bi034253r; DUSCHL A, 1988, J BIOL CHEM, V263, P17016; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Gan BS, 1998, AM J PHYSIOL-CELL PH, V275, pC1158, DOI 10.1152/ajpcell.1998.275.4.C1158; Govorunova E. G., 2017, ANN REV BIO IN PRESS, V86; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; GULIKKRZYWICKI T, 1987, J BIOL CHEM, V262, P15580; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; LEACH SJ, 1960, J AM CHEM SOC, V82, P4790, DOI 10.1021/ja01503a008; Li H, 2015, BIOPHYS J, V109, P1446, DOI 10.1016/j.bpj.2015.08.018; Lindholm L, 2015, BBA-BIOENERGETICS, V1847, P698, DOI 10.1016/j.bbabio.2015.04.011; Lorenz-Fonfria VA, 2014, BBA-BIOENERGETICS, V1837, P626, DOI 10.1016/j.bbabio.2013.10.014; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; RIGAUD JL, 1988, BIOCHEMISTRY-US, V27, P2677, DOI 10.1021/bi00408a007; RIGAUD JL, 1983, BIOCHEM BIOPH RES CO, V111, P373, DOI 10.1016/0006-291X(83)90316-9; Rink T, 1997, BIOPHYS J, V73, P983, DOI 10.1016/S0006-3495(97)78131-1; Sineshchekov OA, 2016, P NATL ACAD SCI USA, V113, pE1993, DOI 10.1073/pnas.1525269113; Sineshchekov OA, 2015, P NATL ACAD SCI USA, V112, P14236, DOI 10.1073/pnas.1513602112; Sineshchekov OA, 2013, BIOPHYS J, V104, P807, DOI 10.1016/j.bpj.2013.01.002; Volz P, 2016, J BIOL CHEM, V291, P17382, DOI 10.1074/jbc.M115.711200; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Wu G, 2007, BIOCHEMISTRY-US, V46, P534, DOI 10.1021/bi061859h	29	7	8	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25319	25325		10.1074/jbc.C116.760041	http://dx.doi.org/10.1074/jbc.C116.760041			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27789708	hybrid, Green Published			2022-12-26	WOS:000390095300004
J	Cui, DW; Feng, LZ; Chen, Y; Lai, SJ; Zhang, ZK; Yu, F; Zheng, SF; Li, ZJ; Yu, HJ				Cui, Dawei; Feng, Luzhao; Chen, Yu; Lai, Shengjie; Zhang, Zike; Yu, Fei; Zheng, Shufa; Li, Zhongjie; Yu, Hongjie			Clinical and Epidemiologic Characteristics of Hospitalized Patients with Laboratory-Confirmed Respiratory Syncytial Virus Infection in Eastern China between 2009 and 2013: A Retrospective Study	PLOS ONE			English	Article							INFLUENZA-LIKE ILLNESS; TRACT INFECTIONS; VIRAL-INFECTIONS; YOUNG-CHILDREN; ADULTS; INFANTS; BURDEN; LOAD; AGE	Respiratory syncytial virus (RSV) is a leading cause of morbidity and mortality worldwide in children aged <5 years and older adults with acute lower respiratory infections (ALRIs). However, few studies regarding the epidemiology of hospitalizations for RSV infection have been performed previously in China. Here, we aimed to describe the clinical and epidemiologic characteristics of hospitalized patients with laboratory-confirmed RSV infection in eastern China. Active surveillance for hospitalized ALRI patients using a broad case definition based on symptoms was performed from 2009-2013 in 12 sentinel hospitals in eastern China. Clinical and epidemiologic data pertaining to hospitalized patients of all ages with laboratory-confirmed RSV infection by PCR assay were collected and analyzed in this study. From 2009 to 2013, 1046 hospitalized patients with laboratory-confirmed RSV infection were enrolled in this study, and 14.7% of patients had subtype A, 24.2% of patients had subtype B, 23.8% of patients with subtype not performed, and 37.3% of patients had RSV coinfections with other viruses. RSV and influenza coinfections (33.3%) were the most common coinfections noted in this study. Moreover, young children aged <5 years (89.1%, 932/1046), particularly young infants aged <1 year (43.3%, 453/1046), represented the highest proportion of patients with RSV infections. In contrast, older adults aged >= 60 years (1.1%, 12/1046) represented the lowest proportion of patients with RSV infections among enrolled patients. The peak RSV infection period occurred mainly during autumn and winter, and 57% and 66% of patients exhibited symptoms such as fever (body temperature >= 38 degrees C) and cough separately. Additionally, only a small number of patients were treated with broad-spectrum antiviral drugs, and most of patients were treated with antimicrobial drugs that were not appropriate for RSV infection. RSV is a leading viral pathogen and a common cause of viral infection in young children aged <5 years with ALRIs in eastern China. Effective vaccines and antiviral agents targeting RSV are needed to mitigate its large public health impact.	[Cui, Dawei; Chen, Yu; Zhang, Zike; Yu, Fei; Zheng, Shufa] Zhejiang Univ, Affiliated Hosp 1, Dept Lab Med, Coll Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Cui, Dawei; Chen, Yu; Zhang, Zike; Yu, Fei; Zheng, Shufa] Key Lab Clin In Vitro Diagnost Techn Zhejiang Pro, Hangzhou 310003, Zhejiang, Peoples R China; [Feng, Luzhao; Lai, Shengjie; Li, Zhongjie; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, 155 Changbai Rd, Beijing 102206, Peoples R China; [Yu, Hongjie] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, 130 Dongan Rd, Shanghai 200032, Peoples R China	Zhejiang University; Chinese Center for Disease Control & Prevention; Fudan University	Yu, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, 155 Changbai Rd, Beijing 102206, Peoples R China.; Yu, HJ (corresponding author), Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, 130 Dongan Rd, Shanghai 200032, Peoples R China.	cfetpyhj@vip.sina.com	Chen, Yi/HIR-2608-2022; Yu, Hongjie/GZK-5351-2022; Cui, Dawei/ABG-4534-2021; Chen, Yu/Y-3292-2019	Lai, Shengjie/0000-0001-9781-8148; cui, dawei/0000-0003-3840-1486	National Science Fund for Distinguished Young Scholars [81525023]; Ministry of Science and Technology of the People's Republic of China (the National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China) [2012ZX10004-201, 2012ZX10004-210]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Ministry of Science and Technology of the People's Republic of China (the National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China)	This study was supported by grants from the National Science Fund for Distinguished Young Scholars (81525023), and the Ministry of Science and Technology of the People's Republic of China (the National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China, 2012ZX10004-201, 2012ZX10004-210).	Bigogo GM, 2013, J INFECT DIS, V208, pS207, DOI 10.1093/infdis/jit489; Byington CL, 2015, PEDIATRICS, V135, pE24, DOI 10.1542/peds.2014-2151; Falsey AR, 2014, J INFECT DIS, V209, P1873, DOI 10.1093/infdis/jit839; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Feng LZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099419; Fleming DM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1218-z; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; Fry AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015098; Hon KL, 2012, J CRIT CARE, V27, P464, DOI 10.1016/j.jcrc.2011.12.001; Huang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064254; Huo XX, 2013, J INFECT DIS, V208, pS184, DOI 10.1093/infdis/jit518; Jin Y, 2012, CLIN MICROBIOL INFEC, V18, P74, DOI 10.1111/j.1469-0691.2011.03541.x; Kaneko M, 2002, J INFECTION, V44, P240, DOI 10.1053/jinf.2002.0981; Lee N, 2015, J INFECT DIS, V212, P1237, DOI 10.1093/infdis/jiv248; Lu LH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1155-x; Luksic I, 2013, CROAT MED J, V54, P122, DOI 10.3325/cmj.2013.54.122; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Naorat S, 2013, J INFECT DIS, V208, pS238, DOI 10.1093/infdis/jit456; Nolan T, 2015, CLIN INFECT DIS, V60, pE80, DOI 10.1093/cid/civ065; Peng ZB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0884-1; Pisesky A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150416; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Simoes EAF, 2015, J INFECT DIS, V211, pS1, DOI 10.1093/infdis/jiu828; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Yu XF, 2015, J CLIN VIROL, V69, P1, DOI 10.1016/j.jcv.2015.05.015; Zachariah P, 2009, PEDIATR INFECT DIS J, V28, P772, DOI 10.1097/INF.0b013e3181a3e5b6; Zhang QL, 2013, PEDIATR PULM, V48, P390, DOI 10.1002/ppul.22608; Zhang RF, 2010, J CLIN MICROBIOL, V48, P4193, DOI 10.1128/JCM.00179-10; Zhang XB, 2014, WORLD J PEDIATR, V10, P360, DOI 10.1007/s12519-014-0513-x	30	13	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165437	10.1371/journal.pone.0165437	http://dx.doi.org/10.1371/journal.pone.0165437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802292	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000386714200023
J	Pagliari, MT; Lotta, LA; de Haan, HG; Valsecchi, C; Casoli, G; Pontiggia, S; Martinelli, I; Passamonti, SM; Rosendaal, FR; Peyvandi, F				Pagliari, Maria Teresa; Lotta, Luca A.; de Haan, Hugoline G.; Valsecchi, Carla; Casoli, Gloria; Pontiggia, Silvia; Martinelli, Ida; Passamonti, Serena M.; Rosendaal, Frits R.; Peyvandi, Flora			Next-Generation Sequencing and In Vitro Expression Study of ADAMTS13 Single Nucleotide Variants in Deep Vein Thrombosis	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; EARLY ATHEROSCLEROSIS; GENETIC-VARIANTS; MUTATIONS; AUTOANTIBODIES; POLYMORPHISMS; MODULATION; ASSAY; RISK; RARE	Background Deep vein thrombosis (DVT) genetic predisposition is partially known. Objectives This study aimed at assessing the functional impact of nine ADAMTS13 single nucleotide variants (SNVs) previously reported to be associated as a group with DVT in a burden test and the individual association of selected variants with DVT risk in two replication studies. Methods Wild-type and mutant recombinant ADAMTS13 were transiently expressed in HEK293 cells. Antigen and activity of recombinant ADAMTS13 were measured by ELISA and FRETS-VWF73 assays, respectively. The replication studies were performed in an Italian case-control study (Milan study; 298/298 patients/controls) using a next-generation sequencing approach and in a Dutch case-control study (MEGA study; 4306/4887 patients/controls) by TaqMan assays. Results In vitro results showed reduced ADAMTS13 activity for three SNVs (p.Val154IIe [15%; 95% confidence interval [CI] 14-16], p.Asp187His [19%; 95%[CI] 17-21], p.Arg421Cys [24%; 95%[CI] 22-26]) similar to reduced plasma ADAMTS13 levels of patients carriers for these SNVs. Therefore these three SNVs were interrogated for risk association. The first replication study identified 3 heterozygous carriers (2 cases, 1 control) of p.Arg421Cys (odds ratio [OR] 2, 95%[CI] 0.18-22.25). The second replication study identified 2 heterozygous carriers (1 case, 1 control) of p.Asp187His ([OR] 1.14, 95%[CI] 0.07-18.15) and 10 heterozygous carriers (4 cases, 6 controls) of p.Arg421Cys ([OR] 0.76, 95%[CI] 0.21-2.68). Conclusions Three SNVs (p.Val154IIe, p.Asp187His and p.Arg421Cys) showed reduced ex vivo and in vitro ADAMTS13 levels. However, the low frequency of these variants makes it difficult to confirm their association with DVT.	[Pagliari, Maria Teresa; Lotta, Luca A.; Valsecchi, Carla; Casoli, Gloria; Pontiggia, Silvia; Martinelli, Ida; Passamonti, Serena M.; Peyvandi, Flora] Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Fdn IRCCS Ca Granda, Milan, Italy; [Pagliari, Maria Teresa; Lotta, Luca A.; Valsecchi, Carla; Casoli, Gloria; Pontiggia, Silvia; Martinelli, Ida; Passamonti, Serena M.; Peyvandi, Flora] Fdn Luigi Villa, Milan, Italy; [de Haan, Hugoline G.; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Peyvandi, Flora] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Milan	Peyvandi, F (corresponding author), Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Fdn IRCCS Ca Granda, Milan, Italy.; Peyvandi, F (corresponding author), Fdn Luigi Villa, Milan, Italy.; Peyvandi, F (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.	flora.peyvandi@unimi.it	Pagliari, Maria Teresa/AAQ-3384-2021; Rosendaal, Frits/Q-3842-2017; Martinelli, ida/J-2287-2015; valsecchi, carla/AAA-3229-2022; Peyvandi, Flora/AAK-7437-2020	Pagliari, Maria Teresa/0000-0003-0778-2271; Rosendaal, Frits/0000-0003-2558-7496; Martinelli, ida/0000-0001-9218-3622; Peyvandi, Flora/0000-0001-7423-9864; Passamonti, Serena Maria/0000-0003-2875-8860; valsecchi, carla/0000-0003-3414-0119; de Haan, Hugoline/0000-0003-1126-4776; Lotta, Luca Andrea/0000-0002-2619-5956	Italian Ministry of Health [RF-2009-1530493, GR-2011-02351977]; Italo Monzino Foundation	Italian Ministry of Health(Ministry of Health, Italy); Italo Monzino Foundation	The study was supported by the Italian Ministry of Health - Grant No. RF-2009-1530493 (Recipient IM), the Italian Ministry of Health - Grant No. GR-2011-02351977 (Recipient MTP) and the Italo Monzino Foundation (Recipient FP).	BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bettoni G, 2012, J THROMB HAEMOST, V10, P1556, DOI 10.1111/j.1538-7836.2012.04808.x; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Bittar LF, 2011, CLIN APPL THROMB-HEM, V17, P514, DOI 10.1177/1076029610375815; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; De Cock E, 2015, J THROMB HAEMOST, V13, P283, DOI 10.1111/jth.12804; De Cristofaro R, 2005, J BIOL CHEM, V280, P23295, DOI 10.1074/jbc.M501143200; de Vries PS, 2015, BLOOD, V125, P3949, DOI 10.1182/blood-2015-02-629865; Edwards NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038864; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Federici AB, 2004, HAEMATOLOGICA, V89, P77; Gandhi C, 2012, BLOOD, V119, P2385, DOI 10.1182/blood-2011-09-376202; Gardner MD, 2009, BLOOD, V113, P1149, DOI 10.1182/blood-2008-03-144683; Heit JA, 2001, THROMB HAEMOSTASIS, V86, P452, DOI 10.1161/ATVBAHA.108.162545; Jin SY, 2012, ARTERIOSCL THROM VAS, V32, P1817, DOI 10.1161/ATVBAHA.112.247262; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; Lotta LA, 2013, J THROMB HAEMOST, V11, P1228, DOI 10.1111/jth.12291; Lotta LA, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-7; Maino A, 2015, J THROMB HAEMOST, V13, P1396, DOI 10.1111/jth.13032; Mancini I, 2012, J THROMB HAEMOST, V10, P1439, DOI 10.1111/j.1538-7836.2012.04744.x; Palla R, 2011, THROMB HAEMOSTASIS, V105, P381, DOI 10.1160/TH10-06-0417; Peyvandi F, 2006, HUM MUTAT, V27, P330, DOI 10.1002/humu.20267; Plaimauer B, 2006, BLOOD, V107, P118, DOI 10.1182/blood-2005-06-2482; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Pozzi N, 2012, BIOPHYS CHEM, V160, P1, DOI 10.1016/j.bpc.2011.07.007; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Rovite V, 2014, THROMB RES, V134, P659, DOI 10.1016/j.thromres.2014.07.011; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Sonneveld MAH, 2015, BLOOD, V126, P2739, DOI [10.1182/blood-2015-05643338, 10.1182/blood-2015-05-643338]; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165665	10.1371/journal.pone.0165665	http://dx.doi.org/10.1371/journal.pone.0165665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802307	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200034
J	Tscheuschler, A; Meffert, P; Beyersdorf, F; Heilmann, C; Kocher, N; Uffelmann, X; Discher, P; Siepe, M; Kari, FA				Tscheuschler, Anke; Meffert, Philipp; Beyersdorf, Friedhelm; Heilmann, Claudia; Kocher, Nadja; Uffelmann, Xenia; Discher, Philipp; Siepe, Matthias; Kari, Fabian A.			MMP-2 Isoforms in Aortic Tissue and Serum of Patients with Ascending Aortic Aneurysms and Aortic Root Aneurysms	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; MATRIX METALLOPROTEINASES; ACTIVATION; COLLAGEN; MODEL	Objective The need for biological markers of aortic wall stress and risk of rupture or dissection of ascending aortic aneurysms is obvious. To date, wall stress cannot be related to a certain biological marker. We analyzed aortic tissue and serum for the presence of different MMP-2 isoforms to find a connection between serum and tissue MMP-2 and to evaluate the potential of different MMP-2 isoforms as markers of high wall stress. Methods Serum and aortic tissue from n = 24 patients and serum from n = 19 healthy controls was analyzed by ELISA and gelatin zymography. 24 patients had ascending aortic aneurysms, 10 of them also had aortic root aneurysms. Three patients had normally functioning valves, 12 had regurgitation alone, eight had regurgitation and stenosis and one had only stenosis. Patients had bicuspid and tricuspid aortic valves (9/15). Serum samples were taken preoperatively, and the aortic wall specimen collected during surgical aortic repair. Results Pro-MMP-2 was identified in all serum and tissue samples. Pro-MMP-2 was detected in all tissue and serum samples from patients with ascending aortic/aortic root aneurysms, irrespective of valve morphology or other clinical parameters and in serum from healthy controls. We also identified active MMP-2 in all tissue samples from patients with ascending aortic/aortic root aneurysms. None of the analyzed serum samples revealed signals relatable to active MMP-2. No correlation between aortic tissue total MMP-2 or tissue pro-MMP2 or tissue active MMP-2 and serum MMP-2 was found and tissue MMP-2/pro-MMP-2/active MMP-2 did not correlate with aortic diameter. This evidence shows that pro-MMP-2 is the predominant MMP-2 species in serum of patients and healthy individuals and in aneurysmatic aortic tissue, irrespective of aortic valve configuration. Active MMP-2 species are either not released into systemic circulation or not detectable in serum. There is no reliable connection between aortic tissue-and serum MMP-2 isoforms, nor any indication that pro-MMP-2 functions as a common marker of high aortic wall stress.	[Tscheuschler, Anke; Meffert, Philipp; Beyersdorf, Friedhelm; Heilmann, Claudia; Kocher, Nadja; Uffelmann, Xenia; Discher, Philipp; Siepe, Matthias; Kari, Fabian A.] Univ Freiburg, Ctr Heart, Dept Cardiovasc Surg, Freiburg, Germany; [Tscheuschler, Anke; Meffert, Philipp; Heilmann, Claudia; Kocher, Nadja; Uffelmann, Xenia; Discher, Philipp; Kari, Fabian A.] Univ Freiburg, Dr Barbara Mez Starck Cardiovasc Res Lab, Ctr Heart, Working Grp Mol & Cellular Pathophysiol Thorac Ao, Freiburg, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Tscheuschler, A (corresponding author), Univ Freiburg, Ctr Heart, Dept Cardiovasc Surg, Freiburg, Germany.; Tscheuschler, A (corresponding author), Univ Freiburg, Dr Barbara Mez Starck Cardiovasc Res Lab, Ctr Heart, Working Grp Mol & Cellular Pathophysiol Thorac Ao, Freiburg, Germany.	anke.tscheuschler@uniklinik-freiburg.de	Beyersdorf, Friedhelm/AAK-3718-2020; Heilmann, Claudia/ABH-3446-2021; Kari, Fabian A/AAE-5604-2021; Siepe, Matthias/AAF-9846-2019	Beyersdorf, Friedhelm/0000-0003-2975-2751; Heilmann, Claudia/0000-0002-7231-5381; Siepe, Matthias/0000-0003-3305-9343; Laschinski, Philipp/0000-0001-8293-7224	German Heart Research Foundation	German Heart Research Foundation	Support was provided by the German Heart Research Foundation, Dr. Rusche Research Grant to FK [http://www.herzstiftung.de]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIDJAR S, 1990, CIRCULATION, V82, P973, DOI 10.1161/01.CIR.82.3.973; Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005; Atkins SK, 2014, BIOMECH MODEL MECHAN, V13, P1209, DOI 10.1007/s10237-014-0567-7; Barbour JR, 2007, J SURG RES, V139, P292, DOI 10.1016/j.jss.2006.09.020; Eckhouse SR, 2013, CIRCULATION, V128, pS186, DOI 10.1161/CIRCULATIONAHA.112.000363; El-Hamamsy I, 2009, NAT REV CARDIOL, V6, P771, DOI 10.1038/nrcardio.2009.191; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C; Guzzardi DG, 2015, J AM COLL CARDIOL, V66, P892, DOI 10.1016/j.jacc.2015.06.1310; Humphrey JD, 2015, CIRC RES, V116, P1448, DOI 10.1161/CIRCRESAHA.114.304936; Huusko T, 2013, J THORAC CARDIOV SUR, V145, P1117, DOI 10.1016/j.jtcvs.2012.04.008; Ikonomidis JS, 2012, ANN THORAC SURG, V93, P457, DOI 10.1016/j.athoracsur.2011.09.057; Ikonomidis JS, 2013, J THORAC CARDIOV SUR, V145, P1326, DOI 10.1016/j.jtcvs.2012.12.027; Ikonomidis JS, 2003, J SURG RES, V115, P157, DOI 10.1016/S0022-4804(03)00193-8; Jones JA, 2011, CIRC-CARDIOVASC GENE, V4, P605, DOI 10.1161/CIRCGENETICS.111.960419; Kari FA, 2015, INTERACT CARDIOV TH, V20, P582, DOI 10.1093/icvts/ivu446; Kimura K, 2010, CLIN EXP PHARMACOL P, V37, P1096, DOI 10.1111/j.1440-1681.2010.05441.x; Kopaliani I, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0419-8; Koullias G, 2005, J THORAC CARDIOV SUR, V130, P677, DOI 10.1016/j.jtcvs.2005.02.052; La Rocca G, 2004, BRIT J CANCER, V90, P1414, DOI 10.1038/sj.bjc.6601725; LeMaire SA, 2005, J SURG RES, V123, P40, DOI 10.1016/j.jss.2004.06.007; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Peake NJ, 2006, ANN RHEUM DIS, V65, P501, DOI 10.1136/ard.2005.039032; Ruddy JM, 2013, PROG CARDIOVASC DIS, V56, P68, DOI 10.1016/j.pcad.2013.04.002; Rylski B, 2014, J AM COLL CARDIOL, V63, P1311, DOI 10.1016/j.jacc.2013.12.028; Saratzis A, 2014, HEART, V100, P916, DOI 10.1136/heartjnl-2013-305130; SATTA J, 1995, J VASC SURG, V22, P155, DOI 10.1016/S0741-5214(95)70110-9; SCHLATMANN TJM, 1977, AM J CARDIOL, V39, P13, DOI 10.1016/S0002-9149(77)80004-0; Shen MC, 2015, ARTERIOSCL THROM VAS, V35, P888, DOI 10.1161/ATVBAHA.114.305115; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Sudhakar YA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04136; Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tronc F, 2000, ARTERIOSCL THROM VAS, V20, pE120, DOI 10.1161/01.ATV.20.12.e120; Verma S, 2014, NEW ENGL J MED, V370, P1920, DOI 10.1056/NEJMra1207059; VINE N, 1991, CLIN SCI, V81, P233, DOI 10.1042/cs0810233; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D	38	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0164308	10.1371/journal.pone.0164308	http://dx.doi.org/10.1371/journal.pone.0164308			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802285	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200009
J	Napoli, PE; Coronella, F; Satta, GM; Iovino, C; Sanna, R; Fossarello, M				Napoli, Pietro Emanuele; Coronella, Franco; Satta, Giovanni Maria; Iovino, Claudio; Sanna, Raffaele; Fossarello, Maurizio			A Simple Novel Technique of Infrared Meibography by Means of Spectral-Domain Optical Coherence Tomography: A Cross-Sectional Clinical Study	PLOS ONE			English	Article							MEIBOMIAN GLAND DYSFUNCTION; TEAR FILM; LID MARGIN; DIAGNOSIS; SYSTEM; LAYER	Purpose To compare a novel spectral-domain optical coherence tomography (SD-OCT) technique with traditional lid transillumination for evaluation of meibomian glands (MGs) and to assess the relation of MG morphologic changes to the glandular atrophy. Design Evaluation of diagnostic technology. Participants Sixty-one patients with obstructive MGD (30 men, 31 women; age [mean +/- standard deviation] 45.1 +/- 12.1 years), and 75 control subjects (32 men, 43 women; 44.1 +/- 12.5 years) were recruited in order to have a balanced distribution of glandular features. Methods Agreement between SD-OCT and lid transillumination examination for the detection of drop-out (partial or complete loss of MGs) and microscopic changes (i.e. shortening, distortion, segmentation and entanglement), as well as the relationship between morphological features and MG atrophy were evaluated. Main Outcome Measures Agreement between the two meibographic techniques, bias in symmetry of classification, and association analysis between microscopic changes and MG dropout. Results Overall agreement for all morphological features was substantial (Cohen kappa coefficient = 0.77; p<0.001), even if, the majority of disagreement occurred for cases with segmentation, where agreement was present in only 108 (81.82%) of 132 eyes with adequate images for interpretation, and where SD-OCT tended to diagnose more cases not detected by traditional lid transillumination (McNemar test, p<0.001). Moreover, segmentation and distortion pattern negatively correlated with the degree of drop-out, whereas shortening and entanglement pattern demonstrated only a weak correlation (Spearman's. was -0.691, -0.491, -0.359, -0.385, respectively). Conclusions Each method has its advantages but in general there was close agreement between these meibographic techniques, particularly for MG dropout, which supports the reliability of our novel, simple and patient-friendly SD-OCT approach.	[Napoli, Pietro Emanuele; Coronella, Franco; Satta, Giovanni Maria; Iovino, Claudio; Sanna, Raffaele; Fossarello, Maurizio] Univ Cagliari, Eye Clin, Dept Surg Sci, Cagliari, Italy	University of Cagliari	Napoli, PE (corresponding author), Univ Cagliari, Eye Clin, Dept Surg Sci, Cagliari, Italy.	pietronapoli@ymail.com	Fossarello, Maurizio/AAD-8235-2021; Iovino, Claudio/O-7680-2019; Napoli, Pietro/AAP-8423-2020; Fossarello, Maurizio/G-2032-2015	Iovino, Claudio/0000-0003-1984-0555; Napoli, Pietro Emanuele/0000-0001-7020-0823; Fossarello, Maurizio/0000-0003-1520-7760				Amano S, 2010, J EYE ATARASHII GANK, V27, P627; Arita R., 2014, CURR OPHTHALMOL REP, V2, P49; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Arita R, 2010, CORNEA, V29, P858, DOI 10.1097/ICO.0b013e3181ca3668; Arita R, 2009, OPHTHALMOLOGY, V116, P2058, DOI 10.1016/j.ophtha.2009.04.037; Arita R, 2009, OPHTHALMOLOGY, V116, P379, DOI 10.1016/j.ophtha.2008.10.012; Breustedt DA, 2006, BBA-PROTEINS PROTEOM, V1764, P161, DOI 10.1016/j.bbapap.2005.12.006; Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; Bron AJ, 2007, OCUL SURF, V5, P108; CHEW CKS, 1993, CURR EYE RES, V12, P247, DOI 10.3109/02713689308999470; Chu R, 2012, OCULAR SURFACE DISOR, V69; Foulks GN, 2007, SURV OPHTHALMOL, V52, P369, DOI 10.1016/j.survophthal.2007.04.009; Hwang HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067143; Hwang HS, 2013, CORNEA, V32, P40, DOI 10.1097/ICO.0b013e318247b2fd; Johnson ME, 2005, CORNEA, V24, P811, DOI 10.1097/01.ico.0000154378.67495.40; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MATHERS WD, 1994, ARCH OPHTHALMOL-CHIC, V112, P448, DOI 10.1001/archopht.1994.01090160022008; MISHIMA S, 1961, EXP EYE RES, V1, P39, DOI 10.1016/S0014-4835(61)80006-7; Napoli PE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30428; Napoli PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115762; Napoli PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109843; Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P4533, DOI 10.1167/iovs.14-14666; Napoli PE, 2014, INVEST OPHTH VIS SCI, V55, P3179, DOI 10.1167/iovs.13-13613; Napoli PE, 2014, CAN J OPHTHALMOL, V49, P210, DOI 10.1016/j.jcjo.2013.10.003; Nichols JJ, 2005, CORNEA, V24, P382, DOI 10.1097/01.ico.0000148291.38076.59; ROBIN JB, 1985, OPHTHALMOLOGY, V92, P1423; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266, DOI 10.1001/archopht.1995.01100100054027; Stanek S, 2000, MIL MED, V165, P591; TAPIE R, 1977, ANN OCUL, V210, P637; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Viso E, 2014, CORNEA, V33, P442, DOI 10.1097/ICO.0000000000000091; Wise RJ, 2012, SAUDI J OPHTHALMOL, V26, P349, DOI 10.1016/j.sjopt.2012.08.007; Wu HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105575; Ye TT, 2014, J CATARACT REFR SURG, V40, P1377, DOI 10.1016/j.jcrs.2013.11.046; Yokoi N, 1999, ARCH OPHTHALMOL-CHIC, V117, P723; Yokoi N, 2007, JPN J OPHTHALMOL, V51, P53, DOI 10.1007/s10384-006-0397-y	36	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165558	10.1371/journal.pone.0165558	http://dx.doi.org/10.1371/journal.pone.0165558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798696	Green Published, gold			2022-12-26	WOS:000386711100045
J	de Sousa, JRP; Carvalho-Filho, FD; Juen, L; Esposito, MC				Pereira de Sousa, Jose Roberto; Carvalho-Filho, Fernando da Silva; Juen, Leandro; Esposito, Maria Cristina			Evaluating the Effects of Different Vegetation Types on Necrophagous Fly Communities (Diptera: Calliphoridae; Sarcophagidae): Implications for Conservation	PLOS ONE			English	Article							CERRADO VEGETATION; HABITAT COMPLEXITY; RESERVA BIOLOGICA; SPECIES-DIVERSITY; NOVA IGUACU; HETEROGENEITY; ASSEMBLAGES; TINGUA; FIELD; DROSOPHILIDAE	The present study was conducted in five different phytogeographic zones of the Brazilian state of Maranhao, three of which (the Amazon Forest, Cerrado, and Palm Groves) are more heterogeneous, whereas the other two (Marshlands and Mangroves) are more homogeneous. In each zone, nine sites were visited for the collection of necrophagous flies using bait traps in 2010, 2011, and 2012. The calliphorid and sarcophagid communities observed at each site were compared in terms of species richness, composition, and abundance. The more heterogeneous zones had higher species richness, except in the case of the sarcophagids in the forest habitats. The calliphorids Chloroprocta idioidea (Robineau- Desvoidy, 1830), Mesembrinella bicolor (Fabricius, 1805), Hemilucilia semi-diaphana (Rondani, 1850) and Lucilia eximia (Wiedemann, 1819) were more closely associated with the Cerrado, Palm Grove and Amazon Forest zones, and Chrysomya megacephala (Fabricius, 194) with the Mangrove. In the sarcophagids, Peckia (Euboettcheria) subducta (Lopes, 1935) and P. (Pattonella) palidipilosa (Curran & Walley, 1934) were associated with the Amazon Forest, and P. (Sarcodexia) lambens (Wiedemann, 1830) and Tricharaea (Sarcophagula) occidua (Fabricius, 1794) with the Palm Grove and Cerrado zones. In the calliphorids, the greatest dissimilarity was recorded between the Amazon Forest and the Mangrove and Lowland grassland zones. In the sarcophagids, by contrast, the greatest dissimilarities were recorded between the Amazon Forest and all the other four zones. In general, then, the phytogeographic zones with the highest environmental heterogeneity were characterized by the greatest species richness and abundance of necrophagous flies.	[Pereira de Sousa, Jose Roberto] Univ Estadual Maranhao, Ctr Estudos Super Imperatriz, Dept Biol & Chem, Imperatriz, MA, Brazil; [Carvalho-Filho, Fernando da Silva] Museu Paraense Emilio Goeldi, Coordenacao Zool Entomol, Dept Zool, Belem, PA, Brazil; [Juen, Leandro; Esposito, Maria Cristina] Fed Univ Para, Inst Biol Sci, Belem, PA, Brazil	Universidade Estadual do Maranhao; Museu Paraense Emilio Goeldi; Universidade Federal do Para	de Sousa, JRP (corresponding author), Univ Estadual Maranhao, Ctr Estudos Super Imperatriz, Dept Biol & Chem, Imperatriz, MA, Brazil.	jrszoo@hotmail.com	de Sousa, José/S-6741-2019; Juen, Leandro/R-4014-2019; Juen, Leandro/I-1338-2012	Juen, Leandro/0000-0002-6188-4386; 	Maranhao State Research Foundation; National Counsel of Technological and Scientific Development; CNPq [303252/2013-8, 309572/2013-4]	Maranhao State Research Foundation; National Counsel of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge the Maranhao State Research Foundation for funding and for providing the first author with a doctoral stipend (JRPS), and the National Counsel of Technological and Scientific Development, for research fellowships (LJ and MCE).r We thank the Maranhao State Research Foundation for funding and for providing the first author with a doctoral stipend. Leandro Juen (process: 303252/2013-8) and Maria Cristina Esposito (process: 309572/2013-4) would like to thank CNPq for research fellowships. The authors are also grateful to Dr. Stephen F. Ferrari and to the editor J. Joe Hull for revising our manuscript and to the anonymous reviewer who has contributed substantially to the improvement of manuscript.	Albiero Daniel, 2007, Acta Amaz., V37, P337, DOI 10.1590/S0044-59672007000300004; Alencar JC, 1998, FLORESTA AMAZO NICA; ALHO C J R, 1981, Revista Brasileira de Biologia, V41, P223; Almeida I.M., 2003, MANUAL COLETA CONSER; Amorim DS, 2002, PRIBES; Anderson MJ, 2005, PERMANOVA FORTRAN CO; [Anonymous], 2002, ATL MAR, V2; AUGUST PV, 1983, ECOLOGY, V64, P1495, DOI 10.2307/1937504; Azevedo ACG, 2002, ECOSSISTEMAS MARANHE; de Carvalho CJB, 2008, REV BRAS ENTOMOL, V52, P390, DOI 10.1590/S0085-56262008000300012; Batista-da-Silva JA, 2014, NEOTROP ENTOMOL, V43, P48, DOI 10.1007/s13744-013-0181-x; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Buenaventura E, 2013, ZOOTAXA, V3622, P1, DOI 10.11646/zootaxa.3622.1.1; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colwell R. K., 2013, STAT ESTIMATION SPEC; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Da Mata RA, 2013, INSECT CONSERV DIVER, V6, P663, DOI 10.1111/icad.12020; de Almeida SDP, 2009, NEOTROP ENTOMOL, V38, P32, DOI 10.1590/S1519-566X2009000100003; de Sousa JRP, 2011, NEOTROP ENTOMOL, V40, P20, DOI 10.1590/S1519-566X2011000100003; de Souza AKP, 2005, REV BRAS ZOOL, V22, P320, DOI 10.1590/S0101-81752005000200004; De Souza CR, 2012, NEOTROP ENTOMOL, V41, P243, DOI 10.1007/s13744-012-0037-9; Delettre R., 1998, BIODIVERS CONSERV, V7, P9, DOI [10.1023/A:1008851511301, DOI 10.1023/A:1008851511301]; Delettre YR, 2005, PEDOBIOLOGIA, V49, P15, DOI 10.1016/j.pedobi.2004.06.010; Dufek MI, 2016, J MED ENTOMOL, P1; Duraes R, 2005, NEOTROP ENTOMOL, V34, P721, DOI 10.1590/S1519-566X2005000500003; EITEN G, 1972, BOT REV, V38, P201, DOI 10.1007/BF02859158; EITEN G, 1982, ECOLOGY TROPICAL SAV, P25; Erzinu║lioglu Z., 1996, NATURALISTS HDB; Esposito Maria Cristina, 2010, Acta Amaz., V40, P579, DOI 10.1590/S0044-59672010000300018; Esposito MC, 2009, CAXIUANA DESAFIOS CO; Felfili JM, 2004, PLANT ECOL, V175, P37, DOI 10.1023/B:VEGE.0000048090.07022.02; Ferraz ACP, 2010, BRAZ J BIOL, V70, P55, DOI 10.1590/S1519-69842010000100009; Ferraz ACP, 2010, NEOTROP ENTOMOL, V39, P476, DOI 10.1590/S1519-566X2010000400004; Ferraz ACP, 2009, REV BRAS ENTOMOL, V53, P620, DOI 10.1590/S0085-56262009000400012; Ferreira MJM., 1978, REV BRAS BIOL, V38, P445; Figueiredo N, 2007, ESTRUTURA COMPOSICAO, P141; Franklin E, 2005, APPL SOIL ECOL, V29, P259, DOI 10.1016/j.apsoil.2004.12.004; Goes-Filho L, 1973, LEVANTAMENTO RECURSO, P71; Gomes L, 2011, ACTA BOT BRAS, V25, P865, DOI 10.1590/S0102-33062011000400013; Goncalves L., 2011, Revista Brasileira de Biociencias, V9, P50; Greenberg B, 1971, FLIES DIS ECOLOGY CL; Guimaraes H.J.L., 2004, ARQ MUS NAC RIO JANE, V62, P45; Guimardcs JH, 1999, MYASIS MAN ANIMALS N; Halffter Gonzalo, 1991, Folia Entomologica Mexicana, V0, P195; HALL M, 1995, ADV PARASIT, V35, P257, DOI 10.1016/S0065-308X(08)60073-1; IBGE (Instituto Brasileiro de Geografia e Estatistica), 2012, MANUAL TECN GEOC, V1; Kosmann Cecilia, 2013, EntomoBrasilis, V6, P74, DOI 10.12741/ebrasilis.v6i1.266; Krell FT, 2003, ECOGRAPHY, V26, P210, DOI 10.1034/j.1600-0587.2003.03278.x; Lassau SA, 2004, ECOGRAPHY, V27, P157, DOI 10.1111/j.0906-7590.2004.03675.x; Legendre P., 2012, NUMERICAL ECOLOGY; LI H, 1995, OIKOS, V73, P280, DOI 10.2307/3545921; LINHARES A X, 1981, Revista Brasileira de Entomologia, V25, P189; Lopes, 1939, REV ENTOMOL, V10, P497; LOPES de SOUZA H., 1958, AN ACAD BRASIL CIENC, V30, P211; LOPES H D S, 1987, Revista Brasileira de Biologia, V47, P329; LOPES H D S, 1989, Revista Brasileira de Biologia, V49, P837; Lopes H. S., 1946, B ESCOLA NACL VET, V1, P62; Lopes H. S., 1976, REV BRAS BIOL, V36, P629; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MADEIRA N G, 1982, Revista Brasileira de Entomologia, V26, P137; Marin-Garcia J, 2010, CONTEMP CARDIOL, P15, DOI 10.1007/978-1-60761-147-9_2; Mello R. P., 2003, ENTOMOL VECTORES, V10, P255; Mochel F.R., 2011, AMAZONIA MARANHENSE, P93; Mulieri PR, 2011, J INSECT SCI, V11, P1, DOI 10.1673/031.011.9101; Mulieri PR, 2008, REV BIOL TROP, V56, P1287; Nunes LAPL, 2004, DESENVOLVIMENTO MEIO, V10, P169; Pape T, 2011, ZOOTAXA, V3148, P222; Pape Thomas, 1996, V8, p558p; Paraluppi N. D., 1996, REV BRAS ZOOL, V13, P553; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; de Sousa JRP, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev054; PIANKA ER, 1995, AM NAT, V146, P398, DOI 10.1086/285806; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; PRADO A P D, 1982, Revista Brasileira de Entomologia, V26, P225; da Costa CMQ, 2009, REV BRAS ENTOMOL, V53, P88, DOI 10.1590/S0085-56262009000100021; Raupp S.V., 2010, REV BIOL NEOTROP, V7, P13; Rivers D. B., 2014, SCI FORENSIC ENTOMOL; Santos AJ, 2009, METODOS ESTUDOS BIOL; SCHWARZKOPF L, 1989, BIOL CONSERV, V48, P1, DOI 10.1016/0006-3207(89)90055-4; Shewell G.E., 1987, Agriculture Canada Monograph, P1159; Shewell G.E., 1987, Agriculture Canada Monograph, P1133; Shewell GE., 1987, MANUAL NEARTIC DIPTE; Silva HG, 2008, REV ARVORE, V32, P921, DOI 10.1590/S0100-67622008000500017; Sousa JRP, 2010, REV BRAS ENTOMOL, V54, P270; Spector S, 2003, BIOTROPICA, V35, P394; Svenning JC, 2001, BOT REV, V67, P1, DOI 10.1007/BF02857848; Svenning JC, 1999, J ECOL, V87, P55, DOI 10.1046/j.1365-2745.1999.00329.x; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; TIBANA R, 1985, Revista Brasileira de Biologia, V45, P485; TIBANA R, 1981, Revista Brasileira de Biologia, V41, P625; TIBANA R, 1976, Revista Brasileira de Biologia, V36, P723; Tidon R, 2006, BIOL J LINN SOC, V87, P233, DOI 10.1111/j.1095-8312.2006.00570.x; Townsend C.R., 2006, FUNDAMENTOS ECOLOGIA; WILLMER PG, 1982, OECOLOGIA, V53, P382, DOI 10.1007/BF00389018; WILLMER PG, 1981, OECOLOGIA, V50, P250, DOI 10.1007/BF00348047; Yepes-Gaurisas D, 2013, REV BIOL TROP, V61, P1275; Zumpt F., 1965, MYIASIS MAN ANIMALS	98	17	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0164826	10.1371/journal.pone.0164826	http://dx.doi.org/10.1371/journal.pone.0164826			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798664	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100014
J	Sarker, M; Barua, M; Guerra, F; Saha, A; Aftab, A; Latif, AHMM; Islam, S; Islam, A				Sarker, Malabika; Barua, Mrittika; Guerra, Fiona; Saha, Avijit; Aftab, Afzal; Latif, A. H. M. Mahbub; Islam, Shayla; Islam, Akramul			Double Trouble: Prevalence and Factors Associated with Tuberculosis and Diabetes Comorbidity in Bangladesh	PLOS ONE			English	Article							RISK-FACTORS; MELLITUS	Background Diabetes among tuberculosis patients increases the risk of tuberculosis treatment failure, death, and development of multidrug-resistant tuberculosis. Yet, there is no data is available in Bangladesh on the prevalence of diabetes among tuberculosis patients. The objective of the current study was to estimate prevalence and identify factors associated with tuberculosis-diabetes co-morbidity among TB patients enrolled in the Directly Observed Treatment, Short course program. Methods A community based cross-sectional quantitative study was conducted among 1910 tuberculosis patients living in six urban and eleven rural areas among whom Oral Glucose Tolerance Test (those who fasted) and Random Blood Sugar test (those who did not fast) were performed. Besides glucose levels, data on socio-demographic information, family history of diabetes and anthropometric measurements (height and weight) were also collected. Result Among the 1910 TB patients who participated in screening for diabetes, 245 (12.8%) were found to have diabetes and 296 (15.5%) to have pre-diabetes. Out of those who had diabetes, 34.7% were newly diagnosed through the current study and 65.3% already knew their status. Among those who were found to have prediabetes, 27 (9.1%) had impaired Fasting Blood Glucose (FBG), 230 (77.7%) had Impaired Glucose Tolerance (IGT), and 39 (13.2%) had both Impaired FBG and IGT. Older age, higher BMI, higher education (secondary level and above), being married, participation in less active work, and family history of diabetes are associated with higher prevalence of diabetes. Conclusion We observed a higher prevalence of diabetes and pre-diabetes in TB patients than reported previously in Bangladesh among the general population which may challenge TB and diabetes control in Bangladesh. Diabetes diagnosis, treatment and care should be integrated in the National TB Program.	[Sarker, Malabika; Barua, Mrittika; Saha, Avijit; Aftab, Afzal] BRAC Univ, James P Grant Sch Publ Hlth, Icddr B, 68 Shaheed Tajuddin Ahmed Sharani,Level 6, Dhaka 1212, Bangladesh; [Guerra, Fiona] Publ Hlth Ontario, 480 Univ Ave,Suite 300, Toronto, ON M5G 1V2, Canada; [Latif, A. H. M. Mahbub] Univ Dhaka, ISRT, Dhaka 1000, Bangladesh; [Islam, Shayla; Islam, Akramul] BRAC, 75 Mohakhali, Dhaka 1212, Bangladesh	Bangladesh Rural Advancement Committee BRAC; BRAC University; International Centre for Diarrhoeal Disease Research (ICDDR); University of Dhaka; Bangladesh Rural Advancement Committee BRAC	Sarker, M (corresponding author), BRAC Univ, James P Grant Sch Publ Hlth, Icddr B, 68 Shaheed Tajuddin Ahmed Sharani,Level 6, Dhaka 1212, Bangladesh.	malabika@bracu.ac.bd	Latif, Mahbub AHM/ABD-1002-2021; Barua, Mrittika/ABU-1532-2022	Latif, Mahbub AHM/0000-0001-7838-2158; Barua, Mrittika/0000-0002-6309-234X; Sarker, Malabika/0000-0001-7293-8805; Aftab, Afzal/0000-0003-3743-6732; Saha, Avijit/0000-0002-1034-7265	Global Fund AIDS Tuberculosis Malaria	Global Fund AIDS Tuberculosis Malaria	Global Fund AIDS Tuberculosis & Malaria provided the funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuSayeed M, 1997, DIABETES CARE, V20, P551, DOI 10.2337/diacare.20.4.551; Adepoyibi T, 2013, PUBLIC HEALTH ACTION, V3, pS10, DOI 10.5588/pha.13.0036; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Amare H, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-6; Amrit Guptan, 2000, Indian Journal of Tuberculosis, V47, P3; Ashrafuzzaman SM, 2012, BIRDEM MED J, V1, P26; Baghaei P, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-58; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Balakrishnan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046502; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7; Chiang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121698; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; Lata H, 2013, INT J PHARM BIO SCI, V4; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; National Tuberculosis Programme, BANGL NAT GUID OP MA; Niazi AK, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-28; Ogbera AO, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000112; Rafiqul Islam, 2012, Food and Public Health, V2, P5; Raghuraman S, 2014, N AM J MED SCI, V6, P30, DOI 10.4103/1947-2714.125863; Rifat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105214; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Saquib N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1032; Saquib N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-434; Skowronski M, 2014, ARCH MED SCI, V10, P1019, DOI 10.5114/aoms.2014.46220; Stop TB Initiative (World Health Organization) WHO Department of Chronic Diseases and Health Promotion International Union against Tuberculosis and Lung Disease, 2011, COLL FRAM CAR CONTR; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; United Nations, 2011, POL DECL HIGH LEV M; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Wang QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082660; WHO, 2004, LANCET, V363, P902; Workneh MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147621; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2014, GLOB TUB REP	39	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165396	10.1371/journal.pone.0165396	http://dx.doi.org/10.1371/journal.pone.0165396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798659	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100032
J	Bapat, AA; Munoz, RM; Von Hoff, DD; Han, HY				Bapat, Aditi A.; Munoz, Ruben M.; Von Hoff, Daniel D.; Han, Haiyong			Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells	PLOS ONE			English	Article							PERINEURAL INVASION; EXPRESSION; PAIN; NEUROTROPHINS; PARACRINE; PCR	Perineural invasion (PNI) is thought to be one of the factors responsible for the high rate of tumor recurrence after surgery and the pain generation associated with pancreatic cancer. Signaling via the nerve growth factor (NGF) pathway between pancreatic cancer cells and the surrounding nerves has been implicated in PNI, and increased levels of these proteins have been correlated to poor prognosis. In this study, we examine the molecular mechanism of the NGF signaling pathway in PNI in pancreatic cancer. We show that knocking down NGF or its receptors, TRKA and p75NTR, or treatment with GW441756, a TRKA kinase inhibitor, reduces the proliferation and migration of pancreatic cancer cells in vitro. Furthermore, pancreatic cancer cells migrate towards dorsal root ganglia (DRG) in a co-culture assay, indicating a paracrine NGF signaling between the DRGs and pancreatic cancer cells. Knocking down the expression of NGF pathway proteins or inhibiting the activity of TRKA by GW441756 reduced the migratory ability of Mia PaCa2 towards the DRGs. Finally, blocking NGF signaling by NGF neutralizing antibodies or GW441756 inhibited the neurite formation in PC-12 cells in response to conditioned media from pancreatic cancer cells, indicating a reciprocal signaling pathway between the pancreatic cancer cells and nerves. Our results indicate that NGF signaling pathway provides a potential target for developing molecularly targeted therapies to decrease PNI and reduce pain generation. Since there are several TRKA antagonists currently in early clinical trials they could now be tested in the clinical situation of pancreatic cancer induced pain.	[Bapat, Aditi A.; Munoz, Ruben M.; Von Hoff, Daniel D.; Han, Haiyong] Translat Genom Res Inst, Clin Translat Res Div, Phoenix, AZ 85004 USA; [Bapat, Aditi A.] Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ USA	Translational Genomics Research Institute; University of Arizona	Han, HY (corresponding author), Translat Genom Res Inst, Clin Translat Res Div, Phoenix, AZ 85004 USA.	hhan@tgen.org			National Cancer Institute (NCI), National Institute of Health (NIH) [CA140924]; Hearst Foundation	National Cancer Institute (NCI), National Institute of Health (NIH); Hearst Foundation	This work was supported in part by a R21 grant (CA140924) to HH from the National Cancer Institute (NCI), National Institute of Health (NIH), and by a grant to DVH from the Hearst Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala GE, 2001, PROSTATE, V49, P213, DOI 10.1002/pros.1137; Bapat AA, 2011, NAT REV CANCER, V11, P695, DOI 10.1038/nrc3131; Bassili M, 2010, CANCER CHEMOTH PHARM, V65, P1047, DOI 10.1007/s00280-009-1110-x; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Cappelletti G, 2007, J NEUROSCI RES, V85, P2702, DOI 10.1002/jnr.21235; Casaccia-Bonnefil P, 1999, ADV EXP MED BIOL, V468, P275; Ceyhan GO, 2008, BIOCHEM BIOPH RES CO, V374, P442, DOI 10.1016/j.bbrc.2008.07.035; Ceyhan GO, 2008, BEST PRACT RES CL GA, V22, P31, DOI 10.1016/j.bpg.2007.10.016; Dai H, 2007, HUM PATHOL, V38, P299, DOI 10.1016/j.humpath.2006.08.002; di Mola FF, 2008, LANGENBECK ARCH SURG, V393, P919, DOI 10.1007/s00423-007-0277-z; Doebele RC, 2015, CANCER DISCOV, V5, P1049, DOI 10.1158/2159-8290.CD-15-0443; Gil Z, 2010, J NATL CANCER I, V102, P107, DOI 10.1093/jnci/djp456; Hirai I, 2002, PANCREAS, V24, P15, DOI 10.1097/00006676-200201000-00003; Jung EJ, 2008, EXP MOL MED, V40, P276, DOI 10.3858/emm.2008.40.3.276; Kayahara M, 2007, PANCREAS, V35, P218, DOI 10.1097/mpa.0b013e3180619677; Ketterer K, 2003, CLIN CANCER RES, V9, P5127; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2008, J GASTROEN HEPATOL, V23, P1852, DOI 10.1111/j.1440-1746.2008.05579.x; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Marchesi F, 2010, CYTOKINE GROWTH F R, V21, P77, DOI 10.1016/j.cytogfr.2009.11.001; Mitsunaga S, 2007, AM J SURG PATHOL, V31, P1636, DOI 10.1097/PAS.0b013e318065bfe6; Nicol GD, 2007, MOL INTERV, V7, P26, DOI 10.1124/mi.7.1.6; Pour PM, 2003, PANCREAS, V26, P322, DOI 10.1097/00006676-200305000-00002; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stephens B, 2008, MOL CANCER THER, V7, P202, DOI 10.1158/1535-7163.MCT-07-0542; Takahashi T, 1997, J SURG ONCOL, V65, P164, DOI 10.1002/(SICI)1096-9098(199707)65:3<164::AID-JSO4>3.0.CO;2-4; Verbeke S, 2010, CELL SIGNAL, V22, P1864, DOI 10.1016/j.cellsig.2010.07.014; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang W, 2009, EJSO-EUR J SURG ONC, V35, P826, DOI 10.1016/j.ejso.2008.10.013; Wood JN, 2010, NEW ENGL J MED, V363, P1572, DOI 10.1056/NEJMe1004416; Xie LF, 2012, BIOCHEM PHARMACOL, V83, P452, DOI 10.1016/j.bcp.2011.11.005; Yi SQ, 2003, PANCREAS, V27, P225, DOI 10.1097/00006676-200310000-00005; Zhang Y, 2005, ONCOL REP, V14, P161; Zhu ZW, 1999, J CLIN ONCOL, V17, P2419, DOI 10.1200/JCO.1999.17.8.2419	36	50	55	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165586	10.1371/journal.pone.0165586	http://dx.doi.org/10.1371/journal.pone.0165586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792755	Green Published, Green Submitted, gold			2022-12-26	WOS:000389537000034
J	Bujalska-Zadrozny, M; Kulik, K; Ordak, M; Sasinowska-Motyl, M; Gasinska, E; de Corde, A; Kowalczyk, A; Sacharczuk, M; Naruszewicz, M				Bujalska-Zadrozny, Magdalena; Kulik, Kamila; Ordak, Michal; Sasinowska-Motyl, Malgorzata; Gasinska, Emilia; de Corde, Anna; Kowalczyk, Agnieszka; Sacharczuk, Mariusz; Naruszewicz, Marek			Micronized Organic Magnesium Salts Enhance Opioid Analgesia in Rats	PLOS ONE			English	Article							PURIFIED FLAVONOID FRACTION; PHYSICOCHEMICAL PROPERTIES; DISSOLUTION ENHANCEMENT; INTESTINAL-ABSORPTION; EXPERIMENTAL-MODELS; NEUROPATHIC PAIN; CONTROLLED TRIAL; DRUG-DELIVERY; FENOFIBRATE; IONS	Purpose As previously reported, magnesium sulphate administered parenterally significantly increased an opioid antinociception in different kinds of pain. Since the typical form of magnesium salts are poorly and slowly absorbed from the gastrointestinal tract we examined whether their micronized form could increase opioids induced antinociception. Methods In behavioural studies on rats morphine, tramadol and oxycodone together with magnesium (lactate dihydrate, hydroaspartate, chloride) in micronized (particles of size D-90 < 50 mu m) and conventional forms were used. Changes in pain thresholds were determined using mechanical stimuli. The intestinal absorption of two forms of magnesium lactate dihydrate (at the doses of 7.5 or 15 mg ions) in the porcine gut sac model were also compared. Results Micronized form of magnesium lactate dihydrate or hydroaspartate but not chloride (15 mg of magnesium ions kg-1) enhanced the analgesic activity of orally administered opioids, significantly faster and more effective in comparison to the conventional form of magnesium salts (about 40% for oxycodone administered together with a micronized form of magnesium hydroaspartate). Moreover, in vitro studies of transport across porcine intestines of magnesium ions showed that magnesium salts administered in micronized form were absorbed from the intestines to a greater extent than the normal form of magnesium salts. Conclusions The co-administration of micronized magnesium organic salts with opioids increased their synergetic analgesic effect. This may suggest an innovative approach to the treatment of pain in clinical practice.	[Bujalska-Zadrozny, Magdalena; Kulik, Kamila; Ordak, Michal; Sasinowska-Motyl, Malgorzata; Gasinska, Emilia; de Corde, Anna; Kowalczyk, Agnieszka] Med Univ Warsaw, Dept Pharmacodynam, Ctr Preclin Res & Technol, Warsaw, Poland; [Ordak, Michal] Med Univ Warsaw, Chair & Dept Psychiat, Warsaw, Poland; [Sacharczuk, Mariusz] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Cytogenet, Magdalenka, Poland; [Naruszewicz, Marek] Med Univ Warsaw, Dept Pharmacognosy & Mol Basis Phytotherapy, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Medical University of Warsaw	Bujalska-Zadrozny, M (corresponding author), Med Univ Warsaw, Dept Pharmacodynam, Ctr Preclin Res & Technol, Warsaw, Poland.	mbujalska@gmail.com	Ordak, Michal/B-4479-2017	Ordak, Michal/0000-0001-5652-4397; Sacharczuk, Mariusz/0000-0002-6309-5292	Warsaw Medical University; National Centre for Research and Development [INNOTECH-K2/IN2/70/183154/NCBR/13]	Warsaw Medical University; National Centre for Research and Development	This work was supported by statutory funds of Warsaw Medical University as well as grant from the National Centre for Research and Development, INNOTECH-K2/IN2/70/183154/NCBR/13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTURA BT, 1994, J AM COLL NUTR, V13, P447; Bansal K, 2011, IJRPC, V3, P315; Bansal K, 2012, ARCH PHARM PRACT, V3, P261, DOI 10.4103/2045-080X.106239; Begon S, 2002, ANESTHESIOLOGY, V96, P627, DOI 10.1097/00000542-200203000-00019; Begon S, 2000, BRAIN RES, V887, P436, DOI 10.1016/S0006-8993(00)03028-6; Bohn T, 2008, CURR NUTR FOOD SCI, V4, P53, DOI 10.2174/157340108783497427; Bujalska M, 2008, PHARMACOLOGY, V82, P180, DOI 10.1159/000151346; Bujalska M, 2009, PHARMACOL REP, V61, P1096, DOI 10.1016/S1734-1140(09)70172-0; Buvanendran A, 2002, ANESTH ANALG, V95, P661, DOI 10.1097/00000539-200209000-00031; da Costa Maira Assis, 2012, Pharmaceutics, V5, P1, DOI 10.3390/pharmaceutics5010001; Danielsson G, 2002, EUR J VASC ENDOVASC, V23, P73, DOI 10.1053/ejvs.2001.1531; de Lignieres B, 1999, CLIN THER, V21, P41, DOI 10.1016/S0149-2918(00)88267-3; Dokoumetzidis A, 2006, INT J PHARMACEUT, V321, P1, DOI 10.1016/j.ijpharm.2006.07.011; Dorkoosh FA, 2002, INT J PHARMACEUT, V247, P47, DOI 10.1016/S0378-5173(02)00361-7; Han X, 2011, INT J PHARMACEUT, V415, P185, DOI 10.1016/j.ijpharm.2011.05.070; Howells LM, 2011, CANCER PREV RES, V4, P1419, DOI 10.1158/1940-6207.CAPR-11-0148; Khan F, 2010, AAPS PHARMSCITECH, V11, P1368, DOI 10.1208/s12249-010-9505-x; Koinig H, 1998, ANESTH ANALG, V87, P206, DOI 10.1097/00000539-199807000-00042; Malon A, 2005, SENSOR ACTUAT B-CHEM, V108, P828, DOI 10.1016/j.snb.2004.12.091; Malon A, 2002, ANAL BIOCHEM, V302, P220, DOI 10.1006/abio.2001.5504; McGregor L, 1999, THROMB RES, V94, P235, DOI 10.1016/S0049-3848(98)00216-3; Mura P, 2002, J PHARMACEUT BIOMED, V30, P227, DOI 10.1016/S0731-7085(02)00252-2; Okopien B, 2006, PHARMACOL REP, V58, P729; Ozalevli M, 2005, ACTA ANAESTH SCAND, V49, P1514, DOI 10.1111/j.1399-6576.2005.00793.x; Parsons CG, 2001, EUR J PHARMACOL, V429, P71, DOI 10.1016/S0014-2999(01)01307-3; Polnok A, 2004, INT J PHARMACEUT, V269, P303, DOI 10.1016/j.ijpharm.2003.09.022; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Rawat N., 2011, INT J RECENT ADV PHA, V1, P8; RODRIGUEZ FD, 1992, J NEUROCHEM, V59, P467, DOI 10.1111/j.1471-4159.1992.tb09393.x; Ruan LP, 2006, EUR J MED CHEM, V41, P605, DOI 10.1016/j.ejmech.2006.01.013; Rylander R., 2014, Journal of Pharmacy and Nutrition Sciences, V4, P57; Suresh S, 2003, ANESTH ANALG, V96, P1413, DOI 10.1213/01.ANE.0000057140.33744.65; Talari R, 2010, AAPS PHARMSCITECH, V11, P786, DOI 10.1208/s12249-010-9441-9; Talari R, 2009, J PHARM PHARM SCI, V12, P250, DOI 10.18433/J31P4P; Vandana KR, 2014, SAUDI PHARM J, V22, P283, DOI 10.1016/j.jsps.2013.05.004; Vargas-Schaffer G, 2014, CAN FAM PHYSICIAN, V60, P235; Voelker M., 2012, Inflammopharmacology, V20, P225, DOI 10.1007/s10787-011-0099-z; Vogt M, 2008, EUR J PHARM BIOPHARM, V68, P283, DOI 10.1016/j.ejpb.2007.05.010; Warenik-Szymankiewicz A, 2005, PRZ MENOPAUZALNY, V1, P15; Zhu JR, 2003, CHINESE MED J-PEKING, V116, P840	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0161776	10.1371/journal.pone.0161776	http://dx.doi.org/10.1371/journal.pone.0161776			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792736	gold, Green Published, Green Submitted			2022-12-26	WOS:000389537000002
J	Kwon, HN; Lim, H				Kwon, Han Na; Lim, Hyunjung			Relationship between Serum Vitamin D Status and Metabolic Risk Factors among Korean Adults with Prediabetes	PLOS ONE			English	Article							PLASMA 25-HYDROXYVITAMIN D; SENSITIVITY CHECK INDEX; NATIONAL-HEALTH; INSULIN SENSITIVITY; PREVENTION; ASSOCIATION; DEFICIENCY; OBESITY	Serum vitamin D status has been associated with prediabetes and metabolic syndrome. Evidence for the increased risk of metabolic disorders in individuals with prediabetes and a low vitamin D status is limited and uncertain. Furthermore, it has not been confirmed whether this possible relationship occurs in the Korean population. The aim of this study was to assess serum vitamin D status and to examine the relationship between serum vitamin D levels and metabolic risk factors in Korean adults with prediabetes. This cross-sectional study was conducted among 60 subjects aged 20-65 years. Participants had fasting glucose levels of 100 to 125 mg/dl. A questionnaire was used to assess vitamin D synthesis from sun exposure and a dietary intake examined using 3-days dietary records. Clinical and biochemical data were also collected. The 2009 harmonized definition of metabolic syndrome was used. Serum vitamin D levels were classified according to criteria from the 2011 Institute of Medicine report. The majority of subjects (75%) had a serum 25(OH) D level < 20 ng/ml, and among them, 31.1% were vitamin D deficiency (< 12 ng/ml). The proportion (42.9%) of subjects having low HDL-cholesterol was the highest among vitamin D deficiency (< 12 ng/ml) group (12 to < 20 ng/ml: 16.1%, >= 20 ng/ml: 6.7%). We observed an inverse relationship between 25(OH) D levels and TG, AI (beta = -6.355, SE = 2.463; beta = -0.020, SE = 0.008) after adjusted confounders. Korean adults with prediabetes were more likely to have low serum 25(OH) D levels. A sufficient 25(OH) D level may have possible beneficial effects on lipid profiles.	[Kwon, Han Na; Lim, Hyunjung] Kyung Hee Univ, Grad Sch East West Med Sci, Dept Med Nutr, Yongin 17104, Gyenggi Do, South Korea; [Lim, Hyunjung] Kyung Hee Univ, Res Inst Med Nutr, Seoul 02447, South Korea	Kyung Hee University; Kyung Hee University	Lim, H (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Dept Med Nutr, Yongin 17104, Gyenggi Do, South Korea.; Lim, H (corresponding author), Kyung Hee Univ, Res Inst Med Nutr, Seoul 02447, South Korea.	hjlim@khu.ac.kr	Lim, Hyunjung/AAJ-4089-2020	Lim, Hyunjung/0000-0001-7632-7315				Abbasi F, 2015, J NUTR, V145, P714, DOI 10.3945/jn.114.209171; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Barengolts E, 2010, ENDOCR PRACT, V16, P476, DOI 10.4158/EP09195.RA; Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009; Calle C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-65; Cho HJ, 2005, BIOL PHARM BULL, V28, P1418, DOI 10.1248/bpb.28.1418; Chon SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089721; Chung JY, 2013, NUTR RES PRACT, V7, P495, DOI 10.4162/nrp.2013.7.6.495; Davidson MB, 2013, DIABETES CARE, V36, P260, DOI 10.2337/dc12-1204; Ding C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061707; Ferrannini E, 2011, MED CLIN N AM, V95, P327, DOI 10.1016/j.mcna.2010.11.005; Fujita T, 2000, J BONE MINER METAB, V18, P109, DOI 10.1007/s007740050101; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Guasch A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-149; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Huang CY, 2015, CLIN NUTR, V34, P484, DOI 10.1016/j.clnu.2014.05.010; Jorde R, 2016, J CLIN ENDOCR METAB, V101, P1647, DOI 10.1210/jc.2015-4013; Kang SW, 2012, J IMMUNOL, V188, P5276, DOI 10.4049/jimmunol.1101211; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kim S, 2012, DIABETES RES CLIN PR, V96, P230, DOI 10.1016/j.diabres.2012.01.001; 나은희, 2015, Laboratory Medicine Online, V5, P84; Korean Diabetes Association, 2015, KOR DIAB FACT SHEET; LAUER RM, 1988, PEDIATRICS, V82, P309; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Lin JS, 2014, ANN INTERN MED, V161, P568, DOI 10.7326/M14-0130; Lips P, 2006, J INTERN MED, V260, P245, DOI 10.1111/j.1365-2796.2006.01685.x; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Majumdar V, 2011, INT J OBESITY, V35, P1131, DOI 10.1038/ijo.2010.232; Mansuri S, 2015, DIABETES RES CLIN PR, V109, P440, DOI 10.1016/j.diabres.2015.04.017; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Mitri J, 2014, EUR J CLIN NUTR, V68, P376, DOI 10.1038/ejcn.2013.293; Orchard TJ, 2005, ANN INTERN MED, V142, P611, DOI 10.7326/0003-4819-142-8-200504190-00009; Parker AR, 2014, J ACAD NUTR DIET, V114, P1739, DOI 10.1016/j.jand.2014.07.020; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Shin JY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-30; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Sooy K, 1999, J BIOL CHEM, V274, P34343, DOI 10.1074/jbc.274.48.34343; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yokoyama H, 2003, DIABETES CARE, V26, P2426, DOI 10.2337/diacare.26.8.2426; Zhou QG, 2008, DIABETES-METAB RES, V24, P459, DOI 10.1002/dmrr.873	43	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165324	10.1371/journal.pone.0165324	http://dx.doi.org/10.1371/journal.pone.0165324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783655	Green Submitted, Green Published, gold			2022-12-26	WOS:000389602800072
J	Nielsen, NH; Jahoor, A; Jensen, D; Orabi, J; Cericola, F; Edriss, V; Jensen, J				Nielsen, Nanna Hellum; Jahoor, Ahmed; Jensen, Due; Orabi, Jihad; Cericola, Fabio; Edriss, Vahid; Jensen, Just			Genomic Prediction of Seed Quality Traits Using Advanced Barley Breeding Lines	PLOS ONE			English	Article							SELECTION; ACCURACY; IMPACT; OPTIMIZATION; INFORMATION; POPULATIONS; IMPROVEMENT	Genomic selection was recently introduced in plant breeding. The objective of this study was to develop genomic prediction for important seed quality parameters in spring barley. The aim was to predict breeding values without expensive phenotyping of large sets of lines. A total number of 309 advanced spring barley lines tested at two locations each with three replicates were phenotyped and each line was genotyped by Illumina iSelect 9Kbarley chip. The population originated from two different breeding sets, which were phenotyped in two different years. Phenotypic measurements considered were: seed size, protein content, protein yield, test weight and ergosterol content. A leave-one-out cross-validation strategy revealed high prediction accuracies ranging between 0.40 and 0.83. Prediction across breeding sets resulted in reduced accuracies compared to the leave-one-out strategy. Furthermore, predicting across full and half-sib-families resulted in reduced prediction accuracies. Additionally, predictions were performed using reduced marker sets and reduced training population sets. In conclusion, using less than 200 lines in the training set can result in low prediction accuracy, and the accuracy will then be highly dependent on the family structure of the selected training set. However, the results also indicate that relatively small training sets (200 lines) are sufficient for genomic prediction in commercial barley breeding. In addition, our results indicate a minimum marker set of 1,000 to decrease the risk of low prediction accuracy for some traits or some families.	[Nielsen, Nanna Hellum; Jahoor, Ahmed; Jensen, Due; Orabi, Jihad; Edriss, Vahid] Nord Seed AS, Grindsnabevej 25, DK-8300 Odder, Denmark; [Cericola, Fabio; Jensen, Just] Aarhus Univ, Ctr Quantitat Genet & Genom, Dept Mol Biol & Genet, Blichers Alle 20, DK-8830 Tjele, Denmark; [Jahoor, Ahmed] Swedish Univ Agr Sci, Dept Plant Breeding, S-2353 Alnarp, Sweden	Aarhus University; Swedish University of Agricultural Sciences	Nielsen, NH (corresponding author), Nord Seed AS, Grindsnabevej 25, DK-8300 Odder, Denmark.	nhni@nordicseed.com	Orabi, Jihad/ABB-1020-2020	Orabi, Jihad/0000-0001-9641-6657; Edriss, Vahid/0000-0003-4361-091X	Innovation Fund Denmark [5184-00032B]; GUDP (Europe)	Innovation Fund Denmark; GUDP (Europe)	This work was funded by the Innovation Fund Denmark (grant no. 5184-00032B) and GUDP (Europe-Funding). The funder provided support in the form of salaries for authors AJ, JDJ, JO, VE, NHN, JJ and FC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albrecht T, 2011, THEOR APPL GENET, V123, P339, DOI 10.1007/s00122-011-1587-7; Ayoub M, 2002, THEOR APPL GENET, V105, P237, DOI 10.1007/s00122-002-0941-1; Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Charmet G, 2014, MOL BREEDING, V34, P1843, DOI 10.1007/s11032-014-0143-y; Combs E, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.11.0030; Crossa J, 2014, HEREDITY, V112, P48, DOI 10.1038/hdy.2013.16; Crossa J, 2013, G3-GENES GENOM GENET, V3, P1903, DOI 10.1534/g3.113.008227; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; FAOStat, 2016, FAO STAT DIV 2016; Fischer TM, 2004, GENET SEL EVOL, V36, P363, DOI 10.1051/gse:2004006; Fox GP, 2003, AUST J AGR RES, V54, P1081, DOI 10.1071/AR02237; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; He S, 2016, THEOR APPL GENET, V129, P641, DOI 10.1007/s00122-015-2655-1; Isidro J, 2015, THEOR APPL GENET, V128, P145, DOI 10.1007/s00122-014-2418-4; Jensen J, 2014, R SCRIPT CALCULATION; Kemper KE, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-014-0074-4; LANDE R, 1990, GENETICS, V124, P743; Lopez-Cruz M, 2015, G3-GENES GENOM GENET, V5, P569, DOI 10.1534/g3.114.016097; Lorenz AJ, 2012, CROP SCI, V52, P1609, DOI 10.2135/cropsci2011.09.0503; Madsen P, 2013, 10 WORLD C GEN APPL; Madsen P., 2013, DMU USERS GUIDE PACK; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; Marquez-Cedillo LA, 2001, THEOR APPL GENET, V103, P625, DOI 10.1007/PL00002919; Matthies IE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110046; Meuwissen THE, 2001, GENETICS, V157, P1819; Nielsen JP, 2003, J CEREAL SCI, V38, P247, DOI 10.1016/S0733-5210(03)00024-9; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Pszczola M, 2012, J DAIRY SCI, V95, P5412, DOI 10.3168/jds.2012-5550; R Core Team, 2018, R LANG ENV STAT COMP; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Sallam AH, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.05.0020; Schmid KJ, 2014, BIOTECH AGR FOREST, V69, P367, DOI 10.1007/978-3-662-44406-1_19; Schmidt M, 2016, THEOR APPL GENET, V129, P203, DOI 10.1007/s00122-015-2639-1; TraitGenetics, SCHWAB 1B STADT SEEL; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wientjes YCJ, 2013, GENETICS, V193, P621, DOI 10.1534/genetics.112.146290; Windhausen VS, 2012, G3-GENES GENOM GENET, V2, P1427, DOI 10.1534/g3.112.003699; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277; Zhu H, 1999, THEOR APPL GENET, V98, P772, DOI 10.1007/s001220051134	41	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164494	10.1371/journal.pone.0164494	http://dx.doi.org/10.1371/journal.pone.0164494			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783639	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800042
J	Shin, JW; Shin, YU; Uhm, KB; Sung, KR; Kang, MH; Cho, HY; Seong, M				Shin, Joong Won; Shin, Yong Un; Uhm, Ki Bang; Sung, Kyung Rim; Kang, Min Ho; Cho, Hee Yoon; Seong, Mincheol			The Effect of Optic Disc Center Displacement on Retinal Nerve Fiber Layer Measurement Determined by Spectral Domain Optical Coherence Tomography	PLOS ONE			English	Article							THICKNESS MEASUREMENTS; MARGIN ANATOMY; GLAUCOMA; REPRODUCIBILITY; VARIABILITY; EYES; OCT	Purpose To investigate the effect of optic disc center displacement on retinal nerve fiber layer (RNFL) measurement determined by spectral domain optical coherence tomography (SD-OCT). Methods The optic disc center was manipulated at 1-pixel intervals in horizontal, vertical, and diagonal directions. According to the manipulated optic disc center location, the RNFL thickness data were resampled: (1) at a 3.46-mm diameter circle; and (2) between a 2.5-mm diameter circle and 5.4-mm square. Error was calculated between the original and resampled RNFL measurements. The tolerable error threshold of the optic disc center displacement was determined by considering test-retest variability of SD-OCT. The unreliable zone was defined as an area with 10% or more variability. Results The maximum tolerable error thresholds of optic disc center displacement on the RNFL thickness map were distributed from 0.042 to 0.09 mm in 8 directions. The threshold shape was vertically elongated. Clinically important unreliable zones were located: (1) at superior and inferior region in the vertical displacement; (2) at inferotemporal region in the horizontal displacement, and (3) at superotemporal or inferotemporal region in the diagonal displacement. The unreliable zone pattern and threshold limit varied according to the direction of optic disc displacement. Conclusions Optic disc center displacement had a considerable impact on whole RNFL thickness measurements. Understanding the effect of optic disc center displacement could contribute to reliable RNFL measurements.	[Shin, Joong Won; Shin, Yong Un; Uhm, Ki Bang; Kang, Min Ho; Cho, Hee Yoon; Seong, Mincheol] Hanyang Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Shin, Joong Won; Sung, Kyung Rim] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Shin, Yong Un; Kang, Min Ho; Cho, Hee Yoon; Seong, Mincheol] Hanyang Univ, Coll Med, Guri Hosp, Dept Ophthalmol, Guri, South Korea	Hanyang University; University of Ulsan; Asan Medical Center; Hanyang University	Seong, M (corresponding author), Hanyang Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.; Seong, M (corresponding author), Hanyang Univ, Coll Med, Guri Hosp, Dept Ophthalmol, Guri, South Korea.	goddns76@hanmail.net	SHIN, Yong-Un/AAI-9824-2020; SHIN, Yong Un/V-7668-2017	SHIN, Yong Un/0000-0003-1251-8985	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [NRF-2015R1C1A2A01053008]	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science, and Technology (no. NRF-2015R1C1A2A01053008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budenz DL, 2008, OPHTHALMOLOGY, V115, P661, DOI 10.1016/j.ophtha.2007.05.035; Cheung CYL, 2009, EYE, V23, P1436, DOI 10.1038/eye.2008.258; Cheung CY, 2011, INVEST OPHTH VIS SCI, V52, P9629, DOI 10.1167/iovs.11-7481; Gabriele ML, 2008, INVEST OPHTH VIS SCI, V49, P2315, DOI 10.1167/iovs.07-0873; Hwang YH, 2012, BRIT J OPHTHALMOL, V96, P1386, DOI 10.1136/bjophthalmol-2012-301713; Kim JS, 2009, BRIT J OPHTHALMOL, V93, P1057, DOI 10.1136/bjo.2009.157875; Leung CKS, 2010, OPHTHALMOLOGY, V117, P2337, DOI 10.1016/j.ophtha.2010.04.002; Leung CKS, 2008, INVEST OPHTH VIS SCI, V49, P4886, DOI 10.1167/iovs.07-1187; Leung CKS, 2012, OPHTHALMOLOGY, V119, P1858, DOI 10.1016/j.ophtha.2012.03.044; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Reis ASC, 2012, INVEST OPHTH VIS SCI, V53, P1852, DOI 10.1167/iovs.11-9309; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Shin JW, 2014, INVEST OPHTH VIS SCI, V55, P3208, DOI 10.1167/iovs.13-13181; Suh MH, 2015, J GLAUCOMA, V24, P238, DOI 10.1097/IJG.0000000000000143; Sung KR, 2012, J GLAUCOMA, V21, P498, DOI 10.1097/IJG.0b013e318220dbb7; Taibbi G, 2014, INVEST OPHTH VIS SCI, V55, P2251, DOI 10.1167/iovs.13-13276; Uchida H, 1996, INVEST OPHTH VIS SCI, V37, P2393; Vizzeri G, 2008, J GLAUCOMA, V17, P341, DOI 10.1097/IJG.0b013e31815c3aeb	18	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165538	10.1371/journal.pone.0165538	http://dx.doi.org/10.1371/journal.pone.0165538			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783663	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800081
J	Grodsky, SM; Moorman, CE; Fritts, SR; Castleberry, SB; Wigley, TB				Grodsky, Steven M.; Moorman, Christopher E.; Fritts, Sarah R.; Castleberry, Steven B.; Wigley, T. Bently			Breeding, Early-Successional Bird Response to Forest Harvests for Bioenergy	PLOS ONE			English	Article							COARSE WOODY DEBRIS; NESTING SUCCESS; HABITAT USE; DEAD WOOD; CONSERVATION; DENSITY; DISTURBANCE; ARTHROPODS; DIVERSITY; ABUNDANCE	Forest regeneration following timber harvest is a principal source of habitat for early-successional birds and characterized by influxes of early-successional vegetation and residual downed woody material. Early-successional birds may use harvest residues for communication, cover, foraging, and nesting. Yet, increased market viability of woody biomass as bioenergy feedstock may intensify harvest residue removal. Our objectives were to: 1) evaluate effects of varying intensities of woody biomass harvest on the early-successional bird community; and (2) document early-successional bird use of harvest residues in regenerating stands. We spot-mapped birds from 15 April-15 July, 2012-2014, in six woody biomass removal treatments within regenerating stands in North Carolina (n = 4) and Georgia (n = 4), USA. Treatments included clearcut harvest followed by: (1) traditional woody biomass harvest with no specific retention target; (2) 15% retention with harvest residues dispersed; (3) 15% retention with harvest residues clustered; (4) 30% retention with harvest residues dispersed; (5) 30% retention with harvest residues clustered; and (6) no woody biomass harvest (i.e., reference site). We tested for treatment-level effects on breeding bird species diversity and richness, early-successional focal species territory density (combined and individual species), counts of breeding birds detected near, in, or on branches of harvest piles/windrows, counts of breeding bird behaviors, and vegetation composition and structure. Pooled across three breeding seasons, we delineated 536 and 654 territories and detected 2,489 and 4,204 birds in the North Carolina and Georgia treatments, respectively. Woody biomass harvest had limited or short-lived effects on the early-successional, breeding bird community. The successional trajectory of vegetation structure, rather than availability of harvest residues, primarily drove avian use of regenerating stands. However, many breeding bird species used downed wood in addition to vegetation, indicating that harvest residues initially may provide food and cover resources for early-successional birds in regenerating stands prior to vegetation regrowth.	[Grodsky, Steven M.; Moorman, Christopher E.] North Carolina State Univ, Dept Forestry & Environm Resources, Fisheries Wildlife & Conservat Biol Program, Box 7646, Raleigh, NC 27695 USA; [Fritts, Sarah R.] Texas Tech Univ, Dept Nat Resources Management, POB 42125, Lubbock, TX 79409 USA; [Castleberry, Steven B.] Univ Georgia, Warnell Sch Forestry & Nat Resources, 180 E Green St, Athens, GA 30602 USA; [Wigley, T. Bently] Natl Council Air & Stream Improvement Inc, POB 340317, Clemson, SC 29634 USA	University of North Carolina; North Carolina State University; Texas Tech University System; Texas Tech University; University System of Georgia; University of Georgia	Grodsky, SM (corresponding author), North Carolina State Univ, Dept Forestry & Environm Resources, Fisheries Wildlife & Conservat Biol Program, Box 7646, Raleigh, NC 27695 USA.	smgrodsky@ucdavis.edu			National Council for Air and Stream Improvement, Inc.; Department of Interior Southeast Climate Science Center; Department of Agriculture National Institute of Food and Agriculture Managed Ecosystems Program; Biofuels Center of North Carolina	National Council for Air and Stream Improvement, Inc.; Department of Interior Southeast Climate Science Center; Department of Agriculture National Institute of Food and Agriculture Managed Ecosystems Program; Biofuels Center of North Carolina	National Council for Air and Stream Improvement, Inc. - http://www.ncasi.org/ - CEM, SBC, SMG; Department of Interior Southeast Climate Science Center - https://www.doi.gov/csc/southeast/ - SMG, CEM; Department of Agriculture National Institute of Food and Agriculture Managed Ecosystems Program - https://nifa.usda.gov/grants - CEM; Biofuels Center of North Carolina - http://www.biofuelscenter.org/ - SMG, SRF, CEM. The author(s) received no specific funding for this work.	Annand EM, 1997, J WILDLIFE MANAGE, V61, P159, DOI 10.2307/3802425; [Anonymous], 2013, FORISK NEWS; Beissinger SR, 2000, AUK, V117, P549, DOI 10.1642/0004-8038(2000)117[0549:ROTACC]2.0.CO;2; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; BRENNAN LA, 1991, WILDLIFE SOC B, V19, P544; Burger LW, 2001, WILDLIFE SO FORESTS, P122; DeGraaf R. M., 1991, Wildlife and habitats in managed landscapes., P153; DeGraaf RM, 2003, FOREST ECOL MANAG, V185, P179, DOI 10.1016/S0378-1127(03)00254-8; Dickson JG, 1995, ECOLOGY MANAGEMENT N, P246; Diefenbach DR, 2003, AUK, V120, P1168, DOI 10.1642/0004-8038(2003)120[1168:VIGBCR]2.0.CO;2; Elliott KJ, 2011, MANAG FOR ECOSYST, V21, P97, DOI 10.1007/978-94-007-1620-9_7; Evans J. M., 2013, FORESTRY BIOENERGY S; Fielding D., 2012, INT J FOREST RES, V2012, DOI [10.1155/2012/256141, DOI 10.1155/2012/256141]; Fritts SR, 2014, BIOMASS BIOENERG, V70, P382, DOI 10.1016/j.biombioe.2014.08.010; Gram WK, 2003, CONSERV BIOL, V17, P1324, DOI 10.1046/j.1523-1739.2003.02171.x; Grodsky SM, 2016, APPL ECOL ENV MGMT, P47; Grodsky SM, 2016, FOREST ECOL MANAG, V379, P91, DOI 10.1016/j.foreco.2016.07.045; Hache S, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00584-080104; Hagan JM, 1999, J FOREST, V97, P6; Haggerty Thomas M., 1995, Birds of North America, V188, P1; Hamel PB, 1992, LAND MANAGERS GUIDE; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; HARMON ME, 1991, BIOSCIENCE, V41, P604, DOI 10.2307/1311697; Hill M. O., 1979, The ecology of even-aged forest plantations. Proceedings of Division I. International Union of Forestry Research Organisations, Edinburgh, September 1978., P175; Homyack JA, 2013, WILDLIFE SOC B, V37, P327, DOI 10.1002/wsb.248; Hothorn T, 2013, PACKAGE MULTCOMP; Hunter WC, 2001, WILDLIFE SOC B, V29, P440; Hutto RL, 2006, CONDOR, V108, P817, DOI 10.1650/0010-5422(2006)108[817:TEOPSL]2.0.CO;2; Jabin M, 2004, FOREST ECOL MANAG, V194, P61, DOI 10.1016/j.foreco.2004.01.053; Janowiak MK, 2010, J FOREST, V108, P16; Jennings SB, 1999, FORESTRY, V72, P59, DOI 10.1093/forestry/72.1.59; Keller JK, 2003, FOREST ECOL MANAG, V174, P541, DOI 10.1016/S0378-1127(02)00074-9; King DI, 2014, FOREST ECOL MANAG, V324, P186, DOI 10.1016/j.foreco.2013.12.001; King DI, 2000, FOREST ECOL MANAG, V129, P227, DOI 10.1016/S0378-1127(99)00167-X; Lanham J. D., 1996, General Technical Report - Southern Research Station, USDA Forest Service, P101; Litvaitis JA, 2001, WILDLIFE SOC B, V29, P466; Loeb S. C., 1996, General Technical Report - Southern Research Station, USDA Forest Service, P108; Loftis DL, 2011, MANAG FOR ECOSYST, V21, P59, DOI 10.1007/978-94-007-1620-9_5; Lohr SM, 2002, CONSERV BIOL, V16, P767, DOI 10.1046/j.1523-1739.2002.01019.x; Mac Nally R, 2001, BIOL CONSERV, V99, P191, DOI 10.1016/S0006-3207(00)00180-4; Mayfield CA, 2007, BIOMASS BIOENERG, V31, P631, DOI 10.1016/j.biombioe.2007.06.021; Mendell BC, 2012, FOR HIST SOC, P1; Moorman CE, 2001, ECOL APPL, V11, P1680, DOI 10.1890/1051-0761(2001)011[1680:EOGSOS]2.0.CO;2; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oswalt SN, 2014, GTRWO91 USDA FOR SER; Parikka M, 2004, BIOMASS BIOENERG, V27, P613, DOI 10.1016/j.biombioe.2003.07.005; Perschel B., 2012, FOREST BIOMASS RETEN; Plush CJ, 2013, J WILDLIFE MANAGE, V77, P200, DOI 10.1002/jwmg.436; R Core Team, 2021, R LANGUAGE ENV STAT; Ranius T, 2006, SCAND J FOREST RES, V21, P201, DOI 10.1080/02827580600688269; REN21, 2013, REN 2013 GLOB STAT R; Riffell S, 2011, FOREST ECOL MANAG, V261, P878, DOI 10.1016/j.foreco.2010.12.021; Sami M, 2001, PROG ENERG COMBUST, V27, P171, DOI 10.1016/S0360-1285(00)00020-4; Shackelford CE, 1997, WILSON BULL, V109, P614; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Sikkema R, 2011, BIOFUEL BIOPROD BIOR, V5, P250, DOI 10.1002/bbb.277; THOMPSON FR, 1993, USDA ROCKY, V229, P353; Tozer DC, 2010, FOREST ECOL MANAG, V259, P1522, DOI 10.1016/j.foreco.2010.01.028; Trani MK, 2001, WILDLIFE SOC B, V29, P413; U.S. Department of Agriculture, 2010, USDA REG ROADM M BIO; Ulyshen MD, 2009, ENVIRON ENTOMOL, V38, P1005, DOI 10.1603/022.038.0407; United States Department of Agriculture (USDA), 2007, PHAS 3 FIELD GUID WO; United States Forest Service, 2008, FOREST INVENTORY; VANWAGNER CE, 1968, FOREST SCI, V14, P20; Venables WN., 2002, MODERN APPL STAT S, V4; Wagner DL, 2003, FOREST ECOL MANAG, V185, P95, DOI 10.1016/S0378-1127(03)00249-4; Whiles M. R., 1996, General Technical Report - Southern Research Station, USDA Forest Service, P94	68	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165070	10.1371/journal.pone.0165070	http://dx.doi.org/10.1371/journal.pone.0165070			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780221	gold, Green Published			2022-12-26	WOS:000389046900026
J	Lin, KH; Liu, CL; Kuo, WW; Paul, CR; Chen, WK; Wen, SY; Day, CH; Wu, HC; Viswanadha, VP; Huang, CY				Lin, Kuan-Ho; Liu, Chien-Liang; Kuo, Wei-Wen; Paul, Catherine Reena; Chen, Wei-Kung; Wen, Su-Ying; Day, Cecilia Hsuan; Wu, Hsi-Chin; Viswanadha, Vijaya Padma; Huang, Chih-Yang			Early Fluid Resuscitation by Lactated Ringer's Solution Alleviate the Cardiac Apoptosis in Rats with Trauma-Hemorrhagic Shock	PLOS ONE			English	Article							TNF-ALPHA; POLYTRAUMA; PATHWAY; SALINE	Cardiac trauma has been recognized as a complication associated with blunt chest trauma involving coronary artery injury, myocardium contusion and myocardial rupture. Secondary cardiac injuries after trauma supposed to be a critical factor in trauma patients, but the mechanism is not fully explored. Overproduction of TNF-alpha had been reported in multiple trauma animals, this induces oxidative stress resulting in cardiac apoptosis. Apoptosis gradually increases after trauma and reaches to a maximum level in 12 h time. TNF-alpha increases the expression of NF kappa B, and induces the expression of caspase-3 and resulted in cell apoptosis. The effect can be attenuated by non-selective caspase inhibitor and IL10. Fas induced cardiac apoptosis and hypertrophy in ischemic heart disease. In this study, we demonstrated a trauma-hemorrhagic shock (THS) model in rats and resuscitated rats by lactated Ringer's (L/R) solution after shock in different hours (0 hour, 4 hours, 8 hours). NF kappa B gradually increased after the first 8 hours of shock, and can be reduced by fluid resuscitation. NF kappa B is known as a downstream pathway of Fas related apoptosis, we found Fas ligand, caspase-8 levels elevate after shock, and can be reduced by resuscitation. In addition, resuscitation can activate insulin-like growth factor (IGF-1)/Akt pathway, at the same time. It can block mitochondrial damage by decrease the effect of tBid. In conclusion, THS can induce secondary cardiac injury. Fas showed to be an important element in caspase cascade induced myocardium apoptosis. By L/R fluid resuscitation, the suppression of caspase cascade and activation of IGF-I/Akt pathway showed antiapoptotic effects in traumatic heart of rats.	[Lin, Kuan-Ho; Wu, Hsi-Chin] China Med Univ, Coll Med, Taichung 40402, Taiwan; [Lin, Kuan-Ho; Chen, Wei-Kung] China Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Liu, Chien-Liang] China Med Univ & Hosp, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Kuo, Wei-Wen; Huang, Chih-Yang] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Paul, Catherine Reena] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Wen, Su-Ying] Taipei City Hosp, Renai Branch, Dept Dermatol, Taipei, Taiwan; [Wen, Su-Ying] Mackay Jr Coll Med Nursing & Management, Ctr Gen Educ, Taipei, Taiwan; [Day, Cecilia Hsuan] MeiHo Univ, Dept Nursing, Pingtung, Taiwan; [Viswanadha, Vijaya Padma] Bharathiar Univ, Dept Biotechnol, Coimbatore 641046, Tamil Nadu, India; [Huang, Chih-Yang] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Taipei City Hospital; Mackay Junior College of Medicine, Nursing & Management; Bharathiar University; China Medical University Taiwan; Asia University Taiwan	Huang, CY (corresponding author), China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan.; Huang, CY (corresponding author), China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan.; Huang, CY (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.	cyhuarig@rnail.cmu.edu.tw	Viswanadha, Vijaya Padma/ABG-4936-2020	Viswanadha, Vijaya Padma/0000-0001-9154-027X	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng SM, 2013, INT J CARDIOL, V167, P478, DOI 10.1016/j.ijcard.2012.01.031; Chou TC, 2014, BIOMEDICINE-TAIWAN, V4, P17, DOI 10.7603/s40681-014-0024-z; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Didwania A, 1997, CRIT CARE MED, V25, P1851, DOI 10.1097/00003246-199711000-00024; El Sayad M, 2014, EMERG MED INT, V2014, DOI 10.1155/2014/638956; Euler G, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00066; Gebhard F, 2008, LANGENBECK ARCH SURG, V393, P825, DOI 10.1007/s00423-008-0334-2; Guan J, 2002, J TRAUMA, V52, P104, DOI 10.1097/00005373-200201000-00018; Hsieh SR, 2014, BIOMEDICINE-TAIWAN, V4, P7, DOI 10.7603/s40681-014-0023-0; Lee P, 2003, AM J PHYSIOL-HEART C, V284, pH456, DOI 10.1152/ajpheart.00777.2002; Lu YQ, 2007, J TRAUMA, V63, P798, DOI 10.1097/TA.0b013e31815202c9; McCunn M, 2000, Curr Opin Anaesthesiol, V13, P147, DOI 10.1097/00001503-200004000-00011; Meldrum DR, 1997, J MOL CELL CARDIOL, V29, P2849, DOI 10.1006/jmcc.1997.0506; Rahbar E, 2015, SHOCK, V44, P417, DOI 10.1097/SHK.0000000000000449; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Shahani R, 2000, AM J PHYSIOL-HEART C, V278, pH942, DOI 10.1152/ajpheart.2000.278.3.H942; Todd SR, 2007, J TRAUMA, V62, P636, DOI 10.1097/TA.0b013e31802ee521; Wilson MH, 2015, LANCET, V386, P2526, DOI 10.1016/S0140-6736(15)00985-X; Wu BU, 2011, CLIN GASTROENTEROL H, V9, P710, DOI 10.1016/j.cgh.2011.04.026; Xu YJ, 2015, INT J CLIN EXP PATHO, V8, P6245	20	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165406	10.1371/journal.pone.0165406	http://dx.doi.org/10.1371/journal.pone.0165406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780234	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900052
J	Tersigni, C; Di Nicuolo, F; Maulucci, G; Rolfo, A; Giuffrida, D; Veglia, M; De Spirito, M; Scambia, G; Todros, T; Di Simone, N				Tersigni, Chiara; Di Nicuolo, Fiorella; Maulucci, Giuseppe; Rolfo, Alessandro; Giuffrida, Domenica; Veglia, Manuela; De Spirito, Marco; Scambia, Giovanni; Todros, Tullia; Di Simone, Nicoletta			Placental Chemokine Receptor D6 Is Functionally Impaired in Pre-Eclampsia	PLOS ONE			English	Article							SCAVENGER RECEPTOR; DECOY; INFLAMMATION; PROTEIN-1; SURFACE; LIGAND; ALPHA; CELLS	Background Pre-eclampsia (PE) is a major cause of maternal and perinatal morbidity and mortality worldwide. It is defined by new onset of hypertension and proteinuria after the 20 th week of gestation and characterized by systemic exaggerated inflammatory response. D6 is a chemokines scavenger receptor that binds with high affinity CC chemokines, internalizes and targets the ligands for degradation. It is expressed in trophoblast-derived tissues and prevents excessive placenta leukocyte infiltration. The aim of this study was to investigate the expression and function of D6 in human placentae from pre-eclamptic and healthy pregnant women. Methods and Results Plasma levels of D6-binding CC chemokines (CCL-2, CCL-3, CCL-4, CCL-7, CCL-11) and pro-inflammatory cytokines (IL-6, TNF-alpha, CRP) were analyzed in 37 healthy pregnant women and 38 patients with PE by multiplex bead assay. Higher circulating levels of CCL7, CCL11, IL-6, (p<0.0001) and CRP (p<0.05) were observed in PE women compared to controls. Levels of circulating CCL4 were decreased in PE (p<0.001), while no significant differences of CCL2, CCL3 or TNF-alpha levels were detected. Immunofluorescent staining of placental sections showed higher expression of D6 receptor in the PE syncytiotrophoblast. Confocal and Western blot (WB) analyses revealed a prevalent distribution of D6 in trophoblast cells membranes in PE. Increased activation of D6 intracellular pathway was observed by Western blot analyses of p-LIMK and p-cofilin in trophoblast cell lysates. D6 functional assays showed reduced scavenging of CCL2 in PE cells compared to controls. Since actin filaments spatial assembling is essential for D6 intracellular trafficking and scavenging activity, we investigated by confocal microscopy trophoblast cytoskeleton organization and we observed a dramatic disarrangement in PE compared to controls. Conclusions our results suggest membrane distribution of D6 receptor on trophoblast cell membranes in PE, together with reduced functionality, probably due to cytoskeleton impairment.	[Tersigni, Chiara; Di Nicuolo, Fiorella; Veglia, Manuela; Scambia, Giovanni; Di Simone, Nicoletta] Univ Cattolica Sacro Cuore, Fdn Policlin Agostino Gemelli, Dept Obstet & Gynaecol, Rome, Italy; [Maulucci, Giuseppe; De Spirito, Marco] Univ Cattolica Sacro Cuore, Inst Phys, Rome, Italy; [Rolfo, Alessandro; Giuffrida, Domenica; Todros, Tullia] Univ Turin, St Anna Hosp, Dept Surg Sci, Turin, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; A.O.U. Citta della Salute e della Scienza di Torino; University of Ferrara; Arcispedale Sant'Anna; University of Turin	Di Simone, N (corresponding author), Univ Cattolica Sacro Cuore, Fdn Policlin Agostino Gemelli, Dept Obstet & Gynaecol, Rome, Italy.	nicoletta.disimone@unicatt.it	Rolfo, Alessandro/L-1089-2019; TERSIGNI, CHIARA/AAB-8388-2022; De Spirito, Marco/U-3817-2019; Maulucci, Giuseppe/C-7400-2009	Rolfo, Alessandro/0000-0001-6730-8067; TERSIGNI, CHIARA/0000-0003-1590-3942; De Spirito, Marco/0000-0003-4260-5107; DI SIMONE, NICOLETTA/0000-0003-1273-3335; Maulucci, Giuseppe/0000-0002-2154-319X	Intesa San Paolo S.P.A. Company, Turin; Italian Government (Ministero dell'Istruzione, dell'Universita e della Ricerca - PRIN) [20085HNE9P]; Carlo Denegri Foundation	Intesa San Paolo S.P.A. Company, Turin; Italian Government (Ministero dell'Istruzione, dell'Universita e della Ricerca - PRIN); Carlo Denegri Foundation	TT e NDS were supported by a Research Grant from Intesa San Paolo S.P.A. Company, Turin and from the Italian Government (Ministero dell'Istruzione, dell'Universita e della Ricerca - PRIN 2008 prot. 20085HNE9P and D1 2012). AR is supported by Carlo Denegri Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by a Research Grant from Intesa Sanpaolo S.P.A. Company, Turin, and from the Italian Government (Ministero dell'Istruzione, dell'Universita e della Ricerca PRIN 2008 and D1 2012).; Alessandro Rolfo is supported by Carlo Denegri Foundation.	American College of Obstetricians and Gynecologists (ACOG), HYP PREGN PRACT GUID; Blackburn PE, 2004, BIOCHEM J, V379, P263, DOI 10.1042/BJ20031266; Bonecchi R, 2004, J IMMUNOL, V172, P4972, DOI 10.4049/jimmunol.172.8.4972; Bonecchi R, 2008, BLOOD, V112, P493, DOI 10.1182/blood-2007-08-108316; Borroni EM, 2009, METHOD ENZYMOL, V460, P231, DOI 10.1016/S0076-6879(09)05211-2; Borroni EM, 2013, SCI SIGNAL, V6, pS1; Cardaropoli S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/639342; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cho Geum Joon, 2015, Obstet Gynecol Sci, V58, P333, DOI 10.5468/ogs.2015.58.5.333; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; Di Simone N, 2000, FERTIL STERIL, V73, P1194, DOI 10.1016/S0015-0282(00)00533-1; Duley L, 2006, BMJ-BRIT MED J, V332, P463, DOI 10.1136/bmj.332.7539.463; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Galbiati S, 2015, CLIN CHEM LAB MED, V53, P1339, DOI 10.1515/cclm-2014-0745; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Ganguly S, 2011, BBA-BIOMEMBRANES, V1808, P1921, DOI 10.1016/j.bbamem.2011.04.001; Hu R, 2007, PLACENTA, V28, P399, DOI 10.1016/j.placenta.2006.07.005; Hunt JS, 2000, SEMIN CELL DEV BIOL, V11, P127, DOI 10.1006/scdb.2000.0158; Kauma S, 2002, OBSTET GYNECOL, V100, P706, DOI 10.1016/S0029-7844(02)02169-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locati M, 2005, CYTOKINE GROWTH F R, V16, P679, DOI 10.1016/j.cytogfr.2005.05.003; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Madigan J, 2010, J IMMUNOL, V184, P3202, DOI 10.4049/jimmunol.0902118; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Maulucci G, 2015, AUTOPHAGY, V11, P1905, DOI 10.1080/15548627.2015.1084455; Maulucci G, 2014, BBA-GEN SUBJECTS, V1840, P2192, DOI 10.1016/j.bbagen.2014.04.005; Mellembakken JR, 2001, THROMB HAEMOSTASIS, V86, P1272; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Murphy PM, 2000, PHARMACOL REV, V52, P145; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nibbs RJB, 1997, J BIOL CHEM, V272, P32078, DOI 10.1074/jbc.272.51.32078; Nibbs RJB, 2001, AM J PATHOL, V158, P867, DOI 10.1016/S0002-9440(10)64035-7; Redman CW, 2014, PLACENTA, V35, pS20, DOI 10.1016/j.placenta.2013.12.008; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Shah TN, 2007, BIOTECHNOL PROGR, V23, P1157, DOI 10.1021/bp0701766; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Yarim GF, 2007, VET RES COMMUN, V31, P565, DOI 10.1007/s11259-007-3551-1	38	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164747	10.1371/journal.pone.0164747	http://dx.doi.org/10.1371/journal.pone.0164747			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780270	gold, Green Published, Green Submitted			2022-12-26	WOS:000389046900016
J	de Souza, LS; Godwin, JC; Renshaw, MA; Larson, E				de Souza, Lesley S.; Godwin, James C.; Renshaw, Mark A.; Larson, Eric			Environmental DNA (eDNA) Detection Probability Is Influenced by Seasonal Activity of Organisms	PLOS ONE			English	Article							FRESH-WATER; BIODIVERSITY; OCCUPANCY; CONSERVATION; TEMPERATURE; OPPORTUNITIES; ABUNDANCE; SCIENCE; DESIGN; TOOL	Environmental DNA (eDNA) holds great promise for conservation applications like the monitoring of invasive or imperiled species, yet this emerging technique requires ongoing testing in order to determine the contexts over which it is effective. For example, little research to date has evaluated how seasonality of organism behavior or activity may influence detection probability of eDNA. We applied eDNA to survey for two highly imperiled species endemic to the upper Black Warrior River basin in Alabama, US: the Black Warrior Water-dog (Necturus alabamensis) and the Flattened Musk Turtle (Sternotherus depressus). Importantly, these species have contrasting patterns of seasonal activity, with N. alabamensis more active in the cool season (October-April) and S. depressus more active in the warm season (May-September). We surveyed sites historically occupied by these species across cool and warm seasons over two years with replicated eDNA water samples, which were analyzed in the laboratory using species-specific quantitative PCR (qPCR) assays. We then used occupancy estimation with detection probability modeling to evaluate both the effects of landscape attributes on organism presence and season of sampling on detection probability of eDNA. Importantly, we found that season strongly affected eDNA detection probability for both species, with N. alabamensis having higher eDNA detection probabilities during the cool season and S. depressus have higher eDNA detection probabilities during the warm season. These results illustrate the influence of organismal behavior or activity on eDNA detection in the environment and identify an important role for basic natural history in designing eDNA monitoring programs.	[de Souza, Lesley S.; Larson, Eric] Univ Illinois, Dept Nat Resources & Environm, Champaign, IL 61820 USA; [de Souza, Lesley S.] Field Museum Nat Hist, Sci & Educ, Chicago, IL 60605 USA; [Godwin, James C.] Auburn Univ, Museum Nat Hist, Alabama Nat Heritage Program, Auburn, AL 36849 USA; [Renshaw, Mark A.] Hawaii Pacific Univ, Ocean Inst, Shrimp Dept, Waimanalo, HI USA	University of Illinois System; University of Illinois Urbana-Champaign; Field Museum of Natural History (Chicago); Auburn University System; Auburn University	de Souza, LS (corresponding author), Univ Illinois, Dept Nat Resources & Environm, Champaign, IL 61820 USA.; de Souza, LS (corresponding author), Field Museum Nat Hist, Sci & Educ, Chicago, IL 60605 USA.	ldesouza@fieldmuseum.org	Larson, Eric R/P-8253-2016	Larson, Eric R/0000-0002-9232-5907; de Souza, Lesley/0000-0002-1669-8074	Alabama Department of Conservation and Natural Resources - Section 6 wildlife grant; U.S. Fish and Wildlife Service; U.S. Forest Service; US Department of Agriculture National Institute of Food and Agriculture Hatch Project [1008988]	Alabama Department of Conservation and Natural Resources - Section 6 wildlife grant; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); US Department of Agriculture National Institute of Food and Agriculture Hatch Project	Support was provided by: Alabama Department of Conservation and Natural Resources - Section 6 wildlife grant; U.S. Fish and Wildlife Service; U.S. Forest Service; and the US Department of Agriculture National Institute of Food and Agriculture Hatch Project 1008988.	Abell R, 2011, CONSERV LETT, V4, P127, DOI 10.1111/j.1755-263X.2010.00153.x; [Anonymous], 2010, SALAMANDERS US CANAD; [Anonymous], 2016, FEDERAL REGISTE 1006; Bailey MA, 2003, CATALOGUE AM AMPHIBI, V761, P1; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Barrett K, 2014, J FISH WILDL MANAG, V5, P282, DOI 10.3996/022014-JFWM-015; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Buhlmann KA, 2009, CHELONIAN CONSERV BI, V8, P116, DOI 10.2744/CCB-0774.1; Bukombe J, 2016, AFR J ECOL, V54, P29, DOI 10.1111/aje.12255; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Canessa S, 2012, BIODIVERS CONSERV, V21, P729, DOI 10.1007/s10531-011-0211-0; Cook RP, 2011, HERPETOL CONSERV BIO, V6, P25; Creer S, 2016, METHODS ECOL EVOL, V7, P1008, DOI 10.1111/2041-210X.12574; Davy CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130965; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; DODD C K JR, 1988, Bulletin of the Florida State Museum Biological Sciences, V34, P1; DODD CK, 1990, BIOL CONSERV, V54, P33; Dodd CK, 2008, CHELONIAN RES MONOGR; Dostine PL, 2013, WILDLIFE RES, V40, P393, DOI 10.1071/WR13057; Duitama J, 2009, NUCLEIC ACIDS RES, V37, P2483, DOI 10.1093/nar/gkp073; Erickson RA, 2016, MOL ECOL RESOUR, V16, P957, DOI 10.1111/1755-0998.12533; Ernst CH, 2009, TURTLES US CANADA; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Guzy JC, 2014, WILDLIFE RES, V41, P243, DOI 10.1071/WR14038; Hanfling B, 2016, MOL ECOL, V25, P3101, DOI 10.1111/mec.13660; Haynes TB, 2013, CAN J FISH AQUAT SCI, V70, P1055, DOI 10.1139/cjfas-2012-0527; Jackson HB, 2015, GLOBAL ECOL BIOGEOGR, V24, P52, DOI 10.1111/geb.12233; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; Leasure DR., 2014, THESIS; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; LYDEARD C, 1995, CONSERV BIOL, V9, P800, DOI 10.1046/j.1523-1739.1995.09040800.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MCARDLE BH, 1990, OIKOS, V57, P276, DOI 10.2307/3565950; Miller DA, 2011, ECOLOGY, V92, P1422, DOI 10.1890/10-1396.1; Minamoto T, 2016, LIMNOLOGY, V17, P23, DOI 10.1007/s10201-015-0457-4; Mittermeier RA, 2015, CHELONIAN CONSERV BI, V14, P2, DOI 10.2744/ccab-14-01-2-10.1; Moreno MCD, 2006, SOUTHEAST NAT, V5, P69; Mount R.H, 1975, REPTILES AMPHIBIANS; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; R Core Team, 2021, R LANGUAGE ENV STAT; Renshaw MA, 2015, MOL ECOL RESOUR, V15, P168, DOI 10.1111/1755-0998.12281; Roussel JM, 2015, J APPL ECOL, V52, P823, DOI 10.1111/1365-2664.12428; Schmelzle MC, 2016, MOL ECOL RESOUR, V16, P895, DOI 10.1111/1755-0998.12501; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Spear SF, 2015, BIOL CONSERV, V183, P38, DOI 10.1016/j.biocon.2014.11.016; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Taylor HR, 2016, TRENDS ECOL EVOL, V31, P171, DOI 10.1016/j.tree.2016.01.002; Tewksbury JJ, 2014, BIOSCIENCE, V64, P300, DOI 10.1093/biosci/biu032; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023	58	67	72	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165273	10.1371/journal.pone.0165273	http://dx.doi.org/10.1371/journal.pone.0165273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776150	Green Submitted, Green Published, gold			2022-12-26	WOS:000389009200053
J	Kato, H; Yamagishi, T; Shimada, T; Matsui, T; Shimojima, M; Saijo, M; Oishi, K				Kato, Hirofumi; Yamagishi, Takuya; Shimada, Tomoe; Matsui, Tamano; Shimojima, Masayuki; Saijo, Masayuki; Oishi, Kazunori		SFTS Epidemiological Res Grp Japa	Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome in Japan, 2013-2014	PLoS One			English	Article							HAEMAPHYSALIS-LONGICORNIS TICKS; SYNDROME VIRUS; SOUTH-KOREA; SYNDROME BUNYAVIRUS; RISK-FACTORS; CHINA; TRANSMISSION; DEATH; IDENTIFICATION; CONTACT	Although severe fever with thrombocytopenia syndrome (SFTS) was first reported from Japan in 2013, the precise clinical features and the risk factors for SFTS have not been fully investigated in Japan. Ninety-six cases of severe fever with thrombocytopenia syndrome (SFTS) were notified through the national surveillance system between April 2013 and September 2014 in Japan. All cases were from western Japan, and 82 cases (85%) had an onset between April and August. A retrospective observational study of the notified SFTS cases was conducted to identify the clinical features and laboratory findings during the same period. Of 96 notified cases, 49 (51%) were included in this study. Most case-patients were of advanced age (median age 78 years) and were retired or unemployed, or farmers. These case-patients had a history of outdoor activity within 2 weeks before the onset of illness. The median serum C-reactive protein concentration was slightly elevated at admission. Fungal infections such as invasive aspergilosis were found in 10% of these case-patients. Hemophagocytosis was observed in 15 of the 18 case-patients (83%) whose bone marrow samples were available. Fifteen cases were fatal, giving a case-fatality proportion of 31%. The proportion of neurological abnormalities and serum concentrations of lactate dehydrogenase and aspartate aminotransferase were significantly higher in the fatal cases than in the nonfatal cases during hospitalization. Appearance of neurological abnormality may be useful for predicting the prognosis in SFTS patients.	[Kato, Hirofumi] Natl Inst Infect Dis, Feild Epidemiol Training Program FETP, Shinju Ku, Tokyo, Japan; [Kato, Hirofumi; Oishi, Kazunori] Tohoku Univ, Grad Sch Med, Div Global Infect Dis, Dept Infect & Epidemiol, Sendai, Miyagi, Japan; [Kato, Hirofumi; Yamagishi, Takuya; Shimada, Tomoe; Matsui, Tamano; Oishi, Kazunori] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinju Ku, Tokyo, Japan; [Shimojima, Masayuki; Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Shinju Ku, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Tohoku University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Oishi, K (corresponding author), Tohoku Univ, Grad Sch Med, Div Global Infect Dis, Dept Infect & Epidemiol, Sendai, Miyagi, Japan.; Oishi, K (corresponding author), Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinju Ku, Tokyo, Japan.	oishik@niid.go.jp	Saijo, Masayuki/L-2697-2019	Saijo, Masayuki/0000-0001-5458-7298	Ministry of Health, Labour and Welfare of Japan [H25-Shinko-Shitei-009]; Japan Agency for Medical Research and Development	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This research was supported by grants for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labour and Welfare of Japan [H25-Shinko-Shitei-009, http://www.mhlw.go.jp/] and the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development [http://www.amed.go.jp/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Cui N, 2014, J CLIN VIROL, V59, P12, DOI 10.1016/j.jcv.2013.10.024; Deng BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080802; Ding F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003267; Fournier PE, 2002, J CLIN MICROBIOL, V40, P2176, DOI 10.1128/JCM.40.6.2176-2181.2002; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Gai ZT, 2012, CLIN INFECT DIS, V54, P249, DOI 10.1093/cid/cir776; Hiraki T, 2014, PATHOL INT, V64, P569, DOI 10.1111/pin.12207; HOOGSTRAAL H, 1968, J PARASITOL, V54, P1197, DOI 10.2307/3276992; Jin C, 2012, P NATL ACAD SCI USA, V109, P10053, DOI 10.1073/pnas.1120246109; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Kim WY, 2015, CLIN INFECT DIS, V60, P1681, DOI 10.1093/cid/civ128; Liu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09679; Liu Q, 2014, LANCET INFECT DIS, V14, P763, DOI 10.1016/S1473-3099(14)70718-2; Luo LM, 2015, EMERG INFECT DIS, V21, P1770, DOI 10.3201/eid2110.150126; Morrissey CO, 2013, LANCET INFECT DIS, V13, P519, DOI 10.1016/S1473-3099(13)70076-8; Ohagi Y, 2014, CASE REP INFECT DIS, V2014, DOI 10.1155/2014/918135; Park SW, 2014, TICKS TICK-BORNE DIS, V5, P975, DOI 10.1016/j.ttbdis.2014.07.020; Saito T, 2015, EMERG INFECT DIS, V21, P487, DOI 10.3201/eid2103.140831; Shin J, 2015, EMERG INFECT DIS, V21, P1704, DOI 10.3201/eid2110.141928; Statistics Bureau Ministry of Internal Affairs and Communication, 2013, CURR POP EST; Sun JM, 2014, INT J INFECT DIS, V25, P180, DOI 10.1016/j.ijid.2014.02.022; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Tang XY, 2013, J INFECT DIS, V207, P736, DOI 10.1093/infdis/jis748; Tani H, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00061-15; United Nations, 2016, WORLD POP PROSP 2012; Weng YL, 2014, BRAZ J INFECT DIS, V18, P88, DOI 10.1016/j.bjid.2013.05.011; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yoshikawa T, 2015, J INFECT DIS, V212, P889, DOI 10.1093/infdis/jiv144; Yoshikawa T, 2014, J CLIN MICROBIOL, V52, P3325, DOI 10.1128/JCM.00742-14; Yu X-J, 2014, NEW ENGL J MED, V364, P1523; Yun SM, 2014, EMERG INFECT DIS, V20, P1358, DOI 10.3201/eid2008.131857	33	96	101	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165207	10.1371/journal.pone.0165207	http://dx.doi.org/10.1371/journal.pone.0165207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776187	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200047
J	Ren, HX; Luo, CM; Feng, YQ; Yao, XL; Shi, Z; Liang, FY; Kang, JX; Wan, JB; Pei, Z; Su, HX				Ren, Huixia; Luo, Chuanming; Feng, Yanqing; Yao, Xiaoli; Shi, Zhe; Liang, Fengyin; Kang, Jing X.; Wan, Jian-Bo; Pei, Zhong; Su, Huanxing			Omega-3 polyunsaturated fatty acids promote amyloid-beta clearance from the brain through mediating the function of the glymphatic system	FASEB JOURNAL			English	Article						extracellular solutes clearance; DHA; perivascular pathways; fish oil; AQP4 polarization	RECEPTOR-RELATED PROTEIN-1; MILD COGNITIVE IMPAIRMENT; DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE; TRANSGENIC MICE; RAT-BRAIN; FISH CONSUMPTION; TAU PATHOLOGY; DOUBLE-BLIND; MOUSE MODEL	Impairment of amyloid-beta (A beta) clearance leads to A beta accumulation in the brain during the development of Alzheimer's disease (AD). Strategies that can restore or improve the clearance function hold great promise in delaying or preventing the onset of AD. Here, we show that n-3 polyunsaturated fatty acids (PUFAs), by use of fat-1 transgenic mice and oral administration of fish oil, significantly promote interstitial A beta clearance from the brain and resist A beta injury. Such beneficial effects were abolished in Aqp4-knockout mice, suggesting that the AQP4-dependent glymphatic system is actively involved in the promoting the effects of n-3 PUFAs on the clearance of extracellular A beta. Imaging on clarified brain tissues clearly displayed that n-3 PUFAs markedly inhibit the activation of astrocytes and protect the AQP4 polarization in the affected brain region after A beta injection. The results of the present study prove a novel mechanism by which n-3 PUFAs exert protective roles in reducing A beta accumulation via mediating the glymphatic system function.-Ren, H., Luo, C., Feng, Y., Yao, X., Shi, Z., Liang, F., Kang, J. X., Wan, J.-B., Pei, Z., Su, H. Omega-3 polyunsaturated fatty acids promote amyloid-b clearance from the brain through mediating the function of the glymphatic system.	[Ren, Huixia; Shi, Zhe; Wan, Jian-Bo; Su, Huanxing] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Macau, Peoples R China; [Luo, Chuanming; Liang, Fengyin] Guangdong Med Univ, Dept Neurol, Clin Med Coll 2, Dongguan, Peoples R China; [Feng, Yanqing; Yao, Xiaoli; Pei, Zhong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Lab Lipid Med & Technol, Boston, MA 02114 USA; [Kang, Jing X.] Harvard Med Sch, Boston, MA USA	University of Macau; Guangdong Medical University; Sun Yat Sen University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Su, HX (corresponding author), Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Macau, Peoples R China.	huanxingsu@umac.mo	Su, Huanxing/X-3980-2019; Liang, Feng/GZK-4305-2022; Liang, Fenghua/HHM-3798-2022; Su, Huanxing/X-3954-2019; Wan, Jian-Bo/D-8368-2014	Su, Huanxing/0000-0002-0513-4943; Su, Huanxing/0000-0003-3254-825X; Wan, Jian-Bo/0000-0002-6750-2617	Macau Science and Technology Development Fund [018/2013/A1, 063/2015/A2]; University of Macau [MYRG122 (Y1-L3)-ICMS12-SHX, MYRG110 (Y1-L2)-ICMS13-SHX]	Macau Science and Technology Development Fund; University of Macau	This study was supported by Macau Science and Technology Development Fund (Grants 018/2013/A1 and 063/2015/A2) and by multiyear research Grants MYRG122 (Y1-L3)-ICMS12-SHX and MYRG110 (Y1-L2)-ICMS13-SHX (University of Macau).	Arsenault D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017397; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Barberger-Gateau P, 2002, BRIT MED J, V325, P932, DOI 10.1136/bmj.325.7370.932; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Broersen LM, 2013, J ALZHEIMERS DIS, V33, P177, DOI 10.3233/JAD-2012-112039; Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Chiu CC, 2008, PROG NEURO-PSYCHOPH, V32, P1538, DOI 10.1016/j.pnpbp.2008.05.015; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Grimm MOW, 2011, J BIOL CHEM, V286, P14028, DOI 10.1074/jbc.M110.182329; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He CW, 2009, P NATL ACAD SCI USA, V106, P11370, DOI 10.1073/pnas.0904835106; Hossain S, 2009, J NEUROCHEM, V111, P568, DOI 10.1111/j.1471-4159.2009.06336.x; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kim HY, 2000, J BIOL CHEM, V275, P35215, DOI 10.1074/jbc.M004446200; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168; Lee LK, 2013, PSYCHOPHARMACOLOGY, V225, P605, DOI 10.1007/s00213-012-2848-0; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Luo CM, 2014, J LIPID RES, V55, P1288, DOI 10.1194/jlr.M046466; Marteinsdottir I, 1998, PROG NEURO-PSYCHOPH, V22, P1007, DOI 10.1016/S0278-5846(98)00052-9; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P1849, DOI 10.1001/archneur.62.12.noc50161; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Nielsen S, 1997, J NEUROSCI, V17, P171; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Orr SK, 2008, CURR OPIN INVEST DR, V9, P735; Perez SE, 2010, J NEUROSCI RES, V88, P1026, DOI 10.1002/jnr.22266; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Potter R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005615; Rashid MA, 2013, J NEUROCHEM, V125, P869, DOI 10.1111/jnc.12255; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Russo I, 2012, J NEUROCHEM, V122, P1181, DOI 10.1111/j.1471-4159.2012.07846.x; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Thal DR, 2008, J CELL MOL MED, V12, P1848, DOI 10.1111/j.1582-4934.2008.00411.x; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142, DOI 10.1093/ajcn/85.4.1142; Willard AM, 2015, ELIFE, V4, DOI 10.7554/eLife.11409; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zheng HY, 2016, BRAIN STRUCT FUNCT, V221, P2375, DOI 10.1007/s00429-015-1020-0; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x; Zlokovic BV, 2000, NAT MED, V6, P718, DOI 10.1038/77397	51	62	66	1	40	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					282	293		10.1096/fj.201600896	http://dx.doi.org/10.1096/fj.201600896			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27789520				2022-12-26	WOS:000392177600027
J	Sun, SH; Zhang, XT; Lyu, L; Li, XX; Yao, SL; Zhang, JJ				Sun, Shuhong; Zhang, Xiaotian; Lyu, Lin; Li, Xixi; Yao, Siliang; Zhang, Junjie			Autotaxin Expression Is Regulated at the Post-transcriptional Level by the RNA-binding Proteins HuR and AUF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOGENIC FACTOR; MESSENGER-RNAS; THP-1 CELLS; ACID; IDENTIFICATION; MOTILITY; TARGET; CARCINOMA; PATHWAYS; SEQUENCE	Autotaxin (ATX) is a key enzyme that converts lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA), a lysophospholipid mediator that regulates cellular activities through its specific G protein-coupled receptors. The ATX-LPA axis plays an important role in various physiological and pathological processes, especially in inflammation and cancer development. Although the transcriptional regulation of ATX has been widely studied, the post-transcriptional regulation of ATX is largely unknown. In this study, we identified conserved adenylate-uridylate (AU)-rich elements in the ATX mRNA 3'-untranslated region (3'UTR). The RNA-binding proteins HuR and AUF1 directly bound to the ATX mRNA 3'UTR and had antagonistic functions in ATX expression. HuR enhanced ATX expression by increasing ATX mRNA stability, whereas AUF1 suppressed ATX expression by promoting ATX mRNA decay. HuR and AUF1 were involved in ATX regulation in Colo320 human colon cancer cells and the LPS-stimulated human monocytic THP-1 cells. HuR knockdown suppressed ATX expression in B16 mouse melanoma cells, leading to inhibition of cell migration. This effect was reversed by AUF1 knockdown to recover ATX expression or by the addition of LPA. These results suggest that the post-transcriptional regulation of ATX expression by HuR and AUF1 modulates cancer cell migration. In summary, we identified HuR and AUF1 as novel post-transcriptional regulators of ATX expression, thereby elucidating a novel mechanism regulating the ATX-LPA axis.	[Sun, Shuhong; Zhang, Xiaotian; Lyu, Lin; Yao, Siliang; Zhang, Junjie] Beijing Normal Univ, Coll Life Sci, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol,Minist Edu, Beijing 100875, Peoples R China; [Li, Xixi] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Zhang, XT; Zhang, JJ (corresponding author), Beijing Normal Univ, Coll Life Sci, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol,Minist Edu, Beijing 100875, Peoples R China.	xiaotianzhang@bnu.edu.cn; jjzhang@bnu.edu.cn		Zhang, Junjie/0000-0001-8809-1485	National Natural Science Foundation of China [31500619, 31470765]; Beijing Normal University [2014NT24]; Key Laboratory of Cell Proliferation and Regulation Biology (Beijing Normal University), Ministry of Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Normal University; Key Laboratory of Cell Proliferation and Regulation Biology (Beijing Normal University), Ministry of Education	This work was supported by Grants 31500619 and 31470765 from the National Natural Science Foundation of China, Grant 2014NT24 from the Young Teacher Fund of Beijing Normal University, and the Open Fund of the Key Laboratory of Cell Proliferation and Regulation Biology (Beijing Normal University), Ministry of Education. The authors declare that they have no conflicts of interest with the contents of this article.	Black EJ, 2004, ONCOGENE, V23, P2357, DOI 10.1038/sj.onc.1207377; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Chang CL, 2008, J BIOMED SCI, V15, P357, DOI 10.1007/s11373-007-9223-x; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Euer N, 2002, ANTICANCER RES, V22, P733; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Farina AR, 2012, FEBS LETT, V586, P3681, DOI 10.1016/j.febslet.2012.08.026; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Grammatikakis I., 2016, WILEY INTERDISCIP RE, DOI [10.1002/wrna.1372, DOI 10.1002/WRNA.1372]; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Li S, 2012, FEBS LETT, V586, P792, DOI 10.1016/j.febslet.2012.01.044; Li S, 2009, BIOCHEM BIOPH RES CO, V378, P264, DOI 10.1016/j.bbrc.2008.11.047; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Moolenaar WH, 2013, BBA-MOL CELL BIOL L, V1831, P13, DOI 10.1016/j.bbalip.2012.09.013; Nabors LB, 2001, CANCER RES, V61, P2154; Nam SW, 2000, ONCOGENE, V19, P241, DOI 10.1038/sj.onc.1203263; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Rubenfeld J, 2006, AM J PHYSIOL-LUNG C, V290, pL66, DOI 10.1152/ajplung.00473.2004; Samadi N, 2011, BIOCHIMIE, V93, P61, DOI 10.1016/j.biochi.2010.08.002; Song JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136629; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Wang L, 2004, CELL SIGNAL, V16, P991, DOI 10.1016/j.cellsig.2004.02.001; Yi XF, 2009, AUST NZ J OBSTET GYN, V49, P93, DOI 10.1111/j.1479-828X.2008.00937.x; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010; Zhu ZP, 2013, TUMOR BIOL, V34, P2299, DOI 10.1007/s13277-013-0774-3; Zucconi B.E., 2013, FRONT BIOSCI, V16, P2307	34	23	24	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25823	25836		10.1074/jbc.M116.756908	http://dx.doi.org/10.1074/jbc.M116.756908			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27784781	Green Published, hybrid			2022-12-26	WOS:000390345200007
J	Alvarez, P; McPhee, CF; Prieto, L; Martin, L; Obiang, J; Avedillo, P; Vargas, A; Rojo, P; Benito, A; Ramos, JT; Holguin, A				Alvarez, Patricia; Fernandez McPhee, Carolina; Prieto, Luis; Martin, Leticia; Obiang, Jacinta; Avedillo, Pedro; Vargas, Antonio; Rojo, Pablo; Benito, Agustin; Tomas Ramos, Jose; Holguin, Africa			HIV-1 Variants and Drug Resistance in Pregnant Women from Bata (Equatorial Guinea): 2012-2013	PLOS ONE			English	Article							NON-B SUBTYPES; TO-CHILD TRANSMISSION; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; TRANSMITTED HIV; GENETIC DIVERSITY; VIRAL LOAD; NAIVE; MUTATIONS; SURVEILLANCE	Objectives This is the first study describing drug resistance mutations (DRM) and HIV-1 variants among infected pregnant women in Equatorial Guinea (GQ), a country with high (6.2%) and increasing HIV prevalence. Methods Dried blood spots (DBS) were collected from November 2012 to December 2013 from 69 HIV-1 infected women participating in a prevention of mother-to-child transmission program in the Hospital Regional of Bata and Primary Health Care Centre Maria a Rafols, Bata, GQ. The transmitted (TDR) or acquired (ADR) antiretroviral drug resistance mutations at partial pol sequence among naive or antiretroviral therapy (ART)-exposed women were defined following WHO or IAS USA 2015 lists, respectively. HIV-1 variants were identified by phylogenetic analyses. Results A total of 38 of 69 HIV-1 specimens were successfully amplified and sequenced. Thirty (79%) belonged to ART-experienced women: 15 exposed to nucleoside reverse transcriptase inhibitors (NRTI) monotherapy, and 15 to combined ART (cART) as first regimen including two NRTI and one non-NRTI (NNRTI) or one protease inhibitor (PI). The TDR rate was only found for PI (3.4%). The ADR rate was 37.5% for NNRTI, 8.7% for NRTI and absent for PI or NRTI+NNRTI. HIV-1 group M non-B variants caused most (97.4%) infections, mainly (78.9%) recombinants: CRF02_AG (55.2%), CRF22_A101 (10.5%), subtype C (10.5%), unique recombinants (5.3%), and A3, D, F2, G, CRF06_cpx and CRF11_cpx (2.6% each). Conclusions The high rate of ADR to retrotranscriptase inhibitors (mainly to NNRTIs) observed among pretreated pregnant women reinforces the importance of systematic DRM monitoring in GQ to reduce HIV-1 resistance transmission and to optimize first and second-line ART regimens when DRM are present.	[Alvarez, Patricia; Martin, Leticia; Holguin, Africa] Hosp Univ Ramon y Cajal, IRYCIS, HIV Mol Epidemiol Lab 1, Dept Microbiol & Parasitol, Madrid, Spain; [Alvarez, Patricia; Martin, Leticia; Holguin, Africa] CIBERESP, Madrid, Spain; [Fernandez McPhee, Carolina] Hosp Univ Gregorio Maranon, Dept Pediat, Madrid, Spain; [Prieto, Luis] Hosp Univ Getafe, Dept Pediat, Madrid, Spain; [Obiang, Jacinta] Minist Sanidad & Bienestar Social, Hosp Reg Bata, Dept Pediat, Bata, Equat Guinea; [Avedillo, Pedro; Vargas, Antonio; Benito, Agustin] RICET, Inst Salud Carlos Madrid 3, Ctr Nacl Med Trop, Madrid, Spain; [Rojo, Pablo] Hosp Univ Doce Octubre, Dept Pediat, Madrid, Spain; [Tomas Ramos, Jose] Hosp Univ Clin San Carlos, Dept Pediat, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; General University Gregorio Maranon Hospital; Hospital Universitario de Getafe; Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Hospital Universitario 12 de Octubre	Holguin, A (corresponding author), Hosp Univ Ramon y Cajal, IRYCIS, HIV Mol Epidemiol Lab 1, Dept Microbiol & Parasitol, Madrid, Spain.; Holguin, A (corresponding author), CIBERESP, Madrid, Spain.	africa.holguin@salud.madrid.org	Prieto, Luis Enrique/HFZ-7903-2022; Holguín, Africa/AAF-9001-2021	Holguín, Africa/0000-0002-1330-8050; Benito, Agustin/0000-0001-8229-5540; vargas, Antonio/0000-0001-6507-1529				Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; Alvarez P, 2014, J VIROL ANTIVIR RES, V3, P2; Alvarez P, 2015, J INFECTION, V71, P368, DOI 10.1016/j.jinf.2015.05.011; Amarakoon II, 2014, W INDIAN MED J, V63, P596, DOI 10.7727/wimj.2014.016; Badillo-Navarro K, 2014, ENFERM INFEC MICR CL, V32, P31, DOI 10.1016/j.eimc.2013.07.003; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bonney E Y, 2013, Ghana Med J, V47, P82; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Bruzzone B, 2015, AIDS RES HUM RETROV, V31, P837, DOI [10.1089/aid.2015.0105, 10.1089/AID.2015.0105]; Cecchini D, 2014, J INT AIDS SOC, V17, P134, DOI 10.7448/IAS.17.4.19704; da Costa ZB, 2013, AIDS PATIENT CARE ST, V27, P439, DOI 10.1089/apc.2012.0448; De Mulder M, 2013, ENFERM INFEC MICR CL, V31, P100, DOI 10.1016/j.eimc.2012.03.008; Djoko CF, 2010, AIDS RES HUM RETROV, V26, P1027, DOI 10.1089/aid.2010.0046; Feucht U, 2012, SAMJ S AFR MED J, V102, P149, DOI 10.7196/SAMJ.4951; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Grossman Z, 2004, ANTIMICROB AGENTS CH, V48, P2159, DOI 10.1128/AAC.48.6.2159-2165.2004; Hauser A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140809; Hemelaar J, 2013, J INFECTION, V66, P391, DOI 10.1016/j.jinf.2012.10.026; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; HIV/AIDS Programme World Health Organization, 2012, WHO HIV DRUG RES REP; Holguin A, 2013, CLIN MICROBIOL INFEC, V19, pE523, DOI 10.1111/1469-0691.12264; Holguin A, 2008, J CLIN MICROBIOL, V46, P2918, DOI 10.1128/JCM.02414-07; Holguin A, 2006, J CLIN VIROL, V36, P264, DOI 10.1016/j.jcv.2006.05.001; Holguin A, 2006, AIDS REV, V8, P98; Imade GE, 2014, AIDS RES HUM RETROV, V30, P127, DOI [10.1089/aid.2013.0074, 10.1089/AID.2013.0074]; Kantor R, 2015, CLIN INFECT DIS, V60, P1541, DOI 10.1093/cid/civ102; Kiptoo M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-517; Larbalestier N, 2003, AIDS, V17, P2665, DOI 10.1097/00002030-200312050-00015; Lima YA, 2016, J MED VIROL IN PRESS; Delicado TL, 2016, J ANTIMICROB CHEMOTH, V71, P362, DOI 10.1093/jac/dkv333; Mackie NE, 2013, AIDS, V27, P2245, DOI 10.1097/QAD.0b013e3283636179; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Ministerio de Sanidad y Bienestar Social de Guinea Ecuatorial, 2009, PROT DIAGN SEG LAB V; Ministerio de Sanidady Bienestar Social Ministerio de Economia Planificacion e Inversiones Publicas ICF International Republica de Guinea Ecuatorial, 2012, ENC DEM SAL EDSGE 1; Moradigaravand D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004439; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Muri L, 2016, AIDS IN PRESS; Mwinga K, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-49; Ortiz M, 2001, AIDS RES HUM RETROV, V17, P851, DOI 10.1089/088922201750252043; Pai NP, 2012, JAIDS-J ACQ IMM DEF, V59, P382, DOI 10.1097/QAI.0b013e31824a0628; Palombi L, 2015, J ANTIMICROB CHEMOTH, V70, P2881, DOI 10.1093/jac/dkv171; Peeters M, 2010, CLIN MICROBIOL INFEC, V16, P1525, DOI 10.1111/j.1469-0691.2010.03300.x; Pernas B, 2014, AIDS, V28, P1837, DOI 10.1097/QAD.0000000000000326; Poveda E, 2008, AIDS, V22, P611, DOI 10.1097/QAD.0b013e3282f51eb9; Prieto L, 2016, ENFERM INFE IN PRESS; Pham QD, 2013, HIV CLIN TRIALS, V14, P34, DOI [10.1410/hct1401-34, 10.1310/hct1401-34]; Ramirez BC, 2008, VIRUS RES, V134, P64, DOI 10.1016/j.virusres.2008.01.007; Republica de Guinea Ecuatorial, 2014, INF NAC PROGR REAL L; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Sagna T, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.26065; Somi GR, 2008, ANTIVIR THER, V13, P77; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Teixeira MD, 2015, INT J STD AIDS, V26, P922, DOI 10.1177/0956462414562477; Vairo F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-439; van de Vijver DAMC, 2005, ANTIVIR THER, V10, pS145; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132; WHO, 2016, GLOB ACT PLAN HIV DR; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2012, WHO MAN HIV DRUG RES; Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010; Yebra G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064293; Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25	65	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165333	10.1371/journal.pone.0165333	http://dx.doi.org/10.1371/journal.pone.0165333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798676	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100027
J	Poimenidou, SV; Chatzithoma, DN; Nychas, GJ; Skandamis, PN				Poimenidou, Sofia V.; Chatzithoma, Danai-Natalia; Nychas, George-John; Skandamis, Panagiotis N.			Adaptive Response of Listeria monocytogenes to Heat, Salinity and Low pH, after Habituation on Cherry Tomatoes and Lettuce Leaves	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACID TOLERANCE; GROWTH TEMPERATURE; FRESH PRODUCE; FOOD SAFETY; SURVIVAL; STRESS; INACTIVATION; SALMONELLA; VEGETABLES	Pathogens found on fresh produce may encounter low temperatures, high acidity and limited nutrient availability. The aim of this study was to evaluate the effect of habituation of Listeria monocytogenes on cherry tomatoes or lettuce leaves on its subsequent response to inhibitory levels of acid, osmotic and heat stress. Habituation was performed by inoculating lettuce coupons, whole cherry tomatoes or tryptic soy broth (TSB) with a three-strains composite of L. monocytogenes, which were further incubated at 5 degrees C for 24 hours or 5 days. Additionally, cells grown overnight in TSB supplemented with 0.6% yeast extract (TSBYE) at 30 degrees C were used as control cells. Following habituation, L. monocytogenes cells were harvested and exposed to: (i) pH 3.5 adjusted with lactic acid, acetic acid or hydrochloric acid (HCl), and pH 1.5 (HCl) for 6 h; (ii) 20% NaCl and (iii) 60 degrees C for 150 s. Results showed that tomato-habituated L. monocytogenes cells were more tolerant (P < 0.05) to acid or osmotic stress than those habituated on lettuce, and habituation on both foods resulted in more stress resistant cells than prior growth in TSB. On the contrary, the highest resistance to heat stress (P < 0.05) was exhibited by the lettuce-habituated L. monocytogenes cells followed by TSB-grown cells at 5 degrees C for 24 h, whereas tomato-habituated cells were highly sensitized. Prolonged starvation on fresh produce (5 days vs. 24 h) increased resistance to osmotic and acid stress, but reduced thermotolerance, regardless of the pre-exposure environment (i.e., tomatoes, lettuce or TSB). These results indicate that L. monocytogenes cells habituated on fresh produce at low temperatures might acquire resistance to subsequent antimicrobial treatments raising important food safety implications.	[Poimenidou, Sofia V.; Chatzithoma, Danai-Natalia; Skandamis, Panagiotis N.] Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Food Qual Control & Hyg, GR-11855 Athens, Greece; [Poimenidou, Sofia V.; Nychas, George-John] Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Food Microbiol & Biotechnol, GR-11855 Athens, Greece	Agricultural University of Athens; Agricultural University of Athens	Skandamis, PN (corresponding author), Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Food Qual Control & Hyg, Iera Odos 75, GR-11855 Athens, Greece.	pskan@aua.gr	Nychas, George-John/B-2734-2009	Nychas, George-John/0000-0002-2673-6425	Greek State Scholarships Foundation (IKY)	Greek State Scholarships Foundation (IKY)	Support was provided by the Greek State Scholarships Foundation (IKY) to Sofia V. Poimenidou (PhD fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 1999, INT J FOOD MICROBIOL, V50, P65, DOI 10.1016/S0168-1605(99)00078-1; Akbas MY, 2007, LETT APPL MICROBIOL, V44, P619, DOI 10.1111/j.1472-765X.2007.02127.x; Albert I, 2005, INT J FOOD MICROBIOL, V100, P197, DOI 10.1016/j.ijfoodmicro.2004.10.016; Bacon RT, 2003, APPL ENVIRON MICROB, V69, P4123, DOI 10.1128/AEM.69.7.4123-4128.2003; Bayles DO, 1996, APPL ENVIRON MICROB, V62, P1116, DOI 10.1128/AEM.62.3.1116-1119.1996; Beales N, 2004, COMPR REV FOOD SCI F, V3, P1, DOI 10.1111/j.1541-4337.2004.tb00057.x; Becker LA, 2000, J BACTERIOL, V182, P7083, DOI 10.1128/JB.182.24.7083-7087.2000; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; BERRANG ME, 1989, J FOOD PROTECT, V52, P702, DOI 10.4315/0362-028X-52.10.702; Beuchat LR, 2004, J FOOD PROTECT, V67, P1238, DOI 10.4315/0362-028X-67.6.1238; Beuchat LR, 1996, J FOOD PROTECT, V59, P204, DOI 10.4315/0362-028X-59.2.204; BEUCHAT LR, 1990, J FOOD SCI, V55, P755, DOI 10.1111/j.1365-2621.1990.tb05222.x; BEUMER RR, 1994, APPL ENVIRON MICROB, V60, P1359, DOI 10.1128/AEM.60.4.1359-1363.1994; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Burgess CM, 2016, INT J FOOD MICROBIOL, V221, P37, DOI 10.1016/j.ijfoodmicro.2015.12.014; Centers for Disease Control and Prevention (CDC), 2015, SURV FOODB DIS OUTBR; Chan YC, 2009, CRIT REV FOOD SCI, V49, P237, DOI 10.1080/10408390701856272; Coroller L, 2006, APPL ENVIRON MICROB, V72, P6493, DOI 10.1128/AEM.00876-06; Doyle MP, 2008, J APPL MICROBIOL, V105, P317, DOI 10.1111/j.1365-2672.2008.03746.x; Dreux N, 2008, J APPL MICROBIOL, V104, P1221, DOI 10.1111/j.1365-2672.2007.03623.x; Ells TC, 2006, INT J FOOD MICROBIOL, V111, P34, DOI 10.1016/j.ijfoodmicro.2006.04.033; Ells TC, 2010, J FOOD PROTECT, V73, P425, DOI 10.4315/0362-028X-73.3.425; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4329; Farber JM, 1998, J FOOD PROTECT, V61, P192, DOI 10.4315/0362-028X-61.2.192; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Ferreira V, 2014, J FOOD PROTECT, V77, P150, DOI 10.4315/0362-028X.JFP-13-150; Fink RC, 2012, APPL ENVIRON MICROB, V78, P1752, DOI 10.1128/AEM.07454-11; Geornaras I, 2006, J FOOD PROTECT, V69, P53, DOI 10.4315/0362-028X-69.1.53; Geornaras I, 2006, FOOD MICROBIOL, V23, P762, DOI 10.1016/j.fm.2006.01.008; Gil MI, 2009, INT J FOOD MICROBIOL, V134, P37, DOI 10.1016/j.ijfoodmicro.2009.05.021; Herbert KC, 2001, MICROBIOL-SGM, V147, P2275, DOI 10.1099/00221287-147-8-2275; Huang YX, 2012, INT J FOOD MICROBIOL, V153, P306, DOI 10.1016/j.ijfoodmicro.2011.11.018; Huang YX, 2011, FOOD CONTROL, V22, P1178, DOI 10.1016/j.foodcont.2011.01.012; Koutsoumanis KP, 2003, APPL ENVIRON MICROB, V69, P7514, DOI 10.1128/AEM.69.12.7514-7516.2003; Lang MM, 2004, J FOOD PROTECT, V67, P1092, DOI 10.4315/0362-028X-67.6.1092; Lianou A, 2007, J FOOD PROTECT, V70, P2172, DOI 10.4315/0362-028X-70.9.2172; Lianou A, 2013, INT J FOOD MICROBIOL, V167, P310, DOI 10.1016/j.ijfoodmicro.2013.09.016; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lou WQ, 1996, J FOOD PROTECT, V59, P465, DOI 10.4315/0362-028X-59.5.465; Lou YQ, 1997, APPL ENVIRON MICROB, V63, P1252, DOI 10.1128/AEM.63.4.1252-1255.1997; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; Miller AJ, 2000, APPL ENVIRON MICROB, V66, P4345, DOI 10.1128/AEM.66.10.4345-4350.2000; Moorhead SM, 2004, INT J FOOD MICROBIOL, V91, P63, DOI 10.1016/S0168-1605(03)00332-5; ODriscoll B, 1996, APPL ENVIRON MICROB, V62, P1693, DOI 10.1128/AEM.62.5.1693-1698.1996; Olaimat AN, 2012, FOOD MICROBIOL, V32, P1, DOI 10.1016/j.fm.2012.04.016; Phan-Thanh L, 1998, J GEN APPL MICROBIOL, V44, P183, DOI 10.2323/jgam.44.183; Poimenidou S, 2009, APPL ENVIRON MICROB, V75, P7182, DOI 10.1128/AEM.01359-09; Poimenidou SV, 2016, INT J FOOD MICROBIOL, V237, P164, DOI 10.1016/j.ijfoodmicro.2016.08.029; Rieu A, 2010, J APPL MICROBIOL, V108, P560, DOI 10.1111/j.1365-2672.2009.04463.x; Sant'Ana AS, 2012, INT J FOOD MICROBIOL, V157, P52, DOI 10.1016/j.ijfoodmicro.2012.04.011; Shan Y, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00373; Shi JX, 1997, FOOD RES INT, V30, P669, DOI 10.1016/S0963-9969(98)00031-3; Skandamis PN, 2008, FOOD MICROBIOL, V25, P294, DOI 10.1016/j.fm.2007.10.008; Sleator RD, 2003, J APPL MICROBIOL, V95, P839, DOI 10.1046/j.1365-2672.2003.02056.x; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; SMITH JL, 1991, J FOOD PROTECT, V54, P166, DOI 10.4315/0362-028X-54.3.166; Takeuchi K, 2000, J FOOD PROTECT, V63, P1433, DOI 10.4315/0362-028X-63.10.1433; Tasara T, 2006, J FOOD PROTECT, V69, P1473, DOI 10.4315/0362-028X-69.6.1473; Vasseur C, 1999, J APPL MICROBIOL, V86, P469, DOI 10.1046/j.1365-2672.1999.00686.x	59	23	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165746	10.1371/journal.pone.0165746	http://dx.doi.org/10.1371/journal.pone.0165746			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798688	Green Submitted, Green Published, gold			2022-12-26	WOS:000386711100060
J	Tokuno, M; Taguchi, K; Yamasaki, K; Sakai, H; Otagiri, M				Tokuno, Masahiro; Taguchi, Kazuaki; Yamasaki, Keishi; Sakai, Hiromi; Otagiri, Masaki			Long-Term Stored Hemoglobin-Vesicles, a Cellular Type of Hemoglobin-Based Oxygen Carrier, Has Resuscitative Effects Comparable to That for Fresh Red Blood Cells in a Rat Model with Massive Hemorrhage without Post-Transfusion Lung Injury	PLOS ONE			English	Article							ANESTHETIZED RATS; TRAUMA-HEMORRHAGE; HEAT-TREATMENT; TRANSFUSION; SHOCK; PRESERVATION; INFUSION; STORAGE; FLUID; MICE	Hemoglobin-vesicles (HbV), encapsulating highly concentrated human hemoglobin in liposomes, were developed as a substitute for red blood cells (RBC) and their safety and efficacy in transfusion therapy has been confirmed in previous studies. Although HbV suspensions are structurally and physicochemically stabile for least 1-year at room temperature, based on in vitro experiments, the issue of whether the use of long-term stored HbV after a massive hemorrhage can be effective in resuscitations without adverse, post-transfusion effects remains to be clarified. We report herein on a comparison of the systemic response and the induction of organ injuries in hemorrhagic shock model rats resuscitated using 1-year-stored HbV, freshly packed RBC (PRBC-0) and by 28-day-stored packed RBC (PRBC-28). The six-hour mortality after resuscitation was not significantly different among the groups. Arterial blood pressure and blood gas parameters revealed that, using HbV, recovery from the shock state was comparable to that when PRBC-0 was used. Although no significant change was observed in serum parameters reflecting liver and kidney injuries at 6 hours after resuscitation among the three resuscitation groups, results based on Evans Blue and protein leakage in bronchoalveolar lavage fluid, the lung wet/dry weight ratio and histopathological findings indicated that HbV as well as PRBC-0 was less predisposed to result in a post-transfusion lung injury than PRBC-28, as evidenced by low levels of myeloperoxidase accumulation and subsequent oxidative damage in the lung. The findings reported herein indicate that 1-year-stored HbV can effectively function as a resuscitative fluid without the induction of post-transfused lung injury and that it is comparable to fresh PRBC, suggesting that HbV is a promising RBC substitute with a long shelf-life.	[Tokuno, Masahiro; Taguchi, Kazuaki; Yamasaki, Keishi; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto, Japan; [Yamasaki, Keishi; Otagiri, Masaki] Sojo Univ, DDS Res Inst, Kumamoto, Japan; [Sakai, Hiromi] Nara Med Univ, Dept Chem, Nara, Japan	Sojo University; Sojo University; Nara Medical University	Otagiri, M (corresponding author), Sojo Univ, Fac Pharmaceut Sci, Kumamoto, Japan.; Otagiri, M (corresponding author), Sojo Univ, DDS Res Inst, Kumamoto, Japan.	otagirim@ph.sojo-u.ac.jp	Sakai, Hiromi/J-2529-2019	Sakai, Hiromi/0000-0002-0681-3032; Yamasaki, Keishi/0000-0003-0537-2367	Ministry of Health, Labor and Welfare of Japan [H24-SOUYAKUSOUGOU-IPPAN-009]; Japan Society for the Promotion of Science (JSPS) (KAKENHI) [26860121]; Grants-in-Aid for Scientific Research [26860121] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by Health Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan (H24-SOUYAKUSOUGOU-IPPAN-009 to HS and MO) and by a Grant-in-Aid for Young Scientist (B) from the Japan Society for the Promotion of Science (JSPS) (KAKENHI 26860121 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2001, ARTIF CELL BLOOD SUB, V29, P381, DOI 10.1081/BIO-100106921; Allan PF, 2011, MIL MED, V176, P332, DOI 10.7205/MILMED-D-10-00272; Araki J, 2015, TRANSPLANTATION, V99, P687, DOI 10.1097/TP.0000000000000528; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Flegel WA, 2014, BRIT J HAEMATOL, V165, P3, DOI 10.1111/bjh.12747; Fujihara M, 2014, ARTIF ORGANS, V38, P234, DOI 10.1111/aor.12148; Kelher MR, 2009, BLOOD, V113, P2079, DOI 10.1182/blood-2008-09-177857; Li H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15271; Maeshima K, 2005, BIOCHEM PHARMACOL, V69, P1667, DOI 10.1016/j.bcp.2005.03.007; Ministry of Health LaW Japan, P BLOOD DON PROM COM; Murakami K, 2002, SHOCK, V18, P236, DOI 10.1097/00024382-200209000-00006; Nagao S, 2016, J CONTROL RELEASE, V234, P49, DOI 10.1016/j.jconrel.2016.05.016; Nagao S, 2014, BIOMATERIALS, V35, P6553, DOI 10.1016/j.biomaterials.2014.04.049; Nicholson SE, 2011, J TRAUMA, V70, P466, DOI 10.1097/TA.0b013e3182032584; Obrador R, 2015, J VET EMERG CRIT CAR, V25, P187, DOI 10.1111/vec.12252; Ogaki S, 2014, J PHARM SCI-US, V103, P2199, DOI 10.1002/jps.24029; SAKAI H, 1993, PROTEIN EXPRES PURIF, V4, P563, DOI 10.1006/prep.1993.1074; Sakai H, 1997, BIOCONJUGATE CHEM, V8, P23, DOI 10.1021/bc960069p; Sakai H, 2000, BIOCONJUGATE CHEM, V11, P425, DOI 10.1021/bc990173h; Sakai H, 2004, BIOMATERIALS, V25, P4317, DOI 10.1016/j.biomaterials.2003.11.005; Sakai H, 2004, CRIT CARE MED, V32, P539, DOI 10.1097/01.CCM.0000109774.99665.22; Sakai H, 2001, AM J PATHOL, V159, P1079, DOI 10.1016/S0002-9440(10)61783-X; Sakai H, 2007, ARTIF CELL BLOOD SUB, V35, P81, DOI 10.1080/10731190600974582; Sakai H, 2009, SHOCK, V31, P192, DOI 10.1097/SHK.0b013e31817d4066; Sakai H, 2009, ARTIF ORGANS, V33, P139, DOI 10.1111/j.1525-1594.2008.00698.x; Seishi Y, 2012, SHOCK, V38, P153, DOI 10.1097/SHK.0b013e31825ad7cf; Shaz BH, 2011, BLOOD, V117, P1463, DOI 10.1182/blood-2010-04-278135; Silliman CC, 1997, TRANSFUSION, V37, P719, DOI 10.1046/j.1537-2995.1997.37797369448.x; Silliman CC, 2009, BLOOD REV, V23, P245, DOI 10.1016/j.blre.2009.07.005; Sparrow RL, 2015, TRANSFUS MED REV, V29, P120, DOI 10.1016/j.tmrv.2014.09.007; Stapley R, 2015, FREE RADICAL BIO MED, V85, P207, DOI 10.1016/j.freeradbiomed.2015.04.025; Taguchi K, 2015, BIOL PHARM BULL, V38, P1606, DOI 10.1248/bpb.b15-00420; Taguchi K, 2010, TOXICOL APPL PHARM, V248, P234, DOI 10.1016/j.taap.2010.08.006; Taguchi K, 2009, DRUG METAB DISPOS, V37, P1456, DOI 10.1124/dmd.109.027094	34	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165557	10.1371/journal.pone.0165557	http://dx.doi.org/10.1371/journal.pone.0165557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798697	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100044
J	Gerlach, C; Klargaard, SK; Starrfelt, R				Gerlach, Christian; Klargaard, Solja K.; Starrfelt, Randi			On the Relation between Face and Object Recognition in Developmental Prosopagnosia: No Dissociation but a Systematic Association	PLOS ONE			English	Article							PERCEPTUAL DIFFERENTIATION; DOMAIN SPECIFICITY; MEMORY TEST; INDIVIDUALS; KNOWLEDGE; AGNOSIA	There is an ongoing debate about whether face recognition and object recognition constitute separate domains. Clarification of this issue can have important theoretical implications as face recognition is often used as a prime example of domain-specificity in mind and brain. An important source of input to this debate comes from studies of individuals with developmental prosopagnosia, suggesting that face recognition can be selectively impaired. We put the selectivity hypothesis to test by assessing the performance of 10 individuals with developmental prosopagnosia on demanding tests of visual object processing involving both regular and degraded drawings. None of the individuals exhibited a clear dissociation between face and object recognition, and as a group they were significantly more affected by degradation of objects than control participants. Importantly, we also find positive correlations between the severity of the face recognition impairment and the degree of impaired performance with degraded objects. This suggests that the face and object deficits are systematically related rather than coincidental. We conclude that at present, there is no strong evidence in the literature on developmental prosopagnosia supporting domain-specific accounts of face recognition.	[Gerlach, Christian; Klargaard, Solja K.] Univ Southern Denmark, Dept Psychol, Odense, Denmark; [Starrfelt, Randi] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen	Gerlach, C (corresponding author), Univ Southern Denmark, Dept Psychol, Odense, Denmark.	cgerlach@health.sdu.dk	Starrfelt, Randi/O-1124-2016	Starrfelt, Randi/0000-0002-5849-5160; Gerlach, Christian/0000-0003-1261-4889	Danish Research Council for the Humanities [DFF - 4001-00115]	Danish Research Council for the Humanities	This work was supported by a grant from the Danish Research Council for the Humanities (DFF - 4001-00115). This funding agency had no role in designing or conducting the study, in writing the report, or in deciding to submit the paper for publication.	Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Behrmann M, 2005, J COGNITIVE NEUROSCI, V17, P1130, DOI 10.1162/0898929054475154; Bowles DC, 2009, COGN NEUROPSYCHOL, V26, P423, DOI 10.1080/02643290903343149; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P4057, DOI 10.1016/j.neuropsychologia.2010.09.017; Caramazza A, 2006, COGN NEUROPSYCHOL, V23, P13, DOI 10.1080/02643290542000021; CARAMAZZA A, 1986, BRAIN COGNITION, V5, P41, DOI 10.1016/0278-2626(86)90061-8; Collins HR, 2012, J COGNITIVE NEUROSCI, V24, P2428, DOI 10.1162/jocn_a_00273; Crawford JR, 2011, CORTEX, V47, P1166, DOI 10.1016/j.cortex.2011.02.017; Crawford JR, 2010, COGN NEUROPSYCHOL, V27, P245, DOI 10.1080/02643294.2010.513967; Crawford JR, 2003, CORTEX, V39, P357, DOI 10.1016/S0010-9452(08)70117-5; DAMASIO AR, 1990, TRENDS NEUROSCI, V13, P95, DOI 10.1016/0166-2236(90)90184-C; Dennett HW, 2012, BEHAV RES METHODS, V44, P587, DOI 10.3758/s13428-011-0160-2; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Duchaine B, 2011, OXFORD HDB FACE PERC, P821; Duchaine B, 2007, COGN NEUROPSYCHOL, V24, P419, DOI 10.1080/02643290701380491; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Freeman P, FACES EMOTION QUESTI; Garrido L, 2008, J NEUROPSYCHOL, V2, P119, DOI 10.1348/174866407X246843; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Gazzaniga M.l.S., 2015, COGNITIVE NEUROSCIEN, Vfifth; Gerlach C, 1999, BRAIN, V122, P2159, DOI 10.1093/brain/122.11.2159; Gerlach C, 2005, VIS COGN, V12, P1409, DOI 10.1080/13506280444000751; Gerlach C, 2001, NEUROPSYCHOLOGIA, V39, P895, DOI 10.1016/S0028-3932(01)00031-8; Gerlach C, 2011, VIS COGN, V19, P1262, DOI 10.1080/13506285.2011.630044; Goffaux V, 2005, PERCEPTION, V34, P77, DOI 10.1068/p5370; Joseph JE, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01165; Laws KR, 2005, CORTEX, V41, P842, DOI 10.1016/S0010-9452(08)70303-4; LloydJones TJ, 1997, MEM COGNITION, V25, P18, DOI 10.3758/BF03197282; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; MCCONACHIE HR, 1976, CORTEX, V12, P76, DOI 10.1016/S0010-9452(76)80033-0; McKone E, 2011, OXFORD HDB FACE PERC, P149, DOI [DOI 10.1093/OXFORDHB/9780199559053.013.0009, 10.1093/oxfordhb/9780199559053.013.0009]; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; NACHSON I, 1995, J CLIN EXP NEUROPSYC, V17, P256, DOI 10.1080/01688639508405122; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Starrfelt R, 2010, CORTEX, V46, P242, DOI 10.1016/j.cortex.2009.03.013; Tanaka J.W., 2011, OXFORD HDB FACE PERC, P177, DOI [DOI 10.1093/OXFORDHB/9780199559053.013.0010, 10.1093/oxfordhb/9780199559053.013.0010]; Zhang J, 2005, PSYCHOMETRIKA, V70, P203, DOI 10.1007/s11336-003-1119-8	39	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165561	10.1371/journal.pone.0165561	http://dx.doi.org/10.1371/journal.pone.0165561			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3YA	27792780	Green Published, Green Submitted, gold			2022-12-26	WOS:000389537000030
J	Seo, MG; Lee, SH; Ouh, IO; Lee, GH; Goo, YK; Kim, S; Kwon, OD; Kwak, D				Seo, Min-Goo; Lee, Seung-Hun; Ouh, In-Ohk; Lee, Gwang Hyeop; Goo, Youn-Kyoung; Kim, Seungjoon; Kwon, Oh-Deog; Kwak, Dongmi			Molecular Detection and Genotyping of Coxiella-Like Endosymbionts in Ticks that Infest Horses in South Korea	PLOS ONE			English	Article							Q-FEVER; TRANSMISSION; PREVALENCE	Members of the genus Coxiella can be transmitted from ticks to humans during contact with animals; Coxiella may thus spread from the infected horses or ticks to humans. In this study, the presence of Coxiella burnetii and Coxiella-like endosymbionts (CLE) in ticks found on infested horses was determined using PCR and genotyping. A total of 213 ticks were randomly collected from 51 horses (4-5 ticks per horse) raised on Jeju Island, Korea, between 2009 and 2013. All ticks were morphologically identified as adult Haemaphysalis longicornis, a predominant tick species widespread in Korea. Based on the results of nested PCR and 16S rRNA sequencing, CLE were detected in 121 (52.4%, 95% CI: 45.9-58.8) ticks. CLE 16S rRNA sequences from 9 randomly selected ticks were 100% identical. Phylogenetic analysis showed that these 9 sequences were highly similar (97.9-100%) to the sequences of clade B species, like the CLE previously described to be found in Haemaphysalis spp. This study showed that CLE are prevalent in ticks that infest horses reared on Jeju Island, and this is, to the best of our knowledge, the first study to describe CLE occurrence in ticks infesting animals reared in Korea. Because of the high prevalence of CLE in ticks found on horses, CLE transmission from ticks to other animals and humans remains a possibility. This warrants a detailed study of other hosts and regions. Considering the zoonotic potential of Coxiella, further strategic surveillance of Coxiella transmission is necessary.	[Seo, Min-Goo; Lee, Seung-Hun; Kim, Seungjoon; Kwon, Oh-Deog; Kwak, Dongmi] Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea; [Seo, Min-Goo; Ouh, In-Ohk] Anim & Plant Quarantine Agcy, Gimcheon, South Korea; [Lee, Gwang Hyeop] Seowon Equine Clin, Jeju, South Korea; [Goo, Youn-Kyoung] Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Daegu, South Korea; [Kwak, Dongmi] Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea	Kyungpook National University; Animal & Plant Quarantine Agency; Kyungpook National University; Kyungpook National University	Kwak, D (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea.; Kwak, D (corresponding author), Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea.	dmkwak@knu.ac.kr		Seo, Min-Goo/0000-0003-1752-5105; Kwak, Dongmi/0000-0003-0876-3179	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2013102]; Seowon Equine Clinic	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); Seowon Equine Clinic	This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant No. NRF-2013R1A1A2013102). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Seowon Equine Clinic provided support in the form of salary for author GHL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	[Anonymous], 1980, Med J Aust, V2, P3; Arthan W, 2015, TICKS TICK-BORNE DIS, V6, P63, DOI 10.1016/j.ttbdis.2014.09.005; Barandika JF, 2008, VECTOR-BORNE ZOONOT, V8, P829, DOI 10.1089/vbz.2008.0023; Barker SC, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P1, DOI 10.1017/CBO9780511551802.002; BEAMAN MH, 1989, AUST NZ J MED, V19, P254, DOI 10.1111/j.1445-5994.1989.tb00258.x; Duron O, 2015, TRENDS PARASITOL, V31, P536, DOI 10.1016/j.pt.2015.06.014; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Klyachko O, 2007, APPL ENVIRON MICROB, V73, P6584, DOI 10.1128/AEM.00537-07; Lee JH, 2004, MICROBIOL IMMUNOL, V48, P125, DOI 10.1111/j.1348-0421.2004.tb03498.x; Lee SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156727; Lee SH, 2014, J VET MED SCI, V76, P1663, DOI 10.1292/jvms.14-0353; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Ministry of Agriculture Food and Rural Affairs South Korea, 2015, REP FACT FIND SURV H; Muramatsu Y, 2014, SE ASIAN J TROP MED, V45, P1167; Nett RJ, 2012, CASE REP INFECT DIS, V2012, DOI 10.1155/2012/916142; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Reiczigel J, 2010, EPIDEMIOL INFECT, V138, P1674, DOI 10.1017/S0950268810000385; Seo MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156710; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan CK, 2000, DIS AQUAT ORGAN, V41, P115, DOI 10.3354/dao041115; Tozer SJ, 2014, ZOONOSES PUBLIC HLTH, V61, P105, DOI 10.1111/zph.12051	24	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165784	10.1371/journal.pone.0165784	http://dx.doi.org/10.1371/journal.pone.0165784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792764	Green Published, Green Submitted, gold			2022-12-26	WOS:000389537000050
J	von Dohren, J				von Dohren, Jorn			Development of the Nervous System of Carinina ochracea (Palaeonemer-tea, Nemertea)	PLOS ONE			English	Article							RIBBON WORM RELATIONSHIPS; PILIDIUM LARVA; PHYLOGENY; SEROTONIN; NEUROGENESIS; EXPRESSION; EVOLUTION; EPIDERMIS; MOLLUSCA; CELLS	The various clades of Lophotrochozoa possess highly disparate adult morphologies. Most of them, including Nemertea (ribbon worms), are postulated to develop via a pelagic larva of the trochophora type, which is regarded as plesiomorphic in Lophotrochozoa. With respect to the nervous system, the trochophora larva displays a set of stereotypic features, including an apical organ and trochal neurites, both of which are lost at the onset of metamorphosis. In the investigated larvae of Nemertea, the nervous system is somewhat divergent from the postulated hypothetical trochophore-like pattern. Moreover, no detailed data is available for the "hidden" trochophore larva, the hypothetical ancestral larval type of palaeonemertean species. Therefore, the development of the nervous system in the larva of Carinina ochracea, a basally branching palaeonemertean species, was studied by means of immunofluorescence and confocal laserscanning microscopy. Like in the other investigated nemertean larvae, the prospective adult central nervous system in C. ochracea develops in an anterior to posterior direction, as an anterior brain with paired longitudinal nerve cords. Thus, development of the adult nervous system in Nemertea is largely congruent with currently accepted hypotheses of nervous system development in Spiralia. In early development, transitory apical, serotonin-like immunoreactive flask-shaped cells are initially present, but the trochal neurites that have been considered as pivotal to lophotrochozoan development, are absent. In the light of the above stated hypothesis, trochal neurites have to be interpreted as reduced in Nemertea. On the other hand, due to the unsettled systematic status of Palaeonemertea, more comparative data are desirable to answer the remaining questions regarding the evolution of nervous system development in Nemertea.	[von Dohren, Jorn] Univ Bonn, Inst Evolutionary Biol & Ecol, Bonn, Germany	University of Bonn	von Dohren, J (corresponding author), Univ Bonn, Inst Evolutionary Biol & Ecol, Bonn, Germany.	jdoehren@evolution.uni-bonn.de						Andrade SCS, 2014, MOL BIOL EVOL, V31, P3206, DOI 10.1093/molbev/msu253; Andrade SCS, 2012, CLADISTICS, V28, P141, DOI 10.1111/j.1096-0031.2011.00376.x; Beckers P, 2015, STRUCTURE EVOLUTION; Beckers P., 2011, NEMERTEAN NERVOUS SY; Beckers P, 2015, ZOOL SCI, V32, P531, DOI 10.2108/zs140270; Beckers P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066137; Burger O, 1895, FAUNA FLORA GOLFES N; CANTELL CE, 1967, ARK ZOOL, V18, P489; Chernyshev A V, 2010, Dokl Biol Sci, V430, P48; Dickinson AJG, 2000, BIOL BULL-US, V199, P305, DOI 10.2307/1543187; Dunn CW, 2014, ANNU REV ECOL EVOL S, V45, P371, DOI 10.1146/annurev-ecolsys-120213-091627; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GIBSON R, 1995, J NAT HIST, V29, P271, DOI 10.1080/00222939500770161; Gibson R, 1972, NEMERTEANS; Giribet G, 2016, ORG DIVERS EVOL, V16, P419, DOI 10.1007/s13127-015-0236-4; Haszprunar G., 1996, ORIGIN EVOLUTIONARY, P3; HAYSCHMIDT A, 1990, ZOOMORPHOLOGY, V109, P231, DOI 10.1007/BF00312190; Hejnol A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0045; Helm C, 2014, ZOOMORPHOLOGY, P1; Hessling R, 2003, HYDROBIOLOGIA, V496, P225, DOI 10.1023/A:1026153016913; Hiebert LS, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0021-7; Hiebert LS, 2010, J NAT HIST, V44, P2331, DOI 10.1080/00222933.2010.504893; Hindinger S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-31; JACOB MH, 1984, J NEUROSCI, V4, P1225; Kajihara Hiroshi, 2008, Species Diversity, V13, P245; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Kristof A, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-5; Kvist S, 2015, HYDROBIOLOGIA, V760, P105, DOI 10.1007/s10750-015-2310-5; Kvist Sebastian, 2014, Invertebrate Systematics, V28, P287; Laumer CE, 2015, CURR BIOL, V25, P2000, DOI 10.1016/j.cub.2015.06.068; Marlow H, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-7; Maslakova SA, 2004, EVOL DEV, V6, P219, DOI 10.1111/j.1525-142X.2004.04027.x; Maslakova SA, 2014, INT J DEV BIOL, V58, P585, DOI 10.1387/ijdb.140090sm; Maslakova SA, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-30; Maslakova SA, 2010, INTEGR COMP BIOL, V50, P734, DOI 10.1093/icb/icq096; Maslakova SA, 2009, BIOL BULL-US, V216, P273, DOI 10.2307/25548160; Muller MC, 1999, NERVENSYSTEM POLYCHA; Nemertini Friedrich H., 1979, MORPHOGENESE TIERE E; Neves RC, 2010, INVERTEBR BIOL, V129, P17, DOI 10.1111/j.1744-7410.2010.00187.x; Nielsen C, 2015, J EXP BIOL, V218, P629, DOI 10.1242/jeb.109603; Nielsen C, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-171; Norenburg Jon L., 2002, P163; Okusu A, 2002, BIOL BULL-US, V203, P87, DOI 10.2307/1543461; PAGE LR, 1992, BIOL BULL, V182, P348, DOI 10.2307/1542255; Redl E, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-48; Richter S., 2015, STRUCTURE EVOLUTION, P313; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt-Rhaesa A, 2015, STRUCTURE EVOLUTION; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Struck TH, 2014, MOL BIOL EVOL, P1, DOI [10.1093/molbev/msu143, DOI 10.1093/M0LBEV/MSU143]; Thollesson M, 2003, P ROY SOC B-BIOL SCI, V270, P407, DOI 10.1098/rspb.2002.2254; Turbeville J.M., 1991, P285; von Dohren J, 2008, PHYLOGENIE NEMERTEA; von Dohren J, 2015, EVOLUTIONARY DEVELOP, P155, DOI DOI 10.1007/978-3-7091-1871-9_8; von Dohren J, HELGOL MAR RES; Wanninger A, 2008, ACTA BIOL HUNG, V59, P127, DOI 10.1556/ABiol.59.2008.Suppl.21; Wanninger A., 2007, MODERN RES ED TOPICS, P353; Wanninger A., 2015, FRONT ECOL EVOL, V3, P1, DOI DOI 10.3389/FEV0.2015.00054; Wanninger A, 2009, BIOL BULL-US, V216, P293	60	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165649	10.1371/journal.pone.0165649	http://dx.doi.org/10.1371/journal.pone.0165649			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792762	Green Published, gold			2022-12-26	WOS:000389537000041
J	Koire, A; Gilbert, BE; Sucgang, R; Zechiedrich, L				Koire, Amanda; Gilbert, Brian E.; Sucgang, Richard; Zechiedrich, Lynn			Repurposed Transcriptomic Data Reveal Small Viral RNA Produced by Influenza Virus during Infection in Mice	PLoS One			English	Article							A VIRUSES; RESOURCE; GENES; CYCLE	Influenza virus, a highly infectious ssRNA virus, replicates in the nucleus of host cells. This unusual feature brings the possibility that the virus may hijack host small noncoding RNA metabolism. Influenza small viral RNA production has been examined in vitro but has not yet been studied in an in vivo setting. We assessed small RNA species from influenza virus during mouse infection by mining publicly available mouse small RNA transcriptome data. We uncovered 26 nt reads corresponding to svRNA, a small viral RNA previously detected in vitro that regulates the transition from transcription to replication during infection, and found a strong positive correlation between svRNA production and host susceptibility to influenza virus infection. We also detected significant overrepresentation of a non-coding 23 nt sequence that we speculate may behave like a miRNA and work with influenza protein NS1 to prevent the transcription and maturation of interferon-stimulated mRNAs.	[Koire, Amanda; Zechiedrich, Lynn] Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Gilbert, Brian E.; Zechiedrich, Lynn] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Sucgang, Richard; Zechiedrich, Lynn] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Zechiedrich, Lynn] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zechiedrich, L (corresponding author), Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Zechiedrich, L (corresponding author), Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.	elz@bcm.edu	Zechiedrich, Elizabeth Lynn/S-4720-2019	Bakkalbasi, Erol/0000-0003-1289-9853; Zechiedrich, Lynn/0000-0003-0533-1637	Baylor Research Advocates for Student Scientists; National Institutes of Health [R01AI054830, R56 AI054830, R01GM115501]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115501] Funding Source: NIH RePORTER	Baylor Research Advocates for Student Scientists; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.K. is supported by the Baylor Research Advocates for Student Scientists. This work was supported by National Institutes of Health grants R01AI054830, R56 AI054830, and R01GM115501 to L.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Yehuda S, 2000, GENETICS, V154, P61; Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196; Furuse Y, 2011, INFECT GENET EVOL, V11, P1150, DOI 10.1016/j.meegid.2011.04.006; Hutchinson EC, 2009, VACCINE, V27, P6270, DOI 10.1016/j.vaccine.2009.05.053; Kanellos I, 2014, SSDBM, V47, DOI [10.1145/2618243.2618289, DOI 10.1145/2618243.2618289]; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LU Y, 1994, GENE DEV, V8, P1817, DOI 10.1101/gad.8.15.1817; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Ni ZY, 2014, NAT STRUCT MOL BIOL, V21, P686, DOI 10.1038/nsmb.2853; Peng XX, 2011, MBIO, V2, DOI 10.1128/mBio.00198-11; Peng XX, 2010, MBIO, V1, DOI 10.1128/mBio.00206-10; Perez JT, 2012, J VIROL, V86, P13475, DOI 10.1128/JVI.02295-12; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Szewczyk B, 2014, ACTA BIOCHIM POL, V61, P397; Umbach JL, 2010, MBIO, V1, DOI 10.1128/mBio.00204-10; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165729	10.1371/journal.pone.0165729	http://dx.doi.org/10.1371/journal.pone.0165729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788253	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900120
J	Pytka, K; Gluch-Lutwin, M; Knutelska, J; Jakubczyk, M; Waszkielewicz, A; Kotanska, M				Pytka, Karolina; Gluch-Lutwin, Monika; Knutelska, Joanna; Jakubczyk, Magdalena; Waszkielewicz, Anna; Kotanska, Magdalena			HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in Rats	PLoS One			English	Article							DOUBLE-BLIND; ANTIDEPRESSANTS; DERIVATIVES; DEPRESSION; WEIGHT; METAANALYSIS; CHOLESTEROL; HOMEOSTASIS; METABOLISM; FLUOXETINE	Older and even new antidepressants cause adverse effects, such as orthostatic hypotension, hyper-or hypoglycemia, liver injury or lipid disorders. In our previous experiments we showed significant antidepressant-and anxiolytic-like activities of dual 5-HT1A and 5-HT7 antagonists with alpha(1)-adrenolitic properties i.e. 1-[(2,6-dimethylphenoxy)ethoxyethy1]-4-(2methoxyphenyl)piperazine hydrochloride (HBK-14) and 1-[(2-chloro-6-methylphenoxy) ethoxyethyl]-4-(2-methoxyphenyl)piperazine hydrochloride (HBK-15). Here, we evaluated the influence of chronic administration of HBK-14 and HBK-15 on blood pressure (non-invasive blood pressure measurement system for rodents), lipid profile (total cholesterol, low density lipoproteins LDL, high density lipoproteins HDL, triglycerides), glucose level, and liver enzymes activity (aspartate aminotransferase, alanine aminotransferase, y-glutamyl transferase). We determined potential antihistaminic (isolated guinea pig ileum) and antioxidant properties (ferric reducing ability of plasma FRAP, non-protein thiols NPSH, stable free radical diphenylpicrylhydrazyl DPPH) cytotoxicity. Our experiments revealed that HBK-14 and HBK-15 did not influence blood pressure, lipid profile, glucose level or liver enzymes activity in rats after 2-week treatment. We also showed that none of the compounds possessed antioxidant or cytotoxic properties at antidepressant-and anxiolytic-like doses. HBK-14 and HBK-15 very weakly blocked H-1 receptors in guinea pig ileum. Positive results of our preliminary experiments on the safety of HBK-14 and HBK-15 encourage further studies concerning their effectiveness in the treatment of depression and/or anxiety disorders.	[Pytka, Karolina; Knutelska, Joanna; Jakubczyk, Magdalena; Kotanska, Magdalena] Jagiellonian Univ, Coll Med, Fac Pharm, Dept Pharmacodynam, Krakow, Poland; [Gluch-Lutwin, Monika] Jagiellonian Univ, Coll Med, Dept Pharmacobiol, Fac Pharm, Krakow, Poland; [Waszkielewicz, Anna] Jagiellonian Univ, Coll Med, Dept Bioorgan Chem, Chair Organ Chem,Fac Pharm, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Pytka, K (corresponding author), Jagiellonian Univ, Coll Med, Fac Pharm, Dept Pharmacodynam, Krakow, Poland.	karolina.pytka@uj.edu.pl	Kotańska, Magdalena/AAX-5140-2021; Głuch-Lutwin, Monika/AAE-2702-2019; Pytka, Karolina/Z-5491-2019	Kotańska, Magdalena/0000-0002-3946-1192; Głuch-Lutwin, Monika/0000-0003-1632-6569; Pytka, Karolina/0000-0001-7134-9515; Waszkielewicz, Anna/0000-0002-2871-9418; Knutelska, Joanna/0000-0002-2480-1617	Jagiellonian University [K/DSC/001955]; Jagiellonian University Student's Grant [19/2015]	Jagiellonian University; Jagiellonian University Student's Grant	This study was supported by Jagiellonian University grant number K/DSC/001955 and Jagiellonian University Student's Grant number 19/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2002, OBES RES, V10, P633, DOI 10.1038/oby.2002.86; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bilici M, 2001, J AFFECT DISORDERS, V64, P43, DOI 10.1016/S0165-0327(00)00199-3; Bradwejn J, 2005, BRIT J PSYCHIAT, V187, P352, DOI 10.1192/bjp.187.4.352; Briscoe VJ, 2008, DIABETES, V57, P2453, DOI 10.2337/db08-0236; Cherin P, 1997, J CLIN EPIDEMIOL, V50, P313, DOI 10.1016/S0895-4356(96)00385-X; Conrad MA, 2016, J PEDIATR-US, V169, P313, DOI 10.1016/j.jpeds.2015.10.065; Dudek M, 2016, EUR J PHARMACOL, V776, P146, DOI 10.1016/j.ejphar.2016.02.047; Erenmemisoglu A, 1999, J PHARM PHARMACOL, V51, P741, DOI 10.1211/0022357991772899; FULLER RW, 1979, LIFE SCI, V25, P1237, DOI 10.1016/0024-3205(79)90466-1; Gahr M, 2016, J CLIN PHARMACOL, V56, P769, DOI 10.1002/jcph.662; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Goldstein MR, 2010, MED HYPOTHESES, V74, P955, DOI 10.1016/j.mehy.2009.11.041; GUPTA B, 1992, INDIAN J MED RES-B, V96, P65; Hennings JM, 2012, CURR PHARM DESIGN, V18, P5900; Kedare SB, 2011, J FOOD SCI TECH MYS, V48, P412, DOI 10.1007/s13197-011-0251-1; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Kopf D, 2004, J CLIN PSYCHOPHARM, V24, P527, DOI 10.1097/01.jcp.0000138762.23482.63; Kowalczyk-Pachel D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147238; Lara N, 2003, J CLIN PSYCHIAT, V64, P1455, DOI 10.4088/JCP.v64n1209; Liang YJ, 2014, INT J BEHAV MED, V21, P590, DOI 10.1007/s12529-013-9358-2; McIntyre RS, 2006, EXPERT OPIN DRUG SAF, V5, P523, DOI 10.1517/14740338.5.4.523; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Mogilski S, 2015, PHARMACOL BIOCHEM BE, V133, P99, DOI 10.1016/j.pbb.2015.03.019; NOO OLAW, 2010, GUIDE CARE USE LAB A, P1; Pacher P, 2004, CURR PHARM DESIGN, V10, P2463, DOI 10.2174/1381612043383872; Patra Bichitra Nanda, 2014, Indian J Psychol Med, V36, P129, DOI 10.4103/0253-7176.130968; POLLOCK BG, 1994, PSYCHOPHARMACOL BULL, V30, P145; Pytka K, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00229; Pytka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142499; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Suen Christopher F D Li Wai, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-201022; Tabak F, 2009, DIGEST DIS SCI, V54, P1589, DOI 10.1007/s10620-008-0524-3; Voican CS, 2014, AM J PSYCHIAT, V171, P404, DOI 10.1176/appi.ajp.2013.13050709; Waszkielewicz AM, 2015, CHEM BIOL DRUG DES, V85, P326, DOI 10.1111/cbdd.12394; YERAGANI VK, 1990, PSYCHIAT RES, V32, P207, DOI 10.1016/0165-1781(90)90089-N	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165495	10.1371/journal.pone.0165495	http://dx.doi.org/10.1371/journal.pone.0165495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788267	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900097
J	Saigi-Morgui, N; Quteineh, L; Bochud, PY; Crettol, S; Kutalik, Z; Wojtowicz, A; Bibert, S; Beckmann, S; Mueller, NJ; Binet, I; van Delden, C; Steiger, J; Mohacsi, P; Stirnimann, G; Soccal, PM; Pascual, M; Eap, CB				Saigi-Morgui, Nuria; Quteineh, Lina; Bochud, Pierre-Yves; Crettol, Severine; Kutalik, Zoltan; Wojtowicz, Agnieszka; Bibert, Stephanie; Beckmann, Sonja; Mueller, Nicolas J.; Binet, Isabelle; van Delden, Christian; Steiger, Jurg; Mohacsi, Paul; Stirnimann, Guido; Soccal, Paola M.; Pascual, Manuel; Eap, Chin B.		Swiss Transplant Cohort Study	Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations	PLOS ONE			English	Article							BODY-MASS INDEX; LIVER-TRANSPLANTATION; FOLLOW-UP; OBESITY; KIDNEY; LOCI; ASSOCIATION; POLYMORPHISMS; OVERWEIGHT; COMMON	Background Polygenic obesity in Solid Organ Transplant (SOT) populations is considered a risk factor for the development of metabolic abnormalities and graft survival. Few studies to date have studied the genetics of weight gain in SOT recipients. We aimed to determine whether weighted genetic risk scores (w-GRS) integrating genetic polymorphisms from GWAS studies (SNP group# 1 and SNP group#2) and from Candidate Gene studies (SNP group#3) influence BMI in SOT populations and if they predict >= 10% weight gain (WG) one year after transplantation. To do so, two samples (n(A) = 995, n(B) = 156) were obtained from naturalistic studies and three w-GRS were constructed and tested for association with BMI over time. Prediction of 10% WG at one year after transplantation was assessed with models containing genetic and clinical factors. Results w-GRS were associated with BMI in sample A and B combined (BMI increased by 0.14 and 0.11 units per additional risk allele in SNP group# 1 and #2, respectively, p-values<0.008). w-GRS of SNP group#3 showed an effect of 0.01 kg/m(2) per additional risk allele when combining sample A and B (p-value 0.04). Models with genetic factors performed better than models without in predicting 10% WG at one year after transplantation. Conclusions This is the first study in SOT evaluating extensively the association of w-GRS with BMI and the influence of clinical and genetic factors on 10% of WG one year after transplantation, showing the importance of integrating genetic factors in the final model. Genetics of obesity among SOT recipients remains an important issue and can contribute to treatment personalization and prediction of WG after transplantation.	[Saigi-Morgui, Nuria; Quteineh, Lina; Crettol, Severine; Eap, Chin B.] Univ Lausanne Hosp, Dept Psychiat, Unit Pharmacogenet & Clin Psychopharmacol, Prilly, Switzerland; [Bochud, Pierre-Yves; Wojtowicz, Agnieszka; Bibert, Stephanie] Univ Hosp, Infect Dis Serv, Lausanne, Switzerland; [Bochud, Pierre-Yves; Wojtowicz, Agnieszka; Bibert, Stephanie] Univ Lausanne, Lausanne, Switzerland; [Kutalik, Zoltan] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland; [Beckmann, Sonja] Univ Basel, Inst Nursing Sci, Basel, Switzerland; [Mueller, Nicolas J.] Univ Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Binet, Isabelle] Kantonsspital, Serv Nephrol & Transplantat Med, St Gallen, Switzerland; [van Delden, Christian] Univ Hosp, Infect Dis Serv, Geneva, Switzerland; [Steiger, Jurg] Univ Hosp, Serv Nephrol, Basel, Switzerland; [Mohacsi, Paul] Univ Hosp, Swiss Cardiovasc Ctr Bern, Bern, Switzerland; [Stirnimann, Guido] Inselspital Bern, Univ Clin Visceral Surg & Med, Bern, Switzerland; [Soccal, Paola M.] Univ Hosp, Serv Pulm Med, Geneva, Switzerland; [Pascual, Manuel] Univ Lausanne Hosp, Transplant Ctr, Lausanne, Switzerland; [Eap, Chin B.] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; University of Basel; University of Zurich; University Zurich Hospital; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Geneva; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Lausanne	Eap, CB (corresponding author), Univ Lausanne Hosp, Dept Psychiat, Unit Pharmacogenet & Clin Psychopharmacol, Prilly, Switzerland.; Eap, CB (corresponding author), Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.	chin.eap@chuv.ch	Bochud, Pierre-Yves/ABE-5979-2020; Hofbauer, Gunther/B-2671-2010; Study, STCS Swiss Transplant Cohort/G-8344-2017; Kutalik, Zoltan/HHZ-5697-2022; Mueller, Nicolas J./B-6864-2013	Hofbauer, Gunther/0000-0003-0542-7989; Study, STCS Swiss Transplant Cohort/0000-0002-6369-819X; Kutalik, Zoltan/0000-0001-8285-7523; Mueller, Nicolas J./0000-0002-1059-3191; Eap, Chin/0000-0002-5439-0230; Buhler, Leo/0000-0002-9461-8498; Pascual, Manuel A./0000-0001-7747-1693; Saigi, Nuria/0000-0003-2503-1818; Bochud, Pierre-Yves/0000-0002-2208-4757; De Geest, Sabina/0000-0001-6596-7237; Bibert, Stephanie/0000-0001-5170-7506	Swiss National Science Foundation [324730_144064, 31003A-143914]; Roche Organ Transplantation Research Foundation [152358701]; Swiss Transplant Cohort Study; Leenaards Foundation; Swiss University Hospitals (G15) and transplant centers	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Organ Transplantation Research Foundation; Swiss Transplant Cohort Study; Leenaards Foundation; Swiss University Hospitals (G15) and transplant centers	This work has been funded in part by the Swiss National Science Foundation (CBE: 324730_144064). LQ and CBE received research support from the Roche Organ Transplantation Research Foundation (#152358701) and the Swiss Transplant Cohort Study in the past 3 years. ZK was funded by the Swiss National Science Foundation (31003A-143914) and the Leenaards Foundation. This study has been conducted in the framework of the Swiss Transplant Cohort Study, supported by the Swiss National Science Foundation and the Swiss University Hospitals (G15) and transplant centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Allen JG, 2010, J HEART LUNG TRANSPL, V29, P1026, DOI 10.1016/j.healun.2010.05.005; Balla A, 2009, CURR OPIN ORGAN TRAN, V14, P375, DOI 10.1097/MOT.0b013e32832dbb98; Beckmann S, 2015, SYST REV, V4, DOI 10.1186/2046-4053-4-2; Belsky DW, 2013, BIODEMOGR SOC BIOL, V59, P85, DOI 10.1080/19485565.2013.774628; Borobia AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041360; Cashion A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059962; Cashion Ann K, 2007, Prog Transplant, V17, P40; Chakkera HA, 2013, DIABETES CARE, V36, P1406, DOI 10.2337/dc12-2067; Clunk JM, 2001, AM J KIDNEY DIS, V38, P349, DOI 10.1053/ajkd.2001.26100; Crettol S, 2008, PHARMACOGENET GENOM, V18, P307, DOI 10.1097/FPC.0b013e3282f7046f; Crettol S, 2008, THER DRUG MONIT, V30, P689, DOI 10.1097/FTD.0b013e31818a2a60; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Fougeray S, 2011, TRANSPL P, V43, P3418, DOI 10.1016/j.transproceed.2011.09.022; Friedman AN, 2003, AM J KIDNEY DIS, V41, P480, DOI 10.1053/ajkd.2003.50059; Goumidi L, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-62; Gutierrez-Aguilar R, 2015, PHYSIOL BEHAV, V150, P38, DOI 10.1016/j.physbeh.2015.03.027; Gutierrez-Aguilar R, 2012, OBESITY, V20, P306, DOI 10.1038/oby.2011.236; Halme L, 1997, TRANSPLANT INT, V10, P284; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hoehn RS, 2014, LIVER TRANSPLANT, V20, P1347, DOI 10.1002/lt.23956; Homayouni R, 2005, BIOINFORMATICS, V21, P104, DOI 10.1093/bioinformatics/bth464; Horne BD, 2005, ANN HUM GENET, V69, P176, DOI 10.1046/j.1529-8817.2005.00155.x; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; JOHNSON CP, 1993, TRANSPLANTATION, V56, P822, DOI 10.1097/00007890-199310000-00008; Kim WR, 2013, AM J TRANSPLANT, V13, P73, DOI 10.1111/ajt.12021; Koller MT, 2013, EUR J EPIDEMIOL, V28, P347, DOI 10.1007/s10654-012-9754-y; Kugler C, 2015, PROG TRANSPLANT, V25, P49, DOI 10.7182/pit2015668; Lin X, 2009, DIABETOLOGIA, V52, P600, DOI 10.1007/s00125-008-1254-y; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; McCaughan JA, 2014, J AM SOC NEPHROL, V25, P1037, DOI 10.1681/ASN.2013040383; Patel M G, 1998, J Ren Nutr, V8, P137, DOI 10.1016/S1051-2276(98)90005-X; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Peterson RE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-368; PFEIFFER T, 1994, MED KLIN, V89, P635; Pham PTT, 2011, DIABETES METAB SYNDR, V4, P175, DOI 10.2147/DMSO.S19027; Pischon T, 2001, NEPHROL DIAL TRANSPL, V16, P14, DOI 10.1093/ndt/16.1.14; Quteineh L, 2017, PHARMACOGENOMICS J, V17, P69, DOI 10.1038/tpj.2015.82; R Core Team, 2021, R LANGUAGE ENV STAT; Reisaeter AV, 2001, TRANSPL P, V33, p8S, DOI 10.1016/S0041-1345(01)02229-1; Robin X, 2014, PROC DISPL AN ROC CU; SIMOPOULOS AP, 1987, ANN NY ACAD SCI, V499, P4, DOI 10.1111/j.1749-6632.1987.tb36193.x; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Toniutto P, 2005, TRANSPLANTATION, V79, P1338, DOI 10.1097/01.TP.0000158712.42875.51; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Watt KD, 2013, AM J TRANSPLANT, V13, P2450, DOI 10.1111/ajt.12355; Wawrzynowicz-Syczewska M, 2009, ANN TRANSPL, V14, P45; Weiss ES, 2009, J HEART LUNG TRANSPL, V28, P1150, DOI 10.1016/j.healun.2009.06.009; Williams JJ, 2006, J HEART LUNG TRANSPL, V25, P36, DOI 10.1016/j.healun.2005.06.016; World Health Organization,, 2015, OB OV; Zhu JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091442	54	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164443	10.1371/journal.pone.0164443	http://dx.doi.org/10.1371/journal.pone.0164443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788139	Green Published, gold, Green Accepted			2022-12-26	WOS:000389604900021
J	Zhou, C; Wang, YK; Qiao, CJ; Dai, WH				Zhou, Chao; Wang, Yueke; Qiao, Chunjie; Dai, Weihua			Calibration Method of an Ultrasonic System for Temperature Measurement	PLoS One			English	Article							ACOUSTIC CENTER; PURE WATER; MICROPHONES; SPEED; SOUND	System calibration is fundamental to the overall accuracy of the ultrasonic temperature measurement, and it is basically involved in accurately measuring the path length and the system latency of the ultrasonic system. This paper proposes a method of high accuracy system calibration. By estimating the time delay between the transmitted signal and the received signal at several different temperatures, the calibration equations are constructed, and the calibrated results are determined with the use of the least squares algorithm. The formulas are deduced for calculating the calibration uncertainties, and the possible influential factors are analyzed. The experimental results in distilled water show that the calibrated path length and system latency can achieve uncertainties of 0.058 mm and 0.038 mu s, respectively, and the temperature accuracy is significantly improved by using the calibrated results. The temperature error remains within +/- 0.04 degrees C consistently, and the percentage error is less than 0.15%.	[Zhou, Chao; Wang, Yueke; Qiao, Chunjie; Dai, Weihua] Natl Univ Def Technol, Coll Mechatron Engn & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Zhou, C (corresponding author), Natl Univ Def Technol, Coll Mechatron Engn & Automat, Changsha, Hunan, Peoples R China.	zhouchaowhu@126.com						[Anonymous], 1994, 50801 IEC INT; [Anonymous], 1994, TERMINOLOGY; Barrera-Figueroa S, 2006, J ACOUST SOC AM, V120, P2668, DOI 10.1121/1.2345830; Barth M, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/3/035102; Bazan I, 2009, ULTRASONICS, V49, P358, DOI 10.1016/j.ultras.2008.10.012; BILANIUK N, 1993, J ACOUST SOC AM, V93, P1609, DOI 10.1121/1.406819; Bramanti M, 1996, IEEE T INSTRUM MEAS, V45, P159, DOI 10.1109/19.481329; Cox JR, 1954, THESIS; DELGROSS.VA, 1972, J ACOUST SOC AM, V52, P1442, DOI 10.1121/1.1913258; Fan W, 2013, ULTRASONICS, V53, P897, DOI 10.1016/j.ultras.2012.12.014; Fei Y.T., 2010, ERROR THEORY DATA PR; Gelat PN, 2005, ULTRASONICS, V43, P331, DOI 10.1016/j.ultras.2004.08.003; Jacobsen F, 2004, J ACOUST SOC AM, V115, P1468, DOI 10.1121/1.1652036; JUHL P, 1994, J SOUND VIB, V177, P433, DOI 10.1006/jsvi.1994.1445; Kay SM, 1993, FOUNDAMENTALS STAT S, VI; Mi X. B., 2003, J NANJING U, V39, P517; Qiao CJ, 2013, PROCEEDINGS OF 2013 IEEE 11TH INTERNATIONAL CONFERENCE ON ELECTRONIC MEASUREMENT & INSTRUMENTS (ICEMI), P110, DOI 10.1109/ICEMI.2013.6743065; Rasmussen K, 1993, PL07 TECHN U DENM; Shaw A, 2008, ULTRASONICS, V48, P234, DOI 10.1016/j.ultras.2007.10.010; Srinivasan K, 2013, MEASUREMENT, V46, P315, DOI 10.1016/j.measurement.2012.07.003; Zhao S, 2013, 6 INT S PREC MECH ME; Zhou C, 2016, MEASUREMENT, V88, P1, DOI 10.1016/j.measurement.2016.03.037	22	1	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165335	10.1371/journal.pone.0165335	http://dx.doi.org/10.1371/journal.pone.0165335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788252	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900064
J	Wang, CH				Wang, Chenhui			Adaptive Fuzzy Control for Uncertain Fractional-Order Financial Chaotic Systems Subjected to Input Saturation	PLOS ONE			English	Article							OUTPUT-FEEDBACK CONTROL; MIMO NONLINEAR-SYSTEMS; LINEAR-SYSTEMS; ACTIVE CONTROL; SYNCHRONIZATION; DYNAMICS; STABILIZATION; PERTURBATION; ANTIWINDUP; DESIGN	In this paper, control of uncertain fractional-order financial chaotic system with input saturation and external disturbance is investigated. The unknown part of the input saturation as well as the system's unknown nonlinear function is approximated by a fuzzy logic system. To handle the fuzzy approximation error and the estimation error of the unknown upper bound of the external disturbance, fractional-order adaptation laws are constructed. Based on fractional Lyapunov stability theorem, an adaptive fuzzy controller is designed, and the asymptotical stability can be guaranteed. Finally, simulation studies are given to indicate the effectiveness of the proposed method.	[Wang, Chenhui] Xiamen Univ Technol, Coll Appl Math, Xiamen 361024, Peoples R China	Xiamen University of Technology	Wang, CH (corresponding author), Xiamen Univ Technol, Coll Appl Math, Xiamen 361024, Peoples R China.	chwang@xmut.edu.cn			National Natural Science Foundation of China [11302184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 11302184).	Aguila-Camacho N, 2014, COMMUN NONLINEAR SCI, V19, P2951, DOI 10.1016/j.cnsns.2014.01.022; [Anonymous], 1998, FRACTIONAL DIFFERENT; Baskonus HM, 2015, ENTROPY-SWITZ, V17, P5771, DOI 10.3390/e17085771; Boulkroune A, 2010, FUZZY SET SYST, V161, P797, DOI 10.1016/j.fss.2009.04.011; Boulkroune A, 2016, NEUROCOMPUTING, V179, P318, DOI 10.1016/j.neucom.2015.12.010; Boulkroune A, 2015, COMPLEXITY, V21, P180, DOI 10.1002/cplx.21596; Chen LP, 2011, DISCRETE DYN NAT SOC, V2011, DOI 10.1155/2011/958393; Chen WC, 2008, CHAOS SOLITON FRACT, V36, P1305, DOI 10.1016/j.chaos.2006.07.051; Gallegos JA, 2016, APPL MATH COMPUT, V287, P161, DOI 10.1016/j.amc.2016.04.039; Grimm G, 2003, IEEE T AUTOMAT CONTR, V48, P1509, DOI 10.1109/TAC.2003.816965; HARTLEY TT, 1995, IEEE T CIRCUITS-I, V42, P485, DOI 10.1109/81.404062; He W, 2016, IEEE T SYST MAN CY-S, V46, P334, DOI 10.1109/TSMC.2015.2429555; Huang XL, 2016, J FRANKLIN I, V353, P2398, DOI 10.1016/j.jfranklin.2016.04.004; Ji H, 2016, IET CONTROL THEORY A; Kapoor N, 1998, AUTOMATICA, V34, P559, DOI 10.1016/S0005-1098(97)00194-5; Kocamaz UE, 2015, INF TECHNOL CONTROL, V44, P172, DOI 10.5755/j01.itc.44.2.7732; Li Y, 2009, AUTOMATICA, V45, P1965, DOI 10.1016/j.automatica.2009.04.003; Li YM, 2016, IEEE T FUZZY SYST, V24, P841, DOI 10.1109/TFUZZ.2015.2486811; Li YM, 2015, IEEE T CYBERNETICS, V45, P2299, DOI 10.1109/TCYB.2014.2370645; Li YM, 2014, FUZZY SET SYST, V248, P138, DOI 10.1016/j.fss.2013.11.006; Lim YH, 2013, IEEE T AUTOMAT CONTR, V58, P1062, DOI 10.1109/TAC.2012.2218064; Liu H, 2016, NEUROCOMPUTING; Liu H, 2015, ENTROPY-SWITZ, V17, P7185, DOI 10.3390/e17107185; Liu H, 2015, CHINESE PHYS B, V24, DOI 10.1088/1674-1056/24/9/090505; Liu H, 2015, ACTA PHYS SIN-CH ED, V64, DOI 10.7498/aps.64.070503; Liu H, 2012, CHINESE PHYS B, V21, DOI 10.1088/1674-1056/21/12/120505; Lu P, 2014, INT J ELEC POWER, V62, P130, DOI 10.1016/j.ijepes.2014.04.028; Luo JH, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/891639; Pan I, 2015, APPL MATH MODEL, V39, P500, DOI 10.1016/j.apm.2014.06.005; Pan YP, 2015, AUTOMATICA, V57, P29, DOI 10.1016/j.automatica.2015.03.033; Pan YP, 2015, IEEE T CYBERNETICS, V45, P588, DOI 10.1109/TCYB.2014.2331460; Pan YP, 2013, IEEE T FUZZY SYST, V21, P1123, DOI 10.1109/TFUZZ.2013.2244899; Pan YP, 2011, IEEE T FUZZY SYST, V19, P807, DOI 10.1109/TFUZZ.2011.2144600; Rigatos G, 2016, FUZZY SET SYST, V290, P138, DOI 10.1016/j.fss.2015.08.027; Safarinejadian B, 2016, INT J CONTROL, V89, P2277, DOI 10.1080/00207179.2016.1155237; Shen J, 2014, AUTOMATICA, V50, P547, DOI 10.1016/j.automatica.2013.11.018; STUTZER MJ, 1980, J ECON DYN CONTROL, V2, P353, DOI 10.1016/0165-1889(80)90070-6; Tacha OI, 2016, APPL MATH COMPUT, V276, P200, DOI 10.1016/j.amc.2015.12.015; Thirlwall AP, 2015, EC DYNAMICS TRADE GR; Tong SC, 2009, IEEE T FUZZY SYST, V17, P1059, DOI 10.1109/TFUZZ.2009.2021648; Tong SC, 2013, IEEE T FUZZY SYST, V21, P134, DOI 10.1109/TFUZZ.2012.2204065; Uyaroglu Y, 2014, INTERNATIONAL WORK-CONFERENCE ON TIME SERIES (ITISE 2014), P260; Wang L.-X., 1994, ADAPTIVE FUZZY SYSTE; Wang Y, 2015, J APPL ANAL COMPUT, V5, P210; Wang Y, 2014, EUR PHYS J-SPEC TOP, V223, P1591, DOI 10.1140/epjst/e2014-02181-3; Wang Z, 2012, NEUROCOMPUTING, V83, P83, DOI 10.1016/j.neucom.2011.11.018; Xin BG, 2015, NONLINEAR DYNAM, V79, P1399, DOI 10.1007/s11071-014-1749-7; Xu YH, 2015, MATH METHOD APPL SCI, V38, P4279, DOI 10.1002/mma.3364; Yu HJ, 2012, NONLINEAR DYNAM, V67, P2171, DOI 10.1007/s11071-011-0137-9; Zhang XD, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/3/030509; Zhao MC, 2014, APPL MATH COMPUT, V233, P320, DOI 10.1016/j.amc.2013.12.085	51	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164791	10.1371/journal.pone.0164791	http://dx.doi.org/10.1371/journal.pone.0164791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783648	gold, Green Submitted, Green Published			2022-12-26	WOS:000389602800049
J	Hrinkevich, KH; Progar, RA; Shaw, DC				Hrinkevich, Kathryn H.; Progar, Robert A.; Shaw, David C.			Climate Risk Modelling of Balsam Woolly Adelgid Damage Severity in Subalpine Fir Stands of Western North America	PLOS ONE			English	Article							UNITED-STATES; CAROLINA; APHID; PRECIPITATION; TEMPERATURE	The balsam woolly adelgid (Adelges piceae (Ratzeburg) (Homoptera: Adelgidae)) (BWA) is a nonnative, invasive insect that threatens Abies species throughout North America. It is well established in the Pacific Northwest, but continues to move eastward through Idaho and into Montana and potentially threatens subalpine fir to the south in the central and southern Rocky Mountains. We developed a climatic risk model and map that predicts BWA impacts to subalpine fir using a two-step process. Using 30-year monthly climate normals from sites with quantitatively derived BWA damage severity index values, we built a regression model that significantly explained insect damage. The sites were grouped into two distinct damage categories (high damage and mortality versus little or no mortality and low damage) and the model estimates for each group were used to designate distinct value ranges for four climatic risk categories: minimal, low, moderate, and high. We then calculated model estimates for each cell of a 4-kilometer resolution climate raster and mapped the risk categories over the entire range of subalpine fir in the western United States. The spatial variation of risk classes indicates a gradient of climatic susceptibility generally decreasing from the Olympic Peninsula in Washington and the Cascade Range in Oregon and Washington moving eastward, with the exception of some high risk areas in northern Idaho and western Montana. There is also a pattern of decreasing climatic susceptibility from north to south in the Rocky Mountains. Our study provides an initial step for modeling the relationship between climate and BWA damage severity across the range of subalpine fir. We showed that September minimum temperature and a metric calculated as the maximum May temperature divided by total May precipitation were the best climatic predictors of BWA severity. Although winter cold temperatures and summer heat have been shown to influence BWA impacts in other locations, these variables were not as predictive as spring and fall conditions in the Pacific Northwest.	[Hrinkevich, Kathryn H.; Shaw, David C.] Oregon State Univ, Dept Forest Engn Resources & Management, Corvallis, OR 97331 USA; [Progar, Robert A.] USDA Forest Serv PNW Res Stn, Forestry Sci Lab, La Grande, OR USA	Oregon State University	Hrinkevich, KH (corresponding author), Oregon State Univ, Dept Forest Engn Resources & Management, Corvallis, OR 97331 USA.	hrinkevk@onid.orstate.edu	Shaw, David/A-1191-2018	Shaw, David/0000-0002-3898-782X	United States Department of Agriculture Forest Service Forest Health Protection Special Technology Development Program [R1-2012-04]; USDA Forest Service State and Private Forestry Special Technology Development Program; Forest Health Protection	United States Department of Agriculture Forest Service Forest Health Protection Special Technology Development Program; USDA Forest Service State and Private Forestry Special Technology Development Program; Forest Health Protection	This work was supported by United States Department of Agriculture Forest Service Forest Health Protection Special Technology Development Program Project Number R1-2012-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the USDA Forest Service State and Private Forestry Special Technology Development Program and Forest Health Protection, which also helped with site selection and background knowledge. Special Thanks to Joel McMillin, Rick Kelsey, Amy Gannon, Laura Lowery and Tim Harrington for very helpful reviews.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AMMAN GD, 1966, J ECON ENTOMOL, V59, P508, DOI 10.1093/jee/59.3.508; AMMAN GD, 1962, J ECON ENTOMOL, V55, P96, DOI 10.1093/jee/55.1.96; Balch RE, 1952, USITC PUBL, V867; BRYANT DG, 1974, CAN ENTOMOL, V106, P1075, DOI 10.4039/Ent1061075-10; Ciesla WM, 2011, FOREST ENTOMOLOGY: A GLOBAL PERSPECTIVE, P1, DOI 10.1002/9781444397895; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; GREENBANK DO, 1970, CAN ENTOMOL, V102, P546, DOI 10.4039/Ent102546-5; HAIN F.P., 1988, DYNAMICS FOREST INSE, P88; Hain FP, 1991, NE153 US DA FOR SERV, P271; Harris JWE., 1968, BCX20 FOR RES LAB; HOLLINGSWORTH RG, 1991, FLA ENTOMOL, V74, P179, DOI 10.2307/3495294; Hrinkevich KH, 2015, FOREST SCI, V62, P181; Johnson NE, 1957, 18 USDA FOR SERV PAC; JOHNSON NORMAN E., 1963, JOUR FOREST, V61, P854; Lass L. W., 2014, INT J FOR RES; Little E., 1971, CONIFERS IMPORTANT H, V1; Livingston R. L., 2000, Western Journal of Applied Forestry, V15, P227; Lowery L, 2014, EVALUATION EXTENT NO; McManamay RH, 2011, CASTANEA, V76, P1, DOI 10.2179/09-059.1; Melillo J., 2014, CLIMATE CHANGE IMPAC, P195, DOI DOI 10.7930/J0TD9V7H; MITCHELL R. G., 1961, CANADIAN ENTOMOL, V93, P794; Mitchell R.G., 1966, INFESTATION CHARACTE; Mitchell RG, 1970, PEST LEAFLET, V118; Mitchell Russel G., 2001, Western Journal of Applied Forestry, V16, P121; Newton L.P., 2005, P 3 S HEMLOCK WOOLLY, P199; Overhulser D. L., 2004, BALSAM WOOLLY ADELGI; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Quiring D, 2008, FOREST CHRON, V84, P558, DOI 10.5558/tfc84558-4; Ragenovich I.R., 2006, FOREST INSECT DIS LE, V118; Rudinsky JA, 1957, WEYERHAEUSER CO B; Schooley H.O., 1978, NX160 CAN FOR SERV N; Splechtna BE, 2000, ANN FOREST SCI, V57, P89; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Turnquist R., 1993, BALSAM WOOLLY ADELGI; Vitousek PM, 1996, AM SCI, V84, P468; WOOD R O, 1968, Journal of the Entomological Society of British Columbia, V65, P13; Woods TAD, 1967, BIMONTHLY RES NOTES, V23, P44	40	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165094	10.1371/journal.pone.0165094	http://dx.doi.org/10.1371/journal.pone.0165094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780227	Green Submitted, Green Published, gold			2022-12-26	WOS:000389046900027
J	Barrois, R; Gregory, T; Oudre, L; Moreau, T; Truong, C; Pulini, AA; Vienne, A; Labourdette, C; Vayatis, N; Buffat, S; Yelnik, A; de Waele, C; Laporte, S; Vidal, PP; Ricard, D				Barrois, R.; Gregory, Th.; Oudre, L.; Moreau, Th.; Truong, Ch.; Pulini, A. Aram; Vienne, A.; Labourdette, Ch.; Vayatis, N.; Buffat, S.; Yelnik, A.; de Waele, C.; Laporte, S.; Vidal, P. P.; Ricard, D.			An Automated Recording Method in Clinical Consultation to Rate the Limp in Lower Limb Osteoarthritis	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; KNEE ADDUCTION MOMENT; GAIT ANALYSIS; LOADING RESPONSE; STEP DETECTION; WALKING; SEVERITY; JOINT; ACCELEROMETRY; PATTERNS	For diagnosis and follow up, it is important to be able to quantify limp in an objective, and precise way adapted to daily clinical consultation. The purpose of this exploratory study was to determine if an inertial sensor-based method could provide simple features that correlate with the severity of lower limb osteoarthritis evaluated by the WOMAC index without the use of step detection in the signal processing. Forty-eight patients with lower limb osteoarthritis formed two severity groups separated by the median of the WOMAC index (G1, G2). Twelve asymptomatic age-matched control subjects formed the control group (G0). Subjects were asked to walk straight 10 meters forward and 10 meters back at self-selected walking speeds with inertial measurement units (IMU) (3-D accelerometers, 3-D gyroscopes and 3-D magnetometers) attached on the head, the lower back (L3-L4) and both feet. Sixty parameters corresponding to the mean and the root mean square (RMS) of the recorded signals on the various sensors (head, lower back and feet), in the various axes, in the various frames were computed. Parameters were defined as discriminating when they showed statistical differences between the three groups. In total, four parameters were found discriminating: mean and RMS of the norm of the acceleration in the horizontal plane for contralateral and ipsilateral foot in the doctor's office frame. No discriminating parameter was found on the head or the lower back. No discriminating parameter was found in the sensor linked frames. This study showed that two IMUs placed on both feet and a step detection free signal processing method could be an objective and quantitative complement to the clinical examination of the physician in everyday practice. Our method provides new automatically computed parameters that could be used for the comprehension of lower limb osteoarthritis. It may not only be used in medical consultation to score patients but also to monitor the evolution of their clinical syndrome during and after rehabilitation. Finally, it paves the way for the quantification of gait in other fields such as neurology and for monitoring the gait at a patient's home.	[Barrois, R.; Oudre, L.; Moreau, Th.; Truong, Ch.; Pulini, A. Aram; Vienne, A.; Labourdette, Ch.; Vayatis, N.; Buffat, S.; Yelnik, A.; de Waele, C.; Vidal, P. P.; Ricard, D.] Univ Paris 05, SSA, CNRS, Cognit & Act Grp,Cognac G, Paris, France; [Gregory, Th.] Univ Paris 05, HEGP, Serv Chirurg Orthoped & Traumatol, Paris, France; [Oudre, L.] Univ Paris 13, Inst Galilee, Villetaneuse, France; [Labourdette, Ch.; Vayatis, N.] Ecole Normale Super, Ctr Math & Leurs Applicat, Cachan, France; [Buffat, S.] Inst Rech Biomed Armees, Bretigny Sur Orge, France; [Yelnik, A.] Diderot Univ, GH St Louis Lariboisiere F Widal, AP HP, PRM Dept, Paris, France; [Laporte, S.] Arts & Metiers Paris Tech, LBM Inst Biomecan Humaine Georges Charpak, 151 Blvd Hop, F-75003 Paris, France; [Ricard, D.] Hop Instruct Armees Percy, Serv Neurol, Serv Sante Armees, Clamart, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Arts et Metiers Institute of Technology; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Ricard, D (corresponding author), Hop Instruct Armees Percy, Serv Neurol, Serv Sante Armees, Clamart, France.	damien.ricard@m4x.org	Moreau, Thomas/AAB-9940-2019; Oudre, Laurent/AAM-5129-2020; Shideler III, Blynn/ABH-1451-2021; Buffat, Stephane/R-2838-2016	Moreau, Thomas/0000-0002-1523-3419; Oudre, Laurent/0000-0002-4750-2265; Shideler III, Blynn/0000-0002-4520-9700; Truong, Charles/0000-0002-8527-8161; Buffat, Stephane/0000-0002-7484-9627	SATT lnnov Ile de France	SATT lnnov Ile de France	SATT lnnov Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Blynn Shideler for writing assistance. SAT T Ile-de-France Innov for funding.	Al-Zahrani KS, 2002, DISABIL REHABIL, V24, P275, DOI 10.1080/09638280110087098; Andriacchi TP, 1997, GAIT POSTURE, V5, P256, DOI 10.1016/S0966-6362(97)00013-1; Angst F, 2001, ANN RHEUM DIS, V60, P834; Astephen JL, 2008, J BIOMECH, V41, P868, DOI 10.1016/j.jbiomech.2007.10.016; Astephen JL, 2005, CLIN BIOMECH, V20, P209, DOI 10.1016/j.clinbiomech.2004.09.007; Auvinet B, 2002, GAIT POSTURE, V16, P124, DOI 10.1016/S0966-6362(01)00203-X; Baliunas AJ, 2002, OSTEOARTHR CARTILAGE, V10, P573, DOI 10.1053/joca.2002.0797; Barrois R, 2015, COMPUT METHOD BIOMEC, V18, P1880, DOI 10.1080/10255842.2015.1072414; BELLAMY N, 1989, SEMIN ARTHRITIS RHEU, V18, P14, DOI 10.1016/0049-0172(89)90010-3; Bolink SAAN, 2016, CLIN BIOMECH, V32, P171, DOI 10.1016/j.clinbiomech.2015.11.014; Bolink SAAN, 2015, KNEE, V22, P618, DOI 10.1016/j.knee.2015.04.002; Bolink SAAN, 2015, HIP INT, V25, P413, DOI 10.5301/hipint.5000282; Brandes M, 2008, GAIT POSTURE, V28, P74, DOI 10.1016/j.gaitpost.2007.10.004; BRINKMANN JR, 1985, PHYS THER, V65, P1055, DOI 10.1093/ptj/65.7.1055; Chen CPC, 2003, AM J PHYS MED REHAB, V82, P307, DOI 10.1097/01.PHM.0000056987.33630.56; Childs JD, 2004, CLIN BIOMECH, V19, P44, DOI 10.1016/j.clinbiomech.2003.08.007; Cognolato M., 2012, EXPT VALIDATION XSEN; Del Din S, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0154-5; Dieppe PA, 2004, J RHEUMATOL, V31, P50; Dijkstra B, 2008, AGE AGEING, V37, P436, DOI 10.1093/ageing/afn097; Ervin Lowry KA, 2015, IEEE T NEUR SYS REH, V22, P603, DOI [10.1109/TNSRE.2013.2265887.A, DOI 10.1109/TNSRE.2013.2265887.A]; Fortune E, STEP COUNTS USING TR, P1; Gok H, 2002, ACTA ORTHOP SCAND, V73, P647, DOI 10.1080/000164702321039606; Hanlon M, 2006, GAIT POSTURE, V24, P280, DOI 10.1016/j.gaitpost.2005.10.007; Hannan MT, 2000, J RHEUMATOL, V27, P1513; Heiden TL, 2009, CLIN BIOMECH, V24, P833, DOI 10.1016/j.clinbiomech.2009.08.005; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Herzog W, 2006, BIOMECH MODEL MECHAN, V5, P64, DOI 10.1007/s10237-006-0029-y; Hinman RS, 2002, ARCH PHYS MED REHAB, V83, P1080, DOI 10.1053/apmr.2002.33068; Hirasaki E, 1999, EXP BRAIN RES, V127, P117, DOI 10.1007/s002210050781; Huang SC, 2008, MED ENG PHYS, V30, P997, DOI 10.1016/j.medengphy.2008.02.006; Hubble RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123705; Hurwitz DE, 2002, J ORTHOPAED RES, V20, P101, DOI 10.1016/S0736-0266(01)00081-X; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kaufman KR, 2001, J BIOMECH, V34, P907, DOI 10.1016/S0021-9290(01)00036-7; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; Kiss RM, 2011, J ELECTROMYOGR KINES, V21, P695, DOI 10.1016/j.jelekin.2011.07.011; LAFORTUNE MA, 1991, J BIOMECH, V24, P877, DOI 10.1016/0021-9290(91)90166-K; Landry SC, 2007, J BIOMECH, V40, P1754, DOI 10.1016/j.jbiomech.2006.08.010; Lewek MD, 2004, OSTEOARTHR CARTILAGE, V12, P745, DOI 10.1016/j.joca.2004.05.005; Libby R, 2008, SENSORS PETERBOROUGH, V116, P1; Liikavainio T, 2010, KNEE, V17, P69, DOI 10.1016/j.knee.2009.05.003; Lindemann U, 2006, CLIN REHABIL, V20, P413, DOI 10.1191/0269215506cr958oa; Llikavainio T, 2007, KNEE, V14, P231, DOI 10.1016/j.knee.2007.03.001; Marschollek M, 2008, IEEE ENG MED BIO, P1319, DOI 10.1109/IEMBS.2008.4649407; McConnell S, 2001, ARTHRIT RHEUM-ARTHR, V45, P453, DOI 10.1002/1529-0131(200110)45:5<453::AID-ART365>3.0.CO;2-W; McKean KA, 2007, CLIN BIOMECH, V22, P400, DOI 10.1016/j.clinbiomech.2006.11.006; Mizuike C, 2009, GAIT POSTURE, V30, P60, DOI 10.1016/j.gaitpost.2009.02.017; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P320, DOI 10.1016/S0268-0033(98)00089-8; Moe-Nilssen R, 1998, ARCH PHYS MED REHAB, V79, P1377, DOI 10.1016/S0003-9993(98)90231-3; Mundermann A, 2005, ARTHRITIS RHEUM-US, V52, P2835, DOI 10.1002/art.21262; Mundermann A, 2004, ARTHRITIS RHEUM-US, V50, P1172, DOI 10.1002/art.20132; Nagano Y, 2012, KNEE, V19, P628, DOI 10.1016/j.knee.2011.11.002; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Roos EM, 1999, SCAND J RHEUMATOL, V28, P210; Rutherford DJ, 2011, CLIN BIOMECH, V26, P377, DOI 10.1016/j.clinbiomech.2010.11.018; Sabatini A. M., 2004, Proceedings of the 21st IEEE Instrumentation and Measurement Technology Conference (IEEE Cat. No.04CH37510), P881, DOI 10.1109/IMTC.2004.1351203; Sharma L, 2006, CURR OPIN RHEUMATOL, V18, P147, DOI 10.1097/01.bor.0000209426.84775.f8; Silvernail JF, 2013, GAIT POSTURE, V37, P575, DOI 10.1016/j.gaitpost.2012.09.016; Smith AJ, 2004, J ORTHOP RES, V22, P260, DOI 10.1016/S0736-0266(03)00184-0; Staab W, 2014, J PHYS THER SCI, V26, P997, DOI 10.1589/jpts.26.997; STAUFFER RN, 1977, CLIN ORTHOP RELAT R, P246; Tas S, 2014, ACTA ORTHOP TRAUMATO, V48, P635, DOI 10.3944/AOTT.2014.13.0071; Theiler R, 1999, OSTEOARTHR CARTILAGE, V7, P515, DOI 10.1053/joca.1999.0262; Thuer G, 2009, THESIS, P1; Turcot K, 2008, ARCH PHYS MED REHAB, V89, P732, DOI 10.1016/j.apmr.2007.09.033; Turcot K, 2008, IEEE T BIO-MED ENG, V55, P1415, DOI 10.1109/TBME.2007.912428; van den Noort JC, 2012, J BIOMECH, V45, P281, DOI 10.1016/j.jbiomech.2011.10.027; Wilson JLA, 2012, CLIN BIOMECH, V27, P210, DOI 10.1016/j.clinbiomech.2011.09.009; Witvrouw E, 2002, KNEE SURG SPORT TR A, V10, P347, DOI 10.1007/s00167-002-0302-2; Ying H, 2007, IFMBE PROC, V13, P80; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007; Zeni JA, 2009, CLIN BIOMECH, V24, P372, DOI 10.1016/j.clinbiomech.2009.02.001	74	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164975	10.1371/journal.pone.0164975	http://dx.doi.org/10.1371/journal.pone.0164975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776168	gold, Green Published, Green Submitted			2022-12-26	WOS:000389009200032
J	Okumura, Y; Kobayashi, T; Itakura, S				Okumura, Yuko; Kobayashi, Tessei; Itakura, Shoji			Eye Contact Affects Object Representation in 9-Month-Old Infants	PLoS One			English	Article							JOINT ATTENTION; GAZE; INDIVIDUATION; TELEVISION; PERCEPTION; LANGUAGE; SEARCH; TASK	Social cues in interaction with others enable infants to extract useful information from their environment. Although previous research has shown that infants process and retain different information about an object depending on the presence of social cues, the effect of eye contact as an isolated independent variable has not been investigated. The present study investigated how eye contact affects infants' object processing. Nine-month-olds engaged in two types of social interactions with an experimenter. When the experimenter showed an object without eye contact, the infants processed and remembered both the object's location and its identity. In contrast, when the experimenter showed the object while making eye contact with the infant, the infant preferentially processed object's identity but not its location. Such effects might assist infants to selectively attend to useful information. Our findings revealed that 9-month-olds' object representations are modulated in accordance with the context, thus elucidating the function of eye contact for infants' object representation.	[Okumura, Yuko; Kobayashi, Tessei] NTT Corp, NTT Commun Sci Labs, Kyoto, Japan; [Itakura, Shoji] Kyoto Univ, Grad Sch Letters, Dept Psychol, Kyoto, Japan	Nippon Telegraph & Telephone Corporation; Kyoto University	Okumura, Y (corresponding author), NTT Corp, NTT Commun Sci Labs, Kyoto, Japan.	okumura.yuko@lab.ntt.co.jp		Okumura, Yuko/0000-0002-2389-5818	Nippon Telegraph; Telephone Corporation; Grants-in-Aid for Scientific Research [25245067] Funding Source: KAKEN	Nippon Telegraph; Telephone Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors received no specific funding for this work. Nippon Telegraph and Telephone Corporation provided support in the form of salaries for authors [Yuko Okumura and Tessei Kobayashi], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson DR, 2005, AM BEHAV SCI, V48, P505, DOI 10.1177/0002764204271506; Barr R, 1999, CHILD DEV, V70, P1067, DOI 10.1111/1467-8624.00079; Brooks R, 2005, DEVELOPMENTAL SCI, V8, P535, DOI 10.1111/j.1467-7687.2005.00445.x; Cleveland A, 2007, INFANT CHILD DEV, V16, P295, DOI 10.1002/icd.508; CSIBRA G, 2010, MIND LANG, V25, P141, DOI DOI 10.1111/J.1468-0017.2009.01384.X; Csibra G, 2011, PHILOS T R SOC B, V366, P1149, DOI 10.1098/rstb.2010.0319; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; de Bordes PF, 2013, J EXP CHILD PSYCHOL, V116, P443, DOI 10.1016/j.jecp.2012.09.008; Egyed K, 2013, PSYCHOL SCI, V24, P1348, DOI 10.1177/0956797612471952; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Grossmann T, 2007, SOC COGN AFFECT NEUR, V2, P284, DOI 10.1093/scan/nsm025; Haun DBM, 2006, CURR BIOL, V16, P1736, DOI 10.1016/j.cub.2006.07.049; Johnson KM, 2016, INFANT CHILD DEV, V25, P406, DOI 10.1002/icd.1942; Kaldy Z, 2003, DEVELOPMENTAL SCI, V6, P360; KELLMAN PJ, 1983, COGNITIVE PSYCHOL, V15, P483, DOI 10.1016/0010-0285(83)90017-8; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Mareschal D, 1999, DEVELOPMENTAL SCI, V2, P306, DOI 10.1111/1467-7687.00076; Marno H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122129; Okumura Y, 2013, INTERACT STUD, V14, P351, DOI 10.1075/is.14.3.03oku; Okumura Y, 2013, COGNITION, V128, P127, DOI 10.1016/j.cognition.2013.03.011; Olah K, 2015, INFANT BEHAV DEV, V41, P73, DOI 10.1016/j.infbeh.2015.08.003; Parise E, 2008, SOC NEUROSCI-UK, V3, P141, DOI 10.1080/17470910701865458; Senju A, 2008, CURR BIOL, V18, P668, DOI 10.1016/j.cub.2008.03.059; Striano T, 2006, EUR J DEV PSYCHOL, V3, P289, DOI 10.1080/17405620600879779; Theuring C, 2007, EUR J DEV PSYCHOL, V4, P65, DOI 10.1080/17405620601051246; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Topal J, 2008, SCIENCE, V321, P1831, DOI 10.1126/science.1161437; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Tremoulet PD, 2000, COGNITIVE DEV, V15, P499, DOI 10.1016/S0885-2014(01)00038-7; Wilcox T, 1999, COGNITION, V72, P125, DOI 10.1016/S0010-0277(99)00035-9; Wilcox T, 2015, TRENDS COGN SCI, V19, P406, DOI 10.1016/j.tics.2015.04.009; Woodward AL, 2003, DEVELOPMENTAL SCI, V6, P297, DOI 10.1111/1467-7687.00286; Wu R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00251; Wu R, 2011, DEV PSYCHOL, V47, P1220, DOI 10.1037/a0024023; Xu F, 1996, COGNITIVE PSYCHOL, V30, P111, DOI 10.1006/cogp.1996.0005; Yoon JMD, 2008, P NATL ACAD SCI USA, V105, P13690, DOI 10.1073/pnas.0804388105	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165145	10.1371/journal.pone.0165145	http://dx.doi.org/10.1371/journal.pone.0165145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED7AX	27776155	Green Published, gold, Green Submitted			2022-12-26	WOS:000389009200043
J	Kim, YJ; Jung, K; Baek, DS; Hong, SS; Kim, YS				Kim, Y-J; Jung, K.; Baek, D-S; Hong, S-S; Kim, Y-S			Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin beta 1-drivenSrc-Akt bypass signaling	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; TUMOR-GROWTH; BISPECIFIC ANTIBODY; MONOCLONAL-ANTIBODY; ACTIVATION; ANGIOGENESIS; PENETRATION; FIBRONECTIN; METASTASIS	Pancreatic ductal adenocarcinoma (PDAC) cells usually overexpress the epidermal growth factor receptor (EGFR); however, most are resistant to the anti-EGFR monoclonal antibody, cetuximab. In this study, we report that the molecular mechanism of resistance to cetuximab in PDAC cells is mediated by the overexpression of active integrin beta 1 with downstream Src-Akt activation; this triggers an EGFR ligand-independent proliferation signaling, bypassing EGFR-blocking effect. Knockdown of integrin beta 1 or inhibition of Src or Akt sensitized cetuximab-resistant (Ctx(R)) PDAC cells to cetuximab. We found that neuropilin-1 (NRP1) physically interacts with active integrin beta 1, but not inactive one, on the cell surface. To inhibit active integrin beta 1-driven signaling by targeting NRP1, while suppressing EGFR signaling, we generated an EGFR and NRP1 dual targeting antibody, Ctx-TPP11, by genetic fusion of the NRP1-targeting peptide, TPP11, to the C terminus of the cetuximab heavy chain (Ctx-TPP11). We demonstrate that Ctx-TPP11 efficiently inhibited the growth of CtxR PDAC cells, in vitro and in vivo. The sensitization mechanism involved downregulating active integrin beta 1 levels through NRP1-coupled internalization mediated by the TPP11 moiety, leading to the inhibition of active integrin beta 1-driven bypass signaling. Our findings identify aberrant active integrin beta 1-driven Src-Akt hyperactivation as a primary resistance mechanism to cetuximab in PDAC cells and offer an effective therapeutic strategy to overcome this resistance using an EGFR and NRP1 dual targeting antibody.	[Kim, Y-J; Jung, K.; Baek, D-S; Kim, Y-S] Ajou Univ, Dept Mol Sci & Technol, 206 Worldcup Ro, Suwon 16499, South Korea; [Hong, S-S] Inha Univ, Dept Biomed Sci, Coll Med, Incheon, South Korea	Ajou University; Inha University	Kim, YS (corresponding author), Ajou Univ, Dept Mol Sci & Technol, 206 Worldcup Ro, Suwon 16499, South Korea.	kimys@ajou.ac.kr		Kim, Yong-Sung/0000-0003-2673-1509; Baek, Du-San/0000-0002-5356-6716; Jung, Keunok/0000-0003-2967-8432	Mid-career Researcher Program from the National Research Foundation - Korean government [2016R1A2A2A05005108]; Pioneer Research Center Program from the National Research Foundation - the Korean government [2014M3C1A3051470]	Mid-career Researcher Program from the National Research Foundation - Korean government; Pioneer Research Center Program from the National Research Foundation - the Korean government	This work was supported by grants from the Mid-career Researcher Program (2016R1A2A2A05005108) and the Pioneer Research Center Program (2014M3C1A3051470) from the National Research Foundation funded by the Korean government.	Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Arnoletti JP, 2004, J GASTROINTEST SURG, V8, P960, DOI 10.1016/j.gassur.2004.09.021; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Choi DK, 2014, MABS-AUSTIN, V6, P1402, DOI 10.4161/mabs.36389; Choi HJ, 2013, MOL CANCER THER, V12, P2748, DOI 10.1158/1535-7163.MCT-13-0628; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; De Franceschi N, 2015, J CELL SCI, V128, P839, DOI 10.1242/jcs.161653; Fotopoulou C, 2010, ANTICANCER RES, V30, P4619; Fukahi K, 2004, CLIN CANCER RES, V10, P581, DOI 10.1158/1078-0432.CCR-0930-03; Fukasawa M, 2007, CANCER BIOL THER, V6, P1173; Garrido-Laguna I, 2015, NAT REV CLIN ONCOL, V12, P319, DOI 10.1038/nrclinonc.2015.53; Guo HF, 2015, J BIOL CHEM, V290, P29120, DOI 10.1074/jbc.R115.687327; Hou S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18430; Iida M, 2013, ONCOGENE, V32, P759, DOI 10.1038/onc.2012.90; Jia H, 2010, BRIT J CANCER, V102, P541, DOI 10.1038/sj.bjc.6605539; Kanda R, 2013, CANCER RES, V73, P6243, DOI 10.1158/0008-5472.CAN-12-4502; Kim YJ, 2015, J CONTROL RELEASE, V216, P56, DOI 10.1016/j.jconrel.2015.08.016; Larbouret C, 2012, NEOPLASIA, V14, P121, DOI 10.1593/neo.111602; Li BH, 2013, CANCER RES, V73, P6471, DOI 10.1158/0008-5472.CAN-13-0657; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Matsushita A, 2007, CANCER RES, V67, P10309, DOI 10.1158/0008-5472.CAN-07-3256; Nguyen DH, 2002, J IMMUNOL, V168, P4121, DOI 10.4049/jimmunol.168.8.4121; Okon IS, 2014, J CLIN INVEST, V124, P4590, DOI 10.1172/JCI75371; Oliveira-Cunha Melissa, 2011, Cancers (Basel), V3, P1513, DOI 10.3390/cancers3021513; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Philip PA, 2010, J CLIN ONCOL, V28, P3605, DOI 10.1200/JCO.2009.25.7550; Prud'homme GJ, 2012, ONCOTARGET, V3, P921, DOI 10.18632/oncotarget.626; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Shin TH, 2014, MOL CANCER THER, V13, P651, DOI 10.1158/1535-7163.MCT-13-0748; Sugahara KN, 2015, MOL CANCER THER, V14, P120, DOI 10.1158/1535-7163.MCT-14-0366; Sung ES, 2009, MOL CANCER THER, V8, P2276, DOI 10.1158/1535-7163.MCT-09-0235; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wong MH, 2014, CLIN CANCER RES, V20, P4047, DOI 10.1158/1078-0432.CCR-13-3377; Yaqoob U, 2012, CANCER RES, V72, P4047, DOI 10.1158/0008-5472.CAN-11-3907; Ye F, 2012, BLOOD, V119, P26, DOI 10.1182/blood-2011-04-292128; Zeng FW, 2014, ANTI-CANCER DRUG, V25, P663, DOI 10.1097/CAD.0000000000000091	40	33	34	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 4	2017	36	18					2543	2552		10.1038/onc.2016.407	http://dx.doi.org/10.1038/onc.2016.407			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET9AN	27797376				2022-12-26	WOS:000400597300005
J	Liao, YH; Chiang, KH; Shieh, JM; Huang, CR; Shen, CJ; Huang, WC; Chen, BK				Liao, Y-H; Chiang, K-H; Shieh, J-M; Huang, C-R; Shen, C-J; Huang, W-C; Chen, B-K			Epidermal growth factor-induced ANGPTL4 enhances anoikis resistance and tumour metastasis in head and neck squamous cell carcinoma	ONCOGENE			English	Article							ANGIOPOIETIN-LIKE 4; COLORECTAL-CANCER; FACTOR RECEPTOR; VASCULAR-PERMEABILITY; ACTIVATION; EXPRESSION; INVASION; ANGIOGENESIS; DEGRADATION; PROGRESSION	Epidermal growth factor (EGF) is important for cancer cell proliferation, angiogenesis and metastasis in many types of cancer. However, the mechanisms involved in EGF-induced head and neck squamous cell carcinoma (HNSCC) metastasis remain largely unknown. In this study, we reveal that angiopoietin-like 4 (ANGPTL4) plays an important role in the regulation of EGF-induced cancer metastasis. We showed that EGF-induced ANGPTL4 expression promoted anoikis resistance and cancer cell migration and invasion in HNSCC. In addition, depletion of ANGPTL4 inhibited EGF-induced cancer cell invasion. Autocrine production of EGF-induced ANGPTL4 regulated the expression of matrix metalloproteinases (MMPs). The induction of MMP-1 gene expression by ANGPTL4-activated integrin beta 1 signalling occurred through the AP-1 binding site in the MMP-1 gene promoter. Furthermore, down-regulation of MMP-1 impeded EGF- and recombinant ANGPTL4-enhanced HNSCC cell migration and invasion. Depletion of ANGPTL4 significantly blocked EGF-primed extravasation and metastatic seeding of tumour cells and MMP-1 expression in lungs. However, no effect of ANGPTL4 on tumour growth was observed. These results suggest that EGF-induced expression and autocrine production of ANGPTL4 enhances HNSCC metastasis via the up-regulation of MMP-1 expression. Inhibition of ANGPTL4 expression may be a potential strategy for the treatment of EGFR-mediated HNSCC metastasis.	[Liao, Y-H; Huang, C-R; Shen, C-J; Huang, W-C; Chen, B-K] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan, Taiwan; [Chiang, K-H; Shieh, J-M] Chi Mei Med Ctr, Dept Chest Med, Tainan, Taiwan; [Huang, C-R] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Huang, W-C] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan; [Chen, B-K] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan, Taiwan; [Chen, B-K] Taipei Med Univ, Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan	National Cheng Kung University; Chi Mei Hospital; Taipei Medical University; Academia Sinica - Taiwan; National Cheng Kung University; Taipei Medical University	Huang, WC; Chen, BK (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, 1 Univ Rd, Tainan 701, Taiwan.	wchuang1@gate.sinica.edu.tw; bkchen58@mail.ncku.edu.tw	Huang, Wan-Chen/N-2472-2019	Huang, Wan-Chen/0000-0002-7341-4373; Huang, Chi-Ruei/0000-0001-9646-8852; Chen, Ben-Kuen/0000-0002-4720-4364	Ministry of Science and Technology of Taiwan [NSC 102-2628-B-006- 011-MY3, MOST 105-2320-B-006-022-MY3]; National Cheng Kung University	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University	This work was supported by the Ministry of Science and Technology of Taiwan [Grant NSC 102-2628-B-006- 011-MY3; MOST 105-2320-B-006-022-MY3]; and National Cheng Kung University [the Headquarters of University Advancement]. We thank for the kind gift of MMP-1 gene promoter-PGL3 from Dr Ju-Ming Wang.	Akishima-Fukasawa Y, 2011, HISTOPATHOLOGY, V59, P470, DOI 10.1111/j.1365-2559.2011.03964.x; Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Carvalho AL, 2005, INT J CANCER, V114, P806, DOI 10.1002/ijc.20740; Chang KY, 2011, CLIN CANCER RES, V17, P7116, DOI 10.1158/1078-0432.CCR-11-0796; Chang WC, 2015, ONCOTARGET, V6, P7741, DOI 10.18632/oncotarget.3482; Dawson JC, 2012, ONCOGENE, V31, P1781, DOI 10.1038/onc.2011.376; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Huang RL, 2011, BLOOD, V118, P3990, DOI 10.1182/blood-2011-01-328716; Humtsoe JO, 2010, ONCOGENE, V29, P1214, DOI 10.1038/onc.2009.419; Katanasaka Y, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-31; Kersten S, 2009, ARTERIOSCL THROM VAS, V29, P969, DOI 10.1161/ATVBAHA.108.182147; Kim SH, 2011, CANCER RES, V71, P7010, DOI 10.1158/0008-5472.CAN-11-1262; Kimura R, 2011, BBA-MOL CELL RES, V1813, P1543, DOI 10.1016/j.bbamcr.2011.04.008; Kuo TC, 2013, J CLIN INVEST, V123, P1082, DOI 10.1172/JCI64044; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Maekawa Yuichiro, 2011, Inflammation & Allergy Drug Targets, V10, P229; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Masuelli L, 2012, J CELL PHYSIOL, V227, P3344, DOI 10.1002/jcp.24034; Mathieu M, 2014, J BIOL CHEM, V289, P8402, DOI 10.1074/jbc.M113.539825; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Murata M, 2009, J ORTHOP RES, V27, P50, DOI 10.1002/jor.20703; Nakayama T, 2011, ONCOL REP, V25, P929, DOI 10.3892/or.2011.1176; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Okochi-Takada E, 2014, ONCOGENE, V33, P2273, DOI 10.1038/onc.2013.174; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Sun Y, 2014, ONCOL LETT, V8, P211, DOI 10.3892/ol.2014.2071; Tanaka J, 2015, J ORAL PATHOL MED, V44, P126, DOI 10.1111/jop.12212; Terada LS, 2011, CANCER CELL, V19, P297, DOI 10.1016/j.ccr.2011.02.019; Tichet M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7993; Xiao YC, 2015, CANCER LETT, V361, P22, DOI 10.1016/j.canlet.2015.02.021; Zeng QH, 2002, J BIOL CHEM, V277, P25203, DOI 10.1074/jbc.M201598200; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018; Zuo JH, 2011, J CELL BIOCHEM, V112, P2508, DOI 10.1002/jcb.23175	41	40	41	3	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2228	2242		10.1038/onc.2016.371	http://dx.doi.org/10.1038/onc.2016.371			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	27797381	Green Published, hybrid			2022-12-26	WOS:000399782700004
J	Aoun, J; Hayashi, M; Sheikh, IA; Sarkar, P; Saha, T; Ghosh, P; Bhowmick, R; Ghosh, D; Chatterjee, T; Chakrabarti, P; Chakrabarti, MK; Hoque, KM				Aoun, Joydeep; Hayashi, Mikio; Sheikh, Irshad Ali; Sarkar, Paramita; Saha, Tultul; Ghosh, Priyanka; Bhowmick, Rajsekhar; Ghosh, Dipanjan; Chatterjee, Tanaya; Chakrabarti, Pinak; Chakrabarti, Manoj K.; Hoque, Kazi Mirajul			Anoctamin 6 Contributes to Cl- Secretion in Accessory Cholera Enterotoxin (Ace)-stimulated Diarrhea AN ESSENTIAL ROLE FOR PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE (PIP2) SIGNALING IN CHOLERA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CHANNEL; TMEM16 PROTEIN FAMILY; SCRAMBLASE ACTIVITY; ION-CHANNEL; RHO GTPASES; EXPRESSION; ACE; MODULATION; 4-KINASE; DOMAIN	Accessory cholera enterotoxin (Ace) of Vibrio cholerae has been shown to contribute to diarrhea. However, the signaling mechanism and specific type of Cl- channel activated by Ace are still unknown. We have shown here that the recombinant Ace protein induced I-Cl of apical plasma membrane, which was inhibited by classical CaCC blockers. Surprisingly, an Ace-elicited rise of current was neither affected by ANO1 (TMEM16A)specific inhibitor T16A((inh))-AO1(TAO1) nor by the cystic fibrosis transmembrane conductance regulator (CFTR) blocker, CFTR inh-172. Ace stimulated whole-cell current in Caco-2 cells. However, the apical I-Cl was attenuated by knockdown of ANO6 (TMEM16F). This impaired phenotype was restored by re-expression of ANO6 in Caco-2 cells. Whole-cell patch clamp recordings of ANO currents in HEK293 cells transiently expressing mouse ANO1-mCherry or ANO6-GFP confirmed that Ace induced Cl- secretion. Application of Ace produced ANO6 but not the ANO1 currents. Ace was not able to induce a [Ca2+](i) rise in Caco-2 cells, but cellular abundance of phosphatidylinositol 4,5-bisphosphate (PIP2) increased. Identification of the PIP2-binding motif at the N-terminal sequence among human and mouse ANO6 variants along with binding of PIP2 directly to ANO6 in HEK293 cells indicate likely PIP2 regulation of ANO6. The biophysical and pharmacological properties of Ace stimulated Cl- current along with intestinal fluid accumulation, and binding of PIP2 to the proximal KR motif of channel proteins, whose mutagenesis correlates with altered binding of PIP2, is comparable with ANO6 stimulation. We conclude that ANO6 is predominantly expressed in intestinal epithelia, where it contributes secretory diarrhea by Ace stimulation in a calcium-independent mechanism of RhoA-ROCK-PIP2 signaling.	[Aoun, Joydeep; Sheikh, Irshad Ali; Sarkar, Paramita; Saha, Tultul; Ghosh, Priyanka; Bhowmick, Rajsekhar; Chakrabarti, Manoj K.; Hoque, Kazi Mirajul] Natl Inst Cholera & Enter Dis, Mol Pathophysiol Div, P-33,CIT Rd, Kolkata 700010, India; [Hayashi, Mikio] Kansai Med Univ, Dept Physiol, 5-1,Shimmachi 2, Hirakata, Osaka 5731010, Japan; [Ghosh, Dipanjan] Univ Calcutta, Dept Biotechnol, Coll Sci & Technol, 35 Ballygunge Circular Rd, Kolkata 700019, India; [Chatterjee, Tanaya; Chakrabarti, Pinak] Bose Inst, Dept Biochem, P-1-12 CIT Rd, Kolkata 700054, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Kansai Medical University; University of Calcutta; Department of Science & Technology (India); Bose Institute	Hoque, KM (corresponding author), Natl Inst Cholera & Enter Dis, Mol Pathophysiol Div, P-33,CIT Rd, Kolkata 700010, India.	kmh_niced@yahoo.co.in	VELAYUTHAM, RAVICHANDIRAN/HGU-8028-2022; Sheikh, Irshad/AAD-6196-2022; Kazi, Mirajul Hoque/AAR-5291-2021	Aoun, Joydeep/0000-0003-1938-2830; Saha, Tultul/0000-0002-7913-9640	Government of India, Ministry of Science and Technology, Department of Biotechnology [BT/HRD/35/02/07/2009]; Japan Society for the Promotion of Science KAKENHI [24790226]; Indian Council of Medical Research, Government of India; Department of Science and Technology fellowship	Government of India, Ministry of Science and Technology, Department of Biotechnology; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Department of Science and Technology fellowship(Department of Science & Technology (India))	This work was supported in part by Government of India, Ministry of Science and Technology, Department of Biotechnology Grant BT/HRD/35/02/07/2009 (to K. M. H.), Japan Society for the Promotion of Science KAKENHI Grant 24790226 (to M. H.), Indian Council of Medical Research, Government of India (to I. A. S., J. A.), and a Department of Science and Technology fellowship (to P. S.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1582, DOI 10.1111/bph.12446; Anvari S, 2012, CELL J, V14, P209; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bhattacharya M, 2004, BIOCHEM SOC T, V32, P1040, DOI 10.1042/BST0321040; BOIVIN D, 1995, AM J PHYSIOL-RENAL, V269, pF180, DOI 10.1152/ajprenal.1995.269.2.F180; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chatterjee T, 2011, BIOCHEMISTRY-US, V50, P2962, DOI 10.1021/bi101673x; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DE SN, 1953, J PATHOL BACTERIOL, V66, P559, DOI 10.1002/path.1700660228; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; Fasano A, 1997, J CLIN INVEST, V99, P1158, DOI 10.1172/JCI119271; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hoque KM, 2010, J GEN PHYSIOL, V135, P43, DOI 10.1085/jgp.200910339; Hoque KM, 2005, AM J PHYSIOL-GASTR L, V288, pG956, DOI 10.1152/ajpgi.00441.2004; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kunzelmann K, 2001, NEWS PHYSIOL SCI, V16, P167; Morris AP, 1999, AM J PHYSIOL-GASTR L, V277, pG431, DOI 10.1152/ajpgi.1999.277.2.G431; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Ousingsawat J, 2011, PFLUG ARCH EUR J PHY, V461, P579, DOI 10.1007/s00424-011-0947-0; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schultheiss G, 2005, PFLUG ARCH EUR J PHY, V449, P553, DOI 10.1007/s00424-004-1365-3; Scudieri P, 2015, J PHYSIOL-LONDON, V593, P3829, DOI 10.1113/JP270691; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; Sheikh IA, 2013, J BIOL CHEM, V288, P20404, DOI 10.1074/jbc.M113.467860; Shimizu T, 2013, AM J PHYSIOL-CELL PH, V304, pC748, DOI 10.1152/ajpcell.00228.2012; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; TRUCKSIS M, 1993, P NATL ACAD SCI USA, V90, P5267, DOI 10.1073/pnas.90.11.5267; Trucksis M, 2000, AM J PHYSIOL-CELL PH, V279, pC567, DOI 10.1152/ajpcell.2000.279.3.C567; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang SA, 2004, J BIOL CHEM, V279, P42331, DOI 10.1074/jbc.M404335200; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; YU FX, 1992, J BIOL CHEM, V267, P14616	50	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26816	26836		10.1074/jbc.M116.719823	http://dx.doi.org/10.1074/jbc.M116.719823			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27799301	hybrid, Green Published			2022-12-26	WOS:000391571400020
J	Young, PA; Migliorini, M; Strickland, DK				Young, Patricia A.; Migliorini, Mary; Strickland, Dudley K.			Evidence That Factor VIII Forms a Bivalent Complex with the Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) IDENTIFICATION OF CLUSTER IV ON LRP1 AS THE MAJOR BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-VIII; HIGH-AFFINITY BINDING; ALPHA-2-MACROGLOBULIN RECEPTOR; LIGAND-BINDING; FACTOR IXA; RAP COMPLEX; MOUSE MODEL; A2 DOMAIN; CHAPERONE; RESIDUES	Hemophilia A is a bleeding disorder caused by a deficiency in coagulation factor VIII (fVIII) that affects 1 in 5,000 males. Current prophylactic replacement therapy, although effective, is difficult to maintain due to the cost and frequency of injections. Hepatic clearance of fVIII is mediated by the LDL receptor-related protein 1 (LRP1), a member of the LDL receptor family. Although it is well established that fVIII binds LRP1, the molecular details of this interaction are unclear as most of the studies have been performed using fragments of fVIII and LRP1. In the current investigation, we examine the binding of intact fVIII to full-length LRP1 to gain insight into the molecular interaction. Chemical modification studies confirm the requirement for lysine residues in the interaction of fVIII with LRP1. Examination of the ionic strength dependence of the interaction of fVIII with LRP1 resulted in a Debye-Huckel plot with a slope of 1.8 +/- 0.5, suggesting the involvement of two critical charged residues in the interaction of fVIII with LRP1. Kinetic studies utilizing surface plasmon resonance techniques reveal that the high affinity of fVIII for LRP1 results from avidity effects mediated by the interactions of two sites in fVIII with complementary sites on LRP1 to form a bivalent fVIII.LRP1 complex. Furthermore, although fVIII bound avidly to soluble forms of clusters II and IV from LRP1, only soluble cluster IV competed with the binding of fVIII to full-length LRP1, revealing that cluster IV represents the major fVIII binding site in LRP1.	Univ Maryland, Ctr Vasc & Inflammatory Dis, Sch Med, Baltimore, MD 21201 USA; Univ Maryland, Dept Surg, Sch Med, Baltimore, MD 21201 USA; Univ Maryland, Dept Physiol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Strickland, DK (corresponding author), Ctr Vasc & Inflammatory Dis, Biopk 1,R219,800 W Baltimore St, Baltimore, MD 21201 USA.	dstrickland@som.umaryland.edu			National Institutes of Health [HL114379, HL120388, T32 HL007698, F31 HL131283]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114379, R01HL120388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL114379 and HL120388 (to D. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Grants T32 HL007698 and F31 HL131283.	ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; Bloem E, 2013, J BIOL CHEM, V288, P29670, DOI 10.1074/jbc.M113.473116; Bovenschen N, 2006, J THROMB HAEMOST, V4, P1487, DOI 10.1111/j.1538-7836.2006.01965.x; Bovenschen N, 2005, BLOOD, V106, P906, DOI 10.1182/blood-2004-11-4230; Bovenschen N, 2003, J BIOL CHEM, V278, P9370, DOI 10.1074/jbc.M212053200; Bovenschen N, 2003, BLOOD, V101, P3933, DOI 10.1182/blood-2002-07-2081; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Collins PW, 2009, J THROMB HAEMOST, V7, P413, DOI 10.1111/j.1538-7836.2008.03270.x; Doering CB, 2002, J BIOL CHEM, V277, P38345, DOI 10.1074/jbc.M206959200; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; Everett LA, 2014, BLOOD, V123, P3697, DOI 10.1182/blood-2014-02-554501; Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fischer K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006745; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; HEALEY JF, 1995, J BIOL CHEM, V270, P14505, DOI 10.1074/jbc.270.24.14505; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Kurasawa JH, 2015, BIOCHEMISTRY-US, V54, P481, DOI 10.1021/bi5011688; Lee D, 2007, PROTEIN SCI, V16, P1628, DOI 10.1110/ps.072865407; Lenting PJ, 1999, J BIOL CHEM, V274, P23734, DOI 10.1074/jbc.274.34.23734; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; LIND P, 1995, EUR J BIOCHEM, V232, P19, DOI 10.1111/j.1432-1033.1995.tb20776.x; Makarova A, 2008, NEUROSCI LETT, V442, P91, DOI 10.1016/j.neulet.2008.06.070; Meijer AB, 2007, BBA-PROTEINS PROTEOM, V1774, P714, DOI 10.1016/j.bbapap.2007.04.003; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Pipe SW, 1999, BLOOD, V93, P176, DOI 10.1182/blood.V93.1.176.401k07_176_183; Prasad JM, 2016, J BIOL CHEM, V291, P18430, DOI 10.1074/jbc.M116.744904; Prasad JM, 2015, J BIOL CHEM, V290, P17262, DOI 10.1074/jbc.M115.660084; Rastegarlari G, 2012, BLOOD, V119, P2126, DOI 10.1182/blood-2011-08-373605; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Saenko EL, 1999, J BIOL CHEM, V274, P37685, DOI 10.1074/jbc.274.53.37685; Saenko EL, 2002, BRIT J HAEMATOL, V119, P323, DOI 10.1046/j.1365-2141.2002.03793.x; Sarafanov AG, 2006, BIOCHEMISTRY-US, V45, P1829, DOI 10.1021/bi0520380; Sarafanov AG, 2007, THROMB HAEMOSTASIS, V98, P1170, DOI 10.1160/TH07-05-0353; Schwarz HP, 2000, BLOOD, V95, P1703, DOI 10.1182/blood.V95.5.1703.005k20_1703_1708; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; Svensson LA, 2013, BIOL CHEM, V394, P761, DOI 10.1515/hsz-2012-0298; van den Biggelaar M, 2015, J BIOL CHEM, V290, P16463, DOI 10.1074/jbc.M115.650911; Vlot AJ, 1996, BLOOD, V87, P1809; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Wohner N, 2015, J THROMB HAEMOST, V13, P815, DOI 10.1111/jth.12885	51	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26035	26044		10.1074/jbc.M116.754622	http://dx.doi.org/10.1074/jbc.M116.754622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27794518	hybrid, Green Published			2022-12-26	WOS:000390345200023
J	Alves, CJ; Alencastre, IS; Neto, E; Ribas, J; Ferreira, S; Vasconcelos, DM; Sousa, DM; Summavielle, T; Lamghari, M				Alves, Cecilia J.; Alencastre, Ines S.; Neto, Estrela; Ribas, Joao; Ferreira, Sofia; Vasconcelos, Daniel M.; Sousa, Daniela M.; Summavielle, Teresa; Lamghari, Meriem			Bone Injury and Repair Trigger Central and Peripheral NPY Neuronal Pathways	PLOS ONE			English	Article							NEUROPEPTIDE-Y Y1; IMMUNOREACTIVE NERVES; KNOCKOUT MICE; Y-1 RECEPTOR; EXPRESSION; IMMUNE; INHIBITION; DIFFERENTIATION; STABILIZATION; LOCALIZATION	Bone repair is a specialized type of wound repair controlled by complex multi-factorial events. The nervous system is recognized as one of the key regulators of bone mass, thereby suggesting a role for neuronal pathways in bone homeostasis. However, in the context of bone injury and repair, little is known on the interplay between the nervous system and bone. Here, we addressed the neuropeptide Y (NPY) neuronal arm during the initial stages of bone repair encompassing the inflammatory response and ossification phases in femoral-defect mouse model. Spatial and temporal analysis of transcriptional and protein levels of NPY and its receptors, Y1R and Y2R, reported to be involved in bone homeostasis, was performed in bone, dorsal root ganglia (DRG) and hypothalamus after femoral injury. The results showed that NPY system activity is increased in a time- and space-dependent manner during bone repair. Y1R expression was trigged in both bone and DRG throughout the inflammatory phase, while a Y2R response was restricted to the hypothalamus and at a later stage, during the ossification step. Our results provide new insights into the involvement of NPY neuronal pathways in bone repair.	[Alves, Cecilia J.; Alencastre, Ines S.; Neto, Estrela; Vasconcelos, Daniel M.; Sousa, Daniela M.; Summavielle, Teresa; Lamghari, Meriem] Univ Porto, I3S, Oporto, Portugal; [Alves, Cecilia J.; Alencastre, Ines S.; Neto, Estrela; Ribas, Joao; Ferreira, Sofia; Vasconcelos, Daniel M.; Sousa, Daniela M.; Lamghari, Meriem] Univ Porto, Inst Engn Biomed INEB, Oporto, Portugal; [Neto, Estrela] Univ Porto FMUP, Fac Med, Oporto, Portugal; [Vasconcelos, Daniel M.; Lamghari, Meriem] Univ Porto, ICBAS, Oporto, Portugal; [Summavielle, Teresa] Univ Porto, IBMC, Oporto, Portugal; [Summavielle, Teresa] Inst Politecn Porto, Escola Super Tecnol Saude Porto, Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Polytechnic Institute of Porto	Lamghari, M (corresponding author), Univ Porto, I3S, Oporto, Portugal.; Lamghari, M (corresponding author), Univ Porto, Inst Engn Biomed INEB, Oporto, Portugal.; Lamghari, M (corresponding author), Univ Porto, ICBAS, Oporto, Portugal.	lamghari@ineb.up.pt	Neto, Estrela C/M-2561-2013; Summavielle, Teresa/C-9776-2012; Sousa, Daniela/C-1485-2014; Summavielle, Teresa/ABB-5335-2020; Lamghari, Meriem/K-2159-2013	Neto, Estrela C/0000-0003-2334-2292; Summavielle, Teresa/0000-0003-2548-6281; Sousa, Daniela/0000-0001-8498-0664; Summavielle, Teresa/0000-0003-2548-6281; Vasconcelos, Daniel/0000-0003-3474-5193; Lamghari, Meriem/0000-0002-2500-4548; Alencastre, Ines/0000-0002-5591-5596; Alves, Cecilia Juliana/0000-0002-0719-574X; Ferreira, Sofia/0000-0003-2066-6865	Norte Portugal Regional Operational Programme (NORTE) under the PORTUGAL Partnership Agreement, through the European Regional Development Fund (ERDF) [NORTE-01-0145-FEDER-000012]; FCT [SFRH/BPD/63618/2009, SFRH/BPD/75285/2010, SFRH/BD/81152/2011, SFRH/BD/87516/2012]	Norte Portugal Regional Operational Programme (NORTE) under the PORTUGAL Partnership Agreement, through the European Regional Development Fund (ERDF); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This article is a result of the project NORTE-01-0145-FEDER-000012, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). CJA, ISA, EN and DMV are supported by FCT (SFRH/BPD/63618/2009, SFRH/BPD/75285/2010, SFRH/BD/81152/2011, and SFRH/BD/87516/2012, respectively).	Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Allison SJ, 2006, J BIOL CHEM, V281, P23436, DOI 10.1074/jbc.M604839200; Amano S, 2007, BBA-GEN SUBJECTS, V1770, P966, DOI 10.1016/j.bbagen.2007.02.009; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; BJURHOLM A, 1988, J AUTONOM NERV SYST, V25, P119, DOI 10.1016/0165-1838(88)90016-1; Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265; Brothers SP, 2010, EMBO MOL MED, V2, P429, DOI 10.1002/emmm.201000100; Brumovsky PR, 2004, BRAIN RES, V1006, P87, DOI 10.1016/j.brainres.2003.09.085; Campbell TM, 2003, CALCIFIED TISSUE INT, V73, P49, DOI 10.1007/s00223-002-2120-4; Chandrasekharan B, 2013, AM J PHYSIOL-GASTR L, V304, pG949, DOI 10.1152/ajpgi.00493.2012; Chen XL, 1997, AM J PHYSIOL-HEART C, V273, pH1737, DOI 10.1152/ajpheart.1997.273.4.H1737; Ekstrand AJ, 2003, P NATL ACAD SCI USA, V100, P6033, DOI 10.1073/pnas.1135965100; Farzi A, 2015, ACTA PHYSIOL, V213, P603, DOI 10.1111/apha.12445; Ferreira-Gomes J, 2012, MOL PAIN, V8, DOI [10.1186/1744-8069-850, 10.1186/1744-8069-8-50]; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Gibbs JL, 2006, PAIN, V124, P167, DOI 10.1016/j.pain.2006.04.013; HILL EL, 1991, CELL TISSUE RES, V264, P469, DOI 10.1007/BF00319037; Hirsch D, 2012, CELL MOL NEUROBIOL, V32, P645, DOI 10.1007/s10571-011-9793-z; Igwe JC, 2009, J CELL BIOCHEM, V108, P621, DOI 10.1002/jcb.22294; Kostic S, 2013, EUR J PAIN, V17, P493, DOI 10.1002/j.1532-2149.2012.00218.x; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Lee NJ, 2011, BONE, V48, P461, DOI 10.1016/j.bone.2010.10.174; Lee NJ, 2010, J BONE MINER RES, V25, P1736, DOI 10.1002/jbmr.61; Li JJ, 2005, PAIN, V118, P232, DOI 10.1016/j.pain.2005.08.023; Long H, 2010, ACTA ORTHOP, V81, P639, DOI 10.3109/17453674.2010.504609; Lundberg P, 2007, J BIOL CHEM, V282, P19082, DOI 10.1074/jbc.M609629200; MANTYH PW, 1994, J NEUROSCI, V14, P3958; Nunes AF, 2010, FEBS J, V277, P263, DOI 10.1111/j.1742-4658.2009.07482.x; Otkjaer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008671; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Pongratz G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0504-2; Sapunar D, 2011, PAIN, V152, P1173, DOI 10.1016/j.pain.2011.01.045; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7; Shi YC, 2012, BONE, V50, P430, DOI 10.1016/j.bone.2011.10.001; Silva AP, 2005, BIOL CELL, V97, P457, DOI 10.1042/BC20040102; Singer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057929; Sousa DM, 2013, J ORTHOP RES, V31, P1570, DOI 10.1002/jor.22400; Sousa DM, 2012, BONE, V51, P8, DOI 10.1016/j.bone.2012.03.020; Taylor BK, 2014, NEUROSCIENCE, V256, P178, DOI 10.1016/j.neuroscience.2013.10.054; von Horsten S, 1998, BRAIN RES, V806, P282, DOI 10.1016/S0006-8993(98)00772-0; WAKISAKA S, 1991, NEUROSCI LETT, V124, P200, DOI 10.1016/0304-3940(91)90093-9; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Wheway J, 2007, CURR TOP MED CHEM, V7, P1743, DOI 10.2174/156802607782341046; Wheway J, 2007, PEPTIDES, V28, P453, DOI 10.1016/j.peptides.2006.09.030; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; ZHANG X, 1994, P NATL ACAD SCI USA, V91, P11738, DOI 10.1073/pnas.91.24.11738	50	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165465	10.1371/journal.pone.0165465	http://dx.doi.org/10.1371/journal.pone.0165465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802308	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200024
J	Zhao, XY; Zheng, TC; Shao, LT; Xiao, ZH; Wang, FW; Li, SC; Zang, L; Zheng, M; Li, Y; Qu, GZ				Zhao, Xiyang; Zheng, Tangchun; Shao, Longting; Xiao, Zhenhai; Wang, Fuwei; Li, Shuchun; Zang, Lina; Zheng, Mi; Li, Ying; Qu, Guan-Zheng			Variation Analysis of Physiological Traits in Betula platyphylla Overexpressing TaLEA-ThbZIP Gene under Salt Stress	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ELEVATED CO2; LEA PROTEINS; TOLERANCE; ARABIDOPSIS; EXPRESSION; EMBRYOGENESIS; POPULATIONS; SUPEROXIDE; RESISTANCE	The aim of this study was to determine whether transgenic birch (Betula platyphylla) ectopic overexpressing a late embryogenesis abundant (LEA) gene and a basic leucine zipper (bZIP) gene from the salt-tolerant genus Tamarix (salt cedar) show increased tolerance to salt (NaCl) stress. Co-transfer of TaLEA and ThbZIP in birch under the control of two independent CaMV 35S promoters significantly enhanced salt stress. PCR and northern blot analyses indicated that the two genes were ectopically overexpressed in several dual-gene transgenic birch lines. We compared the effects of salt stress among three transgenic birch lines (L-4, L-5, and L-8) and wild type (WT). In all lines, the net photosynthesis values were higher before salt stress treatment than afterwards. After the salt stress treatment, the transgenic lines L-4 and L-8 showed higher values for photosynthetic traits, chlorophyll fluorescence, peroxidase and superoxide dismutase activities, and lower malondialdehyde and Na+ contents, compared with those in WT and L-5. These different responses to salt stress suggested that the transcriptional level of the TaLEA and ThbZIP genes differed among the transgenic lines, resulting in a variety of genetic and phenotypic effects. The results of this research can provide a theoretical basis for the genetic engineering of saltt-olerant trees.	[Zhao, Xiyang; Zheng, Tangchun; Shao, Longting; Zang, Lina; Zheng, Mi; Li, Ying; Qu, Guan-Zheng] Northeast Forestry Univ, Sch Forestry, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China; [Zheng, Tangchun] Beijing Forestry Univ, Beijing Key Lab Ornamental Plants Germplasm Innov, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing Lab Urban & Rural Ecol Environm,Natl Engn, Beijing 100083, Peoples R China; [Xiao, Zhenhai; Wang, Fuwei; Li, Shuchun] Forestry Dept Jilin Prov, Tree Seedling Management Stn, Changchun 130000, Peoples R China	Northeast Forestry University - China; Beijing Forestry University	Zhao, XY; Li, Y; Qu, GZ (corresponding author), Northeast Forestry Univ, Sch Forestry, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China.	zhaoxyphd@163.com; winglee.sakuraco@gmail.com; quguanzheng@yahoo.com			National 863 Program of China [2013AA102704]; National Science and Technology Pillar Program of China [2012BAD21B02]	National 863 Program of China(National High Technology Research and Development Program of China); National Science and Technology Pillar Program of China	This work was supported by the National 863 Program of China (No. 2013AA102704) and National Science and Technology Pillar Program of China (No. 2012BAD21B02).; This work was supported by the grants from the National 863 Program of China (No. 2013AA102704) and the National Science and Technology Pillar Program of China (No. 2012BAD21B02).	Ahuja MR, 2009, TREES-STRUCT FUNCT, V23, P1125, DOI 10.1007/s00468-009-0362-8; ALARCON JJ, 1993, PHYSIOL PLANTARUM, V89, P441, DOI 10.1111/j.1399-3054.1993.tb05196.x; Baucher M, 2003, CRIT REV BIOCHEM MOL, V38, P305, DOI 10.1080/10409230390242443; Bent AF, 2000, PLANT PHYSIOL, V124, P1540, DOI 10.1104/pp.124.4.1540; Bohnert HJ, 1996, ANN NY ACAD SCI, V792, P115, DOI 10.1111/j.1749-6632.1996.tb32498.x; Chen FG, 2010, PHYSIOL PLANTARUM, V140, P163, DOI 10.1111/j.1399-3054.2010.01393.x; Cheng YunJiang, 2003, Plant Molecular Biology Reporter, V21, p177a, DOI 10.1007/BF02774246; Deng JY, 2009, THESIS; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; DIPPERY JK, 1995, OECOLOGIA, V101, P13, DOI 10.1007/BF00328894; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; Filichkin SA, 2006, PLANT SCI, V171, P206, DOI 10.1016/j.plantsci.2006.03.011; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Gal TZ, 2004, FEBS LETT, V577, P21, DOI 10.1016/j.febslet.2004.09.049; Gao SQ, 2011, PLANT MOL BIOL, V75, P537, DOI 10.1007/s11103-011-9738-4; Gao WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067462; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Hansen JK, 1997, SILVAE GENET, V46, P107; Health RL, 1968, BIOCH BIOPHYS, V125, P189; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jiang J, 2001, B BOT RES, V21, P136; Jiang TB, 2011, MOL BREEDING, V27, P347, DOI 10.1007/s11032-010-9436-y; Karakas D, 2000, HORTSCIENCE, V35, P83; KELLOGG EW, 1975, J BIOL CHEM, V250, P8812; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lee SC, 2006, PLANTA, V224, P1209, DOI 10.1007/s00425-006-0302-4; Li BL, 1989, ACTA PHYTOPHYSIOGICA, V15, P6; Li KaiLong, 2006, Journal of Beijing Forestry University, V28, P82; LI P, 1995, CHEM IND FOR PROD, V15, P13; Li YuanYuan, 2013, Journal of Nanjing Forestry University (Natural Sciences Edition), V37, P6; Liang CY, 2004, PLANT SCI, V167, P491, DOI 10.1016/j.plantsci.2004.04.015; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Liimatainen J, 2012, J CHEM ECOL, V38, P1410, DOI 10.1007/s10886-012-0199-2; Linnakoski R, 2009, PERSOONIA, V23, P9, DOI 10.3767/003158509X468038; Liu Xia, 2013, Journal of Southwest Forestry University, V33, P93; Mukherjee K, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-18; Park BJ, 2005, PLANT GROWTH REGUL, V45, P165, DOI 10.1007/s10725-004-7924-y; Qu GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063398; Qu GZ, 2012, PLANT MOL BIOL REP, V30, P512, DOI 10.1007/s11105-011-0371-9; Rao MV, 1966, PLANT PHYSIOL, V110, P125; RoyChoudhury A, 2007, PLANT CELL REP, V26, P1839, DOI 10.1007/s00299-007-0371-2; Shao HB, 2005, COLLOID SURFACE B, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; Singh S, 2005, PROTEIN SCI, V14, P2601, DOI 10.1110/ps.051579205; Surabhi GK, 2009, ENVIRON EXP BOT, V66, P160, DOI 10.1016/j.envexpbot.2009.02.004; Taniguchi T, 2008, J WOOD SCI, V54, P408, DOI 10.1007/s10086-008-0967-3; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Wang YC, 2006, PLANT SCI, V171, P655, DOI 10.1016/j.plantsci.2006.06.011; Wang YC, 2010, J PLANT PHYSIOL, V167, P222, DOI 10.1016/j.jplph.2009.09.008; Ward JK, 1999, TREE PHYSIOL, V19, P211; [魏志刚 Wei Zhigang], 2006, [分子植物育种, Molecular Plant Breeding], V4, P835; Wei Z, 2010, PLANT MOL BIOL REP, V28, P169, DOI 10.1007/s11105-009-0138-8; White T. L., 2007, FOREST GENETICS; Xu HG, 2004, HALOPHYTE SALINIZATI; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Yang C.P., 2004, SCI SILVAE SINICAE, V40, P14; Yu Fang-yuan, 2004, Journal of Forestry Research (Harbin), V15, P24, DOI 10.1007/BF02858005; [于振群 YU Zhenqun], 2007, [西北林学院学报, Journal of Northwest Forestry College], V22, P47; Zeng J, 2003, EUPHYTICA, V134, P33, DOI 10.1023/A:1026113506563; Zhan YaGuang, 2006, Bulletin of Botanical Research, V26, P480; Zhao XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119259; Zhou Yu-mei, 2002, Journal of Forestry Research (Harbin), V13, P209, DOI 10.1007/BF02871699	63	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0164820	10.1371/journal.pone.0164820	http://dx.doi.org/10.1371/journal.pone.0164820			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802286	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200010
J	Lee, G; Jung, H; Yoon, M				Lee, Geumhui; Jung, Heejun; Yoon, Minjung			The Lin28 Expression in Stallion Testes	PLOS ONE			English	Article							STEM-CELLS; LIN-28; GENE; PLURIPOTENCY; MEIOSIS; MARKER; FAMILY	The molecular markers for specific germ cell stages can be utilized for identifying, monitoring, and separating a particular stage of germ cells. The RNA-binding protein Lin28 is expressed in gonocytes of human fetal testes. The Lin28 expression is restricted to a very small population of spermatogonial cells in human, mice, and monkey. The main objective of this study was to investigate the expression pattern of Lin28 in stallion testes at different reproductive stages. Based on the presence or absence of full spermatogenesis and lumina in seminiferous tubules, the testicular samples were categorized into two reproductive stages pre-pubertal and post-pubertal. We performed a reverse transcription polymerase chain reaction to confirm the presence of Lin28 mRNA in the testicular tissues and a western blot analysis to verify the cross-reactivity of rabbit Lin28 antibody with horse testicular tissue. For immunohistochemistry, Lin28 (rabbit anti-human), GATA4 (goat antihuman) or DAZL (goat anti-human) antibodies were used. The results of RT-PCR confirmed the expression of Lin28 mRNA in the stallion testes. The western blot analysis showed that the expression of 28 kDa Lin28 protein was localized in the cytoplasm of spermatogonia at both reproductive stages. The numbers of Lin28-positive germ cells per 1000 Sertoli cells in pre- and post-pubertal stages were 253 +/- 8.66 and 29.67 +/- 2.18, respectively. At both reproductive stages, all Lin28 positive cells showed no co-stained with GATA4 antibody, whereas only some of the Lin28-positive germ cells showed co-staining with DAZL antibody. The results from whole-mount staining showed that the Lin28 expression was limited to A(single) (A(s)) and A(paired) (A(pr)) spermatogonia. In conclusion, Lin28 might be utilized as a molecular marker for undifferentiated spermatogonial stem cells when used with DAZL antibody.	[Lee, Geumhui; Yoon, Minjung] Kyungpook Natl Univ, Dept Horse Compan & Wild Anim Sci, Sangju, South Korea; [Jung, Heejun; Yoon, Minjung] Kyungpook Natl Univ, Dept Anim Sci & Biotechnol, Sangju, South Korea	Kyungpook National University; Kyungpook National University	Yoon, M (corresponding author), Kyungpook Natl Univ, Dept Horse Compan & Wild Anim Sci, Sangju, South Korea.; Yoon, M (corresponding author), Kyungpook Natl Univ, Dept Anim Sci & Biotechnol, Sangju, South Korea.	mjyoonemail@gmail.com			Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) [114052-3]; Ministry of Agriculture, Food and Rural Affairs (MAFRA) [114052-3]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET); Ministry of Agriculture, Food and Rural Affairs (MAFRA)	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET), 114052-3, http/www.ipet.re.kr/.; Authors would like to thank Dr. Deokjin Jang and Yongwoo Jun (Kyungpook National University) for their assistance in the data collection. This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Advanced Production Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (114052-3)	Aeckerle N, 2015, MOL HUM REPROD, V21, P552, DOI 10.1093/molehr/gav016; Aeckerle N, 2012, MOL HUM REPROD, V18, P477, DOI 10.1093/molehr/gas025; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Costa GMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044091; Darr H, 2009, STEM CELLS, V27, P352, DOI 10.1634/stemcells.2008-0720; Golestaneh N, 2009, STEM CELLS DEV, V18, P1115, DOI 10.1089/scd.2008.0347; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Jung HJ, 2014, ANIM REPROD SCI, V147, P32, DOI 10.1016/j.anireprosci.2014.03.011; Jung H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108825; Kim JY, 2015, REPROD DOMEST ANIM, V50, P1032, DOI 10.1111/rda.12632; Lin YM, 2001, MOL HUM REPROD, V7, P1015, DOI 10.1093/molehr/7.11.1015; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Rocchietti-March M, 2000, INT J ANDROL, V23, P51, DOI 10.1046/j.1365-2605.2000.00207.x; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yoshida S, 2007, ANN NY ACAD SCI, V1120, P47, DOI 10.1196/annals.1411.003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	26	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165011	10.1371/journal.pone.0165011	http://dx.doi.org/10.1371/journal.pone.0165011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798668	gold, Green Submitted, Green Published			2022-12-26	WOS:000386711100017
J	Otwoma, LM; Kochzius, M				Otwoma, Levy Michael; Kochzius, Marc			Genetic Population Structure of the Coral Reef Sea Star Linckia laevigata in the Western Indian Ocean and Indo-West Pacific	PLOS ONE			English	Article							COMPARATIVE PHYLOGEOGRAPHY; HOLOTHUROIDEA POPULATIONS; CONTRASTING PATTERNS; SPECIES BOUNDARIES; TIGER PRAWN; FLOW; ECHINODERMATA; GROWTH; DIFFERENTIATION; CONNECTIVITY	The coral reef sea star Linckia laevigata is common on shallow water coral reefs of the Indo-West Pacific. Its large geographic distribution and comprehensive data from previous studies makes it suitable to examine genetic differentiation and connectivity over large geographical scales. Based on partial sequences of the mitochondrial cytochrome oxidase I (COI) gene this study investigates the genetic population structure and connectivity of L. laevigata in the Western Indian Ocean (WIO) and compares it to previous studies in the Indo-Malay-Philippines Archipelago (IMPA). A total of 138 samples were collected from nine locations in the WIO. AMOVA revealed a low but significant Phi(ST)-value of 0.024 for the WIO populations. In the hierarchical AMOVA, the following grouping rejected the hypothesis of panmixia: (1) Kenya (Watamu, Mombasa, Diani) and Tanzanian Island populations (Misali and Jambiani) and (2) the rest of the WIO sites (mainland Tanzania and Madagascar; Phi(CT) = 0.03). The genetic population structure was stronger and more significant (Phi(ST) = 0.13) in the comparative analysis of WIO and IMPA populations. Three clades were identified in the haplotype network. The strong genetic differentiation (Phi(CT) = 0.199, P < 0.001) suggests that Indo-West Pacific populations of L. laevigata can be grouped into four biogeographic regions: (1) WIO (2) Eastern Indian Ocean (3) IMPA and (4) Western Pacific. The findings of this study support the existence of a genetic break in the Indo-West Pacific consistent with the effect of lowered sea level during the Pleistocene, which limited gene flow between the Pacific and Indian Ocean.	[Otwoma, Levy Michael] Kenya Marine & Fisheries Res Inst, POB 81651, Mombasa, Kenya; [Otwoma, Levy Michael; Kochzius, Marc] Vrije Univ Brussel, Marine Biol, Pl Laan 2, B-1050 Brussels, Belgium	Vrije Universiteit Brussel	Otwoma, LM (corresponding author), Kenya Marine & Fisheries Res Inst, POB 81651, Mombasa, Kenya.; Otwoma, LM (corresponding author), Vrije Univ Brussel, Marine Biol, Pl Laan 2, B-1050 Brussels, Belgium.	levyot@yahoo.com	Kochzius, Marc/AAN-3799-2021	Kochzius, Marc/0000-0001-8953-4719; Otwoma, Levy/0000-0002-9811-0560	Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO) for the project 'Connectivity of Coral Reefs and Mangroves in the Western Indian Ocean' (COCOMA-WIO) [1501612N]; Vrije Universiteit Brussel [OZR2068BOF]; Vlaamse Interuniversitaire Raad - Universitaire Ontwikkelingssamenwerking (VLIR-UOS)	Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO) for the project 'Connectivity of Coral Reefs and Mangroves in the Western Indian Ocean' (COCOMA-WIO); Vrije Universiteit Brussel; Vlaamse Interuniversitaire Raad - Universitaire Ontwikkelingssamenwerking (VLIR-UOS)	Funding for this project was obtained from Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO) for the project 'Connectivity of Coral Reefs and Mangroves in the Western Indian Ocean' (COCOMA-WIO; grant 1501612N); Vrije Universiteit Brussel (OZR2068BOF). Vlaamse Interuniversitaire Raad - Universitaire Ontwikkelingssamenwerking (VLIR-UOS) provided a scholarship to Lew Otwoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar DSR, 2016, J MAR BIOL ASSOC UK, V96, P707, DOI 10.1017/S0025315415000971; Ayre DJ, 2000, EVOLUTION, V54, P1590; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Bell BE, 1972, E AFRICA ITS PEOPLE, P243; Benzie JAH, 2002, MOL ECOL, V11, P2553, DOI 10.1046/j.1365-294X.2002.01638.x; Benzie JAH, 1999, EVOLUTION, V53, P1782, DOI 10.1111/j.1558-5646.1999.tb04562.x; BURTON RS, 1982, ESTUARINE COMP, P537, DOI DOI 10.1016/B978-0-12-404070-0.50038-7; Clark AM, 1971, SHALLOW WATER INDO W, P238; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Crandall ED, 2014, B MAR SCI, V90, P399, DOI 10.5343/bms.2013.1052; Crandall ED, 2008, MOL ECOL, V17, P5276, DOI 10.1111/j.1365-294X.2008.03995.x; Duda TF, 1999, MAR BIOL, V134, P705, DOI 10.1007/s002270050586; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fauvelot C, 2002, MAR BIOL, V141, P773, DOI 10.1007/s00227-002-0869-7; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fratini S, 2002, J EXP MAR BIOL ECOL, V272, P103, DOI 10.1016/S0022-0981(02)00052-7; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2013, J BIOGEOGR, V40, P1638, DOI 10.1111/jbi.12126; Galloway R. W., 1981, ECOLOGICAL BIOGEOGRA, P51; Gopurenko D, 1999, MAR BIOL, V134, P227, DOI 10.1007/s002270050541; Gordon A.L, 2005, OCEANOGRAPHY, V18, P15, DOI [10.5670/oceanog.2005.01, DOI 10.5670/OCEANOG.2005.01]; Gordon AL, 1996, NATURE, V379, P146, DOI 10.1038/379146a0; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hellberg ME, 2002, B MAR SCI, V70, P273; Hoareau TB, 2013, J BIOGEOGR, V40, P2167, DOI 10.1111/jbi.12155; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Hui M, 2016, J MOLLUS STUD, V82, P403, DOI 10.1093/mollus/eyw001; Huyghe F, 2016, MAR ECOL; Imron, 2007, MOL ECOL, V16, P289, DOI 10.1111/j.1365-294X.2006.03141.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kochzius M, 2003, MOL PHYLOGENET EVOL, V28, P396, DOI 10.1016/S1055-7903(02)00444-X; Kochzius M, 2009, MAR ECOL PROG SER, V396, P211, DOI 10.3354/meps08281; Kochzius M, 2008, MOL ECOL, V17, P3775, DOI 10.1111/j.1365-294X.2008.03803.x; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Lessios HA, 1999, EVOLUTION, V53, P806, DOI 10.1111/j.1558-5646.1999.tb05374.x; Lessios HA, 2003, EVOLUTION, V57, P2026, DOI 10.1554/02-681; MANTEL N, 1967, CANCER RES, V27, P209; MCCLANAHAN TR, 1988, MAR ECOL PROG SER, V44, P191, DOI 10.3354/meps044191; MCMILLAN WO, 1995, P ROY SOC B-BIOL SCI, V260, P229, DOI 10.1098/rspb.1995.0085; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Muths D, 2015, MAR ECOL-EVOL PERSP, V36, P447, DOI 10.1111/maec.12153; NEI M, 1989, MOL BIOL EVOL, V6, P290; Nei M., 1987, MOL EVOLUTIONARY GEN; Pellissier L, 2014, SCIENCE, V344, P1016, DOI 10.1126/science.1249853; Ragionieri L, 2010, ESTUAR COAST SHELF S, V86, P179, DOI 10.1016/j.ecss.2009.11.002; Reid DG, 2006, J BIOGEOGR, V33, P990, DOI 10.1111/j.1365-2699.2006.01469.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Schneider S, 1999, GENETICS, V152, P1079; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schouten MW, 2003, DEEP-SEA RES PT II, V50, P1987, DOI 10.1016/S0967-0645(03)00042-0; Sheppard Charles R.C., 2000, P3; Silva IC, 2010, MAR BIOL, V157, P1113, DOI 10.1007/s00227-010-1393-9; Silva IC, 2010, BIOL J LINN SOC, V99, P28, DOI 10.1111/j.1095-8312.2009.01338.x; TAJIMA F, 1989, GENETICS, V123, P585; Taylor MS, 2005, EVOLUTION, V59, P374; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timm J, 2008, MOL PHYLOGENET EVOL, V49, P268, DOI 10.1016/j.ympev.2008.04.024; Uthicke S, 2003, MOL ECOL, V12, P2635, DOI 10.1046/j.1365-294X.2003.01954.x; Uthicke S, 2001, MAR ECOL PROG SER, V216, P109, DOI 10.3354/meps216109; van der Ven RM, 2016, J BIOGEOGR, V43, P510, DOI 10.1111/jbi.12643; Vogler C, 2008, BIOL LETTERS, V4, P696, DOI 10.1098/rsbl.2008.0454; Vogler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043499; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Williams ST, 2000, MAR BIOL, V136, P137, DOI 10.1007/s002270050016; WILLIAMS ST, 1993, MAR BIOL, V117, P71, DOI 10.1007/BF00346427; Williams ST, 1998, EVOLUTION, V52, P87, DOI 10.1111/j.1558-5646.1998.tb05141.x; WYRTKI K, 1961, PHYS OCEANOGRAPHY SE; Yamaguchi M., 1973, P369; YAMAGUCHI M, 1977, PAC SCI, V31, P13; York KL, 2008, MOL ECOL, V17, P1948, DOI 10.1111/j.1365-294X.2008.03735.x	74	28	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165552	10.1371/journal.pone.0165552	http://dx.doi.org/10.1371/journal.pone.0165552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798700	Green Published, gold			2022-12-26	WOS:000386711100043
J	Kim, BJ; Kim, AR; Lee, C; Kim, SY; Kim, NKD; Chang, MY; Rhee, J; Park, MH; Koo, SK; Kim, MY; Han, JH; Oh, SH; Park, WY; Choi, BY				Kim, Bong Jik; Kim, Ah Reum; Lee, Chung; Kim, So Young; Kim, Nayoung K. D.; Chang, Mun Young; Rhee, Jihye; Park, Mi-Hyun; Koo, Soo Kyung; Kim, Min Young; Han, Jin Hee; Oh, Seung-Ha; Park, Woong-Yang; Choi, Byung Yoon			Discovery of CDH23 as a Significant Contributor to Progressive Postlingual Sensorineural Hearing Loss in Koreans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SYNDROME TYPE 1D; USHER-SYNDROME; DEAFNESS DFNB12; CADHERIN GENE; TIP-LINK; MUTATIONS; MICE; STEREOCILIA; VARIANTS	CDH23 mutations have mostly been associated with prelingual severe-to-profound sensorineural hearing loss (SNHL) in either syndromic or nonsyndromic SNHL (DFNB12). Herein, we demonstrate the contribution of CDH23 mutations to postlingual nonsyndromic SNHL (NS-SNHL). We screened 32 Korean adult probands with postlingual NS-SNHL sporadically or in autosomal recessive fashion using targeted panel or whole exome sequencing. We identified four (12.5%, 4/32) potential postlingual DFNB12 families that segregated the recessive CDH23 variants, qualifying for our criteria along with rapidly progressive SNHL. Three of the four families carried one definite pathogenic CDH23 variant previously known as the prelingual DFNB12 variant in a trans configuration with rare CDH23 variants. To determine the contribution of rare CDH23 variants to the postlingual NS-SNHL, we checked the minor allele frequency (MAF) of CDH23 variants detected from our postlingual NS-SNHL cohort and prelingual NS-SNHL cohort, among the 2040 normal control chromosomes. The allele frequency of these CDH23 variants in our postlingual cohort was 12.5%, which was significantly higher than that of the 2040 control chromosomes (5.53%), confirming the contribution of these rare CDH23 variants to postlingual NS-SNHL. Furthermore, MAF of rare CDH23 variants from the postlingual NS-SNHL group was significantly higher than that from the prelingual NS-SNHL group. This study demonstrates an important contribution of CDH23 mutations to poslingual NS-SNHL and shows that the phenotypic spectrum of DFNB12 can be broadened even into the presbycusis, depending on the pathogenic potential of variants. We also propose that pathogenic potential of CDH23 variants and the clinical fate of DFNB12 may be predicted by MAF.	[Kim, Bong Jik; Kim, Ah Reum; Kim, So Young; Chang, Mun Young; Rhee, Jihye; Oh, Seung-Ha] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Otorhinolaryngol, Seoul, South Korea; [Lee, Chung; Kim, Nayoung K. D.; Park, Woong-Yang] Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Lee, Chung] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Suwon, South Korea; [Park, Mi-Hyun; Koo, Soo Kyung] Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Chungcheongbuk Do, South Korea; [Kim, Min Young; Han, Jin Hee; Choi, Byung Yoon] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol, Seongnam, South Korea; [Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Seoul National University (SNU); Sungkyunkwan University (SKKU)	Choi, BY (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol, Seongnam, South Korea.	choiby2010@gmail.com		Kim, Bong Jik/0000-0002-6384-2171; Park, Woong-Yang/0000-0003-4234-0380	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C1867, HI15C1632]; Korea National Institute of Health intramural research grant [4861-307-210-13, 2012-NG61004-00]; Korea Biobank Project [4851-307, KBP-2014-035]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Korea National Institute of Health intramural research grant; Korea Biobank Project	This work was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (www.mohw.go.kr/) (HI14C1867 and HI15C1632 to BYC); and also by the Korea National Institute of Health intramural research grant 4861-307-210-13 (2012-NG61004-00 to SKK); and Korea Biobank Project (http://www.nih.go.kr/NIH_NEW/main.isp) (4851-307, KBP-2014-035 to SKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2008, MOL VIS, V14, P2227; Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Chang MY, 2015, MOL CELLS, V38, P781, DOI 10.14348/molcells.2015.0078; Clark J G, 1981, ASHA, V23, P493; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Friedman TB, 2011, ADV OTO-RHINO-LARYNG, V70, P56, DOI 10.1159/000322473; Han F, 2012, PHARMACOGENOMICS J, V12, P30, DOI 10.1038/tpj.2010.60; Hequembourg S, 2001, JARO-J ASSOC RES OTO, V2, P118, DOI 10.1007/s101620010075; Holme RH, 2004, JARO-J ASSOC RES OTO, V5, P66, DOI 10.1007/s10162-003-4021-2; Kane KL, 2012, HEARING RES, V283, P80, DOI 10.1016/j.heares.2011.11.007; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kim BJ, 2016, EUR ARCH OTO-RHINO-L, V273, P2993, DOI 10.1007/s00405-015-3885-1; Kim SY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0624-8; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mchugh RK, 2006, ANAT REC PART A, V288A, P370, DOI 10.1002/ar.a.20297; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Miyagawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040366; Miyasaka Y, 2013, EXP ANIM TOKYO, V62, P333, DOI 10.1538/expanim.62.333; Mizutari K, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0276-z; Moteki H, 2016, CLIN GENET, V89, P466, DOI 10.1111/cge.12677; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Oh SK, 2013, BBA-MOL BASIS DIS, V1832, P285, DOI 10.1016/j.bbadis.2012.05.009; Ohmen J, 2014, JARO-J ASSOC RES OTO, V15, P335, DOI 10.1007/s10162-014-0443-2; Park JH, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0167-8; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Schultz JM, 2011, J MED GENET, V48, P767, DOI 10.1136/jmedgenet-2011-100262; Shearer AE, 2014, AM J HUM GENET, V95, P445, DOI 10.1016/j.ajhg.2014.09.001; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Wada T, 2001, BIOCHEM BIOPH RES CO, V283, P113, DOI 10.1006/bbrc.2001.4724; Woo HM, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-46; Zheng QY, 2005, HUM MOL GENET, V14, P103, DOI 10.1093/hmg/ddi010	35	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165680	10.1371/journal.pone.0165680	http://dx.doi.org/10.1371/journal.pone.0165680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792758	Green Submitted, Green Published, gold			2022-12-26	WOS:000389537000045
J	Naylor, RW; McGhee, CNJ; Cowan, CA; Davidson, AJ; Holm, TM; Sherwin, T				Naylor, Richard W.; McGhee, Charles N. J.; Cowan, Chad A.; Davidson, Alan J.; Holm, Teresa M.; Sherwin, Trevor			Derivation of Corneal Keratocyte-Like Cells from Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							NEURAL CREST CELLS; DIRECTED DIFFERENTIATION; MATRIX; TRANSPARENCY; EXPRESSION; PHENOTYPE; LUMICAN; FATE	Corneal diseases such as keratoconus represent a relatively common disorder in the human population. However, treatment is restricted to corneal transplantation, which only occurs in the most advanced cases. Cell based therapies may offer an alternative approach given that the eye is amenable to such treatments and corneal diseases like keratoconus have been associated specifically with the death of corneal keratocytes. The ability to generate corneal keratocytes in vitro may enable a cell-based therapy to treat patients with keratoconus. Human induced pluripotent stem cells (hiPSCs) offer an abundant supply of cells from which any cell in the body can be derived. In the present study, hiPSCs were successfully differentiated into neural crest cells (NCCs), the embryonic precursor to keratocytes, and then cultured on cadaveric corneal tissue to promote keratocyte differentiation. The hiPSC-derived NCCs were found to migrate into the corneal stroma where they acquired a keratocyte-like morphology and an expression profile similar to corneal keratocytes in vivo. These results indicate that hiPSCs can be used to generate corneal keratocytes in vitro and lay the foundation for using these cells in cornea cell-based therapies.	[Naylor, Richard W.; McGhee, Charles N. J.; Sherwin, Trevor] Univ Auckland, Dept Ophthalmol, Auckland 1142, New Zealand; [Cowan, Chad A.; Holm, Teresa M.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Davidson, Alan J.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1142, New Zealand	University of Auckland; Harvard University; University of Auckland	Sherwin, T (corresponding author), Univ Auckland, Dept Ophthalmol, Auckland 1142, New Zealand.; Holm, TM (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	t.holm@auckland.ac.nz; sherwin@auckland.ac.nz	Sherwin, Trevor/A-1217-2008	Naylor, Richard/0000-0003-2901-7677; McGhee, Charles NJ/0000-0001-7048-0706; Sherwin, Trevor/0000-0002-9090-1034	Hadden Tom Cat Trust Post-Doctoral Fellowship held in the School Of Medicine Fund [9113/370-4211]; Hadden Tom Cat Trust for the School of Medicine, University of Auckland [9113/370-4211]	Hadden Tom Cat Trust Post-Doctoral Fellowship held in the School Of Medicine Fund; Hadden Tom Cat Trust for the School of Medicine, University of Auckland	The authors received a Hadden Tom Cat Trust Post-Doctoral Fellowship held in the School Of Medicine Fund (grant #9113/370-4211).; Financial support for this project was provided by the Hadden Tom Cat Trust for the School of Medicine, University of Auckland (grant# 9113/370-4211).	Alomar TS, 2011, INVEST OPHTH VIS SCI, V52, P8193, DOI 10.1167/iovs.11-8047; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Chambers SM, 2016, METHODS MOL BIOL, V1307, P329, DOI 10.1007/7651_2013_59; Chan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056831; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Du YQ, 2010, MOL VIS, V16, P2680; Endo Y, 2012, DEV CELL, V23, P305, DOI 10.1016/j.devcel.2012.07.006; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Hertsenberg AJ, 2016, METHODS MOL BIOL, V1341, P285, DOI 10.1007/7651_2015_231; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Kanemura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085336; Kao WWY, 2002, GLYCOCONJUGATE J, V19, P275, DOI 10.1023/A:1025396316169; Kim WJ, 1999, EXP EYE RES, V69, P475, DOI 10.1006/exer.1999.0719; Kinikoglu B, 2014, EXP BIOL MED, V239, P159, DOI 10.1177/1535370213513997; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021; Liu HS, 2012, J CELL MOL MED, V16, P1114, DOI 10.1111/j.1582-4934.2011.01418.x; Liu HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010707; Lwigale PY, 2005, DEV BIOL, V288, P284, DOI 10.1016/j.ydbio.2005.09.046; Ma XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076103; McGhee CNJ, 2015, CORNEA, V34, pS16, DOI 10.1097/ICO.0000000000000504; Menendez L, 2013, NAT PROTOC, V8, P203, DOI 10.1038/nprot.2012.156; Milet C, 2012, DEV BIOL, V366, P96, DOI 10.1016/j.ydbio.2012.01.016; Niederer RL, 2008, INVEST OPHTH VIS SCI, V49, P2964, DOI 10.1167/iovs.07-0968; Norman B, 2004, INVEST OPHTH VIS SCI, V45, P429, DOI 10.1167/iovs.03-0449; Pei Y, 2006, EXP EYE RES, V83, P1063, DOI 10.1016/j.exer.2006.05.011; Ren YJ, 2013, ACTA BIOMATER, V9, P7727, DOI 10.1016/j.actbio.2013.04.034; Song WK, 2015, STEM CELL REP, V4, P860, DOI 10.1016/j.stemcr.2015.04.005; Stramer BM, 2003, INVEST OPHTH VIS SCI, V44, P4237, DOI 10.1167/iovs.02-1188; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Young RD, 2014, P NATL ACAD SCI USA, V111, P687, DOI 10.1073/pnas.1313561110; Zadnik K, 1996, CORNEA, V15, P139, DOI 10.1097/00003226-199603000-00006	39	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165464	10.1371/journal.pone.0165464	http://dx.doi.org/10.1371/journal.pone.0165464			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792791	Green Published, Green Submitted, gold			2022-12-26	WOS:000389537000022
J	Wen, H; Xie, WX; Pei, JH				Wen, Hui; Xie, Weixin; Pei, Jihong			A Structure-Adaptive Hybrid RBF-BP Classifier with an Optimized Learning Strategy	PLOS ONE			English	Article							DIFFERENTIAL EVOLUTION; NEURAL-NETWORK; DESIGN; ALGORITHM; SCHEME	This paper presents a structure-adaptive hybrid RBF-BP (SAHRBF-BP) classifier with an optimized learning strategy. SAHRBF-BP is composed of a structure-adaptive RBF network and a BP network of cascade, where the number of RBF hidden nodes is adjusted adaptively according to the distribution of sample space, the adaptive RBF network is used for nonlinear kernel mapping and the BP network is used for nonlinear classification. The optimized learning strategy is as follows: firstly, a potential function is introduced into training sample space to adaptively determine the number of initial RBF hidden nodes and node parameters, and a form of heterogeneous samples repulsive force is designed to further optimize each generated RBF hidden node parameters, the optimized structure-adaptive RBF network is used for adaptively nonlinear mapping the sample space; then, according to the number of adaptively generated RBF hidden nodes, the number of subsequent BP input nodes can be determined, and the overall SAHRBF-BP classifier is built up; finally, different training sample sets are used to train the BP network parameters in SAHRBF-BP. Compared with other algorithms applied to different data sets, experiments show the superiority of SAHRBF-BP. Especially on most low dimensional and large number of data sets, the classification performance of SAHRBF-BP outperforms other training SLFNs algorithms.	[Wen, Hui; Xie, Weixin; Pei, Jihong] Shenzhen Univ, ATR Key Lab Natl Def, Shenzhen 518060, Peoples R China	Shenzhen University	Pei, JH (corresponding author), Shenzhen Univ, ATR Key Lab Natl Def, Shenzhen 518060, Peoples R China.	jhpei@szu.edu.cn			National Natural Science Foundation of China [61331021, U1301251]; Shenzhen Science and Technology Plan [JCYJ20130408173025036]; Shenzhen Science and Technology Plan Project [JCYJ20130408173025036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Plan; Shenzhen Science and Technology Plan Project	This work was supported by National Natural Science Foundation of China (No. 61331021 and No. U1301251), http://www.nsfc.gov.cn/ (Pei JH received the funding) and the Shenzhen Science and Technology Plan (JCYJ20130408173025036), http//sfms.szns.gov.cn/egrantweb/index### (Pei JH received the funding).; The authors thank the support provided by the National Natural Science Foundation of China (No. 61331021 and No. U1301251), and the Shenzhen Science and Technology Plan Project (JCYJ20130408173025036). The authors thank to Dr. Hongguang Fan for helping to organize data sets.	Blake CL, 1998, UCI REPOSITORY MACHI; Bors A. G., 1994, Digital Signal Processing, V4, P173, DOI 10.1006/dspr.1994.1016; Bortman M, 2009, IEEE T NEURAL NETWOR, V20, P1039, DOI 10.1109/TNN.2009.2019270; Cao JW, 2012, NEURAL PROCESS LETT, V36, P285, DOI 10.1007/s11063-012-9236-y; CHANG C.C., 2003, LIBSVM LIB SUPPORT V; Constantinopoulos C, 2006, IEEE T NEURAL NETWOR, V17, P966, DOI 10.1109/TNN.2006.875982; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Feng GR, 2009, IEEE T NEURAL NETWOR, V20, P1352, DOI 10.1109/TNN.2009.2024147; HAYIN S, 2009, NEURAL NETWORKS LEAR, V3rd; Huang GB, 2005, IEEE T NEURAL NETWOR, V16, P57, DOI 10.1109/TNN.2004.836241; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2004, IEEE T SYST MAN CY B, V34, P2284, DOI 10.1109/TSMCB.2004.834428; Huang GB, 2008, NEUROCOMPUTING, V71, P3460, DOI 10.1016/j.neucom.2007.10.008; Huang GB, 2007, NEUROCOMPUTING, V70, P3056, DOI 10.1016/j.neucom.2007.02.009; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P879, DOI 10.1109/TNN.2006.875977; Ilonen J, 2003, NEURAL PROCESS LETT, V17, P93, DOI 10.1023/A:1022995128597; KADIRKAMANATHAN V, 1993, NEURAL COMPUT, V5, P954, DOI 10.1162/neco.1993.5.6.954; Karayiannis NB, 1997, IEEE T NEURAL NETWOR, V8, P1492, DOI 10.1109/72.641471; LeCun Y, 2012, LECT NOTES COMPUT SC, V7700, P9, DOI DOI 10.1007/3-540-49430-8_; Lowe D, 1998, NEUROCOMPUTING, V19, P199, DOI 10.1016/S0925-2312(97)00065-9; Lu YW, 1997, NEURAL COMPUT, V9, P461, DOI 10.1162/neco.1997.9.2.461; MEISEL WS, 1969, IEEE T COMPUT, VC 18, P911, DOI 10.1109/T-C.1969.222546; Moody J, 1989, NEURAL COMPUT, V1, P281, DOI 10.1162/neco.1989.1.2.281; Mountrakis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040093; Oh SK, 2012, NEUROCOMPUTING, V78, P121, DOI 10.1016/j.neucom.2011.06.031; Panchapakesan C, 2002, IEEE T NEURAL NETWOR, V13, P1299, DOI 10.1109/TNN.2002.804286; Pedrycz W, 1998, IEEE T NEURAL NETWOR, V9, P601, DOI 10.1109/72.701174; Platt J, 1991, NEURAL COMPUT, V3, P213, DOI 10.1162/neco.1991.3.2.213; Roh SB, 2010, FUZZY SET SYST, V161, P1803, DOI 10.1016/j.fss.2009.10.014; Rubio-Solis A, 2015, IEEE T FUZZY SYST, V23, P457, DOI 10.1109/TFUZZ.2014.2315656; Salmeron M, 2001, NEUROCOMPUTING, V41, P153, DOI 10.1016/S0925-2312(00)00363-5; Savitha R, 2012, NEURAL COMPUT, V24, P1297, DOI 10.1162/NECO_a_00254; Staiano A, 2006, NEUROCOMPUTING, V69, P1570, DOI 10.1016/j.neucom.2005.06.014; Subramanian Kartick, 2013, IEEE Transactions on Fuzzy Systems, V21, P1080, DOI 10.1109/TFUZZ.2013.2242894; Subudhi B, 2008, NEURAL PROCESS LETT, V27, P285, DOI 10.1007/s11063-008-9077-x; Suresh S, 2010, NEUROCOMPUTING, V73, P3012, DOI 10.1016/j.neucom.2010.07.003; Xie TT, 2012, IEEE T NEUR NET LEAR, V23, P609, DOI 10.1109/TNNLS.2012.2185059; Yu H, 2014, IEEE T NEUR NET LEAR, V25, P1793, DOI 10.1109/TNNLS.2013.2295813; Zhu BL, 2015, ENG OPTIMIZ, V47, P390, DOI 10.1080/0305215X.2014.892596; Zhu QY, 2005, PATTERN RECOGN, V38, P1759, DOI 10.1016/j.patcog.2005.03.028	41	6	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0164719	10.1371/journal.pone.0164719	http://dx.doi.org/10.1371/journal.pone.0164719			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792737	Green Published, Green Submitted, gold			2022-12-26	WOS:000389537000011
J	Connell, BJ; Chang, SY; Prakash, E; Yousfi, R; Mohan, V; Posch, W; Wilflingseder, D; Moog, C; Kodama, EN; Clayette, P; Lortat-Jacob, H				Connell, Bridgette Janine; Chang, Sui-Yuan; Prakash, Ekambaranellore; Yousfi, Rahima; Mohan, Viswaraman; Posch, Wilfried; Wilflingseder, Doris; Moog, Christiane; Kodama, Eiichi N.; Clayette, Pascal; Lortat-Jacob, Hugues			A Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 Upregulation	PLoS One			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN GP120; ANTI-HIV AGENTS; NATURAL-PRODUCTS; COUMARIN DERIVATIVES; ENTRY INHIBITORS; DRUG DISCOVERY; TYPE-1 GP120; IN-VIVO; INFECTION	Amongst the many strategies aiming at inhibiting HIV-1 infection, blocking viral entry has been recently recognized as a very promising approach. Using diverse in vitro models and a broad range of HIV-1 primary patient isolates, we report here that IND02, a type A procyanidin polyphenol extracted from cinnamon, that features trimeric and pentameric forms displays an anti-HIV-1 activity against CXCR4 and CCR5 viruses with 1-7 mu M ED50 for the trimer. Competition experiments, using a surface plasmon resonance-based binding assay, revealed that INDO2 inhibited envelope binding to CD4 and heparan sulphate (HS) as well as to an antibody (mAb 17b) directed against the gp120 co-receptor binding site with an IC50 in the low pM range. INDO2 has thus the remarkable property of simultaneously blocking gp120 binding to its major host cell surface counterparts. Additionally, the IND02-trimer impeded up-regulation of the inhibitory receptors Tim-3 and PD-1 on CD4(+) and CD8(+) cells, thereby demonstrating its beneficial effect by limiting T cell exhaustion. Among naturally derived products significantly inhibiting HIV-1, the IND02-trimer is the first component demonstrating an entry inhibition property through binding to the viral envelope glycoprotein. These data suggest that cinnamon, a widely consumed spice, could represent a novel and promising candidate for a cost-effective, natural entry inhibitor for HIV-1 which can also down-modulate T cell exhaustion markers Tim-3 and PD-1.	[Connell, Bridgette Janine; Lortat-Jacob, Hugues] Univ Grenoble Alpes, Inst Biol Struct, UMR 5075, CNRS,CEA, F-38027 Grenoble, France; [Chang, Sui-Yuan] Natl Taiwan Univ Hosp, Sch Med Technol, Coll Med, Taipei, Taiwan; [Prakash, Ekambaranellore; Mohan, Viswaraman] Ind Biotech Pvt Ltd, Pune, Maharashtra, India; [Yousfi, Rahima; Clayette, Pascal] CEA, Bertin Pharma, Lab Neurovirol, F-92265 Fontenay Aux Roses, France; [Posch, Wilfried; Wilflingseder, Doris] Med Univ Innsbruck, Div Hyg & Med Microbiol, Innsbruck, Austria; [Moog, Christiane] NSERM, U1110, FMTS, Inst Virol, 3 Rue Koeberle, F-67000 Strasbourg, France; [Kodama, Eiichi N.] Tohoku Univ, Sch Med, Div Emerging Infect Dis, Miyagi Communitiy Hlth Promot,Aoba Ku, Bldg 1,Rm 515,2-1 Seiryocho, Sendai, Miyagi 9808575, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; National Taiwan University; National Taiwan University Hospital; CEA; Medical University of Innsbruck; Institut National de la Sante et de la Recherche Medicale (Inserm); Tohoku University	Lortat-Jacob, H (corresponding author), Univ Grenoble Alpes, Inst Biol Struct, UMR 5075, CNRS,CEA, F-38027 Grenoble, France.; Prakash, E (corresponding author), Ind Biotech Pvt Ltd, Pune, Maharashtra, India.	prakash@indusbiotech.com; Hugues.Lortat-Jacob@ibs.fr	C, Moog/E-3962-2016; Kodama, Eiichi N/C-4032-2009; Posch, Wilfried/AAH-6845-2019	C, Moog/0000-0002-0916-156X; Kodama, Eiichi N/0000-0002-6622-2752; Posch, Wilfried/0000-0001-8955-7654; Wilflingseder, Doris/0000-0002-5888-5118; CHANG, SUI-YUAN/0000-0002-6009-6724; Ekambaranellore, Prakash/0000-0003-3128-9524; Connell, Bridgette/0000-0003-2482-826X	Indus Biotech; Agence Nationale de la Recherche sur le SIDA (ANRS); Sidaction; la Fondation Pierre Berge; National Science Council (NSC), Taiwan; Agence Nationale de la Recherche [ANR-10-INSB-05-02, ANR-10-LABX-49-01]; NIH AIDS Research and Reference Reagent Program from the UNAIDS Network for HIV Isolation and Characterization [92UG029, 98IN017]; FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]; Austrian Science Fund (FWF) [P 25389] Funding Source: researchfish	Indus Biotech; Agence Nationale de la Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Sidaction; la Fondation Pierre Berge; National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH AIDS Research and Reference Reagent Program from the UNAIDS Network for HIV Isolation and Characterization; FRISBI; GRAL; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Indus Biotech and the Agence Nationale de la Recherche sur le SIDA (ANRS). B.J.C. was supported by a grant from Sidaction and "la Fondation Pierre Berge". SYC acknowledges the funding from National Science Council (NSC), Taiwan. This work also used the platforms of the Grenoble Instruct centre supported by the Agence Nationale de la Recherche (ANR-10-INSB-05-02 and ANR-10-LABX-49-01). Dr. Ekambaranellore Prakash from Indus Biotech was involved in planning the experimental study. Indus Biotech was involved in the preparation and analysis of the compounds INDO2 and INDO2-trimer which were isolated, purified and characterized by Dr. Mohan Vishwaraman. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Agence Nationale de la Recherche sur le SIDA (ANRS) and B. J.C. was supported by a grant from Sidaction and "la Fondation Pierre Berge". Sui-Yuan Chang acknowledges the funding from National Science Council (NSC), Taiwan. Soluble CD4 and mAb 17b were obtained through the NIH AIDS Research and Reference Reagent Program from Drs. S. Iyer, J. Robinson and J. Sodroski, respectively. The following HIV-1 strains were obtained through the NIH AIDS Research and Reference Reagent Program from the UNAIDS Network for HIV Isolation and Characterization (92UG029 and 98IN017), Dr. N. Halsey (92HT599), Drs. D. Ellenberger, P. Sullivan and R.B. Lal (96USHIPS4). This work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01). We thank Karen Storck and Sylvie Schmidt for technical assistance and Dr Melanie Lambotin for fruitful discussions.	Acharya P, 2011, ACS CHEM BIOL, V6, P1069, DOI 10.1021/cb200068b; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Baleux F, 2009, NAT CHEM BIOL, V5, P743, DOI 10.1038/nchembio.207; Baltina LA, 2003, CURR MED CHEM, V10, P155, DOI 10.2174/0929867033368538; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Basmaciogullari S, 2002, J VIROL, V76, P10791, DOI 10.1128/JVI.76.21.10791-10800.2002; Ben Amor N, 2007, J MED CHEM, V50, P3937, DOI 10.1021/jm070508d; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Connell BJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00385; Connell BJ, 2012, CHEM BIOL, V19, P131, DOI 10.1016/j.chembiol.2011.12.009; Cos P, 2004, J NAT PROD, V67, P284, DOI 10.1021/np034016p; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fink Ryan C., 2009, Antiviral Chemistry & Chemotherapy, V19, P243; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Gruenwald J, 2010, CRIT REV FOOD SCI, V50, P822, DOI 10.1080/10408390902773052; Herschhorn A, 2014, NAT CHEM BIOL, V10, P845, DOI [10.1038/NCHEMBIO.1623, 10.1038/nchembio.1623]; Imparl-Radosevich J, 1998, HORM RES, V50, P177, DOI 10.1159/000023270; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Jung M, 2000, CURR MED CHEM, V7, P649, DOI 10.2174/0929867003374822; Kamiya K, 2001, CHEM PHARM BULL, V49, P551, DOI 10.1248/cpb.49.551; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; KASHMAN Y, 1992, J MED CHEM, V35, P2735, DOI 10.1021/jm00093a004; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; KILKUSKIE RE, 1992, BIOORG MED CHEM LETT, V2, P1529, DOI 10.1016/S0960-894X(00)80422-9; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kodama E, 1996, ANTIVIR RES, V31, P159, DOI 10.1016/0166-3542(96)06966-5; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Lin WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130389; Lozano V, 2011, J MED CHEM, V54, P5335, DOI 10.1021/jm200560r; Maeda Y, 1998, J INFECT DIS, V177, P1207, DOI 10.1086/515282; Matthee G, 1999, PLANTA MED, V65, P493, DOI 10.1055/s-1999-14004; McGovern R, 2011, ANTIVIR THER, V16, pA97; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; PATIL AD, 1995, J ORG CHEM, V60, P1182, DOI 10.1021/jo00110a021; Peterson DW, 2009, J ALZHEIMERS DIS, V17, P585, DOI 10.3233/JAD-2009-1083; Premanathan M, 2000, INDIAN J MED RES, V112, P73; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Saklani A, 2008, DRUG DISCOV TODAY, V13, P161, DOI 10.1016/j.drudis.2007.10.010; Schoene NW, 2005, CANCER LETT, V230, P134, DOI 10.1016/j.canlet.2004.12.039; Seitz M, 2010, CHEM COMMUN, V46, P7754, DOI 10.1039/c0cc02913k; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Singh IP, 2005, CURR SCI INDIA, V89, P269; SOLECKI RS, 1975, SCIENCE, V190, P880, DOI 10.1126/science.190.4217.880; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200; Wang YH, 2013, J AGR FOOD CHEM, V61, P4470, DOI 10.1021/jf4005862; Wu QH, 2016, ARCH TOXICOL, V90, P1817, DOI 10.1007/s00204-016-1744-5; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Yang SS, 2001, J NAT PROD, V64, P265, DOI 10.1021/np0003995; Yu DL, 2003, MED RES REV, V23, P322, DOI 10.1002/med.10034; Zhang WT, 2001, BIOCHEMISTRY-US, V40, P1662, DOI 10.1021/bi001397m	61	23	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165386	10.1371/journal.pone.0165386	http://dx.doi.org/10.1371/journal.pone.0165386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788205	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900074
J	Sen, S; Sirobhushanam, S; Johnson, SR; Song, Y; Tefft, R; Gatto, C; Wilkinson, BJ				Sen, Suranjana; Sirobhushanam, Sirisha; Johnson, Seth R.; Song, Yang; Tefft, Ryan; Gatto, Craig; Wilkinson, Brian J.			Growth-Environment Dependent Modulation of Staphylococcus aureus Branched-Chain to Straight-Chain Fatty Acid Ratio and Incorporation of Unsaturated Fatty Acids	PLoS One			English	Article							GRAM-POSITIVE PATHOGENS; LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI; STRESS RESISTANCE; HUMAN SKIN; MEMBRANE; VIRULENCE; SUSCEPTIBILITY; LIPIDS; DEHYDROGENASE	The fatty acid composition of membrane glycerolipids is a major determinant of Staphylococcus aureus membrane biophysical properties that impacts key factors in cell physiology including susceptibility to membrane active antimicrobials, pathogenesis, and response to environmental stress. The fatty acids of S. aureus are considered to be a mixture of branched-chain fatty acids (BCFAs), which increase membrane fluidity, and straight-chain fatty acids (SCFAs) that decrease it. The balance of BCFAs and SCFAs in USA300 strain JE2 and strain SH1000 was affected considerably by differences in the conventional laboratory medium in which the strains were grown with media such as Mueller-Hinton broth and Luria broth resulting in high BCFAs and low SCFAs, whereas growth in Tryptic Soy Broth and Brain-Heart Infusion broth led to reduction in BCFAs and an increase in SCFAs. Straight-chain unsaturated fatty acids (SCUFAs) were not detected. However, when S. aureus was grown ex vivo in serum, the fatty acid composition was radically different with SCUFAs, which increase membrane fluidity, making up a substantial proportion of the total (<25%) with SCFAs (>37%) and BCFAs (>36%) making up the rest. Staphyloxanthin, an additional major membrane lipid component unique to S. aureus, tended to be greater in content in cells with high BCFAs or SCUFAs. Cells with high staphyloxanthin content had a lower membrane fluidity that was attributed to increased production of staphyloxanthin. S. aureus saves energy and carbon by utilizing host fatty acids for part of its total fatty acids when growing in serum, which may impact biophysical properties and pathogenesis given the role of SCUFAs in virulence. The nutritional environment in which S. aureus is grown in vitro or in vivo in an infection is likely to be a major determinant of membrane fatty acid composition.	[Sen, Suranjana; Sirobhushanam, Sirisha; Johnson, Seth R.; Song, Yang; Tefft, Ryan; Gatto, Craig; Wilkinson, Brian J.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA	Illinois State University	Wilkinson, BJ (corresponding author), Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA.	bjwilkin@ilstu.edu	Sirobhushanam, Sirisha/I-7180-2019	Sirobhushanam, Sirisha/0000-0003-1542-7317	National Institutes of Health [1R15AI099977, 1R15GM61583]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI099977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by grant 1R15AI099977 to Brian Wilkinson and Craig Gatto and grant 1R15GM61583 to Craig Gatto from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTENBERN RA, 1977, ANTIMICROB AGENTS CH, V11, P574, DOI 10.1128/AAC.11.3.574; Annous BA, 1997, APPL ENVIRON MICROB, V63, P3887, DOI 10.1128/AEM.63.10.3887-3894.1997; Bose JL, 2014, INFECT IMMUN, V82, P1813, DOI 10.1128/IAI.01655-13; Bramkamp M, 2015, MICROBIOL MOL BIOL R, V79, P81, DOI 10.1128/MMBR.00036-14; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Cartron ML, 2014, ANTIMICROB AGENTS CH, V58, P3599, DOI 10.1128/AAC.01043-13; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chaves-Moreno D, 2016, SCI REP-UK, V6, DOI 10.1038/srep33174; Citterio L, 2016, RES MICROBIOL, V167, P72, DOI 10.1016/j.resmic.2015.10.002; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Clinical Laboratory Standard Institute, 2015, M07A10 CLIN LAB STAN, VTwelfth; Davis AO, 2005, J APPL MICROBIOL, V98, P364, DOI 10.1111/j.1365-2672.2004.02460.x; Edgcomb MR, 2000, BBA-BIOMEMBRANES, V1463, P31, DOI 10.1016/S0005-2736(99)00179-0; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; GARBER ED, 1960, ANN NY ACAD SCI, V88, P1187, DOI 10.1111/j.1749-6632.1960.tb20108.x; Hamosh M, 1998, BIOL NEONATE, V74, P163, DOI 10.1159/000014021; Hiron A, 2007, J BACTERIOL, V189, P5119, DOI 10.1128/JB.00274-07; HOLMAN RT, 1995, J NUTR, V125, P901; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Julotok M, 2010, APPL ENVIRON MICROB, V76, P1423, DOI 10.1128/AEM.01592-09; Kaiser JC, 2016, MOL MICROBIOL, V102, P850, DOI 10.1111/mmi.13495; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kenny JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004344; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krismer B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003862; Kuhn S, 2015, INT J MED MICROBIOL, V305, P196, DOI 10.1016/j.ijmm.2014.12.016; LEGENDRE S, 1980, BIOCHIM BIOPHYS ACTA, V602, P491, DOI 10.1016/0005-2736(80)90328-4; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Massey RC, 2002, INFECT IMMUN, V70, P5339, DOI 10.1128/IAI.70.10.5339-5345.2002; Nguyen MT, 2016, INFECT IMMUN, V84, P205, DOI 10.1128/IAI.00822-15; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; Missiakas DM, 2013, CURR PROTOCOLS MICRO; Mitchell NJ, 2016, BBA-BIOMEMBRANES, V1858, P988, DOI 10.1016/j.bbamem.2015.10.014; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Nakamura T, 2003, BRIT J NUTR, V89, P267, DOI 10.1079/BJN2002747; NIKAIDO H, 1976, BIOCHIM BIOPHYS ACTA, V433, P118, DOI 10.1016/0005-2736(76)90182-6; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Oleary W.M., 1988, MICROBIAL LIPIDS, P117; Oogai Y, 2011, APPL ENVIRON MICROB, V77, P8097, DOI 10.1128/AEM.05316-11; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P5729, DOI 10.1128/AAC.01038-13; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Parsons JB, 2012, J BACTERIOL, V194, P5294, DOI 10.1128/JB.00743-12; Parsons JB, 2011, CURR OPIN MICROBIOL, V14, P544, DOI 10.1016/j.mib.2011.07.029; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; PAYNE JW, 1968, J BIOL CHEM, V243, P6291; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Porta A, 2010, J BACTERIOL, V192, P1988, DOI 10.1128/JB.00988-09; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Qiu XY, 2005, PROTEIN SCI, V14, P2087, DOI 10.1110/ps.051501605; Ray B, 2009, MICROB PATHOGENESIS, V47, P94, DOI 10.1016/j.micpath.2009.05.001; Sabirova JS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1956-8; SCHLEIFER KH, 1990, J APPL BACTERIOL, V69, pS9, DOI 10.1111/j.1365-2672.1990.tb01794.x; SHIMOMURA Y, 1986, J CHROMATOGR, V383, P9, DOI 10.1016/S0378-4347(00)83435-0; SILBERT DF, 1973, BIOCHIM BIOPHYS ACTA, V311, P349, DOI 10.1016/0005-2736(73)90315-5; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; Song Y, 2013, MICROB DRUG RESIST, V19, P247, DOI 10.1089/mdr.2012.0195; STEWART ME, 1992, SEMIN DERMATOL, V11, P100; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Sun Y, 2012, J BACTERIOL, V194, P5274, DOI 10.1128/JB.00045-12; Takigawa H, 2005, DERMATOLOGY, V211, P240, DOI 10.1159/000087018; TOWNSEND DE, 1992, J BACTERIOL, V174, P2702, DOI 10.1128/jb.174.8.2702-2710.1992; Wilkinson BJ, 1997, STAPHYLOCOCCI HUMAN, P1; WILLECKE K, 1971, J BIOL CHEM, V246, P5264; Wisniewska A, 2006, ACTA BIOCHIM POL, V53, P475; Yao JW, 2015, J BIOL CHEM, V290, P5940, DOI 10.1074/jbc.R114.636241; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhu K, 2005, MICROBIOL-SGM, V151, P615, DOI 10.1099/mic.0.27634-0	76	46	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165300	10.1371/journal.pone.0165300	http://dx.doi.org/10.1371/journal.pone.0165300			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788193	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900059
J	Takano, T; Nawata, A; Sakai, T; Matsuyama, T; Ito, T; Kurita, J; Terashima, S; Yasuike, M; Nakamura, Y; Fujiwara, A; Kumagai, A; Nakayasu, C				Takano, Tomokazu; Nawata, Akatsuki; Sakai, Takamitsu; Matsuyama, Tomomasa; Ito, Takafumi; Kurita, Jun; Terashima, Sachiko; Yasuike, Motoshige; Nakamura, Yoji; Fujiwara, Atushi; Kumagai, Akira; Nakayasu, Chihaya			Full-Genome Sequencing and Confirmation of the Causative Agent of Erythrocytic Inclusion Body Syndrome in Coho Salmon Identifies a New Type of Piscine Orthoreovirus	PLoS One			English	Article							VIRUS-LIKE PARTICLES; ONCORHYNCHUS-KISUTCH; ATLANTIC SALMON; SYNDROME EIBS; FAMILY REOVIRIDAE; SALAR L.; PRV; TSHAWYTSCHA; PROGRESSION; PROTEOMICS	Erythrocytic inclusion body syndrome (EIBS) causes mass mortality in farmed salmonid fish, including the coho salmon, Onchorhynchus kisutchi, and chinook salmon, 0. tshawytscha. The causative agent of the disease is a virus with an icosahedral virion structure, but this virus has not been characterized at the molecular level. In this study, we sequenced the genome of a virus purified from EIBS-affected coho salmon. The virus has 10 dsRNA genomic segments (L1, L2, L3, Ml, M2, M3, Si, S2, S3, and S4), which closely resembles the genomic organization of piscine orthoreovirus (PRV), the causative agent of heart and skeletal inflammation (HSMI) in Atlantic salmon and HSMI-like disease in coho salmon. The genomic segments of the novel virus contain at least 10 open reading frames (ORFs): lambda 1 (lambda 1), lambda 2, lambda 3, mu 1 (mu 1), mu 2, mu NS, sigma 1 (sigma 1), sigma 2, sigma 3, and sigma NS. An additional ORF encoding a 12.6-kDa protein (homologue of PRV p13) occurs in the same genomic segment as sigma 3. Phylogenetic analyses based on S1 and lambda 3 suggest that this novel virus is closely related to PRV, but distinctly different. Therefore, we designated the new virus `piscine orthoreovirus 2' (PRV-2). Reverse transcription quantitative real-time PCR revealed a significant increase in PRV-2 RNA in fish blood after the artificial infection of EIBS-naive fish but not in that of fish that had recovered from EIBS. The degree of anemia in each fish increased as the PRV-2 RNA increased during an epizootic season of EIBS on an inland coho salmon farm. These results indicate that PRV-2 is the probable causative agent of EIBS in coho salmon, and that the host acquires immunity to reinfection with this virus. Further research is required to determine the host range of PRV species and the relationship between EIBS and HSMI in salmonid fish.	[Takano, Tomokazu; Sakai, Takamitsu; Matsuyama, Tomomasa; Ito, Takafumi; Kurita, Jun; Terashima, Sachiko; Nakayasu, Chihaya] Japan Fisheries Res & Educ Agcy, Res Ctr Fish Dis, Natl Res Inst Aquaculture, Minamiise, Mie, Japan; [Nawata, Akatsuki; Kumagai, Akira] Miyagi Prefecture Fisheries Technol Inst, Ishinomaki, Miyagi, Japan; [Yasuike, Motoshige; Nakamura, Yoji; Fujiwara, Atushi] Japan Fisheries Res & Educ Agcy, Res Ctr Bioinformat & Biosci, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Nakayasu, Chihaya] Southeast Asian Fisheries Dev Ctr, Dept Aquaculture, Iloilo, Philippines	Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Southeast Asian Fisheries Development Center	Takano, T (corresponding author), Japan Fisheries Res & Educ Agcy, Res Ctr Fish Dis, Natl Res Inst Aquaculture, Minamiise, Mie, Japan.	takanoto@fra.affrc.go.jp			Agriculture Forestry and Fisheries Research Council Japan	Agriculture Forestry and Fisheries Research Council Japan	This work was supported by a Grant-in-Aid from the Agriculture Forestry and Fisheries Research Council Japan.; This work was supported by a Grant-in-Aid from the Agriculture Forestry and Fisheries Research Council Japan. We would like to thank Dr. Hideo Fukuda (Emeritus professor for Tokyo University of Marine Science and Technology) for technical support of virus purification.	Arakawa C. K., 1989, Viruses of lower vertebrates., P442; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Attoui H., 2012, VIRUS TAXONOMY, P541, DOI [DOI 10.1016/B978-0-12-384684-6.00051-3, 10.1016/B978-0-12-384684-6.00051-3]; CHAPPELL JD, 1994, J VIROL, V68, P750, DOI 10.1128/JVI.68.2.750-756.1994; Dermody T.S., 2013, FIELDS VIROLOGY, P1304; Duncan R, 1999, VIROLOGY, V260, P316, DOI 10.1006/viro.1999.9832; Finstad OW, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-35; Garseth AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082202; Garver KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146229; Godoy MG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0554-y; HAYAKAWA Y, 1989, FISH PATHOL, V24, P203, DOI 10.3147/jsfp.24.203; HEDRICK RP, 1990, AQUACULTURE, V89, P377, DOI 10.1016/0044-8486(90)90140-I; Juan HF, 2005, PROTEOMICS, V5, P840, DOI 10.1002/pmic.200401056; Key T, 2013, J GEN VIROL, V94, P1039, DOI 10.1099/vir.0.048637-0; Kibenge FSB, 2016, AQUACULTURE VIROLOGY, P205, DOI 10.1016/B978-0-12-801573-5.00014-0; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEEK SL, 1987, CAN J FISH AQUAT SCI, V44, P685, DOI 10.1139/f87-083; Lunder T., 1990, Bulletin of the European Association of Fish Pathologists, V10, P21; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Markussen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070075; Meyers TR, 2007, DIS AQUAT ORGAN, V76, P169, DOI 10.3354/dao076169; MICHAK P, 1992, DIS AQUAT ORGAN, V12, P229, DOI 10.3354/dao012229; Nibert ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068607; OKAMOTO N, 1992, FISH PATHOL, V27, P153, DOI 10.3147/jsfp.27.153; OKAMOTO N, 1992, FISH PATHOL, V27, P213, DOI 10.3147/jsfp.27.213; Olsen AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131638; Ouattara LA, 2011, EMERG INFECT DIS, V17, P1436, DOI 10.3201/eid1708.101528; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Piacentini S. C., 1989, Journal of Aquatic Animal Health, V1, P173, DOI 10.1577/1548-8667(1989)001&lt;0173:EOEIBS&gt;2.3.CO;2; Rodger H. D., 1991, Bulletin of the European Association of Fish Pathologists, V11, P108; Rodger HD, 1998, J FISH DIS, V21, P101, DOI 10.1046/j.1365-2761.1998.00083.x; SAKAI T, 1994, FISHERIES SCI, V60, P519, DOI 10.2331/suisan.60.605; Siah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141475; Sibley SD, 2016, J GEN VIROL, V97, P2482, DOI 10.1099/jgv.0.000568; Sun W, 2006, MOL CELL PROTEOMICS, V5, P769, DOI 10.1074/mcp.T500022-MCP200; Takahashi K., 1992, Journal of Aquatic Animal Health, V4, P174, DOI 10.1577/1548-8667(1992)004&lt;0174:EOEIBS&gt;2.3.CO;2; TAKAHASHI K, 1994, J FISH DIS, V17, P77, DOI 10.1111/j.1365-2761.1994.tb00347.x; TAKAHASHI K, 1992, FISH PATHOL, V27, P89, DOI 10.3147/jsfp.27.89; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watanabe K, 2006, DIS AQUAT ORGAN, V70, P183, DOI 10.3354/dao070183; Wessel O, 2015, VET RES, V46, DOI 10.1186/s13567-015-0154-7	42	55	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165424	10.1371/journal.pone.0165424	http://dx.doi.org/10.1371/journal.pone.0165424			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788206	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900082
J	Minami, A; Saito, M; Mamada, S; Ieno, D; Hikita, T; Takahashi, T; Otsubo, T; Ikeda, K; Suzuki, T				Minami, Akira; Saito, Masakazu; Mamada, Shou; Ieno, Daisuke; Hikita, Tomoya; Takahashi, Tadanobu; Otsubo, Tadamune; Ikeda, Kiyoshi; Suzuki, Takashi			Role of Sialidase in Long-Term Potentiation at Mossy Fiber-CA3 Synapses and Hippocampus-Dependent Spatial Memory	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; POLYSIALIC ACID; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; NMDA RECEPTORS; PSA-NCAM; 2 FORMS; BRAIN; NEU4; EXPRESSION	Sialic acid bound to glycans in glycolipids and glycoproteins is essential for synaptic plasticity and memory. Sialidase (EC 3.2.1.18), which has 4 isozymes including Neu1, Neu2, Neu3 and Neu4, regulates the sialylation level of glycans by removing sialic acid from sialyl-glycoconjugate. In the present study, we investigated the distribution of sialidase activity in rat hippocampus and the role of sialidase in hippocampal memory processing. We previously developed a highly sensitive histochemical imaging probe for sialidase activity, BTP3-Neu5Ac. BTP3-Neu5Ac was cleaved efficiently by rat Neu2 and Neu4 at pH 7.3 and by Neu1 and Neu3 at pH 4.6. When a rat hippocampal acute slice was stained with BTP3-Neu5Ac at pH 7.3, mossy fiber terminal fields showed relatively intense sialidase activity. Thus, the role of sialidase in the synaptic plasticity was investigated at mossy fiber terminal fields. The long-term potentiation (LTP) at mossy fiber-CA3 pyramidal cell synapses was impaired by 2,3-dehydro-2-deoxy-N-acetylneuraminic acid (DANA), a sialidase inhibitor. DANA also failed to decrease paired-pulse facilitation after LTP induction. We also investigated the role of sialidase in hippocampus-dependent spatial memory by using the Morris water maze. The escape latency time to reach the platform was prolonged by DANA injection into the hippocampal CA3 region or by knockdown of Neu4 without affecting motility. The results show that the regulation of sialyl signaling by Neu4 is involved in hippocampal memory processing.	[Minami, Akira; Saito, Masakazu; Mamada, Shou; Ieno, Daisuke; Hikita, Tomoya; Takahashi, Tadanobu; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Suruga Ku, Shizuoka 4228526, Japan; [Otsubo, Tadamune; Ikeda, Kiyoshi] Hiroshima Int Univ, Sch Pharmaceut Sci, Dept Organ Chem, Kure, Hiroshima 7370112, Japan	University of Shizuoka	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp		Otsubo, Tadamune/0000-0003-1949-9780	KAKENHI [16K08277]; Hokuto Foundation for Bioscience; Takahashi Industrial and Economic Research Foundation; Futaba Electronics Memorial Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hokuto Foundation for Bioscience(Hokuto Foundation for Bioscience); Takahashi Industrial and Economic Research Foundation; Futaba Electronics Memorial Foundation	This research was supported by a grant provided by Grant-in-Aid for Scientific Research (C) (KAKENHI; no. 16K08277), the Hokuto Foundation for Bioscience, Takahashi Industrial and Economic Research Foundation, and Futaba Electronics Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Fujii S, 2002, GLYCOBIOLOGY, V12, P339, DOI 10.1093/glycob/12.5.339; Furuse H, 1998, EXP BRAIN RES, V123, P307, DOI 10.1007/s002210050573; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Gilbert PE, 2009, PROG NEURO-PSYCHOPH, V33, P774, DOI 10.1016/j.pnpbp.2009.03.037; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; Hasegawa T, 2001, BIOCHEM BIOPH RES CO, V280, P726, DOI 10.1006/bbrc.2000.4186; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Hensbroek RA, 2003, BEHAV BRAIN RES, V138, P215, DOI 10.1016/S0166-4328(02)00243-7; Hoffman KB, 1997, BRAIN RES, V753, P309, DOI 10.1016/S0006-8993(96)01468-0; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Jung WR, 2008, NEUROSCI LETT, V439, P220, DOI 10.1016/j.neulet.2008.05.020; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Katafuchi T, 2000, LEARN MEMORY, V7, P383, DOI 10.1101/lm.33900; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Magesh S, 2008, BIOORG MED CHEM LETT, V18, P532, DOI 10.1016/j.bmcl.2007.11.084; Meilandt WJ, 2004, J NEUROSCI, V24, P2953, DOI 10.1523/JNEUROSCI.5569-03.2004; Minami A, 2002, BRAIN RES, V936, P91, DOI 10.1016/S0006-8993(02)02499-X; Minami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081941; Minami A, 2013, BIOL PHARM BULL, V36, P1990, DOI 10.1248/bpb.b13-00657; Minami A, 2012, TRENDS GLYCOSCI GLYC, V24, P112, DOI 10.4052/tigg.24.112; Minami A, 2011, NEUROIMAGE, V58, P34, DOI 10.1016/j.neuroimage.2011.06.017; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 1999, GENOMICS, V57, P137, DOI 10.1006/geno.1999.5749; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; RAMIREZ OA, 1990, BRAIN RES, V506, P291, DOI 10.1016/0006-8993(90)91264-H; Ramirez-Amaya V, 2001, J NEUROSCI, V21, P7340; Rebola N, 2011, NAT NEUROSCI, V14, P691, DOI 10.1038/nn.2809; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Savotchenko A, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/908190; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Seki T, 1999, J COMP NEUROL, V410, P115, DOI 10.1002/(SICI)1096-9861(19990719)410:1<115::AID-CNE10>3.0.CO;2-C; Senkov O, 2012, INT J BIOCHEM CELL B, V44, P591, DOI 10.1016/j.biocel.2012.01.008; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; Shiozaki K, 2014, FISH PHYSIOL BIOCHEM, V40, P1461, DOI 10.1007/s10695-014-9940-9; Shiozaki K, 2011, J BIOL CHEM, V286, P21052, DOI 10.1074/jbc.M111.231191; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Sumida M, 2015, J BIOL CHEM, V290, P13202, DOI 10.1074/jbc.M115.638759; Takahashi K, 2012, J BIOL CHEM, V287, P14816, DOI 10.1074/jbc.M111.324186; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078125; WIERASZKO A, 1985, BRAIN RES, V345, P159, DOI 10.1016/0006-8993(85)90847-9; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	47	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165257	10.1371/journal.pone.0165257	http://dx.doi.org/10.1371/journal.pone.0165257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783694	gold, Green Published, Green Submitted			2022-12-26	WOS:000389602800065
J	Adilardi, RS; Ojanguren-Affilastro, AA; Mola, LM				Sebastian Adilardi, Renzo; Alejandro Ojanguren-Affilastro, Andres; Maria Mola, Liliana			Sex-Linked Chromosome Heterozygosity in Males of Tityus confluens (Buthidae): A Clue about the Presence of Sex Chromosomes in Scorpions	PLOS ONE			English	Article							PALESTINIAN TERRITORIES; AUSTRALIAN SCORPIONS; CYTOGENETIC ANALYSIS; KARYOTYPE EVOLUTION; COMPLEX; HETEROCHROMATIN; POLYMORPHISM; SEQUENCES; MEIOSIS; BORELLI	Scorpions of the genus Tityus show holokinetic chromosomes, achiasmatic male meiosis and an absence of heteromorphic sex chromosomes, like all Buthidae. In this work, we analysed the meiotic behaviour and chromosome rearrangements of a population of the scorpion Tityus confluens, characterising the cytotypes of males, females and embryos with different cytogenetic techniques. This revealed that all the females were structural homozygotes, while all the males were structural heterozygotes for different chromosome rearrangements. Four different cytotypes were described in males, which differed in chromosome number (2n = 5 and 2n = 6) and meiotic multivalent configurations (chains of four, five and six chromosomes). Based on a detailed mitotic and meiotic analysis, we propose a sequence of chromosome rearrangements that could give rise to each cytotype and in which fusions have played a major role. Based on the comparison of males, females and a brood of embryos, we also propose that the presence of multivalents in males and homologous pairs in females could be associated with the presence of cryptic sex chromosomes, with the male being the heterogametic sex. We propose that the ancestral karyotype of this species could have had homomorphic XY/XX (male/female) sex chromosomes and a fusion could have occurred between the Y chromosome and an autosome.	[Sebastian Adilardi, Renzo; Maria Mola, Liliana] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IEGEBA CONICET UBA, Dept Ecol Genet & Evoluc,Lab Citogenet & Evoluc, Buenos Aires, DF, Argentina; [Alejandro Ojanguren-Affilastro, Andres] Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Aracnol, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN)	Mola, LM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, IEGEBA CONICET UBA, Dept Ecol Genet & Evoluc,Lab Citogenet & Evoluc, Buenos Aires, DF, Argentina.	lilimola@yahoo.com.ar	Mola, Liliana Maria/AAN-6792-2020	Mola, Liliana Maria/0000-0003-2511-8067; Adilardi, Renzo/0000-0001-7279-3853	National Council of Scientific and Technological Research (CONICET) [PIP 0342, PIP 2014-0107]; National Agency for Scientific and Technological Promotion (ANPCyT) [PICT 2010-1665]	National Council of Scientific and Technological Research (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Agency for Scientific and Technological Promotion (ANPCyT)(ANPCyT)	This work was supported by grants from the National Council of Scientific and Technological Research (CONICET) (PIP 0342 and PIP 2014-0107) and National Agency for Scientific and Technological Promotion (ANPCyT) (PICT 2010-1665) to LMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adilardi RS, 2013, J ARACHNOL, V41, P222, DOI 10.1636/B12-77.1; Bertani R, 2005, ZOOTAXA, P1; Bressa MJ, 1998, CARYOLOGIA, V51, P253, DOI 10.1080/00087114.1998.10797417; Bures P, 2012, PLANT GENOME DIVERSI, V2, P187, DOI DOI 10.1007/978-3-7091-1160-4_12; Camacho J.P.M., 2014, PROTOCOLS CYTOGENETI, P416, DOI [10.1201/b17450-12., DOI 10.1201/B17450-12]; Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602; Darlington CD., 1958, EVOLUTION GENETIC SY; Green JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150292; GUENIN H.-A, 1957, REV SUISSE ZOOL, V64, P349; Hall AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-273; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; Jankowska M, 2015, CHROMOSOMA, V124, P519, DOI 10.1007/s00412-015-0524-y; Lopez-Fernandez C, 2004, GENOME, V47, P757, DOI 10.1139/G03-143; Lourenco WR, 2007, AMAZONIANA, V19, P77; LOURENCO W R, 1980, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V2, P793; Lourenco Wilson R., 2006, Entomologische Mitteilungen aus dem Zoologischen Museum Hamburg, V14, P307; Mandrioli M, 2014, COMP CYTOGENET, V8, P259, DOI 10.3897/CompCytogen.v8i4.8568; Mattos VF, 2014, ZOOL SCI, V31, P603, DOI 10.2108/zs140005; Mattos VF, 2013, CHROMOSOME RES, V21, P121, DOI 10.1007/s10577-013-9342-3; MAURY E A, 1974, Physis Seccion C los Continentes y los Organismos Terrestres, V33, P85; Mola LM, 2006, BAG-J BASIC APPL GEN, V17, P17; Monti V, 2011, CHROMOSOME RES, V19, P625, DOI 10.1007/s10577-011-9222-7; Ojanguren Affilastro AA, 2005, REV IBER ARACNOL, V11, P75; Piza ST, 1947, ESC SUPER AGR LUIZ Q, V62, P183, DOI [10.1590/S0071-12761947000100008, DOI 10.1590/S0071-12761947000100008]; Qumsiyeh MB, 2014, CYTOLOGIA, V79, P277, DOI 10.1508/cytologia.79.277; Qumsiyeh MB, 2013, ZOOL MIDDLE EAST, V59, P70, DOI 10.1080/09397140.2013.795070; Rego A, 2003, CHROMOSOME RES, V11, P681, DOI 10.1023/A:1025937808382; Schneider MC, 2009, J HERED, V100, P545, DOI 10.1093/jhered/esp023; Schneider MC, 2009, CHROMOSOME RES, V17, P883, DOI 10.1007/s10577-009-9076-4; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; Adilardi RS, 2015, GENETICA, V143, P393, DOI 10.1007/s10709-015-9838-1; Adilardi RS, 2014, COMP CYTOGENET, V8, P81, DOI 10.3897/CompCytogen.v8i2.6461; SHANAHAN CM, 1989, GENOME, V32, P882, DOI 10.1139/g89-525; SHANAHAN CM, 1989, GENOME, V32, P890, DOI 10.1139/g89-526; Sharma PP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2953; Sichova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064520; SRIVASTAVA M, 1961, CARYOLOGIA, V14, P63, DOI 10.1080/00087114.1961.10796012; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Vanzela ALL, 2000, BOT J LINN SOC, V134, P557, DOI 10.1006/bojl.2000.0352; WHITE M J D, 1973, P961	41	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164427	10.1371/journal.pone.0164427	http://dx.doi.org/10.1371/journal.pone.0164427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783630	Green Submitted, gold, Green Published			2022-12-26	WOS:000389602800038
J	Wultsch, C; Caragiulo, A; Dias-Freedman, I; Quigley, H; Rabinowitz, S; Amato, G				Wultsch, Claudia; Caragiulo, Anthony; Dias-Freedman, Isabela; Quigley, Howard; Rabinowitz, Salisa; Amato, George			Genetic Diversity and Population Structure of Mesoamerican Jaguars (Panthera onca): Implications for Conservation and Management	PLOS ONE			English	Article							PUMAS PUMA-CONCOLOR; CENTRAL-AMERICA; BIODIVERSITY CONSERVATION; HABITAT FRAGMENTATION; SEX IDENTIFICATION; GENOTYPING ERRORS; R-PACKAGE; MEXICO; DNA; LANDSCAPE	Mesoamerican jaguars (Panthera onca) have been extirpated from over 77% of their historic range, inhabiting fragmented landscapes at potentially reduced population sizes. Maintaining and restoring genetic diversity and connectivity across human-altered landscapes has become a major conservation priority; nonetheless large-scale genetic monitoring of natural populations is rare. This is the first regional conservation genetic study of jaguars to primarily use fecal samples collected in the wild across five Mesoamerican countries: Belize, Costa Rica, Guatemala, Honduras, and Mexico. We genotyped 445 jaguar fecal samples and examined patterns of genetic diversity and connectivity among 115 individual jaguars using data from 12 microsatellite loci. Overall, moderate levels of genetic variation were detected (N-A = 4.50 +/- 1.05, A(R) = 3.43 +/- 0.22, H-E = 0.59 +/- 0.04), with Mexico having the lowest genetic diversity, followed by Honduras, Guatemala, Belize, and Costa Rica. Population-based gene flow measures (F-ST = 0.09 to 0.15, D-est = 0.09 to 0.21), principal component analysis, and Bayesian clustering applied in a hierarchical framework revealed significant genetic structure in Mesoamerican jaguars, roughly grouping individuals into four genetic clusters with varying levels of admixture. Gene flow was highest among Selva Maya jaguars (northern Guatemala and central Belize), whereas genetic differentiation among all other sampling sites was moderate. Genetic subdivision was most pronounced between Selva Maya and Honduran jaguars, suggesting limited jaguar movement between these close geographic regions and ultimately refuting the hypothesis of contemporary panmixia. To maintain a critical linkage for jaguars dispersing through the Mesoamerican landscape and ensure long-term viability of this near threatened species, we recommend continued management and maintenance of jaguar corridors. The baseline genetic data provided by this study underscores the importance of understanding levels of genetic diversity and connectivity to making informed management and conservation decisions with the goal to maintain functional connectivity across the region.	[Wultsch, Claudia; Caragiulo, Anthony; Rabinowitz, Salisa; Amato, George] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Dias-Freedman, Isabela] Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ USA; [Wultsch, Claudia; Quigley, Howard] Panthera, New York, NY 10018 USA	American Museum of Natural History (AMNH); Rutgers State University Newark; Rutgers State University New Brunswick	Wultsch, C (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.	cwultsch@amnh.org		Caragiulo, Anthony/0000-0002-4629-7896; Dias-Freedman, Isabela/0000-0002-1924-5097	Panthera; Woodland Park Zoo Jaguar Conservation Fund	Panthera; Woodland Park Zoo Jaguar Conservation Fund	This work was funded by the following institutions and/or grant programs: Panthera (http://www.panthera.org/; received by GA). Woodland Park Zoo Jaguar Conservation Fund (https://www.zoo.org/conservation/jaguar; received by CW). Panthera's field programs supported this research through sample collection across several Mesoamerican countries. Woodland Park Zoo had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Villordo-Galvan JA, 2010, SOUTHWEST NAT, V55, P394, DOI 10.1894/CLG-30.1; Allendorf F. W., 2013, CONSERVATION AND THE; Arriaga L, 2000, REGIONES TERRESTRES, DOI [10.5962/bhl.title.118644, DOI 10.5962/BHL.TITLE.118644]; Balkenhol N, 2014, ECOGRAPHY, V37, P552, DOI 10.1111/j.1600-0587.2013.00462.x; Calderon Quinonez AP, 2013, THESIS; Caragiulo A, 2015, ORYX, V49, P632, DOI 10.1017/S0030605314000817; Caragiulo A, 2014, MITOCHONDR DNA, V25, P304, DOI 10.3109/19401736.2013.800486; Carmichael LE, 2001, MOL ECOL, V10, P2787, DOI 10.1046/j.1365-294X.2001.t01-1-01408.x; Caso A, 2008, THE IUCN RED LIST OF; Castaneda F, 2011, REV MESOAMERICANA, V15, P73; Castaneda F, 2011, ESTADO DEL JAGUAR PA; Ceballos G., 2005, BIODIVERSITAS, V62, P1; Colchero F, 2011, ANIM CONSERV, V14, P158, DOI 10.1111/j.1469-1795.2010.00406.x; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; CRAWSHAW PG, 1991, J ZOOL, V223, P357, DOI 10.1111/j.1469-7998.1991.tb04770.x; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; DeClerck FAJ, 2010, BIOL CONSERV, V143, P2301, DOI 10.1016/j.biocon.2010.03.026; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Eizirik E, 2001, MOL ECOL, V10, P65, DOI 10.1046/j.1365-294X.2001.01144.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Figueroa O. A., 2013, THESIS U FLORIDA; Food and Agriculture Organization of the United States, 2010, GLOBAL FOREST RESOUR; Francis RM, 2017, MOL ECOL RESOUR, V17, P27, DOI 10.1111/1755-0998.12509; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gonzalez-Maya JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124480; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Grigione MM, 2009, ORYX, V43, P78, DOI 10.1017/S0030605308002019; Haag T, 2010, MOL ECOL, V19, P4906, DOI 10.1111/j.1365-294X.2010.04856.x; Harvey CA, 2008, CONSERV BIOL, V22, P8, DOI 10.1111/j.1523-1739.2007.00863.x; Hernandez-SaintMartin AD, 2015, NAT AREA J, V35, P308, DOI 10.3375/043.035.0213; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huete-Perez JA, 2015, ENVIRON SCI TECHNOL, V49, P3989, DOI 10.1021/acs.est.5b00215; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Jackson P., 1996, BIOL CONSERVATION; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jordan CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151372; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kelly MJ, 2012, TECH ECOL CONSERVAT, P47; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; Larson SE, 1997, ZOO BIOL, V16, P107, DOI 10.1002/(SICI)1098-2361(1997)16:2<107::AID-ZOO2>3.3.CO;2-M; Lonsinger RC, 2015, CONSERV GENET RESOUR, V7, P841, DOI 10.1007/s12686-015-0506-7; Lopez G, CONNECTIVITY AMONG J; Macdonald DW, 2010, BIOLOGY AND CONSERVA; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; MENOTTIRAYMOND MA, 1995, J HERED, V86, P319, DOI 10.1093/oxfordjournals.jhered.a111594; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petracca LS, 2014, J NAT CONSERV, V22, P436, DOI 10.1016/j.jnc.2014.04.002; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pocock R. I., 1939, Novitates Zoologicae, V41, P406; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2011, R A LANGUAGE AND ENV; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Redo DJ, 2012, P NATL ACAD SCI USA, V109, P8839, DOI 10.1073/pnas.1201664109; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rodriguez-Soto C, 2011, DIVERS DISTRIB, V17, P350, DOI 10.1111/j.1472-4642.2010.00740.x; Rueness EK, 2003, MOL ECOL, V12, P2623, DOI 10.1046/j.1365-294X.2003.01952.x; Ruiz-Garcia M, 2013, MOL POPULATION GENET, P413; Sanchez F, 2015, NAT AREA J, V35, P308; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; SCHALLER GB, 1980, BIOTROPICA, V12, P161, DOI 10.2307/2387967; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; SEYMOUR KL, 1989, MAMMALIAN SPECIES, V340, P1, DOI DOI 10.2307/3504096; Soto Fournier S., 2014, THESIS; Sunquist ME, 2002, WILD CATS OF THE WOR, V1; SWANK W G, 1989, Oryx, V23, P14; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tucker JM, 2014, CONSERV GENET, V15, P123, DOI 10.1007/s10592-013-0525-4; Urquiza-Haas T, 2009, BIOL CONSERV, V142, P134, DOI 10.1016/j.biocon.2008.10.007; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wei K, 2008, CONSERV GENET, V9, P225, DOI 10.1007/s10592-006-9279-6; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wultsch C., 2016, PLOS ONE, V11; Wultsch C, 2015, WILDLIFE SOC B, V39, P403, DOI 10.1002/wsb.540; Wultsch C, 2014, MOL ECOL RESOUR, V14, P1171, DOI 10.1111/1755-0998.12266; Zanin M, 2016, EUR J WILDLIFE RES, V62, P461, DOI 10.1007/s10344-016-1019-8; Zanin M, 2015, ORYX, V49, P96, DOI 10.1017/S0030605313001609; Zeilhofer P, 2014, BIOTROPICA, V46, P98, DOI 10.1111/btp.12074; Zeller KA, 2007, JAGUARS IN THE NEW M; Zeller KA., 2013, MOL POPULATION GENET, P629	95	35	37	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0162377	10.1371/journal.pone.0162377	http://dx.doi.org/10.1371/journal.pone.0162377			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783617	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800011
J	Pedersen, ATM; Nowak, MD; Brysting, AK; Elven, R; Bjora, CS				Pedersen, A. Tiril M.; Nowak, Michael D.; Brysting, Anne K.; Elven, Reidar; Bjora, Charlotte S.			Hybrid Origins of Carex rostrata var. borealis and C-stenolepis, Two Problematic Taxa in Carex Section Vesicariae (Cyperaceae)	PLOS ONE			English	Article							SHORT-BEAKED TAXA; SEDGES CAREX; POPULATION-STRUCTURE; OVALES CYPERACEAE; CHROMOSOME-NUMBER; SPECIATION; EVOLUTION; HYBRIDIZATION; CIRCUMPOLAR; PHYLOGENY	Hybridization is frequent in the large and ecologically significant genus Carex (Cyperaceae). In four important sections of the northern regions (Ceratocystis, Glareosae, Phacocystis and Vesicariae), the frequent occurrence of hybrids often renders the identification of "pure" species and hybrids difficult. In this study we address the origins and taxonomic rank of two taxa of section Vesicariae: Carex rostrata var. borealis and C. stenolepis. The origin and taxonomic status of C. stenolepis has been the subject of substantial debate over the years, whereas C. rostrata var. borealis has received very little attention in the years since its first description in the 19th century. By performing an extensive sampling of relevant taxa from a broad distribution range, and analyzing data from fifteen microsatellite loci developed specifically for our study together with pollen stainability measures, we resolve the hybrid origins of C. rostrata var. borealis and C. stenolepis and provide new insights into this taxonomically challenging group of sedges. Our results are in accordance with previous findings suggesting that C. stenolepis is a hybrid between C. vesicaria and C. saxatilis. They are also in accordance with a previous proposition that C. rostrata var. borealis is a hybrid between C. rostrata and C. rotundata, and furthermore suggest that both hybrids are the result of multiple, recent (i.e., postglacial) hybridization events. We found little evidence for successful sexual reproduction within C. rostrata var. borealis and C. stenolepis, but conclude that the common and recurrent, largely predictable occurrence of these taxa justifies accepting both hybrids as hybrid species with binomial names. There are, however, complications as to types and priority names, and we therefore choose to address these problems in a separate paper.	[Pedersen, A. Tiril M.; Nowak, Michael D.; Elven, Reidar; Bjora, Charlotte S.] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Brysting, Anne K.] Univ Oslo, Dept Biosci, CEES, Oslo, Norway	University of Oslo; University of Oslo	Pedersen, ATM (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	t.m.pedersen@nhm.uio.no	Brysting, Anne Krag/G-5032-2017; Nowak, Michael/M-3747-2017	Brysting, Anne Krag/0000-0003-0388-4406; Nowak, Michael/0000-0001-8924-6506	Natural History Museum, University of Oslo	Natural History Museum, University of Oslo	This work was funded by the Natural History Museum, University of Oslo. Publishing costs were covered by the Open Access Publishing fund for UiO researchers, University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, FLORA N AM N MEXICO; Bergeron A., 2014, PHYTONEURON, V52, P1; Blytt A. G, 1876, NYT MAGAZIN NATURVID, V21, P279; BORGEN L, 1983, Nordic Journal of Botany, V3, P301, DOI 10.1111/j.1756-1051.1983.tb01942.x; Buerkle CA, 2005, MOL ECOL NOTES, V5, P684, DOI 10.1111/j.1471-8286.2005.01011.x; CAYOUETTE J, 1992, BOT REV, V58, P351, DOI 10.1007/BF02858773; Cayouette J, 1991, CYPERACEAE NEWS, V9, P6; Clay DL, 2012, AM J BOT, V99, P1976, DOI 10.3732/ajb.1200326; Dragon JA, 2009, AM J BOT, V96, P1896, DOI 10.3732/ajb.0800404; Drury W.H., 1956, RHODORA, V58, P51; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Egorova T.V., 1999, SEDGES CAREX L RUSSI; Ehrich D, 2007, MOL ECOL, V16, P2542, DOI 10.1111/j.1365-294X.2007.03299.x; Elven R., 2013, DISTRIBUTION MAPS NO, P139; Elven R., 2011, ANNOTATED CHECKLIST; FORD BA, 1991, SYST BOT, V16, P116, DOI 10.2307/2418977; FORD BA, 1993, CAN J BOT, V71, P486, DOI 10.1139/b93-053; FORD BA, 1992, SYST BOT, V17, P620, DOI 10.2307/2419731; Gebauer S, 2014, ORG DIVERS EVOL, V14, P247, DOI 10.1007/s13127-014-0171-9; Gompert Z, 2010, MOL ECOL RESOUR, V10, P378, DOI 10.1111/j.1755-0998.2009.02733.x; Govaerts R, 2007, WORLD CHECKLIST CYPE; Heilborn O, 1934, HEREDITAS, V19, P233; Heilborn O., 1932, SVENSK BOT TIDSKR, V26, P137; Hipp Andrew L., 2007, Aliso, V23, P193; Hipp AL, 2007, EVOLUTION, V61, P2175, DOI 10.1111/j.1558-5646.2007.00183.x; Hipp AL, 2006, INT J PLANT SCI, V167, P1029, DOI 10.1086/505538; Hipp AL, 2009, BOT REV, V75, P96, DOI 10.1007/s12229-008-9022-8; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Hylander N., 1966, NORDISK KARLVAXTFLOR; Jakobsen A., 1980, THESIS; Jermy C, 2007, SEDGES BRIT ISLES BS; Jimenez-Mejias P, 2016, SYST BOT, V41, P500, DOI 10.1600/036364416X692497; Jimenez-Mejias P, 2011, AM J BOT, V98, P1855, DOI 10.3732/ajb.1100120; Johnson MG, 2016, CONSERV GENET, V17, P593, DOI 10.1007/s10592-015-0808-z; Jonsdottir IS, 2000, ECOGRAPHY, V23, P402; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Korpelainen H, 2010, PLANT SYST EVOL, V287, P141, DOI 10.1007/s00606-010-0307-0; KUKKONEN I, 1988, AQUAT BOT, V30, P5, DOI 10.1016/0304-3770(88)90003-4; LAINE U, 1987, Memoranda Societatis pro Fauna et Flora Fennica, V63, P37; Lamont BB, 2003, J EVOLUTION BIOL, V16, P551, DOI 10.1046/j.1420-9101.2003.00548.x; Lid J, 2005, NORSK FLORA, P960; Lipnerova I, 2013, ANN BOT-LONDON, V111, P79, DOI 10.1093/aob/mcs239; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Maneval WE, 1936, STAIN TECHNOL, V2, P9; Pritchard JK, 2000, GENETICS, V155, P945; Rentsch JD, 2012, ECOL EVOL, V2, P2213, DOI 10.1002/ece3.328; REZNICEK AA, 1990, CAN J BOT, V68, P1409, DOI 10.1139/b90-180; Reznicek AA, 2002, FLORA N AM N MEXICO, V23, P501; Rohlf F.J., 2000, NTSYSPC NUMERICAL TA; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schonswetter P, 2008, AM J BOT, V95, P1006, DOI 10.3732/ajb.2007196; Schumer M, 2014, EVOLUTION, V68, P1553, DOI 10.1111/evo.12399; Shekhovtsov SV, 2012, NORD J BOT, V30, P343, DOI 10.1111/j.1756-1051.2011.01405.x; Stace C.A., 2015, HYBRID FLORA BRIT IS; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; von Hagen KB, 2008, PLANT SYST EVOL, V274, P179, DOI 10.1007/s00606-008-0046-7; Waterway MJ, 2015, BOT J LINN SOC, V179, P1, DOI 10.1111/boj.12298	59	13	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165430	10.1371/journal.pone.0165430	http://dx.doi.org/10.1371/journal.pone.0165430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780239	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900056
J	Rovira-Graells, N; Aguilera-Simon, S; Tinto-Font, E; Cortes, A				Rovira-Graells, Nuria; Aguilera-Simon, Sara; Tinto-Font, Elisabet; Cortes, Alfred			New Assays to Characterise Growth-Related Phenotypes of Plasmodium falciparum Reveal Variation in Density-Dependent Growth Inhibition between Parasite Lines	PLOS ONE			English	Article							RED-BLOOD-CELLS; MALARIA PARASITES; CLAG3 GENES; COMMUNICATION; INFECTIONS; EXPRESSION; ABILITY; CYCLE	The growth phenotype of asexual blood stage malaria parasites can influence their virulence and also their ability to survive and achieve transmission to the next host, but there are few methods available to characterise parasite growth parameters in detail. We developed a new assay to measure growth rates at different starting parasitaemias in a 96-well format and applied it to characterise the growth of Plasmodium falciparum lines 3D7-A and 3D7-B, previously shown to have different invasion rates and to use different invasion pathways. Using this simple and accurate assay we found that 3D7-B is more sensitive to high initial parasitaemia than 3D7-A. This result indicates that different parasite lines show variation in their levels of density-dependent growth inhibition. We also developed a new assay to compare the duration of the asexual blood cycle between different parasite lines. The assay is based on the tight synchronisation of cultures to a 1 h parasite age window and the subsequent monitoring of schizont bursting and formation of new rings by flow cytometry. Using this assay we observed differences in the duration of the asexual blood cycle between parasite lines 3D7 and HB3. These two new assays will be useful to characterise variation in growth-related parameters and to identify growth phenotypes associated with the targeted deletion of specific genes or with particular genomic, transcriptomic or proteomic patterns. Furthermore, the identification of density-dependent growth inhibition as an intrinsic parasite property that varies between parasite lines expands the repertoire of measurable growth-related phenotypic traits that have the potential to influence the outcome of a malarial blood infection.	[Rovira-Graells, Nuria; Aguilera-Simon, Sara; Tinto-Font, Elisabet; Cortes, Alfred] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Catalonia, Spain; [Cortes, Alfred] ICREA, Barcelona, Catalonia, Spain	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; ICREA	Cortes, A (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Catalonia, Spain.; Cortes, A (corresponding author), ICREA, Barcelona, Catalonia, Spain.	alfred.cortes@isglobal.org	Tintó-Font, Elisabet/AGY-9736-2022; Closas, Alfred Cortes/I-8134-2015	Closas, Alfred Cortes/0000-0003-0730-6582; Tinto-Font, Elisabet/0000-0002-5770-0556	Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2013-43601-R]; European Regional Development Fund (ERDF, European Union); Department of Economy and Knowledge of the Government of Catalonia [2014 SGR 485]; MINECO [BES-2014-067901]; European social fund (EU); ICREA Funding Source: Custom	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); European Regional Development Fund (ERDF, European Union); Department of Economy and Knowledge of the Government of Catalonia; MINECO(Spanish Government); European social fund (EU)(European Social Fund (ESF)European Commission); ICREA(ICREA)	This research was supported by Spanish Ministry of Economy and Competitiveness (MINECO, http://www.mineco.gob.es/portal/site/mineco/idi) grant SAF2013-43601-R to AC, co-funded by the European Regional Development Fund (ERDF, European Union, http://ec.europa.eu/regional_policy/en/funding/erdf/), and grant 2014 SGR 485 to AC from the Secretary for Universities and Research under the Department of Economy and Knowledge of the Government of Catalonia (http://universitatsirecerca.gencat.cat/ca/inici/). ET-F is supported by fellowship BES-2014-067901 by MINECO, co-funded by the European social fund (EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala HBR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-577; Bartfai R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001223; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Carter Lucy M., 2013, Evolution Medicine and Public Health, P135, DOI 10.1093/emph/eot011; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; Cortes A, 2005, INT J PARASITOL, V35, P125, DOI 10.1016/j.ijpara.2004.11.004; Cortes A, 2004, BLOOD, V104, P2961, DOI 10.1182/blood-2004-06-2136; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; de Koning-Ward TF, 2015, NAT REV MICROBIOL, V13, P373, DOI 10.1038/nrmicro3450; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Kafsack BFC, 2014, NATURE, V507, P248, DOI 10.1038/nature12920; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mancio-Silva L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2539; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Mantel PY, 2013, CELL HOST MICROBE, V13, P521, DOI 10.1016/j.chom.2013.04.009; Margos G, 2004, PARASITOLOGY, V129, P273, DOI 10.1017/S0031182004005657; Martin-Jaular L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026588; Mideo N, 2012, FUTURE MICROBIOL, V7, P17, DOI [10.2217/fmb.11.134, 10.2217/FMB.11.134]; Mira-Martinez S, 2013, CELL MICROBIOL, V15, P1913, DOI 10.1111/cmi.12162; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Nilsson SK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004871; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; Reilly HB, 2007, INT J PARASITOL, V37, P1599, DOI 10.1016/j.ijpara.2007.05.003; Rovira-Graells N, 2015, NUCLEIC ACIDS RES, V43, P8243, DOI 10.1093/nar/gkv730; Rovira-Graells N, 2012, GENOME RES, V22, P925, DOI 10.1101/gr.129692.111; Schoepflin S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-250; Urban P, 2011, J CONTROL RELEASE, V151, P202, DOI 10.1016/j.jconrel.2011.01.001; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Wilson DW, 2013, ANTIMICROB AGENTS CH, V57, P1455, DOI 10.1128/AAC.01881-12	36	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165358	10.1371/journal.pone.0165358	http://dx.doi.org/10.1371/journal.pone.0165358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780272	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900048
J	Santos, M; Kitzman, DW; Matsushita, K; Loehr, L; Sueta, CA; Shah, AM				Santos, Mario; Kitzman, Dalane W.; Matsushita, Kunihiro; Loehr, Laura; Sueta, Carla A.; Shah, Amil M.			Prognostic Importance of Dyspnea for Cardiovascular Outcomes and Mortality in Persons without Prevalent Cardiopulmonary Disease: The Atherosclerosis Risk in Communities Study	PLOS ONE			English	Article							HEART-FAILURE INCIDENCE; RESPIRATORY SYMPTOMS; PREDICTORS; SURVIVAL; AMERICAN	Background The relationship between dyspnea and incident heart failure (HF) and myocardial infarction (MI) among patients without previously diagnosed cardiopulmonary disease is unclear. We studied the prognostic relevance of self-reported dyspnea for cardiovascular outcomes and all-cause mortality in persons without previously diagnosed cardiopulmonary disease. Methods and Results We studied 10 881 community-dwelling participants (mean age 57 +/- 6, 56% women, 25% black) who were free of prevalent cardiopulmonary disease from Atherosclerosis Risk in Communities Study. Dyspnea status at study entry using the modified Medical Research Council (mMRC) scale. The primary outcomes were time to HF, MI or all-cause death. Dyspnea prevalence was 22%, and was mild (mMRC grade 1 or 2) in 21% and moderate-to-severe (mMRC 3 or 4) in 1%. The main correlates of dyspnea were older age, female sex, higher BMI and active smoking. Over a follow-up of 19 +/- 5 years, greater self-reported dyspnea severity was associated with worse prognosis. Mild dyspnea was associated with significantly heightened risk of HF (adjusted Hazard Ratio, HR, 1.30; 95% CI: 1.16-1.46), MI (adjusted HR 1.34; 95% CI: 1.20-1.50), and death (adjusted HR 1.16; 95% CI: 1.06-1.26), with moderate/severe dyspnea associated with an even greater risk (adjusted HR 2.14, 95% CI: 1.59-2.89; 1.93, 95% CI: 1.41-2.56; 1.96, 95% CI: 1.55-2.48, respectively). Conclusion In community-dwelling persons free of previously diagnosed cardiopulmonary disease, self-reported dyspnea is common and, even when of mild intensity, it is independently associated with a greater risk of incident HF, MI, and death. Our data emphasize the prognostic importance of even mild self-reported dyspnea for cardiovascular outcomes.	[Santos, Mario; Shah, Amil M.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Santos, Mario] Univ Porto, Fac Med, Cardiovasc R&D Unit, Dept Physiol & Cardiothorac Surg, Porto, Portugal; [Kitzman, Dalane W.] Wake Forest Baptist Med Ctr, Winston Salem, NC USA; [Matsushita, Kunihiro] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Loehr, Laura; Sueta, Carla A.] Univ N Carolina, Chapel Hill, NC USA	Harvard University; Brigham & Women's Hospital; Universidade do Porto; Wake Forest University; Wake Forest Baptist Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of North Carolina; University of North Carolina Chapel Hill	Shah, AM (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	ashah11@partners.org	Matsushita, Kunihiro/AAJ-5817-2020; Matsushita, Kunihiro/B-1021-2018; Sueta, Carla/AAH-8100-2021	Matsushita, Kunihiro/0000-0002-7179-718X; Matsushita, Kunihiro/0000-0002-7179-718X; Santos, Mario/0000-0002-4509-0260; Loehr, Laura/0000-0002-9054-1825	Portuguese Foundation for Science and Technology [HMSP-ICJ/0013/2012]; National Institutes of Health [1K08HL116792-01A1]; American Heart Association [14CRP20380422]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	Work for this manuscript was supported research grants from the Portuguese Foundation for Science and Technology (HMSP-ICJ/0013/2012; M.S.), the National Institutes of Health (grant 1K08HL116792-01A1; A.M.S.), and the American Heart Association (grant 14CRP20380422; A.M.S.). The sponsors had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.	Abidov A, 2005, NEW ENGL J MED, V353, P1889, DOI 10.1056/NEJMoa042741; Banzett RB, 2014, EUR RESPIR J, V43, P1547, DOI 10.1183/09031936.00031114; Bell EJ, 2013, MED SCI SPORT EXER, V45, P901, DOI 10.1249/MSS.0b013e31827d87ec; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Carlsson AC, 2016, EUR J PREV CARDIOL, V23, P359, DOI 10.1177/2047487314568034; FLETCHER CM, 1959, BMJ-BRIT MED J, V2, P257, DOI 10.1136/bmj.2.5147.257; Folsom AR, 2009, CIRC-HEART FAIL, V2, P11, DOI 10.1161/CIRCHEARTFAILURE.108.794933; Frostad A, 2006, J INTERN MED, V259, P520, DOI 10.1111/j.1365-2796.2006.01631.x; Gerlach Y, 2013, INT J OBESITY, V37, P341, DOI 10.1038/ijo.2012.49; Gronseth R, 2014, EUR RESPIR J, V43, P1610, DOI 10.1183/09031936.00036813; KROENKE K, 1990, ARCH INTERN MED, V150, P1685, DOI 10.1001/archinte.150.8.1685; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Murad K, 2012, HEART FAIL REV, V17, P581, DOI 10.1007/s10741-011-9258-y; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Rosengren A, 1998, INT J EPIDEMIOL, V27, P962, DOI 10.1093/ije/27.6.962; SORLIE PD, 1989, AM REV RESPIR DIS, V140, P379, DOI 10.1164/ajrccm/140.2.379; van Mourik Y, 2014, AGE AGEING, V43, P319, DOI 10.1093/ageing/afu001; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	22	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165111	10.1371/journal.pone.0165111	http://dx.doi.org/10.1371/journal.pone.0165111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780208	Green Submitted, Green Published, gold			2022-12-26	WOS:000389046900029
J	Valverde, JR; Gullon, S; Mellado, RP				Valverde, Jose R.; Gullon, Sonia; Perez Mellado, Rafael			Looking for Rhizobacterial Ecological Indicators in Agricultural Soils Using 16S rRNA metagenomic Amplicon Data	PLOS ONE			English	Article							HERBICIDE GLYPHOSATE; DIVERSITY; COMMUNITIES; BACTERIAL; MICROBIOME; SEQUENCES; GRADIENT; GROWTH; HEALTH	Introduction Biological communities present in soil are essential to sustainable and productive agricultural practices; however, an accurate determination of the ecological status of agricultural soils remains to date an elusive task. An ideal indicator should be pervasive, play a relevant role in the ecosystem, show a rapid and proportional answer to external perturbations and be easily and economically measurable. Rhizobacteria play a major role in determining soil properties, becoming an attractive candidate for the detection of ecological indicators. The application of massive sequencing technologies to metagenomic analysis is providing an increasingly more precise view of the structure and composition of soil communities. In this work, we analyse soil rhizobacterial composition under various stress levels to search for potential ecological indicators. General Biodiversity Indicators Our results suggest that the Shannon index requires observation of a relatively large number of individuals to be representative of the true population diversity, and that the Simpson index may underestimate rare taxa in rhizobacterial environments. Taxonomical Classification Methods Detection of indicator taxa requires comparison of taxonomical classification of sequences. We have compared RDP classifier, RTAX and similarity-based taxonomical classification and selected the latter for taxonomical assignment because it provides larger detail. Taxonomy-Based Ecological Indicators The study of significant variations in common, clearly identified, taxa, using paired datasets allows minimization of non-treatment effects and avoidance of false positives. We have identified taxa associated to specific perturbations as well as taxa generally affected in treated soils. Changes in these taxa, or combinations of them, may be used as ecological indicators of soil health. The overall number and magnitude of changes detected in taxonomic groups does also increase with stress. These changes constitute an alternative indicator to measuring specific taxa, although their determination requires large sample sizes, better obtained by massive sequencing. Summary The main ecological indicators available are the Shannon index, OTU counts and estimators, overall detection of the number and proportion of changes, and changes of specific indicator taxa. Massive sequencing remains the most accurate tool to measure rhizobacterial ecological indicators. When massive sequencing is not an option, various cultivable taxonomic groups, such as specific groups in the Actinobacteria tree, are attractive as potential indicators of large disruptions to the rhizobiome.	[Valverde, Jose R.; Gullon, Sonia; Perez Mellado, Rafael] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Valverde, JR (corresponding author), CSIC, Ctr Nacl Biotecnol, Madrid, Spain.	jrvalverde@cnb.csic.es	Valverde, Jose R/K-8853-2014; Gullón, Sonia/P-7460-2018; Mellado, Rafael P/D-2680-2009	Valverde, Jose R/0000-0002-6655-7114; 	Spanish Ministry of the Environment and Rural and Marine affairs [EG022008]; European Union [IFS-2013-323494]	Spanish Ministry of the Environment and Rural and Marine affairs(Spanish Government); European Union(European Commission)	The Spanish Ministry of the Environment and Rural and Marine affairs has commissioned and supported this research trhough grant No. EG022008 URL: http.//www.magrama.gob.es/ (RPM SG). Additional Support was from the European Union through grant IFS-2013-323494 URL: http://ec.europa.eu/europeaid/index_en.htm (to RPM and JRV).	Barriuso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035481; Barriuso J, 2012, J MICROBIOL BIOTECHN, V22, P159, DOI 10.4014/jmb.1107.07036; Barriuso J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027558; Barriuso J, 2011, MICROBES ENVIRON, V26, P332, DOI 10.1264/jsme2.ME11137; Barriuso J, 2010, ENVIRON MICROBIOL, V12, P1021, DOI 10.1111/j.1462-2920.2009.02146.x; Caldwell AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0106355; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Chau JF, 2011, ENVIRON FORENSICS, V12, P333, DOI 10.1080/15275922.2011.622348; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; de-Bashan LE, 2012, APPL SOIL ECOL, V61, P171, DOI 10.1016/j.apsoil.2011.09.003; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Figuerola ELM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051075; Koberl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024452; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Pereira P, 2011, ISRN ECOLOGY; Rangarajan S, 2002, MICROBIAL ECOL, V43, P280, DOI 10.1007/s00248-002-2004-1; Rao D., 2007, J INDIAN SOC SOIL SC, V55, P392; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Souza RC, 2013, APPL SOIL ECOL, V72, P49, DOI 10.1016/j.apsoil.2013.05.021; Sun RB, 2015, SOIL BIOL BIOCHEM, V88, P9, DOI 10.1016/j.soilbio.2015.05.007; Tilak KVBR, 2005, CURR SCI INDIA, V89, P136; Uroz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055929; Valverde JR, 2014, J MICROBIOL BIOTECHN, V24, P1473, DOI 10.4014/jmb.1405.05054; Valverde JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058118; van Elsas JD, 2008, TRENDS BIOTECHNOL, V26, P591, DOI 10.1016/j.tibtech.2008.07.004; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; Wemheuer F, 2013, THESIS; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41	34	3	3	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165204	10.1371/journal.pone.0165204	http://dx.doi.org/10.1371/journal.pone.0165204			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780257	Green Submitted, Green Published, gold			2022-12-26	WOS:000389046900036
J	Meeks, D; Robinson, SE; Macleod, D; Oteng-Ntim, E				Meeks, Daveena; Robinson, Susan E.; Macleod, David; Oteng-Ntim, Eugene			Birth Weights in Sickle Cell Disease Pregnancies: A Cohort Study	PLOS ONE			English	Article							FETAL-GROWTH; OUTCOMES; WOMEN	Pregnancy in women with Sickle Cell Disease (SCD) has been linked with an increased incidence of adverse foetal outcomes when compared to women without haemoglobinopathies (HbAA). There's a paucity of data into foetal outcomes for infants born to women with SCD. Customised growth charts have been demonstrated to be better than population-based growth charts at identifying unhealthy small babies. We analysed the mean birth weight and customised birth weight centiles of infants born to mothers with SCD versus mothers with HbAA genotype, to quantify the risk of having a smaller baby. Birth weight and birth weight centiles were analysed for 88 women with SCD (50 HbSS; 38 HbSC) and 176 controls (HbAA). Statistically significant differences were seen in the mean birth weight (P value = 0.004) and the mean birth weight centiles (P value = 0.016). We conclude that SCD is a risk factor for having a smaller baby.	[Meeks, Daveena; Oteng-Ntim, Eugene] Kings Coll London, Sch Med, London, England; [Meeks, Daveena] Royal Sussex Cty Hosp, Dept Intens Care & Anaesthet, Brighton, E Sussex, England; [Robinson, Susan E.] Guys & St Thomas NHS Fdn Trust, Dept Haematol, London, England; [Macleod, David; Oteng-Ntim, Eugene] London Sch Hyg & Trop Med, London, England; [Oteng-Ntim, Eugene] St Thomas Hosp, Kings Coll London, Womens Hlth Acad Ctr, London, England; [Oteng-Ntim, Eugene] St Thomas Hosp, Kings Hlth Partners, London, England	University of London; King's College London; University of Brighton; Guy's & St Thomas' NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Oteng-Ntim, E (corresponding author), Kings Coll London, Sch Med, London, England.; Oteng-Ntim, E (corresponding author), London Sch Hyg & Trop Med, London, England.; Oteng-Ntim, E (corresponding author), St Thomas Hosp, Kings Coll London, Womens Hlth Acad Ctr, London, England.; Oteng-Ntim, E (corresponding author), St Thomas Hosp, Kings Hlth Partners, London, England.	Eugene.oteng-ntim@gstt.nhs.uk		Macleod, David/0000-0002-2371-5709; Robinson, Susan/0000-0001-5279-5536	Medical Research Council [MR/K012126/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Balihallimath RL, 2013, J CLIN DIAGN RES, V7, P2428, DOI 10.7860/JCDR/2013/7478.3564; BILLETT HH, 1993, AM J HEMATOL, V42, P305, DOI 10.1002/ajh.2830420311; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Carberry AE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008549.pub2; Chappell LC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6398; Chung JGY, 2013, EUR J OBSTET GYN R B, V167, P149, DOI 10.1016/j.ejogrb.2012.11.020; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; (CMACE) C. f.M.a.C.E, 2011, PER MORT 2009 UK; Elenga N, 2016, OBSTET GYNECOL INT, V2016, DOI 10.1155/2016/9069054; Gardosi J, 2009, AM J OBSTET GYNECOL, V201, pe1, DOI DOI 10.1016/J.AJ0G.2009.04.034; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Gardosi J, 2012, ARCH DIS CHILD-FETAL, V97, pF314, DOI 10.1136/fetalneonatal-2012-301708; Grivell RM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007113.pub3; Hawfield Amret, 2009, Ther Adv Cardiovasc Dis, V3, P65, DOI 10.1177/1753944708097114; Howard J, 2012, BEST PRACT RES CL OB, V26, P25, DOI 10.1016/j.bpobgyn.2011.10.001; Kelly Y, 2009, J PUBLIC HEALTH-UK, V31, P131, DOI 10.1093/pubmed/fdn057; MacMullen NJ, 2011, MCN-AM J MATERN-CHIL, V36, P232, DOI 10.1097/NMC.0b013e3182182215; Miranda ML, 2011, PUBLIC HEALTH REP, V126, P797, DOI 10.1177/003335491112600605; Oteng-Ntim E, 2015, BLOOD, V125, P3316, DOI 10.1182/blood-2014-11-607317; Oteng-Ntim E, 2015, BRIT J HAEMATOL, V169, P129, DOI 10.1111/bjh.13270; Patel RR, 2004, INT J EPIDEMIOL, V33, P107, DOI 10.1093/ije/dyg238; Rathod Kalpana B, 2007, Indian J Pathol Microbiol, V50, P698; Streetly A, 2011, STANDARDS LINKED ANT; Sweet D., 2012, STAT B INFANT PERINA; Tan TL, 2008, BJOG-INT J OBSTET GY, V115, P1116, DOI 10.1111/j.1471-0528.2008.01776.x; Thame MM, 2016, EUR J OBSTET GYN R B, V203, P16, DOI 10.1016/j.ejogrb.2016.05.002; Thame MM, 2013, EUR J OBSTET GYN R B, V170, P62, DOI 10.1016/j.ejogrb.2013.04.013; Yu CKH, 2009, J OBSTET GYNAECOL, V29, P512, DOI 10.1080/01443610903003175	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165238	10.1371/journal.pone.0165238	http://dx.doi.org/10.1371/journal.pone.0165238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776167	Green Accepted, Green Published, gold			2022-12-26	WOS:000389009200049
J	Zhou, WL; Wang, GH; Wang, CM; Ren, FZ; Hao, YL				Zhou, Wanli; Wang, Guohong; Wang, Chunmei; Ren, Fazheng; Hao, Yanling			Both IIC and IID Components of Mannose Phosphotransferase System Are Involved in the Specific Recognition between Immunity Protein PedB and Bacteriocin-Receptor Complex	PLoS One			English	Article							PEDIOCIN-LIKE BACTERIOCINS; LACTIC-ACID BACTERIA; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; ELECTROPORATION; EXPRESSION; EFFICIENCY; TARGET	Upon exposure to exogenous pediocin-like bacteriocins, immunity proteins specifically bind to the target receptor of the mannose phosphotransferase system components (man-PTS IIC and IID), therefore preventing bacterial cell death. However, the specific recognition of immunity proteins and its associated target receptors remains poorly understood. In this study, we constructed hybrid receptors to identify the domains of IIC and/or IID recognized by the immunity protein PedB, which confers immunity to pediocin PA-1. Using Lactobacillus plantarum man-PTS EII mutant W903, the IICD components of four pediocin PA-1-sensitive strains (L. plantarum WQ0815, Leuconostoc mesenteroides 05-43, Lactobacillus salivarius REN and Lactobacillus acidophilus 05-172) were respectively co-expressed with the immunity protein PedB. Well-diffusions assays showed that only the complex formed by LpIICD from L. plantarum WQ0815 with pediocin PA-1 could be recognized by PedB. In addition, a two-step PCR approach was used to construct hybrid receptors by combining LpIIC or LpIID recognized by PedB with the other three heterologous IID or IIC compounds unrecognized by PedB, respectively. The results showed that all six hybrid receptors were recognized by pediocin PA-1. However, when IIC or IID of L. plantarum WQ0815 was replaced with any corresponding IIC or IID component from L. mesenteroides 05-43, L. salivarius REN and L. acidophilus 05-172, all the hybrid receptors could not be recognized by PedB. Taken altogether, we concluded that both IIC and IID components of the mannose phosphotransferase system play an important role in the specific recognition between the bacteriocin-receptor complex and the immunity protein PedB.	[Zhou, Wanli; Wang, Guohong; Wang, Chunmei; Ren, Fazheng; Hao, Yanling] China Agr Univ, Innovat Ctr Food Nutr & Human Hlth Beijing, Coll Food Sci & Nutrit Engn, Beijing, Peoples R China; [Ren, Fazheng; Hao, Yanling] Minist Educ & Beijing Municipal, Key Lab Funct Dairy, Beijing, Peoples R China	China Agricultural University	Hao, YL (corresponding author), China Agr Univ, Innovat Ctr Food Nutr & Human Hlth Beijing, Coll Food Sci & Nutrit Engn, Beijing, Peoples R China.; Hao, YL (corresponding author), Minist Educ & Beijing Municipal, Key Lab Funct Dairy, Beijing, Peoples R China.	haoyl@cau.edu.cn			Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; National Natural Science Foundation of China [21076223]	Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry and the National Natural Science Foundation of China (No.21076223) to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Cui YH, 2012, INT J MOL SCI, V13, P16668, DOI 10.3390/ijms131216668; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eijsink VGH, 1998, APPL ENVIRON MICROB, V64, P3275; Ennahar S, 2000, FEMS MICROBIOL REV, V24, P85, DOI 10.1111/j.1574-6976.2000.tb00534.x; Fimland G, 1996, APPL ENVIRON MICROB, V62, P3313, DOI 10.1128/AEM.62.9.3313-3318.1996; Fimland G, 2002, MICROBIOL-SGM, V148, P3661, DOI 10.1099/00221287-148-11-3661; Johnsen L, 2004, APPL ENVIRON MICROB, V70, P2647, DOI 10.1128/AEM.70.5.2647-2652.2004; Johnsen L, 2005, J BIOL CHEM, V280, P9243, DOI 10.1074/jbc.M412712200; Kjos M, 2010, J BACTERIOL, V192, P5906, DOI 10.1128/JB.00777-10; Kjos M, 2009, MICROBIOL-SGM, V155, P2949, DOI 10.1099/mic.0.030015-0; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Nes I.F., 2001, PEPTIDE ANTIBIOTICS, P81; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Russell WM, 2001, APPL ENVIRON MICROB, V67, P4361, DOI 10.1128/AEM.67.9.4361-4364.2001; Sprules T, 2004, BIOCHEMISTRY-US, V43, P11740, DOI 10.1021/bi048854+; Thompson K, 1996, J MICROBIOL METH, V26, P73, DOI 10.1016/0167-7012(96)00845-7; Todorov SD, 2005, PROCESS BIOCHEM, V40, P365, DOI 10.1016/j.procbio.2004.01.011; VANDEGUCHTE M, 1989, APPL ENVIRON MICROB, V55, P224, DOI 10.1128/AEM.55.1.224-228.1989; Wang F, 2008, CHINESE J ANAL CHEM, V36, P740, DOI 10.1016/S1872-2040(08)60040-7; Xie Y, 2011, FOOD CONTROL, V22, P1027, DOI 10.1016/j.foodcont.2010.12.007; Zhou WanLi, 2014, China Dairy Industry, V42, P4	26	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164973	10.1371/journal.pone.0164973	http://dx.doi.org/10.1371/journal.pone.0164973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776158	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200031
J	Jenkins, LM; Singh, P; Varadaraj, A; Lee, NY; Shah, S; Flores, HV; O'Connell, K; Mythreye, K				Jenkins, Laura M.; Singh, Priyanka; Varadaraj, Archana; Lee, Nam Y.; Shah, Shreya; Flores, Haley V.; O'Connell, Kathleen; Mythreye, Karthikeyan			Altering the Proteoglycan State of Transforming Growth Factor Type III Receptor (TRIII)/Betaglycan Modulates Canonical Wnt/-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell signaling; glycosaminoglycan; transforming growth factor (TGF-); Wnt signaling; TBRIII; betaglycan	TGF-BETA RECEPTOR; HEPARAN-SULFATE; OVARIAN-CANCER; MESENCHYMAL TRANSITION; MAMMARY TUMORIGENESIS; CHONDROITIN SULFATE; LIGAND-BINDING; CELL-SURVIVAL; EXPRESSION; PROMOTES	Hyperactive Wnt/-catenin signaling is linked to cancer progression and developmental abnormalities, making identification of mechanisms controlling Wnt/-catenin signaling vital. Transforming growth factor type III receptor (TRIII/betaglycan) is a transmembrane proteoglycan co-receptor that exists with or without heparan and/or chondroitin sulfate glycosaminoglycan (GAG) modifications in cells and has established roles in development and cancer. Our studies here demonstrate that TRIII, independent of its TGF co-receptor function, regulates canonical Wnt3a signaling by controlling Wnt3a availability through its sulfated GAG chains. Our findings revealed, for the first time, opposing functions for the different GAG modifications on TRIII suggesting that Wnt interactions with the TRIII heparan sulfate chains result in inhibition of Wnt signaling, likely via Wnt sequestration, whereas the chondroitin sulfate GAG chains on TRIII promote Wnt3a signaling. These studies identify a novel, dual role for TRIII/betaglycan and define a key requirement for the balance between chondroitin sulfate and heparan sulfate chains in dictating ligand responses with implications for both development and cancer.	[Jenkins, Laura M.; Singh, Priyanka; Varadaraj, Archana; Shah, Shreya; Flores, Haley V.; O'Connell, Kathleen; Mythreye, Karthikeyan] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Mythreye, Karthikeyan] Univ South Carolina, Dept Drug Discovery & Biomed Sci, South Carolina Coll Pharm, Columbia, SC 29208 USA; [Lee, Nam Y.] Ohio State Univ, Coll Pharm, Div Pharmacol, Columbus, OH 43210 USA	University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University System of Ohio; Ohio State University	Mythreye, K (corresponding author), Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.	mythreye@sc.edu	Karthikeyan, Mythreye/ABC-7345-2020	Karthikeyan, Mythreye/0000-0001-5478-0098; Varadaraj, Archana/0000-0002-1868-1268; JENKINS, LAURA/0000-0003-0563-9519	Ovarian Cancer Research Fund [258785]; National Institutes of Health [P20 GM109091]; Minority Graduate Research Fellowship from the University of South Carolina; NATIONAL CANCER INSTITUTE [R01CA178443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109091] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minority Graduate Research Fellowship from the University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant 258785 from the Ovarian Cancer Research Fund (to K. M.), National Institutes of Health Grant P20 GM109091 (to K. M.), and a Minority Graduate Research Fellowship from the University of South Carolina (to L. M. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; ANDRES JL, 1992, J BIOL CHEM, V267, P5927; Arend RC, 2013, GYNECOL ONCOL, V131, P772, DOI 10.1016/j.ygyno.2013.09.034; Asad M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.302; Badiglian L, 2009, ONCOL REP, V21, P313, DOI 10.3892/or_00000223; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Capurro M, 2014, J CELL SCI, V127, P1565, DOI 10.1242/jcs.140871; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; CHEIFETZ S, 1988, J BIOL CHEM, V263, P16984; CHEIFETZ S, 1989, J BIOL CHEM, V264, P12025; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COHEN IR, 1994, CANCER RES, V54, P5771; De Cat B, 2003, J CELL BIOL, V163, P625, DOI 10.1083/jcb.200302152; Dhodapkar MV, 1998, BLOOD, V91, P2679, DOI 10.1182/blood.V91.8.2679.2679_2679_2688; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Eickelberg O, 2002, J BIOL CHEM, V277, P823, DOI 10.1074/jbc.M105110200; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Finger EC, 2008, J BIOL CHEM, V283, P34808, DOI 10.1074/jbc.M804741200; Fjeldstad K, 2005, CURR DRUG TARGETS, V6, P665, DOI 10.2174/1389450054863662; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Gatza CE, 2010, CELL SIGNAL, V22, P1163, DOI 10.1016/j.cellsig.2010.01.016; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; Hempel N, 2007, CANCER RES, V67, P5231, DOI 10.1158/0008-5472.CAN-07-0035; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; Jemth P, 2002, J BIOL CHEM, V277, P30567, DOI 10.1074/jbc.M203404200; Jovanovic B, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3684; King ML, 2015, ONCOGENE, V34, P3452, DOI 10.1038/onc.2014.277; Knelson EH, 2013, J CLIN INVEST, V123, P4786, DOI 10.1172/JCI69657; KOKENYESI R, 1994, J BIOL CHEM, V269, P12304; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Lambert KE, 2011, MOL BIOL CELL, V22, P1463, DOI 10.1091/mbc.E10-11-0877; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; Mendoza V, 2009, BIOCHEMISTRY-US, V48, P11755, DOI 10.1021/bi901528w; Meyer AE, 2014, MOL BIOL CELL, V25, P2291, DOI 10.1091/mbc.E14-03-0825; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mythreye K, 2013, ONCOGENE, V32, P1416, DOI 10.1038/onc.2012.157; Mythreye K, 2009, CELL CYCLE, V8, P3069, DOI 10.4161/cc.8.19.9419; Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; O'Connell MP, 2009, J BIOL CHEM, V284, P28704, DOI 10.1074/jbc.M109.028498; Oh SY, 2013, BIOCHEM J, V454, P79, DOI 10.1042/BJ20121701; Peters MG, 2003, BREAST CANCER RES TR, V80, P221, DOI 10.1023/A:1024549729256; Prinz RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092381; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Qi LS, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0107-4; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Sakane H, 2010, J CELL SCI, V123, P360, DOI 10.1242/jcs.058008; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SEGARINI PR, 1988, J BIOL CHEM, V263, P8366; Shiau CE, 2010, DEV BIOL, V348, P107, DOI 10.1016/j.ydbio.2010.09.017; Shortkroff S, 2007, OSTEOARTHR CARTILAGE, V15, P147, DOI 10.1016/j.joca.2006.07.004; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Steller MD, 2005, MOL CANCER RES, V3, P50; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; Tung EKK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036565; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; Usongo M, 2013, DEV DYNAM, V242, P291, DOI 10.1002/dvdy.23919; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Verras M, 2004, CANCER RES, V64, P8860, DOI 10.1158/0008-5472.CAN-04-2370; Vinyoles M, 2014, MOL CELL, V53, P444, DOI 10.1016/j.molcel.2013.12.010; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Willis CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103966	77	14	14	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25716	25728		10.1074/jbc.M116.748624	http://dx.doi.org/10.1074/jbc.M116.748624			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27784788	hybrid, Green Published			2022-12-26	WOS:000390095300036
J	Tarca, AL; Hernandez-Andrade, E; Ahn, H; Garcia, M; Xu, Z; Korzeniewski, SJ; Saker, H; Chaiworapongsa, T; Hassan, SS; Yeo, L; Romero, R				Tarca, Adi L.; Hernandez-Andrade, Edgar; Ahn, Hyunyoung; Garcia, Maynor; Xu, Zhonghui; Korzeniewski, Steven J.; Saker, Homam; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Yeo, Lami; Romero, Roberto			Single and Serial Fetal Biometry to Detect Preterm and Term Small- and Large-for-Gestational-Age Neonates: A Longitudinal Cohort Study	PLOS ONE			English	Article							3RD TRIMESTER; INTERNATIONAL STANDARDS; ABDOMINAL CIRCUMFERENCE; ULTRASOUND MEASUREMENTS; GROWTH-RETARDATION; WEIGHT; IDENTIFICATION; PREDICTION; DOPPLER; FETUSES	Objectives To assess the value of single and serial fetal biometry for the prediction of small- (SGA) and large-for-gestational-age (LGA) neonates delivered preterm or at term. Methods A cohort study of 3,971 women with singleton pregnancies was conducted from the first trimester until delivery with 3,440 pregnancies (17,334 scans) meeting the following inclusion criteria: 1) delivery of a live neonate after 33 gestational weeks and 2) two or more ultrasound examinations with fetal biometry parameters obtained at <= 36 weeks. Primary outcomes were SGA (<5th centile) and LGA (>95th centile) at birth based on INTERGROWTH-21st gender-specific standards. Fetus-specific estimated fetal weight (EFW) trajectories were calculated by linear mixed-effects models using data up to a fixed gestational age (GA) cutoff (28, 32, or 36 weeks) for fetuses having two or more measurements before the GA cutoff and not already delivered. A screen test positive for single biometry was based on Z-scores of EFW at the last scan before each GA cut-off so that the false positive rate (FPR) was 10%. Similarly, a screen test positive for the longitudinal analysis was based on the projected (extrapolated) EFW at 40 weeks from all available measurements before each cutoff for each fetus. Results Fetal abdominal and head circumference measurements, as well as birth weights in the Detroit population, matched well to the INTERGROWTH-21st standards, yet this was not the case for biparietal diameter (BPD) and femur length (FL) (up to 9% and 10% discrepancy for mean and confidence intervals, respectively), mainly due to differences in the measurement technique. Single biometry based on EFW at the last scan at <= 32 weeks (GA IQR: 27.4-30.9 weeks) had a sensitivity of 50% and 53% (FPR = 10%) to detect preterm and term SGA and LGA neonates, respectively (AUC of 82% both). For the detection of LGA using data up to 32- and 36-week cutoffs, single biometry analysis had higher sensitivity than longitudinal analysis (52% vs 46% and 62% vs 52%, respectively; both p<0.05). Restricting the analysis to subjects with the last observation taken within two weeks from the cutoff, the sensitivity for detection of LGA, but not SGA, increased to 65% and 72% for single biometry at the 32- and 36-week cutoffs, respectively. SGA screening performance was higher for preterm (<37 weeks) than for term cases (73% vs 46% sensitivity; p<0.05) for single biometry at <= 32 weeks. Conclusions When growth abnormalities are defined based on birth weight, growth velocity (captured in the longitudinal analysis) does not provide additional information when compared to the last measurement for predicting SGA and LGA neonates, with both approaches detecting one-half of the neonates (FPR = 10%) from data collected at <= 32 weeks. Unlike for SGA, LGA detection can be improved if ultrasound scans are scheduled as close as possible to the gestational-age cutoff when a decision regarding the clinical management of the patient needs to be made. Screening performance for SGA is higher for neonates that will be delivered preterm.	[Tarca, Adi L.; Hernandez-Andrade, Edgar; Ahn, Hyunyoung; Garcia, Maynor; Xu, Zhonghui; Korzeniewski, Steven J.; Saker, Homam; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Yeo, Lami; Romero, Roberto] NICHD, Perinatol Res Branch, NIH, DHHS, Bethesda, MD USA; [Tarca, Adi L.; Hernandez-Andrade, Edgar; Ahn, Hyunyoung; Garcia, Maynor; Xu, Zhonghui; Korzeniewski, Steven J.; Saker, Homam; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Yeo, Lami; Romero, Roberto] NICHD, Perinatol Res Branch, NIH, DHHS, Detroit, MI USA; [Tarca, Adi L.; Hernandez-Andrade, Edgar; Ahn, Hyunyoung; Garcia, Maynor; Korzeniewski, Steven J.; Saker, Homam; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Yeo, Lami] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI USA; [Tarca, Adi L.] Wayne State Univ, Coll Engn, Dept Comp Sci, Detroit, MI USA; [Korzeniewski, Steven J.; Romero, Roberto] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; Michigan State University; University of Michigan System; University of Michigan; Wayne State University	Tarca, AL; Romero, R (corresponding author), NICHD, Perinatol Res Branch, NIH, DHHS, Bethesda, MD USA.; Tarca, AL; Romero, R (corresponding author), NICHD, Perinatol Res Branch, NIH, DHHS, Detroit, MI USA.; Tarca, AL (corresponding author), Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI USA.; Tarca, AL (corresponding author), Wayne State Univ, Coll Engn, Dept Comp Sci, Detroit, MI USA.; Romero, R (corresponding author), Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.; Romero, R (corresponding author), Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA.; Romero, R (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA.	atarca@med.wayne.edu; romeror@mail.nih.gov	Xu, Zhonghui/F-3353-2018; Korzeniewski, Steven J/U-6481-2017; Romero, Roberto/A-5268-2019	Xu, Zhonghui/0000-0002-6469-9178; Korzeniewski, Steven J/0000-0002-8895-6052; Tarca, Adi Laurentiu/0000-0003-1712-7588; Romero, Roberto/0000-0002-4448-5121	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH/DHHS); NICHD/NIH/DHHS [HHSN275201300006C]; Perinatal Initiative of the Wayne State University School of Medicine (WSUSOM); Department of Obstetrics and Gynecology of the WSUSOM; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002401] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH/DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD/NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Perinatal Initiative of the Wayne State University School of Medicine (WSUSOM); Department of Obstetrics and Gynecology of the WSUSOM; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH/DHHS), and, in part, with Federal funds from NICHD/NIH/DHHS under Contract No. HHSN275201300006C. ALT and SJK were supported by the Perinatal Initiative of the Wayne State University School of Medicine (WSUSOM), and the Department of Obstetrics and Gynecology of the WSUSOM.	Albert PS, 2012, STAT MED, V31, P143, DOI 10.1002/sim.4405; Albert PS, COMBINATION LONGITUD; Bakalis S., 2015, ULTRASOUND OBSTET GY; Barker ED, 2013, OBSTET GYNECOL, V122, P248, DOI 10.1097/AOG.0b013e31829ca9a7; Blake KV, 2002, J EPIDEMIOL COMMUN H, V56, P713, DOI 10.1136/jech.56.9.713; Boulvain M, 2015, LANCET; Bricker L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001451.pub3; Brodszki J, 2000, ACTA OBSTET GYN SCAN, V79, P723, DOI 10.1034/j.1600-0412.2000.079009723.x; Callec R, 2015, ULTRASOUND OBST GYN, V46, P216, DOI 10.1002/uog.14755; CHANG TC, 1994, BRIT J OBSTET GYNAEC, V101, P422, DOI 10.1111/j.1471-0528.1994.tb11916.x; CHANG TC, 1993, OBSTET GYNECOL, V82, P230; Chauhan SP, 2006, CLIN OBSTET GYNECOL, V49, P284, DOI 10.1097/00003081-200606000-00010; Claesson R, 2007, ACTA OBSTET GYN SCAN, V86, P652, DOI 10.1080/00016340701207682; Conde-Agudelo A, 2013, BJOG-INT J OBSTET GY, V120, P681, DOI 10.1111/1471-0528.12172; Degani S, 2001, OBSTET GYNECOL SURV, V56, P159, DOI 10.1097/00006254-200103000-00023; Deter RL, 2014, J MATERN-FETAL NEO M, V27, P543, DOI 10.3109/14767058.2013.833904; Di Lorenzo G, 2013, EUR J OBSTET GYN R B, V166, P133, DOI 10.1016/j.ejogrb.2012.10.010; Fadigas C, 2015, ULTRASOUND OBST GYN, V45, P559, DOI 10.1002/uog.14816; Gardosi J, 2009, AM J OBSTET GYNECOL, V201; Ghi T, 2016, J ULTRAS MED, V35, P83, DOI 10.7863/ultra.15.03003; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; Henriksen T, 2008, ACTA OBSTET GYN SCAN, V87, P134, DOI 10.1080/00016340801899289; Iraola A, 2008, J PERINAT MED, V36, P531, DOI 10.1515/JPM.2008.100; LAURIN J, 1987, ACTA OBSTET GYN SCAN, V66, P337, DOI 10.3109/00016348709103649; Lee W, 2009, ULTRASOUND OBST GYN, V34, P556, DOI 10.1002/uog.7327; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; Liu DP, 2014, BIOSTATISTICS, V15, P706, DOI 10.1093/biostatistics/kxu020; Louis GMB, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.032; Marsal K, 1992, Int J Technol Assess Health Care, V8 Suppl 1, P160; McKenna D, 2003, OBSTET GYNECOL, V101, P626, DOI 10.1016/S0029-7844(02)03122-8; Ogasawara KK, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.031; Owen P, 2001, OBSTET GYNECOL, V97, P499, DOI 10.1016/S0029-7844(00)01155-8; Owen P, 1996, BRIT J OBSTET GYNAEC, V103, P60, DOI 10.1111/j.1471-0528.1996.tb09516.x; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Romero R, 2015, LANCET, V386, P2038, DOI 10.1016/S0140-6736(15)00148-8; ROSSAVIK IK, 1984, J CLIN ULTRASOUND, V12, P529, DOI 10.1002/jcu.1870120902; ROYSTON P, 1995, STAT MED, V14, P1417, DOI 10.1002/sim.4780141303; Salomon LJ, 2011, ULTRASOUND OBST GYN, V37, P116, DOI 10.1002/uog.8831; Sjaarda LA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.006; Souka AP, 2013, PRENATAL DIAG, V33, P915, DOI 10.1002/pd.4161; Sovio U, 2015, LANCET; Unterscheider J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-63; Unterscheider J, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.007; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; White SW, 2015, J MATERN-FETAL NEO M, V14, P1	45	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0164161	10.1371/journal.pone.0164161	http://dx.doi.org/10.1371/journal.pone.0164161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802270	gold, Green Published, Green Submitted			2022-12-26	WOS:000386714200005
J	Ostadkarampour, M; Muller, M; Ockinger, J; Kullberg, S; Linden, A; Eklund, A; Grunewald, J; Wahlstrom, J				Ostadkarampour, Mahyar; Muller, Malin; Ockinger, Johan; Kullberg, Susanna; Linden, Anders; Eklund, Anders; Grunewald, Johan; Wahlstrom, Jan			Distinctive Regulatory T Cells and Altered Cytokine Profile Locally in the Airways of Young Smokers with Normal Lung Function	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INCREASED EXPRESSION; COPD; SMOKING; AUTOIMMUNITY; HELIOS; IL-17; INFLAMMATION; INCREASE	Smoking influences the immune system in different ways and, hypothetically, effects on pulmonary effector and regulatory T cells emerge as potentially detrimental. Therefore, we characterized the frequencies and characteristics of CD4+ and CD8+ T cell subsets in the blood and lungs of young tobacco smokers. Bronchoalveolar lavage (BAL) and peripheral blood were obtained from healthy moderate smokers (n = 18; 2-24 pack-years) and never-smokers (n = 15), all with normal lung function. Cells were stimulated ex vivo and key intracellular cytokines (IFN gamma, IL-17, IL-10 and TNF alpha) and transcription factors (Foxp3, T-bet and Helios) were analyzed using flow cytometry. Our results indicate that smoking is associated with a decline in lung IL-17+ CD4+ T cells, increased IFN gamma+ CD8+ T cells and these alterations relate to the history of daily cigarette consumption. There is an increased fraction of Foxp3+ regulatory T cells being Helios-in the lungs of smokers. Cytokine production is mainly confined to the Helios-T cells, both in regulatory and effector subsets. Moreover, we detected a decline of Helios+Foxp3-postulated regulatory CD8+ T cells in smokers. These alterations in the immune system are likely to increase risk for infection and may have implications for autoimmune processes initiated in the lungs among tobacco smokers.	[Ostadkarampour, Mahyar; Ockinger, Johan; Kullberg, Susanna; Eklund, Anders; Grunewald, Johan; Wahlstrom, Jan] Karolinska Inst, Dept Med Solna, Resp Med Unit, Stockholm, Sweden; [Muller, Malin] Karolinska Inst, Dept Med Solna, Rheumatol Res Unit, Stockholm, Sweden; [Ostadkarampour, Mahyar; Muller, Malin; Ockinger, Johan; Eklund, Anders; Grunewald, Johan; Wahlstrom, Jan] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Linden, Anders] Karolinska Inst, Inst Environm Med IMM, Unit Lung & Airway Res, Stockholm, Sweden; [Kullberg, Susanna; Linden, Anders; Eklund, Anders; Grunewald, Johan] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Ostadkarampour, M (corresponding author), Karolinska Inst, Dept Med Solna, Resp Med Unit, Stockholm, Sweden.; Ostadkarampour, M (corresponding author), Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.	mahyar.ostad@gmail.com	Kullberg, Susanna/AAF-4057-2020; Grunewald, Johan/GQZ-8122-2022	Kullberg, Susanna/0000-0003-2844-4773; Grunewald, Johan/0000-0003-0473-3984	Swedish Heart Lung Foundation; Swedish Research Council; Stockholm County Council; Novartis collaborative grant; Torsten and Ragnar Sbderberg's Foundation; King Oscar II Jubilee Foundation; Karolinska Institutet; Mats Kleberg Foundation	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Novartis collaborative grant; Torsten and Ragnar Sbderberg's Foundation; King Oscar II Jubilee Foundation; Karolinska Institutet(Karolinska Institutet); Mats Kleberg Foundation	The study was supported by grants from: The Swedish Heart Lung Foundation; The Swedish Research Council; The Stockholm County Council; Novartis collaborative grant; Torsten and Ragnar Sbderberg's Foundation; The King Oscar II Jubilee Foundation; Karolinska Institutet; and The Mats Kleberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Benita Engvall, Helene Blomqvist, Gunnel de Forest and Margitha Dahl for skillful technical assistance. The study was supported by grants from the Swedish Heart Lung Foundation, The Swedish Research Council, through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, Novartis collaborative grant, Torsten and Ragnar Soderberg's Foundation, The King Oscar II Jubilee Foundation, Karolinska Institutet and The Mats Kleb erg Foundation.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Andelid K, 2015, INT J CHRONIC OBSTR, V10, P689, DOI 10.2147/COPD.S76273; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Barnes PJ, 2004, PLOS MED, V1, P25, DOI 10.1371/journal.pmed.0010020; Berer K, 2014, FEBS LETT, V588, P4207, DOI 10.1016/j.febslet.2014.04.007; Caramori G, 2014, INT J CHRONIC OBSTR, V9, P397, DOI 10.2147/COPD.S42544; Chinoy H, 2012, ANN RHEUM DIS, V71, P961, DOI 10.1136/annrheumdis-2011-200182; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Ellis SDP, 2014, EXPERT REV CLIN IMMU, V10, P203, DOI 10.1586/1744666X.2014.871203; Eustace A, 2011, CHEST, V139, P1089, DOI 10.1378/chest.10-0779; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Forsslund H, 2014, CHEST, V145, P711, DOI 10.1378/chest.13-0873; Freeman CM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-13; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Hori S, 2014, IMMUNOL REV, V259, P159, DOI 10.1111/imr.12175; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laan M, 1999, J IMMUNOL, V162, P2347; Lee BJ, 2011, EXP MOL MED, V43, P169, DOI 10.3858/emm.2011.43.4.018; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Massilamany C, 2016, CURR OPIN VIROL, V16, P8, DOI 10.1016/j.coviro.2015.10.004; Modestou MA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-64; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; Raffin C, 2013, J IMMUNOL, V191, P4619, DOI 10.4049/jimmunol.1301378; Ross EM, 2014, EUR J IMMUNOL, V44, P2048, DOI 10.1002/eji.201343999; Samarkos Michael, 2005, Current Drug Targets - Inflammation and Allergy, V4, P99, DOI 10.2174/1568010053622821; Sdralia ND, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-82; Shan M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranlsmed.3000154; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Takatori H, 2015, ARTHRITIS RHEUMATOL, V67, P1491, DOI 10.1002/art.39091; Tanigawa T, 1998, ARCH ENVIRON HEALTH, V53, P378, DOI 10.1080/00039899809605724; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Vanaudenaerde BM, 2011, AM J RESP CRIT CARE, V183, P977, DOI 10.1164/rccm.201007-1196PP; Wahlstrom J, 2009, CLIN IMMUNOL, V133, P353, DOI 10.1016/j.clim.2009.08.008; Zhang JQ, 2013, INT IMMUNOPHARMACOL, V15, P58, DOI 10.1016/j.intimp.2012.10.018	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0164751	10.1371/journal.pone.0164751	http://dx.doi.org/10.1371/journal.pone.0164751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798682	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100013
J	van Lieshout, R; Pisters, MF; Vanwanseele, B; de Bie, RA; Wouters, EJ; Stukstette, MJ				van Lieshout, Remko; Pisters, Martijn F.; Vanwanseele, Benedicte; de Bie, Rob A.; Wouters, Eveline J.; Stukstette, Mirelle J.			Biofeedback in Partial Weight Bearing: Usability of Two Different Devices from a Patient's and Physical Therapist's Perspective	PLOS ONE			English	Article							LOWER-EXTREMITY; TECHNOLOGY; VALIDITY; FEEDBACK; USERS	Background Partial weight bearing is frequently instructed by physical therapists in patients after lower-limb trauma or surgery. The use of biofeedback devices seems promising to improve the patient's compliance with weight-bearing instructions. SmartStep and OpenGo-Science are biofeedback devices that provide real-time feedback. For a successful implementation, usability of the devices is a critical aspect and should be tested from a user's perspective. Aim To describe the usability from the physical therapists' and a patients' perspective of Smart-step and OpenGo-Science to provide feedback on partial weight bearing during supervised rehabilitation of patients after lower-limb trauma or surgery. Methods In a convergent mixed-methods design, qualitative and quantitative data were collected. Usability was subdivided into user performance, satisfaction and acceptability. Patients prescribed with partial weight bearing and their physical therapists were asked to use SmartStep and OpenGo-Science during supervised rehabilitation. Usability was qualitatively tested by a think-aloud method and a semi-structured interview and quantitatively tested by the System-Usability-Scale (SUS) and closed questions. For the qualitative data thematic content analyses were used. Results Nine pairs of physical therapists and their patients participated. The mean SUS scores for patients and physical therapists were for SmartStep 70 and 53, and for OpenGo-Science 79 and 81, respectively. Scores were interpreted with the Curved Grading Scale. The qualitative data showed that there were mixed views and perceptions from patients and physical therapists on satisfaction and acceptability. Conclusion This study gives insight in the usability of two biofeedback devices from the patient's and physical therapist's perspective. The overall usability from both perspectives seemed to be acceptable for OpenGo-Science. For SmartStep, overall usability seemed only acceptable from the patient's perspective.	[van Lieshout, Remko; Pisters, Martijn F.; Stukstette, Mirelle J.] Julius Hlth Care Ctr, Ctr Phys Therapy Res & Innovat Primary Care, Utrecht, Netherlands; [van Lieshout, Remko; Pisters, Martijn F.; Stukstette, Mirelle J.] Univ Med Ctr Utrecht, Phys Therapy Res, Clin Hlth Sci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [van Lieshout, Remko; Pisters, Martijn F.; Stukstette, Mirelle J.] Univ Med Ctr Utrecht, Dept Rehabil Nursing Sci & Sport, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [de Bie, Rob A.; Stukstette, Mirelle J.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands; [Pisters, Martijn F.; Vanwanseele, Benedicte; Wouters, Eveline J.] Fontys Univ Appl Sci, Dept Hlth Innovat & Technol, Eindhoven, Netherlands; [Vanwanseele, Benedicte] Katholieke Univ Leuven, Dept Kinesiol, Human Movement Biomech Res Grp, Leuven, Belgium	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Maastricht University; KU Leuven	Stukstette, MJ (corresponding author), Julius Hlth Care Ctr, Ctr Phys Therapy Res & Innovat Primary Care, Utrecht, Netherlands.; Stukstette, MJ (corresponding author), Univ Med Ctr Utrecht, Phys Therapy Res, Clin Hlth Sci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.; Stukstette, MJ (corresponding author), Univ Med Ctr Utrecht, Dept Rehabil Nursing Sci & Sport, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.; Stukstette, MJ (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands.	m.j.p.m.stukstette@umcutrecht.nl	Vanwanseele, Benedicte/AAQ-1706-2021	Vanwanseele, Benedicte/0000-0002-6158-9483; Pisters, Martijn F./0000-0002-2875-1709	Scientific College Physical Therapy (WCF) of the Royal Dutch Society for Physical Therapy (KNGF)	Scientific College Physical Therapy (WCF) of the Royal Dutch Society for Physical Therapy (KNGF)	The Scientific College Physical Therapy (WCF) of the Royal Dutch Society for Physical Therapy (KNGF) funded the study (https://www.fysionet-evidencebased.nl/index.php/wcf-projecten). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maskari A, 2010, J AM SOC INF SCI TEC, V61, P859, DOI 10.1002/asi.21300; [Anonymous], 1998, 924111 ISO; Arthanat S, 2007, DISABIL REHABIL-ASSI, V2, P235, DOI 10.1080/17483100701343665; Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Boland MR, 2014, J BIOMED INFORM, V52, P141, DOI 10.1016/j.jbi.2013.12.004; Borsci S, 2015, INT J HUM-COMPUT INT, V31, P484, DOI 10.1080/10447318.2015.1064648; Borsci S, 2014, EXPERT REV MED DEVIC, V11, P513, DOI 10.1586/17434440.2014.940312; Borsci S, 2013, ACM T COMPUT-HUM INT, V20, DOI 10.1145/2506210; Borsci S, 2009, COGN PROCESS, V10, P193, DOI 10.1007/s10339-009-0268-9; Brooke J., 1996, USABILITY EVALUATION, V189, P4; Dabke HV, 2004, CLIN ORTHOP RELAT R, P282, DOI 10.1097/01.blo.0000127116.13377.65; Daniels Jeremy, 2007, J Clin Monit Comput, V21, P323, DOI 10.1007/s10877-007-9091-y; De Bleser L, 2011, CIN-COMPUT INFORM NU, V29, P489, DOI 10.1097/NCN.0b013e31821a1555; De Bleser L, 2010, SENSORS-BASEL, V10, P1535, DOI 10.3390/s100301535; Denhaerynck K, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-5; Distasio Anthony J. Ii, 1994, Contemporary Orthopaedics, V29, P273; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Fu MC, 2014, ORTHOPEDICS, V37, pE993, DOI 10.3928/01477447-20141023-56; Gray F B, 1998, Am J Orthop (Belle Mead NJ), V27, P558; Hensel BK, 2006, J AM MED INFORM ASSN, V13, P428, DOI 10.1197/jamia.M2026; Hermsen S, 2016, COMPUT HUM BEHAV, V57, P61, DOI 10.1016/j.chb.2015.12.023; Hurkmans HL, 2007, ARCH PHYS MED REHAB, V88, P200, DOI 10.1016/j.apmr.2006.11.005; Hurkmans HL, 2012, ARCH PHYS MED REHAB, V93, P565, DOI 10.1016/j.apmr.2011.11.019; Hurkmans HLP, 2003, CLIN BIOMECH, V18, P576, DOI 10.1016/S0268-0033(03)00116-5; Hustedt Joshua W., 2012, Yale Journal of Biology and Medicine, V85, P119; Hustedt JW, 2012, ORTHOPEDICS, V35, pE31, DOI 10.3928/01477447-20111122-14; Isakov E, 2007, Eura Medicophys, V43, P21; Lewis JR, 2014, INT J HUM-COMPUT INT, V30, P663, DOI 10.1080/10447318.2014.930311; Lewis JR, 2009, LECT NOTES COMPUT SC, V5619, P94, DOI 10.1007/978-3-642-02806-9_12; LEWIS JR, 1994, HUM FACTORS, V36, P368, DOI 10.1177/001872089403600215; Lyles CR, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0534-9; Mavcic B, 2012, INT ORTHOP, V36, P689, DOI 10.1007/s00264-012-1487-8; MEADOWS TH, 1990, J BONE JOINT SURG AM, V72A, P1074, DOI 10.2106/00004623-199072070-00018; NIELSEN J, 1993, HUMAN FACTORS IN COMPUTING SYSTEMS, P206; Peek STM, 2014, INT J MED INFORM, V83, P235, DOI 10.1016/j.ijmedinf.2014.01.004; Rubin Guy, 2010, Orthopedics, V33, P729, DOI 10.3928/01477447-20100826-02; Ruiz FK, 2014, ORTHOPEDICS, V37, pE552, DOI 10.3928/01477447-20140528-55; Sauro J, 2012, QUANTIFYING THE USER EXPERIENCE: PRACTICAL STATISTICS FOR USER RESEARCH, P1, DOI 10.1016/B978-0-12-384968-7.00001-1; Shah SGS, 2009, INT J TECHNOL ASSESS, V25, P514, DOI 10.1017/S0266462309990328; Sigrist R, 2013, PSYCHON B REV, V20, P21, DOI 10.3758/s13423-012-0333-8; Tullis T., 2013, MEASURING USER EXPER; Turner Carl, 2006, INT ENCY ERGONOMICS, V3, P3084, DOI DOI 10.1201/9780849375477.CH597; van Hoof J, 2011, INT J AMBIENT COMPUT, V3, P25, DOI 10.4018/jaci.2011100103; Van Hoof J, 2012, GERONTECHNOLOGY, V11, P134; Van Lieshout R, 2016, J ORTHOP SPORT PHYS, V46, P993, DOI 10.2519/jospt.2016.6625; Vasarhelyi A, 2006, GAIT POSTURE, V23, P99, DOI 10.1016/j.gaitpost.2004.12.005; VIRZI RA, 1992, HUM FACTORS, V34, P457, DOI 10.1177/001872089203400407; Vredenburg K., 2002, Conference Proceedings. Conference on Human Factors in Computing Systems. CHI 2002, P471, DOI 10.1145/503376.503460; Wessels RD, 2003, DISABIL REHABIL, V25, P267, DOI 10.1080/0963828021000031197; Winstein CJ, 1996, PHYS THER, V76, P985, DOI 10.1093/ptj/76.9.985; Yu S, 2014, ORTHOPEDICS, V37, pE10, DOI 10.3928/01477447-20131219-10	51	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165199	10.1371/journal.pone.0165199	http://dx.doi.org/10.1371/journal.pone.0165199			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798674	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100022
J	Yin, YX; Lan, JH; Nguyen, D; Valenzuela, N; Takemura, P; Bolon, YT; Springer, B; Saito, K; Zheng, Y; Hague, T; Pasztor, A; Horvath, G; Rigo, K; Reed, EF; Zhang, QH				Yin, Yuxin; Lan, James H.; Nguyen, David; Valenzuela, Nicole; Takemura, Ping; Bolon, Yung-Tsi; Springer, Brianna; Saito, Katsuyuki; Zheng, Ying; Hague, Tim; Pasztor, Agnes; Horvath, Gyorgy; Rigo, Krisztina; Reed, Elaine F.; Zhang, Qiuheng			Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA: Results from over 10,000 Donor Recruitment Samples	PLOS ONE			English	Article							HIGH-RESOLUTION; CLINICAL-APPLICATIONS; CELL TRANSPLANTATION; C EXPRESSION; POLYMORPHISM; ASSOCIATION; BINDING; ALLELE; LEVEL; LOCI	Background Unambiguous HLA typing is important in hematopoietic stem cell transplantation (HSCT), HLA disease association studies, and solid organ transplantation. However, current molecular typing methods only interrogate the antigen recognition site (ARS) of HLA genes, resulting in many cis-trans ambiguities that require additional typing methods to resolve. Here we report high-resolution HLA typing of 10,063 National Marrow Donor Program (NMDP) registry donors using long-range PCR by next generation sequencing (NGS) approach on buccal swab DNA. Methods Multiplex long-range PCR primers amplified the full-length of HLA class I genes (A, B, C) from promotor to 3' UTR. Class II genes (DRB1, DQB1) were amplified from exon 2 through part of exon 4. PCR amplicons were pooled and sheared using Covaris fragmentation. Library preparation was performed using the Illumina TruSeq Nano kit on the Beckman FX automated platform. Each sample was tagged with a unique barcode, followed by 2x250 bp paired-end sequencing on the Illumina MiSeq. HLA typing was assigned using Omixon Twin software that combines two independent computational algorithms to ensure high confidence in allele calling. Consensus sequence and typing results were reported in Histoimmunogenetics Markup Language (HML) format. All homozygous alleles were confirmed by Luminex SSO typing and exon novelties were confirmed by Sanger sequencing. Results Using this automated workflow, over 10,063 NMDP registry donors were successfully typed under high-resolution by NGS. Despite known challenges of nucleic acid degradation and low DNA concentration commonly associated with buccal-based specimens, 97.8% of samples were successfully amplified using long-range PCR. Among these, 98.2% were successfully reported by NGS, with an accuracy rate of 99.84% in an independent blind Quality Control audit performed by the NDMP. In this study, NGS-HLA typing identified 23 null alleles (0.023%), 92 rare alleles (0.091%) and 42 exon novelties (0.042%). Conclusion Long-range, unambiguous HLA genotyping is achievable on clinical buccal swab-extracted DNA. Importantly, full-length gene sequencing and the ability to curate full sequence data will permit future interrogation of the impact of introns, expanded exons, and other gene regulatory sequences on clinical outcomes in transplantation.	[Yin, Yuxin; Nguyen, David; Valenzuela, Nicole; Takemura, Ping; Zheng, Ying; Reed, Elaine F.; Zhang, Qiuheng] Univ Calif Los Angeles, Immunogenet Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lan, James H.] Univ British Columbia, Clinician Investigator Program, Vancouver, BC, Canada; [Bolon, Yung-Tsi; Springer, Brianna] Natl Marrow Donor Program, Minneapolis, MN USA; [Saito, Katsuyuki] Thermo Fisher Sci, Lambda 1, Canoga Pk, CA USA; [Hague, Tim; Pasztor, Agnes; Horvath, Gyorgy; Rigo, Krisztina] Omixon LTD, Budapest, Hungary	University of California System; University of California Los Angeles; University of British Columbia; National Marrow Donor Program; Thermo Fisher Scientific	Zhang, QH (corresponding author), Univ Calif Los Angeles, Immunogenet Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.		Valenzuela, Nicole M/H-8290-2017; Lan, James/ABB-7521-2021	Valenzuela, Nicole M/0000-0003-2024-5382; 	NMDP [RFQ C14-0040]	NMDP	This study was supported by NMDP for RFQ#C14-0040, https://bethematch.org/. Katsuyuki Saito is employed by One Lambda, Thermo Fisher Scientific. One Lambda, Thermo Fisher Scientific provided support in providing HLA amplification primers, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. Tim Hague, Agnes Pasztor, Gyorgy Horvath and Krisztina Rigo are employed by Omixon LTD. Omixon LTD provided support in providing analysis software, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adriaanse MP, 2016, J GASTROENTEROL HEPA; Balas A, 2015, TISSUE ANTIGENS, V86, P56, DOI 10.1111/tan.12583; Barone JC, 2015, HUM IMMUNOL, V76, P903, DOI 10.1016/j.humimm.2015.09.014; Bentley G, 2009, TISSUE ANTIGENS, V74, P393, DOI 10.1111/j.1399-0039.2009.01345.x; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Duke JL, 2016, HLA, V87, P141, DOI 10.1111/tan.12736; Ehrenberg PK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-864; Erlich H, 2012, TISSUE ANTIGENS, V80, P1, DOI 10.1111/j.1399-0039.2012.01881.x; Freeman B, 1997, BEHAV GENET, V27, P251, DOI 10.1023/A:1025614231190; Furst D, 2013, BLOOD, V122, P3220, DOI 10.1182/blood-2013-02-482547; Gabriel C, 2009, HUM IMMUNOL, V70, P960, DOI 10.1016/j.humimm.2009.08.009; Gao Suqing, 2014, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V31, P496, DOI 10.3760/cma.j.issn.1003-9406.2014.04.019; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hosomichi K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-355; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Lan JH, 2015, CURR OPIN ORGAN TRAN, V20, P461, DOI 10.1097/MOT.0000000000000217; Lan JH, 2015, HUM IMMUNOL, V76, P166, DOI 10.1016/j.humimm.2014.12.016; Lange V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-63; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Lind C, 2010, HUM IMMUNOL, V71, P1033, DOI 10.1016/j.humimm.2010.06.016; Loupy A, 2013, NEW ENGL J MED, V369, P1215, DOI 10.1056/NEJMoa1302506; Mack SJ, 2015, HUM IMMUNOL, V76, P975, DOI 10.1016/j.humimm.2015.09.016; Mack SJ, 2015, HUM IMMUNOL, V76, P954, DOI 10.1016/j.humimm.2015.09.011; Milius RP, 2015, HUM IMMUNOL, V76, P963, DOI 10.1016/j.humimm.2015.08.001; Neisig A, 1998, J IMMUNOL, V160, P171; Ozaki Y, 2014, TISSUE ANTIGENS, V83, P10, DOI 10.1111/tan.12258; Ozaki Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1514-4; Pan WJ, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-10; Patrushev LI, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1442, DOI 10.1134/S0006297914130021; Petersdorf EW, 2015, NEW ENGL J MED, V373, P599, DOI 10.1056/NEJMoa1500140; Petersdorf EW, 2014, BLOOD, V124, P3996, DOI 10.1182/blood-2014-09-599969; Rearick D, 2011, NUCLEIC ACIDS RES, V39, P2357, DOI 10.1093/nar/gkq1080; Rudney JD, 2006, ARCH ORAL BIOL, V51, P291, DOI 10.1016/j.archoralbio.2005.09.003; Shiina T, 2012, TISSUE ANTIGENS, V80, P305, DOI 10.1111/j.1399-0039.2012.01941.x; Smith DM, 2005, TISSUE ANTIGENS, V66, P93, DOI 10.1111/j.1399-0039.2005.00444.x; Thorsby E, 2005, TRANSPL IMMUNOL, V14, P175, DOI 10.1016/j.trim.2005.03.021; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109	37	31	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165810	10.1371/journal.pone.0165810	http://dx.doi.org/10.1371/journal.pone.0165810			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798706	gold, Green Submitted, Green Published			2022-12-26	WOS:000386711100068
J	Kawahara, G; Hayashi, YK				Kawahara, Genri; Hayashi, Yukiko K.			Characterization of Zebrafish Models of Marinesco-Sjogren Syndrome	PLOS ONE			English	Article							SIL1; MYOPATHY; PROTEIN; COCHAPERONE; NEURODEGENERATION; CATARACT; MUTANT; EMBRYO; MOUSE; GENE	SIL1 is a nucleotide exchange factor for the endoplasmic reticulum chaperone, BiP. Mutations in the SIL1 gene cause Marinesco-Sjogren syndrome (MSS), an autosomal recessive disease characterized by cerebellar ataxia, mental retardation, congenital cataracts, and myopathy. To create novel zebrafish models of MSS for therapeutic drug screening, we analyzed phenotypes in sil1 knock down fish by two different antisense oligo morpholinos. Both sil1 morphants had abnormal formation of muscle fibers and irregularity of the myosepta. Moreover, they showed smaller-sized eyes and loss of purkinje cells in cerebellar area compared to controls. Immunoblotting analysis revealed increased protein amounts of BiP, lipidated LC3, and caspase 3. These data supported that the sil1 morphants can represent mimicking phenotypes of human MSS. The sil1 morphants phenocopy the human MSS disease pathology and are a good animal model for therapeutic studies.	[Kawahara, Genri; Hayashi, Yukiko K.] Tokyo Med Univ, Dept Pathophysiol, Tokyo, Japan	Tokyo Medical University	Hayashi, YK (corresponding author), Tokyo Med Univ, Dept Pathophysiol, Tokyo, Japan.	yhayashi@tokyo-med.ac.jp			Japan Society for the Promotion of Science (JSPS); MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Research on rare and intractable diseases, Health and Labor Science Research Grants; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [26-8]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research on rare and intractable diseases, Health and Labor Science Research Grants; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan)	This work was supported partly by a Grant-in-Aid for challenging Exploratory Research from Japan Society for the Promotion of Science (JSPS), partly by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, partly by Research on rare and intractable diseases, Health and Labor Science Research Grants, and partly by Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP (26-8).	Anttonen AK, 2005, NAT GENET, V37, P1309, DOI 10.1038/ng1677; Bassett DI, 2003, HUM MOL GENET, V12, pR265, DOI 10.1093/hmg/ddg279; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; de L'Etang AF, 2015, NAT NEUROSCI, V18, P227, DOI 10.1038/nn.3903; Goto M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-58; Granato M, 1996, DEVELOPMENT, V123, P399; Guyon JR, 2009, HUM MOL GENET, V18, P202, DOI 10.1093/hmg/ddn337; HERVA R, 1987, NEUROPEDIATRICS, V18, P164, DOI 10.1055/s-2008-1052473; Inaguma Y, 2014, EMBO MOL MED, V6, P414, DOI 10.1002/emmm.201303069; Kaslin J, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-9; Kawahara G, 2011, P NATL ACAD SCI USA, V108, P5331, DOI 10.1073/pnas.1102116108; Kawahara G, 2010, HUM MOL GENET, V19, P623, DOI 10.1093/hmg/ddp528; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Roos A, 2014, ACTA NEUROPATHOL, V127, P761, DOI 10.1007/s00401-013-1224-4; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; SJoGREN TORSTEN, 1950, CONFINIA NEUROL, V10, P293; SUPERNEAU DW, 1987, EUR NEUROL, V26, P8, DOI 10.1159/000116305; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620; Zhao LH, 2010, HUM MOL GENET, V19, P25, DOI 10.1093/hmg/ddp464; Zoghbi HY, 2005, NAT GENET, V37, P1302, DOI 10.1038/ng1205-1302	21	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165563	10.1371/journal.pone.0165563	http://dx.doi.org/10.1371/journal.pone.0165563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792754	gold, Green Published, Green Submitted			2022-12-26	WOS:000389537000031
J	Elshorbagy, AK; Jerneren, F; Scudamore, CL; McMurray, F; Cater, H; Hough, T; Cox, R; Refsum, H				Elshorbagy, Amany K.; Jerneren, Fredrik; Scudamore, Cheryl L.; McMurray, Fiona; Cater, Heather; Hough, Tertius; Cox, Roger; Refsum, Helga			Exploring the Lean Phenotype of Glutathione-Depleted Mice: Thiol, Amino Acid and Fatty Acid Profiles	PLoS One			English	Article							DIET-INDUCED OBESITY; OXIDATIVE STRESS; INSULIN-RESISTANCE; DEFICIENT MICE; CYSTEINE DIOXYGENASE; GLUCOSE-TOLERANCE; STEAROYL-COENZYME; LIPID-METABOLISM; BODY-COMPOSITION; REDOX STATUS	Background Although reduced glutathione (rGSH) is decreased in obese mice and humans, block of GSH synthesis by buthionine sulfoximine (BSO) results in a lean, insulin-sensitive phenotype. Data is lacking about the effect of BSO on GSH precursors, cysteine and glutamate. Plasma total cysteine (tCys) is positively associated with stearoyl-coenzyme A desaturase (SCD) activity and adiposity in humans and animal models. Objective To explore the phenotype, amino acid and fatty acid profiles in BSO-treated mice. Design Male C3H/HeH mice aged 11 weeks were fed a high-fat diet with or without BSO in drinking water (30 mmol/L) for 8 weeks. Amino acid and fatty acid changes were assessed, as well as food consumption, energy expenditure, locomotor activity, body composition and liver vacuolation (steatosis). Results Despite higher food intake, BSO decreased particularly fat mass but also lean mass (both P<0.001), and prevented fatty liver vacuolation. Physical activity increased during the dark phase. BSO decreased plasma free fatty acids and enhanced insulin sensitivity. BSO did not alter liver rGSH, but decreased plasma total GSH (tGSH) and rGSH (by similar to 70%), and liver tGSH (by 82%). Glutamate accumulated in plasma and liver. Urine excretion of cysteine and its precursors was increased by BSO. tCys, rCys and cystine decreased in plasma (by 23-45%, P<0.001 for all), but were maintained in liver, at the expense of decreased taurine. Free and total plasma concentrations of the SCD products, oleic and palmitoleic acids were decreased (by 27-38%, P < 0.001 for all). Conclusion Counterintuitively, block of GSH synthesis decreases circulating tCys, raising the question of whether the BSO-induced obesity-resistance is linked to cysteine depletion. Cysteine-supplementation of BSO-treated mice is warranted to dissect the effects of cysteine and GSH depletion on energy metabolism.	[Elshorbagy, Amany K.] Univ Alexandria, Dept Physiol, Fac Med, Alexandria, Egypt; [Jerneren, Fredrik; Refsum, Helga] Univ Oxford, Dept Pharmacol, Oxford, England; [Scudamore, Cheryl L.; Cater, Heather; Hough, Tertius] MRC Harwell Inst, Mary Lyon Ctr, Harwell Campus, Oxford, England; [McMurray, Fiona; Cox, Roger] MRC Harwell Inst, Mammalian Genet Unit, Harwell Campus, Oxford, England; [Refsum, Helga] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway	Egyptian Knowledge Bank (EKB); Alexandria University; University of Oxford; MRC Harwell; MRC Harwell; University of Oslo	Elshorbagy, AK (corresponding author), Univ Alexandria, Dept Physiol, Fac Med, Alexandria, Egypt.	amany.elshorbagy@alexmed.edu.eg	Refsum, Helga/A-4073-2010	Scudamore, Cheryl/0000-0002-7101-1714; Elshorbagy, Amany/0000-0002-8624-860X; Jerneren, Fredrik/0000-0003-0897-7177; Cox, Roger/0000-0001-7170-5014; Cater, Heather/0000-0002-8696-6070	Research Council of Norway; Charles Wolfson Charitable Trust; Throne Holst Foundation; Medical Research Council [MC_UP_1502/1, MC_U142661184, G0901338] Funding Source: researchfish; MRC [MC_U142661184, MC_UP_1502/1, G0901338] Funding Source: UKRI	Research Council of Norway(Research Council of Norway); Charles Wolfson Charitable Trust; Throne Holst Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study has received funding from The Research Council of Norway, the Charles Wolfson Charitable Trust, and the Throne Holst Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Professor A David Smith for valuable discussions around the study, Ms Cheryl Turner for expert help with the mass spectrometry assays, and the staff at the Mary Lyon Centre for assistance with the animal work. The study has received funding from The Research Council of Norway, the Charles Wolfson Charitable Trust, and the Throne Holst Foundation.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Auwerx J., 2003, NUCL RECEPT SIGNAL, V1, P006; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Barbato DL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13091; Brandsch C, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-50; Brownlow BS, 1996, PHYSIOL BEHAV, V60, P37, DOI 10.1016/0031-9384(95)02210-4; CARSON NAJ, 1963, ARCH DIS CHILD, V38, P425, DOI 10.1136/adc.38.201.425; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Nguyen D, 2012, OBESITY, V20, P1755, DOI 10.1038/oby.2012.46; Deng P, 2015, BIOCHEM BIOPH RES CO, V458, P123, DOI 10.1016/j.bbrc.2015.01.080; Di Renzo L, 2010, OBESITY, V18, P2125, DOI 10.1038/oby.2010.50; Elshorbagy AK, 2012, NUTR METAB CARDIOVAS, V22, P1031, DOI 10.1016/j.numecd.2011.01.008; Elshorbagy AK, 2008, AM J CLIN NUTR, V88, P738, DOI 10.1093/ajcn/88.3.738; Elshorbagy AK, 2014, MAMM GENOME, V25, P455, DOI 10.1007/s00335-014-9527-x; Elshorbagy AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044166; Elshorbagy AK, 2012, J NUTR BIOCHEM, V23, P332, DOI 10.1016/j.jnutbio.2010.12.009; Elshorbagy AK, 2012, CURR OPIN CLIN NUTR, V15, P49, DOI 10.1097/MCO.0b013e32834d199f; Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215; Elshorbagy AK, 2010, NUTRITION, V26, P1201, DOI 10.1016/j.nut.2009.09.017; Elshorbagy AK, 2009, OBESITY, V17, P1435, DOI 10.1038/oby.2008.671; Fekete K, 2015, OBES REV, V16, P488, DOI 10.1111/obr.12280; Findeisen HM, 2011, OBESITY, V19, P2429, DOI 10.1038/oby.2011.298; Guarino MP, 2003, AM J PHYSIOL-GASTR L, V284, pG588, DOI 10.1152/ajpgi.00423.2002; Gupta S, 2014, FASEB J, V28, P781, DOI 10.1096/fj.13-240770; Gupta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027598; Haj-Yasein NN, 2013, J INHERIT METAB D S1, V36; Haque JA, 2010, LAB INVEST, V90, P1704, DOI 10.1038/labinvest.2010.112; Hargreaves IP, 2002, AMINO ACIDS, V22, P109, DOI 10.1007/s007260200000; Jankovic A, 2014, METABOLISM, V63, P661, DOI 10.1016/j.metabol.2014.01.009; Jerneren F, 2015, AM J CLIN NUTR, V102, P215, DOI 10.3945/ajcn.114.103283; Jerneren F, 2015, J PHARMACOL TOX MET, V71, P13, DOI 10.1016/j.vascn.2014.11.001; Kaur S, 2008, BRIT J DERMATOL, V159, P1364, DOI 10.1111/j.1365-2133.2008.08759.x; Kendig EL, 2011, TOXICOL APPL PHARM, V257, P338, DOI 10.1016/j.taap.2011.09.017; Kulak A, 2012, BEHAV BRAIN RES, V226, P563, DOI 10.1016/j.bbr.2011.10.020; Kwon DY, 2009, J NUTR, V139, P63, DOI 10.3945/jn.108.094771; Lee JJ, 2015, AM J CLIN NUTR, V101, P34, DOI 10.3945/ajcn.114.092262; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Peter A, 2009, CLIN CHEM, V55, P2113, DOI 10.1373/clinchem.2009.127274; Refsum H, 2004, CLIN CHEM, V50, P1769, DOI 10.1373/clinchem.2004.036194; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Shackelford C, 2002, TOXICOL PATHOL, V30, P93, DOI 10.1080/01926230252824761; Stipanuk MH, 2009, AMINO ACIDS, V37, P55, DOI 10.1007/s00726-008-0202-y; THANISLASS J, 1995, BIOCHEM PHARMACOL, V50, P229, DOI 10.1016/0006-2952(95)00123-H; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x; Vinknes KJ, 2013, PROSTAG LEUKOTR ESS, V89, P297, DOI 10.1016/j.plefa.2013.09.007; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Watanabe Toshiyuki, 2003, J Toxicol Sci, V28, P455, DOI 10.2131/jts.28.455; Wijekoon EP, 2007, BIOCHEM SOC T, V35, P1175, DOI 10.1042/BST0351175	54	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0163214	10.1371/journal.pone.0163214	http://dx.doi.org/10.1371/journal.pone.0163214			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788147	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900005
J	Goergen, G; Kumar, PL; Sankung, SB; Togola, A; Tamo, M				Goergen, Georg; Kumar, P. Lava; Sankung, Sagnia B.; Togola, Abou; Tamo, Manuele			First Report of Outbreaks of the Fall Armyworm Spodoptera frugiperda (J E Smith) (Lepidoptera, Noctuidae), a New Alien Invasive Pest in West and Central Africa	PLOS ONE			English	Article								The fall armyworm Spodoptera frugiperda is a prime noctuid pest of maize on the American continents where it has remained confined despite occasional interceptions by European quarantine services in recent years. The pest has currently become a new invasive species in West and Central Africa where outbreaks were recorded for the first time in early 2016. The presence of at least two distinct haplotypes within samples collected on maize in Nigeria and Sao Tome suggests multiple introductions into the African continent. Implications of this new threat to the maize crop in tropical Africa are briefly discussed.	[Goergen, Georg; Tamo, Manuele] Int Inst Trop Agr, 08 BP 0932 Tri Postal, Cotonou, Benin; [Kumar, P. Lava] IITA, PMB 5320, Ibadan, Nigeria; [Sankung, Sagnia B.] FAO, BP 2643, Libreville, Gabon; [Togola, Abou] IITA, PMB 3112, Kano, Nigeria	CGIAR; International Institute of Tropical Agriculture (IITA); Food & Agriculture Organization of the United Nations (FAO); CGIAR; International Institute of Tropical Agriculture (IITA)	Goergen, G (corresponding author), Int Inst Trop Agr, 08 BP 0932 Tri Postal, Cotonou, Benin.	g.goergen@cgiar.org		Goergen, Georg/0000-0003-4496-0495; Tamo, Manuele/0000-0002-5863-7421	CGIAR Research Program on MAIZE	CGIAR Research Program on MAIZE(CGIAR)	The authors gratefully acknowledge the CGIAR Research Program on MAIZE for financial support.r The authors are grateful to Silvestro Meseka, Ojo Tayo and Omolara Ayanniyi, Maize Improvement Programme, IITA Ibadan, Nigeria; Rachael Aderanti, Entomology Unit, IITA Kano, Nigeria; Samuel Alaohuo, Virology and Molecular Diagnostics Unit, IITA Ibadan, Nigeria; Oluwakemi Odeyemi, Institute of Agricultural Research and Training (IAR&T), Ibadan, Nigeria; and Komi Agboka, University of Lome, Togo for providing samples of the fall army worm from various locations in West Africa. Similarly we thank Obinna Ajuonu and Herve Houngue for assistance in the collection of field data in Benin. The authors gratefully acknowledge the CGIAR Research Program on MAIZE for financial support.	Adamczyk JJ, 1999, FLA ENTOMOL, V82, P230, DOI 10.2307/3496574; Alves L, 2010, 48 C SOC BRAS EC ADM; [Anonymous], 2015, 71241 OEPPEPPO PM EU, P410, DOI [10.1111/epp.12258, DOI 10.1111/EPP.12258]; ATKINSON PR, 1980, J ENTOMOL SOC S AFR, V43, P171; BROWN ES, 1975, B ENTOMOL RES, V65, P221, DOI 10.1017/S0007485300005939; Chapman JW, 2000, BEHAV ECOL SOCIOBIOL, V48, P321, DOI 10.1007/s002650000237; De-Almeida S.R., 2002, J BIOSCIENCES, V18, P41; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HARRIS K. M., 1962, BULL ENTOMOL RES, V53, P139, DOI 10.1017/S0007485300048021; JOHNSON SJ, 1987, INSECT SCI APPL, V8, P543, DOI 10.1017/S1742758400022591; Murúa Gabriela, 2004, Acta Zool. Mex, V20, P199; PAIR SD, 1986, FLA ENTOMOL, V69, P468, DOI 10.2307/3495380; Pogue M., 2002, MEM AM ENTOMOL SOC, V43, P1; Rose DJW, 2000, AFRICAN ARMYWORM HDB; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]	18	571	717	21	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165632	10.1371/journal.pone.0165632	http://dx.doi.org/10.1371/journal.pone.0165632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788251	gold, Green Published			2022-12-26	WOS:000389604900117
J	Starnino, L; Busque, L; Tardif, JC; D'Antono, B				Starnino, Louisia; Busque, Lambert; Tardif, Jean-Claude; D'Antono, Bianca			Psychological Profiles in the Prediction of Leukocyte Telomere Length in Healthy Individuals	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; QUALITY-OF-LIFE; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; DEPRESSIVE SYMPTOMS; PHYSIOLOGICAL-RESPONSES; DEFENSIVE HOSTILITY; GENDER-DIFFERENCES; ANXIETY DISORDERS	Background Shorter telomere length (TL) may signal premature cellular aging and increased risk for disease. While depression and psychosocial stress have been associated with shorter telomeres, other psychological risk factors for cardiovascular disease have received less attention. Purpose To evaluate the association between TL and psychological risk factors (symptoms of anxiety and depression, hostility and defensiveness traits) for heart disease, and to examine whether chronological age and sex moderate the associations observed. Methods 132 healthy men and women (M-age = 45.34 years) completed the Marlowe-Crowne Social Desirability Scale, the Beck Depression Inventory II, The Beck Anxiety Inventory and the Cook-Medley Hostility Scale. Relative TL was measured by quantitative polymerase chain reaction (PCR) of total genomic DNA samples. A series of hierarchical linear regressions were performed controlling for pertinent covariates. Results Shorter TL was observed among individuals high in defensiveness (beta = -.221) and depressive symptoms (beta = -.213), as well as in those with less hostility (beta = .256) and anxiety (beta = .220)(all Ps<.05). Psychological variables explained 19% of the variance over and above that explained by covariates (age, sex, exercise, alcohol consumption, systemic inflammation, and 24-hr mean arterial pressure). Age moderated the relation between TL and defensiveness (beta = .179, p = .03). Sex did not influence any of the relations. Conclusions Telomere length is associated with psychological burden though the direction of effect differs depending on the psychological variables under study. Further research is needed to determine the reasons for and implications of these seemingly contradictory findings.	[Starnino, Louisia; Tardif, Jean-Claude; D'Antono, Bianca] Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada; [Starnino, Louisia; D'Antono, Bianca] Univ Quebec, Dept Psychol, Montreal, PQ, Canada; [Busque, Lambert] Univ Montreal, Res Ctr, Div Hematol, Hop Maison Neuve Rosemont, Montreal, PQ, Canada; [Tardif, Jean-Claude] Montreal Heart Inst, Dept Med, Montreal, PQ, Canada; [Tardif, Jean-Claude] Univ Montreal, Montreal, PQ, Canada; [D'Antono, Bianca] Univ Montreal, Dept Psychol, Montreal, PQ, Canada	Universite de Montreal; University of Quebec; University of Quebec Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	D'Antono, B (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada.; D'Antono, B (corresponding author), Univ Quebec, Dept Psychol, Montreal, PQ, Canada.; D'Antono, B (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.	bianca.d.antono@umontreal.ca			Canadian Institutes of Health Research (CIHR) [79456, 111017]; Montreal Heart Institute Foundation (MHIF); Fonds de recherche du Quebec-Sante (FRQS) [31767]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Montreal Heart Institute Foundation (MHIF); Fonds de recherche du Quebec-Sante (FRQS)	This study was supported by grants awarded to Dr. D'Antono by the Canadian Institutes of Health Research (CIHR; MOP #79456 and #111017) and the Montreal Heart Institute Foundation (MHIF). Louisia Starnino is supported by the Fonds de recherche du Quebec-Sante (FRQS) (#31767). Dr. Tardif holds the Canada Research Chair (tier 1) in translational and personalized medicine and the Universite de Montreal Pfizer endowed research chair in atherosclerosis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; BAREFOOT JC, 1983, PSYCHOSOM MED, V45, P59, DOI 10.1097/00006842-198303000-00008; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, BECK DEPRESSION INVE, pb9; Bermudez J, 1994, 4 C EV PSIC SANT COM; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2011, COLD SPRING HARBOR P, V3; Boks MP, 2015, PSYCHONEUROENDOCRINO, V51, P506, DOI 10.1016/j.psyneuen.2014.07.011; Brydon L, 2012, BIOL PSYCHIAT, V71, P767, DOI 10.1016/j.biopsych.2011.08.020; Carty CL, 2015, ARTERIOSCL THROM VAS, V35, P2225, DOI 10.1161/ATVBAHA.115.305838; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chida Y, 2008, PSYCHOL BULL, V134, P829, DOI 10.1037/a0013342; Pedroso DCC, 2015, FERTIL STERIL, V103, P542, DOI 10.1016/j.fertnstert.2014.10.035; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Compare A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00384; Cook WW, 1954, J APPL PSYCHOL, V38, P414, DOI 10.1037/h0060667; CRINO MD, 1983, PSYCHOL REP, V53, P963, DOI 10.2466/pr0.1983.53.3.963; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; D'Antono B, 2013, J PSYCHOSOM RES, V75, P262, DOI 10.1016/j.jpsychores.2013.05.010; Degerman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113387; Demarble JB, 2014, J PSYCHOSOM RES, V76, P384, DOI 10.1016/j.jpsychores.2014.02.010; DENOLLET J, 1991, PSYCHOSOM MED, V53, P538, DOI 10.1097/00006842-199109000-00005; Dragomir AI, 2014, PSYCHOPHYSIOLOGY, V51, P921, DOI 10.1111/psyp.12231; EATON WW, 1989, ACTA PSYCHIAT SCAND, V79, P163, DOI 10.1111/j.1600-0447.1989.tb08584.x; Epel ES, 2010, BRAIN BEHAV IMMUN, V24, P531, DOI 10.1016/j.bbi.2009.11.018; Epel ES, 2009, AGING-US, V1, P81; Everson-Rose SA, 2014, STROKE, V45, P2318, DOI 10.1161/STROKEAHA.114.004815; Everson-Rose SA, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.08.010; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Frasure-Smith N, 2006, CAN J PSYCHIAT, V51, P730, DOI 10.1177/070674370605101202; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Gentile C, 2015, ANN BEHAV MED, V49, P112, DOI 10.1007/s12160-014-9639-2; Geronimus AT, 2015, J HEALTH SOC BEHAV, V56, P199, DOI 10.1177/0022146515582100; Gonda X, 2009, EUR ARCH PSY CLIN N, V259, P106, DOI 10.1007/s00406-008-0842-7; Gordon JL, 2012, PSYCHOPHYSIOLOGY, V49, P1082, DOI 10.1111/j.1469-8986.2012.01397.x; Hartmann N, 2010, DEPRESS ANXIETY, V27, P1111, DOI 10.1002/da.20749; HAYCOCK PC, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/BMJ.G4227; HELMERS KF, 1995, HEALTH PSYCHOL, V14, P202, DOI 10.1037/0278-6133.14.3.202; Hoen PW, 2013, PSYCHOL MED, V43, P689, DOI 10.1017/S0033291712001766; Hoen PW, 2011, PSYCHOSOM MED, V73, P541, DOI 10.1097/PSY.0b013e31821b1f6e; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Huzen J, 2010, AGE AGEING, V39, P223, DOI 10.1093/ageing/afp256; Jorgensen RS, 1996, PSYCHOL BULL, V120, P293, DOI 10.1037/0033-2909.120.2.293; Jorgensen RS, 2001, PSYCHOSOM MED, V63, P463, DOI 10.1097/00006842-200105000-00016; Juster RP, 2013, STRESS, V16, P616, DOI 10.3109/10253890.2013.835395; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Khan FM, 2010, CURR ATHEROSCLER REP, V12, P105, DOI 10.1007/s11883-010-0096-5; Khayyam-Nekouei Z, 2013, ARYA ATHEROSCLER, V9, P102; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067227; Kinser PA, 2013, NURS RES PRACT, V2013, DOI 10.1155/2013/469070; Koh DJ, 2016, ANN REHABIL MED-ARM, V40, P412, DOI 10.5535/arm.2016.40.3.412; Kuznetsova T, 2010, AM J EPIDEMIOL, V172, P440, DOI 10.1093/aje/kwq142; Ladwig KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064762; Lemogne C, 2015, HEALTH PSYCHOL, V34, P181, DOI 10.1037/hea0000129; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Levesque K, 2010, PSYCHOPHYSIOLOGY, V47, P332, DOI 10.1111/j.1469-8986.2009.00943.x; Levesque K, 2009, BIOL PSYCHOL, V80, P354, DOI 10.1016/j.biopsycho.2008.12.003; Li P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094442; Lin J, 2015, CANCER EPIDEM BIOMAR, V24, P336, DOI 10.1158/1055-9965.EPI-14-0992; LLABRE MM, 1991, PSYCHOPHYSIOLOGY, V28, P701, DOI 10.1111/j.1469-8986.1991.tb01017.x; Ludlow AT, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/601368; Lynch SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146723; Mann SJ, 1998, J PSYCHOSOM RES, V45, P139, DOI 10.1016/S0022-3999(97)00293-6; MARKOVITZ JH, 1991, J HYPERTENS, V9, P399, DOI 10.1097/00004872-199105000-00003; Miller SB, 1998, INT J PSYCHOPHYSIOL, V28, P193, DOI 10.1016/S0167-8760(97)00096-2; Mollica L, 2009, J GERONTOL A-BIOL, V64, P965, DOI 10.1093/gerona/glp065; Muezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003; Mwendwa DT, 2013, PSYCHOL HEALTH MED, V18, P431, DOI 10.1080/13548506.2012.736623; Needham BL, 2015, MOL PSYCHIATR, V20, P520, DOI 10.1038/mp.2014.89; Needham BL, 2013, SOC SCI MED, V85, P1, DOI 10.1016/j.socscimed.2013.02.023; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Nyklicek I, 1998, J BEHAV MED, V21, P145, DOI 10.1023/A:1018775807593; Okereke OI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040516; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8; Pasupathi M, 1999, PSYCHOL AGING, V14, P170, DOI 10.1037/0882-7974.14.1.170; PAULHUS DL, 1984, J PERS SOC PSYCHOL, V46, P598, DOI 10.1037/0022-3514.46.3.598; Pavanello S, 2011, INT J CANCER, V129, P983, DOI 10.1002/ijc.25999; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Pragodpol P, 2013, J CARDIOVASC NURS, V28, P277, DOI 10.1097/JCN.0b013e31824af56e; Prasad K, 2004, J CARDIOVASC PHARM T, V9, P203, DOI 10.1177/107424840400900308; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rafanelli C, 2015, PSYCHOL HEALTH, P1; Rappaport LM, 2014, J COUNS PSYCHOL, V61, P253, DOI 10.1037/a0035625; Raschenberger J, 2015, ATHEROSCLEROSIS, V242, P529, DOI 10.1016/j.atherosclerosis.2015.08.020; Robles TF, 2011, SOC PERSONAL PSYCHOL, V5, P518, DOI 10.1111/j.1751-9004.2011.00368.x; Rode L, 2014, J CLIN ENDOCR METAB, V99, pE1671, DOI 10.1210/jc.2014-1161; Rutledge T, 2003, ANN BEHAV MED, V25, P34, DOI 10.1207/S15324796ABM2501_05; Rutledge T, 2002, PSYCHOSOM MED, V64, P758, DOI 10.1097/01.PSY.0000031578.42041.1C; Shaffer JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048318; Shalev I, 2014, MOL PSYCHIATR, V19, P1163, DOI 10.1038/mp.2013.183; Shin C, 2016, ALCOHOL CLIN EXP RES, V40, P765, DOI 10.1111/acer.13005; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Skilton MR, 2007, BIOL PSYCHIAT, V62, P1251, DOI 10.1016/j.biopsych.2007.01.012; SMITH TW, 1985, HEALTH PSYCHOL, V4, P503, DOI 10.1037/0278-6133.4.6.503; SMITH TW, 1989, J BEHAV MED, V12, P135, DOI 10.1007/BF00846547; Soares-Miranda L, 2015, MED SCI SPORT EXER, V47, P2525, DOI 10.1249/MSS.0000000000000720; Somers JM, 2006, CAN J PSYCHIAT, V51, P100, DOI 10.1177/070674370605100206; Spaderna H, 2014, HEALTH PSYCHOL, V33, P1328, DOI 10.1037/hea0000033; Stafford M, 2012, EUR J PUBLIC HEALTH, V22, P301, DOI 10.1093/eurpub/ckr007; Starkweather Angela R, 2014, BMC Res Notes, V7, P423, DOI 10.1186/1756-0500-7-423; Sun YH, 2015, CARCINOGENESIS, V36, P1327, DOI 10.1093/carcin/bgv133; Sykes DH, 2002, INT J EPIDEMIOL, V31, P1227, DOI 10.1093/ije/31.6.1227; Teyssier JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049677; Vasan RS, 2009, CIRCULATION, V120, P1195, DOI 10.1161/CIRCULATIONAHA.109.853895; Verhoeven JE, 2014, MOL PSYCHIATR, V19, P895, DOI 10.1038/mp.2013.151; Verhoeven JE, 2015, BRIT J PSYCHIAT, V206, P371, DOI 10.1192/bjp.bp.114.151027; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Weisberg YJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00178; Wikgren M, 2012, BIOL PSYCHIAT, V71, P294, DOI 10.1016/j.biopsych.2011.09.015; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Zalli A, 2014, P NATL ACAD SCI USA, V111, P4519, DOI 10.1073/pnas.1322145111	115	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165482	10.1371/journal.pone.0165482	http://dx.doi.org/10.1371/journal.pone.0165482			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VY	27788238	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900093
J	Andrianou, XD; Gangler, S; Piciu, A; Charisiadis, P; Zira, C; Aristidou, K; Piciu, D; Hauser, R; Makris, KC				Andrianou, Xanthi D.; Gangler, Stephanie; Piciu, Andra; Charisiadis, Pantelis; Zira, Christina; Aristidou, Kyriacos; Piciu, Doina; Hauser, Russ; Makris, Konstantinos C.			Human Exposures to Bisphenol A, Bisphenol F and Chlorinated Bisphenol A Derivatives and Thyroid Function	PLOS ONE			English	Article							STRUCTURAL ANALOGS; UNITED-STATES; US ADULTS; HEALTH; ASSOCIATION; NUTRITION; TRICLOSAN; ETIOLOGY	Although the increasing prevalence of thyroid nodular disease (TND) has been partially attributed to the more frequent usage of improved diagnostics, environmental factors, such as exposures to thyroid-disrupting chemicals may contribute to TND and altered thyroid function. We investigated the association between exposures to bisphenol A (BPA), its chlorinated derivatives (ClxBPA), and bisphenol F (BPF) with TND and thyroid measures in adult women. A case-control study in Cyprus and Romania (n = 212) was conducted, where cases were those with thyroid nodules (diameter >3mm), and controls without nodules. Serum TSH and free thyroxine and urinary levels of BPA, BPF and ClxBPA were measured using immunoassays and tandem mass spectrometry, respectively. The association between exposures to BPA compounds and TND, adjusting for age, BMI, thyroid hormones and urinary iodine was assessed using logistic regression. Linear regression was used to explore associations between urinary BPA, BPF and ClxBPA and serum thyroid hormones. With the exception of a chlorinated BPA compound (30%), the rest of bisphenols were quantified in 100% of urine samples. A positive and significant (p<0.05) association was observed between urinary BPA and serum TSH that remained after adjusting for urinary creatinine, age, BMI, study site and disease status; there was no significant association between BPF or ClxBPA with TSH. None of the BPA compounds were associated with higher odds of TND. Our study found associations of urinary BPA with TSH but not with BPF or ClxBPA. A larger study would be justified.	[Andrianou, Xanthi D.; Gangler, Stephanie; Charisiadis, Pantelis; Makris, Konstantinos C.] Cyprus Univ Technol, Cyprus Int Inst Environm & Publ Hlth, Limassol, Cyprus; [Zira, Christina] Archbishop Makarios III Hosp, Dept Endocrinol, Nicosia, Cyprus; [Aristidou, Kyriacos] Archbishop Makarios III Hosp, Dept Radiol, Nicosia, Cyprus; [Piciu, Andra] Prof Dr Ion Chiricuta Inst Oncol, Dept Med Oncol, Cluj Napoca, Romania; [Piciu, Andra; Piciu, Doina] Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca, Romania; [Piciu, Doina] Chiricuta Inst Oncol, Dept Nucl Med, Cluj Napoca, Romania; [Hauser, Russ] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Cyprus International Institute for Environmental & Public Health; Cyprus University of Technology; Oncology Institute Prof. Dr. Ion Chiricuta; Iuliu Hatieganu University of Medicine & Pharmacy; Oncology Institute Prof. Dr. Ion Chiricuta; Harvard University; Harvard T.H. Chan School of Public Health	Makris, KC (corresponding author), Cyprus Univ Technol, Cyprus Int Inst Environm & Publ Hlth, Limassol, Cyprus.	konstantinos.makris@cut.ac.cy	PICIU, DOINA/AAC-4121-2019; Andrianou, Xanthi/AAV-7277-2020; Makris, Konstantinos/GNP-4408-2022; Piciu, Andra/AAM-6570-2020; Charisiadis, Pantelis/E-7240-2012	PICIU, DOINA/0000-0001-6184-7449; Andrianou, Xanthi/0000-0002-2906-5743; Charisiadis, Pantelis/0000-0001-7260-192X; Makris, Konstantinos/0000-0001-5251-8619; Gangler, Stephanie/0000-0002-7799-1514	Harvard-NIEHS Center for Environmental Health [P30ES000002]; Cyprus Research Promotion Foundation; European Commission [Y-POY/0713/18]; Executive Unit for Financing Higher Education, Research, Development and Innovation (UEFISCDI) [761/15.03.2014]	Harvard-NIEHS Center for Environmental Health; Cyprus Research Promotion Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Executive Unit for Financing Higher Education, Research, Development and Innovation (UEFISCDI)	This work was supported in part by a pilot project grant from the Harvard-NIEHS Center for Environmental Health (P30ES000002) and in part by the Cyprus Research Promotion Foundation with Structural Funds from the European Commission (Project Protocol Number: Y-POY/0713/18), both awarded to KCM. The Romanian partner (DP) was supported by the Executive Unit for Financing Higher Education, Research, Development and Innovation (UEFISCDI), grant no 761/15.03.2014. The authors would like to thank Margarita Agathokleous, Thalia Theofanous, and Irene Rassia for their help with recruitment and data collection in Cyprus, and Prof. Costas Christophi for his advice on the statistical analysis.	Andra SS, 2015, ENVIRON INT, V85, P352, DOI 10.1016/j.envint.2015.09.011; Andra SS, 2015, J ENVIRON SCI HEAL A, V50, P1169, DOI 10.1080/10934529.2015.1047674; Angerer J., 2010, MAK COLLECTION OCCUP, P169; [Anonymous], SJPLOT DATA VISUALIZ; [Anonymous], IOD SALT SUCH LITTL; [Anonymous], STARGAZER WELL FORMA; Bergman Heindel J, 2013, STATE SCI ENDOCRINE; Bisphenol F, 2013, BISPH HAZ SUBST DAT; Boas M, 2012, MOL CELL ENDOCRINOL, V355, P240, DOI 10.1016/j.mce.2011.09.005; CDC, 2015, 4 NAT REP HUM EXP EN; CDC, 2007, UR IOD ICPMS REN IND; Chevrier J, 2013, ENVIRON HEALTH PERSP, V121, P138, DOI 10.1289/ehp.1205092; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Dean DS, 2008, BEST PRACT RES CL EN, V22, P901, DOI 10.1016/j.beem.2008.09.019; Ferlay J, 2013, GLOBOCAN 2012 V1 0; Geens T, 2015, ENVIRON INT, V76, P98, DOI 10.1016/j.envint.2014.12.003; Hansen PS, 2005, CLIN ENDOCRINOL, V62, P380, DOI 10.1111/j.1365-2265.2005.02230.x; IARC (International Agency for Research on Cancer), 2015, EUCAN FACTSH CYPR; IARC (International Agency for Research on Cancer), 2015, EUCAN FACTSH ROM; Kalyvas H, 2014, SCI TOTAL ENVIRON, V490, P254, DOI 10.1016/j.scitotenv.2014.04.072; Knudsen N, 2014, BEST PRACT RES CL EN, V28, P495, DOI 10.1016/j.beem.2014.02.005; Krause M, 2012, INT J ANDROL, V35, P424, DOI 10.1111/j.1365-2605.2012.01280.x; Lauritsen JM, 2000, EPIDATA DATA ENTRY D; Liao CY, 2014, ARCH ENVIRON CON TOX, V67, P50, DOI 10.1007/s00244-014-0016-8; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P9138, DOI 10.1021/es302004w; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Piciu Andra, 2015, Clujul Med, V88, P494, DOI 10.15386/cjmed-518; R Core Team, 2013, R LANG ENV STAT COMP; Revelle W., 2015, PSYCH PROCEDURES PSY; Rochester JR, 2015, ENVIRON HEALTH PERSP, V123, P643, DOI 10.1289/ehp.1408989; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Romano ME, 2015, ENVIRON RES, V138, P453, DOI 10.1016/j.envres.2015.03.003; Rosenmai AK, 2014, TOXICOL SCI, V139, P35, DOI 10.1093/toxsci/kfu030; RStudio Team, 2015, INT DEV ENV R; SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), 2015, SAF US BISPH A MED D; US Food and Drug Administration, 2014, BISPH A BPA US FOOD; van der Haar F, 2011, FOOD NUTR BULL, V32, pS175, DOI 10.1177/15648265110324S401; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Wang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141248; Wang TG, 2013, EPIDEMIOLOGY, V24, P295, DOI 10.1097/EDE.0b013e318280e02f; Webster GM, 2016, ENVIRON HEALTH PERSP, V124, P935, DOI 10.1289/ehp.1409589; Wickham H., 2015, R PACKAGE VERSION, V0.4, P156; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; Ye XY, 2015, ENVIRON SCI TECHNOL, V49, P11834, DOI 10.1021/acs.est.5b02135; Yoshida K., 2015, TABLEONE CREATE TABL; Zhou XL, 2014, J CHROMATOGR B, V944, P152, DOI 10.1016/j.jchromb.2013.11.009; Zimmermann MB, 2012, NUTR REV, V70, P553, DOI 10.1111/j.1753-4887.2012.00528.x	50	57	61	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0155237	10.1371/journal.pone.0155237	http://dx.doi.org/10.1371/journal.pone.0155237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783680	Green Submitted, Green Published, gold			2022-12-26	WOS:000389602800002
J	Schott, AS; Behr, J; Quinn, J; Vogel, RF				Schott, Ann-Sophie; Behr, Juergen; Quinn, Jennifer; Vogel, Rudi F.			MALDI-TOF Mass Spectrometry Enables a Comprehensive and Fast Analysis of Dynamics and Qualities of Stress Responses of Lactobacillus paracasei subsp paracasei F19	PLOS ONE			English	Article							DNA-BINDING PROTEIN; ASSISTED-LASER-DESORPTION/IONIZATION; ACID TOLERANCE RESPONSE; WALL TEICHOIC-ACIDS; HEAT-SHOCK; LACTOCOCCUS-LACTIS; RAPID IDENTIFICATION; STREPTOCOCCUS-MUTANS; BACILLUS-SUBTILIS; OSMOTIC-STRESS	Lactic acid bacteria (LAB) are widely used as starter cultures in the manufacture of foods. Upon preparation, these cultures undergo various stresses resulting in losses of survival and fitness. In order to find conditions for the subsequent identification of proteomic biomarkers and their exploitation for preconditioning of strains, we subjected Lactobacillus (Lb.) paracasei subsp. paracasei TMW 1.1434 (F19) to different stress qualities (osmotic stress, oxidative stress, temperature stress, pH stress and starvation stress). We analysed the dynamics of its stress responses based on the expression of stress proteins using MALDI-TOF mass spectrometry (MS), which has so far been used for species identification. Exploiting the methodology of accumulating protein expression profiles by MALDI-TOF MS followed by the statistical evaluation with cluster analysis and discriminant analysis of principle components (DAPC), it was possible to monitor the expression of low molecular weight stress proteins, identify a specific time point when the expression of stress proteins reached its maximum, and statistically differentiate types of adaptive responses into groups. Above the specific result for F19 and its stress response, these results demonstrate the discriminatory power of MALDI-TOF MS to characterize even dynamics of stress responses of bacteria and enable a knowledge-based focus on the laborious identification of biomarkers and stress proteins. To our knowledge, the implementation of MALDI-TOF MS protein profiling for the fast and comprehensive analysis of various stress responses is new to the field of bacterial stress responses. Consequently, we generally propose MALDI-TOF MS as an easy and quick method to characterize responses of microbes to different environmental conditions, to focus efforts of more elaborate approaches on time points and dynamics of stress responses.	[Schott, Ann-Sophie; Quinn, Jennifer; Vogel, Rudi F.] Tech Univ Munich, Lehrstuhl Tech Mikrobiol, D-85354 Freising Weihenstephan, Germany; [Behr, Juergen] Tech Univ Munich, Bavarian Ctr Biomol Mass Spectrometry, Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich	Behr, J (corresponding author), Tech Univ Munich, Bavarian Ctr Biomol Mass Spectrometry, Freising Weihenstephan, Germany.	juergen.behr@wzw.tum.de		Behr, Juergen/0000-0001-8782-4456	German Federal Office of Agriculture and Food [BLE 2817400111]	German Federal Office of Agriculture and Food	Parts of the presented work were funded by the German Federal Office of Agriculture and Food in project BLE 2817400111, www.ble.de, AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla Nazar M, 2013, Pak J Biol Sci, V16, P275, DOI 10.3923/pjbs.2013.275.280; Alispahic M, 2010, J MED MICROBIOL, V59, P295, DOI 10.1099/jmm.0.016576-0; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Bauer SAW, 2012, J BIOTECHNOL, V159, P351, DOI 10.1016/j.jbiotec.2011.06.010; Beales N, 2004, COMPR REV FOOD SCI F, V3, P1, DOI 10.1111/j.1541-4337.2004.tb00057.x; Behr J, 2007, APPL ENVIRON MICROB, V73, P3300, DOI 10.1128/AEM.00124-07; Bergenholtz AS, 2012, CRYOBIOLOGY, V64, P152, DOI 10.1016/j.cryobiol.2012.01.002; Bernhardt J, 1997, MICROBIOL-UK, V143, P999, DOI 10.1099/00221287-143-3-999; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bove CG, 2012, PROTEOMICS, V12, P3206, DOI 10.1002/pmic.201200157; Broadbent JR, 1999, CRYOBIOLOGY, V39, P88, DOI 10.1006/cryo.1999.2190; Buckenhuskes H.J., 1997, FOOD MICROBIOLOGY FU, V2nd ed., P595; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; BURKS C, 1985, COMPUT APPL BIOSCI, V1, P225; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Carminati D., 2010, BIOTECHNOLOGY LACTIC, P177; Chan LL, 2006, PROTEOMICS, V6, P654, DOI 10.1002/pmic.200401350; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Claydon MA, 1996, NAT BIOTECHNOL, V14, P1584, DOI 10.1038/nbt1196-1584; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; DALGAARD P, 1994, INT J FOOD MICROBIOL, V23, P391, DOI 10.1016/0168-1605(94)90165-1; De Angelis M, 2004, APPL ENVIRON MICROB, V70, P1336, DOI 10.1128/AEM.70.3.1336-1346.2004; De Angelis M, 2001, MICROBIOL-SGM, V147, P1863, DOI 10.1099/00221287-147-7-1863; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; De Vuyst L., 2010, BIOTECHNOLOGY LACTIC, P301, DOI DOI 10.1002/9780813820866.CH17; Demirev PA, 2005, ANAL CHEM, V77, P7455, DOI 10.1021/ac051419g; Demirev PA, 1999, ANAL CHEM, V71, P2732, DOI 10.1021/ac990165u; Desmond C, 2004, APPL ENVIRON MICROB, V70, P5929, DOI 10.1128/AEM.70.10.5929-5936.2004; Duwat P, 2000, INT J FOOD MICROBIOL, V55, P83, DOI 10.1016/S0168-1605(00)00179-3; Eaton J. W., 2009, GNU OCTAVE VERSION 3; Eaton JW, 2003, INT WORKSH DISTR STA; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fadda S, 2010, INT J FOOD MICROBIOL, V142, P36, DOI 10.1016/j.ijfoodmicro.2010.05.014; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Flahaut S, 1997, APPL ENVIRON MICROB, V63, P812, DOI 10.1128/AEM.63.2.812-814.1997; Flahaut S, 1996, FEMS MICROBIOL LETT, V138, P49, DOI 10.1016/0378-1097(96)00080-8; Frank A, 2005, ANAL CHEM, V77, P964, DOI 10.1021/ac048788h; Giard JC, 1996, CURR MICROBIOL, V32, P264, DOI 10.1007/s002849900048; Glaasker E, 1996, J BACTERIOL, V178, P575, DOI 10.1128/jb.178.3.575-582.1996; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; HARTKE A, 1994, APPL ENVIRON MICROB, V60, P3474, DOI 10.1128/AEM.60.9.3474-3478.1994; Heller KJ, 2001, AM J CLIN NUTR, V73, p374S, DOI 10.1093/ajcn/73.2.374s; HENGGEARONIS R, 1993, CELL, V72, P165, DOI 10.1016/0092-8674(93)90655-A; Holland LM, 2011, MICROBIOL-SGM, V157, P408, DOI 10.1099/mic.0.042234-0; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Hormann S, 2006, PROTEOMICS, V6, P1878, DOI 10.1002/pmic.200402086; Hsieh SY, 2008, MOL CELL PROTEOMICS, V7, P448, DOI 10.1074/mcp.M700339-MCP200; Hug SM, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0457-3; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Johnson EA, 2003, MICROBIAL STRESS ADAPTATION AND FOOD SAFETY, P75; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jorgensen CM, 2004, EUR J BIOCHEM, V271, P2438, DOI 10.1111/j.1432-1033.2004.04168.x; Kahm M, 2010, J STAT SOFTW, V33, P1; KARAS M, 1990, TRAC-TREND ANAL CHEM, V9, P321, DOI 10.1016/0165-9936(90)85065-F; Karas M, 1993, SPECTROSCOPIC METHOD, P215; Katz FS, 2003, J BIOL CHEM, V278, P35889, DOI 10.1074/jbc.M305470200; Kern CC, 2013, J MICROBIOL METH, V93, P185, DOI 10.1016/j.mimet.2013.03.012; Kilstrup M, 1997, APPL ENVIRON MICROB, V63, P1826, DOI 10.1128/AEM.63.5.1826-1837.1997; KING VA, 1989, J FOOD SCI, V54, P1573, DOI 10.1111/j.1365-2621.1989.tb05163.x; Lacroix C, 2007, CURR OPIN BIOTECH, V18, P176, DOI 10.1016/j.copbio.2007.02.002; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; LIEBERMAN I, 1956, J BIOL CHEM, V222, P765; Lorca GL, 2001, CURR MICROBIOL, V42, P21, DOI 10.1007/s002840010172; Mantini D, 2010, J PROTEOMICS, V73, P562, DOI 10.1016/j.jprot.2009.11.004; Martin-Galiano AJ, 2005, MICROBIOL-SGM, V151, P3935, DOI 10.1099/mic.0.28238-0; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; McCarthy A, 2010, CHEM BIOL, V17, P675, DOI 10.1016/j.chembiol.2010.07.004; Meryman HT, 2007, TRANSFUSION, V47, P935, DOI 10.1111/j.1537-2995.2007.01212.x; MERYMAN HT, 1977, CRYOBIOLOGY, V14, P287, DOI 10.1016/0011-2240(77)90177-8; Minnig K, 2005, MICROBIOL-SGM, V151, P3041, DOI 10.1099/mic.0.28021-0; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Octave C., 2014, GNU OCT 3 8 1; Olszewski M, 2014, MICROBIOL RES, V169, P139, DOI 10.1016/j.micres.2013.07.010; Panoff JM, 2000, CRYOBIOLOGY, V40, P264, DOI 10.1006/cryo.2000.2240; Peel TN, 2015, DIAGN MICR INFEC DIS, V81, P163, DOI 10.1016/j.diagmicrobio.2014.11.015; Prasad J, 2003, APPL ENVIRON MICROB, V69, P917, DOI 10.1128/AEM.69.2.917-925.2003; PRUITT KM, 1979, GROWTH, V43, P19; QUIVEY RG, 1995, FEMS MICROBIOL LETT, V126, P257, DOI 10.1016/0378-1097(95)00019-2; RCore Team, 2020, R LANG ENV STAT COMP; Rodrigo MAM, 2014, J PHARMACEUT BIOMED, V95, P245, DOI 10.1016/j.jpba.2014.03.007; SALOTRA P, 1995, FEMS MICROBIOL LETT, V131, P57, DOI 10.1111/j.1574-6968.1995.tb07754.x; Sanders JW, 1999, FEMS MICROBIOL REV, V23, P483, DOI 10.1111/j.1574-6976.1999.tb00409.x; Santivarangkna C, 2007, BIOTECHNOL PROGR, V23, P302, DOI 10.1021/bp060268f; Scheyhing CH, 2004, LETT APPL MICROBIOL, V39, P284, DOI 10.1111/j.1472-765X.2004.01578.x; Schurr BC, 2015, FOOD MICROBIOL, V46, P501, DOI 10.1016/j.fm.2014.09.018; Serrazanetti DI, 2011, APPL ENVIRON MICROB, V77, P2656, DOI 10.1128/AEM.01826-10; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Soldo B, 2002, J BACTERIOL, V184, P4316, DOI 10.1128/JB.184.15.4316-4320.2002; Steffen SE, 2002, J BIOL CHEM, V277, P14493, DOI 10.1074/jbc.M112444200; Storz G, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P157; Svensater G, 2000, MICROBIOL-UK, V146, P107, DOI 10.1099/00221287-146-1-107; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Teunissen CE, 2011, MULT SCLER J, V17, P838, DOI 10.1177/1352458511399614; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Tymczyszyn EE, 2008, INT J FOOD MICROBIOL, V128, P342, DOI 10.1016/j.ijfoodmicro.2008.09.009; Usbeck JC, 2014, APPL MICROBIOL BIOT, V98, P3737, DOI 10.1007/s00253-014-5586-x; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; Vergara-Irigaray M, 2008, MICROBIOL-SGM, V154, P865, DOI 10.1099/mic.0.2007/013292-0; Vrancken G., 2010, BIOTECHNOL LACT ACID, P193; Walker DC, 1999, APPL ENVIRON MICROB, V65, P3033; Wang JX, 2014, FUNCT INTEGR GENOMIC, V14, P431, DOI 10.1007/s10142-014-0370-7; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; Wieme AD, 2014, INT J FOOD MICROBIOL, V185, P41, DOI 10.1016/j.ijfoodmicro.2014.05.003; Williams TL, 2003, J AM SOC MASS SPECTR, V14, P342, DOI 10.1016/S1044-0305(03)00065-5; Xu Q, 2011, COMP BIOCHEM PHYS B, V159, P92, DOI 10.1016/j.cbpb.2011.02.005; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	108	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165504	10.1371/journal.pone.0165504	http://dx.doi.org/10.1371/journal.pone.0165504			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783652	Green Submitted, Green Published, gold			2022-12-26	WOS:000389602800080
J	Wiberg-Itzel, E; Pembe, AB; Jarnbert-Pettersson, H; Norman, M; Wihlback, AC; Hoesli, I; Bernasconi, MT; Azria, E; Akerud, H; Darj, E				Wiberg-Itzel, Eva; Pembe, Andrea B.; Jarnbert-Pettersson, Hans; Norman, Margareta; Wihlback, Anna-Carin; Hoesli, Irene; Bernasconi, Monya Todesco; Azria, Elie; Akerud, Helena; Darj, Elisabet			Lactate in Amniotic Fluid: Predictor of Labor Outcome in Oxytocin-Augmented Primiparas' Deliveries	PLOS ONE			English	Article							ASSOCIATION; MORTALITY; DYSTOCIA; UTERUS; WOMEN; PH	Background One of the major complications related to delivery is labor dystocia, or an arrested labor progress. Many dystocic deliveries end vaginally after administration of oxytocin, but a large numbers of women with labor dystocia will undergo a long and unsafe parturition. As a result of the exertion required in labor, the uterus produces lactate. The uterine production of lactate is mirrored by the level of lactate in amniotic fluid (AFL). Objectives To evaluate whether the level of AFL, analysed in a sample of amniotic fluid collected vaginally at arrested labor when oxytocin was needed, could predict labor outcome in nulliparous deliveries. Methods A prospective multicentre study including 3000 healthy primiparous women all with a singleton pregnancy, gestational age 37 to 42 weeks and no maternal/fetal chronic and/or pregnancy-related conditions. A spontaneous onset of labor, regular contractions and cervical dilation >= 3 cm were required before the women were invited to take part in the study. Results AFL, analysed within 30 minutes before augmentation, provides information about delivery outcome. Sensitivity for an acute cesarean section according to high (>= 10.1 mmol/l) or low (< 10.1mmol/l) AFL values was 39.0% (95% CI; 27-50), specificity 90.3% (95% CI; 87-93) PPV 37.3% (95% CI; 27-48) and NPV was 91.0% (95% CI; 88-93). The overall percentage of correct predictions of delivery outcome when the AFL level was used was 83.7%. Deliveries with a high AFL-level correlated with delivery time > 12h (p = 0.04), post-partum fever (> 38 degrees C, p = 0.01) and post-partum haemorrhage > 1.5L (p = 0.04). Conclusion The AFL is a good predictor of delivery outcome in arrested nulliparous deliveries. Low levels of AFL may support the decision to continue a prolonged vaginal labor by augmentation with oxytocin. A high level of AFL correlates with operative interventions and post-partum complications.	[Wiberg-Itzel, Eva; Jarnbert-Pettersson, Hans] Soder Hosp, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Pembe, Andrea B.] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Norman, Margareta] Danderyd Hosp, Karolinska Inst, Stockholm, Sweden; [Wihlback, Anna-Carin] Umea Univ, Umea, Sweden; [Hoesli, Irene] Univ Basel, Basel, Switzerland; [Bernasconi, Monya Todesco] Kantonsspital, Aarau, Switzerland; [Azria, Elie] Hosp Bichat Claude Bernard, Paris, France; [Akerud, Helena; Darj, Elisabet] Uppsala Univ, KBH, Uppsala, Sweden; [Darj, Elisabet] Norwegian Univ Sci & Technol, Trondheim, Norway	Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Danderyds Hospital; Karolinska Institutet; Umea University; University of Basel; Kantonsspital Aarau AG (KSA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Uppsala University; Norwegian University of Science & Technology (NTNU)	Wiberg-Itzel, E (corresponding author), Soder Hosp, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden.	eva@itzel.eu	PEMBE, ANDREA BARNABAS/GLV-2523-2022; Wiberg-Itzel, Eva/AAO-4169-2021	PEMBE, ANDREA BARNABAS/0000-0002-8090-3298; Wiberg-Itzel, Eva/0000-0002-4835-9616; Azria, Elie/0000-0002-6159-6253	Bill and Melinda Gates Foundation, Grand Challenge Exploration round 6; Engqvist's Memorial Fund (Sweden); Johan and Jacob Soderberg Foundation (Sweden)	Bill and Melinda Gates Foundation, Grand Challenge Exploration round 6; Engqvist's Memorial Fund (Sweden); Johan and Jacob Soderberg Foundation (Sweden)	The study was funded by The Bill and Melinda Gates Foundation, Grand Challenge Exploration round 6. Further funders were Engqvist's Memorial Fund (Sweden) and the Johan and Jacob Soderberg Foundation (Sweden). The sponsors had no role in the design of the analysis, interpretation of the results, writing the report, or the decision to submit the manuscript for publication. The corresponding author had final responsibility for the decision to submit for publication.	Akerud H, 2009, AM J PHYSIOL-ENDOC M, V297, pE1414, DOI 10.1152/ajpendo.00458.2009; *AM COLL OBST GYN, 1996, INT J GYNECOL OBSTET, V53, P73; American College of Obstetricians and Gynecologists, 1995, ACOG TECHN B; [Anonymous], 1995, CHLINICAL B DYSTOCIA; Arrowsmith Sarah, 2010, Obstet Gynaecol Reprod Med, V20, P241; El-Hamamy E., 2005, CURR OBSTET GYNAECOL, V15, P1, DOI DOI 10.1016/J.CUR0BGYN.2004.09.001; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; FRIEDMAN EA, 1955, OBSTET GYNECOL, V6, P567, DOI 10.1097/00006250-195512000-00001; GREISS FC, 1965, AM J OBSTET GYNECOL, V93, P917, DOI 10.1016/0002-9378(65)90150-X; HEATON RC, 1992, PFLUG ARCH EUR J PHY, V422, P24, DOI 10.1007/BF00381509; Hoffman MK, 2006, OBSTET GYNECOL, V107, P1029, DOI 10.1097/01.AOG.0000210528.32940.c6; Johns NE, 2010, LANCET S2, V381, pS68, DOI [10.1016/s0140-6736(13)61322-7, DOI 10.1016/S0140-6736(13)61322-7]; Jonsson M, 2008, ACTA OBSTET GYN SCAN, V87, P745, DOI 10.1080/00016340802220352; Larcombe-McDouall J, 1999, J PHYSIOL-LONDON, V518, P783, DOI 10.1111/j.1469-7793.1999.0783p.x; Lavender T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005461.pub2; Lowe NK, 2007, J MIDWIFERY WOM HEAL, V52, P216, DOI 10.1016/j.jmwh.2007.03.003; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Marshall NE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.035; Murphy M, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.035; Selin L, 2008, ACTA OBSTET GYN SCAN, V87, P216, DOI 10.1080/00016340701837744; SHMIGOL AV, 1995, PFLUG ARCH EUR J PHY, V431, P135, DOI 10.1007/BF00374388; STUDD JWW, 1972, P ROY SOC MED, V65, P700, DOI 10.1177/003591577206500818; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; WHO, PART MAN LAB 1994; Wiberg-Itzel E, 2008, ACTA OBSTET GYN SCAN, V87, P924, DOI 10.1080/00016340802295636; Wiberg-Itzel E, 2014, ACTA OBSTET GYN SCAN, V93, P80, DOI 10.1111/aogs.12261; Wiberg-Itzel E, 2011, OBSTET GYNECOL, V118, P135, DOI 10.1097/AOG.0b013e318220c0d4; Wiberg-Itzel E, 2010, EUR J OBSTET GYN R B, V152, P34, DOI 10.1016/j.ejogrb.2010.05.005; Wray S, 2007, EXP PHYSIOL, V92, P621, DOI 10.1113/expphysiol.2007.038125; Wray S, 2014, EXP PHYSIOL, V99, P487, DOI 10.1113/expphysiol.2013.072819	32	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0161546	10.1371/journal.pone.0161546	http://dx.doi.org/10.1371/journal.pone.0161546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783611	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800009
J	Nicoletto, BB; Krolikowski, TC; Crispim, D; Canani, LH				Nicoletto, Brune Bellincanta; Krolikowski, Thaiana Cirino; Crispim, Daisy; Canani, Luis Henrique			Serum and Urinary Progranulin in Diabetic Kidney Disease	PLOS ONE			English	Article							EPITHELIN PRECURSOR; GROWTH-FACTOR; EXPRESSION; PGRN	Progranulin has been recognized as an adipokine related to obesity, insulin resistance and type 2 diabetes mellitus (T2DM). There are scarce data regarding progranulin and kidney disease, but there are some data linking diabetic kidney disease (DKD) and increased progranulin levels. We aimed to better describe the relationship between serum and urinary progranulin levels and DKD in T2DM. This is a case-control study including four groups of subjects: 1) Advanced DKD cases: T2DM patients with estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m(2); 2) Albuminuric DKD cases: T2DM patients with urinary albumin excretion (UAE) >= 30 mg/g creatinine and eGFR >= 60 mL/min/1.73m(2); 3) Diabetic controls: T2DM patients with UAE >30 mg/g creatinine and eGFR >= 60 mL/min/1.73m(2); and 4) Non-diabetic controls: individuals without T2DM. Progranulin was determined by enzyme-linked immunosorbent assay. One hundred and fourteen patients were included (23 advanced DKD cases, 25 albuminuric DKD cases, 40 diabetic controls and 26 non-diabetic controls). Serum progranulin was increased in advanced DKD compared to other groups [ 70.84 (59.04-83.16) vs. albuminuric cases 57.16 (42.24-67.38), diabetic controls 57.28 (42.08-70.47) and non-diabetic controls 44.54 (41.44-53.32) ng/mL; p<0.001]. Urinary progranulin was decreased in advanced DKD cases compared to albuminuric cases [ 10.62 (6.30-16.08) vs. 20.94 (12.35-30.22); diabetic controls 14.06 (9.88-20.82) and non-diabetic controls 13.51 (7.94-24.36) ng/mL; p = 0.017]. There was a positive correlation between serum progranulin and body mass index (r = 0.27; p = 0.004), waist circumference (r = 0.25; p = 0.007); body fat percentage (r = 0.20; p = 0.042), high-sensitive C reactive protein (r = 0.35; p<0.001) and interleukin-6 (r = 0.37; p<0.001) and a negative correlation with eGFR (r = -0.22; p = 0.023). Urinary progranulin was positively associated with albuminuria (r = 0.25; p = 0.010). In conclusion, progranulin is affected by a decrease in eGFR, being at a higher concentration in serum and lower in urine of DKD patients with T2DM and eGFR <60 mL/min/1.73m(2). It is also associated with markers of obesity and inflammation.	[Nicoletto, Brune Bellincanta; Crispim, Daisy; Canani, Luis Henrique] Univ Fed Rio Grande Sul UFRGS, Sch Med, Post Grad Med Sci Program Endocrinol, Porto Alegre, RS, Brazil; [Krolikowski, Thaiana Cirino] Univ Fed Rio Grande Sul UFRGS, Sch Med, Nutr Course, Porto Alegre, RS, Brazil; [Crispim, Daisy; Canani, Luis Henrique] Hosp Clin Porto Alegre, Div Endocrinol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Nicoletto, BB (corresponding author), Univ Fed Rio Grande Sul UFRGS, Sch Med, Post Grad Med Sci Program Endocrinol, Porto Alegre, RS, Brazil.	brunanicaletto@gmail.com	Crispim, Daisy/R-5170-2019; Canani, Luis H/G-9686-2012	Crispim, Daisy/0000-0001-5095-9269; Canani, Luis H/0000-0002-1813-4491	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - www.cnpq.br) and Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre (www.hcpa.edu.br). BBN, TCK and LHC are recipients of scholarships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS72, DOI 10.2337/dc16-S012; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; Delanghe JR, 2011, CLIN CHEM LAB MED, V49, P977, DOI 10.1515/CCLM.2011.167; Ebert T, 2015, KIDNEY INT, V88, P1197, DOI 10.1038/ki.2015.266; Hanas R, 2010, DIABETES RES CLIN PR, V90, P228, DOI 10.1016/j.diabres.2010.05.011; He ZH, 1999, CANCER RES, V59, P3222; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2002, CANCER RES, V62, P5590; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li HX, 2014, ENDOCRINOLOGY, V155, P3493, DOI 10.1210/en.2014-1058; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Monami G, 2009, AM J PATHOL, V174, P1037, DOI 10.2353/ajpath.2009.080735; Nguyen AD, 2013, TRENDS ENDOCRIN MET, V24, P597, DOI 10.1016/j.tem.2013.08.003; Nicoletto BB, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0112-6; Qu H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/360190; Richter J, 2013, DIABETES CARE, V36, P410, DOI 10.2337/dc12-0220; Schlatzer D, 2012, DIABETES CARE, V35, P549, DOI 10.2337/dc11-1491; Suenaga K, 1991, Nihon Jinzo Gakkai Shi, V33, P43; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Xu L, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/357279; Yokoyama H, 2012, DIABETOLOGIA, V55, P1911, DOI 10.1007/s00125-012-2536-y; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zhou M, 2015, KIDNEY INT, V87, P918, DOI 10.1038/ki.2014.403	31	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165177	10.1371/journal.pone.0165177	http://dx.doi.org/10.1371/journal.pone.0165177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776152	Green Published, gold, Green Submitted			2022-12-26	WOS:000389009200045
J	Boehm, E; Zornoza, M; Jourdain, AA; Magdalena, AD; Garcia-Consuegra, I; Merino, RT; Orduna, A; Martin, MA; Martinou, JC; De la Fuente, MA; Simarro, M				Boehm, Erik; Zornoza, Maria; Jourdain, Alexis A.; Delmiro Magdalena, Aitor; Garcia-Consuegra, Ines; Torres Merino, Rebeca; Orduna, Antonio; Martin, Miguel A.; Martinou, Jean-Claude; De la Fuente, Miguel A.; Simarro, Maria			Role of FAST Kinase Domains 3 (FASTKD3) in Post-transcriptional Regulation of Mitochondrial Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; RNA GRANULES; SUPERCOMPLEX; ORGANIZATION; MUTATION; TRANSLATION; COX7A2L; RAP	The Fas-activated serine/threonine kinase (FASTK) family of proteins has recently emerged as a central regulator of mitochondrial gene expression through the function of an unusual RNA-binding domain named RAP (for RNA-binding domain abundant in Apicomplexans), shared by all six members of the family. Here we describe the role of one of the less characterized members, FASTKD3, in mitochondrial RNA metabolism. First, we show that, in contrast to FASTK, FASTKD2, and FASTKD5, FASTKD3 does not localize in mitochondrial RNA granules, which are sites of processing and maturation of mtRNAs and ribosome biogenesis. Second, we generated FASTKD3 homozygous knockout cell lines by homologous recombination and observed that the absence of FASTKD3 resulted in increased steady-state levels and half-lives of a subset of mature mitochondrial mRNAs: ND2, ND3, CYTB, COX2, and ATP8/6. No aberrant processing of RNA precursors was observed. Rescue experiments demonstrated that RAP domain is required for FASTKD3 function in mRNA stability. Besides, we describe that FASTKD3 is required for efficient COX1 mRNA translation without altering mRNA levels, which results in a decrease in the steady-state levels of COX1 protein. This finding is associated with reduced mitochondrial complex IV assembly and activity. Our observations suggest that the function of this family of proteins goes beyond RNA processing and ribosome assembly and includes RNA stability and translation regulation within mitochondria.	[Boehm, Erik; Jourdain, Alexis A.; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Zornoza, Maria; Torres Merino, Rebeca; De la Fuente, Miguel A.] Univ Valladolid, Inst Biol & Genet Mol, Dept Biol Histol & Farmacol, Valladolid 47003, Spain; [Delmiro Magdalena, Aitor; Garcia-Consuegra, Ines; Martin, Miguel A.] Hosp Univ 12 Octubre i 12, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Inst Invest, U723, Madrid 28041, Spain; [Orduna, Antonio; Simarro, Maria] Fac Med, Dept Microbiol, Edificio Ciencias Salud, Valladolid 47005, Spain; [Simarro, Maria] Fac Enfermeria, Dept Enfermeria, Edificio Ciencias Salud,Avda Ramon & Cajal 7, Valladolid 47005, Spain; [Jourdain, Alexis A.] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA	University of Geneva; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Simarro, M (corresponding author), Fac Enfermeria, Dept Enfermeria, Edificio Ciencias Salud,Avda Ramon & Cajal 7, Valladolid 47005, Spain.	maria.simarro.grande@uva.es	de la Fuente, Miguel A/C-7478-2013; Delmiro Magdalena, Aitor/H-4769-2017; Orduna, Antonio/I-3498-2019; Martin, Miguel A/S-2758-2018; Jourdain, Alexis A./ABF-4838-2020; Orduna, Antonio/K-7325-2019; Simarro, Maria/M-3947-2015	de la Fuente, Miguel A/0000-0003-4619-8756; Martin, Miguel A/0000-0003-4741-772X; martinou, Jean-claude/0000-0002-9847-2051; Simarro, Maria/0000-0001-8917-7328; Jourdain, Alexis A./0000-0001-5321-6938	Consejeria de Sanidad JCyL [BIO/VA20/15, BIO/VA21/15]; Roche Diagnostics S.L.; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung [310030B_160257/1]; iGE3; State of Geneva	Consejeria de Sanidad JCyL; Roche Diagnostics S.L.; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); iGE3; State of Geneva	This work was supported by Consejeria de Sanidad JCyL Grants BIO/VA20/15 (to M. S.) and BIO/VA21/15 (to M. A. D. l. F.), Roche Diagnostics S.L. (to M. S.), the Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung Grant 310030B_160257/1 (to J. C. M.), iGE3, and the State of Geneva. The authors declare that they have no conflicts of interest with the contents of this article.	Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Enriquez JA, 2016, ANNU REV PHYSIOL, V78, P533, DOI 10.1146/annurev-physiol-021115-105031; Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Boulouis A, 2015, PLANT CELL, V27, P984, DOI 10.1105/tpc.15.00010; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Eberhard S, 2011, PLANT J, V67, P1055, DOI 10.1111/j.1365-313X.2011.04657.x; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jourdain AA, 2016, J CELL BIOL, V212, P611, DOI 10.1083/jcb.201507125; Jourdain AA, 2015, CELL REP, V10, P1110, DOI 10.1016/j.celrep.2015.01.063; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kleinknecht L, 2014, PLANT CELL, V26, P777, DOI 10.1105/tpc.114.122853; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lagouge M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005423; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lee I, 2004, TRENDS BIOCHEM SCI, V29, P567, DOI 10.1016/j.tibs.2004.09.005; Lefebvre-Legendre L, 2015, PLANT PHYSIOL, V167, P1527, DOI 10.1104/pp.114.253906; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Mourier A, 2014, CELL METAB, V20, P1069, DOI 10.1016/j.cmet.2014.11.005; Nagao A, 2008, METHOD ENZYMOL, V447, P489, DOI 10.1016/S0076-6879(08)02223-4; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Perez-Perez R, 2016, CELL REP, V16, P2387, DOI 10.1016/j.celrep.2016.07.081; Popow J, 2015, RNA, V21, P1873, DOI 10.1261/rna.052365.115; Rivier C, 2001, EMBO J, V20, P1765, DOI 10.1093/emboj/20.7.1765; Simarro M, 2007, P NATL ACAD SCI USA, V104, P11370, DOI 10.1073/pnas.0704964104; Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035; Xu F, 2008, BIOCHEM J, V416, P15, DOI 10.1042/BJ20080847; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	24	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25877	25887		10.1074/jbc.M116.730291	http://dx.doi.org/10.1074/jbc.M116.730291			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27789713	hybrid, Green Published			2022-12-26	WOS:000390345200011
J	Wang, XB; Wang, LF; Shangguan, Z				Wang, Xiubo; Wang, Lifang; Shangguan, Zhouping			Leaf Gas Exchange and Fluorescence of Two Winter Wheat Varieties in Response to Drought Stress and Nitrogen Supply	PLOS ONE			English	Article							WATER-USE EFFICIENCY; CHLOROPHYLL FLUORESCENCE; PHOTOSYSTEM-II; DURUM-WHEAT; PHOTOSYNTHESIS; L.; NUTRITION; CARBON; ROOT; PARAMETERS	Water and nitrogen supply are the two primary factors limiting productivity of wheat (Triticum aestivum L.). In our study, two winter wheat varieties, Xinong 979 and large-spike wheat, were evaluated for their physiological responses to different levels of nitrogen and water status during their seedling stage grown in a phytotron. Our results indicated that drought stress greatly reduced the net photosynthetic rate (P-n), transpiration rate (E), and stomatal conductance (G(s)), but with a greater increase in instantaneous water use efficiency (WUE). At the meantime, the nitrogen (N) supply improved photosynthetic efficiency under water deficit. Parameters inferred from chlorophyll a measurements, i.e., photochemical quenching coefficient (qP), the maximum photochemical efficiency (F-v/F-m), the quantum yield of photosystemII(Phi(PSII)), and the apparent photosynthetic electron transport rate (ETR) decreased under water stress at all nitrogen levels and declined in N-deficient plants. The root-shoot ratio (R/S) increased slightly with water stress at a low N level; the smallest root-shoot ratio was found at a high N level and moderate drought stress treatment. These results suggest that an appropriate nitrogen supply may be necessary to enhance drought resistance in wheat by improving photosynthetic efficiency and relieving photoinhibition under drought stress. However, an excessive N supply had no effect on drought resistance, which even showed an adverse effect on plant growth. Comparing the two cultivars, Xinong 979 has a stronger drought resistance compared with large-spike wheat under N deficiency.	[Shangguan, Zhouping] Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; Minist Water Resources, Yangling 712100, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources	Shangguan, Z (corresponding author), Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China.	shangguan@ms.iswc.ac.cn			National Natural Science Foundation of China [31370425]; National Key Technology RD Program [2015BAD22B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program)	The study was financially supported by the National Natural Science Foundation of China (31370425) and the National Key Technology R&D Program (2015BAD22B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdiyev T, 2016, AGRICULTURE FORESTRY, V62, DOI 10.17707/AgricultForest.62.1.16; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Carvalho P, 2014, J INTEGR PLANT BIOL, V56, P455, DOI 10.1111/jipb.12109; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Chen YH, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0069-4; DaMatta FM, 2002, TREES-STRUCT FUNCT, V16, P555, DOI 10.1007/s00468-002-0205-3; dos Santos CM, 2013, IND CROP PROD, V41, P203, DOI 10.1016/j.indcrop.2012.04.003; Elazab A, 2016, PLANTA, V244, P125, DOI 10.1007/s00425-016-2500-z; Elazab A, 2012, FUNCT PLANT BIOL, V39, P379, DOI 10.1071/FP11237; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; Hanachi S, 2014, PHOTOSYNTHETICA, V52, P57, DOI 10.1007/s11099-014-0007-z; Hura T, 2007, ACTA PHYSIOL PLANT, V29, P103, DOI 10.1007/s11738-006-0013-2; Kaur G, 2015, INT J AGRIC BIOL, V17, P531, DOI 10.17957/IJAB/17.3.14.539; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Lin YC, 2013, J INTEGR AGR, V12, P2164, DOI [10.1016/S2095-3119(13)60346-9, 10.1016/s2095-3119(13)60346-9]; Liu M., 2012, AFR J AGR RES, V7, P4751; Liu RX, 2008, AGR WATER MANAGE, V95, P1261, DOI 10.1016/j.agwat.2008.05.002; Lopes MS, 2006, PHYSIOL PLANTARUM, V126, P435, DOI 10.1111/j.1399-3054.2006.00595.x; Mardanov A, 1998, DEV PLANT SOIL SCI, V82, P147; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Miller AJ, 2005, PLANT SOIL, V274, P1, DOI 10.1007/s11104-004-0965-1; Ostroumov EE, 2014, ADV PHOTOSYNTH RESP, V40, P97, DOI 10.1007/978-94-017-9032-1_4; Pan J, 2012, J PHYS CHEM B, V116, P2014, DOI 10.1021/jp212441b; Pan X, 2011, PHOTOSYNTHETICA, V49, P309, DOI 10.1007/s11099-011-0031-1; Papageorgiou C., 2004, CHLOROPHYLL FLUORESC, P1, DOI DOI 10.1007/978-1-4020-3218-9_1; Papageorgiou GC, 2014, ADV PHOTOSYNTH RESP, V40, P1, DOI 10.1007/978-94-017-9032-1_1; Papageorgiou GC, 2011, J PHOTOCH PHOTOBIO B, V104, P258, DOI 10.1016/j.jphotobiol.2011.03.008; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Rouhi V, 2007, ENVIRON EXP BOT, V59, P117, DOI 10.1016/j.envexpbot.2005.10.001; Said SA, 2013, PHOTOSYNTHETICA, V51, P552, DOI 10.1007/s11099-013-0055-9; Shangguan ZP, 2004, BOT BULL ACAD SINICA, V45, P49; Shangguan ZP, 2000, J PLANT PHYSIOL, V156, P46, DOI 10.1016/S0176-1617(00)80271-0; Shangguan ZP, 2000, ENVIRON EXP BOT, V44, P141, DOI 10.1016/S0098-8472(00)00064-2; Shaw B, 2002, PLANT GROWTH REGUL, V37, P77, DOI 10.1023/A:1020381513976; Silva EN, 2010, J ARID ENVIRON, V74, P1130, DOI 10.1016/j.jaridenv.2010.05.036; Slabbert RM, 2011, PLANT PHYSIOL BIOCH, V49, P978, DOI 10.1016/j.plaphy.2011.05.001; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Tezara W, 2005, PHOTOSYNTHETICA, V43, P37, DOI 10.1007/s11099-005-7045-5; Tezara W, 1999, NATURE, V401, P914, DOI 10.1038/44842; Wang CY, 2014, FIELD CROP RES, V165, P138, DOI 10.1016/j.fcr.2014.04.011; Wang L, 2015, NEW ZEAL J CROP HORT, V43, P182, DOI 10.1080/01140671.2014.994644; Waraich EA, 2011, J PLANT NUTR, V34, P1867, DOI 10.1080/01904167.2011.600413; Wu FZ, 2008, PHOTOSYNTHETICA, V46, P40, DOI 10.1007/s11099-008-0008-x; Yin CY, 2006, PHOTOSYNTHETICA, V44, P62, DOI 10.1007/s11099-005-0159-y; Zhang XC, 2013, PHOTOSYNTHETICA, V51, P593, DOI 10.1007/s11099-013-0059-5; Zhao LJ, 2007, J PLANT NUTR, V30, P947, DOI 10.1080/15226510701375572; Zivcak M, 2014, PLANT SOIL ENVIRON, V60, P210, DOI 10.17221/73/2014-PSE	51	48	51	10	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165733	10.1371/journal.pone.0165733	http://dx.doi.org/10.1371/journal.pone.0165733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802318	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200047
J	Bot, SD; Mackenbach, JD; Nijpels, G; Lakerveld, J				Bot, Sandra D.; Mackenbach, Joreintje D.; Nijpels, Giel; Lakerveld, Jeroen			Association between Social Network Characteristics and Lifestyle Behaviours in Adults at Risk of Diabetes and Cardiovascular Disease	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; INTERVENTIONS; CONCORDANCE; PREVENTION; GUIDELINES; MORTALITY; SPOUSES; SUPPORT; HEALTH	Objectives In this exploratory study we examined the associations between several social network characteristics and lifestyle behaviours in adults at increased risk of diabetes and cardiovascular diseases. In addition, we explored whether similarities in lifestyle between individuals and their network members, or the level of social support perceived by these individuals, could explain these associations. Methods From the control group of the Hoorn Prevention Study, participants with high and low educational attainment were approached for a structured interview between April and August 2010. Inclusion was stopped when fifty adults agreed to participate. Participants and a selection of their network members (e.g. spouses, best friends, neighbours, colleagues) completed a questionnaire on healthy lifestyle that included questions on fruit and vegetable intake, daily physical activity and leisure-time sedentary behaviour. We first examined associations between network characteristics and lifestyle using regression analyses. Second, we assessed associations between network characteristics and social support, social support and lifestyle, and compared the participants' lifestyles to those of their network members using concordance correlation coefficients. Results Fifty adults (50/83 x 100 = 62% response) and 170 of their network members (170/192 x 100 = 89% response) participated in the study. Individuals with more close-knit relationships, more friends who live nearby, and a larger and denser network showed higher levels of vegetable consumption and physical activity, and lower levels of sedentary behaviour. Perceived social norms or perceived support for behavioural change were not related to healthy lifestyle. Except for spousal concordance for vegetable intake, the lifestyle of individuals and their network members were not alike. Conclusions Study results suggest that adults with a larger and denser social network have a healthier lifestyle. Underlying mechanisms for these associations should be further explored, as the current results suggest a minimal role for social support and modelling by network members.	[Bot, Sandra D.; Nijpels, Giel] VU Med Ctr Amsterdam, Dept Gen Practice & Elderly Care, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Mackenbach, Joreintje D.; Lakerveld, Jeroen] VU Med Ctr Amsterdam, Dept Epidemiol & Biostat, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bot, SD (corresponding author), VU Med Ctr Amsterdam, Dept Gen Practice & Elderly Care, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.	sdmbot@gmail.com	Mackenbach, Joreintje Dingena/U-9131-2019	Mackenbach, Joreintje Dingena/0000-0002-2783-721X; Lakerveld, Jeroen/0000-0002-8551-6748; Nijpels, Giel/0000-0002-3679-9710				Ajrouch KJ, 2005, J GERONTOL B-PSYCHOL, V60, pS311, DOI 10.1093/geronb/60.6.S311; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Angermayr L, 2010, ANN BEHAV MED, V40, P49, DOI 10.1007/s12160-010-9206-4; [Anonymous], 1999, NETWORKS GLOBAL VILL; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123; BOXMAN EAW, 1991, SOC NETWORKS, V13, P51, DOI 10.1016/0378-8733(91)90013-J; Chau JY, 2015, BRIT J SPORT MED, V49, P737, DOI 10.1136/bjsports-2012-091974; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; Curioni CC, 2005, INT J OBESITY, V29, P1168, DOI 10.1038/sj.ijo.0803015; de la Haye K, 2011, SOC SCI MED, V73, P719, DOI 10.1016/j.socscimed.2011.06.023; Emmons KM, 2007, HEALTH EDUC BEHAV, V34, P315, DOI 10.1177/1090198106288011; Fleming P, 2008, CAN FAM PHYSICIAN, V54, P1706; GIANNETTI VJ, 1985, SOC SCI MED, V20, P241, DOI 10.1016/0277-9536(85)90237-0; Hannon PA, 2003, APPETITE, V40, P77, DOI 10.1016/S0195-6663(02)00140-X; Hawe P, 2004, J EPIDEMIOL COMMUN H, V58, P971, DOI 10.1136/jech.2003.014530; Heritage Z, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-243; Huurre T, 2007, J AFFECT DISORDERS, V100, P55, DOI 10.1016/j.jad.2006.09.019; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Lakerveld J, 2013, PREV MED, V57, P351, DOI 10.1016/j.ypmed.2013.06.011; Lakerveld J, 2011, PATIENT EDUC COUNS, V85, pE53, DOI 10.1016/j.pec.2011.01.014; Lakerveld Jeroen, 2008, BMC Endocr Disord, V8, P6, DOI 10.1186/1472-6823-8-6; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Maia J, 2014, J SCI MED SPORT, V17, P381, DOI 10.1016/j.jsams.2013.09.004; MCCALLISTER L, 1978, SOCIOL METHOD RES, V7, P131, DOI 10.1177/004912417800700202; McLaughlin D, 2010, J HEALTH PSYCHOL, V15, P671, DOI 10.1177/1359105310368177; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; MOORE G, 1990, AM SOCIOL REV, V55, P726, DOI 10.2307/2095868; Pachucki MA, 2011, AM J PUBLIC HEALTH, V101, P2170, DOI 10.2105/AJPH.2011.300282; Potter J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071052; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Sawka KJ, 2014, ASS ASPECTS FRIENDSH, P2014, DOI [10.1155/2014/632689, DOI 10.1155/2014/632689]; Schwingshackl L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140846; Sedentary Behaviour Research Network (SBRN), WHAT IS SED BEH; Shelton RC, 2011, AM J PUBLIC HEALTH, V101, P2102, DOI 10.2105/AJPH.2010.196030; Slootmaker SM, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1139; Sorensen G, 2007, AM J PUBLIC HEALTH, V97, P1216, DOI 10.2105/AJPH.2006.088120; Spanier PA, 2001, CAN J PUBLIC HEALTH, V92, P210, DOI 10.1007/BF03404308; Stahl T, 2001, SOC SCI MED, V52, P1, DOI 10.1016/S0277-9536(00)00116-7; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Van der Gaag M. P. J., 2003, CREATION RETURNS SOC; van Lee L, 2016, EUR J CLIN NUTR, V70, P262, DOI 10.1038/ejcn.2015.163; Volker B., 2001, TIJDSCHRIFTVOOR SOCI, P337; von dem Knesebeck O, 2005, SOZ PRAVENTIV MED, V50, P311, DOI 10.1007/s00038-005-4045-y; Vonneilich N, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-43; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.x	56	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165041	10.1371/journal.pone.0165041	http://dx.doi.org/10.1371/journal.pone.0165041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6BX	27798709	gold, Green Submitted, Green Published			2022-12-26	WOS:000386711100018
J	Hendricks, C; Dubail, J; Brohee, L; Delforge, Y; Colige, A; Deroanne, C				Hendricks, Celine; Dubail, Johanne; Brohee, Laura; Delforge, Yves; Colige, Alain; Deroanne, Christophe			A Novel Physiological Glycosaminoglycan-Deficient Splice Variant of Neuropilin-1 Is Anti-Tumorigenic In Vitro and In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-CELLS; CANCER; RECEPTOR; IDENTIFICATION; EXPRESSION; INVASION; BINDING; ANGIOGENESIS; PROGRESSION	Neuropilin-1 (NRP1) is a transmembrane protein acting as a co-receptor for several growth factors and interacting with other proteins such as integrins and plexins/semaphorins. It is involved in axonal development, angiogenesis and cancer progression. Its primary mRNA is subjected to alternative splicing mechanisms generating different isoforms, some of which lack the transmembrane domain and display antagonist properties to NRP1 full size (FS). NRP1 is further post-translationally modified by the addition of glycosaminoglycans (GAG) side chains through an O-glycosylation site at serine(612). Here, we characterized a novel splice variant which has never been investigated, NRP1-Delta 7, differing from the NRP1-FS by a deletion of 7 amino acids occurring two residues downstream of the O-glycosylation site. This short sequence contains two aspartic residues critical for efficient glycosylation. As expected, the high molecular weight products appearing as a smear in SDS-PAGE and reflecting the presence of GAG in NRP1-FS were undetectable in the NRP1-Delta 7 protein. NRP1-Delta 7 mRNA was found expressed at an appreciable level, between 10 and 30% of the total NRP1, by various cells lines and tissues from human and murine origin. To investigate the biological properties of this isoform, we generated prostatic (PC3) and breast (MDA-MB-231) cancer cells able to express recombinant NRP1-FS or NRP1-Delta 7 in a doxycycline-inducible manner. Cells with increased expression of NRP1-Delta 7 were characterized in vitro by a significant reduction of proliferation, migration and anchorage-independent growth, while NRP1-FS had the expected opposite "pro-tumoral" effects. Upon VEGF-A(165) treatment, a lower internalization rate was observed for NRP1-Delta 7 than for NRP1-FS. Finally, we showed that NRP1-Delta 7 inhibited growth of prostatic tumors and their vascularization in vivo. This report identifies NRP1-Delta 7 as a splice variant displaying anti-tumorigenic properties in vitro and in vivo, emphasizing the need to consider this isoform in future studies.	[Hendricks, Celine; Dubail, Johanne; Brohee, Laura; Delforge, Yves; Colige, Alain; Deroanne, Christophe] Univ Liege, Lab Connect Tissues Biol, Tour Pathol, GIGA Canc, Sart Tilman Par Liege, Belgium	University of Liege	Colige, A (corresponding author), Univ Liege, Lab Connect Tissues Biol, Tour Pathol, GIGA Canc, Sart Tilman Par Liege, Belgium.	acolige@ulg.ac.be	Dubail, Johanne/AAB-1980-2021	Dubail, Johanne/0000-0001-9124-9765; Brohee, Laura/0000-0001-8498-1579	National Fund for Scientific Research, Belgium [7.4544.13F, 7.4546.15]; Centre Anticancereux of the University of Liege, Belgium; Research Concerted Actions of the University of Liege (ARC) [10/15-02]	National Fund for Scientific Research, Belgium(Fonds de la Recherche Scientifique - FNRS); Centre Anticancereux of the University of Liege, Belgium; Research Concerted Actions of the University of Liege (ARC)	This work was supported by grants from the National Fund for Scientific Research, Belgium (F.N.R.S-Televie, #7.4544.13F (CH) and #7.4546.15 (LB); http://www.fnrs.be/en/), from the Centre Anticancereux of the University of Liege, Belgium (http://www.fondsleonfredencq.be/) and from Research Concerted Actions of the University of Liege (ARC, #10/15-02 (YD); https://www.ulg.ac.be/cms/c_337341/fr/actions-de-rechercheconcertees-arc). AC is a Senior Research Associate and CD a Research Associate, both at the Belgian F.R.S.-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelder RE, 2002, CANCER RES, V62, P7203; Brohee L, 2015, ONCOTARGET, V6, P11264, DOI 10.18632/oncotarget.3595; Cackowski FC, 2004, GENOMICS, V84, P82, DOI 10.1016/j.ygeno.2004.02.001; Cao S, 2010, J CLIN INVEST, V120, P2379, DOI 10.1172/JCI41203; Delcombel R, 2013, ANGIOGENESIS, V16, P353, DOI 10.1007/s10456-012-9320-y; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Frankel P, 2008, EMBO REP, V9, P983, DOI 10.1038/embor.2008.151; Fukasawa M, 2007, CANCER BIOL THER, V6, P1173; Gabriel M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1259-0; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; LABOISSE CL, 1981, CANCER RES, V41, P310; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; Luo MN, 2016, CANCER LETT, V373, P1, DOI 10.1016/j.canlet.2016.01.010; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Nakayama M, 2013, EXP CELL RES, V319, P1340, DOI 10.1016/j.yexcr.2013.03.008; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Prud'homme GJ, 2012, ONCOTARGET, V3, P921, DOI 10.18632/oncotarget.626; Rizzolio S, 2012, CANCER RES, V72, P5801, DOI 10.1158/0008-5472.CAN-12-0995; Rossignol M, 2000, GENOMICS, V70, P211, DOI 10.1006/geno.2000.6381; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Tao Qi, 2003, Angiogenesis, V6, P39; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; West DC, 2005, J BIOL CHEM, V280, P13457, DOI 10.1074/jbc.M410924200; Yaqoob U, 2012, CANCER RES, V72, P4047, DOI 10.1158/0008-5472.CAN-11-3907; ZHANG LJ, 1995, J BIOL CHEM, V270, P27127, DOI 10.1074/jbc.270.45.27127	29	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165153	10.1371/journal.pone.0165153	http://dx.doi.org/10.1371/journal.pone.0165153			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798666	gold, Green Published, Green Submitted			2022-12-26	WOS:000386711100019
J	Hyun, SH; Ahn, HK; Lee, JH; Choi, JY; Kim, BT; Park, YH; Im, YH; Lee, JE; Nam, SJ; Lee, KH				Hyun, Seung Hyup; Ahn, Hee Kyung; Lee, Joo Hee; Choi, Joon Young; Kim, Byung-Tae; Park, Yeon Hee; Im, Young-Hyuck; Lee, Jeong Eon; Nam, Seok Jin; Lee, Kyung-Han			Body Mass Index with Tumor F-18-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; POOLED ANALYSIS; OBESITY; WOMEN; SURVIVAL; SUBTYPES; OUTCOMES; INSULIN; PREMENOPAUSAL; CHEMOTHERAPY	Purpose To investigate the combined prognostic impact of body mass index (BMI) and tumor standardized uptake value (SUV) measured on pretreatment 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in patients with breast cancer. Methods We evaluated a cohort of 332 patients with newly diagnosed breast cancer (stage I-III) who underwent pretreatment FDG PET/CT followed by curative resection. Patients were categorized as overweight (BMI >= 23 kg/m(2)) or normal weight (BMI < 23 kg/m(2)). Primary tumor maximum SUV was measured by FDG PET/CT. Associations between BMI and tumor SUV with disease recurrence were assessed using Cox regression models. Results Median follow-up was 39 months. There were 76 recurrences and 15 cancer-related deaths. Multivariable Cox regression analysis demonstrated that high tumor SUV (hazard ratio [HR] = 1.75; 95% CI, 1.02-3.02; P = 0.044) and overweight (HR = 1.84; 95% CI, 1.17-2.89; P = 0.008) were independent poor prognostic factors. Positive hormone receptor status was an independent predictor of favorable outcome (HR = 0.42; 95% CI, 0.26-0.68; P < 0.001). Overweight patients with high tumor SUV had a two-fold risk of recurrence compared to patients with normal weight or low tumor SUV after adjusting for clinical stage and tumor subtype (HR = 2.06; 95% CI, 1.30-3.27; P = 0.002). Conclusions In patients with breast cancer, higher tumor SUV was associated with a more adverse outcome particularly in overweight women. BMI status combined with tumor SUV data allows better risk-stratification of breast cancer, independent of clinical stage and tumor subtype.	[Hyun, Seung Hyup; Lee, Joo Hee; Choi, Joon Young; Kim, Byung-Tae; Lee, Kyung-Han] Sungkyunkwan Univ, Dept Nucl Med, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Ahn, Hee Kyung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Hematol & Oncol, Inchon, South Korea; [Park, Yeon Hee; Im, Young-Hyuck] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Lee, Jeong Eon; Nam, Seok Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Breast & Endocrine Surg,Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Gachon University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, KH (corresponding author), Sungkyunkwan Univ, Dept Nucl Med, Samsung Med Ctr, Sch Med, Seoul, South Korea.	khnm.lee@samsung.com	Choi, Joon Young/D-6140-2017		Samsung Corporation	Samsung Corporation(Samsung)	The authors received no specific funding for this work. Samsung Medical Center, which is administratively separate from the Samsung Corporation, provided support in the form of salaries for authors SHH, JHL, JYC, B-TK, YHP, Y-HI, JEL, SJN, and K-HL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahn S, 2014, BREAST CANCER RES, V16, P3418; Baba S, 2014, J NUCL MED, V55, P736, DOI 10.2967/jnumed.113.129395; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Basu S, 2008, CANCER-AM CANCER SOC, V112, P995, DOI 10.1002/cncr.23226; Berclaz G, 2004, ANN ONCOL, V15, P875, DOI 10.1093/annonc/mdh222; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Colleoni M, 2005, LANCET, V366, P1108, DOI 10.1016/S0140-6736(05)67110-3; Dawood S, 2012, CLIN BREAST CANCER, V12, P364, DOI 10.1016/j.clbc.2012.07.013; Vicente AMG, 2013, EUR J NUCL MED MOL I, V40, P1304, DOI 10.1007/s00259-013-2418-7; Goodwin PJ, 2012, J CLIN ONCOL, V30, P164, DOI 10.1200/JCO.2011.36.2723; Griggs JJ, 2005, ARCH INTERN MED, V165, P1267, DOI 10.1001/archinte.165.11.1267; Hair BY, 2015, CANCER EPIDEM BIOMAR, V24, P580, DOI 10.1158/1055-9965.EPI-14-1017; Horn J, 2014, INT J CANCER, V135, P2678, DOI 10.1002/ijc.28912; Kadoya T, 2013, BREAST CANCER RES TR, V141, P269, DOI 10.1007/s10549-013-2687-7; Kann S, 2014, GLAND SURG, V3, P181, DOI 10.3978/j.issn.2227-684X.2013.12.01; Koo HR, 2014, EUR RADIOL, V24, P610, DOI 10.1007/s00330-013-3037-1; Ladoire S, 2014, EUR J CANCER, V50, P506, DOI 10.1016/j.ejca.2013.11.013; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Loi S, 2005, CANCER EPIDEM BIOMAR, V14, P1686, DOI 10.1158/1055-9965.EPI-05-0042; Lu YN, 2011, J CLIN ONCOL, V29, P3358, DOI 10.1200/JCO.2010.34.2048; Maiti B, 2010, BREAST CANCER RES TR, V121, P479, DOI 10.1007/s10549-009-0591-y; Minicozzi P, 2013, EUR J CANCER, V49, P3881, DOI 10.1016/j.ejca.2013.08.004; Mowad R, 2013, J SURG RES, V184, P253, DOI 10.1016/j.jss.2013.05.037; Niraula S, 2012, BREAST CANCER RES TR, V134, P769, DOI 10.1007/s10549-012-2073-x; Pajares B, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3572; Pichard C, 2008, MATURITAS, V60, P19, DOI 10.1016/j.maturitas.2008.03.002; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Sparano JA, 2012, CANCER-AM CANCER SOC, V118, P5937, DOI 10.1002/cncr.27527; Strong AL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3569; Ueda S, 2008, JPN J CLIN ONCOL, V38, P250, DOI 10.1093/jjco/hyn019; URSIN G, 1995, EPIDEMIOLOGY, V6, P137, DOI 10.1097/00001648-199503000-00009; Yanai A, 2014, INT J CLIN ONCOL, V19, P467, DOI 10.1007/s10147-013-0585-y; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; Yang YZ, 2012, J MAMMARY GLAND BIOL, V17, P251, DOI 10.1007/s10911-012-9268-y	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165814	10.1371/journal.pone.0165814	http://dx.doi.org/10.1371/journal.pone.0165814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798667	Green Submitted, Green Published, gold			2022-12-26	WOS:000386711100069
J	Du Preez, C; Curtis, JMR; Clarke, ME				Du Preez, Cherisse; Curtis, Janelle M. R.; Clarke, M. Elizabeth			The Structure and Distribution of Benthic Communities on a Shallow Seamount (Cobb Seamount, Northeast Pacific Ocean)	PLOS ONE			English	Article							BRITISH-COLUMBIA; WATER CORALS; SEA; ECOLOGY; DEPTH; CIRCULATION; BIOLOGY	Partially owing to their isolation and remote distribution, research on seamounts is still in its infancy, with few comprehensive datasets and empirical evidence supporting or refuting prevailing ecological paradigms. As anthropogenic activity in the high seas increases, so does the need for better understanding of seamount ecosystems and factors that influence the distribution of sensitive benthic communities. This study used quantitative community analyses to detail the structure, diversity, and distribution of benthic mega-epifauna communities on Cobb Seamount, a shallow seamount in the Northeast Pacific Ocean. Underwater vehicles were used to visually survey the benthos and seafloor in similar to 1600 images (similar to 5 m(2) in size) between 34 and 1154 m depth. The analyses of 74 taxa from 11 phyla resulted in the identification of nine communities. Each community was typified by taxa considered to provide biological structure and/or be a primary producer. The majority of the community- defining taxa were either cold-water corals, sponges, or algae. Communities were generally distributed as bands encircling the seamount, and depth was consistently shown to be the strongest environmental proxy of the community-structuring processes. The remaining variability in community structure was partially explained by substrate type, rugosity, and slope. The study used environmental metrics, derived from ship-based multibeam bathymetry, to model the distribution of communities on the seamount. This model was successfully applied to map the distribution of communities on a 220 km(2) region of Cobb Seamount. The results of the study support the paradigms that seamounts are diversity 'hotspots', that the majority of seamount communities are at risk to disturbance from bottom fishing, and that seamounts are refugia for biota, while refuting the idea that seamounts have high endemism.	[Du Preez, Cherisse] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada; [Curtis, Janelle M. R.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada; [Clarke, M. Elizabeth] NOAA, Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Seattle, WA 98115 USA; [Du Preez, Cherisse] Penn State Univ, Dept Biol, State Coll, PA 16804 USA	Fisheries & Oceans Canada; Fisheries & Oceans Canada; National Oceanic Atmospheric Admin (NOAA) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Du Preez, C (corresponding author), Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada.; Du Preez, C (corresponding author), Penn State Univ, Dept Biol, State Coll, PA 16804 USA.	cpdupreez@hotmail.com		Du Preez, Cherisse/0000-0001-6239-2191	DFO's International Governance Strategy; NOM Fisheries' Deep Sea Coral Research and Technology Program; NOM Fisheries' Office of Science and Technology	DFO's International Governance Strategy; NOM Fisheries' Deep Sea Coral Research and Technology Program; NOM Fisheries' Office of Science and Technology	This research was supported by DFO's International Governance Strategy. Work conducted by NOAA was funded by NOM Fisheries' Deep Sea Coral Research and Technology Program and NOM Fisheries' Office of Science and Technology.	[Anonymous], 2005, FUNDAMENTALS ECOLOGY; [Anonymous], 1950, COMMERCIAL FISH REV, V12, P32; Baker E, 2013, DEEP SEA MIN COB RIC, V1C; Ban SS, 2016, GLOB ECOL CONSERV, V8, P41, DOI 10.1016/j.gecco.2016.07.004; BIRKELAND C, 1971, Northwest Science, V45, P193; Bo M, 2012, HYDROBIOLOGIA, V687, P163, DOI 10.1007/s10750-011-0964-1; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; Breiman L., 2001, MACH LEARN, V45, P5; Bryan TL, 2006, DEEP-SEA RES PT I, V53, P1865, DOI 10.1016/j.dsr.2006.09.006; Budinger T, 1960, TECHNICAL REPORT; BUDINGER TF, 1967, DEEP-SEA RES, V14, P191, DOI 10.1016/0011-7471(67)90005-8; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; BYRNE M, 1981, CAN J ZOOL, V59, P11, DOI 10.1139/z81-003; CAIRNS S D, 1992, Palaios, V7, P96, DOI 10.2307/3514799; Canessa R, 2003, CAN TECH REP FISH AQ; Cardigos F, 2005, CHEM GEOL, V224, P153, DOI 10.1016/j.chemgeo.2005.07.019; Chaytor JD, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001712; Clark MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029232; Clark MR, 2011, OCEAN COAST MANAGE, V54, P19, DOI 10.1016/j.ocecoaman.2010.10.006; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clarke ME, 2010, 2010 IEEE OES AUT UN; Codiga DL, 1997, J GEOPHYS RES-OCEANS, V102, P22993, DOI 10.1029/97JC01451; Curtis JM, 2012, CAN TECH REP FISH AQ; DESONIE DL, 1990, J GEOPHYS RES-SOLID, V95, P12697, DOI 10.1029/JB095iB08p12697; DeVogelaere AP, 2005, ERLANGEN EARTH C SER, P1189, DOI 10.1007/3-540-27673-4_61; Diekmann R, 2004, THESIS; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dolan MFJ, 2008, DEEP-SEA RES PT I, V55, P1564, DOI 10.1016/j.dsr.2008.06.010; Douglas D, 2011, 201103 OR DEP FISH W; DOWER J, 1992, DEEP-SEA RES, V39, P1139, DOI 10.1016/0198-0149(92)90061-W; Du Preez C, 2015, CAN TECH3122 FISH AQ; Du Preez C, 2014, THESIS; Du Preez C, 2015, LANDSCAPE ECOL, V30, P181, DOI 10.1007/s10980-014-0118-8; Du Preez C, 2011, MAR ECOL PROG SER, V425, P217, DOI 10.3354/meps09005; Dunn DC, 2009, MAR ECOL PROG SER, V377, P1, DOI 10.3354/meps07839; FAO, 2009, INT GUID MAN DEEP SE, p73p; FARROW GE, 1985, MAR GEOL, V65, P73, DOI 10.1016/0025-3227(85)90047-7; FREELAND H, 1994, DEEP-SEA RES PT I, V41, P1715, DOI 10.1016/0967-0637(94)90069-8; FUJITA T, 1988, DEEP-SEA RES, V35, P2029, DOI 10.1016/0198-0149(88)90123-9; Gaines, 2007, ENCY TIDEPOOLS ROCKY; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Harriague AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110880; Harris PT, 2012, ELSEV INSIGHT, P3, DOI 10.1016/B978-0-12-385140-6.00001-3; KENSLEY B, 1980, Annals of the South African Museum, V83, P13; Knudby A, 2014, SPECIES DISTRIBUTION; Krautter M, 2001, FACIES, V44, P265, DOI 10.1007/BF02668178; Long DJ, 2014, DEEP-SEA RES PT II, V99, P158, DOI 10.1016/j.dsr2.2013.05.032; McClain CR, 2015, MAR ECOL-EVOL PERSP, V36, P210, DOI 10.1111/maec.12136; McClain CR, 2010, MAR ECOL-EVOL PERSP, V31, P14, DOI 10.1111/j.1439-0485.2010.00367.x; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; MENARD HW, 1983, SCIENCE, V220, P913, DOI 10.1126/science.220.4600.913; Misic C, 2012, DEEP-SEA RES PT I, V67, P1, DOI 10.1016/j.dsr.2012.04.012; Neves BM, 2014, DEEP-SEA RES PT II, V99, P169, DOI 10.1016/j.dsr2.2013.05.026; North Pacific Fisheries Commission (NPFC), 2009, 6 INT M MAN HIGH SEA; NOWELL ARM, 1984, ANNU REV ECOL SYST, V15, P303, DOI 10.1146/annurev.es.15.110184.001511; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PARKER T, 1994, BIOL BULL-US, V187, P336, DOI 10.2307/1542290; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; PEARSON DE, 1993, FISH B-NOAA, V91, P573; Pereira GH, 2012, J COASTAL RES, V28, P261, DOI 10.2112/11T-00007.1; Pratt RM, 1967, J HOPKINS OCEANOGRAP, V3, P145; Puniwai NPF, 2002, THESIS; R Core Team, 2013, LANG ENV STAT COMP; Ramos M, 2016, MAR ECOL-EVOL PERSP, V37, P1057, DOI 10.1111/maec.12353; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; Rosenberg G, 2009, MALACOLOG 4 1 1 DATA; Round F.E., 1981, ECOLOGY ALGAE; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Ryan WBF, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002332; Sautya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016162; Schlacher TA, 2007, MAR ECOL PROG SER, V340, P73, DOI 10.3354/meps340073; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thresher R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085872; Tittensor DP, 2010, MAR ECOL-EVOL PERSP, V31, P212, DOI 10.1111/j.1439-0485.2010.00393.x; Tittley I, 2014, HELGOLAND MAR RES, V68, P307, DOI 10.1007/s10152-014-0391-6; U.N. General Assembly, 1982, CONV LAW SEA, DOI DOI 10.1111/j.1467-2979.2008.00310.x; Wagner D, 2012, ADV MAR BIOL, V63, P67, DOI 10.1016/B978-0-12-394282-1.00002-8; Wicksten MK, 2014, ZOOKEYS, P45, DOI 10.3897/zookeys.457.6280; WoRMS editorial board, 2016, WORLD REGISTER MARIN; Wright D. J., 2012, ARCGISBENTHIC TERRAI; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004	82	29	31	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165513	10.1371/journal.pone.0165513	http://dx.doi.org/10.1371/journal.pone.0165513			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792782	Green Published, Green Submitted, gold			2022-12-26	WOS:000389537000027
J	Menendez, CA; Accordino, SR; Gerbino, DC; Appignanesi, GA				Menendez, Cintia A.; Accordino, Sebastian R.; Gerbino, Dario C.; Appignanesi, Gustavo A.			Hydrogen Bond Dynamic Propensity Studies for Protein Binding and Drug Design	PLOS ONE			English	Article							P53 CORE DOMAIN; SMALL MOLECULES; LIGAND-BINDING; HYDROPHOBIC ENCLOSURE; RESCUE; MUTANT; MDM2; INTERFACES; INHIBITORS	We study the dynamic propensity of the backbone hydrogen bonds of the protein MDM2 (the natural regulator of the tumor suppressor p53) in order to determine its binding properties. This approach is fostered by the observation that certain backbone hydrogen bonds at the p53-binding site exhibit a dynamical propensity in simulations that differs markedly form their state-value (that is, formed/not formed) in the PDB structure of the apo protein. To this end, we conduct a series of hydrogen bond propensity calculations in different contexts: 1) computational alanine-scanning studies of the MDM2-p53 interface; 2) the formation of the complex of MDM2 with the disruptive small molecule Nutlin-3a (dissecting the contribution of the different molecular fragments) and 3) the binding of a series of small molecules (drugs) with different affinities for MDM2. Thus, the relevance of the hydrogen bond propensity analysis for protein binding studies and as a useful tool to complement existing methods for drug design and optimization will be made evident.	[Appignanesi, Gustavo A.] Univ Nacl Sur, INQUISUR UNS CONICET, Bahia Blanca, Buenos Aires, Argentina; Univ Nacl Sur, Dept Quim, Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; National University of the South	Appignanesi, GA (corresponding author), Univ Nacl Sur, INQUISUR UNS CONICET, Bahia Blanca, Buenos Aires, Argentina.	appignan@criba.edu.ar			CONICET; UNS	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNS	GM and DCG are research members of CONICET. CAM and SRA thank CONICET for a fellowship. Financial support from CONICET (PIP-2012-2014) and UNS (PGI-2014-2017) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accordino SR, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12059-0; Accordino SR, 2012, PROTEINS, V80, P1755, DOI 10.1002/prot.24069; Allen JG, 2009, J MED CHEM, V52, P7044, DOI 10.1021/jm900681h; Basse N, 2010, CHEM BIOL, V17, P46, DOI 10.1016/j.chembiol.2009.12.011; Sierra MB, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13062-7; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; Brown CJ, 2011, TRENDS PHARMACOL SCI, V32, P53, DOI 10.1016/j.tips.2010.11.004; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Case D.A., 2008, AMBER10; Ding K, 2005, J AM CHEM SOC, V127, P10130, DOI 10.1021/ja051147z; Fernandez A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.018102; Fernandez A, 2010, TRANSFORMATIVE CONCEPTS FOR DRUG DESIGN: TARGET WRAPPING, P1, DOI 10.1007/978-3-642-11792-3_1; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Kulp JL, 2011, J AM CHEM SOC, V133, P10740, DOI 10.1021/ja203929x; Menendez CA, 2015, EUR PHYS J E, V38, DOI 10.1140/epje/i2015-15107-3; Miyazaki M, 2013, BIOORG MED CHEM LETT, V23, P728, DOI 10.1016/j.bmcl.2012.11.091; Qvist J, 2008, P NATL ACAD SCI USA, V105, P6296, DOI 10.1073/pnas.0709844105; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang L, 2011, P NATL ACAD SCI USA, V108, P1326, DOI 10.1073/pnas.1016793108; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Young T, 2007, P NATL ACAD SCI USA, V104, P808, DOI 10.1073/pnas.0610202104	25	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165767	10.1371/journal.pone.0165767	http://dx.doi.org/10.1371/journal.pone.0165767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792778	Green Published, gold, Green Submitted			2022-12-26	WOS:000389537000049
J	Gu, CF; Wilson, MSC; Jessen, HJ; Saiardi, A; Shears, SB				Gu, Chunfang; Wilson, Miranda S. C.; Jessen, Henning J.; Saiardi, Adolfo; Shears, Stephen B.			Inositol Pyrophosphate Profiling of Two HCT116 Cell Lines Uncovers Variation in InsP(8) Levels	PLoS One			English	Article							BIS-DIPHOSPHOINOSITOL TETRAKISPHOSPHATE; ION CHROMATOGRAPHY; POLYPHOSPHATES; PHOSPHATES; KINASE; INSTABILITY; METABOLISM; TURNOVER; STRESS; GROWTH	The HCT116 cell line, which has a pseudo-diploid karotype, is a popular model in the fields of cancer cell biology, intestinal immunity, and inflammation. In the current study, we describe two batches of diverged HCT116 cells, which we designate as HCT116(NIH) and HCT116(UCL). Using both gel electrophoresis and HPLC, we show that HCT116(UCL)cells contain 6-fold higher levels of InsP(8) than HCT116(NIH) cells. This observation is significant because InsP(8) is one of a group of molecules collectively known as Inositol pyrophosphates' (PP-InsPs) highly 'energetic' and conserved regulators of cellular and organismal metabolism. Variability in the cellular levels of InsP(8) within divergent HCT116 cell lines could have impacted the phenotypic data obtained in previous studies. This difference in InsP(8) levels is more remarkable for being specific; levels of other inositol phosphates, and notably InsP(6) and 5-InsP(7), are very similar in both HCT116(NIH) and HCT116(UCL)-lines. We also developed a new HPLC procedure to record 1-InsP(7) levels directly (for the first time in any mammalian cell line); 1-InsP(7) comprised <2% of total InsP(7) in HCT116(NIH) and HCT116(UCL) lines. The elevated levels of InsP(8) in the HCT116(UCL) lines were not due to an increase in expression of the PP-InsP kinases (IP6Ks and PPIP5Ks), nor to a decrease in the capacity to dephosphorylate InsP(8). We discuss how the divergent PP-InsP profiles of the newly-designated HCT116(NIH) and HCT116(UCL) lines should be considered an important research opportunity: future studies using these two lines may uncover new features that regulate InsP(8)s turnover, and may also yield new directions for studying InsP(8) function.	[Gu, Chunfang; Shears, Stephen B.] NIEHS, Lab Signal Transduct, NIH, 101 TW Alexander Dr, Res Triangle Pk, NC 27709 USA; [Wilson, Miranda S. C.; Saiardi, Adolfo] UCL, Med Res Council Lab Mol Cell Biol, London, England; [Jessen, Henning J.] Albert Ludwigs Univ, Inst Organ Chem, Albertstr 21, D-79104 Freiburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of London; University College London; University of Freiburg	Shears, SB (corresponding author), NIEHS, Lab Signal Transduct, NIH, 101 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.; Saiardi, A (corresponding author), UCL, Med Res Council Lab Mol Cell Biol, London, England.	dmcbado@ucl.ac.uk; shears@niehs.nih.gov	Shears, Stephen B/C-6335-2019; Jessen, Henning/O-1157-2019; Wilson, Miranda/W-1453-2019; Jessen, Henning/F-5108-2014	Shears, Stephen B/0000-0001-7309-8916; Jessen, Henning/0000-0002-1025-9484; Wilson, Miranda/0000-0001-7521-4036; Jessen, Henning/0000-0002-1025-9484	UK Medical Research Council (MRC) [1201814]; Intramural Research Program of the NIH / National Institute of Environmental Health Sciences; Swiss National Science Foundation [PP00P2_157607]; Medical Research Council [MC_U122680443, MC_UU_12018/4] Funding Source: researchfish; MRC [MC_UU_12018/4, MC_U122680443] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural Research Program of the NIH / National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (MRC) core support to the MRC/UCL Laboratory for Molecular Cell Biology University Unit (MC UU 1201814), and by the Intramural Research Program of the NIH / National Institute of Environmental Health Sciences. HJJ acknowledges support from the Swiss National Science Foundation (grant number PP00P2_157607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Capes-Davis A, 2013, INT J CANCER, V132, P2510, DOI 10.1002/ijc.27931; Capolicchio S, 2014, ANGEW CHEM INT EDIT, V53, P9508, DOI 10.1002/anie.201404398; Capolicchio S, 2013, ANGEW CHEM INT EDIT, V52, P6912, DOI 10.1002/anie.201301092; Chen QC, 2003, J CHROMATOGR A, V1018, P41, DOI 10.1016/j.chroma.2003.08.040; Choi K, 2005, CELL SIGNAL, V17, P1533, DOI 10.1016/j.cellsig.2005.03.021; Choi K, 2008, MOL PHARMACOL, V74, P527, DOI 10.1124/mol.107.044628; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; Geraghty RJ, 2014, BRIT J CANCER, V111, P1021, DOI 10.1038/bjc.2014.166; Ingram SW, 2003, BIOCHEM J, V369, P519, DOI 10.1042/BJ20020733; Irvine RF, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150181; Kilari RS, 2013, FEBS LETT, V587, P3464, DOI 10.1016/j.febslet.2013.08.035; KOI M, 1994, CANCER RES, V54, P4308; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; LEE DP, 1984, J CHROMATOGR SCI, V22, P327, DOI 10.1093/chromsci/22.8.327; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; O'Gorman A, 2010, AM J PHYSIOL-GASTR L, V299, pG96, DOI 10.1152/ajpgi.00460.2009; Padmanabhan U, 2009, J BIOL CHEM, V284, P10571, DOI 10.1074/jbc.M900752200; Pavlovic I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10622; Pesesse X, 2004, J BIOL CHEM, V279, P43378, DOI 10.1074/jbc.C400286200; Pisani F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085533; Pulloor NK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003981; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao F, 2015, P NATL ACAD SCI USA, V112, P1773, DOI 10.1073/pnas.1424642112; Ribas M, 2002, FASEB J, V16, P289, DOI 10.1096/fj.02-0425fje; Safrany ST, 1998, EMBO J, V17, P1710, DOI 10.1093/emboj/17.6.1710; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Shears Stephen B, 2015, Adv Biol Regul, V57, P203, DOI 10.1016/j.jbior.2014.09.015; Shears SB, 2009, MOL PHARMACOL, V76, P236, DOI 10.1124/mol.109.055897; Shelor CP, 2015, ANAL CHEM, V87, P4851, DOI 10.1021/acs.analchem.5b00351; Steidle EA, 2016, J BIOL CHEM; WANG H., 2015, EURASIP J WIREL COMM, V2015, P1, DOI DOI 10.1016/J.TPLANTS.2015.04.003; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Wu MX, 2013, CHEM SCI, V4, P405, DOI 10.1039/c2sc21553e; Wundenberg T, 2012, BIOL CHEM, V393, P979, DOI 10.1515/hsz-2012-0133	45	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165286	10.1371/journal.pone.0165286	http://dx.doi.org/10.1371/journal.pone.0165286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788189	Green Submitted, gold, Green Published			2022-12-26	WOS:000389604900056
J	Wang, X; Feng, YM; Li, JL; Zhang, W; Wang, J; Lewis, RA; Wong, LJ				Wang, Xia; Feng, Yanming; Li, Jianli; Zhang, Wei; Wang, Jing; Lewis, Richard A.; Wong, Lee-Jun			Retinal Diseases Caused by Mutations in Genes Not Specifically Associated with the Clinical Diagnosis	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; LEBER CONGENITAL AMAUROSIS; COMPREHENSIVE MOLECULAR DIAGNOSIS; RETINITIS-PIGMENTOSA PATIENTS; X-LINKED RETINOSCHISIS; 157 FAMILIES; POPULATION; CAPTURE; PANEL; IDENTIFICATION	Purpose When seeking a confirmed molecular diagnosis in the research setting, patients with one descriptive diagnosis of retinal disease could carry pathogenic variants in genes not specifically associated with that description. However, this event has not been evaluated systematically in clinical diagnostic laboratories that validate fully all target genes to minimize false negatives/positives. Methods We performed targeted next-generation sequencing analysis on 207 ocular disease-related genes for 42 patients whose DNA had been tested negative for disease-specific panels of genes known to be associated with retinitis pigmentosa, Leber congenital amaurosis, or exudative vitreoretinopathy. Results Pathogenic variants, including single nucleotide variations and copy number variations, were identified in 9 patients, including 6 with variants in syndromic retinal disease genes and 3 whose molecular diagnosis could not be distinguished easily from their submitted clinical diagnosis, accounting for 21% (9/42) of the unsolved cases. Conclusion Our study underscores the clinical and genetic heterogeneity of retinal disorders and provides valuable reference to estimate the fraction of clinical samples whose retinal disorders could be explained by genes not specifically associated with the corresponding clinical diagnosis. Our data suggest that sequencing a larger set of retinal disorder related genes can increase the molecular diagnostic yield, especially for clinically hard-to-distinguish cases.	[Wang, Xia; Zhang, Wei; Wang, Jing; Lewis, Richard A.; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Feng, Yanming; Li, Jianli; Wong, Lee-Jun] Baylor Genet, Houston, TX USA; [Lewis, Richard A.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Wong, LJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Wong, LJ (corresponding author), Baylor Genet, Houston, TX USA.	ljwong@bcm.edu	Wang, Xia/O-4036-2014	Wang, Xia/0000-0002-7750-1167	Research to Prevent Blindness, New York	Research to Prevent Blindness, New York(Research to Prevent Blindness (RPB))	This work is partially supported by "Research to Prevent Blindness, New York" to RAL. The funder provided support in the form of salaries for author RAL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Al-Gazali L, 2010, HUM MUTAT, V31, P505, DOI 10.1002/humu.21232; [Anonymous], 1998, Hum Mol Genet, V7, P1185; Beales PL, 1999, J MED GENET, V36, P437; Billingsley G, 2010, J MED GENET, V47, P453, DOI 10.1136/jmg.2009.073205; Bravo-Gil N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23910; Chiang J, 2015, EXPERT REV MOL DIAGN, V15, P1269, DOI 10.1586/14737159.2015.1081057; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Consugar MB, 2015, GENET MED, V17, P253, DOI 10.1038/gim.2014.172; Coppieters F, 2012, GENET MED, V14, P576, DOI 10.1038/gim.2011.51; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Daiger SP, 2014, ADV EXP MED BIOL, V801, P123, DOI 10.1007/978-1-4614-3209-8_16; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Ellingford JM, 2015, LANCET, V385, P1916, DOI 10.1016/S0140-6736(15)60496-2; Estrada-Cuzcano A, 2012, ARCH OPHTHALMOL-CHIC, V130, P1425, DOI 10.1001/archophthalmol.2012.2434; Feng YM, 2015, GENET MED, V17, P99, DOI 10.1038/gim.2014.80; Gilmour DF, 2015, EYE, V29, P1, DOI 10.1038/eye.2014.70; Glockle N, 2014, EUR J HUM GENET, V22, P99, DOI 10.1038/ejhg.2013.72; Gonzalez-del Pozo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116176; Greven C M, 1990, Trans Am Ophthalmol Soc, V88, P211; Haim Marianne, 2002, Acta Ophthalmol Scand Suppl, P1; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Huang XF, 2015, GENET MED, V17, P307, DOI 10.1038/gim.2014.193; Imhoff O, 2011, CLIN J AM SOC NEPHRO, V6, P22, DOI 10.2215/CJN.03320410; Jackson H, 2001, BRIT J OPHTHALMOL, V85, P936, DOI 10.1136/bjo.85.8.936; Konrad M, 1996, HUM MOL GENET, V5, P367, DOI 10.1093/hmg/5.3.367; Liu XX, 2015, JAMA OPHTHALMOL, V133, P427, DOI 10.1001/jamaophthalmol.2014.5831; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Oishi M, 2014, INVEST OPHTH VIS SCI, V55, P7369, DOI 10.1167/iovs.14-15458; Perez-Carro R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19531; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Salvo J, 2015, INVEST OPHTH VIS SCI, V56, P1937, DOI 10.1167/iovs.14-16065; Seong MW, 2015, J MOL DIAGN, V17, P100, DOI 10.1016/j.jmoldx.2014.09.003; Shukla D, 2007, AM J OPHTHALMOL, V144, P419, DOI 10.1016/j.ajo.2007.05.016; Sikkink SK, 2007, J MED GENET, V44, P225, DOI 10.1136/jmg.2006.047340; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Wang J, 2014, INVEST OPHTH VIS SCI, V55, P6213, DOI 10.1167/iovs.14-14936; Wang J, 2012, MOL GENET METAB, V106, P221, DOI 10.1016/j.ymgme.2012.03.005; Wang X, 2013, J MED GENET, V50, P674, DOI 10.1136/jmedgenet-2013-101558; Weisschuh N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145951; Werdich XQ, 2014, SEMIN OPHTHALMOL, V29, P319, DOI 10.3109/08820538.2014.959202; Xu Yan, 2015, Mol Vis, V21, P477; Xu Y, 2014, HUM GENET, V133, P1255, DOI 10.1007/s00439-014-1460-2; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhao L, 2015, HUM GENET, V134, P217, DOI 10.1007/s00439-014-1512-7	53	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165405	10.1371/journal.pone.0165405	http://dx.doi.org/10.1371/journal.pone.0165405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788217	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900078
J	Macena, BCL; Hazin, FHV				Macena, Bruno C. L.; Hazin, Fabio H. V.			Whale Shark (Rhincodon typus) Seasonal Occurrence, Abundance and Demographic Structure in the Mid-Equatorial Atlantic Ocean	PLOS ONE			English	Article							SAINT-PAUL ARCHIPELAGO; WORLDS LARGEST FISH; NINGALOO REEF; REPRODUCTIVE-BIOLOGY; SATELLITE TRACKING; FORAGING ECOLOGY; POPULATION-SIZE; INDIAN-OCEAN; SAO-PAULO; PETER	Whale sharks are generally associated with environmental factors that drive their movements to specific locations where food availability is high. Consequently, foraging is believed to be the main reason for the formation of whale shark aggregations. Feeding aggregations occur mainly in nearshore areas and are composed primarily of immature individuals. Conversely, aggregations of mature adults are rarely observed, and their occurrence is correlated with oceanic environments. Despite an increase in the number of whale shark studies, information on mating and parturition grounds is still lacking. In the present work, we assessed the ecological and behavioural aspects of the whale sharks that visit the archipelago of Sao Pedro and Sao Paulo (ASPSP), located similar to 1,000 km off the coast of Brazil in the equatorial Atlantic Ocean. Forty-nine whale sharks were recorded from February 2005 to May 2014. The estimated mean +/- SD size was 8.27 +/- 2.52 m (range: 2.5-14.0 m) with no significant differences in size across the year. The maturational stages were classified by size as immature (<8.0 m; 32.56%) and mature (>9.0 m; 46.51%); with almost half of the observed animals being mature specimens. The majority of sightings occurred between February and June. During this period, the ocean current weakens and the waters are enriched by eggs and larvae of fishes and invertebrates that attract marine life to forage. At the same time, evidence of reproductive activity in adult females (i.e. swollen abdomen and bite marks on the pectoral fins), and the potential mating behaviour exhibited by one male, suggest that the ASPSP area might also have a role in whale shark reproduction. Irrespective of its use for feeding or reproduction, this insular habitat serves as a meeting point for both juvenile and adult whale sharks, and may play an important ecological role for the species.	[Macena, Bruno C. L.; Hazin, Fabio H. V.] Univ Fed Rural Pernambuco, Dept Pesca Aquicultura, Recife, PE, Brazil; [Macena, Bruno C. L.] Univ Fed Rural Pernambuco, Dept Oceanog, Recife, PE, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal Rural de Pernambuco (UFRPE)	Macena, BCL (corresponding author), Univ Fed Rural Pernambuco, Dept Pesca Aquicultura, Recife, PE, Brazil.; Macena, BCL (corresponding author), Univ Fed Rural Pernambuco, Dept Oceanog, Recife, PE, Brazil.	brunomacena@gmail.com	Macena, Bruno/ABD-2959-2021	Macena, Bruno/0000-0001-5010-8560	Secretaria da Comissao Interministerial para os Recursos do Mar (SECIRM/Brazilian Navy); Brazilian Council for Scientific and Technological Development (CNPq) [405460/2012-0]; Grupo Fundacao Boticario de Protecao a Natureza [0760_20072]; CNPq [140567/2012-7]	Secretaria da Comissao Interministerial para os Recursos do Mar (SECIRM/Brazilian Navy); Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Grupo Fundacao Boticario de Protecao a Natureza; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The Secretaria da Comissao Interministerial para os Recursos do Mar (SECIRM/Brazilian Navy; www.mar.mil.br/secirm/portugues/arquipelago) and Brazilian Council for Scientific and Technological Development (CNPq; www.cnpq.br) provided grant (#405460/2012-0; FHVH) for logistics and equipment through Pro-Arquipelago/Oceanic Islands Program. The Grupo Fundacao Boticario de Protecao a Natureza (www.fundacaogrupoboticario.org.br) provided grant (#0760_20072; FHVH) for equipment. The CNPq also provided the PhD scholarship grant (#140567/2012-7) for BCLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aca EQ, 2011, ASIA LIFE SCI, V20, P361; Acuna-Marrero D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115946; Afonso P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102060; Ara M., 2009, ARQUIPELAGO SAO PEDR, P106; Araujo G, 2014, PEERJ, V2, DOI 10.7717/peerj.543; Beckley LE, 1997, ENVIRON BIOL FISH, V50, P343, DOI 10.1023/A:1007355709632; Bezerra NPA, 2013, REV BIOL TROP, V61, P1327; Bonfil R, 2008, SHARKS OPEN OCEANS B; Bradshaw CJA, 2007, J ANIM ECOL, V76, P480, DOI 10.1111/j.1365-2656.2006.01201.x; Brandao MC, 2013, MAR ECOL-EVOL PERSP, V34, P171, DOI 10.1111/j.1439-0485.2012.00531.x; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Castro JI, 1996, B MAR SCI, V59, P508; Clingham E, 2016, PEERJ PREPRINTS, V4, DOI 10.7287/peerj.preprints.1885v1; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Compagno L. J. V., 2001, FAO SPECIES CATALOGU, V2; Davies TK, 2012, WILDLIFE RES, V39, P696, DOI 10.1071/WR12092; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Fox S, 2013, J FISH BIOL, V83, P574, DOI 10.1111/jfb.12195; Freire AS, 2011, HELGOLAND MAR RES, V65, P263, DOI 10.1007/s10152-010-0220-5; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; Gadig OBF, 2008, SERIE BIODIVERSIDADE, VII, P31; Genner MJ, 2010, J PLANKTON RES, V32, P699, DOI 10.1093/plankt/fbp082; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Gunn J., 1992, Australian Fisheries, V51, P22; Gunn JS, 1999, MAR BIOL, V135, P553, DOI 10.1007/s002270050656; Hazin FHV, 2008, BRAZ J BIOL, V68, P385, DOI 10.1590/S1519-69842008000200021; Hekinian R, 2000, MAR GEOPHYS RES, V21, P529, DOI 10.1023/A:1004819701870; Hekinian R., 1982, PETROLOGY OCEAN FLOO; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Holmberg J, 2008, ECOL APPL, V18, P222, DOI 10.1890/07-0315.1; Holmberg Jason, 2009, Endangered Species Research, V7, P39, DOI 10.3354/esr00186; Hsu HH, 2014, J FISH BIOL, V85, P1753, DOI 10.1111/jfb.12498; Hsu HH, 2012, J FISH BIOL, V80, P1595, DOI 10.1111/j.1095-8649.2012.03234.x; Hsu HH, 2014, MAR FRESHWATER RES, V65, P1145, DOI 10.1071/MF13330; Hsu HH, 2007, FISH RES, V84, P25, DOI 10.1016/j.fishres.2006.11.030; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; Ketchum JT, 2013, ENVIRON BIOL FISH, V96, P779, DOI 10.1007/s10641-012-0071-9; Kukuyev EI, 1996, J ICHTHYOLOGY, V36, P203; Kumari B, 2010, INT J REMOTE SENS, V31, P379, DOI 10.1080/01431160902893444; Lessa RP, 1999, ARCH FISH MAR RES, V47, P239; Dos Santos ACL, 2014, SCI MAR, V78, P363, DOI 10.3989/scimar.04013.08A; Lumpkin R, 2005, DEEP-SEA RES PT I, V52, P495, DOI 10.1016/j.dsr.2004.09.001; Macedo-Soares LCP, 2012, MAR ECOL PROG SER, V444, P207, DOI 10.3354/meps09436; Macedo-Soares L.C.P., 2009, ARQUIPELAGO SAO PEDR, P128; MacNeil MA, 2008, J FISH BIOL, V73, P1748, DOI 10.1111/j.1095-8649.2008.02067.x; Martin RA, 2007, FISH RES, V84, P10, DOI 10.1016/j.fishres.2006.11.010; Matsunaga H., 2003, 16 M STAND COMM TUN, V12, P1; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Mendonca Sibele A., 2012, Pan-American Journal of Aquatic Sciences, V7, P21; Ministerio do Meio Ambiente-MMA, 2004, INSTR NORM, V5; MOLINARI RL, 1986, PROG OCEANOGR, V16, P91, DOI 10.1016/0079-6611(86)90008-X; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Nelson JD, 2007, FISH RES, V84, P47, DOI 10.1016/j.fishres.2006.11.013; Norman BM, 2007, FISH RES, V84, P81, DOI 10.1016/j.fishres.2006.11.015; Oliveira G.M., 1997, B TECNICO CIENTIFICO, V5, P31; PAI M V, 1983, Indian Journal of Fisheries, V30, P157; Pankhurst NW, 2011, MAR FRESHWATER RES, V62, P1015, DOI 10.1071/MF10269; Pierce S. J., 2016, IUCN RED LIST THREAT, V2016; Pinheiro HT, 2009, ZOOTAXA, P45, DOI 10.11646/zootaxa.2298.1.3; Pinheiro PB, 2011, BRAZ J BIOL, V71, P99, DOI 10.1590/S1519-69842011000100015; Pratt HL, 2001, ENVIRON BIOL FISH, V60, P157; Pravin P, 2000, CURR SCI INDIA, V79, P310; Ramirez-Macias D, 2012, J FISH BIOL, V80, P1401, DOI 10.1111/j.1095-8649.2012.03258.x; Ramirez-Macias Deni, 2012, Endangered Species Research, V18, P115, DOI 10.3354/esr00437; Riley MJ, 2010, AQUAT BIOL, V8, P145, DOI 10.3354/ab00215; Rohner CA, 2013, MAR ECOL PROG SER, V482, P153, DOI 10.3354/meps10290; Rohner CA, 2011, J FISH BIOL, V78, P378, DOI 10.1111/j.1095-8649.2010.02861.x; Rohner CA, 2015, PEERJ, V3, DOI 10.7717/peerj.886; Rowat D, 2008, ENVIRON BIOL FISH, V82, P215, DOI 10.1007/s10641-007-9280-z; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2007, ENVIRON BIOL FISH, V80, P465, DOI 10.1007/s10641-006-9148-7; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Rowat D, 2009, ORYX, V43, P591, DOI 10.1017/S0030605309990408; Satyanarayana-Rao K, 1986, MAR FISH INF SERV TE, V66, P22; Schott FA, 1998, J PHYS OCEANOGR, V28, P1904, DOI 10.1175/1520-0485(1998)028<1904:TAPOTU>2.0.CO;2; Sequeira A, 2012, DIVERS DISTRIB, V18, P504, DOI 10.1111/j.1472-4642.2011.00853.x; Sequeira AMM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150668; Sequeira AMM, 2014, J EXP MAR BIOL ECOL, V450, P21, DOI 10.1016/j.jembe.2013.10.019; Sequeira AMM, 2013, MAR ECOL PROG SER, V478, P185, DOI 10.3354/meps10166; SIMPFENDORFER CA, 1992, AUST J MAR FRESH RES, V43, P67, DOI 10.1071/MF9920067; Sims DW, 2004, J ANIM ECOL, V73, P333, DOI 10.1111/j.0021-8790.2004.00810.x; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V390, P84, DOI 10.1016/j.jembe.2010.05.009; Soto Jules M.R., 2000, Biociencias, V8, P137; Speed CW, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-2; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; Stramma L, 1999, DEEP-SEA RES PT II, V46, P279, DOI 10.1016/S0967-0645(98)00109-X; Taylor J. G., 1999, Journal of the Royal Society of Western Australia, V82, P57; Taylor JG, 2007, FISH RES, V84, P65, DOI 10.1016/j.fishres.2006.11.014; Team RC, 2015, R LANG ENV STAT COMP; Travassos P, 1999, ARCH FISH MAR RES, V47, P211; Turnbull SD, 2006, NORTHEAST NAT, V13, P57, DOI 10.1656/1092-6194(2006)13[57:ROOART]2.0.CO;2; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; Vaske Teodoro Jr, 2003, Boletim do Instituto de Pesca (Sao Paulo), V29, P173; Vaske-Jr T, 1825, ELAGATIS BIPINNULATA; VIANA D, 2013, INT J PLANT ANIMAL S, V1, P49; Viana DF, 2015, BOL INST PESCA, V41, P239; Vianna GMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095565; von Brockel K, 1999, ARCH FISH MAR RES, V47, P223; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Ward-Paige CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025609; Wilson SG, 2001, ENVIRON BIOL FISH, V61, P1, DOI 10.1023/A:1011069914753; WOLFSON FH, 1983, J FISH BIOL, V22, P647, DOI 10.1111/j.1095-8649.1983.tb04224.x	105	24	25	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164440	10.1371/journal.pone.0164440	http://dx.doi.org/10.1371/journal.pone.0164440			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783634	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800040
J	Perez-Porcuna, TM; Pereira-da-Silva, HD; Ascaso, C; Malheiro, A; Buhrer, S; Martinez-Espinosa, F; Abellana, R				Maria Perez-Porcuna, Tomas; Doyle Pereira-da-Silva, Helio; Ascaso, Carlos; Malheiro, Adriana; Buhrer, Samira; Martinez-Espinosa, Flor; Abellana, Rosa			Prevalence and Diagnosis of Latent Tuberculosis Infection in Young Children in the Absence of a Gold Standard	PLOS ONE			English	Article							GAMMA-RELEASE ASSAY; MYCOBACTERIUM-TUBERCULOSIS; DISEASE; TESTS; METAANALYSIS; PERFORMANCE; COUNTRIES; UTILITY; AGE	Introduction For adequate disease control the World Health Organization has proposed the diagnosis and treatment of latent tuberculous infection (LTBI) in groups of risk of developing the disease such as children. There is no gold standard (GS) test for the diagnosis of LTBI. The objective of this study was to estimate the prevalence of LTBI in young children in contact with a household case of tuberculosis (TB-HCC) and determine the accuracy and precision of the Tuberculin Skin Test (TST) and QuantiFERON-TB Gold in-tube (QFT) used in the absence of a GS. Methods We conducted a cross-sectional study in children up to 6 years of age in Manaus/ Brazil during the years 2009-2010. All the children had been vaccinated with the BCG and were classified into two groups according to the presence of a TB-HCC or no known contact with tuberculosis (TB). The variables studied were: the TST and QFT results and the intensity and length of exposure to the index tuberculosis case. We used the latent class model to determine the prevalence of LTBI and the accuracy of the tests. Results Fifty percent of the children with TB-HCC had LTBI, with the prevalence depending on the intensity and length of exposure to the index case. The sensitivity and specificity of TST were 73% [95% confidence interval (CI): 53-91] and 97% (95% CI: 89-100), respectively, versus 53% (95% CI: 41-66) and 81% (95% CI: 71-90) for QFT. The positive predictive value of TST in children with TB-HCC was 91% (95% CI: 61-99), being 74% for QFT (95% CI: 47-95). Conclusions This is one of the first studies to estimate the prevalence of LTBI in children and the parameters of the main diagnostic tests using a latent class model. Our results suggest that children in contact with an index case have a high risk of infection. The accuracy and the predictive value of the two tests did not significantly differ. Combined use of the two tests showed scarce improvement in the diagnosis of LTBI.	[Maria Perez-Porcuna, Tomas; Doyle Pereira-da-Silva, Helio; Ascaso, Carlos; Abellana, Rosa] Univ Barcelona, Fac Med, Dept Salut Publ, Barcelona, Catalunya, Spain; [Maria Perez-Porcuna, Tomas] Hosp Univ Mutua Terrassa, Unitat Invest Fundacio Mutua Terrassa, CAP Valldoreix, Serv Pediat, Terrassa, Catalunya, Spain; [Ascaso, Carlos] Inst Invest Biomed August Pi & Sunyer, Barcelona, Catalunya, Spain; [Malheiro, Adriana] Fundacao Hematol & Hemoterapia Amazonas, Lab Multidisciplinar, Manaus, Amazonas, Brazil; [Malheiro, Adriana] Univ Fed Amazonas, Inst Ciencias Biol, Manaus, Amazonas, Brazil; [Buhrer, Samira] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [Martinez-Espinosa, Flor] Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Manaus, Amazonas, Brazil; [Martinez-Espinosa, Flor] Fundacao Oswaldo Cruz, Fiocruz Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil	University of Barcelona; Hospital Universitario Mutua Terrassa; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidade Federal de Amazonas; Universidade Federal de Goias; Fundacao Oswaldo Cruz	Perez-Porcuna, TM; Abellana, R (corresponding author), Univ Barcelona, Fac Med, Dept Salut Publ, Barcelona, Catalunya, Spain.; Perez-Porcuna, TM (corresponding author), Hosp Univ Mutua Terrassa, Unitat Invest Fundacio Mutua Terrassa, CAP Valldoreix, Serv Pediat, Terrassa, Catalunya, Spain.	tomas.perez.porcuna@gmail.com; rabellana@ub.edu	Abellana, Rosa/D-7305-2014	Abellana, Rosa/0000-0003-4487-4431; Perez-Porcuna, Tomas Maria/0000-0002-9951-7768; Ascaso Terren, Carlos/0000-0002-4895-7616				Bergamini BM, 2009, PEDIATRICS, V123, pe419, DOI 10.1542/peds.2008-1722; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; Cruz AT, 2014, CURR OPIN PEDIATR, V26, P106, DOI 10.1097/MOP.0000000000000049; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Gelman A, 1996, Stat Methods Med Res, V5, P339, DOI 10.1177/096228029600500402; Grare M, 2010, DIAGN MICR INFEC DIS, V66, P366, DOI 10.1016/j.diagmicrobio.2009.11.002; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Lewinsohn DA, 2008, PEDIATR RES, V63, P115, DOI 10.1203/PDR.0b013e3181652085; Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Martinez EZ, 2008, CANCER INFORM, V6, P33; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, INT J TUBERC LUNG D, V12, P895; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Perez-Porcuna TSM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097992; Ritz N, 2012, AM J RESP CRIT CARE, V185, P213, DOI 10.1164/rccm.201104-0714OC; Seddon JA, 2016, THORAX, V71, P932, DOI 10.1136/thoraxjnl-2015-207687; Sollai S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S6; Starke JR, 2014, PEDIATRICS, V134, pE1763, DOI 10.1542/peds.2014-2983; Starke JR, 2003, TUBERCULOSIS, V83, P208, DOI 10.1016/S1472-9792(02)00088-4; Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885; WHO, GLOB TUB REP 2014; World Health Organization, SYST SCREEN ACT TUB; World Health Organization, GUID NAT TUB PROGR M	29	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164181	10.1371/journal.pone.0164181	http://dx.doi.org/10.1371/journal.pone.0164181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783642	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800029
J	Yao, JJ; Zhou, GQ; Zhang, F; Zhang, WJ; Lin, L; Tang, LL; Mao, YP; Ma, J; Sun, Y				Yao, Jin-Jin; Zhou, Guan-Qun; Zhang, Fan; Zhang, Wang-Jian; Lin, Li; Tang, Ling-Long; Mao, Yan-Ping; Ma, Jun; Sun, Ying			Neoadjuvant and Concurrent Chemotherapy Have Varied Impacts on the Prognosis of Patients with the Ascending and Descending Types of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							INDUCTION CHEMOTHERAPY; CISPLATIN-RADIOTHERAPY; RADIATION-THERAPY; PHASE-III; CHEMORADIOTHERAPY; METAANALYSIS; SURVIVAL; TRIAL; EXPERIENCE; MANAGEMENT	Purpose To compare the outcomes of patients with ascending type (T4&N0-1) and descending type (T1-2&N3) of nasopharyngeal carcinoma (NPC) treated with concurrent chemoradiotherapy (CCRT), neoadjuvant chemotherapy (NACT) + intensity-modulated radiotherapy (RT) or NACT + CCRT. Methods Retrospective analysis of 839 patients with ascending or descending types of NPC treated at a single institution between October 2009 to February 2012. CCRT was delivered to 236 patients, NACT + RT to 302 patients, and NACT + CCRT to 301 patients. Results The 4-year overall survival rate, distant metastasis-free survival rate, local relapse-free survival rate, nodal relapse-free survival rate, loco-regional relapse-free survival rate, and progression free survival rate were 75.2% and 73.4% (P = 0.114), 85.7% and 74.1% (P = 0.008), 88.8% and 97.1% (P = 0.013), 96.9% and 94.1% (P = 0.122), 86.9% and 91.2% (P = 0.384), 73.7% and 66.2% (P = 0.063) in ascending type and descending type. Subgroup analyses indicated that NACT + RT significantly improved distant metastasis-free survival rate and progression-free survival rate when compared with CCRT in the ascending type, and there were no significant differences between the survival curves of NACT + RT and NACT + CCRT. For descending type, there were no significant differences among the survival curves of NACT + RT, CCRT, and NACT + CCRT groups, and the survival benefit mainly came from CCRT. Conclusions Compared with NACT + CCRT or CCRT, NACT + RT may be a reasonable approach for ascending type. Although concurrent chemotherapy was effective in descending type, NACT + CCRT may be a more appropriate strategy for descending type.	[Yao, Jin-Jin; Zhou, Guan-Qun; Lin, Li; Tang, Ling-Long; Mao, Yan-Ping; Ma, Jun; Sun, Ying] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Yao, Jin-Jin; Zhang, Fan] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Radiat Oncol, Zhuhai 519001, Guangdong, Peoples R China; [Zhang, Wang-Jian] Sun Yat Sen Univ, Sch Publ Hlth, Hlth Informat Res Ctr, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Wang-Jian] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Wang-Jian] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Key Lab Med, Guangzhou 510080, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Sun, Y (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China.	sunying@sysucc.org.cn	Zhang, Wang-Jian/K-2242-2019; Zhang, Wangjian/AAU-6705-2021	Zhang, Wangjian/0000-0001-9655-6385	Science and Technology Project of Guangzhou City, China [14570006]; National Natural Science Foundation of China [81372409, 81402532]; Sun Yatsen University Clinical Research 5010 Program [2012011]	Science and Technology Project of Guangzhou City, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun Yatsen University Clinical Research 5010 Program	This work was funded by the Science and Technology Project of Guangzhou City, China (No. 14570006), the National Natural Science Foundation of China (No.81372409), the Sun Yatsen University Clinical Research 5010 Program (No.2012011), and the National Natural Science Foundation of China (No.81402532)	Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Chan ATC, 2005, J NATL CANCER I, V97, P536, DOI 10.1093/jnci/dji084; Chen C, 2013, CANCER CHEMOTH PHARM, V71, P371, DOI 10.1007/s00280-012-2020-x; Chen JLY, 2013, STRAHLENTHER ONKOL, V189, P1001, DOI 10.1007/s00066-013-0429-8; Chen YP, 2015, J CANCER, V6, P883, DOI 10.7150/jca.11814; Chua DTT, 2005, J CLIN ONCOL, V23, P1118, DOI 10.1200/JCO.2005.12.081; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; El-Sherbieny E, 2011, ASIAN PAC J CANCER P, V12, P1739; Fan TY, 2013, ONCOL LETT, V5, P889, DOI 10.3892/ol.2013.1137; Hareyama M, 2002, CANCER, V94, P2217, DOI 10.1002/cncr.10473; Hsiung CY, 2002, INT J RADIAT ONCOL, V53, P638, DOI 10.1016/S0360-3016(02)02760-8; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Lin JC, 2004, INT J RADIAT ONCOL, V60, P156, DOI 10.1016/j.ijrobp.2004.03.002; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Lin SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-39; Lu TX, 2004, INT J RADIAT ONCOL, V58, P682, DOI 10.1016/S0360-3016(03)01508-6; Ma J, 2001, J CLIN ONCOL, V19, P1350, DOI 10.1200/JCO.2001.19.5.1350; National Comprehensive Cancer Network, 2008, HEAD NECK CANC VERS; Sun P, 2014, J BUON, V19, P474; Sun XM, 2014, RADIOTHER ONCOL, V110, P398, DOI 10.1016/j.radonc.2013.10.020; Sun XM, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-265; Teo PML, 1999, INT J RADIAT ONCOL, V43, P261, DOI 10.1016/S0360-3016(98)00383-6; Wei WI, 2000, CRIT REV ONCOL HEMAT, V33, P91, DOI 10.1016/S1040-8428(99)00069-4; Wong FCS, 2010, INT J RADIAT ONCOL, V76, P138, DOI 10.1016/j.ijrobp.2009.01.084; Xiao C, 2013, MOL CLIN ONCOL, V1, P507, DOI 10.3892/mco.2013.75; Yin L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137383; Zhang BL, 2015, ORAL ONCOL, V51, P1041, DOI 10.1016/j.oraloncology.2015.08.005; Zhang L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-558; Zhao C, 2015, RADIAT ONCOL, V10, P17, DOI [10.1186/s13014-014-0326-z, DOI 10.1186/S13014-014-0326-Z.]	33	6	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0161878	10.1371/journal.pone.0161878	http://dx.doi.org/10.1371/journal.pone.0161878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783618	Green Submitted, Green Published, gold			2022-12-26	WOS:000389602800010
J	Ren, H; Birch, NP; Suresh, V				Ren, Hui; Birch, Nigel P.; Suresh, Vinod			An Optimised Human Cell Culture Model for Alveolar Epithelial Transport	PLOS ONE			English	Article							IN-VITRO MODEL; SODIUM-CHANNELS; FLUID TRANSPORT; II CELLS; ENDOTHELIAL-CELLS; LUNG; CFTR; BARRIER; A549; EXPRESSION	Robust and reproducible in vitro models are required for investigating the pathways involved in fluid homeostasis in the human alveolar epithelium. We performed functional and phenotypic characterisation of ion transport in the human pulmonary epithelial cell lines NCI-H441 and A549 to determine their similarity to primary human alveolar type II cells. NCI-H441 cells exhibited high expression of junctional proteins ZO-1, and E-cadherin, seal-forming claudin-3, -4, -5 and Na+-K+-ATPase while A549 cells exhibited high expression of pore-forming claudin-2. Consistent with this phenotype NCI-H441, but not A549, cells formed a functional barrier with active ion transport characterised by higher electrical resistance (529 +/- 178 Omega cm(2) vs 28 +/- 4 Omega cm(2)), lower paracellular permeability ((176 +/- 42) x 10(-8) cm/s vs (738 +/- 190) x 10(-8) cm/s) and higher transepithelial potential difference (11.9 +/- 4 mV vs 0 mV). Phenotypic and functional properties of NCI-H441 cells were tuned by varying cell seeding density and supplement concentrations. The cells formed a polarised monolayer typical of in vivo epithelium at seeding densities of 100,000 cells per 12-well insert while higher densities resulted in multiple cell layers. Dexamethasone and insulin-transferrin-selenium supplements were required for the development of high levels of electrical resistance, potential difference and expression of claudin-3 and Na+-K(+)A-TPase. Treatment of NCI-H441 cells with inhibitors and agonists of sodium and chloride channels indicated sodium absorption through ENaC under baseline and forskolin-stimulated conditions. Chloride transport was not sensitive to inhibitors of the cystic fibrosis transmembrane conductance regulator (CFTR) under either condition. Channels inhibited by 5-nitro-1-(3-phenylpropylamino) benzoic acid (NPPB) contributed to chloride secretion following forskolin stimulation, but not at baseline. These data precisely define experimental conditions for the application of NCI-H441 cells as a model for investigating ion and water transport in the human alveolar epithelium and also identify the pathways of sodium and chloride transport.	[Ren, Hui; Suresh, Vinod] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand; [Ren, Hui; Birch, Nigel P.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Birch, Nigel P.] Univ Auckland, Ctr Brain Res, Auckland, New Zealand; [Birch, Nigel P.] Brain Res New Zealand, Auckland, New Zealand; [Suresh, Vinod] Univ Auckland, Dept Engn Sci, Auckland, New Zealand; [Suresh, Vinod] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland; University of Auckland	Ren, H (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand.; Ren, H (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	hren587@aucklanduni.ac.nz	Suresh, Vinod/D-2327-2010	Suresh, Vinod/0000-0002-7198-1446; Ren, Hui/0000-0002-0166-8614	Marsden Fund by the Royal Society of New Zealand [U0A1411]; Maurice Wilkins Centre for Molecular Biodiscovery by the Maurice Wilkins Centre; University of Auckland's Faculty Research Development Fund by the University of Auckland; Cross Faculty Research Initiatives by the University of Auckland; University of Auckland	Marsden Fund by the Royal Society of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); Maurice Wilkins Centre for Molecular Biodiscovery by the Maurice Wilkins Centre; University of Auckland's Faculty Research Development Fund by the University of Auckland; Cross Faculty Research Initiatives by the University of Auckland; University of Auckland	This research was supported by: 1) the Marsden Fund (grant U0A1411) by the Royal Society of New Zealand (Recipient: VS), http://www.royalsociety.org.nz/programmes/funds/marsden/; 2) the Maurice Wilkins Centre for Molecular Biodiscovery by the Maurice Wilkins Centre (Recipient: VS), http://www.mauricewilkinscentre.org/; 3) the University of Auckland's Faculty Research Development Fund and Cross Faculty Research Initiatives by the University of Auckland (Recipient: VS), http://www.auckland.ac.nz; 4) University of Auckland Doctoral Scholarship (Recipient: HR), http://www.auckland.ac.nz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus M, 2011, AM J RESP CELL MOL, V44, P53, DOI 10.1165/2009-0335OC; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Barok Z, 2000, J BIOL CHEM, V275, P26507, DOI 10.1074/jbc.M910007199; Blank F, 2006, J AEROSOL MED, V19, P392, DOI 10.1089/jam.2006.19.392; Bove PF, 2014, AM J RESP CELL MOL, V50, P767, DOI 10.1165/rcmb.2013-0071OC; Bove PF, 2010, J BIOL CHEM, V285, P34939, DOI 10.1074/jbc.M110.162933; Cerrada A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110195; Chen L, 2009, AM J RESP CELL MOL, V40, P588, DOI 10.1165/rcmb.2008-0034OC; Chen SP, 2005, J APPL PHYSIOL, V98, P322, DOI 10.1152/japplphysiol.00681.2004; Dagenais A, 2001, AM J PHYSIOL-LUNG C, V281, pL217, DOI 10.1152/ajplung.2001.281.1.L217; Dobbs LG, 2007, RESP PHYSIOL NEUROBI, V159, P283, DOI 10.1016/j.resp.2007.06.011; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Ehrhardt Carsten, 2008, V7, P258; Elbert KJ, 1999, PHARMACEUT RES, V16, P601, DOI 10.1023/A:1018887501927; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Fang XH, 2010, J BIOL CHEM, V285, P26211, DOI 10.1074/jbc.M110.119917; Farinha Carlos M, 2004, J Cyst Fibros, V3 Suppl 2, P73, DOI 10.1016/j.jcf.2004.05.017; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Guney S, 2007, AM J PHYSIOL-LUNG C, V293, pL1332, DOI 10.1152/ajplung.00338.2006; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; GUMBINER B, 1987, AM J PHYSIOL, V253, pC749, DOI 10.1152/ajpcell.1987.253.6.C749; Hamai H, 2009, J LIPID RES, V50, P1101, DOI 10.1194/jlr.M800427-JLR200; Han DY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-65; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hermanns MI, 2004, LAB INVEST, V84, P736, DOI 10.1038/labinvest.3700081; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Hu YJ, 2013, MOL BIOL REP, V40, P6123, DOI 10.1007/s11033-013-2724-y; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Hunter MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011598; Hwang TC, 1999, TRENDS PHARMACOL SCI, V20, P448, DOI 10.1016/S0165-6147(99)01386-3; Ingbar DH, 2009, AM J PHYSIOL-LUNG C, V297, pL813, DOI 10.1152/ajplung.00324.2009; Kopeikin Z, 2010, J GEN PHYSIOL, V136, P659, DOI 10.1085/jgp.201010518; Korbmacher JP, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.201; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Kulaksiz H, 2002, P NATL ACAD SCI USA, V99, P6796, DOI 10.1073/pnas.102171199; Lazrak A, 2003, AM J PHYSIOL-LUNG C, V285, pL443, DOI 10.1152/ajplung.00412.2002; Lazrak A, 2000, AM J PHYSIOL-LUNG C, V278, pL848, DOI 10.1152/ajplung.2000.278.4.L848; Leibel S, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00036; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Ma TH, 2000, J CLIN INVEST, V105, P93, DOI 10.1172/JCI8258; Mairbaurl H, 1997, AM J PHYSIOL-LUNG C, V273, pL797, DOI 10.1152/ajplung.1997.273.4.L797; Mitchell LA, 2011, AM J PHYSIOL-LUNG C, V301, pL40, DOI 10.1152/ajplung.00299.2010; Neuhaus W, 2012, DIFFERENTIATION, V84, P294, DOI 10.1016/j.diff.2012.08.006; Nie HG, 2009, J PHYSIOL-LONDON, V587, P2663, DOI 10.1113/jphysiol.2009.170324; Rehan VK, 2002, MOL GENET METAB, V76, P46, DOI 10.1016/S1096-7192(02)00022-7; Rene C, 2005, NUCLEIC ACIDS RES, V33, P5271, DOI 10.1093/nar/gki837; Rucka Z, 2013, INT J MOL MED, V32, P211, DOI 10.3892/ijmm.2013.1363; Salomon JJ, 2014, MOL PHARMACEUT, V11, P995, DOI 10.1021/mp4006535; Sartori C, 2002, EUR RESPIR J, V20, P1299, DOI 10.1183/09031936.02.00401602; Shlyonsky V, 2005, J BIOL CHEM, V280, P24181, DOI 10.1074/jbc.M413823200; Soini Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-70; Sporty JL, 2008, EXPERT OPIN DRUG MET, V4, P333, DOI [10.1517/17425255.4.4.333, 10.1517/17425255.4.4.333 ]; Verkman AS, 2007, RESP PHYSIOL NEUROBI, V159, P324, DOI 10.1016/j.resp.2007.02.012; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; Wang Q, 2007, KIDNEY INT, V72, P1448, DOI 10.1038/sj.ki.5002579; Wills NK, 2012, EPITHELIAL TRANSPORT; Woollhead AM, 2005, J PHYSIOL-LONDON, V566, P781, DOI 10.1113/jphysiol.2005.088674; Xu YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011004; Xu Y, 2010, EURASIP J WIREL COMM, DOI 10.1155/2010/818964; Yoshida Y, 2009, INVEST OPHTH VIS SCI, V50, P2103, DOI 10.1167/iovs.08-3046	60	57	58	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165225	10.1371/journal.pone.0165225	http://dx.doi.org/10.1371/journal.pone.0165225			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780255	Green Published, gold, Green Submitted			2022-12-26	WOS:000389046900037
J	Simonik, EA; Cai, Y; Kimmelshue, KN; Brantley-Sieders, DM; Loomans, HA; Andl, CD; Westlake, GM; Youngblood, VM; Chen, J; Yarbrough, WG; Brown, BT; Nagarajan, L; Brandt, SJ				Simonik, Elizabeth A.; Cai, Ying; Kimmelshue, Katherine N.; Brantley-Sieders, Dana M.; Loomans, Holli A.; Andl, Claudia D.; Westlake, Grant M.; Youngblood, Victoria M.; Chen, Jin; Yarbrough, Wendell G.; Brown, Brandee T.; Nagarajan, Lalitha; Brandt, Stephen J.			LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer)	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; STEM-CELLS; IN-VITRO; MOLECULAR PATHOGENESIS; MESENCHYMAL TRANSITION; GENE-EXPRESSION; TRANSCRIPTION; ANGIOGENESIS; LEUKEMIA; INVASION	Squamous cell carcinoma of the head and neck (HNSCC) accounts for more than 300,000 deaths worldwide per year as a consequence of tumor cell invasion of adjacent structures or metastasis. LIM-only protein 4 (LMO4) and LIM-domain binding protein 1 (LDB1), two directly interacting transcriptional adaptors that have important roles in normal epithelial cell differentiation, have been associated with increased metastasis, decreased differentiation, and shortened survival in carcinoma of the breast. Here, we implicate two LDB1-binding proteins, single-stranded binding protein 2 (SSBP2) and 3 (SSBP3), in controlling LMO4 and LDB1 protein abundance in HNSCC and in regulating specific tumor cell functions in this disease. First, we found that the relative abundance of LMO4, LDB1, and the two SSBPs correlated very significantly in a panel of human HNSCC cell lines. Second, expression of these proteins in tumor primaries and lymph nodes involved by metastasis were concordant in 3 of 3 sets of tissue. Third, using a Matrigel invasion and organotypic reconstruct assay, CRISPR/Cas9-mediated deletion of LDB1 in the VU-SCC-1729 cell line, which is highly invasive of basement membrane and cellular monolayers, reduced tumor cell invasiveness and migration, as well as proliferation on tissue culture plastic. Finally, inactivation of the LDB1 gene in these cells decreased growth and vascularization of xenografted human tumor cells in vivo. These data show that LMO4, LDB1, and SSBP2 and/or SSBP3 regulate metastasis, proliferation, and angiogenesis in HNSCC and provide the first evidence that SSBPs control LMO4 and LDB1 protein abundance in a cancer context.	[Simonik, Elizabeth A.; Cai, Ying; Loomans, Holli A.; Andl, Claudia D.; Youngblood, Victoria M.; Chen, Jin; Brandt, Stephen J.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Brantley-Sieders, Dana M.; Westlake, Grant M.; Chen, Jin; Brandt, Stephen J.] Vanderbilt Univ, Med Ctr, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kimmelshue, Katherine N.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Andl, Claudia D.] Vanderbilt Univ, Med Ctr, Dept Surg, 221 Kirkland Hall, Nashville, TN 37235 USA; [Chen, Jin; Brandt, Stephen J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Yarbrough, Wendell G.; Brown, Brandee T.] Vanderbilt Univ, Med Ctr, Dept Otolaryngol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Yarbrough, Wendell G.; Brown, Brandee T.] Vanderbilt Univ, Med Ctr, Barry Baker Lab Head & Neck Oncol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Chen, Jin; Yarbrough, Wendell G.; Brandt, Stephen J.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Chen, Jin; Brandt, Stephen J.] VA Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Nagarajan, Lalitha] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Yarbrough, Wendell G.] Yale Sch Med & Canc Ctr, Dept Surg, Otolaryngol Sect, New Haven, CT 06520 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of Texas System; UTMD Anderson Cancer Center	Brandt, SJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Brandt, SJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA.; Brandt, SJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Brandt, SJ (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.; Brandt, SJ (corresponding author), VA Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA.	stephen.brandt@vanderbilt.edu		Chen, Jin/0000-0002-5557-2079; Loomans-Kropp, Holli/0000-0002-9681-8725	NIH [5T32 CA009592-25, R01 CA148934]; Caridad Bolivar Bacardi Research and Fellowship Training Fund; Vanderbilt Ingram Cancer Center Starbrite award; VA Merit Review Awards; NCI Cancer Center Support Grant [P30 CA068485]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caridad Bolivar Bacardi Research and Fellowship Training Fund; Vanderbilt Ingram Cancer Center Starbrite award; VA Merit Review Awards(US Department of Veterans Affairs); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH training grant #5T32 CA009592-25 (to E.A.S.), the Caridad Bolivar Bacardi Research and Fellowship Training Fund (to E.A.S.), Vanderbilt Ingram Cancer Center Starbrite award (to S.J.B.), VA Merit Review Awards (to S.J.B. and J.C.), NCI Cancer Center Support Grant P30 CA068485 (to Vanderbilt Ingram Cancer Center), and NIH grant R01 CA148934 (to D.M.B.-S.). The views expressed in the article do not necessarily represent the views of the VA.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; ALBINI A, 1987, CANCER RES, V47, P3239; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Andl CD, 2010, NEOPLASIA, V12, P485, DOI 10.1593/neo.10216; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Armeanu-Ebinger S, 2011, INT J ONCOL, V38, P993, DOI 10.3892/ijo.2011.921; Bayarsaihan D, 1998, BIOCHEM J, V331, P447, DOI 10.1042/bj3310447; Benson E, 2014, ORAL ONCOL, V50, P565, DOI 10.1016/j.oraloncology.2013.09.008; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bjerkvig R, 2009, SEMIN CANCER BIOL, V19, P279, DOI 10.1016/j.semcancer.2009.09.001; Brantley-Sieders DM, 2011, CANCER RES, V71, P976, DOI 10.1158/0008-5472.CAN-10-3396; Cai Y, 2008, BIOCHEM BIOPH RES CO, V373, P303, DOI 10.1016/j.bbrc.2008.06.027; Chai RC, 2015, CANCER MED-US, V4, P596, DOI 10.1002/cam4.424; Dey-Guha I, 2009, INT J BIOL SCI, V5, P686; Du L, 2016, ONCOGENE, V35, P4641, DOI 10.1038/onc.2016.1; Du L, 2012, J ONCOL, V2012, DOI 10.1155/2012/450179; Duncan LD, 2013, J ORAL MAXIL SURG, V71, P1367, DOI 10.1016/j.joms.2013.02.019; Ferronha T, 2013, J NEUROSCI, V33, P2773, DOI 10.1523/JNEUROSCI.4511-12.2013; Floor S, 2011, ONCOGENE, V30, P4609, DOI 10.1038/onc.2011.184; Gungor C, 2007, P NATL ACAD SCI USA, V104, P15000, DOI 10.1073/pnas.0703738104; Ho YT, 2009, CANCER LETT, V279, P155, DOI 10.1016/j.canlet.2009.01.033; Kim SH, 2015, CELL DEATH DIFFER, V22, P1517, DOI 10.1038/cdd.2015.7; Kuo CL, 2014, ONCOL REP, V32, P355, DOI 10.3892/or.2014.3209; Kwong RA, 2011, HISTOPATHOLOGY, V58, P477, DOI 10.1111/j.1365-2559.2011.03765.x; Lee SK, 2005, MOL CELL NEUROSCI, V28, P205, DOI 10.1016/j.mcn.2004.04.010; Li J, 2014, J IMMUNOL, V193, P4654, DOI 10.4049/jimmunol.1300337; Li S, 2015, CANCER LETT, V357, P438, DOI 10.1016/j.canlet.2014.12.013; Li S, 2014, INT J ONCOL, V44, P1806, DOI 10.3892/ijo.2014.2362; Liang H, 2005, ONCOGENE, V24, P2625, DOI 10.1038/sj.onc.1208167; Liang LZ, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-325; Liu JW, 2008, CLIN CANCER RES, V14, P3754, DOI 10.1158/1078-0432.CCR-07-4763; Ma S, 2007, J PATHOL, V211, P278, DOI 10.1002/path.2109; Marur S, 2014, CURR OPIN ONCOL, V26, P252, DOI 10.1097/CCO.0000000000000072; Mizunuma H, 2003, BRIT J CANCER, V88, P1543, DOI 10.1038/sj.bjc.6600952; Montanez-Wiscovich ME, 2009, ONCOGENE, V28, P3608, DOI 10.1038/onc.2009.221; Ochoa SD, 2012, DEV BIOL, V361, P313, DOI 10.1016/j.ydbio.2011.10.034; Ohira M, 2005, CANCER LETT, V228, P5, DOI 10.1016/j.canlet.2005.01.054; Panwar A, 2014, CANCER TREAT REV, V40, P215, DOI 10.1016/j.ctrv.2013.09.006; Parfenov M, 2014, P NATL ACAD SCI USA, V111, P15544, DOI 10.1073/pnas.1416074111; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Sum EYM, 2005, P NATL ACAD SCI USA, V102, P7659, DOI 10.1073/pnas.0502990102; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Sun ZJ, 2010, HISTOPATHOLOGY, V57, P622, DOI 10.1111/j.1365-2559.2010.03676.x; Tian YP, 2010, CLIN EXP METASTAS, V27, P455, DOI 10.1007/s10585-010-9332-1; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Visvader JE, 1997, P NATL ACAD SCI USA, V94, P13707, DOI 10.1073/pnas.94.25.13707; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; White RA, 2010, ONCOGENE, V29, P5437, DOI 10.1038/onc.2010.306; Wu WS, 2014, GENOME RES, V24, P1945, DOI 10.1101/gr.164830.113; Xiao YY, 2012, CLIN CANCER RES, V18, P3154, DOI 10.1158/1078-0432.CCR-11-2778; Xu ZX, 2007, GENE DEV, V21, P942, DOI 10.1101/gad.1528507; Xu ZX, 2003, MOL CELL BIOL, V23, P7585, DOI 10.1128/MCB.23.21.7585-7599.2003; Yamada Y, 2002, ONCOGENE, V21, P1309, DOI 10.1038/sj.onc.1205285; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yamada Y, 2000, P NATL ACAD SCI USA, V97, P320, DOI 10.1073/pnas.97.1.320; Youngblood V, 2015, MOL CANCER RES, V13, P524, DOI 10.1158/1541-7786.MCR-14-0142; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang F., 2011, J METALLURGY, V14, DOI [10.1155/2011/563413, DOI 10.1038/NI.1978]	64	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164804	10.1371/journal.pone.0164804	http://dx.doi.org/10.1371/journal.pone.0164804			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780223	gold, Green Published, Green Submitted			2022-12-26	WOS:000389046900019
J	Chariker, JH; Miller, DM; Rouchka, EC				Chariker, Julia H.; Miller, Donald M.; Rouchka, Eric C.			Computational Analysis of G-Quadruplex Forming Sequences across Chromosomes Reveals High Density Patterns Near the Terminal Ends	PLOS ONE			English	Article							MESSENGER-RNA; G-QUARTET; DNA; SYNAPSIS; PROMOTER; INTRON; ROLES; IDENTIFICATION; PROTOONCOGENE; TELOMERASE	G-quadruplex structures (G4) are found throughout the human genome and are known to play a regulatory role in a variety of molecular processes. Structurally, they have many configurations and can form from one or more DNA strands. At the gene level, they regulate gene expression and protein synthesis. In this paper, chromosomal-level patterns of distribution are analyzed on the human genome to identify high-level distribution patterns potentially related to global functional processes. Here we show unique high density banding patterns on individual chromosomes that are highly correlated, appearing in a mirror pattern, across forward and reverse DNA strands. The highest density of G4 sequences occurs within four megabases of one end of most chromosomes and contains G4 motifs that bind with zinc finger proteins. These findings suggest that G4 may play a role in global chromosomal processes such as those found in meiosis.	[Chariker, Julia H.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; [Chariker, Julia H.; Rouchka, Eric C.] Univ Louisville, Kentucky Biomed Res Infrastruct Network Bioinform, Louisville, KY 40292 USA; [Miller, Donald M.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Miller, Donald M.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Rouchka, Eric C.] Univ Louisville, Dept Comp Engn & Comp Sci, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville	Rouchka, EC (corresponding author), Univ Louisville, Kentucky Biomed Res Infrastruct Network Bioinform, Louisville, KY 40292 USA.; Rouchka, EC (corresponding author), Univ Louisville, Dept Comp Engn & Comp Sci, Louisville, KY 40292 USA.	eric.rouchka@louisville.edu		Rouchka, Eric/0000-0003-3487-6572; Chariker, Julia/0000-0001-6805-7220	National Institutes of Health (NIH) National Institute of General Medical Sciences [P20GM103436, P20GM106396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health (NIH) National Institute of General Medical Sciences (https://www.nigms.nih.gov/) grants P20GM103436 (Nigel Cooper, PI) and P20GM106396 (Donald Miller, P1). The contents of this work are solely the responsibility of the authors and do not represent the official views of the NIH or the National Institute for General Medical Sciences (NIGMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adobe Photoshop CS5, AD PHOT CS5; ANSCOMBE FJ, 1973, AM STAT, V27, P17, DOI 10.2307/2682899; Arthanari H, 2001, CHEM BIOL, V8, P221, DOI 10.1016/S1074-5521(01)00007-2; Beaudoin JD, 2013, NUCLEIC ACIDS RES, V41, P5898, DOI 10.1093/nar/gkt265; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fisette JF, 2012, J NEUROCHEM, V121, P763, DOI 10.1111/j.1471-4159.2012.07680.x; Gomez D, 2004, NUCLEIC ACIDS RES, V32, P371, DOI 10.1093/nar/gkh181; Hawley RS, 2009, NAT CELL BIOL, V11, P917, DOI 10.1038/ncb0809-917; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kudlicki AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146174; Kumar P, 2011, NUCLEIC ACIDS RES; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; Maizels N, 2006, RSC BIOMOL SCI, P228; Marcel V, 2011, CARCINOGENESIS, V32, P271, DOI 10.1093/carcin/bgq253; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Petraccone L, 2013, TOP CURR CHEM, V330, P23, DOI 10.1007/128_2012_350; Phillips CM, 2006, DEV CELL, V11, P817, DOI 10.1016/j.devcel.2006.09.020; Phillips CM, 2009, NAT CELL BIOL, V11, P934, DOI 10.1038/ncb1904; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Qin M, 2015, J PHYS CHEM B; Ray S, 2014, P NATL ACAD SCI USA, V111, P2990, DOI 10.1073/pnas.1321436111; Ribeiro MM, 2015, HUM GENET, V134, P37, DOI 10.1007/s00439-014-1485-6; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Tsai ZT-Y, 2013, NUCLEIC ACIDS RES; Venczel EA, 1996, J MOL BIOL, V257, P219, DOI 10.1006/jmbi.1996.0157; von Hacht A, 2014, NUCLEIC ACIDS RES, V42, P6630, DOI 10.1093/nar/gku290; Wong HM, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/564946; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zerbino DR, 2016, DATABASE-OXFORD, DOI 10.1093/database/bav119; Zhang Y, 2014, RNA BIOL, V11, P1364, DOI 10.1080/15476286.2014.996464	48	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165101	10.1371/journal.pone.0165101	http://dx.doi.org/10.1371/journal.pone.0165101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776185	gold, Green Submitted, Green Published			2022-12-26	WOS:000389009200040
J	Ehlers, K; Bhide, AS; Tekleyohans, DG; Wittkop, B; Snowdon, RJ; Becker, A				Ehlers, Katrin; Bhide, Amey S.; Tekleyohans, Dawit G.; Wittkop, Benjamin; Snowdon, Rod J.; Becker, Annette			The MADS Box Genes ABS, SHP1, and SHP2 Are Essential for the Coordination of Cell Divisions in Ovule and Seed Coat Development and for Endosperm Formation in Arabidopsis thaliana	PLOS ONE			English	Article							REGULATORY FUNCTIONS; PROTEIN INTERACTIONS; SHATTERPROOF GENES; EMBRYO DEVELOPMENT; FLOWER DEVELOPMENT; MATERNAL CONTROL; DOMAIN PROTEIN; EXPRESSION; TRANSCRIPTION; SIZE	Seed formation is a pivotal process in plant reproduction and dispersal. It begins with megagametophyte development in the ovule, followed by fertilization and subsequently coordinated development of embryo, endosperm, and maternal seed coat. Two closely related MADS-box genes, SHATTERPROOF 1 and 2 (SHP1 and SHP2) are involved in specifying ovule integument identity in Arabidopsis thaliana. The MADS box gene ARABIDOPSIS BSISTER (ABS or TT16) is required, together with SEEDSTICK (STK) for the formation of endothelium, part of the seed coat and innermost tissue layer formed by the maternal plant. Little is known about the genetic interaction of SHP1 and SHP2 with ABS and the coordination of endosperm and seed coat development. In this work, mutant and expression analysis shed light on this aspect of concerted development. Triple tt16 shp1 shp2 mutants produce malformed seedlings, seed coat formation defects, fewer seeds, and mucilage reduction. While shp1 shp2 mutants fail to coordinate the timely development of ovules, tt16 mutants show less peripheral endosperm after fertilization. Failure in coordinated division of the innermost integument layer in early ovule stages leads to inner seed coat defects in tt16 and tt16 shp1 shp2 triple mutant seeds. An antagonistic action of ABS and SHP1/SHP2 is observed in inner seed coat layer formation. Expression analysis also indicates that ABS represses SHP1, SHP2, and FRUITFUL expression. Our work shows that the evolutionary conserved B-sister genes are required not only for endothelium but also for endosperm development and genetically interact with SHP1 and SHP2 in a partially antagonistic manner.	[Ehlers, Katrin; Bhide, Amey S.; Tekleyohans, Dawit G.; Becker, Annette] Justus Liebig Univ, Inst Bot, Heinrich Buff Ring 38, D-35392 Giessen, Germany; [Wittkop, Benjamin; Snowdon, Rod J.] Justus Liebig Univ, Dept Plant Breeding, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany; [Tekleyohans, Dawit G.] Univ Bremen, Dept Biol & Chem, Leobener Str 2, D-28359 Bremen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Bremen	Becker, A (corresponding author), Justus Liebig Univ, Inst Bot, Heinrich Buff Ring 38, D-35392 Giessen, Germany.	annette.becker@bot1.bio.uni-giessen.de	Becker, Annette/F-2355-2014; Becker, Annette/AAD-5156-2019	Becker, Annette/0000-0002-3229-2162; Becker, Annette/0000-0002-3229-2162; Tekleyohans, Dawit Girma/0000-0001-7383-5971	German Research Foundation (DFG) [BE 2547/8-1, BE2547/9-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Two grants from the German Research Foundation (DFG) funded the work included in this project: BE 2547/8-1 and BE2547/9-1 to Annette Becker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Claudia Jung-Blasini and Andrea Weisert for excellent technical support. The help of the imaging unit at the Biomedical Research Center Seltersberg (BFS) of the Justus Liebig University Giessen is highly appreciated. This work was supported by funding from the German Research Foundation (DFG) grant BE2547/8-1 and BE 2547/9-1 to A. Becker.	Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Becker A, 2000, MOL BIOL EVOL, V17, P1425, DOI 10.1093/oxfordjournals.molbev.a026243; Becker A, 2002, MOL GENET GENOMICS, V266, P942, DOI 10.1007/s00438-001-0615-8; Beeckman T, 2000, J PLANT RES, V113, P139, DOI 10.1007/PL00013924; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Berger F, 2003, CURR OPIN PLANT BIOL, V6, P42, DOI 10.1016/S1369526602000043; BOWMAN JL, 1991, PLANT CELL, V3, P749, DOI 10.1105/tpc.3.8.749; Chaudhury AM, 2001, SEMIN CELL DEV BIOL, V12, P381, DOI 10.1006/scdb.2001.0267; Chen G, 2012, BIOCATAL AGRIC BIOTE, V1, P203, DOI 10.1016/j.bcab.2012.03.012; Chen GQ, 2013, PLANT J, V74, P663, DOI 10.1111/tpj.12151; CLARK SE, 1993, DEVELOPMENT, V119, P397; Colombo M, 2010, DEV BIOL, V337, P294, DOI 10.1016/j.ydbio.2009.10.043; Costa LM, 2004, TRENDS PLANT SCI, V9, P507, DOI 10.1016/j.tplants.2004.08.007; Davis AM, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-3; Dean G, 2011, MOL PLANT, V4, P1074, DOI 10.1093/mp/ssr040; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Deng W, 2012, PLANT PHYSIOL, V160, P978, DOI 10.1104/pp.112.198713; Efremova N, 2004, PLANT MOL BIOL, V56, P821, DOI 10.1007/s11103-004-5576-y; Erdmann R, 2010, PLANT J, V63, P914, DOI 10.1111/j.1365-313X.2010.04290.x; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Ferrandiz C, 1999, ANNU REV BIOCHEM, V68, P321, DOI 10.1146/annurev.biochem.68.1.321; Flanagan CA, 1996, PLANT J, V10, P343, DOI 10.1046/j.1365-313X.1996.10020343.x; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Francoz E, 2015, TRENDS PLANT SCI, V20, P515, DOI 10.1016/j.tplants.2015.04.008; Garcia D, 2005, PLANT CELL, V17, P52, DOI 10.1105/tpc.104.027136; Garcia D, 2003, PLANT PHYSIOL, V131, P1661, DOI 10.1104/pp.102.018762; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; Guignard L, 1899, REV GEN BOT, V11, P129; Hehenberger E, 2012, DEVELOPMENT, V139, P2031, DOI 10.1242/dev.077057; Ingouff M, 2006, PLANT CELL, V18, P3491, DOI 10.1105/tpc.106.047266; Kaufmann K, 2005, MOL GENET GENOMICS, V274, P103, DOI 10.1007/s00438-005-0010-y; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Khan D, 2014, PLANT SCI, V223, P146, DOI 10.1016/j.plantsci.2014.03.016; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Lee DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058748; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Mizzotti C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004856; Mizzotti C, 2012, PLANT J, V70, P409, DOI 10.1111/j.1365-313X.2011.04878.x; Nakamura S, 2010, BIOSCI BIOTECH BIOCH, V74, P1315, DOI 10.1271/bbb.100184; Nawaschin S., 1898, B IMP ACAD SCI, V9, P377; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; North HM, 2014, ANN BOT-LONDON, V114, P1251, DOI 10.1093/aob/mcu011; O'Maoileidigh DS, 2013, PLANT CELL, V25, P2482, DOI 10.1105/tpc.113.113209; O'Maoileidigh DS, 2014, NEW PHYTOL, V201, P16, DOI 10.1111/nph.12444; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Orozco-Arroyo G, 2015, PLANT REPROD, V28, P17, DOI 10.1007/s00497-015-0255-5; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; PETERSON CM, 1989, AGRON J, V81, P245, DOI 10.2134/agronj1989.00021962008100020022x; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Ray S, 1996, DEV BIOL, V180, P365, DOI 10.1006/dbio.1996.0309; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Roszak P, 2011, P NATL ACAD SCI USA, V108, P20826, DOI 10.1073/pnas.1117111108; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stadler R, 2005, PLANT PHYSIOL, V139, P701, DOI 10.1104/pp.105.065607; Stangeland B, 2003, J EXP BOT, V54, P279, DOI 10.1093/jxb/54.381.279; ten Hove CA, 2015, DEVELOPMENT, V142, P420, DOI 10.1242/dev.111500; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Weigel D., 2002, ARABIDOPSIS LAB MANU; Xu WJ, 2016, PLANT CELL, V28, P1343, DOI 10.1105/tpc.16.00041; YADEGARI R, 1994, PLANT CELL, V6, P1713, DOI 10.1105/tpc.6.12.1713; Yang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051435; Yin LL, 2012, PLANT CELL, V24, P1049, DOI 10.1105/tpc.111.094854; Zahn LM, 2006, EVOL DEV, V8, P30, DOI 10.1111/j.1525-142X.2006.05073.x; Zheng YM, 2009, PLANT CELL, V21, P2563, DOI 10.1105/tpc.109.068890	72	38	43	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165075	10.1371/journal.pone.0165075	http://dx.doi.org/10.1371/journal.pone.0165075			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776173	gold, Green Published, Green Submitted			2022-12-26	WOS:000389009200038
J	Mita, P; Savas, JN; Briggs, EM; Ha, S; Gnanakkan, V; Yates, JR; Robins, DM; David, G; Boeke, JD; Garabedian, MJ; Logan, SK				Mita, Paolo; Savas, Jeffrey N.; Briggs, Erica M.; Ha, Susan; Gnanakkan, Veena; Yates, John R.; Robins, Diane M.; David, Gregory; Boeke, Jef D.; Garabedian, Michael J.; Logan, Susan K.			URI Regulates KAP1 Phosphorylation and Transcriptional Repression via PP2A Phosphatase in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; prostate cancer; protein phosphatase 2 (PP2A); transcription regulation; transcription repressor; unconventional prefoldin RPB5 interactor (URI)	ANTISENSE PROMOTER; BINDING-PROTEIN; GENES; EXPRESSION; RETROTRANSPOSITION; METHYLTRANSFERASE; RETROELEMENTS; COMPLEXES; ELEMENTS; SUBUNIT	URI (unconventional prefoldin RPB5 interactor protein) is an unconventional prefoldin, RNA polymerase II interactor that functions as a transcriptional repressor and is part of a larger nuclear protein complex. The components of this complex and the mechanism of transcriptional repression have not been characterized. Here we show that KAP1 (KRAB-associated protein 1) and the protein phosphatase PP2A interact with URI. Mechanistically, we show that KAP1 phosphorylation is decreased following recruitment of PP2A by URI. We functionally characterize the novel URI-KAP1-PP2A complex, demonstrating a role of URI in retrotransposon repression, a key function previously demonstrated for the KAP1-SETDB1 complex. Microarray analysis of annotated transposons revealed a selective increase in the transcription of LINE-1 and L1PA2 retroelements upon knockdown of URI. These data unveil a new nuclear function of URI and identify a novel post-transcriptional regulation of KAP1 protein that may have important implications in reactivation of transposable elements in prostate cancer cells.	[Mita, Paolo; Boeke, Jef D.] NYU, Sch Med, Inst Syst Genet, New York, NY 10016 USA; [Mita, Paolo; Briggs, Erica M.; Ha, Susan; David, Gregory; Boeke, Jef D.; Logan, Susan K.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, 550 First Ave,MSB424, New York, NY 10016 USA; [Ha, Susan; Garabedian, Michael J.; Logan, Susan K.] NYU, Sch Med, Dept Urol, 550 First Ave,MSB424, New York, NY 10016 USA; [Garabedian, Michael J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Savas, Jeffrey N.; Yates, John R.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Gnanakkan, Veena; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Robins, Diane M.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA	New York University; New York University; New York University; New York University; Scripps Research Institute; Johns Hopkins University; University of Michigan System; University of Michigan	Logan, SK (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, 550 First Ave,MSB424, New York, NY 10016 USA.; Logan, SK (corresponding author), NYU, Sch Med, Dept Urol, 550 First Ave,MSB424, New York, NY 10016 USA.	susan.logan@nyumc.org		Robins, Diane M./0000-0001-6727-6309; Logan, Susan/0000-0002-7904-5927; , gregory/0000-0002-3371-4558	National Institutes of Health [R01 CA112226, P41 GM103533, R01 MH067880]; National Institute on Aging [F32 AG039127]; Department of Defense [W81XWH-10-1-0431]; urology department at New York University School of Medicine; NATIONAL CANCER INSTITUTE [R01CA112226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107632, T32GM066704, P41GM103533, T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG039127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Defense(United States Department of Defense); urology department at New York University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01 CA112226 (to S. K. L.) and P41 GM103533 and R01 MH067880 (to J. R. Y.), National Institute on Aging Fellowship F32 AG039127 (to J. N. S.), Department of Defense Fellowship W81XWH-10-1-0431 (to P. M.), and funds from the urology department at New York University School of Medicine (to S. K. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandrova EA, 2012, GENE, V511, P46, DOI 10.1016/j.gene.2012.09.026; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Blasche S, 2013, METHODS MOL BIOL, V1064, P17, DOI 10.1007/978-1-62703-601-6_2; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Miron-Garcia MC, 2014, NUCLEIC ACIDS RES, V42, P9666, DOI 10.1093/nar/gku685; Castro-Diaz N, 2014, GENE DEV, V28, P1397, DOI 10.1101/gad.241661.114; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; Djouder N, 2007, MOL CELL, V28, P28, DOI 10.1016/j.molcel.2007.08.010; Dorjsuren D, 1998, MOL CELL BIOL, V18, P7546, DOI 10.1128/MCB.18.12.7546; Doucet-O'Hare TT, 2015, P NATL ACAD SCI USA, V112, pE4894, DOI 10.1073/pnas.1502474112; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Ewing AD, 2015, GENOME RES, V25, P1536, DOI 10.1101/gr.196238.115; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gnanakkan VP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-869; Goering W, 2011, CARCINOGENESIS, V32, P1484, DOI 10.1093/carcin/bgr181; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Guicciardi ME, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.17pe9; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kazazian HH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-62; Kirchner J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-36; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; LI XX, 2010, 2010 C MOD HYDR ENG, P1; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu JP, 2012, CELL CYCLE, V11, P2643, DOI 10.4161/cc.20957; Lu YY, 2013, CELL SIGNAL, V25, P479, DOI [10.1016/j.cellsig.2012.11.004, 10.3760/cma.j.issn.2095-4352.2013.08.008]; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Mita P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063879; Mita P, 2011, MOL CELL BIOL, V31, P3639, DOI 10.1128/MCB.05429-11; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Nyswaner KM, 2008, GENETICS, V178, P197, DOI 10.1534/genetics.107.082602; Parusel CT, 2006, DEVELOPMENT, V133, P621, DOI 10.1242/dev.02235; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Rangwala SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r100; Rodic N, 2015, NAT MED, V21, P1060, DOI 10.1038/nm.3919; Rodic N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003402; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wei WX, 2003, CELL RES, V13, P111, DOI 10.1038/sj.cr.7290155; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005	57	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25516	25528		10.1074/jbc.M116.741660	http://dx.doi.org/10.1074/jbc.M116.741660			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27780869	hybrid, Green Published			2022-12-26	WOS:000390095300020
J	Dobson, R; Ramagopalan, S; Topping, J; Smith, P; Solanky, B; Schmierer, K; Chard, D; Giovannoni, G				Dobson, Ruth; Ramagopalan, Sreeram; Topping, Joanne; Smith, Paul; Solanky, Bhavana; Schmierer, Klaus; Chard, Declan; Giovannoni, Gavin			A Risk Score for Predicting Multiple Sclerosis	PLOS ONE			English	Article							RADIOLOGICALLY ISOLATED SYNDROME; CLINICALLY ISOLATED SYNDROMES; EPSTEIN-BARR-VIRUS; SEX-RATIO; MRI; MS; SUSCEPTIBILITY; METAANALYSIS; ASSOCIATION; DIAGNOSIS	Objective Multiple sclerosis (MS) develops as a result of environmental influences on the genetically susceptible. Siblings of people with MS have an increased risk of both MS and demonstrating asymptomatic changes in keeping with MS. We set out to develop an MS risk score integrating both genetic and environmental risk factors. We used this score to identify siblings at extremes of MS risk and attempted to validate the score using brain MRI. Methods 78 probands with MS, 121 of their unaffected siblings and 103 healthy controls were studied. Personal history was taken, and serological and genetic analysis using the illumina immunochip was performed. Odds ratios for MS associated with each risk factor were derived from existing literature, and the log values of the odds ratios from each of the risk factors were combined in an additive model to provide an overall score. Scores were initially calculated using log odds ratio from the HLA-DRB1*1501 allele only, secondly using data from all MS-associated SNPs identified in the 2011 GWAS. Subjects with extreme risk scores underwent validation studies. MRI was performed on selected individuals. Results There was a significant difference in the both risk scores between people with MS, their unaffected siblings and healthy controls (p<0.0005). Unaffected siblings had a risk score intermediate to people with MS and controls (p<0.0005). The best performing risk score generated an AUC of 0.82 (95% CI 0.75 +/- 0.88). Interpretations The risk score demonstrates an AUC on the threshold for clinical utility. Our score enables the identification of a high-risk sibling group to inform pre-symptomatic longitudinal studies.	[Dobson, Ruth; Ramagopalan, Sreeram; Topping, Joanne; Schmierer, Klaus; Giovannoni, Gavin] Queen Mary Univ London, London, England; [Dobson, Ruth; Ramagopalan, Sreeram; Topping, Joanne; Schmierer, Klaus; Giovannoni, Gavin] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, London, England; [Smith, Paul; Schmierer, Klaus; Giovannoni, Gavin] Barts Hlth NHS Trust, Royal London Hosp, London, England; [Solanky, Bhavana; Chard, Declan] UCL, NMR Res Unit, Queen Sq Multiple Sclerosis Ctr, Inst Neurol, London, England; [Chard, Declan] Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Dobson, R (corresponding author), Queen Mary Univ London, London, England.; Dobson, R (corresponding author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst, London, England.	ruth.dobson@qmul.ac.uk	Schmierer, Klaus/W-3253-2019	Chard, Declan/0000-0003-3076-2682; Solanky, Bhavana/0000-0002-5946-7604	MS Society of Great Britain and Northern Ireland [940/10]	MS Society of Great Britain and Northern Ireland	This study was funded by the MS Society of Great Britain and Northern Ireland (Grant ref 940/10). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Bostrom I, 2013, MULT SCLER J, V19, P46, DOI 10.1177/1352458512446169; Charil A, 2006, LANCET NEUROL, V5, P841, DOI 10.1016/S1474-4422(06)70572-5; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Dahl AK, 2013, OBESITY, V21, P1293, DOI 10.1002/oby.20299; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; Dobson R, 2012, J NEUROLNEUROSURG PS; Dobson R, 2012, MULT SCLER J, V18, P600, DOI 10.1177/1352458511426740; Gianfrancesco MA, 2014, OBES RES CLIN PRACT, V8, pE435, DOI 10.1016/j.orcp.2014.01.002; Granberg T, 2013, MULT SCLER J, V19, P271, DOI 10.1177/1352458512451943; Haghighi S, 2004, ACTA NEUROL SCAND, V109, P97, DOI 10.1034/j.1600-0404.2003.00197.x; Handel AE, 2012, MULT SCLER RELAT DIS, V1, P39, DOI 10.1016/j.msard.2011.08.005; Handel AE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016149, 10.1371/journal.pone.0014606]; Hedstrom AK, 2015, EUR J NEUROL, V22, P578, DOI 10.1111/ene.12620; KURTZKE JF, 1980, ACTA NEUROL SCAND, V62, P65, DOI 10.1111/j.1600-0404.1980.tb03006.x; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; LYNCH SG, 1990, NEUROLOGY, V40, P900, DOI 10.1212/WNL.40.6.900; Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5; Montalban X, 2010, NEUROLOGY, V74, P427, DOI 10.1212/WNL.0b013e3181cec45c; Morris Z, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3016; Mowry EM, 2010, ANN NEUROL, V67, P618, DOI 10.1002/ana.21972; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Okuda DT, 2009, NEUROLOGY, V72, P800, DOI 10.1212/01.wnl.0000335764.14513.1a; Orton SM, 2011, NEUROLOGY, V76, P425, DOI 10.1212/WNL.0b013e31820a0a9f; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sundstrom P, 2004, NEUROLOGY, V62, P2277, DOI 10.1212/01.WNL.0000130496.51156.D7; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; TIENARI PJ, 1992, J NEUROL NEUROSUR PS, V55, P883, DOI 10.1136/jnnp.55.10.883; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0164992	10.1371/journal.pone.0164992	http://dx.doi.org/10.1371/journal.pone.0164992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802296	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200014
J	Uhl, B; Dietrich, D; Branchi, V; Semaan, A; Schaefer, P; Gevensleben, H; Rostamzadeh, B; Lingohr, P; Schafer, N; Kalff, JC; Kristiansen, G; Matthaei, H				Uhl, Barbara; Dietrich, Dimo; Branchi, Vittorio; Semaan, Alexander; Schaefer, Pauline; Gevensleben, Heidrun; Rostamzadeh, Babak; Lingohr, Philipp; Schaefer, Nico; Kalff, Joerg C.; Kristiansen, Glen; Matthaei, Hanno			DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract	PLOS ONE			English	Article							POSITIVE BREAST-CANCER; CLINICAL VALIDATION; ANTIGEN RECURRENCE; GENE-EXPRESSION; PROMOTES; MULTICENTER; PITUITARY; RISK; CHOLANGIOCARCINOMA; HYPOMETHYLATION	Biliary tract cancers (BTC) are rare but highly aggressive malignant epithelial tumors. In order to improve the outcome in this lethal disease, novel biomarkers for diagnosis, prognosis, and therapy response prediction are urgently needed. DNA promoter methylation of PITX2 variants (PITX2ab, PITX2c) and intragenic methylation of the PITX2 adjacent non-coding RNA (PANCR) were investigated by methylations-specific qPCR assays in formalin-fixed paraffin-embedded tissue from 80 patients after resection for BTC. Results were correlated with clinicopathologic data and outcome. PITX2 variants and PANCR showed significant hypermethylation in tumor vs. normal adjacent tissue (p < 0.001 and p = 0.015), respectively. In survival analysis, dichotomized DNA methylation of variant PITX2c and PANCR were significantly associated with overall survival (OS). Patients with high tumor methylation levels of PITX2c had a shorter OS compared to patients with low methylation (12 vs. 40 months OS; HR 2.48 [1.38-4.48], p = 0.002). In contrast, PANCR hypermethylation was associated with prolonged survival (25 vs. 19 months OS; HR 0.54 [0.30-0.94], p = 0.015) and qualified as an independent prognostic factor on multivariate analysis. The biomarkers investigated in this study may help to identify BTC subpopulations at risk for worse survival. Further studies are needed to evaluate if PITX2 might be a clinically useful biomarker for an optimized and individualized treatment.	[Uhl, Barbara; Dietrich, Dimo; Gevensleben, Heidrun; Kristiansen, Glen] Univ Bonn, Inst Pathol, Bonn, Germany; [Dietrich, Dimo] Univ Hosp Bonn, Dept Otolaryngol Head & Neck Surg, Bonn, Germany; [Branchi, Vittorio; Semaan, Alexander; Schaefer, Pauline; Lingohr, Philipp; Schaefer, Nico; Kalff, Joerg C.; Matthaei, Hanno] Univ Bonn, Dept Surg, Bonn, Germany; [Rostamzadeh, Babak] Klinikum Stuttgart, Dept Neuroradiol, Katharinenhosp, Stuttgart, Germany	University of Bonn; University of Bonn; University of Bonn; Klinikum Stuttgart	Matthaei, H (corresponding author), Univ Bonn, Dept Surg, Bonn, Germany.		Kalff, Joerg C/U-8580-2017	Semaan, Alexander/0000-0001-5424-3217				Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Banez LL, 2010, J UROLOGY, V184, P149, DOI 10.1016/j.juro.2010.03.012; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chang TC, 2012, BRIT J OPHTHALMOL, V96, P318, DOI 10.1136/bjophthalmol-2011-300801; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; Dietrich D, 2013, J MOL DIAGN, V15, P270, DOI 10.1016/j.jmoldx.2012.11.002; Dietrich D, 2012, DIAGN MOL PATHOL, V21, P93, DOI 10.1097/PDM.0b013e318240503b; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; Gore-Panter SR, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003197; Harbeck N, 2008, J CLIN ONCOL, V26, P5036, DOI 10.1200/JCO.2007.14.1697; Hartmann O, 2009, CLIN CANCER RES, V15, P315, DOI 10.1158/1078-0432.CCR-08-0166; Hemming AW, 2005, ANN SURG, V241, P693, DOI 10.1097/01.sla.0000160701.38945.82; Hezel AF, 2010, J CLIN ONCOL, V28, P3531, DOI 10.1200/JCO.2009.27.4787; Hirose H, 2011, ANN SURG ONCOL, V18, P3005, DOI 10.1245/s10434-011-1653-z; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Huang Y, 2010, CELL CYCLE, V9, P1333, DOI 10.4161/cc.9.7.11126; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Jung M, 2017, METHODS MOL BIOL, V1589, P139, DOI 10.1007/7651_2015_260; Kato Y, 2011, CELL MOL LIFE SCI, V68, P2555, DOI 10.1007/s00018-011-0695-5; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Li ML, 2014, NAT GENET, V46, P872, DOI 10.1038/ng.3030; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Litovkin K, 2014, J CANCER RES CLIN, V140, P1849, DOI 10.1007/s00432-014-1738-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma MZ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.541; Maier S, 2007, EUR J CANCER, V43, P1679, DOI 10.1016/j.ejca.2007.04.025; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Nakanuma Y, 2010, PATHOL INT, V60, P419, DOI 10.1111/j.1440-1827.2010.02543.x; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Nimmrich I, 2008, BREAST CANCER RES TR, V111, P429, DOI 10.1007/s10549-007-9800-8; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Schatz P, 2010, J MOL DIAGN, V12, P345, DOI 10.2353/jmoldx.2010.090088; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sincic N, 2011, CURR OPIN ONCOL, V23, P69, DOI 10.1097/CCO.0b013e3283412eb4; Valle Juan, 2010, N Engl J Med, V362, P1273, DOI 10.1056/NEJMoa0908721; Wang Q, 2016, ONCOTARGET, V7, P11208, DOI 10.18632/oncotarget.7158; Weiss G, 2009, J UROLOGY, V181, P1678, DOI 10.1016/j.juro.2008.11.120; Wu XS, 2014, CANCER BIOL THER, V15, P806, DOI 10.4161/cbt.28584	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165769	10.1371/journal.pone.0165769	http://dx.doi.org/10.1371/journal.pone.0165769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798672	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100065
J	Chatterjee, J; Dionora, J; Elmido-Mabilangan, A; Wanchana, S; Thakur, V; Bandyopadhyay, A; Brar, DS; Quick, WP				Chatterjee, Jolly; Dionora, Jacqueline; Elmido-Mabilangan, Abigail; Wanchana, Samart; Thakur, Vivek; Bandyopadhyay, Anindya; Brar, Darshan S.; Quick, William Paul			lThe Evolutionary Basis of Naturally Diverse Rice Leaves Anatomy	PLOS ONE			English	Article							LEAF SHAPE; ENVIRONMENTAL VARIATION; TRANSCRIPTION FACTOR; PHYLOGENETIC SIGNAL; CELL-PROLIFERATION; GENE FAMILY; EXPRESSION; MODEL; OVEREXPRESSION; PHOTOSYNTHESIS	Rice contains genetically and ecologically diverse wild and cultivated species that show a wide variation in plant and leaf architecture. A systematic characterization of leaf anatomy is essential in understanding the dynamics behind such diversity. Therefore, leaf anatomies of 24 Oryza species spanning 11 genetically diverse rice genomes were studied in both lateral and longitudinal directions and possible evolutionary trends were examined. A significant inter-species variation in mesophyll cells, bundle sheath cells, and vein structure was observed, suggesting precise genetic control over these major rice leaf anatomical traits. Cellular dimensions, measured along three growth axes, were further combined proportionately to construct three-dimensional (3D) leaf anatomy models to compare the relative size and orientation of the major cell types present in a fully expanded leaf. A reconstruction of the ancestral leaf state revealed that the following are the major characteristics of recently evolved rice species: fewer veins, larger and laterally elongated mesophyll cells, with an increase in total mesophyll area and in bundle sheath cell number. A huge diversity in leaf anatomy within wild and domesticated rice species has been portrayed in this study, on an evolutionary context, predicting a two-pronged evolutionary pathway leading to the `sativa leaf type' that we see today in domesticated species.	[Chatterjee, Jolly; Dionora, Jacqueline; Elmido-Mabilangan, Abigail; Wanchana, Samart; Thakur, Vivek; Bandyopadhyay, Anindya; Quick, William Paul] Int Rice Res Inst, Genet & Biotechnol Div, Rice Ctr C4, DAPO BOX 7777, Los Banos, Metro Manila, Philippines; [Brar, Darshan S.] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, DAPO BOX 7777, Los Banos, Metro Manila, Philippines; [Quick, William Paul] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Brar, Darshan S.] Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana, Punjab, India	CGIAR; International Rice Research Institute (IRRI); CGIAR; International Rice Research Institute (IRRI); University of Sheffield; Punjab Agricultural University	Quick, WP (corresponding author), Int Rice Res Inst, Genet & Biotechnol Div, Rice Ctr C4, DAPO BOX 7777, Los Banos, Metro Manila, Philippines.; Quick, WP (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	w.p.quick@irri.org	Wanchana, Samart/AAF-5773-2020	Chatterjee, Jolly/0000-0003-2370-4185; Wanchana, Samart/0000-0002-5459-3425	Bill and Melinda Gates Foundation [OPPGD1394]; Department for International Development	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department for International Development	We are grateful to Bill and Melinda Gates Foundation (http://www.gatesfoundation.org, Grant Number: OPPGD1394) and Department for International Development (https./www.gov.uk/government/organisations/department-for-international-development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 1999, THEOR APPL GENET, V98, P1320, DOI 10.1007/s001220051198; Ammiraju JSS, 2008, PLANT CELL, V20, P3191, DOI 10.1105/tpc.108.063727; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dai MQ, 2007, PLANT PHYSIOL, V144, P380, DOI 10.1104/pp.107.095737; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans JR, 2009, J EXP BOT, V60, P2235, DOI 10.1093/jxb/erp117; Evans Jr, 2004, ECOL STU AN, V178, P107; Farris JS, 2008, CLADISTICS, V24, P89; Feldman AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094947; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fujino K, 2008, MOL GENET GENOMICS, V279, P499, DOI 10.1007/s00438-008-0328-3; Gaut BS, 1999, MOL BIOL EVOL, V16, P1086, DOI 10.1093/oxfordjournals.molbev.a026198; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Ge S, 2002, AM J BOT, V89, P1967, DOI 10.3732/ajb.89.12.1967; Giuliani R, 2013, PLANT PHYSIOL, V162, P1632, DOI 10.1104/pp.113.217497; Govaerts YM, 1996, APPL OPTICS, V35, P6585, DOI 10.1364/AO.35.006585; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo YL, 2005, AM J BOT, V92, P1548, DOI 10.3732/ajb.92.9.1548; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Hu J, 2010, PLANT MOL BIOL, V73, P283, DOI 10.1007/s11103-010-9614-7; Ishida N, 2000, ANN BOT-LONDON, V86, P259, DOI 10.1006/anbo.2000.1181; Ishiwata A, 2013, PLANT CELL PHYSIOL, V54, P779, DOI 10.1093/pcp/pct032; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Joshi SP, 2000, THEOR APPL GENET, V100, P1311, DOI 10.1007/s001220051440; Kim GT, 1998, GENE DEV, V12, P2381, DOI 10.1101/gad.12.15.2381; Li L, 2010, MOL PLANT, V3, P807, DOI 10.1093/mp/ssq022; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Lu F, 2009, P NATL ACAD SCI USA, V106, P2071, DOI 10.1073/pnas.0812798106; Maddison WP, 2011, MESQUITE MODULAR SYS; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; McKown AD, 2007, AM J BOT, V94, P382, DOI 10.3732/ajb.94.3.382; Narita NN, 2004, PLANT J, V38, P699, DOI 10.1111/j.1365-313X.2004.02078.x; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Paradis E, 2001, PACKAGE APE; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Pick TR, 2011, PLANT CELL, V23, P4208, DOI 10.1105/tpc.111.090324; Ren FG, 2003, THEOR APPL GENET, V108, P113, DOI 10.1007/s00122-003-1414-x; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Sanchez P.L., 2013, GENETICS GENOMICS RI, P616, DOI DOI 10.1007/978-1-4614-7903-1_2; SAS, 1999, SAS VERS 9 1; Scafaro AP, 2011, PLANT CELL ENVIRON, V34, P1999, DOI 10.1111/j.1365-3040.2011.02398.x; Scarpella E, 2010, COLD SPRING HARB PER; Shi ZY, 2007, PLANTA, V226, P99, DOI 10.1007/s00425-006-0472-0; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Smillie IRA, 2012, J EXP BOT, V63, P4563, DOI 10.1093/jxb/ers142; Somerville C.R., 2002, AM SOC PLANT BIOL, DOI [10. 1199/ tab. 0072, DOI 10.1199/TAB.0072]; Stuppy WH, 2003, TRENDS PLANT SCI, V8, P2, DOI 10.1016/S1360-1385(02)00004-3; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; Tsuge T, 1996, DEVELOPMENT, V122, P1589; Tsukaya H, 2005, INT J DEV BIOL, V49, P547, DOI 10.1387/ijdb.041921ht; Vaughan D.A., 1994, GENETIC HDB; Verboven P, 2015, PLANT J, V81, P169, DOI 10.1111/tpj.12701; Wang P, 2013, PLANT J, V75, P656, DOI 10.1111/tpj.12229; Wuyts N, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-17; XIE Y, 1990, GENE, V87, P185, DOI 10.1016/0378-1119(90)90300-G; XIE Y, 1989, PLANT MOL BIOL, V13, P53, DOI 10.1007/BF00027335; Yoshida H, 2008, FIELD CROP RES, V108, P222, DOI 10.1016/j.fcr.2008.05.004; Yoshida H, 2009, FIELD CROP RES, V113, P227, DOI 10.1016/j.fcr.2009.05.010; Zhang GH, 2009, PLANT CELL, V21, P719, DOI 10.1105/tpc.108.061457; Zhao SQ, 2010, CELL RES, V20, P935, DOI 10.1038/cr.2010.109	66	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0164532	10.1371/journal.pone.0164532	http://dx.doi.org/10.1371/journal.pone.0164532			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792743	gold, Green Accepted, Green Published			2022-12-26	WOS:000389537000009
J	Chen, IC; Lin, YT; Hsu, JH; Liu, YC; Wu, JR; Dai, ZK				Chen, I-Chen; Lin, Yu-Tsai; Hsu, Jong-Hau; Liu, Yi-Ching; Wu, Jiunn-Ren; Dai, Zen-Kong			Nasal Airflow Measured by Rhinomanometry Correlates with FeNO in Children with Asthma	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; ALLERGEN CHALLENGE; CLINICAL-PRACTICE; DUST-MITE; RESISTANCE; RHINITIS; PROVOCATION; PATENCY; RHINOSINUSITIS; LINK	Background Rhinitis and asthma share similar immunopathological features. Rhinomanometry is an important test used to assess nasal function and spirometry is an important tool used in asthmatic children. The degree to which the readouts of these tests are correlated has yet to be established. We sought to clarify the relationship between rhinomanometry measurements, fractional exhaled nitric oxide (FeNO), and spirometric measurements in asthmatic children. Methods Patients' inclusion criteria: age between 5 and 18 years, history of asthma with nasal symptoms, and no anatomical deformities. All participants underwent rhinomanometric evaluations and pulmonary function and FeNO tests. Results Total 84 children were enrolled. By rhinomanometry, the degree of nasal obstruction was characterized as follows: (1) no obstruction in 33 children, (2) slight obstruction in 29 children, and (3) moderate obstruction in 22 children. FeNO was significantly lower in patients without obstruction than those with slight or moderate obstruction. Dividing patients according to ATS Clinical Practice Guidelines regarding FeNO, patients < 12 years with FeNO > 20 ppb had a lower total nasal airflow rate than those with FeNO < 20 ppb. Patients >= 12 years with FeNO > 25 ppb had a lower total nasal airflow rate than those with FeNO < 25 ppb. Conclusions Higher FeNO was associated with a lower nasal airflow and higher nasal resistance. This supports a relationship between upper and lower airway inflammation, as assessed by rhinomanometry and FeNO. The results suggest that rhinomanometry may be integrated as part of the functional assessment of asthma.	[Chen, I-Chen; Hsu, Jong-Hau; Liu, Yi-Ching; Wu, Jiunn-Ren; Dai, Zen-Kong] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Lin, Yu-Tsai] Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Lin, Yu-Tsai] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Hsu, Jong-Hau; Wu, Jiunn-Ren; Dai, Zen-Kong] Kaohsiung Med Univ, Coll Med, Dept Pediat, Sch Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University	Dai, ZK (corresponding author), Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan.; Dai, ZK (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Pediat, Sch Med, Kaohsiung, Taiwan.	zenkong@kmu.edu.tw		Chen, I-Chen/0000-0002-9770-8544	Kaohsiung Medical University Hospital, Taiwan [KMUH-2M30]	Kaohsiung Medical University Hospital, Taiwan	This research was supported by the grant from the Kaohsiung Medical University Hospital, Taiwan (KMUH-2M30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 1995, ASTHMA RHINITIS, P1057; Andre RF, 2009, CLIN OTOLARYNGOL, V34, P518, DOI 10.1111/j.1749-4486.2009.02042.x; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Baudoin T, 1999, AM J RHINOL, V13, P229, DOI 10.2500/105065899781389786; Blaiss MS, 2005, ALLERGY ASTHMA PROC, V26, P35; Braunstahl Gert-Jan, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P176, DOI 10.1097/01.moo.0000193186.15440.39; Braunstahl GJ, 2003, CURR OPIN PULM MED, V9, P46, DOI 10.1097/00063198-200301000-00008; Carney AS, 2000, CLIN OTOLARYNGOL, V25, P499, DOI 10.1046/j.1365-2273.2000.00384.x; Chawes BLK, 2010, CHEST, V137, P1332, DOI 10.1378/chest.09-2601; Chiron R, 2010, J ASTHMA, V47, P604, DOI 10.3109/02770901003759402; Clement P A, 1984, Rhinology, V22, P151; Clement PAR, 2005, RHINOLOGY, V43, P169; Davila I, 2015, J INVEST ALLERG CLIN, V25, P120; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Fraser L, 2009, CLIN OTOLARYNGOL, V34, P151, DOI 10.1111/j.1749-4486.2009.01887.x; Global Initiative for Asthma (GINA), 2012, GLOB STRAT ASTHM MAN; Gustafsson PM, 2006, INT J CLIN PRACT, V60, P321, DOI 10.1111/j.1368-5031.2006.00798.x; Hellings PW, 2009, IMMUNOL ALLERGY CLIN, V29, P733, DOI 10.1016/j.iac.2009.08.001; Horak F, 1998, ALLERGY, V53, P68, DOI 10.1111/j.1398-9995.1998.tb03775.x; Julia JC, 2011, ALLERGOL IMMUNOPATH, V39, P342, DOI 10.1016/j.aller.2010.10.004; Kem EB, 1977, RHINOLOGY, V15, P115; Kirerleri E, 2006, ASIAN PAC J ALLERGY, V24, P117; Kobayashi R, 2012, ACTA OTO-LARYNGOL, V132, P197, DOI 10.3109/00016489.2011.630017; Kobayashi R, 2011, AURIS NASUS LARYNX, V38, P73, DOI 10.1016/j.anl.2010.06.002; Lieberman P, 2000, PEDIATR ANN, V29, P405, DOI 10.3928/0090-4481-20000701-07; Malm L, 2000, RHINOLOGY, V38, P1; MCLEAN JA, 1978, J ALLERGY CLIN IMMUN, V61, P191, DOI 10.1016/0091-6749(78)90450-5; Merkle J, 2014, RHINOLOGY, V52, P292, DOI 10.4193/Rhino13.220; Ottaviano G, 2016, ALLERGY, V71, P162, DOI 10.1111/all.12778; Pallanch JF, 2012, RHINOLOGY DIS NOSE S; Pelikan Z, 2009, INT ARCH ALLERGY IMM, V148, P330, DOI 10.1159/000170387; Ragab S, 2006, EUR RESPIR J, V28, P68, DOI 10.1183/09031936.06.00043305; Silkoff PE, 1998, J ASTHMA, V35, P473, DOI 10.3109/02770909809071000; Slutsky AS, 1999, AM J RESP CRIT CARE, V160, P2104; Stanciulescu Cristiana, 2015, Pneumologia, V64, P40; STENIUSAARNIALA BSM, 1978, CLIN ALLERGY, V8, P403, DOI 10.1111/j.1365-2222.1978.tb00476.x; Vogt Klaus, 2010, Rhinol Suppl, V21, P1; Wang DY, 1996, INT ARCH ALLERGY IMM, V110, P85, DOI 10.1159/000237316; Yavuz ST, 2014, INT J PEDIATR OTORHI, V78, P843, DOI 10.1016/j.ijporl.2014.02.026; Zapletal A, 2002, PEDIATR PULM, V33, P174, DOI 10.1002/ppul.10066	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165440	10.1371/journal.pone.0165440	http://dx.doi.org/10.1371/journal.pone.0165440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792747	gold, Green Published, Green Submitted			2022-12-26	WOS:000389537000021
J	Miranda, AM; Steluti, J; Fisberg, RM; Marchioni, DM				Miranda, Andreia Machado; Steluti, Josiane; Fisberg, Regina Mara; Marchioni, Dirce Maria			Association between Polyphenol Intake and Hypertension in Adults and Older Adults: A Population-Based Study in Brazil	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; OLIVE OIL; FLAVONOID INTAKE; DIETARY-INTAKE; NITRIC-OXIDE; RISK; MORTALITY; PLASMA; CONSUMPTION	Background/Objective Hypertension is an important risk factor for cardiovascular disease, and diet has been identified as a modifiable factor for preventing and controlling hypertension. Besides, epidemiological studies have suggested an inverse association between polyphenol intake and cardiovascular diseases. The aim of this study was to evaluate the association between the intake of polyphenols and hypertension in a general population of Sao Paulo. Methods Data came from the 'Health Survey of Sao Paulo (ISA-Capital)' among 550 adults and older adults in Sao Paulo, Brazil. Diet was assessed by two 24-hour dietary recalls (24HR). Usual intakes were calculated using the Multiple Source Method. Polyphenol intake was calculated by matching food consumption data from the 24HR with the Phenol-Explorer database. The associations between the hypertension and tertiles of the total and classes of polyphenols intake were tested by multivariate logistic regression analysis. Results After multivariate adjustment for potential confounding factors the findings showed an inverse and linearly association between the hypertension and highest tertiles of tyrosols (OR = 0.33; 95% CI 0.18, 0.64), alkylphenols (OR = 0.45; 95% CI 0.23, 0.87), lignans (OR = 0.49; 95% CI 0.25, 0.98), as well as stilbenes (OR = 0.60; 95% CI 0.36, 0.98), and other polyphenols (OR = 0.33; 95% CI 0.14, 0.74). However, total polyphenol intake, and phenolic acids were significantly associated only in the middle tertile with hypertension and flavonoids were not significant associated. Conclusion There is an inverse and linearly association between the highest tertile of some classes of polyphenols, such as, tyrosols, alkylphenols, lignans, stilbenes, other polyphenols and hypertension.	[Miranda, Andreia Machado; Steluti, Josiane; Fisberg, Regina Mara; Marchioni, Dirce Maria] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Miranda, AM (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, SP, Brazil.	andreia.am.miranda@gmail.com	Marchioni, Dirce/ABH-7023-2020; Marchioni, Dirce M/C-6053-2012; Fisberg, Regina M/C-4069-2012; Fisberg, Regina Mara/Q-6494-2019; Steluti, Josiane/A-5017-2015; Miranda, Andreia/E-4538-2018	Marchioni, Dirce/0000-0002-6810-5779; Marchioni, Dirce M/0000-0002-6810-5779; Fisberg, Regina M/0000-0002-4490-9035; Fisberg, Regina Mara/0000-0002-4490-9035; Steluti, Josiane/0000-0001-7629-4189; Miranda, Andreia/0000-0002-8500-0549	Sao Paulo Research Foundation (FAPESP) [2009/15831-0, 2014/04540-2]; National Counsel of Technological and Scientific Development (CNPq) [481176/2008-0, 473100/2009-6, 306029/2011-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to express their gratitude for financial support from Sao Paulo Research Foundation (FAPESP) (grant numbers 2009/15831-0 and 2014/04540-2), and from National Counsel of Technological and Scientific Development (CNPq) (procedurals 481176/2008-0 and 473100/2009-6, and grant number 306029/2011-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriantsitohaina R, 2012, BRIT J NUTR, V108, P1532, DOI 10.1017/S0007114512003406; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Bernatova I, 2002, AM J PHYSIOL-HEART C, V282, pH942, DOI 10.1152/ajpheart.00724.2001; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594; Chobanian AV, 2009, NEW ARMEN MED J, V3, P60, DOI 10.1056/NEJMsa0903829; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de la Torre-Carbot K, 2010, J NUTR, V140, P501, DOI 10.3945/jn.109.112912; Di Benedetto R, 2007, NUTR METAB CARDIOVAS, V17, P535, DOI 10.1016/j.numecd.2006.03.005; Di Castelnuovo A, 2012, EUR J INTERN MED, V23, P15, DOI 10.1016/j.ejim.2011.07.014; Galleano M, 2010, CURR PHARM BIOTECHNO, V11, P837, DOI 10.2174/138920110793262114; Guenther P. M., 1995, INT C DIET ASS METH; Haubrock J, 2011, J NUTR, V141, P914, DOI 10.3945/jn.109.120394; Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457; Instituto Brasileiro de Geografia e Estatistica, 2005, PESQ NAC AM DOM; Jacobs DR, 1998, AM J CLIN NUTR, V68, P248, DOI 10.1093/ajcn/68.2.248; Knekt P, 1996, BRIT MED J, V312, P478, DOI 10.1136/bmj.312.7029.478; Lin J, 2007, AM J EPIDEMIOL, V165, P1305, DOI 10.1093/aje/kwm016; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Manach C, 2005, CURR OPIN LIPIDOL, V16, P77, DOI 10.1097/00041433-200502000-00013; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; McCullough ML, 2012, AM J CLIN NUTR, V95, P454, DOI 10.3945/ajcn.111.016634; Medina-Remon A, 2015, NUTR METAB CARDIOVAS, V25, P60, DOI 10.1016/j.numecd.2014.09.001; Medina-Remon A, 2013, MINI-REV MED CHEM, V13, P1137, DOI 10.2174/1389557511313080002; Mendez MA, 2011, AM J EPIDEMIOL, V173, P448, DOI 10.1093/aje/kwq380; Miranda AM, 2016, BRIT J NUTR, V115, P1061, DOI 10.1017/S0007114515005061; Miyawaki T, 2009, J NUTR SCI VITAMINOL, V55, P87, DOI 10.3177/jnsv.55.87; Moreno-Luna R, 2012, AM J HYPERTENS, V25, P1299, DOI 10.1038/ajh.2012.128; Nakachi K, 2000, BIOFACTORS, V13, P49, DOI 10.1002/biof.5520130109; Perez-Jimenez J, 2010, J AGR FOOD CHEM, V58, P4959, DOI 10.1021/jf100128b; [Anonymous], 2007, Arq. Bras. Cardiol., V89, pe24, DOI 10.1590/S0066-782X2007001500012; Stoclet JC, 2004, EUR J PHARMACOL, V500, P299, DOI 10.1016/j.ejphar.2004.07.034; Tresserra-Rimbau A, 2014, NUTR METAB CARDIOVAS, V24, P639, DOI 10.1016/j.numecd.2013.12.014; Tresserra-Rimbau A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-77; Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231; Utsugi MT, 2008, HYPERTENS RES, V31, P1435, DOI 10.1291/hypres.31.1435; Wang Y, 2013, NUTRIENTS, V5, P2969, DOI 10.3390/nu5082969; World Health Organisation, 2000, REP WHO CONS	39	45	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165791	10.1371/journal.pone.0165791	http://dx.doi.org/10.1371/journal.pone.0165791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792767	gold, Green Published, Green Submitted			2022-12-26	WOS:000389537000051
J	Kim, JS; Kim, W; Woo, JS; Lee, TW; Ihm, CG; Kim, YG; Moon, JY; Lee, SH; Jeong, MH; Jeong, KH				Kim, Jin Sug; Kim, Weon; Woo, Jong Shin; Lee, Tae Won; Ihm, Chun Gyoo; Kim, Yang Gyoon; Moon, Joo Young; Lee, Sang Ho; Jeong, Myung Ho; Jeong, Kyung Hwan		Korea Acute Myocardial Infarction	The Predictive Role of Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio According to Renal Function in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR OUTCOMES; REVERSE EPIDEMIOLOGY; INSULIN-RESISTANCE; NATIONAL-HEALTH; RISK; MORTALITY; ATHEROSCLEROSIS; ASSOCIATION; HEART	Objective A high serum triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio has been reported as an independent predictor for cardiovascular events in the general population. However, the prognostic value of this ratio in patients with renal dysfunction is unclear. We examined the association of the TG/HDL-C ratio with major adverse cardiovascular events (MACEs) according to renal function in patients with acute myocardial infarction (AMI). Method This study was based on the Korea Acute Myocardial Infarction Registry database. Of 13,897 patients who were diagnosed with AMI, the study population included the 7,016 patients with available TG/HDL-C ratio data. Patients were stratified into three groups according to their estimated glomerular filtration rate (eGFR), and the TG/HDL-C ratio was categorized into tertiles. We investigated 12-month MACEs, which included cardiac death, myocardial infarction, and repeated percutaneous coronary intervention or coronary artery bypass grafting. Results During the 12-month follow up period, 593 patients experienced MACEs. There was a significant association between the TG/HDL-C ratio and MACEs (p<0.001) in the entire study cohort. Having a TG/HDL-C ratio value in the highest tertile of TG/HDL-C ratio was an independent factor associated with increased risk of MACEs (hazard ratio [HR], 1.56; 95% confidence interval [CI], 1.26-1.93; p<0.001). Then we performed subgroup analyses according to renal function. In patients with normal renal function (eGFR >= 90 ml/min/1.73m(2)) and mild renal dysfunction (eGFR >= 60 to < 90ml/min/1.73m(2)), a higher TG/HDL-C ratio was significantly associated with increased risk of MACEs (HR, 1.64; 95% Cl, 1.04-2.60; p = 0.035; and HR, 1.56; 95% Cl, 1.14-2.12; p = 0.005, respectively). However, in patients with moderate renal dysfunction (eGFR < 60 ml/min/1.73m2), TG/HDL-C ratio lost its predictive value on the risk of MACEs (HR, 1.23; 95% Cl, 0.82-1.83; p = 0.317). Conclusions In patients with AMI, TG/HDL-C ratio is a useful independent predictor of 12-month MACEs. However, this ratio does not have predictive power in patients with moderate renal dysfunction.	[Kim, Jin Sug] Kyung Hee Univ, Grad Sch, Dept Med, Seoul, South Korea; [Kim, Weon; Woo, Jong Shin] Kyung Hee Univ, Sch Med, Div Cardiol, Dept Internal Med, Seoul, South Korea; [Lee, Tae Won; Ihm, Chun Gyoo; Kim, Yang Gyoon; Moon, Joo Young; Lee, Sang Ho; Jeong, Kyung Hwan] Kyung Hee Univ, Sch Med, Div Nephrol, Dept Internal Med, Seoul, South Korea; [Jeong, Myung Ho] Chonnam Natl Univ Hosp, Div Cardiol, Dept Med, Gwangju, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Chonnam National University; Chonnam National University Hospital	Jeong, KH (corresponding author), Kyung Hee Univ, Sch Med, Div Nephrol, Dept Internal Med, Seoul, South Korea.	aprilhwan@naver.com	Kim, Jin Sug/AAY-6890-2021; /W-5371-2019	Kim, Jin Sug/0000-0001-7361-8715; Seong, In-Whan/0000-0003-4628-0258; Jeong, Jin-Ok/0000-0003-0763-4754	Ministry of Health Welfare [H15C0166]	Ministry of Health Welfare	This research was supported by the Ministry of Health & Welfare (H15C0166). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakris GL, 2002, J HUM HYPERTENS, V16, P185, DOI 10.1038/sj.jhh.1001315; Bittner V, 2009, AM HEART J, V157, P548, DOI 10.1016/j.ahj.2008.11.014; Chen HY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000619; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Hadaegh F, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-85; Jeppesen J, 2001, ARCH INTERN MED, V161, P361, DOI 10.1001/archinte.161.3.361; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Kang HT, 2011, KIDNEY BLOOD PRESS R, V34, P173, DOI 10.1159/000323895; Kim JS, 2012, DIABETES RES CLIN PR, V97, P132, DOI 10.1016/j.diabres.2012.04.022; Kovesdy CP, 2007, SEMIN DIALYSIS, V20, P566, DOI 10.1111/j.1525-139X.2007.00335.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Millan J, 2009, VASC HEALTH RISK MAN, V5, P757; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Pecoits R, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_11.28; Razani B, 2008, ENDOCRIN METAB CLIN, V37, P603, DOI 10.1016/j.ecl.2008.05.001; Ren XX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154345; Sarnak MJ, 2000, AM J KIDNEY DIS, V35, pS117, DOI 10.1016/S0272-6386(00)70239-3; Sonmez A, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0031-4; Tsimihodimos Vasilis, 2011, Open Cardiovasc Med J, V5, P41, DOI 10.2174/1874192401105010041; Turak O, 2016, J CLIN HYPERTENS, V18, P772, DOI 10.1111/jch.12758; Unal HU, 2016, J CLIN HYPERTENS, V18, P951, DOI 10.1111/jch.12807; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wan K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123521; Zoppini G, 2010, ATHEROSCLEROSIS, V212, P287, DOI 10.1016/j.atherosclerosis.2010.04.035	28	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165484	10.1371/journal.pone.0165484	http://dx.doi.org/10.1371/journal.pone.0165484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788233	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900094
J	Craig, EH; Adams, JR; Waits, LP; Fuller, MR; Whittington, DM				Craig, Erica H.; Adams, Jennifer R.; Waits, Lisette P.; Fuller, Mark R.; Whittington, Diana M.			Nuclear and MitochondrialDNA Analyses of Golden Eagles (Aquila chrysaetos canadensis) from Three Areas in Western North America; Initial Results and Conservation Implications	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC DIVERSITY; UNITED-STATES; DNA; LANDSCAPE; RAPTOR; SELECTION; DISTANCE; BEHAVIOR; LOCI	Understanding the genetics of a population is a critical component of developing conservation strategies. We used archived tissue samples from golden eagles (Aquila chrysaetos canadensis) in three geographic regions of western North America to conduct a preliminary study of the genetics of the North American subspecies, and to provide data for United States Fish and Wildlife Service (USFWS) decision-making for golden eagle management. We used a combination of mitochondrial DNA (mtDNA) D-loop sequences and 16 nuclear DNA (nDNA) microsatellite loci to investigate the extent of gene flow among our sampling areas in Idaho, California and Alaska and to determine if we could distinguish birds from the different geographic regions based on their genetic profiles. Our results indicate high genetic diversity, low genetic structure and high connectivity. Nuclear DNA Fst values between Idaho and California were low but significantly different from zero (0.026). Bayesian clustering methods indicated a single population, and we were unable to distinguish summer breeding residents from different regions. Results of the mtDNA AMOVA showed that most of the haplotype variation (97%) was within the geographic populations while 3% variation was partitioned among them. One haplotype was common to all three areas. One region-specific haplotype was detected in California and one in Idaho, but additional sampling is required to determine if these haplotypes are unique to those geographic areas or a sampling artifact. We discuss potential sources of the high gene flow for this species including natal and breeding dispersal, floaters, and changes in migratory behavior as a result of environmental factors such as climate change and habitat alteration. Our preliminary findings can help inform the USFWS in development of golden eagle management strategies and provide a basis for additional research into the complex dynamics of the North American subspecies.	[Craig, Erica H.] Aquila Environm, Fairbanks, AK 99709 USA; [Adams, Jennifer R.; Waits, Lisette P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83844 USA; [Fuller, Mark R.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Boise, ID USA; [Whittington, Diana M.] US Fish & Wildlife Serv Headquarters, Falls Church, VA USA	Idaho; University of Idaho; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Craig, EH (corresponding author), Aquila Environm, Fairbanks, AK 99709 USA.; Adams, JR (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83844 USA.	goea.rs@gmail.com; adamsj@uidaho.edu	Adams, Jennifer R/H-1780-2011	Waits, Lisette/0000-0002-1323-0812	US Geological Survey; US Geological Survey/ US Fish and Wildlife Service Science Support Partnership Program (EC)	US Geological Survey(United States Geological Survey); US Geological Survey/ US Fish and Wildlife Service Science Support Partnership Program (EC)	This research was funded by the US Geological Survey and the US Geological Survey/ US Fish and Wildlife Service Science Support Partnership Program (EC). The College of Natural Resources at the University of Idaho helped fund salaries for LW and JA. Aquila Environmental helped fund the salary for EC.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; [Anonymous], 2006, MOL ECOL NOTES, DOI [DOI 10.1111/J.1471-8286.2005.01155.X, DOI doi:10.1111/j.1471-8286.2005.01155.x]; [Anonymous], 2013, FED REG, V78, P78; Banks SC, 2013, TRENDS ECOL EVOL, V28, P670, DOI 10.1016/j.tree.2013.08.005; Betini GS, 2015, ECOL LETT, V18, P526, DOI 10.1111/ele.12432; Bielikova M, 2010, BIOLOGIA, V65, P1081, DOI 10.2478/s11756-010-0112-9; Bourke BP, 2010, CONSERV GENET, V11, P1837, DOI 10.1007/s10592-010-0076-x; BROWN JL, 1969, WILSON BULL, V81, P293; Bush KL, 2005, CONSERV GENET, V6, P867, DOI 10.1007/s10592-005-9040-6; Chabot AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043627; Clobert J., 2001, DISPERSAL CAUSES CON; Copeland Holly E., 2011, P7; Corander J, 2006, FISH B-NOAA, V104, P550; Dawnay N, 2009, FORENSIC SCI INT-GEN, V3, pE63, DOI 10.1016/j.fsigen.2008.07.001; Domenech R, 2015, J RAPTOR RES, V49, P429, DOI 10.3356/rapt-49-04-429-440.1; Doyle JM, 2016, CONSERV GENET, V17, P1307, DOI 10.1007/s10592-016-0863-0; Doyle JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095599; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Ferrer M, 2008, J APPL ECOL, V45, P1453, DOI 10.1111/j.1365-2664.2008.01497.x; Fu YX, 1997, GENETICS, V147, P915; Gebhardt KJ, 2009, J FIELD ORNITHOL, V80, P183, DOI 10.1111/j.1557-9263.2009.00221.x; Haig SM, 2011, AUK, V128, P205, DOI 10.1525/auk.2011.128.2.205; Haworth PF, 2006, BIRD STUDY, V53, P265, DOI 10.1080/00063650609461442; Hether TD, 2012, J EVOLUTION BIOL, V25, P1039, DOI 10.1111/j.1420-9101.2012.02497.x; Hoffman SW, 2003, CONDOR, V105, P397, DOI 10.1650/7146; Hull JM, 2008, CONSERV GENET, V9, P305, DOI 10.1007/s10592-007-9342-y; Hull JM, 2008, MOL ECOL, V17, P810, DOI 10.1111/j.1365-294X.2007.03632.x; Hunt G, 2006, CEC5002006056 PIER E, P17; Hunt WG, 1998, OIKOS, V82, P191, DOI 10.2307/3546929; Jeltsch F, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-6; Johnson GD, 2011, AVIAN BAT HABITAT CU; Kalinowski ST, 2002, MOL ECOL, V11, P1263, DOI 10.1046/j.1365-294X.2002.01520.x; Katzner T, 2012, AUK, V129, P168, DOI 10.1525/auk.2011.11078; Katzner TE, 2017, CONSERV BIOL, V31, P406, DOI 10.1111/cobi.12836; Kochert M. N., 2002, GOLDEN EAGLE AQUILA; Kochert MN, 2002, J RAPTOR RES, V36, P32; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Liedvogel M, 2011, TRENDS ECOL EVOL, V26, P561, DOI 10.1016/j.tree.2011.07.009; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Masuda R, 1998, ZOO BIOL, V17, P111, DOI 10.1002/(SICI)1098-2361(1998)17:2<111::AID-ZOO6>3.0.CO;2-C; McIntyre CL, 2008, AUK, V125, P214, DOI 10.1525/auk.2008.125.1.214; Mcintyre CL, 2012, IBIS, V154, P124, DOI 10.1111/j.1474-919X.2011.01181.x; Miller MP, 2012, J HERED, V103, P503, DOI 10.1093/jhered/ess024; Millsap BA, 2006, WILDLIFE SOC B, V34, P1392, DOI 10.2193/0091-7648(2006)34[1392:EOFHOW]2.0.CO;2; Millsap BA, 2014, J RAPTOR RES, V48, P13, DOI 10.3356/JRR-13-00005.1; Millsap BA, 2013, J WILDLIFE MANAGE, V77, P1436, DOI 10.1002/jwmg.588; Nebel C, 2015, BIOL J LINN SOC, V116, P328, DOI 10.1111/bij.12583; Newton I., 1988, P761; Oyler-McCance Sara J., 2005, P632; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pagel JE, 2013, J RAPTOR RES, V47, P311, DOI 10.3356/JRR-12-00019.1; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Paprocki N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086814; Pearce JM, 2006, CONDOR, V108, P474, DOI 10.1650/0010-5422(2006)108[474:DGATVO]2.0.CO;2; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Poessel SA, 2016, EUR J WILDLIFE RES, V62, P377, DOI 10.1007/s10344-016-1010-4; Pritchard JK, 2000, GENETICS, V155, P945; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Runge JP, 2006, AM NAT, V167, P925, DOI 10.1086/503531; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Sergio F, 2006, BIOL CONSERV, V133, P32, DOI 10.1016/j.biocon.2006.05.015; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Sonsthagen SA, 2012, BIOL CONSERV, V146, P116, DOI 10.1016/j.biocon.2011.11.031; Steenhof K, 1997, J ANIM ECOL, V66, P350, DOI 10.2307/5981; STEENHOF K, 1984, J FIELD ORNITHOL, V55, P357; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Suchentrunk F, 1999, BIOL CONSERV, V90, P151, DOI 10.1016/S0006-3207(99)00025-7; TAJIMA F, 1989, GENETICS, V123, P597; Taylor BL, 1999, MOL ECOL, V8, pS11, DOI 10.1046/j.1365-294X.1999.00797.x; U. S. Fish and Wildlife Service/, 2016, BALD GOLDEN EAGLES P; USFWS, 2009, FIN ENV ASS PROP PER; USFWS, 2008, BIRDS CONS CONC 2008, P85; USFWS, 2014, FED REGISTER, V79, P35564; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilcove D.S., 1984, American Birds, V38, P10	81	7	7	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164248	10.1371/journal.pone.0164248	http://dx.doi.org/10.1371/journal.pone.0164248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783687	Green Submitted, Green Published, gold			2022-12-26	WOS:000389602800033
J	Dellabianca, NA; Pierce, GJ; Rey, AR; Scioscia, G; Miller, DL; Torres, MA; Viola, MNP; Goodall, RNP; Schiavini, ACM				Dellabianca, Natalia A.; Pierce, Graham J.; Raya Rey, Andrea; Scioscia, Gabriela; Miller, David L.; Torres, Monica A.; Paso Viola, M. Natalia; Goodall, R. Natalie P.; Schiavini, Adrian C. M.			Spatial Models of Abundance and Habitat Preferences of Commerson's and Peale's Dolphin in Southern Patagonian Waters	PLOS ONE			English	Article							CETACEAN HABITAT; CLIMATE-CHANGE; MARINE; VARIABILITY	Commerson's dolphins (Cephalorhynchus c. commersonii) and Peale's dolphins (Lagenorhynchus australis) are two of the most common species of cetaceans in the coastal waters of southwest South Atlantic Ocean. Both species are listed as Data Deficient by the IUCN, mainly due to the lack of information about population sizes and trends. The goal of this study was to build spatially explicit models for the abundance of both species in relation to environmental variables using data collected during eight scientific cruises along the Patagonian shelf. Spatial models were constructed using generalized additive models. In total, 88 schools (212 individuals) of Commerson's dolphin and 134 schools (465 individuals) of Peale's dolphin were recorded in 8,535 km surveyed. Commerson's dolphin was found less than 60 km from shore; whereas Peale's dolphins occurred over a wider range of distances from the coast, the number of animals sighted usually being larger near or far from the coast. Fitted models indicate overall abundances of approximately 22,000 Commerson's dolphins and 20,000 Peale's dolphins in the total area studied. This work provides the first large-scale abundance estimate for Peale's dolphin in the Atlantic Ocean and an update of population size for Commerson's dolphin. Additionally, our results contribute to baseline data on suitable habitat conditions for both species in southern Patagonia, which is essential for the implementation of adequate conservation measures.	[Dellabianca, Natalia A.; Raya Rey, Andrea; Scioscia, Gabriela; Torres, Monica A.; Paso Viola, M. Natalia; Goodall, R. Natalie P.; Schiavini, Adrian C. M.] Ctr Austral Invest Cient CADIC CONICET, Ushuaia, Tierra Del Fueg, Argentina; [Dellabianca, Natalia A.; Torres, Monica A.; Goodall, R. Natalie P.] Museo Acatushun Aves & Mamiferos Marinos Australe, Ushuaia, Tierra Del Fueg, Argentina; [Pierce, Graham J.] Univ Aberdeen, Oceanlab, Newburgh, Aberdeen, Scotland; [Pierce, Graham J.] Univ Aveiro, CESAM, Aveiro, Portugal; [Pierce, Graham J.] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Miller, David L.] Integrated Stat, Woods Hole, MA USA; [Miller, David L.] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Scotland; [Miller, David L.] Univ St Andrews, Sch Math & Stat, St Andrews, Scotland	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Aberdeen; Universidade de Aveiro; Universidade de Aveiro; University of St Andrews; University of St Andrews	Dellabianca, NA (corresponding author), Ctr Austral Invest Cient CADIC CONICET, Ushuaia, Tierra Del Fueg, Argentina.; Dellabianca, NA (corresponding author), Museo Acatushun Aves & Mamiferos Marinos Australe, Ushuaia, Tierra Del Fueg, Argentina.	ndellabianc@gmail.com	Pierce, Graham/A-5404-2018	Pierce, Graham/0000-0002-4744-4501; Paso Viola, Maria Natalia/0000-0001-9344-1910; Miller, David/0000-0002-9640-6755; Raya Rey, Andrea/0000-0003-0127-6650; Schiavini, Adrian Carlos Miguel/0000-0001-6621-4827	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); CONICET; Cetacean Society International	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Cetacean Society International	This research was possible with the support of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). Funding for travel to and accommodation for NAD in Aberdeen, Scotland was provided by CONICET and Cetacean Society International. The work of NAD was part of a postdoctoral fellowship funded by CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; AGUAYOL A, 1975, J FISH RES BOARD CAN, V32, P1123, DOI 10.1139/f75-134; Aiguez MA, 1997, REP INT WHAL COMMN, V47, P723; Ballance LT, 2009, ENCY MARINE MAMMALS, P208, DOI 10.1016/B978-0-12-373553-9.00052-3; Best B, 2009, PREDICTIVE MARINE MA, P119; Borchers D.L., 2002, ESTIMATING ANIMAL AB; Brownell Jr R. L., 1999, HDB MARINE MAMMALS 2, V6, P105; Buckland S.T., 2001, pi; Coscarella Mariano A., 2003, Journal of Cetacean Research and Management, V5, P77; Coscarella MA, 2010, J ETHOL, V28, P183, DOI 10.1007/s10164-009-0171-y; Cotte C, 2009, DEEP-SEA RES PT I, V56, P801, DOI 10.1016/j.dsr.2008.12.008; Crespo Enrique A., 1997, Journal of Northwest Atlantic Fishery Science, V22, P189; Davis RW, 2002, DEEP-SEA RES PT I, V49, P121, DOI 10.1016/S0967-0637(01)00035-8; Dellabianca N, 2012, POLAR BIOL, V35, P1921, DOI 10.1007/s00300-012-1217-0; Garaffo GV, 2011, MAR ECOL PROG SER, V421, P217, DOI 10.3354/meps08912; Garaffo GV, 2010, J MAMMAL, V91, P54, DOI 10.1644/09-MAMM-A-105R1.1; Gibbons J, 2002, PROGRAMA MONITOREO P; Gill PC, 2011, MAR ECOL PROG SER, V421, P243, DOI 10.3354/meps08914; Goodall R., 1994, HDB MARINE MAMMALS, P241; Goodall R.N.P., 1988, Reports of the International Whaling Commission Special Issue, P3; GOODALL R N P, 1978, Scientific Reports of the Whales Research Institute Tokyo, P197; Goodall R.N.P., 1980, REPORT INT WHALING C, V30, P445; Goodall R. Natalie P., 1997, Report of the International Whaling Commission, V47, P757; Goodall RNP, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P844; Goodall RNP, 1994, REP INT WHAL COMM, V15, P295; Hammond P. S., 2008, IUCN RED LIST THREAT; Harwood J, 2001, J MAMMAL, V82, P630, DOI 10.1644/1545-1542(2001)082<0630:MMATEI>2.0.CO;2; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; Heinrich S, 2006, THESIS; Iniguez Miguel A., 2003, Latin American Journal of Aquatic Mammals, V2, P87; Learmonth JA, 2006, OCEANOGR MAR BIOL, V44, P431; Leatherwood S., 1988, Reports of the International Whaling Commission Special Issue, P93; Lescrauwaet AC, 2000, REV CHIL HIST NAT, V73, P473; Lescrauwaet Ann-Katrien, 1997, Report of the International Whaling Commission, V47, P747; MacLeod Colin D., 2009, Endangered Species Research, V7, P125, DOI 10.3354/esr00197; Marra G, 2011, COMPUT STAT DATA AN, V55, P2372, DOI 10.1016/j.csda.2011.02.004; Marubini F, 2009, MAR ECOL PROG SER, V381, P297, DOI 10.3354/meps07893; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; Mora NJ, 2002, THESIS; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Palka DL, 2001, CAN J FISH AQUAT SCI, V58, P777, DOI 10.1139/cjfas-58-4-777; Pedraza S. N., 2008, THESIS; Pierce GJ, 2010, J MAR BIOL ASSOC UK, V90, P1547, DOI 10.1017/S0025315410000664; Reeves RR, 2013, IUCN RED LIST THREAT; Riccialdelli L, 2010, MAR ECOL PROG SER, V418, P235, DOI 10.3354/meps08826; Righi CF, 2013, AQUAT MAMM, V39, P1, DOI 10.1578/AM.39.1.2013.1; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Santora JA, 2010, MAR MAMMAL SCI, V26, P960, DOI 10.1111/j.1748-7692.2010.00377.x; Torres LG, 2008, ECOL APPL, V18, P1702, DOI 10.1890/07-1455.1; Venegas Claudio C., 1996, Anales del Instituto de la Patagonia Serie Ciencias Naturales, V24, P41; VENEGAS-C C, 1987, Anales del Instituto de la Patagonia Serie Ciencias Naturales, V17, P69; Viddi Francisco A., 2005, Aquatic Mammals, V31, P176, DOI 10.1578/AM.31.2.2005.176; Viddi FA, 2010, ICES J MAR SCI, V67, P959, DOI 10.1093/icesjms/fsp288; WHITE R.W., 2002, DISTRIBUTION SEABIRD; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2008, J ROY STAT SOC B, V70, P931, DOI 10.1111/j.1467-9868.2008.00665.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	58	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0163441	10.1371/journal.pone.0163441	http://dx.doi.org/10.1371/journal.pone.0163441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783627	Green Submitted, gold, Green Published			2022-12-26	WOS:000389602800016
J	Hankins, C; Warren, M; Njeuhmeli, E				Hankins, Catherine; Warren, Mitchell; Njeuhmeli, Emmanuel			Voluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geography	PLOS ONE			English	Article								Over 11 million voluntary medical male circumcisions (VMMC) have been performed of the projected 20.3 million needed to reach 80% adult male circumcision prevalence in priority sub-Saharan African countries. Striking numbers of adolescent males, outside the 15-49-year-old age target, have been accessing VMMC services. What are the implications of overall progress in scale-up to date? Can mathematical modeling provide further insights on how to efficiently reach the male circumcision coverage levels needed to create and sustain further reductions in HIV incidence to make AIDS no longer a public health threat by 2030? Considering ease of implementation and cultural acceptability, decision makers may also value the estimates that mathematical models can generate of immediacy of impact, cost-effectiveness, and magnitude of impact resulting from different policy choices. This supplement presents the results of mathematical modeling using the Decision Makers' Program Planning Tool Version 2.0 (DMPPT 2.0), the Actuarial Society of South Africa (ASSA2008) model, and the age structured mathematical (ASM) model. These models are helping countries examine the potential effects on program impact and cost-effectiveness of prioritizing specific subpopulations for VMMC services, for example, by client age, HIV-positive status, risk group, and geographical location. The modeling also examines long-term sustainability strategies, such as adolescent and/or early infant male circumcision, to preserve VMMC coverage gains achieved during rapid scale-up. The 2016-2021 UNAIDS strategy target for VMMC is an additional 27 million VMMC in high HIV-prevalence settings by 2020, as part of access to integrated sexual and reproductive health services for men. To achieve further scale-up, a combination of evidence, analysis, and impact estimates can usefully guide strategic planning and funding of VMMC services and related demand-creation strategies in priority countries. Mid-course corrections now can improve cost-effectiveness and scale to achieve the impact needed to help turn the HIV pandemic on its head within 15 years.	[Hankins, Catherine] London Sch Hyg & Trop Med, London, England; [Hankins, Catherine] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Warren, Mitchell] AVAC, New York, NY USA; [Njeuhmeli, Emmanuel] USAID, Washington, DC 20523 USA	University of London; London School of Hygiene & Tropical Medicine; United States Agency for International Development (USAID)	Njeuhmeli, E (corresponding author), USAID, Washington, DC 20523 USA.	enjeuhmeli@usaid.gov		Hankins, Catherine/0000-0002-1642-8592	United States President's Emergency Plan for AIDS Relief (PEPFAR); United States Agency for International Development (USAID) [AID-OAA-A-10-00067, AID-OAA-14-00026]	United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This manuscript is made possible by the generous support of the American people through the United States Presidents Emergency Plan for AIDS Relief (PEPFAR) with the United States Agency for International Development (USAID) under the Cooperative Agreement Health Policy Project, Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010, and Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of PEPFAR, USAID, or the United States Government.	Awad SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145729; Awad SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140818; Birx DL, 2014, DELIVERING AIDS FREE; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Futures Institute, 2011, GOALS MAN MOD EST EF; Haacker M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002012; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Katz I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-956; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164144; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155734; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158693; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156776; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157071; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156909; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153363; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156521; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158767; Njeuhmeli E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159167; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; PEPFAR, 2015, PEPFAR COUNTR REG OP PEPFAR COUNTR REG OP; PEPFAR, PEPFAR TECHN CONS CO; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Schneider MT, 2016, AIDS, V30, P1475, DOI 10.1097/QAD.0000000000001081; Tchuenche M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160207; Tobian AAR, 2015, NAT REV UROL, V12, P661, DOI 10.1038/nrurol.2015.253; UNAIDS, 2015, FAST TRACK COMB PREV; UNAIDS, 2015, UNAIDS 2016 2021 STR; UNAIDS, 2011, JOINT STRAT ACT FRAM; UNAIDS, 2015, UND FAST TRACK; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Weiss HA, 2010, BMC UROL, V10, DOI 10.1186/1471-2490-10-2; WHO, 2016, FRAMW VOL MED MAL CI	35	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0160699	10.1371/journal.pone.0160699	http://dx.doi.org/10.1371/journal.pone.0160699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783613	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000389602800006
J	Gella, P; Salas, M; Mencia, M				Gella, Pablo; Salas, Margarita; Mencia, Mario			Engineering Permissive Insertion Sites in the Bacteriophage Phi29 DNA-Linked Terminal Protein	PLOS ONE			English	Article							PHAGE PHI-29; PRIMING ACTIVITY; REPLICATION; POLYMERASE; INITIATION; AMPLIFICATION; PHAGE-PHI-29; RESIDUES; SEQUENCE; TRANSPOSITION	Many different DNA delivery vehicles have been developed and tested, all with their advantages and disadvantages. The bacteriophage phi29 terminal protein (TP) is covalently linked to the 5' ends of the phage genome during the DNA replication process. Our approach is to utilize this TP as a platform to incorporate different protein or peptide modules that can target the DNA to the interior of the cell, to the nucleus, or even to subcellular compartments. In order to be able to insert different peptide modules on the TP sequence to endow it with desired functions and/or eliminate unwanted regions of the protein, we have carried out a transposition screening to detect insertion-permissive points on the sequence of the TP. We report the functional characterization of 12 insertion mutants of the TP, and the identification of one site at position 38 that allows the insertion of peptides up to 17 amino acids in length while maintaining the ability of the TP to support DNA amplification in vitro. A protein with one insertion at that position containing a cysteine residue, a linker, and a thrombin recognition site was purified and its amplification activity was optimized.	[Gella, Pablo; Salas, Margarita; Mencia, Mario] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Salas, M; Mencia, M (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	msalas@cbm.csic.es; mmencia@cbm.csic.es	Mencía, Mario/F-8197-2013; Salas, Margarita/J-9873-2014; Mencia, Mario/AAS-4554-2020	Mencía, Mario/0000-0002-3151-929X; Salas, Margarita/0000-0001-5939-3441; Mencia, Mario/0000-0003-3936-0655; Gella, Pablo/0000-0003-4547-9898	Spanish Ministry of Economy and Competitiveness [BFU2014-52656]; Fundacion Ramon Areces; Consejo Superior de Investigaciones Cientificas	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion Ramon Areces; Consejo Superior de Investigaciones Cientificas	This work was supported by the Spanish Ministry of Economy and Competitiveness [BFU2014-52656 P to MS]; Fundacion Ramon Areces institutional grant to the Centro de Biologia Molecular 'Sever Ochoa'. Predoctoral fellowship JAEdoc of Consejo Superior de Investigaciones Cientificas to PG]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhasin A, 1999, J BIOL CHEM, V274, P37021, DOI 10.1074/jbc.274.52.37021; Billerbeck S, 2013, CHEMBIOCHEM, V14, P2310, DOI 10.1002/cbic.201300332; BLANCO L, 1994, P NATL ACAD SCI USA, V91, P12198, DOI 10.1073/pnas.91.25.12198; Buchholz CJ, 2015, TRENDS BIOTECHNOL, V33, P777, DOI 10.1016/j.tibtech.2015.09.008; Calles B, 2013, ACS SYNTH BIOL, V2, P594, DOI 10.1021/sb400050k; Chang HC, 2005, J MOL BIOL, V353, P397, DOI 10.1016/j.jmb.2005.08.052; Crystal RG, 2014, HUM GENE THER, V25, P3, DOI 10.1089/hum.2013.2527; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; del Prado A, 2012, NUCLEIC ACIDS RES, V40, P3886, DOI 10.1093/nar/gkr1283; Espin D, 2010, P NATL ACAD SCI USA, V107, P16548, DOI [10.1073/pnas.1010530107, DOI 10.1073/PNAS.1010530107]; GARMENDIA C, 1990, GENE, V88, P73, DOI 10.1016/0378-1119(90)90061-U; Giraldez T, 2005, J GEN PHYSIOL, V126, P429, DOI 10.1085/jgp.200509368; Goryshin IY, 1998, J BIOL CHEM, V273, P7367, DOI 10.1074/jbc.273.13.7367; GUTIERREZ J, 1986, VIROLOGY, V155, P474, DOI 10.1016/0042-6822(86)90209-6; HERMOSO JM, 1980, P NATL ACAD SCI-BIOL, V77, P6425, DOI 10.1073/pnas.77.11.6425; Holguera I, 2014, MOL MICROBIOL, V91, P232, DOI 10.1111/mmi.12456; Illana B, 1999, J BIOL CHEM, V274, P15073, DOI 10.1074/jbc.274.21.15073; Illana B, 1998, VIROLOGY, V248, P12, DOI 10.1006/viro.1998.9276; Kamtekar S, 2006, EMBO J, V25, P1335, DOI 10.1038/sj.emboj.7601027; Kauffman WB, 2015, TRENDS BIOCHEM SCI, V40, P749, DOI 10.1016/j.tibs.2015.10.004; Ketteler R, 2002, J BIOL CHEM, V277, P26547, DOI 10.1074/jbc.M202287200; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Lazaro JM, 1995, PURIFICATION BACTERI, V262, P42; Liu H, 2003, CURR TOP MICROBIOL, V272, P131; Martinez-Garcia E, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-38; Mencia M, 2011, P NATL ACAD SCI USA, V108, P18655, DOI 10.1073/pnas.1114397108; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PENALVA MA, 1982, P NATL ACAD SCI-BIOL, V79, P5522, DOI 10.1073/pnas.79.18.5522; Perez-Arnaiz P, 2007, NUCLEIC ACIDS RES, V35, P7061, DOI 10.1093/nar/gkm749; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramamoorth M, 2015, J CLIN DIAGN RES, V9, pGE1, DOI 10.7860/JCDR/2015/10443.5394; Redondo RA, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00216-13, DOI 10.1128/GENOMEA.00216-13]; Redrejo-Rodriguez M, 2012, P NATL ACAD SCI USA, V109, P18482, DOI 10.1073/pnas.1216635109; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SALAS M, 1978, J MOL BIOL, V119, P269, DOI 10.1016/0022-2836(78)90438-2; Salas M., 2006, RECENT ADV DNA VIRUS, P259; Serna-Rico A, 2000, J BIOL CHEM, V275, P40529, DOI 10.1074/jbc.M007855200; Silva AC, 2015, CURR DRUG METAB, V16, P3, DOI 10.2174/1389200216666150401110211; SOENGAS MS, 1995, J MOL BIOL, V253, P517, DOI 10.1006/jmbi.1995.0570; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; ZABALLOS A, 1989, GENE, V83, P187, DOI 10.1016/0378-1119(89)90104-2; ZABALLOS A, 1989, NUCLEIC ACIDS RES, V17, P10353, DOI 10.1093/nar/17.24.10353	43	0	0	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164901	10.1371/journal.pone.0164901	http://dx.doi.org/10.1371/journal.pone.0164901			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780219	gold, Green Published			2022-12-26	WOS:000389046900023
J	Kuklik, P; Schaffer, B; Hoffmann, BA; Ganesan, AN; Schreiber, D; Moser, JM; Akbulak, RO; Sultan, A; Steven, D; Maesen, B; Schotten, U; Meyer, C; Willems, S				Kuklik, Pawel; Schaeffer, Benjamin; Hoffmann, Boris A.; Ganesan, Anand N.; Schreiber, Doreen; Moser, Julia M.; Akbulak, Ruken O.; Sultan, Arian; Steven, Daniel; Maesen, Bart; Schotten, Ulrich; Meyer, Christian; Willems, Stephan			Local Electrical Dyssynchrony during Atrial Fibrillation: Theoretical Considerations and Initial Catheter Ablation Results	PLOS ONE			English	Article							PULMONARY VEIN ISOLATION; EXCITABLE MEDIA; AF; ELECTROGRAMS; MULTICENTER; SUBSTRATE	Background Electrogram-based identification of the regions maintaining persistent Atrial Fibrillation (AF) is a subject of ongoing debate. Here, we explore the concept of local electrical dyssynchrony to identify AF drivers. Methods and Results Local electrical dyssynchrony was calculated using mean phase coherence. High-density epicardial mapping along with mathematical model were used to explore the link between local dyssynchrony and properties of wave conduction. High-density mapping showed a positive correlation between the dyssynchrony and number of fibrillatory waves (R-2 = 0.68, p<0.001). In the mathematical model, virtual ablation at high dyssynchrony regions resulted in conduction regularization. The clinical study consisted of eighteen patients undergoing catheter ablation of persistent AF. High-density maps of left atrial (LA) were constructed using a circular mapping catheter. After pulmonary vein isolation, regions with the top 10% of the highest dyssynchrony in LA were targeted during ablation and followed with ablation of complex atrial electrograms. Catheter ablation resulted in termination during ablation at high dyssynchrony regions in 7 (41%) patients. In another 4 (24%) patients, transient organization was observed. In 6 (35%) there was no clear effect. Long-term follow-up showed 65% AF freedom at 1 year and 22% at 2 years. Conclusions Local electrical dyssynchrony provides a reasonable estimator of regional AF complexity defined as the number of fibrillatory waves. Additionally, it points to regions of dynamical instability related with action potential alternans. However, despite those characteristics, its utility in guiding catheter ablation of AF is limited suggesting other factors are responsible for AF persistence.	[Kuklik, Pawel; Schaeffer, Benjamin; Hoffmann, Boris A.; Schreiber, Doreen; Moser, Julia M.; Akbulak, Ruken O.; Sultan, Arian; Steven, Daniel; Meyer, Christian; Willems, Stephan] Univ Hamburg Hosp, Univ Heart Ctr, Dept Cardiol Electrophysiol, Hamburg, Germany; [Ganesan, Anand N.] Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia; [Ganesan, Anand N.] Flinders Med Ctr, Dept Cardiovasc Med, Adelaide, SA, Australia; [Maesen, Bart] Maastricht Univ, Dept Cardiothorac Surg, Med Ctr, Maastricht, Netherlands; [Schotten, Ulrich] Maastricht Univ, Dept Physiol, Maastricht, Netherlands; [Meyer, Christian; Willems, Stephan] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Flinders University South Australia; Flinders Medical Centre; Maastricht University; Maastricht University; German Centre for Cardiovascular Research	Kuklik, P (corresponding author), Univ Hamburg Hosp, Univ Heart Ctr, Dept Cardiol Electrophysiol, Hamburg, Germany.	p.kuklik@uke.de	Ganesan, Anand/AAG-9125-2021; Maesen, Bart/AAH-3272-2019; Ganesan, Anand N/A-4902-2019; Kuklik, Pawel/A-8813-2011	Ganesan, Anand/0000-0002-2734-3025; Maesen, Bart/0000-0001-8622-1450; Ganesan, Anand N/0000-0002-2734-3025; Sultan, Arian/0000-0003-1807-4860; Meyer, Christian/0000-0003-0217-3960; Kuklik, Pawel/0000-0001-8440-654X; Schotten, Ulrich/0000-0003-1532-3315				Atienza F, 2014, J AM COLL CARDIOL, V64, P2455, DOI 10.1016/j.jacc.2014.09.053; Baumert M, 2016, P IEEE, V104, P416, DOI 10.1109/JPROC.2015.2505318; Benharash P, 2015, CIRC-ARRHYTHMIA ELEC, V8, P554, DOI 10.1161/CIRCEP.115.002721; Haissaguerre M, 2005, J CARDIOVASC ELECTR, V16, P1125, DOI 10.1111/j.1540-8167.2005.00307.x; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hiromoto K, 2005, CIRC J, V69, P1368, DOI 10.1253/circj.69.1368; Kuklik P, 2005, CHAOS, V15, DOI 10.1063/1.1947427; Kuklik P, 2014, IEEE T BIOMEDICAL EN, DOI [10.1109/TBME.2014, DOI 10.1109/TBME.2014]; Lau DH, 2015, HEART RHYTHM, V12, P1415, DOI 10.1016/j.hrthm.2015.03.017; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Narayan SM, 2011, CIRCULATION, V123, P2922, DOI 10.1161/CIRCULATIONAHA.110.977827; Nishida K, 2010, J AM COLL CARDIOL, V56, P1728, DOI 10.1016/j.jacc.2010.05.051; Oral H, 2009, J AM COLL CARDIOL, V53, P782, DOI 10.1016/j.jacc.2008.10.054; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; ten Tusscher KHWJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.062902; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Verma A, 2014, CIRC-ARRHYTHMIA ELEC, V7, P55, DOI 10.1161/CIRCEP.113.000890; Vogler J, 2015, J AM COLL CARDIOL, V66, P2743, DOI 10.1016/j.jacc.2015.09.088; Wynn GJ, 2016, HEART RHYTHM, V13, P399, DOI 10.1016/j.hrthm.2015.10.006; Zeemering S, 2012, IEEE ENG MED BIO, P6357, DOI 10.1109/EMBC.2012.6347448	20	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164236	10.1371/journal.pone.0164236	http://dx.doi.org/10.1371/journal.pone.0164236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780243	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900008
J	Nishiguchi, KM; Yokoyama, Y; Fujii, Y; Fujita, K; Tomiyama, Y; Kawasaki, R; Furukawa, T; Ono, F; Shimozawa, N; Togo, M; Suzuki, M; Nakazawa, T				Nishiguchi, Koji M.; Yokoyama, Yu; Fujii, Yusuke; Fujita, Kosuke; Tomiyama, Yusuke; Kawasaki, Ryo; Furukawa, Toshinori; Ono, Fumiko; Shimozawa, Nobuhiro; Togo, Mutsumi; Suzuki, Michihiro; Nakazawa, Toru			Analysis of Macular Drusen and Blood Test Results in 945 Macaca fascicularis	PLoS One			English	Article							AGE-RELATED MACULOPATHY; FACTOR-H POLYMORPHISM; RHESUS-MONKEYS; BRUCHS MEMBRANE; HIGH-RISK; DEGENERATION; VARIANT; GENES; ASSOCIATION; PREVALENCE	Age-dependent formation of macular drusen caused by the focal accumulation of extracellular deposits beneath the retinal pigment epithelium precede the development of age related macular degeneration (AMD), one of the leading causes of blindness worldwide. It is established that inflammation contributes to the pathogenesis of drusen and AMD. However, development of a preemptive therapeutic strategy targeting macular drusen and AMD has been impeded by the lack of relevant animal models because most laboratory animals lack macula, an anatomic feature present only in humans and a subset of monkeys. Reportedly, macular drusen and macular degeneration develop in monkeys in an age-dependent manner. In this study, we analyzed blood test results from 945 Macaca fascicularis, 317 with and 628 without drusen. First, a trend test for drusen frequency (the Cochran-Armitage test) was applied to the quartile data for each parameter. We selected variables with an increasing or decreasing trend with higher quartiles at P < 0.05, to which multivariate logistic regression analysis was applied. This revealed a positive association of age (odds ratio [OR]: 1.10 per year, 95% confidence interval [CI]: 1.07-1.12) and white blood cell count (OR: 1.01 per 1 x 10(3)/mu l, 95% CI: 1.00-1.01) with drusen. When the monkeys were divided by age, the association between drusen and white blood cell count was only evident in younger monkeys (OR: 1.01 per 1 x 10(3)/mu l, 95% CI: 1.00-1.02). In conclusion, age and white blood cell count may be associated with drusen development in M. fascicularis. Systemic inflammation may contribute to drusen formation in monkeys.	[Nishiguchi, Koji M.; Nakazawa, Toru] Tohoku Univ, Dept Adv Ophthalm Med, Grad Sch Med, Sendai, Miyagi, Japan; [Yokoyama, Yu; Fujii, Yusuke; Tomiyama, Yusuke; Nakazawa, Toru] Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi, Japan; [Fujita, Kosuke; Nakazawa, Toru] Tohoku Univ, Dept Retinal Dis Control, Grad Sch Med, Sendai, Miyagi, Japan; [Kawasaki, Ryo] Yamagata Univ, Dept Publ Hlth, Grad Sch Med Sci, Yamagata, Japan; [Furukawa, Toshinori] Kurashiki Univ Sci & Arts, Dept Comparat Anim Sci, Kurashiki, Okayama, Japan; [Ono, Fumiko] Chiba Inst Sci, Fac Risk Management, Choshi, Japan; [Ono, Fumiko] Chiba Inst Sci, Fac Crisis Management, Choshi, Japan; [Shimozawa, Nobuhiro] Natl Inst Biomed Innovat Hlth & Nutr, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan; [Togo, Mutsumi; Suzuki, Michihiro] Corp Prod & Res Lab Primates, Tsukuba, Ibaraki, Japan	Tohoku University; Tohoku University; Tohoku University; Yamagata University	Nishiguchi, KM (corresponding author), Tohoku Univ, Dept Adv Ophthalm Med, Grad Sch Med, Sendai, Miyagi, Japan.	nishiguchi@oph.med.tohoku.ac.jp	Kawasaki, Ryo/B-7266-2009; Kawasaki, Ryo/H-9716-2019	Kawasaki, Ryo/0000-0002-7492-6303; 	Japan Society for the Promotion of Science KAKENHI [TN 26293372, KMN 16K11315]; SENJU Pharmaceutical Co., Ltd	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SENJU Pharmaceutical Co., Ltd	This study was supported by Japan Society for the Promotion of Science KAKENHI Grants-in-Aid for Scientific Research B (TN 26293372) and Japan Society for the Promotion of Science KAKENHI Grants-in-Aid for Scientific Research Research C (KMN 16K11315). This study was also supported by SENJU Pharmaceutical Co., Ltd (KMN and TN). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Airi Takagi at the Clinical Research, Innovation and Education Center, Tohoku University Hospital for the constructive discussion and kindly providing advice for our statistical analysis. The manuscript was edited by a professional English editing service (Enago, Tokyo, Japan; www.enago.jp).	BRESSLER NM, 1995, ARCH OPHTHALMOL-CHIC, V113, P301, DOI 10.1001/archopht.1995.01100030055022; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; ELMOFTY AAM, 1980, EXP EYE RES, V31, P147, DOI 10.1016/0014-4835(80)90075-5; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Francis PJ, 2008, HUM MOL GENET, V17, P2673, DOI 10.1093/hmg/ddn167; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gouras P, 2008, GRAEF ARCH CLIN EXP, V246, P1395, DOI 10.1007/s00417-008-0910-8; Gouras P, 2010, GRAEF ARCH CLIN EXP, V248, P973, DOI 10.1007/s00417-010-1325-x; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; HOPE GM, 1992, BRIT J OPHTHALMOL, V76, P11, DOI 10.1136/bjo.76.1.11; Johnson PT, 2003, INVEST OPHTH VIS SCI, V44, P4481, DOI 10.1167/iovs.03-0436; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Kobayashi H, 2014, EXP ANIM TOKYO, V63, P305, DOI 10.1538/expanim.63.305; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; MONACO WA, 1990, OPTOMETRY VISION SCI, V67, P532, DOI 10.1097/00006324-199007000-00011; Nicolas MG, 1996, EXP EYE RES, V62, P211, DOI 10.1006/exer.1996.0026; Nishiguchi KM, 2012, INVEST OPHTH VIS SCI, V53, P508, DOI 10.1167/iovs.11-8425; Robman L, 2005, AM J EPIDEMIOL, V161, P1013, DOI 10.1093/aje/kwi130; SARKS JP, 1994, EYE, V8, P269, DOI 10.1038/eye.1994.57; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Shankar A, 2007, AM J EPIDEMIOL, V165, P375, DOI 10.1093/aje/kwk022; Suzuki MT, 2003, PRIMATES, V44, P291, DOI 10.1007/s10329-002-0016-6; Tsuchida J, 2008, J AM ASSOC LAB ANIM, V47, P29; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; Umeda S, 2005, INVEST OPHTH VIS SCI, V46, P683, DOI 10.1167/iovs.04-1031; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164899	10.1371/journal.pone.0164899	http://dx.doi.org/10.1371/journal.pone.0164899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776188	Green Published, gold			2022-12-26	WOS:000389009200027
J	Kont, R; Kari, J; Borch, K; Westh, P; Valjamae, P				Kont, Riin; Kari, Jeppe; Borch, Kim; Westh, Peter; Valjamae, Priit			Inter-domain Synergism Is Required for Efficient Feeding of Cellulose Chain into Active Site of Cellobiohydrolase Cel7A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; CARBOHYDRATE-BINDING MODULES; CRYSTALLINE CELLULOSE; RECALCITRANT POLYSACCHARIDES; PROCESSIVE CELLULASES; GLYCOSIDE HYDROLASES; SUBSTRATE AFFINITY; KINETIC-MODEL; HYDROLYSIS; DEGRADATION	Structural polysaccharides like cellulose and chitin are abundant and their enzymatic degradation to soluble sugars is an important route in green chemistry. Processive glycoside hydrolases (GHs), like cellobiohydrolase Cel7A of Trichoderma reesei (TrCel7A) are key components of efficient enzyme systems. TrCel7A consists of a catalytic domain (CD) and a smaller carbohydrate-binding module (CBM) connected through the glycosylated linker peptide. A tunnel-shaped active site rests in the CD and contains 10 glucose unit binding sites. The active site of TrCel7A is lined with four Trp residues with two of them, Trp-40 and Trp-38, in the substrate binding sites near the tunnel entrance. Although addressed in numerous studies the elucidation of the role of CBM and active site aromatics has been obscured by a complex multistep mechanism of processive GHs. Here we studied the role of the CBM-linker and Trp-38 of TrCel7A with respect to binding affinity, on-and off-rates, processivity, and synergism with endoglucanase. The CBM-linker increased the on-rate and substrate affinity of the enzyme. The Trp-38 to Ala substitution resulted in increased off-rates and decreased processivity. The effect of the Trp-38 to Ala substitution on on-rates was strongly dependent on the presence of the CBM-linker. This compensation between CBM-linker and Trp-38 indicates synergism between CBM-linker and CD in feeding the cellulose chain into the active site. The inter-domain synergism was pre-requisite for the efficient degradation of cellulose in the presence of endoglucanase.	[Kont, Riin; Valjamae, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Kari, Jeppe; Westh, Peter] Roskilde Univ, Dept Sci & Environm, DK-4000 Roskilde, Denmark; [Borch, Kim] Novozymes AS, DK-2880 Bagsvaerd, Denmark	University of Tartu; Roskilde University; Novozymes	Valjamae, P (corresponding author), Riia 23B-202, EE-51010 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018; Kari, Jeppe/AAP-6649-2021; Westh, Peter/AAR-9731-2021	Väljamäe, Priit/0000-0002-1035-9493; Kari, Jeppe/0000-0003-3792-3856; Westh, Peter/0000-0002-6185-0637	Danish Agency for Science, Technology, and Innovation; Programme Commission on Sustainable Energy and Environment [2104-07-0028]; Carlsberg Foundation [2013-01-0208]; Estonian Science Agency [PUT1024]; Novo Nordisk Fonden [NNF15OC0016606] Funding Source: researchfish	Danish Agency for Science, Technology, and Innovation; Programme Commission on Sustainable Energy and Environment; Carlsberg Foundation(Carlsberg Foundation); Estonian Science Agency; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Agency for Science, Technology, and Innovation, Programme Commission on Sustainable Energy and Environment Grant 2104-07-0028, Carlsberg Foundation Grant 2013-01-0208, and Estonian Science Agency Grant PUT1024. K. B. works at Novozymes, which is a major enzyme producing company.	Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; BHIKHABHAI R, 1984, Journal of Applied Biochemistry, V6, P336; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Cruys-Bagger N, 2016, J PHYS CHEM B, V120, P5591, DOI 10.1021/acs.jpcb.6b01877; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Fox JM, 2013, NAT CHEM BIOL, V9, P356, DOI 10.1038/nchembio.1227; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; GhattyVenkataKrishna PK, 2013, BIOPHYS J, V104, P904, DOI 10.1016/j.bpj.2012.12.052; Guo J, 2013, BIOMACROMOLECULES, V14, P1268, DOI 10.1021/bm300810t; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Hilden L, 2005, J BIOTECHNOL, V118, P386, DOI 10.1016/j.jbiotec.2005.05.001; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jalak J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108181; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jana S, 2016, J PHYS CHEM B, V120, P1236, DOI 10.1021/acs.jpcb.5b12610; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Kostylev M, 2014, BIOTECHNOL BIOENG, V111, P664, DOI 10.1002/bit.25139; Kostylev M, 2013, BIOCHEMISTRY-US, V52, P5656, DOI 10.1021/bi400358v; Kurasin M, 2015, J BIOL CHEM, V290, P29074, DOI 10.1074/jbc.M115.684977; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; Luterbacher JS, 2013, BIOTECHNOL BIOENG, V110, P108, DOI 10.1002/bit.24597; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Nakamura A, 2013, J BIOL CHEM, V288, P13503, DOI 10.1074/jbc.M113.452623; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Sammond DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048615; Shang BZ, 2013, J BIOL CHEM, V288, P29081, DOI 10.1074/jbc.M113.497412; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Sipos B, 2010, APPL BIOCHEM BIOTECH, V161, P347, DOI 10.1007/s12010-009-8824-4; Sorensen TH, 2015, J BIOL CHEM, V290, P22193, DOI 10.1074/jbc.M115.658930; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Sugimoto N, 2012, LANGMUIR, V28, P14323, DOI 10.1021/la302352k; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Valjamae P, 2001, EUR J BIOCHEM, V268, P4520, DOI 10.1046/j.1432-1327.2001.02377.x; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Varnai A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-30; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhang G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7625; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x	71	24	25	4	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26013	26023		10.1074/jbc.M116.756007	http://dx.doi.org/10.1074/jbc.M116.756007			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27780868	Green Published, hybrid			2022-12-26	WOS:000390345200021
J	Bleymuller, WM; Lammermann, N; Ebbes, M; Maynard, D; Geerds, C; Niemann, HH				Bleymueller, Willem M.; Laemmermann, Nina; Ebbes, Maria; Maynard, Daniel; Geerds, Christina; Niemann, Hartmut H.			MET-activating Residues in the B-repeat of the Listeria monocytogenes Invasion Protein InlB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cell surface receptor; dimerization; growth factor; protein domain; protein structure; protein-protein interaction; receptor tyrosine kinase; signal transduction; structure-function	RECEPTOR TYROSINE KINASE; HEPATOCYTE GROWTH-FACTOR; LEUCINE-RICH REPEAT; STEM-CELL FACTOR; TUMOR PROGRESSION; STRUCTURAL BASIS; MAMMALIAN-CELLS; SCATTER FACTOR; INIB PROTEIN; GW DOMAINS	The facultative intracellular pathogen Listeria monocytogenes causes listeriosis, a rare but life-threatening disease. Host cell entry begins with activation of the human receptor tyrosine kinase MET through the bacterial invasion protein InlB, which contains an internalin domain, a B-repeat, and three GW domains. The internalin domain is known to bind MET, but no interaction partner is known for the B-repeat. Adding the B-repeat to the internalin domain potentiates MET activation and is required to stimulate Madin-Darby canine kidney (MDCK) cell scatter. Therefore, it has been hypothesized that the B-repeat may bind a co-receptor on host cells. To test this hypothesis, we mutated residues that might be important for binding an interaction partner. We identified two adjacent residues in strand 2 of the -grasp fold whose mutation abrogated induction of MDCK cell scatter. Biophysical analysis indicated that these mutations do not alter protein structure. We then tested these mutants in human HT-29 cells that, in contrast to the MDCK cells, were responsive to the internalin domain alone. These assays revealed a dominant negative effect, reducing the activity of a construct of the internalin domain and mutated B-repeat below that of the individual internalin domain. Phosphorylation assays of MET and its downstream targets AKT and ERK confirmed the dominant negative effect. Attempts to identify a host cell receptor for the B-repeat were not successful. We conclude that there is limited support for a co-receptor hypothesis and instead suggest that the B-repeat contributes to MET activation through low affinity homodimerization.	[Bleymueller, Willem M.; Laemmermann, Nina; Ebbes, Maria; Maynard, Daniel; Geerds, Christina; Niemann, Hartmut H.] Univ Bielefeld, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany	University of Bielefeld	Niemann, HH (corresponding author), Univ Bielefeld, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany.	Hartmut.Niemann@uni-bielefeld.de	Niemann, Hartmut/F-7947-2011	Niemann, Hartmut/0000-0002-8582-0360	Deutsche Forschungsgemeinschaft [NI694/1-3, NI694/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants NI694/1-3 and NI694/3-1 from the Deutsche Forschungsgemeinschaft (to H. H. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Basilico C, 2014, J CLIN INVEST, V124, P3172, DOI 10.1172/JCI72316; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Bierne H, 2002, J CELL SCI, V115, P3357; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Burroughs AM, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-4; Carpenter BL, 2015, J BIOL CHEM, V290, P27228, DOI 10.1074/jbc.M115.686873; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chen PH, 2015, J MOL BIOL, V427, P3921, DOI 10.1016/j.jmb.2015.10.003; Copp J, 2003, J BIOL CHEM, V278, P7783, DOI 10.1074/jbc.M211666200; Dietz MS, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-6; Ebbes M, 2011, J BIOL CHEM, V286, P15496, DOI 10.1074/jbc.M110.189951; Ferraris DM, 2010, J MOL BIOL, V395, P522, DOI 10.1016/j.jmb.2009.10.074; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Graille M, 2001, STRUCTURE, V9, P679, DOI 10.1016/S0969-2126(01)00630-X; He LJ, 2012, BBA-BIOMEMBRANES, V1818, P995, DOI 10.1016/j.bbamem.2011.07.044; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7373; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Jung C, 2009, MOL MICROBIOL, V72, P1196, DOI 10.1111/j.1365-2958.2009.06716.x; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Koschut D, 2016, BBA-MOL CELL RES, V1863, P1552, DOI 10.1016/j.bbamcr.2016.04.015; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Machner MP, 2003, MOL MICROBIOL, V48, P1525, DOI 10.1046/j.1365-2958.2003.03532.x; Marino M, 2002, EMBO J, V21, P5623, DOI 10.1093/emboj/cdf558; Matsushita A, 2007, CANCER RES, V67, P10309, DOI 10.1158/0008-5472.CAN-07-3256; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Niemann HH, 2013, BBA-PROTEINS PROTEOM, V1834, P2195, DOI 10.1016/j.bbapap.2012.10.012; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Olaku V, 2011, MOL BIOL CELL, V22, P2777, DOI 10.1091/mbc.E11-02-0134; Opatowsky Y, 2014, P NATL ACAD SCI USA, V111, P1772, DOI 10.1073/pnas.1323254111; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Overington J.P., 1992, CURR OPIN STRUC BIOL, V2, P394, DOI 10.1016/0959-440X(92)90231-U; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Perica T, 2010, CURR OPIN STRUC BIOL, V20, P367, DOI 10.1016/j.sbi.2010.03.007; Reshetnyak AV, 2015, MOL CELL, V57, P191, DOI 10.1016/j.molcel.2014.11.021; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulz GE, 2010, J MOL BIOL, V395, P834, DOI 10.1016/j.jmb.2009.10.044; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; STERNBERG MJE, 1990, PROTEIN ENG, V3, P245, DOI 10.1093/protein/3.4.245; STOKER M, 1985, J CELL SCI, V77, P209; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Ueki R, 2016, ANGEW CHEM INT EDIT, V55, P579, DOI 10.1002/anie.201508572; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	61	6	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25567	25577		10.1074/jbc.M116.746685	http://dx.doi.org/10.1074/jbc.M116.746685			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27789707	Green Published, hybrid			2022-12-26	WOS:000390095300024
J	Jafari, N; Zheng, QD; Li, LQ; Li, W; Qi, L; Xiao, JY; Gao, TY; Huang, C				Jafari, Naser; Zheng, Qiaodan; Li, Liqing; Li, Wei; Qi, Lei; Xiao, Jianyong; Gao, Tianyan; Huang, Cai			p70S6K1 (S6K1)-mediated Phosphorylation Regulates Phosphatidylinositol 4-Phosphate 5-Kinase Type I Degradation and Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; cell migration; phosphatidylinositol kinase; protein degradation; S6 kinase; PIP5K1C	FOCAL ADHESION DYNAMICS; E3 UBIQUITIN LIGASES; PHOSPHATE KINASE; BREAST-CANCER; MATRIX METALLOPROTEINASES; N-WASP; MIGRATION; GAMMA; PROTEIN; TALIN	Phosphatidylinositol 4-phosphate 5-kinase type I (PIPKI90) ubiquitination and subsequent degradation regulate focal adhesion assembly, cell migration, and invasion. However, it is unknown how upstream signals control PIPKI90 ubiquitination or degradation. Here we show that p70S6K1 (S6K1), a downstream target of mechanistic target of rapamycin (mTOR), phosphorylates PIPKI90 at Thr-553 and Ser-555 and that S6K1-mediated PIPKI90 phosphorylation is essential for cell migration and invasion. Moreover, PIPKI90 phosphorylation is required for the development of focal adhesions and invadopodia, key machineries for cell migration and invasion. Surprisingly, substitution of Thr-553 and Ser-555 with Ala promoted PIPKI90 ubiquitination but enhanced the stability of PIPKI90, and depletion of S6K1 also enhanced the stability of PIPKI90, indicating that PIPKI90 ubiquitination alone is insufficient for its degradation. These data suggest that S6K1-mediated PIPKI90 phosphorylation regulates cell migration and invasion by controlling PIPKI90 degradation.	[Jafari, Naser; Zheng, Qiaodan; Li, Liqing; Li, Wei; Qi, Lei; Xiao, Jianyong; Gao, Tianyan; Huang, Cai] Univ Kentucky, Markey Canc Ctr, BBSRB Rm B359,741 S Limestone, Lexington, KY 40506 USA; [Huang, Cai] Univ Kentucky, Dept Pharmacol & Nutr Sci, BBSRB Rm B359,741 S Limestone, Lexington, KY 40506 USA; [Jafari, Naser; Huang, Cai] Vet Affairs Med Ctr, Lexington, KY 40502 USA	University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Huang, C (corresponding author), Univ Kentucky, Markey Canc Ctr, BBSRB Rm B359,741 S Limestone, Lexington, KY 40506 USA.; Huang, C (corresponding author), Univ Kentucky, Dept Pharmacol & Nutr Sci, BBSRB Rm B359,741 S Limestone, Lexington, KY 40506 USA.	cai-huang@uky.edu	li, li/GPX-3938-2022; Li, Li/AEM-3636-2022; li, li/HII-4157-2022; LI, LI QING/GRR-8855-2022; LI, LI/GVS-5344-2022; li, li/AAT-2097-2020		American Cancer Society Research Scholar [RSG-13-184-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA133429, P30CA177558] Funding Source: NIH RePORTER	American Cancer Society Research Scholar(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by American Cancer Society Research Scholar Grant RSG-13-184-01-CSM (to C. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Brown GT, 2015, J PATHOL, V237, P273, DOI 10.1002/path.4586; Chen C, 2015, ONCOGENE, V34, P4635, DOI 10.1038/onc.2014.393; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Dar A, 2014, MOL CELL BIOL, V34, P4049, DOI 10.1128/MCB.00838-14; Deng SS, 2014, CELL ADHES MIGR, V8, P49, DOI 10.4161/cam.27480; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Han SW, 2006, CANCER RES, V66, P315, DOI 10.1158/0008-5472.CAN-05-2367; HONEYMAN TW, 1983, BIOCHEM J, V212, P489, DOI 10.1042/bj2120489; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huang C, 2010, BIOTECHNIQUES, V49, P881, DOI 10.2144/000113550; Huang C, 2010, CELL ADHES MIGR, V4, P10, DOI 10.4161/cam.4.1.9834; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Khotskaya YB, 2014, AM J TRANSL RES, V6, P361; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Li X, 2013, J CELL SCI, V126, P2617, DOI 10.1242/jcs.117044; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Locascio A, 2001, CURR OPIN GENET DEV, V11, P464, DOI 10.1016/S0959-437X(00)00218-5; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Le OTT, 2015, BBA-MOL CELL RES, V1853, P2432, DOI 10.1016/j.bbamcr.2015.07.001; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Qi L, 2016, J CELL SCI, V129, P3661, DOI 10.1242/jcs.185959; Rafiq K, 2012, J BIOL CHEM, V287, P5327, DOI 10.1074/jbc.M111.307009; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sekine Y, 2007, J IMMUNOL, V179, P2397, DOI 10.4049/jimmunol.179.4.2397; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Shi Z, 2012, REPROD SYS SEX DISOR, V1, P102, DOI [10.4172/2161-038X.1000102, DOI 10.4172/2161-038X.1]; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Weiner H, 1999, FEBS LETT, V455, P75, DOI 10.1016/S0014-5793(99)00868-6; Wu ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024775; Xu Q, 2012, NUCLEIC ACIDS RES, V40, P761, DOI 10.1093/nar/gkr730; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	52	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25729	25741		10.1074/jbc.M116.742742	http://dx.doi.org/10.1074/jbc.M116.742742			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27780861	Green Published, hybrid			2022-12-26	WOS:000390095300037
J	Gong, WW; Wei, XL; Liang, YJ; Zou, GY; Hu, RY; Deng, SM; Zhang, ZT; Pan, J; Choi, BCK; Yu, M				Gong, Weiwei; Wei, Xiaolin; Liang, Yujia; Zou, Guanyang; Hu, Ruying; Deng, Simin; Zhang, Zhitong; Pan, Jing; Choi, Bernard C. K.; Yu, Min			Urban and Rural Differences of Acute Cardiovascular Disease Events: A Study from the Population-Based Real-Time Surveillance System in Zhejiang, China in 2012	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; STROKE INCIDENCE; GLOBAL BURDEN; EPIDEMIOLOGY; RISK; PREVALENCE; MORTALITY; MIDDLE; COMMUNITIES; SUBTYPES	Zhejiang province, China, has implemented a population based, real-time surveillance system that tracks acute cardiovascular diseases (CVDs) events since 2001. This study aimed to describe the system and report CVD incidence, mortality and case-fatality between urban and rural areas in Zhejiang in 2012. The surveillance system employs a stratified random sampling method covering all permanent residents of 30 counties/districts in Zhejiang. Acute CVD events such as coronary heart disease (CHD) and stroke were defined, registered and reviewed based on the adapted MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) definitions. Data were collected from health facilities, vital registries, supplementary surveys, and additional investigations, and were checked for data quality before input in the system. We calculated the rates and compared them by gender, age and region. In 2012, the incidence, mortality and case-fatality of total acute CVD events were 367.0 (CHD 59.1, stroke 307.9), 127.1 (CHD 43.3, stroke 83.8) per 100,000 and 34.6% (CHD 73.2%, stroke 27.2%), respectively. Compared with rural areas, urban areas reported higher incidence and mortality but lower case-fatality rates for CHD (P<0.001), while lower incidence but higher mortality and case-fatality rates for stroke (P<0.001). We found significant differences on CHD and stroke epidemics between urban and rural areas in Zhejiang. Special attentions need to be given to stroke control, especially in rural areas.	[Gong, Weiwei; Hu, Ruying; Pan, Jing; Yu, Min] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wei, Xiaolin; Choi, Bernard C. K.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Clin Publ Hlth, Toronto, ON, Canada; [Wei, Xiaolin; Choi, Bernard C. K.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Liang, Yujia; Zou, Guanyang; Deng, Simin; Zhang, Zhitong] China Global Hlth Res & Dev, Shenzhen, Peoples R China	University of Toronto; University of Toronto	Yu, M (corresponding author), Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	myu@cdc.zj.com			UK aid from the UK government; Department for International Development (DFID) [201025] Funding Source: researchfish	UK aid from the UK government(CGIAR); Department for International Development (DFID)	The authors would like to thank the county and municipality CDC, hospitals and health care facilities in Zhejiang who reported and quality checked the cardiovascular events. We also thank Nilam Ashra-McGrath for editorial support. This study obtained data-analysis guidance from COMDIS-HSD, a research consortium funded by UK aid from the UK government: however, the views expressed do not necessarily reflect the UK government's official policies.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Allender S, 2012, CORONARY HEART DIS S; Barrett-Connor E., 2011, NATIONWIDE FRAMEWORK; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Diseases CNCfC, 2012, REP CARD DIS CHIN; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Giampaoli S, 2007, EUR J CARDIOV PREV R, V14, pS23, DOI 10.1097/01.hjr.0000277987.10473.6f; Hata J, 2013, CIRC J, V77, P1923, DOI 10.1253/circj.CJ-13-0786; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Moran A. E., 2014, CIRCULATION; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; OECD, 2011, HOSP MORT FOLL AC MY; Ounpuu S, 2001, AM HEART J, V141, P711, DOI 10.1067/mhj.2001.114974; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Statistics ZPBo, 2013, STAT YB ZHEJ; Sun HX, 2013, J STROKE, V15, P109, DOI 10.5853/jos.2013.15.2.109; Tang X, 2013, J AM COLL CARDIOLOGY, V61; Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; Turin TC, 2007, CIRC J, V71, P1617, DOI 10.1253/circj.71.1617; Wang JH, 2015, NEUROLOGY, V84, P374, DOI 10.1212/WNL.0000000000001175; WANG Xiao-ping WY-k, 2007, CHINESE PRIMARY HLTH, V21; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Wegner M. V., 2010, Chronic disease epidemiology and control, P95; Wei XL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-354; Wei XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054169; WHO, 1999, WHO MONICA MAN; World Health Organization, 2015, RAIS BLOOD PRESS SBP; World Health Organization, TOB US DAT COUNTR; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Wu ZS, 2001, CIRCULATION, V103, P462; Xu H, 2015, AM HEART J; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; [俞敏 Yu Min], 2002, [中国卫生统计, Chinese Journal of Health Statistics], V19, P151; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423; Zhang YN, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/436125	45	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165647	10.1371/journal.pone.0165647	http://dx.doi.org/10.1371/journal.pone.0165647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802321	gold, Green Published, Green Submitted			2022-12-26	WOS:000386714200033
J	Shapiro, JM; Chung, WH; Ogawa, K; Barker, L; Carlson, R; Wands, JR; Li, JS				Shapiro, Jason M.; Chung, Waihong; Ogawa, Kosuke; Barker, Luke; Carlson, Rolf; Wands, Jack R.; Li, Jisu			Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPase	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; MEDIATED ENDOCYTOSIS; MALIGNANT PHENOTYPE; CANCER-CELLS; EXPRESSION; ANTIBODY; THERAPY; PROLIFERATION; LEUKEMIA; TISSUES	We previously isolated AF20, a murine monoclonal antibody that recognizes a cell surface glycoprotein of approximately 90-110 kDa. The AF20 antigen is specifically expressed in human hepatoma and colon cancer cell lines, and thus could serve as a cancer biomarker. To uncover the molecular identity of the AF20 antigen, a combination of ion-exchange chromatography, immunoprecipitation, and SDS-polyacrylamide gel electrophoresis was employed to purify the AF20 antigen followed by trypsin digestion and mass spectrometry. Surprisingly, three host proteins were thus purified from human hepatoma and colon cancer cell lines: transferrin receptor 1 (TFR1), heat shock protein 90 (HSP90), and Na+/K+ ATPase or Mg++ ATPase. Co-immunoprecipitation followed by Western blot analysis confirmed interaction among the three proteins. However, only the cDNA encoding TFR1 conferred strong cell surface staining by the AF20 antibody following its transient transfection into a cell line lacking endogenous AF20. In support of the molecular identity of AF20 as TFR1, diferric but not iron-free transferrin could prevent AF20 antigen-antibody interaction during immunoprecipitation. Moreover, very similar patterns of AF20 and TFR1 overexpression was documented in colon cancer tissues. In conclusion, AF20 is glycosylated TFR1. This finding could explain the molecular structure of AF20, its cell surface localization, as well as overexpression in cancer cells. Glycosylated TFR1 should serve as a usefulness target for anti-cancer therapy, or a vehicle for delivery of anti-tumor drugs with high affinity and specificity. The biological significance of the complex formation between TFR1, HSP90, and/or transporting ATPase warrants further investigation.	[Shapiro, Jason M.; Chung, Waihong; Ogawa, Kosuke; Barker, Luke; Carlson, Rolf; Wands, Jack R.; Li, Jisu] Brown Univ, Rhode Isl Hosp, Liver Res Ctr, Providence, RI 02903 USA; [Shapiro, Jason M.; Chung, Waihong; Ogawa, Kosuke; Barker, Luke; Carlson, Rolf; Wands, Jack R.; Li, Jisu] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Shapiro, Jason M.] Hasbro Childrens Hosp, Div Pediat Gastroenterol Nutr & Liver Dis, Providence, RI USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Hasbro Children's Hospital	Li, JS (corresponding author), Brown Univ, Rhode Isl Hosp, Liver Res Ctr, Providence, RI 02903 USA.; Li, JS (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	Ji_Su_Li_MD@brown.edu		Barker, Luke/0000-0003-4202-5428	National Institutes of Health [T32DK066415, CA123544, R21AI107618]; NIH [T32DK066415, CA123544, R21AI107618]; NATIONAL CANCER INSTITUTE [R01CA123544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (grant number T32DK066415, CA123544 and R21AI107618, http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants T32DK066415, CA123544 to JRW, and R21AI107618 to JL.	BLEIL JD, 1982, EMBO J, V1, P351, DOI 10.1002/j.1460-2075.1982.tb01173.x; Brookes MJ, 2006, GUT, V55, P1449, DOI 10.1136/gut.2006.094060; Callens C, 2008, LEUKEMIA, V22, P42, DOI 10.1038/sj.leu.2404958; Daniels TR, 2012, BBA-GEN SUBJECTS, V1820, P291, DOI 10.1016/j.bbagen.2011.07.016; Daniels TR, 2011, J IMMUNOTHER, V34, P500, DOI 10.1097/CJI.0b013e318222ffc8; Daniels-Wells TR, 2013, TOXICOL IN VITRO, V27, P220, DOI 10.1016/j.tiv.2012.10.006; Das Gupta A, 1990, Hematol Pathol, V4, P37; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Fan KL, 2012, NAT NANOTECHNOL, V7, P459, DOI [10.1038/nnano.2012.90, 10.1038/NNANO.2012.90]; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; HABESHAW JA, 1983, LANCET, V1, P498; Jones DT, 2006, CANCER RES, V66, P2749, DOI 10.1158/0008-5472.CAN-05-3857; KONDO K, 1990, CHEST, V97, P1367, DOI 10.1378/chest.97.6.1367; Magro G, 2011, THYROID, V21, P267, DOI 10.1089/thy.2010.0173; Mohr L, 2004, GASTROENTEROLOGY, V127, pS225, DOI 10.1053/j.gastro.2004.09.037; MORADPOUR D, 1995, HEPATOLOGY, V22, P1527, DOI 10.1016/0270-9139(95)90161-2; Ng PP, 2002, P NATL ACAD SCI USA, V99, P10706, DOI 10.1073/pnas.162362999; PRIOR R, 1990, VIRCHOWS ARCH A, V416, P491, DOI 10.1007/BF01600299; RECKHOW CL, 1988, J BIOL CHEM, V263, P7297; Rodriguez JA, 2011, LEUKEMIA LYMPHOMA, V52, P2169, DOI 10.3109/10428194.2011.596964; Ryschich E, 2004, EUR J CANCER, V40, P1418, DOI 10.1016/j.ejca.2004.01.036; Sakurai K, 2014, HEPATO-GASTROENTEROL, V61, P426, DOI 10.5754/hge13969; SEYMOUR GJ, 1987, UROL RES, V15, P341; Smilevska T, 2006, LEUKEMIA RES, V30, P183, DOI 10.1016/j.leukres.2005.06.006; SUTHERLAND R, 1981, P NATL ACAD SCI-BIOL, V78, P4515, DOI 10.1073/pnas.78.7.4515; Tortorella S, 2014, J MEMBRANE BIOL, V247, P291, DOI 10.1007/s00232-014-9637-0; Wands JR, 1997, J VIRAL HEPATITIS, V4, P60, DOI 10.1111/j.1365-2893.1997.tb00181.x; WILSON B, 1988, P NATL ACAD SCI USA, V85, P3140, DOI 10.1073/pnas.85.9.3140; Yang DC, 2001, ANTICANCER RES, V21, P541	29	3	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165227	10.1371/journal.pone.0165227	http://dx.doi.org/10.1371/journal.pone.0165227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802297	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200020
J	Lv, JL; Liu, H; Wang, XH; Li, KH; Tian, CY; Liu, XJ				Lv, Jinling; Liu, Hua; Wang, Xihe; Li, Kaihui; Tian, Changyan; Liu, Xuejun			Highly Arid Oasis Yield, Soil Mineral N Accumulation and N Balance in a Wheat-Cotton Rotation with Drip Irrigation and Mulching Film Management	PLOS ONE			English	Article							INPUT-OUTPUT BUDGETS; NITROGEN INPUT; INORGANIC NITROGEN; LAND-USE; DEPOSITION; REGION; WATERSHEDS; GRASSLAND; QUALITY; SYSTEM	Few systematic studies have been carried out on integrated N balance in extremely arid oasis agricultural areas. A two-year field experiment was conducted to evaluate the N input and output balances under long-term fertilization conditions. Five treatments were chosen, namely CK (no fertilizer), NPK, NPKS (10% straw return N and 90% chemical N), NPKM (one third urea-N, two thirds sheep manure) and NPKM+ (1.5 times NPKM). The results show an abundance of dry and wet N deposition (33 kg N ha(-1) yr(-1)) in this area. All treatments (excluding CK) showed no significant difference in wheat production (P>0.05). NPKM gave higher cotton yields (P<0.05). In both crops, NPKM and NPKS treatments had a relatively higher N harvest index (NHI). 15 N-labeled results reveal that the fertilizer N in all N treatments leached to<1 m depth and a high proportion of fertilizer-N remained in the top 60 cm of the soil profile. The NPKM+ treatment had the highest residual soil mineral N (N-min, 558 kg Nd ha(-1)), and NPKM and NPKS treatments had relatively low soil N-min values (275 and 293 kg N ha-1, respectively). Most of the treatments exhibited very high apparent N losses, especially the NPKM+ treatment (369kg N ha(-1)). Our arid research area had a strikingly high N loss compared to less arid agricultural areas. Nitrogen inputs therefore need careful reconsideration, especially the initial soil Nmin, fertilizer N inputs, dry and wet deposition, and appropriate organic and straw inputs which are all factors that must be taken into account under very arid conditions.	[Lv, Jinling; Li, Kaihui; Tian, Changyan] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi 830011, Peoples R China; [Liu, Xuejun] China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China; [Lv, Jinling] Henan Acad Agr Sci, Inst Plant Nutr Resources & Environm Sci, Zhengzhou, Peoples R China; [Liu, Hua; Wang, Xihe] Xinjiang Acad Agr Sci, Soil & Fertilizer Inst, Urumqi 830000, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; China Agricultural University; Henan Academy of Agricultural Sciences	Liu, XJ (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China.	liu310@cau.edu.cn	Liu, Xuejun/AAA-7412-2022		Chinese National Basic Research Program [2014CB954202]; China National Funds for Distinguished Young Scientists [40425007]; West Light Foundation of the Chinese Academy of Sciences [XBBS201206]; Research Foundation for Outstanding Young Talents of Xinjiang, China [2013721048]	Chinese National Basic Research Program(National Basic Research Program of China); China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Research Foundation for Outstanding Young Talents of Xinjiang, China	This work was financially supported by the Chinese National Basic Research Program (2014CB954202), the China National Funds for Distinguished Young Scientists (40425007), the West Light Foundation of the Chinese Academy of Sciences (XBBS201206) and the Research Foundation for Outstanding Young Talents of Xinjiang, China (2013721048).; We thank Dr. Peter Christie for substantially re-writing the text to correct numerous linguistic errors and to correct a number of scientific and technical errors and omissions. This work was financially supported by the Chinese National Basic Research Program (2014CB954202), the China National Funds for Distinguished Young Scientists (40425007), the West Light Foundation of the Chinese Academy of Sciences (XBBS201206) and the Research Foundation for Outstanding Young Talents of Xinjiang, China (2013721048).	[Anonymous], 2014, XINJIANG AGR STAT YB; Bandyopadhyay KK, 2010, IRRIGATION SCI, V28, P285, DOI 10.1007/s00271-009-0190-z; Cui ZL, 2006, PEDOSPHERE, V16, P806, DOI 10.1016/S1002-0160(06)60117-3; Dong J., 2006, PEDOSPHERE, V16, P806; Du CY, 2008, WATER AIR SOIL POLL, V190, P171, DOI 10.1007/s11270-007-9590-y; Fang SZ, 2011, NEW FOREST, V41, P147, DOI 10.1007/s11056-010-9217-9; Fang YT, 2008, BIOGEOSCIENCES, V5, P339, DOI 10.5194/bg-5-339-2008; Giles J, 2005, NATURE, V433, P791, DOI 10.1038/433791a; Gong Z.T., 2007, PEDOGENESIS SOIL TAX; Granados MR, 2013, AGR WATER MANAGE, V119, P121, DOI 10.1016/j.agwat.2012.12.014; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Ito M, 2005, BIOGEOCHEMISTRY, V72, P283, DOI 10.1007/s10533-004-0361-1; Jensen ES, 2003, PLANT SOIL, V252, P177, DOI 10.1023/A:1024189029226; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kahl J, 1999, ENVIRON MONIT ASSESS, V55, P113, DOI 10.1023/A:1006162927311; Kaur A, 2012, RES CROP, V13, P708; Kochy M, 2005, LANDSCAPE ECOL, V20, P191, DOI 10.1007/s10980-004-2264-x; Li CJ, 2011, PLANT SOIL, V342, P221, DOI 10.1007/s11104-010-0686-6; Li KH, 2012, BIOGEOSCIENCES, V9, P4013, DOI 10.5194/bg-9-4013-2012; Liu X. E, 2015, EUROPEAN J AGRONOMY, P7071; Liu XJ, 2005, NUTR CYCL AGROECOSYS, V71, P289, DOI 10.1007/s10705-004-6801-4; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lv JL, 2014, NUTR CYCL AGROECOSYS, V98, P15, DOI 10.1007/s10705-013-9592-7; Ma Xu, 2006, Arid Land Geography, V29, P439; MacDonald JA, 2002, GLOBAL CHANGE BIOL, V8, P1028, DOI 10.1046/j.1365-2486.2002.00532.x; Riedell WE, 2009, AGRON J, V101, P870, DOI 10.2134/agronj2008.0186x; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Rust S, 2000, ALLG FORST JAGDZTG, V171, P61; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Schwinning S, 2005, RANGELAND ECOL MANAG, V58, P565, DOI 10.2111/03-126.1; Wang FX, 2011, FIELD CROP RES, V122, P78, DOI 10.1016/j.fcr.2011.02.009; Wang J. H.-Y., 2001, THESIS; Xu M. G., 2006, CHINESE SOIL FERTILI; Xu XM, 2013, EUR J PLANT PATHOL, V135, P695, DOI 10.1007/s10658-012-0106-2; Zhang QQ, 2013, COMMUN SOIL SCI PLAN, V44, P2064, DOI 10.1080/00103624.2013.783055; Zhang Y, 2012, CHINESE GEOGR SCI, V22, P232, DOI 10.1007/s11769-012-0530-4; Zheng JH, 2013, AGR WATER MANAGE, V129, P181, DOI 10.1016/j.agwat.2013.08.001; Zheng JH, 2013, IRRIGATION SCI, V31, P995, DOI 10.1007/s00271-012-0378-5	39	5	6	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165404	10.1371/journal.pone.0165404	http://dx.doi.org/10.1371/journal.pone.0165404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798654	Green Submitted, Green Published, gold			2022-12-26	WOS:000386711100034
J	Missihoun, TD; Kotchoni, SO; Bartels, D				Missihoun, Tagnon D.; Kotchoni, Simeon O.; Bartels, Dorothea			Active Sites of Reduced Epidermal Fluorescence1 (REF1) Isoforms Contain Amino Acid Substitutions That Are Different between Monocots and Dicots	PLOS ONE			English	Article							ALDEHYDE-DEHYDROGENASE GENES; CAFFEOYL-COA 3-O-METHYLTRANSFERASE; ARABIDOPSIS-THALIANA; BRACHYPODIUM-DISTACHYON; FERULIC ACID; LIGNIN BIOSYNTHESIS; SHIKIMATE ESTERASE; MOLECULAR-CLONING; SWISS-PDBVIEWER; MODEL	Plant aldehyde dehydrogenases (ALDHs) play important roles in cell wall biosynthesis, growth, development, and tolerance to biotic and abiotic stresses. The Reduced Epidermal Fluorescence1 is encoded by the subfamily 2C of ALDHs and was shown to oxidise coniferaldehyde and sinapaldehyde to ferulic acid and sinapic acid in the phenylpropanoid pathway, respectively. This knowledge has been gained from works in the dicotyledon model species Arabidopsis thaliana then used to functionally annotate ALDH2C isoforms in other species, based on the orthology principle. However, the extent to which the ALDH isoforms differ between monocotyledons and dicotyledons has rarely been accessed side-by-side. In this study, we used a phylogenetic approach to address this question. We have analysed the ALDH genes in Brachypodium distachyon, alongside those of other sequenced monocotyledon and dicotyledon species to examine traits supporting either a convergent or divergent evolution of the ALDH2C/REF1-type proteins. We found that B. distachyon, like other grasses, contains more ALDH2C/REF1 isoforms than A. thaliana and other dicotyledon species. Some amino acid residues in ALDH2C/REF1 isoforms were found as being conserved in dicotyledons but substituted by non-equivalent residues in monocotyledons. One example of those substitutions concerns a conserved phenylalanine and a conserved tyrosine in monocotyledons and dicotyledons, respectively. Protein structure modelling suggests that the presence of tyrosine would widen the substrate-binding pocket in the dicotyledons, and thereby influence substrate specificity. We discussed the importance of these findings as new hints to investigate why ferulic acid contents and cell wall digestibility differ between the dicotyledon and monocotyledon species.	[Missihoun, Tagnon D.; Kotchoni, Simeon O.] Rutgers State Univ, Dept Biol, Camden, NJ 08102 USA; [Kotchoni, Simeon O.] Rutgers State Univ, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA; [Bartels, Dorothea] Univ Bonn, Inst Mol Physiol & Biotechnol Plants IMBIO, Bonn, Germany	Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University Camden; Rutgers State University New Brunswick; University of Bonn	Kotchoni, SO (corresponding author), Rutgers State Univ, Dept Biol, Camden, NJ 08102 USA.	tagnon1980@gmail.com; simeon.kotchoni@rutgers.edu		Missihoun, Tagnon/0000-0001-5905-2970				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barros J, 2015, ANN BOT-LONDON, V115, P1053, DOI 10.1093/aob/mcv046; Bartley LE, 2013, PLANT PHYSIOL, V161, P1615, DOI 10.1104/pp.112.208694; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Brocker C, 2013, PLANTA, V237, P189, DOI 10.1007/s00425-012-1749-0; Brutnell TP, 2015, ANNU REV PLANT BIOL, V66, P465, DOI 10.1146/annurev-arplant-042811-105528; Buanafina MMDO, 2008, PLANT BIOTECHNOL J, V6, P264, DOI 10.1111/j.1467-7652.2007.00317.x; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Chakraborty M, 2015, MOL BIOL EVOL, V32, P1029, DOI 10.1093/molbev/msu407; Chen CY, 2000, PLANT PHYSIOL, V123, P853, DOI 10.1104/pp.123.3.853; Chen Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101136; Chernikova D, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-26; Cui XQ, 1996, SCIENCE, V272, P1334, DOI 10.1126/science.272.5266.1334; de Oliveira DM, 2015, PLANT BIOTECHNOL J, V13, P1224, DOI 10.1111/pbi.12292; Deuschle K, 2004, PLANT CELL, V16, P3413, DOI 10.1105/tpc.104.023622; Dolinski K, 2007, ANNU REV GENET, V41, P465, DOI 10.1146/annurev.genet.40.110405.090439; dos Santos WD, 2008, J CHEM ECOL, V34, P1230, DOI 10.1007/s10886-008-9522-3; Douche T, 2013, PROTEOMICS, V13, P2438, DOI 10.1002/pmic.201200507; Drew DP, 2013, INT J MOL SCI, V14, P9080, DOI 10.3390/ijms14059080; Fitzgerald TL, 2015, ANN BOT-LONDON, V115, P717, DOI 10.1093/aob/mcv010; Fry JD, 2008, EVOLUTION, V62, P66, DOI 10.1111/j.1558-5646.2007.00288.x; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Girin T, 2014, J EXP BOT, V65, P5683, DOI 10.1093/jxb/eru376; Grabber JH, 1998, J AGR FOOD CHEM, V46, P2609, DOI 10.1021/jf9800099; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; Ha CM, 2016, PLANT J, V86, P363, DOI 10.1111/tpj.13177; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harris PJ, 2010, PHYTOCHEM REV, V9, P19, DOI 10.1007/s11101-009-9146-4; He DH, 2014, GENE, V549, P123, DOI 10.1016/j.gene.2014.07.054; Hou QC, 2015, ANN BOT-LONDON, V115, P465, DOI 10.1093/aob/mcu152; Jimenez-Lopez JC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-43; Kim NH, 2015, J EXP BOT, V66, P3367, DOI 10.1093/jxb/erv147; Kirch HH, 2005, PLANT MOL BIOL, V57, P315, DOI 10.1007/s11103-004-7796-6; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kirch HH, 2001, PLANT J, V28, P555, DOI 10.1046/j.1365-313X.2001.01176.x; Koncitikova R, 2015, BIOCHEM J, V468, P109, DOI 10.1042/BJ20150009; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Kotchoni SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011516; Kotchoni SO, 2012, GENE, V495, P128, DOI 10.1016/j.gene.2011.12.035; Lam TBT, 2003, PHYTOCHEMISTRY, V64, P603, DOI 10.1016/S0031-9422(03)00301-7; Liu F, 2002, PLANT PHYSIOL, V130, P1657, DOI 10.1104/pp.012336; Marriott PE, 2016, NEW PHYTOL, V209, P1366, DOI 10.1111/nph.13684; Marriott PE, 2014, P NATL ACAD SCI USA, V111, P14601, DOI 10.1073/pnas.1414020111; Missihoun TD, 2015, PLANT CELL PHYSIOL, V56, P1798, DOI 10.1093/pcp/pcv105; Missihoun TD, 2011, PLANTA, V233, P369, DOI 10.1007/s00425-010-1297-4; Molinari HBC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00050; Nair RB, 2004, PLANT CELL, V16, P544, DOI 10.1105/tpc.017509; Olofsson L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-45; Pasquet JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-629; SCHMITT D, 1991, J BIOL CHEM, V266, P17416; Shin JH, 2009, PLANT PHYSIOL, V149, P905, DOI 10.1104/pp.108.130716; Sobreira TJP, 2011, P NATL ACAD SCI USA, V108, P226, DOI 10.1073/pnas.1011223108; Stiti N, 2014, BBA-PROTEINS PROTEOM, V1844, P681, DOI 10.1016/j.bbapap.2014.01.008; Stiti N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00065; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teoh KH, 2009, BOTANY, V87, P635, DOI 10.1139/B09-032; Tsuji H, 2003, FEBS LETT, V546, P369, DOI 10.1016/S0014-5793(03)00631-8; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Wei Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-10; Wen YQ, 2012, PLANTA, V236, P525, DOI 10.1007/s00425-012-1624-z; Xue JS, 2015, PLANT J, V83, P375, DOI 10.1111/tpj.12902; Zhong RQ, 1998, PLANT CELL, V10, P2033, DOI 10.1105/tpc.10.12.2033; Zhong RQ, 2000, PLANT PHYSIOL, V124, P563, DOI 10.1104/pp.124.2.563	70	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165867	10.1371/journal.pone.0165867	http://dx.doi.org/10.1371/journal.pone.0165867			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798665	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100071
J	Kang, SWS; Haydar, G; Taniane, C; Farrell, G; Arias, IM; Lippincott-Schwartz, J; Fu, D				Kang, Sun Woo Sophie; Haydar, Ghada; Taniane, Caitlin; Farrell, Geoffrey; Arias, Irwin M.; Lippincott-Schwartz, Jennifer; Fu, Dong			AMPK Activation Prevents and Reverses Drug-Induced Mitochondrial and Hepatocyte Injury by Promoting Mitochondrial Fusion and Function	PLOS ONE			English	Article							ACETAMINOPHEN-INDUCED HEPATOTOXICITY; INDUCED LIVER-INJURY; N-TERMINAL KINASE; PROTEIN-KINASE; CELL-DEATH; PERMEABILITY TRANSITION; CULTURED-HEPATOCYTES; ENERGY-EXPENDITURE; DNA FRAGMENTATION; OXIDATIVE STRESS	Mitochondrial damage is the major factor underlying drug-induced liver disease but whether conditions that thwart mitochondrial injury can prevent or reverse drug-induced liver damage is unclear. A key molecule regulating mitochondria quality control is AMP activated kinase ( AMPK). When activated, AMPK causes mitochondria to elongate/fuse and proliferate, with mitochondria now producing more ATP and less reactive oxygen species. Autophagy is also triggered, a process capable of removing damaged/defective mitochondria. To explore whether AMPK activation could potentially prevent or reverse the effects of drug-induced mitochondrial and hepatocellular damage, we added an AMPK activator to collagen sandwich cultures of rat and human hepatocytes exposed to the hepatotoxic drugs, acetaminophen or diclofenac. In the absence of AMPK activation, the drugs caused hepatocytes to lose polarized morphology and have significantly decreased ATP levels and viability. At the subcellular level, mitochondria underwent fragmentation and had decreased membrane potential due to decreased expression of the mitochondrial fusion proteins Mfn1, 2 and/or Opa1. Adding AICAR, a specific AMPK activator, at the time of drug exposure prevented and reversed these effects. The mitochondria became highly fused and ATP production increased, and hepatocytes maintained polarized morphology. In exploring the mechanism responsible for this preventive and reversal effect, we found that AMPK activation prevented drug-mediated decreases in Mfn1, 2 and Opa1. AMPK activation also stimulated autophagy/mitophagy, most significantly in acetaminophen-treated cells. These results suggest that activation of AMPK prevents/reverses drug-induced mitochondrial and hepatocellular damage through regulation of mitochondrial fusion and autophagy, making it a potentially valuable approach for treatment of drug-induced liver injury.	[Kang, Sun Woo Sophie; Haydar, Ghada; Taniane, Caitlin; Fu, Dong] Univ Sydney, Fac Pharm, Sydney, NSW, Australia; [Farrell, Geoffrey] Australian Natl Univ, Sch Med, Liver Res Grp, Canberra, ACT, Australia; [Arias, Irwin M.] NICHHD, NIH, Bethesda, MD 20892 USA; [Lippincott-Schwartz, Jennifer] Janelia Res Campus, Howard Hughes Med Inst, Ashburn, VA USA	University of Sydney; Australian National University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Howard Hughes Medical Institute	Fu, D (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW, Australia.	dong.fu@sydney.edu.au		Fu, Dong/0000-0002-6865-5033	University of Sydney Deputy Vice Chancellor Research (DVCR) compact fund, Innovative Challenge, Faculty of Pharmacy	University of Sydney Deputy Vice Chancellor Research (DVCR) compact fund, Innovative Challenge, Faculty of Pharmacy	The University of Sydney Deputy Vice Chancellor Research (DVCR) compact fund, Innovative Challenge, Faculty of Pharmacy, 2013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by The University of Sydney Deputy Vice-Chancellor Research (DVCR) compact fund, Innovative Challenge, Faculty of Pharmacy.	Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12; Apostolova N, 2011, HEPATOLOGY, V54, P1009, DOI 10.1002/hep.24459; Baulies A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18017; Blieden M, 2014, EXPERT REV CLIN PHAR, V7, P341, DOI 10.1586/17512433.2014.904744; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chitturi S, 2012, DRUG INDUCED LIVER D, P703; Dai YL, 2015, INT J BIOL SCI, V11, P1272, DOI 10.7150/ijbs.12108; Dargan PI, 2001, EMERG MED J, V18, P178, DOI 10.1136/emj.18.3.178; Davern TJ, 2012, CLIN LIVER DIS, V16, P231, DOI 10.1016/j.cld.2012.03.002; Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115; Elmorsy E, 2017, HUM EXP TOXICOL, V36, P616, DOI 10.1177/0960327116660751; Ferner RE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2218; Fu D, 2013, P NATL ACAD SCI USA, V110, P7288, DOI 10.1073/pnas.1304285110; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Fu D, 2010, J CELL SCI, V123, P3294, DOI 10.1242/jcs.068098; Gyamlani GG, 2002, CRIT CARE, V6, P155, DOI 10.1186/cc1475; Han D, 2013, TRENDS PHARMACOL SCI, V34, P243, DOI 10.1016/j.tips.2013.01.009; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hickey EJ, 2001, FREE RADICAL BIO MED, V31, P139, DOI 10.1016/S0891-5849(01)00560-3; Hodgman MJ, 2012, CRIT CARE CLIN, V28, P499, DOI 10.1016/j.ccc.2012.07.006; Igusa Y, 2012, J GASTROENTEROL, V47, P433, DOI 10.1007/s00535-011-0500-0; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Jaeschke H, 2016, GASTROENTEROLOGY, V151, P371, DOI 10.1053/j.gastro.2016.02.087; Jemnitz K, 2008, TOXICOL IN VITRO, V22, P961, DOI 10.1016/j.tiv.2008.02.001; Jones DP, 2010, MOL INTERV, V10, P98, DOI 10.1124/mi.10.2.7; Jose C, 2011, BBA-BIOENERGETICS, V1807, P707, DOI 10.1016/j.bbabio.2010.12.002; Kaplowitz N, 2004, HEPATOLOGY, V40, P23, DOI 10.1002/hep.20312; KRETZROMMEL A, 1993, TOXICOL APPL PHARM, V120, P155, DOI 10.1006/taap.1993.1097; Kumar A, 2016, CELL MICROBIOL, V18, P1815, DOI 10.1111/cmi.12625; LECLUYSE EL, 1994, AM J PHYSIOL, V266, pC1764, DOI 10.1152/ajpcell.1994.266.6.C1764; Lee YM, 2008, BIOCHEM BIOPH RES CO, V370, P641, DOI 10.1016/j.bbrc.2008.04.003; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; Lim MS, 2006, TOXICOL APPL PHARM, V217, P322, DOI 10.1016/j.taap.2006.09.012; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mitra Kasturi, 2010, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0425s46; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Morigi M, 2015, J CLIN INVEST, V125, P715, DOI 10.1172/JCI77632; Musch A, 2014, EXP CELL RES, V328, P276, DOI 10.1016/j.yexcr.2014.06.006; Nadanaciva S, 2011, CURR PHARM DESIGN, V17, P2100, DOI 10.2174/138161211796904795; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Ni HM, 2012, AUTOPHAGY, V8, P709, DOI 10.4161/auto.19659; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; Pessayre Dominique, 2010, Handb Exp Pharmacol, P311, DOI 10.1007/978-3-642-00663-0_11; Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Russmann S, 2009, CURR MED CHEM, V16, P3041, DOI 10.2174/092986709788803097; Saberi B, 2014, HEPATOLOGY, V59, P1543, DOI 10.1002/hep.26625; Sauer H, 2012, INT J ONCOL, V40, P501, DOI 10.3892/ijo.2011.1230; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shen C, 2016, TUMOR BIOL, V37, P11199, DOI 10.1007/s13277-016-5007-0; Swift B, 2010, DRUG METAB REV, V42, P446, DOI 10.3109/03602530903491881; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Wessels B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100525; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Win S, 2016, HEPATOLOGY, V63, P1987, DOI 10.1002/hep.28486; Yan HM, 2010, TOXICOL SCI, V117, P515, DOI 10.1093/toxsci/kfq208; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yao XF, 2016, TOXICOL SCI, V153, P198, DOI 10.1093/toxsci/kfw118; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yuan LY, 2013, CLIN LIVER DIS, V17, P507, DOI 10.1016/j.cld.2013.07.002; Zang Y, 2008, J BIOL CHEM, V283, P6201, DOI 10.1074/jbc.M708619200; Zhang JH, 2013, REDOX BIOL, V1, P19, DOI 10.1016/j.redox.2012.11.008; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	74	84	85	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165638	10.1371/journal.pone.0165638	http://dx.doi.org/10.1371/journal.pone.0165638			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792760	Green Submitted, Green Published, gold			2022-12-26	WOS:000389537000039
J	Axelsen, PH; Murphy, RC; Igarashi, M; Rapoport, SI				Axelsen, Paul H.; Murphy, Robert C.; Igarashi, Miki; Rapoport, Stanley I.			Increased omega 6-Containing Phospholipids and Primary omega 6 Oxidation Products in the Brain Tissue of Rats on an omega 3-Deficient Diet	PLoS One			English	Article							POLYUNSATURATED FATTY-ACIDS; N-3 PUFA DEPRIVATION; ALPHA-LINOLENIC ACID; AMYLOID-BETA PROTEINS; DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE; DOCOSAPENTAENOIC ACID; MOUSE MODEL; ARACHIDONIC-ACID; INFUSED RATS	Polyunsaturated fatty acyl (PUFA) chains in both the omega 3 and omega 6 series are essential for normal animal brain development, and cannot be interconverted to compensate for a dietary deficiency of one or the other. Paradoxically, a dietary omega 3-PUFA deficiency leads to the accumulation of docosapentaenoate (DPA, 22:5 omega 6), an omega 6-PUFA chain that is normally scarce in the brain. We applied a high-precision LC/MS method to characterize the distribution of DPA chains across phospholipid headgroup classes, the fatty acyl chains with which they were paired, and the extent to which they were oxidatively damaged in the cortical brain of rats on an omega 3-deficient diet. Results indicate that dietary omega 3-PUFA deficiency markedly increased the concentrations of phospholipids with DPA chains across all headgroup subclasses, including plasmalogen species. The concentrations of phospholipids containing docosahexaenoate chains (22:6 omega 3) decreased 20-25%, while the concentrations of phospholipids containing arachidonate chains (20:4 omega 6) did not change significantly. Although DPA chains are more saturated than DHA chains, a larger fraction of DPA chains were monohydroxylated, particularly among diacyl-phosphatidylethanolamines and plasmalogen phosphatidylethanolamines, suggesting that they were disproportionately subjected to oxidative stress. Differences in the pathological significance of omega 3 and omega 6 oxidation products suggest that greater oxidative damage among the omega 6 PUFAs that increase in response to dietary omega 3 deficiency may have pathological significance in Alzheimer's disease.	[Axelsen, Paul H.] Univ Penn, Dept Pharmacol, Sch Med, Philadelphia, PA 19104 USA; [Axelsen, Paul H.] Univ Penn, Dept Biochem & Biophys, Sch Med, Philadelphia, PA 19104 USA; [Axelsen, Paul H.] Univ Penn, Dept Med, Sch Med, Philadelphia, PA 19104 USA; [Murphy, Robert C.] Univ Colorado, Denver Hlth Sci Ctr, Dept Pharmacol, Mail Stop 8303, Aurora, CO 80045 USA; [Igarashi, Miki; Rapoport, Stanley I.] NIA, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA; [Igarashi, Miki] RIKEN, Yokohama Branch, Ctr Integrat Med Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); RIKEN	Axelsen, PH (corresponding author), Univ Penn, Dept Pharmacol, Sch Med, Philadelphia, PA 19104 USA.; Axelsen, PH (corresponding author), Univ Penn, Dept Biochem & Biophys, Sch Med, Philadelphia, PA 19104 USA.; Axelsen, PH (corresponding author), Univ Penn, Dept Med, Sch Med, Philadelphia, PA 19104 USA.	axe@pharm.med.upenn.edu	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	NIH [AG20238, GM76201, NS74178, GM069338]; American Health Assistance Foundation; Glenn Foundation; Alzheimer's Association; Intramural Research Program of the National Institutes on Aging, NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Glenn Foundation; Alzheimer's Association(Alzheimer's Association); Intramural Research Program of the National Institutes on Aging, NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the NIH (AG20238, GM76201, and NS74178), the American Health Assistance Foundation, the Glenn Foundation, and the Alzheimer's Association to PHA, and a large scale collaborative grant from the NIH (GM069338, LipidMaps) to RCM. The work by MI and SIR was supported entirely by the Intramural Research Program of the National Institutes on Aging, NIH.	Amtul Z, 2011, J BIOL CHEM, V286, P6100, DOI 10.1074/jbc.M110.183608; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Axelsen PH, 2010, J LIPID RES, V51, P660, DOI [10.1194/jlr.d001750, 10.1194/jlr.D001750]; BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880; BOURRE JM, 1989, J NUTR, V119, P15, DOI 10.1093/jn/119.1.15; BOWRY VW, 1993, J AM CHEM SOC, V115, P6029, DOI 10.1021/ja00067a019; Brand A, 2010, J NEUROCHEM, V114, P1393, DOI 10.1111/j.1471-4159.2010.06866.x; Calon F, 2005, EUR J NEUROSCI, V22, P617, DOI 10.1111/j.1460-9568.2005.04253.x; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Calon F, 2007, PROSTAG LEUKOTR ESS, V77, P287, DOI 10.1016/j.plefa.2007.10.019; CONNOR WE, 1992, NUTR REV, V50, P21; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Dangi B, 2010, BIOCHEM PHARMACOL, V79, P251, DOI 10.1016/j.bcp.2009.08.001; Dangi B, 2009, J BIOL CHEM, V284, P14744, DOI 10.1074/jbc.M809014200; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; DeMar JC, 2004, J NEUROCHEM, V91, P1125, DOI 10.1111/j.1471-4159.2004.02789.x; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Eskici G, 2012, BIOCHEMISTRY-US, V51, P6289, DOI 10.1021/bi3006169; Farias SE, 2008, J LIPID RES, V49, P1990, DOI 10.1194/jlr.M800200-JLR200; Flock MR, 2014, PROSTAG LEUKOTR ESS, V91, P161, DOI 10.1016/j.plefa.2014.07.006; Furman R, 2016, ACS CHEM NEUROSCI, V7, P367, DOI 10.1021/acschemneuro.5b00316; Hashimoto M, 2005, BBA-MOL CELL BIOL L, V1738, P91, DOI 10.1016/j.bbalip.2005.11.011; Hashimoto M, 2005, J NUTR, V135, P549, DOI 10.1093/jn/135.3.549; Igarashi M, 2007, J LIPID RES, V48, P2463, DOI 10.1194/jlr.M700315-JLR200; Igarashi M, 2007, J LIPID RES, V48, P1150, DOI 10.1194/jlr.M600549-JLR200; Igarashi M, 2007, J LIPID RES, V48, P152, DOI 10.1194/jlr.M600396-JLR200; Innis SM, 2000, DEV NEUROSCI-BASEL, V22, P474, DOI 10.1159/000017478; Kaur G, 2011, PROG LIPID RES, V50, P28, DOI 10.1016/j.plipres.2010.07.004; KAYGANICH K, 1991, J AM SOC MASS SPECTR, V2, P45, DOI 10.1016/1044-0305(91)80060-K; Kim HW, 2011, PROSTAG LEUKOTR ESS, V85, P361, DOI 10.1016/j.plefa.2011.08.002; Koppaka V, 2003, J BIOL CHEM, V278, P36277, DOI 10.1074/jbc.M301334200; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Liu L, 2008, J MOL BIOL, V377, P1236, DOI 10.1016/j.jmb.2008.01.057; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Marrow JD, 1994, BIOCHIM BIOPHYS ACTA, V1210, P244; Mitchell DC, 2012, CHEM PHYS LIPIDS, V165, P393, DOI 10.1016/j.chemphyslip.2012.02.008; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; Moore SA, 2001, J MOL NEUROSCI, V16, P195, DOI 10.1385/JMN:16:2-3:195; Moriguchi T, 2013, LIPIDS, V48, P343, DOI 10.1007/s11745-013-3775-5; MORROW JD, 1992, PROSTAGLANDINS, V44, P155, DOI 10.1016/0090-6980(92)90077-7; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; Murray IVJ, 2005, BIOCHEMISTRY-US, V44, P12606, DOI 10.1021/bi050926p; Nakamura MT, 2003, PROSTAG LEUKOTR ESS, V68, P145, DOI 10.1016/S0952-3278(02)00264-8; Rao JS, 2007, MOL PSYCHIATR, V12, P151, DOI 10.1038/sj.mp.4001887; REEVES PG, 1993, J NUTR, V123, P1923, DOI 10.1093/jn/123.11.1923; Reich EE, 2000, BIOCHEMISTRY-US, V39, P2376, DOI 10.1021/bi992000l; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; SPRECHER H, 1986, PROSTAG LEUKOTR ESS, V23, P129, DOI 10.1016/0262-1746(86)90175-7; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Uauy R, 2000, P NUTR SOC, V59, P3, DOI 10.1017/S0029665100000021; Williard DE, 2001, J LIPID RES, V42, P1368; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7	55	4	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164326	10.1371/journal.pone.0164326	http://dx.doi.org/10.1371/journal.pone.0164326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788153	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900017
J	Belkhir, L; Elens, L; Zech, F; Panin, N; Vincent, A; Yombi, JC; Vandercam, B; Haufroid, V				Belkhir, Leila; Elens, Laure; Zech, Francis; Panin, Nadtha; Vincent, Anne; Yombi, Jean Cyr; Vandercam, Bernard; Haufroid, Vincent			Interaction between Darunavir and Etravirine Is Partly Mediated by CYP3A5 Polymorphism	PLOS ONE			English	Article							EXPERIENCED HIV-1-INFECTED PATIENTS; SPECTROMETRY LC-MS/MS; CLINICAL PHARMACOKINETICS; TMC125 ETRAVIRINE; VARIANT ALLELE; DOUBLE-BLIND; DARUNAVIR/RITONAVIR; EFFICACY; SAFETY; RITONAVIR	Objectives To assess the impact of the loss-of-function CYP3A5* 3 allele (rs776746, 6986A>G SNP) on darunavir (DRV) plasma concentrations. Methods 135 HIV-1 infected patients treated with DRV-based therapy were included in the study and plasma samples were obtained immediately before drug intake in order to determine DRV trough concentrations using an ultra performance liquid chromatography method (UPLC) with diode-array detection (DAD). Noteworthy is the fact that in 16 (11.9%) patients, etravirine (ETR) was combined with DRV. CYP3A5 genotypes were determined using real time PCR method (TaqMan (R) genotyping assay). The patients were then classified into CYP3A5 expressors (CYP3A5* 1 allele carriers) and non-expressors (CY P3A5* 3 homozygous). Subsequently, the association between DRV plasma trough concentration ([DRV](plasma)) and CYP3A5 genotype-based expression status was analyzed. Results 45% of the patients were classified as CYP3A5 expressors. In the whole cohort, mean [DRV](plasma) was not different between CYP3A5 expressors and non-expressors (1894ng/ml [CI95%: 1566-2290] versus 1737ng/ml [CI95%: 1468-2057], p = 0.43). However, in the subgroup of the 16 patients receiving DRV combined with ETR, a significantly lower [DRV]plasma was observed for CYP3A5 expressors when compared to non-expressors (1385ng/ml [CI95%:886.3-2165] versus 3141ng/m1 [CI95%:2042-4831], p = 0.007). Conclusions Interaction between DRV and ETR is partly mediated by CYP3A5 polymorphism with lower DRV plasma trough concentrations in CYP3A5 expressors suggesting a specific ETR-driven CYP3A5 activation only in CYP3A5 expressors. Consequently, these patients might be more at risk of infra-therapeutic [DRV](plasma). This potentially important observation is a good illustration of a genotype-based drug interaction, which could also have considerable consequences if translated to other CYP3A5-metabolized drugs. Further investigations are thus needed to confirm this association and to explore its clinical impact, mainly in the African population among whom CYP3A5 expressors are more frequent, before recommending systematic CYP3A5 pre-emptive genotyping for DRV-ETR co-administration.	[Belkhir, Leila; Zech, Francis; Vincent, Anne; Yombi, Jean Cyr; Vandercam, Bernard] Catholic Univ Louvain, Clin Univ St Luc, Dept Internal Med, AIDS Reference Ctr, Brussels, Belgium; [Belkhir, Leila; Elens, Laure; Panin, Nadtha; Haufroid, Vincent] Catholic Univ Louvain, Inst Rech Expt & Clin, Louvain Ctr Toxicol & Appl Pharmacol, Brussels, Belgium; [Elens, Laure] Catholic Univ Louvain, Louvain Drug Res Inst, Integrated PharmacoMetr PharmacoGen & PharmacoKin, Brussels, Belgium; [Haufroid, Vincent] Catholic Univ Louvain, Clin Univ St Luc, Dept Clin Chem, Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Belkhir, L (corresponding author), Catholic Univ Louvain, Clin Univ St Luc, Dept Internal Med, AIDS Reference Ctr, Brussels, Belgium.; Belkhir, L (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Louvain Ctr Toxicol & Appl Pharmacol, Brussels, Belgium.	leila.belkhir@uclouvain.be		Elens, Laure/0000-0002-0039-3583; Zech, Francis/0000-0002-5224-3712				Andries K, 2004, ANTIMICROB AGENTS CH, V48, P4680, DOI 10.1128/AAC.48.12.4680-4686.2004; [Anonymous], 2006, PREZ DAR PRESCR INF; [Anonymous], 2008, INT ETR TABL FULL PR; Barrail-Tran A, 2010, AIDS, V24, P2572, DOI 10.1097/QAD.0b013e32833d89fa; Belkhir L, 2016, CLIN BIOCHEM, V49, P580, DOI 10.1016/j.clinbiochem.2015.12.011; Boffito M, 2007, AIDS, V21, P1449, DOI 10.1097/QAD.0b013e3282170ab1; Burk O, 2004, J BIOL CHEM, V279, P38379, DOI 10.1074/jbc.M404949200; Centers for Disease Control, 2015, HIV AFR AM; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; De Meyer S, 2005, ANTIMICROB AGENTS CH, V49, P2314, DOI 10.1128/AAC.49.6.2314-2321.2005; Deeks ED, 2014, DRUGS, V74, P99, DOI 10.1007/s40265-013-0159-3; Elens L, 2009, J CHROMATOGR B, V877, P1805, DOI 10.1016/j.jchromb.2009.04.046; Elens L, 2013, PHARMACOGENOMICS, V14, P47, DOI [10.2217/pgs.12.187, 10.2217/PGS.12.187]; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2015, HIV AIDS SURV EUR 20; European Medicines Agency, 2009, INT TABL SUMM PROD C; HOETELMANS R, 2003, 10 C RETR OPP INF FE; Hsu A, 1998, CLIN PHARMACOKINET, V35, P275, DOI 10.2165/00003088-199835040-00002; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Institut scientifique de Sante publique (WIV-ISP), 2014, EP SIDA INF VIH BELG; Josephson F, 2007, CLIN PHARMACOL THER, V81, P708, DOI 10.1038/sj.clpt.6100117; Kakuda T, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/186987; Kakuda TN, 2014, J CLIN PHARMACOL, V54, P422, DOI 10.1002/jcph.214; Kakuda TN, 2011, ANTIMICROB AGENTS CH, V55, P2290, DOI 10.1128/AAC.01046-10; Katlama C, 2007, AIDS, V21, P395, DOI 10.1097/QAD.0b013e328013d9d7; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lazzarin A, 2007, LANCET, V370, P39, DOI 10.1016/S0140-6736(07)61048-4; Madruga JV, 2007, LANCET, V370, P29, DOI 10.1016/S0140-6736(07)61047-2; McKeage K, 2009, DRUGS, V69, P477, DOI 10.2165/00003495-200969040-00007; Mills AM, 2009, AIDS, V23, P1679, DOI 10.1097/QAD.0b013e32832d7350; Morlat P., 2013, PRISE CHARGE MED PER; Rittweger M, 2007, CLIN PHARMACOKINET, V46, P739, DOI 10.2165/00003088-200746090-00002; Schiller DS, 2009, CLIN THER, V31, P692, DOI 10.1016/j.clinthera.2009.04.020; Scholler-Gyure M, 2007, ANTIVIR THER, V12, P789; SCHOLLERGYURE M, 2006, 8 INT C DRUG THER HI; Sekar V. S-GS, 2006, AIDS 2006 16 INT AID; Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389; Van Schaik RHN, 2002, CLIN CHEM, V48, P1668; Yanakakis LJ, 2012, DRUG METAB DISPOS, V40, P803, DOI 10.1124/dmd.111.044404; Zhang XY, 2013, THER DRUG MONIT, V35, P209, DOI 10.1097/FTD.0b013e318280d0ad	39	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165631	10.1371/journal.pone.0165631	http://dx.doi.org/10.1371/journal.pone.0165631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788239	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900116
J	Cheng, HX; Burroughs-Garcia, J; Birkness, JE; Trinidad, JC; Deans, MR				Cheng, Haixia; Burroughs-Garcia, Jessica; Birkness, Jacqueline E.; Trinidad, Jonathan C.; Deans, Michael R.			Disparate Regulatory Mechanisms Control Fat3 and P75(NTR) Protein Transport through a Conserved Kif5-Interaction Domain	PLOS ONE			English	Article							PLANAR-CELL-POLARITY; HIPPOCAMPAL-NEURONS; KINESIN-1 BINDING; AXONAL-TRANSPORT; ACTIN DYNAMICS; MDCK CELLS; MOTOR; LOCALIZATION; RECEPTOR; KIF5B	Directed transport delivers proteins to specific cellular locations and is one mechanism by which cells establish and maintain polarized cellular architectures. The atypical cadherin Fat3 directs the polarized extension of dendrites in retinal amacrine cells by influencing the distribution of cytoskeletal regulators during retinal development, however the mechanisms regulating the distribution of Fat3 remain unclear. We report a novel Kinesin/Kif5 Interaction domain (Kif5-ID) in Fat3 that facilitates Kif5B binding, and determines the distribution of Fat3 cytosolic domain constructs in neurons and MDCK cells. The Kif5-ID sequence is conserved in the neurotrophin receptor P75(NTR), which also binds Kif5B, and Kif5-ID mutations similarly result in P75(NTR) mislocalization. Despite these similarities, Kif5B-mediated protein transport is differentially regulated by these two cargos. For Fat3, the Kif5-ID is regulated by alternative splicing, and the timecourse of splicing suggests that the distribution of Fat3 may switch between early and later stages of retinal development. In contrast, P75(NTR) binding to Kif5B is enhanced by tyrosine phosphorylation and thus has the potential to be dynamically regulated on a more rapid time scale.	[Cheng, Haixia; Burroughs-Garcia, Jessica; Deans, Michael R.] Univ Utah, Sch Med, Dept Surg, Div Otolaryngol Head & Neck Surg, Salt Lake City, UT 84112 USA; [Birkness, Jacqueline E.] Johns Hopkins Univ, Zanvyl Krieger Sch Arts & Sci, Baltimore, MD USA; [Trinidad, Jonathan C.] Indiana Univ, Dept Chem, Bloomington, IN USA; [Deans, Michael R.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Johns Hopkins University; Indiana University System; Indiana University Bloomington; Utah System of Higher Education; University of Utah	Deans, MR (corresponding author), Univ Utah, Sch Med, Dept Surg, Div Otolaryngol Head & Neck Surg, Salt Lake City, UT 84112 USA.; Deans, MR (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	Michael.Deans@utah.edu	Birkness-Gartman, Jacqueline/GSE-3415-2022; Trinidad, Jonathan/GWR-2077-2022	Deans, Michael/0000-0001-6319-7945; Birkness-Gartman, Jacqueline/0000-0002-1224-3304	National Institutes of Health [R01 EY021146, T32 EY024234]; NATIONAL EYE INSTITUTE [R01EY021146, P30EY014800, T32EY024234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the National Institutes of Health grants R01 EY021146 (MRD) and T32 EY024234 (JBG). The funders had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.; We thank Megan Williams (Univ. of Utah) for cultured hippocampal neurons and pCAG vectors, Geri Kreitzer (Cornell Univ.) for the P75-GFP plasmid, Donald Arnold (USC) for YFP-KIF5B and dominant-negative GFP-KIF5B plasmids and Randall Reed (Johns Hopkins Univ.) for the pCMV-GST plasmid. This work was funded by the National Institutes of Health grants R01 EY021146 (MRD) and T32 EY024234 (JBG).	Applied_ BioSystems, 2005, REAL TIM PCR SYST CH; Astanina K, 2010, CELL MOL LIFE SCI, V67, P1331, DOI 10.1007/s00018-009-0253-6; Braun GS, 2007, J BIOL CHEM, V282, P22823, DOI 10.1074/jbc.M701758200; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Cho KI, 2007, TRAFFIC, V8, P1722, DOI 10.1111/j.1600-0854.2007.00647.x; Colman DR, 1999, NEURON, V23, P649, DOI 10.1016/S0896-6273(01)80024-6; Deans MR, 2013, SEMIN CELL DEV BIOL, V24, P490, DOI 10.1016/j.semcdb.2013.03.001; Deans MR, 2011, NEURON, V71, P820, DOI 10.1016/j.neuron.2011.06.026; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Dodding MP, 2011, EMBO J, V30, P4523, DOI 10.1038/emboj.2011.326; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Emanuela P, 2009, J COMP NEUROL, V517, P737, DOI 10.1002/cne.22200; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jacobson C, 2007, DEV CELL, V13, P457, DOI 10.1016/j.devcel.2007.09.011; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Krol A, 2016, DEVELOPMENT, V143, P2172, DOI 10.1242/dev.133678; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; Mavlyutov TA, 2002, TRAFFIC, V3, P630, DOI 10.1034/j.1600-0854.2002.30905.x; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Nagae S, 2007, DEV DYNAM, V236, P534, DOI 10.1002/dvdy.21030; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Ohrt T, 2004, CELL SIGNAL, V16, P1291, DOI 10.1016/j.cellsig.2004.03.017; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rivera J, 2007, EUR J NEUROSCI, V25, P136, DOI 10.1111/j.1460-9568.2006.05277.x; SONG WX, 1994, P NATL ACAD SCI USA, V91, P163, DOI 10.1073/pnas.91.1.163; Tanoue T, 2005, J CELL SCI, V118, P2347, DOI 10.1242/jcs.02398; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Tsai RYL, 1997, BIOTECHNIQUES, V23, P794, DOI 10.2144/97235bm06; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Wan J, 2011, NUCLEIC ACIDS RES, V39, P7920, DOI 10.1093/nar/gkr545; Xue XX, 2010, J CELL SCI, V123, P1732, DOI 10.1242/jcs.056366; Youker RT, 2013, MOL BIOL CELL, V24, P1996, DOI 10.1091/mbc.E13-02-0078; Zuccaro E, 2014, CELL REP, V7, P138, DOI 10.1016/j.celrep.2014.02.039	41	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165519	10.1371/journal.pone.0165519	http://dx.doi.org/10.1371/journal.pone.0165519			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788242	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900102
J	Fedoseienko, A; Wieringa, HW; Wisman, GBA; Duiker, E; Reyners, AKL; Hofker, MH; van der Zee, AGJ; van de Sluis, B; van Vugt, MATM				Fedoseienko, Alina; Wieringa, Hylke W.; Wisman, G. Bea A.; Duiker, Evelien; Reyners, Anna K. L.; Hofker, Marten H.; van der Zee, Ate G. J.; van de Sluis, Bart; van Vugt, Marcel A. T. M.			Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer	PLoS One			English	Article							NF-KAPPA-B; COPPER TRANSPORTER ATP7A; DOMAIN-CONTAINING 1; UBIQUITIN LIGASE; POOR SURVIVAL; PROTEIN; EXPRESSION; MURR1; RESISTANCE; DISEASE	Copper metabolism MURR1 domain 1 (COMMD1) protein is a multifunctional protein, and its expression has been correlated with patients' survival in different types of cancer. In vitro studies revealed that COMMD1 plays a role in sensitizing cancer cell lines to cisplatin, however, the mechanism and its role in platinum sensitivity in cancer has yet to be established. We evaluated the role of COMMD1 in cisplatin sensitivity in A2780 ovarian cancer cells and the relation between COMMD1 expression and response to platinum-based therapy in advanced stage high-grade serous ovarian cancer (HGSOC) patients. We found that elevation of nuclear COMMD1 expression sensitized A2780 ovarian cancer cells to cisplatin-mediated cytotoxicity. This was accompanied by a more effective G2/M checkpoint, and decreased protein expression of the DNA repair gene BRCA1, and the apoptosis inhibitor BCL2. Furthermore, COMMD1 expression was immunohistochemically analyzed in two tissue micro-arrays (TMAs), representing a historical cohort and a randomized clinical trial-based cohort of advanced stage HGSOC tumor specimens. Expression of COMMD1 was observed in all ovarian cancer samples, however, specifically nuclear expression of COMMD1 was only observed in a subset of ovarian cancers. In our historical cohort, nuclear COMMD1 expression was associated with an improved response to chemotherapy (OR = 0.167; P= 0.038), although this association could not be confirmed in the second cohort, likely due to sample size. Taken together, these results suggest that nuclear expression of COMMD1 sensitize ovarian cancer to cisplatin, possibly by modulating the G(2)/M checkpoint and through controlling expression of genes involved in DNA repair and apoptosis.	[Fedoseienko, Alina; Hofker, Marten H.; van de Sluis, Bart] Univ Groningen, Univ Med Ctr Groningen, Mol Genet Sect, Dept Pediat, Groningen, Netherlands; [Wieringa, Hylke W.; Reyners, Anna K. L.; van Vugt, Marcel A. T. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Duiker, Evelien] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Wieringa, Hylke W.; Wisman, G. Bea A.; van der Zee, Ate G. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol Oncol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	van de Sluis, B (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Mol Genet Sect, Dept Pediat, Groningen, Netherlands.; van Vugt, MATM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands.	a.j.a.van.de.sluis@umcg.nl; m.vugt@umcg.nl		Fedoseienko, Alina/0000-0001-5059-0211; Duiker, Evelien/0000-0002-9450-5282; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365	Netherlands Organisation for Scientific Research (NWO-ALW) [817.02.022]; Netherlands Organisation for Scientific Research (NWO-VIDI) [016.136.334]; Dutch Cancer Society [RUG/NKB 2010-4833]; Junior Scientific Master class (JSM) of the University of Groningen	Netherlands Organisation for Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); Junior Scientific Master class (JSM) of the University of Groningen	This research was financially supported by the Netherlands Organisation for Scientific Research (NWO-ALW grant 817.02.022 to B.v.d.S. and NWO-VIDI grant 016.136.334 to M.A.T.M.v.V.) and by the Dutch Cancer Society (RUG/NKB 2010-4833 grant to M.A.T.M.v.V.). H.W.W. was supported by a fellowship of the Junior Scientific Master class (JSM) of the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to dedicate this paper to Marten Hofker, who passed away during the revision of this manuscript. We thank members of the Medical Oncology and Molecular Genetics Section for helpful suggestions. We thank Marieke Everts for her expertise and assistance during immunohistochemistry of the TMAs. This research was financially supported by the Netherlands Organisation for Scientific Research (NWO-ALW grant 817.02.022 to B.v.d.S. and NWO-VIDI grant 016.136.334 to M.A.T.M.v.V.) and by the Dutch Cancer Society (RUG/NKB 2010-4833 grant to M.A.T.M.v.V.). H.W.W. was supported by a fellowship of the Junior Scientific Master class (JSM) of the University of Groningen.; We would like to dedicate this paper to Marten Hofker, who passed away during the revision of this manuscript. We thank members of the Medical Oncology and Molecular Genetics Section for helpful suggestions. We thank Marieke Everts for her expertise and assistance during immunohistochemistry of the TMAs. This research was financially supported by the Netherlands Organisation for Scientific Research (NWO-ALW grant 817.02.022 to B.v.d.S. and NWO-VIDI grant 016.136.334 to M.A.T.M.v.V.) and by the Dutch Cancer Society (RUG/NKB 2010-4833 grant to M.A.T.M.v.V.). H.W.W. was supported by a fellowship of the Junior Scientific Master class (JSM) of the University of Groningen.	Alkema NG, 2014, GYNECOL ONCOL, V133, P591, DOI 10.1016/j.ygyno.2014.03.557; Annunziata CM, 2010, CANCER-AM CANCER SOC, V116, P3276, DOI 10.1002/cncr.25190; Bartuzi P, 2014, BBA-MOL BASIS DIS, V1842, P2257, DOI 10.1016/j.bbadis.2014.06.035; Bartuzi P, 2013, BBA-MOL BASIS DIS, V1832, P2315, DOI 10.1016/j.bbadis.2013.09.014; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Dai HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139663; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; de Graeff P, 2006, BRIT J CANCER, V95, P627, DOI 10.1038/sj.bjc.6603300; Fedoseienko A, 2014, ANN NY ACAD SCI, V1314, P6, DOI 10.1111/nyas.12353; Fernandez Masso JR, 2013, J AMINO ACIDS, V2013, P1; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Guo RX, 2008, PATHOL INT, V58, P749, DOI 10.1111/j.1440-1827.2008.02306.x; Harte MT, 2014, ONCOGENE, V33, P713, DOI 10.1038/onc.2013.10; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Kwiecinska A, 2014, GENE CHROMOSOME CANC, V53, P750, DOI 10.1002/gcc.22184; Leonhardt K, 2009, J BIOL CHEM, V284, P7793, DOI 10.1074/jbc.M805145200; Lesnock JL, 2013, BRIT J CANCER, V108, P1231, DOI 10.1038/bjc.2013.70; Li HY, 2014, GASTROENTEROLOGY, V147, P184, DOI 10.1053/j.gastro.2014.04.007; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Mangala LS, 2009, CLIN CANCER RES, V15, P3770, DOI 10.1158/1078-0432.CCR-08-2306; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; Materia S, 2012, J BIOL CHEM, V287, P2485, DOI 10.1074/jbc.M111.302216; Miyayama T, 2010, BIOCHEM J, V429, P53, DOI 10.1042/BJ20100223; Muller PAJ, 2009, TRAFFIC, V10, P514, DOI 10.1111/j.1600-0854.2009.00892.x; PARKER RJ, 1991, J CLIN INVEST, V87, P772, DOI 10.1172/JCI115080; Phillips-Krawczak CA, 2015, MOL BIOL CELL, V26, P91, DOI 10.1091/mbc.E14-06-1073; Reyners AKL, 2012, ANN ONCOL, V23, P2896, DOI 10.1093/annonc/mds107; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Roossink F, 2012, INT J CANCER, V131, P2056, DOI 10.1002/ijc.27488; Safaei R, 2008, MOL PHARMACOL, V73, P461, DOI 10.1124/mol.107.040980; Samimi G, 2003, CLIN CANCER RES, V9, P5853; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seeber LMS, 2011, CRIT REV ONCOL HEMAT, V78, P173, DOI 10.1016/j.critrevonc.2010.05.003; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Taskinen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091031; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; van Kruchten M, 2015, GYNECOL ONCOL, V138, P634, DOI 10.1016/j.ygyno.2015.06.032; Vonk WIM, 2012, CELL MOL LIFE SCI, V69, P149, DOI 10.1007/s00018-011-0743-1; Woods NT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002255; Yeh D-W, 2015, CELL DEATH DIFFER	44	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165385	10.1371/journal.pone.0165385	http://dx.doi.org/10.1371/journal.pone.0165385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788210	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900073
J	Goncalves, O; Castro, LFC; Smolka, AJ; Fontainhas, A; Wilson, JM				Goncalves, Odete; Castro, L. Filipe C.; Smolka, Adam J.; Fontainhas, Antonio; Wilson, Jonathan M.			The Gastric Phenotype in the Cypriniform Loaches: A Case of Reinvention?	PLOS ONE			English	Article							COBITOIDEA TELEOSTEI; ORDER CYPRINIFORMES; ATLANTIC STINGRAY; RE-EVOLUTION; DOLLOS LAW; K+-ATPASE; FISHES; GENE; EXPRESSION; SEQUENCE	The stomach, which is characterized by acid peptic digestion in vertebrates, has been lost secondarily multiple times in the evolution of the teleost fishes. The Cypriniformes are largely seen as an agastric order; however, within the superfamily Cobitoidea, the closely related sister groups Nemacheilidae and Balitoridae have been identified as gastric families. The presence of these most recently diverged gastric families in an otherwise agastric clade indicates that either multiple (>2-3) loss events occurred with the Cyprinidae, Catostomidae and Cobitidae, or that gastric reinvention arose in a recent ancestor of the Nema-cheilidae/Balitoridae sister clade. In the present study, the foregut regions of Cobitidae, Nemacheilidae/Balitoridae and the ancestral Botiidae family members were examined for the presence of gastric glands and gastric proton pump (Atp4a) a subunit expression by histology and immunohistochemistry respectively. Atp4a gene expression was assessed by reverse transcriptase-polymerase chain reaction (RT-PCR). Gastric glands expressing apical H+/K+-ATPase a subunit and isolated partial sequences of atp4a, identified using degenerate primers showing clear orthology to other vertebrate atp4a sequences, were detected in representative species from Nemacheilidae/Balitoridae and Botiidae, but not Cobitidae (Misgurnus anguillicaudatus). In summary, we provide evidence for an uninterrupted gastric evolutionary lineage in the Cobitoidea, making it highly improbable that the stomach was reinvented in the Nemacheilidae/Balitoridae clade consistent with Dollo's principle. These results also indicate that the gastric trait may be present elsewhere in the Cobitoidea.	[Goncalves, Odete; Wilson, Jonathan M.] CIIMAR, Mol Physiol Lab, Porto, Portugal; [Goncalves, Odete; Wilson, Jonathan M.] Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal; [Castro, L. Filipe C.] CIIMAR, Anim Genet & Evolut, Porto, Portugal; [Castro, L. Filipe C.] Univ Porto, Fac Ciencias, Porto, Portugal; [Smolka, Adam J.] Med Univ South Carolina, Charleston, SC 29425 USA; [Fontainhas, Antonio] Univ Tras Os Montes & Alto Douro, Vila Real, Portugal; [Wilson, Jonathan M.] Wilfrid Laurier Univ, Waterloo, ON, Canada	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Medical University of South Carolina; University of Tras-os-Montes & Alto Douro; Wilfrid Laurier University	Wilson, JM (corresponding author), CIIMAR, Mol Physiol Lab, Porto, Portugal.	wilson.jm.cimar@gmail.com	Castro, Filipe/AAA-2197-2022; Wilson, Jonathan/I-6071-2012; Wilson, Jonathan Mark/AAG-6481-2019; Quality, Aquaculture Seafood/AAD-7718-2019	Castro, Filipe/0000-0001-7697-386X; Wilson, Jonathan/0000-0003-3681-1166; Wilson, Jonathan Mark/0000-0003-3681-1166; Marinho Goncalves Ferreira, Odete/0000-0002-0875-3512	Fundacao para Ciencias e Technologia (Portugal) [PTDC/MAR/98035]; Natural Sciences and Engineering Research Council (Canada) [RGPIN-2014-04289]; FCT [SFRH/ BD/ 79821/ 2011]	Fundacao para Ciencias e Technologia (Portugal); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The Fundacao para Ciencias e Technologia (Portugal) (PTDC/MAR/98035) and the Natural Sciences and Engineering Research Council (Canada) (RGPIN-2014-04289) grants to JW provided material support for the work. OG was supported by FCT scholarship (SFRH/ BD/ 79821/ 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrington E.J.W., 1957, PHYSL FISHES, V1, P109, DOI DOI 10.1016/B978-1-4832-2817-4.50009-3; Barrington EJW, 1942, BIOL REV CAMB PHILOS, V17, P1; Boyce R, 2009, NUCLEIC ACIDS RES, V37, pW222, DOI 10.1093/nar/gkp379; Bucking C, 2009, AQUACULT NUTR, V15, P282, DOI 10.1111/j.1365-2095.2008.00593.x; Cain K, 2011, FISH PHYSIOL, V30, P111, DOI 10.1016/S1546-5098(10)03003-7; Castro LFC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2669; Chen WJ, 2007, J FISH BIOL, V70, P202, DOI 10.1111/j.1095-8649.2007.01395.x; Chen WJ, 2009, J FISH BIOL, V75, P2197, DOI 10.1111/j.1095-8649.2009.02398.x; Chen WJ, 2008, GENE, V423, P125, DOI 10.1016/j.gene.2008.07.016; Choe KP, 2004, AM J PHYSIOL-REG I, V287, pR981, DOI 10.1152/ajpregu.00513.2003; Collin R, 2003, P ROY SOC B-BIOL SCI, V270, P2551, DOI 10.1098/rspb.2003.2517; Collin R, 2007, BIOL BULL-US, V212, P83, DOI 10.2307/25066586; Collin R, 2008, TRENDS ECOL EVOL, V23, P602, DOI 10.1016/j.tree.2008.06.013; Castro LFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032852; Dobreff M, 1927, PFLUG ARCH GES PHYS, V217, P221, DOI 10.1007/BF01723674; Dollo L, 1903, E BULL ACAD R SCI BE, P792; Domes K, 2007, P NATL ACAD SCI USA, V104, P7139, DOI 10.1073/pnas.0700034104; Durr KL, 2010, J BIOL CHEM, V285, P39366, DOI 10.1074/jbc.M110.133470; Edinger L., 1877, ARCH MIKROSK ANAT, V13, P651; GOULD S J, 1970, Journal of the History of Biology, V3, P189, DOI 10.1007/BF00137351; Grande T, 2010, GONORYNCHIFORMES AND, DOI [10.1201/b10194, DOI 10.1201/B10194]; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HENNIG W, 1965, ANNU REV ENTOMOL, V10, P97, DOI 10.1146/annurev.en.10.010165.000525; Hiroi J, 2008, J EXP BIOL, V211, P2584, DOI 10.1242/jeb.018663; Jaroszewska M, 2008, J FISH BIOL, V72, P1773, DOI 10.1111/j.1095-8649.2008.01870.x; Jeuken M, 1957, THESIS; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KAPOOR BG, 1975, ADV MAR BIOL, V13, P109; KOBEGENOVA S S, 1991, Voprosy Ikhtiologii, V31, P965; KOELZ HR, 1992, SCAND J GASTROENTERO, V27, P2, DOI 10.3109/00365529209095998; Kohlsdorf T, 2006, EVOLUTION, V60, P1896; Kopic S, 2010, AM J PHYSIOL-CELL PH, V298, pC1, DOI 10.1152/ajpcell.00478.2009; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Liu SQ, 2012, GENE, V508, P60, DOI 10.1016/j.gene.2012.07.040; LOBEL PS, 1981, J FISH BIOL, V19, P365, DOI 10.1111/j.1095-8649.1981.tb05842.x; MARSHALL CR, 1994, P NATL ACAD SCI USA, V91, P12283, DOI 10.1073/pnas.91.25.12283; Mayden RL, 2008, J SYST EVOL, V46, P424, DOI 10.3724/SP.J.1002.2008.08062; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; MCMAHON BR, 1987, J EXP BIOL, V133, P371; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Nelson J.S, 2016, FISHES WORLD, Vfifith, DOI DOI 10.1093/sysbio/sys029; REIFEL CW, 1978, J MORPHOL, V158, P155, DOI 10.1002/jmor.1051580203; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos CRA, 1997, COMP BIOCHEM PHYS B, V117, P185, DOI 10.1016/S0305-0491(96)00328-8; SAWADA Y, 1982, Memoirs of the Faculty of Fisheries Hokkaido University, V28, P65; Shin JM, 2009, PFLUG ARCH EUR J PHY, V457, P609, DOI 10.1007/s00424-008-0495-4; Siebert D., 1987, THESIS; Simpson GG, 1953, THE MAJOR FEATURES O; Slechtova V, 2007, MOL PHYLOGENET EVOL, V44, P1358, DOI 10.1016/j.ympev.2007.02.019; Smit H, 1968, HDB PHYSL, V5, P135; SMOLKA A, 1992, BIOCHIM BIOPHYS ACTA, V1108, P75, DOI 10.1016/0005-2736(92)90116-4; SMOLKA AJ, 1994, J HISTOCHEM CYTOCHEM, V42, P1323, DOI 10.1177/42.10.7930514; Sugiura SH, 2006, J EXP BIOL, V209, P3719, DOI 10.1242/jeb.02436; Suicmez M, 2005, FOLIA BIOL, V53, P95; Sullivan MX, 1907, THE PHYSIOLOGY OF TH; Swofford David L., 1996, P407; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang QY, 2006, MOL PHYLOGENET EVOL, V39, P347, DOI 10.1016/j.ympev.2005.08.007; Tomic N, 2011, PERSPECT BIOL MED, V54, P332, DOI 10.1353/pbm.2011.0034; Uchida S, 2000, NEUROPHARMACOLOGY, V39, P191, DOI 10.1016/S0028-3908(99)00111-2; Ura K, 1996, ZOOL SCI, V13, P219, DOI 10.2108/zsj.13.219; VERIGINA I A, 1990, Voprosy Ikhtiologii, V30, P897; Verigina IA, 1986, VOP IKHTIOL, V6, P1036; WESTERN JRH, 1971, J FISH BIOL, V3, P225, DOI 10.1111/j.1095-8649.1971.tb03667.x; Whiting MF, 2003, NATURE, V421, P264, DOI 10.1038/nature01313; Wiens JJ, 2007, EVOLUTION, V61, P1886, DOI 10.1111/j.1558-5646.2007.00159.x; Wilson JM, 2011, FISH PHYSIOL, V30, P1, DOI 10.1016/S1546-5098(10)03001-3; Wilson JM, 2002, J EXP ZOOL, V293, P192, DOI 10.1002/jez.10124; Wilson JM, 2007, MAR BIOL, V151, P1633, DOI 10.1007/s00227-006-0579-7; Wu X, 1981, SCI CHINA, V3, P369; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	73	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0163696	10.1371/journal.pone.0163696	http://dx.doi.org/10.1371/journal.pone.0163696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783698	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800019
J	Montecino-Latorre, D; Eisenlord, ME; Turner, M; Yoshioka, R; Harvell, CD; Pattengill-Semmens, CV; Nichols, JD; Gaydos, JK				Montecino-Latorre, Diego; Eisenlord, Morgan E.; Turner, Margaret; Yoshioka, Reyn; Harvell, C. Drew; Pattengill-Semmens, Christy V.; Nichols, Janna D.; Gaydos, Joseph K.			Devastating Transboundary Impacts of Sea StarWasting Disease on Subtidal Asteroids	PLOS ONE			English	Article							MASS MORTALITY; SURVEILLANCE; RESPONSES; PATTERNS	Sea star wasting disease devastated intertidal sea star populations from Mexico to Alaska between 2013-15, but little detail is known about its impacts to subtidal species. We assessed the impacts of sea star wasting disease in the Salish Sea, a Canadian / United States transboundary marine ecosystem, and world-wide hotspot for temperate asteroid species diversity with a high degree of endemism. We analyzed roving diver survey data for the three most common subtidal sea star species collected by trained volunteer scuba divers between 2006-15 in 5 basins and on the outer coast of Washington, as well as scientific strip transect data for 11 common subtidal asteroid taxa collected by scientific divers in the San Juan Islands during the spring/summer of 2014 and 2015. Our findings highlight differential susceptibility and impact of sea star wasting disease among asteroid species populations and lack of differences between basins or on Washington's outer coast. Specifically, severe depletion of sunflower sea stars (Pycnopodia helianthoides) in the Salish Sea support reports of major declines in this species from California to Alaska, raising concern for the conservation of this ecologically important subtidal predator.	[Montecino-Latorre, Diego] Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA; [Eisenlord, Morgan E.; Yoshioka, Reyn; Harvell, C. Drew] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Turner, Margaret] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA; [Pattengill-Semmens, Christy V.; Nichols, Janna D.] REEF, Key Largo, FL USA; [Gaydos, Joseph K.] Univ Calif Davis, SeaDoc Soc, Karen C Drayer Wildlife Hlth Ctr, Orcas Isl Off, Washington, DC USA	University of California System; University of California Davis; Cornell University; Northeastern University; University of California System; University of California Davis	Gaydos, JK (corresponding author), Univ Calif Davis, SeaDoc Soc, Karen C Drayer Wildlife Hlth Ctr, Orcas Isl Off, Washington, DC USA.	jkgaydos@ucdavis.edu		Gaydos, Joseph/0000-0001-6599-8797	SeaDoc Society	SeaDoc Society	Funding for 100 focused Advanced Assessment Team REEF surveys in the San Juan Islands in 2013, 2014 and 2015 was provided by the SeaDoc Society and numerous private donors (including S. and N. Albouq, L. Ceder, C. Curry, J. Luce, A. Phelps Ford, the Seattle Aquarium and M. Wyckoff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the more than 600 trained REEF surveyors who contributed data between 2006 and 2015. We also thank Friday Harbor Laboratories Dive Safety Officer P. Kitaeff and the scientific divers that contributed to the strip transect surveys. Funding for 100 focused Advanced Assessment Team REEF surveys in the San Juan Islands in 2013, 2014 and 2015 was provided by the SeaDoc Society and numerous private donors (including S. and N. Albouq, L. Ceder, C. Curry, J. Luce, A. Phelps Ford, the Seattle Aquarium and M. Wyckoff). We also thank Mrs. Baileys 6th grade class and Kevin Schofield for funding subtidal transect surveys and Billie Swalla, Director, Friday Harbor Laboratories for providing lab and diving facilities. Finally, we appreciate the suggestions provided by the editor and two anonymous reviewers, which strengthened this manuscript.	Bates AE, 2009, DIS AQUAT ORGAN, V86, P245, DOI 10.3354/dao02125; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Box GEP, 2015, TIME SERIES ANAL; Carson HS, 2016, FISH RES, V179, P179, DOI 10.1016/j.fishres.2016.03.001; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; DUGGINS DO, 1983, ECOLOGY, V64, P1610, DOI 10.2307/1937514; Duggins DO, 1980, THESIS; DUNGAN ML, 1982, SCIENCE, V216, P989, DOI 10.1126/science.216.4549.989; Eckert G.L., 2000, P 5 CAL ISL S US DEP, P390; Eisenlord ME, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0212; Eviner Valerie T., 2008, P260; Fuess LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133053; Gahl MK, 2012, CONSERV BIOL, V26, P135, DOI 10.1111/j.1523-1739.2011.01801.x; Gaydos JK, 2008, ECOHEALTH, V5, P460, DOI 10.1007/s10393-009-0209-1; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Hall Spencer R., 2008, P223; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Hyndman R. J., 2007, AUTOMATIC TIME SERIE; Kohl WT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153670; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lafferty Kevin D., 2008, P205; Lessios HA, 2005, CORAL REEFS, V24, P125, DOI 10.1007/s00338-004-0443-5; LESSIOS HA, 1984, CORAL REEFS, V3, P173, DOI 10.1007/BF00288252; MAUZEY KP, 1968, ECOLOGY, V49, P603, DOI 10.2307/1935526; MENGE BA, 1979, OECOLOGIA, V41, P245, DOI 10.1007/BF00377430; Menge BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153994; Miner CM, 2006, MAR ECOL PROG SER, V327, P107, DOI 10.3354/meps327107; Moore SK, 2008, ESTUAR COAST SHELF S, V80, P545, DOI 10.1016/j.ecss.2008.09.016; Morner T, 2002, REV SCI TECH OIE, V21, P67, DOI 10.20506/rst.21.1.1321; NORES JER, 1995, J GEN VIROL, V76, P2779, DOI 10.1099/0022-1317-76-11-2779; PAINE RT, 1969, LIMNOL OCEANOGR, V14, P710, DOI 10.4319/lo.1969.14.5.0710; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pattengill-Semmens C, REEF ENVIRONMENTAL E; Pattengill-Semmens CV, 2003, ENVIRON MONIT ASSESS, V81, P43, DOI 10.1023/A:1021300302208; Plummer M, 2003, JAGS A PROGRAM FOR A; R Core Team, 2014, R A LANGUAGE AND ENV; Schmitt EF, 1996, B MAR SCI, V59, P404; Schultz JA, 2016, PEERJ, V4, DOI 10.7717/peerj.1980; Shivji M, 1983, FEEDING AND DISTRIBU; Stallknecht DE, 2007, CURR TOP MICROBIOL, V315, P445; Su Y-S, 2015, R PACKAGE VERSION 0; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Thomson RE, 1994, REVIEW OF THE MARINE, P13; University of California-Santa Cruz, PACIFIC ROCKY INTERT; Wares JP, 2016, PEERJ, V4, DOI 10.7717/peerj.1876; Wobeser GA, 1994, DISEASES IN WILD ANI	53	49	49	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0163190	10.1371/journal.pone.0163190	http://dx.doi.org/10.1371/journal.pone.0163190			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783620	Green Submitted, Green Published, gold			2022-12-26	WOS:000389602800015
J	Li, X; Wang, HD; Gao, YY; Li, LW; Tang, C; Wen, GD; Zhou, Y; Zhou, ML; Mao, L; Fan, YW				Li, Xiang; Wang, Handong; Gao, Yongyue; Li, Liwen; Tang, Chao; Wen, Guodao; Zhou, Yuan; Zhou, Mengliang; Mao, Lei; Fan, Youwu			Protective Effects of Quercetin on Mitochondrial Biogenesis in Experimental Traumatic Brain Injury via the Nrf2 Signaling Pathway	PLOS ONE			English	Article							CEREBRAL ISCHEMIA-REPERFUSION; INDUCED OXIDATIVE STRESS; MEMORY-IMPAIRMENT; INDUCED APOPTOSIS; ACTIVATION; MICE; INFLAMMATION; ENHANCEMENT; HEPATITIS; NRF2/HO-1	The present investigation was carried out to elucidate a possible molecular mechanism related to the protective effect of quercetin administration against oxidative stress on various mitochondrial respiratory complex subunits with special emphasis on the role of nuclear factor erythroid 2-related factor 2 (Nrf2) in mitochondrial biogenesis. Recently, quercetin has been proved to have a protective effect against mitochondria damage after traumatic brain injury (TBI). However, its precise role and underlying mechanisms in traumatic brain injury are not yet fully understood. The aim of the present study was to investigate the effect of quercetin on the potential mechanism of these effects in a weight-drop model of TBI in male mice that were treated with quercetin or vehicle via intraperitoneal injection administrated 30 min after TBI. In this experiment, ICR mice were divided into four groups: A sham group, TBI group, TBI + vehicle group, and TBI + quercetin group. Brain samples were collected 24 h later for analysis. Quercetin treatment resulted in an upregulation of Nrf2 expression and cytochrome c, malondialdehyde (MDA) and superoxide dismutase ( SOD) levels were restored by quercetin treatment. Quercetin markedly promoted the translocation of Nrf2 protein from the cytoplasm to the nucleus. These observations suggest that quercetin improves mitochondrial function in TBI models, possibly by activating the Nrf2 pathway.	[Li, Xiang; Wang, Handong; Gao, Yongyue; Li, Liwen; Tang, Chao; Wen, Guodao; Zhou, Yuan; Zhou, Mengliang; Mao, Lei; Fan, Youwu] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China	Nanjing University	Wang, HD; Mao, L; Fan, YW (corresponding author), Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com; njmaolei@126.com; njywfan@163.com	Wang, Han/GPW-9809-2022	Wang, Handong/0000-0001-5989-9338; Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of China [81371357]; Nanjing Military Region Foundation, PLA Grant [14MS104, 15MS126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Military Region Foundation, PLA Grant	This work was supported by the National Natural Science Foundation of China (81371357) and the Nanjing Military Region Foundation, PLA Grant (14MS104, 15MS126).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Baburamani AA, 2015, INT J MOL SCI, V16, P22509, DOI 10.3390/ijms160922509; Bachmetov L, 2012, J VIRAL HEPATITIS, V19, pE81, DOI 10.1111/j.1365-2893.2011.01507.x; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Bournival J, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/921941; Carrasco-Pozo C, 2016, J NUTR BIOCHEM, V27, P289, DOI 10.1016/j.jnutbio.2015.09.016; Chen C, 2012, J ASIAN NAT PROD RES, V14, P877, DOI 10.1080/10286020.2012.702108; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Hindy N, 2014, EUR J TRAUMA EMERG S, V40, P481, DOI 10.1007/s00068-013-0337-8; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Go KL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/183469; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Halder S, 2016, BIOL TRACE ELEM RES, V171, P391, DOI 10.1007/s12011-015-0544-8; Halder S, 2016, DRUG CHEM TOXICOL, V39, P272, DOI 10.3109/01480545.2015.1092042; Hu YY, 2015, BRAIN RES, V1605, P39, DOI 10.1016/j.brainres.2015.02.015; Kambe Y, 2016, J MOL NEUROSCI; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Kimura T, 2016, AMINO ACIDS; Kompanje EJO, 2007, SCI ENG ETHICS, V13, P371, DOI 10.1007/s11948-007-9027-4; Kulkarni GV, 1998, EXP CELL RES, V245, P170, DOI 10.1006/excr.1998.4245; Kysenius K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107129; Lawrence NJ, 2008, DNA REPAIR, V7, P281, DOI 10.1016/j.dnarep.2007.10.005; Lei XF, 2016, MOL MED REP, V13, P412, DOI 10.3892/mmr.2015.4534; Li RR, 2015, INT J MED SCI, V12, P432, DOI 10.7150/ijms.11402; Liu P, 2015, RESTOR NEUROL NEUROS, V33, P143, DOI 10.3233/RNN-140446; Liu WC, 2017, J NEUROSURG, V127, P8, DOI 10.3171/2016.4.JNS152909; Liu Y, 2015, J NEUROL SCI, V351, P88, DOI 10.1016/j.jns.2015.02.045; Marcolin E, 2012, J NUTR, V142, P1821, DOI 10.3945/jn.112.165274; Petzold A, 2007, NEUROL RES, V29, P691, DOI 10.1179/016164107X240080; Sanganahalli BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063317; Sharma DR, 2015, NEUROTOXICOLOGY, V51, P116, DOI 10.1016/j.neuro.2015.10.002; Sharma DR, 2013, NEUROTOX RES, V23, P336, DOI 10.1007/s12640-012-9351-6; Shen J, 2007, BIOCHEM PHARMACOL, V73, P1901, DOI 10.1016/j.bcp.2007.03.009; Wang L, 2015, INT J CLIN EXP PATHO, V8, P11503; Whitman SA, 2013, EXP CELL RES, V319, P2673, DOI 10.1016/j.yexcr.2013.07.015; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060	40	43	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164237	10.1371/journal.pone.0164237	http://dx.doi.org/10.1371/journal.pone.0164237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780244	Green Published, gold, Green Submitted			2022-12-26	WOS:000389046900009
J	Zhang, YH; Chu, C; Wang, SP; Chen, L; Lu, J; Kong, XY; Huang, T; Li, HP; Cai, YD				Zhang, Yu-Hang; Chu, Chen; Wang, Shaopeng; Chen, Lei; Lu, Jing; Kong, XiangYin; Huang, Tao; Li, HaiPeng; Cai, Yu-Dong			The Use of Gene Ontology Term and KEGG Pathway Enrichment for Analysis of Drug Half-Life	PLOS ONE			English	Article							METABOLIZING ENZYME-SYSTEM; AMINO-ACID-COMPOSITION; FUCOSYLATED CHONDROITIN SULFATE; ALBUMIN-BINDING DOMAIN; VOLTAGE-GATED SODIUM; ALPHA-LINOLENIC ACID; IN-VIVO; RECEPTOR AGONIST; STEADY-STATE; PREDICTION	A drug's biological half-life is defined as the time required for the human body to metabolize or eliminate 50% of the initial drug dosage. Correctly measuring the half-life of a given drug is helpful for the safe and accurate usage of the drug. In this study, we investigated which gene ontology (GO) terms and biological pathways were highly related to the determination of drug half-life. The investigated drugs, with known half-lives, were analyzed based on their enrichment scores for associated GO terms and KEGG pathways. These scores indicate which GO terms or KEGG pathways the drug targets. The feature selection method, minimum redundancy maximum relevance, was used to analyze these GO terms and KEGG pathways and to identify important GO terms and pathways, such as sodium-independent organic anion transmembrane transporter activity (GO: 0015347), monoamine transmembrane transporter activity (GO: 0008504), negative regulation of synaptic transmission (GO: 0050805), neuroactive ligand-receptor interaction (hsa04080), serotonergic synapse (hsa04726), and linoleic acid metabolism (hsa00591), among others. This analysis confirmed our results and may show evidence for a new method in studying drug half-lives and building effective computational methods for the prediction of drug half-lives.	[Zhang, Yu-Hang; Wang, Shaopeng; Cai, Yu-Dong] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China; [Zhang, Yu-Hang; Kong, XiangYin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China; [Chu, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China; [Lu, Jing] Yantai Univ, Collaborat Innovat Ctr Adv Drug Delivery Syst & B, Minist Educ, Sch Pharm,Key Lab Mol Pharmacol & Drug Evaluat, Yantai 264005, Peoples R China; [Li, HaiPeng] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Key Lab Computat Biol, CAS MPG Partner Inst Computat Biol, Shanghai 200031, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Maritime University; Yantai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Cai, YD (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China.	tohuangtao@l26.com; lihaipeng@picb.ac.cn; cai_yud@126.com	Zhang, Yu-Hang/O-9774-2015; Chen, Lei/A-2275-2011; Chu, Chen/J-6527-2019; Zhang, Yu-Hang/AAQ-9012-2021	Zhang, Yu-Hang/0000-0003-3825-0796; Chen, Lei/0000-0003-3068-1583; Chu, Chen/0000-0001-8084-0867; Zhang, Yu-Hang/0000-0003-3825-0796; cai, yudong/0000-0001-5664-7979	National Natural Science Foundation of China [31371335, 61303099]; Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) [2016245]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS)	National Natural Science Foundation of China (31371335, 61303099), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (31371335, 61303099), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245).	Arnot JA, 2014, ENVIRON SCI TECHNOL, V48, P723, DOI 10.1021/es4029414; BACON E, 1989, DEV BRAIN RES, V47, P293, DOI 10.1016/0165-3806(89)90185-5; Basuli F, 2015, NUCL MED BIOL, V42, P219, DOI 10.1016/j.nucmedbio.2014.11.011; Berezhkovskiy LM, 2013, J PHARM SCI-US, V102, P761, DOI 10.1002/jps.23396; Bhatt DK, 2013, CEPHALALGIA, V33, P87, DOI 10.1177/0333102412466967; BLUSCHKE V, 1976, ARZNEIMITTEL-FORSCH, V26, P591; Bohmer T, 1998, AGE AGEING, V27, P222, DOI 10.1093/ageing/27.2.222; BORELGIRAUD N, 1976, CLIN CHIM ACTA, V71, P117, DOI 10.1016/0009-8981(76)90521-0; BREUER J, 1973, Z KLIN CHEM KLIN BIO, V11, P263; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; CATELLA F, 1990, P NATL ACAD SCI USA, V87, P5893, DOI 10.1073/pnas.87.15.5893; Catterall WA, 2015, MOL PHARMACOL, V88, P141, DOI 10.1124/mol.114.097659; Chen D, 2012, J CLIN PHARMACOL, V52, P319, DOI 10.1177/0091270010397049; Chen H, 2015, CLIN DRUG INVEST, V35, P151, DOI 10.1007/s40261-014-0265-3; Chen L, 2016, COMB CHEM HIGH T SCR, V19, P136, DOI 10.2174/1386207319666151110122453; Chen L, 2015, AMINO ACIDS, V47, P1485, DOI 10.1007/s00726-015-1974-5; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107767; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2013, CURR BIOINFORM, V8, P545, DOI 10.2174/1574893611308050004; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen L, 2009, J PROTEOME RES, V8, P5212, DOI 10.1021/pr900554a; CONARD GJ, 1984, AM J CARDIOL, V53, pB41, DOI 10.1016/0002-9149(84)90501-0; DEGEN J, 1993, MED KLIN, V88, P129; Diepstraten J, 2015, EUR J CLIN PHARMACOL, V71, P25, DOI 10.1007/s00228-014-1760-4; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; DOWN WH, 1974, ARZNEIMITTELFORSCH, V24, P1986; Elaut G, 2007, J PHARMACOL EXP THER, V321, P400, DOI 10.1124/jpet.106.116202; Evertts AG, 2013, J BIOL CHEM, V288, P12142, DOI 10.1074/jbc.M112.428318; Ferrer I, 1997, J NEUROPATH EXP NEUR, V56, P1; Frampton JE, 2007, CNS DRUGS, V21, P521, DOI 10.2165/00023210-200721060-00007; Gabrielsson J, 2016, AAPS J, V18, P47, DOI 10.1208/s12248-015-9817-6; GEBO H, 1973, DRUG INTEL CLIN PHAR, V7, P357; Gomes CLR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106929; Graham RA, 2011, CLIN CANCER RES, V17, P2512, DOI 10.1158/1078-0432.CCR-10-2736; Gustafsson F, 2014, TOXICOL SCI, V137, P189, DOI 10.1093/toxsci/kft223; Hindmarsh PC, 2015, CLIN ENDOCRINOL, V82, P557, DOI 10.1111/cen.12653; HINO Y, 1974, J BIOCHEM-TOKYO, V76, P735; Hojo R, 2002, ENVIRON HEALTH PERSP, V110, P247, DOI 10.1289/ehp.02110247; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Hu SW, 2014, J MED FOOD, V17, P749, DOI 10.1089/jmf.2013.2924; Hu SW, 2014, J FOOD SCI, V79, pH1424, DOI 10.1111/1750-3841.12465; Huang T, 2012, BIOCHIMIE, V94, P1017, DOI 10.1016/j.biochi.2011.12.024; Iribarren Carlos, 2013, Pharmacoepidemiol Drug Saf, V22, P1222, DOI 10.1002/pds.3479; Johne A, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P397, DOI 10.1007/s00103-005-1012-y; Johnson KE, 2016, MOL CELL ENDOCRINOL, V422, P84, DOI 10.1016/j.mce.2015.12.007; Keenan JM, 2013, J CLIN LIPIDOL, V7, P14, DOI 10.1016/j.jacl.2012.10.004; Keller F, 2011, N-S ARCH PHARMACOL, V383, P7; Kietadisorn R, 2011, AM J PHYSIOL-ENDOC M, V300, pE1176, DOI 10.1152/ajpendo.00084.2011; Killen JD, 2010, ADDICTION, V105, P1660, DOI 10.1111/j.1360-0443.2010.03020.x; Kim EJ, 2014, CLIN CANCER RES, V20, P5937, DOI 10.1158/1078-0432.CCR-14-1269; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320; Lee AYY, 2003, J INTERN MED, V254, P313, DOI 10.1046/j.1365-2796.2003.01224.x; LEE EHY, 1985, J PHARMACOL EXP THER, V234, P141; LEVIS S, 1957, ARCH INT PHARMACOD T, V109, P127; Li ZC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-325; Lim KS, 2008, BRIT J CLIN PHARMACO, V66, P660, DOI 10.1111/j.1365-2125.2008.03267.x; Lindgren J, 2014, BIOPOLYMERS, V102, P252, DOI 10.1002/bip.22474; Liu XP, 2013, BIOINFORMATICS, V29, P1910, DOI 10.1093/bioinformatics/btt303; Liu YN, 2011, ARCH TOXICOL, V85, P1133, DOI 10.1007/s00204-010-0639-0; Lu J, 2016, BBA-GEN SUBJECTS, V1860, P2664, DOI 10.1016/j.bbagen.2016.05.019; Lu J, 2016, J BIOMOL STRUCT DYN, V34, P906, DOI 10.1080/07391102.2015.1060161; Lyseng-Williamson KA, 2014, BIODRUGS, V28, P465, DOI 10.1007/s40259-014-0108-z; Ma TH, 2015, IEICE T INF SYST, VE98D, P902, DOI 10.1587/transinf.2014EDP7283; Mahdi AJ, 2015, BRIT J HAEMATOL, V169, P768, DOI 10.1111/bjh.13360; Malm M, 2014, BIOTECHNOL J, V9, P1215, DOI 10.1002/biot.201400009; Marklund M, 2014, J NUTR, V144, P1674, DOI 10.3945/jn.114.196220; Mathijssen NCJ, 2013, THROMB RES, V132, P256, DOI 10.1016/j.thromres.2013.05.027; Megaraj V, 2014, CHEM RES TOXICOL, V27, P656, DOI 10.1021/tx4004769; MINERS JO, 1986, BRIT J CLIN PHARMACO, V22, P135, DOI 10.1111/j.1365-2125.1986.tb05240.x; Mistraletti G, 2015, MINERVA ANESTESIOL, V81, P1298; Miyasato Katsumasa, 2010, Nihon Rinsho, V68, P1431; MODELL W, 1962, CLIN PHARMACOL THER, V3, P235, DOI 10.1002/cpt196232235; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Montoro JB, 1999, HAEMOPHILIA, V5, P371; Moriyama B, 2011, MYCOSES, V54, pE877, DOI 10.1111/j.1439-0507.2011.02016.x; Mukherjee S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001987; Naziroglu M, 2014, J MEMBRANE BIOL, V247, P253, DOI 10.1007/s00232-014-9630-7; Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479; ORTON TC, 1982, DRUG METAB DISPOS, V10, P110; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Rahman W, 2013, NEUROSCI LETT, V557, P19, DOI 10.1016/j.neulet.2013.08.004; RASPE HH, 1987, Z RHEUMATOL, V46, P71; Saccenti E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119856; Sagcal-Gironella ACP, 2011, CLIN THER, V33, P1524, DOI 10.1016/j.clinthera.2011.09.015; Sanford M, 2009, DRUGS, V69, P461, DOI 10.2165/00003495-200969040-00006; Schaal W, 2013, BIOINFORMATICS, V29, P2369, DOI 10.1093/bioinformatics/btt390; Shafran Y, 2012, ANAL CHEM, V84, P7315, DOI 10.1021/ac202741z; Sikkel MB, 2013, CARDIOVASC RES, V98, P286, DOI 10.1093/cvr/cvt012; SIMONS FER, 1984, J PEDIATR-US, V104, P123; Sullivan BP, 2013, BLOOD, V121, P1868, DOI 10.1182/blood-2012-09-455436; TRNAVSKY K, 1975, AGENTS ACTIONS, V5, P549, DOI 10.1007/BF01972693; Turner JV, 2003, J PHARM SCI, V92, P552, DOI 10.1002/jps.10314; Vrancken K, 2013, AM J PHYSIOL-REG I, V305, pR1401, DOI 10.1152/ajpregu.00266.2013; Wakao M, 2015, BIOORG MED CHEM LETT, V25, P1407, DOI 10.1016/j.bmcl.2015.02.054; WANG RIH, 1980, JAMA-J AM MED ASSOC, V243, P1901; Wen XZ, 2015, INFORM SCIENCES, V295, P395, DOI 10.1016/j.ins.2014.10.040; Worboys PD, 2015, EUR J CLIN PHARMACOL, V71, P707, DOI 10.1007/s00228-015-1847-6; Xiao YL, 2014, INT J PHARMACEUT, V465, P143, DOI 10.1016/j.ijpharm.2014.02.009; Yan JH, 2014, J CLIN PHARMACOL, V54, P800, DOI 10.1002/jcph.285; Yarwood A, 2013, GENES IMMUN, V14, P325, DOI 10.1038/gene.2013.23; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang P., 2015, J SENSORS, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0133137; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203; Zhou K, 2013, BIOCHEM PHARMACOL, V85, P1848, DOI 10.1016/j.bcp.2013.04.014; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024	110	13	13	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165496	10.1371/journal.pone.0165496	http://dx.doi.org/10.1371/journal.pone.0165496			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780226	Green Published, gold, Green Submitted			2022-12-26	WOS:000389046900060
J	Asiankoohi, E; Herrera-Malaver, B; Rezaei, MN; Steensels, J; Courtin, CM; Verstrepen, KJ				Asiankoohi, Elham; Herrera-Malaver, Beatriz; Rezaei, Mohammad Naser; Steensels, Jan; Courtin, Christophe M.; Verstrepen, Kevin J.			Non-Conventional Yeast Strains Increase the Aroma Complexity of Bread	PLoS One			English	Article							SACCHAROMYCES-CEREVISIAE STRAINS; COMMERCIAL BAKERS YEASTS; TORULASPORA-DELBRUECKII; KLUYVEROMYCES-MARXIANUS; DOUGH FERMENTATION; VOLATILE COMPOUNDS; LEAVENING ABILITY; FREEZE TOLERANCE; POTENT ODORANTS; STARTER CULTURE	Saccharomyces cerevisiae is routinely used yeast in food fermentations because it combines several key traits, including fermentation efficiency and production of desirable flavors. However, the dominance of S. cerevisiae in industrial fermentations limits the diversity in the aroma profiles of the end products. Hence, there is a growing interest in non-conventional yeast strains that can help generate the diversity and complexity desired in today's diversified and consumer-driven markets. Here, we selected a set of non-conventional yeast strains to examine their potential for bread fermentation. Here, we tested ten non-conventional yeasts for bread fermentation, including two Saccharomyces species that are not currently used in bread making and 8 non-Saccharomyces strains. The results show that Torulaspora delbrueckii and Saccharomyces bayanus combine satisfactory dough fermentation with an interesting flavor profile. Sensory analysis and HS-SPME-GCMS analysis confirmed that these strains produce aroma profiles that are very different from that produced by a commercial bakery strain. Moreover, bread produced with these yeasts was preferred by a majority of a trained sensory panel. These results demonstrate the potential of T. delbrueckii and S. bayanus as alternative yeasts for bread dough leavening, and provide a general experimental framework for the evaluation of more yeasts and bacteria.	[Asiankoohi, Elham; Herrera-Malaver, Beatriz; Steensels, Jan; Verstrepen, Kevin J.] VIB Ctr Microbiol, Syst Biol Lab, Leuven, Belgium; [Asiankoohi, Elham; Herrera-Malaver, Beatriz; Steensels, Jan; Verstrepen, Kevin J.] Katholieke Univ Leuven, CMPG Lab Genet & Genom, Leuven, Belgium; [Rezaei, Mohammad Naser; Courtin, Christophe M.] Katholieke Univ Leuven, Lab Food Chem & Biochem, Leuven, Belgium; [Rezaei, Mohammad Naser; Courtin, Christophe M.] Katholieke Univ Leuven, Leuven Food Sci & Nutr Res Ctr LFoRCe, Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven	Verstrepen, KJ (corresponding author), VIB Ctr Microbiol, Syst Biol Lab, Leuven, Belgium.; Verstrepen, KJ (corresponding author), Katholieke Univ Leuven, CMPG Lab Genet & Genom, Leuven, Belgium.; Courtin, CM (corresponding author), Katholieke Univ Leuven, Lab Food Chem & Biochem, Leuven, Belgium.; Courtin, CM (corresponding author), Katholieke Univ Leuven, Leuven Food Sci & Nutr Res Ctr LFoRCe, Leuven, Belgium.	Christophe.Courtin@biw.kuleuven.be; Kevin.Verstrepen@biw.vib-kuleuven.be	Courtin, Christophe M/Q-1916-2016; Verstrepen, Kevin/AAA-4343-2021	Courtin, Christophe M/0000-0002-1203-9063; Herrera-Malaver, Beatriz/0000-0002-5096-9974; Verstrepen, Kevin/0000-0002-3077-6219; Rezaei, Mohammad Naser/0000-0002-6626-6739	KU Leuven (Research Fund, IDO program) [IDO/12/011]; ERC [241426]; FWO [G.0544.10N]; Human Frontier Science Program [RGP0050/2013]	KU Leuven (Research Fund, IDO program); ERC(European Research Council (ERC)European Commission); FWO(FWO); Human Frontier Science Program(Human Frontier Science Program)	This study is supported by a research grant from the KU Leuven (Research Fund, IDO program (IDO/12/011)), ERC Starting Grant (No 241426), FWO (No G.0544.10N) and Human Frontier Science Program (RGP0050/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson J., 2004, GUIDE YEAST GENETICS; Adams R. P, 2009, IDENTIFICATION ESSEN; Almeida MJ, 1996, APPL ENVIRON MICROB, V62, P4401, DOI 10.1128/AEM.62.12.4401-4404.1996; Alves-Araujo C, 2004, FEMS MICROBIOL LETT, V240, P7, DOI 10.1016/j.femsle.2004.09.008; Annan NT, 2003, J APPL MICROBIOL, V94, P462, DOI 10.1046/j.1365-2672.2003.01852.x; [Anonymous], 2000, APPR METH AN; [Anonymous], 2011, STANDARD REFERENCE D; Birch AN, 2013, J CEREAL SCI, V58, P318, DOI 10.1016/j.jcs.2013.05.009; Birch AN, 2013, FOOD RES INT, V52, P160, DOI 10.1016/j.foodres.2013.03.011; Birch AN, 2013, LWT-FOOD SCI TECHNOL, V50, P480, DOI 10.1016/j.lwt.2012.08.019; Birch AN, 2014, CEREAL CHEM, V91, P105, DOI 10.1094/CCHEM-06-13-0121-RW; Brinker EM, 2007, Google Patents, Patent No. [US 20100143534 A1, 20100143534]; Burke D., 2000, METHODS YEAST GENETI; Busko M, 2010, FOOD ADDIT CONTAM A, V27, P1574, DOI 10.1080/19440049.2010.506600; Christiaens JF, 2014, CELL REP, V9, P425, DOI 10.1016/j.celrep.2014.09.009; Clemente-Jimenez JM, 2005, INT J FOOD MICROBIOL, V98, P301, DOI 10.1016/j.ijfoodmicro.2004.06.007; Crafack M, 2013, INT J FOOD MICROBIOL, V167, P103, DOI 10.1016/j.ijfoodmicro.2013.06.024; Daenen L, 2008, FEMS YEAST RES, V8, P1103, DOI 10.1111/j.1567-1364.2008.00421.x; De Vuyst L, 2014, FOOD MICROBIOL, V37, P11, DOI 10.1016/j.fm.2013.06.002; Domizio P, 2007, INT J FOOD MICROBIOL, V115, P281, DOI 10.1016/j.ijfoodmicro.2006.10.052; Domizio P, 2011, INT J FOOD MICROBIOL, V147, P170, DOI 10.1016/j.ijfoodmicro.2011.03.020; FRASSE P, 1993, FOOD SCI TECHNOL-LEB, V26, P126; Frauendorfer F, 2006, J AGR FOOD CHEM, V54, P5521, DOI 10.1021/jf060728k; Gallone B, 2016, CELL IN PRESS; HALANG WA, 1978, ANAL CHEM, V50, P1829, DOI 10.1021/ac50035a026; Hernandez-Lopez MJ, 2003, ANTON LEEUW INT J G, V84, P125, DOI 10.1023/A:1025413520192; JOOSTEN HMLJ, 1989, APPL ENVIRON MICROB, V55, P2356, DOI 10.1128/AEM.55.9.2356-2359.1989; Lee SJ, 2003, J AGR FOOD CHEM, V51, P8036, DOI 10.1021/jf034747v; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Lilly M, 2000, APPL ENVIRON MICROB, V66, P744, DOI 10.1128/AEM.66.2.744-753.2000; Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66; McKinnon CM, 1996, CEREAL CHEM, V73, P45; Meilgaard M., 2015, SENSORY EVALUATION T, V5; Mondello L., 2011, WILEY FFNSC LIB MASS; Moreira N, 2008, INT J FOOD MICROBIOL, V124, P231, DOI 10.1016/j.ijfoodmicro.2008.03.025; Nikolaou E, 2006, FOOD MICROBIOL, V23, P205, DOI 10.1016/j.fm.2005.03.004; OHSHIMA Y, 1987, APPL ENVIRON MICROB, V53, P1512, DOI 10.1128/AEM.53.7.1512-1514.1987; Pacheco A, 2012, EMERGING ROLE YEAST; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Plessas S, 2008, FOOD CHEM, V106, P985, DOI 10.1016/j.foodchem.2007.07.012; Poinot P, 2007, FOOD RES INT, V40, P1170, DOI 10.1016/j.foodres.2007.06.011; Pozo-Bayon MA, 2006, FOOD REV INT, V22, P335, DOI 10.1080/87559120600864829; Rainieri S, 2000, ANN MICROBIOL, V50, P15; Randez-Gil F, 2013, ANNU REV FOOD SCI T, V4, P191, DOI 10.1146/annurev-food-030212-182609; Rezaei MN, 2014, FOOD MICROBIOL, V39, P108, DOI 10.1016/j.fm.2013.11.013; Rojas V, 2001, INT J FOOD MICROBIOL, V70, P283, DOI 10.1016/S0168-1605(01)00552-9; Rossouw D, 2012, APPL MICROBIOL BIOT, V93, P1207, DOI 10.1007/s00253-011-3564-0; Rychlik Michael, 1996, Lebensmittel-Wissenschaft and Technologie, V29, P515, DOI 10.1006/fstl.1996.0079; Saerens S, 2013, Enhancement of beer flavor by a combination of Pichia yeast and different hop varieties patent, Patent No. [WO/2013/030398, 2013030398, WO 2013030398 A1]; Saerens SMG, 2010, MICROB BIOTECHNOL, V3, P165, DOI 10.1111/j.1751-7915.2009.00106.x; SCHIEBERLE P, 1991, Z LEBENSM UNTERS FOR, V192, P130, DOI 10.1007/BF01202626; SCHIEBERLE P, 1994, Z LEBENSM UNTERS FOR, V198, P292, DOI 10.1007/BF01193177; Schuller D, 2005, APPL MICROBIOL BIOT, V68, P292, DOI 10.1007/s00253-005-1994-2; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Spano G, 2010, EUR J CLIN NUTR, V64, pS95, DOI 10.1038/ejcn.2010.218; Steensels J, 2014, FEMS MICROBIOL REV, V38, P947, DOI 10.1111/1574-6976.12073; Steensels J, 2014, ANNU REV MICROBIOL, V68, P61, DOI 10.1146/annurev-micro-091213-113025; Verstrepen KJ, 2003, J BIOSCI BIOENG, V96, P110, DOI 10.1016/S1389-1723(03)90112-5; Wedral D, 2010, LWT-FOOD SCI TECHNOL, V43, P1474, DOI 10.1016/j.lwt.2010.06.010; Yang DS, 2008, J AGR FOOD CHEM, V56, P235, DOI 10.1021/jf072360c	60	58	60	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165126	10.1371/journal.pone.0165126	http://dx.doi.org/10.1371/journal.pone.0165126			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776154	Green Submitted, gold, Green Published			2022-12-26	WOS:000389009200041
J	Ye, XQ; Meng, JL; Zeng, B; Wu, M; Zhang, YY; Zhang, XP				Ye, Xiao Qi; Meng, Jin Liu; Zeng, Bo; Wu, Ming; Zhang, Ye Yi; Zhang, Xiao Ping			Submergence Causes Similar Carbohydrate Starvation but Faster Post-Stress Recovery than Darkness in Alternanthera philoxeroides Plants	PLoS One			English	Article							2 WETLAND PLANTS; UNDERWATER PHOTOSYNTHESIS; QUIESCENCE STRATEGIES; DE-SUBMERGENCE; TERRESTRIAL; TOLERANCE; ACCLIMATION; RESPONSES; RESERVES; TISSUES	Carbon assimilation by submerged plants is greatly reduced due to low light levels. It is hypothesized that submergence reduces carbohydrate contents and that plants recover from submergence in the same way as darkness-treated plants. To test this hypothesis, the responses of plants to submergence and darkness were studied and compared. Plants of a submergence-tolerant species, Alternanthera philoxeroides, were exposed to well drained and illuminated conditions, complete submergence conditions or darkness conditions followed by a recovery growth period in a controlled experiment. The biomass maintenance and accumulation, carbohydrate content dynamics and respiration rate in the plants were assessed to quantify the carbohydrate utilization rate and regrowth. The submerged plants maintained higher chlorophyll contents, more green leaf tissue and more biomass; recovered more quickly; and accumulated more carbohydrates and biomass than darkness-treated plants. The respiration rate was continuously reduced in the same pattern under both stress conditions but was maintained at a significantly lower level in the submerged plants; the total soluble sugar and total fructan contents were decreased at approximately the same rate of decrease, reaching similar low levels, in the two stress treatments. The A. philoxeroides plants were more tolerant of submergence than darkness. The faster recovery of desubmerged plants could not be explained by the similar carbohydrate contents at the start of recovery. Other types of carbon reserves besides carbohydrates or other mechanisms such as higher post-stress photosynthetic performance might be involved.	[Ye, Xiao Qi; Meng, Jin Liu; Wu, Ming] Natl Forestry Bur, Chinese Acad Forestry, Inst Subtrop Forestry, Res Stn Hangzhou Bay Wetlands Ecosyst, Fuyang, Peoples R China; [Ye, Xiao Qi; Zeng, Bo; Zhang, Ye Yi; Zhang, Xiao Ping] Southwest Univ, Sch Life Sci, Key Lab Ecoenvironm Three Gorges Reservoir Reg,Mi, Chongqing Key Lab Plant Ecol & Resources Three Go, Chongqing, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF; Southwest University - China	Zeng, B (corresponding author), Southwest Univ, Sch Life Sci, Key Lab Ecoenvironm Three Gorges Reservoir Reg,Mi, Chongqing Key Lab Plant Ecol & Resources Three Go, Chongqing, Peoples R China.	bzeng@swu.edu.cn	Campos, Gustavo R C Ribeiro/O-3981-2017		National Natural Science Foundation of China [31400480, 31070474, 31370443, 31400378]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/, grant numbers 31400480, 31370443 and 31070474 to BZ and 31400378 to XQY). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Banerjee S, 2015, PLANT GENE TRAIT, V6, P1; BARCLAY AM, 1983, ANN BOT-LONDON, V51, P255; BAYSDORFER C, 1988, PLANT PHYSIOL, V88, P1381, DOI 10.1104/pp.88.4.1381; Bertrand A, 2003, J EXP BOT, V54, P1721, DOI 10.1093/jxb/erg182; BLACK MA, 1981, NEW PHYTOL, V89, P557, DOI 10.1111/j.1469-8137.1981.tb02335.x; BOWEN BJ, 1993, ANN BOT-LONDON, V72, P7, DOI 10.1006/anbo.1993.1075; Chen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081456; Colmer TD, 2008, NEW PHYTOL, V177, P918, DOI 10.1111/j.1469-8137.2007.02318.x; Das KK, 2005, PLANT SCI, V168, P131, DOI 10.1016/j.plantsci.2004.07.023; Das KK, 2009, ENVIRON EXP BOT, V66, P425, DOI 10.1016/j.envexpbot.2009.02.015; Fan SF, 2015, HYDROBIOLOGIA, V746, P159, DOI 10.1007/s10750-014-2005-3; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; HOLMES MG, 1987, PLANT LIFE AQUATIC A, P3; JACKSON MB, 1985, ANNU REV PLANT PHYS, V36, P145, DOI 10.1146/annurev.pp.36.060185.001045; Jackson MB, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv078; JONES MGK, 1977, PLANT PHYSIOL, V60, P379, DOI 10.1104/pp.60.3.379; Klee O., 1998, EINFACHE ANALYSEMETH; Luo FL, 2012, J PLANT PHYSIOL, V169, P1680, DOI 10.1016/j.jplph.2012.06.015; Luo FL, 2011, ANN BOT-LONDON, V107, P49, DOI 10.1093/aob/mcq212; Luo FL, 2009, ANN BOT-LONDON, V104, P1435, DOI 10.1093/aob/mcp257; Mommer L, 2005, ANN BOT-LONDON, V96, P581, DOI 10.1093/aob/mci212; Mommer L, 2005, NEW PHYTOL, V167, P197, DOI 10.1111/j.1469-8137.2005.01404.x; Sainty G., 1997, WETLANDS ECOLOGY MAN, V5, P195, DOI DOI 10.1023/A:1008248921849; Sarkar RK, 1996, J PLANT PHYSIOL, V149, P623, DOI 10.1016/S0176-1617(96)80344-0; Vervuren PJA, 2003, J ECOL, V91, P135, DOI 10.1046/j.1365-2745.2003.00749.x; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; Wang N, 2009, PLANT BIOLOGY, V11, P483, DOI 10.1111/j.1438-8677.2008.00133.x; WHITE LM, 1973, J RANGE MANAGE, V26, P13, DOI 10.2307/3896873; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6	30	9	9	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165193	10.1371/journal.pone.0165193	http://dx.doi.org/10.1371/journal.pone.0165193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776170	gold, Green Published, Green Submitted			2022-12-26	WOS:000389009200046
J	Baranek, M; Cechova, J; Kovacs, T; Eichmeier, A; Wang, SL; Raddova, J; Necas, T; Ye, XG				Baranek, Miroslav; Cechova, Jana; Kovacs, Tamas; Eichmeier, Ales; Wang, Shunli; Raddova, Jana; Necas, Tomas; Ye, Xingguo			Use of Combined MSAP and NGS Techniques to Identify Differentially Methylated Regions in Somaclones: A Case Study of Two Stable Somatic Wheat Mutants	PLOS ONE			English	Article							DNA METHYLATION; TRANSPOSABLE ELEMENTS; GENETIC-ANALYSIS; TISSUE-CULTURE; PLANT; IDENTIFICATION; SEQUENCE; STRESS; AMPLIFICATION; POLYMORPHISM	The appearance of somaclonal variability induced by in vitro cultivation is relatively frequent and can, in some cases, provide a valuable source of new genetic variation for crop improvement. The cause of this phenomenon remains unknown; however, there are a number of reports suggesting that epigenetics, including DNA methylations, are an important factor. In addition to the non-heritable DNA methylation changes caused by transient and reversible stress-responsive gene regulation, recent evidence supports the existence of mitotically and meiotically inherited changes. The induction of phenotypes via stable DNA methylation changes has occasionally great economical value; however, very little is known about the genetic or molecular basis of these phenotypes. We used a novel approach consisting of a standard MSAP analysis followed by deep amplicon sequencing to better understand this phenomenon. Our models included two wheat genotypes, and their somaclones induced using in vitro cultivation with a changed heritable phenotype (shortened stem height and silenced high molecular weight glutenin). Using this novel procedure, we obtained information on the dissimilarity of DNA methylation landscapes between the standard cultivar and its respective somaclones, and we extracted the sequences and genome regions that were differentially methylated between subjects. Transposable elements were identified as the most likely factor for producing changes in somaclone properties. In summary, the novel approach of combining MSAP and NGS is relatively easy and widely applicable, which is a rather unique feature compared with the currently available techniques in the epigenetics field.	[Baranek, Miroslav; Cechova, Jana; Eichmeier, Ales; Raddova, Jana] Mendel Univ Brno, Fac Hort, Mendeleum Dept Genet, Lednice, Czech Republic; [Kovacs, Tamas] Enviroinvest Co, Pecs, Hungary; [Wang, Shunli; Ye, Xingguo] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Necas, Tomas] Mendel Univ Brno, Fac Hort, Dept Fruit Growing, Lednice, Czech Republic	Mendel University in Brno; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Mendel University in Brno	Baranek, M (corresponding author), Mendel Univ Brno, Fac Hort, Mendeleum Dept Genet, Lednice, Czech Republic.	baranek@mendelu.cz	Baránek, Miroslav/E-8371-2016; Eichmeier, Aleš/F-1209-2016; Cechova, Jana/AAJ-8398-2020; Raddová, Jana/AAO-9431-2020; Necas, Tomas/H-2048-2014	Baránek, Miroslav/0000-0002-1583-3588; Eichmeier, Aleš/0000-0001-7358-3903; Cechova, Jana/0000-0003-3027-6916; Raddová, Jana/0000-0002-5723-6028; Necas, Tomas/0000-0001-5781-2737; Kovacs, Tamas/0000-0001-6647-8136; Wang, Shunli/0000-0002-2700-009X	Czech Ministry of Education, Youth and Sports; program Kontakt II; project Development of crop stress metabolism and genomics methods in Czech Republic and China [LH12196]; Hungarian government; EU; Enviroinvest Corp; Hungarian Government [GOP-1.3.2-09-2010-0023]	Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); program Kontakt II; project Development of crop stress metabolism and genomics methods in Czech Republic and China; Hungarian government; EU(European Commission); Enviroinvest Corp; Hungarian Government	This study was funded by the Czech Ministry of Education, Youth and Sports; program Kontakt II; project LH12196-Development of crop stress metabolism and genomics methods in Czech Republic and China. Details are available on https://www.isvav.czprojectDetail.do?rowld=LH12196. Enviroinvest Corp. is a research company financed by the Hungarian government and EU. The DNA sequencing experiments and bioinformatics analysis were performed by this company. Enviroinvest Corp provided support in the form of salary for TK. This research tasks fit into one of the research projects of Enviroinvest funded by the EU and by the Hungarian Government (GOP-1.3.2-09-2010-0023). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alzohairy AM, 2012, LIFE SCI J, V9, P5019; Baranek M, 2012, ACTA HORTIC, V961, P73; Baranek M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126638; Baranek M, 2010, PLANT CELL TISS ORG, V101, P11, DOI 10.1007/s11240-009-9656-1; Baranek M, 2009, GENET MOL BIOL, V32, P834, DOI 10.1590/S1415-47572009005000079; Bednarek PT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-10; Bousios A, 2016, CURR OPIN PLANT BIOL, V30, P123, DOI 10.1016/j.pbi.2016.02.009; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Damasco OP, 1998, ACTA HORTIC, P79, DOI 10.17660/ActaHortic.1998.490.5; Dann AL, 2011, PLANT CELL REP, V30, P631, DOI 10.1007/s00299-010-0983-9; Daron J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0546-4; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Emaldi U., 2004, Fruits (Paris), V59, P257, DOI 10.1051/fruits:2004024; Feng ZX, 2014, NUCLEIC ACIDS RES, V42, P13488, DOI 10.1093/nar/gku1097; Fiuk A, 2010, PLANT MOL BIOL REP, V28, P413, DOI 10.1007/s11105-009-0167-3; Fraga ME, 2002, BIOTECHNIQUES, V33, P632, DOI 10.2144/02333rv01; Fraga MF, 2002, ELECTROPHORESIS, V23, P1677, DOI 10.1002/1522-2683(200206)23:11&lt;1677::AID-ELPS1677&gt;3.0.CO;2-Z; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GALE MD, 1981, EUPHYTICA, V30, P355, DOI 10.1007/BF00033997; Gao XA, 2010, J PLANT GROWTH REGUL, V29, P257, DOI 10.1007/s00344-009-9133-4; GUENZI AC, 1992, THEOR APPL GENET, V84, P952, DOI 10.1007/BF00227409; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Jiao JN, 2014, BIOCHEM GENET, V52, P372, DOI 10.1007/s10528-014-9654-9; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; KARP A, 1995, EUPHYTICA, V85, P295, DOI 10.1007/BF00023959; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kitimu SR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00590; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Kuksova VB, 1997, PLANT CELL TISS ORG, V49, P17, DOI 10.1023/A:1005830305206; Kwasniewska J, 2012, ACTA BIOL CRACOV BOT, V54, P93, DOI 10.2478/v10182-012-0028-5; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Latzel V, 2014, OIKOS, V123, P41, DOI 10.1111/j.1600-0706.2013.00537.x; Leal F, 2006, PLANT CELL REP, V25, P978, DOI 10.1007/s00299-006-0162-1; Lei C.P., 2006, ASIA PACIFIC J MOL B, V14, P47; Liu HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146933; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Machczynska J, 2014, PLANT CELL TISS ORG, V119, P289, DOI 10.1007/s11240-014-0533-1; Machczynska J, 2014, MOL BREEDING, V34, P845, DOI 10.1007/s11032-014-0079-2; MANN MB, 1977, NUCLEIC ACIDS RES, V4, P4211, DOI 10.1093/nar/4.12.4211; Matsunaga W, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00048; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; MCPHEETERS K, 1983, EUPHYTICA, V32, P351, DOI 10.1007/BF00021443; Mehta YR, 2000, GENET MOL BIOL, V23, P617, DOI 10.1590/S1415-47572000000300021; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Popescu CF, 2002, VITIS, V41, P177; Predieri S, 2001, PLANT CELL TISS ORG, V64, P185, DOI 10.1023/A:1010623203554; Rathore MS, 2015, PLANT GROWTH REGUL, V75, P11, DOI 10.1007/s10725-014-9926-8; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Saez-Laguna E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103145; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shi HD, 2003, CANCER RES, V63, P2164; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Suprasanna P, 2008, AUST J CROP SCI, V1, P47; Tang Na, 2009, Scientia Agricultura Sinica, V42, P3774; Tang XM, 2014, MOL GENET GENOMICS, V289, P1075, DOI 10.1007/s00438-014-0869-6; Tsaftaris AS, 2007, PLANT BREEDING REV, DOI [10.1002/9780470380130.ch2, DOI 10.1002/9780470380130.CH2]; Vogel N, 2009, TRANSFUS MED HEMOTH, V36, P253, DOI 10.1159/000225089; Voronova A, 2014, TREE GENET GENOMES, V10, P937, DOI 10.1007/s11295-014-0733-1; WALDER RY, 1983, J BIOL CHEM, V258, P1235; Wang K, 2013, CROP SCI, V53, P1032, DOI 10.2135/cropsci2012.11.0620; Wang YM, 2004, CELL MOL BIOL LETT, V9, P543; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Winfield MO, 2012, PLANT BIOTECHNOL J, V10, P733, DOI 10.1111/j.1467-7652.2012.00713.x; Xiao LL, 2014, J PLANT GENETIC RESO, V15, P172; Yang SongJie, 2006, Scientia Agricultura Sinica, V39, P1680; Yuo T, 2012, J EXP BOT, V63, P5223, DOI 10.1093/jxb/ers182; Zhang D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096879	76	11	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165749	10.1371/journal.pone.0165749	http://dx.doi.org/10.1371/journal.pone.0165749			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792769	Green Submitted, Green Published, gold			2022-12-26	WOS:000389537000048
J	Gao, ZX; Lu, Y; Ke, J; Li, T; Hu, P; Song, Y; Xu, CY; Wang, J; Cheng, J; Zhang, L; Duan, H; Yuan, HJ; Ma, FR				Gao, Zixuan; Lu, Yu; Ke, Jia; Li, Tao; Hu, Ping; Song, Yu; Xu, Chiyu; Wang, Jie; Cheng, Jing; Zhang, Lei; Duan, Hong; Yuan, Huijun; Ma, Furong			Application of SNPscan in Genetic Screening for Common Hearing Loss Genes	PLOS ONE			English	Article							MUTATIONS; GJB2; DEAFNESS; IMPAIRMENT; SPECTRUM	The current study reports the successful application of a fast and efficient genetic screening system for common hearing loss (HL) genes based on SNPscan genotyping technology. Genetic analysis of 115 variants in common genes related to HL, GJB2, SLC26A4 and MT-RNR, was performed on 695 subjects with non-syndromic hearing loss (NSHL) from the Northern China. The results found that 38.7% (269/695) of cases carried bi-allelic pathogenic variants in GJB2 and SLC26A4 and 0.7% (5/695) of cases carried homoplasmic MT-RNR1 variants. The variant allele frequency of GJB2, SLC26A4 and MT-RNR1 was 19.8% (275/1390), 21.9% (304/1390), and 0.86% (6/695), respectively. This approach can explain similar to 40% of NSHL cases and thus is a useful tool for establishing primary molecular diagnosis of NSHL in clinical genetics.	[Gao, Zixuan; Ke, Jia; Li, Tao; Hu, Ping; Song, Yu; Xu, Chiyu; Wang, Jie; Ma, Furong] Peking Univ, Hosp 3, Dept Otolaryngol, Beijing, Peoples R China; [Lu, Yu; Duan, Hong] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Beijing, Peoples R China; [Cheng, Jing; Zhang, Lei; Yuan, Huijun] Third Mil Med Univ, Southwest Hosp, Ctr Med Genet, Chongqing, Peoples R China	Peking University; Chinese People's Liberation Army General Hospital; Army Medical University	Ma, FR (corresponding author), Peking Univ, Hosp 3, Dept Otolaryngol, Beijing, Peoples R China.	furongma@163.com			Key Clinical Department of Ministry of Health Foundation [62450-10]	Key Clinical Department of Ministry of Health Foundation	These investigations were supported by Key Clinical Department of Ministry of Health Foundation (62450-10) to Furong Ma.; We sincerely thank all the patients and everyone for their participation and support in this study. These investigations were supported by Key Clinical Department of Ministry of Health Foundation (62450-10) to Furong Ma.	Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; Dai P, 2006, BIOCHEM BIOPH RES CO, V340, P194, DOI 10.1016/j.bbrc.2005.11.156; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Du W, 2014, GENOMICS, V104, P264, DOI 10.1016/j.ygeno.2014.07.009; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Gabriel H, 2001, Hum Mutat, V17, P521, DOI 10.1002/humu.1138; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Ji YB, 2011, ACTA OTO-LARYNGOL, V131, P124, DOI 10.3109/00016489.2010.483479; Jiang H, 2014, MOL MED REP, V10, P379, DOI 10.3892/mmr.2014.2148; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/00125817-200207000-00004; Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x; Kupka Susan, 2002, Hum Mutat, V19, P308, DOI 10.1002/humu.9017; Liu XZ, 2008, ACTA OTO-LARYNGOL, V128, P732, DOI 10.1080/00016480701719011; Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Ohtsuka A, 2003, HUM GENET, V112, P329, DOI 10.1007/s00439-002-0889-x; Rennels M, 2005, LANCET, V365, P2085, DOI 10.1016/S0140-6736(05)66724-4; Roux Anne-Francoise, 2004, BMC Med Genet, V5, P5; Runge-Samuelson C, 2009, PHYSIOL GENOMICS, V39, P83, DOI 10.1152/physiolgenomics.00125.2009; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79	20	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165650	10.1371/journal.pone.0165650	http://dx.doi.org/10.1371/journal.pone.0165650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792752	Green Published, gold, Green Submitted			2022-12-26	WOS:000389537000042
J	Bulut, SD; Bulut, S; Atalan, DG; Berkol, T; Gurcay, E; Turker, T; Aydemir, C				Bulut, Suheyla Dogan; Bulut, Serdar; Atalan, Dicle Gorkem; Berkol, Tonguc; Gurcay, Eda; Turker, Turker; Aydemir, Cigdem			The Relationship between Symptom Severity and Low Vitamin D Levels in Patients with Schizophrenia	PLOS ONE			English	Article							D DEFICIENCY; BRAIN-DEVELOPMENT; NERVOUS-SYSTEM; HORMONE; RISK; INTERVENTIONS; POPULATION; NUTRITION; PSYCHOSIS; CALCIUM	Background In recent years, the relationship between schizophrenia and environmental factors has come into prominence. This study investigated the relationship between vitamin D levels and the positive and negative symptoms of schizophrenia by comparing vitamin D levels between patients with schizophrenia and a healthy control group. Methods The study included 80 patients diagnosed with schizophrenia and 74 age- and sex-matched controls. The Scale for the Assessment of Negative Symptoms ( SANS) and the Scale for the Assessment of Positive Symptoms ( SAPS) were used to evaluate symptom severity. The 25-hydroxyvitamin D (25OHD) levels of all subjects both patients and healthy controls were analyzed in relation to measurements of symptom severity. Results There were no significant differences between the groups in terms of age, sex, or physical activity. Their mean 25OHD levels were also similar ( 23.46 +/- 13.98ng/mL for the patient group and 23.69 +/- 9.61ng/mL for the control group). But when patients with schizophrenia were grouped based on their vitamin D levels, the results indicated a statistically significant differences between their vitamin D levels and their total SANS, affective flattening, and total SAPS, bizarre behavior and positive formal thought disorder scores (p = 0.019, p = 0.004, p = 0.015, p = 0.009 and p = 0.019, respectively). There is a negative correlation between 25OHD levels and SANS total points (r=-0.232, p = 0.038); a negative correlation for attention points (r = -0.227, p = 0.044) and negative correlation with positive formal thoughts (r = -0.257, p = 0.021). Conclusion The results of this study show a relationship between lower levels of vitamin D and the occurrence of positive and negative symptoms, along with increased severity of symptoms at lower levels of vitamin D, suggesting that treatment for schizophrenia should include assessment of patients' vitamin D levels. We recommend that patients with schizophrenia should be assessed with regard to their vitamin D levels.	[Bulut, Suheyla Dogan] Diskapi Yildirim Beyazit Teaching & Res Hosp, Dept Psychiat, Ankara, Turkey; [Bulut, Serdar] Yenimahalle Teaching & Res Hosp, Dept Psychiat, Ankara, Turkey; [Atalan, Dicle Gorkem] Erenkoy Teaching & Res Hosp Neurol & Psychiat Dis, Dept Psychiat, Istanbul, Turkey; [Berkol, Tonguc] Bakirkoy Mazhar Osman Teaching & Res Hosp Neurol, Dept Psychiat, Istanbul, Turkey; [Gurcay, Eda] Diskapi Yildirim Beyazit Teaching & Res Hosp, Phys Med & Rehabil Dept, Ankara, Turkey; [Turker, Turker] Gulhane Mil Med Acad, Dept Publ Hlth, Ankara, Turkey; [Aydemir, Cigdem] Numune Teaching & Res Hosp, Dept Psychiat, Ankara, Turkey	Diskapi Yildirim Beyazit Training & Research Hospital; Ankara Yenimahalle Training & Research Hospital; Erenkoy Mental & Neurological Disorders Education & Research Hospital; Istanbul Bakirkoy Mental Health & Neurology Training & Research Hospital; Diskapi Yildirim Beyazit Training & Research Hospital; Gulhane Military Medical Academy; Ankara Numune Training & Research Hospital	Bulut, SD (corresponding author), Diskapi Yildirim Beyazit Teaching & Res Hosp, Dept Psychiat, Ankara, Turkey.	dr_sdbulut@hotmail.com	BULUT, Süheyla DOĞAN/AAD-6108-2020					Amaral AD, 2014, IJCNMH, V1, P1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 2014, PSYCHIATRY, V162, P441; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berg AO, 2010, J CLIN PSYCHIAT, V71, P1598, DOI 10.4088/JCP.09m05299yel; Bhat S, 2012, PROG NEUROBIOL, V99, P1, DOI 10.1016/j.pneurobio.2012.06.001; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; BUFFINGTON C, 1993, OBES SURG, V3, P421, DOI 10.1381/096089293765559142; Calvo MS, 2005, J NUTR, V135, P310, DOI 10.1093/jn/135.2.310; Crews M, 2013, SCHIZOPHR RES, V150, P533, DOI 10.1016/j.schres.2013.08.036; DEVGUN MS, 1981, AM J CLIN NUTR, V34, P1501, DOI 10.1093/ajcn/34.8.1501; Erkoc $, 1991, D S NEN ADAM, V4, P16; Erkoc S, 1991, DUSUNEN ADAM, V4, P20; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles D, 2011, SEMIN CELL DEV BIOL, V22, P629, DOI 10.1016/j.semcdb.2011.05.004; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Gerdhem P, 2005, OSTEOPOROSIS INT, V16, P1425, DOI 10.1007/s00198-005-1860-1; Graham K.A., 2014, EARLY INTER IN PRESS; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Itzhaky D, 2012, ISR MED ASSOC J, V14, P88; Jamilian H, 2013, INT J PSYCHIAT CLIN, V17, P30, DOI 10.3109/13651501.2012.667111; KAHN RS, 1994, SCHIZOPHR RES, V11, P217, DOI 10.1016/0920-9964(94)90015-9; Kalueff AV, 2007, CURR OPIN CLIN NUTR, V10, P12, DOI 10.1097/MCO.0b013e328010ca18; Kassi Eva N, 2015, Hormones (Athens), V14, P245, DOI 10.14310/horm.2002.1521; Kesby JP, 2006, BIOL PSYCHIAT, V60, P591, DOI 10.1016/j.biopsych.2006.02.033; Kesby James P, 2012, Psychopharmacology (Berl), V220, P455, DOI 10.1007/s00213-011-2492-0; Kesby JP, 2010, PSYCHOPHARMACOLOGY, V208, P159, DOI 10.1007/s00213-009-1717-y; Laruelle M, 2014, CURR OPIN PHARMACOL, V14, P97, DOI 10.1016/j.coph.2014.01.001; Lawrie SM, 1998, BRIT J PSYCHIAT, V172, P110, DOI 10.1192/bjp.172.2.110; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; McGrath J, 1999, SCHIZOPHR RES, V40, P173, DOI 10.1016/S0920-9964(99)00052-3; McGrath JJ, 2011, SCHIZOPHR B, V36, P1073; Meli G, 2012, J MATERN-FETAL NEO M, V25, P2559, DOI 10.3109/14767058.2012.699118; Meyer U, 2010, PROG NEUROBIOL, V90, P285, DOI 10.1016/j.pneurobio.2009.10.018; Narr KL, 2005, BIOL PSYCHIAT, V58, P32, DOI 10.1016/j.biopsych.2005.03.043; Nimitphong H, 2011, CURR OPIN CLIN NUTR, V14, P7, DOI 10.1097/MCO.0b013e3283414c38; O'Loan J, 2007, PSYCHONEUROENDOCRINO, V32, P227, DOI 10.1016/j.psyneuen.2006.12.006; Sachdeva S, 2009, INDIAN J DERMATOL VE, V75, P93, DOI 10.4103/0378-6323.45238; TORREY EF, 1977, ARCH GEN PSYCHIAT, V34, P1065; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wrzosek M, 2013, PHARMACOL REP, V65, P271, DOI 10.1016/S1734-1140(13)71003-X; Yuksel RN, 2014, THER ADV PSYCHOPHARM, V4, P268, DOI 10.1177/2045125314553612	45	16	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165284	10.1371/journal.pone.0165284	http://dx.doi.org/10.1371/journal.pone.0165284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VY	27788194	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900055
J	Liu, YN; Chen, AS; Kamphaengkham, S; Leenasirimakul, P; Jirawison, C; Ausayakhun, S; Margolis, TP; Keenan, JD				Liu, Yingna; Chen, Alexander S.; Kamphaengkham, Siripim; Leenasirimakul, Prattana; Jirawison, Choeng; Ausayakhun, Somsanguan; Margolis, Todd P.; Keenan, Jeremy D.			Diagnostic Utility of Ocular Symptoms and Vision for Cytomegalovirus Retinitis	PLoS One			English	Article							OPHTHALMIC MANIFESTATIONS; HIV; COHORT; HAART; INDIA; ERA	Purpose Cytomegalovirus (CMV) retinitis remains a leading cause of blindness in countries with a high burden of AIDS. Although dilated fundus examinations are recommended for those with CD4 counts below 100 cells/mu L, in practice only those with poor vision and/or symptoms are routinely referred for screening. Therefore, the predictive value of this common practice should be assessed. Methods This is a prospective cross-sectional study. Patients with known HIV and a CD4 count of less than 100 cells/mu L attending an HIV clinic in Chiang Mai, Thailand completed a standardized questionnaire about visual symptoms and underwent visual acuity testing and dilated fundus examination. Participants without CMV retinitis were invited for repeated examinations every 3 months until their CD4 count exceeded 100 cells/mu L. Patient-level statistical analyses were conducted to calculate diagnostic test characteristics, with boot-strapping to account for correlated data. Results Of 103 study participants, 16 had CMV retinitis diagnosed at some point during the study. Participants with CMV retinitis were more likely to complain of visual symptoms compared to those without CMV retinitis (p = 0.01), including scotoma (p = 0.0002), itchy or watery eyes (p < 0.0001), and eye pain (p = 0.003); they were also more likely to have visual acuity worse than Counting Fingers (p = 0.0003). However, the absence of eye symptoms and the absence of poor vision did not strongly affect the probability that a patient did not have disease (negative likelihood ratio 0.56 and 0.76, respectively). Conclusions Ocular symptoms and poor visual acuity were poor diagnostic indicators for the presence of CMV retinitis. Systematic screening of HIV patients with CD4 counts below 100 cells/mu l should be carried out to detect disease at an early stage, when blindness can still be prevented.	[Liu, Yingna] Harvard Med Sch, Boston, MA USA; [Liu, Yingna; Keenan, Jeremy D.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Chen, Alexander S.] Yale Univ, New Haven, CT USA; [Kamphaengkham, Siripim; Leenasirimakul, Prattana] Nakornping Hosp, Dept Internal Med, Chiang Mai, Thailand; [Kamphaengkham, Siripim; Leenasirimakul, Prattana] Nakornping Hosp, Chiang Mai, Thailand; [Jirawison, Choeng] Nakornping Hosp, Dept Ophthalmol, Chiang Mai, Thailand; [Ausayakhun, Somsanguan] Chiang Mai Univ, Fac Med, Dept Ophthalmol, Chiang Mai, Thailand; [Margolis, Todd P.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Keenan, Jeremy D.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA	Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Yale University; Chiang Mai University; Washington University (WUSTL); University of California System; University of California San Francisco	Keenan, JD (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA.	jeremy.keenan@ucsf.edu	Keenan, Jeremy David/AAO-5882-2020	Keenan, Jeremy David/0000-0002-7118-1457	Fortisure Foundation, San Francisco, CA; That Man May See, San Francisco, CA; Research to Prevent Blindness, New York, NY; Doris Duke Charitable Foundation (New York, New York) through the Doris Duke International Clinical Research Fellows Program at the University of California, San Francisco	Fortisure Foundation, San Francisco, CA; That Man May See, San Francisco, CA; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Doris Duke Charitable Foundation (New York, New York) through the Doris Duke International Clinical Research Fellows Program at the University of California, San Francisco	This study was supported by the Fortisure Foundation, San Francisco, CA (JDK), That Man May See, San Francisco, CA (JDK), and Research to Prevent Blindness, New York, NY (JDK). YL is a Doris Duke International Clinical Research Fellow. She received a grant from the Doris Duke Charitable Foundation (New York, New York) through the Doris Duke International Clinical Research Fellows Program at the University of California, San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colby DJ, 2014, INT J STD AIDS, V25, P516, DOI 10.1177/0956462413515197; Ford N, 2013, CLIN INFECT DIS, V57, P1351, DOI 10.1093/cid/cit494; Gharai S, 2008, OPHTHAL EPIDEMIOL, V15, P264, DOI 10.1080/09286580802077716; Hodge WG, 2004, OPHTHALMOLOGY, V111, P1326, DOI 10.1016/j.ophtha.2004.03.001; Jirawison C, 2014, JAMA OPHTHALMOL; Panayiotakopoulos GD, 2003, RHEUMATOLOGY, V42, P1164, DOI 10.1093/rheumatology/keg316; Pathai S, 2011, TROP MED INT HEALTH, V16, P356, DOI 10.1111/j.1365-3156.2010.02712.x; Pathai S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-158; Rutar T, 2015, BRIT J OPHTHALMOL, V99, P650, DOI 10.1136/bjophthalmol-2014-305557	9	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165564	10.1371/journal.pone.0165564	http://dx.doi.org/10.1371/journal.pone.0165564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788232	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900108
J	Tam, A; Bates, JHT; Churg, A; Wright, JL; Man, SFP; Sin, DD				Tam, Anthony; Bates, Jason H. T.; Churg, Andrew; Wright, Joanne L.; Man, S. F. Paul; Sin, Don D.			Sex-Related Differences in Pulmonary Function following 6 Months of Cigarette Exposure: Implications for Sexual Dimorphism in Mild COPD	PLoS One			English	Article							SMOKE-INDUCED EMPHYSEMA; GENDER-DIFFERENCES; LUNG-FUNCTION; MICE; PRESSURE; AIRWAY	Female smokers have increased risk of chronic obstructive pulmonary disease (COPD) compared with male smokers who have a similar history of cigarette smoke exposure. We have shown previously that chronic smoke exposure for 6 months leads to increased airway wall remodeling in female C57BL/6 mice compared with male C57BL/6 mice. These differences, however, were not evident in female ovariectomized mice exposed to cigarette smoke. Herein, we report on the pulmonary function test results from the flexiVent system, which was used to determine the potential functional consequences of the histologic changes observed in these mice. We found that tissue damping (G) was increased in female compared to male or ovariectomized female mice after smoke exposure. At low oscillating frequencies, complex input resistance (Zrs) and impedance (Xrs) of the respiratory system was increased and decreased, respectively, in female but not in male or ovariectomized female mice after smoke exposure. Quasistatic pressure-volume curves revealed a reduction in inspiratory capacity in female mice but not in male or ovariectomized female mice after smoke exposure. The remaining lung function measurements including quasistatic compliance were similar amongst all groups. This is the first study characterizing a sexual dimorphism in respiratory functional properties in a mouse model of COPD. These findings demonstrate that increased airway remodeling in female mice following chronic smoke exposure is associated with increased tissue resistance in the peripheral airways. These data may explain the importance of female sex hormones and the increased risk of airway disease in female smokers.	[Tam, Anthony; Man, S. F. Paul; Sin, Don D.] St Pauls Hosp, Ctr Heart Lung Innovat, Dept Med, Vancouver, BC, Canada; [Bates, Jason H. T.] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; [Churg, Andrew; Wright, Joanne L.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada	St. Paul's Hospital; University of Saskatchewan; University of Vermont; University of British Columbia	Sin, DD (corresponding author), St Pauls Hosp, Ctr Heart Lung Innovat, Dept Med, Vancouver, BC, Canada.	Don.Sin@hli.ubc.ca	Sin, Don/AAC-2219-2021		Canadian Institutes of Health Research [115142]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This was funded by the Canadian Institutes of Health Research (grant # 115142 to Don Sin). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates JHT, 2003, J APPL PHYSIOL, V94, P1297, DOI 10.1152/japplphysiol.00706.2002; BATTIG K, 1982, PSYCHOPHARMACOLOGY, V76, P139, DOI 10.1007/BF00435268; CASTLEDEN CM, 1975, BRIT J IND MED, V32, P115; Churg A, 2007, THORAX, V62, P706, DOI 10.1136/thx.2006.068353; Counter WB, 2013, AM J PHYSIOL-LUNG C, V304, pL831, DOI 10.1152/ajplung.00281.2012; Crane-Godreau MA, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00132; De Langhe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043123; Dransfield MT, 2006, RESP MED, V100, P1110, DOI 10.1016/j.rmed.2005.09.019; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Ionescu C, 2010, COMPUT METH PROG BIO, V97, P78, DOI 10.1016/j.cmpb.2009.06.006; March TH, 2006, TOXICOL SCI, V92, P545, DOI 10.1093/toxsci/kfl016; Martinez FJ, 2007, AM J RESP CRIT CARE, V176, P243, DOI 10.1164/rccm.200606-828OC; Prescott E, 1997, EUR RESPIR J, V10, P822; SALAZAR E, 1964, J APPL PHYSIOL, V19, P97, DOI 10.1152/jappl.1964.19.1.97; Sasaki M, 2015, AM J PHYSIOL-LUNG C, V308, pL1039, DOI 10.1152/ajplung.00366.2014; Tam A, 2015, AM J RESP CRIT CARE; Van Winkle LS, 2002, AM J PHYSIOL-LUNG C, V282, pL1122, DOI 10.1152/ajplung.00309.2001; WRIGHT JL, 1993, J APPL PHYSIOL, V74, P1320, DOI 10.1152/jappl.1993.74.3.1320	18	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164835	10.1371/journal.pone.0164835	http://dx.doi.org/10.1371/journal.pone.0164835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788167	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900028
J	Dunn, MJ; Jackson, JA; Adlard, S; Lynnes, AS; Briggs, DR; Fox, D; Waluda, CM				Dunn, Michael J.; Jackson, Jennifer A.; Adlard, Stacey; Lynnes, Amanda S.; Briggs, Dirk R.; Fox, Derren; Waluda, Claire M.			Population Size and Decadal Trends of Three Penguin Species Nesting at Signy Island, South Orkney Islands	PLOS ONE			English	Article							CLIMATE-CHANGE; ANTARCTIC PENINSULA; SEA-ICE; PYGOSCELIS PENGUINS; LAURIE ISLAND; CHINSTRAP; VARIABILITY; RESPONSES; SUCCESS; CENSUS	We report long-term changes in population size of three species of sympatrically breeding pygoscelid penguins: Ade A lie (Pygoscelis adeliae), chinstrap (Pygoscelis antarctica) and gentoo (Pygoscelis papua ellsworthii) over a 38 year period at Signy Island, South Orkney Islands, based on annual counts from selected colonies and decadal all-island systematic counts of occupied nests. Comparing total numbers of breeding pairs over the whole island from 1978/79 to 2015/16 revealed varying fortunes: gentoo penguin pairs increased by 255%, (3.5% per annum), chinstrap penguins declined by 68% (-3.6% per annum) and Ade A lie penguins declined by 42% (-1.5% per annum). The chinstrap population has declined steadily over the last four decades. In contrast, Ade A lie and gentoo penguins have experienced phases of population increase and decline. Annual surveys of selected chinstrap and Ade A lie colonies produced similar trends from those revealed by island-wide surveys, allowing total island population trends to be inferred relatively well. However, while the annual colony counts of chinstrap and Ade A lie penguins showed a trend consistent in direction with the results from all-island surveys, the magnitude of estimated population change was markedly different between colony wide and all island counts. Annual population patterns suggest that pair numbers in the study areas partly reflect immigration and emigration of nesting birds between different parts of the island. Breeding success for all three species remained broadly stable over time in the annually monitored colonies. Breeding success rates in gentoo and chinstrap penguins were strongly correlated, despite the differing trends in population size. This study shows the importance of effective, standardised monitoring to accurately determine long-term population trajectories. Our results indicate significant declines in the Ade A lie and chinstrap penguin populations at Signy Island over the last five decades, and a gradual increase in gentoo breeding pairs.	[Dunn, Michael J.; Jackson, Jennifer A.; Adlard, Stacey; Briggs, Dirk R.; Fox, Derren; Waluda, Claire M.] British Antarctic Survey, Nat Environm Res Council, Madingley Rd, Cambridge CB3 0ET, England; [Lynnes, Amanda S.] Int Assoc Antarct Tour Operators, 320 Thames St,Suite 264, Newport, RI 02840 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Dunn, MJ (corresponding author), British Antarctic Survey, Nat Environm Res Council, Madingley Rd, Cambridge CB3 0ET, England.	mdunn@bas.ac.uk		Jackson, Jennifer/0000-0003-4158-1924; Dunn, Michael/0000-0003-4633-5466	Natural Environment Research Council; Natural Environment Research Council [bas0100035] Funding Source: researchfish; NERC [bas0100035] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study is part of the Ecosystems component of the British Antarctic Survey Polar Science for Planet Earth Programme, funded by the Natural Environment Research Council.; We thank all the members of the Signy Island Research Station, British Antarctic Survey (BAS) who have contributed to and supported the long-term penguin monitoring programme. We also thank Laura Gerrish for her mapping assistance, Dr Richard Phillips and two anonymous reviewers for their helpful advice and comments. This study is part of the Ecosystems component of the British Antarctic Survey Polar Science for Planet Earth Programme, funded by The Natural Environment Research Council.	Baylis Alastair M. M., 2013, Marine Ornithology, V41, P1; Boersma PD, 2008, BIOSCIENCE, V58, P597, DOI 10.1641/B580707; Carlini AR, 2009, POLAR BIOL, V32, P1427, DOI 10.1007/s00300-009-0637-y; CCAMLR C, 2004, STANDARD METHODS FOR; Clucas GV, 2014, SCI REP-UK, V4, DOI 10.1038/srep05024; Conroy J.W.H., 1975, Bulletin Br Antarct Surv, VNo. 40, P23; Coria Nestor R., 2011, Marine Ornithology, V39, P207; Croxall J.P., 1988, P261; CROXALL J.P., 1981, BR ANTARCT SURV B, V54, P47; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; Croxall JP, 1979, THE DISTRIBUTION OF; Croxall JP, 1985, PROCEEDINGS OF THE F; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Dunn MJ, 2016, POLAR BIOL, V39, P1309, DOI 10.1007/s00300-015-1855-0; Forcada J, 2006, GLOBAL CHANGE BIOL, V12, P411, DOI 10.1111/j.1365-2486.2006.01108.x; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; FRASER WR, 1992, POLAR BIOL, V11, P525; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Goebel ME, 2015, POLAR BIOL, V38, P619, DOI 10.1007/s00300-014-1625-4; Harris C.M., 2015, IMPORTANT BIRD AREAS; Hinke JT, 2007, OECOLOGIA, V153, P845, DOI 10.1007/s00442-007-0781-4; Juares MA, 2013, POLAR RES, V32, DOI 10.3402/polar.v32i0.18448; LISHMAN GS, 1985, J ZOOL, V205, P245, DOI 10.1111/j.1469-7998.1985.tb03532.x; Lynch HJ, 2014, AUK, V131, P457, DOI 10.1642/AUK-14-31.1; Lynch HJ, 2009, CCAMLR SCI, V16, P149; Lynch HJ, 2012, ECOLOGY, V93, P1367; Lynch HJ, 2010, POLAR BIOL, V33, P493, DOI 10.1007/s00300-009-0726-y; Lynch Heather J., 2008, Marine Ornithology, V36, P83; Miller AK, 2008, MAR BIOL, V154, P201, DOI 10.1007/s00227-008-0909-z; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Naveen R, 2012, POLAR BIOL, V35, P1879, DOI 10.1007/s00300-012-1230-3; Newbery KB, 2009, COLD REG SCI TECHNOL, V55, P47, DOI 10.1016/j.coldregions.2008.06.001; Patterson D. L., 2008, Marine Ornithology, V36, P115; PONCET S, 1985, BRIT ANTARCT SURV B, P71; REILLY P N, 1981, Notornis, V28, P189; ROBERTSON G, 1986, AUST WILDLIFE RES, V13, P583; Rombola E, 2003, POLAR BIOL, V26, P41, DOI 10.1007/s00300-002-0444-1; ROOTES DM, 1988, BRIT ANTARCT SURV B, P87; Southwell C, 2010, CCAMLR SCI, V17, P229; Southwell C, 2013, POLAR BIOL, V36, P843, DOI 10.1007/s00300-013-1310-z; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; Trathan PN, 2012, ECOGRAPHY, V35, P983, DOI 10.1111/j.1600-0587.2012.07330.x; Trathan PN, 1996, POLAR BIOL, V16, P321; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Van Franeker JA, 2001, ANTARCT SCI, V13, P430, DOI 10.1017/S0954102001000591; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Waluda CM, 2014, POLAR BIOL, V37, P1849, DOI 10.1007/s00300-014-1566-y; Waluda CM, 2010, POLAR BIOL, V33, P305, DOI 10.1007/s00300-009-0706-2; Williams T.D., 1995, PENGUINS	51	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164025	10.1371/journal.pone.0164025	http://dx.doi.org/10.1371/journal.pone.0164025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783668	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000389602800024
J	Rawcliffe, DFR; Osterman, L; Lindsten, H; Holmberg, M				Rawcliffe, Denise F. R.; Osterman, Lennart; Lindsten, Hans; Holmberg, Monica			The High Level of Aberrant Splicing of ISCU in Slow-Twitch Muscle May Involve the Splicing Factor SRSF3	PLOS ONE			English	Article							PRE-MESSENGER-RNA; SUCCINATE-DEHYDROGENASE; LACTIC-ACIDOSIS; INTRON MUTATION; FACTOR SRP20; SR PROTEINS; MYOPATHY; EXPRESSION; DEFICIENCY; GENE	Hereditary myopathy with lactic acidosis (HML) is an autosomal recessive disease caused by an intronic one-base mutation in the iron-sulfur cluster assembly (ISCU) gene, resulting in aberrant splicing. The incorrectly spliced transcripts contain a 100 or 86 bp intron sequence encoding a non-functional ISCU protein, which leads to defects in several Fe-S containing proteins in the respiratory chain and the TCA cycle. The symptoms in HML are restricted to skeletal muscle, and it has been proposed that this effect is due to higher levels of incorrectly spliced ISCU in skeletal muscle compared with other energy-demanding tissues. In this study, we confirm that skeletal muscle contains the highest levels of incorrect ISCU splice variants compared with heart, brain, liver and kidney using a transgenic mouse model expressing human HML mutated ISCU. We also show that incorrect splicing occurs to a significantly higher extent in the slow-twitch soleus muscle compared with the gastrocnemius and quadriceps. The splicing factor serine/arginine-rich splicing factor 3 (SRSF3) was identified as a potential candidate for the slow fiber specific regulation of ISCU splicing since this factor was expressed at higher levels in the soleus compared to the gastrocnemius and quadriceps. We identified an interaction between SRSF3 and the ISCU transcript, and by overexpressing SRSF3 in human myoblasts we observed increased levels of incorrectly spliced ISCU, while knockdown of SRSF3 resulted in decreased levels. We therefore suggest that SRSF3 may participate in the regulation of the incorrect splicing of mutant ISCU and may, at least partially, explain the muscle-specific symptoms of HML.	[Rawcliffe, Denise F. R.; Osterman, Lennart; Holmberg, Monica] Umea Univ, Dept Med Biosci, Med & Clin Genet, Umea, Sweden; [Lindsten, Hans] Umea Univ Hosp, Dept Pharmacol & Clin Neurosci, Clin Neurosci, Umea, Sweden	Umea University; Umea University	Rawcliffe, DFR (corresponding author), Umea Univ, Dept Med Biosci, Med & Clin Genet, Umea, Sweden.	denise.rawcliffe@umu.se		Rawcliffe, Denise/0000-0001-6632-5770	Swedish Medical Research Council [K2012-68X-15022-09-3]; Medical Faculty at Umea University	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Medical Faculty at Umea University	This work was funded by Swedish Medical Research Council, K2012-68X-15022-09-3 (www.vr.se), and Medical Faculty at Umea University (www.medfak.umu.se).	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Antunes-Martins A, 2007, LEARN MEMORY, V14, P693, DOI 10.1101/lm.640307; AYANE M, 1991, NUCLEIC ACIDS RES, V19, P1273, DOI 10.1093/nar/19.6.1273; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bertchtold MW, 2000, PHYSIAL REV, V80, P1215; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; Chemello F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016807; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422; Hanamura A, 1998, RNA, V4, P430; Jacobs RA, 2013, J GERONTOL A; Jang HN, 2014, BBA-GENE REGUL MECH, V1839, P25, DOI 10.1016/j.bbagrm.2013.11.006; Blanco FJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00054; Jumaa H, 1999, CURR BIOL, V9, P899, DOI 10.1016/S0960-9822(99)80394-7; Jumaa H, 1997, MOL CELL BIOL, V17, P3116, DOI 10.1128/MCB.17.6.3116; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077; Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152; LARSSON LE, 1964, J NEUROL NEUROSUR PS, V27, P361, DOI 10.1136/jnnp.27.5.361; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Nierobisz LS, 2012, ANIM GENET, V43, P298, DOI 10.1111/j.1365-2052.2011.02249.x; Nordin A, 2012, HUM MUTAT, V33, P467, DOI 10.1002/humu.22002; Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010; Schindler S, 2009, ELECTROPHORESIS, V30, P3674, DOI 10.1002/elps.200900292; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Tang Y, 2013, ONCOGENE, V32, P2792, DOI 10.1038/onc.2012.288; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; Ulf Drugge MH, 1995, J MED GENET, V32, P344; Wang ZX, 2012, J MOL CELL BIOL, V4, P79, DOI 10.1093/jmcb/mjr030; Wee CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115205	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165453	10.1371/journal.pone.0165453	http://dx.doi.org/10.1371/journal.pone.0165453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783661	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800075
J	Kogot-Levin, A; Saada, A; Leibowitz, G; Soiferman, D; Douiev, L; Raz, I; Weksler-Zangen, S				Kogot-Levin, Aviram; Saada, Ann; Leibowitz, Gil; Soiferman, Devorah; Douiev, Liza; Raz, Itamar; Weksler-Zangen, Sarah			Upregulation of Mitochondrial Content in Cytochrome c Oxidase Deficient Fibroblasts	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; COHEN DIABETIC-RAT; OXIDATIVE-PHOSPHORYLATION; MITOPHAGY; BIOENERGETICS; INHIBITION; BIOGENESIS; DEFECTS; DISEASE; FUSION	Cytochrome-c-oxidase (COX) deficiency is a frequent cause of mitochondrial disease and is associated with a wide spectrum of clinical phenotypes. We studied mitochondrial function and biogenesis in fibroblasts derived from the Cohen (CDs) rat, an animal model of COX deficiency. COX activity in CDs-fibroblasts was 50% reduced compared to control rat fibroblasts (P<0.01). ROS-production in CDs fibroblasts increased, along with marked mitochondrial fragmentation and decreased mitochondrial membrane-potential, indicating mitochondrial dysfunction. Surprisingly, cellular ATP content, oxygen consumption rate (OCR) and the extracellular acidification rate (ECAR) were unchanged. To clarify the discrepancy between mitochondrial dysfunction and ATP production, we studied mitochondrial biogenesis and turnover. The content of mitochondria was higher in CDs-fibroblasts. Consistently, AMPK activity and the expression of NRF1-target genes, NRF2 and PGC1-alpha that mediate mitochondrial biogenesis were increased (P<0.01 vs control fibroblast). In CDs-fibrobalsts, the number of autophagosomes (LC3+puncta) containing mitochondria in CDs fibroblasts was similar to that in control fibroblasts, suggesting that mitophagy was intact. Altogether, our findings demonstrate that mitochondrial dysfunction and oxidative stress are associated with an increase in mitochondrial biogenesis, resulting in preservation of ATP generation.	[Kogot-Levin, Aviram; Leibowitz, Gil; Raz, Itamar; Weksler-Zangen, Sarah] Hadassah Hebrew Univ Med Ctr, Dept Internal Med, Diabet Unit, Jerusalem, Israel; [Saada, Ann; Soiferman, Devorah; Douiev, Liza] Hadassah Hebrew Univ Med Ctr, Monique & Jacques Roboh Dept Genet Res, Jerusalem, Israel; [Saada, Ann; Soiferman, Devorah; Douiev, Liza] Hadassah Hebrew Univ Med Ctr, Dept Genet & Metab Dis, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Weksler-Zangen, S (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Internal Med, Diabet Unit, Jerusalem, Israel.	sarahz@hadassah.org.il	Saada, Ann/J-6864-2017	Saada, Ann/0000-0003-2951-0656; Douiev-Charpak, Liza/0000-0001-5120-698X	Ministry of Science and Culture of the State of Lower Saxony, Hannover, Germany; AM Cohen Foundation for the Advancement of Research of the Cohen Diabetic Rat	Ministry of Science and Culture of the State of Lower Saxony, Hannover, Germany; AM Cohen Foundation for the Advancement of Research of the Cohen Diabetic Rat	This work was supported by grants from a joint research project by the Ministry of Science and Culture of the State of Lower Saxony, Hannover, Germany, by grants to Sarah Weksler-Zangen from the AM Cohen Foundation for the Advancement of Research of the Cohen Diabetic Rat. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhag UN, 2015, EUR J HUM GENET, V23, P159, DOI 10.1038/ejhg.2014.85; Aure K, 2007, NEUROMUSCULAR DISORD, V17, P368, DOI 10.1016/j.nmd.2007.01.019; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; BRUNORI M, 1995, BIOCHIMIE, V77, P668, DOI 10.1016/0300-9084(96)88182-X; CALHOUN MW, 1994, TRENDS BIOCHEM SCI, V19, P325, DOI 10.1016/0968-0004(94)90071-X; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; De Paepe B, 2012, PEDIATR RES, V72, P232, DOI 10.1038/pr.2012.84; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Enriquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207; Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276; Golubitzky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026883; Guillery O, 2008, NEUROMUSCULAR DISORD, V18, P319, DOI 10.1016/j.nmd.2007.12.008; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Liot G, 2009, CELL DEATH DIFFER, V16, P899, DOI 10.1038/cdd.2009.22; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Mijaljica D, 2010, METHODS MOL BIOL, V648, P93, DOI 10.1007/978-1-60761-756-3_6; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ornoy A, 2009, REPROD TOXICOL, V28, P521, DOI 10.1016/j.reprotox.2009.06.005; PARADIES G, 1993, ARCH GERONTOL GERIAT, V16, P263, DOI 10.1016/0167-4943(93)90037-I; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076; Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015; Saada A, 2014, INT J BIOCHEM CELL B, V48, P60, DOI 10.1016/j.biocel.2013.12.010; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; SOHAL RS, 1993, FREE RADICAL BIO MED, V14, P583, DOI 10.1016/0891-5849(93)90139-L; Soiferman D, 2014, BIOCHIMIE, V100, P184, DOI 10.1016/j.biochi.2013.08.024; Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011; Weksler-Zangen S, 2001, DIABETES, V50, P2521, DOI 10.2337/diabetes.50.11.2521; Weksler-Zangen S, 2014, AM J PHYSIOL-ENDOC M, V306, pE648, DOI 10.1152/ajpendo.00451.2013; Weksler-Zangen S, 2013, AM J PHYSIOL-ENDOC M, V304, pE1023, DOI 10.1152/ajpendo.00036.2013; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	43	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165417	10.1371/journal.pone.0165417	http://dx.doi.org/10.1371/journal.pone.0165417			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780242	Green Submitted, gold, Green Published			2022-12-26	WOS:000389046900054
J	Prist, PR; Uriarte, M; Tambosi, LR; Prado, A; Pardini, R; D'Andrea, PS; Metzger, JP				Prist, Paula Ribeiro; Uriarte, Maria; Tambosi, Leandro Reverberi; Prado, Amanda; Pardini, Renata; D'Andrea, Paulo Sergio; Metzger, Jean Paul			Landscape, Environmental and Social Predictors of Hantavirus Risk in Sao Paulo, Brazil	PLOS ONE			English	Article							PULMONARY SYNDROME; SMALL MAMMALS; POPULATION-DYNAMICS; EPIDEMIOLOGIC CONSIDERATIONS; HABITAT FRAGMENTATION; FOREST FRAGMENTATION; HEMORRHAGIC-FEVER; BAYESIAN MEASURES; RENAL SYNDROME; PUUMALA-VIRUS	Hantavirus Pulmonary Syndrome (HPS) is a disease caused by Hantavirus, which are negative-sense RNA viruses in the family Bunyaviridae that are highly virulent to humans. Numerous factors modify risk of Hantavirus transmission and consequent HPS risk. Human-driven landscape change can foster transmission risk by increasing numbers of habitat generalist rodent species that serve as the principal reservoir host. Climate can also affect rodent population dynamics and Hantavirus survival, and a number of social factors can influence probability of HPS transmission to humans. Evaluating contributions of these factors to HPS risk may enable predictions of future outbreaks, and is critical to development of effective public health strategies. Here we rely on a Bayesian model to quantify associations between annual HPS incidence across the state of Sao Paulo, Brazil (1993-2012) and climate variables (annual precipitation, annual mean temperature), landscape structure metrics (proportion of native habitat cover, number of forest fragments, proportion of area planted with sugarcane), and social factors (number of men older than 14 years and Human Development Index). We built separate models for the main two biomes of the state (cerrado and Atlantic forest). In both biomes Hantavirus risk increased with proportion of land cultivated for sugarcane and HDI, but proportion of forest cover, annual mean temperature, and population at risk also showed positive relationships in the Atlantic forest. Our analysis provides the first evidence that social, landscape, and climate factors are associated with HPS incidence in the Neotropics. Our risk map can be used to support the adoption of preventive measures and optimize the allocation of resources to avoid disease propagation, especially in municipalities that show medium to high HPS risk (> 5% of risk), and aimed at sugarcane workers, minimizing the risk of future HPS outbreaks.	[Prist, Paula Ribeiro; Tambosi, Leandro Reverberi; Prado, Amanda; Metzger, Jean Paul] Univ Sao Paulo, Biosci Inst, Dept Ecol, Sao Paulo, SP, Brazil; [Uriarte, Maria; Tambosi, Leandro Reverberi] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Pardini, Renata] Univ Sao Paulo, Biosci Inst, Dept Zool, Sao Paulo, SP, Brazil; [D'Andrea, Paulo Sergio] Fiocruz MS, Inst Oswaldo Cruz, Dept Trop Med, Rio De Janeiro, RJ, Brazil	Universidade de Sao Paulo; Columbia University; Universidade de Sao Paulo; Fundacao Oswaldo Cruz	Prist, PR (corresponding author), Univ Sao Paulo, Biosci Inst, Dept Ecol, Sao Paulo, SP, Brazil.	pprist@hotmail.com	Tambosi, Leandro R/B-2359-2013; Metzger, Jean Paul/C-2514-2012; Tambosi, Leandro Reverberi/ABH-7869-2020; Pardini, Renata/C-4095-2012; D'Andrea, Paulo S./G-6820-2011; Prist, Paula Ribeiro/E-7801-2015	Tambosi, Leandro R/0000-0001-5486-7310; Metzger, Jean Paul/0000-0002-0087-5240; Tambosi, Leandro Reverberi/0000-0001-5486-7310; Pardini, Renata/0000-0002-3769-8401; Prist, Paula Ribeiro/0000-0003-2809-0434; D'Andrea, Paulo Sergio/0000-0001-7880-8761	Sao Paulo research foundation FAPESP [2013/23457-6]; Brazilian Ministry of Education (CAPES); FAPESP [2013/12515-5]; National Council for Scientific and Technological Development (CNPQ) [307934/2011-0, 308205/2014-6]; Coordenacao de Aperfeigoamento de Pessoal de Ensino Superior (CAPES) Foundation [068/2013]	Sao Paulo research foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeigoamento de Pessoal de Ensino Superior (CAPES) Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was developed within the "Interface project," supported by the Sao Paulo research foundation FAPESP (n. 2013/23457-6). PP was funded by the Brazilian Ministry of Education (CAPES) doctoral studentship during 2012-2013, and by FAPESP grant 2013/12515-5. JP and RP were funded by the National Council for Scientific and Technological Development (CNPQ, 307934/2011-0 and 308205/2014-6, respectively). LRT was funded by Coordenacao de Aperfeigoamento de Pessoal de Ensino Superior (CAPES) Foundation (project 068/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was developed within the "Interface project," supported by the Sao Paulo research foundation FAPESP (n. 2013/23457-6). PP was funded by the Brazilian Ministry of Education (CAPES) doctoral studentship during 2012-2013, and by FAPESP grant 2013/12515-5. JP and RP were funded by the National Council for Scientific and Technological Development (CNPQ, 307934/2011-0 and 308205/2014-6, respectively). LRT was funded by Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) Foundation (project 068/2013). We would like to thank all the researchers that provided insights that greatly improved previous versions, especially Naomi Schwartz, Benedicte Bachelot, Andrew Quebbeman, Mariana Vidal, Natalia Aristizabal, and Patricia Ruggiero, for comments on drafts of the manuscript. We also would like to give a special thanks to Town Peterson and an anonymous reviewer for insights and comments on manuscript, which greatly improved this article.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Borrero MAV, 2003, BIOMASS BIOENERG, V25, P287, DOI 10.1016/S0961-9534(03)00032-1; Brown JH, 2002, BIOSCIENCE, V52, P979, DOI 10.1641/0006-3568(2002)052[0979:RARCDO]2.0.CO;2; Brownstein JS, 2005, OECOLOGIA, V146, P469, DOI 10.1007/s00442-005-0251-9; Camargo Jr AS, 2008, AN IWORKSHOP OBS SET; Campos GM, 2003, J MED VIROL, V71, P417, DOI 10.1002/jmv.10489; Carver S, 2015, BIOSCIENCE, V65, P651, DOI 10.1093/biosci/biv047; CDC, 2014, HSP UPD REC RISK RED; Coutinho L.M., 1978, REV BRASILEIRA BOT, V7, P17; D’Andrea PS., 2007, Braz. J. Biol., V67, P179, DOI 10.1590/S1519-69842007000100025; Dalmagro AD, 2005, AUSTRAL ECOL, V30, P353, DOI 10.1111/j.1442-9993.2005.01447.x; de Oliveira SV, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0036-5; Ferreira JBD, 2014, LAND USE POLICY, V36, P595, DOI 10.1016/j.landusepol.2013.10.015; Donalisio MR, 2011, ACTA TROP, V119, P125, DOI 10.1016/j.actatropica.2011.04.019; Drebot M.A., 2000, CAN COMMUN DIS REP, V26, P65; Durigan G, 2007, SCI AGR, V64, P355, DOI 10.1590/S0103-90162007000400006; Elkhoury MD, 2012, T ROY SOC TROP MED H, V106, P298, DOI 10.1016/j.trstmh.2012.01.002; Engelthaler DM, 1999, EMERG INFECT DIS, V5, P87, DOI 10.3201/eid0501.990110; Fan Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008470; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; Figueiredo L T, 2001, Rev Soc Bras Med Trop, V34, P13, DOI 10.1590/S0037-86822001000100003; Figueiredo LTM, 2000, INFORM EPIDEMIOLOGIC, V9, P161; Figueiredo LTM, 2009, EMERG INFECT DIS, V15, P561, DOI 10.3201/eid1504.080289; Fortin M.-J., 2002, ENCY ENV, V4, P2051, DOI [10.1002/9780470057339.vas039, DOI 10.1002/9780470057339]; Fredo CE, 2014, ANAL INDICADORAS AGR; Funk CC, 2014, US GEOL SURV DATA SE, V832, P4, DOI 10.3133/ds832; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 2007, DATA ANAL USING REGR; Gheler-Costa C, 2013, AGR ECOSYST ENVIRON, V171, P85, DOI 10.1016/j.agee.2013.03.016; Gheler-Costa C, 2012, MAMMALIA, V76, P185, DOI 10.1515/mammalia-2011-0109; Goodin DG, 2006, GLOBAL ECOL BIOGEOGR, V15, P519, DOI 10.1111/j.1466-822x.2006.00244.x; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; IBGE, MAP AGR EST 2014; Jiang G, 2011, CAN J ZOOL, V89, P678, DOI [10.1139/Z11-048, 10.1139/z11-048]; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kallio ER, 2006, J GEN VIROL, V87, P2127, DOI 10.1099/vir.0.81643-0; Khamis F. G., 2012, Journal of Applied Sciences, V12, P1564, DOI 10.3923/jas.2012.1564.1571; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; LEE HW, 1981, AM J TROP MED HYG, V30, P477, DOI 10.4269/ajtmh.1981.30.477; Lehmer EM, 2012, ECOHEALTH, V9, P205, DOI 10.1007/s10393-012-0765-7; Li CP, 2013, AM J TROP MED HYG, V89, P1006, DOI 10.4269/ajtmh.12-0473; Linard C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-15; Liu J, 2012, EPIDEMIOL INFECT, V1, P1, DOI DOI 10.5897/AJB12.763; Luis AD, 2010, J ANIM ECOL, V79, P462, DOI 10.1111/j.1365-2656.2009.01646.x; MacNeil A, 2011, EMERG INFECT DIS, V17, P1195, DOI 10.3201/eid1707.101306; Martin PS, 2012, FOREST ECOL MANAG, V282, P185, DOI 10.1016/j.foreco.2012.07.002; Martinelli LA, 2010, CURR OPIN ENV SUST, V2, P431, DOI 10.1016/j.cosust.2010.09.008; MESERVE PL, 1995, J MAMMAL, V76, P580, DOI 10.2307/1382367; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; MMA, 2015, PROJ TERRACLASS CERR; de Sousa RLM, 2008, INTERVIROLOGY, V51, P299, DOI 10.1159/000171818; Murua R, 2003, OIKOS, V102, P137, DOI 10.1034/j.1600-0706.2003.12226.x; Nassar AM, 2008, SUGARCANE ETHANOL: CONTRIBUTIONS TO CLIMATE CHANGE MITIGATION AND THE ENVIRONMENT, P63; Norman MJT, 1995, ECOLOGY TROPICAL FOO, V2, DOI [10.1017/CBO9781139172479, DOI 10.1017/CBO9781139172479]; Olifiers N., 2005, Braz. J. Biol., V65, P495, DOI 10.1590/S1519-69842005000300015; Oliveira RC, 2014, ACTA TROP, V131, P1, DOI 10.1016/j.actatropica.2013.11.016; Oliveira RS, 2005, FUNCT ECOL, V19, P574, DOI 10.1111/j.1365-2435.2005.01003.x; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Parshad VR, 1986, J BIOSCIENCE, V5, P729; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pereira LE, 2007, B EPIDEMIOL PAULISTA, V4; Pereira LE., 2007, B EPIDEMIOL PAULISTA, V4, P4; Puttker T, 2008, STUD NEOTROP FAUNA E, V43, P11, DOI 10.1080/01650520701553651; Puttker T, 2015, OIKOS, V124, P206, DOI 10.1111/oik.01018; Ribeiro H, 2010, SAUDE SOC-SAO PAULO, V19, P48, DOI 10.1590/S0104-12902010000100005; Rubio AV, 2014, ECOHEALTH, V11, P526, DOI 10.1007/s10393-014-0944-9; Smeets E, 2008, BIOMASS BIOENERG, V32, P781, DOI 10.1016/j.biombioe.2008.01.005; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stevens KB, 2011, SPAT SPATIO-TEMPORAL, V2, P125, DOI 10.1016/j.sste.2011.07.007; Suzan G, 2008, ANN NY ACAD SCI, V1149, P80, DOI 10.1196/annals.1428.063; Suzan G, 2008, J MAMMAL, V89, P684, DOI 10.1644/07-MAMM-A-015R1.1; Suzuki A, 2004, EMERG INFECT DIS, V10, P2127, DOI 10.3201/eid1012.040295; Teixeira BR, 2014, AM J TROP MED HYG, V91, P249, DOI 10.4269/ajtmh.13-0465; Tersago K, 2009, EPIDEMIOL INFECT, V7, P1; Rudorff BFT, 2010, REMOTE SENS-BASEL, V2, P1057, DOI 10.3390/rs2041057; Tsai Pui-Jen, 2012, Glob J Health Sci, V4, P63, DOI 10.5539/gjhs.v4n5p63; Umetsu F, 2007, LANDSCAPE ECOL, V22, P517, DOI 10.1007/s10980-006-9041-y; Vadell MV, 2011, TROP MED INT HEALTH, V16, P1342, DOI 10.1111/j.1365-3156.2011.02838.x; Vapalahti K, 2010, EPIDEMIOL INFECT, V138, P576, DOI 10.1017/S095026880999077X; Verdade L.M., 2012, J SUSTAINABLE BIOENE, V2, P138, DOI DOI 10.4236/JSBS.2012.24020; Vieira EM, 2005, MAMM BIOL, V70, P359, DOI 10.1016/j.mambio.2005.08.002; Watson DC, 2014, CRIT REV MICROBIOL, V40, P261, DOI 10.3109/1040841X.2013.783555; Yahnke CJ, 2001, AM J TROP MED HYG, V65, P768, DOI 10.4269/ajtmh.2001.65.768; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450; Yates TL, 2002, BIOSCIENCE, V52, P989, DOI 10.1641/0006-3568(2002)052[0989:TEAEHO]2.0.CO;2; Zeier M, 2005, VIRUS GENES, V30, P157, DOI 10.1007/s11262-004-5625-2	92	25	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0163459	10.1371/journal.pone.0163459	http://dx.doi.org/10.1371/journal.pone.0163459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780250	Green Submitted, Green Published, gold			2022-12-26	WOS:000389046900004
J	Denis, M; Gregory, A; Bayat, M; Fazzio, RT; Whaley, DH; Ghosh, K; Shah, S; Fatemi, M; Allzad, A				Denis, Max; Gregory, Adriana; Bayat, Mandi; Fazzio, Robert T.; Whaley, Dana H.; Ghosh, Karthik; Shah, Sejal; Fatemi, Mostafa; Allzad, Azra			Correlating Tumor Stiffness with Immunohistochemical Subtypes of Breast Cancers: Prognostic Value of Comb-Push Ultrasound Shear Elastography for Differentiating Luminal Subtypes	PLOS ONE			English	Article							WAVE ELASTOGRAPHY; PROGESTERONE-RECEPTOR; EXPRESSION; CUSE; FEATURES; BENIGN; KI-67; SIZE; TIME; KI67	Purpose The purpose of our study is to correlate quantitatively measured tumor stiffness with immunohistochemical (IHC) subtypes of breast cancer. Additionally, the influence of prognostic histologic features (cancer grade, size, lymph node status, and histological type and grade) to the tumor elasticity and IHC profile relationship will be investigated. Methods Under an institutional review board (IRB) approved protocol, B-mode ultrasound (US) and comb-push ultrasound shear elastography (CUSE) were performed on 157 female patients with suspicious breast lesions. Out of 157 patients 83 breast cancer patients confirmed by pathology were included in this study. The association between CUSE mean stiffness values and the aforementioned prognostic features of the breast cancer tumors were investigated. Results Our results demonstrate that the most statistically significant difference (p = 0.0074) with mean elasticity is tumor size. When considering large tumors (size >= 8mm), thus minimizing the statistical significance of tumor size, a significant difference (p< 0.05) with mean elasticity is obtained between luminal A of histological grade I and luminal B (Ki-67 > 20%) subtypes. Conclusion Tumor size is an independent factor influencing mean elasticity. The Ki-67 proliferation index and histological grade were dependent factors influencing mean elasticity for the differentiation between luminal subtypes. Future studies on a larger group of patients may broaden the clinical significance of these findings.	[Denis, Max; Fazzio, Robert T.; Whaley, Dana H.; Allzad, Azra] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA; [Gregory, Adriana; Bayat, Mandi; Fatemi, Mostafa; Allzad, Azra] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Ghosh, Karthik; Allzad, Azra] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA; [Shah, Sejal] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Denis, M (corresponding author), Mayo Clin, Dept Radiol, Rochester, MN 55905 USA.	denis.max@mayo.edu		Fatemi, Mostafa/0000-0002-6603-9077	National Institutes of Health (NIH) [R01CA148994, R01CA148994-S1, R01EB17213, R01CA168575, R01CA174723]; NATIONAL CANCER INSTITUTE [R01CA148994] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants R01CA148994 (AA), R01CA148994-S1 (AA), R01EB17213 (MF), R01CA168575 (MF), and R01CA174723 (MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi I, 2015, INTEGR BIOL-UK, V7, P1120, DOI 10.1039/c5ib00040h; Bae SY, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1121-4; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Bhargava R, 2009, INT J CLIN EXP PATHO, V2, P444; Bijker N, 2013, CURR TREAT OPTION ON, V14, P75, DOI 10.1007/s11864-012-0217-1; BORG A, 1990, CANCER RES, V50, P4332; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chang JM, 2013, EUR RADIOL, V23, P2450, DOI 10.1007/s00330-013-2866-2; Chang JM, 2011, BREAST CANCER RES TR, V129, P89, DOI 10.1007/s10549-011-1627-7; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Choi WJ, 2014, ULTRASOUND MED BIOL, V40, P269, DOI 10.1016/j.ultrasmedbio.2013.09.028; Denis M, 2015, COMB PUSH ULTRASOUND; Denis M, 2015, IEEE T ULTRASON FERR, V62, P1644, DOI 10.1109/TUFFC.2015.007043; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Engel Michael E, 1998, J Cell Biochem, V72 Suppl 30-31, P111, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<111::AID-JCB15>3.0.CO;2-5; Evans A, 2016, BREAST, V26, P115, DOI 10.1016/j.breast.2016.01.009; Evans A, 2012, RADIOLOGY, V263, P673, DOI 10.1148/radiol.12111317; Feeley LP, 2014, MODERN PATHOL, V27, P554, DOI 10.1038/modpathol.2013.153; Ganau S, 2015, EUR J RADIOL, V84, P617, DOI 10.1016/j.ejrad.2014.12.020; Goldhirsch A, 2011, ANN ONCOL; Gregory A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137898; Inic Z, 2014, CLIN MED INSIGHTS-ON, V8, P107, DOI 10.4137/CMO.S18006; KASAI C, 1985, IEEE T SON ULTRASON, V32, P458, DOI 10.1109/T-SU.1985.31615; Khokher S, 2013, ASIAN PAC J CANCER P, V14, P3223, DOI 10.7314/APJCP.2013.14.5.3223; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Longo DL, 2012, NEW ENGL J MED, V366, P956, DOI 10.1056/NEJMe1200656; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; LOVEKIN C, 1991, BRIT J CANCER, V63, P439, DOI 10.1038/bjc.1991.101; Mehrmohammadi M, 2015, IEEE T MED IMAGING, V34, P97, DOI 10.1109/TMI.2014.2346498; Mouw JK, 2014, NAT MED, V20, P360, DOI 10.1038/nm.3497; Nishimura R, 2010, EXP THER MED, V1, P747, DOI 10.3892/etm.2010.133; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Sanchez-Munoz A, 2008, CLIN TRANSL ONCOL, V10, P646, DOI 10.1007/s12094-008-0265-y; Sandrin L., 2002, ACOUST IMAGING, P485, DOI 10.1007/0-306-47107-8_68.; SEWELL CW, 1995, RADIOL CLIN N AM, V33, P1067; Skerl K, 2015, CLIN RADIOL, V70, P1421, DOI 10.1016/j.crad.2015.08.010; Song PF, 2013, IEEE T MED IMAGING, V32, P1435, DOI 10.1109/TMI.2013.2257831; Song PF, 2012, IEEE T MED IMAGING, V31, P1821, DOI 10.1109/TMI.2012.2205586; Stefansson OA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3020; Tang P, 2009, DIAGN MOL PATHOL, V18, P125, DOI 10.1097/PDM.0b013e31818d107b; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Untch M, 2013, BREAST CARE, V8, P221, DOI 10.1159/000351692; Yaghan R, 1998, EUR J SURG ONCOL, V24, P424, DOI 10.1016/S0748-7983(98)92341-1; Yersal O, 2014, WORLD J CLIN ONCOL, V5, P412, DOI 10.5306/wjco.v5.i3.412; Youk JH, 2013, BREAST CANCER RES TR, V138, P119, DOI 10.1007/s10549-013-2407-3	50	25	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165003	10.1371/journal.pone.0165003	http://dx.doi.org/10.1371/journal.pone.0165003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776153	gold, Green Published, Green Submitted			2022-12-26	WOS:000389009200034
J	Nakamoto, K; Watanabe, M; Sada, M; Inui, T; Nakamura, M; Honda, K; Wade, H; Mikami, Y; Matsuzaki, H; Horie, M; Noguchi, S; Yamauchi, Y; Koyama, H; Kogane, T; Kohyama, T; Takizawal, H				Nakamoto, Keitaro; Watanabe, Masato; Sada, Mitsuru; Inui, Toshiya; Nakamura, Masuo; Honda, Kojiro; Wade, Hiroo; Mikami, Yu; Matsuzaki, Hirotaka; Horie, Masafumi; Noguchi, Satoshi; Yamauchi, Yasuhiro; Koyama, Hikari; Kogane, Toshiyuki; Kohyama, Tadashi; Takizawal, Hajime			Serum Reactive Oxygen Metabolite Levels Predict Severe Exacerbations of Asthma	PLoS One			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INCREASED OXIDATIVE STRESS; S-TRANSFERASE P1; BRONCHIAL HYPERRESPONSIVENESS; AIRWAY INFLAMMATION; CHILDHOOD ASTHMA; POLYMORPHISM; POLLUTION; RADICALS; GSTP1	Background and Purpose Bronchial asthma (BA) is a chronic airway disease characterized by airway hyperresponsiveness and remodeling, which are intimately linked to chronic airway inflammation. Reactive oxygen species (ROS) such as hydrogen peroxide are generated by inflammatory cells that are involved in the pathogenesis of BA. However, the role of ROS in the management of BA patients is not yet clear. We attempted to determine the role of ROS as a biomarker in the clinical setting of BA. Subjects and Methods We enrolled patients with BA from 2013 through 2015 and studied the degrees of asthma control, anti-asthma treatment, pulmonary function test results, fractional exhaled nitric oxide (FeNO), serum reactive oxygen metabolite (ROM) levels, and serum levels of interleukin (IL)-6 and IL-8. Results We recruited 110 patients with BA. Serum ROM levels correlated with white blood cell (WBC) count (rs = 0.273, p = 0.004), neutrophil count (rs = 0.235, p = 0.014), CRP (rs = 0.403, p < 0.001), and IL-6 (rs = 0.339, p < 0.001). Serum ROM levels and IL-8 and CRP levels negatively correlated with %FEV1 (rs = -0.240, p = 0.012, rs = -0.362, p < 0.001, rs = -0.197, p = 0.039, respectively). Serum ROM levels were significantly higher in patients who experienced severe exacerbation within 3 months than in patients who did not (339 [302-381] vs. 376 [352-414] CARR U, p < 0.025). Receiver-operating characteristics analysis showed that ROM levels correlated significantly with the occurrence of severe exacerbation (area under the curve: 0.699, 95% CI: 0.597-0.801, p = 0.025). Conclusions Serum levels of ROM were significantly associated with the degrees of airway obstruction, WBC counts, neutrophil counts, IL-6, and severe exacerbations. This biomarker may be useful in predicting severe exacerbations of BA.	[Nakamoto, Keitaro; Watanabe, Masato; Sada, Mitsuru; Inui, Toshiya; Nakamura, Masuo; Honda, Kojiro; Wade, Hiroo; Takizawal, Hajime] Kyorin Univ, Sch Med, Dept Resp Med, Tokyo, Japan; [Mikami, Yu; Matsuzaki, Hirotaka; Horie, Masafumi; Noguchi, Satoshi; Yamauchi, Yasuhiro] Univ Tokyo, Dept Resp Med, Grad Sch Med, Tokyo, Japan; [Koyama, Hikari; Kogane, Toshiyuki; Kohyama, Tadashi] Teikyo Univ, Dept Internal Med, Mizonokuchi Hosp, Kawasaki, Kanagawa, Japan	Kyorin University; University of Tokyo; Teikyo University	Takizawal, H (corresponding author), Kyorin Univ, Sch Med, Dept Resp Med, Tokyo, Japan.	htakizawa.alg@gmail.com		Sada, Mitsuru/0000-0002-1088-2954; MIKAMI, YU/0000-0003-3262-2958; Nakamoto, Keitaro/0000-0002-7140-6273	Japan Society for the Promotion of Science [15K09189]; Environmental Restoration and Conservation Agency; Grants-in-Aid for Scientific Research [15K19172] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Environmental Restoration and Conservation Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-In-Aid for Scientific Research (KAKENHI), Japan Society for the Promotion of Science, Project/Area Number 15K09189, https://www.jsps.go.jp/english/index.html; and Grant in Aid, Environmental Restoration and Conservation Agency, (1)-3, http://www.erca.go.jp/erca.go.jp/erca/english/index.html.; This research was supported in part by the Environmental Restoration and Conservation Agency and by Grants-In-Aid for Scientific Research (KAKENHI) (No. 15K09189).	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; [Anonymous], 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Barbaro MPF, 2007, INT J IMMUNOPATH PH, V20, P753, DOI 10.1177/039463200702000411; BARNES PJ, 1990, FREE RADICAL BIO MED, V9, P235, DOI 10.1016/0891-5849(90)90034-G; Bowler RP, 2002, J ALLERGY CLIN IMMUN, V110, P349, DOI 10.1067/mai.2002.126780; Brisk R, 2016, CURR OPIN PULM MED, V22, P32, DOI 10.1097/MCP.0000000000000222; Canova C, 2012, EPIDEMIOLOGY, V23, P607, DOI 10.1097/EDE.0b013e3182572563; Cornelli U., 1999, INT UNION ANGIOLOGYS, V15, P7; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; DEGENHART HJ, 1986, B EUR PHYSIOPATH RES, V22, P100; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Fryer AA, 2000, AM J RESP CRIT CARE, V161, P1437, DOI 10.1164/ajrccm.161.5.9903006; Heijink I, 2014, THORAX, V69, P5, DOI 10.1136/thoraxjnl-2013-203520; Hirata Y, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001451; HULSMANN AR, 1994, AM J RESP CRIT CARE, V149, P519, DOI 10.1164/ajrccm.149.2.8306055; Ishii T, 1999, THORAX, P54; JARJOUR NN, 1994, J LAB CLIN MED, V123, P131; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; Lee YL, 2005, CHEST, V128, P1156, DOI 10.1378/chest.128.3.1156; Lee YL, 2004, CLIN EXP ALLERGY, V34, P1707, DOI 10.1111/j.1365-2222.2004.02099.x; LI D, 1995, AM J RESP CRIT CARE, V151, P647; MacIntyre EA, 2014, ENVIRON HEALTH PERSP, V122, P418, DOI 10.1289/ehp.1307459; Maneechotesuwan K, 2007, CHEST, V132, P98, DOI 10.1378/chest.06-2982; Melillo G., 2007, RESSEGNA PATOLOGIA A, V22, P98; Minelli C, 2011, FREE RADICAL BIO MED, V51, P925, DOI 10.1016/j.freeradbiomed.2011.02.012; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Morjaria JB, 2011, THORAX, V66, P537, DOI 10.1136/thx.2010.136523; Nadeem A, 2003, J ALLERGY CLIN IMMUN, V111, P72, DOI 10.1067/mai.2003.17; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Petsky HL, 2012, THORAX, V67, P199, DOI 10.1136/thx.2010.135574; RHODEN KJ, 1989, BRIT J PHARMACOL, V98, P325, DOI 10.1111/j.1476-5381.1989.tb16898.x; Suzuki S, 2008, INT ARCH ALLERGY IMM, V146, P67, DOI 10.1159/000126064; Suzuki Y, 2013, J CANCER RES CLIN, V139, P845, DOI 10.1007/s00432-013-1389-1; Thomson NC, 2016, THER ADV RESPIR DIS, V10, P211, DOI 10.1177/1753465816632638; Wood LG, 2012, CHEST, V142, P86, DOI 10.1378/chest.11-1838	35	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164948	10.1371/journal.pone.0164948	http://dx.doi.org/10.1371/journal.pone.0164948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776186	Green Published, gold			2022-12-26	WOS:000389009200029
J	Houwman, JA; Andre, E; Westphal, AH; van Berkel, WJH; van Mierlo, CPM				Houwman, Joseline A.; Andre, Estelle; Westphal, Adrie H.; van Berkel, Willem J. H.; van Mierlo, Carlo P. M.			The Ribosome Restrains Molten Globule Formation in Stalled Nascent Flavodoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA PARALLEL PROTEIN; AZOTOBACTER-VINELANDII APOFLAVODOXIN; IN-VIVO; FOLDING INTERMEDIATE; NMR-SPECTROSCOPY; ENERGY LANDSCAPE; EXCHANGE REVEALS; REDOX PROPERTIES; CHAIN COMPLEXES; PATHWAY	Folding of proteins usually involves intermediates, of which an important type is the molten globule (MG). MGs are ensembles of interconverting conformers that contain (non-) native secondary structure and lack the tightly packed tertiary structure of natively folded globular proteins. Whereas MGs of various purified proteins have been probed to date, no data are available on their presence and/or effect during protein synthesis. To study whether MGs arise during translation, we use ribosomenascent chain (RNC) complexes of the electron transfer protein flavodoxin. Full-length isolated flavodoxin, which contains a non-covalently bound flavin mononucleotide (FMN) as cofactor, acquires its native alpha/beta parallel topology via a folding mechanism that contains an off-pathway intermediate with molten globular characteristics. Extensive population of this MG state occurs at physiological ionic strength for apoflavodoxin variant F44Y, in which a phenylalanine at position 44 is changed to a tyrosine. Here, we show for the first time that ascertaining the binding rate of FMN as a function of ionic strength can be used as a tool to determine the presence of the off-pathway MG on the ribosome. Application of this methodology to F44Y apoflavodoxin RNCs shows that at physiological ionic strength the ribosome influences formation of the off-pathway MG and forces the nascent chain toward the native state.	[Houwman, Joseline A.; Andre, Estelle; Westphal, Adrie H.; van Berkel, Willem J. H.; van Mierlo, Carlo P. M.] Wageningen Univ, Biochem Lab, Stippeneng 4, NL-6708 WE Wageningen, Netherlands	Wageningen University & Research	van Mierlo, CPM (corresponding author), Wageningen Univ, Biochem Lab, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.	carlo.vanmierlo@wur.nl	vanMierlo, Carlo p/B-4491-2016; van Berkel, Willem J.H./O-2431-2014; Westphal, Adrie Herman/L-3517-2019	vanMierlo, Carlo p/0000-0002-5358-8392; van Berkel, Willem J.H./0000-0002-6551-2782; Westphal, Adrie Herman/0000-0003-4264-6267; Houwman, Joseline/0000-0003-1221-990X	ECHO from Netherlands Organisation for Scientific Research (NWO) [711.011.007]	ECHO from Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by ECHO Grant 711.011.007 from Netherlands Organisation for Scientific Research (NWO) (to C. P. M. v. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Baldwin RL, 2013, CURR OPIN STRUC BIOL, V23, P4, DOI 10.1016/j.sbi.2012.11.004; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bhattacharyya S, 2013, CURR OPIN STRUC BIOL, V23, P11, DOI 10.1016/j.sbi.2012.10.010; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; Bollen YJM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2010; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Chakraborty S, 2001, BIOCHEMISTRY-US, V40, P7228, DOI 10.1021/bi010004w; Cymer F, 2015, J BIOL CHEM, V290, P10208, DOI 10.1074/jbc.M115.641555; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; EDMONDSON DE, 1971, BIOCHEMISTRY-US, V10, P133; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Ellis JP, 2008, ACS CHEM BIOL, V3, P555, DOI 10.1021/cb800059u; Ellis JP, 2009, PROTEIN SCI, V18, P2003, DOI 10.1002/pro.196; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; Engelhard M, 1996, FOLD DES, V1, pR31, DOI 10.1016/S1359-0278(96)00016-8; Evans MS, 2008, J MOL BIOL, V383, P683, DOI 10.1016/j.jmb.2008.07.035; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Goldman DH, 2015, SCIENCE, V348, P457, DOI 10.1126/science.1261909; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Holtkamp W, 2015, SCIENCE, V350, P1104, DOI 10.1126/science.aad0344; Houwman JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1317, DOI 10.1016/j.bbapap.2015.06.004; Jaenicke R, 1997, ADV PROTEIN CHEM, V50, P1, DOI 10.1016/S0065-3233(08)60318-6; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kelkar DA, 2012, J BIOL CHEM, V287, P2568, DOI 10.1074/jbc.M111.318766; KLUGKIST J, 1986, EUR J BIOCHEM, V155, P33, DOI 10.1111/j.1432-1033.1986.tb09455.x; KURODA Y, 1992, J MOL BIOL, V223, P1139, DOI 10.1016/0022-2836(92)90265-L; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Lamprou P, 2014, CHEMBIOCHEM, V15, P977, DOI 10.1002/cbic.201400014; Lindhoud S, 2015, J MOL BIOL, V427, P3148, DOI 10.1016/j.jmb.2015.07.002; Lindhoud S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046838; Lindhoud S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041363; LOH SN, 1995, P NATL ACAD SCI USA, V92, P5446, DOI 10.1073/pnas.92.12.5446; Nabuurs SM, 2010, J BIOL CHEM, V285, P4165, DOI 10.1074/jbc.M109.087932; Nabuurs SM, 2009, J AM CHEM SOC, V131, P8290, DOI 10.1021/ja9014309; Nabuurs SM, 2009, J AM CHEM SOC, V131, P2739, DOI 10.1021/ja8089476; Nabuurs SM, 2008, J AM CHEM SOC, V130, P16914, DOI 10.1021/ja803841n; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Plaxco KW, 1996, CURR OPIN STRUC BIOL, V6, P630, DOI 10.1016/S0959-440X(96)80029-7; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; SHASTRY MCR, 1995, J MOL BIOL, V247, P1013, DOI 10.1006/jmbi.1994.0196; Steensma E, 1996, EUR J BIOCHEM, V235, P167, DOI 10.1111/j.1432-1033.1996.00167.x; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; TAYLOR MF, 1990, BIOCHEMISTRY-US, V29, P6911, DOI 10.1021/bi00481a022; Timasheff S. N., 1989, STABILIZATION PROTEI, P331; Van Der Goot Francoise G., 1992, Trends in Cell Biology, V2, P343; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Visser NV, 2008, BIOPHYS J, V95, P2462, DOI 10.1529/biophysj.108.132001; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411	61	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25911	25920		10.1074/jbc.M116.756205	http://dx.doi.org/10.1074/jbc.M116.756205			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27784783	hybrid, Green Published			2022-12-26	WOS:000390345200014
J	Morita, M; Sato, Y; Iwasaki, R; Kobayashi, T; Watanabe, R; Oike, T; Miyamoto, K; Toyama, Y; Matsumoto, M; Nakamura, M; Kawana, H; Nakagawa, T; Miyamoto, T				Morita, Mayu; Sato, Yuiko; Iwasaki, Ryotaro; Kobayashi, Tami; Watanabe, Ryuichi; Oike, Takatsugu; Miyamoto, Kana; Toyama, Yoshiaki; Matsumoto, Morio; Nakamura, Masaya; Kawana, Hiromasa; Nakagawa, Taneaki; Miyamoto, Takeshi			Selective Estrogen Receptor Modulators Suppress Hif1 alpha Protein Accumulation in Mouse Osteoclasts	PLOS ONE			English	Article							VERTEBRAL FRACTURE RISK; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; CLINICAL-TRIAL; TISSUE-SPECIFICITY; BREAST-CANCER; CORTICAL BONE; FEMALE MICE; OSTEOPOROSIS; ALPHA	Anti-bone resorptive drugs such as bisphosphonates, the anti-RANKL antibody (denosumab), or selective estrogen receptor modulators (SERMs) have been developed to treat osteoporosis. Mechanisms underlying activity of bisphosphonates or denosumab in this context are understood, while it is less clear how SERMs like tamoxifen, raloxifene, or bazedoxifene inhibit bone resorption. Recently, accumulation of hypoxia inducible factor 1 alpha (Hif1 alpha) in osteoclasts was shown to be suppressed by estrogen in normal cells. In addition, osteoclast activation and decreased bone mass seen in estrogen-deficient conditions was found to require Hif1a. Here, we used western blot analysis of cultured osteoclast precursor cells to show that tamoxifen, raloxifene, or bazedoxifene all suppress Hif1 alpha protein accumulation. The effects of each SERM on osteoclast differentiation differed in vitro. Our results suggest that interventions such as the SERMs evaluated here could be useful to inhibit Hif1 alpha and osteoclast activity under estrogen-deficient conditions.	[Morita, Mayu; Iwasaki, Ryotaro; Kawana, Hiromasa; Nakagawa, Taneaki] Keio Univ, Div Oral & Maxillofacial Surg, Dept Dent & Oral Surg, Sch Med,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Sato, Yuiko; Kobayashi, Tami; Watanabe, Ryuichi; Oike, Takatsugu; Miyamoto, Kana; Toyama, Yoshiaki; Matsumoto, Morio; Nakamura, Masaya; Miyamoto, Takeshi] Keio Univ, Dept Orthoped Surg, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Kobayashi, Tami] Keio Univ, Dept Musculoskeletal Reconstruct & Regenerat Surg, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Sato, Yuiko; Miyamoto, Takeshi] Keio Univ, Dept Adv Therapy Musculoskeletal Disorders, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan	Keio University; Keio University; Keio University; Keio University	Miyamoto, T (corresponding author), Keio Univ, Dept Orthoped Surg, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.; Miyamoto, T (corresponding author), Keio Univ, Dept Adv Therapy Musculoskeletal Disorders, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	miyamoto@z5.keio.jp	Nakamura, Masaya/K-4111-2013		Japan Agency for Medical Research and Development; Chugai Scientific foundation; Pfizer Japan Inc.; Eli Lilly Scientific foundation; Grants-in-Aid for Scientific Research [16K10917] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Chugai Scientific foundation; Pfizer Japan Inc.(Pfizer); Eli Lilly Scientific foundation(Eli Lilly); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by Grant-in-aid for Scientific Research in Japan and a grant from Japan Agency for Medical Research and Development. This study was also funded in part by a research grant from Chugai Scientific foundation, Pfizer Japan Inc. and Eli Lilly Scientific foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; CHRISTIANSEN C, 1981, LANCET, V1, P459; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Delmas PD, 2002, LANCET, V359, P2018, DOI 10.1016/S0140-6736(02)08827-X; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Diez-Perez Adolfo, 2006, Arq Bras Endocrinol Metab, V50, P720, DOI 10.1590/S0004-27302006000400017; Edwards BJ, 2013, J BONE JOINT SURG AM, V95A, P297, DOI 10.2106/JBJS.K.01181; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Layton D, 2005, OSTEOPOROSIS INT, V16, P490, DOI 10.1007/s00198-004-1710-6; Lello S, 2011, CLIN CASES MINER BON, V8, P29; Li BJ, 2011, J CELL BIOCHEM, V112, P1229, DOI 10.1002/jcb.23049; Li FX, 2016, CANCER CHEMOTH PHARM, V77, P895, DOI 10.1007/s00280-016-2959-0; LOVE RR, 1992, NEW ENGL J MED, V326, P852, DOI 10.1056/NEJM199203263261302; Luckey M, 2004, MENOPAUSE, V11, P405, DOI 10.1097/01.GME.0000119981.77837.1F; Maatta JA, 2013, FASEB J, V27, P478, DOI 10.1096/fj.12-213587; Maeda SS, 2014, ARQ BRAS ENDOCRINOL, V58, P162, DOI 10.1590/0004-2730000003039; Martin-Millan M, 2010, MOL ENDOCRINOL, V24, P323, DOI 10.1210/me.2009-0354; Martinkovich S, 2014, CLIN INTERV AGING, V9, P1437, DOI 10.2147/CIA.S66690; Martino S, 2005, CURR MED RES OPIN, V21, P1441, DOI 10.1185/030079905X61839; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Mazziotti G, 2012, ENDOCRINE, V41, P58, DOI 10.1007/s12020-011-9570-2; Melville KM, 2014, J BONE MINER RES, V29, P370, DOI 10.1002/jbmr.2082; Miller CP, 2001, J MED CHEM, V44, P1654, DOI 10.1021/jm010086m; Miyamoto K, 2011, J EXP MED, V208, P2175, DOI 10.1084/jem.20101890; Miyauchi Y, 2013, P NATL ACAD SCI USA, V110, P16568, DOI 10.1073/pnas.1308755110; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Pinkerton JV, 2014, J STEROID BIOCHEM, V142, P142, DOI 10.1016/j.jsbmb.2013.12.011; PIPER K, 1992, ANAT EMBRYOL, V186, P291; Powles T, 1996, J CLIN ONCOL, V14, P78, DOI 10.1200/JCO.1996.14.1.78; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Ronkin S, 2005, OBSTET GYNECOL, V105, P1397, DOI 10.1097/01.AOG.0000163253.27610.b9; Ryan HE, 2000, CANCER RES, V60, P4010; Sato Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111845; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Silverman SL, 2008, J BONE MINER RES, V23, P1923, DOI 10.1359/JBMR.080710; Tando T, 2016, BIOCHEM BIOPH RES CO, V470, P391, DOI 10.1016/j.bbrc.2016.01.033; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Vanderschueren D, 2014, ENDOCR REV, V35, P906, DOI 10.1210/er.2014-1024; Whyte MP, 2008, J BONE MINER RES, V23, P1698, DOI [10.1359/jbmr.080511, 10.1359/JBMR.080511]; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513	46	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165922	10.1371/journal.pone.0165922	http://dx.doi.org/10.1371/journal.pone.0165922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802325	gold, Green Published, Green Submitted			2022-12-26	WOS:000386714200069
J	Juhas, M; Wong, C; Ajioka, JW				Juhas, Mario; Wong, Christine; Ajioka, James W.			Combining Genes from Multiple Phages for Improved Cell Lysis and DNA Transfer from Escherichia coli to Bacillus subtilis	PLOS ONE			English	Article							EXTRACELLULAR DNA; PROTEIN; BIOSYNTHESIS; INTEGRATION; PATHWAY; SYSTEMS; LAMBDA; STEP	The ability to efficiently and reliably transfer genetic circuits between the key synthetic biology chassis, such as Escherichia coli and Bacillus subtilis, constitutes one of the major hurdles of the rational genome engineering. Using lambda Red recombineering we integrated the thermosensitive lambda repressor and the lysis genes of several bacteriophages into the E. coli chromosome. The lysis of the engineered autolytic cells is inducible by a simple temperature shift. We improved the lysis efficiency by introducing different combinations of lysis genes from bacteriophages lambda, FX174 and MS2 under the control of the thermosensitive lambda repressor into the E. coli chromosome. We tested the engineered autolytic cells by transferring plasmid and bacterial artificial chromosome (BAC)-borne genetic circuits from E. coli to B. subtilis. Our engineered system combines benefits of the two main synthetic biology chassis, E. coli and B. subtilis, and allows reliable and efficient transfer of DNA edited in E. coli into B. subtilis.	[Juhas, Mario; Wong, Christine; Ajioka, James W.] Univ Cambridge, Dept Pathol, Cambridge, England	University of Cambridge	Ajioka, JW (corresponding author), Univ Cambridge, Dept Pathol, Cambridge, England.		Wong, Clemente Michael Vui Ling/M-8372-2013	Wong, Clemente Michael Vui Ling/0000-0003-3431-8896; Wong, Christine/0000-0001-8433-7433	UK Engineering and Physical Sciences Research Council; OpenPlant Fund; SynBio Fund; BBSRC [BB/L014130/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); OpenPlant Fund; SynBio Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the UK Engineering and Physical Sciences Research Council (JWA), OpenPlant Fund (MJ) and SynBio Fund (MJ).	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berry J, 2008, MOL MICROBIOL, V70, P341, DOI 10.1111/j.1365-2958.2008.06408.x; BIENKOWSKASZEWCZYK K, 1981, MOL GEN GENET, V184, P111, DOI 10.1007/BF00271205; Catalao MJ, 2013, FEMS MICROBIOL REV, V37, P554, DOI 10.1111/1574-6976.12006; Commichau FM, 2014, METAB ENG, V25, P38, DOI 10.1016/j.ymben.2014.06.007; Commichau FM, 2013, MOL BIOSYST, V9, P1068, DOI 10.1039/c3mb25595f; Corchero JL, 2001, MICROBIOL RES, V156, P13, DOI 10.1078/0944-5013-00066; Cunningham DS, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-27; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; GANDON S, 2016, WHY BE TEMPERATE LES, V24, P356; Gao YQ, 2013, APPL MICROBIOL BIOT, V97, P7121, DOI 10.1007/s00253-013-5100-x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grundling A, 2001, P NATL ACAD SCI USA, V98, P9348, DOI 10.1073/pnas.151247598; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Hao T, 2013, MOL BIOSYST, V9, P2034, DOI 10.1039/c3mb25568a; Harwood CR, 2008, TRENDS MICROBIOL, V16, P73, DOI 10.1016/j.tim.2007.12.001; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Itaya M, 2010, NUCLEIC ACIDS RES, V38, P2551, DOI 10.1093/nar/gkq142; Juhas M, 2017, CRIT REV BIOTECHNOL, V37, P277, DOI 10.3109/07388551.2016.1141394; Juhas M, 2016, CRIT REV BIOTECHNOL, V36, P416, DOI 10.3109/07388551.2014.989423; Juhas M, 2015, MICROB BIOTECHNOL, V8, P726, DOI 10.1111/1751-7915.12296; Juhas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123007; Juhas M, 2014, MICROBIOL-SGM, V160, P2341, DOI 10.1099/mic.0.079376-0; Juhas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111451; Kaneko S, 2010, J BIOCHEM, V147, P819, DOI 10.1093/jb/mvq012; Lee JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052382; Manabe K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-18; McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921; Merryman C, 2012, METAB ENG, V14, P196, DOI 10.1016/j.ymben.2012.02.005; Miller E M, 1995, Methods Mol Biol, V47, P105; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; Nishihara T, 2003, MICROBIOLOGICA, V26, P163; Park SJ, 2012, APPL MICROBIOL BIOT, V93, P273, DOI 10.1007/s00253-011-3530-x; Shi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081370; Shulman LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039455; Tanaka S, 2012, MOL MICROBIOL, V85, P975, DOI 10.1111/j.1365-2958.2012.08153.x; WALDERICH B, 1989, J BACTERIOL, V171, P3331, DOI 10.1128/jb.171.6.3331-3336.1989; Yadav T, 2014, J BIOL CHEM, V289, P27640, DOI 10.1074/jbc.M114.577924; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; YOUNG RY, 1992, MICROBIOL REV, V56, P430, DOI 10.1128/MMBR.56.3.430-481.1992; Zhang XM, 2009, J MICROBIOL METH, V79, P199, DOI 10.1016/j.mimet.2009.09.001; Zhou L, 2012, METAB ENG, V14, P560, DOI 10.1016/j.ymben.2012.05.004	45	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165778	10.1371/journal.pone.0165778	http://dx.doi.org/10.1371/journal.pone.0165778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798678	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100066
J	Lartey, J; Taggart, J; Robson, S; Taggart, M				Lartey, Jon; Taggart, Julie; Robson, Stephen; Taggart, Michael			Altered Expression of Human Smooth Muscle Myosin Phosphatase Targeting (MYPT) Isovariants with Pregnancy and Labor	PLOS ONE			English	Article							LIGHT-CHAIN PHOSPHATASE; CONTRACTILE RESPONSE; HUMAN MYOMETRIUM; URINARY-BLADDER; SUBUNIT; ISOFORM; PHOSPHORYLATION; HYPERTENSION; SENSITIVITY; RELAXATION	Background Myosin light-chain phosphatase is a trimeric protein that hydrolyses phosphorylated myosin II light chains (MYLII) to cause relaxation in smooth muscle cells including those of the uterus. A major component of the phosphatase is the myosin targeting subunit (MYPT), which directs a catalytic subunit to dephosphorylate MYLII. There are 5 main MYPT family members (MYPT1 (PPP1R12A), MYPT2 (PPP1R12B), MYPT3 (PPP1R16A), myosin binding subunit 85 MBS85 (PPP1R12C) and TIMAP (TGF-beta-inhibited membrane-associated protein (PPP1R16B)). Nitric oxide (NO)-mediated smooth muscle relaxation has in part been attributed to activation of the phosphatase by PKG binding to a leucine zipper (LZ) dimerization domain located at the carboxyl-terminus of PPP1R12A. In animal studies, alternative splicing of PPP1R12A can lead to the inclusion of a 31-nucleotide exonic segment that generates a LZ negative (LZ-) isovariant rendering the phosphatase less sensitive to NO vasodilators and alterations in PPP1R12ALZ-and LZ+ expression have been linked to phenotypic changes in smooth muscle function. Moreover, PPP1R12B and PPP1R12C, but not PPP1R16A or PPP1R16B, have the potential for LZ+/LZ-alternative splicing. Yet, by comparison to animal studies, the information on human MYPT genomic sequences/mRNA expressions is scant. As uterine smooth muscle undergoes substantial remodeling during pregnancy we were interested in establishing the patterns of expression of human MYPT isovariants during this process and also following labor onset as this could have important implications for determining successful pregnancy outcome. Objectives We used cross-species genome alignment, to infer putative human sequences not available in the public domain, and isovariant-specific quantitative PCR, to analyse the expression of mRNA encoding putative LZ+ and LZ-forms of PPP1R12A, PPP1R12B and PPP1R12C as well as canonical PPP1R16A and PPP1R16B genes in human uterine smooth muscle from non-pregnant, pregnant and in-labor donors. Results We found a reduction in the expression of PPP1R12A, PPP1R12BLZ+, PPP1R16A and PPP1R16B mRNA in late pregnancy (not-in-labor) relative to non-pregnancy. PPP1R12ALZ+ and PPP1R12ALZ- mRNA levels were similar in the non-pregnant and pregnant not in labor groups. There was a further reduction in the uterine expression of PPP1R12ALZ+, PPP1R12CLZ+ and PPP1R12ALZ- mRNA with labor relative to the pregnant not-in-labor group. PPP1R12A, PPP1R12BLZ+, PPP1R16A and PPP1R16B mRNA levels were invariant between the not in labor and in-labor groups. Conclusions MYPT proteins are crucial determinants of smooth muscle function. Therefore, these alterations in human uterine smooth muscle MYPT isovariant expression during pregnancy and labor may be part of the important molecular physiological transition between uterine quiescence and activation.	[Lartey, Jon; Robson, Stephen] Newcastle Univ, Sch Med, Inst Cellular Med, William Leech Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Taggart, Julie; Taggart, Michael] Newcastle Univ, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Lartey, J (corresponding author), Newcastle Univ, Sch Med, Inst Cellular Med, William Leech Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jon.lartey@newcastle.ac.uk		Robson, Stephen/0000-0001-7897-7987	National Institute for Health Research Academic Clinical Lecturership [NTH/040/601/A]; Academy of Medical Sciences/ Wellcome Trust Award (Starter Grant Clinical Lecturer Round2 Lartey); Academy of Medical Sciences (AMS) [AMS-SGCL2-Lartey] Funding Source: researchfish; National Institute for Health Research [CL-2012-01-501] Funding Source: researchfish	National Institute for Health Research Academic Clinical Lecturership; Academy of Medical Sciences/ Wellcome Trust Award (Starter Grant Clinical Lecturer Round2 Lartey); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by external funder-National Institute for Health Research Academic Clinical Lecturership (NTH/040/601/A) Award to JL, and external funder-Academy of Medical Sciences/ Wellcome Trust Award (Starter Grant Clinical Lecturer Round2 Lartey) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Arimura T, 2001, J BIOL CHEM, V276, P6073, DOI 10.1074/jbc.M008566200; Borman MA FT, 2011, MOL CELL BIOCHEM, V327, P93; Buxton ILO, 2004, MOL PHARMACOL, V65, P1051, DOI 10.1124/mol.65.5.1051; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; Cheng JC, 2013, LAB INVEST, V93, P422, DOI 10.1038/labinvest.2013.40; Dippold RP, 2014, AM J PHYSIOL-REG I, V307, pR256, DOI 10.1152/ajpregu.00145.2014; Dirksen WP, 2000, AM J PHYSIOL-CELL PH, V278, pC589, DOI 10.1152/ajpcell.2000.278.3.C589; Dordea AC, 2013, MOL HUM REPROD, V19, P727, DOI 10.1093/molehr/gat045; Ekman M, 2005, J GEN PHYSIOL, V125, P187, DOI 10.1085/jgp.200409212; Fisher SA, 2010, PHYSIOL GENOMICS, V42A, P169, DOI 10.1152/physiolgenomics.00111.2010; Fujioka M, 1998, GENOMICS, V49, P59, DOI 10.1006/geno.1998.5222; Gomez-Pinilla PJ, 2008, J PINEAL RES, V44, P416, DOI 10.1111/j.1600-079X.2007.00544.x; Hudson CA, 2012, MOL HUM REPROD, V18, P265, DOI 10.1093/molehr/gar078; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; Lartey J, 2006, BIOL REPROD, V75, P452, DOI 10.1095/biolreprod.105.049130; Lee MR, 1997, J BIOL CHEM, V272, P5063, DOI 10.1074/jbc.272.8.5063; Lontay B, 2010, J BIOL CHEM, V285, P29357, DOI 10.1074/jbc.M110.143966; Lu Y, 2008, AM J PHYSIOL-CELL PH, V294, pC564, DOI 10.1152/ajpcell.00285.2007; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; Payne MC, 2006, J MOL CELL CARDIOL, V40, P274, DOI 10.1016/j.yjmcc.2005.07.009; Payne MC, 2004, AM J PHYSIOL-HEART C, V286, pH1801, DOI 10.1152/ajpheart.00696.2003; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Trujillo M, 2001, J PHARMACOL EXP THER, V296, P841; Wu XQ, 1996, BIOCHEM BIOPH RES CO, V220, P658, DOI 10.1006/bbrc.1996.0460; Yong J, 2006, J BIOL CHEM, V281, P31202, DOI 10.1074/jbc.M607287200; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35	28	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0164352	10.1371/journal.pone.0164352	http://dx.doi.org/10.1371/journal.pone.0164352			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798640	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100008
J	Navasero, MV; Candano, RN; Hautea, DM; Hautea, RA; Shotkoski, FA; Shelton, AM				Navasero, Mario V.; Candano, Randolph N.; Hautea, Desiree M.; Hautea, Randy A.; Shotkoski, Frank A.; Shelton, Anthony M.			Assessing Potential Impact of Bt Eggplants on Non-Target Arthropods in the Philippines	PLOS ONE			English	Article							LONG-TERM ASSESSMENT; TRANSGENIC BT; MULTIPLE CROPS; COTTON; ABUNDANCE; MAIZE; PESTS; ASSEMBLAGES; POPULATIONS; RESISTANCE	Studies on potential adverse effects of genetically engineered crops are part of an environmental risk assessment that is required prior to the commercial release of these crops. Of particular concern are non-target organisms (NTOs) that provide important ecosystem services. Here, we report on studies conducted in the Philippines over three cropping seasons with Bt eggplants expressing Cry1Ac for control of the eggplant fruit and shoot borer (EFSB), Leucinodes orbonalis, to examine potential effects on field abundance, community composition, structure and biodiversity of NTO's, particularly non-target arthropod (NTA) communities. We document that many arthropod taxa are associated with Bt eggplants and their non-Bt comparators and that the number of taxa and their densities varied within season and across trials. However, we found few significant differences in seasonal mean densities of arthropod taxa between Bt and non-Bt eggplants. As expected, a lower abundance of lepidopteran pests was detected in Bt eggplants. Higher abundance of a few nontarget herbivores was detected in non-Bt eggplants as were a few non-target beneficials that might control them. Principal Response Curve (PRC) analyses showed no statistically significant impact of Bt eggplants on overall arthropod communities through time in any season. Furthermore, we found no significant adverse impacts of Bt eggplants on species abundance, diversity and community dynamics, particularly for beneficial NTAs. These results support our previous studies documenting that Bt eggplants can effectively and selectively control the main pest of eggplant in Asia, the EFSB. The present study adds that it can do so without adverse effects on NTAs. Thus, Bt eggplants can be a foundational component for controlling EFSB in an Integrated Pest Management (IPM) program and dramatically reduce dependence on conventional insecticides.	[Navasero, Mario V.; Candano, Randolph N.] Univ Philippines Los Banos, Coll Agr, Natl Crop Protect Ctr CPC, Laguna, Philippines; [Hautea, Desiree M.] Univ Philippines Los Banos, Coll Agr, Inst Plant Breeding CSC, Laguna, Philippines; [Hautea, Randy A.] Int Serv Acquisit Agri Biotech Applicat, Laguna, Philippines; [Shotkoski, Frank A.] Cornell Univ, Int Programs, Ithaca, NY USA; [Shelton, Anthony M.] Cornell NYSAES, Dept Entomol, Geneva, NY USA	University of the Philippines System; University of the Philippines Los Banos; University of the Philippines System; University of the Philippines Los Banos; Cornell University	Hautea, DM (corresponding author), Univ Philippines Los Banos, Coll Agr, Inst Plant Breeding CSC, Laguna, Philippines.	dmh.uplb@gmail.com			United States Agency for International Development (USAID) [GDG-A-00-02-00017-00]; Republic of the Philippines Department of Agriculture-Biotechnology Program Office (DA- Biotech BPO); University of the Philippine Los Banos (UPLB); United States Agency for International Development (USAID) through Cornell University Agricultural Biotechnology Support Project II (ABSPII); Instiute of the Plant Breeding, College of Agriculture, University of the Philippine Los Banos (UPLB)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Republic of the Philippines Department of Agriculture-Biotechnology Program Office (DA- Biotech BPO); University of the Philippine Los Banos (UPLB); United States Agency for International Development (USAID) through Cornell University Agricultural Biotechnology Support Project II (ABSPII)(United States Agency for International Development (USAID)); Instiute of the Plant Breeding, College of Agriculture, University of the Philippine Los Banos (UPLB)	This research was funded through the United States Agency for International Development (USAID Cooperative Agreement GDG-A-00-02-00017-00) to Cornell University Agricultural Biotechnology Support Project II (ABSPII), and matching funds from the Republic of the Philippines Department of Agriculture-Biotechnology Program Office (DA- Biotech BPO) and the University of the Philippine Los Banos (UPLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the following institutions for various critical support: the United States Agency for International Development (USAID) through Cornell University Agricultural Biotechnology Support Project II (ABSPII), the Republic of the Philippines Department of Agriculture-Biotechnology Program Office (DA- Biotech BPO) and the Instiute of the Plant Breeding, College of Agriculture, University of the Philippine Los Banos (UPLB) for the funding support; the Maharashtra Hybrid Seeds Co. Pvt. Ltd. (Mahyco) for providing access to eggplant event EE-1 and regulatory-related information and for various technical assistance/advice in the conduct of laboratory and field activities; and Cornell University and Sathguru Management Consultants for facilitating the technology transfer. We also acknowledge the assistance of UPLB Foundation Inc., the executing agency for the ABSPII project in the Philippines.	Acciarri N, 2000, HORTSCIENCE, V35, P722, DOI 10.21273/HORTSCI.35.4.722; Alam SN., 2003, USDA TECHNICAL B, V28; Allard R.W., 1999, PRINCIPLES PLANT BRE; Arpaia S, 2007, ENVIRON ENTOMOL, V36, P213, DOI 10.1603/0046-225X(2007)36[213:COASAI]2.0.CO;2; Balog A, 2010, CROP PROT, V29, P567, DOI 10.1016/j.cropro.2009.12.020; Bitzer RJ, 2005, ENVIRON ENTOMOL, V34, P1346, DOI 10.1603/0046-225X(2005)034[1346:BACSOE]2.0.CO;2; Brookes Graham, 2013, GM CROPS GLOBAL SOCI; Cannon R. J. C., 2000, Integrated Pest Management Reviews, V5, P151, DOI 10.1023/A:1011347122894; Carpenter Janet E, 2011, GM Crops, V2, P7, DOI 10.4161/gmcr.2.1.15086; Center for Environmental Risk Assessment ILSI Research Foundation, 2011, Environ Biosafety Res, V10, P27, DOI 10.1051/ebr:2012002; Chupungco AR, 2011, PHILIPP J CROP SCI, V36, P37; Cline MG, 1997, AM J BOT, V84, P1064, DOI 10.2307/2446149; Del Prado-Lu JL, 2015, ENVIRON HEALTH PREV, V20, P53, DOI 10.1007/s12199-014-0425-3; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2010, ECOTOXICOLOGY, V19, P1642, DOI 10.1007/s10646-010-0550-8; Devos Y, 2012, TRANSGENIC RES, V21, P1, DOI 10.1007/s11248-011-9515-9; Dhillon MK, 2012, INDIAN J AGR SCI, V82, P248; Francisco S. R, 2009, PROJECTED IMPACTS AG, P35; Francisco SR, 2014, SOCIOECONOMIC IMPACT, P205; Gatehouse AMR, 2011, PHILOS T R SOC B, V366, P1438, DOI 10.1098/rstb.2010.0330; Groot AT, 2002, PLANT J, V31, P387, DOI 10.1046/j.1365-313X.2002.01366.x; Guo YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114228; Hagenbucher S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0042; Hagerty AM, 2005, ENVIRON ENTOMOL, V34, P105, DOI 10.1603/0046-225X-34.1.105; Han P, 2016, J PEST SCI, V89, P859, DOI 10.1007/s10340-016-0791-2; Hautea DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157498; Head G, 2005, ENVIRON ENTOMOL, V34, P1257, DOI 10.1603/0046-225X(2005)034[1257:AMLCOA]2.0.CO;2; Hellmich Richard L., 2008, V5, P119, DOI 10.1007/978-1-4020-8373-0_5; Hwang JS, 2009, ZOOL STUD, V48, P49; Icoz I, 2008, SOIL BIOL BIOCHEM, V40, P559, DOI 10.1016/j.soilbio.2007.11.002; Kennedy George G., 2008, V5, P1; Kos M, 2009, TRENDS BIOTECHNOL, V27, P621, DOI 10.1016/j.tibtech.2009.08.002; Lu JL, 2012, PHILIPP J CROP SCI, V37, P93; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Luttrell R. G., 1995, 1995 Proceedings Beltwide Cotton Conferences, San Antonio, TX, USA, January 4-7, 1995: Volume 2., P760; M/s Maharashtra Hybrid Seeds Company Ltd. (Mahyco) Mumbai University of Agricultural Sciences (UAS) Dharwad and Tamil Nadu Agricultural University (TNAU) Coimbatore, 2009, REP EXP COMM E UNPUB; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Moog F. A., 2006, COUNTRY PASTURE FORA; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1193, DOI 10.1603/0046-225X(2005)034[1193:LAOTEO]2.0.CO;2; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1211, DOI 10.1603/0046-225X(2005)034[1211:LAOTEO]2.0.CO;2; Naranjo SE, 2009, CAB REVIEWS PERSPECT; Naranjo SE, 2011, J AGR FOOD CHEM, V59, P5842, DOI 10.1021/jf102939c; Naranjon Steven E., 2008, V5, P159, DOI 10.1007/978-1-4020-8373-0_6; Navasero MV, 2016, DRYAD DIGITAL REPOSI; Navasero MV, 2004, POPULATION DYNAMICS; O'Callaghan M, 2005, ANNU REV ENTOMOL, V50, P271, DOI 10.1146/annurev.ento.50.071803.130352; Organization for Economic Cooperation and Development, 2007, SERS HARM REG OV BIO, V42; Quicoy C., 2010, PRODUCTIVITY TECHNIC; Quicoy C., 2014, SOCIOECONOMIC IMPACT, P97; Ripalda RR, 2012, PHILIPP J CROP SCI, V37, P1; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; SAS INSTITUTE, 2001, SAS STAT 9 US GUID; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Shelton AM., 2012, CROP PROT, V29, P412; Stevens J., 2012, PESTICIDES ADV CHEM, V25, P269; Talekar NS, 2002, ASIAN VEGETABLE RES; ter Braak CJF, 2002, CANOCO REFERENCE MAN; Torres JB, 2005, ENVIRON ENTOMOL, V34, P1242, DOI 10.1603/0046-225X(2005)034[1242:CAGPAI]2.0.CO;2; Toschki A, 2007, ENVIRON ENTOMOL, V36, P967, DOI 10.1603/0046-225X(2007)36[967:EOCOGM]2.0.CO;2; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Whitehouse MEA, 2005, ENVIRON ENTOMOL, V34, P1224, DOI 10.1603/0046-225X(2005)034[1224:ACOACI]2.0.CO;2; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu Y, 2012, J INTEGR AGR, V11, P1493, DOI 10.1016/S2095-3119(12)60149-X	67	9	11	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165190	10.1371/journal.pone.0165190	http://dx.doi.org/10.1371/journal.pone.0165190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798662	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100021
J	Sauvegarde, C; Paul, D; Bridoux, L; Jouneau, A; Degrelle, SAV; Hue, I; Rezsohazy, RA; Donnay, I				Sauvegarde, Caroline; Paul, Delphine; Bridoux, Laure; Jouneau, Alice; Degrelle, Se A. Verine; Hue, Isabelle; Rezsohazy, Rene A.; Donnay, Isabelle			Dynamic Pattern of HOXB9 Protein Localization during Oocyte Maturation and Early Embryonic Development in Mammals	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MOUSE PREIMPLANTATION EMBRYOS; PRIMITIVE ENDODERM FORMATION; TO-MESENCHYMAL TRANSITION; EARLY LINEAGE SEGREGATION; HOMEOBOX-CONTAINING GENES; INNER CELL MASS; VISCERAL ENDODERM; IN-VITRO; POSTHATCHING DEVELOPMENT	Background We previously showed that the homeodomain transcription factor HOXB9 is expressed in mammalian oocytes and early embryos. However, a systematic and exhaustive study of the localization of the HOXB9 protein, and HOX proteins in general, during mammalian early embryonic development has so far never been performed. Results The distribution of HOXB9 proteins in oocytes and the early embryo was characterized by immunofluorescence from the immature oocyte stage to the peri-gastrulation period in both the mouse and the bovine. HOXB9 was detected at all studied stages with a dynamic expression pattern. Its distribution was well conserved between the two species until the blastocyst stage and was mainly nuclear. From that stage on, trophoblastic cells always showed a strong nuclear staining, while the inner cell mass and the derived cell lines showed important dynamic variations both in staining intensity and in intra-cellular localization. Indeed, HOXB9 appeared to be progressively downregulated in epiblast cells and only reappeared after gastrulation had well progressed. The protein was also detected in the primitive endoderm and its derivatives with a distinctive presence in apical vacuoles of mouse visceral endoderm cells. Conclusions Together, these results could suggest the existence of unsuspected functions for HOXB9 during early embryonic development in mammals.	[Sauvegarde, Caroline; Paul, Delphine; Bridoux, Laure; Rezsohazy, Rene A.; Donnay, Isabelle] Catholic Univ Louvain, ISV, Biol Mol & Cellulaire Anim AMCB, Louvain, Belgium; [Jouneau, Alice; Hue, Isabelle] Univ Paris Saclay, ENVA, INRA, UMR BDR, Jouy En Josas, France; [Degrelle, Se A. Verine] INSERM, U767, Fac Sci Pharmaceut & Biol, UMR S1139, Paris, France; [Degrelle, Se A. Verine] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Degrelle, Se A. Verine] PremUp Fdn, Paris, France	Universite Catholique Louvain; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Donnay, I (corresponding author), Catholic Univ Louvain, ISV, Biol Mol & Cellulaire Anim AMCB, Louvain, Belgium.	isabelle.donnay@uclouvain.be	Degrelle, Severine/AAC-1726-2020; Hue, Isabelle/AAD-2341-2020	Degrelle, Severine/0000-0001-6263-4875; Hue, Isabelle/0000-0002-3873-9738; Jouneau, Alice/0000-0001-5985-9862	FRFC grant from Fonds National de la Recherche Scientifique (Belgium) [2.4566.07]; Action de Recherche Concertee from the Communaute frangaise (Belgium); STSM grant from COST Action [FA0702]; FRIA fellowship from the FNRS (Belgium)	FRFC grant from Fonds National de la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Action de Recherche Concertee from the Communaute frangaise (Belgium); STSM grant from COST Action; FRIA fellowship from the FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by a FRFC grant from Fonds National de la Recherche Scientifique (Belgium Grant number : 2.4566.07); Action de Recherche Concertee from the Communaute frangaise (Belgium); STSM grant from COST Action FA0702 (Gemini). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the team of Professor Schellander from the University of Bonn and in particular Franca Rings and David Tesfaye for the training in microinjection and the fruitful discussions about siRNA. We are very grateful to Gene diffusion (Douai, France), especially Gerard Bernard and Luc Liegeois, for the gift of Dll bovine embryos produced in vivo. We also wish to thank the Awe (Belgium), particularly Christophe Boccart, for the D7 bovine blastocysts produced in vivo. We express our gratitude to Niel Talbot (U.S. Department of Agriculture, Beltsville, USA) for providing the CT-1 cells and for all his advice to establish and maintain the CT-1 cells culture. We thank Deneen Wellik from University of Michigan (Ann Arbor, USA) for generously providing mouse Hox9 expression vectors and Hoxb9<SUP>-/-</SUP> E12.5 embryos, for her interest in our research and for all the discussions about our project. Our appreciation is extended to Pierre Courtois and Patrick Van Der Smissen from the Universite catholique de Louvain (Woluwe-Saint-Lambert, Belgium) for the access to microscope facilities and for thorough advice. We also thank Sebastien Mauen (Celyad, Mont-Saint-Guibert, Belgium) for his assistance in developing an analytical method for images quantification. We acknowledge the IMABIOL platform and the SMCS from the Universite catholique de Louvain (Louvain-la-Neuve, Belgium) for confocal microscopy support and for the statistical analysis, respectively. The authors also thank the Cochin Institute Imaging facility and the HistIM platform (Paris, France). We are very grateful to all members of the Animal Molecular and Cellular Biology team for their assistance in embryo production and Marie-Anne Mauclet for her help with administrative procedures. The authors like to thank Jacqueline Deschamps from Hubrecht Institut (Utrecht, Netherlands) for useful discussions of the results and Francoise Gofflot from Universite catholique de Louvain for stimulating discussions. We acknowledge Marc Pirson for English editing. CS holds a FRIA fellowship from the FNRS (Belgium).	Adjaye J, 2000, MOL HUM REPROD, V6, P707, DOI 10.1093/molehr/6.8.707; Amesse LS, 2003, GYNECOL ONCOL, V90, P512, DOI 10.1016/S0090-8258(03)00357-3; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Artus J, 2014, CELL MOL LIFE SCI, V71, P3327, DOI 10.1007/s00018-014-1630-3; Barcroft LC, 1998, J REPROD FERTIL, V114, P327, DOI 10.1530/jrf.0.1140327; BARNES FL, 1991, MOL REPROD DEV, V29, P117, DOI 10.1002/mrd.1080290205; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; BERNARD O, 1977, J EXP MED, V145, P58, DOI 10.1084/jem.145.1.58; Bielinska M, 1999, INT J DEV BIOL, V43, P183; Blij S, 2012, DEVELOPMENT, V139, P3969, DOI 10.1242/dev.086025; Bridoux L, 2015, BBA-GENE REGUL MECH, V1849, P1298, DOI 10.1016/j.bbagrm.2015.08.006; Cai KQ, 2008, DEV DYNAM, V237, P2820, DOI 10.1002/dvdy.21703; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen F, 1997, DEV BIOL, V181, P186, DOI 10.1006/dbio.1996.8440; Chen F, 1999, P NATL ACAD SCI USA, V96, P541, DOI 10.1073/pnas.96.2.541; Chiba N, 2012, P NATL ACAD SCI USA, V109, P2760, DOI 10.1073/pnas.1018867108; Choi DS, 2011, PROTEOMICS, V11, P2745, DOI 10.1002/pmic.201100022; Cocero MJ, 1996, CRYOBIOLOGY, V33, P502, DOI 10.1006/cryo.1996.0053; CONLON RA, 1992, DEVELOPMENT, V116, P357; Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Degrelle SA, 2011, PLACENTA, V32, P917, DOI 10.1016/j.placenta.2011.08.014; Degrelle SA, 2005, DEV BIOL, V288, P448, DOI 10.1016/j.ydbio.2005.09.043; Donnay I, 2004, THERIOGENOLOGY, V62, P1093, DOI 10.1016/j.theriogenology.2003.12.019; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; El-Hashash AHK, 2010, MECH DEVELOP, V127, P1, DOI 10.1016/j.mod.2009.09.004; ENDERS AC, 1978, ANAT REC, V190, P65, DOI 10.1002/ar.1091900107; Foronda D, 2009, INT J DEV BIOL, V53, P1409, DOI 10.1387/ijdb.072462df; Gao Y, 2010, MOL REPROD DEV, V77, P540, DOI 10.1002/mrd.21180; George F, 2008, THERIOGENOLOGY, V69, P612, DOI 10.1016/j.theriogenology.2007.11.008; Goossens K, 2011, REPROD DOMEST ANIM, V46, P1098, DOI 10.1111/j.1439-0531.2011.01770.x; Goval JJ, 2000, BIOL CELL, V92, P513, DOI 10.1016/S0248-4900(00)01105-9; GRAHAM A, 1991, DEVELOPMENT, V112, P255; Guillomot M, 2010, PLACENTA, V31, P482, DOI 10.1016/j.placenta.2010.03.004; Gupta A, 1996, BIOL REPROD, V55, P796, DOI 10.1095/biolreprod55.4.796; Hayashida T, 2010, P NATL ACAD SCI USA, V107, P1100, DOI 10.1073/pnas.0912710107; HOGAN BLM, 1981, J EMBRYOL EXP MORPH, V62, P379; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Hong BS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-556; Hoshino H, 2015, DEV BIOL, V402, P175, DOI 10.1016/j.ydbio.2015.03.023; Hosseini SM, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0096-3; Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh; Hue I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127330; HUNT P, 1991, DEVELOPMENT, P63; Huntriss J, 2006, MOL HUM REPROD, V12, P283, DOI 10.1093/molehr/gal035; Inman KE, 2006, GENE EXPR PATTERNS, V6, P783, DOI 10.1016/j.modgep.2006.01.010; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; Jedrusik A, 2010, DEV BIOL, V344, P66, DOI 10.1016/j.ydbio.2010.04.017; Kageyama S, 2007, ZYGOTE, V15, P117, DOI 10.1017/S096719940700411X; Kan NG, 2007, DEVELOPMENT, V134, P31, DOI 10.1242/dev.02722; Kawamura N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2069; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; KIMBER SJ, 1994, EUR J CELL BIOL, V63, P102; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Lappin Terence R J, 2006, Ulster Med J, V75, P23; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Ledgard AM, 2006, MOL REPROD DEV, V73, P1084, DOI 10.1002/mrd.20532; Lee JH, 2009, THERIOGENOLOGY, V72, P1023, DOI 10.1016/j.theriogenology.2009.05.021; Li L, 2013, MOL ASPECTS MED, V34, P919, DOI 10.1016/j.mam.2013.01.003; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Maddox-Hyttel P, 2003, REPRODUCTION, V125, P607, DOI 10.1530/rep.0.1250607; Maddox-Hyttel P, 2010, ESSENTIALS OF DOMEST; Magli MC, 1997, J CELL PHYSIOL, V173, P168, DOI 10.1002/(SICI)1097-4652(199711)173:2<168::AID-JCP16>3.0.CO;2-C; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Mamo S, 2011, BIOL REPROD, V85, P1143, DOI 10.1095/biolreprod.111.092643; Maurer ME, 2005, J CELL SCI, V118, P5345, DOI 10.1242/jcs.02650; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Mitchell MD, 2015, AM J OBSTET GYNECOL, V213, pS173, DOI 10.1016/j.ajog.2015.07.001; Munson L, 1996, BIOL REPROD, V55, P748, DOI 10.1095/biolreprod55.4.748; Murasawa H, 2000, ANAT RECORD, V259, P383, DOI 10.1002/1097-0185(20000801)259:4<383::AID-AR20>3.0.CO;2-N; Myers M, 2010, WIRES SYST BIOL MED, V2, P117, DOI 10.1002/wsbm.21; Nagy A., 2003, MANIPULATING THE MOU; Nowotschin S, 2010, CURR OPIN GENET DEV, V20, P420, DOI 10.1016/j.gde.2010.05.008; Ohsugi M, 1997, DEV BIOL, V185, P261, DOI 10.1006/dbio.1997.8560; Ohsugi M, 1996, DEV DYNAM, V206, P391, DOI 10.1002/(SICI)1097-0177(199608)206:4<391::AID-AJA5>3.0.CO;2-D; Ota T, 2006, DIFFERENTIATION, V74, P1, DOI 10.1111/j.1432-0436.2006.00053.x; Ota T, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-49; Ozawa M, 2012, BMC DEV BIOL, V12, P1, DOI 10.1186/1471-213X-12-33; Papanayotou C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001890; PARIA BC, 1992, DEV BIOL, V151, P91, DOI 10.1016/0012-1606(92)90216-4; Paul D, 2014, METHODS MOL BIOL, V1196, P19, DOI 10.1007/978-1-4939-1242-1_2; Paul D, 2011, MOL REPROD DEV, V78, P436, DOI 10.1002/mrd.21321; Peter AT, 2013, THERIOGENOLOGY, V80, P693, DOI 10.1016/j.theriogenology.2013.06.004; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Ponsuksili S, 2001, MOL REPROD DEV, V60, P297, DOI 10.1002/mrd.1091; RACHMAN F, 1984, J REPROD IMMUNOL, V6, P39, DOI 10.1016/0165-0378(84)90040-8; Ravelich SR, 2006, PLACENTA, V27, P307, DOI 10.1016/j.placenta.2005.03.002; Rawat VPS, 2008, BLOOD, V111, P309, DOI 10.1182/blood-2007-04-085407; Rezsohazy R, 2015, DEVELOPMENT, V142, P1212, DOI 10.1242/dev.109785; Rezsohazy R, 2014, DEV DYNAM, V243, P117, DOI 10.1002/dvdy.24060; Richard C, 2015, THERIOGENOLOGY, V83, P1101, DOI 10.1016/j.theriogenology.2014.12.005; Saga Y, 1999, DEVELOPMENT, V126, P3437; Scotti M, 2012, DEVELOPMENT, V139, P731, DOI 10.1242/dev.075408; Sha L, 2015, CLIN EXP MED, V15, P55, DOI 10.1007/s10238-014-0276-7; Shrestha B, 2012, FEBS J, V279, P3715, DOI 10.1111/j.1742-4658.2012.08733.x; SKREB N, 1991, International Journal of Developmental Biology, V35, P161; SLAGER HG, 1991, DEV BIOL, V145, P205, DOI 10.1016/0012-1606(91)90120-R; SOLTER D, 1970, Z ANAT ENTWICKLUNGS, V132, P291, DOI 10.1007/BF00569266; Stephenson RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008235; Stephenson RO, 2010, DEVELOPMENT, V137, P3383, DOI 10.1242/dev.050195; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Takashima Ryoukichi, 1999, Journal of Reproduction and Development, V45, P363, DOI 10.1262/jrd.45.363; Takasuga S, 2013, P NATL ACAD SCI USA, V110, P1726, DOI 10.1073/pnas.1213212110; Topisirovic I, 2005, MOL CELL BIOL, V25, P1100, DOI 10.1128/MCB.25.3.1100-1112.2005; Tsark EC, 1997, MOL REPROD DEV, V47, P271, DOI 10.1002/(SICI)1098-2795(199707)47:3&lt;271::AID-MRD6&gt;3.0.CO;2-I; van den Akker E, 2002, DEVELOPMENT, V129, P2181; van Rooijen C, 2012, DEVELOPMENT, V139, P2576, DOI 10.1242/dev.079848; Vejlsted M, 2006, THERIOGENOLOGY, V65, P153, DOI 10.1016/j.theriogenology.2005.09.021; Vejlsted M, 2005, BIOL REPROD, V72, P678, DOI 10.1095/biolreprod.104.034348; VERLINSKY Y, 1995, MOL REPROD DEV, V41, P127, DOI 10.1002/mrd.1080410202; Villaescusa JC, 2004, GENE, V330, P1, DOI 10.1016/j.gene.2004.01.024; Wada Yoh, 2013, Bioarchitecture, V3, P13, DOI 10.4161/bioa.24126; Wallingford MC, 2014, MECH DEVELOP, V133, P189, DOI 10.1016/j.mod.2014.08.001; Wellik DM, 2011, PEDIATR NEPHROL, V26, P1559, DOI 10.1007/s00467-011-1902-1; Xu B, 2011, P NATL ACAD SCI USA, V108, P4888, DOI 10.1073/pnas.1018161108; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; Zhan J, 2014, BRIT J CANCER, V111, P883, DOI 10.1038/bjc.2014.387; Zhang YM, 2002, AM J OBSTET GYNECOL, V187, P24, DOI 10.1067/mob.2002.122850	124	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165898	10.1371/journal.pone.0165898	http://dx.doi.org/10.1371/journal.pone.0165898			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798681	Green Submitted, Green Published, gold			2022-12-26	WOS:000386711100073
J	Lazicki, PA; Liebman, M; Wander, MM				Lazicki, Patricia A.; Liebman, Matt; Wander, Michelle M.			Root Parameters Show How Management Alters Resource Distribution and Soil Quality in Conventional and Low-Input Cropping Systems in Central Iowa	PLOS ONE			English	Article							ORGANIC-MATTER DYNAMICS; NITROGEN-FERTILIZATION; AGRONOMIC PERFORMANCE; CARBON SEQUESTRATION; GRAIN PRODUCTION; TILLAGE; MECHANISMS; SATURATION; MANURE; GROWTH	Plant-soil relations may explain why low-external input (LEI) diversified cropping systems are more efficient than their conventional counterparts. This work sought to identify links between management practices, soil quality changes, and root responses in a long-term cropping systems experiment in Iowa where grain yields of 3-year and 4-year LEI rotations have matched or exceeded yield achieved by a 2-year maize (Zea mays L.) and soybean (Glycine max L.) rotation. The 2-year system was conventionally managed and chiselploughed, whereas the 3-year and 4-year systems received plant residues and animal manures and were periodically moldboard ploughed. We expected changes in soil quality to be driven by organic matter inputs, and root growth to reflect spatial and temporal fluctuations in soil quality resulting from those additions. We constructed a carbon budget and measured soil quality indicators (SQIs) and rooting characteristics using samples taken from two depths of all crop-phases of each rotation system on multiple dates. Stocks of particulate organic matter carbon (POM-C) and potentially mineralizable nitrogen (PMN) were greater and more evenly distributed in the LEI than conventional systems. Organic C inputs, which were 58% and 36% greater in the 3-year rotation than in the 4-year and 2year rotations, respectively, did not account for differences in SQI abundance or distribution. Surprisingly, SQIs did not vary with crop-phase or date. All biochemical SQIs were more stratified (p< 0.001) in the conventionally-managed soils. While POM-C and PMN in the top 10 cm were similar in all three systems, stocks in the 10-20 cm depth of the conventional system were less than half the size of those found in the LEI systems. This distribution was mirrored by maize root length density, which was also concentrated in the top 10 cm of the conventionally managed plots and evenly distributed between depths in the LEI systems. The plow-down of organic amendments and manures established meaningful differences in SQIs and extended the rhizosphere of the LEI systems. Resulting efficiencies observed in the LEI grain crops indicate that resource distribution as well as abundance is an important component of soil function that helps explain how LEI systems can maintain similar or greater yields with fewer inputs than achieved by their conventional counterparts.	[Lazicki, Patricia A.; Wander, Michelle M.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL USA; [Liebman, Matt] Iowa State Univ, Dept Agron, Ames, IA USA; [Lazicki, Patricia A.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; Iowa State University; University of California System; University of California Davis	Lazicki, PA (corresponding author), Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL USA.; Lazicki, PA (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	palazicki@ucdavis.edu	Lazicki, Patricia/AAS-8383-2021	Lazicki, Patricia/0000-0002-2481-3116; Liebman, Matt/0000-0001-6193-3849	Leopold Center for Sustainable Agriculture [2004-E06, 2007-E09]; University of Illinois College of Agriculture and Consumer Sciences Jonathan Baldwin Turner Fellowship	Leopold Center for Sustainable Agriculture; University of Illinois College of Agriculture and Consumer Sciences Jonathan Baldwin Turner Fellowship	Funding for this experiment was provided by the Leopold Center for Sustainable Agriculture (Projects 2004-E06 and 2007-E09) and the University of Illinois College of Agriculture and Consumer Sciences Jonathan Baldwin Turner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiven S, 2009, SOIL BIOL BIOCHEM, V41, P1, DOI 10.1016/j.soilbio.2008.09.015; Abiven S, 2007, BIOL FERT SOILS, V43, P849, DOI 10.1007/s00374-007-0165-2; Angers DA, 2008, SOIL SCI SOC AM J, V72, P1370, DOI 10.2136/sssaj2007.0342; Angers DA, 1998, BIOGEOCHEMISTRY, V42, P55, DOI 10.1023/A:1005944025343; Aoyama M, 1999, CAN J SOIL SCI, V79, P295, DOI 10.4141/S98-049; Balesdent J, 2000, SOIL TILL RES, V53, P215, DOI 10.1016/S0167-1987(99)00107-5; Ball BC, 2005, CAN J SOIL SCI, V85, P557, DOI 10.4141/S04-078; Bhardwaj AK, 2011, AGR ECOSYST ENVIRON, V140, P419, DOI 10.1016/j.agee.2011.01.005; Bolinder MA, 2007, AGR ECOSYST ENVIRON, V122, P461, DOI 10.1016/j.agee.2007.03.001; BUNDY LG, 1972, SOIL SCI SOC AM PRO, V36, P273, DOI 10.2136/sssaj1972.03615995003600020021x; Buyanovsky GA, 1998, BIOL FERT SOILS, V27, P242, DOI 10.1007/s003740050427; Calonego JC, 2010, EUR J AGRON, V33, P242, DOI 10.1016/j.eja.2010.06.002; Cavigelli MA, 2008, AGRON J, V100, P785, DOI 10.2134/agronj2006.0373; Cavigelli MA, 2013, RENEW AGR FOOD SYST, V28, P145, DOI 10.1017/S1742170512000439; Chassot A, 2001, PLANT SOIL, V231, P123, DOI 10.1023/A:1010335229111; CHEN X, 2014, PLOS ONE, V9; Chung H, 2010, SOIL SCI SOC AM J, V74, P130, DOI 10.2136/sssaj2009.0097; Conant RT, 2007, SOIL TILL RES, V95, P1, DOI 10.1016/j.still.2006.12.006; Coulter JA, 2011, AGRON J, V103, P182, DOI 10.2134/agronj2010.0211; Cruse MJ, 2010, AGRON J, V102, P934, DOI 10.2134/agronj2009.0457; DASILVA AP, 1994, SOIL SCI SOC AM J, V58, P1775, DOI 10.2136/sssaj1994.03615995005800060028x; Delate K, 2004, AGRON J, V96, P1288, DOI 10.2134/agronj2004.1288; Drinkwater LE, 2007, ADV AGRON, V92, P163, DOI 10.1016/S0065-2113(04)92003-2; Dwyer LM, 1996, CAN J SOIL SCI, V76, P23, DOI 10.4141/cjss96-004; Fageria NK, 2011, ADV AGRON, V110, P251, DOI 10.1016/B978-0-12-385531-2.00004-9; Franzluebbers AJ, 1996, SOIL TILL RES, V39, P1, DOI 10.1016/S0167-1987(96)01055-0; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P95, DOI 10.1016/S0167-1987(02)00018-1; Franzluebbers AJ, 2010, SOIL SCI SOC AM J, V74, P347, DOI 10.2136/sssaj2009.0079; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Gulde S, 2008, SOIL SCI SOC AM J, V72, P605, DOI 10.2136/sssaj2007.0251; Guzman JG, 2010, J ENVIRON QUAL, V39, P136, DOI 10.2134/jeq2009.0063; Hallett PD, 2009, PLANT SOIL, V314, P183, DOI 10.1007/s11104-008-9717-y; Harris D, 2001, SOIL SCI SOC AM J, V65, P1853, DOI 10.2136/sssaj2001.1853; Jokela W, 2011, AGRON J, V103, P1552, DOI 10.2134/agronj2010.0454; Karlen DL, 2006, AGRON J, V98, P484, DOI 10.2134/agronj2005.0098; Kemper W. D., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P425; Khan SA, 2007, J ENVIRON QUAL, V36, P1821, DOI 10.2134/jeq2007.0099; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Liebman M, 2008, AGRON J, V100, P600, DOI 10.2134/agronj2007.0222; Liebman M, 2013, RENEW AGR FOOD SYST, V28, P115, DOI 10.1017/S1742170512000300; LINN DM, 1984, SOIL SCI SOC AM J, V48, P1267, DOI 10.2136/sssaj1984.03615995004800060013x; MATERECHERA SA, 1992, PLANT SOIL, V144, P297, DOI 10.1007/BF00012888; MATERECHERA SA, 1991, PLANT SOIL, V135, P31, DOI 10.1007/BF00014776; Moebius-Clune BN, 2008, SOIL SCI SOC AM J, V72, P960, DOI 10.2136/sssaj2007.0248; Nyiraneza J, 2010, AGRON J, V102, P1244, DOI 10.2134/agronj2009.0480; Posner JL, 2008, AGRON J, V100, P253, DOI 10.2134/agronj2007.0058; Puget P, 2001, SOIL SCI SOC AM J, V65, P771, DOI 10.2136/sssaj2001.653771x; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Sainju UM, 2002, SOIL TILL RES, V63, P167, DOI 10.1016/S0167-1987(01)00244-6; Sainju UM, 2008, AGR ECOSYST ENVIRON, V127, P234, DOI 10.1016/j.agee.2008.04.006; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; SCHNURER J, 1982, APPL ENVIRON MICROB, V43, P1256; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Spargo JT, 2011, NUTR CYCL AGROECOSYS, V90, P253, DOI 10.1007/s10705-011-9426-4; Stewart CE, 2008, SOIL BIOL BIOCHEM, V40, P1741, DOI 10.1016/j.soilbio.2008.02.014; TAKAHASHI Y, 1991, SOIL SCI PLANT NUTR, V37, P223, DOI 10.1080/00380768.1991.10415032; Teasdale JR, 2007, AGRON J, V99, P1297, DOI 10.2134/agronj2006.0362; Thorup-Kristensen K, 2003, ADV AGRON, V79, P227, DOI 10.1016/S0065-2113(02)79005-6; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Ugarte CM, 2014, J SOIL WATER CONSERV, V69, P422, DOI 10.2489/jswc.69.5.422; Ugarte CM, 2013, SOIL BIOL BIOCHEM, V64, P103, DOI 10.1016/j.soilbio.2013.03.035; Ugarte CM, 2013, RENEW AGR FOOD SYST, V28, P17, DOI 10.1017/S1742170511000573; Wander Michelle, 2009, P137; Yoo G, 2008, SOIL SCI SOC AM J, V72, P670, DOI 10.2136/sssaj2007.0110; Yoo GY, 2006, J ENVIRON QUAL, V35, P1576, DOI 10.2134/jeq2005.0225; Yu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126293	66	25	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0164209	10.1371/journal.pone.0164209	http://dx.doi.org/10.1371/journal.pone.0164209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792744	Green Published, Green Submitted, gold			2022-12-26	WOS:000389537000006
J	Lemaire, L; Nel, J; Franconi, F; Bastiat, G; Saulnier, P				Lemaire, Laurent; Nel, Janske; Franconi, Florence; Bastiat, Guillaume; Saulnier, Patrick			Perfluorocarbon-Loaded Lipid Nanocapsules to Assess the Dependence of U87-Human Glioblastoma Tumor pO(2) on In Vitro Expansion Conditions	PLoS One			English	Article							OXYGEN-TENSION; VIVO; HYPOXIA; CELLS; METABOLISM; PHENOTYPE; PERFUSION; OXIMETRY; THERAPY; CULTURE	Growing tumor cell lines, such as U87-MG glioma cells, under mild hypoxia (3% O-2) leads to a ca. 40% reduction in growth rate once implanted in the brain of nude mice, as compared to normoxia (21% O-2) grown cells, wherein the former over-express HIF-1 and VEGF-A. Despite developing differently, the tumors have similar: blood perfusion, oxygen consumption, and vascular surface area parameters, whereas the number of blood vessels is nearly doubled in the tumor arising from normoxia cultured cells. Interestingly, tumor oxygen tension, measured using F-19-oximetry, showed that the normoxia grown cells led to tumors characterized by mild hypoxic environment (approximately 4%) conditions, whilst the hypoxia grown cells led to tumors characterized by physioxic environment (approximately 6%) conditions. This reversal in oxygen concentration may be responsible for the apparent paradoxical growth profiles.	[Lemaire, Laurent; Nel, Janske; Bastiat, Guillaume; Saulnier, Patrick] INSERM, Micro & Nanomed Biomimet MINT U1066, Angers, France; [Lemaire, Laurent; Nel, Janske; Bastiat, Guillaume; Saulnier, Patrick] Univ Angers, UMR S1066, Angers, France; [Franconi, Florence] Univ Angers, PRIMEX IRM, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Universite d'Angers	Lemaire, L (corresponding author), INSERM, Micro & Nanomed Biomimet MINT U1066, Angers, France.; Lemaire, L (corresponding author), Univ Angers, UMR S1066, Angers, France.	laurent.lemaire@univ-angers.fr	LEMAIRE, Laurent/A-3100-2011; FRANCONI, Florence/K-4258-2015	LEMAIRE, Laurent/0000-0002-1308-9345; FRANCONI, Florence/0000-0001-6725-0803; Bastiat, Guillaume/0000-0001-6495-6747; Saulnier, Patrick/0000-0002-6408-3533	Comite Inter-Regional Grand Ouest de La Ligue Contre le Cancer (CIRGO)	Comite Inter-Regional Grand Ouest de La Ligue Contre le Cancer (CIRGO)	This work was supported by 'Comite Inter-Regional Grand Ouest de La Ligue Contre le Cancer' (CIRGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2014, NEUROL RES, V36, P1001, DOI 10.1179/1743132814Y.0000000401; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Bourke VA, 2007, INT J RADIAT ONCOL, V67, P1179, DOI 10.1016/j.ijrobp.2006.11.037; Bourseau-Guilmain E, 2012, INT J ONCOL, V40, P1220, DOI 10.3892/ijo.2011.1271; Bruning U, 2012, CELL MOL LIFE SCI, V69, P1319, DOI 10.1007/s00018-011-0876-2; Christen T, 2011, NMR BIOMED, V24, P393, DOI 10.1002/nbm.1603; Clavreul A, 2014, J PATHOL, V233, P74, DOI 10.1002/path.4332; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; Diepart C, 2011, NMR BIOMED, V24, P458, DOI 10.1002/nbm.1604; Diepart C, 2009, RADIAT RES, V172, P220, DOI 10.1667/RR1448.1; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Franconi F, 2010, MED PHYS, V37, P877, DOI 10.1118/1.3298019; Grimes DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153692; Heurtault B, 2002, PHARMACEUT RES, V19, P875, DOI 10.1023/A:1016121319668; Hou HG, 2015, INT J CANCER, V136, P1688, DOI 10.1002/ijc.29132; Hwang SH, 2015, J NUCL MED, V56; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; KALLINOWSKI F, 1989, CANCER RES, V49, P3759; Kathagen A, 2013, ACTA NEUROPATHOL, V126, P763, DOI 10.1007/s00401-013-1173-y; Kober F, 2004, MAGN RESON MED, V51, P62, DOI 10.1002/mrm.10676; Kucharzewska P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116740; Lemaire L, 2013, EUR J PHARM BIOPHARM, V84, P479, DOI 10.1016/j.ejpb.2013.01.003; Lemaire L, 2000, NMR BIOMED, V13, P116, DOI 10.1002/1099-1492(200005)13:3<116::AID-NBM616>3.0.CO;2-D; Lemaire L, 2015, TUMOUR BIOL; Lemasson B, 2011, NMR BIOMED, V24, P473, DOI 10.1002/nbm.1611; Mesti T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099198; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sullivan M, 2006, MOL HUM REPROD, V12, P653, DOI 10.1093/molehr/gal081; Wion D, 2009, CELL STEM CELL, V5, P242, DOI 10.1016/j.stem.2009.08.009	31	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165479	10.1371/journal.pone.0165479	http://dx.doi.org/10.1371/journal.pone.0165479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788227	Green Published, gold			2022-12-26	WOS:000389604900092
J	Mirali, M; Purves, RW; Stonehouse, R; Song, R; Bett, K; Vandenberg, A				Mirali, Mahla; Purves, Randy W.; Stonehouse, Rob; Song, Rui; Bett, Kirstin; Vandenberg, Albert			Genetics and Biochemistry of Zero-Tannin Lentils	PLOS ONE			English	Article							SEED COAT; PHENOLIC-COMPOUNDS; MASS-SPECTROMETRY; BIOSYNTHESIS; ANTHOCYANIN; PIGMENTATION; PROCYANIDIN; VEGETABLES	The zero-tannin trait in lentil is controlled by a single recessive gene (tan) that results in a phenotype characterized by green stems, white flowers, and thin, transparent, or translucent seed coats. Genes that result in zero-tannin characteristics are useful for studies of seed coat pigmentation and biochemical characters because they have altered pigmentation. In this study, one of the major groups of plant pigments, phenolic compounds, was compared among zero-tannin and normal phenotypes and genotypes of lentil. Biochemical data were obtained by liquid chromatography-mass spectrometry (LC-MS). Genomic sequencing was used to identify a candidate gene for the tan locus. Phenolic compound profiling revealed that myricetin, dihydromyricetin, flavan-3-ols, and proanthocyanidins are only detected in normal lentil phenotypes and not in zero-tannin types. The molecular analysis showed that the tan gene encodes a bHLH transcription factor, homologous to the A gene in pea. The results of this study suggest that tan as a bHLH transcription factor interacts with the regulatory genes in the biochemical pathway of phenolic compounds starting from flavonoid-3', 5'-hydroxylase (F3'5'H) and dihydroflavonol reductase (DFR).	[Mirali, Mahla; Purves, Randy W.; Stonehouse, Rob; Song, Rui; Bett, Kirstin; Vandenberg, Albert] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Song, Rui] MIT, Dept Elect Engn & Comp Sci, Dept Biol, Cambridge, MA 02139 USA	University of Saskatchewan; Massachusetts Institute of Technology (MIT)	Mirali, M (corresponding author), Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada.	mam194@mail.usask.ca			Saskatchewan Pulse Growers; NSERC Industrial Research Chair program	Saskatchewan Pulse Growers; NSERC Industrial Research Chair program(Canada Research Chairs)	The authors acknowledge financial assistance from Saskatchewan Pulse Growers and the NSERC Industrial Research Chair program as well as instrumentation provided by Thermo Fisher Scientific (San Jose, CA). We also acknowledge additional support provided by the Health Sciences core mass spectrometry facility and the Pulse Research Crew at the Crop Development Centre, University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge financial assistance from Saskatchewan Pulse Growers and the NSERC Industrial Research Chair program as well as instrumentation provided by Thermo Fisher Scientific (San Jose, CA). We also acknowledge additional support provided by the Health Sciences core mass spectrometryfacility and the Pulse Research Crew at the Crop Development Centre, University of Saskatchewan. We would like to particularly thank R. Varma Penmetsa for initially pointing us towards the gene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera Y, 2010, J AGR FOOD CHEM, V58, P10101, DOI 10.1021/jf102222t; Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; Andersen OM, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 3: DEVELOPMENT & MODIFICATION OF BIOACTIVITY, P547; Appelhagen I, 2011, GENE, V484, P62, DOI 10.1016/j.gene.2011.05.031; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Delgado-Vargas F, 2000, CRIT REV FOOD SCI, V40, P173, DOI 10.1080/10408690091189257; DellaValle DM, 2013, J AGR FOOD CHEM, V61, P8084, DOI 10.1021/jf4022916; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duenas M, 2003, J AGR FOOD CHEM, V51, P7999, DOI 10.1021/jf0303215; Duenas M, 2002, EUR FOOD RES TECHNOL, V215, P478, DOI 10.1007/s00217-002-0603-1; Gallery RE, 2010, J ECOL, V98, P147, DOI 10.1111/j.1365-2745.2009.01589.x; Gonzalez R, 2011, CRIT REV FOOD SCI, V51, P331, DOI 10.1080/10408390903584094; Grignon-Dubois Micheline, 2012, Plants (Basel), V1, P27, DOI 10.3390/plants1010027; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hart JJ, 2015, J AGR FOOD CHEM, V63, P5950, DOI 10.1021/acs.jafc.5b00531; Hellens RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013230; Kaushik P, 2015, MOLECULES, V20, P18464, DOI 10.3390/molecules201018464; Lei YF, 2014, J FUNCT FOODS, V7, P416, DOI 10.1016/j.jff.2014.01.016; Lei ZT, 2011, J BIOL CHEM, V286, P25435, DOI 10.1074/jbc.R111.238691; Li PH, 2016, NEW PHYTOL, V210, P905, DOI 10.1111/nph.13816; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044145; Lopez-Amoros ML, 2006, J FOOD COMPOS ANAL, V19, P277, DOI 10.1016/j.jfca.2004.06.012; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Marles MAS, 2003, PHYTOCHEMISTRY, V62, P663, DOI 10.1016/S0031-9422(02)00488-0; Matus A, 1993, NEW CROPS, P279; Matus A, 1993, LENS NEWSLETTER, V20, P46; Mendel JG., 1865, VERHANDLUNGEN NATURF, V4, P3, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A106151; Mirali M, 2016, EUR FOOD RE IN PRESS; Mirali M, 2014, J CHROMATOGR B, V969, P149, DOI 10.1016/j.jchromb.2014.08.007; Muehlbauer F, 2011, GRAIN LEGUMES, V56; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; Ramljak D, 2005, MOL CANCER THER, V4, P537, DOI 10.1158/1535-7163.MCT-04-0286; Randhir R, 2003, PROCESS BIOCHEM, V38, P945, DOI 10.1016/S0032-9592(02)00219-4; Sharpe AG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-192; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; Smykal P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00351; Spilioti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094860; Toh JY, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0368-y; VAILLANCOURT R, 1986, CAN J PLANT SCI, V66, P241, DOI 10.4141/cjps86-038; VANDENBERG A, 1990, J HERED, V81, P484, DOI 10.1093/oxfordjournals.jhered.a111030; Vermeris W., 2006, PHENOLIC COMPOUND BI; Welch CR, 2008, CURR ANAL CHEM, V4, P75, DOI 10.2174/157341108784587795; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xiao J., 2014, BIOTECHNOL ADV; Xu BJ, 2010, J AGR FOOD CHEM, V58, P1509, DOI 10.1021/jf903532y; Zhang B, 2015, FOOD CHEM, V172, P862, DOI 10.1016/j.foodchem.2014.09.144	47	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164624	10.1371/journal.pone.0164624	http://dx.doi.org/10.1371/journal.pone.0164624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788158	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900024
J	Silva, CO; Petersen, SB; Reis, CP; Rijo, P; Molpeceres, J; Fernandes, AS; Goncalves, O; Gomes, AC; Correia, I; Vorum, H; Neves-Petersen, MT				Silva, Catarina Oliveira; Petersen, Steffen B.; Reis, Catarina Pinto; Rijo, Patricia; Molpeceres, Jesus; Fernandes, Ana Sofia; Goncalves, Odete; Gomes, Andreia C.; Correia, Isabel; Vorum, Henrik; Neves-Petersen, Maria Teresa			EGF Functionalized Polymer-Coated Gold Nanoparticles Promote EGF Photostability and EGFR Internalization for Photothermal Therapy	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HYALURONIC-ACID; N-FORMYLKYNURENINE; CELL UPTAKE; PROTEIN; FLUORESCENCE; TRYPTOPHAN; DITYROSINE; OXIDATION; IDENTIFICATION	The application of functionalized nanocarriers on photothermal therapy for cancer ablation has wide interest. The success of this application depends on the therapeutic efficiency and biocompatibility of the system, but also on the stability and biorecognition of the conjugated protein. This study aims at investigating the hypothesis that EGF functionalized polymer -coated gold nanoparticles promote EGF photostability and EGFR internalization, making these conjugated particles suitable for photothermal therapy. The conjugated gold nanoparticles (100-200 nm) showed a plasmon absorption band located within the near infrared range (650-900 nm), optimal for photothermal therapy applications. The effects of temperature, of polymer-coated gold nanoparticles and of UVB light (295nm) on the fluorescence properties of EGF have been investigated with steady-state and time-resolved fluorescence spectroscopy. The fluorescence properties of EGF, including the formation of Trp and Tyr photoproducts, is modulated by temperature and by the intensity of the excitation light. The presence of polymeric-coated gold nanoparticles reduced or even avoided the formation of Trp and Tyr photoproducts when EGF is exposed to UVB light, protecting this way the structure and function of EGF. Cytotoxicity studies of conjugated nanoparticles carried out in normal-like human keratinocytes showed small, concentration dependent decreases in cell viability (0-25%). Moreover, conjugated nanoparticles could activate and induce the internalization of overexpressed Epidermal Growth Factor Receptor in human lung carcinoma cells. In conclusion, the gold nanoparticles conjugated with Epidermal Growth Factor and coated with biopolymers developed in this work, show a potential application for near infrared photothermal therapy, which may efficiently destroy solid tumours, reducing the damage of the healthy tissue.	[Silva, Catarina Oliveira; Reis, Catarina Pinto; Rijo, Patricia; Fernandes, Ana Sofia] Univ Lusofona, Res Ctr Biosci & Hlth Technol, Lisbon, Portugal; [Silva, Catarina Oliveira; Molpeceres, Jesus] Univ Alcala, Dept Biomed Sci, Fac Pharm, Alcala De Henares, Spain; [Petersen, Steffen B.; Goncalves, Odete] Aalborg Univ, Dept Hlth Sci & Technol, Med Photon Lab, Fac Med, Aalborg, Denmark; [Reis, Catarina Pinto] Univ Lisbon, IBEB, Biophys & Biomed Engn, Fac Sci, Lisbon, Portugal; [Rijo, Patricia; Fernandes, Ana Sofia] Univ Lisbon, Inst Invest Medicamento, IMed ULisboa, Fac Farm, Lisbon, Portugal; [Goncalves, Odete; Gomes, Andreia C.] Univ Minho, CBMA Ctr Mol & Environm Biol, Campus Gualtar, Braga, Portugal; [Goncalves, Odete] Univ Minho, Dept Phys, CFUM Ctr Phys, Campus Gualtar, Braga, Portugal; [Correia, Isabel] Univ Lisbon, Inst Super Tecn, Ctr Quim Estrutural, Lisbon, Portugal; [Vorum, Henrik] Aalborg Univ Hosp, Dept Ophthalmol, Aalborg, Denmark; [Neves-Petersen, Maria Teresa] Aalborg Univ Hosp, Dept Clin Med, Aalborg, Denmark	Lusofona University; Universidad de Alcala; Aalborg University; Universidade de Lisboa; Universidade de Lisboa; Universidade do Minho; Universidade do Minho; Universidade de Lisboa; Instituto Superior Tecnico; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital	Reis, CP (corresponding author), Univ Lusofona, Res Ctr Biosci & Hlth Technol, Lisbon, Portugal.; Reis, CP (corresponding author), Univ Lisbon, IBEB, Biophys & Biomed Engn, Fac Sci, Lisbon, Portugal.; Neves-Petersen, MT (corresponding author), Aalborg Univ Hosp, Dept Clin Med, Aalborg, Denmark.	catarinapintoreis@ulusofona.pt; nevespetersen@gmail.com	Fernandes, Ana S./H-4789-2013; Gomes, Andreia/AAC-9198-2020; iMed.ULisboa, NatProdChem/B-5387-2014; Rijo, Patrícia/O-2657-2015; Gomes, Andreia C/B-5905-2009; Reis, Catarina/M-8132-2013; /Y-9512-2019; Correia, Isabel/H-7772-2012; Silva, Catarina/AAV-8108-2020; Correia, Isabel/AAH-6847-2021; iMed.ULisboa, NanoBB/B-5393-2014	Fernandes, Ana S./0000-0001-6350-0641; Gomes, Andreia/0000-0002-0567-064X; Rijo, Patrícia/0000-0001-7992-8343; Gomes, Andreia C/0000-0002-0567-064X; Reis, Catarina/0000-0002-1046-4031; /0000-0003-4201-0795; Correia, Isabel/0000-0001-7096-4284; Correia, Isabel/0000-0001-7096-4284; Neves-Petersen, Maria Teresa/0000-0003-3178-3709; Oliveira Silva, Catarina/0000-0002-5077-5176	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BBB-BMC/0611/2012]; FCT I.P. [UID/BIA/04050/2013 (POCI-01-0145-FEDER-007569)]; ERDF; European Commission [H2020-644242-SAPHELY, H2020-634013-2-PHOCNOSIS]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT I.P.; ERDF(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	Support was provided by: Fundacao para a Ciencia e Tecnologia (FCT) for the financial support under the project reference PTDC/BBB-BMC/0611/2012 [https://www.fct.pt/apoios/projectos)]. The work at CBMA was supported by the strategic programme UID/BIA/04050/2013 (POCI-01-0145-FEDER-007569) funded by national funds through the FCT I.P. and by the ERDF through the COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI) [https://www.fct.pt/apoios/projectos]; European Commission through the project H2020-644242-SAPHELY (https://saphely.eu/project.php) and the project H2020-634013-2-PHOCNOSIS [http://cordis.europa.eu/project/rcn/193268_en.html].; The authors would like to thank Fundacao para a Ciencia e Tecnologia (FCT) for the financial support under the project reference PTDC/BBB-BMC/0611/2012. The work at CBMA was supported by the strategic programme UID/BIA/04050/2013 (POCI-01-0145-FEDER-007569) funded by national funds through the FCT I.P. and by the ERDF through the COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI). The authors acknowledge the funding from the European Commission through the project H2020-644242-SAPHELY and the project H2020-634013-2-PHOCNOSIS. Finally, the authors would also like to thank the master student Joao Lopes from Universidade Lusofona (Portugal) for the help with in vitro cytotoxic assays. Isabel Correia acknowledges FCT for Investigator FCT contract.	Antczak C, 2012, ASSAY DRUG DEV TECHN, V10, P24, DOI 10.1089/adt.2011.423; Avanti C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086244; BAYSE GS, 1972, BIOCHIM BIOPHYS ACTA, V284, P34; Bracher A, 2013, J INVEST DERMATOL, V133, P230, DOI 10.1038/jid.2012.272; CHAKRABA.B, 1973, J MOL BIOL, V78, P135, DOI 10.1016/0022-2836(73)90433-6; Chevrier DM, 2012, J NANOPHOTONICS, V6, DOI 10.1117/1.JNP.6.064504; Correia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116737; Correia M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111617; Correia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050733; Correia M, 2012, J FLUORESC, V22, P323, DOI 10.1007/s10895-011-0963-7; Creixell M, 2010, J MAGN MAGN MATER, V322, P2244, DOI 10.1016/j.jmmm.2010.02.019; Delehanty JB, 2010, THER DELIV, V1, P411, DOI 10.4155/TDE.10.27; Dreaden TM, 2011, J BIOL CHEM, V286, P22632, DOI 10.1074/jbc.M110.212928; Ferguson EL, 2010, INT J PHARMACEUT, V402, P95, DOI 10.1016/j.ijpharm.2010.09.029; FUKUNAGA Y, 1982, J BIOCHEM-TOKYO, V92, P129, DOI 10.1093/oxfordjournals.jbchem.a133909; Geerlof A, 2006, ACTA CRYSTALLOGR D, V62, P1125, DOI 10.1107/S0907444906030307; Han Q, 2012, BIOCHEM J, V446, P253, DOI 10.1042/BJ20120416; HOLLADAY LA, 1976, BIOCHEMISTRY-US, V15, P2624, DOI 10.1021/bi00657a023; Jacob JS, 1996, J BIOL CHEM, V271, P19950, DOI 10.1074/jbc.271.33.19950; Kennedy LC, 2011, SMALL, V7, P169, DOI 10.1002/smll.201000134; Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Lim J, 2014, ARCH PHARM RES, P1; Liu Y, 2014, MACROMOL RES, V22, P240, DOI 10.1007/s13233-014-2001-5; Lu W, 2009, CLIN CANCER RES, V15, P876, DOI 10.1158/1078-0432.CCR-08-1480; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; Master AM, 2012, NANOMEDICINE-UK, V7, P1895, DOI [10.2217/NNM.12.160, 10.2217/nnm.12.160]; MATRISIAN LM, 1984, J BIOL CHEM, V259, P3047; MEHLER AH, 1950, J BIOL CHEM, V187, P431; Merkus HG, PARTICLE SIZE MEASUR; Minati L, 2012, INT J PHARMACEUT, V438, P45, DOI 10.1016/j.ijpharm.2012.08.057; Murphy CJ, 2005, J PHYS CHEM B, V109, P13857, DOI 10.1021/jp0516846; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Neves-Petersen MT, 2010, J FLUORESC, V20, P483, DOI 10.1007/s10895-009-0570-z; Neves-Petersen MT, 2009, BIOPHYS J, V97, P211, DOI 10.1016/j.bpj.2009.01.065; Neves-Petersen MT, 2006, PROTEIN SCI, V15, P343, DOI 10.1110/ps.051885306; Neves-Petersen MT, 2002, PROTEIN SCI, V11, P588, DOI 10.1110/ps.06002; Neves-Petersen MT, UV LIGHT EFFECTS PRO; PIRIE A, 1972, BIOCHEM J, V128, P1365, DOI 10.1042/bj1281365; PRYOR WA, 1993, J BIOL CHEM, V268, P3120; Qhattal HSS, 2011, MOL PHARMACEUT, V8, P1233, DOI 10.1021/mp2000428; Rijo P, 2013, BIOMED BIOPHARM RES, V9, P225; Rijo P, 2014, MEASUREMENT, V58, P249, DOI 10.1016/j.measurement.2014.08.045; Ryu JH, 2013, BIOMATERIALS, V34, P9149, DOI 10.1016/j.biomaterials.2013.08.026; Salminen H, 2009, EFFECT PHENOLIC RICH; Salminen H, 2008, J AGR FOOD CHEM, V56, P11178, DOI 10.1021/jf8022673; Santana H, 2013, INT J PHARMACEUT, V452, P52, DOI 10.1016/j.ijpharm.2013.04.054; Shen LY, 2012, J COLLOID INTERF SCI, V388, P56, DOI 10.1016/j.jcis.2012.06.079; Shimada T, 2009, ANTICANCER RES, V29, P1009; Silva CO, 2016, THER DELIV, V7, P287, DOI 10.4155/tde-2015-0011; Silva CO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144454; Silva CO, 2015, INT J PHARMACEUT, V493, P271, DOI 10.1016/j.ijpharm.2015.07.044; Su ZC, 2014, MAT SCI ENG C-MATER, V44, P440, DOI 10.1016/j.msec.2014.07.039; TAYLOR JM, 1974, J BIOL CHEM, V249, P2188; TEDER P, 1995, CANCER RES, V55, P3908; Wang MJ, 2013, BBA-MOL CELL BIOL L, V1831, P1089, DOI 10.1016/j.bbalip.2013.01.018; Water JJ, 2014, EUR J PHARM BIOPHARM, V88, P325, DOI 10.1016/j.ejpb.2014.09.001; Yang CH, 2004, J BIOMOL STRUCT DYN, V22, P101, DOI 10.1080/07391102.2004.10506985; Yang F, 2006, BBA-PROTEINS PROTEOM, V1764, P1389, DOI 10.1016/j.bbapap.2006.06.012; Zhang SY, 2014, ACS APPL MATER INTER, V6, P21184, DOI 10.1021/am506112u; Zhang ZH, 2010, SMALL, V6, P430, DOI 10.1002/smll.200901515	62	29	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165419	10.1371/journal.pone.0165419	http://dx.doi.org/10.1371/journal.pone.0165419			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788212	Green Published, gold			2022-12-26	WOS:000389604900079
J	Watson, JT; Haynie, AC				Watson, Jordan T.; Haynie, Alan C.			Using Vessel Monitoring System Data to Identify and Characterize Trips Made by Fishing Vessels in the United States North Pacific	PLOS ONE			English	Article							POSITIONAL DATA; CLIMATE-CHANGE; FISHERY; LOCATION; PATTERNS; LANDINGS; LOGBOOK; FUTURE; RISK	Time spent fishing is the effort metric often studied in fisheries but it may under-represent the effort actually expended by fishers. Entire fishing trips, from the time vessels leave port until they return, may prove more useful for examining trends in fleet dynamics, fisher behavior, and fishing costs. However, such trip information is often difficult to resolve. We identified similar to 30,000 trips made by vessels that targeted walleye pollock (Gadus chalcogrammus) in the Eastern Bering Sea from 2008 - 2014 by using vessel monitoring system (VMS) and landings data. We compared estimated trip durations to observer data, which were available for approximately half of trips. Total days at sea were estimated with < 1.5% error and 96.4% of trip durations were either estimated with < 5% error or they were within expected measurement error. With 99% accuracy, we classified trips as fishing for pollock, for another target species, or not fishing. This accuracy lends strong support to the use of our method with unobserved trips across North Pacific fisheries. With individual trips resolved, we examined potential errors in datasets which are often viewed as " the truth." Despite having > 5 million VMS records (timestamps and vessel locations), this study was as much about understanding and managing data errors as it was about characterizing trips. Missing VMS records were pervasive and they strongly influenced our approach. To understand implications of missing data on inference, we simulated removal of VMS records from trips. Removal of records straightened (i. e., shortened) vessel trajectories, and travel distances were underestimated, on average, by 1.5 - 13.4% per trip. Despite this bias, VMS proved robust for trip characterization and for improved quality control of human-recorded data. Our scrutiny of human-reported and VMS data advanced our understanding of the potential utility and challenges facing VMS users globally.	[Watson, Jordan T.] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Auke Bay Labs, Juneau, AK 99801 USA; [Watson, Jordan T.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK 99801 USA; [Haynie, Alan C.] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Resource Ecol & Fisheries Management Div, Seattle, WA 98115 USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; National Oceanic Atmospheric Admin (NOAA) - USA	Watson, JT (corresponding author), NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Auke Bay Labs, Juneau, AK 99801 USA.; Watson, JT (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK 99801 USA.	jordan.watson@noaa.gov	Watson, Jordan/U-9798-2019	Watson, Jordan/0000-0002-1686-0377	NOM Fisheries Science and Technology through the Spatial Economics Toolbox for Fisheries (FishSET) Project; North Pacific Research Board Bering Sea Integrated Ecosystem Research Program; Alaska Sea Grant [R/112-04]	NOM Fisheries Science and Technology through the Spatial Economics Toolbox for Fisheries (FishSET) Project; North Pacific Research Board Bering Sea Integrated Ecosystem Research Program; Alaska Sea Grant	Funding for this project came from NOM Fisheries Science and Technology through the Spatial Economics Toolbox for Fisheries (FishSET) Project, the North Pacific Research Board Bering Sea Integrated Ecosystem Research Program (www.nprb.org/bering-sea-project), and Alaska Sea Grant R/112-04 (www.seagrant.uaf.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KE, 2010, ICES J MAR SCI, V67, P1076, DOI 10.1093/icesjms/fsp289; AFSC (Alaska Fisheries Science Center), 2016, N PAC GROUNDF OBS PR; Alaska Department of Fish and Game and (CFEC) Alaska Commercial Fisheries Entry Commission, 2015, AL FISH TICK DAT; Bastardie F, 2010, FISH RES, V106, P41, DOI 10.1016/j.fishres.2010.06.016; Chang SK, 2014, CAN J FISH AQUAT SCI, V71, P1363, DOI 10.1139/cjfas-2013-0552; Criddle KR, 2013, MAR POLICY, V40, P91, DOI 10.1016/j.marpol.2013.01.006; Deng R, 2005, CAN J FISH AQUAT SCI, V62, P611, DOI 10.1139/F04-219; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Fissel B, 2015, STOCK ASSESS MENT FI; Haynie AC, 2013, CAN J FISH AQUAT SCI, V70, P841, DOI 10.1139/cjfas-2012-0265; Haynie AC, 2010, J ENVIRON ECON MANAG, V59, P165, DOI 10.1016/j.jeem.2009.11.001; Hintzen NT, 2012, FISH RES, V115, P31, DOI 10.1016/j.fishres.2011.11.007; Hintzen NT, 2010, FISH RES, V101, P108, DOI 10.1016/j.fishres.2009.09.014; Hollowed AB, 2013, ICES J MAR SCI, V70, P1023, DOI 10.1093/icesjms/fst081; Jennings S, 2012, ICES J MAR SCI, V69, P51, DOI 10.1093/icesjms/fsr173; Joo R, 2014, PROG OCEANOGR, V128, P60, DOI 10.1016/j.pocean.2014.08.009; Joo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071246; Kasperski S, 2013, P NATL ACAD SCI USA, V110, P2076, DOI 10.1073/pnas.1212278110; Kotwicki S, 2013, DEEP-SEA RES PT II, V94, P231, DOI 10.1016/j.dsr2.2013.03.017; Last P, 2014, J NAVIGATION, V67, P791, DOI 10.1017/S0373463314000253; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; Marchal P, 2008, ICES J MAR SCI, V65, P674, DOI 10.1093/icesjms/fsn044; Mills CM, 2007, ICES J MAR SCI, V64, P248, DOI 10.1093/icesjms/fsl026; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; NOAA Alaska Fisheries Science Center, 2016, N PAC NORPAC GROUNDF; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Palmer MC, 2008, FISH RES, V89, P57, DOI 10.1016/j.fishres.2007.09.001; Palmer MC, 2009, N AM J FISH MANAGE, V29, P928, DOI 10.1577/M08-135.1; Postlethwaite CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057640; R Core Team, 2013, R LANG ENV STAT COMP; Renner M, 2015, MAR POLLUT BULL, V101, P127, DOI 10.1016/j.marpolbul.2015.11.007; Russo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100195; Russo T, 2011, FISH RES, V108, P184, DOI 10.1016/j.fishres.2010.12.020; Stelzenmuller V, 2008, ICES J MAR SCI, V65, P1081, DOI 10.1093/icesjms/fsn073; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	35	23	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165173	10.1371/journal.pone.0165173	http://dx.doi.org/10.1371/journal.pone.0165173			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788174	gold, Green Submitted, Green Published			2022-12-26	WOS:000389604900050
J	Kasnakoglu, C				Kasnakoglu, Cosku			Investigation of Multi-Input Multi-Output Robust Control Methods to Handle Parametric Uncertainties in Autopilot Design	PLOS ONE			English	Article							H-INFINITY CONTROL; FLIGHT CONTROL; SYSTEM; LAW	Some level of uncertainty is unavoidable in acquiring the mass, geometry parameters and stability derivatives of an aerial vehicle. In certain instances tiny perturbations of these could potentially cause considerable variations in flight characteristics. This research considers the impact of varying these parameters altogether. This is a generalization of examining the effects of particular parameters on selected modes present in existing literature. Conventional autopilot designs commonly assume that each flight channel is independent and develop single-input single-output (SISO) controllers for every one, that are utilized in parallel for actual flight. It is demonstrated that an attitude controller built like this can function flawlessly on separate nominal cases, but can become unstable with a perturbation no more than 2%. Two robust multi-input multi-output (MIMO) design strategies, specifically loop-shaping and mu-synthesis are outlined as potential substitutes and are observed to handle large parametric changes of 30% while preserving decent performance. Duplicating the loop-shaping procedure for the outer loop, a complete flight control system is formed. It is confirmed through software-in-the-loop (SIL) verifications utilizing blade element theory (BET) that the autopilot is capable of navigation and landing exposed to high parametric variations and powerful winds.	[Kasnakoglu, Cosku] TOBB Univ Econ & Technol, Dept Elect & Elect Engn, Ankara, Turkey	TOBB Ekonomi ve Teknoloji University	Kasnakoglu, C (corresponding author), TOBB Univ Econ & Technol, Dept Elect & Elect Engn, Ankara, Turkey.	kasnakoglu@etu.edu.tr		Kasnakoglu, Cosku/0000-0002-9928-727X	Scientific and Technological Research Council of Turkey (TUBITAK) [113E581]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This research was funded by The Scientific and Technological Research Council of Turkey (TUBITAK) under project 113E581.r The author thanks The Scientific and Technological Research Council of Turkey (TUBITAK) for funding this research under project 113E581 as well as the members of the TOBB ETU UAV Laboratory for their valuable contributions.	Ahmad SM, 2001, P I MECH ENG G-J AER, V215, P63, DOI 10.1243/0954410011531772; Akyurek S, 2016, IFAC PAPERSONLINE, V49, P117, DOI 10.1016/j.ifacol.2016.07.509; Akyurek S, 2016, IFAC PAPERSONLINE, V49, P111, DOI 10.1016/j.ifacol.2016.07.507; Akyurek S, 2015, 2015 9TH INTERNATIONAL CONFERENCE ON ELECTRICAL AND ELECTRONICS ENGINEERING (ELECO), P790, DOI 10.1109/ELECO.2015.7394579; [Anonymous], 1996, ROBUST OPTIMAL CONTR; ATHANS M, 1977, IEEE T AUTOMAT CONTR, V22, P768, DOI 10.1109/TAC.1977.1101599; Atlas Emre, 2015, Applied Mechanics and Materials, V789-790, P681, DOI 10.4028/www.scientific.net/AMM.789-790.681; Basri MAM, 2014, T I MEAS CONTROL, V1; Blakelock JH, 1991, AUTOMATIC CONTROL AI; Bruyere L, 2003, P AIAA GUID NAV CONT; Burton T, 2001, WIND ENERGY HDB; Calise AJ, 2001, J GUID CONTROL DYNAM, V24, P896, DOI 10.2514/2.4825; Chabot D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122588; Chao HY, 2010, INT J CONTROL AUTOM, V8, P36, DOI [10.1007/s12555-010-0105-z, 10.1007/S12555-010-0105-z]; CHEN MJ, 1982, INT J CONTROL, V35, P255, DOI 10.1080/00207178208922617; CHIEN IL, 1990, CHEM ENG PROG, V86, P33; Choi B, 2012, AEROSP SCI TECHNOL, V23, P270, DOI 10.1016/j.ast.2011.08.002; de Voogt AJ, 2009, AVIAT SPACE ENVIR MD, V80, P732, DOI 10.3357/ASEM.2521.2009; Doyle J. C., 1985, Proceedings of the 24th IEEE Conference on Decision and Control (Cat. No.85CH2245-9), P260; DOYLE JC, 1989, IEEE T AUTOMAT CONTR, V34, P831, DOI 10.1109/9.29425; Du RL, 2015, AEROSP SCI TECHNOL, V46, P168, DOI 10.1016/j.ast.2015.07.010; Efe MO, 2011, T I MEAS CONTROL, V33, P985, DOI 10.1177/0142331210377227; Ertin OB, 2013, 32 IASTED INT C MOD; Etkin B., 1996, DYNAMICS FLIGHT STAB, V3rd; Federal Aviation Administration, 2008, FLIGHT SIM TRAIN 60; Fletcher R., 1987, PRACTICAL METHODS OP; Gao MZ, 2016, INT J CONTROL AUTOM, V14, P198, DOI 10.1007/s12555-014-0457-x; Gill SJ, 2015, J GUID CONTROL DYNAM, V38, P2301, DOI 10.2514/1.G000966; GLOVER K, 1989, IEEE T AUTOMAT CONTR, V34, P821, DOI 10.1109/9.29424; Goodarzi FA, 2015, INT J CONTROL AUTOM, V13, P1486, DOI 10.1007/s12555-014-0304-0; HO WK, 1995, IEEE T CONTR SYST T, V3, P245, DOI 10.1109/87.388135; Ingram G., 2005, WIND TURBINE BLADE A; Joint Aviation Authorities, 2003, JOINT AV REQ JAR STD, V3; Kang S, 2009, J GUID CONTROL DYNAM, V32, P1622, DOI 10.2514/1.39812; Karagiannis D, 2010, P I MECH ENG G-J AER, V224, P403, DOI 10.1243/09544100JAERO571; Kasnakoglu C, 2010, AIAA GUID NAV CONTR; Kasnakoglu C., 2016, TRANSACTAKYUREK2016D; Kaynak U, 2016, INT J MECH ENG ROBOT, V5, P77, DOI [10.18178/ijmerr.5.1.77-81, DOI 10.18178/IJMERR.5.1.77-81]; Kaynak U, 2010, INT UNM VEH WORKSH U; Korkmaz H, 2013, IFAC WORKSH ADV CONT; Lawrence DA, 2008, J GUID CONTROL DYNAM, V31, P1220, DOI 10.2514/1.34896; LE VX, 1992, IEEE T AUTOMAT CONTR, V37, P384, DOI 10.1109/9.119644; Leisher L, 1957, STABILITY DERIVATIVE, P7; Liu H, 2014, J INTELL ROBOT SYST, V73, P197, DOI 10.1007/s10846-013-9916-5; Liu XG, 2016, T I MEAS CONTROL, V38, P693, DOI 10.1177/0142331215603793; Lykins R., P AIAA PAP 2011 6443, DOI [10.2514/6.2011-6443, DOI 10.2514/6.2011-6443]; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038882; Mendez-Vergara F, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/906367; Murillo MH, 2015, INT J CONTROL AUTOM, V13, P361, DOI 10.1007/s12555-013-0416-y; Nae C., 2010, INCAS B, V2, P37, DOI 10.13111/2066-8201; Nelson R.C., 1998, FLIGHT STABILITY AUT; Neuhart RA, 2009, AIAA ATM FLIGHT MECH, P5731; Ozbek NS, 2015, T I MEAS CONTROL, V1; Rauw MO, 2001, FDC 1 2 A SIMULINK T; Ravanbod L, 2014, J DYN SYST-T ASME, V136, DOI 10.1115/1.4026832; Reiner J, 1996, AUTOMATICA, V32, P1493, DOI 10.1016/S0005-1098(96)00101-X; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050336; Royer D, 2010, AIAA INFOTECH AEROSP; Schittkowski K., 1986, Annals of Operations Research, V5, P485, DOI 10.1007/BF02739235; Schueler CJ, 1967, DTIC DOCUMENT; Shouzhao S, 2014, 33 CHIN CONTR C CCC; STENGEL RF, 1980, J GUID CONTROL, V3, P494, DOI 10.2514/3.55959; Stevens B.L., 2015, AIRCRAFT CONTROL SIM; Tsay TSO, 2007, AEROSP SCI TECHNOL, V11, P553, DOI 10.1016/j.ast.2007.05.005; Wang Q, 2000, J GUID CONTROL DYNAM, V23, P577, DOI 10.2514/2.4580; Wong DKY, 2006, J AIR TRANSP MANAG, V12, P352, DOI 10.1016/j.jairtraman.2006.09.002; Yang CD, 2003, AM CONTR C	67	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165017	10.1371/journal.pone.0165017	http://dx.doi.org/10.1371/journal.pone.0165017			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783706	Green Submitted, Green Published, gold			2022-12-26	WOS:000389602800054
J	Lu-Walther, HW; Hou, WY; Kielhorn, M; Arai, Y; Nagai, T; Kessels, MM; Qualmann, B; Heintzmann, R				Lu-Walther, Hui-Wen; Hou, Wenya; Kielhorn, Martin; Arai, Yoshiyuki; Nagai, Takeharu; Kessels, Michael M.; Qualmann, Britta; Heintzmann, Rainer			Nonlinear Structured Illumination Using a Fluorescent Protein Activating at the Readout Wavelength	PLOS ONE			English	Article							LIVE CELLS; MICROSCOPY; RESOLUTION; NANOSCOPY	Structured illumination microscopy (SIM) is a wide-field technique in fluorescence microscopy that provides fast data acquisition and two-fold resolution improvement beyond the Abbe limit. We observed a further resolution improvement using the nonlinear emission response of a fluorescent protein. We demonstrated a two-beam nonlinear structured illumination microscope by introducing only a minor change into the system used for linear SIM (LSIM). To achieve the required nonlinear dependence in nonlinear SIM (NL-SIM) we exploited the photoswitching of the recently introduced fluorophore Kohinoor. It is particularly suitable due to its positive contrast photoswitching characteristics. Contrary to other reversibly photoswitchable fluorescent proteins which only have high photostability in living cells, Kohinoor additionally showed little degradation in fixed cells over many switching cycles.	[Lu-Walther, Hui-Wen; Kielhorn, Martin; Heintzmann, Rainer] Leibniz Inst Photon Technol, Jena, Germany; [Hou, Wenya; Kessels, Michael M.; Qualmann, Britta] Friedrich Schiller Univ Jena, Jena Univ Hosp, Inst Biochem 1, Jena, Germany; [Arai, Yoshiyuki; Nagai, Takeharu] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Heintzmann, Rainer] Friedrich Schiller Univ Jena, Abbe Ctr Photon, Inst Phys Chem, Jena, Germany; [Kielhorn, Martin] eZono AG, Jena, Germany	Leibniz Institut fur Photonische Technologien; Friedrich Schiller University of Jena; Osaka University; Friedrich Schiller University of Jena	Heintzmann, R (corresponding author), Leibniz Inst Photon Technol, Jena, Germany.; Heintzmann, R (corresponding author), Friedrich Schiller Univ Jena, Abbe Ctr Photon, Inst Phys Chem, Jena, Germany.	heintzmann@gmail.com	Heintzmann, Rainer/AAY-4849-2020	Heintzmann, Rainer/0000-0002-4950-1936; Nagai, Takeharu/0000-0003-2650-9895	Bundesministerium fur Bildung und Forschung [13N13140]; Deutsche Forschungsgemeinschaft [KE685/3-2, RTG1715, TRR 166]; Japan Science and Technology Agency for Core Research for Evolutional Science and Technology (CREST); MEXT [3306, 23115003]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Science and Technology Agency for Core Research for Evolutional Science and Technology (CREST); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Bundesministerium fur Bildung und Forschung (Award Number: 13N13140) to RH, https://www.bmbf.de/, Deutsche Forschungsgemeinschaft (Award Number: KE685/3-2) to MMK, Deutsche Forschungsgemeinschaft (Award Number: RTG1715) to BQ, Deutsche Forschungsgemeinschaft (Award Number: TRR 166 project B5) to BQ and RH, http://www.dfg.de/, Japan Science and Technology Agency for Core Research for Evolutional Science and Technology (CREST), and supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas "Spying minority in biological phenomena (No. 3306)" from MEXT (Award Number: 23115003) to TN. MEXT: http://www.mext.go.jp/english/, CREST:http://www.jst.go.jp/kisoken/crest/en/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Cremer C., 1999, German Patent, Patent No. [199 08 883 A1, 19908883, 199 08 883]; Fiolka R, 2012, P NATL ACAD SCI USA, V109, P5311, DOI 10.1073/pnas.1119262109; Grotjohann T, 2011, NATURE, V478, P204, DOI 10.1038/nature10497; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Heintzmann R, 2002, J OPT SOC AM A, V19, P1599, DOI 10.1364/JOSAA.19.001599; Heintzmann R, 1999, Patent Applicant: Max-Planck Society, priority, Patent No. [WO 0052512, 0052512]; Hirvonen L, 2008, PROC SPIE, V6861, DOI 10.1117/12.763021; Hirvonen LM, 2009, EUR BIOPHYS J BIOPHY, V38, P807, DOI 10.1007/s00249-009-0501-6; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Ingaramo M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9184; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Li D, 2015, SCIENCE, V349, DOI 10.1126/science.aab3500; Lu-Walther HW, 2015, METHODS APPL FLUORES, V3, DOI 10.1088/2050-6120/3/1/014001; Mandula O, 2012, OPT EXPRESS, V20, P24167, DOI 10.1364/OE.20.024167; Rego EH, 2012, P NATL ACAD SCI USA, V109, pE135, DOI 10.1073/pnas.1107547108; Shao L, 2011, NAT METHODS, V1734, P1; Song LY, 2016, MEAS SCI TECHNOL, V27, DOI 10.1088/0957-0233/27/5/055401; Tiwari DK, 2015, NAT METHODS, V12, P515, DOI 10.1038/nmeth.3362; Zhang X, 2016, P NATL ACAD SCI USA, V113, P10364, DOI 10.1073/pnas.1611038113; Zhang X, 2015, ACS NANO, V9, P2659, DOI 10.1021/nn5064387	21	4	5	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165148	10.1371/journal.pone.0165148	http://dx.doi.org/10.1371/journal.pone.0165148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783656	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800059
J	Siravenha, LG; Siravenha, LQ; Madeira, LD; Oliveira, AB; Machado, LFA; Feitosa, RNM; Vallinoto, ACR; Ishak, MDG				Siravenha, Layla Gomes; Siravenha, Leonardo Quintao; Madeira, Lucimar Di Paula; Oliveira-Filho, Aldemir B.; Almeida Machado, Luiz Fernando; Martins Feitosa, Rosimar Neris; Rosario Vallinoto, Antonio Carlos; Guimaraes Ishak, Marluisa de Oliveira			Detection of HCV Persistent Infections in the Dental Pulp: A Novel Approach for the Detection of Past and Ancient Infections	PLOS ONE			English	Article							HEPATITIS-C VIRUS; YERSINIA-PESTIS; DNA; EPIDEMIOLOGY	The dental pulp is a sterile highly vascularized tissue and has been commonly used as a biological material to detect the genome of infectious agents that reach the dental tissue. Indeed, the pulp is also used to reveal past and ancient infections in the field of paleomicro-biology. The present study aimed to detect the presence of Hepatitis C virus (HCV) in a small community (approximately 400 inhabitants) in the Amazon region of Brazil (Nossa Senhora do Perpetuo Socorro, Vizeu, Para, Brazil) and standardize a technique for the detection of the virus in the dental pulp. Serum samples were collected from 48 patients whose teeth were clinically recommended for surgical extraction. The group comprised an equal number of males and females, mostly agriculture workers and housewives, respectively. The majority (64.6%) received less than one minimum wage and were ill educated (less than four years of school years). An enzyme immune assay was used to detect antibodies to HCV and the 9 (18.8%) positive samples were submitted to nucleic acid extraction in the blood (using the EXTRAzol) and the pulp (QIAamp DNA Micro Kit e kit RNeasy Plus Micro). The pulp was removed using a modified protocol without the use of liquid nitrogen. Nucleic acid was found in 8 of the dental pulp, but in 7 of the blood samples. Sequencing of one of the samples showed the presence of genotype 1. Conclusions: A novel simplified methodology for the extraction and amplification of HCV nucleic acid was successful to detect the presence of persistent infections of the virus within the dental pulp tissue. The protocol may be helpful to detect past and ancient infections and to better understand the natural history of HCV.	[Siravenha, Layla Gomes; Siravenha, Leonardo Quintao; Madeira, Lucimar Di Paula; Almeida Machado, Luiz Fernando; Martins Feitosa, Rosimar Neris; Rosario Vallinoto, Antonio Carlos; Guimaraes Ishak, Marluisa de Oliveira] Fed Univ Para, Virol Lab, Inst Ciencias Biol, Belem, Para, Brazil; [Oliveira-Filho, Aldemir B.] Fed Univ Para, Inst Estudos Costeiros, Braganca, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para	Ishak, MDG (corresponding author), Fed Univ Para, Virol Lab, Inst Ciencias Biol, Belem, Para, Brazil.	rishak@ufpa.br	Feitosa, Rosimar/AAH-9855-2020; Machado, Luiz Fernando Almeida/I-2246-2019; Vallinoto, Antonio Carlos/AAL-9501-2020; de Oliveira Filho, Aldemir Branco/N-1530-2019	Feitosa, Rosimar/0000-0003-2044-9350; Machado, Luiz Fernando Almeida/0000-0002-4571-4715; Vallinoto, Antonio Carlos/0000-0003-1135-6507; de Oliveira Filho, Aldemir Branco/0000-0002-4888-3530	Brazilian National Council for Scientific and Technological Development (CNPq)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was partially supported by grants from the Brazilian National Council for Scientific and Technological Development (CNPq). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; We thank all the individuals who participated in the present study. This work was partially supported by grants from the Brazilian National Council for Scientific and Technological Development (CNPq)	Aboudharam G, 2005, MICROB PATHOGENESIS, V38, P47, DOI 10.1016/j.micpath.2004.10.004; Aboudharam G, 2000, MICROB PATHOGENESIS, V28, P249, DOI 10.1006/mpat.1999.0343; Araujo AR, 2011, REV SOC BRAS MED TRO, V44, p638 ; Bammann LL, 1999, ENDODONTIA PRINCIPIO, P169; Brasil. Ministerio da Saude. Secretaria de Vigilancia e Saude, 2005, HEP VIR BRAS AT, p14 ; Busek Solange, 2003, Genet Mol Res, V2, P117; Campiotto S, 2005, BRAZ J MED BIOL RES, V38, P41, DOI 10.1590/S0100-879X2005000100007; Cohen S, 2011, CAMINHOS DA POLPA; Fonseca José Carlos Ferraz da, 2004, Rev. Soc. Bras. Med. Trop., V37, P1, DOI 10.1590/S0037-86822004000700001; Djelouadji Z, 2011, LANCET INFECT DIS, V11, P641, DOI 10.1016/S1473-3099(11)70093-7; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; Estrela C., 2002, CONTROLE INFECCAO EM; FERREIRA CT, 2004, REV BRAS EPIDEMIOL, V7, P483; de Oliveira CSF, 2011, REV SOC BRAS MED TRO, V44, P546, DOI 10.1590/S0037-86822011000500003; Fornaciari G, 2003, LANCET, V362, P1160, DOI 10.1016/S0140-6736(03)14487-X; Gilbert MTP, 2004, MICROBIOL-SGM, V150, P341, DOI 10.1099/mic.0.26594-0; GLICK M, 1991, ORAL SURG ORAL MED O, V71, P733, DOI 10.1016/0030-4220(91)90284-J; GLICK M, 1989, J AM DENT ASSOC, V119, P649, DOI 10.1016/S0002-8177(89)95019-8; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jang JH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/794143; Karim Fawad, 2016, Asian Pac J Cancer Prev, V17, P235; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; La VD, 2004, CLIN INFECT DIS, V39, P1391, DOI 10.1086/424884; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Li HC, 1999, NAT MED, V5, P1428; Love RM, 2002, CRIT REV ORAL BIOL M, V13, P171, DOI 10.1177/154411130201300207; Mahmoudpour Ali, 2007, J Oral Sci, V49, P221, DOI 10.2334/josnusd.49.221; Marcellin P, 2009, LIVER INT, V29, P1, DOI 10.1111/j.1478-3231.2008.01947.x; Monteiro Maria Rita de Cassia Costa, 2004, Rev. Soc. Bras. Med. Trop., V37, P40; Negro F, 2014, DIGEST LIVER DIS, V46, pS158, DOI 10.1016/j.dld.2014.09.023; Nisengard RJ, 1994, ORAL MICROBIOL IMMUN, P391; Oliveira AB, 2010, MEM I OSWALDO CRUZ, V105, P103, DOI 10.1590/S0074-02762010000100016; Pisano JV, 1998, TRATAMENTO ENDODONTI, P693; Rambaut A., 2012, FIGTREE VERSION 1 4; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Raoult D, 2008, PALEOMICROBIOLOGY PA; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Spigelman M, 1993, INT J OSTEOARCHAEOL, V3, P137, DOI DOI 10.1002/0A.1390030211; Tran-Hung L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001062; Vogler Ingridt Hildegard, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P303, DOI 10.1590/S0036-46652004000600002; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; WHO D World Health Organization, 2002, HEP C	44	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165272	10.1371/journal.pone.0165272	http://dx.doi.org/10.1371/journal.pone.0165272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783693	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800067
J	Kadekar, D; Rangole, S; Kale, V; Limaye, L				Kadekar, Darshana; Rangole, Sonal; Kale, Vaijayanti; Limaye, Lalita			Conditioned Medium from Placental Mesenchymal Stem Cells Reduces Oxidative Stress during the Cryopreservation of Ex Vivo Expanded Umbilical Cord Blood Cells	PLOS ONE			English	Article							CONVENTIONAL FREEZING MEDIUM; HUMAN HEMATOPOIETIC-CELLS; IMPROVED CRYOPROTECTION; EXPANSION; ADDITIVES; TREHALOSE; CATALASE; MITOCHONDRIA; COMBINATION; VIABILITY	Background The limited cell dose in umbilical cord blood (UCB) necessitates ex vivo expansion of UCB. Further, the effective cryopreservation of these expanded cells is important in widening their use in the clinics. During cryopreservation, cells experience oxidative stress due to the generation of reactive oxygen species (ROS). Conditioned medium from mesenchymal stem cells (MSCs-CM) has been shown to alleviate the oxidative stress during wound healing, Alzheimer's disease and ischemic disease. This premise prompted us to investigate the influence of MSCs-CM during cryopreservation of expanded UCB cells. Methodology/Principle findings CM-was collected from cord/placental MSCs(C-MSCs-CM, P-MSC-CM). UCB CD34(+) cells were expanded as suspension cultures in serum free medium containing cytokines for 10 days. Cells were frozen with/without C-MSCs-CM and or P-MSCs-CM in the conventional freezing medium containing 20% FCS + 10% DMSO using a programmable freezer and stored in liquid nitrogen. Upon revival, cells frozen with MSCs-CM were found to be superior to cells frozen in conventional medium in terms of viability, CD34(+) content and clonogenecity. Priming of revived cells for 48 hrs with MSCs-CM further improved their transplantation ability, as compared to those cultured without MSCs-CM. P-MSCs-CM radically reduced the oxidative stress in cryopreserved cells, resulting in better post thaw functionality of CD34(+) cells than with C-MSCs-CM. The observed cryoprotective effect of MSCs-CM was primarily due to anti-oxidative and anti-apoptotic properties of the MSCs-CM and not because of the exosomes secreted by them. Conclusions/Significance Our data suggest that MSCs-CM can serve as a valuable additive to the freezing or the priming medium for expanded UCB cells, which would increase their clinical applicability.	[Kadekar, Darshana; Rangole, Sonal; Kale, Vaijayanti; Limaye, Lalita] Natl Ctr Cell Sci, Stem Cell Lab, Pune 411007, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Limaye, L (corresponding author), Natl Ctr Cell Sci, Stem Cell Lab, NCCS Complex,Univ Pune Campus, Pune 411007, Maharashtra, India.	Islimaye@ncces.res.in	Kale, Vaijayanti/R-9342-2019	Kale, Vaijayanti/0000-0001-7498-7563	Defence Research and Development Organisation [LSRB-260/SHDD/2012]; DRDO (LSRB), Govt. of India, New Delhi; University Grants Commission (UGC), New Delhi	Defence Research and Development Organisation(Defence Research & Development Organisation (DRDO)); DRDO (LSRB), Govt. of India, New Delhi; University Grants Commission (UGC), New Delhi(University Grants Commission, India)	This work was supported by the Defence Research and Development Organisation LSRB-260/SH&DD/2012 to LL and VK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank DRDO (LSRB), Govt. of India, New Delhi for funding the project and for providing project assistantship to SR.DK received fellowship from University Grants Commission (UGC), New Delhi. We acknowledge Dr. Godbole, Dr. Prakash Daithankar and Dr. Bapaye for providing cord blood, cord and placenta samples. Thanks to Director, NCCS for support, Nikhat Firdaus Q. Khan for technical help, core facilities of NCCS like FAGS, and Animal House. Dr. Jyoti Rao for proof reading of manuscript.	Bader AM, 2014, CELL PHYSIOL BIOCHEM, V34, P646, DOI 10.1159/000363030; Bakken Anne Margrethe, 2006, Curr Stem Cell Res Ther, V1, P47, DOI 10.2174/157488806775269179; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Cairo MS, 1997, BLOOD, V90, P4665, DOI 10.1182/blood.V90.12.4665.4665_4665_4678; Duchez P, 2013, TRANSFUSION, V53, P2012, DOI 10.1111/trf.12015; Duchez P, 2012, CELL TRANSPLANT, V21, P2517, DOI 10.3727/096368911X637425; Giarratana MC, 1998, BONE MARROW TRANSPL, V22, P707, DOI 10.1038/sj.bmt.1701399; Guarnerio J, 2014, STEM CELL REP, V2, P794, DOI 10.1016/j.stemcr.2014.04.002; Haspel RL, 2008, CURR STEM CELL RES T, V3, P229, DOI 10.2174/157488808786734033; Horwitz M, 2015, CYTOTHERAPY, V17; Hu LP, 2014, BLOOD, V124, pE45, DOI 10.1182/blood-2014-03-559369; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Jameel NM, 2009, J CELL PHYSIOL, V218, P157, DOI 10.1002/jcp.21581; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jun EK, 2014, INT J MOL SCI, V15, P605, DOI 10.3390/ijms15010605; Kadekar D, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0194-y; Kaneyuki Y, 2012, J RADIAT RES, V53, P145, DOI 10.1269/jrr.11099; Katkov II, 1998, CRYOBIOLOGY, V37, P325, DOI 10.1006/cryo.1998.2128; Kearney JN, 1998, BURNS, V24, P507, DOI 10.1016/S0305-4179(98)00068-0; Kim WS, 2009, EXPERT OPIN BIOL TH, V9, P879, DOI 10.1517/14712590903039684; Kozlowska-Skrzypczak M, 2014, TRANSPL P, V46, P2535, DOI 10.1016/j.transproceed.2014.08.023; Kudo Y, 2011, INT J HEMATOL, V93, P645, DOI 10.1007/s12185-011-0830-y; Limaye LS, 1997, STEM CELLS, V15, P353, DOI 10.1002/stem.150353; Limaye LS, 2001, J HEMATOTH STEM CELL, V10, P709, DOI 10.1089/152581601753193931; Lin HD, 2013, STEM CELL REV REP, V9, P172, DOI 10.1007/s12015-013-9426-7; Mayani H, 2011, ARCH MED RES, V42, P645, DOI 10.1016/j.arcmed.2011.11.010; Mendez-Ferrer S, 2015, ANN NY ACAD SCI, V1335, P32, DOI 10.1111/nyas.12641; Mita T, 2015, BEHAV BRAIN RES, V293, P189, DOI 10.1016/j.bbr.2015.07.043; Motta JPR, 2010, CRYOBIOLOGY, V60, P301, DOI 10.1016/j.cryobiol.2010.02.002; Nakagami H, 2001, DIABETES, V50, P1472, DOI 10.2337/diabetes.50.6.1472; Pereira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113769; Pineault N, 2015, EXP HEMATOL, V43, P498, DOI 10.1016/j.exphem.2015.04.011; Ribeiro CA, 2011, J TISSUE ENG REGEN M, V5, P668, DOI 10.1002/term.365; Rodrigues JP, 2008, CRYOBIOLOGY, V56, P144, DOI 10.1016/j.cryobiol.2008.01.003; Rust PA, 2006, CRYOLETTERS, V27, P17; Sasnoor LM, 2005, TRANSPLANTATION, V80, P1251, DOI 10.1097/01.tp.0000169028.01327.90; Sasnoor LM, 2005, TRANSFUSION, V45, P622, DOI 10.1111/j.0041-1132.2005.04288.x; Sasnoor LM, 2003, J HEMATOTH STEM CELL, V12, P553, DOI 10.1089/152581603322448268; Shao LJ, 2011, INT J HEMATOL, V94, P24, DOI 10.1007/s12185-011-0872-1; Talwadekar M., 2014, BIOMED RES J, V1, P126, DOI [10.4103/2349-3666.240999, DOI 10.4103/2349-3666.240999]; Tamama K, 2012, ADV WOUND CARE, V1, P177, DOI 10.1089/wound.2011.0296; Yafe M, 2004, BIOCHEM PHARMACOL, V67, P3539	42	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165466	10.1371/journal.pone.0165466	http://dx.doi.org/10.1371/journal.pone.0165466			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780236	Green Submitted, gold, Green Published			2022-12-26	WOS:000389046900058
J	Park, DW; Sebastiani, A; Yap, CH; Simon, MA; Kim, K				Park, Dae Woo; Sebastiani, Andrea; Yap, Choon Hwai; Simon, Marc A.; Kim, Kang			Quantification of Coupled Stiffness and Fiber Orientation Remodeling in Hypertensive Rat Right-Ventricular Myocardium Using 3D Ultrasound Speckle Tracking with Biaxial Testing	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; FREE-WALL MYOCARDIUM; CONSTITUTIVE RELATION; PASSIVE MYOCARDIUM; PRESSURE-OVERLOAD; MANAGEMENT; STRAIN; MODEL	Mechanical and structural changes of right ventricular (RV) in response to pulmonary hypertension (PH) are inadequately understood. While current standard biaxial testing provides information on the mechanical behavior of RV tissues using surface markers, it is unable to fully assess structural and mechanical properties across the full tissue thickness. In this study, the mechanical and structural properties of normotensive and pulmonary hypertension right ventricular (PHRV) myocardium through its full thickness were examined using mechanical testing combined with 3D ultrasound speckle tracking (3D-UST). RV pressure overload was induced in Sprague-Dawley rats by pulmonary artery (PA) banding. The second Piola-Kirchhoff stress tensors and Green-Lagrangian strain tensors were computed in the RV myocardium using the biaxial testing combined with 3D-UST. A previously established non-linear curve-fitting algorithm was applied to fit experimental data to a Strain Energy Function (SEF) for computation of myofiber orientation. The fiber orientations obtained by the biaxial testing with 3D-UST compared well with the fiber orientations computed from the histology. In addition, the re-orientation of myofiber in the right ventricular free wall (RVFW) along longitudinal direction (apex-to-outflow-tract direction) was noticeable in response to PH. For normotensive RVFW samples, the average fiber orientation angles obtained by 3D-UST with biaxial test spiraled from 20 E at the endo-cardium to -42 degrees at the epi-cardium (Delta= 62 degrees). For PHRV samples, the average fiber orientation angles obtained by 3D-UST with biaxial test had much less spiral across tissue thickness: 3 degrees at endo-cardium to -7 degrees at epi-cardium (Delta = 10 degrees, P< 0.005 compared to normotensive).	[Park, Dae Woo; Kim, Kang] Univ Pittsburgh, Sch Med, Dept Med, Ctr Ultrasound Mol Imaging & Therapeut, Pittsburgh, PA 15213 USA; [Sebastiani, Andrea; Simon, Marc A.; Kim, Kang] Univ Pittsburgh, Med Ctr UPMC, Inst Heart & Vasc, Pittsburgh, PA 15260 USA; [Yap, Choon Hwai] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [Simon, Marc A.; Kim, Kang] Univ Pittsburgh, Sch Engn, Dept Bioengn, Pittsburgh, PA 15261 USA; [Simon, Marc A.; Kim, Kang] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA; [Simon, Marc A.; Kim, Kang] UPMC, Pittsburgh, PA 15260 USA; [Simon, Marc A.; Kim, Kang] Univ Pittsburgh, Heart Lung & Blood Vasc Med Inst, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim, K (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Ctr Ultrasound Mol Imaging & Therapeut, Pittsburgh, PA 15213 USA.; Kim, K (corresponding author), Univ Pittsburgh, Med Ctr UPMC, Inst Heart & Vasc, Pittsburgh, PA 15260 USA.; Kim, K (corresponding author), Univ Pittsburgh, Sch Engn, Dept Bioengn, Pittsburgh, PA 15261 USA.; Kim, K (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.; Kim, K (corresponding author), UPMC, Pittsburgh, PA 15260 USA.; Kim, K (corresponding author), Univ Pittsburgh, Heart Lung & Blood Vasc Med Inst, Pittsburgh, PA 15260 USA.	kangkim@upmc.edu	Simon, Marc/AAH-3404-2020	Simon, Marc/0000-0003-3080-3675	GRO-Samsung; NIH [1 S10 RR027383-01, PO1HL103455]; AHA Beginning Grantin-Aid [10 BGI A3790022]	GRO-Samsung; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Beginning Grantin-Aid	This work was supported by GRO-Samsung, to KK; NIH 1 S10 RR027383-01, to KK; AHA Beginning Grantin-Aid 10 BGI A3790022, to MAS and NIH PO1HL103455, MAS (PI: MTG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 2006, CURR OPIN CARDIOL, V21, P385; Arts T, 2001, AM J PHYSIOL-HEART C, V280, pH2222, DOI 10.1152/ajpheart.2001.280.5.H2222; Benza RL, 2007, J HEART LUNG TRANSPL, V26, P437, DOI 10.1016/j.healun.2007.01.035; Buckberg G D, 2001, Semin Thorac Cardiovasc Surg, V13, P358; Carlsson M, 2007, AM J PHYSIOL-HEART C, V293, pH636, DOI 10.1152/ajpheart.01376.2006; Chen X, 2005, ULTRASONIC IMAGING, V27, P21, DOI 10.1177/016173460502700102; CHUONG CJ, 1991, AM J PHYSIOL, V260, pH1224, DOI 10.1152/ajpheart.1991.260.4.H1224; Driessen NJB, 2005, J BIOMECH ENG-T ASME, V127, P494, DOI 10.1115/1.1894373; Duck F.A., 1990, MED PHYS, V18; GLAGOV S, 1992, J HYPERTENS, V10, pS101; Hill MR, 2014, ANN BIOMED ENG, V42, P2451, DOI 10.1007/s10439-014-1096-3; Holzapfel GA, 2009, PHILOS T R SOC A, V367, P3445, DOI 10.1098/rsta.2009.0091; HUMPHREY JD, 1990, J BIOMECH ENG-T ASME, V112, P340, DOI 10.1115/1.2891194; HUMPHREY JD, 1990, J BIOMECH ENG-T ASME, V112, P333, DOI 10.1115/1.2891193; Humphrey JD., 2002, CARDIOVASCULAR SOLID; Leonard BL, 2012, MICROSC MICROANAL, V18, P50, DOI 10.1017/S1431927611012438; SACKS MS, 1993, J BIOMECH, V26, P1341, DOI 10.1016/0021-9290(93)90357-K; SACKS MS, 1993, J BIOMECH ENG-T ASME, V115, P202, DOI 10.1115/1.2894122; Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671; Scollan DF, 2000, ANN BIOMED ENG, V28, P934, DOI 10.1114/1.1312188; Stuber M, 1999, CIRCULATION, V100, P361, DOI 10.1161/01.CIR.100.4.361; Urheim S, 2000, CIRCULATION, V102, P1158, DOI 10.1161/01.CIR.102.10.1158; Valdez-Jasso D, 2012, J PHYSIOL-LONDON, V590, P4571, DOI 10.1113/jphysiol.2012.233015; Voelkel NF, 2011, COMPR PHYSIOL, V1, P525, DOI 10.1002/cphy.c090008; Yap CH, 2015, ULTRASOUND MED BIOL, V41, P1029, DOI 10.1016/j.ultrasmedbio.2014.10.021	25	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165320	10.1371/journal.pone.0165320	http://dx.doi.org/10.1371/journal.pone.0165320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780271	gold, Green Submitted, Green Published			2022-12-26	WOS:000389046900046
J	Dong, Y; Liu, JD; Zhang, Y; Geng, HW; Rasheed, A; Xiao, YG; Cao, SH; Fu, LP; Yan, J; Wen, W; Zhang, Y; Jing, RL; Xia, XC; He, ZH				Dong, Yan; Liu, Jindong; Zhang, Yan; Geng, Hongwei; Rasheed, Awais; Xiao, Yonggui; Cao, Shuanghe; Fu, Luping; Yan, Jun; Wen, Weie; Zhang, Yong; Jing, Ruilian; Xia, Xianchun; He, Zhonghu			Genome-Wide Association of Stem Water Soluble Carbohydrates in Bread Wheat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RESERVE MOBILIZATION; GENOTYPIC VARIATION; KINASE GENE; AESTIVUM L.; PROTEIN; ACCUMULATION; IDENTIFICATION; PROSPECTS; ENCODES	Water soluble carbohydrates (WSC) in stems play an important role in buffering grain yield in wheat against biotic and abiotic stresses; however, knowledge of genes controlling WSC is very limited. We conducted a genome-wide association study (GWAS) using a high-density 90K SNP array to better understand the genetic basis underlying WSC, and to explore marker-based breeding approaches. WSC was evaluated in an association panel comprising 166 Chinese bread wheat cultivars planted in four environments. Fifty two marker-trait associations (MTAs) distributed across 23 loci were identified for phenotypic best linear unbiased estimates (BLUEs), and 11 MTAs were identified in two or more environments. Liner regression showed a clear dependence of WSC BLUE scores on numbers of favorable (increasing WSC content) and unfavorable alleles (decreasing WSC), indicating that genotypes with higher numbers of favorable or lower numbers of unfavorable alleles had higher WSC content. In silico analysis of flanking sequences of trait-associated SNPs revealed eight candidate genes related to WSC content grouped into two categories based on the type of encoding proteins, namely, defense response proteins and proteins triggered by environmental stresses. The identified SNPs and candidate genes related to WSC provide opportunities for breeding higher WSC wheat cultivars.	[Dong, Yan; Liu, Jindong; Zhang, Yan; Rasheed, Awais; Xiao, Yonggui; Cao, Shuanghe; Fu, Luping; Wen, Weie; Zhang, Yong; Jing, Ruilian; Xia, Xianchun; He, Zhonghu] Chinese Acad Agr Sci, Inst Crop Sci, Natl Wheat Improvement Ctr, Beijing, Peoples R China; [Geng, Hongwei; Wen, Weie] Xinjiang Agr Univ, Coll Agron, 311 Nongda East Rd, Xinjiang 830052, Peoples R China; [Rasheed, Awais; He, Zhonghu] Chinese Acad Agr Sci, Int Maize & Wheat Improvement Ctr CIMMYT China Of, Beijing, Peoples R China; [Yan, Jun] Chinese Acad Agr Sci, Cotton Res Inst, Anyang, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Xinjiang Agricultural University; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	He, ZH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Wheat Improvement Ctr, Beijing, Peoples R China.; He, ZH (corresponding author), Chinese Acad Agr Sci, Int Maize & Wheat Improvement Ctr CIMMYT China Of, Beijing, Peoples R China.	zhhecaas@163.com	He, Zhonghu/E-1625-2015; Rasheed, Awais/A-1623-2010; Liu, Jindong/C-8422-2017	Rasheed, Awais/0000-0003-2528-708X; Liu, Jindong/0000-0002-5927-4845; He, Zhonghu/0000-0003-1384-3712; CAO, SHUANGHE/0000-0002-2905-0728	National Natural Science Foundation of China [31201207, 31371623, 31461143021, 31260327]; Gene Transformation Projects [2016ZX08009-003, 2016ZX08002003-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Gene Transformation Projects	This study was supported by the National Natural Science Foundation of China (31201207, 31371623, 31461143021, 31260327), and Gene Transformation Projects (2016ZX08009-003 and 2016ZX08002003-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Prof. R. A. McIntosh, Plant Breeding Institute, University of Sydney, for critical review of this manuscript. This study was supported by the National Natural Science Foundation of China (31201207, 31260327, 31371623, 31461143021), and Gene Transformation Projects (2016ZX08009-003, 2016ZX08002003-003).	Akpinar BA, 2015, PLANT BIOTECHNOL J, V13, P740, DOI 10.1111/pbi.12302; Alexandratos N, 2012, WORLD AGR 2030 2050, V1, P3; Blum A, 1998, EUPHYTICA, V100, P77, DOI 10.1023/A:1018303922482; Blum A, 1996, WHEAT PROSPECTS GLOB, P135; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chen L, 2012, J EXP BOT, V63, P6211, DOI 10.1093/jxb/ers273; Cloutier S, 2007, PLANT MOL BIOL, V65, P93, DOI 10.1007/s11103-007-9201-8; de Setta N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-540; Diab AA, 2004, THEOR APPL GENET, V109, P1417, DOI 10.1007/s00122-004-1755-0; Dong Y, 2016, THEOR APPL GENET, V129, P1061, DOI 10.1007/s00122-016-2683-5; Dreccer MF, 2009, FIELD CROP RES, V112, P43, DOI 10.1016/j.fcr.2009.02.006; Ehdaie B, 2006, CROP SCI, V46, P735, DOI 10.2135/cropsci2005.04-0033; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Foulkes MJ, 2002, J AGR SCI-CAMBRIDGE, V138, P153, DOI 10.1017/S0021859601001836; Gebbing T, 1999, PLANT PHYSIOL, V121, P871, DOI 10.1104/pp.121.3.871; Goggin DE, 2004, FUNCT PLANT BIOL, V31, P11, DOI 10.1071/FP03123; Gupta P K, 2008, Int J Plant Genomics, V2008, P896451, DOI 10.1155/2008/896451; Hurni S, 2015, P NATL ACAD SCI USA, V112, P8780, DOI 10.1073/pnas.1502522112; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kollers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057500; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119438; Liang WW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-392; Lin F, 2009, J EXP BOT, V60, P3221, DOI 10.1093/jxb/erp157; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Livingston DP, 2006, CRYOBIOLOGY, V52, P200, DOI 10.1016/j.cryobiol.2005.11.001; Meena MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123640; Palm CA, 2010, P NATL ACAD SCI USA, V107, P19661, DOI 10.1073/pnas.0912248107; Pritchard JK, 2000, GENETICS, V155, P945; Quettier AL, 2008, PLANT PHYSIOL, V148, P519, DOI 10.1104/pp.108.123703; Rebetzke GJ, 2008, AUST J AGR RES, V59, P891, DOI 10.1071/AR08067; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rudd JJ, 2008, PLANT PHYSIOL, V147, P802, DOI 10.1104/pp.108.119511; Ruuska SA, 2006, FUNCT PLANT BIOL, V33, P799, DOI 10.1071/FP06062; Salem KFM, 2007, CEREAL RES COMMUN, V35, P1367, DOI 10.1556/CRC.35.2007.3.1; SCHNYDER H, 1993, NEW PHYTOL, V123, P233, DOI 10.1111/j.1469-8137.1993.tb03731.x; Semikhodskii AG, 1997, MAPPING QUANTITATIVE; Setter T. L., 1998, Wheat: research needs beyond 2000 AD. Proceedings of an international conference, 12-14 August 1997, Karnal, India., P237; Shearman VJ, 2005, CROP SCI, V45, P175; Trouvelot S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00592; van Herwaarden A, 2006, P 13 AGR C; van Herwaarden A.F., 2002, P 12 AUSTR PLANT BRE, P878; Wang JX, 2010, J INTEGR PLANT BIOL, V52, P442, DOI 10.1111/j.1744-7909.2010.00906.x; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wang ZH, 2011, ANAL LETT, V44, P2478, DOI 10.1080/00032719.2011.551859; WARDLAW IF, 1994, AUST J PLANT PHYSIOL, V21, P255, DOI 10.1071/PP9940255; Xiao YG, 2012, CROP SCI, V52, P44, DOI 10.2135/cropsci2011.05.0246; Xue GP, 2008, PLANT PHYSIOL, V146, P441, DOI 10.1104/pp.107.113076; Yang DL, 2007, GENETICS, V176, P571, DOI 10.1534/genetics.106.068361; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102917; Zhang SB, 2005, PLANT PHYSIOL, V139, P1107, DOI 10.1104/pp.105.069005; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	56	30	38	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0164293	10.1371/journal.pone.0164293	http://dx.doi.org/10.1371/journal.pone.0164293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802269	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200008
J	Kronimus, Y; Albus, A; Balzer-Geldsetzer, M; Straub, S; Semler, E; Otto, M; Klotsche, J; Dodel, R; Mengel, D				Kronimus, Yannick; Albus, Alexandra; Balzer-Geldsetzer, Monika; Straub, Sarah; Semler, Elisa; Otto, Markus; Klotsche, Jens; Dodel, Richard; Mengel, David		Landscape Consortium	Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; NEUROFIBRILLARY TANGLES; COGNITIVE IMPAIRMENT; AMYLOID-BETA; ANTIBODIES; DIAGNOSIS; PATHOLOGIES; PROGRESSION; AVIDITY	Background and Objective Altered levels of naturally occurring autoantibodies (nAbs) against disease-associated neuronal proteins have been reported for neurodegenerative diseases, such as Alzheimer's (AD) and Parkinson's disease (PD). Recent histopathologic studies suggest a contribution of both Lewy body-and AD-related pathology to Parkinson's disease dementia (PDD). Therefore, we explored nAbs against alpha-synuclein (alpha S), tau and beta-amyloid (A beta) in PDD compared to cognitively normal PD patients. Materials and Methods We established three different ELISAs to quantify the nAbs-tau, nAbs-alpha S, and nAbs-A beta levels and avidity towards their specific antigen in serum samples of 18 non-demented (PDND) and 18 demented PD patients (PDD), which were taken from an ongoing multi-center cohort study (DEMPARK/LANDSCAPE). Results PDD patients had significantly decreased nAbs-tau serum levels compared to PDND patients (p = 0.007), whereas the serum titers of nAbs-alpha S and nAbs-A beta were unchanged. For all three nAbs, no significant differences in avidity were found between PDD and PDND cohorts. However, within both patient groups, nAbs-tau showed lowest avidity to their antigen, followed by nAbs-alpha S, and nAbs-A beta. Though, due to a high interassay coefficient of variability and the exclusion of many samples below the limit of detection, conclusions for nAbs-A beta are only conditionally possible. Conclusion We detected a significantly decreased nAbs-tau serum level in PDD patients, indicating a potential linkage between nAbs-tau serum titer and cognitive deficits in PD. Thus, further investigation in larger samples is justified to confirm our findings.	[Kronimus, Yannick; Albus, Alexandra; Balzer-Geldsetzer, Monika; Dodel, Richard; Mengel, David] Univ Marburg, Dept Neurol, Marburg, Germany; [Dodel, Richard] Univ Clin, Dept Neurogeriatr, Essen, Germany; [Straub, Sarah; Semler, Elisa; Otto, Markus] Univ Ulm, Dept Neurol, Ulm, Germany; [Klotsche, Jens] Leibniz Inst, German Rheumatism Res Ctr Berlin, Berlin, Germany; [Klotsche, Jens] Charite, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany	Philipps University Marburg; University of Duisburg Essen; Ulm University; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dodel, R (corresponding author), Univ Marburg, Dept Neurol, Marburg, Germany.; Dodel, R (corresponding author), Univ Clin, Dept Neurogeriatr, Essen, Germany.	richard.dodel@uk-essen.de	Reetz, Kathrin/H-9510-2012; Otto, Markus/F-4304-2015; Schulz, Jorg B./D-9786-2012	Reetz, Kathrin/0000-0002-9730-9228; Otto, Markus/0000-0003-4273-4267; Schulz, Jorg B./0000-0002-8903-0593; Albus, Alexandra/0000-0002-4897-6972	Novartis; International Parkinson Fonds (Deutschland) GmbH; German Federal Ministry of Education and Research [01GI1008C]; German Federal Ministry of Education and Research (KNDD - FTLDc); JPND network SOPHIA; JPND network BiomarkAPD; JPND network Prefrontals; BIU (Boehringer Ingelheim University of Ulm Institute) [D.5009]; German Ministry for Education and Research (BMBF) [01GI1008C]; German Federal Ministry of Education and Research (KNDD-FTLDc); EU (FAIR-PARK II); foundation of the state Baden-Wurttemberg [D.3830]	Novartis(Novartis); International Parkinson Fonds (Deutschland) GmbH; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (KNDD - FTLDc); JPND network SOPHIA; JPND network BiomarkAPD; JPND network Prefrontals; BIU (Boehringer Ingelheim University of Ulm Institute); German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (KNDD-FTLDc); EU (FAIR-PARK II); foundation of the state Baden-Wurttemberg	The DEMPARK study was funded by an unrestricted grant from Novartis and a grant from the International Parkinson Fonds (Deutschland) GmbH (IPD). The continuation of the study (LANDSCAPE) is part of the Competence Network Degenerative Dementias (KNDD), which was funded by the German Federal Ministry of Education and Research (project number 01GI1008C). The FTD study was supported by the German Federal Ministry of Education and Research (KNDD - FTLDc), the JPND networks SOPHIA, BiomarkAPD and Prefrontals, the EU (FAIR-PARK II), the foundation of the state Baden-Wurttemberg (D.3830), BIU (Boehringer Ingelheim University of Ulm Institute (D.5009)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The DEMPARK study was funded by an unrestricted grant from Novartis and a grant from the International Parkinson Fonds (Deutschland) GmbH (IPD). The continuation of the study (LANDSCAPE) is part of the Competence Network Degenerative Dementias (KNDD) and is funded by the German Ministry for Education and Research (BMBF; project number 01GI1008C).; The FTD study was supported by the German Federal Ministry of Education and Research (KNDD-FTLDc), the JPND networks SOPHIA, BiomarkAPD and Prefrontals, the EU (FAIR-PARK II), the foundation of the state Baden-Wurttemberg (D.3830), BIU (Boehringer Ingelheim University of Ulm Institute (D.5009)).	Aarsland D, 2005, ANN NEUROL, V58, P773, DOI 10.1002/ana.20635; ALONSO AD, 1995, MOL BRAIN RES, V31, P194, DOI 10.1016/0169-328X(95)00051-S; Arias-Bouda LMP, 2003, CLIN DIAGN LAB IMMUN, V10, P702, DOI 10.1128/CDLI.10.4.702-709.2003; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Bach JP, 2012, ADV EXP MED BIOL, V750, P91, DOI 10.1007/978-1-4614-3461-0_7; Balzer-Geldsetzer M, 2011, NEUROEPIDEMIOLOGY, V37, P168, DOI 10.1159/000331490; Bartos A, 2012, J NEUROIMMUNOL, V252, P100, DOI 10.1016/j.jneuroim.2012.08.001; Besong-Agbo D, 2013, NEUROLOGY, V80, P169, DOI 10.1212/WNL.0b013e31827b90d1; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Britschgi M, 2009, P NATL ACAD SCI USA, V106, P12145, DOI 10.1073/pnas.0904866106; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Compta Y, 2014, NEURODEGENER DIS, V13, P154, DOI 10.1159/000354670; Compta Y, 2012, PARKINSONISM RELAT D, V18, P941, DOI 10.1016/j.parkreldis.2012.04.028; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Compta Y, 2009, MOVEMENT DISORD, V24, P2203, DOI 10.1002/mds.22594; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Fialova L, 2012, FOLIA MICROBIOL, V57, P415, DOI 10.1007/s12223-012-0105-x; Fialova L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027476; Gold M, 2012, IMMUNOL REV, V248, P68, DOI 10.1111/j.1600-065X.2012.01128.x; Goodyear MDE, 2007, BRIT MED J, V335, P624, DOI 10.1136/bmj.39339.610000.BE; Halbgebauer S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26145; Hall S, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI 10.1001/archneurol.2012.1654; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Kempster PA, 2010, BRAIN, V133, P1755, DOI 10.1093/brain/awq059; Lutz HU, 2007, J AUTOIMMUN, V29, P287, DOI 10.1016/j.jaut.2007.07.007; Lutz HU, 2009, TRENDS IMMUNOL, V30, P43, DOI 10.1016/j.it.2008.10.002; Maetzler W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088604; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; NOSSENT JC, 1989, ANN RHEUM DIS, V48, P748, DOI 10.1136/ard.48.9.748; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Qu BX, 2014, J NEUROIMMUNOL, V274, P168, DOI 10.1016/j.jneuroim.2014.06.017; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rosenmann H, 2006, NEUROSCI LETT, V410, P90, DOI 10.1016/j.neulet.2006.01.072; Sankaranarayanan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125614; Seltman RE, 2012, CNS DRUGS, V26, P841, DOI 10.2165/11640070-000000000-00000; Shoenfeld Y., 2014, AUTOANTIBODIES; Storace D, 2010, ARCH NEUROL-CHICAGO, V67, P867, DOI 10.1001/archneurol.2010.137; Svenningsson P, 2012, LANCET NEUROL, V11, P697, DOI 10.1016/S1474-4422(12)70152-7; Terryberry JW, 1998, NEUROBIOL AGING, V19, P205, DOI 10.1016/S0197-4580(98)00049-9; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P1562, DOI 10.1001/archneurol.2011.725; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163	45	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0164953	10.1371/journal.pone.0164953	http://dx.doi.org/10.1371/journal.pone.0164953			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802290	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200013
J	Auffret, MD; Karhu, K; Khachane, A; Dungait, JAJ; Fraser, F; Hopkins, DW; Wookey, PA; Singh, BK; Freitag, TE; Hartley, IP; Prosser, JI				Auffret, Marc D.; Karhu, Kristiina; Khachane, Amit; Dungait, Jennifer A. J.; Fraser, Fiona; Hopkins, David W.; Wookey, Philip A.; Singh, Brajesh K.; Freitag, Thomas E.; Hartley, Iain P.; Prosser, James I.			The Role of Microbial Community Composition in Controlling Soil Respiration Responses to Temperature	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; THERMAL-ACCLIMATION; SENSITIVITY; ADAPTATION; FEEDBACKS; ABUNDANCE; ENZYMES; DIVERSITY; DOMINANCE; KINETICS	Rising global temperatures may increase the rates of soil organic matter decomposition by heterotrophic microorganisms, potentially accelerating climate change further by releasing additional carbon dioxide (CO2) to the atmosphere. However, the possibility that microbial community responses to prolonged warming may modify the temperature sensitivity of soil respiration creates large uncertainty in the strength of this positive feedback. Both compensatory responses (decreasing temperature sensitivity of soil respiration in the long-term) and enhancing responses (increasing temperature sensitivity) have been reported, but the mechanisms underlying these responses are poorly understood. In this study, microbial biomass, community structure and the activities of dehydrogenase and beta-glucosidase enzymes were determined for 18 soils that had previously demonstrated either no response or varying magnitude of enhancing or compensatory responses of temperature sensitivity of heterotrophic microbial respiration to prolonged cooling. The soil cooling approach, in contrast to warming experiments, discriminates between microbial community responses and the consequences of substrate depletion, by minimising changes in substrate availability. The initial microbial community composition, determined by molecular analysis of soils showing contrasting respiration responses to cooling, provided evidence that the magnitude of enhancing responses was partly related to microbial community composition. There was also evidence that higher relative abundance of saprophytic Basidiomycota may explain the compensatory response observed in one soil, but neither microbial biomass norenzymatic capacity were significantly affected by cooling. Our findings emphasise the key importance of soil microbial community responses for feedbacks to global change, but also highlight important areas where our understanding remains limited.	[Auffret, Marc D.; Prosser, James I.] Univ Aberdeen, Cruickshank Bldg St Machar Dr, Aberdeen AB24 3UU, Scotland; [Karhu, Kristiina; Hartley, Iain P.] Univ Exeter, Amory Bldg,Rennes Dr, Exeter EX4 4RJ, Devon, England; [Khachane, Amit; Singh, Brajesh K.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2751, Australia; [Dungait, Jennifer A. J.] Rothamsted Res North Wyke, Sustainable Soils & Grassland Syst Dept, Okehampton EX20 2SB, England; [Fraser, Fiona] Cranfield Univ, Sch Energy Environm & Agrifood, Cranfield MK43 0AL, Beds, England; [Hopkins, David W.] Royal Agr Univ, Cirencester GL7 6JS, Glos, England; [Wookey, Philip A.] Heriot Watt Univ, Inst Life & Earth Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Freitag, Thomas E.] Craigiebuckler, James Hutton Inst, Aberdeen AB15 8QH, Scotland; [Karhu, Kristiina] Univ Helsinki, Dept Forest Sci, POB 27, FI-00014 Helsinki, Finland	University of Aberdeen; University of Exeter; Western Sydney University; Cranfield University; Heriot Watt University; James Hutton Institute; University of Helsinki	Auffret, MD (corresponding author), Univ Aberdeen, Cruickshank Bldg St Machar Dr, Aberdeen AB24 3UU, Scotland.	marcauffret@aol.com	Hartley, Iain P/J-7892-2016; Dungait, Jenni/F-1110-2013; Singh, Brajesh/R-6321-2019; Prosser, Jim/F-5280-2010; Wookey, Philip/AAA-6271-2020; Dungait, Jennifer/AAV-7301-2021; Karhu, Kristiina/F-8272-2012	Hartley, Iain P/0000-0002-9183-6617; Dungait, Jenni/0000-0001-9074-4174; Singh, Brajesh/0000-0003-4413-4185; Prosser, Jim/0000-0003-1757-5102; Wookey, Philip/0000-0001-5957-6424; Freitag, Thomas/0000-0001-7655-6433; Fraser, Fiona/0000-0002-8745-3373; Hopkins, David/0000-0003-0953-8643; AUFFRET, Marc/0000-0002-2321-8219	NERC [NE/H022333/1]; Natural Environment Research Council [NE/H022333/1, NBAF010002, NE/H023550/1] Funding Source: researchfish; NERC [NE/H023550/1, NBAF010002] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by NE/H022333/1, NERC http://www.nerc.ac.uk/, IA and JP.	Alef K., 1995, METHODS APPL SOIL MI, DOI DOI 10.1016/B978-0-12-513840-6.X5014-9; Allison SD, 2005, ECOL LETT, V8, P626, DOI 10.1111/j.1461-0248.2005.00756.x; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Bailey VL, 2002, SOIL BIOL BIOCHEM, V34, P997, DOI 10.1016/S0038-0717(02)00033-0; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Billings SA, 2013, GLOBAL CHANGE BIOL, V19, P90, DOI 10.1111/gcb.12029; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Bradford MA, 2010, GLOBAL CHANGE BIOL, V16, P1576, DOI 10.1111/j.1365-2486.2009.02040.x; Bradford MA, 2009, ECOL LETT, V12, pE15, DOI 10.1111/j.1461-0248.2009.01332.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Cline LC, 2015, MOL ECOL, V24, P5045, DOI 10.1111/mec.13361; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Crowther TW, 2013, ECOL LETT, V16, P469, DOI 10.1111/ele.12069; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dick R. P., 1997, P121; Eliasson PE, 2005, GLOBAL CHANGE BIOL, V11, P167, DOI 10.1111/j.1365-2486.2004.00878.x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; German DP, 2012, GLOBAL CHANGE BIOL, V18, P1468, DOI 10.1111/j.1365-2486.2011.02615.x; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Hartley IP, 2008, ECOL LETT, V11, P1092, DOI 10.1111/j.1461-0248.2008.01223.x; Hartley IP, 2008, SOIL BIOL BIOCHEM, V40, P1567, DOI 10.1016/j.soilbio.2008.01.007; Hartley IP, 2007, GLOBAL CHANGE BIOL, V13, P1761, DOI 10.1111/j.1365-2486.2007.01373.x; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Karhu K, 2014, NATURE, V513, P81, DOI 10.1038/nature13604; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Li JW, 2014, BIOGEOCHEMISTRY, V119, P67, DOI 10.1007/s10533-013-9948-8; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Matulich KL, 2015, ECOLOGY, V96, P154, DOI 10.1890/14-0357.1; McMahon SK, 2011, SOIL BIOL BIOCHEM, V43, P287, DOI 10.1016/j.soilbio.2010.10.013; Moorhead DL, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00223; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Paul E.A., 2007, SOIL MICROBIOLOGY EC; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Reay DS, 2007, GREENHOUSE GAS SINKS, P1, DOI 10.1079/9781845931896.0001; Rinnan R, 2009, GLOBAL CHANGE BIOL, V15, P2615, DOI 10.1111/j.1365-2486.2009.01959.x; Robinson CH, 2001, NEW PHYTOL, V151, P341, DOI 10.1046/j.1469-8137.2001.00177.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Salazar-Villegas A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00524; Singh BK, 2006, APPL ENVIRON MICROB, V72, P7278, DOI 10.1128/AEM.00510-06; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steinweg JM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00146; Stone MM, 2012, GLOBAL CHANGE BIOL, V18, P1173, DOI 10.1111/j.1365-2486.2011.02545.x; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Trasar-Cepeda C, 2007, SOIL BIOL BIOCHEM, V39, P311, DOI 10.1016/j.soilbio.2006.08.002; Tucker CL, 2013, GLOBAL CHANGE BIOL, V19, P252, DOI 10.1111/gcb.12036; Turner BL, 2002, APPL SOIL ECOL, V20, P157, DOI 10.1016/S0929-1393(02)00020-3; Wagai R, 2013, GLOBAL CHANGE BIOL, V19, P1114, DOI 10.1111/gcb.12112; Wakelin SA, 2007, FEMS MICROBIOL ECOL, V59, P661, DOI 10.1111/j.1574-6941.2006.00235.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P	60	29	30	8	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165448	10.1371/journal.pone.0165448	http://dx.doi.org/10.1371/journal.pone.0165448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798702	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100036
J	Bao, XY; Zhu, XX; Chang, XF; Wang, SP; Xu, BRBY; Luo, CY; Zhang, ZH; Wang, Q; Rui, YC; Cui, XY				Bao, Xiaoying; Zhu, Xiaoxue; Chang, Xiaofeng; Wang, Shiping; Xu, Burenbayin; Luo, Caiyun; Zhang, Zhenhua; Wang, Qi; Rui, Yichao; Cui, Xiaoying			Effects of Soil Temperature and Moisture on Soil Respiration on the Tibetan Plateau	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; MICROBIAL RESPIRATION; CLIMATE-CHANGE; SUBSTRATE AVAILABILITY; SEMIARID GRASSLAND; THERMAL ADAPTATION; EXTRACTION METHOD; SENSITIVITY; CARBON; ECOSYSTEM	Understanding of effects of soil temperature and soil moisture on soil respiration (Rs) under future warming is critical to reduce uncertainty in predictions of feedbacks to atmospheric CO2 concentrations from grassland soil carbon. Intact cores with roots taken from a full factorial, 5-year alpine meadow warming and grazing experiment in the field were incubated at three different temperatures (i.e. 5, 15 and 25 degrees C) with two soil moistures (i.e. 30 and 60% water holding capacity (WHC)) in our study. Another experiment of glucose-induced respiration (GIR) with 4 h of incubation was conducted to determine substrate limitation. Our results showed that high temperature increased Rs and low soil moisture limited the response of Rs to temperature only at high incubation temperature (i.e. 25 degrees C). Temperature sensitivity (Q(10)) did not significantly decrease over the incubation period, suggesting that substrate depletion did not limit Rs. Meanwhile, the carbon availability index (CAI) was higher at 5 degrees C compared with 15 and 25 degrees C incubation, but GIR increased with increasing temperature. Therefore, our findings suggest that warming-induced decrease in Rs in the field over time may result from a decrease in soil moisture rather than from soil substrate depletion, because warming increased root biomass in the alpine meadow.	[Bao, Xiaoying; Wang, Qi; Rui, Yichao; Cui, Xiaoying] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Zhu, Xiaoxue; Xu, Burenbayin; Luo, Caiyun; Zhang, Zhenhua] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining 810008, Peoples R China; [Wang, Shiping; Wang, Qi] Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Alpine Ecol & Biodivers, Beijing 100101, Peoples R China; [Wang, Shiping] Chinese Acad Sci, CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing 100101, Peoples R China; [Chang, Xiaofeng] Northwest A&F Univ, Inst Soil & Water Conservat, 26 Xinong Rd, Yangling 712100, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China	Wang, SP (corresponding author), Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Alpine Ecol & Biodivers, Beijing 100101, Peoples R China.; Wang, SP (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing 100101, Peoples R China.	wangsp@itpcas.ac.cn	Cui, Xiaoyong/B-3669-2016	Cui, Xiaoyong/0000-0001-7592-5866	Chinese Academy of Sciences [XDB03030403]; National Basic Research Program [2013CB956000]; National Science Foundation of China [41230750, 31272488]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB03030403), the National Basic Research Program (2013CB956000), and the National Science Foundation of China (41230750 and 31272488). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funding from the National Basic Research Program (2013CB956000), the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB03030403), and the National Science Foundation of China (41230750 and 31272488). We are grateful to Dr. Andreas Wilkes for polishing this manuscript.	Almagro M, 2009, SOIL BIOL BIOCHEM, V41, P594, DOI 10.1016/j.soilbio.2008.12.021; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Bradford MA, 2010, GLOBAL CHANGE BIOL, V16, P1576, DOI 10.1111/j.1365-2486.2009.02040.x; Bradford MA, 2009, ECOL LETT, V12, pE15, DOI 10.1111/j.1461-0248.2009.01332.x; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Chang X, 2012, EUR J SOIL SCI, V63, P325, DOI 10.1111/j.1365-2389.2012.01441.x; Chinese Soil Taxonomy Research Group, 1995, CHINESE SOIL TAXONOM, P58; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Conant RT, 2004, SOIL BIOL BIOCHEM, V36, P945, DOI 10.1016/j.soilbio.2004.02.013; Conen F, 2006, BIOGEOSCIENCES, V3, P515, DOI 10.5194/bg-3-515-2006; Craine JM, 2011, SOIL BIOL BIOCHEM, V43, P455, DOI 10.1016/j.soilbio.2010.10.011; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Eliasson PE, 2005, GLOBAL CHANGE BIOL, V11, P167, DOI 10.1111/j.1365-2486.2004.00878.x; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Hartley IP, 2008, ECOL LETT, V11, P1092, DOI 10.1111/j.1461-0248.2008.01223.x; Hartley IP, 2008, SOIL BIOL BIOCHEM, V40, P1567, DOI 10.1016/j.soilbio.2008.01.007; Hartley IP, 2007, GLOBAL CHANGE BIOL, V13, P1761, DOI 10.1111/j.1365-2486.2007.01373.x; Holland EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1137, DOI 10.1029/2000GB001264; HOWARD DM, 1993, SOIL BIOL BIOCHEM, V25, P1537, DOI 10.1016/0038-0717(93)90008-Y; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Luo CY, 2009, SOIL BIOL BIOCHEM, V41, P2493, DOI 10.1016/j.soilbio.2009.09.006; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Nie M, 2013, ECOL LETT, V16, P234, DOI 10.1111/ele.12034; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1754, DOI 10.1111/j.1365-2486.2005.001010.x; Rey A, 2005, EUR J SOIL SCI, V56, P589, DOI 10.1111/j.1365-2389.2004.00699.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Subke JA, 2010, SOIL BIOL BIOCHEM, V42, P1653, DOI 10.1016/j.soilbio.2010.05.026; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Trumbore SE, 1996, SCIENCE, V272, P393, DOI 10.1126/science.272.5260.393; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Waldrop MP, 2004, BIOGEOCHEMISTRY, V67, P235, DOI 10.1023/B:BIOG.0000015321.51462.41; Wang SP, 2012, ECOLOGY, V93, P2365, DOI 10.1890/11-1408.1; Williams MA, 2007, SOIL BIOL BIOCHEM, V39, P2750, DOI 10.1016/j.soilbio.2007.05.025; WRB, 1998, WORLD REF BAS SOIL R; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x	48	30	32	11	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165212	10.1371/journal.pone.0165212	http://dx.doi.org/10.1371/journal.pone.0165212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798671	Green Submitted, Green Published, gold			2022-12-26	WOS:000386711100023
J	Stavropoulos, KKM; Carver, LJ				Stavropoulos, Katherine Kuhl-Meltzoff; Carver, Leslie J.			Neural Correlates of Attention to Human-Made Sounds: An ERP Study	PLOS ONE			English	Article							VOICE PERCEPTION; FACE PERCEPTION; CORTEX; P300; SPEECH; TASK; DISCRIMINATION; SENSITIVITY; STIMULI; NOVELTY	Previous neuroimaging and electrophysiological studies have suggested that human made sounds are processed differently from non-human made sounds. Multiple groups have suggested that voices might be processed as "special," much like faces. Although previous literature has explored neural correlates of voice perception under varying task demands, few studies have examined electrophysiological correlates of attention while directly comparing human made and non-human made sounds. In the present study, we used event-related potentials (ERPs) to compare attention to human versus non-human made sounds in an oddball paradigm. ERP components of interest were the P300, and fronto-temporal positivity to voices (FTVP), which has been reported in previous investigations of voice versus non-voice stimuli. We found that participants who heard human made sounds as "target" or infrequent stimuli had significantly larger FTPV amplitude, shorter FTPV latency, and larger P300 amplitude than those who heard non-human sounds as "target" stimuli. Our results are in concordance with previous findings that human-made and non-human made sounds are processed differently, and expand upon previous literature by demonstrating increased attention to human versus non-human made sounds, even when the non-human made sounds are ones that require immediate attention in daily life (e.g. a car horn). Heightened attention to human-made sounds is important theoretically and has potential for application in tests of social interest in populations with autism.	[Stavropoulos, Katherine Kuhl-Meltzoff] Univ Calif Riverside, Riverside, CA 92521 USA; [Carver, Leslie J.] Univ Calif San Diego, San Diego, CA 92103 USA	University of California System; University of California Riverside; University of California System; University of California San Diego	Stavropoulos, KKM (corresponding author), Univ Calif Riverside, Riverside, CA 92521 USA.	katherine.stavropoulos@ucr.edu		Stavropoulos, Katherine/0000-0001-6371-7808				Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; Belizaire G, 2007, NEUROREPORT, V18, P29; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Capilla A, 2013, CEREB CORTEX, V23, P1388, DOI 10.1093/cercor/bhs119; Charest I, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-127; De Lucia M, 2010, J NEUROSCI, V30, P11210, DOI 10.1523/JNEUROSCI.2239-10.2010; Engel LR, 2009, NEUROIMAGE, V47, P1778, DOI 10.1016/j.neuroimage.2009.05.041; FABIANI M, 1995, PSYCHOPHYSIOLOGY, V32, P579, DOI 10.1111/j.1469-8986.1995.tb01234.x; Fecteau S, 2005, J NEUROPHYSIOL, V94, P2251, DOI 10.1152/jn.00329.2005; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Gunji A, 2003, NEUROSCI LETT, V348, P13, DOI 10.1016/S0304-3940(03)00640-2; Ilan AB, 1999, CLIN NEUROPHYSIOL, V110, P367, DOI 10.1016/S0168-5597(98)00053-7; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; Levy DA, 2001, NEUROREPORT, V12, P2653, DOI 10.1097/00001756-200108280-00013; Levy DA, 2003, PSYCHOPHYSIOLOGY, V40, P291, DOI 10.1111/1469-8986.00031; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Luck S.J., 2005, INTRO EVENT RELATED; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Murray MM, 2006, J NEUROSCI, V26, P1293, DOI 10.1523/JNEUROSCI.4511-05.2006; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; POLICH J, 1986, ELECTROEN CLIN NEURO, V65, P236, DOI 10.1016/0168-5597(86)90059-6; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192	33	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165745	10.1371/journal.pone.0165745	http://dx.doi.org/10.1371/journal.pone.0165745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798701	Green Published, gold			2022-12-26	WOS:000386711100059
J	Bekesi, N; Dorronsoro, C; de la Hoz, A; Marcos, S				Bekesi, Nandor; Dorronsoro, Carlos; de la Hoz, Andres; Marcos, Susana			Material Properties from Air Puff Corneal Deformation by Numerical Simulations on Model Corneas	PLOS ONE			English	Article							COLLAGEN CROSS-LINKING; BIOMECHANICAL PROPERTIES; MECHANICAL-PROPERTIES; PORCINE; STRAIN; ORGANIZATION; ORIENTATION; KERATOCONUS; MICROSCOPY	Objective To validate a new method for reconstructing corneal biomechanical properties from air puff corneal deformation images using hydrogel polymer model corneas and porcine corneas. Methods Air puff deformation imaging was performed on model eyes with artificial corneas made out of three different hydrogel materials with three different thicknesses and on porcine eyes, at constant intraocular pressure of 15 mmHg. The cornea air puff deformation was modeled using finite elements, and hyperelastic material parameters were determined through inverse modeling, minimizing the difference between the simulated and the measured central deformation amplitude and central-peripheral deformation ratio parameters. Uniaxial tensile tests were performed on the model cornea materials as well as on corneal strips, and the results were compared to stress-strain simulations assuming the reconstructed material parameters. Results The measured and simulated spatial and temporal profiles of the air puff deformation tests were in good agreement (< 7% average discrepancy). The simulated stress-strain curves of the studied hydrogel corneal materials fitted well the experimental stress-strain curves from uniaxial extensiometry, particularly in the 0-0.4 range. Equivalent Young's moduli of the reconstructed material properties from air-puff were 0.31, 0.58 and 0.48 MPa for the three polymer materials respectively which differed < 1% from those obtained from extensiometry. The simulations of the same material but different thickness resulted in similar reconstructed material properties. The air-puff reconstructed average equivalent Young's modulus of the porcine corneas was 1.3 MPa, within 18% of that obtained from extensiometry. Conclusions Air puff corneal deformation imaging with inverse finite element modeling can retrieve material properties of model hydrogel polymer corneas and real corneas, which are in good correspondence with those obtained from uniaxial extensiometry, suggesting that this is a promising technique to retrieve quantitative corneal biomechanical properties.	[Bekesi, Nandor; Dorronsoro, Carlos; de la Hoz, Andres; Marcos, Susana] CSIC, Inst Opt Daza de Valdes, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Optica (Daza de Valdes)	Bekesi, N (corresponding author), CSIC, Inst Opt Daza de Valdes, Madrid, Spain.	nandor.bekesi@io.cfmac.csic.es	Dorronsoro, Carlos/AAC-8003-2019; Dorronsoro, Carlos/A-2297-2011	Dorronsoro, Carlos/0000-0001-5968-1128; Dorronsoro, Carlos/0000-0001-5968-1128	European Research Council under the European Union's Seventh Framework Program ERC Advanced Grant agreement [294099]; Comunidad de Madrid; EU Marie Curie COFUND program (FP7) [291820]; Ministerio de Economia y Competitividad [FIS2014-56643-R, FIS2013-49544-EXP]; Ministerio de Economia y Competitividad FPI Fellowship [BES-2015-072197]	European Research Council under the European Union's Seventh Framework Program ERC Advanced Grant agreement; Comunidad de Madrid(Comunidad de Madrid); EU Marie Curie COFUND program (FP7); Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Economia y Competitividad FPI Fellowship	This work was supported by the European Research Council under the European Union's Seventh Framework Program ERC Advanced Grant agreement no. 294099 (erc.europa.eu) to SM; Comunidad de Madrid and EU Marie Curie COFUND program (FP7) 291820 (mvisionconsortium.org/) to NB; Ministerio de Economia y Competitividad Grant FIS2014-56643-R (www.mineco.gob.es) to SM; Ministerio de Economia y Competitividad Grant FIS2013-49544-EXP (www.mineco.gob.es) to CD; Ministerio de Economia y Competitividad FPI Fellowship BES-2015-072197 (www.idi.mineco.gob.es) to AdlH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abahussin M, 2009, INVEST OPHTH VIS SCI, V50, P5159, DOI 10.1167/iovs.09-3669; Abass A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0717; Alonso-Caneiro D, 2011, OPT EXPRESS, V19, P14188, DOI 10.1364/OE.19.014188; ANDREASSEN TT, 1980, EXP EYE RES, V31, P435, DOI 10.1016/S0014-4835(80)80027-3; Ansys, WORKB V15 0 US MAN; Bekesi N, 2014, INVEST OPHTH VIS SCI, V55; Bekesi N, 2016, INVEST OPHTH VIS SCI, V57, P992, DOI 10.1167/iovs.15-18689; Bekesi N, 2015, INVEST OPHTH VIS SCI, V56; Bekesi N, 2011, J TRIBOL-T ASME, V133, DOI 10.1115/1.4004301; Boschetti F, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006089; BRYANT MR, 1994, INVEST OPHTH VIS SCI, V35, P3022; Claes LE, 2009, CLIN ORTHOP RELAT R, V467, P1964, DOI 10.1007/s11999-009-0752-7; Correia FF, 2013, ARQ BRAS OFTALMOL, V76, P278, DOI 10.1590/S0004-27492013000500005; Dias JM, 2013, EXP EYE RES, V115, P41, DOI 10.1016/j.exer.2013.06.004; Dorronsoro C, 2012, BIOMED OPT EXPRESS, V3, P473, DOI 10.1364/BOE.3.000473; Elsheikh A, 2011, ACTA BIOENG BIOMECH, V13, P25; Elsheikh A, 2009, EXP EYE RES, V88, P1084, DOI 10.1016/j.exer.2009.01.010; Fritsch A, 2010, NAT PHYS, V6, P730, DOI 10.1038/nphys1800; Guerin AP, 2008, CURR OPIN NEPHROL HY, V17, P635, DOI 10.1097/MNH.0b013e32830dcd5c; Hollman KW, 2013, ULTRASOUND MED BIOL, V39, P1451, DOI 10.1016/j.ultrasmedbio.2013.02.465; Jester JV, 2010, EYE CONTACT LENS, V36, P260, DOI 10.1097/ICL.0b013e3181ee8992; Kling S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0920; Kling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104904; Kling S, 2013, INVEST OPHTH VIS SCI, V54, P5078, DOI 10.1167/iovs.13-12509; Kling S, 2013, J REFRACT SURG, V29, P490, DOI 10.3928/1081597X-20130617-08; Kling S, 2013, INVEST OPHTH VIS SCI, V54, P881, DOI 10.1167/iovs.12-10852; Kling S, 2012, INVEST OPHTH VIS SCI, V53, P5010, DOI 10.1167/iovs.12-9583; Lai T, 2014, BIOMED OPT EXPRESS, V5, P1494, DOI 10.1364/BOE.5.001494; Li JS, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.121503; Litwiller DV, 2010, J MAGN RESON IMAGING, V32, P44, DOI 10.1002/jmri.22217; Liu J, 2007, J BIOMECH, V40, P1177, DOI 10.1016/j.jbiomech.2006.04.017; Meek KM, 2005, INVEST OPHTH VIS SCI, V46, P1948, DOI 10.1167/iovs.04-1253; Meek KM, 1999, J REFRACT SURG, V15, P695; Pandolfi A, 2010, COMPUTATIONAL MODELING IN BIOMECHANICS, P435, DOI 10.1007/978-90-481-3575-2_15; Rad AS, 2004, J REFRACT SURG, V20, pS718, DOI 10.3928/1081-597X-20040903-18; Romero-Jimenez M, 2010, CONTACT LENS ANTERIO, V33, P157, DOI 10.1016/j.clae.2010.04.006; Sandor GL, 2014, J REFRACT SURG, V30, P660, DOI 10.3928/1081597X-20140903-08; Scarcelli G, 2013, INVEST OPHTH VIS SCI, V54, P1418, DOI 10.1167/iovs.12-11387; Simonini I, J MECH PHYS SOLIDS; Valbon BF, 2014, J REFRACT SURG, V30, P468, DOI 10.3928/1081597X-20140521-01; Vito R P, 1989, Refract Corneal Surg, V5, P82; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Zoltan B, 2013, PERIOD POLYTECH-CIV, V57, P3, DOI 10.3311/PPci.2136	43	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165669	10.1371/journal.pone.0165669	http://dx.doi.org/10.1371/journal.pone.0165669			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792759	Green Published, gold, Green Submitted			2022-12-26	WOS:000389537000043
J	Wise, AK; Tan, J; Wang, YJ; Caruso, F; Shepherd, RK				Wise, Andrew K.; Tan, Justin; Wang, Yajun; Caruso, Frank; Shepherd, Robert K.			Improved Auditory Nerve Survival with Nanoengineered Supraparticles for Neurotrophin Delivery into the Deafened Cochlea	PLOS ONE			English	Article							SPIRAL-GANGLION NEURONS; SENSORINEURAL HEARING-LOSS; MESOPOROUS SILICA NANOPARTICLES; ROUND WINDOW MEMBRANE; CELL-BASED THERAPIES; BDNF GENE-THERAPY; INNER HAIR-CELLS; DRUG-DELIVERY; GUINEA-PIGS; IN-VIVO	Cochlear implants electrically stimulate spiral ganglion neurons (SGNs) in order to provide speech cues to severe-profoundly deaf patients. In normal hearing cochleae the SGNs depend on endogenous neurotrophins secreted by sensory cells in the organ of Corti for survival. SGNs gradually degenerate following deafness and consequently there is considerable interest in developing clinically relevant strategies to provide exogenous neurotrophins to preserve SGN survival. The present study investigated the safety and efficacy of a drug delivery system for the cochlea using nanoengineered silica supraparticles. In the present study we delivered Brain-derived neurotrophic factor (BDNF) over a period of four weeks and evaluated SGN survival as a measure of efficacy. Supraparticles were bilaterally implanted into the basal turn of cochleae in profoundly deafened guinea pigs. One ear received BDNF-loaded supraparticles and the other ear control (unloaded) supraparticles. After one month of treatment the cochleae were examined histologically. There was significantly greater survival of SGNs in cochleae that received BDNF supraparticles compared to the contralateral control cochleae (repeated measures ANOVA, p = 0.009). SGN survival was observed over a wide extent of the cochlea. The supraparticles were well tolerated within the cochlea with a tissue response that was localised to the site of implantation in the cochlear base. Although mild, the tissue response was significantly greater in cochleae treated with BDNF supraparticles compared to the controls (repeated measures ANOVA, p = 0.003). These data support the clinical potential of this technology particularly as the supraparticles can be loaded with a variety of therapeutic drugs.	[Wise, Andrew K.; Shepherd, Robert K.] Bion Inst, 384-388 Albert St, Melbourne, Vic, Australia; [Wise, Andrew K.; Shepherd, Robert K.] Univ Melbourne, Dept Med Bion, Melbourne, Vic, Australia; [Wise, Andrew K.; Tan, Justin; Shepherd, Robert K.] Univ Melbourne, Dept Otolaryngol, Melbourne, Vic, Australia; [Wang, Yajun; Caruso, Frank] Univ Melbourne, ARC Ctr Excellence Convergent Bionano Sci & Techn, Melbourne, Vic, Australia; [Wang, Yajun; Caruso, Frank] Univ Melbourne, Dept Chem & Biomol Engn, Melbourne, Vic, Australia	Bionics Institute; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Wise, AK (corresponding author), Bion Inst, 384-388 Albert St, Melbourne, Vic, Australia.; Wise, AK (corresponding author), Univ Melbourne, Dept Med Bion, Melbourne, Vic, Australia.; Wise, AK (corresponding author), Univ Melbourne, Dept Otolaryngol, Melbourne, Vic, Australia.	awise@bionicsinstitute.org	Caruso, Frank/A-9587-2011; Wang, Yajun/C-6394-2008; Wise, Andrew/B-5943-2014	Caruso, Frank/0000-0002-0197-497X; Wang, Yajun/0000-0002-7557-5883; Tan, Justin/0000-0002-5098-383X; Wise, Andrew/0000-0001-9715-8784	National Health and Medical Research Council [APP1005071, APP1064375]; Australian Research Council [120100030]; National Institutes of Health (USA) [HHS-N-263-2007-00053-C]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Health and Medical Research Council Project Grant APP1005071 and APP1064375, Australian Research Council under the Australian Laureate Fellowship scheme (120100030), and National Institutes of Health (USA) HHS-N-263-2007-00053-C.	Agterberg MJH, 2008, HEARING RES, V244, P25, DOI 10.1016/j.heares.2008.07.004; Agterberg MJH, 2009, JARO-J ASSOC RES OTO, V10, P355, DOI 10.1007/s10162-009-0170-2; Agterberg MJ, 2009, THESIS; Atkinson PJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04733; Atkinson PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052338; Backhouse S, 2008, EXP NEUROL, V214, P193, DOI 10.1016/j.expneurol.2008.08.002; Chikar JA, 2012, BIOMATERIALS, V33, P1982, DOI 10.1016/j.biomaterials.2011.11.052; Coleman B, 2006, CELL TRANSPLANT, V15, P369, DOI 10.3727/000000006783981819; Endo T, 2005, LARYNGOSCOPE, V115, P2016, DOI 10.1097/01.mlg.0000183020.32435.59; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Fransson A, 2010, J NEUROTRAUM, V27, P1745, DOI 10.1089/neu.2009.1218; GEERS A, 1984, J SPEECH HEAR DISORD, V49, P378, DOI 10.1044/jshd.4904.378; George SS, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/036003; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Gillespie LN, 2004, NEUROREPORT, V15, P1121, DOI 10.1097/00001756-200405190-00008; Glueckert R, 2008, J COMP NEUROL, V507, P1602, DOI 10.1002/cne.21619; Goldwyn JH, 2010, HEARING RES, V268, P93, DOI 10.1016/j.heares.2010.05.005; Hardie NA, 1999, HEARING RES, V128, P147, DOI 10.1016/S0378-5955(98)00209-3; He XX, 2008, ANAL CHEM, V80, P9597, DOI 10.1021/ac801882g; Irving S, 2013, HEARING RES, V306, P37, DOI 10.1016/j.heares.2013.09.005; Landry TG, 2013, J COMP NEUROL, V521, P2818, DOI 10.1002/cne.23318; Landry TG, 2011, HEARING RES, V282, P303, DOI 10.1016/j.heares.2011.06.007; LEAKE PA, 1988, HEARING RES, V33, P11, DOI 10.1016/0378-5955(88)90018-4; Leake PA, 1997, HEARING RES, V113, P117, DOI 10.1016/S0378-5955(97)00133-0; Leake PA, 2013, JARO-J ASSOC RES OTO, V14, P187, DOI 10.1007/s10162-013-0372-5; Leake PA, 2011, J COMP NEUROL, V519, P1526, DOI 10.1002/cne.22582; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Mai WX, 2013, INTEGR BIOL-UK, V5, P19, DOI 10.1039/c2ib20137b; McGuinness SL, 2005, OTOL NEUROTOL, V26, P1064, DOI 10.1097/01.mao.0000185063.20081.50; NADOL JB, 1989, ANN OTO RHINOL LARYN, V98, P411, DOI 10.1177/000348948909800602; O'Leary SJ, 2013, HEARING RES, V298, P27, DOI 10.1016/j.heares.2013.01.012; Pettingill LN, 2007, IEEE T BIO-MED ENG, V54, P1138, DOI 10.1109/TBME.2007.895375; Pettingill LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018733; Pinyon JL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008177; Plontke SK, 2008, OTOL NEUROTOL, V29, P401, DOI 10.1097/MAO.0b013e318161aaae; Plontke SK, 2007, LARYNGOSCOPE, V117, P1191, DOI 10.1097/MLG.0b013e318058a06b; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Praetorius M, 2007, ACTA OTO-LARYNGOL, V127, P486, DOI 10.1080/00016480600895102; Rejali D, 2007, HEARING RES, V228, P180, DOI 10.1016/j.heares.2007.02.010; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; Roy S, 2012, NANOMEDICINE-UK, V7, P55, DOI [10.2217/NNM.11.84, 10.2217/nnm.11.84]; Seyyedi M, 2014, OTOL NEUROTOL, V35, P1446, DOI 10.1097/MAO.0000000000000443; Shepherd RK, 2005, J COMP NEUROL, V486, P145, DOI 10.1002/cne.20564; Shepherd RK, 2008, HEARING RES, V242, P100, DOI 10.1016/j.heares.2007.12.005; Shibata SB, 2010, EXP NEUROL, V223, P464, DOI 10.1016/j.expneurol.2010.01.011; Shinohara T, 2002, P NATL ACAD SCI USA, V99, P1657, DOI 10.1073/pnas.032677999; Soderquist RG, 2009, J BIOMED MATER RES A, V91A, P719, DOI 10.1002/jbm.a.32254; Soumen R, 2012, NANOMED-NANOTECHNOL, V8, P271, DOI 10.1016/j.nano.2011.12.005; SPOENDLIN H, 1984, ANN OTO RHINOL LARYN, V93, P76, DOI 10.1177/00034894840930S415; Staecker H, 1996, DEV BRAIN RES, V92, P49, DOI 10.1016/0165-3806(95)00198-0; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Takada Y, 2014, HEARING RES, V309, P124, DOI 10.1016/j.heares.2013.11.009; Tan J, 2006, AM J PATHOL, V169, P528, DOI 10.2353/ajpath.2006.060122; Tan J, 2012, ADV MATER, V24, P3362, DOI 10.1002/adma.201200634; Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763; Thompson BC, 2010, J CONTROL RELEASE, V141, P161, DOI 10.1016/j.jconrel.2009.09.016; Waaijer L, 2013, OTOLOGY NEUROTOLOGY; Wan GQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03564; Wang JG, 2010, CHEM MATER, V22, P3829, DOI 10.1021/cm101217k; Wang Q, 2011, J NEUROSCI, V31, P7938, DOI 10.1523/JNEUROSCI.1434-10.2011; Wang YJ, 2014, SMALL, V10, P4244, DOI 10.1002/smll.201401767; Wang YJ, 2009, J MATER CHEM, V19, P6451, DOI 10.1039/b901742a; Wise AK, 2005, J COMP NEUROL, V487, P147, DOI 10.1002/cne.20563; Wise AK, 2011, NEUROTHERAPEUTICS, V8, P774, DOI 10.1007/s13311-011-0070-0; Wise AK, 2011, HEARING RES, V278, P69, DOI 10.1016/j.heares.2011.04.010; Wise AK, 2010, MOL THER, V18, P1111, DOI 10.1038/mt.2010.28; XU SA, 1993, HEARING RES, V70, P205, DOI 10.1016/0378-5955(93)90159-X; YLIKOSKI J, 1993, HEARING RES, V65, P69, DOI 10.1016/0378-5955(93)90202-C; Zanin MP, 2012, J CONTROL RELEASE, V160, P3, DOI 10.1016/j.jconrel.2012.01.021; Zhu ZY, 2012, HEARING RES, V283, P45, DOI 10.1016/j.heares.2011.11.005; Zilberstein Y, 2012, J NEUROSCI, V32, P405, DOI 10.1523/JNEUROSCI.4678-11.2012; ZIMMERMANN CE, 1995, HEARING RES, V90, P192, DOI 10.1016/0378-5955(95)00165-1; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	75	42	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164867	10.1371/journal.pone.0164867	http://dx.doi.org/10.1371/journal.pone.0164867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788219	gold, Green Submitted, Green Published			2022-12-26	WOS:000389604900032
J	Matsunaga, D; Sreekumar, PG; Ishikawa, K; Terasaki, H; Barron, E; Cohen, P; Kannan, R; Hinton, DR				Matsunaga, Douglas; Sreekumar, Parameswaran G.; Ishikawa, Keijiro; Terasaki, Hiroto; Barron, Ernesto; Cohen, Pinchas; Kannan, Ram; Hinton, David R.			Humanin Protects RPE Cells from Endoplasmic Reticulum Stress-Induced Apoptosis by Upregulation of Mitochondrial Glutathione	PLOS ONE			English	Article							SUBUNIT GENE-EXPRESSION; OXIDATIVE STRESS; MACULAR DEGENERATION; ER STRESS; PEPTIDE HUMANIN; PERMEABILITY TRANSITION; DEATH; INVOLVEMENT; SENESCENCE; BAX	Humanin (HN) is a small mitochondrial-encoded peptide with neuroprotective properties. We have recently shown protection of retinal pigmented epithelium (RPE) cells by HN in oxidative stress; however, the effect of HN on endoplasmic reticulum (ER) stress has not been evaluated in any cell type. Our aim here was to study the effect of HN on ER stress-induced apoptosis in RPE cells with a specific focus on ER-mitochondrial cross-talk. Dose dependent effects of ER stressors (tunicamycin (TM), brefeldin A, and thapsigargin) were studied after 12 hr of treatment in confluent primary human RPE cells with or without 12 hr of HN pretreatment (1-20 mu g/mL). All three ER stressors induced RPE cell apoptosis in a dose dependent manner. HN pretreatment significantly decreased the number of apoptotic cells with all three ER stressors in a dose dependent manner. HN pretreatment similarly protected U-251 glioma cells from TM-induced apoptosis in a dose dependent manner. HN pretreatment significantly attenuated activation of caspase 3 and ER stress-specific caspase 4 induced by TM. TM treatment increased mitochondrial superoxide production, and HN co-treatment resulted in a decrease in mitochondrial superoxide compared to TM treatment alone. We further showed that depleted mitochondrial glutathione (GSH) levels induced by TM were restored with HN co-treatment. No significant changes were found for the expression of several antioxidant enzymes between TM and TM plus HN groups except for the expression of glutamylcysteine ligase catalytic subunit (GCLC), the rate limiting enzyme required for GSH biosynthesis, which is upregulated with TM and TM+HN treatment. These results demonstrate that ER stress promotes mitochondrial alterations in RPE that lead to apoptosis. We further show that HN has a protective effect against ER stress-induced apoptosis by restoring mitochondrial GSH. Thus, HN should be further evaluated for its therapeutic potential in disorders linked to ER stress.	[Matsunaga, Douglas; Hinton, David R.] Univ Southern Calif, Keck Sch Med, USC Roski Eye Inst, Dept Pathol & Ophthalmol, Los Angeles, CA 90033 USA; [Sreekumar, Parameswaran G.; Ishikawa, Keijiro; Terasaki, Hiroto; Barron, Ernesto; Kannan, Ram] Doheny Eye Inst, Arnold & Mabel Beckman Macular Res Ctr, Los Angeles, CA 90033 USA; [Cohen, Pinchas] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA USA	University of Southern California; Doheny Eye Institute; University of Southern California	Hinton, DR (corresponding author), Univ Southern Calif, Keck Sch Med, USC Roski Eye Inst, Dept Pathol & Ophthalmol, Los Angeles, CA 90033 USA.	Dhinton@usc.edu	kannan, ram/ABB-7154-2020	kannan, ram/0000-0002-1583-3414; /0000-0002-9425-3986	National Eye Institute [EY01545]; Arnold and Mabel Beckman Foundation; Research to Prevent Blindness, Inc.; Dean's Research Scholar program at the Keck School of Medicine of the University of Southern California	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Arnold and Mabel Beckman Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Dean's Research Scholar program at the Keck School of Medicine of the University of Southern California	Supported in part by National Eye Institute grant EY01545 (DRH), the Arnold and Mabel Beckman Foundation (DRH, RK), and an unrestricted grant to the Department of Ophthalmology from Research to Prevent Blindness, Inc. DM was funded by the Dean's Research Scholar program at the Keck School of Medicine of the University of Southern California.	Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; Bachar AR, 2010, CARDIOVASC RES, V88, P360, DOI 10.1093/cvr/cvq191; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bian ZM, 2009, INVEST OPHTH VIS SCI, V50, P6006, DOI 10.1167/iovs.09-3628; Cai X, 2012, FRONT BIOSCI-LANDMRK, V17, P1976, DOI 10.2741/4033; Campagne MV, 2014, J PATHOL, V232, P151, DOI 10.1002/path.4266; Chen C, 2014, ANTIOXID REDOX SIGN, V20, P2091, DOI 10.1089/ars.2013.5240; Chin YP, 2013, ENDOCRINOLOGY, V154, P3739, DOI 10.1210/en.2012-2004; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Dou GR, 2012, FREE RADICAL BIO MED, V53, P1111, DOI 10.1016/j.freeradbiomed.2012.06.042; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; He SK, 2008, GRAEF ARCH CLIN EXP, V246, P677, DOI 10.1007/s00417-008-0770-2; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hsiung J, 2015, STEM CELL TRANSL MED, V4, P10, DOI 10.5966/sctm.2014-0205; Kariya S, 2003, MOL CELL BIOCHEM, V254, P83, DOI 10.1023/A:1027372519726; Kozlowski MR, 2012, MED HYPOTHESES, V78, P505, DOI 10.1016/j.mehy.2012.01.018; Kuliawat R, 2013, FASEB J, V27, P4890, DOI 10.1096/fj.13-231092; Li CZ, 2012, INVEST OPHTH VIS SCI, V53, P3241, DOI 10.1167/iovs.11-8406; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; Libby RT, 2010, ADV EXP MED BIOL, V664, P403, DOI 10.1007/978-1-4419-1399-9_46; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Lytvyn Y, 2015, CAN J PHYSIOL PHARM, V93, P239, DOI 10.1139/cjpp-2014-0401; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Naylor RM, 2013, CLIN PHARMACOL THER, V93, P105, DOI 10.1038/clpt.2012.193; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Sauer T, 2008, EXPERT REV OPHTHALMO, V3, P29, DOI 10.1586/17469899.3.1.29; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shimazawa M, 2007, MOL VIS, V13, P578; Sponne I, 2004, MOL CELL NEUROSCI, V25, P95, DOI 10.1016/j.mcn.2003.09.017; Sreekumar PG, 2008, INVEST OPHTH VIS SCI, V49, P1210, DOI 10.1167/iovs.07-0667; Sreekumar PG, 2016, INVEST OPHTH VIS SCI, V57, P1238, DOI 10.1167/iovs.15-17053; Sreekumar PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033420; Sreekumar PG, 2009, EXP EYE RES, V88, P410, DOI 10.1016/j.exer.2008.10.009; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Vogt SD, 2011, EXP EYE RES, V93, P413, DOI 10.1016/j.exer.2011.06.002; Voigt A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12796; Wang T, 2013, BEHAV BRAIN RES, V247, P132, DOI 10.1016/j.bbr.2013.03.023; Widmer RJ, 2013, AM J PHYSIOL-HEART C, V304, pH393, DOI 10.1152/ajpheart.00765.2012; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Wild AC, 2000, FREE RADICAL RES, V32, P281, DOI 10.1080/10715760000300291; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamamuro A, 2011, J PHARMACOL SCI, V115, P239, DOI 10.1254/jphs.10217SC; Yen K, 2013, J MOL ENDOCRINOL, V50, pR11, DOI 10.1530/JME-12-0203; Zarbin MA, 2010, RETINA-J RET VIT DIS, V30, P1350, DOI 10.1097/IAE.0b013e3181f57e30; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015; Zhu DH, 2009, J BIOL CHEM, V284, P9529, DOI 10.1074/jbc.M809393200	62	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165150	10.1371/journal.pone.0165150	http://dx.doi.org/10.1371/journal.pone.0165150			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783653	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800060
J	Vargas, J; Landi, V; Martinez, A; Gomez, M; Camacho, ME; Alvarez, LA; Aguirre, L; Delgado, JV				Vargas, Julio; Landi, Vincenzo; Martinez, Amparo; Gomez, Mayra; Esperanza Camacho, Maria; Angela Alvarez, Luz; Aguirre, Lenin; Vicente Delgado, Juan			Molecular Study of the Amazonian Macabea Cattle History	PLOS ONE			English	Article							GENETIC DIVERSITY; BREEDS; CREOLE; DIFFERENTIATION; CONSERVATION	Macabea cattle are the only Bos taurus breed that have adapted to the wet tropical conditions of the Amazon. This breed has integrated into the culture of the indigenous Shuar-Asuar nations probably since its origins, being one of the few European zoogenetic resources assimilated by the deep-jungle Amazon communities. Despite its potential for local endogenous sustainable development, this breed is currently endangered. The present study used molecular genetics tools to investigate the within-and between-breeds diversity, in order to characterize the breed population, define its associations with other breeds, and infer its origin and evolution. The within-breed genetic diversity showed high values, as indicated by all genetic parameters, such as the mean number of alleles (MNA = 7.25 +/- 2.03), the observed heterozygosity (Ho = 0.72 +/- 0.02) and the expected heterozygosity (He = 0.72 +/- 0.02). The between-breeds diversity analysis, which included factorial correspondence analysis, Reynolds genetic distance, neighbor-joining analysis, and genetic structure analysis, showed that the Macabea breed belongs to the group of the American Creoles, with a Southern-Spain origin. Our outcomes demonstrated that the Macabea breed has a high level of purity and null influences of exotic cosmopolitan breeds with European or Asiatic origin. This breed is an important zoogenetic resource of Ecuador, with relevant and unique attributes; therefore, there is an urgent need to develop conservation strategies for the Macabea breed.	[Vargas, Julio] Univ Nacl Amazonica, Rectoria Puyo, Ecuador; [Landi, Vincenzo; Martinez, Amparo; Gomez, Mayra; Vicente Delgado, Juan] Univ Cordoba, Dept Genet, Cordoba, Spain; [Landi, Vincenzo; Martinez, Amparo; Gomez, Mayra] Anim Breeding Consulting SL, Parque Cient Tecnol Cordoba, Cordoba, Spain; [Esperanza Camacho, Maria] Inst Invest & Formac Agr & Pesquera IFAPA, Alameda Obispo, Cordoba, Spain; [Angela Alvarez, Luz] Univ Nacl Colombia Sede Palmira, Palmira, Colombia; [Aguirre, Lenin] Univ Nacl Loja, Loja, Ecuador	Universidad de Cordoba; Universidad Nacional de Colombia	Landi, V (corresponding author), Univ Cordoba, Dept Genet, Cordoba, Spain.; Landi, V (corresponding author), Anim Breeding Consulting SL, Parque Cient Tecnol Cordoba, Cordoba, Spain.	landivincenzo@yahoo.it	Landi, Vincenzo/T-7484-2017; Martinez, Amparo/ABE-6085-2020; Aguirre, Lenin/AHA-1216-2022; Bermejo, Juan Vicente Delgado/Z-6119-2019	Landi, Vincenzo/0000-0003-1385-8439; Martinez, Amparo/0000-0002-6944-0501; Bermejo, Juan Vicente Delgado/0000-0003-1657-8838; Vargas Burgos, Julio Cesar/0000-0003-2789-8730; Camacho Vallejo, Maria Esperanza/0000-0003-0889-9930; Aguirre Riofrio, Lenin/0000-0002-3251-5805; GOMEZ CARPIO, MAYRA MERCEDES/0000-0002-3426-2231	Universidad Estatal Amazonica [Proyect: evaluacion y contribucion al rescate de la biodiversidad de las razas bovinas y porcinas criollas autoctonas en la region amazonica del Ecuador]	Universidad Estatal Amazonica [Proyect: evaluacion y contribucion al rescate de la biodiversidad de las razas bovinas y porcinas criollas autoctonas en la region amazonica del Ecuador]	Support was provided by the Universidad Estatal Amazonica [Proyect: evaluacion y contribucion al rescate de la biodiversidad de las razas bovinas y porcinas criollas autoctonas en la region amazonica del Ecuador].	Abdul-Muneer PM, 2014, GENET RES INT, V2014, DOI 10.1155/2014/691759; Belkhir K., 2003, GENETIX 4 05 LOGICIE; Bradley DG, 1998, EVOL ANTHROPOL, V6, P79, DOI 10.1002/(SICI)1520-6505(1998)6:3<79::AID-EVAN2>3.0.CO;2-R; Canon J, 2011, ANIMAL, V5, P1323, DOI 10.1017/S1751731111000267; Canon J, 2001, GENET SEL EVOL, V33, P311, DOI 10.1051/gse:2001121; Ceccobelli S, 2013, ITAL J ANIM SCI, V12, DOI 10.4081/ijas.2013.e66; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Delgado JV, 2012, ANIM GENET, V43, P2, DOI 10.1111/j.1365-2052.2011.02207.x; Egito AA, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-83; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2005, SEC GUID DEV NAT FAR; FAO, 2007, ASFD; FAO, 2004, SEC GUID DEV NAT FAR; Ginja C, 2010, J HERED, V101, P201, DOI 10.1093/jhered/esp104; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jay F, 2012, MOL ECOL, V21, P2354, DOI 10.1111/j.1365-294X.2012.05541.x; Langella O, 1999, POPULATION GENETIC S; Martin-Burriel I, 2011, J ANIM SCI, V89, P893, DOI 10.2527/jas.2010-3338; Martinez AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049066; Mateus JC, 2004, ANIM GENET, V35, P106, DOI 10.1111/j.1365-2052.2004.01089.x; Park SDE, 2001, TRYPANOTOLERANCE W A; Liron JP, 2006, J HERED, V97, P331, DOI 10.1093/jhered/esl003; Primo A. T., 1992, Archivos de Zootecnia, V41, P421; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2012, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REYNOLDS J, 1983, GENETICS, V105, P767; Rischkowsky B, 2007, STAT WORLDS AN GEN R; Rosenberg N.A, 2002, DISTRUCT PROGRAM GRA; Rosset E., 2000, CONQUISTA AMAZONAS I; Salamon D, 2014, ANIMAL, V8, P200, DOI 10.1017/S1751731113002243; Tapio I, 2006, CONSERV BIOL, V20, P1768, DOI 10.1111/j.1523-1739.2006.00488.x; Cortes AIV, 2010, LIVEST SCI, V131, P45, DOI 10.1016/j.livsci.2010.02.024; Villalobos-Cortes A, 2015, ITAL J ANIM SCI, V14, P158, DOI 10.4081/ijas.2015.3280; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS, 1990, GENETIC DATA ANAL	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165398	10.1371/journal.pone.0165398	http://dx.doi.org/10.1371/journal.pone.0165398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776178	gold, Green Submitted, Green Published			2022-12-26	WOS:000389009200063
J	Westrom, S; Bonsdorff, TB; Abbas, N; Bruland, OS; Jonasdottir, TJ; Maelandsmo, GM; Larsen, RH				Westrom, Sara; Bonsdorff, Tina B.; Abbas, Nasir; Bruland, Oyvind S.; Jonasdottir, Thora J.; Maelandsmo, Gunhild M.; Larsen, Roy H.			Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma	PLoS One			English	Article							CELL-ADHESION MOLECULE; FULLY HUMAN-ANTIBODIES; GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODY; POOR-PROGNOSIS; HUMAN-MELANOMA; HUMAN SARCOMA; TUMOR-GROWTH; IN-VITRO; EXPRESSION	Background Osteosarcoma is a rare form of cancer but with a substantial need for new active drugs. There is a particular need for targeted therapies to combat metastatic disease. One possible approach is to use an antibody drug conjugate or an antibody radionuclide conjugate to target the osteosarcoma metastases and circulating tumor cells. Herein we have evaluated a radiolabeled monoclonal antibody targeting CD146 both in vitro and in vivo. Methods and Results A murine monoclonal anti-CD146 IgG1 isotype antibody, named OI-3, was developed along with recombinant chimeric versions with human IgG1 or human IgG3 Fc sequences. Using flow cytometry, selective binding of OI-3 to human osteosarcoma cell lines OHS, KPDX and Saos-2 was confirmed. The results confirm a higher expression level of CD146 on human osteosarcoma cells than HER2 and EGFR; antigens targeted by commercially available therapeutic antibodies. The biodistribution of I-125-labeled OI-3 antibody variants was compared with I-125-labeled chimeric anti-EGFR antibody cetuximab in nude mice with subcutaneous OHS osteosarcoma xenografts. OI-3 was able to target CD146 expressing tumors in vivo and showed improved tumor to tissue targeting ratios compared with cetuximab. Subsequently, the three OI-3 variants were conjugated with p-SCN-Bn-DOTA and labeled with a more therapeutically relevant radionuclide, Lu-177, and their biodistributions were studied in the nude mouse model. The Lu-177-labeled OI-3 variants were stable and had therapeutically relevant biodistribution profiles. Dosimetry estimates showed higher absorbed radiation dose to tumor than all other tissues after administration of the chimeric IgG1 OI-3 variant. Conclusion Our results indicate that CD146 can be targeted in vivo by the radiolabeled OI-3 antibodies.	[Westrom, Sara; Bonsdorff, Tina B.; Abbas, Nasir; Jonasdottir, Thora J.] Oncoinvent AS, Oslo, Norway; [Westrom, Sara; Maelandsmo, Gunhild M.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Westrom, Sara; Bruland, Oyvind S.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Bruland, Oyvind S.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway; [Larsen, Roy H.] Sciencons AS, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Larsen, RH (corresponding author), Sciencons AS, Oslo, Norway.	royhlars1@yahoo.no	Mælandsmo, Gunhild Mari/AFV-4446-2022	Westrom, Sara/0000-0001-9556-3807; Bruland, Oyvind Sverre/0000-0003-1631-3733	Innovation Norway [OLBOR-2012/109827]; Norwegian Research Council [235531, 237661]; Oncoinvent AS	Innovation Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission); Oncoinvent AS	This study was funded by: Innovation Norway (www.innovasionnorge.no, OLBOR-2012/109827, Recipient: TBB), the Norwegian Research Council (www.forskningsradet.no, grant numbers 235531 and 237661, Recipients: TJJ and SW, respectively) and Oncoinvent AS (www.oncoinvent.com). The funder provided support in the form of salaries for authors [SW, TBB, NA, OSB, TJJ, RHL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abgenix Inc, 2005, ANN REP 2004 ABG INC; Aldovini D, 2006, INT J CANCER, V119, P1920, DOI 10.1002/ijc.22082; ANDERSON PM, 1995, CANCER RES, V55, P1321; Bacci G, 2005, ACTA ONCOL, V44, P748, DOI 10.1080/02841860500327503; Bidlingmaier S, 2009, CANCER RES, V69, P1570, DOI 10.1158/0008-5472.CAN-08-1363; Bonsdorff TB, 2015, PCTEP2014070395, Patent No. PCT/EP2014/070395; Bruiand OS, 2005, CLIN CANCER RES, V11, P4666, DOI [10.1158/1078-0432.CCR-05-0165, DOI 10.1158/1078-0432.CCR-05-0165]; BRULAND O, 1987, BRIT J CANCER, V56, P21, DOI 10.1038/bjc.1987.146; BRULAND OS, 1988, CANCER RES, V48, P5302; Bruland OS, 2009, CANCER TREAT RES, V152, P509, DOI 10.1007/978-1-4419-0284-9_30; Council of Europe, 1986, COUNC EUR TREAT SER, V123; Dahle J, 2013, ANTICANCER RES, V33, P85; Davies CD, 2001, BRIT J CANCER, V85, P1968, DOI 10.1054/bjoc.2001.2180; De Barros Ana, 2015, MICROCONSTANTS CHINA; Dumars C, 2015, ECTS IBMS; Ebb D, 2012, J CLIN ONCOL, V30, P2545, DOI 10.1200/JCO.2011.37.4546; Ferrari S, 2003, J CLIN ONCOL, V21, P710, DOI 10.1200/JCO.2003.03.141; Hattinger CM, 2015, EXPERT OPIN EMERG DR, V20, P495, DOI 10.1517/14728214.2015.1051965; Kempf-Bielack B, 2005, J CLIN ONCOL, V23, P559, DOI 10.1200/JCO.2005.04.063; Kristiansen G, 2003, ANAL CELL PATHOL, V25, P77, DOI 10.1155/2003/574829; LARSEN RH, 1994, RADIAT RES, V139, P178, DOI 10.2307/3578662; LARSEN RH, 1994, J LABELLED COMPD RAD, V34, P773, DOI 10.1002/jlcr.2580340811; Lee JA, 2012, CANCER RES TREAT, V44, P202, DOI 10.4143/crt.2012.44.3.202; LUCA M, 1993, MELANOMA RES, V3, P35, DOI 10.1097/00008390-199304000-00006; Ma Q, 2012, ONCOL LETT, V3, P797, DOI 10.3892/ol.2012.558; McGary EC, 2003, CLIN CANCER RES, V9, P6560; Melnikova VO, 2006, PIGM CELL RES, V19, P395, DOI 10.1111/j.1600-0749.2006.00331.x; Miller WH, 2005, CANCER BIOTHER RADIO, V20, P436, DOI 10.1089/cbr.2005.20.436; Mills L, 2002, CANCER RES, V62, P5106; Mohseny AB, 2011, LAB INVEST, V91, P1195, DOI 10.1038/labinvest.2011.72; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Pahl JHW, 2012, CLIN CANCER RES, V18, P432, DOI 10.1158/1078-0432.CCR-11-2277; Pihl A., 1985, INT J CANCER, V35, P793; Repetto Llamazares AH, 2013, CURR RADIOPHARM, V6, P20, DOI [10.2174/1874471011306010004, DOI 10.2174/1874471011306010004]; Repetto-Llamazares A, 2014, ANTICANCER RES, V34, P3263; Roberts SS, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00181; Satelli A, 2014, CANCER RES, V74, P1645, DOI 10.1158/0008-5472.CAN-13-1739; Schiano C, 2012, MED ONCOL, V29, P2998, DOI 10.1007/s12032-012-0158-3; SERS C, 1994, CANCER RES, V54, P5689; Shih IM, 1998, MODERN PATHOL, V11, P1098; SMELAND E, 1985, SCAND J IMMUNOL, V21, P205, DOI 10.1111/j.1365-3083.1985.tb01422.x; Solheim OP, 1986, INT J CANCER, V38, P33; Thomann S, 2014, ONCOTARGET, V5, P8614, DOI 10.18632/oncotarget.2345; Trippett TM, 2009, J CLIN ONCOL, V27, P5102, DOI 10.1200/JCO.2008.20.8975; Tu T, 2015, CELL RES, V25, P275, DOI 10.1038/cr.2015.15; Wang ZQ, 2013, CANCER LETT, V330, P150, DOI 10.1016/j.canlet.2012.11.049; Wei QX, 2015, ONCOTARGET, V6, P40283, DOI 10.18632/oncotarget.5375; Wu GJ, 2001, PROSTATE, V48, P305, DOI 10.1002/pros.1111; Wu Z, 2012, TUMOR BIOL, V33, P1619, DOI 10.1007/s13277-012-0417-0; Yan XY, 2003, BLOOD, V102, P184, DOI 10.1182/blood-2002-04-1004; YUAN JH, 1993, J PHARM SCI, V82, P761, DOI 10.1002/jps.2600820718; Zabouo G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2215; Zigler M, 2008, AM J CLIN DERMATOL, V9, P307, DOI 10.2165/00128071-200809050-00004	53	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165382	10.1371/journal.pone.0165382	http://dx.doi.org/10.1371/journal.pone.0165382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776176	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200060
J	Fan, H; Cui, Z; Zhang, H; Mani, SK; Diab, A; Lefrancois, L; Fares, N; Merle, P; Andrisani, O				Fan, H.; Cui, Z.; Zhang, H.; Mani, S. K.; Diab, A.; Lefrancois, L.; Fares, N.; Merle, P.; Andrisani, O.			DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection	ONCOGENE			English	Article							RNA-POLYMERASE-II; STEM-CELL PLURIPOTENCY; PROTEIN 4; METHYLATION; TRANSCRIPTION; EXPRESSION; PROMOTER; COMPLEX; ESBAF	Sal-like protein 4 (SALL4), an embryonic stem cell transcriptional regulator, is re-expressed by an unknown mechanism in poor prognosis hepatocellular carcinoma (HCC), often associated with chronic hepatitis B virus (HBV) infection. Herein, we investigated the mechanism of SALL4 re-expression in HBV-related HCCs. We performed bisulfite sequencing PCR of genomic DNA isolated from HBV-related HCCs and HBV replicating cells, and examined DNA methylation of a CpG island located downstream from SALL4 transcriptional start site (TSS). HBV-related HCCs expressing increased SALL4 exhibited demethylation of specific CpG sites downstream of SALL4 TSS. Similarly, SALL4 re-expression and demethylation of these CpGs was observed in HBV replicating cells. SALL4 is also re-expressed in poor prognosis HCCs of other etiologies. Indeed, increased SALL4 expression in hepatitis C virus-related HCCs correlated with demethylation of these CpG sites. To understand how CpG demethylation downstream of SALL4 TSS regulates SALL4 transcription, we quantified by chromatin immunoprecipitation (ChIP) assays RNA polymerase II occupancy of SALL4 gene, as a function of HBV replication. In absence of HBV replication, RNA polymerase II associated with SALL4 exon1. By contrast, in HBV replicating cells RNA polymerase II occupancy of all SALL4 exons increased, suggesting CpG demethylation downstream from SALL4 TSS influences SALL4 transcriptional elongation. Intriguingly, demethylated CpGs downstream from SALL4 TSS are within binding sites of octamer-binding transcription factor 4 (OCT4) and signal transducer and activator of transcription3 (STAT3). ChIP assays confirmed occupancy of these sites by OCT4 and STAT3 in HBV replicating cells, and sequential ChIP assays demonstrated co-occupancy with chromatin remodeling BRG1/Brahma-associated factors. BRG1 knockdown reduced SALL4 expression, whereas BRG1 overexpression increased SALL4 transcription in HBV replicating cells. We conclude demethylation of CpGs located within OCT4 and STAT3 cis-acting elements, downstream of SALL4 TSS, enables OCT4 and STAT3 binding, recruitment of BRG1, and enhanced RNA polymerase II elongation and SALL4 transcription.	[Fan, H.; Cui, Z.; Zhang, H.; Mani, S. K.; Diab, A.; Andrisani, O.] Dept Basic Med Sci, W Lafayette, IN USA; [Fan, H.; Cui, Z.; Zhang, H.; Mani, S. K.; Diab, A.; Andrisani, O.] Purdue Univ, Purdue Ctr Canc Res, 205 Hansen Bldg,201 South Univ St, W Lafayette, IN 47907 USA; [Lefrancois, L.; Fares, N.; Merle, P.] INSERM, UMR 1052, Ctr Rech Cancerol Lyon, Lyon, France	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Andrisani, O (corresponding author), Purdue Univ, Dept Basic Med Sci, 205 Hansen Bldg,201 South Univ St, W Lafayette, IN 47907 USA.	andrisao@purdue.edu	Diab, Ahmed/X-5165-2018; Kailasam Mani, Saravana Kumar/I-8731-2019	Diab, Ahmed/0000-0001-6626-7013; Kailasam Mani, Saravana Kumar/0000-0002-0407-2314; Andrisani, Ourania/0000-0002-6230-0303; Fares, Nadim/0000-0002-8954-3938	NIH [DK044533, P30CA023168]; French grants PAIR-CHC from Institute National du Cancer (INCa) [2009-143]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044533] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French grants PAIR-CHC from Institute National du Cancer (INCa); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant DK044533 to OA, and French grants PAIR-CHC 2009 (contract #2009-143, project ENELIVI) from Institute National du Cancer (INCa) to PM. Shared Resources (flow cytometry and DNA sequencing) are supported by NIH grant P30CA023168 to Purdue Center for Cancer Research.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bard JD, 2009, FASEB J, V23, P1405, DOI 10.1096/fj.08-117721; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Choi JK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r89; Fan H, 2016, ONCOGENE, V35, P715, DOI 10.1038/onc.2015.122; Gong FD, 2015, GENE DEV, V29, P197, DOI 10.1101/gad.252189.114; He J, 2013, INT J BIOCHEM CELL B, V45, P1962, DOI 10.1016/j.biocel.2013.06.008; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jung YK, 2016, ANN SURG TREAT RES, V91, P23, DOI 10.4174/astr.2016.91.1.23; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liao HF, 2014, DEVELOPMENT, V141, P2402, DOI 10.1242/dev.105130; Liu H, 2004, BLOOD, V104, P2505, DOI 10.1182/blood-2004-02-0483; Mani SKK, 2016, J HEPATOL, V65, P888, DOI 10.1016/j.jhep.2016.05.022; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Marquardt JU, 2013, NEW ENGL J MED, V368, P2316, DOI 10.1056/NEJMe1303026; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Nishino K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013017; Oikawa T, 2013, HEPATOLOGY, V57, P1469, DOI 10.1002/hep.26159; Oikawa T, 2009, GASTROENTEROLOGY, V136, P1000, DOI 10.1053/j.gastro.2008.11.018; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Park H, 2015, J PATHOL TRANSL MED, V49, P373, DOI 10.4132/jptm.2015.07.09; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Selth LA, 2009, COLD SPRING HARBOR P, V2009; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Veloso A, 2014, GENOME RES, V24, P896, DOI 10.1101/gr.171405.113; Yang JC, 2012, J BIOL CHEM, V287, P1996, DOI 10.1074/jbc.M111.308734; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yin F, 2016, WORLD J GASTROENTERO, V22, P2837, DOI 10.3748/wjg.v22.i9.2837; Yong KJ, 2013, NEW ENGL J MED, V368, P2266, DOI 10.1056/NEJMoa1300297; Zeng SS, 2014, J HEPATOL, V60, P127, DOI 10.1016/j.jhep.2013.08.024; Zhang H, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/175940; Zhang H, 2016, HEPATOLOGY, V64, P1033, DOI 10.1002/hep.28698; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	41	22	23	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 27	2017	36	17					2435	2445		10.1038/onc.2016.399	http://dx.doi.org/10.1038/onc.2016.399			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET4QE	27797380	Green Accepted			2022-12-26	WOS:000400268900009
J	Matsumura, K; Kawasaki, Y; Miyamoto, M; Kamoshida, Y; Nakamura, J; Negishi, L; Suda, S; Akiyama, T				Matsumura, K.; Kawasaki, Y.; Miyamoto, M.; Kamoshida, Y.; Nakamura, J.; Negishi, L.; Suda, S.; Akiyama, T.			f0 The novel G-quadruplex-containing long non-coding RNA GSEC antagonizes DHX36 and modulates colon cancer cell migration	ONCOGENE			English	Article							HUMAN COLORECTAL-CANCER; TETRAMOLECULAR QUADRUPLEX; RESOLVING ACTIVITY; PROSTATE-CANCER; MAJOR SOURCE; PROMOTES; EXPRESSION; METASTASIS; GROWTH; GENE	Long non-coding RNAs (lncRNAs) are frequently dysregulated in a variety of human cancers. However, their biological roles in these cancers remain incompletely understood. In this study, we analyze the gene expression profiles of colon cancer tissues and identify a previously unannotated lncRNA, FLJ39051, that we term GSEC (G-quadruplex-forming sequence containing lncRNA), as a lncRNA that is upregulated in colorectal cancer. We further demonstrate that knockdown of GSEC results in the reduction of colon cancer cell motility. We also show that GSEC binds to the DEAH box polypeptide 36 (DHX36) RNA helicase via its G-quadruplex-forming sequence and inhibits DHX36 G-quadruplex unwinding activity. Moreover, knockdown of DHX36 restores the reduced migratory activity of colon cancer cells caused by GSEC knockdown. These results suggest that GSEC plays an important role in colon cancer cell migration by inhibiting the function of DHX36 via its G-quadruplex structure.	[Matsumura, K.; Kawasaki, Y.; Miyamoto, M.; Kamoshida, Y.; Nakamura, J.; Negishi, L.; Suda, S.; Akiyama, T.] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo, Japan	University of Tokyo	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	akiyama@iam.u-tokyo.ac.jp			Research Program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [13J08104]	Research Program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (Integrative Research on Cancer Microenvironment Network) and Research Program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan and Japan Society for the Promotion of Science Grant-in-Aid for JSPS Fellows (Grant Number 13J08104).	Arab K, 2014, MOL CELL, V55, P604, DOI 10.1016/j.molcel.2014.06.031; Bicker S, 2013, GENE DEV, V27, P991, DOI 10.1101/gad.211243.112; Bierhoff H, 2014, MOL CELL, V54, P675, DOI 10.1016/j.molcel.2014.03.032; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Booy EP, 2014, NUCLEIC ACIDS RES, V42, P3346, DOI 10.1093/nar/gkt1340; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Graham Lloyd D, 2011, Genes Cancer, V2, P829, DOI 10.1177/1947601911431081; Gumireddy K, 2013, EMBO J, V32, P2672, DOI 10.1038/emboj.2013.188; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Huang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.541; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Jayaraj GG, 2012, RNA BIOL, V9, P81, DOI 10.4161/rna.9.1.18047; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kim HN, 2011, J BONE MINER RES, V26, P2161, DOI 10.1002/jbmr.426; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Liu XF, 2012, EMBO J, V31, P4415, DOI 10.1038/emboj.2012.292; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; O'Leary VB, 2015, CELL REP, V11, P474, DOI 10.1016/j.celrep.2015.03.043; Prensner JR, 2013, NAT GENET, V45, P1392, DOI 10.1038/ng.2771; Richards EJ, 2015, J BIOL CHEM, V290, P6857, DOI 10.1074/jbc.M114.610915; Sun M, 2015, MOL CELL, V59, P698, DOI 10.1016/j.molcel.2015.06.023; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35; Xing Z, 2014, CELL, V159, P1110, DOI 10.1016/j.cell.2014.10.013; Yanagida S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01305; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010	44	63	66	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	9					1191	1199		10.1038/onc.2016.282	http://dx.doi.org/10.1038/onc.2016.282			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2SV	27797375				2022-12-26	WOS:000395861300003
J	Yin, QH; Zhang, R; Li, L; Wang, YT; Liu, JP; Zhang, J; Bai, L; Cheng, JQ; Fu, P; Liu, F				Yin, Qing-hua; Zhang, Rui; Li, Li; Wang, Yi-ting; Liu, Jing-ping; Zhang, Jie; Bai, Lin; Cheng, Jing-qiu; Fu, Ping; Liu, Fang			Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; RENAL LIPID-METABOLISM; APOLIPOPROTEIN-A-I; PROTEIN-KINASE; ACCELERATES ATHEROSCLEROSIS; GENE-EXPRESSION; EXPORTER ABCA1; INFLAMMATION; ACTIVATION; ACCUMULATION	ATP-binding cassette transporter A1 (ABCA1), which promotes cholesterol efflux from cells and inhibits inflammatory responses, is highly expressed in the kidney. Research has shown that exendin-4, a glucagon-like peptide-1 receptor (GLP-1R) agonist, promotes ABCA1 expression in multiple tissues and organs; however, the mechanisms underlying exendin-4 induction of ABCA1 expression in glomerular endothelial cells are not fully understood. In this study we investigated the effect of exendin-4 on ABCA1 in glomerular endothelial cells of diabetic kidney disease (DKD) and the possible mechanism. We observed a marked increase in glomerular lipid deposits in tissues of patients with DKD and diabetic apolipoprotein E knock-out (apoE(-/-)) mice by Oil Red O staining and biochemical analysis of cholesterol. We found significantly decreased ABCA1 expression in glomerular endothelial cells of diabetic apoE(-/-) mice and increased renal lipid, cholesterol, and inflammatory cytokine levels. Exendin-4 decreased renal cholesterol accumulation and inflammation and increased cholesterol efflux by up-regulating ABCA1. In human glomerular endothelial cells, GLP-1R-mediated signaling pathways (e.g. Ca2+/calmodulin-dependent protein kinase, cAMP/PKA, PI3K/AKT, and ERK1/2) were involved in cholesterol efflux and inflammatory responses by regulating ABCA1 expression. We propose that exendin-4 increases ABCA1 expression in glomerular endothelial cells, which plays an important role in alleviating renal lipid accumulation, inflammation, and proteinuria in mice with type 2 diabetes.	[Yin, Qing-hua; Zhang, Rui; Li, Li; Wang, Yi-ting; Fu, Ping; Liu, Fang] Sichuan Univ, Div Nephrol, West China Hosp, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China; [Liu, Jing-ping; Zhang, Jie; Bai, Lin; Cheng, Jing-qiu] Sichuan Univ, Regenerat Med Res Ctr, Key Lab Transplant Engn & Immunol, Minist Hlth,West China Hosp, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Sichuan University	Liu, F (corresponding author), Sichuan Univ, Div Nephrol, West China Hosp, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China.	liufangfh@163.com	Liu, Jingping/P-8908-2019; wang, yiting/GYU-5306-2022		National Natural Science Foundation of China [81370823, 81670662]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Grants 81370823 and 81670662 from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Aryal B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12313; Attie AD, 2007, TRENDS BIOCHEM SCI, V32, P172, DOI 10.1016/j.tibs.2007.02.001; Birjmohun RS, 2007, ARTERIOSCL THROM VAS, V27, P1153, DOI 10.1161/ATVBAHA.106.136325; Bochem AE, 2015, ARTERIOSCL THROM VAS, V35, P1663, DOI 10.1161/ATVBAHA.114.304959; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Byron A, 2014, J AM SOC NEPHROL, V25, P953, DOI 10.1681/ASN.2013070795; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chehade JM, 2013, METABOLISM, V62, P265, DOI 10.1016/j.metabol.2012.07.005; Cooper Mark E, 2005, Curr Diab Rep, V5, P445, DOI 10.1007/s11892-005-0053-9; Decleves AE, 2014, KIDNEY INT, V85, P611, DOI 10.1038/ki.2013.462; Fujita H, 2014, KIDNEY INT, V85, P579, DOI 10.1038/ki.2013.427; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Gupta A, 2011, NEW ENGL J MED, V364, P1472, DOI 10.1056/NEJMc1101853; Hassan HH, 2008, J BIOL CHEM, V283, P11164, DOI 10.1074/jbc.M707720200; Herman-Edelstein M, 2014, J LIPID RES, V55, P561, DOI 10.1194/jlr.P040501; Hong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082311; Hu YW, 2014, J LIPID RES, V55, P681, DOI 10.1194/jlr.M044669; Hu Yan-Wei, 2009, Atherosclerosis, V204, pe35, DOI 10.1016/j.atherosclerosis.2008.11.003; Huang CX, 2013, J LIPID RES, V54, P1231, DOI 10.1194/jlr.M032482; Igarashi M, 1999, J CLIN INVEST, V103, P185, DOI 10.1172/JCI3326; Izquierdo-Lahuerta A, 2016, J NEPHROL, V29, P603, DOI 10.1007/s40620-016-0278-5; Jandeleit-Dahm K, 1999, KIDNEY INT, V56, pS31, DOI 10.1046/j.1523-1755.1999.07109.x; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Kiss E, 2013, AM J PATHOL, V182, P727, DOI 10.1016/j.ajpath.2012.11.033; Kodera R, 2011, DIABETOLOGIA, V54, P965, DOI 10.1007/s00125-010-2028-x; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Kruit JK, 2012, DIABETES, V61, P659, DOI 10.2337/db11-1341; Li JH, 2010, J CELL MOL MED, V14, P1083, DOI 10.1111/j.1582-4934.2009.00955.x; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113639; Lindahl M, 2015, J LIPID RES, V56, P2248, DOI 10.1194/jlr.M054767; Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; Liu DM, 2005, ENDOCRINOLOGY, V146, P1312, DOI 10.1210/en.2004-1221; Matsumoto K, 2008, EXP HEMATOL, V36, P390, DOI 10.1016/j.exphem.2007.11.013; Merscher-Gomez S, 2013, DIABETES, V62, P3817, DOI 10.2337/db13-0399; Mima A, 2012, DIABETES, V61, P2967, DOI 10.2337/db11-1824; Miyai Y, 2011, J ENDOCRINOL INVEST, V34, pE268, DOI 10.3275/7683; MOORHEAD JF, 1982, LANCET, V2, P1309; Mostafa AM, 2015, BIOCHEM BIOPH RES CO, V468, P900, DOI 10.1016/j.bbrc.2015.11.054; Nagashima M, 2011, DIABETOLOGIA, V54, P2649, DOI 10.1007/s00125-011-2241-2; Natarajan R, 1999, HYPERTENSION, V33, P378, DOI 10.1161/01.HYP.33.1.378; Ou HC, 2010, TOXICOL APPL PHARM, V248, P134, DOI 10.1016/j.taap.2010.07.025; Park CW, 2007, J AM SOC NEPHROL, V18, P1227, DOI 10.1681/ASN.2006070778; Park IK, 1995, J BIOL CHEM, V270, P30464, DOI 10.1074/jbc.270.51.30464; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Soro-Paavonen A, 2006, ANN MED, V38, P229, DOI 10.1080/07853890500526352; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tang CR, 2010, J LIPID RES, V51, P1719, DOI 10.1194/jlr.M003525; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Tashiro Y, 2014, PEPTIDES, V54, P19, DOI 10.1016/j.peptides.2013.12.015; Tremblay F, 2003, DIABETES, V52, P29, DOI 10.2337/diabetes.52.1.29; Tsun JGS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105787; Vaisman BL, 2012, J LIPID RES, V53, P158, DOI 10.1194/jlr.M018713; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Westerterp M, 2016, ARTERIOSCL THROM VAS, V36, P1328, DOI 10.1161/ATVBAHA.115.306670; Westerterp M, 2013, CIRC RES, V112, P1456, DOI 10.1161/CIRCRESAHA.113.301086; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Xing SS, 2015, VASC PHARMACOL, V72, P141, DOI 10.1016/j.vph.2015.07.004; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082275; Zhang Y, 2016, FREE RADICAL BIO MED, V95, P278, DOI 10.1016/j.freeradbiomed.2016.03.035; Zhao HJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE1431, DOI 10.1152/ajpendo.00017.2014; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	67	35	39	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26487	26501		10.1074/jbc.M116.730564	http://dx.doi.org/10.1074/jbc.M116.730564			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27784780	Green Published, hybrid			2022-12-26	WOS:000391568200022
J	Fatehchand, K; McMichael, EL; Reader, BF; Fang, H; Santhanam, R; Gautam, S; Elavazhagan, S; Mehta, P; Buteyn, NJ; Merchand-Reyes, G; Vasu, S; Mo, XK; Benson, DM; Blachly, JS; Carson, WE; Byrd, JC; Butchar, JP; Tridandapani, S				Fatehchand, Kavin; McMichael, Elizabeth L.; Reader, Brenda F.; Fang, Huiqing; Santhanam, Ramasamy; Gautam, Shalini; Elavazhagan, Saranya; Mehta, Payal; Buteyn, Nathaniel J.; Merchand-Reyes, Giovanna; Vasu, Sumithira; Mo, Xiaokui; Benson, Don M.; Blachly, James S.; Carson, William E., III; Byrd, John C.; Butchar, Jonathan P.; Tridandapani, Susheela			Interferon- Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; Fc receptor; interferon; signal transduction; tumor immunology	FC-GAMMA-RI; CHRONIC GRANULOMATOUS-DISEASE; TUMOR-ASSOCIATED MACROPHAGES; AFFINITY IGG RECEPTOR; GEMTUZUMAB OZOGAMICIN; MULTIPLE-MYELOMA; CD38 EXPRESSION; TARGETING CD38; RETINOIC ACID; SCID MICE	Acute myeloid leukemia (AML) is characterized by the proliferation of immature myeloid lineage blasts. Due to its heterogeneity and to the high rate of acquired drug resistance and relapse, new treatment strategies are needed. Here, we demonstrate that IFN promotes AML blasts to act as effector cells within the context of antibody therapy. Treatment with IFN drove AML blasts toward a more differentiated state, wherein they showed increased expression of the M1-related markers HLA-DR and CD86, as well as of FcRI, which mediates effector responses to therapeutic antibodies. Importantly, IFN was able to up-regulate CD38, the target of the therapeutic antibody daratumumab. Because the antigen (CD38) and effector receptor (FcRI) were both simultaneously up-regulated on the AML blasts, we tested whether IFN treatment of the AML cell lines THP-1 and MV4-11 could stimulate them to target one another after the addition of daratumumab. Results showed that IFN significantly increased daratumumab-mediated cytotoxicity, as measured both by Cr-51 release and lactate dehydrogenase release assays. We also found that the combination of IFN and activation of FcR led to the release of granzyme B by AML cells. Finally, using a murine NSG model of subcutaneous AML, we found that treatment with IFN plus daratumumab significantly attenuated tumor growth. Taken together, these studies show a novel mechanism of daratumumab-mediated killing and a possible new therapeutic strategy for AML.	[Fatehchand, Kavin; Carson, William E., III; Byrd, John C.; Tridandapani, Susheela] Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA; [Fatehchand, Kavin; McMichael, Elizabeth L.; Carson, William E., III; Byrd, John C.; Tridandapani, Susheela] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Fatehchand, Kavin; McMichael, Elizabeth L.; Reader, Brenda F.; Fang, Huiqing; Santhanam, Ramasamy; Gautam, Shalini; Elavazhagan, Saranya; Mehta, Payal; Vasu, Sumithira; Benson, Don M.; Blachly, James S.; Carson, William E., III; Byrd, John C.; Butchar, Jonathan P.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Buteyn, Nathaniel J.; Merchand-Reyes, Giovanna; Tridandapani, Susheela] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Tridandapani, S (corresponding author), Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA.; Tridandapani, S (corresponding author), Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA.; Butchar, JP; Tridandapani, S (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.; Tridandapani, S (corresponding author), Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA.	butchar.2@osu.edu; tridandapani.2@osu.edu			National Institutes of Health [P01-CA095426, R01 CA162411, T32 HL007946, P30 CA016058]; NATIONAL CANCER INSTITUTE [R01CA203584, P01CA095426, R35CA197734, P30CA016058, R01CA162411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants P01-CA095426 (to S. T. and J. C. B.); R01 CA162411 (to S. T. and J. C. B.), T32 HL007946 (to B. F. R.), and P30 CA016058 (to the Ohio State University Comprehensive Cancer Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adib-Conquy M, 2014, IMMUNOL CELL BIOL, V92, P256, DOI 10.1038/icb.2013.99; Bevaart L, 2006, CANCER RES, V66, P1261, DOI 10.1158/0008-5472.CAN-05-2856; Bong AB, 2002, DERMATOLOGY, V205, P135, DOI 10.1159/000063904; BREITMAN TR, 1981, BLOOD, V57, P1000; Busfield SJ, 2014, LEUKEMIA, V28, P2213, DOI 10.1038/leu.2014.128; Butchar JP, 2010, CLIN CANCER RES, V16, P2065, DOI 10.1158/1078-0432.CCR-09-2591; Cohen AD, 2002, BONE MARROW TRANSPL, V30, P23, DOI 10.1038/sj.bmt.1703602; Costello RT, 1998, EUR J IMMUNOL, V28, P90, DOI 10.1002/(SICI)1521-4141(199801)28:01<90::AID-IMMU90>3.0.CO;2-5; Curran E, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00083; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dombret H, 2016, BLOOD, V127, P53, DOI 10.1182/blood-2015-08-604520; Elavazhagan S, 2015, J IMMUNOL, V194, P2786, DOI 10.4049/jimmunol.1402316; Errante Paolo R, 2008, Recent Pat Antiinfect Drug Discov, V3, P225, DOI 10.2174/157489108786242378; Estey E, 2015, BLOOD, V125, P2461, DOI 10.1182/blood-2015-01-561373; Funaro A, 1997, TISSUE ANTIGENS, V49, P7, DOI 10.1111/j.1399-0039.1997.tb02703.x; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; GRAZIANO RF, 1987, J IMMUNOL, V139, P3536; GRIMALDI JC, 1995, J IMMUNOL, V155, P811; Gupta V, 2011, BLOOD, V117, P2307, DOI 10.1182/blood-2010-10-265603; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Joshi T, 2006, MOL IMMUNOL, V43, P839, DOI 10.1016/j.molimm.2005.06.037; Kell J, 2016, EXPERT REV ANTICANC, V16, P377, DOI 10.1586/14737140.2016.1162099; Keyhani A, 2000, LEUKEMIA RES, V24, P153, DOI 10.1016/S0145-2126(99)00147-2; Lowenberg B, 2016, BLOOD, V127, P1, DOI 10.1182/blood-2015-10-662684; Lokhorst HM, 2015, NEW ENGL J MED, V373, P1207, DOI 10.1056/NEJMoa1506348; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Madera S, 2016, J EXP MED, V213, P225, DOI 10.1084/jem.20150712; Marciano BE, 2004, CLIN INFECT DIS, V39, P692, DOI 10.1086/422993; Masoumi-Dehshiri R, 2014, IRAN J PEDIATR HEMAT, V4, P188; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Moreno-Garcia ME, 2005, J IMMUNOL, V174, P2687, DOI 10.4049/jimmunol.174.5.2687; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nakamura K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26529; Nijhof IS, 2015, LEUKEMIA, V29, P2039, DOI 10.1038/leu.2015.123; Nunoi H, 2004, JPN J INFECT DIS, V57, pS25; Quatromoni JG, 2012, AM J TRANSL RES, V4, P376; Ranganathan P, 2012, BLOOD, V120, P1765, DOI 10.1182/blood-2012-04-423160; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; SHULTZ LD, 1995, J IMMUNOL, V154, P180; So EY, 2010, INT J BIOL SCI, V6, P675; Stein EM, 2016, BLOOD, V127, P71, DOI 10.1182/blood-2015-07-604538; Sutherland MSK, 2013, BLOOD, V122, P1455, DOI 10.1182/blood-2013-03-491506; THOMAS ED, 1979, NEW ENGL J MED, V301, P597, DOI 10.1056/NEJM197909133011109; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; van de Donk NWCJ, 2016, IMMUNOL REV, V270, P95, DOI 10.1111/imr.12389; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; Vasu S, 2016, BLOOD, V127, P2879, DOI 10.1182/blood-2015-11-680546; Wang Z Y, 2000, Lancet Oncol, V1, P101, DOI 10.1016/S1470-2045(00)00017-6; Wilson CJ, 2000, ARCH DIS CHILD, V83, P449, DOI 10.1136/adc.83.5.449; Yea K, 2015, P NATL ACAD SCI USA, V112, pE6158, DOI 10.1073/pnas.1519079112; Zhong RK, 2001, J HEMATOTH STEM CELL, V10, P95, DOI 10.1089/152581601750098318	55	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25656	25666		10.1074/jbc.M116.753145	http://dx.doi.org/10.1074/jbc.M116.753145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27780867	Green Published, hybrid			2022-12-26	WOS:000390095300031
J	Hnida, K; Stamnaes, J; du Pre, MF; Mysling, S; Jorgensen, TJD; Sollid, LM; Iversen, R				Hnida, Kathrin; Stamnaes, Jorunn; du Pre, M. Fleur; Mysling, Simon; Jorgensen, Thomas J. D.; Sollid, Ludvig M.; Iversen, Rasmus			Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; antibody; autoimmunity; enzyme catalysis; mass spectrometry (MS); transglutaminase; capillary electrophoresis; celiac disease; hydrogen; deuterium exchange	PIG LIVER TRANSGLUTAMINASE; TISSUE TRANSGLUTAMINASE; POSTTRANSLATIONAL MODIFICATION; 2-SPECIFIC AUTOANTIBODIES; STRUCTURAL BASIS; PLASMA-CELLS; MECHANISM; IDENTIFICATION; INACTIVATION; BINDING	Transglutaminase 2 (TG2) is a Ca2+-dependent cross-linking enzyme involved in the pathogenesis of CD. We have previously characterized a panel of anti-TG2 mAbs generated from gut plasma cells of celiac patients and identified four epitopes (epitopes 1-4) located in the N-terminal part of TG2. Binding of the mAbs induced allosteric changes in TG2. Thus, we aimed to determine whether these mAbs could influence enzymatic activity through modulation of TG2 susceptibility to oxidative inactivation and Ca2+ affinity. All tested epitope 1 mAbs, as well as 679-14-D04, which recognizes a previously uncharacterized epitope, prevented oxidative inactivation and increased Ca2+ sensitivity of TG2. We have identified crucial residues for binding of 679-14-D04 located within a Ca2+ binding site. Epitope 1 mAbs and 679-14-D04, although recognizing separate epitopes, behaved similarly when assessing their effect on TG2 conformation, suggesting that the shared effects on TG2 function can be explained by induction of the same conformational changes. None of the mAbs targeting other epitopes showed these effects, but epitope 2 mAbs reduced the rate of TG2-catalyzed reactions. Collectively, these effects could be relevant to the pathogenesis of CD. In A20 B cells transduced with TG2-specific B-cell receptor, epitope 2-expressing cells had poorer uptake of TG2-gluten complexes and were less efficient in gluten epitope presentation to T cells than cells expressing an epitope 1 receptor. Thus, the ability of epitope 1-targeting B cells to keep TG2 active and protected from oxidation might explain why generation of epitope 1-targeting plasma cells seems to be favored in celiac patients.	[Hnida, Kathrin; Stamnaes, Jorunn; du Pre, M. Fleur; Sollid, Ludvig M.; Iversen, Rasmus] Univ Oslo, Ctr Immune Regulat, N-0372 Oslo, Norway; [Hnida, Kathrin; Stamnaes, Jorunn; du Pre, M. Fleur; Sollid, Ludvig M.; Iversen, Rasmus] Univ Oslo, Dept Immunol, N-0372 Oslo, Norway; [Hnida, Kathrin; Stamnaes, Jorunn; du Pre, M. Fleur; Sollid, Ludvig M.; Iversen, Rasmus] Oslo Univ Hosp, N-0372 Oslo, Norway; [Mysling, Simon; Jorgensen, Thomas J. D.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Oslo; University of Oslo; University of Oslo; University of Southern Denmark	Hnida, K (corresponding author), Univ Oslo, Ctr Immune Regulat, N-0372 Oslo, Norway.; Hnida, K (corresponding author), Univ Oslo, Dept Immunol, N-0372 Oslo, Norway.	kathrin.hnida@medisin.uio.no		Stamnaes, Jorunn/0000-0002-0257-2112; du Pre, M. Fleur/0000-0001-9231-643X; Jorgensen, Thomas J.D./0000-0002-7149-316X; Mysling, Simon/0000-0003-4221-6320; Iversen, Rasmus/0000-0002-3292-1766	European Community [MRTN-CT-2011-289964, ERC-2010-Ad-268541]; Research Council of Norway through Centres of Excellence [179573/V40]; South-Eastern Norway Regional Health Authority	European Community(European Commission); Research Council of Norway through Centres of Excellence; South-Eastern Norway Regional Health Authority	This work was supported by the European Community's Seventh Framework Programme through Grants MRTN-CT-2011-289964 and ERC-2010-Ad-268541, by the Research Council of Norway through Centres of Excellence Funding Scheme Project 179573/V40, and by the South-Eastern Norway Regional Health Authority. The authors declare that they have no conflicts of interest with the contents of this article.	Adamczyk M, 2015, J CELL SCI, V128, P4615, DOI 10.1242/jcs.175968; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Barone MV, 2007, GASTROENTEROLOGY, V132, P1245, DOI 10.1053/j.gastro.2007.01.030; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; BOOTHE RL, 1969, J BIOL CHEM, V244, P399; Caputo I, 2009, AMINO ACIDS, V36, P693, DOI 10.1007/s00726-008-0120-z; Cardoso I, 2017, AMINO ACIDS, V49, P489, DOI 10.1007/s00726-016-2296-y; Cardoso I, 2015, FEBS J, V282, P2063, DOI 10.1111/febs.13276; Cervio E, 2007, GASTROENTEROLOGY, V133, P195, DOI 10.1053/j.gastro.2007.04.070; Chen X, 2015, J BIOL CHEM, V290, P21365, DOI 10.1074/jbc.M115.669895; CHUNG SI, 1970, J BIOL CHEM, V245, P6424; CONNELLAN JM, 1969, J BIOL CHEM, V244, P3173; Darrah E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005370; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Di Simone N, 2010, AM J GASTROENTEROL, V105, P2254, DOI 10.1038/ajg.2010.233; Dieterich W, 2003, GUT, V52, P1562, DOI 10.1136/gut.52.11.1562; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; FOLK JE, 1967, J BIOL CHEM, V242, P1838; FOLK JE, 1983, ADV ENZYMOL RAMB, V54, P1; Halttunen T, 1999, GASTROENTEROLOGY, V116, P566, DOI 10.1016/S0016-5085(99)70178-2; Han BG, 2010, INT J BIOL MACROMOL, V47, P190, DOI 10.1016/j.ijbiomac.2010.04.023; Iversen R, 2015, J IMMUNOL, V195, P5159, DOI 10.4049/jimmunol.1501363; Iversen R, 2014, P NATL ACAD SCI USA, V111, P17146, DOI 10.1073/pnas.1407457111; Iversen R, 2013, J IMMUNOL, V190, P5981, DOI 10.4049/jimmunol.1300183; Jang TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107005; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Kalliokoski S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065887; Kanchan K, 2013, BIOCHEM J, V455, P261, DOI 10.1042/BJ20130696; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Kiraly R, 2006, J AUTOIMMUN, V26, P278, DOI 10.1016/j.jaut.2006.03.002; Kiraly R, 2009, FEBS J, V276, P7083, DOI 10.1111/j.1742-4658.2009.07420.x; Lai TS, 2007, FASEB J, V21, P4131, DOI 10.1096/fj.06-7598com; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Myrsky E, 2009, CELL MOL LIFE SCI, V66, P3375, DOI 10.1007/s00018-009-0116-1; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Qiao SW, 2011, J IMMUNOL, V187, P3064, DOI 10.4049/jimmunol.1101526; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; Roth EB, 2003, AUTOIMMUNITY, V36, P221, DOI 10.1080/0891693031000118974; ROTH WJ, 1986, J LEUKOCYTE BIOL, V39, P629, DOI 10.1002/jlb.39.6.629; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Snir O, 2015, J IMMUNOL, V194, P5703, DOI 10.4049/jimmunol.1402611; Sollid LM, 1997, GUT, V41, P851, DOI 10.1136/gut.41.6.851; Sollid LM, 2015, DIGEST DIS, V33, P115, DOI 10.1159/000369512; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Sollid LM, 2011, CURR OPIN IMMUNOL, V23, P732, DOI 10.1016/j.coi.2011.08.006; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; UPCHURCH HF, 1987, IN VITRO CELL DEV B, V23, P795; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358	53	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25542	25552		10.1074/jbc.M116.738161	http://dx.doi.org/10.1074/jbc.M116.738161			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27784785	Green Published, hybrid			2022-12-26	WOS:000390095300022
J	Veldhoen, N; Hobbs, J; Ikonomou, G; Hii, M; Lesperance, M; Helbing, CC				Veldhoen, Nik; Hobbs, Jared; Ikonomou, Georgios; Hii, Michael; Lesperance, Mary; Helbing, Caren C.			Implementation of Novel Design Features for qPCR-Based eDNA Assessment	PLOS ONE			English	Article							ENVIRONMENTAL DNA; WATER SAMPLES; TOOL	Environmental stewardship requires timely, accurate information related to the status of a given ecosystem and the species that occupy it. Recent advances in the application of the highly sensitive real-time quantitative polymerase chain reaction (qPCR) towards identification of constituents within environmental DNA (eDNA) now allow targeted detection of the presence of species-specific biological material within a localized geographic region. However, as with all molecular techniques predicated on the specificity and sensitivity of the PCR assay, careful validation of each eDNA qPCR assay in development must be performed both under controlled laboratory conditions and when challenged with field-derived eDNA samples. Such a step-wise approach forms the basis for incorporation of innovative qPCR design features that strengthen the implementation and interpretation of the eDNA assay. This includes empirical determination that the qPCR assay is refractory to the presence of human DNA and the use of a tripartite assay approach comprised of 1) a primer set targeting plant chloroplast that evaluates the presence of amplifiable DNA from field samples to increase confidence in a negative result, 2) an animal group primer set to increase confidence in the assay result, and 3) a species-specific primer set to assess presence of DNA from the target species. To demonstrate this methodology, we generated eDNA assays specific for the North American bullfrog (Lithobates (Rana) catesbeiana) and the Rocky Mountain tailed frog (Ascaphus montanus) and characterized each with respect to detection sensitivity and specificity with demonstrated performance in a field survey scenario. The qPCR design features presented herein address specific challenges of eDNA assays thereby increasing their interpretative power.	[Veldhoen, Nik; Ikonomou, Georgios; Hii, Michael; Helbing, Caren C.] Univ Victoria, Dept Biochem & Microbiol, STN CSC, POB 3055, Victoria, BC V8W 2Y2, Canada; [Hobbs, Jared] Hemmera Envirochem Inc, 303-1221 Broad St, Victoria, BC V8W 2A4, Canada; [Lesperance, Mary] Univ Victoria, Dept Math & Stat, 3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada	University of Victoria; University of Victoria	Helbing, CC (corresponding author), Univ Victoria, Dept Biochem & Microbiol, STN CSC, POB 3055, Victoria, BC V8W 2Y2, Canada.	chelbing@uvic.ca		Helbing, Caren/0000-0002-8861-1070	Natural Sciences and Engineering Research Council of Canada (NSERC) [EGP 477388-14]; Hemmera; NSERC; CCH	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Hemmera; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CCH	This work was supported in part by a Natural Sciences and Engineering Research Council of Canada (NSERC) Engage grant #EGP 477388-14 to CCH and a research agreement between Hemmera and CCH. NSERC provided support in the form of research materials and salary for NV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by a Natural Sciences and Engineering Research Council of Canada (NSERC) Engage grant #EGP 477388-14 to CCH and a research agreement between Hemmera and CCH. NSERC provided support in the form of research materials and salary for NV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. A patent is pending on the concept and some data presented in this study (US provisional application number 62/406,802). The patent is owned by the University of Victoria who will handle commercial and academic licensing agreements. JH is an employee of Hemmera Envirochem Inc. JH was involved with the conceptualization of the overall research goals, identification of appropriate tailed frog survey sites, and water sample collection at these sites. Hemmera provided support for research materials, but did not play a role in the qPCR assay design, data collection and analysis, decision to publish, or preparation of the manuscript with the exception of critical review of the manuscript by JH. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The specific roles of authors are articulated in the 'author contributions' section.	Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Carim KJ, 2016, CONSERV GENET RESOUR, V8, P197, DOI 10.1007/s12686-016-0531-1; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Goldberg CS, 2015, BIOL CONSERV, V183, P1, DOI 10.1016/j.biocon.2014.11.040; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Herder J., 2014, ENV DNA A REV POSSIB; Iulia L, 2013, ROM BIOTECH LETT, V18, P8007; Muhl H, 2010, DIAGN MICR INFEC DIS, V66, P41, DOI 10.1016/j.diagmicrobio.2008.07.011; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Orchard S, 2012, UPDATE BULLFROG CONT; Peterson AC, 2013, BIOL INVASIONS, V15, P2179, DOI 10.1007/s10530-013-0442-y; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; SOMERVILLE CC, 1989, APPL ENVIRON MICROB, V55, P548, DOI 10.1128/AEM.55.3.548-554.1989; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520	24	18	19	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0164907	10.1371/journal.pone.0164907	http://dx.doi.org/10.1371/journal.pone.0164907			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802293	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200012
J	Wan, L; Tong, J; Zhou, JX; Guo, HY; Cui, M; Liu, YG; Ning, LK; Tang, FK				Wan, Long; Tong, Jing; Zhou, Jinxing; Guo, Hongyan; Cui, Ming; Liu, Yuguo; Ning, Like; Tang, Fukai			Variation of Vegetation Ecological Water Consumption and Its Response to Vegetation Coverage Changes in the Rocky Desertification Areas in South China	PLOS ONE			English	Article							KARST REGION; EVAPOTRANSPIRATION ALGORITHM; SOIL-MOISTURE; DIRECT SEARCH; RESTORATION; IMPACT; YIELD; MODEL; MODIS; NDVI	Over the past several decades, rocky desertification has led to severe ecological problems in karst areas in South China. After a rocky desertification treatment project was completed, the vegetation coverage changed greatly and, consequently, increased the ecology water consumption (approximately equal to the actual evapotranspiration) of the regional vegetation. Thus, it intensified the regional water stresses. This study explored the changes in the actual evapotranspiration (ETa) response to the vegetation coverage changes in the rocky desertification areas in South China based on the precipitation (P), potential evapotranspiration (ETp) and NDVI (the normalized difference vegetation index) datasets. The revised Bagrov model was used to simulate the actual evapotranspiration changes with the supposed increasing NDVI. The results indicated that the average NDVI value was lower when the rocky desertification was more severe. The ETa, evapotranspiration efficiency (ETa/ETp) and potential humidity (P/ETp) generally increased with the increasing NDVI. The sensitivity of the ETa response to vegetation coverage changes varied due to different precipitation conditions and different rocky desertification severities. The ETa was more sensitive under drought conditions. When a drought occurred, the ETa exhibited an average increase of 40 similar to 60 mm with the NDVI increasing of 0.1 in the rocky desertification areas. Among the 5 different severity categories of rocky desertification, the ETa values' responses to NDVI changes were less sensitive in the severe rocky desertification areas but more sensitive in the extremely and potential rocky desertification areas. For example, with the NDVI increasing of 0.025, 0.05, 0.075, and 0.1, the corresponding ETa changes increased by an average of 2.64 mm, 10.62 mm, 19.19 mm, and 27.58 mm, respectively, in severe rocky desertification areas but by 4.94 mm, 14.99 mm, 26.80, and 37.13 mm, respectively, in extremely severe rocky desertification areas. Understanding the vegetation ecological water consumption response to the vegetation coverage changes is essential for the vegetation restoration and water stresses mitigation in rocky desertification areas.	[Wan, Long; Tong, Jing; Zhou, Jinxing; Guo, Hongyan] Beijing Forestry Univ, Key Lab State Forestry Adm Soil & Water Conservat, Jianshui Karst Ecosyst, Natl Field Res Stn, Beijing, Peoples R China; [Tong, Jing] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Cui, Ming; Liu, Yuguo; Tang, Fukai] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China; [Ning, Like] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Water Cycle & Related Land Surface Proc, Beijing, Peoples R China; [Ning, Like] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University; Chinese Academy of Forestry; Institute of Desertification Studies, CAF; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, JX (corresponding author), Beijing Forestry Univ, Key Lab State Forestry Adm Soil & Water Conservat, Jianshui Karst Ecosyst, Natl Field Res Stn, Beijing, Peoples R China.	zjx9277@126.com	Jinxing, Zhou/I-6015-2017	Jinxing, Zhou/0000-0003-2182-9849	National Key Research and Development Program of China [2016YFC0502500/2016YFC0502502]; Fundamental Research Funds for the Central Nonprofit Research Institution of CAF (Chinese Academy of Forestry) [CAFYBB2014ZD006]; China Postdoctoral Science Foundation [2015M581002]; Graduate Training and Development Program of Beijing Municipal Commission of Education [BLCXY201508]	National Key Research and Development Program of China; Fundamental Research Funds for the Central Nonprofit Research Institution of CAF (Chinese Academy of Forestry); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Graduate Training and Development Program of Beijing Municipal Commission of Education	This paper was supported by the National Key Research and Development Program of China (Grant No. 2016YFC0502500/2016YFC0502502) (LW has received the funding); the Fundamental Research Funds for the Central Nonprofit Research Institution of CAF (Chinese Academy of Forestry) (Grant No. CAFYBB2014ZD006) (JZ has received the funding); the China Postdoctoral Science Foundation (Grant No. 2015M581002) (LW has received the funding); and the Graduate Training and Development Program of Beijing Municipal Commission of Education (Grant No. BLCXY201508) (JT has received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagrov N., 1953, METEOROG GIDROL, V10, P20; Bai XY, 2013, LAND DEGRAD DEV, V24, P47, DOI 10.1002/ldr.1102; Booth EG, 2010, HYDROL PROCESS, V24, P2934, DOI 10.1002/hyp.7707; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Cao JianHua, 2015, Journal of Resources and Ecology, V6, P247, DOI 10.5814/j.issn.1674-764x.2015.04.008; Carlson TN, 1997, REMOTE SENS ENVIRON, V62, P241, DOI 10.1016/S0034-4257(97)00104-1; Charizopoulos N, 2016, ENVIRON EARTH SCI, V75, P1; Chen HS, 2010, ENVIRON EARTH SCI, V61, P1105, DOI 10.1007/s12665-009-0428-3; Collischonn B, 2008, J HYDROL, V360, P207, DOI 10.1016/j.jhydrol.2008.07.032; Cosrreponding RS, 2004, INT J REMOTE SENS, V25, P2523; Dyck S, 1991, IAHS P VIENN S, V204, P31; Feng XM, 2012, HYDROL EARTH SYST SC, V16, P2617, DOI 10.5194/hess-16-2617-2012; Gao G, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008010; GLUGLA G, 1971, WASSERWIRTSCHAFT WAS, V21, P349; HE Yong-tao, 2004, ENV SCI, V25, P35; HENDRICKSON JD, 1988, WATER RESOUR RES, V24, P691, DOI 10.1029/WR024i005p00691; Huang QH, 2006, ENVIRON GEOL, V49, P1173, DOI 10.1007/s00254-005-0162-4; Huang YH, 2015, SUSTAINABILITY-BASEL, V7, P13597, DOI 10.3390/su71013597; Jiang ZC, 2014, EARTH-SCI REV, V132, P1, DOI 10.1016/j.earscirev.2014.01.005; Li S, 2009, SCI COLD ARID REG, V1, P80; Liu B, 2011, QUATERN INT, V244, P185, DOI 10.1016/j.quaint.2011.02.039; Miegel K, 2013, INT AGROPHYS, V27, P31, DOI 10.2478/v10247-012-0065-z; Mu Q, 2007, REMOTE SENS ENVIRON, V111, P519, DOI 10.1016/j.rse.2007.04.015; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Nicola M, 2005, WATER RESSOUR RES, V41, P3092; Nie YP, 2012, J HYDROL, V420, P264, DOI 10.1016/j.jhydrol.2011.12.011; Nouri H., 2013, HYDROL EARTH SYST SC, V10, P3897, DOI [DOI 10.5194/HESSD-10-3897-2013, 10.5194/hessd-10-3897-2013]; Nzioka JM, 2014, AFRICA J PHYS SCI, V1, P32; Petropoulos GP, 2015, IEEE SENS J, V15, P3412, DOI 10.1109/JSEN.2015.2390031; Rossato L, 2005, PAEDIATR ANAESTH, V15, P1006; Schuol J, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006609; Srivastava PK, 2015, THEO APPL CLIMATO, V3, P1; Srivastava PK, 2015, WATER RESOUR MANAG, V29, P2267, DOI 10.1007/s11269-015-0940-z; Srivastava PK, 2014, HYDROL PROCESS, V28, P4419, DOI 10.1002/hyp.9946; Srivastava PK, 2013, ATMOS SCI LETT, V14, P118, DOI 10.1002/asl2.427; Thapa RB, 2015, REMOTE SENS ENVIRON, V160, P122, DOI 10.1016/j.rse.2015.01.007; [王大华 Wang Dahua], 2016, [地学前缘, Earth Science Frontiers], V23, P1; Wang J, 2008, ENVIRON GEOL, V54, P1185, DOI 10.1007/s00254-007-0901-9; Wang SJ, 2004, LAND DEGRAD DEV, V15, P115, DOI 10.1002/ldr.592; Wang YJ, 2010, ACTA GEOGRAPHICA SIN, V09, P1079; [王玉娟 Wang Yujuan], 2014, [自然资源学报, Journal of Natural Resources], V29, P431; [温志群 Wen Zhiqun], 2010, [地理研究, Geographical Research], V29, P1841; Xu EQ, 2015, LAND DEGRAD DEV, V26, P158, DOI 10.1002/ldr.2193; Yang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134795; Yang T, 2009, STOCH ENV RES RISK A, V23, P1071, DOI 10.1007/s00477-008-0278-7; Yu FK, 2015, PLANT BIOSYST, V149, P100, DOI 10.1080/11263504.2013.817488; Zhang JG, 2011, CLEAN-SOIL AIR WATER, V39, P619, DOI 10.1002/clen.201000528; Zhang J, 2015, HYDROL PROCESS, V29, P2994, DOI 10.1002/hyp.10380; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang X, 2014, INT J APPL EARTH OBS, V31, P86, DOI 10.1016/j.jag.2014.03.009; [赵玲玲 Zhao Lingling], 2011, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V39, P629; Zhao X, 2015, REMOTE SENS-BASEL, V7, P14039, DOI 10.3390/rs71014039	54	6	8	8	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0163566	10.1371/journal.pone.0163566	http://dx.doi.org/10.1371/journal.pone.0163566			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798642	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100003
J	Furqan, MS; Siyal, MY				Furqan, Mohammad Shaheryar; Siyal, Mohammad Yakoob			Elastic-Net Copula Granger Causality for Inference of Biological Networks	PLOS ONE			English	Article							PARTIAL DIRECTED COHERENCE; GENE; EXPRESSION; MODELS; REGULARIZATION; IDENTIFICATION; CONNECTIVITY; REGRESSION; TOOLBOX; LASSO	Aim In bioinformatics, the inference of biological networks is one of the most active research areas. It involves decoding various complex biological networks that are responsible for performing diverse functions in human body. Among these networks analysis, most of the research focus is towards understanding effective brain connectivity and gene networks in order to cure and prevent related diseases like Alzheimer and cancer respectively. However, with recent advances in data procurement technology, such as DNA microarray analysis and fMRI that can simultaneously process a large amount of data, it yields high-dimensional data sets. These high dimensional dataset analyses possess challenges for the analyst. Background Traditional methods of Granger causality inference use ordinary least-squares methods for structure estimation, which confront dimensionality issues when applied to high-dimensional data. Apart from dimensionality issues, most existing methods were designed to capture only the linear inferences from time series data. Method and Conclusion In this paper, we address the issues involved in assessing Granger causality for both linear and nonlinear high-dimensional data by proposing an elegant form of the existing LASSO-based method that we call "Elastic-Net Copula Granger causality". This method provides a more stable way to infer biological networks which has been verified using rigorous experimentation. We have compared the proposed method with the existing method and demonstrated that this new strategy outperforms the existing method on all measures: precision, false detection rate, recall, and F1 score. We have also applied both methods to real HeLa cell data and StarPlus fMRI datasets and presented a comparison of the effectiveness of both methods.	[Furqan, Mohammad Shaheryar; Siyal, Mohammad Yakoob] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore, Singapore; [Furqan, Mohammad Shaheryar] Nanyang Technol Univ, Infocomm Ctr Excellence, INFINITUS, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Furqan, MS (corresponding author), Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore, Singapore.; Furqan, MS (corresponding author), Nanyang Technol Univ, Infocomm Ctr Excellence, INFINITUS, Singapore, Singapore.	mohammad022@e.ntu.edu.sg		Furqan, Mohammad Shaheryar/0000-0002-9634-7345				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amblard PO, 2012, MACH LEARN SIGN PROC; [Anonymous], 2006, HDB TIME SERIES ANAL; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bahadori MT, 2013, 2013 SIAM INT C DAT; Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; Chatr-aryamontri A., 2014, NUCL ACIDS RES; Cheng DH, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P382, DOI 10.1145/2623330.2623709; Eddy WF, 1999, J COMPUT GRAPH STAT, V8, P545, DOI 10.2307/1390875; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Fujita Andre, 2010, Journal of Bioinformatics and Computational Biology, V8, P679, DOI 10.1142/S0219720010004860; Fujita A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-39; Furqan MS, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2156-y; Furqan MS, 2016, J INTEGR NEUROSCI, V15, P55, DOI 10.1142/S0219635216500035; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Green P.J., 1993, NONPARAMETRIC REGRES, DOI DOI 10.1201/B15710; Hlavackova-Schindler K., 2013, ECML PKDD 2013 WORKS; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Hutchinson RA, 2009, NEUROIMAGE, V46, P87, DOI 10.1016/j.neuroimage.2009.01.025; Keller TA, 2001, READING SPAN TIME CO; Kong M, 2000, EMBO J, V19, P1378, DOI 10.1093/emboj/19.6.1378; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liu H, 2009, J MACH LEARN RES, V10, P2295; Liu J, 2014, INT C HLTH INF, V42, P5; Liu Y, COPULA GRANGER 2012; Lozano AC, 2009, BIOINFORMATICS, V25, pI110, DOI 10.1093/bioinformatics/btp199; Lutkepohl H., 2005, NEW INTRO MULTIPLE T, DOI DOI 10.1007/078-3-540-27752-1; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Marinazzo D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056215; Meinshausen N, 2009, LASSO TYPE RECOVERY, P246, DOI [10.1214/07-AOS582, DOI 10.1214/07-AOS582]; Michailidis G, 2013, MATH BIOSCI, V246, P326, DOI 10.1016/j.mbs.2013.10.003; Mitchell T, STARPLUS FMRI DATA C; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Nelsen R. B, 2006, INTRO COPULAS; Ogutu Joseph O, 2012, BMC Proc, V6 Suppl 2, pS10, DOI 10.1186/1753-6561-6-S2-S10; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Qian J, GLMNET MATLAB 2013; Radulovic M, 2010, MOL CELL PROTEOMICS, V9, P145, DOI 10.1074/mcp.M900078-MCP200; Roy Swarup, 2013, Mining Intelligence and Knowledge Exploration. First International Conference, MIKE 2013. Proceedings: LNCS 8284, P432, DOI 10.1007/978-3-319-03844-5_44; Schelter B, 2006, J NEUROSCI METH, V152, P210, DOI 10.1016/j.jneumeth.2005.09.001; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Shimamura T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-41; Siyal MY, 2014, GRANG CAUS COMP AN I; Suk HI, 2013, LECT NOTES COMPUT SC, V8184, P131, DOI 10.1007/978-3-319-02267-3_17; Tam GHF, 2013, IET SYST BIOL, V7, P195, DOI 10.1049/iet-syb.2012.0063; Tam GHF, 2013, 7 INT C SYST BIOL IS; Tam GHF, 2012, SYST BIOL ISB 2012 I; Tao Zhou, 2009, PROGR NATURAL SCI, V01, P1, DOI DOI 10.1371/J0URNAL.PBI0.1000139; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Wang X, 2002, DETECTING COGNITIVE; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Zhang ZG, 2010, 9 INT C MACH LEARN C; Zhenyu Z, 2008, BIOMEDICAL ENG INF 2; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	59	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165612	10.1371/journal.pone.0165612	http://dx.doi.org/10.1371/journal.pone.0165612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792750	Green Published, gold, Green Submitted			2022-12-26	WOS:000389537000037
J	Lacoste, B; Raymond, VA; Lapierre, P; Bilodeau, M				Lacoste, Benoit; Raymond, Valerie-Ann; Lapierre, Pascal; Bilodeau, Marc			Protection against Acute Hepatocellular Injury Afforded by Liver Fibrosis Is Independent of T Lymphocytes	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; IN-VITRO; INFLAMMATORY RESPONSE; CYTOKINE EXPRESSION; GENE-EXPRESSION; RAT HEPATOCYTES; MICE; THIOACETAMIDE; FIBROGENESIS; ACTIVATION	Collagen produced during the process of liver fibrosis can induce a hepatocellular protective response through ERK1 signalling. However, the influence of T cells and associated cytokine production on this protection is unknown. In addition, athymic mice are frequently used in hepatocellular carcinoma xenograft experiments but current methods limit our ability to study the impact of liver fibrosis in this setting due to high mortality. Therefore, a mouse model of liver fibrosis lacking T cells was developed using Foxn1 nu/nu mice and progressive oral administration of thioacetamide (TAA) [0.01-0.02%] in drinking water. Fibrosis developed over a period of 16 weeks (alpha-SMA positive area: 20.0 +/- 2.2%, preCol1a1 mRNA expression: 11.7 +/- 4.1 fold changes, hydroxyproline content: 1041.2 +/- 77 mu g/g of liver) at levels comparable to that of BALB/c mice that received intraperitoneal TAA injections [200 mu g/g of body weight (bw)] (alpha-SMA positive area: 20.9 +/- 2.9%, preCol1a1 mRNA expression: 13.1 +/- 2.3 fold changes, hydroxyproline content: 931.6 +/- 14.8 mu g/g of liver). No mortality was observed. Athymic mice showed phosphorylation of ERK1/2 during fibrogenesis (control 0.03 +/- 0.01 vs 16 weeks 0.22 +/- 0.06AU; P< 0.05). The fibrosis-induced hepatoprotection against cytotoxic agents, as assessed histologically and by serum AST levels, was not affected by the absence of circulating T cells (anti-Fas JO2 [0.5 mu g/g bw] for 6h (fibrotic 4665 +/- 2596 vs non-fibrotic 13953 +/- 2260 U/L; P< 0.05), APAP [750 mg/kg bw] for 6 hours (fibrotic 292 +/- 66 U/L vs non-fibrotic 4086 +/- 2205; P< 0.01) and CCl4 [0.5mL/Kg bw] for 24h (fibrotic 888 +/- 268 vs non-fibrotic 15673 +/- 2782 U/L; P< 0.001)). In conclusion, liver fibrosis can be induced in athymic Foxn1 nu/nu mice without early mortality. Liver fibrosis leads to ERK1/2 phosphorylation. Finally, circulating T lymphocytes and associated cytokines are not involved in the hepatocellular protection afforded by liver fibrosis.	[Lacoste, Benoit; Raymond, Valerie-Ann; Lapierre, Pascal; Bilodeau, Marc] CRCHUM, Lab Hepatol Cellulaire, Montreal, PQ, Canada; [Lapierre, Pascal; Bilodeau, Marc] Univ Montreal, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Bilodeau, M (corresponding author), CRCHUM, Lab Hepatol Cellulaire, Montreal, PQ, Canada.; Bilodeau, M (corresponding author), Univ Montreal, Dept Med, Montreal, PQ, Canada.	marc.bilodeau@umontreal.ca	Bilodeau, Marc/L-2822-2017; Lapierre, Pascal/ABD-2247-2021	Lapierre, Pascal/0000-0002-2753-3566				Bourbonnais E, 2012, GASTROENTEROLOGY, V142, P130, DOI 10.1053/j.gastro.2011.09.033; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Chilakapati J, 2007, TOXICOLOGY, V230, P105, DOI 10.1016/j.tox.2006.11.050; Ethier C, 2003, AM J PHYSIOL-GASTR L, V285, pG298, DOI 10.1152/ajpgi.00040.2003; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Forbes SJ, 2011, BEST PRACT RES CL GA, V25, P207, DOI 10.1016/j.bpg.2011.02.006; Friedman SL, 2006, J GASTROEN HEPATOL, V21, pS79, DOI 10.1111/j.1440-1746.2006.04585.x; Gandillet A, 2005, CELL TRANSPLANT, V14, P277, DOI 10.3727/000000005783983061; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Hajovsky H, 2012, CHEM RES TOXICOL, V25, P1955, DOI 10.1021/tx3002719; Hammerich L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/345803; Hernandez-Gea V, 2012, AUTOPHAGY, V8, P849, DOI 10.4161/auto.19947; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hyon MK, 2011, J VET MED SCI, V73, P739, DOI 10.1292/jvms.10-0311; Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Lang A, 2005, LIVER INT, V25, P808, DOI 10.1111/j.1478-3231.2005.01057.x; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Navarro-Partida J, 2012, EUR J PHARMACOL, V678, P71, DOI 10.1016/j.ejphar.2011.12.025; Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91; Parola M, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-4; Poynard T, 2003, J HEPATOL, V38, P257, DOI 10.1016/S0168-8278(02)00413-0; Ramachandran P, 2012, QJM-INT J MED, V105, P813, DOI 10.1093/qjmed/hcs069; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; Romano R, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/467101; Sakaida I, 1996, HEPATOLOGY, V23, P755, DOI 10.1002/hep.510230416; Sarma D, 2012, CHEM RES TOXICOL, V25, P1868, DOI 10.1021/tx3001658; Starkel P, 2011, BEST PRACT RES CL GA, V25, P319, DOI 10.1016/j.bpg.2011.02.004; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Wells RG, 2008, CLIN LIVER DIS, V12, P759, DOI 10.1016/j.cld.2008.07.008; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056	38	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165360	10.1371/journal.pone.0165360	http://dx.doi.org/10.1371/journal.pone.0165360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792745	Green Submitted, gold, Green Published			2022-12-26	WOS:000389537000018
J	Sun, XW; Hu, YY; Zhang, L; Hu, CY; Guo, GQ; Mao, CC; Xu, JF; Ye, SS; Huang, GL; Xue, XY; Guo, AZ; Shen, X				Sun, Xiangwei; Hu, Yingying; Zhang, Liang; Hu, Changyuan; Guo, Gangqiang; Mao, Chenchen; Xu, Jianfeng; Ye, Sisi; Huang, Guanli; Xue, Xiangyang; Guo, Aizhen; Shen, Xian			Mining, Validation, and Clinical Significance of Colorectal Cancer (CRC)-Associated lncRNAs	PLOS ONE			English	Article							LONG NONCODING RNA; POOR-PROGNOSIS; GASTRIC-CANCER; CELL-PROLIFERATION; COLON-CANCER; METASTASIS; EXPRESSION; METAANALYSIS; MIGRATION; PROSTATE	Background Colorectal cancer (CRC) is one of the deadliest tumours, but its pathogenesis remains unclear. The involvement of differentially expressed long non-coding RNAs (lncRNAs) in CRC tumorigenesis makes them suitable tumour biomarkers. Methods/Findings Here, we screened 150 cases of CRC and 85 cases of paracancerous tissues in the GEO database for differentially expressed lncRNAs. The levels of lncRNA candidates in 84 CRC and paracancerous tissue samples were validated by qRT-PCR and their clinical significance was analyzed. We identified 15 lncRNAs with differential expression in CRC tumours; among them, AK098081 was significantly up-regulated, whereas AK025209, BC040303, BC037331, AK026659, and CR749831 were down-regulated in CRC. In a receiver operating characteristic curve analysis, the area under the curve for the six lncRNAs was 0.914. High expression of AK098081 and low expression of BC040303, CR749831, and BC037331 indicated poor CRC differentiation. CRC patients with lymph node metastasis had lower expression of BC037331. In addition, the group with high AK098081 expression presented significantly lower overall survival and disease-free survival rates than the low-expression group, confirming AK098081 as an independent risk factor for CRC patients. Conclusion/Significance In conclusion, we have identified multiple CRC-associated lncRNAs from microarray expression profiles that can serve as novel biomarkers for the diagnosis and prognosis of CRC.	[Sun, Xiangwei; Zhang, Liang; Hu, Changyuan; Mao, Chenchen; Xu, Jianfeng; Shen, Xian] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gen Surg, Wenzhou, Peoples R China; [Hu, Yingying] Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Wenzhou, Peoples R China; [Guo, Gangqiang; Ye, Sisi; Xue, Xiangyang] Wenzhou Med Univ, Dept Microbiol & Immunol, Inst Mol Virol & Immunol, Inst Trop Med, Wenzhou, Peoples R China; [Huang, Guanli] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Wenzhou, Peoples R China; [Guo, Aizhen] Tongji Univ, Sch Med, Yangpu Hosptial, Dept Internal Med, Shanghai, Peoples R China; [Shen, Xian] Wenzhou Med Univ, Affiliated Hosp 2, Dept Gen Surg, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Tongji University; Wenzhou Medical University	Shen, X (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Gen Surg, Wenzhou, Peoples R China.; Xue, XY (corresponding author), Wenzhou Med Univ, Dept Microbiol & Immunol, Inst Mol Virol & Immunol, Inst Trop Med, Wenzhou, Peoples R China.; Guo, AZ (corresponding author), Tongji Univ, Sch Med, Yangpu Hosptial, Dept Internal Med, Shanghai, Peoples R China.; Shen, X (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Gen Surg, Wenzhou, Peoples R China.	wzxxy001@163.com; cwjcwj1976@smmu.edu; shenxian5166@gmail.com	Hu, Ying/GQZ-8100-2022		National Natural Science Foundation of China [81001343, 81472308, 31470891]; Wenzhou Municipal Science and Technology Bureau [Y20150050, Y20150054, Y20150057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Municipal Science and Technology Bureau	This project was funded by National Natural Science Foundation of China under the grant 81001343 (XYX), 81472308 (XYX), and 31470891 (XS), http://npd.nsfc.gov.cn/granttype1!index.action. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This project was also funded by Wenzhou Municipal Science and Technology Bureau under the grant Y20150050 (GLH), Y20150054 (XS), and Y20150057 (CYH), http://www.wzkj.gov.cn/kjxx/notice-1384.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen N, 2016, ONCOTARGET, V7, P11271, DOI 10.18632/oncotarget.7168; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Chopra P, 2013, INT J DATA MIN BIOIN, V8, P349, DOI 10.1504/IJDMB.2013.056089; Du Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10982; Han D, 2016, ONCOTARGET, V7, P22159, DOI 10.18632/oncotarget.8063; Jonker MJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku343; Khachane AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010316; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Krell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098561; Li YL, 2015, ONCOTARGET, V6, P27641, DOI 10.18632/oncotarget.4737; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Ma YL, 2016, GUT, V65, P1494, DOI 10.1136/gutjnl-2014-308392; Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Nicholson BD, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011134.pub2; Niu H, 2016, TUMOR BIOL, V37, P10097, DOI 10.1007/s13277-015-4350-x; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; Risueno A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-221; Rosikiewicz M, 2016, BIOINFORMATICS, V32, P2565, DOI 10.1093/bioinformatics/btw374; Schmitz SU, 2016, CELL MOL LIFE SCI, V73, P2491, DOI 10.1007/s00018-016-2174-5; Shi YG, 2016, METHODS MOL BIOL, V1402, P43, DOI 10.1007/978-1-4939-3378-5_6; Sillars-Hardebol AH, 2012, GUT, V61, P1568, DOI 10.1136/gutjnl-2011-301153; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang LH, 2016, ELIFE, V5, DOI 10.7554/eLife.14620; Wang XB, 2012, BIOINFORMATICS, V28, P2534, DOI 10.1093/bioinformatics/bts485; Wang YF, 2014, NEOPLASIA, V16, P1094, DOI 10.1016/j.neo.2014.10.008; Wu ZH, 2014, ONCOL REP, V32, P395, DOI 10.3892/or.2014.3186; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35; Yang YB, 2016, TUMOR BIOL, V37, P1183, DOI 10.1007/s13277-015-3903-3; Zhang E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.356; Zhang ZY, 2016, CANCER LETT, V376, P62, DOI 10.1016/j.canlet.2016.03.022; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252	35	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164590	10.1371/journal.pone.0164590	http://dx.doi.org/10.1371/journal.pone.0164590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788162	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900023
J	Kripke, K; Reed, J; Hankins, C; Smiley, G; Laube, C; Njeuhmeli, E				Kripke, Katharine; Reed, Jason; Hankins, Catherine; Smiley, Gregory; Laube, Catey; Njeuhmeli, Emmanuel			Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; VIRAL LOAD; METAANALYSIS; TRANSMISSION	Background The report of the Joint United Nations Programme on HIV/AIDS (UNAIDS) for World AIDS Day 2014 highlighted a Fast-Track Strategy that sets ambitious treatment and prevention targets to reduce global HIV incidence to manageable levels by 2020 and end the AIDS epidemic by 2030. The 90-90-90 treatment targets for 2020 call for 90% of people living with HIV to know their HIV status, 90% of people who know their status to receive treatment, and 90% of people on HIV treatment to be virally suppressed. This paper examines how scaleup of voluntary medical male circumcision (VMMC) services in four priority countries in sub-Saharan Africa could contribute to ending the AIDS epidemic by 2030 in the context of concerted efforts to close the treatment gap, and what the impact of VMMC scale-up would be if the 90-90-90 treatment targets were not completely met. Methods Using the Goals module of the Spectrum suite of models, this analysis modified ART (antiretroviral treatment) scale-up coverage from base scenarios to reflect the 90-90-90 treatment targets in four countries (Lesotho, Malawi, South Africa, and Uganda). In addition, a second scenario was created to reflect viral suppression levels of 75% instead of 90%, and a third scenario was created in which the 90-90-90 treatment targets are reached in women, with men reaching more moderate coverage levels. Regarding male circumcision (MC) coverage, the analysis examined both a scenario in which VMMCs were assumed to stop after 2015, and one in which MC coverage was scaled up to 90% by 2020 and maintained at 90% thereafter. Results Across all four countries, scaling up VMMC is projected to provide further HIV incidence reductions in addition to those achieved by reaching the 90-90-90 treatment targets. If viral suppression levels only reach 75%, scaling up VMMC leads to HIV incidence reduction to nearly the same levels as those achieved with 90-90-90 without VMMC scale-up. If only women reach the 90-90-90 targets, scaling up VMMC brings HIV incidence down to near the levels projected with 90-90-90 without VMMC scale-up. Regarding cost, scaling up VMMC increases the annual costs during the scale-up phase, but leads to lower annual costs after the MC coverage target is achieved. Conclusions The scenarios modeled in this paper show that the highly durable and effective male circumcision intervention increases epidemic impact levels over those of treatment-only strategies, including the case if universal levels of viral suppression in men and women are not achieved by 2020. In the context of 90-90-90, prioritizing continued successful scale-up of VMMC increases the possibility that future generations will be free not only of AIDS but also of HIV.	[Kripke, Katharine] Project SOAR Supporting Operat AIDS Res, Avenir Hlth, Washington, DC 20253 USA; [Reed, Jason] Jhpiego, Washington, DC USA; [Hankins, Catherine] Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands; [Hankins, Catherine] Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Smiley, Gregory] HIV AIDS Reg Support Team, Joint United Nations Programme, Eastern, South Africa; [Laube, Catey] Off US Global AIDS Coordinator, Washington, DC USA; [Njeuhmeli, Emmanuel] United States Agcy Int Dev, Washington, DC USA	Jhpiego; University of Amsterdam; University of Amsterdam; United States Agency for International Development (USAID)	Kripke, K (corresponding author), Project SOAR Supporting Operat AIDS Res, Avenir Hlth, Washington, DC 20253 USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577; Hankins, Catherine/0000-0002-1642-8592	U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) [AID-OAA-14-00026, AID-OAA-A-14-00046]	U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026, and Cooperative Agreement Strengthening High Impact Interventions for an AIDS-free Generation, number AID-OAA-A-14-00046. The information provided does not necessarily reflect the views of USAID, PEPFAR, UNAIDS, or the United States Government, and the contents of this article are the sole responsibility of Projects SOAR and AIDSFree, the Population Council, and the authors. E. Njeuhmeli played a substantial role in study design and manuscript preparation.	[Anonymous], 2011, MMWR, V60, P1618; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Avenir Health, 2015, AVENIR HEALTH UNIT C; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cremin I, 2012, TROP MED INT HEALTH, V17, pe26, DOI 10.1111/j.1365-3156.2011.02937.x; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Department of Health, 2007, SOUTH AFRICA DEMOGRA; Forsythe S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S4; Futures Institute, 2011, GOALS MANUAL A MODEL; Geldsetzer P, 2015, HEALTH HIV AIDS PERS; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Kikuyu V, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083614, DOI 10.1371/JOURNAL.PONE.0083614]; Kripke K, ASSESSING PROGRESS I; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Macro International, 2009, LESOTHO DEMOGRAPHIC; Macro International, 2011, MALAWI DEMOGRAPHIC A; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Thomas AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027561; Uganda Bureau of Statistics, 2012, UGANDA DEMOGRAPHIC A; UNAIDS, 2014, FAST TRACK ENDING TH; UNAIDS, 2015, HOW AIDS CHANGED EVE; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; World Health Organization, 2015, GUIDELINE ON WHEN TO	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0155734	10.1371/journal.pone.0155734	http://dx.doi.org/10.1371/journal.pone.0155734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783681	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800003
J	Huang, CY; Lee, SY; Yang, CW; Hung, SC; Chiang, CK; Huang, JW; Hung, KY				Huang, Chiung-Ying; Lee, Szu-Ying; Yang, Chung-Wei; Hung, Szu-Chun; Chiang, Chih-Kang; Huang, Jenq-Wen; Hung, Kuan-Yu			A Simpler Creatinine Index Can Predict Long-Term Survival in Chinese Hemodialysis Patients	PLOS ONE			English	Article							STAGE RENAL-DISEASE; LEAN BODY-MASS; NUTRITIONAL-STATUS; MORTALITY; ASSOCIATION; OUTCOMES; HEMO	Background Low lean body mass (LBM) is an indicator of malnutrition inflammation syndrome, which is common in hemodialysis (HD) patients. The creatinine index (CI) has been validated as a reliable method to estimate LBM and evaluate the protein-energy status of HD patients. However, the traditional creatinine index formula was complex. We sought to investigate the impact of CI derived from a new simple formula on Chinese HD patient outcomes. Methods In this retrospective cohort study, we enrolled 1269 patients who initiated HD between February 1981 and February 2012 and followed them until the end of February 2013. CI was calculated using the simple creatinine kinetic model (CKM) formula. Multiple linear regression analysis and Cox regression proportional hazard analysis were used to define independent variables and compare survival between groups. Results The 1269 HD patients were categorized into 3 groups according to the tertiles of calculated CI between men and women. Each group consisted of 423 patients (50.6% men, 49.4% women). Patients in the highest sex-specific tertile of CI had longer overall survival (HR, 0.46; P 0.002). BMI did not significantly associate with survival after adjustment (HR, 0.99; P 0.613). Conclusions CI derived from the simple CKM formula serves as a good parameter than BMI to predict the survival of HD patients. The formula could extend its convenient use in clinical practice for HD patients.	[Chiang, Chih-Kang; Huang, Jenq-Wen; Hung, Kuan-Yu] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Taipei, Taiwan; [Huang, Chiung-Ying; Lee, Szu-Ying] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Yun Lin Branch, Huwei, Yun Lin County, Taiwan; [Yang, Chung-Wei] Natl Taiwan Univ, Coll Med & Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Hung, Szu-Chun] Taipei Tzu Chi Hosp, Div Nephrol, New Taipei, Taiwan	National Taiwan University; National Taiwan University; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital	Huang, JW (corresponding author), Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Taipei, Taiwan.	jenqwen@ntuh.gov.tw		Huang, Chiung-Ying/0000-0003-1285-089X; CHIANG, CHIH-KANG/0000-0001-9021-4616; YANG, CHUNG-WEI/0000-0002-8613-3597; HUNG, KUAN-YU/0000-0003-3472-5512; HUANG, JENQ-WEN/0000-0001-8011-2317				[Anonymous], 2000, AM J KIDNEY DIS, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517; Canaud B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093286; Combe C, 2001, AM J KIDNEY DIS, V37, pS81, DOI 10.1053/ajkd.2001.20756; de Mutsert R, 2009, J RENAL NUTR, V19, P127, DOI 10.1053/j.jrn.2008.08.003; Desmeules S, 2004, NEPHROL DIAL TRANSPL, V19, P1182, DOI 10.1093/ndt/gfh016; Dong J, 2011, NEPHROL DIAL TRANSPL, V26, P3715, DOI 10.1093/ndt/gfr142; Dwyer JT, 2005, KIDNEY INT, V68, P1766, DOI 10.1111/j.1523-1755.2005.00593.x; Gallar-Ruiz P, 2012, NEFROLOGIA, V32, P467, DOI 10.3265/Nefrologia.pre2012.Mar.11219; Huang C, 2010, J DEV ORIG HLTH DIS, V1, P412, DOI 10.1017/S2040174410000504; Huang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054976; Johansen KL, 2004, AM J CLIN NUTR, V80, P324, DOI 10.1093/ajcn/80.2.324; Kalantar-Zadeh K, 2003, J RENAL NUTR, V13, P15, DOI 10.1053/jren.2003.50005; Kamimura MA, 2003, NEPHROL DIAL TRANSPL, V18, P101, DOI 10.1093/ndt/18.1.101; KESHAVIAH PR, 1994, J AM SOC NEPHROL, V4, P1475; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Pupim LB, 2004, J RENAL NUTR, V14, P6, DOI 10.1053/j.jrn.2003.10.001; Rambod M, 2009, AM J KIDNEY DIS, V53, P298, DOI 10.1053/j.ajkd.2008.09.018; Rocco MV, 2002, AM J KIDNEY DIS, V39, P245, DOI 10.1053/ajkd.2002.30543; Wong JS, 1999, KIDNEY INT, V55, P2515, DOI 10.1046/j.1523-1755.1999.00464.x; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	20	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165164	10.1371/journal.pone.0165164	http://dx.doi.org/10.1371/journal.pone.0165164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780214	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900031
J	Keddy, KH; Sooka, A; Smith, AM; Musekiwa, A; Tau, NP; Kingman, KP; Angulo, FJ				Keddy, Karen H.; Sooka, Arvinda; Smith, Anthony M.; Musekiwa, Alfred; Tau, Nomsa P.; Kingman, Keith P.; Angulo, Frederick J.		GERMS-SA	Typhoid Fever in South Africa in an Endemic HIV Setting	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHI; SALMONELLA-TYPHI; OUTBREAK; TRANSMISSION; INFECTION; BACTERIAL; FEATURES; SEX	Background Typhoid fever remains an important disease in Africa, associated with outbreaks and the emerging multidrug resistant Salmonella enterica serotype Typhi (Salmonella Typhi) haplotype, H58. This study describes the incidence of, and factors associated with mortality due to, typhoid fever in South Africa, where HIV prevalence is high. Methods and Findings Nationwide active laboratory-based surveillance for culture-confirmed typhoid fever was undertaken from 2003-2013. At selected institutions, additional clinical data from patients were collected including age, sex, HIV status, disease severity and outcome. HIV prevalence among typhoid fever patients was compared to national HIV seroprevalence estimates. The national reference laboratory tested Salmonella Typhi isolates for antimicrobial susceptibility and haplotype. Unadjusted and adjusted logistic regression analyses were conducted determining factors associated with typhoid fever mortality. We identified 855 typhoid fever cases: annual incidence ranged from 0.11 to 0.39 per 100,000 population. Additional clinical data were available for 369 (46.8%) cases presenting to the selected sites. Among typhoid fever patients with known HIV status, 19.3% (29/150) were HIV-infected. In adult females, HIV prevalence in typhoid fever patients was 43.2% (19/44) versus 15.7% national HIV seroprevalence (P < .001); in adult males, 16.3% (7/43) versus 12.3% national HIV seroprevalence (P = .2). H58 represented 11.9% (22/185) of Salmonella Typhi isolates tested. Increased mortality was associated with HIV infection (AOR 10.7; 95% CI 2.3-50.3) and disease severity (AOR 9.8; 95% CI 1.6-60.0) on multivariate analysis. Conclusions Typhoid fever incidence in South Africa was largely unchanged from 2003-2013. Typhoid fever mortality was associated disease severity. HIV infection may be a contributing factor. Interventions mandate improved health care access, including to HIV management programmes as well as patient education. Further studies are necessary to clarify relationships between HIV infection and typhoid fever in adults.	[Keddy, Karen H.; Sooka, Arvinda; Smith, Anthony M.; Tau, Nomsa P.] Natl Inst Communicable Dis, Ctr Enter Dis, Johannesburg, South Africa; [Keddy, Karen H.; Smith, Anthony M.; Kingman, Keith P.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Musekiwa, Alfred] Ctr Dis Control & Prevent, South Africa Global Dis Detect Ctr, Int Emerging Infect Programme, Pretoria, South Africa; [Kingman, Keith P.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Angulo, Frederick J.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global Hlth Protect, Atlanta, GA USA	National Institute for Communicable Diseases (NICD); University of Witwatersrand; Bill & Melinda Gates Foundation; Centers for Disease Control & Prevention - USA	Keddy, KH; Smith, AM (corresponding author), Natl Inst Communicable Dis, Ctr Enter Dis, Johannesburg, South Africa.; Keddy, KH; Smith, AM (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa.	karenk@nicd.ac.za; anthonys@nicd.ac.za	Keddy, Karen Helena/AAZ-2189-2020	Keddy, Karen Helena/0000-0001-8640-2235; Musekiwa, Alfred/0000-0001-5880-3680	National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [5U2GPS001328]; United States Agency for International Development's Antimicrobial Resistance Initiative, transferred via Centers for Disease Control and Prevention (CDC), Atlanta, Georgia [U60/CCU022088]; HHS Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP) [U62/PS0022901]	National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development's Antimicrobial Resistance Initiative, transferred via Centers for Disease Control and Prevention (CDC), Atlanta, Georgia(United States Agency for International Development (USAID)); HHS Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP)	This research has been supported by National Institute for Communicable Diseases (www.nicd.ac.za) of the National Health Laboratory Service, Johannesburg, South Africa and the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) (www.cdc.gov) under the terms of [5U2GPS001328] and, in part, for 2003-2006 by funds from the United States Agency for International Development's Antimicrobial Resistance Initiative, transferred via a cooperative agreement [number U60/CCU022088] from the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia (www.cdc.gov). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NICD/NHLS or CDC. For 2007-2009, it was supported by the HHS Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP) Cooperative Agreement [U62/PS0022901]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa, 2011, ASSA PROV OUTP 11021; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; Colomba C, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-38; Crump JA, 2008, EPIDEMIOL INFECT, V136, P436, DOI 10.1017/S0950268807009338; Crump JA, 2011, CLIN INFECT DIS, V52, P341, DOI 10.1093/cid/ciq103; Dougan G, 2014, ANNU REV MICROBIOL, V68, P317, DOI 10.1146/annurev-micro-091313-103739; Feasey NA, 2010, EMERG INFECT DIS, V16, P1448, DOI 10.3201/eid1609.100125; Feldman C, 2009, CLIN MICROBIOL INFEC, V15, P850, DOI 10.1111/j.1469-0691.2009.02901.x; GOTUZZO E, 1991, ARCH INTERN MED, V151, P381, DOI 10.1001/archinte.151.2.381; Hendriksen RS, 2015, J CLIN MICROBIOL, V53, P262, DOI 10.1128/JCM.02026-14; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000929; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Keddy KH, 2011, EPIDEMIOL INFECT, V139, P1239, DOI 10.1017/S0950268810002207; Keddy KH, 2015, CLIN INFECT DIS, V61, pS272, DOI 10.1093/cid/civ685; Keddy KH, 2012, CLIN INFECT DIS, V54, P1448, DOI 10.1093/cid/cis224; Kerber KJ, 2013, AIDS, V27, P2637, DOI 10.1097/01.aids.0000432987.53271.40; Khan M, 1999, AM J TROP MED HYG, V61, P41, DOI 10.4269/ajtmh.1999.61.41; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lunguya Octavie, 2012, PLoS Negl Trop Dis, V6, pe1921, DOI 10.1371/journal.pntd.0001921; Lutterloh E, 2012, CLIN INFECT DIS, V54, P1100, DOI 10.1093/cid/cis012; Murgia M, 2016, J MICROBIOL METH, V127, P219, DOI 10.1016/j.mimet.2016.06.018; National Department of Health, 2012, 2011 NAT ANT SENT HI; National Department of Health SA, 2003, COMPR HIV AIDS CAR M; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Polonsky JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114702; RAJAGOPALAN P, 1982, CLIN EXP IMMUNOL, V47, P269; Reller ME, 2003, CLIN INFECT DIS, V37, P141, DOI 10.1086/375590; Smith AM, 2011, J MED MICROBIOL, V60, P1405, DOI 10.1099/jmm.0.030700-0; Srinivasan A, 2009, J IMMUNOL, V182, P7838, DOI 10.4049/jimmunol.0900382; Wong VK, 2015, NAT GENET, V47, P632, DOI 10.1038/ng.3281	34	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164939	10.1371/journal.pone.0164939	http://dx.doi.org/10.1371/journal.pone.0164939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780232	Green Published, gold			2022-12-26	WOS:000389046900025
J	Zhao, HT; Du, YL; Gao, PF; Wang, SJ; Pan, JF; Jiang, YS				Zhao, Huiting; Du, Yali; Gao, Pengfei; Wang, Shujie; Pan, Jianfang; Jiang, Yusuo			Antennal Transcriptome and Differential Expression Analysis of Five Chemosensory Gene Families from the Asian Honeybee Apis cerana cerana	PLOS ONE			English	Article							PHEROMONE-BINDING-PROTEIN; MELLIFERA L.; ODORANT; INSECT; BEE; HYMENOPTERA; RECEPTORS; CLONING; LOCALIZATION; EVOLUTION	Chemosensory genes play a central role in sensing chemical signals and guiding insect behavior. The Chinese honeybee, Apis cerana cerana, is one of the most important insect species in China in terms of resource production, and providing high-quality products for human consumption, and also serves as an important pollinator. Communication and foraging behavior of worker bees is likely linked to a complex chemosensory system. Here, we used transcriptome sequencing on adult A. c. cerana workers of different ages to identify the major chemosensory gene families and the differentially expressed genes(DEGs), and to investigate their expression profiles. A total of 109 candidate chemosensory genes in five gene families were identified from the antennal transcriptome assemblies, including 17 OBPs, 6 CSPs, 74 ORs, 10 IRs, and 2SNMPs, in which nineteen DEGs were screened and their expression values at different developmental stages were determined in silico. No chemosensory transcript was specific to a certain developmental period. Thirteen DEGs were upregulated and 6were downregulated. We created extensive expression profiles in six major body tissues using qRT-PCR and found that most DEGs were exclusively or primarily expressed in antennae. Others were abundantly expressed in the other tissues, such as head, thorax, abdomen, legs, and wings. Interestingly, when a DEG was highly expressed in the thorax, it also had a high level of expression in legs, but showed a lowlevel in antennae. This study explored five chemoreceptor superfamily genes using RNA-Seq coupled with extensive expression profiling of DEGs. Our results provide new insights into the molecular mechanism of odorant detection in the Asian honeybee and also serve as an extensive novel resource for comparing and investigating olfactory functionality in hymenopterans.	[Zhao, Huiting] Shanxi Agr Univ, Coll Life Sci, Taigu, Shanxi, Peoples R China; [Du, Yali; Gao, Pengfei; Wang, Shujie; Pan, Jianfang; Jiang, Yusuo] Shanxi Agr Univ, Coll Anim Sci & Technol, Taigu, Shanxi, Peoples R China	Shanxi Agricultural University; Shanxi Agricultural University	Jiang, YS (corresponding author), Shanxi Agr Univ, Coll Anim Sci & Technol, Taigu, Shanxi, Peoples R China.	jiangys-001@163.com			National Natural Science Foundation of China [31502021, 31272513]; Scientific Research Starting Foundation for Introduced Doctor of Shanxi Agriculture University [2013YJ37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Starting Foundation for Introduced Doctor of Shanxi Agriculture University	This work was supported by grants from the National Natural Science Foundation of China (31502021 and 31272513), and Scientific Research Starting Foundation for Introduced Doctor of Shanxi Agriculture University (2013YJ37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Briand L, 2001, EUR J BIOCHEM, V268, P752, DOI 10.1046/j.1432-1327.2001.01927.x; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; Carcaud J, 2015, J NEUROSCI, V35, P4157, DOI 10.1523/JNEUROSCI.0734-14.2015; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; Danty E, 1998, CHEM SENSES, V23, P83, DOI 10.1093/chemse/23.1.83; Dippel S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1141; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Gong L, 2012, B ENTOMOL RES, V102, P600, DOI 10.1017/S0007485312000168; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103420; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hu ZQ, 2013, J INSECT SCI, V13, DOI [10.1673/031.013.2801, 10.1673/031.013.8001]; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li HL, 2016, COMP BIOCHEM PHYS B, V194, P11, DOI 10.1016/j.cbpb.2015.11.014; Li HL, 2008, J CHEM ECOL, V34, P1593, DOI 10.1007/s10886-008-9559-3; Li HL, 2007, CHINESE SCI BULL, V52, P1355, DOI 10.1007/s11434-007-0210-4; Li XM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2236-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2014, J INSECT PHYSIOL, V60, P118, DOI 10.1016/j.jinsphys.2013.11.007; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Nishimura O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050664; Park D, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-1; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rogers ME, 2001, CELL TISSUE RES, V303, P433, DOI 10.1007/s004410000305; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Sandoz JC, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00098; Szyszka P, 2005, J NEUROPHYSIOL, V94, P3303, DOI 10.1152/jn.00397.2005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Weng C, 2015, INT J BIOL MACROMOL, V72, P430, DOI 10.1016/j.ijbiomac.2014.08.046; Wicher D, 2015, PROG MOL BIOL TRANSL, V130, P37, DOI 10.1016/bs.pmbts.2014.11.002; Winston M., 1987, The biology of the honey bee.; Zhao H. K., 2014, J BACTERIOL MYCOL, V1, P1, DOI DOI 10.1049/J0E.2013.0129; Zhao HT, 2014, APPL ENTOMOL ZOOL, V49, P189, DOI 10.1007/s13355-013-0228-9; Zhao YN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148159	54	15	18	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165374	10.1371/journal.pone.0165374	http://dx.doi.org/10.1371/journal.pone.0165374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776190	Green Published, gold, Green Submitted			2022-12-26	WOS:000389009200059
J	Bloom, J; Metz, C; Nalawade, S; Casabar, J; Cheng, KF; He, MZ; Sherry, B; Coleman, T; Forsthuber, T; Al-Abed, Y				Bloom, Joshua; Metz, Christine; Nalawade, Saisha; Casabar, Julian; Cheng, Kai Fan; He, Mingzhu; Sherry, Barbara; Coleman, Thomas; Forsthuber, Thomas; Al-Abed, Yousef			Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE RHEUMATOID-ARTHRITIS; ANTIINFLAMMATORY AGENT 3-FORMYLAMINO-7-METHYLSULFONYLAMINO-6-PHENOXY-4H-1-BENZOPYRAN-4-ONE; KAPPA-B ACTIVATION; ANTIRHEUMATIC DRUG; IN-VITRO; OSTEOCLAST DIFFERENTIATION; SYNOVIAL FIBROBLASTS; CYTOKINE PRODUCTION; REGULATORY ROLE; ADVERSE EVENTS	Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that has been implicated in a broad range of inflammatory and oncologic diseases. MIF is unique among cytokines in terms of its release profile and inflammatory role, notably as an endogenous counter-regulator of the anti-inflammatory effects of glucocorticoids. In addition, it exhibits a catalytic tautomerase activity amenable to the design of high affinity small molecule inhibitors. Although several classes of these compounds have been identified, biologic characterization of these molecules remains a topic of active investigation. In this study, we used in vitro LPS-driven assays to characterize representative molecules from several classes of MIF inhibitors. We determined that MIF inhibitors exhibit distinct profiles of anti-inflammatory activity, especially with regard to TNF alpha. We further investigated a molecule with relatively low anti-inflammatory activity, compound T-614 (also known as the anti-rheumatic drug iguratimod), and found that, in addition to exhibiting selective MIF inhibition in vitro and in vivo, iguratimod also has additive effects with glucocorticoids. Furthermore, we found that iguratimod synergizes with glucocorticoids in attenuating experimental autoimmune encephalitis, a model of multiple sclerosis. Our work identifies iguratimod as a valuable new candidate for drug repurposing to MIF-relevant diseases, including multiple sclerosis.	[Bloom, Joshua; Metz, Christine; Sherry, Barbara; Al-Abed, Yousef] Hofstra Northwell Sch Med, Hempstead, NY 11549 USA; [Bloom, Joshua; Cheng, Kai Fan; He, Mingzhu; Al-Abed, Yousef] Feinstein Inst Med Res, Ctr Mol Innovat, 350 Community Dr, Manhasset, NY 11030 USA; [Metz, Christine] Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY 11030 USA; [Sherry, Barbara] Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA; [Coleman, Thomas] Feinstein Inst Med Res, Off Technol Transfer, Manhasset, NY 11030 USA; [Nalawade, Saisha; Casabar, Julian; Forsthuber, Thomas] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA	Northwell Health; Northwell Health; Northwell Health; Northwell Health; Northwell Health; University of Texas System; University of Texas at San Antonio (UTSA)	Al-Abed, Y (corresponding author), Feinstein Inst Med Res, Ctr Mol Innovat, 350 Community Dr, Manhasset, NY 11030 USA.; Bloom, J (corresponding author), Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA.	jbloom2@northwell.edu; yalabed@northwell.edu	Sherry, Barbara/GSD-7179-2022; Nalawade, Saisha/AAU-7060-2021; Forsthuber, Thomas/AID-8080-2022	Sherry, Barbara/0000-0003-3119-1463; Christine, Metz/0000-0002-1013-1691; /0000-0003-0692-7125	National Institutes of Health from NIAID [R21AI110771]; Small Business Innovation Research Grant [1R43AR062401]; Hofstra-Northwell School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI110771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR062401] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Small Business Innovation Research Grant; Hofstra-Northwell School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant R21AI110771 from NIAID (to T. F.) and Small Business Innovation Research Grant 1R43AR062401 (to T. C.). Yousef Al-Abed is the inventor or co-inventor of several small molecule inhibitors of MIF.r Recipient of M.D./Ph.D. candidate stipend from the Hofstra-Northwell School of Medicine. To whom correspondence may be addressed: Feinstein Institute for Medical Research, 350 Community Dr., Manhasset, NY 11030. Tel.: 516-562-2690; E-mail: jbloom2@northwell.edu.	Aikawa Y, 2002, INFLAMM RES, V51, P188, DOI 10.1007/PL00000291; Aikawa Y, 1998, J NEUROIMMUNOL, V89, P35, DOI 10.1016/S0165-5728(98)00056-3; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Al-Abed Y, 2011, P NATL ACAD SCI USA, V108, P8224, DOI 10.1073/pnas.1017624108; Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Ayroldi E, 2014, FASEB J, V28, P5055, DOI 10.1096/fj.14-254755; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bacher M, 1997, AM J PATHOL, V150, P235; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bloom J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-11; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cheng KF, 2006, BIOORG MED CHEM LETT, V16, P3376, DOI 10.1016/j.bmcl.2006.04.038; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Chesney JA, 2015, MOL MED, V21, pS19, DOI 10.2119/molmed.2015.00055; Ciccone A., 2008, COCHRANE DB SYST REV, V2008; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Crichlow GV, 2007, J BIOL CHEM, V282, P23089, DOI 10.1074/jbc.M701825200; Curtis JR, 2006, ARTHRIT RHEUM-ARTHR, V55, P420, DOI 10.1002/art.21984; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Dickerhof N, 2015, FREE RADICAL BIO MED, V89, P498, DOI 10.1016/j.freeradbiomed.2015.09.009; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Dooley D, 2014, PHARMACOL THERAPEUT, V141, P21, DOI 10.1016/j.pharmthera.2013.08.001; Duan XW, 2015, CLIN RHEUMATOL, V34, P1513, DOI 10.1007/s10067-015-2999-6; Eisai Co. Ltd, 2016, CAR TABL PACK INS; Fan HP, 2014, ARTHRITIS RHEUMATOL, V66, P2059, DOI 10.1002/art.38689; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Gan K, 2016, INT IMMUNOPHARMACOL, V35, P294, DOI 10.1016/j.intimp.2016.03.038; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Greven D, 2010, EXPERT OPIN THER TAR, V14, P253, DOI 10.1517/14728220903551304; Griga T, 2007, HEPATO-GASTROENTEROL, V54, P784; Gu R, 2015, CYTOKINE, V72, P135, DOI 10.1016/j.cyto.2014.11.015; Harper JM, 2010, FASEB J, V24, P2436, DOI 10.1096/fj.09-152223; He XX, 2009, MOL MED, V15, P1, DOI 10.2119/molmed.2008.00107; Healy ZR, 2011, CANCER EPIDEM BIOMAR, V20, P1516, DOI 10.1158/1055-9965.EPI-11-0279; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Huscher D, 2009, ANN RHEUM DIS, V68, P1119, DOI 10.1136/ard.2008.092163; Ioannou K, 2014, INT J ONCOL, V45, P1457, DOI 10.3892/ijo.2014.2551; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Ji NN, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000139; Jiang CL, 2015, STEROIDS, V102, P27, DOI 10.1016/j.steroids.2015.06.015; Johnston L, 2015, IMMUNOBIOLOGY, V220, P1305, DOI 10.1016/j.imbio.2015.07.014; Kaltsonoudis E, 2014, AUTOIMMUN REV, V13, P54, DOI 10.1016/j.autrev.2013.09.002; Kawakami A, 1999, J LAB CLIN MED, V133, P566, DOI 10.1016/S0022-2143(99)90186-5; Kerschbaumer RJ, 2012, J BIOL CHEM, V287, P7446, DOI 10.1074/jbc.M111.329664; Kohno M, 2001, J RHEUMATOL, V28, P2591; Kudrin A, 2006, J BIOL CHEM, V281, P29641, DOI 10.1074/jbc.M601103200; Kuriyama K, 2002, BIOCHEM BIOPH RES CO, V299, P903, DOI 10.1016/S0006-291X(02)02754-7; Lang TL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00577; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lu LJ, 2008, CHINESE MED J-PEKING, V121, P615, DOI 10.1097/00029330-200804010-00008; Lu LJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P979, DOI 10.1002/art.24643; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Luo Q, 2013, J IMMUNOL, V191, P4969, DOI 10.4049/jimmunol.1300832; Matsumoto T, 2013, CLIN RHEUMATOL, V32, P271, DOI 10.1007/s10067-012-2113-2; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Madeira MFM, 2012, MICROBES INFECT, V14, P198, DOI 10.1016/j.micinf.2011.09.005; Morrison MC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00308; Mucke HAM, 2012, DRUG TODAY, V48, P577, DOI 10.1358/dot.2012.48.9.1855758; Okamura K, 2015, MOD RHEUMATOL, V25, P534, DOI 10.3109/14397595.2014.998361; Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444; Onodera S, 2004, ARTHRITIS RHEUM-US, V50, P1437, DOI 10.1002/art.20190; Orita M, 2002, CURR PHARM DESIGN, V8, P1297, DOI 10.2174/1381612023394674; Orita M, 2001, J MED CHEM, V44, P540, DOI 10.1021/jm000386o; Ouertatani-Sakouhi H, 2010, J BIOMOL SCREEN, V15, P347, DOI 10.1177/1087057110363825; Ouertatani-Sakouhi H, 2009, BIOCHEMISTRY-US, V48, P9858, DOI 10.1021/bi900957e; Pantouris G, 2015, CHEM BIOL, V22, P1197, DOI 10.1016/j.chembiol.2015.08.006; Petrovsky N, 2003, IMMUNOL CELL BIOL, V81, P137, DOI 10.1046/j.0818-9641.2002.01148.x; Powell ND, 2005, J IMMUNOL, V175, P5611, DOI 10.4049/jimmunol.175.9.5611; Ratzer R, 2016, MULT SCLER J, V22, P926, DOI 10.1177/1352458515605908; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Santos L, 2001, CLIN EXP IMMUNOL, V123, P309, DOI 10.1046/j.1365-2249.2001.01423.x; Savaskan Nic E, 2012, Int J Cell Biol, V2012, P139573, DOI 10.1155/2012/139573; Sawada T, 2000, IMMUNOPHARMACOLOGY, V49, P285, DOI 10.1016/S0162-3109(00)00242-3; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Senter PD, 2002, P NATL ACAD SCI USA, V99, P144, DOI 10.1073/pnas.011569399; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Stathas T, 2013, EUR REV MED PHARMACO, V17, P1455; Stojanovic I, 2009, IMMUNOLOGY, V126, P74, DOI 10.1111/j.1365-2567.2008.02879.x; Stosic-Grujicic S, 2008, J CELL PHYSIOL, V215, P665, DOI 10.1002/jcp.21346; Tanaka K, 2007, INFLAMM RES, V56, P17, DOI 10.1007/s00011-007-6022-9; Tanaka K, 2003, RHEUMATOLOGY, V42, P1365, DOI 10.1093/rheumatology/keg381; TANAKA K, 1992, ARZNEIMITTEL-FORSCH, V42-2, P935; TANAKA K, 1992, J PHARMACOBIO-DYNAM, V15, P649, DOI 10.1248/bpb1978.15.649; TANAKA K, 1995, JPN J PHARMACOL, V67, P305, DOI 10.1254/jjp.67.305; TANAKA K, 1992, ARZNEIMITTEL-FORSCH, V42-2, P945; Tanaka K, 2009, RHEUMATOL REP, V1, P11, DOI 10.4081/rr.2009.e4; Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288; Vivarelli M, 2007, CLIN EXP RHEUMATOL, V25, P775; Vujicic M, 2014, EUR J PHARMACOL, V740, P683, DOI 10.1016/j.ejphar.2014.06.009; Wei Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/214683; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Wu JP, 2000, NEUROSCI LETT, V292, P203, DOI 10.1016/S0304-3940(00)01472-5; Wust S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008202; Xu L, 2014, J MED CHEM, V57, P3737, DOI 10.1021/jm401908w; Yamamoto T., 2007, JPN PHARMACOL THER, V35, P561; Zhou L, 2012, CLIN VACCINE IMMUNOL, V19, P1065, DOI 10.1128/CVI.05715-11	107	30	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26502	26514		10.1074/jbc.M116.743328	http://dx.doi.org/10.1074/jbc.M116.743328			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27793992	Green Published, hybrid			2022-12-26	WOS:000391568200023
J	Stenvang, M; Dueholm, MS; Vad, BS; Seviour, T; Zeng, GH; Geifman-Shochat, S; Sondergaard, MT; Christiansen, G; Meyer, RL; Kjelleberg, S; Nielsen, PH; Otzen, DE				Stenvang, Marcel; Dueholm, Morten S.; Vad, Brian S.; Seviour, Thomas; Zeng, Guanghong; Geifman-Shochat, Susana; Sondergaard, Mads T.; Christiansen, Gunna; Meyer, Rikke Louise; Kjelleberg, Staffan; Nielsen, Per Halkjaer; Otzen, Daniel E.			Epigallocatechin Gallate Remodels Overexpressed Functional Amyloids in Pseudomonas aeruginosa and Increases Biofilm Susceptibility to Antibiotic Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; CYSTIC-FIBROSIS; ALPHA-SYNUCLEIN; BACTERIAL BIOFILMS; CELL-SURFACE; EGCG; BETA; FIBRILS; INHIBITORS; INFECTION	Epigallocatechin-3-gallate (EGCG) is the major polyphenol in green tea. It has antimicrobial properties and disrupts the ordered structure of amyloid fibrils involved in human disease. The antimicrobial effect of EGCG against the opportunistic pathogen Pseudomonas aeruginosa has been shown to involve disruption of quorum sensing (QS). Functional amyloid fibrils in P. aeruginosa (Fap) are able to bind and retain quorum-sensing molecules, suggesting that EGCG interferes with QS through structural remodeling of amyloid fibrils. Here we show that EGCG inhibits the ability of Fap to form fibrils; instead, EGCG stabilizes protein oligomers. Existing fibrils are remodeled by EGCG into non-amyloid aggregates. This fibril remodeling increases the binding of pyocyanin, demonstrating a mechanism by which EGCG can affect the QS function of functional amyloid. EGCG reduced the amyloid-specific fluorescent thioflavin T signal in P. aeruginosa biofilms at concentrations known to exert an antimicrobial effect. Nanoindentation studies showed that EGCG reduced the stiffness of biofilm containing Fap fibrils but not in biofilm with little Fap. In a combination treatment with EGCG and tobramycin, EGCG had a moderate effect on the minimum bactericidal eradication concentration against wild-type P. aeruginosa biofilms, whereas EGCG had a more pronounced effect when Fap was overexpressed. Our results provide a direct molecular explanation for the ability of EGCG to disrupt P. aeruginosa QS and modify its biofilm and strengthens the case for EGCG as a candidate in multidrug treatment of persistent biofilm infections.	[Stenvang, Marcel; Vad, Brian S.; Zeng, Guanghong; Meyer, Rikke Louise; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark; [Stenvang, Marcel; Vad, Brian S.; Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Meyer, Rikke Louise] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Stenvang, Marcel] Sinodanish Ctr Educ & Res SDC, DK-8000 Aarhus C, Denmark; [Dueholm, Morten S.; Sondergaard, Mads T.; Nielsen, Per Halkjaer] Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Commun, DK-9000 Aalborg, Denmark; [Seviour, Thomas; Kjelleberg, Staffan; Nielsen, Per Halkjaer] Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Geifman-Shochat, Susana] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Kjelleberg, Staffan] Univ New South Wales, Ctr Marine Bioinnovat, Mosman, NSW 2088, Australia; [Kjelleberg, Staffan] Univ New South Wales, Sch Biotechnol & Biomol Sci, Mosman, NSW 2088, Australia	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aalborg University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of New South Wales Sydney; University of New South Wales Sydney	Otzen, DE (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark.; Otzen, DE (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark.	dao@inano.au.dk	Nielsen, Per Halkjær/T-6796-2018; Dueholm, Morten Simonsen/T-6718-2018; Kjelleberg, Staffan/AAB-4641-2020; Meyer, Rikke Louise/AAB-5377-2021; Kjelleberg, Staffan/C-9229-2015	Nielsen, Per Halkjær/0000-0002-6402-1877; Dueholm, Morten Simonsen/0000-0003-4135-2670; Kjelleberg, Staffan/0000-0003-4271-6413; Meyer, Rikke Louise/0000-0002-6485-5134; Kjelleberg, Staffan/0000-0003-4271-6413; Christiansen, Gunna/0000-0003-0540-1367; Sondergaard, Mads Toft/0000-0001-6779-5109	Singapore's National Research Foundation; Ministry of Education; Nanyang Technological University (NTU); National University of Singapore (NUS)	Singapore's National Research Foundation(National Research Foundation, Singapore); Ministry of Education; Nanyang Technological University (NTU)(Nanyang Technological University); National University of Singapore (NUS)(National University of Singapore)	We are grateful to Jorgen Kjems (iNANO, Aarhus University) for the use of the Gel Doc EZ system, Brian S. Vad (iNANO, Aarhus University) for discussion of results and experimental setup, and Chuah York Wieo for assistance with surface plasmon resonance assays. We also appreciate constructive suggestions by Per Hammarstrom and Niels Heegaard. The Singapore Centre on Environmental Life Sciences Engineering is supported by Singapore's National Research Foundation, the Ministry of Education, Nanyang Technological University (NTU), and National University of Singapore (NUS) and hosted by NTU in partnership with NUS.	Andreasen M, 2012, J BIOL CHEM, V287, P34730, DOI 10.1074/jbc.M112.379552; Banerjee D, 2000, DRUGS, V60, P1053, DOI 10.2165/00003495-200060050-00006; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bikels-Goshen T, 2010, INT J FOOD MICROBIOL, V138, P26, DOI 10.1016/j.ijfoodmicro.2010.01.011; Bjarnsholt T, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001420; Cao P, 2012, BIOCHEMISTRY-US, V51, P2670, DOI 10.1021/bi2015162; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiang WC, 2013, ANTIMICROB AGENTS CH, V57, P2352, DOI 10.1128/AAC.00001-13; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cui Y, 2012, FOOD MICROBIOL, V29, P80, DOI 10.1016/j.fm.2011.08.019; DePas WH, 2012, RES MICROBIOL, V163, P592, DOI 10.1016/j.resmic.2012.10.009; Dueholm M. S., 2013, FUNCTIONAL AMYLOIDS, P411; Dueholm MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076630; Dueholm MS, 2013, MICROBIOLOGYOPEN, V2, P365, DOI 10.1002/mbo3.81; Dueholm MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051274; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Dueholm MS, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00898-14; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Ferreira N, 2009, FEBS LETT, V583, P3569, DOI 10.1016/j.febslet.2009.10.062; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Forloni G, 2001, FEBS LETT, V487, P404, DOI 10.1016/S0014-5793(00)02380-2; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Grelle G, 2011, BIOCHEMISTRY-US, V50, P10624, DOI 10.1021/bi2012383; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; He J, 2009, J AGR FOOD CHEM, V57, P11391, DOI 10.1021/jf902664f; Herbst FA, 2015, J PROTEOME RES, V14, P72, DOI 10.1021/pr500938x; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; Huber B, 2003, Z NATURFORSCH C, V58, P879; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Ishii T, 2011, BIOSCI BIOTECH BIOCH, V75, P100, DOI 10.1271/bbb.100600; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jankun J, 1997, NATURE, V387, P561, DOI 10.1038/42381; Jordal PB, 2009, APPL ENVIRON MICROB, V75, P4101, DOI 10.1128/AEM.02107-08; Kim JY, 2016, J AM CHEM SOC, V138, P402, DOI 10.1021/jacs.5b11357; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Kronvall G, 2010, J CLIN MICROBIOL, V48, P4445, DOI 10.1128/JCM.01101-10; Larsen P, 2008, APPL ENVIRON MICROB, V74, P1517, DOI 10.1128/AEM.02274-07; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Liang YC, 1997, J CELL BIOCHEM, V67, P55, DOI 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Lorenzen N, 2014, J BIOL CHEM, V289, P21299, DOI 10.1074/jbc.M114.554667; Maiti TK, 2006, PROTEINS, V64, P355, DOI 10.1002/prot.20995; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Miyata M, 2010, BIOCHEMISTRY-US, V49, P6104, DOI 10.1021/bi1004409; Nakayama M, 2013, FOOD CONTROL, V33, P433, DOI [10.1016/j.foodcont.2013.03.016, 10.1016/j.f]; Nakayama M, 2011, J MICROBIOL METH, V86, P97, DOI 10.1016/j.mimet.2011.04.010; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; O'May C, 2012, BIOFOULING, V28, P1063, DOI 10.1080/08927014.2012.725130; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; PAZ MA, 1991, J BIOL CHEM, V266, P689; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Roberts BE, 2009, NAT CHEM BIOL, V5, P936, DOI 10.1038/nchembio.246; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Ruddy J, 2013, J AEROSOL MED PULM D, V26, P69, DOI 10.1089/jamp.2011.0942; Serra DO, 2016, MOL MICROBIOL, V101, P136, DOI 10.1111/mmi.13379; Seviour T, 2015, J BIOL CHEM, V290, P6457, DOI 10.1074/jbc.M114.613810; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009; Sun Y, 2009, BIOPHYS J, V96, P1026, DOI 10.1016/j.bpj.2008.11.007; Suzuki Y, 2012, BIOCHEMISTRY-US, V51, P8154, DOI 10.1021/bi3012548; Turner KH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004518; Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205; Vert M, 2012, PURE APPL CHEM, V84, P377, DOI 10.1351/PAC-REC-10-12-04; Wiehlmann L, 2007, INT J MED MICROBIOL, V297, P615, DOI 10.1016/j.ijmm.2007.03.014; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Yamada H, 2006, J ALTERN COMPLEM MED, V12, P669, DOI 10.1089/acm.2006.12.669; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang L, 2010, MOLECULES, V15, P780, DOI 10.3390/molecules15020780; Yi SM, 2010, INT J FOOD MICROBIOL, V144, P111, DOI 10.1016/j.ijfoodmicro.2010.09.005; Young LM, 2014, J AM CHEM SOC, V136, P660, DOI 10.1021/ja406831n; Zeng GH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01099; Zeng GH, 2014, LANGMUIR, V30, P4019, DOI 10.1021/la404673q; Zhang YM, 2004, J BIOL CHEM, V279, P30994, DOI 10.1074/jbc.M403697200	81	43	49	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26540	26553		10.1074/jbc.M116.739953	http://dx.doi.org/10.1074/jbc.M116.739953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27784787	Green Published, hybrid			2022-12-26	WOS:000391568200026
J	Davies, HM; Thalassinos, K; Osborne, AR				Davies, Heledd M.; Thalassinos, Konstantinos; Osborne, Andrew R.			Expansion of Lysine-rich Repeats in Plasmodium Proteins Generates Novel Localization Sequences That Target the Periphery of the Host Erythrocyte	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; AMINO-ACID-COMPOSITION; TANDEM REPEATS; MALARIA PARASITES; MEMBRANE PROTEIN-1; SURFACE-ANTIGEN; TRANSCRIPTOME ANALYSIS; MECHANICAL-PROPERTIES; KNOB PROTEIN; FALCIPARUM	Repetitive low complexity sequences, mostly assumed to have no function, are common in proteins that are exported by the malaria parasite into its host erythrocyte. We identify a group of exported proteins containing short lysine-rich tandemly repeated sequences that are sufficient to localize to the erythrocyte periphery, where key virulence-related modifications to the plasma membrane and the underlying cytoskeleton are known to occur. Efficiency of targeting is dependent on repeat number, indicating that novel targeting modules could evolve by expansion of short lysine-rich sequences. Indeed, analysis of fragments of GARP from different species shows that two novel targeting sequences have arisen via the process of repeat expansion in this protein. In the protein Hyp12, the targeting function of a lysine-rich sequence is masked by a neighboring repetitive acidic sequence, further highlighting the importance of repetitive low complexity sequences. We show that sequences capable of targeting the erythrocyte periphery are present in at least nine proteins from Plasmodium falciparum and one from Plasmodium knowlesi. We find these sequences in proteins known to be involved in erythrocyte rigidification and cytoadhesion as well as in previously uncharacterized exported proteins. Together, these data suggest that expansion and contraction of lysine-rich repeats could generate targeting sequences de novo as well as modulate protein targeting efficiency and function in response to selective pressure.	[Davies, Heledd M.; Thalassinos, Konstantinos; Osborne, Andrew R.] Birkbeck & Univ Coll London, Dept Biol Sci, Inst Struct & Mol Biol, London WC1E 6BT, England	University of London; Birkbeck University London	Osborne, AR (corresponding author), Birkbeck & Univ Coll London, Dept Biol Sci, Inst Struct & Mol Biol, London WC1E 6BT, England.	a.osborne@ucl.ac.uk		Davies, Heledd/0000-0003-3475-0080	Wellcome Trust [091095/Z/10/Z, 099764 Z/12/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grants 091095/Z/10/Z and 099764 Z/12/Z. The authors declare that they have no conflicts of interest with the contents of this article.	Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Bennett BJ, 1997, J BIOL CHEM, V272, P15299, DOI 10.1074/jbc.272.24.15299; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Brandt GS, 2013, MOL BIOCHEM PARASIT, V191, P20, DOI 10.1016/j.molbiopara.2013.08.003; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Craig AG, 2012, MALAYS J MED SCI, V19, P5; CULVENOR JG, 1987, EXP PARASITOL, V63, P58, DOI 10.1016/0014-4894(87)90078-6; Dalby AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006231; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Diez-Silva M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00614; DNASTAR, 2014, SEQMAN NGEN VERS 12; Doerig C, 2015, NAT REV MICROBIOL, V13, P160, DOI 10.1038/nrmicro3402; Fankhauser N, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-20; Fatih FA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-33; Ferguson DJP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113923; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FOLEY M, 1991, MOL BIOCHEM PARASIT, V46, P137, DOI 10.1016/0166-6851(91)90207-M; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Frech C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-427; FUJIOKA H, 1994, EXP PARASITOL, V78, P371, DOI 10.1006/expr.1994.1040; Ganguly AK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08617; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gemayel R, 2015, MOL CELL, V59, P615, DOI 10.1016/j.molcel.2015.07.003; Gemayel R, 2012, GENES-BASEL, V3, P461, DOI 10.3390/genes3030461; Glenister FK, 2009, BLOOD, V113, P919, DOI 10.1182/blood-2008-05-157735; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; Goel S, 2014, J BIOL CHEM, V289, P34408, DOI 10.1074/jbc.M114.615393; Guy AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141729; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hirawake H, 1997, BBA-MOL BASIS DIS, V1360, P105, DOI 10.1016/S0925-4439(97)00007-0; Hodder AN, 2009, MOL MICROBIOL, V71, P48, DOI 10.1111/j.1365-2958.2008.06508.x; HOWARD RJ, 1987, J CELL BIOL, V104, P1269, DOI 10.1083/jcb.104.5.1269; Hughes AL, 2004, J MOL EVOL, V59, P528, DOI 10.1007/s00239-004-2645-4; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Jorda J, 2009, BIOINFORMATICS, V25, P2632, DOI 10.1093/bioinformatics/btp482; KAUR P, 1990, INT J PEPT PROT RES, V36, P515; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; KILEJIAN A, 1991, MOL BIOCHEM PARASIT, V44, P175, DOI 10.1016/0166-6851(91)90003-O; Kishore SP, 2009, J MOL EVOL, V68, P706, DOI 10.1007/s00239-009-9245-2; Knuepfer E, 2005, MOL MICROBIOL, V58, P1039, DOI 10.1111/j.1365-2958.2005.04895.x; Lin WH, 2012, NUCLEIC ACIDS RES, V40, P2399, DOI 10.1093/nar/gkr1078; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lopes SCP, 2014, J INFECT DIS, V209, P1403, DOI 10.1093/infdis/jiu018; Luo H, 2014, BRIEF BIOINFORM, V15, P582, DOI 10.1093/bib/bbt003; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Mankelow TJ, 2012, BLOOD CELL MOL DIS, V49, P1, DOI 10.1016/j.bcmd.2012.03.001; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Marti M, 2013, CURR OPIN MICROBIOL, V16, P445, DOI 10.1016/j.mib.2013.04.010; Mayer C, 2012, J BIOL CHEM, V287, P7182, DOI 10.1074/jbc.M111.330779; McHugh E, 2015, MOL MICROBIOL, V98, P1101, DOI 10.1111/mmi.13201; Mendes TAO, 2013, MOL BIOL EVOL, V30, P951, DOI 10.1093/molbev/mst001; Michael TP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000795; Mills JP, 2007, P NATL ACAD SCI USA, V104, P9213, DOI 10.1073/pnas.0703433104; Muralidharan V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003488; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; NASH GB, 1989, BLOOD, V74, P855, DOI 10.1182/blood.V74.2.855.bloodjournal742855; Newman AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-382; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nunes MC, 2007, MOL MICROBIOL, V63, P391, DOI 10.1111/j.1365-2958.2006.05521.x; Nunes MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011747; Oakley MSM, 2006, AM J TROP MED HYG, V75, P279; Oberli A, 2016, CELL MICROBIOL, V18, P1415, DOI 10.1111/cmi.12583; Oberli A, 2014, FASEB J, V28, P4420, DOI 10.1096/fj.14-256057; Otto TD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5754; Paila U, 2008, NUCLEIC ACIDS RES, V36, P6664, DOI 10.1093/nar/gkn635; Parish LA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-160; Pei XH, 2005, J BIOL CHEM, V280, P31166, DOI 10.1074/jbc.M505298200; Pei XH, 2007, J BIOL CHEM, V282, P26754, DOI 10.1074/jbc.M701612200; Pei XH, 2007, BLOOD, V110, P1036, DOI 10.1182/blood-2007-02-076919; Pelle KG, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0133-7; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petersen W, 2015, MOL BIOCHEM PARASIT, V200, P25, DOI 10.1016/j.molbiopara.2015.04.005; Philipps D, 2003, NUCLEIC ACIDS RES, V31, P6502, DOI 10.1093/nar/gkg845; Proellocks NI, 2014, FASEB J, V28, P3103, DOI 10.1096/fj.14-250399; Radfar A, 2009, NAT PROTOC, V4, P1899, DOI 10.1038/nprot.2009.198; Ralph SA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r93; Rambaut A, 2014, FIGTREE; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; SCHERF A, 1992, EMBO J, V11, P2293, DOI 10.1002/j.1460-2075.1992.tb05288.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHOFIELD L, 1991, PARASITOL TODAY, V7, P99, DOI 10.1016/0169-4758(91)90166-L; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Spillman NJ, 2015, ANNU REV BIOCHEM, V84, P813, DOI 10.1146/annurev-biochem-060614-034157; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sundararaman SA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11078; Tan JC, 2010, J MOL EVOL, V71, P268, DOI 10.1007/s00239-010-9381-8; Tanaka TQ, 2013, MOL BIOCHEM PARASIT, V188, P20, DOI 10.1016/j.molbiopara.2013.02.005; Tarr SJ, 2014, MOL BIOCHEM PARASIT, V196, P29, DOI 10.1016/j.molbiopara.2014.07.011; Tiburcio M, 2012, BLOOD, V119, pE172, DOI 10.1182/blood-2012-03-414557; Toll-Riera M, 2012, MOL BIOL EVOL, V29, P883, DOI 10.1093/molbev/msr263; TRIGLIA T, 1987, EMBO J, V6, P1413, DOI 10.1002/j.1460-2075.1987.tb02382.x; TRIGLIA T, 1988, MOL BIOCHEM PARASIT, V31, P199, DOI 10.1016/0166-6851(88)90170-3; van Ooij C, 2013, J BIOL CHEM, V288, P31971, DOI 10.1074/jbc.M113.474189; Verra F, 1999, MOL BIOL EVOL, V16, P627, DOI 10.1093/oxfordjournals.molbev.a026145; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Vignali M, 2011, J CLIN INVEST, V121, P1119, DOI 10.1172/JCI43457; Waller KL, 2007, BBA-BIOMEMBRANES, V1768, P2145, DOI 10.1016/j.bbamem.2007.04.027; Waller KL, 2010, BBA-BIOMEMBRANES, V1798, P861, DOI 10.1016/j.bbamem.2010.01.018; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waterkeyn JG, 2000, EMBO J, V19, P2813, DOI 10.1093/emboj/19.12.2813; Watermeyer JM, 2016, BLOOD, V127, P343, DOI 10.1182/blood-2015-10-674002; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	119	18	18	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26188	26207		10.1074/jbc.M116.761213	http://dx.doi.org/10.1074/jbc.M116.761213			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27777305	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000390345200035
J	Shields-Cutler, RR; Crowley, JR; Miller, CD; Stapleton, AE; Cui, WD; Henderson, JP				Shields-Cutler, Robin R.; Crowley, Jan R.; Miller, Connelly D.; Stapleton, Ann E.; Cui, Weidong; Henderson, Jeffrey P.			Human Metabolome-derived Cofactors Are Required for the Antibacterial Activity of Siderocalin in Urine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDEROPHORE-BINDING-PROTEINS; TRACT-INFECTION; IRON ACQUISITION; STRUCTURAL-CHARACTERIZATION; BACTERIAL-INFECTION; MASS-SPECTROMETRY; IMMUNE-SYSTEM; LIPOCALIN 2; PATHOGEN; ENTEROBACTIN	In human urinary tract infections, host cells release the antimicrobial protein siderocalin (SCN; also known as lipocalin-2, neutrophil gelatinase-associated lipocalin, or 24p3) into the urinary tract. By binding to ferric catechol complexes, SCN can sequester iron, a growth-limiting nutrient for most bacterial pathogens. Recent evidence links the antibacterial activity of SCN in human urine to iron sequestration and metabolomic variation between individuals. To determine whether these metabolomic associations correspond to functional Fe(III)binding SCN ligands, we devised a biophysical protein binding screen to identify SCN ligands through direct analysis of human urine. This screen revealed a series of physiologic unconjugated urinary catechols that were able to function as SCN ligands of which pyrogallol in particular was positively associated with high urinary SCN activity. In a purified, defined culture system, these physiologic SCN ligands were sufficient to activate SCN antibacterial activity against Escherichia coli. In the presence of multiple SCN ligands, native mass spectrometry demonstrated that SCN may preferentially combine different ligands to coordinate iron, suggesting that availability of specific ligand combinations affects in vivo SCN antibacterial activity. These results support a mechanistic link between the human urinary metabolome and innate immune function.	[Shields-Cutler, Robin R.; Miller, Connelly D.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Div Infect Dis, Dept Med, St Louis, MO 63110 USA; [Shields-Cutler, Robin R.; Miller, Connelly D.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Crowley, Jan R.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Stapleton, Ann E.] Univ Washington, Div Allergy & Infect Dis, Dept Med, Seattle, WA 98195 USA; [Cui, Weidong] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; Washington University (WUSTL)	Henderson, JP (corresponding author), Washington Univ, Sch Med, Div Infect Dis, 660 S Euclid, St Louis, MO 63110 USA.	jhenderson@DOM.wustl.edu	Stapleton, Ann E/N-2428-2015; Henderson, Jeffrey P/D-3337-2015	Stapleton, Ann E/0000-0003-0130-8659; 	NIDDK, National Institutes of Health [R01DK099534, P50DK064540, R56DK111930]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000448]; Longer Life Foundation; United States Public Health Service [P41-RR00954, P30-DK20579, P30-DK56341, 8P41GM103422]; National Institutes of Health [T32GM007067-37]; Monsanto Excellence Fund graduate fellowship; Burroughs Wellcome Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064540, R01DK099534, R56DK111930, P30DK056341, P30DK020579, R01DK088830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Longer Life Foundation; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Monsanto Excellence Fund graduate fellowship; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIDDK, National Institutes of Health Grants R01DK099534, P50DK064540, and R56DK111930; National Center for Advancing Translational Sciences, National Institutes of Health Grant UL1TR000448; and the Longer Life Foundation (to J. P. H.). Mass spectrometry was supported by United States Public Health Service Grants P41-RR00954, P30-DK20579, P30-DK56341, and 8P41GM103422. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Grant T32GM007067-37 and a Monsanto Excellence Fund graduate fellowship.r Recipient of a Career Award for Medical Scientists from the Burroughs Wellcome Fund.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, J AM CHEM SOC, V128, P8920, DOI 10.1021/ja062046j; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; Bao GH, 2015, RSC ADV, V5, P28527, DOI 10.1039/c5ra02509e; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Becker KW, 2014, FEMS MICROBIOL REV, V38, P1235, DOI 10.1111/1574-6976.12087; BOOTH AN, 1959, J BIOL CHEM, V234, P3014; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Cherayil BJ, 2011, IMMUNOL RES, V50, P1, DOI 10.1007/s12026-010-8199-1; Clifton MC, 2009, BIOMETALS, V22, P557, DOI 10.1007/s10534-009-9207-6; Correnti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043696; Correnti C, 2012, J BIOL CHEM, V287, P13524, DOI 10.1074/jbc.R111.311829; Cui WD, 2011, ANALYST, V136, P3854, DOI 10.1039/c1an15286f; Doneanu Catalin E, 2004, J Biomol Tech, V15, P208; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Foxman B, 2013, CURR INFECT DIS REP, V15, P124, DOI 10.1007/s11908-013-0317-5; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gomez-Casado C, 2013, J MOL GRAPH MODEL, V45, P111, DOI 10.1016/j.jmgm.2013.08.013; Gonthier MP, 2003, J NUTR, V133, P461, DOI 10.1093/jn/133.2.461; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hoette TM, 2011, ACS CHEM BIOL, V6, P1327, DOI 10.1021/cb200331g; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Paragas N, 2014, J CLIN INVEST, V124, P2963, DOI 10.1172/JCI71630; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Ruotolo BT, 2006, CURR OPIN CHEM BIOL, V10, P402, DOI 10.1016/j.cbpa.2006.08.020; Shields-Cutler RR, 2015, J BIOL CHEM, V290, P15949, DOI 10.1074/jbc.M115.645812; Sia AK, 2013, CURR OPIN CHEM BIOL, V17, P150, DOI 10.1016/j.cbpa.2012.11.014; Sorrell FJ, 2010, J PHARMACEUT BIOMED, V52, P802, DOI 10.1016/j.jpba.2010.02.024; Steigedal M, 2014, J IMMUNOL, V193, P6081, DOI 10.4049/jimmunol.1401528; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106	38	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25901	25910		10.1074/jbc.M116.759183	http://dx.doi.org/10.1074/jbc.M116.759183			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27780864	Green Published, hybrid			2022-12-26	WOS:000390345200013
J	Yang, YK; Yang, C; Chan, WP; Wang, ZQ; Deibel, KE; Pomerantz, JL				Yang, Yong-Kang; Yang, Chao; Chan, Waipan; Wang, Zhaoquan; Deibel, Katelynn E.; Pomerantz, Joel L.			Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IMMUNE-RESPONSES; MALT1 CLEAVES; MICE LACKING; ACTIVATION; CARMA1; LUBAC; UBIQUITINATION; MUTATIONS; COMPLEX	The activation of NF-kappa B downstream of T cell receptor (TCR) engagement is a key signaling step required for normal lymphocyte function during the adaptive immune response. During TCR signaling, the adaptor protein Bcl10 is inducibly recruited to the CARD11 scaffold protein as part of a multicomponent complex that induces I kappa B kinase (IKK) activity and NF-kappa B activation. Here, we show that a consequence of this recruitment is the TCR-induced conjugation of Bcl10 with linear-linked polyubiquitin chains to generate the signaling intermediate Lin(Ub)(n)-Bcl10, which is required for the association of Bcl10 with the NEMO subunit of the IKK complex. The TCR-induced generation of Lin(Ub)(n)-Bcl10 requires Bcl10 lysines 17, 31, and 63, CARD11, MALT1, and the HOIP subunit of the linear ubiquitin chain assembly complex (LUBAC) but not the HOIP accessory protein SHARPIN. CARD11 promotes signal-induced Lin(Ub)(n)-Bcl10 generation by co-recruiting Bcl10 with HOIP, thereby bringing substrate to enzyme. The CARD11-HOIP interaction is rendered TCR-inducible by the four autoinhibitory repressive elements in the CARD11 inhibitory domain and involves the CARD11 coiled-coil domain and two independent regions of HOIP. Interestingly, oncogenic CARD11 variants associated with diffuse large B cell lymphoma spontaneously induce Lin(Ub)(n)-Bcl10 production to extents that correlate with their abilities to activate NF-kappa B and with their enhanced abilities to bind HOIP and Bcl10. Our results define molecular determinants that control the production of Lin(Ub)(n)-Bcl10, an important signaling intermediate in TCR and oncogenic CARD11 signaling.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Chan, Waipan] NIAID, NIH, Lab Syst Biol, Lymphocyte Biol Sect, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pomerantz, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Inst Cell Engn, Miller Res Bldg,Rm 607,733 N Broadway, Baltimore, MD 21205 USA.	joel.pomerantz@jhmi.edu	YANG, YONGKANG/AEP-2772-2022	YANG, YONGKANG/0000-0002-0333-7712	Quest for Cures Grant from the Leukemia and Lymphoma Society [0793-14]; National Institutes of Health [RO1CA177600]; Johns Hopkins University Institute for Cell Engineering; Leukemia and Lymphoma Society	Quest for Cures Grant from the Leukemia and Lymphoma Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Institute for Cell Engineering; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	This work was supported in part by Quest for Cures Grant 0793-14 from the Leukemia and Lymphoma Society, Grant RO1CA177600 from the National Institutes of Health, and funds from The Johns Hopkins University Institute for Cell Engineering. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of a Leukemia and Lymphoma Society Fellow Award.	Alexia C, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004496; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Bu R, 2012, LEUKEMIA LYMPHOMA, V53, P1971, DOI 10.3109/10428194.2012.668286; Chan WP, 2013, MOL CELL BIOL, V33, P429, DOI 10.1128/MCB.00850-12; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; Dubois SM, 2014, BLOOD, V123, P2199, DOI 10.1182/blood-2013-05-504019; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Elton L, 2016, FEBS J, V283, P403, DOI 10.1111/febs.13597; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Greil J, 2013, J ALLERGY CLIN IMMUN, V131, P1376, DOI 10.1016/j.jaci.2013.02.012; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2014, NAT REV MOL CELL BIO, V15, P503, DOI 10.1038/nrm3836; Jattani RP, 2016, J BIOL CHEM, V291, P8338, DOI 10.1074/jbc.M116.717322; Jattani RP, 2016, J BIOL CHEM, V291, P8324, DOI 10.1074/jbc.M115.683714; Jiang CY, 2012, IMMUNOL REV, V246, P141, DOI 10.1111/j.1600-065X.2012.01110.x; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Klein T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9777; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lamason RL, 2010, MOL CELL, V40, P798, DOI 10.1016/j.molcel.2010.11.007; Lamason RL, 2010, BIOCHEMISTRY-US, V49, P8240, DOI 10.1021/bi101052d; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lim KH, 2012, IMMUNOL REV, V246, P359, DOI 10.1111/j.1600-065X.2012.01105.x; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McCully RR, 2008, MOL CELL BIOL, V28, P5668, DOI 10.1128/MCB.00418-08; Montesinos-Rongen M, 2010, ACTA NEUROPATHOL, V120, P529, DOI 10.1007/s00401-010-0709-7; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Paul S, 2012, IMMUNITY, V36, P947, DOI 10.1016/j.immuni.2012.04.008; Pedersen SM, 2016, MOL CELL BIOL, V36, P794, DOI 10.1128/MCB.00876-15; de Diego RP, 2015, J ALLERGY CLIN IMMUN, V136, P1139, DOI 10.1016/j.jaci.2015.06.031; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Sasaki Y, 2013, EMBO J, V32, P2463, DOI 10.1038/emboj.2013.184; Satpathy S., 2015, MOL SYST BIOL, V11, P810, DOI [10.15252/msb.20145880, DOI 10.15252/MSB.20145880]; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Turvey SE, 2014, J ALLERGY CLIN IMMUN, V134, P276, DOI 10.1016/j.jaci.2014.06.015; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Yagi H, 2012, EMBO REP, V13, P462, DOI 10.1038/embor.2012.24; Yang YB, 2016, CANCER CELL, V29, P494, DOI 10.1016/j.ccell.2016.03.006; Yang YB, 2014, CANCER DISCOV, V4, P480, DOI 10.1158/2159-8290.CD-13-0915	58	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25921	25936		10.1074/jbc.M116.754028	http://dx.doi.org/10.1074/jbc.M116.754028			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27777308	Green Published, hybrid			2022-12-26	WOS:000390345200015
J	Chang, WF; Hwu, YM; Xu, J; Lin, CJ; Wang, SW; Cheng, AS; Lu, J; Lu, CH; Sung, LY				Chang, Wei-Fang; Hwu, Yuh-Ming; Xu, Jie; Lin, Chen-Ju; Wang, Sheng-Wen; Cheng, An-Sheng; Lu, Jean; Lu, Chung-Hao; Sung, Li-Ying			Derivation of Patient Specific Pluripotent Stem Cells Using Clinically Discarded Cumulus Cells	PLOS ONE			English	Article							DIFFERENTIATION; IDENTIFICATION; INDUCTION	Induced pluripotent stem cells (iPSCs) are powerful tools for basic and translational research, as well as regenerative medicine. In routine human in vitro fertilization (IVF) practices, cumulus cells (CCs) are discarded, representing a potential source of biological materials for regenerative medicine. In this study, we derived patient-specific iPSCs using CCs from human infertility clinics for the first time. The human cumulus cell derived iPSCs (hc-iPSCs) were characterized for growth, karyotype, expression of pluripotency genes, and were subjected to embryoid bodies (EBs) and teratoma assays to evaluate their differentiation capacity. Hc-iPSCs display typical iPSC characteristics, and are capable of differentiating into all germ layers in vitro and in vivo. We further show that putative primordial germ cell like cells (PGCLCs) can be derived using hc-iPSCs. Our data demonstrate the feasibility of deriving patient-specific pluripotent stem cells using CCs.	[Chang, Wei-Fang; Wang, Sheng-Wen; Sung, Li-Ying] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Hwu, Yuh-Ming; Lin, Chen-Ju; Lu, Chung-Hao] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Hwu, Yuh-Ming; Lin, Chen-Ju] Mackay Med Coll, Dept Obstet & Gynecol, New Taipei, Taiwan; [Hwu, Yuh-Ming] Mackay Jr Coll Med Nursing & Management, Dept Obstet & Gynecol, Taipei, Taiwan; [Xu, Jie] Univ Michigan, Med Ctr, Ctr Adv Models Translat Sci & Therapeut, Ann Arbor, MI USA; [Cheng, An-Sheng] Yupintang Tradit Chinese Med Fdn, Kaohsiung, Taiwan; [Lu, Jean] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Sung, Li-Ying] Natl Taiwan Univ, Ctr Biotechnol, Taipei, Taiwan; [Sung, Li-Ying] Natl Taiwan Univ, Anim Resource Ctr, Taipei, Taiwan; [Sung, Li-Ying] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan	National Taiwan University; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; University of Michigan System; University of Michigan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Sung, LY (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.; Lu, CH (corresponding author), Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.; Sung, LY (corresponding author), Natl Taiwan Univ, Ctr Biotechnol, Taipei, Taiwan.; Sung, LY (corresponding author), Natl Taiwan Univ, Anim Resource Ctr, Taipei, Taiwan.; Sung, LY (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan.	d95642001@gmail.com; liyingsung@ntu.edu.tw		SUNG, LI-YING/0000-0003-1221-2476	Yupintang Traditional Chinese Medicine Foundation (Kaohsiung, Taiwan); Ministry of Science and Technology, Taiwan [104-2313-B-002-035-MY3, 104-2314-B-195-012, 104-2811-B-002-071]; Human Disease iPSC Service Consortium of the National Research Program for Biopharmaceuticals (NRPB) of, the Ministry of Science and Technology (MOST) [MOST 104-2325-B-001-010]	Yupintang Traditional Chinese Medicine Foundation (Kaohsiung, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Human Disease iPSC Service Consortium of the National Research Program for Biopharmaceuticals (NRPB) of, the Ministry of Science and Technology (MOST)	This study was supported by grants from Yupintang Traditional Chinese Medicine Foundation (Kaohsiung, Taiwan) and Ministry of Science and Technology, Taiwan (Grant Number 104-2313-B-002-035-MY3 to L.Y. Sung, 104-2314-B-195-012 to C.H. Lu and 104-2811-B-002-071 to W.F. Chang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. John Yu and Bei-Chia Yang kindly sharing the ESC culture method. We thank the Human Disease iPSC Service Consortium (MOST 104-2325-B-001-010) of the National Research Program for Biopharmaceuticals (NRPB) of, the Ministry of Science and Technology (MOST), for the hb-iPSC generation and technical support. Thanks Dr. Shau-Pin Lin and Chu-Fan Mo sharing the method for neuronal differentiation. We appreciate the technical assistance provide by Chen-Chi Lee. We thank Joint Center for Instruments and Researches, College of Bioresources and Agriculture in National Taiwan University for providing the service for the laser-scanning confocal microscopy and flow cytometry.	Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Anchan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119275; Chang WF, 2015, BRAIN STRUCT FUNCT, V220, P1539, DOI 10.1007/s00429-014-0743-7; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Cho JK, 2002, THERIOGENOLOGY, V57, P1819, DOI 10.1016/S0093-691X(01)00699-9; Chuang CY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0005-5; Di KQ, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124958; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Huang ZW, 2010, MOL HUM REPROD, V16, P715, DOI 10.1093/molehr/gaq031; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kimbrel EA, 2015, NAT REV DRUG DISCOV, V14, P681, DOI 10.1038/nrd4738; La Marca A, 2007, HUM REPROD, V22, P766, DOI 10.1093/humrep/del421; La Marca A, 2011, REPROD BIOMED ONLINE, V22, P341, DOI 10.1016/j.rbmo.2010.11.005; La Marca A, 2014, HUM REPROD UPDATE, V20, P124, DOI 10.1093/humupd/dmt037; Li W, 2012, P NATL ACAD SCI USA, V109, P20853, DOI 10.1073/pnas.1219181110; Lin MH, 2013, FERTIL STERIL, V100, P1296, DOI 10.1016/j.fertnstert.2013.07.1976; Lourenco Barbara, 2014, J Reprod Infertil, V15, P15; Lu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074602; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Qin H, 2014, CELL, V158, P449, DOI 10.1016/j.cell.2014.05.040; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2015, DEVELOPMENT, V142, P3274, DOI 10.1242/dev.114249; Tian X Cindy, 2003, Reprod Biol Endocrinol, V1, P98, DOI 10.1186/1477-7827-1-98; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020	35	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165715	10.1371/journal.pone.0165715	http://dx.doi.org/10.1371/journal.pone.0165715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802323	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200043
J	Weber, L; Thoelken, C; Volk, M; Remes, B; Lechner, M; Klug, G				Weber, Lennart; Thoelken, Clemens; Volk, Marcel; Remes, Bernhard; Lechner, Marcus; Klug, Gabriele			The Conserved Dcw Gene Cluster of R. sphaeroides Is Preceded by an Uncommonly Extended 5' Leader Featuring the sRNA UpsM	PLOS ONE			English	Article							CELL-ENVELOPE BIOSYNTHESIS; REGULATORY SMALL RNAS; ESCHERICHIA-COLI; RHODOBACTER-SPHAEROIDES; MESSENGER-RNA; PHOTOOXIDATIVE STRESS; RIBONUCLEIC-ACID; DIVISION GENES; SINGLET OXYGEN; E. COLI	Cell division and cell wall synthesis mechanisms are similarly conserved among bacteria. Consequently some bacterial species have comparable sets of genes organized in the dcw (division and cell wall) gene cluster. Dcw genes, their regulation and their relative order within the cluster are outstandingly conserved among rod shaped and gram negative bacteria to ensure an efficient coordination of growth and division. A well studied representative is the dcw gene cluster of E. coli. The first promoter of the gene cluster (mraZ1p) gives rise to polycistronic transcripts containing a 38 nt long 5' UTR followed by the first gene mraZ. Despite reported conservation we present evidence for a much longer 5' UTR in the gram negative and rod shaped bacterium Rhodobacter sphaeroides and in the family of Rhodo-bacteraceae. This extended 268 nt long 5' UTR comprises a Rho independent terminator, which in case of termination gives rise to a non-coding RNA (UpsM). This sRNA is conditionally cleaved by RNase E under stress conditions in an Hfq- and very likely target mRNA-dependent manner, implying its function in trans. These results raise the question for the regulatory function of this extended 5' UTR. It might represent the rarely described case of a trans acting sRNA derived from a riboswitch with exclusive presence in the family of Rhodobacteraceae.	[Weber, Lennart; Volk, Marcel; Remes, Bernhard; Klug, Gabriele] Univ Giessen, IFZ, Inst Microbiol & Mol Biol, Giessen, Germany; [Thoelken, Clemens; Lechner, Marcus] Philipps Univ Marburg, Inst Pharmaceut Chem, Marburg, Germany	Justus Liebig University Giessen; Philipps University Marburg	Klug, G (corresponding author), Univ Giessen, IFZ, Inst Microbiol & Mol Biol, Giessen, Germany.	Gabriele.Klug@mikro.bio.uni-giessen.de	Klug, Gabriele/K-5322-2014	Klug, Gabriele/0000-0002-3527-5093; Tholken, Clemens/0000-0003-4328-9193	Deutsche Forschungsgemeinschaft [DFG KI563/20]; DFG International Research Training Group [GRK1384]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG International Research Training Group(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) (DFG KI563/20) and the DFG funded International Research Training Group (GRK1384) (LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnan F, 2015, RNA BIOL, V12, P569, DOI 10.1080/15476286.2015.1031948; APIRION D, 1978, GENETICS, V90, P659; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Berghoff BA, 2011, MOL MICROBIOL, V80, P1479, DOI 10.1111/j.1365-2958.2011.07658.x; Berghoff BA, 2009, MOL MICROBIOL, V74, P1497, DOI 10.1111/j.1365-2958.2009.06949.x; Billenkamp F, 2015, J BACTERIOL, V197, P1839, DOI 10.1128/JB.02475-14; Bilusic I, 2014, RNA BIOL, V11, P641, DOI 10.4161/rna.29299; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Carrion M, 1999, BIOCHIMIE, V81, P879, DOI 10.1016/S0300-9084(00)87172-2; Chao YJ, 2016, MOL CELL, V61, P352, DOI 10.1016/j.molcel.2015.12.023; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; de la Fuente A, 2001, BIOCHIMIE, V83, P109, DOI 10.1016/S0300-9084(00)01212-8; Dufour YS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002929; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eraso JM, 2014, J BACTERIOL, V196, P2053, DOI 10.1128/JB.01370-13; Garst AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003533; Glaeser J, 2005, MICROBIOL-SGM, V151, P1927, DOI 10.1099/mic.0.27789-0; GOLDBLUM K, 1981, J BACTERIOL, V146, P128, DOI 10.1128/JB.146.1.128-132.1981; Hara H, 1997, J BACTERIOL, V179, P5802, DOI 10.1128/jb.179.18.5802-5811.1997; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Ikeda Y, 2011, MOL MICROBIOL, V79, P419, DOI 10.1111/j.1365-2958.2010.07454.x; JANZON L, 1986, FEMS MICROBIOL LETT, V33, P193; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Kim HM, 2014, NUCLEIC ACIDS RES, V42, P2003, DOI 10.1093/nar/gkt1071; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; Mank NN, 2012, P NATL ACAD SCI USA, V109, P16306, DOI 10.1073/pnas.1207067109; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mengin-Lecreulx D, 1998, J BACTERIOL, V180, P4406, DOI 10.1128/JB.180.17.4406-4412.1998; Mingorance J, 2004, J MOL RECOGNIT, V17, P481, DOI 10.1002/jmr.718; Miyakoshi M, 2015, EMBO J, V34, P1478, DOI 10.15252/embj.201490546; Miyakoshi M, 2015, CURR OPIN MICROBIOL, V24, P132, DOI 10.1016/j.mib.2015.01.013; Nuss AM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005087; Nuss AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079520; Nuss AM, 2010, J BACTERIOL, V192, P2613, DOI 10.1128/JB.01605-09; Nuss AM, 2009, J BACTERIOL, V191, P220, DOI 10.1128/JB.00925-08; Papenfort K, 2015, P NATL ACAD SCI USA, V112, pE766, DOI 10.1073/pnas.1500203112; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeiffer V, 2009, NAT STRUCT MOL BIOL, V16, P840, DOI 10.1038/nsmb.1631; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Remes B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-794; Saramago M, 2014, CURR OPIN MICROBIOL, V18, P105, DOI 10.1016/j.mib.2014.02.009; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tamames J, 2001, TRENDS GENET, V17, P124, DOI 10.1016/S0168-9525(00)02212-5; Tamames J, 2001, GENOME BIOL, V2; Vicente M, 1998, CELL MOL LIFE SCI, V54, P317, DOI 10.1007/s000180050158; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Will S, 2012, RNA, V18, P900, DOI 10.1261/rna.029041.111; Wolfinger MT, 2004, J PHYS A-MATH GEN, V37, P4731, DOI 10.1088/0305-4470/37/17/005	59	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165694	10.1371/journal.pone.0165694	http://dx.doi.org/10.1371/journal.pone.0165694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802301	gold, Green Published, Green Submitted			2022-12-26	WOS:000386714200039
J	Li, TY; Cao, YY; Wu, XX; Xu, XF; Wang, WL				Li, Tian Ya; Cao, Yuan Yin; Wu, Xian Xin; Xu, Xiao Feng; Wang, Wan Lin			Seedling Resistance to Stem Rust and Molecular Marker Analysis of Resistance Genes in Wheat Cultivars of Yunnan, China	PLOS ONE			English	Article							RACE UG99; DIVERSITY; SR24; IDENTIFICATION; SR31	Stem rust is one of the most potentially harmful wheat diseases, but has been effectively controlled in China since 1970s. However, the interest in breeding wheat with durable resistance to stem rust has been renewed with the emergence of Ug99 (TTKSK) virulent to the widely used resistance gene Sr31, and by which the wheat stem rust was controlled for 40 years in wheat production area worldwide. Yunnan Province, located on the Southwest border of China, is one of the main wheat growing regions, playing a pivotal role in the wheat stem rust epidemic in China. This study investigated the levels of resistance in key wheat cultivars (lines) of Yunnan Province. In addition, the existence of Sr25, Sr26, Sr28, Sr31, Sr32, and Sr38 genes in 119 wheat cultivars was assessed using specific DNA markers. The results indicated that 77 (64.7%) tested wheat varieties showed different levels of resistance to all the tested races of Puccinia graminis f. sp. tritici. Using molecular markers, we identified the resistance gene Sr31 in 43 samples; Sr38 in 10 samples; Sr28 in 12 samples, and one sample which was resistant against Ug99 (avirulent to Sr32). No Sr25 or Sr26 (effective against Ug99) was identified in any cultivars tested. Furthermore, 5 out of 119 cultivars tested carried both Sr31 and Sr38 and eight contained both Sr31 and Sr28. The results enable the development of appropriate strategies to breed varieties resistant to stem rust.	[Li, Tian Ya; Cao, Yuan Yin; Wu, Xian Xin; Xu, Xiao Feng; Wang, Wan Lin] Shenyang Agr Univ, Coll Plant Protect, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Cao, YY (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Shenyang, Liaoning, Peoples R China.	caoyy66@aliyun.com		Li, Tian Ya/0000-0002-1233-7845	National Key Basic Research Program of China [2013CB127701]; Special Fund for Agroscientific Research in the Public Interest [201303016]; National Natural Science Found of China [31171829]	National Key Basic Research Program of China(National Basic Research Program of China); Special Fund for Agroscientific Research in the Public Interest; National Natural Science Found of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Basic Research Program of China (2013CB127701), the Special Fund for Agroscientific Research in the Public Interest (201303016), and the National Natural Science Found of China (31171829).	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; [Anonymous], 2014, THESIS; [曹远银 CAO Yuan-yin], 2010, [麦类作物学报, Journal of Triticeae Crops], V30, P167; Cao YY, 2007, PLANT PROTECTION, V33, P86; Chen WanQuan, 1997, Acta Agronomica Sinica, V23, P655; Das BK, 2006, PLANT BREEDING, V125, P544, DOI 10.1111/j.1439-0523.2006.01282.x; DYCK PL, 1992, GENOME, V35, P788, DOI 10.1139/g92-120; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Goutam U, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00861; Haile JK, 2013, GENET RESOUR CROP EV, V60, P513, DOI 10.1007/s10722-012-9855-1; Han J. B., 2009, THESIS; [韩建东 HAN Jian-dong], 2010, [麦类作物学报, Journal of Triticeae Crops], V30, P163; Haque A, 2014, BIOINFORMATION, V10, P371, DOI 10.6026/97320630010371; [何中虎 HE Zhonghu], 2008, [麦类作物学报, Journal of Triticeae Crops], V28, P170; Helguera M, 2003, CROP SCI, V43, P1839, DOI 10.2135/cropsci2003.1839; Jin Y, 2008, PLANT DIS, V92, P923, DOI 10.1094/PDIS-92-6-0923; Kokhmetova A. M., 2012, RUSS J GENET APPL RE, V2, P486, DOI [10.1134/S2079059712060081, DOI 10.1134/S2079059712060081]; Kuchel H, 2005, MOL BREEDING, V16, P67, DOI 10.1007/s11032-005-4785-7; LAGUDAH ES, 1991, GENOME, V34, P375, DOI 10.1139/g91-059; Li FengQi, 2009, Journal of Northwest A & F University - Natural Science Edition, V37, P151; Li MJ, 2012, YUNNAN AGR SCI TECHN, V2, P4; Li W., 2012, THESIS; Ma Y., 2013, J TRITICEAE CROPS, V1, P7; [马勇 Ma Yong], 2013, [麦类作物学报, Journal of Triticeae Crops], V33, P34; Mago R, 2005, THEOR APPL GENET, V111, P496, DOI 10.1007/s00122-005-2039-z; Mago R, 2013, THEOR APPL GENET, V126, P2943, DOI 10.1007/s00122-013-2184-8; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; Nazari K, 2009, PLANT DIS, V93, DOI 10.1094/PDIS-93-3-0317B; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; Patpour M, 2016, PLANT DIS, V100, P522, DOI 10.1094/PDIS-06-15-0668-PDN; Pretorius Z. A., 2000, Plant Disease, V84, P203, DOI 10.1094/PDIS.2000.84.2.203B; Pretorius ZA, 2012, EUPHYTICA, V186, P15, DOI 10.1007/s10681-011-0476-0; Rouse MN, 2011, PLANT DIS, V95, P762, DOI 10.1094/PDIS-12-10-0940; Rouse MN, 2012, THEOR APPL GENET, V125, P877, DOI 10.1007/s00122-012-1879-6; Seah S, 2001, THEOR APPL GENET, V102, P600, DOI 10.1007/s001220051686; Singh R.P., 2006, CAB REV, V1, P54, DOI [10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, DOI 10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, 10.1079/PAVSNNR20061054]; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; STAKMAN E. C., 1962, Identification of physiologic races of Puccinia graminis var. tritici.; Stokstad E, 2007, SCIENCE, V315, P1786, DOI 10.1126/science.315.5820.1786; Visser B, 2011, EUPHYTICA, V179, P119, DOI 10.1007/s10681-010-0269-x; [王晓军 WANG Xiaojun], 2008, [麦类作物学报, Journal of Triticeae Crops], V28, P381; [吴限鑫 Wu Xianxin], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P4618; Wu Y. S., 1987, Journal of Shenyang Agricultural University, V18, P105; Wu YS, 1998, YUNNAN AGR SCI TECHN, V2, P9; Yu LX, 2010, MOL BREEDING, V26, P667, DOI 10.1007/s11032-010-9403-7; Zhang SK, 1998, J SHENYANG AGR U, V29, P117; Zhang YG, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-17	47	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165640	10.1371/journal.pone.0165640	http://dx.doi.org/10.1371/journal.pone.0165640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792757	Green Published, Green Submitted, gold			2022-12-26	WOS:000389537000040
J	Hahn, J; Tsoy, OV; Thalmann, S; Cuklina, J; Gelfand, MS; Evguenieva-Hackenberg, E				Hahn, Julia; Tsoy, Olga V.; Thalmann, Sebastian; Cuklina, Jelena; Gelfand, Mikhail S.; Evguenieva-Hackenberg, Elena			Small Open Reading Frames, Non-Coding RNAs and Repetitive Elements in Bradyrhizobium japonicum USDA 110	PLOS ONE			English	Article							TOXIN-ANTITOXIN LOCI; REGULATORY SMALL RNAS; SOYBEAN ROOT-NODULES; ESCHERICHIA-COLI; GENE-REGULATION; SALMONELLA-TYPHIMURIUM; IRON HOMEOSTASIS; VIBRIO-CHOLERAE; ANTISENSE RNA; BACTERIA	Small open reading frames (sORFs) and genes for non-coding RNAs are poorly investigated components of most genomes. Our analysis of 1391 ORFs recently annotated in the soybean symbiont Bradyrhizobium japonicum USDA 110 revealed that 78% of them contain less than 80 codons. Twenty-one of these sORFs are conserved in or outside Alphaproteobacteria and most of them are similar to genes found in transposable elements, in line with their broad distribution. Stabilizing selection was demonstrated for sORFs with proteomic evidence and b111319_1SGA which is conserved at the nucleotide level in 16 alphaproteobacterial species, 79 species from other taxa and 49 other Proteobacteria. Further we used Northern blot hybridization to validate ten small RNAs (BjsR1 to BjsR10) belonging to new RNA families. We found that BjsR1 and BjsR3 have homologs outside the genus Bradyrhizobium, and BjsR5, BjsR6, BjsR7, and BjsR10 have up to four imperfect copies in Bradyrhizobium genomes. BjsR8, BjsR9, and BjsR10 are present exclusively in nodules, while the other sRNAs are also expressed in liquid cultures. We also found that the level of BjsR4 decreases after exposure to tellurite and iron, and this down-regulation contributes to survival under high iron conditions. Analysis of additional small RNAs overlapping with 3'-UTRs revealed two new repetitive elements named Br-REP1 and Br-REP2. These REP elements may play roles in the genomic plasticity and gene regulation and could be useful for strain identification by PCR-fingerprinting. Furthermore, we studied two potential toxin genes in the symbiotic island and confirmed toxicity of the yha Vhomolog b111687 but not of the newly annotated higB homolog b1r0229_1SGA in E. coll. Finally, we revealed transcription interference resulting in an antisense RNA complementary to blr1853, a gene induced in symbiosis. The presented results expand our knowledge on sORFs, non-coding RNAs and repetitive elements in B. japonicum and related bacteria.	[Hahn, Julia; Thalmann, Sebastian; Evguenieva-Hackenberg, Elena] Justus Liebig Univ, Inst Microbiol & Mol Biol, Giessen, Germany; [Tsoy, Olga V.; Cuklina, Jelena; Gelfand, Mikhail S.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Bolshoi Karetny Ln 19, Moscow 127051, Russia; [Cuklina, Jelena] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Gelfand, Mikhail S.] Skolkovo Inst Sci & Technol, Nobel Str 3, Moscow 143026, Russia; [Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Vorobyevy Gory 1-73, Moscow 119234, Russia; [Gelfand, Mikhail S.] Higher Sch Econ, Fac Comp Sci, Kochnovsky Dr 3, Moscow 125319, Russia	Justus Liebig University Giessen; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich; Skolkovo Institute of Science & Technology; Lomonosov Moscow State University; HSE University (National Research University Higher School of Economics)	Evguenieva-Hackenberg, E (corresponding author), Justus Liebig Univ, Inst Microbiol & Mol Biol, Giessen, Germany.; Gelfand, MS (corresponding author), Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Bolshoi Karetny Ln 19, Moscow 127051, Russia.; Gelfand, MS (corresponding author), Skolkovo Inst Sci & Technol, Nobel Str 3, Moscow 143026, Russia.; Gelfand, MS (corresponding author), Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Vorobyevy Gory 1-73, Moscow 119234, Russia.; Gelfand, MS (corresponding author), Higher Sch Econ, Fac Comp Sci, Kochnovsky Dr 3, Moscow 125319, Russia.	gelfand@iitp.ru; Elena.Evguenieva-Hackenberg@mikro.bio.uni-giessen.de	Gelfand, Mikhail S/F-3425-2012; Evguenieva-Hackenberg, Elena/ABA-8876-2020	Evguenieva-Hackenberg, Elena/0000-0001-7270-3168; Cuklina, Jelena/0000-0002-3837-9349; Gelfand, Mikhail/0000-0003-4181-0846; Tsoy, Olga/0000-0002-7592-2080	Deutsche Forschungsgemeinschaft (grant DFG) [EV42/4-2]; Russian Science Foundation [14-24-00155]	Deutsche Forschungsgemeinschaft (grant DFG)(German Research Foundation (DFG)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Deutsche Forschungsgemeinschaft (grant DFG EV42/4-2 to E.E.-H.) and Russian Science Foundation (O.V.T. and M.S.G., grant 14-24-00155). J.H. is a member of IRTG 1384 "Enzymes and multienzyme complexes acting on nucleic acids" supported by Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barcellos FG, 2007, APPL ENVIRON MICROB, V73, P2635, DOI 10.1128/AEM.01823-06; Baumgardt K, 2016, RNA BIOL, V17, P302; BECKER A, 1993, MOL GEN GENET, V241, P367, DOI 10.1007/BF00284690; Becker A, 2014, RNA BIOL, V11, P550, DOI 10.4161/rna.29625; BOCCARD F, 1993, EMBO J, V12, P5019, DOI 10.1002/j.1460-2075.1993.tb06195.x; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; Borukhov S, 2003, CURR OPIN MICROBIOL, V6, P93, DOI 10.1016/S1369-5274(03)00036-5; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Cuklina J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2602-9; DEBRUIJN FJ, 1992, APPL ENVIRON MICROB, V58, P2180, DOI 10.1128/AEM.58.7.2180-2187.1992; Delmotte N, 2010, PROTEOMICS, V10, P1391, DOI 10.1002/pmic.200900710; Desbrosses GJ, 2011, CELL HOST MICROBE, V10, P348, DOI 10.1016/j.chom.2011.09.005; EBELING S, 1991, J BACTERIOL, V173, P6373, DOI 10.1128/jb.173.20.6373-6382.1991; Espeli O, 2001, J MOL BIOL, V314, P375, DOI 10.1006/jmbi.2001.5150; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; Frohlich KS, 2012, NUCLEIC ACIDS RES, V40, P3623, DOI 10.1093/nar/gkr1156; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; HULTON CSJ, 1991, MOL MICROBIOL, V5, P825, DOI 10.1111/j.1365-2958.1991.tb00755.x; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kery MB, 2014, NUCLEIC ACIDS RES, V42, pW124, DOI 10.1093/nar/gku317; Khemici V, 2004, MOL MICROBIOL, V51, P777, DOI 10.1046/j.1365-2958.2003.03862.x; Kopfmann S, 2013, J BIOL CHEM, V288, P7399, DOI 10.1074/jbc.M112.434100; Ledermann R, 2015, MOL PLANT MICROBE IN, V28, P959, DOI 10.1094/MPMI-03-15-0054-TA; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Liang WX, 2015, MOL CELL, V58, P431, DOI 10.1016/j.molcel.2015.03.019; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; Madhugiri R, 2012, RNA BIOL, V9, P47, DOI 10.4161/rna.9.1.18008; Madhugiri R, 2009, FEBS LETT, V583, P2339, DOI 10.1016/j.febslet.2009.06.026; Mank NN, 2012, P NATL ACAD SCI USA, V109, P16306, DOI 10.1073/pnas.1207067109; Delamuta JRM, 2013, INT J SYST EVOL MICR, V63, P3342, DOI 10.1099/ijs.0.049130-0; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; MARTIN GB, 1988, J BACTERIOL, V170, P5452, DOI 10.1128/jb.170.12.5452-5459.1988; Mesa S, 2008, J BACTERIOL, V190, P6568, DOI 10.1128/JB.00748-08; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Nesvizhskii AI, 2014, NAT METHODS, V11, P1114, DOI [10.1038/NMETH.3144, 10.1038/nmeth.3144]; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Ramamurthi KS, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0096-y; REGENSBURGER B, 1983, ARCH MICROBIOL, V135, P103, DOI 10.1007/BF00408017; Repoila F, 2003, MOL MICROBIOL, V48, P855, DOI 10.1046/j.1365-2958.2003.03454.x; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; Sambrook J, 1989, MOL CLONING LAB MANU, V2; Sankari S, 2014, J BIOL CHEM, V289, P16498, DOI 10.1074/jbc.M114.571562; Sarma AD, 2006, PROTEOMICS, V6, P3008, DOI 10.1002/pmic.200500783; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Sesto N, 2013, NAT REV MICROBIOL, V11, P75, DOI 10.1038/nrmicro2934; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Sharma CM, 2014, CURR OPIN MICROBIOL, V19, P97, DOI 10.1016/j.mib.2014.06.010; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; Stead MB, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks680; Storz G, 2014, ANNU REV BIOCHEM, V83, P753, DOI 10.1146/annurev-biochem-070611-102400; Teng Y, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00032; Tobes R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-62; Vinuesa P, 2005, MOL PHYLOGENET EVOL, V34, P29, DOI 10.1016/j.ympev.2004.08.020; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Warren AS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-131; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	67	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165429	10.1371/journal.pone.0165429	http://dx.doi.org/10.1371/journal.pone.0165429			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788207	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900084
J	Oka, M; Yamamoto, M; Mure, K; Takeshita, T; Arita, M				Oka, Mayumi; Yamamoto, Mio; Mure, Kanae; Takeshita, Tatsuya; Arita, Mikio			Relationships between Lifestyle, Living Environments, and Incidence of Hypertension in Japan (in Men): Based on Participant's Data from the Nationwide Medical Check-Up	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; PHYSICAL-ACTIVITY; HEALTH; METAANALYSIS; ASSOCIATION; PREVENTION; WALKING; MORTALITY; BEHAVIOR; SUICIDE	This study aims to investigate factors that contribute to the differences in incidence of hypertension between different regions in Japan, by accounting for not only individual lifestyles, but also their living environments. The target participants of this survey were individuals who received medical treatment for hypertension, as well as hypertension patients who have not received any treatment. The objective variable for analysis was the incidence of hypertension as data aggregated per prefecture. We used data (in men) including obesity, salt intake, vegetable intake, habitual alcohol consumption, habitual smoking, and number of steps walked per day. The variables within living environment included number of rail stations, standard/light vehicle usage, and slope of habitable land. In addition, we analyzed data for the variables related to medical environment including, participation rate in medical check-ups and number of hospitals. We performed multiple stepwise regression analyses to elucidate the correlation of these variables by using hypertension incidence as the objective variable. Hypertension incidence showed a significant negative correlation with walking and medical check-ups, and a significant positive correlation with light-vehicle usage and slope. Between the number of steps and variables related to the living environment, number of rail stations showed a significant positive correlation, while, standard-and light-vehicle usage showed significant negative correlation. Moreover, with stepwise multiple regression analysis, walking showed the strongest effect. The differences in daily walking based on living environment were associated with the disparities in the hypertension incidence in Japan.	[Oka, Mayumi; Yamamoto, Mio; Arita, Mikio] Wakayama Med Univ, Sch Hlth & Nursing Sci, Wakayama, Japan; [Mure, Kanae; Takeshita, Tatsuya] Wakayama Med Univ, Sch Publ Hlth, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University	Oka, M (corresponding author), Wakayama Med Univ, Sch Hlth & Nursing Sci, Wakayama, Japan.	okamayu@gmail.com			Japan Health Foundation [2014-2-10]	Japan Health Foundation(Japan Health Foundation)	This study was partially funded by a grant from the Japan Health Foundation (No. 2014-2-10). The funding source had no involvement in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Christiansen LB, 2014, J TRANSP HEALTH, V1, P316, DOI 10.1016/j.jth.2014.10.002; Chudyk AM, 2015, J TRANSP HEALTH, V2, P50, DOI 10.1016/j.jth.2014.09.008; Durand CP, 2016, J TRANSP HEALTH, V3, P154, DOI 10.1016/j.jth.2015.08.007; Geospatial Information Authority of Japan, 2016, MAPS GEOSP INF; Hamano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049122; Hayashi T, 1999, ANN INTERN MED, V131, P21, DOI 10.7326/0003-4819-131-1-199907060-00005; He F. J., 2013, BMJ, V346; Ishii K, 2010, JPN J HLTH ED PROMOT, V18, P115; Ishii K, 2010, JPN J PHYS FIT SPORT, V59, P215, DOI 10.7600/jspfsm.59.215; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Ministry of Health Labor and Welfare, 2006, NAT HLTH NUTR EX SUR; Ministry of Health Labour and Welfare, 2016, DAT PUBL MED CHECK; Ministry of Health Labour and Welfare, 2016, SURV MED FAC; Ministry of Health Labour and Welfare, 2010, DAT SPEC MED CHECK S; Ministry of Internal Affairs and Communications, 2014, NAT SURV FAM INC EXP; Ministry of Land Infrastructure Transport and Tourism, 2014, REG TRANSP ANN REP; Ministry of Land Infrastructure Transport and Tourism, 2006, THE LAND IN JAP; Mitchell R, 2002, INT J EPIDEMIOL, V31, P831, DOI 10.1093/ije/31.4.831; Newton RL, 2014, OBES REV, V15, P93, DOI 10.1111/obr.12209; Ohta Y, 2015, CLIN EXP HYPERTENS, V37, P433, DOI 10.3109/10641963.2015.1013115; Oka M., 2012, J HLTH WELFARE STAT, V59, P1; Oka M, 2015, PSYCHIAT CLIN NEUROS, V69, P375, DOI 10.1111/pcn.12254; Oka M, 2014, PSYCHOLOGIA, V57, P65, DOI 10.2117/psysoc.2014.65; OURA T, 1990, Japanese Journal of Health and Human Ecology, V56, P64; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Rossi A, 2012, J HYPERTENS, V30, P1277, DOI 10.1097/HJH.0b013e3283544669; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Tsushita K., 2013, EFFECTIVE HLTH POLIC; WILMSHURST P, 1994, BMJ-BRIT MED J, V309, P1029, DOI 10.1136/bmj.309.6961.1029	32	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165313	10.1371/journal.pone.0165313	http://dx.doi.org/10.1371/journal.pone.0165313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788198	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900060
J	Marasco, A; Nocerino, S; Pinto, G; Pollio, A; Trojsi, G; De Natale, A				Marasco, Addolorata; Nocerino, Simona; Pinto, Gabriele; Pollio, Antonino; Trojsi, Giorgio; De Natale, Antonino			Weathering of a Roman Mosaic-A Biological and Quantitative Study on In Vitro Colonization of Calcareous Tesserae by Phototrophic Microorganisms	PLOS ONE			English	Article							STONE MONUMENTS; BIORECEPTIVITY; DIVERSITY; CYANOBACTERIA; LIMESTONES; BIOFILMS; SURFACE; ALGAE	The potential impact of cyanobacteria and microalgae on the weathering of calcareous tesserae from a Roman mosaic of the II Century CE has been followed through in vitro experiments. Laboratory tests were carried out by inoculating mosaic tiles with single strains of Cyanobacteria or Chlorophyta to evaluate the roles of pioneer phototrophic microrganism on the resulting architecture of biofilms. The interaction between tesserae and strains was assessed at the whole substratum and micrometer scales, by image analysis and Confocal Laser Scanning (CLS) microscopy, respectively. The biofilm surface coverage on each tessera varied from 19% (Fischerella ambigua) to 97% (Microcoleus autumnalis). Cyanobacteria showed a better growth on calcareous tesserae, whereas the only green alga attaining a superficial coverage higher than 50% was Coelastrella rubescens. CLS microscopy evidenced two different types of spatial arrangement of the phototrophic organisms on the tesserae, that were defined as compact or porous, respectively. In the first one was measured a reduced number of empty spaces between cells or filaments, whereas in the second type, a reticulate texture allowed the presence of numerous empty volumes. The colonization processes observed are an intrinsic characteristic of each strain. We have proposed a colonization index IC as a sensible tool to describe, in a quantitative way, the pioneering attitude of each photosynthetic microorganism to colonize lithic substrates under laboratory conditions.	[Marasco, Addolorata] Univ Naples Federico II, Complesso Univ Monte St Angelo, Dept Math & Applicat, Via Cintia, I-80126 Naples, Italy; [Nocerino, Simona] Via C Ravizza, I-20149 Milan, Italy; [Pinto, Gabriele; Pollio, Antonino; De Natale, Antonino] Univ Naples Federico II, Complesso Univ Monte SantAngelo, Dept Biol, Via Cintia, I-80126 Naples, Italy; Univ Suor Orsola Benincasa, Via Santa Caterina, I-80135 Siena, Italy	University of Naples Federico II; University of Naples Federico II; Suor Orsola Benincasa University Naples	Marasco, A (corresponding author), Univ Naples Federico II, Complesso Univ Monte St Angelo, Dept Math & Applicat, Via Cintia, I-80126 Naples, Italy.	marasco@unina.it	De Natale, Antonino/AAV-2128-2020; pollio, antonino/AAE-6006-2019; Marasco, Addolorata/H-1890-2012; Marasco, Addolorata/S-3276-2019	De Natale, Antonino/0000-0002-1481-449X; Marasco, Addolorata/0000-0002-8613-7467; Marasco, Addolorata/0000-0002-8613-7467	Analysis of Complex Biological Systems	Analysis of Complex Biological Systems	A.M. has been partially supported by local Grant 2015-2016 "Analysis of Complex Biological Systems".	Alvarez A, 1994, CONSERVATION MONUMEN; ANAGNOSTIDIS K, 1983, NOVA HEDWIGIA, V38, P227; [Anonymous], 1984, 4287 ISO; Barberousse H, 2007, BUILD ENVIRON, V42, P2555, DOI 10.1016/j.buildenv.2006.07.031; Baveye P, 2002, WATER RES, V36, P805, DOI 10.1016/S0043-1354(01)00415-8; Characklis WG, 1990, BIOFILMS, P341; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; Cuzman OA, 2011, IMPORTANCE OF BIOLOGICAL INTERACTIONS IN THE STUDY OF BIODIVERSITY, P367; De Graef B, 2005, SCI TOTAL ENVIRON, V341, P173, DOI 10.1016/j.scitotenv.2004.09.035; Dunbabin K.M.D., 1999, MOSAICS GREEK ROMAN; Falconer K., 2004, FRACTAL GEOMETRY MAT; Gaylarde CC, 2012, CURR MICROBIOL, V65, P183, DOI 10.1007/s00284-012-0123-6; Gerdes G., 2007, ATLAS MICROBIAL MAT, P5, DOI DOI 10.1016/S1574-1966(07)02001-9; GUILLITTE O, 1995, SCI TOTAL ENVIRON, V167, P365, DOI 10.1016/0048-9697(95)04596-S; GUILLITTE O, 1995, SCI TOTAL ENVIRON, V167, P215, DOI 10.1016/0048-9697(95)04582-L; Hartig Sean M, 2013, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1415s102; Keshari N, 2014, INT BIODETER BIODEGR, V90, P45, DOI 10.1016/j.ibiod.2014.01.014; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; Khrisat B, 2011, MEDITERRANEAN ARCHAE, V12, P43; Krumbein WE, 2003, FOSSIL AND RECENT BIOFILMS, P1; Kuehn M, 1998, APPL ENVIRON MICROB, V64, P4115; Lepanto P, 2014, MOL CELL PROBE, V28, P1, DOI 10.1016/j.mcp.2013.10.001; Macedo MF, 2009, MICROBIOL-SGM, V155, P3476, DOI 10.1099/mic.0.032508-0; Miller AZ, 2012, MATER CONSTRUCC, V62, P411, DOI 10.3989/mc.2012.64410; Miller AZ, 2010, GEOL SOC SPEC PUBL, V331, P79, DOI 10.1144/SP331.6; Miller AZ, 2008, SCI TOTAL ENVIRON, V405, P278, DOI 10.1016/j.scitotenv.2008.06.066; Murdock JN, 2007, J PHYCOL, V43, P449, DOI 10.1111/j.1529-8817.2007.00357.x; NICHOLS HW, 1965, J PHYCOL, V1, P34, DOI 10.1111/j.1529-8817.1965.tb04552.x; Ortega Calvo JJ, 1995, SCI TOTAL ENVIRON, V167, P329, DOI [10.1016/0048-9697(95)04593-P, DOI 10.1016/0048-9697(95)04593-P]; PANTAZIDOU A, 1997, P 4 INT S CONS MON M, P355; Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07; SAIZJIMENEZ C, 1991, INT BIODETERIOR, V28, P65, DOI 10.1016/0265-3036(91)90034-O; Santos MFA, 2003, OPTICAL MICROSCOPY M; Scheerer S, 2009, ADV APPL MICROBIOL, V66, P97, DOI 10.1016/S0065-2164(08)00805-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Serra DO, 2013, MBIO, V4, DOI 10.1128/mBio.00103-13; Singh B, 2006, ELSEVIER GEO ENG BOO, V5; Tran TH, 2013, INT BIODETER BIODEGR, V79, P73, DOI 10.1016/j.ibiod.2012.12.012; Tolker-Nielsen T, 2000, MICROB ECOL, V40, P75; Urzi C, 2010, MICROB ECOL, V60, P116, DOI 10.1007/s00248-010-9710-x; Wiktor V, 2011, MATER STRUCT, V44, P623, DOI 10.1617/s11527-010-9653-1; Zammit G., 2008, ART 2008 9 INT C NON, P1; Zhang F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132948	43	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164487	10.1371/journal.pone.0164487	http://dx.doi.org/10.1371/journal.pone.0164487			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783631	gold, Green Submitted, Green Published			2022-12-26	WOS:000389602800041
J	Volotskova, O; Dubrovsky, L; Keidar, M; Bukrinsky, M				Volotskova, Olga; Dubrovsky, Larisa; Keidar, Michael; Bukrinsky, Michael			Cold Atmospheric Plasma Inhibits HIV-1 Replication in Macrophages by Targeting Both the Virus and the Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RETROVIRUS	Cold atmospheric plasma (CAP) is a specific type of partially ionized gas that is less than 104 degrees F at the point of application. It was recently shown that CAP can be used for decontamination and sterilization, as well as anti-cancer treatment. Here, we investigated the effects of CAP on HIV-1 replication in monocyte-derived macrophages (MDM). We demonstrate that pre-treatment of MDM with CAP reduced levels of CD4 and CCR5, inhibiting virus-cell fusion, viral reverse transcription and integration. In addition, CAP pre-treatment affected cellular factors required for post-entry events, as replication of VSV-G-pseudotyped HIV-1, which by-passes HIV receptor-mediated fusion at the plasma membrane during entry, was also inhibited. Interestingly, virus particles produced by CAP-treated cells had reduced infectivity, suggesting that the inhibitory effect of CAP extended to the second cycle of infection. These results demonstrate that anti-HIV activity of CAP involves the effects on target cells and the virus, and suggest that CAP may be considered for potential application as an anti-HIV treatment.	[Keidar, Michael] George Washington Univ, SMHS, Dept Mech & Aerosp Engn, Washington, DC USA; [Dubrovsky, Larisa; Bukrinsky, Michael] George Washington Univ, SMHS, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Volotskova, Olga] New York Univ, Langone Med Ctr, Dept Radiat Oncol, New York, NY USA	George Washington University; George Washington University; New York University; NYU Langone Medical Center	Bukrinsky, M (corresponding author), George Washington Univ, SMHS, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.	mbukrins@gwu.edu			District of Columbia Center for AIDS Research (DC CFAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI117970] Funding Source: NIH RePORTER	District of Columbia Center for AIDS Research (DC CFAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the District of Columbia Center for AIDS Research (DC CFAR).	Aboubakr HA, 2015, APPL ENVIRON MICROB, V81, P3612, DOI 10.1128/AEM.00054-15; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ahlfeld B, 2015, MBIO, V6, DOI 10.1128/mBio.02300-14; Ahn HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086173; Alekseev O, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.2.2; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; Daeschlein G, 2012, J HOSP INFECT, V81, P177, DOI 10.1016/j.jhin.2012.02.012; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Haertel B, 2014, BIOMOL THER, V22, P477, DOI 10.4062/biomolther.2014.105; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Schmidtmayerova H, 1997, VIROLOGY, V232, P379, DOI 10.1006/viro.1997.8584; Sena-Esteves M, 1999, J VIROL, V73, P10426, DOI 10.1128/JVI.73.12.10426-10439.1999; Volotskova O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00636; Yan DY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18339	16	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165322	10.1371/journal.pone.0165322	http://dx.doi.org/10.1371/journal.pone.0165322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783659	Green Submitted, gold, Green Published			2022-12-26	WOS:000389602800071
J	Iwuafor, AA; Ogunsola, FT; Oladele, RO; Oduyebo, OO; Desalu, I; Egwuatu, CC; Nnachi, AU; Akujobi, CN; Rai, IO; Ogban, GI				Iwuafor, Anthony A.; Ogunsola, Folasade T.; Oladele, Rita O.; Oduyebo, Oyin O.; Desalu, Ibironke; Egwuatu, Chukwudi C.; Nnachi, Agwu U.; Akujobi, Comfort N.; Rai, Ita O.; Ogban, Godwin I.			Incidence, Clinical Outcome and Risk Factors of Intensive Care Unit Infections in the Lagos University Teaching Hospital (LUTH), Lagos, Nigeria	PLoS One			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCI; CRITICALLY-ILL PATIENTS; STAPHYLOCOCCUS-AUREUS; PREVALENCE; SURVEILLANCE; MANAGEMENT; PATHOGENS; COMMUNITY; TURKEY	Background Infections are common complications in critically ill patients with associated significant morbidity and mortality. Aim This study determined the prevalence, risk factors, clinical outcome and microbiological profile of hospital-acquired infections in the intensive care unit of a Nigerian tertiary hospital. Materials and Methods This was a prospective cohort study, patients were recruited and followed up between September 2011 and July 2012 until they were either discharged from the ICU or died. Antimicrobial susceptibility testing of isolates was done using CLSI guidelines. Results Seventy-one patients were recruited with a 45% healthcare associated infection rate representing an incidence rate of 79/1000 patient-days in the intensive care unit. Bloodstream infections (BSI) 49.0% (22/71) and urinary tract infections (UTI) 35.6% (16/71) were the most common infections with incidence rates of 162.9/1000 patient-days and 161.6/1000 patient-days respectively. Staphylococcus aureus was the most common cause of BSIs, responsible for 18.2% of cases, while Candida spp. was the commonest cause of urinary tract infections, contributing 25.0% of cases. Eighty percent (8/10) of the Staphylococcus isolates were methicillin-resistant. Gram-negative multidrug bacteria accounted for 57.1% of organisms isolated though they were not ESBL-producing. Use of antibiotics (OR = 2.98; p = 0.03) and surgery (OR = 3.15, p<0.05) in the month preceding ICU admission as well as urethral catheterization (OR = 5.38; p<0.05) and endotracheal intubation (OR = 5.78; p<0.05) were risk factors for infection. Conclusion Our findings demonstrate that healthcare associated infections is a significant risk factor for ICU-mortality and morbidity even after adjusting for APACHE II score.	[Iwuafor, Anthony A.; Rai, Ita O.; Ogban, Godwin I.] Univ Calabar, Dept Med Microbiol & Parasitol, Coll Med Sci, Calabar, Nigeria; [Ogunsola, Folasade T.; Oladele, Rita O.; Oduyebo, Oyin O.] Univ Lagos, Dept Med Microbiol & Parasitol, Coll Med, Lagos, Nigeria; [Desalu, Ibironke] Univ Lagos, Dept Anaesthesia, Coll Med, Lagos, Nigeria; [Egwuatu, Chukwudi C.; Akujobi, Comfort N.] Nnamdi Azikiwe Univ, Dept Med Microbiol & Parasitol, Fac Med, Nnewi Campus, Awka, Nigeria; [Nnachi, Agwu U.] Nnamdi Azikiwe Univ, Dept Immunol, Fac Med, Nnewi Campus, Awka, Nigeria	University of Calabar; University of Lagos; University of Lagos	Iwuafor, AA (corresponding author), Univ Calabar, Dept Med Microbiol & Parasitol, Coll Med Sci, Calabar, Nigeria.	achiton@yahoo.com	; Nnachi, Agwu Ulu/C-4137-2017	Oduyebo, Oyinlola/0000-0002-2894-4367; Nnachi, Agwu Ulu/0000-0001-9468-7605; Desalu, Ibironke/0000-0002-5437-8530				Abubakar AS., 2014, INDIAN J SCI TECH, V2, P42; Aliberti S, 2012, CLIN INFECT DIS, V54, P470, DOI 10.1093/cid/cir840; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; [Anonymous], 1994, Respir Care, V39, P1191; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Brusselaers N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-47; Cevik MA, 2005, J HOSP INFECT, V59, P324, DOI 10.1016/j.jhin.2004.10.012; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Cook D, 1997, CRIT CARE MED, V25, P1417, DOI 10.1097/00003246-199708000-00033; Dabar G, 2015, INT J INFECT DIS, V37, P80, DOI 10.1016/j.ijid.2015.05.024; Drinka P, 2011, JAMDA, V6, P321; Erdem H, 2014, J INFECTION, V68, P131, DOI 10.1016/j.jinf.2013.11.001; Eugene I, 2011, LAB MED, V42, P411; GARIBALDI RA, 1980, NEW ENGL J MED, V303, P316, DOI 10.1056/NEJM198008073030605; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Ho PL, 2003, CRIT CARE MED, V31, P1175, DOI 10.1097/01.CCM.0000059437.01924.97; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hugonnet S, 2007, CRIT CARE MED, V35, P76, DOI 10.1097/01.CCM.0000251125.08629.3F; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Laupland KB, 2004, J HOSP INFECT, V58, P137, DOI 10.1016/j.jhin.2004.06.007; Magill SS, 2012, INFECT CONT HOSP EP, V33, P283, DOI 10.1086/664048; McKibben L, 2005, AM J INFECT CONTROL, V33, P217, DOI 10.1016/j.ajic.2005.04.001; Oguariri O, 2008, WORLD CRITICAL CARE, V6, P2; Okafor UV, 2009, INDIAN J CRIT CARE M, V13, P25, DOI 10.4103/0972-5229.53112; Petrosillo N, 2010, EXPERT REV ANTI-INFE, V8, P289, DOI 10.1586/ERI.10.7; Piccolo CL, 2010, RES J BIOL SCI, V5, P20; PICCOLO NS, 1991, BURNS, V17, P490; Playford EG, 2007, J HOSP INFECT, V65, P204, DOI 10.1016/j.jhin.2006.11.010; Ramsamy Y, 2017, WORLD J SURG, V41, P1165, DOI 10.1007/s00268-016-3531-0; Rosenthal VD, 2006, ANN INTERN MED, V145, P582, DOI 10.7326/0003-4819-145-8-200610170-00007; Srinivasan A, 2003, NEW ENGL J MED, V348, P221, DOI 10.1056/NEJMoa021808; Sutter DE, 2011, INFECT CONT HOSP EP, V32, P854, DOI 10.1086/661284; Tutuncu EE, 2011, SAUDI MED J, V32, P489; Valinteliene R, 1996, J HOSP INFECT, V34, P321, DOI 10.1016/S0195-6701(96)90112-7; Washington AW, 2006, KONEMANS COLOUR ATLA, P1003; WHO, 2016, HLTH CAR ASS INF FAC; Zhanel GG, 2008, CAN J INFECT DIS MED, V19, P243, DOI 10.1155/2008/714846; Zhanel GG, 2010, ANTIMICROB AGENTS CH, V54, P4684, DOI 10.1128/AAC.00469-10	40	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165242	10.1371/journal.pone.0165242	http://dx.doi.org/10.1371/journal.pone.0165242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776162	gold, Green Published, Green Submitted			2022-12-26	WOS:000389009200050
J	Sizemore, GM; Balakrishnan, S; Hammer, AM; Thies, KA; Trimboli, AJ; Wallace, JA; Sizemore, ST; Kladney, RD; Woelke, SA; Yu, L; Fernandez, SA; Chakravarti, A; Leone, G; Ostrowski, MC				Sizemore, G. M.; Balakrishnan, S.; Hammer, A. M.; Thies, K. A.; Trimboli, A. J.; Wallace, J. A.; Sizemore, S. T.; Kladney, R. D.; Woelke, S. A.; Yu, L.; Fernandez, S. A.; Chakravarti, A.; Leone, G.; Ostrowski, M. C.			Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1	ONCOGENE			English	Article							TUMOR-INITIATING CELLS; BREAST-CANCER; STEM/PROGENITOR CELLS; GLAND DEVELOPMENT; GENE-EXPRESSION; TRANSGENIC MICE; THY NEIGHBOR; SELF-RENEWAL; NICHE; TUMORIGENESIS	Fibroblasts within the mammary tumor microenvironment are active participants in carcinogenesis mediating both tumor initiation and progression. Our group has previously demonstrated that genetic loss of phosphatase and tensin homolog (PTEN) in mammary fibroblasts induces an oncogenic secretome that remodels the extracellular milieu accelerating ErbB2-driven mammary tumor progression. While these prior studies highlighted a tumor suppressive role for stromal PTEN, how the adjacent normal epithelium transforms in response to PTEN loss was not previously addressed. To identify these early events, we have evaluated both phenotypic and genetic changes within the pre-neoplastic mammary epithelium of mice with and without stromal PTEN expression. We report that fibroblast-specific PTEN deletion greatly restricts mammary ductal elongation and induces aberrant alveolar side-branching. These mice concomitantly exhibit an expansion of the mammary epithelial stem cell (MaSC) enriched basal/myoepithelial population and an increase in in vitro stem cell activity. Further analysis revealed that NOTCH signaling, specifically through NOTCH3, is diminished in these cells. Mechanistically, JAGGED-1, a transmembrane ligand for the NOTCH receptor, is downregulated in the PTEN-null fibroblasts leading to a loss in the paracrine activation of NOTCH signaling from the surrounding stroma. Reintroduction of JAGGED-1 expression within the PTEN-null fibroblasts was sufficient to abrogate the observed increase in colony forming activity implying a direct role for stromal JAGGED-1 in regulation of MaSC properties. Importantly, breast cancer patients whose tumors express both low stromal JAG1 and low stromal PTEN exhibit a shorter time to recurrence than those whose tumors express low levels of either alone suggesting similar stromal signaling in advanced disease. Combined, these results unveil a novel stromal PTEN-to-JAGGED-1 axis in maintaining the MaSC niche, and subsequently inhibiting breast cancer initiation and disease progression.	[Sizemore, G. M.; Balakrishnan, S.; Hammer, A. M.; Thies, K. A.; Trimboli, A. J.; Wallace, J. A.; Sizemore, S. T.; Kladney, R. D.; Woelke, S. A.; Leone, G.; Ostrowski, M. C.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Sizemore, G. M.; Balakrishnan, S.; Hammer, A. M.; Thies, K. A.; Trimboli, A. J.; Kladney, R. D.; Leone, G.; Ostrowski, M. C.] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Sizemore, S. T.; Chakravarti, A.] Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA; [Yu, L.; Fernandez, S. A.] Ohio State Univ, Dept Biomed Informat, Ctr Biostat, Columbus, OH 43210 USA; [Leone, G.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Sizemore, GM; Ostrowski, MC (corresponding author), Ohio State Univ, Dept Canc Biol & Genet, Comprehens Canc, 570A Biomed Res Tower,460W 12th Ave, Columbus, OH 43210 USA.	gina.sizemore@osumc.edu; michael.ostrowski@osumc.edu	Sizemore, Gina/ABI-7542-2020; yu, lianbo/B-3472-2010; Ostrowski, Michael/H-3108-2011	Ostrowski, Michael/0000-0003-2948-6297	NIH [PO1CA097189]; Department of Defense [W81XWH-14-1-0040]; Pelotonia Fellowship Program; NATIONAL CANCER INSTITUTE [P30CA016058, P01CA097189] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Pelotonia Fellowship Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jason Bice and Daphne Bryant (Solid Tumor Biology Program-Histology Core), Bryan McElwain and Katrina Miller (OSUCCC-Analytic Cytometry) and Sarah Warner (OSUCCC-Genomics) for technical support. This study was supported by the NIH (PO1CA097189, MCO and GL), the Department of Defense (W81XWH-14-1-0040, GMS) and the Pelotonia Fellowship Program (SB and GMS).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Boquest AC, 2005, MOL BIOL CELL, V16, P1131, DOI 10.1091/mbc.E04-10-0949; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Forster N, 2014, DEV CELL, V28, P147, DOI 10.1016/j.devcel.2013.11.019; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Ghiabi P, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0386-3; Ghiabi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112424; Ha HY, 2001, CANCER RES, V61, P984; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kessenbrock K, 2015, MATRIX BIOL, V44-46, P184, DOI 10.1016/j.matbio.2015.01.022; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Liu JC, 2012, P NATL ACAD SCI USA, V109, P5832, DOI 10.1073/pnas.1201105109; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Parsonage G, 2005, TRENDS IMMUNOL, V26, P150, DOI 10.1016/j.it.2004.11.014; Patel PH, 2015, NAT CELL BIOL, V17, P1182, DOI 10.1038/ncb3214; Plaks V, 2015, CELL STEM CELL, V16, P225, DOI 10.1016/j.stem.2015.02.015; Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244; Qiu M, 2013, CANCER LETT, V328, P261, DOI 10.1016/j.canlet.2012.09.023; Radisky DC, 2004, SCIENCE, V303, P775, DOI 10.1126/science.1094412; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Robinson GW, 2008, CELL STEM CELL, V3, P359, DOI 10.1016/j.stem.2008.09.014; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SOULE HD, 1986, IN VITRO CELL DEV B, V22, P6, DOI 10.1007/BF02623435; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Vaillant F, 2007, STEM CELL REV, V3, P114, DOI 10.1007/s12015-007-0018-2; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; Xing F, 2013, EMBO MOL MED, V5, P384, DOI 10.1002/emmm.201201623; Xu KL, 2012, CANCER CELL, V21, P626, DOI 10.1016/j.ccr.2012.03.041; Yamamoto M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3299	58	20	21	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 20	2017	36	16					2297	2308		10.1038/onc.2016.383	http://dx.doi.org/10.1038/onc.2016.383			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DM	27797378	Green Accepted			2022-12-26	WOS:000399782700010
J	Faust, JJ; Doudrick, K; Yang, Y; Capco, DG; Westerhoff, P				Faust, James J.; Doudrick, Kyle; Yang, Yu; Capco, David G.; Westerhoff, Paul			A Facile Method for Separating and Enriching Nano and Submicron Particles from Titanium Dioxide Found in Food and Pharmaceutical Products	PLOS ONE			English	Article							IN-VITRO; ENGINEERED NANOMATERIALS; NANOPARTICLES; CENTRIFUGATION; SEDIMENTATION; TOXICITY; ENVIRONMENT; CHALLENGES; EXPOSURE; GRADIENT	Recent studies indicate the presence of nano-scale titanium dioxide (TiO2) as an additive in human foodstuffs, but a practical protocol to isolate and separate nano-fractions from soluble foodstuffs as a source of material remains elusive. As such, we developed a method for separating the nano and submicron fractions found in commercial-grade TiO2 (E171) and E171 extracted from soluble foodstuffs and pharmaceutical products (e.g., chewing gum, pain reliever, and allergy medicine). Primary particle analysis of commercial-grade E171 indicated that 54% of particles were nano-sized (i.e., < 100 nm). Isolation and primary particle analysis of five consumer goods intended to be ingested revealed differences in the percent of nano-sized particles from 32%-58%. Separation and enrichment of nano- and submicron-sized particles from commercial-grade E171 and E171 isolated from foodstuffs and pharmaceuticals was accomplished using rate-zonal centrifugation. Commercial-grade E171 was separated into nano-and submicron-enriched fractions consisting of a nano: submicron fraction of approximately 0.45:1 and 3.2:1, respectively. E171 extracted from gum had nano: submicron fractions of 1.4:1 and 0.19:1 for nano- and submicron-enriched, respectively. We show a difference in particle adhesion to the cell surface, which was found to be dependent on particle size and epithelial orientation. Finally, we provide evidence that E171 particles are not immediately cytotoxic to the Caco-2 human intestinal epithelium model. These data suggest that this separation method is appropriate for studies interested in isolating the nano-sized particle fraction taken directly from consumer products, in order to study separately the effects of nano and submicron particles.	[Faust, James J.; Capco, David G.] Arizona State Univ, Sch Life Sci, Mol & Cellular Biosci, Tempe, AZ 85287 USA; [Doudrick, Kyle] Dept Civil & Environm Engn & Earth Sci, 156 Fitzpatrick Hall, Notre Dame, IN 46556 USA; [Yang, Yu; Westerhoff, Paul] Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Doudrick, K (corresponding author), Dept Civil & Environm Engn & Earth Sci, 156 Fitzpatrick Hall, Notre Dame, IN 46556 USA.	kdoudrick@nd.edu	Westerhoff, Paul/AAF-1850-2019; Doudrick, Kyle/J-4683-2014	Westerhoff, Paul/0000-0002-9241-8759; Doudrick, Kyle/0000-0003-1912-9819	US Environmental Protection Agency [RD83558001]; National Science Foundation Nanosystems Engineering Research Center for Nanotechnology Enabled Water Treatment (NEWT) [1449500]; NSF/ASEE Small Business Postdoctoral Research Diversity Fellowship; Notre Dame; Maher Alumni Award	US Environmental Protection Agency(United States Environmental Protection Agency); National Science Foundation Nanosystems Engineering Research Center for Nanotechnology Enabled Water Treatment (NEWT); NSF/ASEE Small Business Postdoctoral Research Diversity Fellowship; Notre Dame; Maher Alumni Award	This research was supported by US Environmental Protection Agency (RD83558001) and the National Science Foundation (EEC 1449500) Nanosystems Engineering Research Center for Nanotechnology Enabled Water Treatment (NEWT). KD recognizes funding from NSF/ASEE Small Business Postdoctoral Research Diversity Fellowship and startup funding from Notre Dame. JF was supported in part by the Maher Alumni Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbulut O, 2012, NANO LETT, V12, P4060, DOI 10.1021/nl301452x; Appendix Asadi M., 2005, BEET SUGAR HDB, P769; Auffan M, 2009, NAT NANOTECHNOL, V4, P634, DOI 10.1038/nnano.2009.242; Bae TH, 2005, J MEMBRANE SCI, V249, P1, DOI 10.1016/j.memsci.2004.09.008; Brun E, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-13; Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/NNANO.2011.58, 10.1038/nnano.2011.58]; Dorier M, 2015, NANOSCALE, V7, P7352, DOI 10.1039/c5nr00505a; Dudkiewicz A, 2011, TRAC-TREND ANAL CHEM, V30, P28, DOI 10.1016/j.trac.2010.10.007; Faust JJ, 2014, CELL BIOL TOXICOL, V30, P169, DOI 10.1007/s10565-014-9278-1; Faust JJ, 2014, CELL BIOL TOXICOL, V30, P31, DOI 10.1007/s10565-013-9267-9; Fisichella M, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-18; Hotze EM, 2010, J ENVIRON QUAL, V39, P1909, DOI 10.2134/jeq2009.0462; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; Koeneman BA, 2010, CELL BIOL TOXICOL, V26, P225, DOI 10.1007/s10565-009-9132-z; Kreyling WG, 2010, NANO TODAY, V5, P165, DOI 10.1016/j.nantod.2010.03.004; Kruger K, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2402-6; Lomer MCE, 2000, ANALYST, V125, P2339, DOI 10.1039/b006285p; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; Maynard AD, 2014, NAT NANOTECHNOL, V9, P658, DOI 10.1038/nnano.2014.196; McCracken C, 2016, ENVIRON SCI-NANO, V3, P256, DOI [10.1039/c5en00242g, 10.1039/C5EN00242G]; McCracken C, 2013, CHEM RES TOXICOL, V26, P1514, DOI 10.1021/tx400231u; Mihail CR, 2007, ELECT ENG HDB; MOOSEKER MS, 1976, J CELL BIOL, V71, P417, DOI 10.1083/jcb.71.2.417; Pele LC, 2015, PART FIBRE TOXICOL, V12, DOI 10.1186/s12989-015-0101-9; Qiu PH, 2011, ADV MATER, V23, P4880, DOI 10.1002/adma.201102636; Reed RB, 2014, ACS SUSTAIN CHEM ENG, V2, P1616, DOI 10.1021/sc500108m; Rice J, 1997, SUBCELLULAR FRACTION; Singh G, 2014, COMPR REV FOOD SCI F, V13, P693, DOI 10.1111/1541-4337.12078; Song ZM, 2015, J APPL TOXICOL, V35, P1169, DOI 10.1002/jat.3171; Stanley WM, 1944, J EXP MED, V79, P267, DOI 10.1084/jem.79.3.267; Swindells J. F., 1958, VISCOSITIES SUCROSE; Tarantini A, 2015, TOXICOL IN VITRO, V29, P398, DOI 10.1016/j.tiv.2014.10.023; von der Kammer F, 2012, ENVIRON TOXICOL CHEM, V31, P32, DOI 10.1002/etc.723; Weir A, 2012, ENVIRON SCI TECHNOL, V46, P2242, DOI 10.1021/es204168d; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Yang Y, 2016, SCI TOTAL ENVIRON, V565, P902, DOI 10.1016/j.scitotenv.2016.01.165; Yang Y, 2014, ENVIRON SCI TECHNOL, V48, P6391, DOI 10.1021/es500436x; Zhang Z, 2012, J AGR FOOD CHEM, V60, P10762, DOI 10.1021/jf303423q	38	16	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0164712	10.1371/journal.pone.0164712	http://dx.doi.org/10.1371/journal.pone.0164712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798677	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100012
J	Hsiao, SM; Tsai, YC; Chen, HM; Lin, MY; Chiu, YW; Chen, TH; Wang, SL; Hsiao, PN; Kung, LF; Hwang, SJ; Huang, MF; Yeh, YC; Chen, CS; Kuo, MC				Hsiao, Shih-Ming; Tsai, Yi-Chun; Chen, Hui-Mei; Lin, Ming-Yen; Chiu, Yi-Wen; Chen, Tzu-Hui; Wang, Shu-Li; Hsiao, Pei-Ni; Kung, Lan-Fang; Hwang, Shang-Jyh; Huang, Mei-Feng; Yeh, Yi-Chun; Chen, Cheng-Sheng; Kuo, Mei-Chuan			Association of Fluid Status and Body Composition with Physical Function in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; HEMODIALYSIS-PATIENTS; OLDER-ADULTS; INFLAMMATION; SURVIVAL; DIALYSIS; VOLUME; SPECTROSCOPY; CONSENSUS; OVERLOAD	Background Impairment of physical function and abnormal body composition are the major presentations in patients with chronic kidney disease (CKD). The aim of this study is to investigate the relationship between body composition and physical function in CKD patients. Methods This cross-sectional study enrolled 172 of CKD stages 1-5 from February 2013 to September 2013. Handgrip strength (upper extremity muscle endurance), 30-second chair-stand test (lower extremity muscle endurance) and 2-minute step test (cardiorespiratory endurance) were used as indices of physical function. Body composition, including fluid status (extracellular water/total body water, ECW/TBW), lean tissue index (LTI), and fat tissue index (FTI), was measured using a bioimpedance spectroscopy method. Results All patients with high ECW/TBW had lower handgrip strength and 30-second chair-stand than those with low ECW/TBW (P<0.001 and P = 0.002). CKD patients with high FTI had lower handgrip strength and 30-second chair-stand than those with low FTI (P<0.001 and P = 0.002). These patients with low LTI had lower handgrip strength than those with high LTI (P = 0.04). In multivariate analysis, high ECW/TBW was positively associated with decreased handgrip strength (beta = -41.17, P = 0.03) in CKD patients. High FTI was significantly correlated with decreased times of 30-second chair-stand (beta = -0.13, P = 0.01). There was no significant relationship between body composition and 2-minute step test. Conclusions Our results show a significant association of impaired upper and lower extremity muscle endurance with high fluid status and fat tissue. Evaluation of body composition may assist in indentifying physical dysfunction earlier in CKD patients.	[Hsiao, Shih-Ming; Chen, Tzu-Hui; Wang, Shu-Li; Hsiao, Pei-Ni; Kung, Lan-Fang] Kaohsiung Med Univ Hosp, Dept Nursing, Kaohsiung, Taiwan; [Tsai, Yi-Chun] Kaohsiung Med Univ Hosp, Div Gen Med, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Lin, Ming-Yen; Chiu, Yi-Wen; Hwang, Shang-Jyh; Kuo, Mei-Chuan] Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Hui-Mei; Huang, Mei-Feng; Yeh, Yi-Chun; Chen, Cheng-Sheng] Kaohsiung Med Univ, Grad Med, Kaohsiung, Taiwan; [Chen, Hui-Mei] Kaohsiung Med Univ, Dept Occupat Therapy, Coll Hlth Sci, Kaohsiung, Taiwan; [Lin, Ming-Yen; Chiu, Yi-Wen; Hwang, Shang-Jyh; Kuo, Mei-Chuan] Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Natl Hlth Res Inst, Inst Populat Sci, Miaoli, Taiwan; [Huang, Mei-Feng; Yeh, Yi-Chun; Chen, Cheng-Sheng] Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Kuo, MC (corresponding author), Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan.; Chen, CS (corresponding author), Kaohsiung Med Univ, Grad Med, Kaohsiung, Taiwan.; Kuo, MC (corresponding author), Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan.; Chen, CS (corresponding author), Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan.	sheng@kmu.edu.tw; mechku@cc.kmu.edu.tw	Lin, Ming Yen/A-8637-2010	Lin, Ming Yen/0000-0002-8194-4833; Chen, Hui-Mei/0000-0002-3712-5144	Kaohsiung Medical University Hospital [KMUH-98-P18]	Kaohsiung Medical University Hospital	Miss. Hsiao's research was supported by a grant from the Kaohsiung Medical University Hospital (KMUH-98-P18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2013, SEMIN NEPHROL, V33, P2, DOI 10.1016/j.semnephrol.2012.12.008; Akchurin OM, 2015, BLOOD PURIFICAT, V39, P84, DOI 10.1159/000368940; Carrero JJ, 2013, J RENAL NUTR, V23, P77, DOI 10.1053/j.jrn.2013.01.001; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Chang KV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117167; Chen W, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-55; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Delgado C, 2013, J RENAL NUTR, V23, P356, DOI 10.1053/j.jrn.2013.02.010; DeOreo PB, 1997, AM J KIDNEY DIS, V30, P204, DOI 10.1016/S0272-6386(97)90053-6; Hiraki K, 2013, CLIN EXP NEPHROL, V17, P225, DOI 10.1007/s10157-012-0681-8; Hung SC, 2014, KIDNEY INT, V85, P703, DOI 10.1038/ki.2013.336; Johansen KL, 2014, J AM SOC NEPHROL, V25, P381, DOI 10.1681/ASN.2013040431; Johansen KL, 2000, KIDNEY INT, V57, P2564, DOI 10.1046/j.1523-1755.2000.00116.x; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Kalantar-Zadeh K, 2004, SEMIN DIALYSIS, V17, P455, DOI 10.1111/j.0894-0959.2004.17606.x; Kidde J, 2009, PHYSIOTHER CAN, V61, P197, DOI 10.3138/physio.61.4.197; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Marcelli D, 2015, CLIN J AM SOC NEPHRO, V10, P1192, DOI 10.2215/CJN.08550814; Marcus Robin L, 2012, Curr Gerontol Geriatr Res, V2012, P216185, DOI 10.1155/2012/216185; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1; Padilla J, 2008, J NEPHROL, V21, P550; Passauer J, 2010, NEPHROL DIAL TRANSPL, V25, P545, DOI 10.1093/ndt/gfp517; Pedrosa R, 2009, BRAZ J PHYS THER, V13, P252, DOI 10.1590/S1413-35552009005000030; Roshanravan B, 2013, J AM SOC NEPHROL, V24, P822, DOI 10.1681/ASN.2012070702; Stoenoiu MS, 2003, J AM SOC NEPHROL, V14, P555, DOI 10.1097/01.ASN.0000053420.37216.9E; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Tsai YC, 2015, CLIN J AM SOC NEPHRO, V10, P39, DOI 10.2215/CJN.03610414; Tsai YC, 2014, AM J KIDNEY DIS, V63, P68, DOI 10.1053/j.ajkd.2013.06.011; Vicente-Martinez M, 2004, ARCH MED RES, V35, P220, DOI 10.1016/j.arcmed.2004.01.003; Wust Rob C I, 2007, Int J Chron Obstruct Pulmon Dis, V2, P289	31	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165400	10.1371/journal.pone.0165400	http://dx.doi.org/10.1371/journal.pone.0165400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798648	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100033
J	Ishikane, M; Hayakawa, K; Kutsuna, S; Takeshita, N; Ohmagari, N				Ishikane, Masahiro; Hayakawa, Kayoko; Kutsuna, Satoshi; Takeshita, Nozomi; Ohmagari, Norio			Epidemiology of Blood Stream Infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 Years: Importance of Peripheral Line-Associated Candidemia	PLOS ONE			English	Article							RISK-FACTORS; DISEASES SOCIETY; ANTIFUNGAL SUSCEPTIBILITY; MANAGEMENT; DIAGNOSIS; GUIDELINES; EXPERIENCE; FUNGEMIA; OUTCOMES; UPDATE	Background Candidemia is an important cause of mortality in healthcare settings. Peripheral lines are a source of candidemia, yet few studies have reported on the clinico-epidemiological features of candidemia due to peripheral-line associated blood stream infection (PLABSI). Methods We conducted a single-centre retrospective cohort study of all patients with candidemia between 2002 and 2013. PLABSI was defined as the presence of at least one of the following: the presence of phlebitis or the resolution of clinical symptoms after peripheral-line withdrawal, with careful exclusion of an alternative explanation for bacteraemia. We described the epidemiology of candidemia and assessed predictive factors of PLABSI due to Candida spp., peripheral line-associated candidemia (PLAC), compared with non-PLAC. Results A total of 301 episodes of candidemia, including 37 of PLAC, were diagnosed during the study period. Central-line associated blood stream infection, intra-abdominal infection, and infection of unknown source accounted for the remaining 233, 14, and 17 cases, respectively. The overall incidence rate of candidemia was 0.11/1000 patient-days. In multivariate analysis, cephalosporin exposure (odds ratio [OR] = 2.22, 95% CI 1.04-4.77), polymicrobial bacteraemia/fungaemia (OR = 2.87, 95% CI 1.02-8.10), and ID specialist consultation (OR = 2.40, 95% CI 1.13-5.13) were identified as independent predictors of PLAC. Although non-PLAC had a higher mortality, the length of hospital stay after candidemia was similar between the two groups and candidemia duration was longer in the PLAC group. Conclusion PLACs are an important cause of candidemia in hospitalized patients. Appropriate identification and management of PLAC are crucial.	[Ishikane, Masahiro; Hayakawa, Kayoko; Kutsuna, Satoshi; Takeshita, Nozomi; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dept Dis Control & Prevent Ctr, Tokyo, Japan; [Ishikane, Masahiro] Tohoku Univ, Div Global Infect Dis, Dept Infect & Epidemiol, Grad Sch Med, Sendai, Miyagi 980, Japan	National Center for Global Health & Medicine - Japan; Tohoku University	Ishikane, M (corresponding author), Natl Ctr Global Hlth & Med, Dept Dis Control & Prevent Ctr, Tokyo, Japan.; Ishikane, M (corresponding author), Tohoku Univ, Div Global Infect Dis, Dept Infect & Epidemiol, Grad Sch Med, Sendai, Miyagi 980, Japan.	ishikanemasahiro@gmail.com	Ohmagari, Norio/GLN-5290-2022; Hayakawa, Kayoko/GNW-2394-2022; Ishikane, Masahiro/ABA-9878-2020	Ohmagari, Norio/0000-0002-4622-8970; Ishikane, Masahirio/0000-0002-4719-651X	Grants for International Health Research from the Ministry of Health, Labor, and Welfare of Japan [28S-1106]; Grants for International Medical Cooperation from the National Center for Global Health and Medicine [26S-101]	Grants for International Health Research from the Ministry of Health, Labor, and Welfare of Japan; Grants for International Medical Cooperation from the National Center for Global Health and Medicine	This study was funded by Grants for International Health Research (28S-1106) from the Ministry of Health, Labor, and Welfare of Japan and by Grants for International Medical Cooperation (26S-101) from the National Center for Global Health and Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp S, 2015, MYCOSES, V58, P498, DOI 10.1111/myc.12349; Austin ED, 2016, OPEN FORUM INFECT DI, V3, DOI [10.1093/ofid/ofw072, 10.1093/ofid/ofw234]; Barchiesi F, 2016, INFECTION, V44, P205, DOI 10.1007/s15010-015-0845-z; Coello R, 2003, J HOSP INFECT, V53, P46, DOI 10.1053/jhin.2002.1349; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-012-2769-8]; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Ding XR, 2015, MED MYCOL, V53, P684, DOI 10.1093/mmy/myv060; Fernandez-Ruiz M, 2014, CLIN INFECT DIS, V58, P1413, DOI 10.1093/cid/ciu158; Giri S, 2012, INDIAN J MED MICROBI, V30, P270, DOI 10.4103/0255-0857.99484; Hall WH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-94; Hassan I, 2009, J INFECTION, V59, P360, DOI 10.1016/j.jinf.2009.08.020; Hayakawa K, 2014, ANTIMICROB AGENTS CH, V58, P3441, DOI 10.1128/AAC.02652-13; Hirai Y, 2014, J HOSP INFECT, V87, P54, DOI 10.1016/j.jhin.2014.02.006; Kontoyiannis DP, 2001, CLIN INFECT DIS, V33, P1676, DOI 10.1086/323812; Lionakis MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003079; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Moretti ML, 2013, MED MYCOL, V51, P225, DOI 10.3109/13693786.2012.708107; Nagao M, 2013, CLIN MICROBIOL INFEC, V19, P852, DOI 10.1111/1469-0691.12083; National Healthcare Safety Network, 2013, CENTR LIN ASS BLOODS; NNIS System, 2002, AM J INFECT CONTROL, V30, P458, DOI 10.1067/mic.2002.130032; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oud Lavi, 2016, J Clin Med Res, V8, P40, DOI 10.14740/jocmr2387w; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Peman J, 2012, J ANTIMICROB CHEMOTH, V67, P1181, DOI 10.1093/jac/dks019; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Playford EG, 2010, J HOSP INFECT, V76, P46, DOI 10.1016/j.jhin.2010.01.022; Poikonen E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-312; Pujol M, 2007, J HOSP INFECT, V67, P22, DOI 10.1016/j.jhin.2007.06.017; SHERERTZ RJ, 1990, J CLIN MICROBIOL, V28, P76, DOI 10.1128/JCM.28.1.76-82.1990; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Tortorano AM, 2013, INFECTION, V41, P655, DOI 10.1007/s15010-013-0455-6; Tortorano AM, 2006, INT J ANTIMICROB AG, V27, P359, DOI 10.1016/j.ijantimicag.2006.01.002; Vonberg RP, 2006, INFECT CONT HOSP EP, V27, P357, DOI 10.1086/503339; Walsh TJ, 2002, CLIN INFECT DIS, V34, P600, DOI 10.1086/338715; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; YAMAGUCHI H., 2012, MED MYCOL RES, V3, P17; Yapar N, 2014, THER CLIN RISK MANAG, V10, P95, DOI 10.2147/TCRM.S40160; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922; [No title captured]; [No title captured]; [No title captured]; [No title captured]	43	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165346	10.1371/journal.pone.0165346	http://dx.doi.org/10.1371/journal.pone.0165346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798663	gold, Green Submitted, Green Published			2022-12-26	WOS:000386711100028
J	Ishimoto, K; Kawamata, N; Uchihara, Y; Okubo, M; Fujimoto, R; Gotoh, E; Kakinouchi, K; Mizohata, E; Hino, N; Okada, Y; Mochizuki, Y; Tanaka, T; Hamakubo, T; Sakai, J; Kodama, T; Inoue, T; Tachibana, K; Doi, T				Ishimoto, Kenji; Kawamata, Natsuko; Uchihara, Yoshie; Okubo, Moeka; Fujimoto, Reiko; Gotoh, Eiko; Kakinouchi, Keisuke; Mizohata, Eiichi; Hino, Nobumasa; Okada, Yoshiaki; Mochizuki, Yasuhiro; Tanaka, Toshiya; Hamakubo, Takao; Sakai, Juro; Kodama, Tatsuhiko; Inoue, Tsuyoshi; Tachibana, Keisuke; Doi, Takefumi			Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity	PLOS ONE			English	Article							CPG-BINDING DOMAIN; DNA METHYLATION; TUDOR DOMAIN; PROTEASOME; G9A; IDENTIFICATION; EXPRESSION; STABILITY; COMPLEX; GENES	Posttranslational modifications (PTMs) of proteins play a crucial role in regulating protein-protein interactions, enzyme activity, subcellular localization, and stability of the protein. SET domain, bifurcated 1 (SETDB1) is a histone methyltransferase that regulates the methylation of histone H3 on lysine 9 (H3K9), gene silencing, and transcriptional repression. The C-terminal region of SETDB1 is a key site for PTMs, and is essential for its enzyme activity in mammalian and insect cells. In this study, we aimed to evaluate more precisely the effect of PTMs on the H3K9 methyltransferase activity of SETDB1. Using mass spectrometry analysis, we show that the C-terminal region of human SETDB1 purified from insect cells is ubiquitinated. We also demonstrate that the ubiquitination of lysine 867 of the human SETDB1 is necessary for full H3K9 methyltransferase activity in mammalian cells. Finally, we show that SETDB1 ubiquitination regulates the expression of its target gene, serpin peptidase inhibitor, clade E, member 1 (SERPINE1) by methylating H3K9. These results suggest that the ubiquitination of SETDB1 at lysine 867 controls the expression of its target gene by activating its H3K9 methyltransferase activity.	[Ishimoto, Kenji; Kawamata, Natsuko; Uchihara, Yoshie; Okubo, Moeka; Fujimoto, Reiko; Gotoh, Eiko; Hino, Nobumasa; Okada, Yoshiaki; Tachibana, Keisuke; Doi, Takefumi] Osaka Univ, Grad Sch Pharmaceut Sci, Mol Med Lab, Suita, Osaka, Japan; [Ishimoto, Kenji; Tanaka, Toshiya; Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Meguro Ku, Tokyo, Japan; [Kakinouchi, Keisuke; Mizohata, Eiichi; Inoue, Tsuyoshi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka, Japan; [Mochizuki, Yasuhiro; Hamakubo, Takao] Univ Tokyo, Dept Quantitat Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan; [Sakai, Juro] Univ Tokyo, Res Ctr Adv Sci & Technol, Div Metab Med, Meguro Ku, Tokyo, Japan	Osaka University; University of Tokyo; Osaka University; University of Tokyo; University of Tokyo	Doi, T (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Mol Med Lab, Suita, Osaka, Japan.	doi@phs.osaka-u.ac.jp		Hino, Nobumasa/0000-0002-7072-1183; Sakai, Juro/0000-0003-4043-1035	JSPS KAKENHI [25860253, 15H02896, 25670026, 15H04644]; Grants-in-Aid for Scientific Research [15H02896] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant No. 25860253, 15H02896, 25670026 and 15H04644 (http://www.jsps.go.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Carro S, 2004, J BIOL CHEM, V279, P25623, DOI 10.1074/jbc.M402571200; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Farley AR, 2009, METHOD ENZYMOL, V463, P725, DOI 10.1016/S0076-6879(09)63040-8; Fei Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9651; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Ishimoto K, 2010, BIOCHEM J, V429, P347, DOI 10.1042/BJ20091511; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; Kim HA, 2012, J CLIN INVEST, V122, P3248, DOI 10.1172/JCI61216; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Lomberk G, 2012, J BIOL CHEM, V287, P13026, DOI 10.1074/jbc.M112.342634; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Pek JW, 2012, DEVELOPMENT, V139, P2255, DOI 10.1242/dev.073304; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rodriguez-Paredes M, 2014, ONCOGENE, V33, P2807, DOI 10.1038/onc.2013.239; Roloff TC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-1; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Tachibana K, 2015, BIOCHEM BIOPH RES CO, V465, P725, DOI 10.1016/j.bbrc.2015.08.065; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Watson GW, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.47; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003	44	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165766	10.1371/journal.pone.0165766	http://dx.doi.org/10.1371/journal.pone.0165766			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798683	gold, Green Published, Green Submitted			2022-12-26	WOS:000386711100064
J	Tang, ZY; Wang, XD; Huang, JF; Zhou, XY; Xie, H; Zhu, QL; Huang, MJ; Ni, SS				Tang, Zhiyuan; Wang, Xudong; Huang, Jianfei; Zhou, Xiaoyu; Xie, Hao; Zhu, Qilin; Huang, Minjie; Ni, Songshi			Gene Expression Profiling of Pulmonary Artery in a Rabbit Model of Pulmonary Thromboembolism	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; DOMAIN-CONTAINING ADAPTERS; VENOUS THROMBOEMBOLISM; INFLAMMATORY BIOMARKERS; SIGNALING PATHWAYS; INNATE IMMUNITY; FAMILY-MEMBERS; EMBOLISM; DISEASE; CELLS	Acute pulmonary thromboembolism (PTE) refers to the obstruction of thrombus in pulmonary artery or its branches. Recent studies have suggested that PTE-induced endothelium injury is the major physiological consequence of PTE. And it is reasonal to use PTE-induced endothelium injury to stratify disease severity. According to the massive morphologic and histologic findings, rabbit models could be applied to closely mimic the human PE. Genomewide gene expression profiling has not been attempted in PTE. In this study, we determined the accuracy of rabbit autologous thrombus PTE model for human PTE disease, then we applied gene expression array to identify gene expression changes in pulmonary arteries under PTE to identify potential molecular biomarkers and signaling pathways for PTE. We detected 1343 genes were upregulated and 923 genes were downregulated in PTE rabbits. The expression of several genes (IL-8, TNF-alpha, and CXCL5) with functional importance were further confirmed in transcript and protein levels. The most significantly differentially regulated genes were related to inflammation, immune disease, pulmonary disease, and cardiovascular diseases. Totally 87 genes were up-regulated in the inflammatory genes. We conclude that gene expression profiling in rabbit PTE model could extend the understanding of PTE pathogenesis at the molecular level. Our study provides the fundamental framework for future clinical research on human PTE, including identification of potential biomarkers for prognosis or therapeutic targets for PTE.	[Tang, Zhiyuan; Zhou, Xiaoyu; Zhu, Qilin; Huang, Minjie; Ni, Songshi] Nantong Univ, Affiliated Hosp, Dept Resp Med, Nantong 226001, Jiangsu, Peoples R China; [Wang, Xudong] Nantong Univ, Affiliated Hosp, Dept Lab Med, Nantong 226001, Jiangsu, Peoples R China; [Huang, Jianfei] Nantong Univ, Affiliated Hosp, Dept Pathol, Nantong 226001, Jiangsu, Peoples R China; [Huang, Jianfei] Nantong Univ, Affiliated Hosp, Dept Clin Biobank, Nantong 226001, Jiangsu, Peoples R China; [Xie, Hao] China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Jiangsu, Peoples R China	Nantong University; Nantong University; Nantong University; Nantong University; China Pharmaceutical University	Ni, SS (corresponding author), Nantong Univ, Affiliated Hosp, Dept Resp Med, Nantong 226001, Jiangsu, Peoples R China.	jsntnss@163.com		Huang, Jianfei/0000-0002-1276-5962	National Natural Science Foundation [81503143]; Science and Technology Bureau [MS32015025]; Chinese Postdoctoral Science Foundation [2015M581846]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Bureau; Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by ZT, No.81503143, National Natural Science Foundation, http://www.nsfc.gov.cn; SN, No. MS32015025, Science and Technology Bureau, http://www.ntkj.gov.cni; ZT, No.2015M581846, Chinese Postdoctoral Science Foundation, http://chinapostdoctor.org.cn/WebSite/program/Default.aspx.	Aderem A, 2004, SEMIN IMMUNOL, V16, P55, DOI 10.1016/j.smim.2003.10.002; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alias S, 2013, PULM CIRC, V3, P728, DOI 10.1086/674768; Allen TC, 2014, ARCH PATHOL LAB MED, V138, P266, DOI 10.5858/arpa.2013-0182-RA; Angchaisuksiri P, 2011, THROMB HAEMOSTASIS, V106, P585, DOI 10.1160/TH11-03-0184; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Babaoglu E, 2014, J INVEST MED, V62, P328, DOI 10.2310/JIM.0000000000000041; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Battistini B, 2003, CAN J PHYSIOL PHARM, V81, P555, DOI 10.1139/Y03-017; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Celik A, 2011, J ATHEROSCLER THROMB, V18, P487, DOI 10.5551/jat.7070; Cheuk BLY, 2004, BRIT J SURG, V91, P424, DOI 10.1002/bjs.4454; Dartevelle P, 2004, EUR RESPIR J, V23, P637, DOI 10.1183/09031936.04.00079704; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Dey A, 2000, MOL BIOL CELL, V11, P3835, DOI 10.1091/mbc.11.11.3835; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Halici B, 2014, INFLAMMATION, V37, P1186, DOI 10.1007/s10753-014-9844-y; Hancock HS, 2013, CARDIOL YOUNG, V23, P344, DOI 10.1017/S1047951112001126; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jezovnik MK, 2010, INT ANGIOL, V29, P226; Jha AK, 2013, BMJ QUAL SAF, V22, P809, DOI 10.1136/bmjqs-2012-001748; Ji YQ, 2013, CHINESE MED J-PEKING, V126, P114, DOI 10.3760/cma.j.issn.0366-6999.20120122; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kimura H, 2001, AM J RESP CRIT CARE, V164, P319, DOI 10.1164/ajrccm.164.2.2006154; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kostadima Eleni, 2007, Hellenic J Cardiol, V48, P94; Kostrubiec M, 2005, EUR HEART J, V26, P2166, DOI 10.1093/eurheartj/ehi336; Lang D, 1998, J IMMUNOL, V161, P6871; Lee CH, 2010, J THROMB HAEMOST, V8, P1515, DOI 10.1111/j.1538-7836.2010.03873.x; Li CR, 2015, J GERIATR CARDIOL, V12, P279, DOI 10.11909/j.issn.1671-5411.2015.03.021; Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4; Li XR, 2001, INT J BIOCHEM CELL B, V33, P421, DOI 10.1016/S1357-2725(01)00027-9; LIU F, 1995, MOL CELL BIOL, V15, P3479; Loniewski KJ, 2007, MOL IMMUNOL, V44, P3715, DOI 10.1016/j.molimm.2007.04.002; Lu CL, 2015, ONCOTARGET, V6, P24912, DOI 10.18632/oncotarget.4701; Lu Wei, 2012, Zhonghua Nei Ke Za Zhi, V51, P270; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pieralli F, 2006, AM J CARDIOL, V97, P1386, DOI 10.1016/j.amjcard.2005.11.075; Raskob GE, 2014, ARTERIOSCL THROM VAS, V34, P2363, DOI 10.1161/ATVBAHA.114.304488; Rectenwald JE, 2006, J VASC SURG, V43, P800, DOI 10.1016/j.jvs.2005.12.010; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakao S, 2013, HISTOL HISTOPATHOL, V28, P185, DOI 10.14670/HH-28.185; Shaw JG, 2014, J THORAC DIS, V6, P1532, DOI 10.3978/j.issn.2072-1439.2014.11.33; Tang ZY, 2013, ANAL CHIM ACTA, V772, P59, DOI 10.1016/j.aca.2013.02.013; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; Wan J, 2010, EXP BIOL MED, V235, P989, DOI 10.1258/ebm.2010.010057; Wang H, 2015, MOL MED REP, V11, P2527, DOI 10.3892/mmr.2014.3006; Wang XZ, 2015, CORONARY ARTERY DIS, V26, P612, DOI 10.1097/MCA.0000000000000292; Watts JA, 2011, PULM PHARMACOL THER, V24, P407, DOI 10.1016/j.pupt.2011.01.009; Wood KE, 2002, CHEST, V121, P877, DOI 10.1378/chest.121.3.877; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zagorski J, 2003, J IMMUNOL, V171, P5529, DOI 10.4049/jimmunol.171.10.5529; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	69	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0164530	10.1371/journal.pone.0164530	http://dx.doi.org/10.1371/journal.pone.0164530			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798647	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100009
J	Day, K; Waite, LL; Alonso, A; Irvin, MR; Zhi, D; Thibeault, KS; Aslibekyan, S; Hidalgo, B; Borecki, IB; Ordovas, JM; Arnett, DK; Tiwari, HK; Absher, DM				Day, Kenneth; Waite, Lindsay L.; Alonso, Arnald; Irvin, Marguerite R.; Zhi, Degui; Thibeault, Krista S.; Aslibekyan, Stella; Hidalgo, Bertha; Borecki, Ingrid B.; Ordovas, Jose M.; Arnett, Donna K.; Tiwari, Hemant K.; Absher, Devin M.			Heritable DNA Methylation in CD4(+) Cells among Complex Families Displays Genetic and Non-Genetic Effects	PLOS ONE			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; ALLELE-SPECIFIC METHYLATION; EPIGENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCUS; LIPID-LOWERING DRUGS; FENOFIBRATE TREATMENT; MULTIPLE TISSUES; T-LYMPHOCYTE; DIET; BLOOD	DNA methylation at CpG sites is both heritable and influenced by environment, but the relative contributions of each to DNA methylation levels are unclear. We conducted a heritability analysis of CpG methylation in human CD4+ cells across 975 individuals from 163 families in the Genetics of Lipid-lowering Drugs and Diet Network (GOLDN). Based on a broad-sense heritability (H-2) value threshold of 0.4, we identified 20,575 highly heritable CpGs among the 174,445 most variable autosomal CpGs (SD > 0.02). Tests for associations of heritable CpGs with genotype at 2,145,360 SNPs using 717 of 975 individuals showed that similar to 74% were cis-meQTLs (< 1 Mb away from the CpG), 6% of CpGs exhibited trans-meQTL associations (> 1 Mb away from the CpG or located on a different chromosome), and 20% of CpGs showed no strong significant associations with genotype (based on a p-value threshold of 1e-7). Genes proximal to the genotype independent heritable CpGs were enriched for functional terms related to regulation of T cell activation. These CpGs were also among those that distinguished T cells from other blood cell lineages. Compared to genes proximal to meQTL-associated heritable CpGs, genotype independent heritable CpGs were moderately enriched in the same genomic regions that escape erasure during primordial germ cell development and could carry potential for generational transmission.	[Day, Kenneth; Waite, Lindsay L.; Alonso, Arnald; Thibeault, Krista S.; Absher, Devin M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Waite, Lindsay L.; Zhi, Degui; Hidalgo, Bertha; Tiwari, Hemant K.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Irvin, Marguerite R.; Aslibekyan, Stella; Arnett, Donna K.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Borecki, Ingrid B.] Washington Univ, Div Stat Genom, St Louis, MO USA; [Ordovas, Jose M.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Ordovas, Jose M.] IMDEA Food, Madrid, Spain; [Alonso, Arnald] Vall dHebron Hosp Res Inst, Rheumatol Res Grp, Barcelona, Spain; [Arnett, Donna K.] Univ Kentucky, Coll Publ Hlth, Lexington, KY USA	HudsonAlpha Institute for Biotechnology; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Tufts University; United States Department of Agriculture (USDA); Hospital Universitari Vall d'Hebron; University of Kentucky	Absher, DM (corresponding author), HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA.	dabsher@hudsonalpha.org		Jones, Lindsay/0000-0002-4219-8356; Day, Kenneth/0000-0001-8235-8302	National Institutes of Health National Heart, Blood and Lung Institute [R01 HL104135-01]; U.S. Public Health Service Resource Grant from the National Center for Research Resources [RR03655]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104135] Funding Source: NIH RePORTER	National Institutes of Health National Heart, Blood and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Public Health Service Resource Grant from the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health National Heart, Blood and Lung Institute (R01 HL104135-01: http://www.nhbi.nih.gov) to DMA and DKA. Some of the results in this paper were obtained by using the software package S.A.G.E., which was supported by a U.S. Public Health Service Resource Grant (RR03655) from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Ambatipudi S, 2016, EPIGENOMICS; [Anonymous], 2012, 62 SAGE; Aslibekyan S, 2012, PHARMACOGENET GENOM, V22, P191, DOI 10.1097/FPC.0b013e32834fdd41; Barbosa TD, 2016, MOL METAB, V5, P184, DOI 10.1016/j.molmet.2015.12.002; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Cortijo S, 2014, SCIENCE, V343, P1145, DOI 10.1126/science.1248127; Czyz W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-93; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Evans DM, 2004, GENES IMMUN, V5, P548, DOI 10.1038/sj.gene.6364126; Evans DM, 2004, J ALLERGY CLIN IMMUN, V114, P826, DOI 10.1016/j.jaci.2004.05.060; FILION LG, 1990, J IMMUNOL METHODS, V135, P59, DOI 10.1016/0022-1759(90)90256-U; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gaunt TR, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0926-z; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gibbings D, 2009, J LEUKOCYTE BIOL, V86, P251, DOI 10.1189/jlb.0109040; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Goldeck D, 2016, J GERONTOL A-BIOL, V71, P1537, DOI 10.1093/gerona/glv230; Gordon L, 2012, GENOME RES, V22, P1395, DOI 10.1101/gr.136598.111; Greaves IK, 2012, EPIGENETICS-US, V7, P800, DOI 10.4161/epi.20820; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hall MA, 2000, GENES IMMUN, V1, P423, DOI 10.1038/sj.gene.6363702; Hall MA, 2002, AM J HUM GENET, V70, P1172, DOI 10.1086/340090; Harris RA, 2013, EPIGENETICS-US, V8, P157, DOI 10.4161/epi.23438; Hidalgo B, 2014, DIABETES, V63, P801, DOI 10.2337/db13-1100; Irvin MR, 2014, CIRCULATION, V130, P565, DOI 10.1161/CIRCULATIONAHA.114.009158; Irvin MR, 2010, CIRC-CARDIOVASC GENE, V3, P462, DOI 10.1161/CIRCGENETICS.110.950667; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joubert BR, 2016, AM J HUM GENET, V98, P680, DOI 10.1016/j.ajhg.2016.02.019; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Keen KJ, 2003, STAT MED, V22, P3229, DOI 10.1002/sim.1559; Koch L, 2014, NAT REV GENET, V15, DOI [10.1038/nrg3698, 10.1038/nrg3713]; Kulkarni H, 2015, HUM MOL GENET, V24, P5330, DOI 10.1093/hmg/ddv232; Lee HS, 2015, NUTRIENTS, V7, P9492, DOI 10.3390/nu7115467; Mathew G, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1573; McRae AF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r73; Meaburn EL, 2010, EPIGENETICS-US, V5, P578, DOI 10.4161/epi.5.7.12960; Morgan DK, 2008, MAMM GENOME, V19, P394, DOI 10.1007/s00335-008-9124-y; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Neurauter AA, 2007, ADV BIOCHEM ENG BIOT, P41, DOI [10.1007/10_2007_072, DOI 10.1007/10_2007_072]; Oliver VF, 2015, EPIGENETICS-US, V10, P698, DOI 10.1080/15592294.2015.1060388; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Pinheiro J, 2000, MIXED EFFECTS MODELS, DOI [10.1007/978-1-4419-0318-1, DOI 10.1007/978-1-4419-0318-1]; Plongthongkum N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099313; Prokopuk L, 2015, EPIGENOMICS-UK, V7, P829, DOI 10.2217/epi.15.36; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rubelt F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11112; Schmitz RJ, 2013, GENOME RES, V23, P1663, DOI 10.1101/gr.152538.112; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shah S, 2014, GENOME RES, V24, P1725, DOI 10.1101/gr.176933.114; Shea JM, 2015, DEV CELL, V35, P750, DOI 10.1016/j.devcel.2015.11.024; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Silver MJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0660-y; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Tan QH, 2015, J EXP BIOL, V218, P134, DOI 10.1242/jeb.107151; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Teschendorff AE, 2015, JAMA ONCOL, V1, P476, DOI 10.1001/jamaoncol.2015.1053; Therneau T., 2012, THE IMEKIN FUNCTION; van Dongen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11115; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Waite LL, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00023; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Wilson GA, 2014, GENOME MED, V6, DOI 10.1186/gm536; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138; Zhi D, 2013, EPIGENETICS-US, V8, P802, DOI 10.4161/epi.25501; Zilbauer M, 2013, BLOOD, V122, pE52, DOI 10.1182/blood-2013-05-503201	75	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165488	10.1371/journal.pone.0165488	http://dx.doi.org/10.1371/journal.pone.0165488			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792787	Green Submitted, gold, Green Published			2022-12-26	WOS:000389537000024
J	Jokhadar, SZ; Bozic, B; Kristanc, L; Gomiscek, G				Jokhadar, Spela Zemljic; Bozic, Bojan; Kristanc, Luka; Gomiscek, Gregor			Osmotic Effects Induced by Pore-Forming Agent Nystatin: From Lipid Vesicles to the Cell	PLOS ONE			English	Article							GIANT PHOSPHOLIPID-VESICLES; AMPHOTERICIN-B; ELECTRICAL-PROPERTIES; POLYENE ANTIBIOTICS; BILAYER-MEMBRANES; CHOLESTEROL; PERMEABILITY; ERYTHROCYTE; TRANSPORT; CHANNELS	The responses of Chinese hamster ovary epithelial cells, caused by the pore-forming agent nystatin, were investigated using brightfield and fluorescence microscopy. Different phenomena, i.e., the detachment of cells, the formation of blebs, the occurrence of "cell-vesicles" and cell ruptures, were observed. These phenomena were compared to those discovered in giant lipid vesicles. A theoretical model, based on the osmotic effects that occur due to the size-discriminating nystatin transmembrane pores in lipid vesicles, was extended with a term that considers the conservation of the electric charge density in order to describe the cell's behavior. The increase of the cellular volume was predicted and correlated with the observed phenomena.	[Jokhadar, Spela Zemljic; Bozic, Bojan; Kristanc, Luka; Gomiscek, Gregor] Univ Ljubljana, Fac Med, Inst Biophys, Ljubljana, Slovenia; [Gomiscek, Gregor] Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Jokhadar, SZ (corresponding author), Univ Ljubljana, Fac Med, Inst Biophys, Ljubljana, Slovenia.	spelazemljic-jokhadar@mf.uni-lj.si			Slovenian Research Agency [P1-0055]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	SZJ, BB, GG received funding from the Slovenian Research Agency (https://www.arrs.gov.si, P1-0055). The funders had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript.	Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Baek S, 2013, BIOMOL THER, V21, P42, DOI 10.4062/biomolther.2012.082; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; Chen Y, 2011, BLOOD, V117, P6392, DOI 10.1182/blood-2010-12-322867; Coleman ML, 2002, CELL DEATH DIFFER, V9, P493, DOI 10.1038/sj.cdd.4400987; Coutinho A, 2004, BIOPHYS J, V87, P3264, DOI 10.1529/biophysj.104.044883; Coutinho A, 2003, BIOPHYS J, V84, P3061, DOI 10.1016/S0006-3495(03)70032-0; Desouza Melissa, 2012, Bioarchitecture, V2, P75; Farinas J, 1997, J GEN PHYSIOL, V110, P283, DOI 10.1085/jgp.110.3.283; Finkelstein A., 1978, PHYSL MEMBRANE DISOR, P205; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Gunderson SM, 2000, ANTIMICROB AGENTS CH, V44, P2887, DOI 10.1128/AAC.44.10.2887-2890.2000; Hartsel S, 1996, TRENDS PHARMACOL SCI, V17, P445, DOI 10.1016/S0165-6147(96)01012-7; HOLZ R, 1970, J GEN PHYSIOL, V56, P125, DOI 10.1085/jgp.56.1.125; IKEHARA T, 1986, J MEMBRANE BIOL, V90, P231; Karatekin E, 2003, BIOPHYS J, V84, P1734, DOI 10.1016/S0006-3495(03)74981-9; Katsu T, 2008, ANAL SCI, V24, P1551, DOI 10.2116/analsci.24.1551; KLEINBERG ME, 1984, J MEMBRANE BIOL, V80, P257, DOI 10.1007/BF01868444; KOSLOV MM, 1984, J THEOR BIOL, V109, P17, DOI 10.1016/S0022-5193(84)80108-3; KRAUS M, 1995, EUROPHYS LETT, V32, P431, DOI 10.1209/0295-5075/32/5/009; Kristanc L, 2014, BBA-BIOMEMBRANES, V1838, P2635, DOI 10.1016/j.bbamem.2014.05.019; Kristanc L, 2012, BBA-BIOMEMBRANES, V1818, P636, DOI 10.1016/j.bbamem.2011.11.036; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LEWIS SA, 1977, J GEN PHYSIOL, V70, P427, DOI 10.1085/jgp.70.4.427; Liao RS, 1999, ANTIMICROB AGENTS CH, V43, P1034, DOI 10.1128/AAC.43.5.1034; Lodish H, 2000, MOL CELL BIOL; Malik A, 2015, BASIC CLIN PHARMACOL, V116, P47, DOI 10.1111/bcpt.12279; Mally M, 2002, BIOPHYS J, V83, P944, DOI 10.1016/S0006-3495(02)75220-X; Mally M, 2007, BBA-BIOMEMBRANES, V1768, P1179, DOI 10.1016/j.bbamem.2007.02.015; MARTY A, 1975, J GEN PHYSIOL, V65, P515, DOI 10.1085/jgp.65.4.515; Mayor S, 2011, CELL, V144, P323, DOI 10.1016/j.cell.2011.01.018; Ng AWK, 2003, J PHARM PHARM SCI, V6, P67; Ramos H, 1996, J MEMBRANE BIOL, V152, P65, DOI 10.1007/s002329900086; RENKIN EM, 1954, J GEN PHYSIOL, V38, P225; Romero EA, 2009, J MEMBRANE BIOL, V230, P69, DOI 10.1007/s00232-009-9187-z; Samson E, 2003, MATER STRUCT, V36, P156, DOI 10.1007/BF02479554; SCHULTZ JS, 1979, J GEN PHYSIOL, V73, P49, DOI 10.1085/jgp.73.1.49; Semis R, 2013, MED MYCOL, V51, P422, DOI 10.3109/13693786.2012.731712; Silva L, 2006, BBA-BIOMEMBRANES, V1758, P452, DOI 10.1016/j.bbamem.2006.03.008; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Tewary P, 2006, BIOCHEM BIOPH RES CO, V339, P661, DOI 10.1016/j.bbrc.2005.11.062; Usaj M, 2009, RADIOL ONCOL, V43, P108, DOI 10.2478/v10019-009-0017-9; VERTUTCROQUIN A, 1983, BIOCHEMISTRY-US, V22, P2939, DOI 10.1021/bi00281a024; WILLS NK, 1981, FED PROC, V40, P2202; Zemel A, 2005, EUR BIOPHYS J BIOPHY, V34, P230, DOI 10.1007/s00249-004-0445-9	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165098	10.1371/journal.pone.0165098	http://dx.doi.org/10.1371/journal.pone.0165098			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788169	Green Submitted, gold, Green Published			2022-12-26	WOS:000389604900044
J	Pava, Z; Burdam, FH; Handayuni, I; Trianty, L; Utami, RAS; Tirta, YK; Kenangalem, E; Lampah, D; Kusuma, A; Wirjanata, G; Kho, S; Simpson, JA; Auburn, S; Douglas, NM; Noviyanti, R; Anstey, NM; Poespoprodjo, JR; Marfurt, J; Price, RN				Pava, Zuleima; Burdam, Faustina H.; Handayuni, Irene; Trianty, Leily; Utami, Retno A. S.; Tirta, Yusrifar Kharisma; Kenangalem, Enny; Lampah, Daniel; Kusuma, Andreas; Wirjanata, Grennady; Kho, Steven; Simpson, Julie A.; Auburn, Sarah; Douglas, Nicholas M.; Noviyanti, Rintis; Anstey, Nicholas M.; Poespoprodjo, Jeanne R.; Marfurt, Jutta; Price, Ric N.			Submicroscopic and Asymptomatic Plas-modium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTIONS; POLYMERASE-CHAIN-REACTION; MALARIA INFECTIONS; UNSTABLE MALARIA; HIGH-THROUGHPUT; EPIDEMIOLOGY; POPULATIONS; IMMUNITY; ASSAY	Submicroscopic Plasmodium infections are an important parasite reservoir, but their clinical relevance is poorly defined. A cross-sectional household survey was conducted in southern Papua, Indonesia, using cluster random sampling. Data were recorded using a standardized questionnaire. Blood samples were collected for haemoglobin measurement. Plasmodium parasitaemia was determined by blood film microscopy and PCR. Between April and July 2013, 800 households and 2,830 individuals were surveyed. Peripheral parasitaemia was detected in 37.7% (968/2,567) of individuals, 36.8% (357) of whom were identified by blood film examination. Overall the prevalence of P. falciparum parasitaemia was 15.4% (396/2567) and that of P. vivax18.3% (471/2567). In parasitaemic individuals, submicroscopic infection was significantly more likely in adults (adjusted odds ratio (AOR): 3.82 [95%Cl: 2.49-5.86], p<0.001) compared to children, females (AOR = 1.41 [1.07-1.86], p= 0.013), individuals not sleeping under a bednet (AOR = 1.4 [1.0-1.8], p= 0.035), and being afebrile (AOR = 3.2 [1.49-6.93], p= 0.003). The risk of anaemia (according to WHO guidelines) was 32.8% and significantly increased in those with asymptomatic parasitaemia (AOR 2.9 [95% 2.1-4.0], p= 0.007), and submicroscopic P. falciparum infections (AOR 2.5 [95% 1.7-3.6], p= 0.002). Asymptomatic and submicroscopic infections in this area co -endemic for P. falciparum and P. vivaxconstitute two thirds of detectable parasitaemia and are associated with a high risk of anaemia. Novel public health strategies are needed to detect and eliminate these parasite reservoirs, for the benefit both of the patient and the community.	[Pava, Zuleima; Handayuni, Irene; Wirjanata, Grennady; Kho, Steven; Auburn, Sarah; Douglas, Nicholas M.; Anstey, Nicholas M.; Marfurt, Jutta; Price, Ric N.] Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Burdam, Faustina H.; Kenangalem, Enny; Poespoprodjo, Jeanne R.] Mimika Dist Hlth Author, Timika, Papua, Indonesia; [Burdam, Faustina H.; Kenangalem, Enny; Lampah, Daniel; Poespoprodjo, Jeanne R.] Papuan Hlth & Community Dev Fdn, Timika Malaria Res Programme, Timika, Papua, Indonesia; [Burdam, Faustina H.; Poespoprodjo, Jeanne R.] Univ Gadjah Mada, Dept Publ Hlth, Maternal & Child Hlth & Reprod Hlth, Fac Med, Yogyakarta, Indonesia; [Trianty, Leily; Utami, Retno A. S.; Tirta, Yusrifar Kharisma; Kusuma, Andreas; Noviyanti, Rintis] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Simpson, Julie A.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Douglas, Nicholas M.] Christchurch Hosp, Div Med, Christchurch, New Zealand; [Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England	Charles Darwin University; Menzies School of Health Research; Gadjah Mada University; Eijkman Institute; University of Melbourne; Christchurch Hospital New Zealand; University of Oxford	Price, RN (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.; Price, RN (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.	rprice@menzies.edu.au	Douglas, Nicholas/ABC-3052-2021; Poespoprodjo, Jeanne/AAF-1698-2020; Auburn, Sarah/N-2266-2013	Douglas, Nicholas/0000-0002-7214-4244; Poespoprodjo, Jeanne/0000-0003-1573-734X; Price, Richard/0000-0003-2000-2874; Noviyanti, Rintis/0000-0003-1383-3274; Auburn, Sarah/0000-0002-4638-536X; Pava, Zuleima/0000-0002-4802-0647; Trianty, Leily/0000-0002-4368-476X; Tirta, Yusrifar Kharisma/0000-0001-7592-9445; Wirjanata, Grennady/0000-0002-6858-8547	Wellcome Trust [091625, 099875, PA00P3-139723/1, 512-2010]; NMA (National Health and Medical Research Council (NHMRC) of Australia [1042072]; DFAT (Australian Department of Foreign Affairs and Trade); NHMRC [1037304]	Wellcome Trust(Wellcome TrustEuropean Commission); NMA (National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); DFAT (Australian Department of Foreign Affairs and Trade); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by the Wellcome Trust (Senior Fellowship in Clinical Science awarded to RNP - 091625) and Fellowships to: JRP (Wellcome Trust - 099875), JM (The Swiss National Science Foundation - PA00P3-139723/1), ZP (Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas, Colciencias - 512-2010) and NMA (National Health and Medical Research Council (NHMRC) of Australia - 1042072). The Timika Research Facility and Papuan Health and Community Development Foundation were supported by DFAT (Australian Department of Foreign Affairs and Trade) and the NHMRC (Program Grant 1037304).	Adams M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1038-z; Anstey NM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0958-y; Anstey NM, 2012, ADV PARASIT, V80, P151, DOI 10.1016/B978-0-12-397900-1.00003-7; Barbosa S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003109; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Britton S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0848-3; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; Cheng Q, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003413; Coleman RE, 2004, J MED ENTOMOL, V41, P201, DOI 10.1603/0022-2585-41.2.201; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Cottrell G, 2015, CLIN INFECT DIS, V60, P1481, DOI 10.1093/cid/civ122; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Douglas NM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001575; Douglas NM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-135; Hofmann N, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001788; Howard CT, 2007, AM J TROP MED HYG, V77, P623, DOI 10.4269/ajtmh.2007.77.623; Imwong M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0906-x; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452, DOI 10.4269/ajtmh.2009.80.452; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mohammed AH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-172; Moreira CM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0884-z; Mosha JF, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-221; Nwakanma D, 2008, INT J PARASITOL, V38, P219, DOI 10.1016/j.ijpara.2007.07.003; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Robinson LJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001891; Roper C, 1996, AM J TROP MED HYG, V54, P325, DOI 10.4269/ajtmh.1996.54.325; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Statistics M, 2014, MIM REG FIG; Tiono AB, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-79; von Seidlein L, 2015, EXPERT REV ANTI-INFE, V13, P715, DOI 10.1586/14787210.2015.1031744; Waltmann A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003758; Wampfler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076316; WHO, 2015, WORLD MAL REP 2014; Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2011, HAEM CONC DIAGN AN A, P6	39	40	40	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165340	10.1371/journal.pone.0165340	http://dx.doi.org/10.1371/journal.pone.0165340			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788243	Green Published, gold			2022-12-26	WOS:000389604900065
J	Agrawal, R; Dale, TP; Al-Zubaidi, MA; Malgulwar, PB; Forsyth, NR; Kulshreshtha, R				Agrawal, Rahul; Dale, Tina P.; Al-Zubaidi, Mohammed A.; Malgulwar, Prit Benny; Forsyth, Nicholas R.; Kulshreshtha, Ritu			Pluripotent and Multipotent Stem Cells Display Distinct Hypoxic miRNA Expression Profiles	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; OSTEOGENIC DIFFERENTIATION; MICRORNA REGULATION; INDUCED APOPTOSIS; GENE-EXPRESSION; IN-VIVO; CANCER; IDENTIFICATION; PROLIFERATION; CULTURE	MicroRNAs are reported to have a crucial role in the regulation of self-renewal and differentiation of stem cells. Hypoxia has been identified as a key biophysical element of the stem cell culture milieu however, the link between hypoxia and miRNA expression in stem cells remains poorly understood. We therefore explored miRNA expression in hypoxic human embryonic and mesenchymal stem cells (hESCs and hMSCs). A total of 50 and 76 miRNAs were differentially regulated by hypoxia (2% O-2) in hESCs and hMSCs, respectively, with a negligible overlap of only three miRNAs. We found coordinate regulation of precursor and mature miRNAs under hypoxia suggesting their regulation mainly at transcriptional level. Hypoxia response elements were located upstream of 97% of upregulated hypoxia regulated miRNAs (HRMs) suggesting hypoxia-inducible-factor (HIF) driven transcription. HIF binding to the candidate cis-elements of specific miRNAs under hypoxia was confirmed by Chromatin immunoprecipitation coupled with qPCR. Role analysis of a subset of upregulated HRMs identified linkage to reported inhibition of differentiation while a downregulated subset of HRMs had a putative role in the promotion of differentiation. MiRNA-target prediction correlation with published hypoxic hESC and hMSC gene expression profiles revealed HRM target genes enriched in the cytokine: cytokine receptor, HIF signalling and pathways in cancer. Overall, our study reveals, novel and distinct hypoxia-driven miRNA signatures in hESCs and hMSCs with the potential for application in optimised culture and differentiation models for both therapeutic application and improved understanding of stem cell biology.	[Agrawal, Rahul; Kulshreshtha, Ritu] Indian Inst Technol, Dept Biochem Engn & Biotechnol, Delhi 110016, India; [Dale, Tina P.; Al-Zubaidi, Mohammed A.; Forsyth, Nicholas R.] Keele Univ, Inst Sci & Technol Med, Guy Hilton Res Ctr, Stoke On Trent ST4 7QB, Staffs, England; [Al-Zubaidi, Mohammed A.] Al Mustansiriyah Univ, Coll Pharm, Baghdad, Iraq; [Malgulwar, Prit Benny] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Keele University; Mustansiriya University; All India Institute of Medical Sciences (AIIMS) New Delhi	Kulshreshtha, R (corresponding author), Keele Univ, Inst Sci & Technol Med, Guy Hilton Res Ctr, Thornburrow Dr, Stoke On Trent ST4 7QB, Staffs, England.	n.r.forsyth@keele.ac.uk; ritu@dbeb.iitd.ac.in	Dale, Tina/AAA-3560-2022; Dale, Tina Patricia/ABA-7020-2021; AL-ZUBAIDI, MOHAMMED/M-7900-2019	Dale, Tina/0000-0001-9461-8220; AL-ZUBAIDI, MOHAMMED/0000-0001-6062-3662; Agrawal, Rahul/0000-0003-3538-5433; Malgulwar, Prit Benny/0000-0001-9393-1055	DST-UKIERI program; Department of Biotechnology; EPSRC [EP/H028277/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H028277/1, 1119373] Funding Source: researchfish	DST-UKIERI program; Department of Biotechnology; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	RK and NRF conceived the grant from DST-UKIERI program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RA thanks Department of Biotechnology for Senior Research Fellowship. TD thanks the EPSRC Doctoral Training Centre in Regenerative Medicine. We would like to thank Prof. Chitra Sarkar, All India Institute of Medical Sciences, for help with the ChIP assay. We would also like to thank Eumentis Informatics, Pune for help with the pathway analyses and miRNA: gene networks.	Agrawal R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-686; Bartoszewska S, 2015, FASEB J, V29, P1467, DOI 10.1096/fj.14-267054; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen SW, 2015, FEBS LETT, V589, P710, DOI 10.1016/j.febslet.2015.01.038; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Dolezalova D, 2012, STEM CELLS, V30, P1362, DOI 10.1002/stem.1108; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Felthaus O, 2014, J PERIODONTOL, V85, pE144, DOI 10.1902/jop.2013.130445; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Forsyth NR, 2008, REGEN MED, V3, P817, DOI 10.2217/17460751.3.6.817; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Gerhart J, 2011, DEV BIOL, V359, P12, DOI 10.1016/j.ydbio.2011.08.007; Gits CMM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-429; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Green SL, 2001, MOL CELL BIOL, V21, P1196, DOI 10.1128/MCB.21.4.1196-1206.2001; Haicheur N, 2000, CLIN EXP IMMUNOL, V119, P28, DOI 10.1046/j.1365-2249.2000.01112.x; He SY, 2013, BIOCHEM BIOPH RES CO, V441, P763, DOI 10.1016/j.bbrc.2013.10.151; Hsieh JY, 2013, NUCLEIC ACIDS RES, V41, P9753, DOI 10.1093/nar/gkt666; Huszar JM, 2014, FEBS LETT, V588, P1850, DOI 10.1016/j.febslet.2014.03.057; Hwang S, 2014, FEBS LETT, V588, P2957, DOI 10.1016/j.febslet.2014.05.048; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jauniaux E, 1999, HUM REPROD, V14, P2901, DOI 10.1093/humrep/14.11.2901; Kay AG, 2015, REGEN MED, V10, P109, DOI [10.2217/RME.14.67, 10.2217/rme.14.67]; Kim H, 2013, CELL METAB, V17, P249, DOI 10.1016/j.cmet.2013.01.002; Kim JY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.344; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li HL, 2013, STEM CELL RES, V10, P313, DOI 10.1016/j.scr.2012.11.007; Li J, 2013, J CELL PHYSIOL, V228, P2324, DOI 10.1002/jcp.24402; Lipchina I, 2011, GENE DEV, V25, P2173, DOI 10.1101/gad.17221311; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lonne M, 2013, CELL TISSUE RES, V353, P117, DOI 10.1007/s00441-013-1597-7; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Melton C, 2010, ADV EXP MED BIOL, V695, P105, DOI 10.1007/978-1-4419-7037-4_8; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Muscari C, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-63; Muth M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-24; Narva E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078847; Nie Y, 2011, INT J BIOL SCI, V7, P762, DOI 10.7150/ijbs.7.762; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Piper M, 2014, J NEUROSCI, V34, P2921, DOI 10.1523/JNEUROSCI.2319-13.2014; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x; Shen GM, 2013, ACTA PHARMACOL SIN, V34, P336, DOI 10.1038/aps.2012.195; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Tome M, 2011, CELL DEATH DIFFER, V18, P985, DOI 10.1038/cdd.2010.167; Trohatou O, 2014, STEM CELL TRANSL MED, V3, P54, DOI 10.5966/sctm.2013-0081; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wen ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104666; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; Xiong L, 2012, FEBS J, V279, P4318, DOI 10.1111/febs.12021; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang B, 2011, URBAN PLANNING FORUM, V2011, P1, DOI DOI 10.1371/J0URNAL; Yu KR, 2013, J CELL SCI, V126, P5422, DOI 10.1242/jcs.133314; Yu Zuoren, 2012, Frontiers in Genetics, V3, P191, DOI 10.3389/fgene.2012.00191; Zhang SS, 2012, CELL BIOCHEM FUNCT, V30, P623, DOI 10.1002/cbf.2922; Zhou Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.195	68	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164976	10.1371/journal.pone.0164976	http://dx.doi.org/10.1371/journal.pone.0164976			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783707	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000389602800053
J	d Auriac, MBA				d'Auriac, Marc B. Angles			COMplementary Primer ASymmetric PCR (COMPAS-PCR) Applied to the Identification of Salmo salar, Salmo trutta and Their Hybrids	PLOS ONE			English	Article							THE-EXPONENTIAL (LATE)-PCR; ATLANTIC SALMON; RFLP METHOD; AMPLIFICATION; DNA; DISCRIMINATION; MUTATION; DIFFERENTIATION; EVOLUTION; SEQUENCE	Avoiding complementarity between primers when designing a PCR assay constitutes a central rule strongly anchored in the mind of the molecular scientist. 3'-complementarity will extend the primers during PCR elongation using one another as template, consequently disabling further possible involvement in traditional target amplification. However, a 5'-complementarity will leave the primers unchanged during PCR cycles, albeit sequestered to one another, therefore also suppressing target amplification. We show that 5'-complementarity between primers may be exploited in a new PCR method called COMplementary-Primer-Asymmetric (COMPAS)-PCR, using asymmetric primer concentrations to achieve target PCR amplification. Moreover, such a design may paradoxically reduce spurious nontarget amplification by actively sequestering the limiting primer. The general principles were demonstrated using 5S rDNA direct repeats as target sequences to design a species-specific assay for identifying Salmo salar and Salmo trutta using almost fully complementary primers overlapping the same target sequence. Specificity was enhanced by using 3'-penultimate point mutations and the assay was further developed to enable identification of S. salar x S. trutta hybrids by High Resolution Melt analysis in a 35 min one-tube assay. This small paradigm shift, using highly complementary primers for PCR, should help develop robust assays that previously would not be considered.	[d'Auriac, Marc B. Angles] Norwegian Inst Water Res, Dept Aquaculture, N-0349 Oslo, Norway	Norwegian Institute for Water Research (NIVA)	d Auriac, MBA (corresponding author), Norwegian Inst Water Res, Dept Aquaculture, N-0349 Oslo, Norway.	mad@niva.no	Angles d'Auriac, Marc/ABE-6889-2021	Angles d'Auriac, Marc/0000-0001-6385-663X	Norwegian Institute for Water Research	Norwegian Institute for Water Research	This work was funded by the Norwegian Institute for Water Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2011, FOOD CONTROL, V22, P1333, DOI 10.1016/j.foodcont.2011.02.009; Angles d'Auriac MB, 2014, J FISH BIOL, V84, P1971, DOI 10.1111/jfb.12401; Aranishi F, 2005, MAR BIOTECHNOL, V7, P571, DOI 10.1007/s10126-004-4102-1; Barciszewska MZ, 2001, ACTA BIOCHIM POL, V48, P191; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Bommarito S, 2000, NUCLEIC ACIDS RES, V28, P1929, DOI 10.1093/nar/28.9.1929; BOTTEMA CDK, 1993, MUTAT RES, V288, P93, DOI 10.1016/0027-5107(93)90211-W; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Campo D, 2012, GENOME, V55, P33, DOI 10.1139/G11-074; Carrera E, 2000, J AOAC INT, V83, P341; Carrera E, 2000, INT J FOOD SCI TECH, V35, P401, DOI 10.1046/j.1365-2621.2000.00404.x; Cespedes A, 1999, J AGR FOOD CHEM, V47, P1046, DOI 10.1021/jf9810970; Cha R S, 1992, PCR Methods Appl, V2, P14; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dalvin Sussie, 2010, Investig Genet, V1, P12, DOI 10.1186/2041-2223-1-12; de la Herran R, 2000, PARASITOLOGY, V120, P345, DOI 10.1017/S003118209900565X; Sales JBD, 2011, FOOD CONTROL, V22, P96, DOI 10.1016/j.foodcont.2010.06.011; Degen HJ, 2006, PCR APPL MANUAL; DIEFFENBACH CW, 1993, PCR METH APPL, V3, pS30; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Farmen E, 2014, J TOXICOL ENV HEAL A, V77, P587, DOI 10.1080/15287394.2014.887423; Glaab WE, 1999, MUTAT RES-FUND MOL M, V430, P1, DOI 10.1016/S0027-5107(99)00147-5; Hellberg RSR, 2010, J FOOD SCI, V75, pC595, DOI 10.1111/j.1750-3841.2010.01752.x; Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132; Lebedev AV, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn575; Lindholm M, 2016, HYDROBIOLOGIA, V772, P189, DOI 10.1007/s10750-016-2660-7; Liu Q, 1997, GENOME RES, V7, P389, DOI 10.1101/gr.7.4.389; Martins Cesar, 2004, P335; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; PENDAS AM, 1995, MOL ECOL, V4, P275, DOI 10.1111/j.1365-294X.1995.tb00220.x; PENDAS AM, 1994, CYTOGENET CELL GENET, V67, P31, DOI 10.1159/000133792; Pierce KE, 2005, P NATL ACAD SCI USA, V102, P8609, DOI 10.1073/pnas.0501946102; Pinhal D, 2008, GENET MOL BIOL, V31, P361, DOI 10.1590/S1415-47572008000200033; Poritz MA, 2014, J MOL DIAGN, V16, P159, DOI 10.1016/j.jmoldx.2014.01.001; Rasmussen RS, 2010, J AQUAT FOOD PROD T, V19, P3, DOI 10.1080/10498850903297576; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rodrigues LFS, 2011, AQUAC RES, V42, P1117, DOI 10.1111/j.1365-2109.2010.02698.x; Rychlik Wojciech, 2007, V402, P35; Sanchez JA, 2004, P NATL ACAD SCI USA, V101, P1933, DOI 10.1073/pnas.0305476101; SantaLucia John Jr., 2007, V402, P3; Satterfield BC, 2014, J MOL DIAGN, V16, P163, DOI 10.1016/j.jmoldx.2013.10.004; SOMMER SS, 1989, MAYO CLIN PROC, V64, P1361, DOI 10.1016/S0025-6196(12)65378-6; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Tognoli C, 2011, FOOD CHEM, V129, P1860, DOI 10.1016/j.foodchem.2011.05.133; Wangh LJ, 2002, LATE PCR2003, Patent No. 200320021219; Yuryev A., 2007, PCR PRIMER DESIGN	47	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165468	10.1371/journal.pone.0165468	http://dx.doi.org/10.1371/journal.pone.0165468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783658	Green Submitted, gold, Green Published			2022-12-26	WOS:000389602800076
J	Dismuke, WM; Klingeborn, M; Stamer, WD				Dismuke, W. Michael; Klingeborn, Mikael; Stamer, W. Daniel			Mechanism of Fibronectin Binding to Human Trabecular Meshwork Exosomes and Its Modulation by Dexamethasone	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; LINKED ACTIN NETWORKS; EXTRACELLULAR-MATRIX; INTRAOCULAR-PRESSURE; ORGAN-CULTURE; ENDOTHELIAL-CELLS; OUTFLOW FACILITY; GLAUCOMA; EXPRESSION; MIGRATION	Exosomes are emerging as important mediators of cell-matrix interactions by means of specific adhesion proteins. Changes in the tissue-specific exosomal protein expression may underlie pathological conditions whereby extracellular matrix turnover and homeostasis is disrupted. Ocular hypertension due to extracellular matrix accumulation in the trabecular meshwork is a hallmark of glucocorticoid-induced glaucoma. In the trabecular meshwork, exosomal fibronectin mediates cell matrix interactions at cellular structures called "invadosomes". Trabecular meshwork cells use invadosomes to turn over their surrounding matrix and maintain passageways for flow of aqueous humor. In this study, we observed that human trabecular meshwork explants treated with dexamethasone released exosomes with significantly reduced amounts of fibronectin bound per exosome. Further, we found that exosome-fibronectin binding is heparan sulfate-dependent, consistent with our observation that trabecular meshwork exosomes are enriched in the heparin/heparan sulfate binding annexins A2 and A6. In this way, dexamethasone-treated explants released exosomes with a significant reduction in annexin A2 and A6 per exosome. Interestingly, we did not detect exosomal matrix metalloproteinases, but we identified abundant dipeptidyl peptidase 4, a serine protease whose activity was reduced on exosomes isolated from dexamethasone-treated explants. Together, our findings demonstrate mechanistically how corticosteroid-induced alterations in exosomal adhesion cargo and properties can account for the pathological matrix accumulation seen in many glaucoma patients.	[Dismuke, W. Michael; Klingeborn, Mikael; Stamer, W. Daniel] Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA; [Stamer, W. Daniel] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA	Duke University; Duke University	Stamer, WD (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA.	dan.stamer@duke.edu	Klingeborn, Mikael/AAC-2471-2019	Klingeborn, Mikael/0000-0003-2907-0371	National Institutes of Health [F32 EY023468]; Glaucoma Research Foundation Shaffer Grant; National Institutes of Health Core Grant for Vision Research [EY005722]; Research to Prevent Blindness; Bright Focus Foundation [M2015221]; NATIONAL EYE INSTITUTE [P30EY005722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Research Foundation Shaffer Grant; National Institutes of Health Core Grant for Vision Research; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Bright Focus Foundation(BrightFocus Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by National Institutes of Health grant F32 EY023468 (WMD), Glaucoma Research Foundation Shaffer Grant (WMD), National Institutes of Health Core Grant for Vision Research to Duke University EY005722, Unrestricted Grant from Research to Prevent Blindness to Duke University, Bright Focus Foundation grant M2015221 (MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOTT TS, 1988, INVEST OPHTH VIS SCI, V29, P90; Adcock Ian M, 2004, Proc Am Thorac Soc, V1, P247, DOI 10.1513/pats.200402-001MS; Aga M, 2008, INVEST OPHTH VIS SCI, V49, P5353, DOI 10.1167/iovs.07-1666; Balaj L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10266; BECKER B, 1963, JAMA-J AM MED ASSOC, V185, P884, DOI 10.1001/jama.1963.03060110088027; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Broxmeyer HE, 2012, NAT MED, V18, P1786, DOI 10.1038/nm.2991; Cheng HC, 2003, J BIOL CHEM, V278, P24600, DOI 10.1074/jbc.M303424200; Clark AF, 2009, EXP EYE RES, V88, P752, DOI 10.1016/j.exer.2008.10.004; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; Clark R, 2013, MOL CELL PROTEOMICS, V12, P194, DOI 10.1074/mcp.M112.019745; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Dickerson JE, 1998, EXP EYE RES, V66, P731, DOI 10.1006/exer.1997.0470; Fang YT, 2012, J CELL PHYSIOL, V227, P2775, DOI 10.1002/jcp.23026; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; Ghersi G, 2002, J BIOL CHEM, V277, P29231, DOI 10.1074/jbc.M202770200; Ghersi G, 2006, CANCER RES, V66, P4652, DOI 10.1158/0008-5472.CAN-05-1245; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; GRANT W M, 1951, Trans Am Acad Ophthalmol Otolaryngol, V55, P774; Greening DW, 2015, METHODS MOL BIOL, V1295, P179, DOI 10.1007/978-1-4939-2550-6_15; Hakulinen J, 2008, J CELL BIOCHEM, V105, P1211, DOI 10.1002/jcb.21923; Han H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070595; Han KY, 2015, INVEST OPHTH VIS SCI, V56, P5323, DOI 10.1167/iovs.14-14417; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Hoffman EA, 2009, INVEST OPHTH VIS SCI, V50, P1313, DOI 10.1167/iovs.08-2326; Hoshino D, 2013, CELL REP, V5, P1159, DOI 10.1016/j.celrep.2013.10.050; Ishitsuka R, 1998, J BIOL CHEM, V273, P9935, DOI 10.1074/jbc.273.16.9935; Ji H, 2013, PROTEOMICS, V13, P1672, DOI 10.1002/pmic.201200562; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Kassam G, 1997, J BIOL CHEM, V272, P15093, DOI 10.1074/jbc.272.24.15093; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Llobet A, 1999, INVEST OPHTH VIS SCI, V40, P113; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; MARTIN RA, 1993, BIOCHIM BIOPHYS ACTA, V1164, P252, DOI 10.1016/0167-4838(93)90256-Q; Matsumoto Y, 1997, INVEST OPHTH VIS SCI, V38, P1902; Mu W, 2013, NEOPLASIA, V15, P875, DOI 10.1593/neo.13786; Nangami G, 2014, EXP CELL RES, V328, P388, DOI 10.1016/j.yexcr.2014.08.037; O'Reilly S, 2011, INVEST OPHTH VIS SCI, V52, P7316, DOI 10.1167/iovs.10-6692; Ou X, 2013, BLOOD, V122, P161, DOI 10.1182/blood-2013-02-487470; Overby DR, 2014, INVEST OPHTH VIS SCI, V55, P4922, DOI 10.1167/iovs.14-14429; Prendes MA, 2013, BRIT J OPHTHALMOL, V97, P680, DOI 10.1136/bjophthalmol-2011-301132; Purushothaman A, 2016, J BIOL CHEM, V291, P1652, DOI 10.1074/jbc.M115.686295; Quigley HA, 1996, NUMBER, V80, P389; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Rieu S, 2000, EUR J BIOCHEM, V267, P583, DOI 10.1046/j.1432-1327.2000.01036.x; Rohrborn D, 2014, FEBS LETT, V588, P3870, DOI 10.1016/j.febslet.2014.08.029; Saltel F, 2011, EUR J CELL BIOL, V90, P100, DOI 10.1016/j.ejcb.2010.05.011; SAMPLES JR, 1993, INVEST OPHTH VIS SCI, V34, P3386; SHIRATO S, 1989, INVEST OPHTH VIS SCI, V30, P2499; Skiba NP, 2013, J PROTEOME RES, V12, P3010, DOI 10.1021/pr4003678; SNYDER RW, 1993, EXP EYE RES, V57, P461, DOI 10.1006/exer.1993.1148; Stamer WD, 2011, J PROTEOMICS, V74, P796, DOI 10.1016/j.jprot.2011.02.024; STAMER WD, 1995, CURR EYE RES, V14, P611, DOI 10.3109/02713689508998409; Stamer WD, 1998, INVEST OPHTH VIS SCI, V39, P1804; STEELY HT, 1992, INVEST OPHTH VIS SCI, V33, P2242; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Sung BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8164; Tektas OY, 2009, EXP EYE RES, V88, P769, DOI 10.1016/j.exer.2008.11.025; Tsuboi N, 2012, INVEST OPHTH VIS SCI, V53, P6702, DOI 10.1167/iovs.12-10376; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vranka JA, 2015, EXP EYE RES, V133, P112, DOI 10.1016/j.exer.2014.07.014; Wang RS, 2015, J BIOL CHEM, V290, P30684, DOI 10.1074/jbc.M115.671735; Wang XM, 2006, ADV EXP MED BIOL, V575, P213; Wordinger RJ, 1998, INVEST OPHTH VIS SCI, V39, P1575; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; Zhou LL, 1998, INT J MOL MED, V1, P339	68	29	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165326	10.1371/journal.pone.0165326	http://dx.doi.org/10.1371/journal.pone.0165326			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783649	gold, Green Submitted, Green Published			2022-12-26	WOS:000389602800073
J	Liu, TL; Barritt, AS; Weinberger, M; Paul, JE; Fried, B; Trogdon, JG				Liu, Tsai-Ling; Barritt, A. Sidney; Weinberger, Morris; Paul, John E.; Fried, Bruce; Trogdon, Justin G.			Who Treats Patients with Diabetes and Compensated Cirrhosis	PLOS ONE			English	Article							COLORECTAL-CANCER SURVIVORS; PREVENTIVE CARE; LIVER-CIRRHOSIS; UNITED-STATES; ADMINISTRATIVE DATA; DISEASE; IMPACT; ASSOCIATION; SEVERITY; MELLITUS	Background Increasingly, patients with multiple chronic conditions are being managed in patient-centered medical homes (PCMH) that coordinate primary and specialty care. However, little is known about the types of providers treating complex patients with diabetes and compensated cirrhosis. Objective We examined the mix of physician specialties who see patients dually-diagnosed with diabetes and compensated cirrhosis. Design Retrospective cross-sectional study using 2000-2013 MarketScan (R) Commercial Claims and Encounters and Medicare Supplemental Databases. Patients We identified 22,516 adults (>= 18 years) dually-diagnosed with diabetes and compensated cirrhosis. Patients with decompensated cirrhosis, HIV/AIDS, or liver transplantation prior to dual diagnosis were excluded. Main Measures Physician mix categories: patients were assigned to one of four physician mix categories: primary care physicians (PCP) with no gastroenterologists (GI) or endocrinologists (ENDO); GI/ENDO with no PCP; PCP and GI/ENDO; and neither PCP nor GI/ENDO. Health care utilization: annual physician visits and health care expenditures were assessed by four physician mix categories. Key Results Throughout the 14 years of study, 92% of patients visited PCPs (54% with GI/ENDO and 39% with no GI/ENDO). The percentage who visited PCPs without GI/ENDO decreased 22% (from 63% to 49%), while patients who also visited GI/ENDO increased 71% (from 25% to 42%). Conclusions This is the first large nationally representative study to document the types of physicians seen by patients dually-diagnosed with diabetes and cirrhosis. A large proportion of these complex patients only visited PCPs, but there was a trend toward greater specialty care. The trend toward co-management by both PCPs and GI/ENDOs suggests that PCMH initiatives will be important for these complex patients. Documenting patterns of primary and specialty care is the first step toward improved care coordination.	[Liu, Tsai-Ling; Weinberger, Morris; Paul, John E.; Fried, Bruce; Trogdon, Justin G.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC 27514 USA; [Liu, Tsai-Ling] Carolinas HealthCare Syst, Ctr Outcomes Res & Evaluat CORE, Charlotte, NC 28262 USA; [Barritt, A. Sidney] Univ N Carolina, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Weinberger, Morris] Durham VAMC Ctr Hlth Serv Res, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Carolinas HealthCare System; University of North Carolina; University of North Carolina Chapel Hill	Liu, TL (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC 27514 USA.	tlliu@unc.edu	Barritt, Sid/AAC-8688-2022	Liu, Tsai-Ling/0000-0001-6661-082X; Barritt, Alfred/0000-0002-4200-3256	Department of Epidemiology, UNC Gillings School of Global Public Health; Cecil G. Sheps Center for Health Services Research, UNC; CER Strategic Initiative of UNC's Clinical Translational Science Award [1 ULI RR025747]; UNC School of Medicine; Worldwide Health Economics and Outcomes Research at Bristol-Myers Squibb (BMS); VA Health Services Research Senior Career Scientist Award [RCS 91-408]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER	Department of Epidemiology, UNC Gillings School of Global Public Health; Cecil G. Sheps Center for Health Services Research, UNC; CER Strategic Initiative of UNC's Clinical Translational Science Award; UNC School of Medicine; Worldwide Health Economics and Outcomes Research at Bristol-Myers Squibb (BMS); VA Health Services Research Senior Career Scientist Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The database infrastructure used for this project was funded by the Department of Epidemiology, UNC Gillings School of Global Public Health; the Cecil G. Sheps Center for Health Services Research, UNC; the CER Strategic Initiative of UNC's Clinical Translational Science Award (1 ULI RR025747); and the UNC School of Medicine. TLL was supported by a pre-doctoral Fellowship from Worldwide Health Economics and Outcomes Research at Bristol-Myers Squibb (BMS). BMS had no role in the study design, analysis, interpretation, preparation, review, approval, or decision to submit the manuscript for publication. MW was supported by a VA Health Services Research Senior Career Scientist Award (RCS 91-408).; The database infrastructure used for this project was funded by the Department of Epidemiology, UNC Gillings School of Global Public Health; the Cecil G. Sheps Center for Health Services Research, UNC; the CER Strategic Initiative of UNC's Clinical Translational Science Award (1 ULI RR025747); and the UNC School of Medicine. Tsai-Ling Liu was supported by a pre-doctoral Fellowship from Worldwide Health Economics and Outcomes Research at Bristol-Myers Squibb (BMS). BMS had no role in the study design, analysis, interpretation; preparation, review, approval, or decision to submit the manuscript for publication. Morris Weinberger was supported by a VA Health Services Research Senior Career Scientist Award (RCS 91-408). This study was presented an earlier version of the manuscript as a poster at the AcademyHealth in Minneapolis, MN, in June 2015.	American Academy of Family Physicians (AAFP) American Academy of Pediatrics (AAP) American College of Physicians (ACP) American Osteopathic Association (AOA), 2007, JOINT PRINC PAT CTR, P3; Ananthakrishnan AN, 2010, J GEN INTERN MED, V25, P1164, DOI 10.1007/s11606-010-1457-z; Barritt AS, 2013, LIVER TRANSPLANT, V19, P377, DOI 10.1002/lt.23588; Bini EJ, 2001, HEPATOLOGY, V34, P1089, DOI 10.1053/jhep.2001.29204; Bowman BT, 2013, MED CLIN N AM, V97, P157, DOI 10.1016/j.mcna.2012.10.012; Cassidy A, 2010, HLTH AFF; CDC, 2014, CDCS DIV DIAB TRANSL, P6; CMS, 2014, QUAL RAT SYST MEAS T; David G, 2015, HEALTH SERV RES, V50, P418, DOI 10.1111/1475-6773.12218; Davis K, 2011, J GEN INTERN MED, V26, P1201, DOI 10.1007/s11606-011-1720-y; Deaths Heron M., 2015, NATL VITAL STAT REPO, V64, P94; Earle CC, 2003, J CLIN ONCOL, V21, P1447, DOI 10.1200/JCO.2003.03.060; Eide MJ, 2009, J AM ACAD DERMATOL, V60, P51, DOI 10.1016/j.jaad.2008.08.040; Flottemesch TJ, 2012, AM J MANAG CARE, V18, P677; Freeman RB, 2002, LIVER TRANSPLANT, V8, P851, DOI 10.1053/jlts.2002.35927; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Grattagliano I, 2011, WORLD J GASTROENTERO, V17, P2273, DOI 10.3748/wjg.v17.i18.2273; Haley WE, 2015, AM J KIDNEY DIS, V65, P67, DOI 10.1053/j.ajkd.2014.06.031; Henry L, 2014, NAT REV GASTRO HEPAT, V11, P520, DOI 10.1038/nrgastro.2014.122; Hickman IJ, 2007, AM J MED, V120, P829, DOI 10.1016/j.amjmed.2007.03.025; Liu TL, 2016, DIGEST DIS SCI, V61, P3335, DOI 10.1007/s10620-016-4261-8; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Petit JM, 2014, ACTA DIABETOL, V51, P455, DOI 10.1007/s00592-013-0538-y; Scaglione S, 2015, J CLIN GASTROENTEROL, V49, P690, DOI 10.1097/MCG.0000000000000208; Schmidt ML, 2015, GASTROENTEROLOGY, V148, P967, DOI 10.1053/j.gastro.2015.01.032; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; Snyder CF, 2008, J CLIN ONCOL, V26, P1073, DOI 10.1200/JCO.2007.11.9859; Snyder CF, 2008, J GEN INTERN MED, V23, P254, DOI 10.1007/s11606-007-0497-5; Snyder CF, 2011, J CANCER SURVIV, V5, P283, DOI 10.1007/s11764-011-0181-y; Snyder CF, 2009, J CLIN ONCOL, V27, P1054, DOI 10.1200/JCO.2008.18.0950; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Tedjaseputra A., 2015, J ASIAN MED STUDENTS, V4, P14; The Dartmouth Atlas of Health Care, DARTM I HEAL POL CLI; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389; Wlazlo N, 2010, DIABETIC MED, V27, P1308, DOI 10.1111/j.1464-5491.2010.03093.x	36	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165574	10.1371/journal.pone.0165574	http://dx.doi.org/10.1371/journal.pone.0165574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783702	gold, Green Published, Green Submitted			2022-12-26	WOS:000389602800082
J	Maini, AA; George, MJ; Motwani, MP; Day, RM; Gilroy, DW; O'Brien, AJ				Maini, Alexander A.; George, Marc J.; Motwani, Madhur P.; Day, Richard M.; Gilroy, Derek W.; O'Brien, Alastair J.			A Comparison of Human Neutrophils Acquired from Four Experimental Models of Inflammation	PLOS ONE			English	Article							IMMUNE DYSFUNCTION; BINDING PROTEIN; CRITICALLY-ILL; CANTHARIDIN; CHEMOTAXIS; BLISTERS	Defects in neutrophil function have been implicated in a wide spectrum of clinical conditions. Several models are employed to study activated human neutrophils akin to those found at a site of inflammation. These include whole blood (WB) ex vivo stimulation with lipopolysaccharide (LPS) and in vivo techniques: cantharidin blister, skin windows and intra-dermal injection of UV-killed E. coli (UVKEc). Neutrophils obtained from these have never been compared. We compared the activation status of neutrophils from each technique in order to inform the optimal model for use in human studies. Healthy male volunteers were randomised to undergo one of the four techniques (n = 5/group). LPS: WB stimulated with 1ng/ml of LPS for 4 hours. Cantharidin: 12.5 mu l of 0.1% cantharidin elicited a single blister, aspirated at 24 hours. Skin windows: four 6mm mechanical-suction blisters created, de-roofed and an exudate-collection chamber placed over the windows for 4 hours before aspiration. UVKEc: 1.5 x 10(7) UVKEc injected intra-dermally. A single 10mm mechanical-suction blister formed and aspirated at 4 hours. Unstimulated WB used as the control. Flow cytometry was used to determine activation status using CD16, CD11b, CD54, CD62L and CD88. Functional status was assessed with a phagocytosis assay. The pattern of neutrophil activation was similar in all models. Neutrophil CD11b was elevated in all models, most markedly in UVKEc (p<0.0001), and CD54 was also elevated but only significant in the LPS model (p = 0.001). CD62L was significantly reduced in all 4 models (p<0.0001) and CD88 was also suppressed in all. There were no changes in CD16 in any model, neither was there any significant difference in the phagocytic capacity of the neutrophils. In summary, there are no significant differences in activation marker expression or phagocytic capacity in the neutrophils obtained from each technique. Therefore we believe whole blood stimulation is the best model in experimentally challenging inpatient populations.	[Maini, Alexander A.; George, Marc J.; Motwani, Madhur P.; Gilroy, Derek W.; O'Brien, Alastair J.] UCL, Ctr Clin Pharmacol, Div Med, London, England; [Day, Richard M.] UCL, UCL Appl Biomech Engn, Div Med, London, England	University of London; University College London; University of London; University College London	Maini, AA (corresponding author), UCL, Ctr Clin Pharmacol, Div Med, London, England.	a.maini@uci.ac.uk	Gilroy, Derek W/C-2588-2009; Gilroy, Derek/AAP-7227-2020	Gilroy, Derek/0000-0003-3476-0844; Day, Richard/0000-0002-3124-2294; O'Brien, Alastair/0000-0002-9168-7009; Maini, Alexander/0000-0002-0497-1571	Medical Research Council UK [MR/M005291/1]; MRC [MR/M005291/1, MC_PC_13078] Funding Source: UKRI; Medical Research Council [MR/M005291/1, MC_PC_13078] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Medical Research Council UK gave funding to grant number MR/M005291/1. This funding was won by DG and AOB (http://www.mrc.multi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Binder R, 1999, MOL IMMUNOL, V36, P885, DOI 10.1016/S0161-5890(99)00110-8; BRIHEIM G, 1988, INFLAMMATION, V12, P141, DOI 10.1007/BF00916397; Chiriaco M, 2016, PEDIAT ALLERG IMM-UK, V27, P242, DOI 10.1111/pai.12527; Condliffe AM, 1996, IMMUNOLOGY, V89, P105, DOI 10.1046/j.1365-2567.1996.d01-711.x; Day RM, 2001, J IMMUNOL METHODS, V257, P213, DOI 10.1016/S0022-1759(01)00467-7; Dhanda AD, 2015, WORLD J GASTROENTERO, V21, P11904, DOI 10.3748/wjg.v21.i42.11904; Follin P, 1999, J IMMUNOL METHODS, V232, P55, DOI 10.1016/S0022-1759(99)00153-2; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; Gomes NE, 2010, BRAZ J MED BIOL RES, V43, P853, DOI 10.1590/S0100-879X2010000900007; Harbord MWN, 2006, ALIMENT PHARM THER, V24, P651, DOI 10.1111/j.1365-2036.2006.03016.x; Holloway RA, 2013, CURR OPIN PULM MED, V19, P95, DOI 10.1097/MCP.0b013e32835cfff5; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Jenner W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089375; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; KUHNS DB, 1992, J CLIN INVEST, V89, P1734, DOI 10.1172/JCI115775; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Motwani MP, 2016, J PATHOL CLIN RES, V2, P154, DOI 10.1002/cjp2.43; Segre E, 2016, SHOCK, V45, P490, DOI 10.1097/SHK.0000000000000557; Tritto G, 2011, J HEPATOL, V55, P574, DOI 10.1016/j.jhep.2010.11.034; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; YEE J, 1994, ARCH SURG-CHICAGO, V129, P99	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165502	10.1371/journal.pone.0165502	http://dx.doi.org/10.1371/journal.pone.0165502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780229	gold, Green Published, Green Submitted			2022-12-26	WOS:000389046900061
J	Ma, J; Zhang, XF; Feng, YB; Zhang, H; Wang, XJ; Zheng, YH; Qiao, WT; Liu, XQ				Ma, Jing; Zhang, Xianfeng; Feng, Yanbin; Zhang, Hui; Wang, Xiaojun; Zheng, Yonghui; Qiao, Wentao; Liu, Xinqi			Structural and Functional Study of Apoptosis-linked Gene-2 center dot Heme-binding Protein 2 Interactions in HIV-1 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY SPLICED ISOFORM; RETICULUM EXIT SITES; PROTEOME-SCALE MAP; CELL-DEATH; ALG-2; BINDING; MEMBRANE; PATHWAY; ALIX; GENE	In the HIV-1 replication cycle, the endosomal sorting complex required for transport (ESCRT) machinery promotes viral budding and release in the late stages. In this process, the ESCRT proteins, ALIX and TSG101, are recruited through interactions with HIV-1 Gag p6. ALG-2, also known as PDCD6, interacts with both ALIX and TSG101 and bridges ESCRT-III and ESCRT-I. In this study, we show that ALG-2 affects HIV-1 production negatively at both the exogenous and endogenous levels. Through a yeast two-hybrid screen, we identified HEBP2 as the binding partner of ALG-2, and we solved the crystal structure of the ALG-2 center dot HEBP2 complex. The function of ALG2 center dot HEBP2 complex in HIV-1 replication was further explored. ALG-2 inhibits HIV-1 production by affecting Gag expression and distribution, and HEBP2 might aid this process by tethering ALG-2 in the cytoplasm.	[Ma, Jing; Feng, Yanbin; Zhang, Hui; Qiao, Wentao; Liu, Xinqi] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhang, Xianfeng; Wang, Xiaojun; Zheng, Yonghui] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, CAAS Michigan State Univ Joint Lab Innate Immun, Harbin 150069, Peoples R China; [Ma, Jing; Qiao, Wentao] Nankai Univ, Coll Life Sci, Key Lab Mol Microbiol & Technol, Minist Educ, Tianjin 300071, Peoples R China	Nankai University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Nankai University	Qiao, WT; Liu, XQ (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Qiao, WT (corresponding author), Nankai Univ, Coll Life Sci, Key Lab Mol Microbiol & Technol, Minist Educ, Tianjin 300071, Peoples R China.	wentaoqiao@nankai.edu.cn; liu2008@nankai.edu.cn	Ma, Jing/GQH-0676-2022; Zheng, Yong-Hui/AAP-4492-2021; zhang, xian/GYA-0290-2022	Ma, Jing/0000-0002-8096-4832; Zheng, Yong-Hui/0000-0002-1098-7385; Wang, Xiaojun/0000-0003-4521-4099	National Key Project on Major Infectious Diseases from the Ministry of Science and Technology [2012ZX10001008, 2012ZX10001-006]; National Natural Science Foundation of China [31370925, 31640024]	National Key Project on Major Infectious Diseases from the Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Project on Major Infectious Diseases from the Ministry of Science and Technology Grants 2012ZX10001008 and 2012ZX10001-006 and National Natural Science Foundation of China Grants 31370925 and 31640024. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambrosi E, 2011, BIOCHEM J, V438, P291, DOI 10.1042/BJ20110257; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Bregnard C, 2013, J VIROL, V87, P3729, DOI 10.1128/JVI.02477-12; Caillat C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9781; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Finzi A, 2013, CELL MICROBIOL, V15, P809, DOI 10.1111/cmi.12074; Furuta RA, 2006, MICROBES INFECT, V8, P520, DOI 10.1016/j.micinf.2005.08.004; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Harila K, 2006, J VIROL, V80, P3765, DOI 10.1128/JVI.80.8.3765-3772.2006; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Hurley JH, 2015, EMBO J, V34, P2398, DOI 10.15252/embj.201592484; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Inuzuka T, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-25; Jang IK, 2002, MOL CELL BIOL, V22, P4094, DOI 10.1128/MCB.22.12.4094-4100.2002; Jia J, 2001, STRUCTURE, V9, P267, DOI 10.1016/S0969-2126(01)00585-8; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Katoh K, 2005, BIOCHEM J, V391, P677, DOI 10.1042/BJ20050398; Krebs J, 2000, BBA-MOL CELL RES, V1498, P153, DOI 10.1016/S0167-4889(00)00091-4; la Cour JM, 2003, AM J PATHOL, V163, P81, DOI 10.1016/S0002-9440(10)63632-2; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; la Cour JM, 2008, MOL ONCOL, V1, P431, DOI 10.1016/j.molonc.2007.08.002; Lacana E, 1997, J IMMUNOL, V158, P5129; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Liu XY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002373; Maki M, 2012, FEBS J, V279, P1414, DOI 10.1111/j.1742-4658.2012.08560.x; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Martin-Serrano J, 2007, CELL HOST MICROBE, V1, P5, DOI 10.1016/j.chom.2007.02.006; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Okumura M, 2009, BIOCHEM BIOPH RES CO, V386, P237, DOI 10.1016/j.bbrc.2009.06.015; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peel S, 2011, TRENDS BIOCHEM SCI, V36, P199, DOI 10.1016/j.tibs.2010.09.004; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Lopez-Huertas MR, 2013, J BIOL CHEM, V288, P7626, DOI 10.1074/jbc.M112.408294; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Su D, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-31; Subramanian L, 2004, BIOCHEMISTRY-US, V43, P11175, DOI 10.1021/bi048848d; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Suzuki K, 2012, CANCER SCI, V103, P1788, DOI 10.1111/j.1349-7006.2012.02362.x; Szigeti A, 2006, FEBS LETT, V580, P6447, DOI 10.1016/j.febslet.2006.10.067; Szigeti A, 2010, J BIOL CHEM, V285, P2140, DOI 10.1074/jbc.M109.015222; Takahashi T, 2015, INT J MOL SCI, V16, P3677, DOI 10.3390/ijms16023677; Takahashi T, 2012, INT J MOL SCI, V13, P7532, DOI 10.3390/ijms13067532; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Vlach J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00232; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zylka MJ, 1999, MOL BRAIN RES, V74, P175, DOI 10.1016/S0169-328X(99)00277-6	59	17	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26670	26685		10.1074/jbc.M116.752444	http://dx.doi.org/10.1074/jbc.M116.752444			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27784779	hybrid, Green Published			2022-12-26	WOS:000391571400008
J	Canonico, B; Cesarini, E; Salucci, S; Luchetti, F; Falcieri, E; Di Sario, G; Palma, F; Papa, S				Canonico, Barbara; Cesarini, Erica; Salucci, Sara; Luchetti, Francesca; Falcieri, Elisabetta; Di Sario, Gianna; Palma, Fulvio; Papa, Stefano			Defective Autophagy, Mitochondrial Clearance and Lipophagy in Niemann-Pick Type B Lymphocytes	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISORDERS; CELL-DEATH; MONITORING AUTOPHAGY; NEURODEGENERATIVE DISEASES; PERMEABILITY TRANSITION; BINDING PARTNER; RAT HEPATOCYTES; LIPID DROPLETS; NERVOUS-SYSTEM; SELF-DIGESTION	Niemann-Pick disease type A (NP-A) and type B (NP-B) are lysosomal storage diseases (LSDs) caused by sphingomyelin accumulation in lysosomes relying on reduced or absent acid sphingomyelinase. A considerable body of evidence suggests that lysosomal storage in many LSD impairs autophagy, resulting in the accumulation of poly-ubiquitinated proteins and dysfunctional mitochondria, ultimately leading to cell death. Here we test this hypothesis in a cellular model of Niemann-Pick disease type B, in which autophagy has never been studied. The basal autophagic pathway was first examined in order to evaluate its functionality using several autophagy-modulating substances such as rapamycin and nocodazole. We found that human NP-B B lymphocytes display considerable alteration in their autophagic vacuole accumulation and mitochondrial fragmentation, as well as mitophagy induction (for damaged mitochondria clearance). Furthermore, lipid traceability of intra and extra-cellular environments shows lipid accumulation in NP-B B lymphocytes and also reveals their peculiar trafficking/management, culminating in lipid microparticle extrusion (by lysosomal exocytosis mechanisms) or lipophagy. All of these features point to the presence of a deep autophagy/mitophagy alteration revealing autophagic stress and defective mitochondrial clearance. Hence, rapamycin might be used to regulate autophagy/ mitophagy (at least in part) and to contribute to the clearance of lysosomal aberrant lipid storage.	[Canonico, Barbara; Cesarini, Erica; Salucci, Sara; Luchetti, Francesca; Falcieri, Elisabetta; Di Sario, Gianna; Palma, Fulvio; Papa, Stefano] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Falcieri, Elisabetta] CNR, Rizzoli Orthopaed Inst, IGM, Bologna, Italy; [Falcieri, Elisabetta] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy	University of Urbino; Consiglio Nazionale delle Ricerche (CNR); IRCCS Istituto Ortopedico Rizzoli; University of Urbino	Canonico, B (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy.			Canonico, Barbara/0000-0003-3383-715X	Niemann-Pick ONLUS Italian Association	Niemann-Pick ONLUS Italian Association	This study was supported by the Niemann-Pick ONLUS Italian Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2014, BIOCHEMISTRY-MOSCOW+, V79, P619, DOI 10.1134/S0006297914070049; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Barbosa AD, 2015, CURR OPIN CELL BIOL, V35, P91, DOI 10.1016/j.ceb.2015.04.017; BLANCHETTEMACKIE EJ, 1983, J LIPID RES, V24, P229; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Canonico B, 2014, APOPTOSIS, V19, P1225, DOI 10.1007/s10495-014-1005-0; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Corcelle-Termeau E, 2016, AUTOPHAGY, V12, P833, DOI 10.1080/15548627.2016.1159378; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Diaz G, 2008, MICRON, V39, P819, DOI 10.1016/j.micron.2008.01.001; Disatnik MH, 2015, J MOL MED, V93, P279, DOI 10.1007/s00109-015-1256-4; Dolman Nick J, 2013, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1230s65; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; FP, 2006, J MICROSC-OXFORD, V224, P213, DOI [10.1111/j.1365-2818.2006.01706.x, DOI 10.1111/J.1365-2818.2006.01706.X]; Gabande-Rodriguez E, 2014, CELL DEATH DIFFER, V21, P864, DOI 10.1038/cdd.2014.4; Galluzzi L, 2008, BIOCHEM SOC T, V36, P786, DOI 10.1042/BST0360786; Gerasimenko JV, 2001, CURR BIOL, V11, pR971, DOI 10.1016/S0960-9822(01)00577-2; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Heath-Engel HM, 2006, BBA-MOL CELL RES, V1763, P549, DOI 10.1016/j.bbamcr.2006.02.006; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim I, 2011, AM J PHYSIOL-CELL PH, V300, pC308, DOI 10.1152/ajpcell.00056.2010; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lee SJ, 2013, ADV METEOROL, V2013, DOI 10.1155/2013/381630; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Lemasters JJ, 1999, AM J PHYSIOL-GASTR L, V276, pG1, DOI 10.1152/ajpgi.1999.276.1.G1; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lieberman AP, 2012, AUTOPHAGY, V8, P719, DOI 10.4161/auto.19469; Luchetti F, 2007, TOXICOL IN VITRO, V21, P293, DOI 10.1016/j.tiv.2006.08.003; Luchetti F, 2009, FREE RADICAL BIO MED, V46, P339, DOI 10.1016/j.freeradbiomed.2008.09.017; Luchetti F, 2015, STEROIDS, V99, P204, DOI 10.1016/j.steroids.2015.02.008; Luchetti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035766; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mauro-Lizcano M, 2015, AUTOPHAGY, V11, P833, DOI 10.1080/15548627.2015.1034403; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Meyer W, 2009, J MICROSC-OXFORD, V233, P5, DOI 10.1111/j.1365-2818.2008.03089.x; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mochizuki I, 2011, MITOCHONDRION, V11, P601, DOI 10.1016/j.mito.2011.03.009; Munafo DB, 2001, J CELL SCI, V114, P3619; Nikoletopoulou V, 2015, CELL DEATH DIFFER, V22, P398, DOI 10.1038/cdd.2014.204; Oh M, 2008, BIOCHEM BIOPH RES CO, V369, P1179, DOI 10.1016/j.bbrc.2008.03.019; Ordonez MP, 2012, HUM MOL GENET, V21, P2651, DOI 10.1093/hmg/dds090; Paglin S, 2001, CANCER RES, V61, P439; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Raben N, 2009, METHOD ENZYMOL, V453, P417, DOI 10.1016/S0076-6879(08)04021-4; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Rodriguez-Enriquez S, 2009, AUTOPHAGY, V5, P1099, DOI 10.4161/auto.5.8.9825; Roy D, 2004, SCIENCE, V304, P1515, DOI 10.1126/science.1098371; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Salucci S, 2015, J DERMATOL SCI, V80, P61, DOI 10.1016/j.jdermsci.2015.07.002; Salucci S, 2013, HISTOL HISTOPATHOL, V28, P1073, DOI 10.14670/HH-28.1073; Salucci S, 2010, MICRON, V41, P966, DOI 10.1016/j.micron.2010.07.002; Samie MA, 2014, J LIPID RES, V55, P995, DOI 10.1194/jlr.R046896; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schuchman EH, 2001, METABOLIC MOL BASES, V3, P3589; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Soubannier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052830; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Zamai L, 2004, APOPTOSIS, V9, P235, DOI 10.1023/B:APPT.0000018805.63663.a5; Zhang LS, 2009, ACTA BIOCH BIOPH SIN, V41, P437, DOI 10.1093/abbs/gmp031; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	84	30	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165780	10.1371/journal.pone.0165780	http://dx.doi.org/10.1371/journal.pone.0165780			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798705	gold, Green Published, Green Submitted			2022-12-26	WOS:000386711100067
J	Zeng, HW; Wen, FQ; Huang, WX; Gan, YG; Zeng, WB; Chen, RR; He, YX; Wang, YK; Liu, ZY; Liang, CH; Wong, KKL				Zeng, Hongwu; Wen, Feiqiu; Huang, Wenxian; Gan, Yungen; Zeng, Weibin; Chen, Ranran; He, Yanxia; Wang, Yonker; Liu, Zaiyi; Liang, Changhong; Wong, Kelvin K. L.			New Findings, Classification and Long-Term Follow-Up Study Based on MRI Characterization of Brainstem Encephalitis Induced by Enterovirus 71	PLOS ONE			English	Article							FOOT-MOUTH DISEASE; NEUROLOGIC COMPLICATIONS; RISK-FACTORS; INFECTION; CHILDREN; TAIWAN; HAND; ENCEPHALOMYELITIS; EPIDEMIC; OUTBREAK	Background To report the diversity of MRI features of brainstem encephalitis (BE) induced by Enterovirus 71. This is supported by implementation and testing of our new classification scheme in order to improve the diagnostic level on this specific disease. Methods Neuroimaging of 91 pediatric patients who got EV71 related BE were hospitalized between March, 2010 to October, 2012, were analyzed retrospectively. All patients underwent pre- and post-contrast MRI scan. Thereafter, 31 patients were randomly called back for follow-up MRI study during December 2013 to August 2014. The MRI signal patterns of BE primary lesion were analyzed and classified according to MR signal alteration at various disease stages. Findings in fatal and non-fatal cases were compared, and according to the MRI scan time point during the course of this disease, the patients' conditions were classified as 1) acute stage, 2) convalescence stage, 3) post mortem stage, and 4) long term follow-up study. Results 103 patients were identified. 11 patients did not undergo MRI, as they died within 48 hours. One patient died on 14 th day without MR imaging. 2 patients had postmortem MRI. Medical records and imaging were reviewed in the 91 patients, aged 4 months to 12 years, and two cadavers who have had MRI scan. At acute stage: the most frequent pattern (40 patients) was foci of prolonged T1 and T2 signal, with (15) or without (25) contrast enhancement. We observed a novel pattern in 4 patients having foci of low signal intensity on T2WI, with contrast enhancement. Another pattern in 10 patients having foci of contrast enhancement without abnormalities in T1WI or T2WI weighted images. Based on 2 cases, the entire medulla and pons had prolonged T1 and T2 signal, and 2 of our postmortem cases demonstrated the same pattern. At convalescence stage, the pattern observed in 4 patients was foci of prolonged T1 and T2 signal without contrast enhancement. Follow-up MR study of 31 cases showed normal in 26 cases, and demonstrated foci of prolonged T1 and T2 signal with hyper-intensity on FLAIR in 3 cases, or of prolonged T1 and T2 signal with hypo-intensity on FLAIR in 2 cases. Most importantly, MR findings of each case were thoroughly investigated and classified according to phases and MRI signal alteration. Conclusions This study has provided enhanced and useful information for the MRI features of BE induced by EV71, apart from common practice established by previous reports. In addition, a classification scheme that summarizes all types of features based on the MRI signal at the four different stages of the disease would be helpful to improve the diagnostic level.	[Zeng, Hongwu; Wen, Feiqiu; Huang, Wenxian; Gan, Yungen; Zeng, Weibin; Chen, Ranran; He, Yanxia] Shenzhen Childrens Hosp, Radiol Neurol & Pediat Intens Care Unit Dept, Shenzhen, Guangdong, Peoples R China; [Zeng, Hongwu; Liu, Zaiyi; Liang, Changhong] Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Zeng, Hongwu; Liang, Changhong] Southern Med Univ, Sch Med, Guangzhou, Guangdong, Peoples R China; [Wang, Yonker] Univ Kentucky, Coll Med, Dept Radiol, Lexington, KY USA; [Wong, Kelvin K. L.] Univ Western Sydney, Sch Med, Penrith, NSW 1797, Australia	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; University of Kentucky; Western Sydney University	Liang, CH (corresponding author), Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China.; Liang, CH (corresponding author), Southern Med Univ, Sch Med, Guangzhou, Guangdong, Peoples R China.	cjr.lchh@vip.163.com	Wong, Kelvin Kian Loong/ABA-3915-2021; Zeng, Hongwu/F-2572-2017; Wong, Kelvin/AAL-8636-2021; Liang, Chang Hong/L-1885-2016	Wong, Kelvin Kian Loong/0000-0002-8600-1105; Zeng, Hongwu/0000-0002-7832-3702; 	Science, Technology and Innovation Grant of Shenzhen Municipality [JCYJ20140416141331532]	Science, Technology and Innovation Grant of Shenzhen Municipality	This project was supported by Science, Technology and Innovation Grant of Shenzhen Municipality (No. JCYJ20140416141331532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Shenzhen Children's Hospital for the use of magnetic resonance imaging scanner and assistance in scanning the subject used in this research. This project was supported by Science, Technology and Innovation Grant of Shenzhen Municipality (No. JCYJ20140416141331532). We deeply appreciate the 42nd President of the American Society of Neuroradiology, Dr. Victor M Haughton, who is based in Department of Radiology, University of Wisconsin Madison, for his advice and contribution to this work.	Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; He Yan-xia, 2009, Zhonghua Er Ke Za Zhi, V47, P338; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsueh C, 2000, MODERN PATHOL, V13, P1200, DOI 10.1038/modpathol.3880222; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Jang S, 2012, NEURORADIOLOGY, V54, P239, DOI 10.1007/s00234-011-0921-8; Kim SJ, 2013, J KOREAN MED SCI, V28, P120, DOI 10.3346/jkms.2013.28.1.120; Lee KY, 2014, J CLIN NEUROSCI, V21, P416, DOI 10.1016/j.jocn.2013.04.032; Li JJ, 2012, INT J NEUROSCI, V122, P338, DOI 10.3109/00207454.2012.657379; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087603; Liu Kun, 2012, Zhonghua Yi Xue Za Zhi, V92, P1742; Lu Min, 2009, Chinese Journal of Pathology, V38, P81, DOI 10.3760/cma.j.issn.0529-5807.2009.02.004; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Shen WC, 1999, AM J NEURORADIOL, V20, P1889; Wang SM, 2014, EXPERT REV ANTI-INFE, V12, P447, DOI 10.1586/14787210.2014.895666; Wei Dan, 2010, Zhonghua Er Ke Za Zhi, V48, P220; Zeng HW, 2012, NEURORADIOLOGY, V54, P623, DOI 10.1007/s00234-011-0979-3	17	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0162877	10.1371/journal.pone.0162877	http://dx.doi.org/10.1371/journal.pone.0162877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798639	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100001
J	Furtauer, S; Flandorfer, H				Fuertauer, Siegfried; Flandorfer, Hans			The Cu-Li-Sn Phase Diagram: Isopleths, Liquidus Projection and Reaction Scheme	PLOS ONE			English	Article							THERMODYNAMIC ASSESSMENT; LITHIUM; LITHIATION; ENTHALPY; SYSTEM	The Cu-Li-Sn phase diagram was constructed based on XRD and DTA data of 60 different alloy compositions. Eight ternary phases and 14 binary solid phases form 44 invariant ternary reactions, which are illustrated by a Scheil-Schulz reaction scheme and a liquidus projection. Phase equilibria as a function of concentration and temperature are shown along nine isopleths. This report together with an earlier publication of our group provides for the first time comprehensive investigations of phase equilibria and respective phase diagrams. Most of the phase equilibria could be established based on our experimental results. Only in the Li-rich part where many binary and ternary compounds are present estimations had to be done which are all indicated by dashed lines. A stable ternary miscibility gap could be found which was predicted by modelling the liquid ternary phase in a recent work. The phase diagrams are a crucial input for material databases and thermodynamic optimizations regarding new anode materials for high-power Li-ion batteries.	[Fuertauer, Siegfried; Flandorfer, Hans] Univ Vienna, Inst Inorgan Chem Funct Mat, Wahringerstr 42, A-1090 Vienna, Austria	University of Vienna	Furtauer, S (corresponding author), Univ Vienna, Inst Inorgan Chem Funct Mat, Wahringerstr 42, A-1090 Vienna, Austria.	siegfried.fuertauer@univie.ac.at	; Flandorfer, Hans/A-8383-2014	Furtauer, Siegfried/0000-0001-8939-3661; Flandorfer, Hans/0000-0002-9692-2119	Austrian Science Fund (FWF) part of the DFG Priority Program SPP 1473 "WeNDeLIB" [I559-N19]	Austrian Science Fund (FWF) part of the DFG Priority Program SPP 1473 "WeNDeLIB"(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (FWF) under the project I559-N19, which was part of the DFG Priority Program SPP 1473 "WeNDeLIB".	Bochvar N, 2007, C CU FE TERNARY PHAS; Bochvar N, 1992, AL CU SN TERNARY PHA; Calisto, 2011, CAL PROC; Choi W, 2004, ELECTROCHEM COMMUN, V6, P816, DOI 10.1016/j.elecom.2004.05.018; Flandorfer H, 2007, THERMOCHIM ACTA, V459, P34, DOI 10.1016/j.tca.2007.04.004; Furtauer S, 2016, J ALLOY COMPD, V682, P713, DOI 10.1016/j.jallcom.2016.04.247; Furtauer S, 2013, J CHEM THERMODYN, V61, P105, DOI 10.1016/j.jct.2013.01.030; Furtauer S, 2013, INTERMETALLICS, V34, P142, DOI 10.1016/j.intermet.2012.10.004; Furtauer S, 2016, Z KRIST-CRYST MATER, V231, P79, DOI 10.1515/zkri-2015-1884; Furtauer S, 2015, Z KRIST-CRYST MATER, V230, P97, DOI 10.1515/zkri-2014-1778; Furtauer S, 2014, J SOLID STATE CHEM, V220, P198, DOI 10.1016/j.jssc.2014.08.006; Gasior W, 2009, CALPHAD, V33, P215, DOI 10.1016/j.calphad.2008.10.006; Grobner J, 2005, JOM-US, V57, P19, DOI 10.1007/s11837-005-0110-5; Jansen AN, 2011, J ALLOY COMPD, V509, P4457, DOI 10.1016/j.jallcom.2011.01.111; Kepler KD, 1999, ELECTROCHEM SOLID ST, V2, P307, DOI 10.1149/1.1390819; Li D, 2016, CALPHAD, V53, P105, DOI 10.1016/j.calphad.2016.04.003; Li D, 2014, CALPHAD, V47, P181, DOI 10.1016/j.calphad.2014.09.002; Li D, 2013, INTERMETALLICS, V34, P148, DOI 10.1016/j.intermet.2012.10.010; Palatnik L.S., 1964, PHASE EQUILIBRIA MUL; Pelton A.D., 1986, B PHASE DIAG, V7, P142, DOI DOI 10.1007/BF02881552; Proteus, 2011, NETZSCH PROT SOFTW T; Sangster J, 1998, J PHASE EQUILIB, V19, P70, DOI 10.1007/s11669-006-5008-6; Saunders N., 1990, B ALLOY PHASE DIAGR, V11, P278, DOI [10.1007/BF03029299, DOI 10.1007/BF03029299]; Seifert HJ, 2015, MAT NEW DESIGN IMPRO; Sharma S, 2003, J ELECTROCHEM SOC, V150, pA330, DOI 10.1149/1.1544634; Spencer PJ, 2008, CALPHAD, V32, P1, DOI 10.1016/j.calphad.2007.10.001; Turchanin M, 2007, CU FE BINARY PHASE D; WEN CJ, 1981, J ELECTROCHEM SOC, V128, P1181, DOI 10.1149/1.2127590; Winter F, 2013, Z ANORG ALLG CHEM, V639, P2790, DOI 10.1002/zaac.201300220	29	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165058	10.1371/journal.pone.0165058	http://dx.doi.org/10.1371/journal.pone.0165058			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788175	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900041
J	Kilci, O; Un, C; Sacan, O; Gamli, M; Baskan, S; Baydar, M; Ozkurt, B				Kilci, Oya; Un, Canan; Sacan, Ozlem; Gamli, Mehmet; Baskan, Semih; Baydar, Mustafa; Ozkurt, Bulent			Postoperative Mortality after Hip Fracture Surgery: A 3 Years Follow Up	PLOS ONE			English	Article							PERIOPERATIVE MORTALITY; ELDERLY-PATIENTS; RISK-FACTORS; COMPLICATIONS; ANESTHESIA; LENGTH; TRENDS; STAY	Background and Aims To determine mortality rates and predisposing factors in patients operated for a hip fracture in a 3-year follow-up period. Methods The study included patients who underwent primary surgery for a hip fracture. The inclusion criteria were traumatic, non-traumatic, osteoporotic and pathological hip fractures requiring surgery in all age groups and both genders. Patients with periprosthetic fractures or previous contralateral hip fracture surgery and patients who could not be contacted by telephone were excluded. At 36 months after surgery, evaluation was made using a structured telephone interview and a detailed examination of the hospital medical records, especially the documents written during anesthesia by the anesthesiologists and the documents written at the time of follow-up visits by the orthopaedic surgeons. A total of 124 cases were analyzed and 4 patients were excluded due to exclusion criteria. The collected data included demographics, type of fracture, co-morbidities, American Society of Anesthesiologists (ASA) scores, anesthesia techniques, operation type (intramedullary nailing or arthroplasty; cemented-noncemented), peroperative complications, refracture during the follow-up period, survival period and mortality causes. Results The total 120 patients evaluated comprised 74 females(61.7%) and 46 males (38.3%) with a mean age of 76.9 +/- 12.8 years (range 23-95 years). The ASA scores were ASA I (0.8%), ASA II (21.7%), ASA III (53.3%) and ASA IV (24.2%). Mortality was seen in 44 patients (36.7%) and 76 patients (63.3%) survived during the 36-month follow-up period. Of the surviving patients, 59.1% were female and 40.9% were male. The survival period ranged between 1-1190 days. The cumulative mortality rate in the first, second and third years were 29.17%, 33.33% and 36.67% respectively. The factors associated with mortality were determined as increasing age, high ASA score, coronary artery disease, congestive heart failure, Alzheimer's disease, Parkinson's disease, malignancycementation and peroperative complications such as hypotension (p<0.05). Mortality was highest in the first month after fracture. Conclusion The results of this study showed higher mortality rates in patients with high ASA scores due to associated co-morbidities such as congestive heart failure, malignancy and Alzheimer's disease or Parkinson's disease. The use of cemented prosthesis was also seen to significantly increase mortality whereas no effect was seen from the anesthesia technique used. Treatment of these patients with a multidiciplinary approach in an orthogeriatric ward is essential. There is a need for further studies concerning cemented vs. uncemented implant use and identification of the best anesthesia technique to decrease mortality rates in these patients.	[Kilci, Oya; Un, Canan; Sacan, Ozlem; Gamli, Mehmet; Baskan, Semih; Baydar, Mustafa] Ankara Numune Training & Res Hosp, Dept Anesthesiol & Reanimat, Ankara, Turkey; [Ozkurt, Bulent] Ankara Numune Training & Res Hosp, Dept Orthoped & Traumatol, Ankara, Turkey	Ankara Numune Training & Research Hospital; Ankara Numune Training & Research Hospital	Kilci, O (corresponding author), Ankara Numune Training & Res Hosp, Dept Anesthesiol & Reanimat, Ankara, Turkey.	oyakilci@gmail.com	KILCI, OYA/AAA-2554-2022; başkan, semih/AAC-6252-2019	başkan, semih/0000-0003-0096-7097; Baydar, Mustafa/0000-0002-9333-7213				Barnett S. R., 2009, FREQUEQNTLY ASKED QU; Bilsel Kerem, 2013, Eur J Orthop Surg Traumatol, V23, P895, DOI 10.1007/s00590-012-1104-y; Chatterton BD, 2015, BONE JOINT J, V97B, P246, DOI 10.1302/0301-620X.97B2.35248; Clague JE, 2002, INJURY, V33, P1, DOI 10.1016/S0020-1383(01)00142-5; Eneroth M, 2006, CLIN ORTHOP RELAT R, P212, DOI 10.1097/01.blo.0000224054.86625.06; Giversen IM, 2007, OSTEOPOROSIS INT, V18, P721, DOI 10.1007/s00198-006-0300-1; Gonzalez-Rozas M, 2012, AGING CLIN EXP RES, V24, P181; Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736; Hasegawa Y, 2007, J ORTHOP SCI, V12, P113, DOI 10.1007/s00776-006-1097-7; Heidari SM, 2011, J RES MED SCI, V16, P323; Hosmer DW, 1999, WILEY PS TX; Hossain M, 2012, INJURY, V43, P2161, DOI 10.1016/j.injury.2012.08.043; Kannus P, 2005, ANN MED, V37, P303, DOI 10.1080/07853890510007197; Karagiannis A, 2006, CALCIFIED TISSUE INT, V78, P72, DOI 10.1007/s00223-005-0169-6; Koc M, 2014, TURK J ANAESTHESIOL, V42, P133, DOI 10.5152/TJAR.2014.07108; Kopp L, 2009, ACTA CHIR ORTHOP TR, V76, P41; Kurma V. P., 2008, SAARC J ANESTH, V1, P39; Liu SS, 2009, INT ORTHOP, V33, P643, DOI 10.1007/s00264-008-0549-4; Meyer HE, 2000, OSTEOPOROSIS INT, V11, P228, DOI 10.1007/s001980050285; Panula J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-105; Rix Thomas E, 2007, World J Emerg Surg, V2, P16, DOI 10.1186/1749-7922-2-16; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Sepah YJ, 2010, INT ORTHOP, V34, P431, DOI 10.1007/s00264-009-0803-4; Talsnes O, 2013, INT ORTHOP, V37, P1135, DOI 10.1007/s00264-013-1851-3; Urwin SC, 2000, BRIT J ANAESTH, V84, P450, DOI 10.1093/oxfordjournals.bja.a013468; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Vidan M, 2005, J AM GERIATR SOC, V53, P1476, DOI 10.1111/j.1532-5415.2005.53466.x; Wagner P, 2012, GERIATR ORTHOP SURG, V3, P55, DOI 10.1177/2151458512450708; White SM, 2014, ANAESTHESIA, V69, P224, DOI 10.1111/anae.12542; Zakriya KJ, 2002, ANESTH ANALG, V94, P1628, DOI 10.1097/00000539-200206000-00050	30	46	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0162097	10.1371/journal.pone.0162097	http://dx.doi.org/10.1371/journal.pone.0162097			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788137	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900002
J	Makovac, E; Cercignani, M; Serra, L; Torso, M; Spano, B; Petrucci, S; Ricciardi, L; Ginevrino, M; Caltagirone, C; Bentivoglio, AR; Valente, EM; Bozzali, M				Makovac, Elena; Cercignani, Mara; Serra, Laura; Torso, Mario; Spano, Barbara; Petrucci, Simona; Ricciardi, Lucia; Ginevrino, Monia; Caltagirone, Carlo; Bentivoglio, Anna Rita; Valente, Enza Maria; Bozzali, Marco			Brain Connectivity Changes in Autosomal Recessive Parkinson Disease: A Model for the Sporadic Form	PLoS One			English	Article							MONTREAL COGNITIVE ASSESSMENT; NETWORK CONNECTIVITY; FUNCTIONAL NETWORKS; NORMATIVE DATA; PINK1; REORGANIZATION; VARIABILITY; IMPAIRMENT; MUTATIONS; LEVODOPA	Biallelic genetic mutations in the Park2 and PINK1 genes are frequent causes of autosomal recessive PD. Carriers of single heterozygous mutations may manifest subtle signs of disease, thus providing a unique model of preclinical PD. One emerging hypothesis suggests that non-motor symptom of PD, such as cognitive impairment may be due to a distributed functional disruption of various neuronal circuits. Using resting-state functional MRI (RS-fMRI), we tested the hypothesis that abnormal connectivity within and between brain networks may account for the patients' cognitive status. Eight homozygous and 12 heterozygous carriers of either PINK1 or Park2 mutation and 22 healthy controls underwent RS-fMRI and cognitive assessment. RS-fMRI data underwent independent component analysis to identify five networks of interest: default-mode network, salience network, executive network, right and left fronto-parietal networks. Functional connectivity within and between each network was assessed and compared between groups. All mutation carriers were cognitively impaired, with the homozygous group reporting a more prominent impairment in visuo-spatial working memory. Changes in functional connectivity were evident within all networks between homozygous carriers and controls. Also heterozygotes reported areas of reduced connectivity when compared to controls within two networks. Additionally, increased inter-network connectivity was observed in both groups of mutation carriers, which correlated with their spatial working memory performance, and could thus be interpreted as compensatory. We conclude that both homozygous and heterozygous carriers exhibit pathophysiological changes unveiled by RS-fMRI, which can account for the presence/ severity of cognitive symptoms.	[Makovac, Elena; Serra, Laura; Torso, Mario; Spano, Barbara; Bozzali, Marco] IRCCS Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy; [Cercignani, Mara] Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Brighton, E Sussex, England; [Petrucci, Simona; Ginevrino, Monia; Valente, Enza Maria] IRCCS Casa Sollievo Sofferenza, CSS Mendel Lab, San Giovanni Rotondo, Italy; [Petrucci, Simona] Univ Roma La Sapienza, Dept Neurol & Psychiat, Rome, Italy; [Ricciardi, Lucia] UCL, Sobell Dept Motor Neurosci & Movement Disorders, Inst Neurol, London, England; [Caltagirone, Carlo] IRCCS Santa Lucia Fdn, Dept Clin & Behav Neurol, Rome, Italy; [Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Bentivoglio, Anna Rita] Catholic Univ, Dept Neurosci, Rome, Italy; [Valente, Enza Maria] Univ Salerno, Dept Med & Surg, Sect Neurosci, Salerno, Italy	IRCCS Santa Lucia; University of Brighton; University of Sussex; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome; University of London; University College London; IRCCS Santa Lucia; University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Salerno	Bozzali, M (corresponding author), IRCCS Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy.	m.bozzali@hsantalucia.it	Bozzali, Marco/AAC-1031-2022; Ginevrino, Monia/AAB-6826-2022; Ginevrino, Monia/K-2171-2018; Valente, Enza Maria/G-2942-2017; Spano', Barbara/AAG-1671-2021; Bentivoglio, Anna Rita/K-3752-2018; Torso, Mario/ADO-3442-2022	Ginevrino, Monia/0000-0002-2782-6369; Ginevrino, Monia/0000-0002-2782-6369; Valente, Enza Maria/0000-0002-0600-6820; Spano', Barbara/0000-0002-5291-0984; Torso, Mario/0000-0002-5284-9167; Bozzali, Marco/0000-0002-0568-2026; Bentivoglio, Anna Rita/0000-0002-9663-095X; Cercignani, Mara/0000-0002-4550-2456	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grants of the Italian Ministry of Health (Ricerca Corrente 2015 to MB and to EMV).	[Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; Baggio HC, 2014, HUM BRAIN MAPP, V35, P4620, DOI 10.1002/hbm.22499; Benbunan BR, 2004, J NEURAL TRANSM, V111, P47, DOI 10.1007/s00702-003-0079-6; Borroni B, 2012, NEUROBIOL AGING, V33, P2506, DOI 10.1016/j.neurobiolaging.2011.10.031; Brun L, 2014, CLIN NEUROL NEUROSUR, V127, P93, DOI 10.1016/j.clineuro.2014.10.006; Buhmann C, 2005, BRAIN, V128, P2281, DOI 10.1093/brain/awh572; Caccappolo E, 2011, J INT NEUROPSYCH SOC, V17, P91, DOI 10.1017/S1355617710001190; Carlesimo G., 2002, NUOVA RIV NEUROL, V12, P1, DOI DOI 10.1080/17408989.2016.1268591; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Esposito F, 2013, BRAIN, V136, P710, DOI 10.1093/brain/awt007; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Goetz CG, 2010, MOVEMENT DISORD, V25, P1190, DOI 10.1002/mds.23096; Golden C.J., 1978, STROOP COLOR WORD TE; Gorges M, 2015, NEUROBIOL AGING, V36, P1727, DOI 10.1016/j.neurobiolaging.2014.12.026; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kandiah N, 2014, PARKINSONISM RELAT D, V20, P1145, DOI 10.1016/j.parkreldis.2014.08.002; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Khan NL, 2002, ANN NEUROL, V52, P849, DOI 10.1002/ana.10417; Klein C, 2007, LANCET NEUROL, V6, P652, DOI 10.1016/S1474-4422(07)70174-6; Krajcovicova L, 2012, J NEURAL TRANSM, V119, P443, DOI 10.1007/s00702-011-0723-5; Lee EY, 2010, BRAIN, V133, P2677, DOI 10.1093/brain/awq197; Lohmann E, 2009, NEUROLOGY, V72, P110, DOI 10.1212/01.wnl.0000327098.86861.d4; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Perfetti B, 2010, PARKINSONISM RELAT D, V16, P46, DOI 10.1016/j.parkreldis.2009.07.011; Petrucci S, 2014, CURRENT MOL IN PERSS; Rektorova I, 2012, NEURODEGENER DIS, V10, P232, DOI 10.1159/000334765; Ricciardi L, 2014, MOVEMENT DISORD, V29, P1561, DOI 10.1002/mds.25994; Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004; Tahmasian M, 2015, CORTEX, V73, P80, DOI 10.1016/j.cortex.2015.08.005; Tessitore A, 2012, NEUROLOGY, V79, P2226, DOI 10.1212/WNL.0b013e31827689d6; van Nuenen BFL, 2009, NEUROLOGY, V72, P1041, DOI 10.1212/01.wnl.0000338699.56379.11; Xu JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087078; Xu JS, 2013, NEUROIMAGE, V79, P62, DOI 10.1016/j.neuroimage.2013.04.038	42	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0163980	10.1371/journal.pone.0163980	http://dx.doi.org/10.1371/journal.pone.0163980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788143	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000389604900011
J	Stalder, G; Que, YA; Calzavarini, S; Burnier, L; Kosinski, C; Ballabeni, P; Roger, T; Calandra, T; Duchosal, MA; Liaudet, L; Eggimann, P; Angelillo-Scherrer, A				Stalder, Gregoire; Que, Yok Ai; Calzavarini, Sara; Burnier, Laurent; Kosinski, Christophe; Ballabeni, Pierluigi; Roger, Thierry; Calandra, Thierry; Duchosal, Michel A.; Liaudet, Lucas; Eggimann, Philippe; Angelillo-Scherrer, Anne			Study of Early Elevated Gas6 Plasma Level as a Predictor of Mortality in a Prospective Cohort of Patients with Sepsis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE UNITS; GROWTH-ARREST; PROTEIN-S; BIOMARKERS; INHIBITION; RECEPTORS; LIGAND; TISSUE; CELLS	Background Growth arrest-specific gene 6 (Gas6), a vitamin K-dependent protein interacting with anionic phospholipids and TAM tyrosine kinase receptors, is elevated in plasma of septic patients. Previous studies did not find different levels between survivors and non-survivors at admission because either they included a low number of patients (<50) or a low number of non-survivors (5%). Objectives To determine, in a larger cohort of septic patients comprising an expected number of non-survivors, the performance of the plasma level of Gas6 and its soluble receptor Axl (sAxl) within 24 hours of admission to predict in-ICU mortality. Patients Septic adults with or without shock. Methods Gas6 and sAxl were prospectively measured by ELISA at day 0, 3, 7, and then weekly until discharge or death. Results We evaluated 129 septic patients, including 82 with and 47 without shock, with in-ICU mortality rate of 19.4% and in-hospital mortality rate of 26%. Gas6 level was higher in non-survivors than in survivors (238 vs. 167%, P = 0.003); this difference remained constant during the ICU stay. The area under the ROC curve for Gas6 (0.695 [95% CI: 0.58-0.81]) was higher than for sAxl, procalcitonin, CRP, IL-1beta, IL-6 and-alpha, and slightly higher than for IL-8, IL-10, SOFA and APACHEII scores in predicting in-ICU mortality. Considering 249% as a cut-off value, Gas6 measurement had a negative predictive value for mortality of 87%. Conclusion It seems that Gas6 plasma level within 24 hours of ICU admission may predicts in-ICU mortality in patients with sepsis. If our result are confirmed in external validation, Gas6 plasma level measurement could contribute to the identification of patients who may benefit most from more aggressive management.	[Stalder, Gregoire; Calzavarini, Sara; Burnier, Laurent; Kosinski, Christophe; Duchosal, Michel A.; Angelillo-Scherrer, Anne] CHU Vaudois, Serv & Cent Lab Hematol, Lausanne, Switzerland; [Stalder, Gregoire; Que, Yok Ai; Calzavarini, Sara; Burnier, Laurent; Kosinski, Christophe; Ballabeni, Pierluigi; Roger, Thierry; Calandra, Thierry; Duchosal, Michel A.; Liaudet, Lucas; Eggimann, Philippe; Angelillo-Scherrer, Anne] Univ Lausanne, Lausanne, Switzerland; [Que, Yok Ai; Liaudet, Lucas; Eggimann, Philippe] CHU Vaudois, Serv Adult Intens Care Med, Lausanne, Switzerland; [Que, Yok Ai] Univ Bern, Univ Hosp Bern, Inselspital, Dept Intens Care Med, Bern, Switzerland; [Calzavarini, Sara; Angelillo-Scherrer, Anne] Univ Bern, Univ Hosp Bern, Inselspital, Dept Hematol, Bern, Switzerland; [Calzavarini, Sara; Angelillo-Scherrer, Anne] Univ Bern, Univ Hosp Bern, Inselspital, Cent Hematol Lab, Bern, Switzerland; [Calzavarini, Sara; Angelillo-Scherrer, Anne] Univ Bern, Dept Clin Res, Bern, Switzerland; [Ballabeni, Pierluigi] CHU Vaudois, Clin Res Ctr, Lausanne, Switzerland; [Roger, Thierry; Calandra, Thierry] CHU Vaudois, Infect Dis Serv, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Angelillo-Scherrer, A (corresponding author), CHU Vaudois, Serv & Cent Lab Hematol, Lausanne, Switzerland.; Angelillo-Scherrer, A (corresponding author), Univ Lausanne, Lausanne, Switzerland.; Angelillo-Scherrer, A (corresponding author), Univ Bern, Univ Hosp Bern, Inselspital, Dept Hematol, Bern, Switzerland.; Angelillo-Scherrer, A (corresponding author), Univ Bern, Univ Hosp Bern, Inselspital, Cent Hematol Lab, Bern, Switzerland.; Angelillo-Scherrer, A (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	anne.angelillo-scherrer@insel.ch	Liaudet, Lucas/E-1322-2017; Calandra, Thierry/D-9017-2015; Calzavarini, Sara/AAU-9368-2020; Que, Yok Ai/AAE-5474-2020; Roger, Thierry/G-2007-2012; Kosinski, Christophe/ABB-6319-2021; Burnier, Laurent P/E-5807-2011	Liaudet, Lucas/0000-0003-2670-4930; Calandra, Thierry/0000-0003-3051-1285; Calzavarini, Sara/0000-0002-7494-2995; Que, Yok Ai/0000-0001-9443-6101; Roger, Thierry/0000-0002-9358-0109; Burnier, Laurent P/0000-0001-7767-0334; Stalder, Gregoire/0000-0002-0536-5418; Ballabeni, Pierluigi/0000-0002-1572-7179; Stalder, Gregoire/0000-0001-6204-6491; Kosinski, Christophe/0000-0002-7544-498X; Angelillo-Scherrer, Anne/0000-0003-2872-4863; de Kaenel, Isabelle/0000-0002-6124-7846	La Fondation Pierre Mercier pour la Science; Novartis Foundation; Swiss National Foundation for Scientific Research [310030_153436, 310030-135822, PP00P3-106690, PP00P3-123430, 3232-066350.01, 3200-066351.01]; Loterie Romande	La Fondation Pierre Mercier pour la Science; Novartis Foundation(Novartis); Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); Loterie Romande	This work was supported by La Fondation Pierre Mercier pour la Science (to AAS), the Novartis Foundation (to MS), the Swiss National Foundation for Scientific Research grants 310030_153436, 310030-135822, PP00P3-106690, PP00P3-123430, 3232-066350.01, 3200-066351.01 (to MS) and an unrestricted grant from the Loterie Romande (to YAQ and PE).; This work was supported by La Fondation Pierre Mercier pour la Science (to AAS), the Novartis Foundation (to AAS), the Swiss National Foundation for Scientific Research grants 310030_153436, 310030-135822, PP00P3-106690, PP00P3-123430, 3232-066350.01, 3200-066351.01 (to AAS) and an unrestricted grant from the Loterie Romande to YAQ and PE	Angelillo-Scherrer A, 2005, J CLIN INVEST, V115, P237, DOI 10.1172/JCI200522079; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; Avanzi GC, 1997, EXP HEMATOL, V25, P1219; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; Borgel D, 2006, CRIT CARE MED, V34, P219, DOI 10.1097/01.CCM.0000195014.56254.8A; Clauser S, 2007, CLIN CHEM, V53, P1808, DOI 10.1373/clinchem.2007.089102; Deng TT, 2012, IMMUNOLOGY, V135, P40, DOI 10.1111/j.1365-2567.2011.03511.x; Ekman C, 2010, CRIT CARE, V14, DOI 10.1186/cc9233; ESMON CT, 1989, J BIOL CHEM, V264, P4743; Faix JD, 2013, CRIT REV CL LAB SCI, V50, P23, DOI 10.3109/10408363.2013.764490; Feng XY, 2011, IMMUNOLOGY, V132, P287, DOI 10.1111/j.1365-2567.2010.03364.x; Giangola MD, 2013, SHOCK, V40, P485, DOI 10.1097/SHK.0b013e3182a588c1; Gibot S, 2007, CRIT CARE, V11, DOI 10.1186/cc5158; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; NAKANO T, 1995, J BIOL CHEM, V270, P5702, DOI 10.1074/jbc.270.11.5702; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Prieto AL, 1999, BRAIN RES, V816, P646, DOI 10.1016/S0006-8993(98)01159-7; Que YA, 2015, CHEST, V148, P674, DOI 10.1378/chest.15-0123; Que YA, 2012, CRIT CARE, V16, DOI 10.1186/cc11406; Robins RS, 2013, BLOOD, V121, P692, DOI 10.1182/blood-2012-05-433730; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; Samraj RS, 2013, SHOCK, V40, P358, DOI 10.1097/SHK.0b013e3182a66bd6; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Scutera S, 2009, J IMMUNOL, V183, P3004, DOI 10.4049/jimmunol.0804384; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Slade E, 2003, CRIT CARE, V7, P1, DOI 10.1186/cc1876; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Tjwa M, 2008, BLOOD, V111, P4096, DOI 10.1182/blood-2007-05-089565; Uehara S, 2009, J GASTROEN HEPATOL, V24, P1567, DOI 10.1111/j.1440-1746.2009.05875.x; van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752; Vincent JL, 2011, CRIT CARE CLIN, V27, P241, DOI 10.1016/j.ccc.2010.12.010; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986	41	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0163542	10.1371/journal.pone.0163542	http://dx.doi.org/10.1371/journal.pone.0163542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788141	gold, Green Submitted, Green Published			2022-12-26	WOS:000389604900007
J	Hao, XD; Chen, ZL; Qu, ML; Zhao, XW; Li, SX; Chen, P				Hao, Xiao-Dan; Chen, Zhao-Li; Qu, Ming-Li; Zhao, Xiao-Wen; Li, Su-Xia; Chen, Peng			Decreased Integrity, Content, and Increased Transcript Level of Mitochondrial DNA Are Associated with Keratoconus	PLOS ONE			English	Article							CORNEAL ALDEHYDE DEHYDROGENASE; PERIPHERAL-BLOOD CELLS; OXIDATIVE STRESS; COPY NUMBER; PATHOLOGICAL CORNEAS; DIABETIC-RETINOPATHY; HUMAN EYE; DAMAGE; AGE; FIBROBLASTS	Oxidative stress may play an important role in the pathogenesis of keratoconus (KC). Mitochondrial DNA (mtDNA) is involved in mitochondrial function, and the mtDNA content, integrity, and transcript level may affect the generation of reactive oxygen species (ROS) and be involved in the pathogenesis of KC. We designed a case-control study to research the relationship between KC and mtDNA integrity, content and transcription. One-hundred ninety-eight KC corneas and 106 normal corneas from Chinese patients were studied. Quantitative real-time PCR was used to measure the relative mtDNA content, transcript levels of mtDNA and related genes. Long-extension PCR was used to detect mtDNA damage. ROS, mitochondrial membrane potential and ATP were measured by respective assay kit, and Mito-Tracker Green was used to label the mitochondria. The relative mtDNA content of KC corneas was significantly lower than that of normal corneas (P = 9.19x10(-24)), possibly due to decreased expression of the mitochondrial transcription factor A (TFAM) gene (P = 3.26x10(-3)). In contrast, the transcript levels of mtDNA genes were significantly increased in KC corneas compared with normal corneas (NADH dehydrogenase subunit 1 [ND1]: P = 1.79x10(-3); cytochrome c oxidase subunit 1 [COX1]: P = 1.54x10(-3); NADH dehydrogenase subunit 1, [ND6]: P = 4.62x10(-3)). The latter may be the result of increased expression levels of mtDNA transcription-related genes mitochondrial RNA polymerase (POLRMT) (P = 2.55x10(-4)) and transcription factor B2 mitochondrial (TFB2M) (P = 7.88x10(-5)). KC corneas also had increased mtDNA damage (P = 3.63x10(-10)), higher ROS levels, and lower mitochondrial membrane potential and ATP levels compared with normal corneas. Decreased integrity, content and increased transcript level of mtDNA are associated with KC. These changes may affect the generation of ROS and play a role in the pathogenesis of KC.	[Hao, Xiao-Dan; Chen, Zhao-Li; Qu, Ming-Li; Zhao, Xiao-Wen; Chen, Peng] Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Peoples R China; [Li, Su-Xia] Shandong Acad Med Sci, Shandong Eye Inst, Shandong Eye Hosp, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Chen, P (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Peoples R China.	chenpeng599205@126.com	hao, xiaodan/ABD-7161-2021	Hao, Xiao-dan/0000-0002-4611-8325	National Natural Science Foundation of China [81300742, 81500763]; Young and Middle-Aged Scientists Research Awards Fund of Shangdong Province, China [BS2015YY014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young and Middle-Aged Scientists Research Awards Fund of Shangdong Province, China	This work was supported by the National Natural Science Foundation of China (http/Mownsfcgovcni)(81500763(XH), 81300742(PC)) and the Young and Middle-Aged Scientists Research Awards Fund of Shangdong Province, China (http/www.sdnsfgoycn/portal/) (BS2015YY014 (XH)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395; Behndig A, 2001, INVEST OPHTH VIS SCI, V42, P2293; Bi R, 2010, HUM MUTAT, V31, P538, DOI 10.1002/humu.21220; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Chen P, 2014, INVEST OPHTH VIS SCI, V55, P8031, DOI 10.1167/iovs.14-14098; Chwa M, 2008, INVEST OPHTH VIS SCI, V49, P4361, DOI 10.1167/iovs.08-1969; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; Flynn JM, 2013, FREE RADICAL BIO MED, V62, P4, DOI 10.1016/j.freeradbiomed.2013.05.027; Gaziev AI, 2014, BIOGERONTOLOGY, V15, P417, DOI 10.1007/s10522-014-9515-2; Gendron SP, 2013, MUTAGENESIS, V28, P197, DOI 10.1093/mutage/ges071; Gendron SP, 2012, MECH AGEING DEV, V133, P68, DOI 10.1016/j.mad.2012.01.002; Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343; GONDHOWIARDJO TD, 1993, CORNEA, V12, P146, DOI 10.1097/00003226-199303000-00010; GONDHOWIARDJO TD, 1993, CORNEA, V12, P310, DOI 10.1097/00003226-199307000-00006; Hao XD, 2015, EXP EYE RES, V132, P59, DOI 10.1016/j.exer.2015.01.016; HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M; He YH, 2014, NEUROBIOL AGING; Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611; Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1; Kok YO, 2012, CORNEA, V31, P581, DOI 10.1097/ICO.0b013e31820cd61d; Kowluru RA, 2015, BBA-MOL BASIS DIS, V1852, P2474, DOI 10.1016/j.bbadis.2015.08.001; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P3521, DOI 10.1167/iovs.10-6163; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI [10.1590/S1415-47572013000300002, 10.1590/s1415-47572013000300002]; Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NOHL H, 1994, ANN BIOL CLIN-PARIS, V52, P199; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Rahman I, 2009, EYE, V23, P1288, DOI 10.1038/eye.2008.305; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5; Santos JM, 2011, FREE RADICAL BIO MED, V51, P1849, DOI 10.1016/j.freeradbiomed.2011.08.017; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Tinaztepe OE, 2016, CURR EYE RES, P1; Wojcik KA, 2013, INT J MOL SCI, V14, P19294, DOI 10.3390/ijms140919294; Zhou QJ, 2008, MOL VIS, V14, P2556	45	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165580	10.1371/journal.pone.0165580	http://dx.doi.org/10.1371/journal.pone.0165580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783701	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800083
J	Tchuenche, M; Palmer, E; Hate, V; Thambinayagam, A; Loykissoonlal, D; Njeuhmeli, E; Forsythe, S				Tchuenche, Michel; Palmer, Eurica; Hate, Vibhuti; Thambinayagam, Ananthy; Loykissoonlal, Dayanund; Njeuhmeli, Emmanuel; Forsythe, Steven			The Cost of Voluntary Medical Male Circumcision in South Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV PREVENTION; RISK; TRANSMISSION; WOMEN; MEN	Given compelling evidence associating voluntary medical male circumcision (VMMC) with men's reduced HIV acquisition through heterosexual intercourse, South Africa in 2010 began scaling up VMMC. To project the resources needed to complete 4.3 million circumcisions between 2010 and 2016, we (1) estimated the unit cost to provide VMMC; (2) assessed cost drivers and cost variances across eight provinces and VMMC service delivery modes; and (3) evaluated the costs associated with mobilize and motivate men and boys to access VMMC services. Cost data were systematically collected and analyzed using a provider's perspective from 33 Government and PEPFAR-supported (U.S. President's Emergency Plan for AIDS Relief) urban, rural, and peri-urban VMMC facilities. The cost per circumcision performed in 2014 was US$132 (R1,431): higher in public hospitals (US$158 [R1,710]) than in health centers and clinics (US$121 [R1,309]). There was no substantial difference between the cost at fixed circumcision sites and fixed sites that also offer outreach services. Direct labor costs could be reduced by 17% with task shifting from doctors to professional nurses; this could have saved as much as $15 million (R163.20 million) in 2015, when the goal was 1.6 million circumcisions. About $14.2 million (R154 million) was spent on medical male circumcision demand creation in South Africa in 2014-D primarily on personnel, including community mobilizers (36%), and on small and mass media promotions (35%). Calculating the unit cost of VMMC demand creation was daunting, because data on the denominator (number of people reached with demand creation messages or number of people seeking VMMC as a result of demand creation) were not available. Because there are no "dose-response" data on demand creation ($X in demand creation will result in an additional Z% increase in VMMC clients), research is needed to determine the appropriate amount and allocation of demand creation resources.	[Tchuenche, Michel; Forsythe, Steven] Project SOAR Supporting Operat AIDS Res, Avenir Hlth, Hlth Policy Project, Washington, DC 20253 USA; [Palmer, Eurica] Palladium Consultant, Hlth Policy Project, Johannesburg, South Africa; [Hate, Vibhuti] George Washington Univ, Washington, DC USA; [Thambinayagam, Ananthy; Njeuhmeli, Emmanuel] USAID, Pretoria, South Africa; [Loykissoonlal, Dayanund] Natl Dept Hlth, Pretoria, South Africa; [Njeuhmeli, Emmanuel] USAID, Washington, DE USA	George Washington University; United States Agency for International Development (USAID); United States Agency for International Development (USAID)	Tchuenche, M (corresponding author), Project SOAR Supporting Operat AIDS Res, Avenir Hlth, Hlth Policy Project, Washington, DC 20253 USA.	JMTchuenche@avenirhealth.org	Forsythe, Steven/AAL-7558-2020; Tchuenche, JM/AAT-9984-2021	Forsythe, Steven/0000-0002-4409-5991; Tchuenche, JM/0000-0001-8655-6154	U.S. President's Emergency Plan for AIDS Relief (PEPFAR); United States Agency for International Development (USAID) [AID-OAA-A-10-00067, AID-OAA-14-00026, AID-OAA-A-14-00046]; PEPFAR; National Department of Health; Alfred Bere (CDC/South Africa)	U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); PEPFAR; National Department of Health; Alfred Bere (CDC/South Africa)	This manuscript is made possible by the generous support of the American people through the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR) with the United States Agency for International Development (USAID) under the Cooperative Agreement Health Policy Project, Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010, Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026, and Cooperative Agreement Strengthening High Impact Interventions for an AIDS-free Generation, number AID-OAA-A-14-00046. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International United States of America, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of PEPFAR, USAID, the South African National Department of Health, or the United States Government.; The Health Policy Project (HPP), in collaboration with the National Department of Health (NDOH), jointly conducted the VMMC costing activity of the PEPFAR-supported sites in South Africa. The HPP costing team would like to acknowledge the support provided by the following: the National Department of Health, especially Dr. Yogan Pillay, Collen Bonnecwe, and Nqeketo Ayanda; PEPFAR, especially Isaac Choge (USAID/South Africa) and Alfred Bere (CDC/South Africa); and all the provincial Department of Health and facility staff who helped collect data. Additional thanks go to Katharine Kripke (HPP/Avenir Health) and Melissa Schnure (HPP/Palladium) for their support and assistance in completing this study. Special thanks also go to the stakeholder engagement and data collection team of senior researchers Dr. Lahla Ngubeni, Professor Welile Shasha, and Benjamin Makhubele and researchers, Fulufhelo Maphiri, Zakes Hlatshwayo, and Theron Dladla.	[Anonymous], 2009, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003362.PUB2; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bautista-Arredondo S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0599-9; Bertrand J. T., 2013, SYSTEMATIC MONITORIN; Bertrand JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027562; Bollinger L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084701; Chu K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000078; Dankie B, 2015, 7TH SOUTH AFRICAN AI; Duffy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063134; Exavery A, 2015, HIV AIDS-RES PALLIAT, V7, P105, DOI 10.2147/HIV.S76694; Ford N, 2012, AIDS, V26, P559, DOI 10.1097/QAD.0b013e32834f3264; Govender K, 2013, S AFR HLTH REV SAHR; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Health Policy Initiative, 2010, COST WORKB; Hutchinson J., 1855, MED TIMES GAZETTE, VII, P542, DOI DOI 10.1056/NEJM185608280550404; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kim HY, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29116; Kioko U, 2010, ESTIMATING COSTS IMP; Lei JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125436; Mahomed O, 2010, COSTING MALE CIRCUMC; Mehta SD, 2013, AIDS, V27, P2899, DOI 10.1097/01.aids.0000432444.30308.2d; Menon V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083925; National Department of Health (NDOH), 2012, STRAT PLAN SCAL MED; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; RAS GJ, 1983, S AFR MED J, V64, P140; Richardson ET, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19035; Shisana O., 2014, AFRICAN NATL HIV P; South African National AIDS Committee (SANANC), 2011, NAT STRAT PLAN HIV S; UNAIDS, 2011, JOINT STRAT ACT FRAM; Uthman OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009628; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X; WHO, 2015, PROGR BRIEF VOL MED; WHO, 2009, FACTSH VOL MED MAL C; World Health Organization, 2008, OP GUID SCAL MAL CIR; Zaiontz C, 2 SAMPLE T TEST UNEQ	39	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0160207	10.1371/journal.pone.0160207	http://dx.doi.org/10.1371/journal.pone.0160207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783612	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800005
J	Dahlin, AM; Wibom, C; Ghasimi, S; Brannstrom, T; Andersson, U; Melin, B				Dahlin, Anna M.; Wibom, Carl; Ghasimi, Soma; Brannstrom, Thomas; Andersson, Ulrike; Melin, Beatrice			Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NONCODING RNA; SUSCEPTIBILITY; IMPUTATION; MUTATION; LOCI; IDH1; POLYMORPHISM; SURVIVAL; HOTSPOT	Genome-wide association studies and candidate gene studies have identified several genetic variants that increase glioma risk. The majority of these variants are non-coding and the mechanisms behind the increased risk in carriers are not known. In this study, we hypothesize that some of the established glioma risk variants induce aberrant DNA methylation in the developing tumor, either locally (gene-specific) or globally (genome-wide). In a pilot data set including 77 glioma patients, we used Illumina beadchip technology to analyze genetic variants in blood and DNA methylation in matched tumor samples. To validate our findings, we used data from the Cancer Genome Atlas, including 401 glioblastoma patients. Consensus clustering identified the glioma CpG island methylator phenotype (gCIMP) and two additional subgroups with distinct patterns of global DNA methylation. In the pilot dataset, gCIMP was associated with two genetic variants in CDKN2B-AS1, rs1412829 and rs4977756 (9p21.3, p = 8.1 x 10(-7) and 4.8 x 10(-5), respectively). The association was in the same direction in the TCGA dataset, although statistically significant only when combining individuals with AG and GG genotypes. We also investigated the relation between glioma risk variants and DNA methylation in the promoter region of genes located within 30 kb of each variant. One association in the pilot dataset, between the TERT risk variant rs2736100 and lower methylation of cg23827991 (in TERT; p = 0.001), was confirmed in the TCGA dataset (p = 0.001). In conclusion, we found an association between rs1412829 and rs4977756 (9p21.3, CDKN2B-AS1) and global DNA methylation pattern in glioma, for which a trend was seen also in the TCGA glioblastoma dataset. We also found an association between rs2736100 (in TERT) and levels of methylation at cg23827991 (localized in the same gene, 3.3 kbp downstream of the risk variant), which was validated in the TCGA dataset. Except for this one association, we did not find strong evidence for gene-specific DNA methylation mediated by glioma risk variants.	[Dahlin, Anna M.; Wibom, Carl; Ghasimi, Soma; Andersson, Ulrike; Melin, Beatrice] Umea Univ, Dept Radiat Sci, Oncol, Umea, Sweden; [Brannstrom, Thomas] Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden	Umea University; Umea University	Melin, B (corresponding author), Umea Univ, Dept Radiat Sci, Oncol, Umea, Sweden.	beatrice.melin@umu.se		Dahlin, Anna/0000-0002-6754-2571	Acta Oncologica Foundation through Royal Swedish Academy of Science; Swedish Cancer Foundation; Swedish Research council; Cancer Research Foundation in Northern Sweden; Umea University	Acta Oncologica Foundation through Royal Swedish Academy of Science; Swedish Cancer Foundation; Swedish Research council(Swedish Research CouncilEuropean Commission); Cancer Research Foundation in Northern Sweden; Umea University	This work was supported by Acta Oncologica Foundation through the Royal Swedish Academy of Science (BM salary), the Swedish Cancer Foundation (BM), the Swedish Research council (BM), the Cancer Research Foundation in Northern Sweden (BM), and Umea University Hospital (cutting edge grant and Umea University Young Investigator Award; BM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo F, 2011, CANCER RES, V71, P5365, DOI 10.1158/0008-5472.CAN-10-4379; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi BJ, 2015, WORLD J GASTROENTERO, V21, P9328, DOI 10.3748/wjg.v21.i31.9328; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Enciso-Mora V, 2013, BRIT J CANCER, V108, P2178, DOI 10.1038/bjc.2013.155; Ghasimi S, 2016, J NEURO-ONCOL, V127, P483, DOI 10.1007/s11060-016-2066-4; Heyn H, 2014, CELL REP, V7, P331, DOI 10.1016/j.celrep.2014.03.016; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Jenkins RB, 2012, NAT GENET, V44, P1122, DOI 10.1038/ng.2388; Kitahara CM, 2014, CANCER EPIDEM BIOMAR, V23, P47, DOI 10.1158/1055-9965.EPI-13-0913; Laffaire J, 2011, NEURO-ONCOLOGY, V13, P84, DOI 10.1093/neuonc/noq110; LOUIS DN, 1993, J NEUROPATH EXP NEUR, V52, P31, DOI 10.1097/00005072-199301000-00005; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Mur P, 2013, ACTA NEUROPATHOL, V126, P277, DOI 10.1007/s00401-013-1130-9; Nagarajan RP, 2014, GENOME RES, V24, P761, DOI 10.1101/gr.164707.113; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2013, R A LANGUAGE AND ENV; Rajaraman P, 2012, HUM GENET, V131, P1877, DOI 10.1007/s00439-012-1212-0; Sanson M, 2011, HUM MOL GENET, V20, P2897, DOI 10.1093/hmg/ddr192; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shi JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4365; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van den Bent MJ, 2011, CLIN CANCER RES, V17, P7148, DOI 10.1158/1078-0432.CCR-11-1274; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang YF, 2015, EUR J HUM GENET, V23, P1723, DOI 10.1038/ejhg.2015.48; Wang ZM, 2014, HUM MOL GENET, V23, P6616, DOI 10.1093/hmg/ddu363; Wei RR, 2015, CLIN CANCER RES, V21, P5173, DOI 10.1158/1078-0432.CCR-15-0009; Wibom C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047929; Wiestler B, 2014, ACTA NEUROPATHOL, V128, P561, DOI 10.1007/s00401-014-1315-x; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Zhou L, 2016, ONCOTARGET, V7, P51943, DOI 10.18632/oncotarget.10460	38	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0163067	10.1371/journal.pone.0163067	http://dx.doi.org/10.1371/journal.pone.0163067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780202	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900002
J	Ullah, I; Bhattacharyya, K; Shafie, S; Khan, I				Ullah, Imran; Bhattacharyya, Krishnendu; Shafie, Sharidan; Khan, Ilyas			Unsteady MHD Mixed Convection Slip Flow of Casson Fluid over Nonlinearly Stretching Sheet Embedded in a Porous Medium with Chemical Reaction, Thermal Radiation, Heat Generation/Absorption and Convective Boundary Conditions	PLOS ONE			English	Article							STAGNATION POINT FLOW; MASS-TRANSFER; LAYER-FLOW; NANOFLUID; DIFFUSION; SURFACE; SUCTION	Numerical results are presented for the effect of first order chemical reaction and thermal radiation on mixed convection flow of Casson fluid in the presence of magnetic field. The flow is generated due to unsteady nonlinearly stretching sheet placed inside a porous medium. Convective conditions on wall temperature and wall concentration are also employed in the investigation. The governing partial differential equations are converted to ordinary differential equations using suitable transformations and then solved numerically via Keller-box method. It is noticed that fluid velocity rises with increase in radiation parameter in the case of assisting flow and is opposite in the case of opposing fluid while radiation parameter has no effect on fluid velocity in the forced convection. It is also seen that fluid velocity and concentration enhances in the case of generative chemical reaction whereas both profiles reduces in the case of destructive chemical reaction. Further, increase in local unsteadiness parameter reduces fluid velocity, temperature and concentration. Over all the effects of physical parameters on fluid velocity, temperature and concentration distribution as well as on the wall shear stress, heat and mass transfer rates are discussed in detail.	[Ullah, Imran; Shafie, Sharidan] Univ Teknol Malaysia, Dept Math Sci, Fac Sci, Utm Johor Bahru 81310, Johor, Malaysia; [Bhattacharyya, Krishnendu] Banaras Hindu Univ, Inst Sci, Dept Math, Varanasi 221005, Uttar Pradesh, India; [Khan, Ilyas] Majmaah Univ, Coll Engn, Majmaah 11952, Saudi Arabia	Universiti Teknologi Malaysia; Banaras Hindu University (BHU); Majmaah University	Shafie, S (corresponding author), Univ Teknol Malaysia, Dept Math Sci, Fac Sci, Utm Johor Bahru 81310, Johor, Malaysia.	sharidan@utm.my	Ullah, Imran/HHD-3325-2022; Khan, Ilyas/C-8770-2019; Bhattacharyya, Krishnendu/A-8327-2011; Ullah, Imran/Z-1172-2019	Khan, Ilyas/0000-0002-2056-9371; Bhattacharyya, Krishnendu/0000-0001-7975-0709; Ullah, Imran/0000-0002-0233-2194				Ahmed N, 2018, NEURAL COMPUT APPL, V29, P501, DOI 10.1007/s00521-016-2463-9; Aurangzaib, 2012, INT J ADV ENG SCI AP, V4, P217, DOI 10.1007/s12572-012-0066-y; Benazir AJ, 2016, INT J ENG RES AFR, V21, P69, DOI 10.4028/www.scientific.net/JERA.21.69; Bhattacharyya K, 2013, CHEM ENG COMMUN, V200, P379, DOI 10.1080/00986445.2012.712577; Bhattacharyya K, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/9/094702; Casson N., 1959, RHEOL DISPERSE SYST, P84; Cebeci T., 1988, PHYS COMPUTATIONAL A; Chamkha AJ, 2010, CHEM ENG COMMUN, V197, P846, DOI 10.1080/00986440903359087; Cortell R, 2007, APPL MATH COMPUT, V184, P864, DOI 10.1016/j.amc.2006.06.077; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Grubka L.J., 1977, ASME J HEAT TRANSF, V19, P53; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Hsiao K.-L., 2010, WORLD ACAD SCI ENG T, V62, P338; Hsiao KL, 2017, APPL THERM ENG, V112, P1281, DOI 10.1016/j.applthermaleng.2016.08.208; Hsiao KL, 2016, APPL THERM ENG, V98, P850, DOI 10.1016/j.applthermaleng.2015.12.138; Hsiao KL, 2011, INT J NONLIN MECH, V46, P1, DOI 10.1016/j.ijnonlinmec.2010.06.005; Ibrahim W, 2016, J AEROSPACE ENG, V29, DOI 10.1061/(ASCE)AS.1943-5525.0000529; Jat RN, 2014, THERM ENERGY POWER E, V3, P191; Kechil SA, 2009, J POROUS MEDIA, V12, P1053, DOI 10.1615/JPorMedia.v12.i11.30; Khan U, 2016, AEROSP SCI TECHNOL, V50, P196, DOI 10.1016/j.ast.2015.12.032; Khan U, 2016, CHEM ENG SCI, V141, P17, DOI 10.1016/j.ces.2015.10.032; Khan U, 2017, NEURAL COMPUT APPL, V28, P37, DOI 10.1007/s00521-015-2035-4; Khan WA, 2016, INT J HEAT MASS TRAN, V96, P525, DOI 10.1016/j.ijheatmasstransfer.2016.01.052; Khan WA, 2015, CAN J CHEM ENG, V93, P1880, DOI 10.1002/cjce.22283; Kumaran V, 1996, ACTA MECH, V116, P229, DOI 10.1007/BF01171433; Mabood F, 2015, CHEM ENG J, V273, P430, DOI 10.1016/j.cej.2015.03.037; Magyari E, 1999, J PHYS D APPL PHYS, V32, P577, DOI 10.1088/0022-3727/32/5/012; Makinde OD, 2013, INT J HEAT MASS TRAN, V62, P526, DOI 10.1016/j.ijheatmasstransfer.2013.03.049; Mohyud-Din ST, 2018, NEURAL COMPUT APPL, V29, P793, DOI 10.1007/s00521-016-2493-3; Mohyud-Din ST, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/2568785; Mohyud-Din ST, 2015, APPL SCI-BASEL, V5, P1639, DOI 10.3390/app5041639; Mohyud-Din ST, 2015, AEROSP SCI TECHNOL, V46, P514, DOI 10.1016/j.ast.2015.07.020; Mukhopadhyay S, 2009, INT J HEAT MASS TRAN, V52, P3261, DOI 10.1016/j.ijheatmasstransfer.2008.12.029; Mukhopadhyay S, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/11/114702; Nadeem S, 2013, ALEX ENG J, V52, P577, DOI 10.1016/j.aej.2013.08.005; Oyelakin IS, 2016, ALEX ENG J, V55, P1025, DOI 10.1016/j.aej.2016.03.003; Pop I, 1996, MECH RES COMMUN, V23, P413, DOI 10.1016/0093-6413(96)00040-7; Pramanik S, 2014, AIN SHAMS ENG J, V5, P205, DOI 10.1016/j.asej.2013.05.003; REHER EO, 1969, CHEM TECH-LEIPZIG, V21, P137; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Seini IY, 2014, INT J NUMER METHOD H, V24, P643, DOI 10.1108/HFF-04-2012-0094; Sharidan S., 2006, International Journal of Applied Mechanics and Engineering, V11, P647; Takhar HS, 2000, INT J ENG SCI, V38, P1303, DOI 10.1016/S0020-7225(99)00079-8	43	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165348	10.1371/journal.pone.0165348	http://dx.doi.org/10.1371/journal.pone.0165348			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776174	Green Submitted, Green Published, gold			2022-12-26	WOS:000389009200058
J	Zhou, XB; Smith, H; Silva, AG; Belnap, J; Garcia-Pichel, F				Zhou, Xiaobing; Smith, Hilda; Silva, Ana Giraldo; Belnap, Jayne; Garcia-Pichel, Ferran			Differential Responses of Dinitrogen Fixation, Diazotrophic Cyanobacteria and Ammonia Oxidation Reveal a Potential Warming-Induced Imbalance of the N-Cycle in Biological Soil Crusts	PLOS ONE			English	Article							NITROGEN-FIXATION; GURBANTUNGGUT DESERT; OXIDIZING ARCHAEA; MICROBIAL BIOMASS; TENGGER DESERT; ARID LANDS; TEMPERATURE; DISTURBANCE; DIVERSITY; CARBON	N-2 fixation and ammonia oxidation (AO) are the two most important processes in the nitrogen (N) cycle of biological soil crusts (BSCs). We studied the short-term response of acetylene reduction assay (ARA) rates, an indicator of potential N-2 fixation, and AO rates to temperature (T,-5 degrees C to 35 degrees C) in BSC of different successional stages along the BSC ecological succession and geographic origin (hot Chihuahuan and cooler Great Basin deserts). ARA in all BSCs increased with T until saturation occurred between 15 and 20 degrees C, and declined at 30-35 degrees C. Culture studies using cyanobacteria isolated from these crusts indicated that the saturating effect was traceable to their inability to grow well diazotrophically within the high temperature range. Below saturation, temperature response was exponential, with Q(10) significantly different in the two areas (similar to 5 for Great Basin BSCs; 2-3 for Chihuahuan BSCs), but similar between the two successional stages. However, in contrast to ARA, AO showed a steady increase to 30-35 degrees C in Great Basin, and Chihuhuan BSCs showed no inhibition at any tested temperature. The T response of AO also differed significantly between Great Basin Q(10) of 4.5-4.8) and Chihuahuan (Q(10) of 2.4-2.6) BSCs, but not between successional stages. Response of ARA rates to T did not differ from that of AO in either desert. Thus, while both processes scaled to T in unison until 20 degrees C, they separated to an increasing degree at higher temperature. As future warming is likely to occur in the regions where BSCs are often the dominant living cover, this predicted decoupling is expected to result in higher proportion of nitrates in soil relative to ammonium. As nitrate is more easily lost as leachate or to be reduced to gaseous forms, this could mean a depletion of soil N over large landscapes globally.	[Zhou, Xiaobing; Silva, Ana Giraldo; Garcia-Pichel, Ferran] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Zhou, Xiaobing] Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi 830011, Xinjiang, Peoples R China; [Smith, Hilda; Belnap, Jayne] US Geol Survey, Southwest Biol Sci Ctr, Moab, UT 84532 USA; [Silva, Ana Giraldo; Garcia-Pichel, Ferran] Arizona State Univ, Biodesign Inst, Ctr Fundamental & Appl Microbi, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe	Garcia-Pichel, F (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.; Garcia-Pichel, F (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Fundamental & Appl Microbi, Tempe, AZ 85287 USA.	ferran@asu.edu		Giraldo-Silva, Ana/0000-0001-5235-9291				Barger NN, 2006, BIOGEOCHEMISTRY, V77, P247, DOI 10.1007/s10533-005-1424-7; Barger NN, 2013, ECOL PROCESS, V2, P16, DOI [10.1186/2192-1709-2-16, DOI 10.1186/2192-1709-2-16]; Bates ST, 2012, MYCOLOGIA, V104, P353, DOI 10.3852/11-232; Bates ST, 2010, J ARID ENVIRON, V74, P1192, DOI 10.1016/j.jaridenv.2010.05.033; Belnap J, 1997, LAND DEGRAD DEV, V8, P355, DOI 10.1002/(SICI)1099-145X(199712)8:4<355::AID-LDR266>3.0.CO;2-H; Belnap J, 2001, ECOL STU AN, V150, P281; Belnap J, 2002, BIOL FERT SOILS, V35, P128, DOI 10.1007/s00374-002-0452-x; Belnap J., 2003, BIOL SOIL CRUSTS STR, P3; Belnap J, 2006, HYDROL PROCESS, V20, P3159, DOI 10.1002/hyp.6325; Beraldi-Campesi H, 2009, GEOBIOLOGY, V7, P348, DOI 10.1111/j.1472-4669.2009.00204.x; Beraldi-Campesi H, 2014, BOL SOC GEOL MEX, V66, P65, DOI 10.18268/BSGM2014v66n1a6; Bowen JL, 2013, MAR ECOL PROG SER, V492, P1, DOI 10.3354/meps10526; Brankatschk R, 2013, FEMS MICROBIOL ECOL, V83, P149, DOI 10.1111/j.1574-6941.2012.01459.x; BROOKS SJ, 1984, J BACTERIOL, V157, P460, DOI 10.1128/JB.157.2.460-464.1984; Couradeau E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10373; Delgado-Baquerizo M, 2013, PLANT SOIL, V366, P35, DOI 10.1007/s11104-012-1404-3; Elbert W, 2012, NAT GEOSCI, V5, P459, DOI 10.1038/ngeo1486; Evans RD, 1999, ECOLOGY, V80, P150, DOI 10.1890/0012-9658(1999)080[0150:LTCODO]2.0.CO;2; GALLARDO A, 1992, BIOGEOCHEMISTRY, V18, P1, DOI 10.1007/BF00000423; Garcia-Pichel F, 2003, MICROB ECOL, V46, P312, DOI 10.1007/s00248-003-1004-0; Garcia-Pichel F., 2002, ENCY ENV MICROBIOLOG, P1019; Garcia-Pichel F, 2013, SCIENCE, V340, P1574, DOI 10.1126/science.1236404; Garcia-Pichel F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007801; GarciaPichel F, 1996, J PHYCOL, V32, P774, DOI 10.1111/j.0022-3646.1996.00774.x; GARCIAPICHEL F, 1991, J PHYCOL, V27, P395, DOI 10.1111/j.0022-3646.1991.00395.x; Grote EE, 2010, GLOBAL CHANGE BIOL, V16, P2763, DOI 10.1111/j.1365-2486.2010.02201.x; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; HENNECKE H, 1979, ARCH MICROBIOL, V123, P259, DOI 10.1007/BF00406659; Johnson SL, 2007, ENVIRON MICROBIOL, V9, P680, DOI 10.1111/j.1462-2920.2006.01187.x; Johnson SL, 2012, GLOBAL CHANGE BIOL, V18, P2583, DOI 10.1111/j.1365-2486.2012.02709.x; Johnson SL, 2005, ENVIRON MICROBIOL, V7, P1, DOI 10.1111/j.1462-2920.2004.00649.x; Lange OL, 1998, FUNCT ECOL, V12, P195, DOI 10.1046/j.1365-2435.1998.00192.x; Langhans TM, 2009, FLORA, V204, P157, DOI 10.1016/j.flora.2008.01.001; LAYZELL DB, 1984, CAN J BOT, V62, P965, DOI 10.1139/b84-135; Li XR, 2010, HYDROL PROCESS, V24, P3621, DOI 10.1002/hyp.7791; Li XR, 2002, BIOL FERT SOILS, V35, P147, DOI 10.1007/s00374-002-0453-9; Marusenko Y, 2013, NICHE DIFFERENTIATIO; Marusenko Y., 2013, ECOL PROCESS, V2, P9, DOI DOI 10.1186/2192-1709-2-9; Marusenko Y, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu023; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Pepe-Ranney C, 2016, ISME J, V10, P287, DOI 10.1038/ismej.2015.106; Poulter B, 2014, NATURE, V509, P600, DOI 10.1038/nature13376; Rajeev L, 2013, ISME J, V7, P2178, DOI 10.1038/ismej.2013.83; Reyes BA, 2008, J BIOL RHYTHM, V23, P95, DOI 10.1177/0748730407311855; Sher Y, 2013, FEMS MICROBIOL ECOL, V86, P544, DOI 10.1111/1574-6941.12180; Soule T, 2009, SOIL BIOL BIOCHEM, V41, P2069, DOI 10.1016/j.soilbio.2009.07.023; Strauss SL, 2012, BIOGEOCHEMISTRY, V108, P171, DOI 10.1007/s10533-011-9587-x; Su YG, 2011, EUR J SOIL BIOL, V47, P182, DOI 10.1016/j.ejsobi.2011.04.001; Wu N, 2009, J ARID ENVIRON, V73, P828, DOI 10.1016/j.jaridenv.2009.04.002; Yeager CM, 2007, FEMS MICROBIOL ECOL, V60, P85, DOI 10.1111/j.1574-6941.2006.00265.x; Zelikova TJ, 2012, PLANT SOIL, V355, P265, DOI 10.1007/s11104-011-1097-z; Zhang J, 2009, J HYDROL, V379, P220, DOI 10.1016/j.jhydrol.2009.09.053; Zhang XY, 2013, PROC INT CONF DOC, P8, DOI 10.1109/ICDAR.2013.11; Zhang YM, 2006, GEODERMA, V132, P441, DOI 10.1016/j.geoderma.2005.06.008; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao Y, 2010, J ARID ENVIRON, V74, P1186, DOI 10.1016/j.jaridenv.2010.04.006; ZHU J, 1981, J BACTERIOL, V145, P1116, DOI 10.1128/JB.145.2.1116-1118.1981; Zielke M, 2002, ARCT ANTARCT ALP RES, V34, P293, DOI 10.2307/1552487	58	23	28	11	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164932	10.1371/journal.pone.0164932	http://dx.doi.org/10.1371/journal.pone.0164932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776160	gold, Green Published, Green Submitted			2022-12-26	WOS:000389009200028
J	Cai, XY; Zhou, YD; Nwokonko, RM; Loktionova, NA; Wang, XM; Xin, P; Trebak, M; Wang, YJ; Gill, DL				Cai, Xiangyu; Zhou, Yandong; Nwokonko, Robert M.; Loktionova, Natalia A.; Wang, Xianming; Xin, Ping; Trebak, Mohamed; Wang, Youjun; Gill, Donald L.			The Orai1 Store-operated Calcium Channel Functions as a Hexamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNEL; SUBUNIT STOICHIOMETRY; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; CA2+ ENTRY; STIM1; ACTIVATION; PORE; DOMAIN; SELECTIVITY	Orai channels mediate store-operated Ca2+ signals crucial in regulating transcription in many cell types, and implicated in numerous immunological and inflammatory disorders. Despite their central importance, controversy surrounds the basic subunit structure of Orai channels, with several biochemical and biophysical studies suggesting a tetrameric structure yet crystallographic evidence indicating a hexamer. We systematically investigated the subunit configuration of the functional Orai1 channel, generating a series of tdTomato-tagged concatenated Orai1 channel constructs (dimers to hexamers) expressed in CRISPR-derived ORAI1 knock-out HEK cells, stably expressing STIM1-YFP. Surface biotinylation demonstrated that the full-length concatemers were surface membrane-expressed. Unexpectedly, Orai1 dimers, trimers, tetramers, pentamers, and hexamers all mediated similar and substantial store-operated Ca2+ entry. Moreover, each Orai1 concatemer mediated Ca2+ currents with inward rectification and reversal potentials almost identical to those observed with expressed Orai1 monomer. In Orai1 tetramers, subunit-specific replacement with Orai1 E106A "pore-inactive" subunits revealed that functional channels utilize only the N-terminal dimer from the tetramer. In contrast, Orai1 E106A replacement in Orai1 hexamers established that all the subunits can contribute to channel formation, indicating a hexameric channel configuration. The critical Ca2+ selectivity filter-forming Glu-106 residue may mediate Orai1 channel assembly around a central Ca2+ ion within the pore. Thus, multiple E106A substitutions in the Orai1 hexamer may promote an alternative "trimer-of-dimers" channel configuration in which the C-terminal E106A subunits are excluded from the hexameric core. Our results argue strongly against a tetrameric configuration for Orai1 channels and indicate that the Orai1 channel functions as a hexamer.	[Cai, Xiangyu; Zhou, Yandong; Nwokonko, Robert M.; Loktionova, Natalia A.; Wang, Xianming; Xin, Ping; Trebak, Mohamed; Gill, Donald L.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA; [Wang, Youjun] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resources & Mol Dev, Beijing 100875, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Beijing Normal University	Zhou, YD; Gill, DL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	zhouyd@psu.edu; dongill@psu.edu	Wang, Youjun/H-4016-2013; Nwokonko, Robert/ABH-3833-2020; zhou, Yandong/AAN-3947-2021	Wang, Youjun/0000-0003-0961-1716; Nwokonko, Robert/0000-0002-0793-7379; zhou, Yandong/0000-0003-3503-0296	National Institute of Health [R01 GM120783, R01 GM109279]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123364, R01HL097111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109279, R01GM120783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG050072] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in whole or part by National Institute of Health Grants R01 GM120783 and R01 GM109279. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amcheslavsky A, 2015, BIOPHYS J, V108, P237, DOI 10.1016/j.bpj.2014.11.3473; Demuro A, 2011, P NATL ACAD SCI USA, V108, P17832, DOI 10.1073/pnas.1114814108; Derler I, 2016, AM J PHYSIOL-CELL PH, V310, pC643, DOI 10.1152/ajpcell.00007.2016; Derler I, 2013, J BIOL CHEM, V288, P29025, DOI 10.1074/jbc.M113.501510; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; Hogan PG, 2015, CELL CALCIUM, V58, P357, DOI 10.1016/j.ceca.2015.07.001; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kar P, 2013, CHANNELS, V7, P374, DOI 10.4161/chan.25298; Li PY, 2016, MOL BIOL CELL, V27, P2542, DOI 10.1091/mbc.E16-03-0163; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Madl J, 2010, J BIOL CHEM, V285, P41135, DOI 10.1074/jbc.M110.177881; Mancarella S, 2011, J BIOL CHEM, V286, P44788, DOI 10.1074/jbc.M111.303081; Mancarella S, 2011, NAT CHEM BIOL, V7, P344, DOI 10.1038/nchembio.587; Maruyama Y, 2009, J BIOL CHEM, V284, P13676, DOI 10.1074/jbc.M900812200; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Palty R, 2015, CELL RES, V25, P963, DOI 10.1038/cr.2015.80; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Perni S, 2015, P NATL ACAD SCI USA, V112, pE5533, DOI 10.1073/pnas.1515606112; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Rothberg BS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003971; Shim AHR, 2015, J MOL BIOL, V427, P77, DOI 10.1016/j.jmb.2014.09.021; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Thompson JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01961; Thompson JL, 2009, J BIOL CHEM, V284, P6620, DOI 10.1074/jbc.M808346200; Tirado-Lee L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128622; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wu MM, 2014, MOL BIOL CELL, V25, P3672, DOI 10.1091/mbc.E14-06-1107; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhou Y., 2016, NAT COMMUN IN PRESS; Zhou YD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9395; Zhou YD, 2015, MOL CELL, V58, P197, DOI 10.1016/j.molcel.2015.04.003; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	45	74	75	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25764	25775		10.1074/jbc.M116.758813	http://dx.doi.org/10.1074/jbc.M116.758813			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27780862	Green Published, hybrid			2022-12-26	WOS:000390345200001
J	Liu, X; Cai, XL; Hu, B; Mei, ZC; Zhang, DW; Ouyang, G; Wang, J; Zhang, W; Xiao, WH				Liu, Xing; Cai, Xiaolian; Hu, Bo; Mei, Zhichao; Zhang, Dawei; Ouyang, Gang; Wang, Jing; Zhang, Wei; Xiao, Wuhan			Forkhead Transcription Factor 3a (FOXO3a) Modulates Hypoxia Signaling via Up-regulation of the von Hippel-Lindau Gene (VHL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FOXO; hypoxia; hypoxia-inducible factor (HIF); stress; transcription regulation; zebrafish; pVHL	HIGH-ALTITUDE ADAPTATION; CELL RENAL-CARCINOMA; OXIDATIVE STRESS; HIF-ALPHA; PROTEASOMAL DEGRADATION; INDUCIBLE FACTORS; BETA-CATENIN; PVHL; PROTEIN; PATHWAY	FOXO3a, a member of the forkhead homeobox type O (FOXO) family of transcriptional factors, regulates cell survival in response to DNA damage, caloric restriction, and oxidative stress. The von Hippel-Lindau (VHL) tumor suppressor gene encodes a component of the E3 ubiquitin ligase complex that mediates hypoxia-inducible factor degradation under aerobic conditions, thus acting as one of the key regulators of hypoxia signaling. However, whether FOXO3a impacts cellular hypoxia stress remains unknown. Here we show that FOXO3a directly binds to the VHL promoter and up-regulates VHL expression. Using a zebrafish model, we confirmed the up-regulation of vhl by foxo3b, an ortholog of mammalian FOXO3a. Furthermore, by employing the clustered regularly interspaced short palindromic repeats (CRISPR)-associated RNA-guided endonuclease Cas9 (CRISPR/Cas9) technology, we deleted foxo3b in zebrafish and determined that expression of hypoxia-inducible genes was affected under hypoxia. Moreover, foxo3b-null zebrafish exhibited impaired acute hypoxic tolerance, resulting in death. In conclusion, our findings suggest that, by modulating hypoxia-inducible factor activity via up-regulation of VHL, FOXO3a (foxo3b) plays an important role in survival in response to hypoxic stress.	[Liu, Xing; Cai, Xiaolian; Hu, Bo; Mei, Zhichao; Zhang, Dawei; Ouyang, Gang; Wang, Jing; Zhang, Wei; Xiao, Wuhan] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan 430072, Peoples R China; [Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Zhang, Wei/I-1481-2017; Xiao, Wuhan/GLU-7352-2022; hu, bo/ABC-3810-2021	hu, bo/0000-0001-5656-9632	National Natural Science Foundation in China (NSFC) [31401072]; Chinese Academy of Sciences Major Scientific and Technological Project [XDA08010208]; NSFC [31461163003, 91631102, 31671315]	National Natural Science Foundation in China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Major Scientific and Technological Project; NSFC(National Natural Science Foundation of China (NSFC))	Supported by National Natural Science Foundation in China (NSFC) Grant 31401072.; Supported by Chinese Academy of Sciences Major Scientific and Technological Project XDA08010208 and NSFC Grants 31461163003, 91631102, and 31671315.	Asikainen TM, 2005, P NATL ACAD SCI USA, V102, P10212, DOI 10.1073/pnas.0504520102; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham AW, 2014, GENE DEV, V28, P2189, DOI 10.1101/gad.250167.114; Brenkman AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002819; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen JX, 2015, CELL SIGNAL, V27, P2314, DOI 10.1016/j.cellsig.2015.08.011; Chen Z, 2014, MOL CELL BIOL, V34, P1085, DOI 10.1128/MCB.00718-13; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Dansen TB, 2009, NAT CHEM BIOL, V5, P664, DOI 10.1038/nchembio.194; Du J, 2015, J IMMUNOL, V195, P1782, DOI 10.4049/jimmunol.1500588; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Feng X, 2011, EMBO J, V30, P3397, DOI 10.1038/emboj.2011.248; Ferber EC, 2012, CELL DEATH DIFFER, V19, P968, DOI 10.1038/cdd.2011.179; Gamper AM, 2012, MOL CELL, V45, P233, DOI 10.1016/j.molcel.2011.11.031; Gerez J, 2015, ONCOGENE, V34, P4855, DOI 10.1038/onc.2014.407; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Ji W, 2014, BIOCHEM J, V457, P185, DOI 10.1042/BJ20130793; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kim JJ, 2015, GENE DEV, V29, P2244, DOI 10.1101/gad.268128.115; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Liu D, 2014, J GENET GENOMICS, V41, P43, DOI 10.1016/j.jgg.2013.11.004; Liu JX, 2009, J BIOL CHEM, V284, P16679, DOI 10.1074/jbc.M109.009654; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nunez-O'Mara A, 2015, J CELL SCI, V128, P40, DOI 10.1242/jcs.151514; Okumura F, 2016, MOL CELL BIOL, V36, P1803, DOI 10.1128/MCB.00067-16; Onnis B, 2013, J CLIN INVEST, V123, P1615, DOI 10.1172/JCI59623; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Petousi N, 2014, J APPL PHYSIOL, V116, P875, DOI 10.1152/japplphysiol.00605.2013; Putker M, 2013, MOL CELL, V49, P730, DOI 10.1016/j.molcel.2012.12.014; Ratcliffe PJ, 2013, J PHYSIOL-LONDON, V591, P2027, DOI 10.1113/jphysiol.2013.251470; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Song D, 2014, J BIOL CHEM, V289, P14656, DOI 10.1074/jbc.M113.541227; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang J, 2014, MOL ENDOCRINOL, V28, P239, DOI 10.1210/me.2013-1258; Xie XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024469; Yang F, 2015, NEUROSCIENCE, V304, P250, DOI 10.1016/j.neuroscience.2015.07.051; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhou JG, 2009, J BIOL CHEM, V284, P19142, DOI 10.1074/jbc.M109.010439	62	17	21	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25692	25705		10.1074/jbc.M116.745471	http://dx.doi.org/10.1074/jbc.M116.745471			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27777301	Green Published, hybrid			2022-12-26	WOS:000390095300034
J	Jella, KK; Yu, L; Yue, Q; Friedman, D; Duke, BJ; Alli, AA				Jella, Kishore Kumar; Yu, Ling; Yue, Qiang; Friedman, Daniel; Duke, Billie J.; Alli, Abdel A.			Exosomal GAPDH from Proximal Tubule Cells Regulate ENaC Activity	PLOS ONE			English	Article							EPITHELIAL SODIUM-CHANNEL; XENOPUS 2F3 CELLS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; NA+ CHANNELS; INTRACELLULAR CALCIUM; ANIONIC PHOSPHOLIPIDS; GLYCOLYTIC-ENZYMES; GAMMA-SUBUNIT; A6 CELLS; PROTEIN	Exosomes are nanometer-scale, cell-derived vesicles that contain various molecules including nucleic acids, proteins, and lipids. These vesicles can release their cargo into adjacent or distant cells and mediate intercellular communication and cellular function. Here we examined the regulation of epithelial sodium channels in mpkCCD cells and distal tubule Xenopus 2F3 cells by exosomes isolated from proximal tubule LLC-PK1 cells. Cultured mpkCCD cells were stained with CTX coupled to a green fluorophore in order to label the cell membranes and freshly isolated exosomes from LLC-PK1 cells were labeled with the red lipophilic dye PKH26 in order to visualize uptake of exosomes into the cells. Single-channel patch clamp recordings showed the open probability of ENaC in Xenopus 2F3 cells and in freshly isolated split-open tubules decreased in response to exogenous application of exosomes derived from LLC-PK1 proximal tubule cells. Active GAPDH was identified within exosomes derived from proximal tubule LLC-PK1 cells. The effect on ENaC activity in Xenopus 2F3 cells was blunted after application of exosomes transfected with the GAPDH inhibitor heptelidic acid. Also, we show GAPDH and ENaC subunits associate in mpkCCD cells. These studies examine a potential role for exosomes in the regulation of ENaC activity and examine a possible mechanism for communication from proximal tubule cells to distal tubule and collecting duct cells.	[Alli, Abdel A.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL USA; [Alli, Abdel A.] Univ Florida, Coll Med, Dept Med, Div Nephrol Hypertens & Renal Transplantat, Gainesville, FL USA; [Jella, Kishore Kumar] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA USA; [Yue, Qiang; Friedman, Daniel; Duke, Billie J.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA USA; [Yu, Ling] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Emory University; Emory University; Nanjing Agricultural University	Alli, AA (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL USA.; Alli, AA (corresponding author), Univ Florida, Coll Med, Dept Med, Div Nephrol Hypertens & Renal Transplantat, Gainesville, FL USA.	aalli@ufl.edu			US National Aeronautics and Space Administration award [NNX15AD63G]; Robert P. Apkarian Integrated Electron Microscopy Core; Integrated Cellular Imaging Microscopy Core at Emory University;  [K01 DK099617]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK099617] Funding Source: NIH RePORTER	US National Aeronautics and Space Administration award; Robert P. Apkarian Integrated Electron Microscopy Core; Integrated Cellular Imaging Microscopy Core at Emory University; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a K01 DK099617 to MA, a US National Aeronautics and Space Administration award NNX15AD63G to WSD, and in part by the Robert P. Apkarian Integrated Electron Microscopy Core and the Integrated Cellular Imaging Microscopy Core at Emory University.	Alli AA, 2015, AM J PHYSIOL-RENAL, V309, pF456, DOI 10.1152/ajprenal.00631.2014; Alli AA, 2012, AM J PHYSIOL-RENAL, V303, pF800, DOI 10.1152/ajprenal.00703.2011; Alli AA, 2012, J BIOL CHEM, V287, P30073, DOI 10.1074/jbc.M111.338574; Antonyak MA, 2015, P NATL ACAD SCI USA, V112, P3589, DOI 10.1073/pnas.1502590112; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; Chen RW, 1999, J NEUROSCI, V19, P9654; Cueille N, 2007, J PROTEOME RES, V6, P2640, DOI 10.1021/pr070081z; Gildea JJ, 2014, CLIN BIOCHEM, V47, P89, DOI 10.1016/j.clinbiochem.2014.06.018; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; Haerteis S, 2012, PFLUG ARCH EUR J PHY, V464, P353, DOI 10.1007/s00424-012-1138-3; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Ilatovskaya DV, 2011, FASEB J, V25, P2688, DOI 10.1096/fj.10-167262; Jella KK, 2014, RADIAT RES, V181, P138, DOI 10.1667/RR13337.1; Jovov B, 1999, J BIOL CHEM, V274, P37845, DOI 10.1074/jbc.274.53.37845; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Ma HP, 2005, J AM SOC NEPHROL, V16, P3182, DOI 10.1681/ASN.2005040434; Ma HP, 2002, AM J PHYSIOL-RENAL, V282, pF501, DOI 10.1152/ajprenal.00147.2001; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Malik B, 2006, AM J PHYSIOL-RENAL, V290, pF1285, DOI 10.1152/ajprenal.00432.2005; Mazzochi C, 2006, AM J PHYSIOL-RENAL, V291, pF1113, DOI 10.1152/ajprenal.00195.2006; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; MINASCHEK G, 1992, EUR J CELL BIOL, V58, P418; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Patel AB, 2012, AM J PHYSIOL-RENAL, V303, pF540, DOI 10.1152/ajprenal.00133.2012; Patterson RL, 2005, P NATL ACAD SCI USA, V102, P1357, DOI 10.1073/pnas.0409657102; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reifenberger MS, 2014, AM J PHYSIOL-RENAL, V307, pF86, DOI 10.1152/ajprenal.00251.2013; Renigunta A, 2011, CELL PHYSIOL BIOCHEM, V28, P663, DOI 10.1159/000335761; ROBBINS AR, 1995, J CELL BIOL, V130, P1093, DOI 10.1083/jcb.130.5.1093; Sun Y, 2011, ACTA PHARMACOL SIN, V32, P789, DOI 10.1038/aps.2011.72; Taruno A, 2008, AM J PHYSIOL-RENAL, V294, pF177, DOI 10.1152/ajprenal.00250.2007; Thai TL, 2015, J BIOL CHEM, V290, P28805, DOI 10.1074/jbc.M115.668293; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; van Balkom BWM, 2011, KIDNEY INT, V80, P1138, DOI 10.1038/ki.2011.292; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zeringer Emily, 2015, Cold Spring Harb Protoc, V2015, P319, DOI 10.1101/pdb.top074476	44	45	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165763	10.1371/journal.pone.0165763	http://dx.doi.org/10.1371/journal.pone.0165763			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802315	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200050
J	Kim, SP; Broussard, JL; Kolka, CM				Kim, Stella P.; Broussard, Josiane L.; Kolka, Cathryn M.			Isoflurane and Sevoflurane Induce Severe Hepatic Insulin Resistance in a Canine Model	PLOS ONE			English	Article							GLUCOSE-HOMEOSTASIS; METABOLIC SYNDROME; FATTY-ACID; ANESTHESIA; DOGS; HALOTHANE; SKELETAL; SURGERY; LIVER	Introduction Anesthesia induces insulin resistance, which may contribute to elevated blood glucose and adverse post-operative outcomes in critically ill patients, and impair glycemic control in surgical patients with diabetes. However, little is known about the mechanisms by which anes-thesia impairs insulin sensitivity. Here we investigate the effects of anesthesia on insulin sensitivity in metabolic tissues. Methods Hyperinsulinemic-euglycemic clamps were performed in 32 lean (control diet; n = 16 conscious versus n = 16 anesthetized) and 24 fat-fed (6 weeks fat-feeding; n = 16 conscious versus n = 8 anesthetized) adult male mongrel dogs in conjunction with tracer methodology to differentiate hepatic versus peripheral insulin sensitivity. Propofol was administered as an intravenous bolus (3mg/kg) to initiate anesthesia, which was then maintained with inhaled sevoflurane or isoflurane (2-3%) for the duration of the procedure. Results Anesthesia reduced peripheral insulin sensitivity by approximately 50% in both lean and fat-fed animals as compared to conscious animals, and insulin action at the liver was almost completely suppressed during anesthesia such that hepatic insulin sensitivity was decreased by 75.5% and; 116.2% in lean and fat-fed groups, respectively. Conclusion Inhaled anesthesia induces severe hepatic insulin resistance in a canine model. Countermeasures that preserve hepatic insulin sensitivity may represent a therapeutic target that could improve surgical outcomes in both diabetic and healthy patients.	[Kim, Stella P.; Broussard, Josiane L.; Kolka, Cathryn M.] Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA; [Broussard, Josiane L.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	Cedars Sinai Medical Center; University of Colorado System; University of Colorado Boulder	Kolka, CM (corresponding author), Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA.	Cathryn.Kolka@cshs.org	Kolka, Cathryn/B-1526-2015	Kolka, Cathryn/0000-0002-6636-7062	NIH [DK29867, DK27619]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK29867 and DK27619. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behdad S, 2014, DIABETES METAB J, V38, P311, DOI 10.4093/dmj.2014.38.4.311; Bergman RN, 2007, DIABETES, V56, P1489, DOI 10.2337/db07-9903; Broussard JL, 2016, OBESITY SIL IN PRESS; CARMICHAEL FJ, 1993, ANESTHESIOLOGY, V79, P1051, DOI 10.1097/00000542-199311000-00024; Dalal A, 2013, HEPATIC SURG INTECH, DOI [10.1152/ajpendo.00466.2009, DOI 10.1152/AJPENDO.00466.2009]; DILTOER M, 1988, ANESTHESIOLOGY, V68, P880, DOI 10.1097/00000542-198806000-00008; FINEGOOD DT, 1987, DIABETES, V36, P914, DOI 10.2337/diabetes.36.8.914; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; Grundmann U, 1997, ACTA ANAESTH SCAND, V41, P760, DOI 10.1111/j.1399-6576.1997.tb04780.x; HORBER FF, 1990, ANESTHESIOLOGY, V73, P82, DOI 10.1097/00000542-199007000-00013; Ionut V, 2010, AM J PHYSIOL-ENDOC M, V298, pE38, DOI 10.1152/ajpendo.00466.2009; Iwasaka H, 1996, CAN J ANAESTH, V43, P1059, DOI 10.1007/BF03011909; Kim SP, 2003, DIABETES, V52, P2453, DOI 10.2337/diabetes.52.10.2453; Kolka CM, 2015, AM J PHYSIOL-ENDOC M, V308, pE1001, DOI 10.1152/ajpendo.00015.2015; Kratzing C, 2011, P NUTR SOC, V70, P311, DOI 10.1017/S0029665111000450; Mittelman SD, 2000, DIABETES, V49, P2116, DOI 10.2337/diabetes.49.12.2116; Ouattara A, 2005, ANESTHESIOLOGY, V103, P687, DOI 10.1097/00000542-200510000-00006; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; REBRIN K, 1995, DIABETES, V44, P1038, DOI 10.2337/diabetes.44.9.1038; Schricker T, 2001, J APPL PHYSIOL, V91, P2523, DOI 10.1152/jappl.2001.91.6.2523; Tanaka Tadashi, 2005, J Anesth, V19, P277, DOI 10.1007/s00540-005-0341-1; Topal A, 2003, J VET MED A, V50, P530, DOI 10.1111/j.1439-0442.2004.00589.x; Verkest KR, 2014, VET J, V199, P24, DOI 10.1016/j.tvjl.2013.09.057; Yasuda Y, 2013, BIOCHEM BIOPH RES CO, V431, P81, DOI 10.1016/j.bbrc.2012.12.084	24	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0163275	10.1371/journal.pone.0163275	http://dx.doi.org/10.1371/journal.pone.0163275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802272	gold, Green Published, Green Submitted			2022-12-26	WOS:000386714200003
J	Sastre, N; Francino, O; Curti, JN; Armenta, TC; Fraser, DL; Kelly, RM; Hunt, E; Silbermayr, K; Zewe, C; Sanchez, A; Ferrer, L				Sastre, Natalia; Francino, Olga; Curti, Joseph N.; Armenta, Tiffany C.; Fraser, Devaughn L.; Kelly, Rochelle M.; Hunt, Erin; Silbermayr, Katja; Zewe, Christine; Sanchez, Armand; Ferrer, Lluis			Detection, Prevalence and Phylogenetic Relationships of Demodex spp and further Skin Prostigmata Mites (Acari, Arachnida) in Wild and Domestic Mammals	PLOS ONE			English	Article							NATURAL TRANSMISSION; GENE-SEQUENCES; GENOMIC DNA; FOLLICULORUM; DEMODICOSIS; EXTRACTION; SOFTWARE; BIOLOGY; CANIS; MODEL	This study was conceived to detect skin mites in social mammals through real-time qPCR, and to estimate taxonomic Demodex and further Prostigmata mite relationships in different host species by comparing sequences from two genes: mitochondrial 16S rRNA and nuclear 18S rRNA. We determined the mite prevalence in the hair follicles of marmots (13%) and bats (17%). The high prevalence found in marmots and bats by sampling only one site on the body may indicate that mites are common inhabitants of their skin. Since we found three different mites (Neuchelacheles sp, Myobia sp and Penthaleus sp) in three bat species (Miotis yumanensis, Miotis californicus and Corynorhinus townsendii) and two different mites (both inferred to be members of the Prostigmata order) in one marmot species (Marmota flaviventris), we tentatively concluded that these skin mites 1) cannot be assigned to the same genus based only on a common host, and 2) seem to evolve according to the specific habitat and/or specific hair and sebaceous gland of the mammalian host. Moreover, two M. yumanensis bats harbored identical Neuchelacheles mites, indicating the possibility of interspecific cross-infection within a colony. However, some skin mites species are less restricted by host species than previously thought. Specifically, Demodex canis seems to be more transmissible across species than other skin mites. D. canis have been found mostly in dogs but also in cats and captive bats. In addition, we report the first case of D. canis infestation in a domestic ferret (Mustela putorius). All these mammalian hosts are related to human activities, and D. canis evolution may be a consequence of this relationship. The monophyletic Demodex clade showing closely related dog and human Demodex sequences also supports this likely hypothesis.	[Sastre, Natalia; Curti, Joseph N.; Armenta, Tiffany C.; Fraser, Devaughn L.; Sanchez, Armand] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Sastre, Natalia; Francino, Olga] Univ Autonoma Barcelona, Ser Vet Genet Mol, Bellaterra, Spain; [Armenta, Tiffany C.] Rocky Mt Biol Labs, Crested Butte, CO USA; [Kelly, Rochelle M.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Hunt, Erin] Calif Wolf Ctr, Julian, CA USA; [Silbermayr, Katja] Vetmeduni Vienna, Inst Parasitol, Dept Pathobiol, Vienna, Austria; [Zewe, Christine; Ferrer, Lluis] Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA USA	University of California System; University of California Los Angeles; Autonomous University of Barcelona; University of Washington; University of Washington Seattle; University of Veterinary Medicine Vienna; Tufts University	Sastre, N (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA.; Sastre, N (corresponding author), Univ Autonoma Barcelona, Ser Vet Genet Mol, Bellaterra, Spain.	natalia.sastre@uab.cat	Francino, Olga/K-5683-2017; Curti, Joseph/AAZ-5011-2020; Armenta, Tiffany C/M-9612-2017; Sanchez, Armand/L-7905-2015; ferrer, lluis/ABE-5179-2020	Francino, Olga/0000-0002-9022-3835; Curti, Joseph/0000-0003-4630-9073; Armenta, Tiffany C/0000-0002-5000-5315; Sanchez, Armand/0000-0001-9160-1124; ferrer, lluis/0000-0003-1537-0074; Sastre Alaiz, Natalia/0000-0002-0758-9124	University of California, Los Angeles	University of California, Los Angeles(University of California System)	We are grateful to the personnel from the California Wolf Center, especially to Norm Switzer, for supplying wolf hair samples. We thank Ivan Ravera and Diana Ferreira from the Veterinary School, Universitat Autonoma de Barcelona for describing morphologically the Demodex samples and Melissa Nashat from the Rockefeller University, Memorial Sloan-Kettering Cancer Center for providing the 18S rDNA primers. Thanks are due also to Robert K. Wayne from the University of California, Los Angeles for supporting this research.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Alvarez L, 2007, ANN TROP MED PARASIT, V101, P529, DOI 10.1179/136485907X193888; ARMITAGE KB, 1991, ANNU REV ECOL SYST, V22, P379, DOI 10.1146/annurev.es.22.110191.002115; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Beale K, 2012, J FELINE MED SURG, V14, P209, DOI 10.1177/1098612X12439268; Bochkov AV, 2004, INVERTEBR SYST, V18, P547, DOI 10.1071/IS04013; Brigham RM, 1997, J MAMMAL, V78, P1231, DOI 10.2307/1383066; Cao Yong-Sheng, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P271; CONROY JD, 1982, J AM ANIM HOSP ASSOC, V18, P405; de Rojas M, 2012, PARASITOL RES, V110, P227, DOI 10.1007/s00436-011-2476-3; DESCH C, 1972, J PARASITOL, V58, P169, DOI 10.2307/3278267; DESCH C, 1979, CORNELL VET, V69, P280; Desch CE, 2003, J MED ENTOMOL, V40, P146, DOI 10.1603/0022-2585-40.2.146; Desch Clifford E. Jr., 1996, International Journal of Acarology, V22, P187; Erbagci Z, 1998, INT J DERMATOL, V37, P421, DOI 10.1046/j.1365-4362.1998.00218.x; FAIN A, 1994, INT J PARASITOL, V24, P1273, DOI 10.1016/0020-7519(94)90194-5; Feldman SH, 2011, COMPARATIVE MED, V61, P484; Ferreira D, 2015, VET DERMATOL, V26, P239, DOI 10.1111/vde.12206; FISHER WF, 1980, VET PARASITOL, V7, P233, DOI 10.1016/0304-4017(80)90027-8; Frank LA, 2013, VET DERMATOL, V24, P367, DOI 10.1111/vde.12030; FRASE B A, 1980, Mammalian Species, P1, DOI 10.2307/3503965; GARVEN HSD, 1946, LANCET, V251, P44; GREVE JH, 1966, J AM VET MED ASSOC, V148, P1043; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ivarez-Castaneda S., 2008, MYOTIS LUCIFUGUS THE; Izdebska JN, 2014, J PARASITOL, V100, P784, DOI 10.1645/14-532.1; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kethley JB, 1982, ACARIFORMES SYNOPSIS, P117; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kligman AM, 2011, J INVEST DERMATOL, V131, P8, DOI 10.1038/jid.2010.335; Klompen H, 2007, MOL PHYLOGENET EVOL, V43, P936, DOI 10.1016/j.ympev.2006.10.024; Lacey N, 2011, DERMATOLOGY, V222, P128, DOI 10.1159/000323009; Lankton JS, 2013, J ZOO WILDLIFE MED, V44, P124, DOI 10.1638/1042-7260-44.1.124; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindquist EE, 1996, ERIOPHYOID MITES THE, V6, P301, DOI DOI 10.1016/S1572-4379(96)80019-4; Lowenstein C, 2005, VET REC, V157, P290, DOI 10.1136/vr.157.10.290; Mangold AJ, 1998, PARASITOL RES, V84, P31, DOI 10.1007/s004360050352; Mangold AJ, 1998, PARASITOL RES, V84, P478, DOI 10.1007/s004360050433; Mech LD, 1999, CAN J ZOOL, V77, P1196, DOI 10.1139/cjz-77-8-1196; Mech LD, 1970, THE WOLF THE ECOLOGY; Mueller RS, 2004, VET DERMATOL, V15, P75, DOI 10.1111/j.1365-3164.2004.00344.x; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nei M, 1975, MOL POPULATION GENET; NUTTING W B, 1975, New Zealand Journal of Zoology, V2, P219; NUTTING WB, 1976, CORNELL VET, V66, P214; Palopoli MF, 2015, P NATL ACAD SCI USA, V112, P15958, DOI 10.1073/pnas.1512609112; Palopoli MF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1124; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ravera I, 2013, VET DERMATOL, V24, P168, DOI 10.1111/j.1365-3164.2012.01099.x; Ravera I, 2011, PARASITOL RES, V108, P305, DOI 10.1007/s00436-010-2062-0; Saridomichelakis M, 1999, J SMALL ANIM PRACT, V40, P529, DOI 10.1111/j.1748-5827.1999.tb03014.x; Sastre N, 2013, PARASITOL RES, V112, P3369, DOI 10.1007/s00436-013-3531-z; Sastre N, 2012, VET DERMATOL, V23, DOI 10.1111/vde.12001; Scott D, 2001, PARASITIC SKIN DIS M, P457; Silbermayr K, 2015, PARASITOL RES, V114, P747, DOI 10.1007/s00436-014-4243-8; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thoemmes MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106265; Toops E, 2010, INT J APPL RES VET M, V8, P31; Tsao WC, 2008, ZOOL STUD, V47, P633; Umina PA, 2004, EXP APPL ACAROL, V34, P211, DOI 10.1007/s10493-004-1804-z; Woolley TA, 1988, ACAROLOGY MITES AND; Yabsley Michael J, 2013, ISRN Parasitol, V2013, P342918, DOI 10.5402/2013/342918; Zhao YE, 2012, PARASITOL RES, V111, P1113, DOI 10.1007/s00436-012-2941-7; Zhao YE, 2012, EXP PARASITOL, V131, P45, DOI 10.1016/j.exppara.2012.02.025; Zhao Ya-E, 2009, Acta Entomologica Sinica, V52, P1273; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429	69	17	18	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165765	10.1371/journal.pone.0165765	http://dx.doi.org/10.1371/journal.pone.0165765			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802314	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200051
J	Christopher, A; Hameister, H; Corrigall, H; Ebenhoh, O; Muller, B; Ullner, E				Christopher, Andrea; Hameister, Heike; Corrigall, Holly; Ebenhoeh, Oliver; Mueller, Berndt; Ullner, Ekkehard			Modelling Robust Feedback Control Mechanisms That Ensure Reliable Coordination of Histone Gene Expression with DNA Replication	PLOS ONE			English	Article							LOOP BINDING-PROTEIN; MESSENGER-RNA METABOLISM; HELA-CELL CYCLE; S-PHASE; TRIGGERS DEGRADATION; MAMMALIAN-CELLS; IN-VITRO; U7 SNRNP; HINF-P; SLBP	Histone proteins are key elements in the packing of eukaryotic DNA into chromosomes. A little understood control system ensures that histone gene expression is balanced with DNA replication so that histone proteins are produced in appropriate amounts. Disturbing or disrupting this system affects genome stability and gene expression, and has detrimental consequences for human development and health. It has been proposed that feedback control involving histone proteins contributes to this regulation and there is evidence implicating cell cycle checkpoint molecules activated when DNA synthesis is impaired in this control. We have developed mathematical models that incorporate these control modes in the form of inhibitory feedback of histone gene expression from free histone proteins, and alternatively a direct link that couples histone RNA synthesis to DNA synthesis. Using our experimental evidence and related published data we provide a simplified description of histone protein synthesis during S phase. Both models reproduce the coordination of histone gene expression with DNA replication during S phase and the down-regulation of histone RNA when DNA synthesis is interrupted, but only the model incorporating histone protein feedback control was able to effectively simulate the coordinate expression of a simplified histone gene family. Our combined theoretical and experimental approach supports the hypothesis that the regulation of histone gene expression involves feedback control.	[Christopher, Andrea; Corrigall, Holly; Ebenhoeh, Oliver; Mueller, Berndt; Ullner, Ekkehard] Univ Aberdeen Foresterhill, Inst Med Sci, Sch Med Med Sci & Nutr, Aberdeen, Scotland; [Hameister, Heike; Ullner, Ekkehard] Univ Aberdeen, Dept Phys SUPA, Aberdeen, Scotland; [Hameister, Heike; Ullner, Ekkehard] Univ Aberdeen, ICSMB, Aberdeen, Scotland; [Ebenhoeh, Oliver] Univ Dusseldorf, Inst Quantitat & Theoret Biol, Cluster Excellence Plant Sci CEPLAS, Dusseldorf, Germany; [Hameister, Heike] Merck Serono GmbH, Darmstadt, Germany	University of Aberdeen; University of Aberdeen; University of Aberdeen; Heinrich Heine University Dusseldorf; University of Cologne; Merck KGaA; EMD Serono Inc.	Ebenhoh, O; Muller, B; Ullner, E (corresponding author), Univ Aberdeen Foresterhill, Inst Med Sci, Sch Med Med Sci & Nutr, Aberdeen, Scotland.; Ullner, E (corresponding author), Univ Aberdeen, Dept Phys SUPA, Aberdeen, Scotland.; Ullner, E (corresponding author), Univ Aberdeen, ICSMB, Aberdeen, Scotland.; Ebenhoh, O (corresponding author), Univ Dusseldorf, Inst Quantitat & Theoret Biol, Cluster Excellence Plant Sci CEPLAS, Dusseldorf, Germany.	oliver.ebenhoeh@hhu.de; b.mueller@abdn.ac.uk; e.ullner@abdn.ac.uk		Muller, Berndt/0000-0003-1279-5421	University of Aberdeen through a Milner Studentship; University of Aberdeen; Deutsche Forschungsgemeinschaft [Cluster of Excellence on Plant Sciences, CEPLAS] [EXC 1028]; Scottish Universities Life Sciences Alliance (SULSA)	University of Aberdeen through a Milner Studentship; University of Aberdeen; Deutsche Forschungsgemeinschaft [Cluster of Excellence on Plant Sciences, CEPLAS]; Scottish Universities Life Sciences Alliance (SULSA)	Andrea Christopher was supported by the University of Aberdeen through a Milner Studentship. Heike Hameister was supported by a Postgraduate Research Studentship of the University of Aberdeen. Oliver Ebenhbh was supported by the University of Aberdeen and the Deutsche Forschungsgemeinschaft [Cluster of Excellence on Plant Sciences, CEPLAS (EXC 1028)]. Berndt Willer was supported by the University of Aberdeen. Ekkehard Ullner was supported by the Scottish Universities Life Sciences Alliance (SULSA). The funders provided support in the form of salaries for authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Heike Hameister is currently employed by Merck Serono GmbH. Merck Serono GmbH did not provide any support for this work and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	BANDYOPADHYAY R, 1987, BIOCHEMISTRY-US, V26, P2938, DOI 10.1021/bi00384a040; BARBU V, 1989, NUCLEIC ACIDS RES, V17, P7115, DOI 10.1093/nar/17.17.7115; BAUMBACH LL, 1987, BIOCHEMISTRY-US, V26, P6178, DOI 10.1021/bi00393a034; BAUMBACH LL, 1984, BIOCHEMISTRY-US, V23, P1618, DOI 10.1021/bi00303a006; Bieler J, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145218; Choe J, 2014, NUCLEIC ACIDS RES, V42, P9334, DOI 10.1093/nar/gku610; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DELISLE AJ, 1983, MOL CELL BIOL, V3, P1920, DOI 10.1128/MCB.3.11.1920; Djakbarova U, 2014, J CELL BIOCHEM, V115, P523, DOI 10.1002/jcb.24686; Dominski Z, 1999, MOL CELL BIOL, V19, P3561; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GALLINARI P, 1989, MOL CELL BIOL, V9, P1566, DOI 10.1128/MCB.9.4.1566; Gorgoni B, 2005, RNA, V11, P1030, DOI 10.1261/rna.7281305; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Hameister H., 2012, THESIS; HARRIS ME, 1991, MOL CELL BIOL, V11, P2416, DOI 10.1128/MCB.11.5.2416; HEINTZ N, 1983, MOL CELL BIOL, V3, P539, DOI 10.1128/MCB.3.4.539; HELMS S, 1984, FEBS LETT, V168, P65, DOI 10.1016/0014-5793(84)80207-0; Hoffmann J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102238; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kolev NG, 2005, GENE DEV, V19, P2583, DOI 10.1101/gad.1371105; Koseoglu MM, 2008, MOL CELL BIOL, V28, P4469, DOI 10.1128/MCB.01416-07; Koseoglu MM, 2010, CELL CYCLE, V9, P3857, DOI 10.4161/cc.9.19.13300; Krishnan N, 2012, MOL CELL BIOL, V32, P4306, DOI 10.1128/MCB.00382-12; KROEGER PE, 1995, J CELL BIOCHEM, V57, P191, DOI 10.1002/jcb.240570204; Lee KH, 2009, CHEMBIOCHEM, V10, P1313, DOI 10.1002/cbic.200900154; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; LUSCHER B, 1987, EMBO J, V6, P1721, DOI 10.1002/j.1460-2075.1987.tb02423.x; Martin F, 1997, EMBO J, V16, P769, DOI 10.1093/emboj/16.4.769; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; MCLAREN RS, 1993, J BIOL CHEM, V268, P14637; Miele A, 2005, MOL CELL BIOL, V25, P6140, DOI 10.1128/MCB.25.14.6140-6153.2005; Mitra P, 2003, MOL CELL BIOL, V23, P8110, DOI 10.1128/MCB.23.22.8110-8123.2003; MORRIS TD, 1991, MOL CELL BIOL, V11, P544, DOI 10.1128/MCB.11.1.544; Muller B, 2007, J CELL BIOL, V179, P1385, DOI 10.1083/jcb.200708106; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Muller B, 1997, SEMIN CELL DEV BIOL, V8, P567, DOI 10.1006/scdb.1997.0182; PELTZ SW, 1987, MOL CELL BIOL, V7, P4345, DOI 10.1128/MCB.7.12.4345; Pirngruber J, 2010, ONCOGENE; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; PLUMB M, 1983, NUCLEIC ACIDS RES, V11, P7927, DOI 10.1093/nar/11.22.7927; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Rattray AMJ, 2012, BIOCHEM SOC T, V40, P880, DOI 10.1042/BST20120065; Romeo V, 2016, CURR OPIN CELL BIOL, V40, P23, DOI 10.1016/j.ceb.2016.01.015; Sanchez R, 2002, MOL CELL BIOL, V22, P7093, DOI 10.1128/MCB.22.20.7093-7104.2002; Singh RK, 2010, CELL CYCLE, V9, P4236, DOI 10.4161/cc.9.20.13636; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; SITTMAN DB, 1983, P NATL ACAD SCI-BIOL, V80, P1849, DOI 10.1073/pnas.80.7.1849; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Takami Y, 1997, J MOL BIOL, V265, P394, DOI 10.1006/jmbi.1996.0733; TAKAMI Y, 1995, J MOL BIOL, V250, P420, DOI 10.1006/jmbi.1995.0387; Wagner EJ, 2005, BIOCHEM SOC T, V33, P471, DOI 10.1042/BST0330471; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Whitfield ML, 2004, NUCLEIC ACIDS RES, V32, P4833, DOI 10.1093/nar/gkh798; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Zhang MY, 2012, BIOCHEMISTRY-US, V51, P3215, DOI 10.1021/bi2018255; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhao XJ, 2004, J CELL SCI, V117, P6043, DOI 10.1242/jcs.01523; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zheng LX, 2003, MOL CELL BIOL, V23, P1590, DOI 10.1128/MCB.23.5.1590-1601.2003	66	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165848	10.1371/journal.pone.0165848	http://dx.doi.org/10.1371/journal.pone.0165848			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798685	Green Submitted, Green Published, gold			2022-12-26	WOS:000386711100070
J	Chung, CJ; Cha, SH; Grimm, AL; Chung, G; Gibson, KA; Yoon, KJ; Parish, SM; Ho, CS; Lee, SS				Chung, Chungwon J.; Cha, Sang-Ho; Grimm, Amanda L.; Chung, Grace; Gibson, Kathleen A.; Yoon, Kyoung-Jin; Parish, Steven M.; Ho, Chak-Sum; Lee, Stephen S.			Recognition of Highly Diverse Type-1 and-2 Porcine Reproductive and Respiratory Syndrome Viruses (PRRSVs) by T-Lymphocytes Induced in Pigs after Experimental Infection with a Type-2 PRRSV Strain	PLOS ONE			English	Article							CELL EPITOPES; MOLECULAR CHARACTERIZATION; NONSTRUCTURAL PROTEINS; SWINE INFERTILITY; IMMUNE-RESPONSES; PASSIVE TRANSFER; EFFICACY; VACCINE; IDENTIFICATION; PATHOGENICITY	Background/Aim Live attenuated vaccines confer partial protection in pigs before the appearance of neutralizing antibodies, suggesting the contribution of cell-mediated immunity (CMI). However, PRRSV-specific T-lymphocyte responses and protective mechanisms need to be further defined. To this end, the hypothesis was tested that PRRSV-specific T-lymphocytes induced by exposure to type-2 PRRSV can recognize diverse isolates. Methods An IFN-gamma ELISpot assay was used to enumerate PRRSV-specific T-lymphocytes from PRRSVSD23983-infected gilts and piglets born after in utero infection against 12 serologically and genetically distinct type-1 and -2 PRRSV isolates. The IFN-gamma ELISpot assay using synthetic peptides spanning all open reading frames of PRRSVSD23983 was utilized to localize epitopes recognized by T-lymphocytes. Virus neutralization tests were carried out using the challenge strain (type-2 PRRSVSD23983) and another strain (type-2 PRRSVVR2332) with high genetic similarity to evaluate cross-reactivity of neutralizing antibodies in gilts after PRRSVSD23983 infection. Results At 72 days post infection, T-lymphocytes from one of three PRRSVSD23983-infected gilts recognized all 12 diverse PRRSV isolates, while T-lymphocytes from the other two gilts recognized all but one isolate. Furthermore, five of nine 14-day-old piglets infected in utero with PRRSVSD23983 had broadly reactive T-lymphocytes, including one piglet that recognized all 12 isolates. Overlapping peptides encompassing all open reading frames of PRRSVSD23983 were used to identify >= 28 peptides with T-lymphocyte epitopes from 10 viral proteins. This included one peptide from the M protein that was recognized by T-lymphocytes from all three gilts representing two completely mismatched MHC haplotypes. In contrast to the broadly reactive T-lymphocytes, neutralizing antibody responses were specific to the infecting PRRSVSD23983 isolate. Conclusion These results demonstrated that T-lymphocytes recognizing antigenically and genetically diverse isolates were induced by infection with a type 2 PRRSV strain (SD23983). If these reponses have cytotoxic or other protective functions, they may help overcome the suboptimal heterologous protection conferred by conventional vaccines.	[Chung, Chungwon J.; Grimm, Amanda L.; Chung, Grace] VMRD Inc, Pullman, WA 99163 USA; [Chung, Chungwon J.; Chung, Grace] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99163 USA; [Cha, Sang-Ho] Anim & Plant Quarantine Agcy, Dept Virol, Anyang, South Korea; [Gibson, Kathleen A.; Yoon, Kyoung-Jin] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA; [Parish, Steven M.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99163 USA; [Ho, Chak-Sum] Gift Life Michigan, Ann Arbor, MI 48108 USA; [Lee, Stephen S.] Univ Idaho, Dept Stat, Moscow, ID 83844 USA	Washington State University; Animal & Plant Quarantine Agency; Iowa State University; Washington State University; Idaho; University of Idaho	Chung, CJ (corresponding author), VMRD Inc, Pullman, WA 99163 USA.; Chung, CJ (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99163 USA.	chungcw@vetmed.wsu.edu		Chung, Chungwon/0000-0002-4525-5539	Animal and Plant Quarantine Agency, Republic of Korea [QIA I-1541780-2012-14-03]	Animal and Plant Quarantine Agency, Republic of Korea	This work was supported by funding from Animal and Plant Quarantine Agency, Republic of Korea (QIA I-1541780-2012-14-03; http://qia.go.kr) given to CJC.; This work was supported by funding from Animal and Plant Quarantine Agency, Republic of Korea (QIA I-1541780-2012-14-03). The authors are grateful to Drs. Robert H. Mealey and Siddra Hines for critical review of manuscript, as well as Mr. TJ Heiniger and Ms. Jan Luft for providing assistance in animal care.	Allende R, 2000, J VIROL, V74, P10834, DOI 10.1128/JVI.74.22.10834-10837.2000; An TQ, 2011, EMERG INFECT DIS, V17, P1782, DOI 10.3201/eid1709.110411; An TQ, 2010, EMERG INFECT DIS, V16, P365, DOI 10.3201/eid1602.090005; Batista L, 2004, CAN J VET RES, V68, P267; Bautista EM, 1999, ARCH VIROL, V144, P117, DOI 10.1007/s007050050489; Brar MS, 2015, J GEN VIROL; Burgara-Estrella A, 2013, VIRUSES-BASEL, V5, P663, DOI 10.3390/v5020663; Charerntantanakul Wasin, 2012, World J Virol, V1, P23, DOI 10.5501/wjv.v1.i1.23; CHRISTIANSON WT, 1992, AM J VET RES, V53, P485; Chung C, 2015, PROCEEDING OF THE 7T, V66; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; Costers S, 2009, VET RES, V40, DOI 10.1051/vetres/2009029; Diaz I, 2009, VACCINE, V27, P5603, DOI 10.1016/j.vaccine.2009.07.029; Duan X, 1997, VET MICROBIOL, V56, P9, DOI 10.1016/S0378-1135(96)01347-8; Feng WH, 2001, J VIROL, V75, P4889, DOI 10.1128/JVI.75.10.4889-4895.2001; Fuertes LL, 1999, VIRUS RES, V64, P33, DOI 10.1016/S0168-1702(99)00073-8; Geldhof MF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-182; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han J, 2007, J VIROL, V81, P9878, DOI 10.1128/JVI.00562-07; Ho CS, 2010, ANIM GENET, V41, P428, DOI 10.1111/j.1365-2052.2010.02019.x; Ho CS, 2009, ANIM GENET, V40, P468, DOI 10.1111/j.1365-2052.2009.01860.x; Holtkamp DJ, 2011, INT PRRS S 86, V86; Jeong HJ, 2010, CLIN VACCINE IMMUNOL, V17, P503, DOI 10.1128/CVI.00365-09; Karniychuk UU, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-30; Kim WI, 2008, VIRUS GENES, V37, P380, DOI 10.1007/s11262-008-0278-1; Klinge KL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-177; Labarque GG, 2000, J GEN VIROL, V81, P1327, DOI 10.1099/0022-1317-81-5-1327; Leng X, 2012, CLIN VACCINE IMMUNOL, V19, P1199, DOI 10.1128/CVI.05646-11; Li B, 2009, EMERG INFECT DIS, V15, P2032, DOI 10.3201/eid1512.090390; Li J, 2012, VIROLOGY, V433, P367, DOI 10.1016/j.virol.2012.08.026; Li YH, 2014, P NATL ACAD SCI USA, V111, pE2172, DOI 10.1073/pnas.1321930111; Lopez OJ, 2007, CLIN VACCINE IMMUNOL, V14, P269, DOI 10.1128/CVI.00304-06; Mateu E, 2003, J GEN VIROL, V84, P529, DOI 10.1099/vir.0.18478-0; Meier WA, 2003, VIROLOGY, V309, P18, DOI 10.1016/S0042-6822(03)00009-6; Meng XJ, 2000, VET MICROBIOL, V74, P309, DOI 10.1016/S0378-1135(00)00196-6; Metwally S, 2010, TRANSBOUND EMERG DIS, V57, P315, DOI 10.1111/j.1865-1682.2010.01152.x; Mokhtar H, 2014, VACCINE, V32, P6828, DOI 10.1016/j.vaccine.2014.04.054; Morgan SB, 2013, VET MICROBIOL, V163, P13, DOI 10.1016/j.vetmic.2012.11.024; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Ni JQ, 2012, J VET DIAGN INVEST, V24, P349, DOI 10.1177/1040638711434111; Nielsen HS, 2001, J GEN VIROL, V82, P1263, DOI 10.1099/0022-1317-82-6-1263; Okuda Y, 2008, J VET MED SCI, V70, P1017, DOI 10.1292/jvms.70.1017; Opriessnig T, 2002, J VIROL, V76, P11837, DOI 10.1128/JVI.76.23.11837-11844.2002; Osorio FA, 2002, VIROLOGY, V302, P9, DOI 10.1006/viro.2002.1612; Parida R, 2012, VIRUS RES, V169, P13, DOI 10.1016/j.virusres.2012.06.024; Park C, 2014, VET MICROBIOL, V172, P432, DOI 10.1016/j.vetmic.2014.05.030; Petry DB, 2005, J ANIM SCI, V83, P1494; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Shi M, 2013, J VIROL, V87, P10904, DOI 10.1128/JVI.01270-13; Shi M, 2010, VIRUS RES, V154, P7, DOI 10.1016/j.virusres.2010.08.014; Shimizu M, 1996, VET IMMUNOL IMMUNOP, V50, P19, DOI 10.1016/0165-2427(95)05494-4; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tong GZ, 2007, EMERG INFECT DIS, V13, P1434, DOI 10.3201/eid1309.070399; Van Breedam W, 2010, J GEN VIROL, V91, P1659, DOI 10.1099/vir.0.020503-0; Van Gorp H, 2008, J GEN VIROL, V89, P2943, DOI 10.1099/vir.0.2008/005009-0; Vashisht K, 2008, VACCINE, V26, P4747, DOI 10.1016/j.vaccine.2008.06.047; Vu HLX, 2008, PROCEEDING OF CRWAD, P119; Wang YX, 2011, VIRUS RES, V158, P108, DOI 10.1016/j.virusres.2011.03.018; Weesendorp E, 2013, VET MICROBIOL, V163, P1, DOI 10.1016/j.vetmic.2012.09.013; Wei YW, 2013, VET MICROBIOL, V166, P337, DOI 10.1016/j.vetmic.2013.05.014; Welch SKW, 2010, VIRUS RES, V154, P98, DOI 10.1016/j.virusres.2010.07.018; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wu WH, 2001, VIROLOGY, V287, P183, DOI 10.1006/viro.2001.1034; Xiao ZG, 2004, J VIROL, V78, P5923, DOI 10.1128/JVI.78.11.5923-5933.2004; YOON KJ, 1995, J VET DIAGN INVEST, V7, P305, DOI 10.1177/104063879500700302; Zuckermann FA, 2007, VET MICROBIOL, V123, P69, DOI 10.1016/j.vetmic.2007.02.009	68	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165450	10.1371/journal.pone.0165450	http://dx.doi.org/10.1371/journal.pone.0165450			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798650	Green Submitted, Green Published, gold			2022-12-26	WOS:000386711100037
J	Everett, MV; Park, LK; Berntson, EA; Elz, AE; Whitmire, CE; Keller, AA; Clarke, ME				Everett, Meredith V.; Park, Linda K.; Berntson, Ewann A.; Elz, Anna E.; Whitmire, Curt E.; Keller, Aimee A.; Clarke, M. Elizabeth			Large-Scale Genotyping-by-Sequencing Indicates High Levels of Gene Flow in the Deep-Sea Octocoral Swiftia simplex (Nutting 1909) on the West Coast of the United States	PLOS ONE			English	Article							POPULATION-STRUCTURE; CONNECTIVITY; SOFTWARE; CONSERVATION; DISPERSAL; STACKS; REEFS; TOOL	Deep-sea corals are a critical component of habitat in the deep-sea, existing as regional hotspots for biodiversity, and are associated with increased assemblages of fish, including commercially important species. Because sampling these species is so difficult, little is known about the connectivity and life history of deep-sea octocoral populations. This study evaluates the genetic connectivity among 23 individuals of the deep-sea octocoral Swiftia simplex collected from Eastern Pacific waters along the west coast of the United States. We utilized high-throughput restriction-site associated DNA (RAD)-tag sequencing to develop the first molecular genetic resource for the deep-sea octocoral, Swiftia simplex. Using this technique we discovered thousands of putative genome-wide SNPs in this species, and after quality control, successfully genotyped 1,145 SNPs across individuals sampled from California to Washington. These SNPs were used to assess putative population structure across the region. A STRUCTURE analysis as well as a principal coordinates analysis both failed to detect any population differentiation across all geographic areas in these collections. Additionally, after assigning individuals to putative population groups geographically, no significant FST values could be detected (FST for the full data set 0.0056), and no significant isolation by distance could be detected (p = 0.999). Taken together, these results indicate a high degree of connectivity and potential panmixia in S. simplex along this portion of the continental shelf.	[Everett, Meredith V.] NOAA, Natl Res Council, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Park, Linda K.; Berntson, Ewann A.; Elz, Anna E.] NOAA, Conservat Biol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Whitmire, Curt E.; Keller, Aimee A.] NOAA, Fishery Resource Anal & Monitoring Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Clarke, M. Elizabeth] NOAA, Off Sci Director, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	National Academies of Sciences, Engineering & Medicine; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Everett, MV (corresponding author), NOAA, Natl Res Council, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	Meredith.Everett@noaa.gov			NOAA's Deep Sea Coral Research and Technology Program; National Oceanic and Atmospheric Administration's Deep Sea Coral Research and Technology Program (DSCRTP); DSCRTP	NOAA's Deep Sea Coral Research and Technology Program; National Oceanic and Atmospheric Administration's Deep Sea Coral Research and Technology Program (DSCRTP); DSCRTP	Support was provided by an Internal Grant from NOAA's Deep Sea Coral Research and Technology Program [http://deepseacoraldata.noaa.gov].; This research was supported by the the National Oceanic and Atmospheric Administration's Deep Sea Coral Research and Technology Program (DSCRTP). The authors would like to thank Tom Hourigan and the DSCRTP for supporting this project. The authors would also like to thank NOAA's RACE and FRAM divisions, plus the support staff and captains for the WCBTS and RACE trawl surveys as well as Lonny Lundsten and the Monterey Bay Aquarium Research Institute for their critical support in obtaining the samples used in this study.	[Anonymous], 2015, FASTQC QUAL CONTR TO; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bayer FM, 2001, P BIOL SOC WASH, V114, P309; Benestan L, 2015, MOL ECOL, V24, P3299, DOI 10.1111/mec.13245; Boehm JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116219; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Breedy O, 2014, J MAR BIOL ASSOC UK, V94, P493, DOI 10.1017/S0025315413001835; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Corander J, 2013, MOL ECOL, V22, P2931, DOI 10.1111/mec.12174; Costantini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061546; Costello MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051629; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feehan KA, 2015, J MAR BIOL ASSOC UK, V95, P691, DOI 10.1017/S0025315415000053; Graham CF, 2015, MOL ECOL RESOUR, V15, P1304, DOI 10.1111/1755-0998.12404; Herrera S, 2012, MOL ECOL, V21, P6053, DOI 10.1111/mec.12074; Herrera S, 2016, MOL PHYLOGENET EVOL, V100, P70, DOI 10.1016/j.ympev.2016.03.010; Hourigan T, 2015, 191 NOAA NOS NCCOS, V191, DOI [10.1016/j.dsr2.2013.05.027, DOI 10.1016/J.DSR2.2013.05.027]; Hourigan T. F., 2007, STATE DEEP CORAL ECO, P1; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jeffries DL, 2015, BIORXIV, DOI [10.1101/025973, DOI 10.1101/025973]; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jones GP, 2007, OCEANOGRAPHY, V20, P100, DOI 10.5670/oceanog.2007.33; Kahng SE, 2011, MAR ECOL PROG SER, V443, P265, DOI 10.3354/meps09414; Keller AA, 2012, FISH B-NOAA, V110, P205; Lacharite M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065394; Larson WA, 2014, EVOL APPL, V7, P355, DOI 10.1111/eva.12128; Lauth RR, 1997, 1996 PACIFIC W COAST, P156; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Lundsten L, 2009, MAR ECOL PROG SER, V374, P23, DOI 10.3354/meps07745; McFadden CS, 2011, MOL ECOL RESOUR, V11, P19, DOI 10.1111/j.1755-0998.2010.02875.x; Miller K, 2010, MAR ECOL-EVOL PERSP, V31, P144, DOI 10.1111/j.1439-0485.2010.00380.x; Morrison CL, 2011, CONSERV GENET, V12, P713, DOI 10.1007/s10592-010-0178-5; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Nutting CC, 1909, ALCYONARIA CALIFORNI; Palumbi SR, 2003, ECOL APPL, V13, pS146; Pante E, 2015, HEREDITY, V114, P450, DOI 10.1038/hdy.2014.105; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Pujolar JM, 2014, MOL ECOL, V23, P2514, DOI 10.1111/mec.12753; Quattrini AM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0008; Quattrini AM, 2014, DEEP-SEA RES PT II, V99, P92, DOI 10.1016/j.dsr2.2013.05.027; Reitzel AM, 2013, MOL ECOL, V22, P2953, DOI 10.1111/mec.12228; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Smilansky V, 2014, MAR BIOL, V161, P853, DOI 10.1007/s00227-013-2385-3; Stone RP, 2015, ICES J MAR SCI, V72, P900, DOI 10.1093/icesjms/fsu190; Stone RP, 2007, STATE DEEP CORAL ECO, P65; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Underwood JN, 2009, ECOL APPL, V19, P18, DOI 10.1890/07-1461.1; Whitmire CE, 2007, THE STATE OF DEEP, P365; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649; Wright EP, 2015, MAR ECOL-EVOL PERSP, V36, P659, DOI 10.1111/maec.12174	57	11	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165279	10.1371/journal.pone.0165279	http://dx.doi.org/10.1371/journal.pone.0165279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798660	gold, Green Published, Green Submitted			2022-12-26	WOS:000386711100024
J	Jang, SP; Oh, JG; Kang, DH; Kang, JY; Kang, SW; Hajjar, RJ; Park, WJ				Jang, Seung Pil; Oh, Jae Gyun; Kang, Dong Hoon; Kang, Ju Young; Kang, Sang Won; Hajjar, Roger J.; Park, Woo Jin			A Decoy Peptide Targeted to Protein Phosphatase 1 Attenuates Degradation of SERCA2a in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							SARCO/ENDOPLASMIC RETICULUM CA2+-ATPASE; PULMONARY ARTERIAL-HYPERTENSION; GENE-TRANSFER; HEART-FAILURE; SARCOPLASMIC-RETICULUM; PHOSPHOLAMBAN PHOSPHORYLATION; INTIMAL PROLIFERATION; CORONARY ANGIOPLASTY; CALPAIN; CALCIUM	Neointimal growth in the injured vasculature is largely facilitated by the proliferation of vascular smooth muscle cells (VSMC), which associates with reduced sarco/endoplasmic reticulum Ca2+-ATPase (SERCA2a) activity. The gene transfer-mediated restoration of the SERCA2a level thus attenuates neointimal growth and VSMC proliferation. We previously reported that a peptide targeted to protein phosphatase 1, psi PLB-SE, normalizes SERCA2a activity in cardiomyocytes. In this study, we found that psi PLB-SE attenuated neointimal growth in balloon-injured rat carotid arteries, and the proliferation and migration of VSMC cultured in high-serum media (synthetic conditions). In parallel, psi PLB-SE inhibited the degradation of SERCA2a in the injured carotid arteries and VSMC under synthetic conditions. The calpain inhibitor MDL28170 also attenuated SERCA2a degradation and VSMC proliferation under synthetic conditions, indicating that calpain degrades SERCA2a. The Ca2+ ionophore A23187 induced SERCA2a degradation in VSMC, which was blocked by either psi PLB-SE or MDL28170. Additionally, psi PLB-SE normalized the cytosolic Ca2+ level in VSMC that was increased by either A23187 or synthetic stimulation. Collectively, these data indicate that psi PLB-SE corrects the abnormal Ca2+ handling by activating SERCA2a, which further protects SERCA2a from calpain-dependent degradation in VSMC. We conclude that psi PLB-SE may form the basis of a therapeutic strategy for vascular proliferative disorders.	[Jang, Seung Pil; Kang, Ju Young; Park, Woo Jin] Gwangju Inst Sci & Technol, Coll Life Sci, Gwangju, South Korea; [Oh, Jae Gyun; Hajjar, Roger J.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA; [Kang, Dong Hoon; Kang, Sang Won] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea	Gwangju Institute of Science & Technology (GIST); Icahn School of Medicine at Mount Sinai; Ewha Womans University	Park, WJ (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, Gwangju, South Korea.	woojinpark@icloud.com			NIH [R01 HL117505, HL093183, P50 HL112324]; NHLBI Program of Excellence in Nano-Technology Award [HHSN268201000045C]; Bio & Medical Technology Development Program of NRF - Korean government [NRF-2015M3A9E6028951]; Basic Research Laboratory Program of NRF - Korean government [2016R1A4A1009895]; Systems Biology Infrastructure Establishment Grant by GIST; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL112324, R01HL117505, R01HL093183] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Program of Excellence in Nano-Technology Award; Bio & Medical Technology Development Program of NRF - Korean government; Basic Research Laboratory Program of NRF - Korean government; Systems Biology Infrastructure Establishment Grant by GIST; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Hajjar was funded by NIH grants (R01 HL117505, HL093183, and P50 HL112324) and a NHLBI Program of Excellence in Nano-Technology Award (HHSN268201000045C). Dr. Park was supported by the Bio & Medical Technology Development Program (NRF-2015M3A9E6028951) and the Basic Research Laboratory Program (2016R1A4A1009895) of NRF funded by the Korean government and a Systems Biology Infrastructure Establishment Grant provided by GIST.; Dr. Hajjar was funded by NIH grants (R01 HL117505, HL093183, and P50 HL112324) and a NHLBI Program of Excellence in Nano-Technology Award (HHSN268201000045C). Dr. Park was supported by the Bio & Medical Technology Development Program (NRF-2015M3A9E6028951) and the Basic Research Laboratory Program (2016R1A4A1009895) of NRF funded by the Korean government and a Systems Biology Infrastructure Establishment Grant provided by GIST.	Ariyoshi H, 1998, ARTERIOSCL THROM VAS, V18, P493, DOI 10.1161/01.ATV.18.3.493; AUSTIN GE, 1985, J AM COLL CARDIOL, V6, P369, DOI 10.1016/S0735-1097(85)80174-1; del Monte F, 2001, CIRCULATION, V104, P1424, DOI 10.1161/hc3601.095574; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Fernandez-Velasco M, 2014, CELL CALCIUM, V56, P397, DOI 10.1016/j.ceca.2014.08.007; Hadri L, 2013, CIRCULATION, V128, P512, DOI 10.1161/CIRCULATIONAHA.113.001585; Hadri L, 2010, MOL THER, V18, P1284, DOI 10.1038/mt.2010.77; HANKE H, 1992, HERZ, V17, P300; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Heijman J, 2012, WIEN MED WOCHENSCHR, V162, P287, DOI 10.1007/s10354-012-0109-9; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Khorchid A, 2002, NAT STRUCT BIOL, V9, P239, DOI 10.1038/nsb0402-239; Kuhr FK, 2012, AM J PHYSIOL-HEART C, V302, pH1546, DOI 10.1152/ajpheart.00944.2011; Lipskaia L, 2005, CIRC RES, V97, P488, DOI 10.1161/01.RES.0000180663.42594.aa; Lipskaia L, 2013, GENE THER, V20, P396, DOI 10.1038/gt.2012.50; Lipskaia L, 2014, CIRCULATION, V129, P773, DOI 10.1161/CIRCULATIONAHA.113.002565; LIU MW, 1989, CIRCULATION, V79, P1374, DOI 10.1161/01.CIR.79.6.1374; Lompre AM, 2013, GENE THER, V20, P901, DOI 10.1038/gt.2013.13; Lou Q, 2012, ADV EXP MED BIOL, V740, P1145, DOI 10.1007/978-94-007-2888-2_52; MACDOUGALL LK, 1991, EUR J BIOCHEM, V196, P725, DOI 10.1111/j.1432-1033.1991.tb15871.x; Matsumura Y, 2001, J MOL CELL CARDIOL, V33, P1133, DOI 10.1006/jmcc.2001.1373; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Nicolaou P, 2009, J MOL CELL CARDIOL, V47, P365, DOI 10.1016/j.yjmcc.2009.05.010; Novak K, 1998, NAT MED, V4, P989, DOI 10.1038/1965; Oh JG, 2013, J MOL CELL CARDIOL, V56, P63, DOI 10.1016/j.yjmcc.2012.12.005; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Sakata S, 2007, AM J PHYSIOL-HEART C, V292, pH2356, DOI 10.1152/ajpheart.01310.2006; Sande JB, 2002, CARDIOVASC RES, V53, P382, DOI 10.1016/S0008-6363(01)00489-8; Schwinger RHG, 1999, J MOL CELL CARDIOL, V31, P479, DOI 10.1006/jmcc.1998.0897; STEENAART NAE, 1992, ARCH BIOCHEM BIOPHYS, V293, P17, DOI 10.1016/0003-9861(92)90359-5; Thyberg J, 1999, LAB INVEST, V79, P1077; Vallot O, 2000, ARTERIOSCL THROM VAS, V20, P1225, DOI 10.1161/01.ATV.20.5.1225	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165569	10.1371/journal.pone.0165569	http://dx.doi.org/10.1371/journal.pone.0165569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792751	Green Submitted, Green Published, gold			2022-12-26	WOS:000389537000033
J	McCallum, AD; Nyirenda, D; Lora, W; Khoo, SH; Sloan, DJ; Mwandumba, HC; Desmond, N; Davies, GR				McCallum, Andrew D.; Nyirenda, Deborah; Lora, Wezzie; Khoo, Saye H.; Sloan, Derek J.; Mwandumba, Henry C.; Desmond, Nicola; Davies, Geraint R.			Perceptions of Research Bronchoscopy in Malawian Adults with Pulmonary Tuberculosis: A Cross-Sectional Study	PLOS ONE			English	Article							INFORMED-CONSENT; RESEARCH PARTICIPANTS; KENYAN COAST; FIBEROPTIC BRONCHOSCOPY; TRIAL; COMPLICATIONS; EXPERIENCES; COMMUNITIES	Bronchoscopy is an established research tool in Malawi, enabling collection of pulmonary samples for immunological, pharmacological, and microbiological studies. It is, however, an invasive clinical procedure that offers no direct benefit to volunteering participants when used in a research capacity alone, and thus informed consent is essential. This study aimed to explore TB patients' understanding of research bronchoscopy, what would motivate them to participate in research bronchoscopy, and their concerns, in order to inform consenting processes for future clinical studies. We used a qualitative research design. Two focus group discussions were conducted with community members and TB patients to understand their perceptions of bronchoscopy. Transcripts were coded by multiple coauthors and thematic content analysis was used to analyse main findings. We found that Malawian patients with pulmonary TB were willing to participate in a study using research bronchoscopy for health assessment and access to improved healthcare. We identified information of value to potential participants when consenting to that may lessen some of the anxieties expressed by participants. Patient and public involvement is essential to improve informed consent and institutional trust.	[McCallum, Andrew D.; Nyirenda, Deborah; Lora, Wezzie; Sloan, Derek J.; Mwandumba, Henry C.; Desmond, Nicola; Davies, Geraint R.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [McCallum, Andrew D.; Khoo, Saye H.; Sloan, Derek J.; Davies, Geraint R.] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [McCallum, Andrew D.; Davies, Geraint R.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [McCallum, Andrew D.; Nyirenda, Deborah; Sloan, Derek J.; Mwandumba, Henry C.; Desmond, Nicola] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Sloan, Derek J.] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England	University of Malawi; University of Liverpool; University of Liverpool; Liverpool School of Tropical Medicine; Liverpool Heart & Chest Hospital	McCallum, AD (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.; McCallum, AD (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England.; McCallum, AD (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.; McCallum, AD (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.	andrew.mccallum@lstmed.ac.uk	Desmond, Nicola/ABA-6504-2020; Desmond, Nicola/GYQ-8574-2022	Desmond, Nicola/0000-0002-2874-8569; Davies, Geraint/0000-0002-3819-490X; Sloan, Derek James/0000-0002-7888-5449; McCallum, Andrew/0000-0003-0814-3834; Nyirenda, Deborah/0000-0002-5867-4687	University of Liverpool Integrated Clinical Academic Training Programme; Wellcome Trust Clinical PhD Fellowship [105392/B/14/Z]; National Institute for Health Research [ACF-2013-07-011] Funding Source: researchfish	University of Liverpool Integrated Clinical Academic Training Programme; Wellcome Trust Clinical PhD Fellowship(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by University of Liverpool Integrated Clinical Academic Training Programme, experience at another institution, https://www.liverpool.ac.uk/integrated-clinical-academic-training/ (ADM); and Wellcome Trust Clinical PhD Fellowship, 105392/B/14/Z, http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/PhD-funding-and-undergraduate-opportunities/WTD037337.htm?utm_campaign=clinical_phd&utm_source=nature&utm_medum=print (ADM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the University of Liverpool Integrated Clinical Academic Training Programme, and a Wellcome Trust Clinical PhD Fellowship (105392/B/14/Z to A.D.M.). We would like to thank Mrs Rose Malamba, nurse-in-charge in the Clinical Investigation Unit, QECH, for her expertise in preparing a Chichewa information sheet. We would also like to thank all study participants for sharing their time and opinions so readily, without whom this work would not be possible.	Afolabi MO, 2014, TROP MED INT HEALTH, V19, P625, DOI 10.1111/tmi.12288; APPELBAUM PS, 1982, INT J LAW PSYCHIAT, V5, P319, DOI 10.1016/0160-2527(82)90026-7; Boulanger RF, 2013, LANCET INFECT DIS, V13, P540, DOI 10.1016/S1473-3099(13)70042-2; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; CREDLE WF, 1974, AM REV RESPIR DIS, V109, P67; Doshi MS, 2013, J MED ETHICS, V39, P391, DOI 10.1136/medethics-2012-100755; Dudley L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128817; Fernandez Conrad V, 2003, IRB, V25, P12, DOI 10.2307/3564300; Ives J, 2013, J MED ETHICS, V39, P181, DOI 10.1136/medethics-2011-100150; McGraw MJ, 2010, PRINCIPLES GOOD CLIN; Mfutso-Bengo J, 2015, J EMPIR RES HUM RES, V10, P59, DOI 10.1177/1556264614559888; Mfutso-Bengo J, 2008, MALAWI MED J, V20, P64; Mikesell L, 2013, AM J PUBLIC HEALTH, V103, pE7, DOI 10.2105/AJPH.2013.301605; Molyneux CS, 2005, SOC SCI MED, V61, P1463, DOI 10.1016/j.socscimed.2004.11.073; Molyneux CS, 2005, SOC SCI MED, V61, P443, DOI 10.1016/j.socscimed.2004.12.003; Molyneux CS, 2004, SOC SCI MED, V59, P2547, DOI 10.1016/j.socscimed.2004.03.037; Molyneux S, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-13; Mtunthama N, 2008, J MED ETHICS, V34, P303, DOI 10.1136/jme.2007.020461; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Partridge AH, 2002, JAMA-J AM MED ASSOC, V288, P363, DOI 10.1001/jama.288.3.363; Partridge AH, 2003, JNCI-J NATL CANCER I, V95, P491; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Preziosi MP, 1997, NEW ENGL J MED, V336, P370, DOI 10.1056/NEJM199701303360511; Ravitsky V, 2006, AM J BIOETHICS, V6, P8, DOI 10.1080/15265160600934772; Rose AS, 2007, SEMIN RESP CRIT CARE, V28, P561, DOI 10.1055/s-2007-991528; Snowdon C, 1998, BMJ-BRIT MED J, V317, P21, DOI 10.1136/bmj.317.7150.21; SURATT PM, 1976, CHEST, V69, P747, DOI 10.1378/chest.69.6.747; Thorogood A, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-88	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165734	10.1371/journal.pone.0165734	http://dx.doi.org/10.1371/journal.pone.0165734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3YA	27792765	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000389537000047
J	Boucheix, O; Blakytny, R; Haroutunian, G; Henriksson, M; Laporte, R; Milano, S; Reinheimer, TM				Boucheix, Olivier; Blakytny, Robert; Haroutunian, Gerard; Henriksson, Marie; Laporte, Regent; Milano, Stephane; Reinheimer, Torsten M.			Selepressin and Arginine Vasopressin Do Not Display Cardiovascular Risk in Atherosclerotic Rabbit	PLOS ONE			English	Article							SEPTIC SHOCK; FE 202158; INOTROPIC AGENTS; SEVERE SEPSIS; RHABDOMYOLYSIS; AGONIST; INFUSION; EPINEPHRINE; MORTALITY; NECROSIS	Background Septic shock remains associated with significant mortality rates. Arginine vasopressin (AVP) and analogs with V-1A receptor agonist activity are increasingly used to treat fluid resistant vasodilatory hypotension, including catecholamine-refractory septic shock. Clinical studies have been restricted to healthy volunteers and catecholamine-refractory septic shock patients excluding subjects with cardiac co-morbidities because of presumed safety issues. The novel selective V-1A receptor agonist selepressin, with short half-life, has been designed to avoid V-2 receptor-related complications and long-term V-1A receptor activation. Cardiovascular safety of selepressin, AVP, and the septic shock standard of care norepinephrine was investigated in a rabbit model of early-stage atherosclerosis. Methods Atherosclerosis was established in New Zealand White rabbits using a 1% cholesterol-containing diet. Selepressin, AVP, or norepinephrine was administered as cumulative intravenous infusion rates to atherosclerotic and non-atherosclerotic animals. Results Selepressin and AVP induced a slight dose-dependent increase in arterial pressure (AP) associated with a moderate decrease in heart rate, no change in stroke volume, and a moderate decrease in aortic blood flow (ABF). In contrast, norepinephrine induced a marked dose-dependent increase in AP associated with a lesser decrease in the heart rate, an increase in stroke volume, and a moderate increase in ABF. For all three vasopressors, there was no difference in responses between atherosclerotic and non-atherosclerotic animals. Conclusion Further studies should be considered using more advanced atherosclerosis models, including with septic shock, before considering septic shock clinical trials of patients with comorbidities. Here, selepressin and AVP treatments did not display relevant cardiovascular risk in early-stage rabbit atherosclerosis.	[Boucheix, Olivier] Charles River France, St Germain Sur Larbresle, France; [Blakytny, Robert] TransEdEng, Ulm, Germany; [Henriksson, Marie; Reinheimer, Torsten M.] Ferring Pharmaceut AS, Copenhagen, Denmark; [Laporte, Regent] Biotech & Pharma R&D Consultants, Laporte & Associates LLC, San Diego, CA USA; [Milano, Stephane] Double Strand Consulting, St Nizier Dazergues, France	Ferring Pharmaceuticals	Reinheimer, TM (corresponding author), Ferring Pharmaceut AS, Copenhagen, Denmark.	trr@ferring.com		Laporte, Regent/0000-0002-9308-2097	Ferring Pharmaceuticals A/S, Copenhagen, Denmark	Ferring Pharmaceuticals A/S, Copenhagen, Denmark(Ferring Pharmaceuticals)	This study was funded by Ferring Pharmaceuticals A/S, Copenhagen, Denmark, playing a role in its design, and personnel from the funder (MH, RL, TMR) contributed to preparation of the manuscript. The funder provided support in the form of salaries for authors MH, RB, RL, and TMR. The specific roles of these authors are articulated in the 'author contributions' section.	Agrawal A, 2012, INDIAN PEDIATR, V49, P297, DOI 10.1007/s13312-012-0046-0; Boucheix OB, 2013, SHOCK, V39, P533, DOI 10.1097/SHK.0b013e31828aac4b; CHENG CP, 1993, AM J PHYSIOL, V264, pH53, DOI 10.1152/ajpheart.1993.264.1.H53; Christaki E, 2008, CURR OPIN CRIT CARE, V14, P580, DOI 10.1097/MCC.0b013e32830f1e25; Collier B, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.05.003; COWLEY AW, 1982, INT REV PHYSIOL, V26, P189; Daly KA, 2011, TISSUE ENG PART C-ME, V17, P631, DOI 10.1089/ten.tec.2010.0699; Eisenburger P, 2000, WIEN KLIN WOCHENSCHR, V112, P174; Elshourbagy NA, 2014, MED PRIN PRACT, V23, P99, DOI 10.1159/000356856; Fang W, 2005, PHARMACOTHERAPY, V25, P1266, DOI 10.1592/phco.2005.25.9.1266; Gavel NT, 2011, ACTA PHYSIOL HUNG, V98, P273, DOI 10.1556/APhysiol.98.2011.3.4; Guillamet MCV, 2012, CURR INFECT DIS REP, V14, P493, DOI 10.1007/s11908-012-0279-z; Hasser EM, 1997, CLIN EXP PHARMACOL P, V24, P102, DOI 10.1111/j.1440-1681.1997.tb01791.x; JOCKERSWRETOU E, 1975, CLIN CHIM ACTA, V58, P223, DOI 10.1016/0009-8981(75)90441-6; Kampmeier TG, 2010, MINERVA ANESTESIOL, V76, P844; Karlsson S, 2007, INTENS CARE MED, V33, P435, DOI 10.1007/s00134-006-0504-z; Kaufmann JE, 2003, J THROMB HAEMOST, V1, P682, DOI 10.1046/j.1538-7836.2003.00190.x; Kim EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097841; Laporte R, 2008, CRIT CARE S2, V12, pP407; Laporte R, 2011, J PHARMACOL EXP THER, V337, P786, DOI 10.1124/jpet.111.178848; LESCH M, 1976, AM J CARDIOL, V37, P508, DOI 10.1016/0002-9149(76)90389-1; Lewandrowski KB, 2014, CLIN LAB MED, V34, P31, DOI 10.1016/j.cll.2013.11.001; Martin CM, 2009, CRIT CARE MED, V37, P81, DOI 10.1097/CCM.0b013e31819285f0; Maybauer MO, 2014, CRIT CARE MED, V42, pE525, DOI 10.1097/CCM.0000000000000300; MORENOSANCHEZ D, 1991, GASTROENTEROLOGY, V101, P529, DOI 10.1016/0016-5085(91)90034-I; NOTTERMAN DA, 1991, CRIT CARE CLIN, V7, P583, DOI 10.1016/S0749-0704(18)30297-5; NUSSEY SS, 1986, THROMB HAEMOSTASIS, V55, P34; Parrillo JE, 2008, NEW ENGL J MED, V358, P954, DOI 10.1056/NEJMe0800245; PIERCE ST, 1993, AM J GASTROENTEROL, V88, P424; Quenot JP, 2013, CRIT CARE, V17, DOI 10.1186/cc12598; Rehberg S, 2012, CRIT CARE MED, V40, P1957, DOI 10.1097/CCM.0b013e31824e0fe5; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Russell JA, 2009, CRIT CARE MED, V37, P811, DOI 10.1097/CCM.0b013e3181961ace; Spronk PE, 2004, CRIT CARE, V8, P462, DOI 10.1186/cc2894; Su FH, 2012, CRIT CARE MED, V40, pU41; TISDALE JE, 1995, ANN PHARMACOTHER, V29, P269, DOI 10.1177/106002809502900309; Wetterholm R, 2007, ULTRASOUND MED BIOL, V33, P720, DOI 10.1016/j.ultrasmedbio.2006.11.012; Wilfert K, 2000, HYPERTENSION, V35, P685, DOI 10.1161/01.HYP.35.2.685; Wisniewski K, 2011, J MED CHEM, V54, P4388, DOI 10.1021/jm200278m; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841	40	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165422	10.1371/journal.pone.0165422	http://dx.doi.org/10.1371/journal.pone.0165422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788216	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900080
J	Liu, KD; Siew, ED; Reeves, WB; Himmelfarb, J; Go, AS; Hsu, CY; Bennett, MR; Devarajan, P; Ikizler, TA; Kaufman, JS; Kimmel, PL; Chinchilli, VM; Parikh, CR				Liu, Kathleen D.; Siew, Edward D.; Reeves, W. Brian; Himmelfarb, Jonathan; Go, Alan S.; Hsu, Chi-yuan; Bennett, Michael R.; Devarajan, Prasad; Ikizler, T. Alp; Kaufman, James S.; Kimmel, Paul L.; Chinchilli, Vernon M.; Parikh, Chirag R.		ASSESS-AKI Study Investigators	Storage Time and Urine Biomarker Levels in the ASSESS-AKI Study	PLoS One			English	Article							ACUTE KIDNEY INJURY; LONG-TERM STORAGE; GELATINASE-ASSOCIATED LIPOCALIN; MOLECULE-1 KIM-1; ALBUMIN; NGAL; DISEASE; SAMPLES; -20-DEGREES-C; PREVALENCE	Background Although stored urine samples are often used in biomarker studies focused on acute and chronic kidney disease, how storage time impacts biomarker levels is not well understood. Methods 866 subjects enrolled in the NIDDK-sponsored ASsessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study were included. Samples were processed under standard conditions and stored at -70 degrees C until analyzed. Kidney injury molecule- 1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18 (IL-18), and liver fatty acid binding protein (L-FABP) were measured in urine samples collected during the index hospitalization or an outpatient visit 3 months later. Mixed effects models were used to determine the effect of storage time on biomarker levels and stratified by visit. Results Median storage was 17.8 months (25-75% IQR 10.6-23.7) for samples from the index hospitalization and 14.6 months (IQR 7.3-20.4) for outpatient samples. In the mixed effects models, the only significant association between storage time and biomarker concentration was for KIM-1 in outpatient samples, where each month of storage was associated with a 1.7% decrease (95% CI -3% to -0.3%). There was no relationship between storage time and KIM-1 levels in samples from the index hospitalization. Conclusion There was no significant impact of storage time over a median of 18 months on urine KIM-1, NGAL, IL-18 or L-FABP in hospitalized samples; a statistically significant effect towards a decrease over time was noted for KIM-1 in outpatient samples. Additional studies are needed to determine whether longer periods of storage at -70 degrees C systematically impact levels of these analytes.	[Liu, Kathleen D.; Hsu, Chi-yuan] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Siew, Edward D.; Ikizler, T. Alp] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN USA; [Reeves, W. Brian] Penn State Coll Med, Dept Med, Div Nephrol, Hershey, PA USA; [Himmelfarb, Jonathan] Univ Washington, Dept Med, Kidney Res Inst, Seattle, WA USA; [Go, Alan S.; Hsu, Chi-yuan] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Bennett, Michael R.; Devarajan, Prasad] Cincinnati Childrens Hosp Med Ctr, Div Nephrol, Cincinnati, OH 45229 USA; [Kaufman, James S.] VA New York Harbor Healthcare Syst, Res Serv, New York, NY USA; [Kaufman, James S.] VA New York Harbor Healthcare Syst, Renal Sect, New York, NY USA; [Kaufman, James S.] NYU, Sch Med, New York, NY USA; [Kimmel, Paul L.] NIDDK, Div Kidney Urol & Hematol Dis, NIH, Bethesda, MD 20892 USA; [Chinchilli, Vernon M.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Parikh, Chirag R.] Yale Univ, Sch Med, Dept Med, Nephrol Sect, New Haven, CT 06510 USA; [Parikh, Chirag R.] Yale Univ, Sch Med, Program Appl Translat Res, New Haven, CT USA	University of California System; University of California San Francisco; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Washington; University of Washington Seattle; Kaiser Permanente; Cincinnati Children's Hospital Medical Center; New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Yale University; Yale University	Liu, KD (corresponding author), Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA.	kathleen.liu@ucsf.edu	Go, Alan S./AAE-7745-2019	Siew, Edward/0000-0003-1343-8784; Liu, Kathleen/0000-0003-4891-8649	Vanderbilt Center for Kidney Disease (VCKD);  [U01-DK082223];  [U01-DK082185];  [U01-DK082192];  [P50-DK096418];  [U01-DK082183];  [U01-DK084012];  [R01 DK098233]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK084012, U01DK082223, R01DK098233] Funding Source: NIH RePORTER	Vanderbilt Center for Kidney Disease (VCKD); ; ; ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by research grants U01-DK082223, U01-DK082185, U01-DK082192, P50-DK096418, U01-DK082183, U01-DK084012 and R01 DK098233. A NIDDK Program Officer was involved in the study design, data collection, and preparation of the manuscript, though decisions were made in collaboration with other authors, and no official approval from NIDDK was required for manuscript submission. From the National Institute of Digestive, Diabetes and Kidney Disease and by UL1-RR024131 from the National Center for Research Resources of the National Institutes of Health, U.S. Department of Health and Human Services. EDS is also supported by the Vanderbilt Center for Kidney Disease (VCKD).	Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; COLLINS ACG, 1993, DIABETOLOGIA, V36, P993, DOI 10.1007/BF02374489; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Dieplinger B, 2009, CLIN CHIM ACTA, V409, P33, DOI 10.1016/j.cca.2009.08.010; Domthong U, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-144; GIAMPIETRO O, 1993, CLIN CHEM, V39, P533; Go AS, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-22; Grenier FC, 2010, CLIN BIOCHEM, V43, P615, DOI 10.1016/j.clinbiochem.2009.12.008; Haase-Fielitz A, 2014, ANN CLIN BIOCHEM, V51, P335, DOI 10.1177/0004563214521795; Haase-Fielitz A, 2009, AM J KIDNEY DIS, V53, P564, DOI 10.1053/j.ajkd.2009.01.009; Hardikar S, 2014, CANCER CAUSE CONTROL, V25, P969, DOI 10.1007/s10552-014-0396-0; Kamijo-Ikemori A, 2006, CLIN CHIM ACTA, V374, P1, DOI 10.1016/j.cca.2006.05.038; Kohli P, 2012, CLIN CHEM, V58, P257, DOI 10.1373/clinchem.2011.173369; Liu KD, 2012, KIDNEY INT IN PRESS; MACNEIL MLW, 1991, CLIN CHEM, V37, P2120; MANLEY SE, 1992, CLIN CHEM, V38, P2294; Parikh CR, 2014, AM J KIDNEY DIS, V63, P567, DOI 10.1053/j.ajkd.2013.09.013; Parikh CR, 2010, ANN CLIN BIOCHEM, V47, P301, DOI 10.1258/acb.2010.010076; Parrinello CM, 2015, CLIN CHEM, V61, P938, DOI 10.1373/clinchem.2015.238873; Pennemans V, 2012, CLIN CHEM LAB MED, V50, P539, DOI 10.1515/CCLM.2011.796; Schuh MP, 2016, AM J KIDNEY DIS, V67, P56, DOI 10.1053/j.ajkd.2015.04.040; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI 10.1681/ASN.2010080796; Tencer J, 1997, SCAND J UROL NEPHROL, V31, P67, DOI 10.3109/00365599709070305; Tomonaga Y, 2012, CLIN CHIM ACTA, V413, P733, DOI 10.1016/j.cca.2012.01.001; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; van de Vrie M, 2014, AM J KIDNEY DIS, V63, P573, DOI 10.1053/j.ajkd.2013.10.010	26	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164832	10.1371/journal.pone.0164832	http://dx.doi.org/10.1371/journal.pone.0164832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788160	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900027
J	Strombach, T; Margittai, Z; Gorczyca, B; Kalenscher, T				Strombach, Tina; Margittai, Zsofia; Gorczyca, Barbara; Kalenscher, Tobias			Gender-Specific Effects of Cognitive Load on Social Discounting	PLOS ONE			English	Article							SELF-CONTROL; EGO-DEPLETION; DECISION-MAKING; WILLPOWER; PRESSURE; FAIRNESS; CHOKING; SIGNALS; GLUCOSE; ENERGY	We live busy, social lives, and meeting the challenges of our complex environments puts strain on our cognitive systems. However, cognitive resources are limited. It is unclear how cognitive load affects social decision making. Previous findings on the effects of cognitive load on other-regarding preferences have been ambiguous, allowing no coherent opinion whether cognitive load increases, decreases or does not affect prosocial considerations. Here, we suggest that social distance between individuals modulates whether generosity towards a recipient increases or decreases under cognitive load conditions. Participants played a financial social discounting task with several recipients at variable social distance levels. In this task, they could choose between generous alternatives, yielding medium financial rewards for the participant and recipient at variable social distances, or between a selfish alternative, yielding larger rewards for the participant alone. We show that the social discount function of male participants was significantly flattened under high cognitive load conditions, suggesting they distinguished less between socially close and socially distant recipients. Unexpectedly, the cognitive-load effect on social discounting was gender-specific: while social discounting was strongly dependent on cognitive load in men, women were nearly unaffected by cognitive load manipulations. We suggest that cognitive load leads men, but not women to simplify the decision problem by neglecting the social distance information. We consider our study a good starting point for further experiments exploring the role of gender in prosocial choice.	[Strombach, Tina; Margittai, Zsofia; Gorczyca, Barbara; Kalenscher, Tobias] Heinrich Heine Univ Dusseldorf, Comparat Psychol, Univ Str 1, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Kalenscher, T (corresponding author), Heinrich Heine Univ Dusseldorf, Comparat Psychol, Univ Str 1, D-40225 Dusseldorf, Germany.	tobias.kalenscher@hhu.de	Kalenscher, Tobias/U-8438-2019	Kalenscher, Tobias/0000-0002-0358-9020; Margittai, Zsofia/0000-0003-0121-1216				Achtziger A, 2016, J ECON PSYCHOL, V53, P1, DOI 10.1016/j.joep.2015.12.005; Achtziger A, 2015, J NEUROSCI PSYCHOL E, V8, P1, DOI 10.1037/npe0000031; BAUMEISTER RF, 1984, J PERS SOC PSYCHOL, V46, P610, DOI 10.1037/0022-3514.46.3.610; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; BAUMEISTER RF, 1986, EUR J SOC PSYCHOL, V16, P361, DOI 10.1002/ejsp.2420160405; Benjamin DJ, 2013, J EUR ECON ASSOC, V11, P1231, DOI 10.1111/jeea.12055; Cappelletti D, 2011, J ECON PSYCHOL, V32, P940, DOI 10.1016/j.joep.2011.08.001; Carter EC, 2015, J EXP PSYCHOL GEN, V144, P796, DOI 10.1037/xge0000083; Chapple CL, 2010, J CRIM JUST, V38, P1122, DOI 10.1016/j.jcrimjus.2010.08.004; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Cornelissen G, 2011, PERS SOC PSYCHOL B, V37, P1080, DOI 10.1177/0146167211405996; DeWall CN, 2008, PERS SOC PSYCHOL B, V34, P1653, DOI 10.1177/0146167208323981; EAGLY AH, 1986, PSYCHOL BULL, V100, P283, DOI 10.1037/0033-2909.100.3.283; Eckel CC, 1998, ECON J, V108, P726, DOI 10.1111/1468-0297.00311; Eifler W., 2009, KUTTNER KOLBENMASCHI, V7; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Fennis BM, 2011, EUR J SOC PSYCHOL, V41, P580, DOI 10.1002/ejsp.828; Franco-Watkins AM, 2006, J EXP PSYCHOL LEARN, V32, P443, DOI 10.1037/0278-7393.32.2.443; Gailliot MT, 2007, PERS SOC PSYCHOL REV, V11, P303, DOI 10.1177/1088868307303030; Gailliot MT, 2007, J PERS SOC PSYCHOL, V92, P325, DOI 10.1037/0022-3514.92.2.325; Goto T, 2013, MOTIV EMOTION, V37, P726, DOI 10.1007/s11031-013-9356-3; Halali E, 2014, J EXP PSYCHOL GEN, V143, P745, DOI 10.1037/a0033824; Hauge KE, 2009, WORK PAP EC, V371; Hinson JM, 2003, J EXP PSYCHOL LEARN, V29, P298, DOI 10.1037/0278-7393.29.2.298; Inzlicht M, 2007, PSYCHOL SCI, V18, P933, DOI 10.1111/j.1467-9280.2007.02004.x; Jones B, 2006, PSYCHOL SCI, V17, P283, DOI 10.1111/j.1467-9280.2006.01699.x; Kahn JR, 2011, J MARRIAGE FAM, V73, P77, DOI 10.1111/j.1741-3737.2010.00790.x; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Lighthall NR, 2012, SOC COGN AFFECT NEUR, V7, P476, DOI 10.1093/scan/nsr026; Loewenstein G., 2015, DECISION, P55, DOI [DOI 10.1037/DEC0000029, 10.1037/dec0000029]; Margittai Z, 2015, HORM BEHAV, V73, P75, DOI 10.1016/j.yhbeh.2015.05.019; Margittai Z, 2016, PSYCHONEUROENDOCRINO, V64, P131, DOI 10.1016/j.psyneuen.2015.11.018; Martinsson P, 2014, J ECON PSYCHOL, V45, P213, DOI 10.1016/j.joep.2014.09.004; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Moore D.A., 2004, SOC JUSTICE RES, V17, P189, DOI [10.1023/B:SORE.0000027409.88372.b4, DOI 10.1023/B:S0RE.0000027409.88372.B4]; Olson EA, 2016, J BEHAV DECIS MAKING, V29, P60, DOI 10.1002/bdm.1876; Plott Charles R., 2008, HDB EXPT EC RESULTS, V1, P509, DOI DOI 10.1016/S1574-0722(07)00057-1; Rachlin H, 2008, J BEHAV DECIS MAKING, V21, P29, DOI 10.1002/bdm.567; RAND DG, 2014, NAT COMMUN, V5; Roch SG, 2000, ORGAN BEHAV HUM DEC, V83, P185, DOI 10.1006/obhd.2000.2915; Saade RG, 2007, COMPUT HUM BEHAV, V23, P525, DOI 10.1016/j.chb.2004.10.035; Salmon SJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00647; Schulz JF, 2014, J ECON PSYCHOL, V41, P77, DOI 10.1016/j.joep.2012.08.007; Shiv B, 1999, J CONSUM RES, V26, P278, DOI 10.1086/209563; SIMON JL, 1995, RATION SOC, V7, P367, DOI 10.1177/104346319500700402; Soutschek A, 2013, PSYCHOL RES-PSYCH FO, V77, P333, DOI 10.1007/s00426-012-0429-9; Strombach T, 2015, P NATL ACAD SCI USA, V112, P1619, DOI 10.1073/pnas.1414715112; Strombach T, 2014, J BEHAV DECIS MAKING, V27, P235, DOI 10.1002/bdm.1802; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sweller J., 1994, LEARN INSTR, V4, P295, DOI DOI 10.1016/0959-4752(94)90003-5; Vohs KD, 2012, J EXP SOC PSYCHOL, V48, P943, DOI 10.1016/j.jesp.2012.03.002; Weber EU, 2009, ANNU REV PSYCHOL, V60, P53, DOI 10.1146/annurev.psych.60.110707.163633; Wheeler SC, 2007, J EXP SOC PSYCHOL, V43, P150, DOI 10.1016/j.jesp.2006.01.001; Wilson GF, 2002, INT J AVIAT PSYCHOL, V12, P3, DOI 10.1207/S15327108IJAP1201_2	54	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165289	10.1371/journal.pone.0165289	http://dx.doi.org/10.1371/journal.pone.0165289			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VY	27788192	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900057
J	Byun, JM; Kim, HL; Shin, DY; Koh, Y; Yoon, SS; Seong, MW; Park, SS; Kim, JH; Lee, YG; Kim, I				Byun, Ja Min; Kim, Hea-Lim; Shin, Dong-Yeop; Koh, Youngil; Yoon, Sung-Soo; Seong, Moon-Woo; Park, Sung Sup; Kim, Jin Hee; Lee, Yun-Gyoo; Kim, Inho			The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW TRANSPLANTATION; ACUTE GRAFT; GENE POLYMORPHISMS; COMMON MUTATION; LEUKEMIA; TOXICITY; RISK; SURVIVAL; EFFICACY	Pharmacogenomics can explain the inter-individual differences in response to drugs, including methotrexate (MTX) used for acute graft-versus-host disease (aGVHD) prophylaxis during hematopoietic stem cell transplantation (HSCT). In real-world practice, pre-planned MTX dose is arbitrarily modified according to observed toxicity which can lead to unexpected and severe aGVHD development. We aimed to validate the influence of MTHFR C677T polymorphism on the outcomes of allogenic HSCT in a relatively under-represented homogenous Asian population. A total of 177 patients were divided into 677TT group versus 677C-carriers (677CT+ 677CC), and clinical outcomes along with baseline characteristics were analyzed and compared. Although there was a tendency towards increased peak liver function test results and accordingly greater delta values between the highest and the baseline in 677TT group, we found no associations between genotypes and hepatotoxicity. However, the incidence of acute liver GVHD (>= grade 2) was significantly higher in the 677TT group than in the 677CC + 677CT group (P = 0.016). A total of 25 patients (14.1%) expired due to transplantation related mortality (TRM) during the first 180 days after HSCT. Patients carrying 677TT genotype were more likely to experience early TRM than 677C-carriers. The same pattern was observed in the cumulative TRM rate, and 677TT genotype patients were more prone to cumulative TRM (P = 0.010). This translated into shorter OS for patients with 677TT compared to 677C-carriers (P = 0.010). The 3-year survival after HSCT was 29.9% for 677TT cases and 47.1% for 677C-carriers. The multivariate analysis identified 677TT genotype (HR = 1.775. 95% CI 1.122 +/- 2.808, P = 0.014) and non-CR state (HR = 2.841. 95% CI 1.627 +/- 4.960, P<0.001) as predictors for survival. In conclusion, the MTHFR 677TT genotype appears to be associated with acute liver GVHD, and represent a risk factor for TRM and survival in patients undergoing HSCT with MTX as GVHD prophylaxis.	[Byun, Ja Min; Shin, Dong-Yeop; Koh, Youngil; Yoon, Sung-Soo; Kim, Inho] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Hea-Lim] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Shin, Dong-Yeop; Koh, Youngil; Yoon, Sung-Soo; Kim, Inho] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Seong, Moon-Woo; Park, Sung Sup] Seoul Natl Univ Hosp, Dept Lab Med, Seoul, South Korea; [Kim, Jin Hee] Sejong Univ, Dept Integrat Biosci & Biotechnol, Seoul, South Korea; [Lee, Yun-Gyoo] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Sejong University; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, I (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Internal Med, Seoul, South Korea.	gosciny@gmail.com; ihkimmd@snu.ac.kr	Yoon, Sung-Soo/J-2773-2012; Byun, Ja Min/AAI-2125-2020; Kim, Jin Hee/AET-7817-2022	Byun, Ja Min/0000-0003-1780-5553; Park, Sung Sup/0000-0003-3754-4848; Seong, Moon-Woo/0000-0003-2954-3677; KIM, JIN HEE/0000-0003-1204-7079	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016-0024046, NRF-2011-0024046]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016-0024046, NRF-2011-0024046).	BAGGOTT JE, 1986, BIOCHEM J, V236, P193, DOI 10.1042/bj2360193; BLOUNT BC, 1995, BAILLIERE CLIN HAEM, V8, P461, DOI 10.1016/S0950-3536(05)80216-1; Chiusolo P, 2002, ANN ONCOL, V13, P1915, DOI 10.1093/annonc/mdf322; Couriel DR, 2004, BIOL BLOOD MARROW TR, V10, P178, DOI 10.1016/j.bbmt.2003.10.006; Filipovich AH, 2008, BEST PRACT RES CL HA, V21, P251, DOI 10.1016/j.beha.2008.02.008; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Kalayoglu-Besisik S, 2003, TRANSPLANTATION, V76, P1775, DOI 10.1097/01.TP.0000093831.63661.DF; Kim I, 2007, ANN HEMATOL, V86, P41, DOI 10.1007/s00277-006-0184-3; Koreth J, 2013, BLOOD, V122, P1690, DOI 10.1182/blood-2013-07-514125; Kumar S, 2002, BONE MARROW TRANSPL, V30, P161, DOI 10.1038/sj.bmt.1703616; Longo-Sorbello GSA, 2001, HAEMATOLOGICA, V86, P121; MCDONALD GB, 1993, ANN INTERN MED, V118, P255, DOI 10.7326/0003-4819-118-4-199302150-00003; Ongaro A, 2009, HAEMATOL-HEMATOL J, V94, P1391, DOI 10.3324/haematol.2009.008326; Pihusch M, 2004, TRANSPLANTATION, V78, P911, DOI 10.1097/01.tp.0000136988.38919.fb; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Robien K, 2006, BIOL BLOOD MARROW TR, V12, P973, DOI 10.1016/j.bbmt.2006.05.016; Rocha V, 2009, LEUKEMIA, V23, P545, DOI 10.1038/leu.2008.323; Soydan E, 2008, BONE MARROW TRANSPL, V42, P429, DOI 10.1038/bmt.2008.184; STORB R, 1986, NEW ENGL J MED, V314, P729, DOI 10.1056/NEJM198603203141201; Sugimoto K, 2008, INT J HEMATOL, V87, P451, DOI 10.1007/s12185-008-0061-z; Ulrich CM, 2001, BLOOD, V98, P231, DOI 10.1182/blood.V98.1.231; Urano W, 2002, PHARMACOGENETICS, V12, P183, DOI 10.1097/00008571-200204000-00002	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0163998	10.1371/journal.pone.0163998	http://dx.doi.org/10.1371/journal.pone.0163998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783703	Green Submitted, Green Published, gold			2022-12-26	WOS:000389602800022
J	de Oliveira, EF; Casaril, AE; Fernandes, WS; Ravanelli, MD; Medeiros, MJ; Gamarra, RM; Paranhos, AC; Oshiro, ET; de Oliveira, AG; Galati, EAB				de Oliveira, Everton Falcao; Casaril, Aline Etelvina; Fernandes, Wagner Souza; Ravanelli, Michelle de Saboya; de Medeiros, Marcio Jose; Gamarra, Roberto Macedo; Paranhos Filho, Antonio Conceicao; Oshiro, Elisa Teruya; de Oliveira, Alessandra Gutierrez; Bianchi Galati, Eunice Aparecida			Monthly Distribution of Phlebotomine Sand Flies, and Biotic and Abiotic Factors Related to Their Abundance, in an Urban Area to Which Visceral Leishmaniasis Is Endemic in Corumba, Brazil	PLOS ONE			English	Article							LUTZOMYIA-LONGIPALPIS DIPTERA; CUTANEOUS LEISHMANIASIS; SPATIAL-DISTRIBUTION; RURAL AREA; PSYCHODIDAE; FAUNA; STATE; FOCUS; URBANIZATION; WHITMANI	The monthly distribution and abundance of sand flies are influenced by both biotic and abiotic factors. The present study aimed to evaluate the seasonal distribution of sand flies and the relation between their abundance and environmental parameters, including vegetation and climate. This study was conducted over a 2-year period (April 2012 to March 2014). Monthly distribution was evaluated through the weekly deployment of CDC light traps in the peridomicile area of 5 residences in an urban area of the municipality of Corumba in the State of Mato Grosso do Sul, Brazil. Meteorological data were obtained from the Mato Grosso do Sul Center for Weather, Climate, and Water Resources. The spectral indices were calculated based on spatial resolution images (GeoEye) and the percentage of vegetal coverage. Differences in the abundance of sand flies among the collection sites were assessed using the Kruskal-Wallis test, and the strength of correlations between environmental variables was determined by calculating Spearman's correlation coefficients. Lutzomyia cruzi, Lu. forattinii, and Evandromyia corumbaensis were the most frequently found species. Although no significant association was found among these sand fly species and the tested environmental variables (vegetation and climate), high population peaks were found during the rainy season, whereas low peaks were observed in the dry season. The monthly distribution of sand flies was primarily determined by Lu. cruzi, which accounted for 93.94% of the specimens collected each month throughout the experimental period. The fact that sand flies were detected year-round indicates a continuous risk of infection to humans, demonstrating the need for targeted management and education programs.	[de Oliveira, Everton Falcao; Bianchi Galati, Eunice Aparecida] Univ Sao Paulo, Fac Saude Publ, Programa Posgrad Saude Publ, Sao Paulo, SP, Brazil; [Casaril, Aline Etelvina; Fernandes, Wagner Souza; Oshiro, Elisa Teruya; de Oliveira, Alessandra Gutierrez] Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Lab Parasitol Humana, Campo Grande, MS, Brazil; [Ravanelli, Michelle de Saboya] IAGRO, Agencia Estadual Def Sanitaria Anim & Vegetal, Corumba, MS, Brazil; [de Oliveira, Everton Falcao; de Medeiros, Marcio Jose] Univ Fed Rio de Janeiro, Dept Estat, Campus Macae, Macae, RJ, Brazil; [Gamarra, Roberto Macedo; Paranhos Filho, Antonio Conceicao] Univ Fed Mato Grosso do Sul, Fac Engn Arquitetura & Urbanismo & Geog, Lab Geoproc Aplicacoes Ambientais, Campo Grande, MS, Brazil; [Bianchi Galati, Eunice Aparecida] Univ Fed Mato Grosso do Sul, Dept Epidemiol, Fac Saude Publ, Campo Grande, MS, Brazil	Universidade de Sao Paulo; Universidade Federal de Mato Grosso do Sul; Universidade Federal do Rio de Janeiro; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	de Oliveira, EF; Galati, EAB (corresponding author), Univ Sao Paulo, Fac Saude Publ, Programa Posgrad Saude Publ, Sao Paulo, SP, Brazil.; de Oliveira, EF (corresponding author), Univ Fed Rio de Janeiro, Dept Estat, Campus Macae, Macae, RJ, Brazil.; Galati, EAB (corresponding author), Univ Fed Mato Grosso do Sul, Dept Epidemiol, Fac Saude Publ, Campo Grande, MS, Brazil.	efalcao.olivera@gmail.com; egalati@usp.br	Oliveira, Everton F/L-3261-2016; Fernandes, Wagner/CAH-5898-2022; Filho, Antonio Conceição Paranhos/C-7467-2018; Medeiros, Marcio/ABF-4771-2020	Oliveira, Everton F/0000-0002-0074-5278; Filho, Antonio Conceição Paranhos/0000-0002-9838-5337; Macedo Gamarra, Roberto/0000-0002-0049-0009; Medeiros, Marcio/0000-0001-8562-256X	Sao Paulo Research Foundation (FAPESP) [2011/23414-0]; Foundation for Development Support of Education, Science and Technology of the State of Mato Grosso do Sul (FUNDECT/DECITMS/CNPq/SES) [04/2013-PPSUS-MS-23/200.537/2013]; Brazilian National Council for Scientific and Technological Development (CNPq) [304122/2015-7]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Foundation for Development Support of Education, Science and Technology of the State of Mato Grosso do Sul (FUNDECT/DECITMS/CNPq/SES); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Sao Paulo Research Foundation (FAPESP 2011/23414-0), the Foundation for Development Support of Education, Science and Technology of the State of Mato Grosso do Sul (FUNDECT/DECITMS/CNPq/SES No 04/2013-PPSUS-MS-23/200.537/2013), and the Brazilian National Council for Scientific and Technological Development (CNPq 304122/2015-7).	Aguiar GM, 2003, FLEBOTOMINEOS BRASIL; Alexander B, 2002, EMERG INFECT DIS, V8, P1480, DOI 10.3201/eid0812.010485; de Souza AAA, 2016, PARASITE, V23, DOI 10.1051/parasite/2016022; Almeida Paulo Silva de, 2010, Rev. Bras. entomol., V54, P304, DOI 10.1590/S0085-56262010000200014; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Aparicio C, 2004, REV SAUDE PUBL, V38, P511, DOI 10.1590/S0034-89102004000400005; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Braga-Miranda LC, 2006, REV SAUDE PUBL, V40, P324, DOI 10.1590/S0034-89102006000200021; Brazil R. P., 2003, FLEBOTOMINEOS BRASIL, P266; Brazilian Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estatistica-IBGE), 2014, EST POP RES; Camara G, 2001, INTRO CIENCIA GEOINF, P12; Campbell-Lendrum DH, 1999, MED VET ENTOMOL, V13, P209, DOI 10.1046/j.1365-2915.1999.00169.x; Carlson TN, 2000, GLOBAL PLANET CHANGE, V25, P49, DOI 10.1016/S0921-8181(00)00021-7; Carvalho GML, 2008, VECTOR-BORNE ZOONOT, V8, P407, DOI 10.1089/vbz.2007.0180; Casaril AE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-364; Cross ER, 1996, AM J TROP MED HYG, V54, P530, DOI 10.4269/ajtmh.1996.54.530; DAJOZ R., 2005, PRINCIPIOS ECOLOGIA; de Brito VN, 2014, MEM I OSWALDO CRUZ, V109, P899, DOI 10.1590/0074-0276140112; Carvalho GMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052254; De Oliveira EF, 2013, J MED ENTOMOL, V50, P277, DOI 10.1603/ME12082; de Oliveira EF, 2015, MEM I OSWALDO CRUZ, V110, P1051, DOI 10.1590/0074-02760150317; de Oliveira EF, 2013, J VECTOR ECOL, V38, P224, DOI 10.1111/j.1948-7134.2013.12034.x; de Oliveira EF, 2012, MEM I OSWALDO CRUZ, V107, P396, DOI 10.1590/S0074-02762012000300015; de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015; de Souza CM, 2004, MEM I OSWALDO CRUZ, V99, P795, DOI 10.1590/S0074-02762004000800003; Deane LM, 1956, LEISHMANIOSE VISCERA; Dos Santos SO, 1998, MED VET ENTOMOL, V12, P315, DOI 10.1046/j.1365-2915.1998.00104.x; Santos Soraya Oliveira dos, 2003, Rev. Soc. Bras. Med. Trop., V36, P633; Elnaiem DA, 1998, ANN TROP MED PARASIT, V92, P877, DOI 10.1080/00034989858925; Ximenes MDFD, 2006, J MED ENTOMOL, V43, P990, DOI 10.1603/0022-2585(2006)43[990:EOAFOS]2.0.CO;2; GALATI E A B, 1985, Revista Brasileira de Entomologia, V29, P261; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Galati EAB, 1996, REV SAUDE PUBL, V30, P115, DOI 10.1590/S0034-89101996000200002; Galati EAB, 1997, REV SAUDE PUBL, V31, P378, DOI 10.1590/S0034-89101997000400007; GARMS R, 1979, TROPENMED PARASITOL, V30, P345; HADDOW A. J., 1960, BULL ENT RES, V50, P759, DOI 10.1017/S000748530005478X; HADDOW AJ, 1954, B ENTOMOL RES, V45, P199, DOI 10.1017/S0007485300026900; Kakitani I, 2003, REV SAUDE PUBL, V37, P280, DOI 10.1590/S0034-89102003000300003; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Lainson R, 2005, TOPLEY WILSONS MICRO, P313; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Marcondes CB, 2007, ENTOMOL NEWS, V118, P351, DOI 10.3157/0013-872X(2007)118[351:APOGAS]2.0.CO;2; Mato Grosso do Sul, 1990, ATL MULT; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; MIGONE L. E., 1913, Bulletin de la Societe de Pathologie Exotique, V6, P118; Missawa NA, 2006, REV SOC BRAS MED TRO, V39, P337, DOI 10.1590/S0037-86822006000400004; NOVO E.M.L.M, 2008, SENSORIAMENTO REMOTO; de Andrade ARO, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-260; Oliveira EF, 2015, J MED ENTOMOL, V52, P925, DOI 10.1093/jme/tjv102; Oliveira EF, 2016, AM J TROP M IN PRESS; Ozbel Y, 2011, J VECTOR ECOL, V36, pS99, DOI 10.1111/j.1948-7134.2011.00118.x; Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0551; PCI Geomatics, 2003, PCI GEOM 9 1 WIND; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Rangel EF, 2008, CAD SAUDE PUBLICA, V24, P2948, DOI 10.1590/S0102-311X2008001200025; RCore Team, 2020, R LANG ENV STAT COMP; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Saraiva L, 2009, J MED ENTOMOL, V46, P1159, DOI 10.1603/033.046.0525; Jeraldo VDS, 2012, REV SOC BRAS MED TRO, V45, P318, DOI 10.1590/S0037-86822012000300008; Fernandez MS, 2010, ACTA TROP, V114, P81, DOI 10.1016/j.actatropica.2010.01.008; Soriano BMA, 1997, CARACTERIZAC CLIMA T; Teodoro U, 2007, REV SAUDE PUBL, V41, P383, DOI 10.1590/S0034-89102007000300009; Werneck GL, 2007, EPIDEMIOL INFECT, V135, P195, DOI 10.1017/S0950268806006881; Zeledon R., 1984, Memorias do Instituto Oswaldo Cruz, V79, P455, DOI 10.1590/S0074-02761984000400010	65	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165155	10.1371/journal.pone.0165155	http://dx.doi.org/10.1371/journal.pone.0165155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VE	27783667	Green Published, Green Submitted, gold			2022-12-26	WOS:000389602800061
J	Lerch, AP; Pfammatter, JA; Bentz, BJ; Raffa, KF				Lerch, Andrew P.; Pfammatter, Jesse A.; Bentz, Barbara J.; Raffa, Kenneth F.			Mountain Pine Beetle Dynamics and Reproductive Success in Post-Fire Lodgepole and Ponderosa Pine Forests in Northeastern Utah	PLOS ONE			English	Article							FIRE SURROGATE TREATMENTS; BARK BEETLE; TREE MORTALITY; PRESCRIBED FIRE; SPATIOTEMPORAL PATTERNS; NORTHERN ARIZONA; ROCKY-MOUNTAINS; RESIN DEFENSES; ATTACKS; OUTBREAKS	Fire injury can increase tree susceptibility to some bark beetles (Curculionidae, Scolytinae), but whether wildfires can trigger outbreaks of species such as mountain pine beetle (Den-droctonus ponderosae Hopkins) is not well understood. We monitored 1173 lodgepole (Pinus contorta var. latifolia Doug.) and 599 ponderosa (Pinus ponderosa Doug. ex Law) pines for three years post-wildfire in the Uinta Mountains of northeastern Utah in an area with locally endemic mountain pine beetle. We examined how the degree and type of fire injury influenced beetle attacks, brood production, and subsequent tree mortality, and related these to beetle population changes over time. Mountain pine beetle population levels were high the first two post-fire years in lodgepole pine, and then declined. In ponderosa pine, populations declined each year after initial post-fire sampling. Compared to trees with strip or failed attacks, mass attacks occurred on trees with greater fire injury, in both species. Overall, a higher degree of damage to crowns and boles was associated with higher attack rates in ponderosa pines, but additional injury was more likely to decrease attack rates in lodgepole pines. In lodgepole pine, attacks were initially concentrated on fireinjured trees, but during subsequent years beetles attacked substantial numbers of uninjured trees. In ponderosa pine, attacks were primarily on injured trees each year, although these stands were more heavily burned and had few uninjured trees. In total, 46% of all lodgepole and 56% of ponderosa pines underwent some degree of attack. Adult brood emergence within caged bole sections decreased with increasing bole char in lodgepole pine but increased in ponderosa pine, however these relationships did not scale to whole trees. Mountain pine beetle populations in both tree species four years post-fire were substantially lower than the year after fire, and wildfire did not result in population outbreaks.	[Lerch, Andrew P.; Raffa, Kenneth F.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Pfammatter, Jesse A.] Univ Wisconsin, Dept Neurosci, Madison, WI USA; [Bentz, Barbara J.] USDA, Forest Serv, Rocky Mt Res Stn, Logan, UT USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); United States Forest Service	Lerch, AP (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	lerch.andrew@gmail.com			USDA Forest Service, State and Private Forestry, Forest Health Monitoring [INT-F-08-01]	USDA Forest Service, State and Private Forestry, Forest Health Monitoring	USDA Forest Service, State and Private Forestry, Forest Health Monitoring, INT-F-08-01; BJB KFR.	Amman G. D., 1980, INT89 USDA FOR SERV; Amman G.D., 1983, INT145 USDA FOR SERV; Anhold J. A., 1996, Western Journal of Applied Forestry, V11, P50; [Anonymous], INT398 USDA FOR SERV; Baker WL, 2007, J BIOGEOGR, V34, P251, DOI 10.1111/j.1365-2699.2006.01592.x; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bentz BJ, 2006, CAN J FOREST RES, V36, P351, DOI [10.1139/x05-241, 10.1139/X05-241]; Breece CR, 2008, FOREST ECOL MANAG, V255, P119, DOI 10.1016/j.foreco.2007.08.026; Carroll A.L., 2006, MOUNTAIN PINE BEETLE; Chapman TB, 2012, ECOLOGY, V93, P2175, DOI 10.1890/11-1055.1; CHRISTIANSEN E, 1987, FOREST ECOL MANAG, V22, P89, DOI 10.1016/0378-1127(87)90098-3; Davis RS, 2012, CAN J FOREST RES, V42, P2022, DOI 10.1139/x2012-147; Elkin CM, 2004, ENVIRON ENTOMOL, V33, P1070, DOI 10.1603/0046-225X-33.4.1070; Faccoli M, 2014, FORESTS, V5, P88, DOI 10.3390/f5010088; Fettig C, 2010, FOREST SCI, V56, P60; Fettig CJ, 2008, CAN J FOREST RES, V38, P924, DOI 10.1139/X07-243; Fowler JF, 2004, RMRSGTR132 USDA FOR; GEISZLER DR, 1984, Z ANGEW ENTOMOL, V98, P389; Hagle S.K., 2003, R10308 USDA FOR SERV; Hood S.M., 2007, RMRSGTR199 USDA FOR; Hood S, 2007, CAN J FOREST RES, V37, P1058, DOI 10.1139/X06-313; Hood S, 2015, ECOLOGY, V96, P1846, DOI 10.1890/14-0487.1; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; JAKUBAS WJ, 1994, J WILDLIFE MANAGE, V58, P35, DOI 10.2307/3809546; Keyser TL, 2006, FOREST SCI, V52, P530; Kulakowski D, 2013, FOREST ECOL MANAG, V289, P544, DOI 10.1016/j.foreco.2012.10.020; Lerch A, 2013, THESIS; Lombardero MJ, 2006, FOREST ECOL MANAG, V225, P349, DOI 10.1016/j.foreco.2006.01.010; Lotan J.E., 1985, LODGEPOLE PINE SPECI, P133; Maloney PE, 2008, CAN J FOREST RES, V38, P3011, DOI 10.1139/X08-141; McHugh CW, 2003, ENVIRON ENTOMOL, V32, P510, DOI 10.1603/0046-225X-32.3.510; Meddens AJH, 2012, ECOL APPL, V22, P1876, DOI 10.1890/11-1785.1; Perrakis DDB, 2011, NAT AREA J, V31, P14, DOI 10.3375/043.031.0103; Powell EN, 2012, ECOL MONOGR, V82, P69, DOI 10.1890/11-0607.1; Powell EN, 2011, J CHEM ECOL, V37, P1184, DOI 10.1007/s10886-011-0031-4; R Development Core Team, 2016, R LANG ENV STAT COMP; RANKIN LJ, 1991, CAN J FOREST RES, V21, P1029, DOI 10.1139/x91-141; Rasmussen LA, 1996, INTRP487 USDA FOR SE; Rawlings JO, 1998, APPL REGRESSION ANAL, DOI 10.1007/b98890; Ryan K. C., 1996, The ecological implications of fire in Greater Yellowstone. Proceedings of the Second Biennial Conference on the Greater Yellowstone Ecosystem, Yellowstone National Park, Wyoming, USA, 19-21 September, 1993., P151; Samman S, 2000, RMRSGTR62 US DEP AGR; Santoro AE, 2001, FOREST ECOL MANAG, V144, P245, DOI 10.1016/S0378-1127(00)00389-3; Schmitz R.F., 1984, INT348 USDA FOR SERV; Six DL, 2009, FOREST ECOL MANAG, V258, P761, DOI 10.1016/j.foreco.2009.05.016; Tabacaru CA, 2015, FOREST ECOL MANAG, V337, P98, DOI 10.1016/j.foreco.2014.10.026; Tabacaru CA, 2016, J APPL ECOL, V53, P222, DOI 10.1111/1365-2664.12546; USDA Farm Service Agency-Aerial Photography Field Office, 2007, NAT AGR IM PROGR 200; USDA Forest Service, 2010, FOR HLTH PROT INT NO; Wallin KF, 2003, ENVIRON ENTOMOL, V32, P652, DOI 10.1603/0046-225X-32.3.652; [No title captured]	50	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164738	10.1371/journal.pone.0164738	http://dx.doi.org/10.1371/journal.pone.0164738			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783632	gold, Green Submitted, Green Published			2022-12-26	WOS:000389602800047
J	Schimmack, S; Kneller, S; Dadabaeva, N; Bergmann, F; Taylor, A; Hackert, T; Werner, J; Strobel, O				Schimmack, Simon; Kneller, Sarah; Dadabaeva, Nigora; Bergmann, Frank; Taylor, Andrew; Hackert, Thilo; Werner, Jens; Strobel, Oliver			Epithelial to Stromal Re-Distribution of Primary Cilia during Pancreatic Carcinogenesis	PLOS ONE			English	Article							STELLATE CELLS; CANCER-CELLS; HEDGEHOG; CILIOGENESIS; BIOLOGY; LESIONS; ROLES; MODEL	Background The Hedgehog (HH) pathway is a mediator in pancreatic ductal adenocarcinoma (PDAC). Surprisingly, previous studies suggested that primary cilia (PC), the essential organelles for HH signal transduction, were lost in PDAC. The aim of this study was to determine the presence of PC in human normal pancreas, chronic pancreatitis, and during carcinogenesis to PDAC with focus on both epithelia and stroma. Methods PC were analyzed in paraffin sections from normal pancreas, chronic pancreatitis, intraductal papillary-mucinous neoplasia, and PDAC, as well as in primary human pancreatic stellate cells (PSC) and pancreatic cancer cell lines by double immunofluorescence staining for acetylated alpha-tubuline and gamma-tubuline. Co-staining for the HH receptors PTCH1, PTCH2 and SMO was also performed. Results PC are gradually lost during pancreatic carcinogenesis in the epithelium: the fraction of cells with PC gradually and significantly decreased from 32% in ducts of normal pancreas, to 21% in ducts of chronic pancreatitis, to 18% in PanIN1a, 6% in PanIN2, 3% in PanIN3 and to 1.2% in invasive PDAC. However, this loss of PC in the neoplastic epithelium is accompanied by a gain of PC in the surrounding stroma. The fraction of stromal cells with PC significantly increased from 13% around normal ducts to about 30% around PanIN and PDAC. HH-receptors were detected in tumor stroma but not in epithelial cells. PC are also present in PSC and pancreatic cancer cell lines. Conclusion PC are not lost during pancreatic carcinogenesis but re-distributed from the epithelium to the stroma. This redistribution may explain the re-direction of HH signaling towards the stroma during pancreatic carcinogenesis.	[Schimmack, Simon; Kneller, Sarah; Taylor, Andrew; Hackert, Thilo; Werner, Jens; Strobel, Oliver] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Bergmann, Frank] Inst Pathol Heidelberg, Neuenheimer Feld 224, D-69120 Heidelberg, Germany; [Werner, Jens] Univ Hosp Gen Visceral Transplantat Vasc & Thorac, Campus Grosshadern,Marchioninistr 15, D-81377 Munich, Germany	Ruprecht Karls University Heidelberg; University of Munich	Strobel, O (corresponding author), Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.	oliver.strobel@med.uni-heidelberg.de		Strobel, Oliver/0000-0001-5100-8449	Heidelberger Stiftung Chirurgie, BMBF [NGFNplus-01GS08114]; BMBH [01EY1101]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Heidelberger Stiftung Chirurgie, BMBF(Federal Ministry of Education & Research (BMBF)); BMBH; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	The tissue bank (Pancobank: N. Giese and M. Buchler) at the European Pancreas Center was supported by grants from the Heidelberger Stiftung Chirurgie, BMBF (NGFNplus-01GS08114), and BMBH (P. Schirmacher, Institute of Pathology, University of Heidelberg; BMBF grant 01EY1101). We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. We thank Susann Wendler for her technical help with the immunofluorescence staining.	Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Ashizawa N, 1999, HISTOL HISTOPATHOL, V14, P539, DOI 10.14670/HH-14.539; Aughsteen AA, 2001, EUR J MORPHOL, V39, P277, DOI 10.1076/ejom.39.5.277.7380; Basten Sander G, 2013, Cilia, V2, P6, DOI 10.1186/2046-2530-2-6; BOCKMAN DE, 1986, INT J PANCREATOL, V1, P21; Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1; Cervantes S, 2010, P NATL ACAD SCI USA, V107, P10109, DOI 10.1073/pnas.0909900107; Emoto K, 2014, HUM PATHOL, V45, P817, DOI 10.1016/j.humpath.2013.11.017; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fritz S, 2010, PANCREAS, V39, P308, DOI 10.1097/MPA.0b013e3181bd5c10; Goetz SC, 2009, METHOD CELL BIOL, V94, P199, DOI 10.1016/S0091-679X(08)94010-3; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Hu ZF, 2015, CELL REP, V10, P1803, DOI 10.1016/j.celrep.2015.02.044; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Izawa Ichiro, 2015, Cilia, V4, P12, DOI 10.1186/s13630-015-0021-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kim S, 2011, CELL CYCLE, V10, P2683, DOI 10.4161/cc.10.16.17009; Klein WM, 2002, MODERN PATHOL, V15, P441, DOI 10.1038/modpathol.3880544; Lodish H, 2008, MOL CELL BIOL; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Menzl Ina, 2014, Cilia, V3, P7, DOI 10.1186/2046-2530-3-7; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Miyoshi K, 2011, ACTA MED OKAYAMA, V65, P279; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Nielsen SK, 2008, DEV DYNAM, V237, P2039, DOI 10.1002/dvdy.21610; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Plotnikova OV, 2008, CANCER RES, V68, P2058, DOI 10.1158/0008-5472.CAN-07-5838; Plotnikova OV, 2009, METHOD CELL BIOL, V94, P137, DOI 10.1016/S0091-679X(08)94007-3; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Satir P, 2008, HISTOCHEM CELL BIOL, V129, P687, DOI 10.1007/s00418-008-0416-9; Seeger-Nukpezah Tamina, 2013, Drug Discov Today Dis Mech, V10, pe135; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Seeley ES, 2009, METHOD CELL BIOL, V94, P299, DOI 10.1016/S0091-679X(08)94015-2; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Strobel O, 2010, GASTROENTEROLOGY, V138, P1166, DOI 10.1053/j.gastro.2009.12.005; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Vonlaufen A, 2008, CANCER RES, V68, P7707, DOI 10.1158/0008-5472.CAN-08-1132; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wann AKT, 2012, CELL MOL LIFE SCI, V69, P2967, DOI 10.1007/s00018-012-0980-y; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	58	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164231	10.1371/journal.pone.0164231	http://dx.doi.org/10.1371/journal.pone.0164231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783689	Green Submitted, Green Published, gold			2022-12-26	WOS:000389602800032
J	Shi, CS; Huang, TH; Lin, CK; Li, JM; Chen, MH; Tsai, ML; Chang, CC				Shi, Chung-Sheng; Huang, Tzu-Hsiung; Lin, Chin-Kuo; Li, Jhy-Ming; Chen, Mei-Hsin; Tsai, Mei-Ling; Chang, Chih-Ching			VEGF Production by Ly6C(+high) Monocytes Contributes to Ventilator-Induced Lung Injury	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PULMONARY MICROVASCULAR INJURY; RESPIRATORY MECHANICS; MARGINATED MONOCYTES; LEUKOCYTE ADHESION; EPITHELIAL BARRIER; OXIDATIVE STRESS; CELL-ADHESION; RAT MODEL; MICE	Background Mechanical ventilation is a life-saving procedure for patients with acute respiratory failure, although it may cause pulmonary vascular inflammation and leakage, leading to ventilato-rinduced lung injury (VILI). Ly6C(+high) monocytes are involved in the pathogenesis of VILI. In this study, we investigated whether pulmonary infiltrated Ly6C+high monocytes produce vascular endothelial growth factor (VEGF) and contribute to VILI. Methods A clinically relevant two-hit mouse model of VILI, with intravenous lipopolysaccharide (LPS, 20 ng/mouse) immediately before high tidal volume (HTV, 20 mL/kg) ventilation (LPS +HTV), was established. Blood gas and respiratory mechanics were measured to ensure the development of VILI. Flow cytometry and histopathological analyses revealed pulmonary infiltration of leukocytes subsets. Clodronate liposomes were intravenously injected to deplete pulmonary monocytes. In vitro endothelial cell permeability assay with sorted Ly6C(+high) monocytes condition media assessed the role of Ly6C(+high) monocytes in vascular permeability. Results LPS+HTV significantly increased total proteins, TNF-alpha, IL-6, vascular endothelial growth factor (VEGF) and mononuclear cells in the bronchoalveolar lavage fluid (BALF). Pulmonary Ly6C(+high) monocytes (SSClow CD11b(+) F4/80(+) Ly6C(+high)), but not Ly6C(+low) monocytes (SSClow CD11b(+) F4/80(+) Ly6C(+low)), were significantly elevated starting at 4 hr. Clodronate liposomes were able to significantly reduce pulmonary Ly6C(+high) monocytes, and VEGF and total protein in BALF, and restore PaO2/FiO(2). There was a strong correlation between pulmonary Ly6C(+high) monocytes and BALF VEGF (R-2 = 0.8791, p< 0.001). Moreover, sorted Ly6C(+high) monocytes were able to produce VEGF, resulting in an increased permeability of endothelial cell monolayer in an in vitro endothelial cell permeability assay. Conclusion VEGF produced by pulmonary infiltrated Ly6C(+high) monocytes regulates vasculature permeability in a two-hit model of HTV-induced lung injury. Ly6C(+high) monocytes play an important role in the pathogenesis of VILI.	[Shi, Chung-Sheng; Li, Jhy-Ming; Chen, Mei-Hsin] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Shi, Chung-Sheng] Chang Gung Mem Hosp, Div Urol, Dept Surg, Chiayi, Taiwan; [Huang, Tzu-Hsiung] Chang Gung Mem Hosp, Dept Resp Therapy, Chiayi, Taiwan; [Lin, Chin-Kuo] Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Tsai, Mei-Ling] Natl Cheng Kung Univ, Dept Physiol, Coll Med, Tainan, Taiwan; [Chang, Chih-Ching] Natl Cheng Kung Univ, Dept Environm & Occupat Hlth, Coll Med, Tainan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Cheng Kung University; National Cheng Kung University	Chang, CC (corresponding author), Natl Cheng Kung Univ, Dept Environm & Occupat Hlth, Coll Med, Tainan, Taiwan.	chang3@mail.ncku.edu.tw		Lin, Chin-Kuo/0000-0002-5940-3715; Shi, Chung-Sheng/0000-0002-5548-7675	Chang Gung Memorial Hospital Research Foundation [CMRPG6D0021, CMRPG6B0091]; Ministry of Science and Technology (ROC) [NSC 010-2314-B-006-053-MY2]	Chang Gung Memorial Hospital Research Foundation; Ministry of Science and Technology (ROC)	This study was supported in part by grants (CMRPG6D0021 and CMRPG6B0091) from the Chang Gung Memorial Hospital Research Foundation to Tzu-Hsiung Huang, and grant (NSC 010-2314-B-006-053-MY2) from Ministry of Science and Technology (ROC) to Chih-Ching Chang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; BATES JHT, 1988, J APPL PHYSIOL, V64, P2204, DOI 10.1152/jappl.1988.64.5.2204; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Charavaryamath C, 2006, ANAT REC PART A, V288A, P1259, DOI 10.1002/ar.a.20401; Cho M, 2001, AM J PHYSIOL-HEART C, V280, pH2357, DOI 10.1152/ajpheart.2001.280.5.H2357; Choi WI, 2003, AM J RESP CRIT CARE, V167, P1627, DOI 10.1164/rccm.200210-1216OC; Choudhury S, 2004, AM J PHYSIOL-LUNG C, V287, pL902, DOI 10.1152/ajplung.00187.2004; Correa FCF, 2001, J APPL PHYSIOL, V91, P803, DOI 10.1152/jappl.2001.91.2.803; Curley GF, 2011, ANESTHESIOLOGY, V115, P1022, DOI 10.1097/ALN.0b013e31823422c9; DelMaschio A, 1996, J CELL BIOL, V135, P497, DOI 10.1083/jcb.135.2.497; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Dhaliwal K, 2012, AM J RESP CRIT CARE, V186, P514, DOI 10.1164/rccm.201112-2132OC; DOHERTY DE, 1994, J IMMUNOL, V153, P241; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; DREYFUSS D, 1985, AM REV RESPIR DIS, V132, P880; Esser S, 1998, J CELL SCI, V111, P1853; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Fu PF, 2011, CRIT CARE MED, V39, P2711, DOI 10.1097/CCM.0b013e3182284a5f; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Huang HC, 2003, J BIOL CHEM, V278, P46750, DOI 10.1074/jbc.M305216200; *INT CONS C INT CA, 1999, AM J RESP CRIT CARE, V160, P2118, DOI DOI 10.1164/AJRCCM.160.6.ATS16060; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Karmpaliotis D, 2002, AM J PHYSIOL-LUNG C, V283, pL585, DOI 10.1152/ajplung.00048.2002; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; KUROSE I, 1994, CIRC RES, V74, P336, DOI 10.1161/01.RES.74.2.336; Li LF, 2011, TRANSL RES, V157, P293, DOI 10.1016/j.trsl.2010.12.009; Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009; Mason RJ, 1996, AM J PHYSIOL-LUNG C, V271, pL46, DOI 10.1152/ajplung.1996.271.1.L46; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Mazzoni MC, 1996, CARDIOVASC RES, V32, P709, DOI 10.1016/0008-6363(96)00146-0; Medford ARL, 2006, THORAX, V61, P621, DOI 10.1136/thx.2005.040204; Monteiller C, 2007, OCCUP ENVIRON MED, V64, P609, DOI 10.1136/oem.2005.024802; Muller HC, 2010, CRIT CARE, V14, DOI 10.1186/cc9209; Mura M, 2004, J APPL PHYSIOL, V97, P1605, DOI 10.1152/japplphysiol.00202.2004; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; O'Dea KP, 2009, J IMMUNOL, V182, P1155, DOI 10.4049/jimmunol.182.2.1155; O'Dea KP, 2005, AM J RESP CRIT CARE, V172, P1119, DOI 10.1164/rccm.200504-605OC; O'Mahony DS, 2006, CRIT CARE, V10, DOI 10.1186/cc5050; Papaiahgari S, 2007, AM J RESP CRIT CARE, V176, P1222, DOI 10.1164/rccm.200701-060OC; PARKER JC, 1993, CRIT CARE MED, V21, P131, DOI 10.1097/00003246-199301000-00024; Pinhu L, 2003, LANCET, V361, P332, DOI 10.1016/S0140-6736(03)12329-X; Schafer G, 2003, J BIOL CHEM, V278, P8190, DOI 10.1074/jbc.M211999200; Schmitz H, 1999, J CELL SCI, V112, P137; Syrkina O, 2008, RESPIROLOGY, V13, P333, DOI 10.1111/j.1440-1843.2008.01279.x; Van Ginderachter JA, 2012, BLOOD, V120, P499, DOI 10.1182/blood-2012-05-430660; Webb NJA, 1998, CYTOKINE, V10, P254, DOI 10.1006/cyto.1997.0297; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Wilson MR, 2009, AM J RESP CRIT CARE, V179, P914, DOI 10.1164/rccm.200806-877OC; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045	49	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165317	10.1371/journal.pone.0165317	http://dx.doi.org/10.1371/journal.pone.0165317			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783650	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800070
J	Sufit, A; Lee-Sherick, AB; DeRyckere, D; Rupji, M; Dwivedi, B; Varella-Garcia, M; Pierce, AM; Kowalski, J; Wang, XD; Frye, SV; Earp, HS; Keating, AK; Graham, DK				Sufit, Alexandra; Lee-Sherick, Alisa B.; DeRyckere, Deborah; Rupji, Manali; Dwivedi, Bhakti; Varella-Garcia, Marileila; Pierce, Angela M.; Kowalski, Jeanne; Wang, Xiaodong; Frye, Stephen V.; Earp, H. Shelton; Keating, Amy K.; Graham, Douglas K.			MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; CENTRAL-NERVOUS-SYSTEM; INCREASES CHEMOSENSITIVITY; LUNG-CANCER; INTERFERENCE; SUPPRESSION; APOPTOSIS; LINES; AXL	Background MER receptor tyrosine kinase (MERTK) is expressed in a variety of malignancies, including glioblastoma multiforme (GBM). Our previous work demonstrated that inhibition of MERTK using RNA interference induced cell death and chemosensitivity in GBM cells, implicating MERTK as a potential therapeutic target. Here we investigate whether a novel MERTK-selective small molecule tyrosine kinase inhibitor, UNC2025, has similar anti-tumor effects in GBM cell lines. Methods Correlations between expression of GAS6, a MERTK ligand, and prognosis were determined using data from the TCGA database. GBM cell lines (A172, SF188, U251) were treated in vitro with increasing doses of UNC2025 (50-400nM). Cell count and viability were determined by trypan blue exclusion. Cell cycle profiles and induction of apoptosis were assessed by flow cytometric analysis after BrdU or Po-Pro-1/propidium iodide staining, respectively. Polyploidy was detected by propidium iodide staining and metaphase spread. Cellular senescence was determined by beta-galactosidase staining and senescence-associated secretory cytokine analysis. Results Decreased overall survival significantly correlated with high levels of GAS6 expression in GBM, highlighting the importance of TAM kinase signaling in GBM tumorigenesis and/or therapy resistance and providing strong rationale for targeting these pathways in the clinic. All three GBM cell lines exhibited dose dependent reductions in cell number and colony formation (>90% at 200nM) after treatment with UNC2025. Cell cycle analysis demonstrated accumulation of cells in the G2/M phase and development of polyploidy. After extended exposure, 60-80% of cells underwent apoptosis. The majority of surviving cells (65-95%) were senescent and did not recover after drug removal. Thus, UNC2025 mediates antitumor activity in GBM by multiple mechanisms. Conclusions The findings described here provide further evidence of oncogenic roles for MERTK in GBM, demonstrate the importance of kinase activity for MERTK tumorigenicity and validate UNC2025, a novel MERTK inhibitor, as a potential therapeutic agent for treatment of GBM.	[Sufit, Alexandra; Lee-Sherick, Alisa B.; Varella-Garcia, Marileila; Pierce, Angela M.; Keating, Amy K.] Univ Colorado, Aurora, CO 80045 USA; [Lee-Sherick, Alisa B.; Keating, Amy K.] Childrens Hosp Colorado, Aurora, CO 80045 USA; [DeRyckere, Deborah; Graham, Douglas K.] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA; [DeRyckere, Deborah; Graham, Douglas K.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Rupji, Manali; Dwivedi, Bhakti; Kowalski, Jeanne] Emory Univ, Winship Canc Inst, Atlanta, GA 30333 USA; [Kowalski, Jeanne] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30333 USA; [Wang, Xiaodong; Frye, Stephen V.; Graham, Douglas K.] Univ N Carolina, Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Frye, Stephen V.; Earp, H. Shelton] Univ N Carolina, Sch Med, Dept Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; Emory University; Rollins School Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Graham, DK (corresponding author), Univ Colorado, Anschutz Med Campus,12800 E 19th Ave, Aurora, CO 80045 USA.	Amy.Keating@ucdenver.edu; Douglas.Graham@choa.org	Rupji, Manali/A-9170-2018; Rupji, Manali/K-1977-2019	Rupji, Manali/0000-0002-0520-1624; Rupji, Manali/0000-0002-0520-1624; Kowalski, Jeanne/0000-0003-3458-3024; Lee Sherick, Alisa/0000-0002-1177-7208; Dwivedi, Bhakti/0000-0002-9029-3737	NIH [R01 1CA137078, K1268372, TL1 TR001080]; St. Baldrick's Foundation; NIH/NCI [P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292, P30CA046934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH R01 1CA137078 to DKG, K1268372 to AKK, TL1 TR001080 to AS; and the St. Baldrick's Foundation Scholar Award AKK.; The authors thank the University of Colorado Cancer Center Flow Cytometry Core and the Molecular Pathology shared resources for technical assistance (P30CA046934). We would also like to thank Andrea Griesinger, Dr. Nicholas Foreman and Dr. John Tentler for use of reagents. Research reported in this publication was supported in part by the Biostatistics and Bioinformatics shared resource of Winship Cancer Institute of Emory University and NIH/NCI under award number P30CA138292. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476; Brandao LN, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2012.46; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen J, 1997, ONCOGENE, V14, P2033, DOI 10.1038/sj.onc.1201039; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cummings CT, 2015, MOL CANCER THER, V14, P2014, DOI 10.1158/1535-7163.MCT-15-0116; Cummings CT, 2014, ONCOTARGET, V5, P10434, DOI 10.18632/oncotarget.2142; Cummings CT, 2013, CLIN CANCER RES, V19, P5275, DOI 10.1158/1078-0432.CCR-12-1451; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Hendruschk S, 2011, NEURO-ONCOLOGY, V13, P1074, DOI 10.1093/neuonc/nor098; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Keating AK, 2006, ONCOGENE, V25, P6092, DOI 10.1038/sj.onc.1209633; Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707; Knubel KH, 2014, ONCOTARGET, DOI 10.18632/oncotarget.1793; Lai PC, 2012, PEDIATR NEONATOL, V53, P199, DOI 10.1016/j.pedneo.2012.04.008; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Linger RMA, 2013, ONCOGENE, V32, P3420, DOI 10.1038/onc.2012.355; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mao H, 2012, CANCER INVEST, V30, P48, DOI 10.3109/07357907.2011.630050; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Quignon F, 2007, ONCOGENE, V26, P165, DOI 10.1038/sj.onc.1209787; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Saito T, 2008, BRIT J CANCER, V98, P345, DOI 10.1038/sj.bjc.6604160; Schlegel J, 2013, J CLIN INVEST, V123, P2257, DOI 10.1172/JCI67816; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wang Y, 2013, ONCOGENE, V32, P872, DOI 10.1038/onc.2012.104; Yeung YT, 2013, BRIT J PHARMACOL, V168, P591, DOI 10.1111/bph.12008; Zadeh G, 2013, CANCER CELL, V24, P403, DOI 10.1016/j.ccr.2013.09.017; Zhang WH, 2014, J MED CHEM, V57, P7031, DOI 10.1021/jm500749d	37	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0165107	10.1371/journal.pone.0165107	http://dx.doi.org/10.1371/journal.pone.0165107			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783662	gold, Green Published, Green Submitted			2022-12-26	WOS:000389602800058
J	Liao, WY; Menge, DNL				Liao, Wenying; Menge, Duncan N. L.			Demography of Symbiotic Nitrogen-Fixing Trees Explains Their Rarity and Successional Decline in Temperate Forests in the United States	PLOS ONE			English	Article							FIXATION; GROWTH; PHOSPHORUS; LEAF; LIMITATION; MORTALITY; PHOTOSYNTHESIS; CONSTRAINTS; SURVIVAL; DROUGHT	Symbiotic nitrogen (N) fixation is the major N input to many ecosystems. Although temperate forests are commonly N limited, symbiotic N-fixing trees ("N fixers") are rare and decline in abundance as succession proceeds-a challenging paradox that remains unexplained. Understanding demographic processes that underlie N fixers' rarity and successional decline would provide a proximate answer to the paradox. Do N fixers grow slower, die more frequently, or recruit less in temperate forests? We quantified demographic rates of N-fixing and non-fixing trees across succession using U.S. forest inventory data. We used an individual-based model to evaluate the relative contribution of each demographic process to community dynamics. Compared to non-fixers, N fixers had lower growth rates, higher mortality rates, and lower recruitment rates throughout succession. The mortality effect contributed more than the growth effect to N fixers' successional decline. Canopy and understory N fixers experienced these demographic disadvantages, indicating that factors in addition to light limitation likely contribute to N fixers' successional decline. We show that the rarity and successional decline of N-fixing trees in temperate forests is due more to their survival disadvantage than their growth disadvantage, and a recruitment disadvantage might also play a large role.	[Liao, Wenying; Menge, Duncan N. L.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Liao, Wenying] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Columbia University; Princeton University	Liao, WY (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.; Liao, WY (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	wenyingl@princeton.edu		Liao, Wenying/0000-0001-8777-1817	National Science Foundation [DEB-1457650]	National Science Foundation(National Science Foundation (NSF))	DNLM acknowledges support from the National Science Foundation (DEB-1457650). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the USDA and Jeremy Lichstein for gathering and preparing the data. Ben Taylor, Tom Bytnerowicz, Andrew Quebbeman, Belie Bachelot, Naomi Schwartz, Elizabeth Min, Rachel Arkebauer, Maria Uriarte, and Kevin Griffin commented on earlier drafts. D.N.L.M. acknowledges support from the National Science Foundation (DEB-1457650).	Adams MA, 2016, P NATL ACAD SCI USA, V113, P4098, DOI 10.1073/pnas.1523936113; Baribault TW, 2012, ECOL MONOGR, V82, P189, DOI 10.1890/11-1013.1; Batterman SA, 2013, NATURE, V502, P224, DOI 10.1038/nature12525; Binkley D., 1994, BIOL MANAGEMENT RED, P57; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolker B.M., 2010, BBMLE TOOLS GEN MAXI; Brown KR, 2011, FOREST ECOL MANAG, V262, P791, DOI 10.1016/j.foreco.2011.05.013; Cernusak LA, 2013, NEW PHYTOL, V200, P950, DOI 10.1111/nph.12423; Chazdon R.L., 2014, 2 GROWTH PROMISE TRO, DOI DOI 10.1017/CBO9781107415324.004; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; Corby HDL, 2011, BOT J LINN SOC, V167, P251, DOI 10.1111/j.1095-8339.2011.01174.x; CREWS TE, 1993, BIOGEOCHEMISTRY, V21, P141, DOI 10.1007/BF00001115; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Desprez-Loustau ML, 2006, ANN FOREST SCI, V63, P597, DOI 10.1051/forest:2006040; Finzi AC, 2009, BIOGEOCHEMISTRY, V95, P309, DOI 10.1007/s10533-009-9338-4; Gholz H, 1987, AGROFORESTRY REALITI; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; GUTSCHICK VP, 1981, AM NAT, V118, P607, DOI 10.1086/283858; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Hulme PE, 1996, J ECOL, V84, P43, DOI 10.2307/2261698; Huntley JC, 1990, BLACK LOCUST ROBINA; HussDanell K, 1997, NEW PHYTOL, V136, P375, DOI 10.1046/j.1469-8137.1997.00755.x; Knops JMH, 2000, ECOSCIENCE, V7, P166, DOI 10.1080/11956860.2000.11682585; Kurokawa H, 2010, FUNCT ECOL, V24, P513, DOI 10.1111/j.1365-2435.2009.01676.x; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lichstein JW, 2009, ECOL STUD-ANAL SYNTH, V207, P301, DOI 10.1007/978-3-540-92706-8_14; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; MEAD DJ, 1992, CAN J FOREST RES, V22, P1192, DOI 10.1139/x92-158; Menge DNL, 2015, DIVERSITY NITROGEN F; Menge DNL, NEW PHYTOL; Menge DNL, 2008, P NATL ACAD SCI USA, V105, P1573, DOI 10.1073/pnas.0711411105; Menge DNL, 2016, NEW PHYTOL, V209, P965, DOI 10.1111/nph.13734; Menge DNL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012056; Menge DNL, 2009, AM NAT, V174, P465, DOI 10.1086/605377; Osnas JLD, 2013, SCIENCE, V340, P741, DOI 10.1126/science.1231574; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; PREGITZER KS, 1995, NEW PHYTOL, V129, P579, DOI 10.1111/j.1469-8137.1995.tb03025.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; Reich PB, 1998, FUNCT ECOL, V12, P395, DOI 10.1046/j.1365-2435.1998.00209.x; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; RITCHIE ME, 1995, ECOLOGY, V76, P2648, DOI 10.2307/2265835; Roach BA, 1965, SILVICS TREES US, P642; Sprent J.I., 2009, LEGUME NODULATION GL; Stone KR, 2009, ROBINIA PSEUDOACACIA, P273; Thomas RQ, 2010, NAT GEOSCI, V3, P13, DOI 10.1038/NGEO721; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; Uchytil R.J, 1989, ALNUS VIRIDIS SUBSP; Uliassi DD, 2002, ECOLOGY, V83, P88, DOI 10.1890/0012-9658(2002)083[0088:LTSNFI]2.0.CO;2; *USDA, 2005, FOR INV AN NAT COR F, V1; Vadeboncoeur MA, 2010, CAN J FOREST RES, V40, P1766, DOI 10.1139/X10-127; Vitousek PM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0119; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vitousek PM, 1999, BIOGEOCHEMISTRY, V46, P179, DOI 10.1007/BF01007579; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright S Joseph, 2010, Ecology, V91, P3664, DOI 10.1890/09-2335.1; Wyckoff PH, 2002, J ECOL, V90, P604, DOI 10.1046/j.1365-2745.2002.00691.x; Yelenik S, 2013, ECOLOGY, V94, P739, DOI 10.1890/12-0278.1; ZIMMERMAN JK, 1994, J ECOL, V82, P911, DOI 10.2307/2261454	59	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164522	10.1371/journal.pone.0164522	http://dx.doi.org/10.1371/journal.pone.0164522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780268	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900013
J	Zhang, WY; Cao, ZQ; Zhou, Q; Chen, J; Xu, GW; Gu, JF; Liu, LJ; Wang, ZQ; Yang, JC; Zhang, H				Zhang, Weiyang; Cao, Zhuanqin; Zhou, Qun; Chen, Jing; Xu, Gengwen; Gu, Junfei; Liu, Lijun; Wang, Zhiqin; Yang, Jianchang; Zhang, Hao			Grain Filling Characteristics and Their Relations with Endogenous Hormones in Large-and Small-Grain Mutants of Rice	PLOS ONE			English	Article							POSTANTHESIS DEVELOPMENT; ABSCISIC-ACID; SUPERIOR SPIKELETS; SINK STRENGTH; INFERIOR SPIKELETS; ETHYLENE INTERACT; POLYAMINE LEVELS; WHEAT; INVOLVEMENT; CYTOKININ	This study determined if the variation in grain filling parameters between two different spikelet types of rice (Oryza sativa L.) is regulated by the hormonal levels in the grains. Two rice mutants, namely, a large-grain mutant (AZU-M) and a small-grain mutant (ZF802-M), and their respective wild types (AZU-WT and ZF802-WT) were grown in the field. The endosperm cell division rate, filling rate, and hormonal levels: zeatin + zeatin riboside (Z+ZR), indo-3-acetic acid (IAA), polyamines (PAs), and abscisic acid (ABA) were determined. The results showed that there was no significant difference between the filling and endosperm cell division rates. These rates were synchronous between the superior and inferior spikelets for both mutants. However, the abovementioned parameters were significantly different between the two spikelet types for the two wild types. The superior spikelets filled faster and their filling rate was higher compared to the inferior ones. Changes in the concentrations of plant hormones were consistent with the observed endosperm cell division rate and the filling rate for both types of spikelets of mutant and wild type plants. Regression analysis showed a significant positive correlation between cell division and filling rates with the concentrations of the investigated hormones. Exogenous chemical application verified the role of ABA, IAA, and PAs in grain filling. The results indicate that poor filling of inferior spikelets in rice occurs primarily due to the reduced hormone concentrations therein, leading to lower division rate of endosperm cells, fewer endosperm cells, slower filling rate, and smaller grain weight.	[Zhang, Weiyang; Cao, Zhuanqin; Zhou, Qun; Chen, Jing; Xu, Gengwen; Gu, Junfei; Liu, Lijun; Wang, Zhiqin; Yang, Jianchang; Zhang, Hao] Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Jiangsu Key Lab Crop Genet & Physiol, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Zhang, H (corresponding author), Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Jiangsu Key Lab Crop Genet & Physiol, Yangzhou, Jiangsu, Peoples R China.	haozhang@yzu.edu.cn	Gu, Junfei/T-1999-2019; Gu, Junfei/L-5043-2016	Gu, Junfei/0000-0003-0002-0725	National Basic Research Program (973 Program) [2015CB150404, 2012CB114306]; National Natural Science Foundation of China [31271641, 31201155, 31371562, 31471438, 31461143105]; National Key Technology Support Program of China [2011BAD161314, 2012BAD04B08, 2014AA10A605]; Ph.D. Programs Foundation of Ministry of Education of China [20123250120001]; Top Talent Support Plan of Yangzhou University, Shenzhen Overseas Talents Innovation & Entrepreneurship Funding Scheme (The Peacock Scheme); Natural Science Foundation of the Jiangsu Higher Education Institutions [15KJA210005]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program of China(National Key Technology R&D Program); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Top Talent Support Plan of Yangzhou University, Shenzhen Overseas Talents Innovation & Entrepreneurship Funding Scheme (The Peacock Scheme); Natural Science Foundation of the Jiangsu Higher Education Institutions; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National Basic Research Program (973 Program, 2015CB150404; 2012CB114306), the National Natural Science Foundation of China (31271641; 31201155; 31371562; 31471438; 31461143105), the National Key Technology Support Program of China (2011BAD161314; 2012BAD04B08; 2014AA10A605), the Ph.D. Programs Foundation of Ministry of Education of China (20123250120001), Top Talent Support Plan of Yangzhou University, Shenzhen Overseas Talents Innovation & Entrepreneurship Funding Scheme (The Peacock Scheme), the Natural Science Foundation of the Jiangsu Higher Education Institutions (15KJA210005), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Basic Research Program (973 Program, 2015CB150404; 2012CB114306), the National Natural Science Foundation of China (31271641; 31201155; 31371562; 31471438; 31461143105), the National Key Technology Support Program of China (2011BAD16B14; 2012BAD04B08; 2014AA10A605), the Ph.D. Programs Foundation of Ministry of Education of China (20123250120001), Top Talent Support Plan of Yangzhou University, Shenzhen Overseas Talents Innovation & Entrepreneurship Funding Scheme (The Peacock Scheme), the Natural Science Foundation of the Jiangsu Higher Education Institutions (15KJA210005), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Argueso CT, 2009, PLANT CELL ENVIRON, V32, P1147, DOI 10.1111/j.1365-3040.2009.01940.x; Beltrano J, 1999, J PLANT GROWTH REGUL, V18, P59, DOI 10.1007/PL00007049; BOLLMARK M, 1988, J PLANT PHYSIOL, V132, P262, DOI 10.1016/S0176-1617(88)80102-0; Cao ZH, 2014, THESIS; Chen TT, 2013, J EXP BOT, V64, P2523, DOI 10.1093/jxb/ert115; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; Davies Peter J., 1995, P1; Davies PJ, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P1; EEUWENS CJ, 1975, J EXP BOT, V26, P1, DOI 10.1093/jxb/26.1.1; FLORES HE, 1982, PLANT PHYSIOL, V69, P701, DOI 10.1104/pp.69.3.701; Fu J, 2011, FIELD CROP RES, V123, P170, DOI 10.1016/j.fcr.2011.05.015; He Z.P., 1993, GUIDANCE EXPT CHEM C, P60; Hummel I, 2004, J EXP BOT, V55, P1125, DOI 10.1093/jxb/erh126; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; KATO T, 1993, JPN J CROP SCI, V62, P456, DOI 10.1626/jcs.62.456; Kato T, 2004, J AGR SCI, V142, P177, DOI 10.1017/S0021859604004265; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Liang JS, 2001, PHYSIOL PLANTARUM, V112, P470, DOI 10.1034/j.1399-3054.2001.1120403.x; Liang YL, 2002, CROP SCI, V42, P1217, DOI 10.2135/cropsci2002.1217; Liu HP, 2004, PLANT SCI, V166, P1261, DOI 10.1016/j.plantsci.2003.12.039; LUR HS, 1993, PLANT PHYSIOL, V103, P273, DOI 10.1104/pp.103.1.273; MORRIS RO, 1993, AUST J PLANT PHYSIOL, V20, P621, DOI 10.1071/PP9930621; MURTY PSS, 1982, INDIAN J PLANT PHYSI, V25, P40; Paschalidis KA, 2005, PLANT PHYSIOL, V138, P142, DOI 10.1104/pp.104.055483; Qin Z, 1984, CHINA SCI, V12, P1103; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; SETH AK, 1967, J EXP BOT, V18, P65, DOI 10.1093/jxb/18.1.65; Sharp RE, 2004, J EXP BOT, V55, P2343, DOI 10.1093/jxb/erh276; SINGH BK, 1982, PLANT SCI LETT, V26, P273, DOI 10.1016/0304-4211(82)90101-8; SUZUKI Y, 1981, PLANT CELL PHYSIOL, V22, P1085; Walden R, 1997, PLANT PHYSIOL, V113, P1009, DOI 10.1104/pp.113.4.1009; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang ZQ, 2012, PLANT GROWTH REGUL, V66, P215, DOI 10.1007/s10725-011-9644-4; Wang ZhiQin, 1998, Acta Agronomica Sinica, V24, P782; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2003, PLANT GROWTH REGUL, V41, P185, DOI 10.1023/B:GROW.0000007503.95391.38; Yang JC, 2002, CROP SCI, V42, P766, DOI 10.2135/cropsci2002.0766; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yang JC, 2008, PLANTA, V228, P137, DOI 10.1007/s00425-008-0725-1; Yang JC, 2007, J EXP BOT, V58, P1545, DOI 10.1093/jxb/erm032; Yang JC, 2006, NEW PHYTOL, V171, P293, DOI 10.1111/j.1469-8137.2006.01753.x; Yang JianChang, 1999, Chinese agricultural sciences., P61; Yang JianJun, 2010, Medicinal Plant, V1, P1, DOI 10.1080/00103624.2011.528493; Zahedi M, 2003, J AGR SCI-CAMBRIDGE, V141, P203, DOI 10.1017/S0021859603003411; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; ZHU Q, 1988, Acta Agronomica Sinica, V14, P182	46	34	36	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165321	10.1371/journal.pone.0165321	http://dx.doi.org/10.1371/journal.pone.0165321			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780273	gold, Green Published, Green Submitted			2022-12-26	WOS:000389046900047
J	Giustino, TF; Fitzgerald, PJ; Maren, S				Giustino, Thomas F.; Fitzgerald, Paul J.; Maren, Stephen			Fear Expression Suppresses Medial Prefrontal Cortical Firing in Rats	PLoS One			English	Article							CONDITIONED FEAR; PRELIMBIC CORTEX; BASOLATERAL AMYGDALA; INFRALIMBIC CORTEX; NEURONAL CIRCUITS; EXTINCTION; HIPPOCAMPAL; ACTIVATION; MEMORY; MICE	The medial prefrontal cortex (mPFC) plays a crucial role in emotional learning and memory in rodents and humans. While many studies suggest a differential role for the prelimbic (PL) and infralimbic (IL) subdivisions of mPFC, few have considered the relationship between neural activity in these two brain regions recorded simultaneously in behaving animals. Importantly, how concurrent PL and IL activity relate to conditioned freezing behavior is largely unknown. Here we used single-unit recordings targeting PL and IL in awake, behaving rats during the acquisition and expression of conditioned fear. On Day 1, rats received either signaled or unsignaled footshocks in the recording chamber; an auditory conditioned stimulus (CS) preceded signaled footshocks. Twenty-four hours later, animals were returned to the recording chamber (modified to create a novel context) where they received 5 CS-alone trials. After fear conditioning, both signaled and unsignaled rats exhibited high levels of post-shock freezing that was associated with an enduring suppression of mPFC spontaneous firing, particularly in the IL of signaled rats. Twenty-four hours later, CS presentation produced differential conditioned freezing in signaled and unsignaled rats: freezing increased in rats that had received signaled shocks, but decreased in animals in the unsignaled condition (i.e., external inhibition). This group difference in CS-evoked freezing was mirrored in the spontaneous firing rate of neurons in both PL and IL. Interestingly, differences in PL and IL firing rate highly correlated with freezing levels. In other words, in the signaled group IL spontaneous rates were suppressed relative to PL, perhaps limiting IL-mediated suppression of fear and allowing PL activity to dominate performance, resulting in high levels of freezing. This was not observed in the unsignaled group, which exhibited low freezing. These data reveal that the activity of mPFC neurons is modulated by both associative and nonassociative stimuli that regulate conditioned fear.	[Maren, Stephen] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA; Texas A&M Univ, Inst Neurosci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Maren, S (corresponding author), Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA.	maren@tamu.edu	Maren, Stephen/B-6182-2014	Maren, Stephen/0000-0002-9342-7411; Giustino, Thomas/0000-0002-5361-8045	National Institutes of Health [R01MH065961]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institutes of Health (R01MH065961) (https://www.nimh.nih.gov/indeks.shtml). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Chang CH, 2011, LEARN MEMORY, V18, P221, DOI 10.1101/lm.2070111; Chang CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011971; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Cruz E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103596; Dejean C, 2015, BIOL PSYCHIAT, V78, P298, DOI 10.1016/j.biopsych.2015.03.017; Dunsmoor JE, 2015, BIOL PSYCHIAT, V78, P203, DOI 10.1016/j.biopsych.2014.12.008; Fitzgerald PJ, 2014, NEUROBIOL LEARN MEM, V113, P69, DOI 10.1016/j.nlm.2013.11.002; Fitzgerald PJ, 2015, P NATL ACAD SCI USA, V201500682; Giustino TF, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00298; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hobin JA, 2003, J NEUROSCI, V23, P8410; Ji GC, 2010, J NEUROSCI, V30, P5451, DOI 10.1523/JNEUROSCI.0225-10.2010; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Laurent V, 2009, LEARN MEMORY, V16, P520, DOI 10.1101/lm.1474609; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 1998, J NEUROSCI, V18, P3088; Maren S, 2014, NEUROBIOL LEARN MEM, V108, P88, DOI 10.1016/j.nlm.2013.06.004; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MITCHELL D, 1985, BEHAV NEURAL BIOL, V43, P212, DOI 10.1016/S0163-1047(85)91387-1; Morawska MM, 2012, J EXP BIOL, V215, P1394, DOI 10.1242/jeb.068213; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Orsini CA, 2011, J NEUROSCI, V31, P17269, DOI 10.1523/JNEUROSCI.4095-11.2011; Pavlov I.P., 1927, CONDITIONED REFLEXES; Poulos AM, 2015, BEHAV NEUROSCI, V129, P62, DOI 10.1037/bne0000033; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Sangha S, 2014, NEUROPSYCHOPHARMACOL, V39, P2405, DOI 10.1038/npp.2014.89; Santini E, 2008, J NEUROSCI, V28, P4028, DOI 10.1523/JNEUROSCI.2623-07.2008; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; SERVATIUS RJ, 1994, BEHAV NEUROSCI, V108, P1101, DOI 10.1037/0735-7044.108.6.1101; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Sierra-Mercado D, 2006, EUR J NEUROSCI, V24, P1751, DOI 10.1111/j.1460-9568.2006.05014.x; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Thiel CM, 1998, NEUROSCIENCE, V85, P1253, DOI 10.1016/S0306-4522(98)00030-X; Thompson BM, 2010, LEARN MEMORY, V17, P591, DOI 10.1101/lm.1920810; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Zhu XO, 1997, NEUROSCI LETT, V229, P141, DOI 10.1016/S0304-3940(97)00437-0	44	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165256	10.1371/journal.pone.0165256	http://dx.doi.org/10.1371/journal.pone.0165256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776157	Green Published, gold, Green Submitted			2022-12-26	WOS:000389009200052
J	Marino, JS; Stechschulte, LA; Stec, DE; Nestor-Kalinoski, A; Coleman, S; Hinds, TD				Marino, Joseph S.; Stechschulte, Lance A.; Stec, David E.; Nestor-Kalinoski, Andrea; Coleman, Sydni; Hinds, Terry D., Jr.			Glucocorticoid Receptor beta Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR 21; FATTY LIVER-DISEASE; GLYCOGEN-SYNTHASE KINASE-3-BETA; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; GENE-EXPRESSION; METABOLIC SYNDROME; MICE LACKING; NONALCOHOLIC STEATOHEPATITIS; LIPID-METABOLISM	Glucocorticoids (GCs) regulate energy supply in response to stress by increasing hepatic gluconeogenesis during fasting. Long-term GC treatment induces hepatic steatosis and weight gain. GC signaling is coordinated via the GC receptor (GR) GR alpha, as the GR beta isoform lacks a ligand-binding domain. The roles of the GR isoforms in the regulation of lipid accumulation is unknown. The purpose of this study was to determine whether GR beta inhibits the actions of GCs in the liver, or enhances hepatic lipid accumulation. We show that GR beta expression is increased in adipose and liver tissues in obese high-fat fed mice. Adenovirus-mediated delivery of hepatic GR beta overexpression (GR beta-Ad) resulted in suppression of gluconeogenic genes and hyperglycemia in mice on a regular diet. Furthermore, GR beta-Ad mice had increased hepatic lipid accumulation and serum triglyceride levels possibly due to the activation of NF-kappa B signaling and increased tumor necrosis factor alpha (TNF alpha) and inducible nitric-oxide synthase expression, indicative of enhanced M1 macrophages and the development of steatosis. Consequently, GR beta-Ad mice had increased glycogen synthase kinase 3 beta (GSK3 beta) activity and reduced hepatic PPAR alpha and fibroblast growth factor 21 (FGF21) expression and lower serum FGF21 levels, which are two proteins known to increase during fasting to enhance the burning of fat by activating the beta-oxidation pathway. In conclusion, GR beta antagonizes the GC-induced signaling during fasting via GR alpha and the PPAR alpha-FGF21 axis that reduces fat burning. Furthermore, hepatic GR beta increases inflammation, which leads to hepatic lipid accumulation.	[Marino, Joseph S.] Univ N Carolina, Dept Kinesiol, Lab Syst Physiol, Charlotte, NC 28223 USA; [Stechschulte, Lance A.] Univ Toledo, Coll Med, Dept Orthoped, Toledo, OH 43614 USA; [Nestor-Kalinoski, Andrea] Univ Toledo, Coll Med, Adv Microscopy & Imaging Ctr, Dept Surg, Toledo, OH 43614 USA; [Hinds, Terry D., Jr.] Univ Toledo, Coll Med, Ctr Hypertens & Personalized Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Stec, David E.] Univ Mississippi, Med Ctr, Cardiovasc Renal Res Ctr, Dept Physiol & Biophys,Mississippi Ctr Obes Res, Jackson, MS 39216 USA; [Coleman, Sydni] Univ Cincinnati, Coll Med, Cincinnati, OH 45220 USA	University of North Carolina; University of North Carolina Charlotte; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Mississippi; University of Mississippi Medical Center; University System of Ohio; University of Cincinnati	Hinds, TD (corresponding author), Univ Toledo, Coll Med, 3000 Arlington Ave,Mail Stop 1008, Toledo, OH 43614 USA.	Terry.Hinds@utoledo.edu	; Hinds, Terry/B-8495-2015	Marino, Joseph/0000-0002-6207-5986; Hinds, Terry/0000-0002-7599-1529; Stechschulte, Lance/0000-0001-9783-6194	University of Toledo deArce-Memorial Endowment Fund; National Institutes of Health [L32MD009154]; NHLBI [K01HL-125445, PO1HL-051971, HL088421]; NIGMS [P20GM-104357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971, K01HL125445, R01HL088421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	University of Toledo deArce-Memorial Endowment Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Toledo deArce-Memorial Endowment Fund (to T. D. H), National Institutes of Health Grant L32MD009154 (to T. D. H.), NHLBI Grants K01HL-125445 (to T. D. H.), PO1HL-051971, and HL088421 (to D. E. S.), and NIGMS Grant P20GM-104357 (to D. E. S.). The authors declare that they have no conflict of interests with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Bozzetto L, 2016, NUTR METAB CARDIOVAS, V26, P623, DOI 10.1016/j.numecd.2016.01.011; Camporez JPG, 2015, J ENDOCRINOL, V226, P207, DOI 10.1530/JOE-15-0136; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Christodoulopoulos P, 2000, J ALLERGY CLIN IMMUN, V106, P479; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; DuBois DC, 2013, STEROIDS, V78, P312, DOI 10.1016/j.steroids.2012.11.014; Dunderski J, 2009, J MED BIOCHEM, V28, P248, DOI 10.2478/v10011-009-0022-y; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019; Ge X, 2011, J BIOL CHEM, V286, P34533, DOI 10.1074/jbc.M111.248591; Goecke A, 2006, IMMUNOBIOLOGY, V211, P85, DOI 10.1016/j.imbio.2005.11.002; Goyal R, 2012, N AM J MED SCI, V4, P180, DOI 10.4103/1947-2714.94944; He B, 2016, MOL CELL BIOL, V36, P714, DOI 10.1128/MCB.00908-15; Hinds TD, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020232; Hinds TD, 2014, OBESITY, V22, P705, DOI 10.1002/oby.20559; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; John K, 2016, AM J PHYSIOL-ENDOC M, V310, pE249, DOI 10.1152/ajpendo.00478.2015; Kimura R, 2011, BIOCHEM BIOPH RES CO, V410, P1, DOI 10.1016/j.bbrc.2011.05.057; Komatsu M, 2015, BBA-MOL BASIS DIS, V1852, P473, DOI 10.1016/j.bbadis.2014.12.011; Lee SJ, 2008, GASTROENTEROLOGY, V135, P2084, DOI 10.1053/j.gastro.2008.08.007; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; McBeth L, 2016, ONCOTARGET, V7, P27313, DOI 10.18632/oncotarget.8430; Meli R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00177; Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798; Moon YS, 2004, METABOLISM, V53, P863, DOI 10.1016/j.metabol.2004.02.007; Nandan D, 2012, J IMMUNOL, V188, P367, DOI 10.4049/jimmunol.1100076; Nwaneri Assumpta C, 2016, Cancer Cell Microenviron, V3; O'Brien KA, 2012, ARTERIOSCL THROM VAS, V32, P2232, DOI 10.1161/ATVBAHA.112.254680; Paschos P, 2009, HIPPOKRATIA, V13, P9; Patel R, 2015, MOL ENDOCRINOL, V29, P213, DOI 10.1210/me.2014-1259; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Ramakrishnan SK, 2016, J BIOL CHEM, V291, P8121, DOI 10.1074/jbc.M116.714014; Rando G, 2016, ELIFE, V5, DOI 10.7554/eLife.11853; Robert O, 2016, J HEPATOL, V64, P916, DOI 10.1016/j.jhep.2015.11.023; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Samms RJ, 2016, ENDOCRINOLOGY, V157, P1467, DOI 10.1210/en.2015-1722; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003; Sharma M, 2015, J CLIN EXP HEPATOL, V5, P147, DOI 10.1016/j.jceh.2015.02.002; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shulman GI, 2014, NEW ENGL J MED, V371, P2237; Smith BW, 2011, CRIT REV CL LAB SCI, V48, P97, DOI 10.3109/10408363.2011.596521; Stec DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153427; Stechschulte LA, 2016, ENDOCRINOLOGY, V157, P3888, DOI 10.1210/en.2015-1996; Stechschulte LA, 2014, J BIOL CHEM, V289, P17885, DOI 10.1074/jbc.M113.544072; Tipoe GL, 2009, HISTOL HISTOPATHOL, V24, P1161, DOI 10.14670/HH-24.1161; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vasudevan KM, 2004, MOL CELL BIOL, V24, P1007, DOI 10.1128/MCB.24.3.1007-1021.2004; Vazquez-Tello A, 2013, J CLIN IMMUNOL, V33, P466, DOI 10.1007/s10875-012-9828-3; Wang Y, 2011, ONCOGENE, V30, P4327, DOI 10.1038/onc.2011.144; Warrier M, 2010, ENDOCRINOLOGY, V151, P3225, DOI 10.1210/en.2009-1158; Webster JC, 2001, P NATL ACAD SCI USA, V98, P6865, DOI 10.1073/pnas.121455098; Wuescher L, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.7; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zhao L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10222	66	47	51	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25776	25788		10.1074/jbc.M116.752311	http://dx.doi.org/10.1074/jbc.M116.752311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27784782	Green Published, hybrid			2022-12-26	WOS:000390345200002
J	Sun, B; Guo, WT; Tian, XX; Yao, JJ; Zhang, L; Wang, RW; Chen, SRW				Sun, Bo; Guo, Wenting; Tian, Xixi; Yao, Jinjing; Zhang, Lin; Wang, Ruiwu; Chen, S. R. Wayne			The Cytoplasmic Region of Inner Helix S6 Is an Important Determinant of Cardiac Ryanodine Receptor Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CA2+ RELEASE; CRYSTAL-STRUCTURES; VENTRICULAR-TACHYCARDIA; DISEASE MUTATIONS; ACTIVATION; THRESHOLD; PROTEINS; MYOCYTES; DOMAINS; FORMS	The ryanodine receptor (RyR) channel pore is formed by four S6 inner helices, with its intracellular gate located at the S6 helix bundle crossing region. The cytoplasmic region of the extended S6 helix is held by the U motif of the central domain and is thought to control the opening and closing of the S6 helix bundle. However, the functional significance of the S6 cytoplasmic region in channel gating is unknown. Here we assessed the role of the S6 cytoplasmic region in the function of cardiac RyR (RyR2) via structure-guided site-directed mutagenesis. We mutated each residue in the S6 cytoplasmic region of the mouse RyR2 ((4876)QQEQVKEDM(4884)) and characterized their functional impact. We found that mutations Q4876A, V4880A, K4881A, and M4884A, located mainly on one side of the S6 helix that faces the U motif, enhanced basal channel activity and the sensitivity to Ca2+ or caffeine activation, whereas mutations Q4877A, E4878A, Q4879A, and D4883A, located largely on the opposite side of S6, suppressed channel activity. Furthermore, V4880A, a cardiac arrhythmia-associated mutation, markedly enhanced the frequency of spontaneous openings and the sensitivity to cytosolic and luminal Ca2+ activation of single RyR2 channels. V4880A also increased the propensity and reduced the threshold for arrhythmogenic spontaneous Ca2+ release in HEK293 cells. Collectively, our data suggest that interactions between the cytoplasmic region of S6 and the U motif of RyR2 are important for stabilizing the closed state of the channel. Mutations in the S6/U motif domain interface likely destabilize the closed state of RyR2, resulting in enhanced basal channel activity and sensitivity to activation and increased propensity for spontaneous Ca2+ release and cardiac arrhythmias.	[Sun, Bo; Guo, Wenting; Tian, Xixi; Yao, Jinjing; Zhang, Lin; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary	Chen, SRW (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca			Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS); AIHS Graduate Studentship Award; University of Calgary; Alberta Innovates [201300501, 201500221] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS); AIHS Graduate Studentship Award; University of Calgary; Alberta Innovates	This work was supported by research grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada, the Canada Foundation for Innovation, and the Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research (to S. R. W. C.). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of the Heart and Stroke Foundation of Canada Junior Fellowship Award and the Alberta Innovates-Health Solutions (AIHS) Fellowship Award.r Recipients of the AIHS Graduate Studentship Award.r Recipient of the University of Calgary Eyes High Postdoctoral Fellowship Award.	Amador F. J., 2013, J MOL BIOL; Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Bagattin A, 2004, CLIN CHEM, V50, P1148, DOI 10.1373/clinchem.2003.030734; Bai XC, 2016, CELL RES; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Diaz ME, 1997, J PHYSIOL-LONDON, V501, P3, DOI 10.1111/j.1469-7793.1997.003bo.x; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Guo WT, 2016, J BIOL CHEM, V291, P2150, DOI 10.1074/jbc.M115.693325; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kimlicka L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2501; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6397; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu YJ, 2015, J BIOL CHEM, V290, P7736, DOI 10.1074/jbc.M114.618827; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Van Petegem F, 2015, J MOL BIOL, V427, P31, DOI 10.1016/j.jmb.2014.08.004; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Wang RW, 2003, BIOPHYS J, V84, p427A; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	39	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26024	26034		10.1074/jbc.M116.758821	http://dx.doi.org/10.1074/jbc.M116.758821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27789712	Green Published, hybrid			2022-12-26	WOS:000390345200022
J	Van de Velde, LA; Murray, PJ				Van de Velde, Lee-Ann; Murray, Peter J.			Proliferating Helper T Cells Require Rictor/mTORC2 Complex to Integrate Signals from Limiting Environmental Amino Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; CYCLE PROGRESSION; MAMMALIAN TARGET; GLUTAMINE UPTAKE; LEUCINE SENSOR; MTORC1 PATHWAY; ACTIVATION; DIFFERENTIATION; METABOLISM; MECHANISM	Antigen-stimulated T cells require elevated importation of essential and non-essential amino acids to generate large numbers of daughter cells necessary for effective immunity to pathogens. When amino acids are limiting, T cells arrest in the G(1) phase of the cell cycle, suggesting that they have specific sensing mechanisms to ensure sufficient amino acids are available for multiple rounds of daughter generation. We found that activation of mTORC1, which is regulated by amino acid amounts, was uncoupled from limiting amino acids in the G(1) phase of the cell cycle. Instead, we found that Rictor/mTORC2 has an essential role in T cell amino acid sensing. In the absence of Rictor, CD4(+) T cells proliferate normally in limiting arginine or leucine. Our data suggest that Rictor/mTORC2 controls an amino acid-sensitive checkpoint that allows T cells to determine whether the microenvironment contains sufficient resources for daughter cell generation.	[Van de Velde, Lee-Ann; Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Van de Velde, Lee-Ann; Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.; Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.murray@stjude.org	Murray, Peter J/K-4725-2018	Murray, Peter J/0000-0001-6329-9802	National Institutes of Health [CA189990]; Cancer Center [P30 CA21765]; American Lebanese Syrian Associated Charities	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by National Institutes of Health Grant CA189990 and Cancer Center Core Grant P30 CA21765 (to P. J. M.) and the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blagosklonny MV, 2002, CELL CYCLE, V1, P103, DOI 10.4161/cc.1.2.108; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Carroll B, 2016, ELIFE, V5, DOI 10.7554/eLife.11058; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dyachok J, 2016, J BIOL CHEM, V291, P22414, DOI 10.1074/jbc.M116.732511; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hwang LN, 2006, CANCER RES, V66, P1132, DOI 10.1158/0008-5472.CAN-05-1679; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kinjyo I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7301; Lee JH, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2885; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Murray PJ, 2016, NAT IMMUNOL, V17, P132, DOI 10.1038/ni.3323; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Ross SH, 2016, IMMUNITY, V45, P685, DOI 10.1016/j.immuni.2016.07.022; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2016, NATURE, V536, P229, DOI 10.1038/nature19079; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Taylor DK, 2006, J IMMUNOL, V177, P2216, DOI 10.4049/jimmunol.177.4.2216; Van de Velde L. A., 2016, CELL REP IN PRESS; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Werner A, 2016, EUR J IMMUNOL, V46, P92, DOI 10.1002/eji.201546047; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yoon MS, 2016, CELL REP, V16, P1510, DOI 10.1016/j.celrep.2016.07.008	38	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25815	25822		10.1074/jbc.C116.763623	http://dx.doi.org/10.1074/jbc.C116.763623			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27799302	hybrid, Green Published			2022-12-26	WOS:000390345200006
J	Liu, X; Ye, YK; Mi, Q; Huang, W; He, T; Huang, P; Xu, NN; Wu, QY; Wang, AL; Li, Y; Yuan, H				Liu, Xing; Ye, Yongkai; Mi, Qi; Huang, Wei; He, Ting; Huang, Pin; Xu, Nana; Wu, Qiaoyu; Wang, Anli; Li, Ying; Yuan, Hong			A Predictive Model for Assessing Surgery-Related Acute Kidney Injury Risk in Hypertensive Patients: A Retrospective Cohort Study	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-RENAL-FAILURE; CARDIAC-SURGERY; URINARY INTERLEUKIN-18; METAANALYSIS; SOCIETY; DISEASE; BYPASS; SCORE; ALBUMINURIA	Background Acute kidney injury (AKI) is a serious post-surgery complication; however, few preoperative risk models for AKI have been developed for hypertensive patients undergoing general surgery. Thus, in this study involving a large Chinese cohort, we developed and validated a risk model for surgery-related AKI using preoperative risk factors. Methods and Findings This retrospective cohort study included 24,451 hypertensive patients aged >= 18 years who underwent general surgery between 2007 and 2015. The endpoints for AKI classification utilized by the KDIGO (Kidney Disease: Improving Global Outcomes) system were assessed. The most discriminative predictor was selected using Fisher scores and was subsequently used to construct a stepwise multivariate logistic regression model, whose performance was evaluated via comparisons with models used in other published works using the net reclassification index (NRI) and integrated discrimination improvement (IDI) index. Results Surgery-related AKI developed in 1994 hospitalized patients (8.2%). The predictors identified by our Xiang-ya Model were age, gender, eGFR, NLR, pulmonary infection, prothrombin time, thrombin time, hemoglobin, uric acid, serum potassium, serum albumin, total cholesterol, and aspartate amino transferase. The area under the receiver-operating characteristic curve (AUC) for the validation set and cross validation set were 0.87 (95% CI 0.86-0.89) and (0.89; 95% CI 0.88-0.90), respectively, and was therefore similar to the AUC for the training set (0.89; 95% CI 0.88-0.90). The optimal cutoff value was 0.09. Our model outperformed that developed by Kate et al., which exhibited an NRI of 31.38% (95% CI 25.7%-37.1%) and an IDI of 8% (95% CI 5.52%-10.50%) for patients who underwent cardiac surgery (n = 2101). Conclusions/Significance We developed an AKI risk model based on preoperative risk factors and biomarkers that demonstrated good performance when predicting events in a large cohort of hypertensive patients who underwent general surgery.	[Liu, Xing; Huang, Wei; He, Ting; Huang, Pin; Wu, Qiaoyu; Li, Ying; Yuan, Hong] Cent S Univ, Xiangya Hosp 3, Dept Cardiol, Changsha 410013, Hunan, Peoples R China; [Ye, Yongkai] Natl Univ Def Technol, Sch Comp, Changsha 410073, Hunan, Peoples R China; [Mi, Qi] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA 15260 USA; [Xu, Nana; Li, Ying; Yuan, Hong] Cent S Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha 410013, Hunan, Peoples R China; [Wang, Anli] Cent S Univ, Xiangya Hosp 3, Dept Informat, Changsha 410013, Hunan, Peoples R China	Central South University; National University of Defense Technology - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Central South University	Li, Y; Yuan, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Cardiol, Changsha 410013, Hunan, Peoples R China.; Li, Y; Yuan, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha 410013, Hunan, Peoples R China.	37618190@qq.com; yuanhongxy3@163.com			Fundamental Research Funds of Central South University [2015zzts122]; National Science Foundation of China [81273594, 81503071]; National Key Technology RD Program [2012BAI37B05]; National Science and Technology Major Project [2012ZX09303014001]; Mittal Innovation Funds of Central South University [15MX49]	Fundamental Research Funds of Central South University; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); National Science and Technology Major Project; Mittal Innovation Funds of Central South University	This study was supported by the Fundamental Research Funds of Central South University (no. 2015zzts122), the National Science Foundation of China (no. 81273594, 81503071), the National Key Technology R&D Program (no. 2012BAI37B05), the National Science and Technology Major Project (no. 2012ZX09303014001), and the Mittal Innovation Funds of Central South University (15MX49).	Aguado-Fraile E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127175; Akrawinthawong K, 2013, CARDIORENAL MED, V3, P7, DOI 10.1159/000346815; Ali FN, 2013, PEDIATR NEPHROL, V28, P959, DOI 10.1007/s00467-012-2395-2; Bedford M., 2016, DEV RISK MODELS PRED; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Berg KS, 2013, EUR J ANAESTH, V30, P704, DOI 10.1097/EJA.0b013e328365ae64; Birnie K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0606-x; Boos CJ, 2006, CURR PHARM DESIGN, V12, P1623, DOI 10.2174/138161206776843313; Buelow MW, 2012, CONGENIT HEART DIS, V7, P441, DOI 10.1111/j.1747-0803.2012.00662.x; Cardoso B, 2016, REV PORT CARDIOL, V35, P99, DOI 10.1016/j.repc.2015.06.006; Chang CH, 2016, INT J MED SCI, V13, P19, DOI 10.7150/ijms.13253; Chang CH, 2015, ANN THORAC SURG, V99, P123, DOI 10.1016/j.athoracsur.2014.07.072; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Cullen MR, 2014, ANN CLIN BIOCHEM, V51, P392, DOI 10.1177/0004563213507438; Demirjian S, 2012, AM J KIDNEY DIS, V59, P382, DOI 10.1053/j.ajkd.2011.10.046; Englberger L, 2010, AM J KIDNEY DIS, V56, P623, DOI 10.1053/j.ajkd.2010.04.017; Evans RG, 2013, CLIN EXP PHARMACOL P, V40, P106, DOI 10.1111/1440-1681.12031; Ferenbach David A, 2016, Nephrol Ther, V12 Suppl 1, pS41, DOI 10.1016/j.nephro.2016.02.005; Gammelager H, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0492-2; Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034; HUANG W, 2015, MEDICINE, V94, DOI DOI 10.1097/MD; Huen SC, 2012, ANN THORAC SURG, V93, P337, DOI 10.1016/j.athoracsur.2011.09.010; James MT, 2015, AM J KIDNEY DIS, V66, P602, DOI 10.1053/j.ajkd.2015.02.338; Jiang Jun, 2014, Zhonghua Nei Ke Za Zhi, V53, P947; Kandler K, 2014, J CARDIOTHOR VASC AN, V28, P1448, DOI 10.1053/j.jvca.2014.04.019; Kane-Gill SL, 2015, AM J KIDNEY DIS, V65, P860, DOI 10.1053/j.ajkd.2014.10.018; Kaushal GP, 2014, J AM SOC NEPHROL, V25, P877, DOI 10.1681/ASN.2013070780; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kiers HD, 2013, NEPHROL DIAL TRANSPL, V28, P345, DOI 10.1093/ndt/gfs518; Kim WH, 2013, J CARDIOTHOR VASC AN, V27, P1158, DOI 10.1053/j.jvca.2013.04.007; Kribben A, 2003, DEUT MED WOCHENSCHR, V128, P1231; Lin X, 2015, J TRAD CHIN MED MANA, V13, P79; Liu YW, 2013, AM J KIDNEY DIS, V62, P1058, DOI 10.1053/j.ajkd.2013.05.014; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Najjar M, 2015, EXPERT REV CARDIOVAS, V13, P301, DOI 10.1586/14779072.2015.1002467; Ng SY, 2014, J THORAC CARDIOV SUR, V147, P1875, DOI 10.1016/j.jtcvs.2013.06.049; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Palit S, 2015, CLIN J AM SOC NEPHRO, V10, P934, DOI 10.2215/CJN.08620814; Patschan Daniel, 2015, J Inj Violence Res, V7, P19, DOI 10.5249/jivr.v7i1.604; Pickering JW, 2015, AM J KIDNEY DIS, V65, P283, DOI 10.1053/j.ajkd.2014.09.008; Pietri P, 2015, CURR MED CHEM, V22, P2754, DOI 10.2174/0929867322666150420104727; Rewa O, 2014, NAT REV NEPHROL, V10, P193, DOI 10.1038/nrneph.2013.282; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Slankamenac K, 2009, ANN SURG, V250, P720, DOI 10.1097/SLA.0b013e3181bdd840; Wong Brian, 2015, Can J Kidney Health Dis, V2, P3, DOI 10.1186/s40697-015-0037-x; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; Zhang W, 2015, CARDIORENAL MED, V5, P40, DOI 10.1159/000369834; Zhang ZH, 2015, HEART LUNG VESSEL, V7, P64; 高秀林, 2007, [北京医学, Beijing Medical Journal], V29, P559	50	6	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165280	10.1371/journal.pone.0165280	http://dx.doi.org/10.1371/journal.pone.0165280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802302	Green Published, gold, Green Submitted			2022-12-26	WOS:000386714200021
J	Gai, SY; Da, FP; Fang, X				Gai, Shaoyan; Da, Feipeng; Fang, Xu			A Novel Camera Calibration Method Based on Polar Coordinate	PLOS ONE			English	Article								A novel calibration method based on polar coordinate is proposed. The world coordinates are expressed in the form of polar coordinates, which are converted to world coordinates in the calibration process. In the beginning, the calibration points are obtained in polar coordinates. By transformation between polar coordinates and rectangular coordinates, the points turn into form of rectangular coordinates. Then, the points are matched with the corresponding image coordinates. At last, the parameters are obtained by objective function optimization. By the proposed method, the relationships between objects and cameras are expressed in polar coordinates easily. It is suitable for multi-camera calibration. Cameras can be calibrated with fewer points. The calibration images can be positioned according to the location of cameras. The experiment results demonstrate that the proposed method is an efficient calibration method. By the method, cameras are calibrated conveniently with high accuracy.	[Gai, Shaoyan; Da, Feipeng; Fang, Xu] Southeast Univ, Key Lab Measurement & Control Complex Syst Engn, Minist Educ, Sch Automat, Nanjing 210096, Jiangsu, Peoples R China; [Gai, Shaoyan] Huazhong Univ Sci & Technol, State Key Lab Digital Mfg Equipment & Technol, Wuhan 430074, Peoples R China; [Gai, Shaoyan] Jiangsu Univ, Minist Educ, Key Lab Modern Agr Equipment & Technol, Zhenjiang 212013, Peoples R China	Southeast University - China; Huazhong University of Science & Technology; Jiangsu University	Gai, SY (corresponding author), Southeast Univ, Key Lab Measurement & Control Complex Syst Engn, Minist Educ, Sch Automat, Nanjing 210096, Jiangsu, Peoples R China.; Gai, SY (corresponding author), Huazhong Univ Sci & Technol, State Key Lab Digital Mfg Equipment & Technol, Wuhan 430074, Peoples R China.; Gai, SY (corresponding author), Jiangsu Univ, Minist Educ, Key Lab Modern Agr Equipment & Technol, Zhenjiang 212013, Peoples R China.	qxxymm@163.com			National Natural Science Foundation of P.R.China [61628304, 51475092]; Open Research Foundation of Key Laboratory of Modern Agricultural Equipment and Technology in Jiangsu University [NZ201301]; Open Research Foundation of State Key Lab. of Digital Manufacturing Equipment & Technology in Huazhong University of Science Technology [DMETKF2012002]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of P.R.China(National Natural Science Foundation of China (NSFC)); Open Research Foundation of Key Laboratory of Modern Agricultural Equipment and Technology in Jiangsu University; Open Research Foundation of State Key Lab. of Digital Manufacturing Equipment & Technology in Huazhong University of Science Technology; Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by National Natural Science Foundation of P.R.China (61628304, 51475092), the Open Research Foundation of Key Laboratory of Modern Agricultural Equipment and Technology in Jiangsu University (NZ201301), the Open Research Foundation of State Key Lab. of Digital Manufacturing Equipment & Technology in Huazhong University of Science & Technology (DMETKF2012002), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by National Natural Science Foundation of P.R.China(61628304, 51475092). Open Research Foundation of Key Laboratory of Modern Agricultural Equipment and Technology in Jiangsu University (NZ201301). Open Research Foundation of State Key Lab. of Digital Manufacturing Equipment & Technology in Huazhong University of Science & Technology (DMETKF2012002). A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Baccarelli E, 2016, IEEE NETWORK, V30, P54, DOI 10.1109/MNET.2016.7437025; Busca G, 2011, OPT LASER ENG, V49, P210, DOI 10.1016/j.optlaseng.2010.09.016; Chatterjee C, 2000, MACH VISION APPL, V12, P84, DOI 10.1007/s001380050127; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109809; Da FP, 2008, APPL OPTICS, V47, P377, DOI 10.1364/AO.47.000377; Deng XY, 2016, MITOCHONDRIAL DNA A, V27, P3391, DOI 10.3109/19401736.2015.1018235; Gai SY, 2016, OPT EXPRESS, V24, P17686, DOI 10.1364/OE.24.017686; Gai SY, 2011, OPT LASER ENG, V49, P547, DOI 10.1016/j.optlaseng.2010.12.004; Heikkila J, 2000, IEEE T PATTERN ANAL, V22, P1066, DOI 10.1109/34.879788; Hong YZ, 2015, OPT EXPRESS, V23, P23992, DOI 10.1364/OE.23.023992; Jin T, 2015, PLOS ONE, V10; Keyvanpour M.R., 2013, INT J SOFTWARE ENG I, V7, P93; Kojima Y, 2005, PROC SPIE, V5665, P156, DOI 10.1117/12.587700; Liu Y H, 2010, COMP DES APPL ICCDA; Liu Y, 2015, RADIOENGINEERING, V24, P305, DOI 10.13164/re.2015.0305; Loaiza ME, 2011, COMPUT GRAPH-UK, V35, P198, DOI 10.1016/j.cag.2010.12.007; Pouryazdan M, 2016, IEEE ACCESS, V4, P529, DOI 10.1109/ACCESS.2016.2519820; Ricolfe-Viala C, 2011, OPT EXPRESS, V19, P10769, DOI 10.1364/OE.19.010769; Salvi J, 2010, PATTERN RECOGN, V35, P1617; Sun QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106911; Tavoli R, 2013, 2013 36TH INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS AND SIGNAL PROCESSING (TSP), P773, DOI 10.1109/TSP.2013.6614043; TSAI RY, 1987, IEEE T ROBOTIC AUTOM, V3, P323, DOI 10.1109/JRA.1987.1087109; Ueshiba T, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P966; Wang CX, 2014, APPL OPTICS, V53, P6222, DOI 10.1364/AO.53.006222; Wei W, 2016, IET IMAGE PROCESSING; Xiong JP, 2016, IEEE ACCESS, V4, P3076, DOI 10.1109/ACCESS.2016.2580594; Xu Q, 2016, IEEE ACCESS, V4, P2840, DOI 10.1109/ACCESS.2016.2575863; Yang JC, 2015, IEEE SENS J, V15, P4508, DOI 10.1109/JSEN.2015.2421518; Yang JC, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030421; Yang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145800; Yang Jian, 2011, Optics and Precision Engineering, V19, P1134, DOI 10.3788/OPE.20111905.1134; Zappa E, 2012, OPT LASER ENG, V50, P1140, DOI 10.1016/j.optlaseng.2012.03.008; Zhang Guangjun, 2006, Journal of Beijing University of Aeronautics and Astronautics, V32, P1268; Zhang ZY, 2004, IEEE T PATTERN ANAL, V26, P892, DOI 10.1109/TPAMI.2004.21; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718; Zhi YA, 2015, OPT LETT, V40, P1683, DOI 10.1364/OL.40.001683; Zhou Z., 2015, PLOS ONE, V10	37	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165487	10.1371/journal.pone.0165487	http://dx.doi.org/10.1371/journal.pone.0165487			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798651	Green Published, Green Submitted, gold			2022-12-26	WOS:000386711100040
J	Gantner, P; Bani-Sadr, F; Garraffo, R; Roger, PM; Treger, M; Jovelin, T; Pugliese, P; Rey, D				Gantner, Pierre; Bani-Sadr, Firouze; Garraffo, Rodolphe; Roger, Pierre-Marie; Treger, Michele; Jovelin, Thomas; Pugliese, Pascal; Rey, David		Dat'AIDS Cohort	Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; PHARMACOKINETICS; DARUNAVIR/RITONAVIR; NUCLEOSIDE; DARUNAVIR; TENOFOVIR/EMTRICITABINE; ABACAVIR/LAMIVUDINE; INFLAMMATION	Objectives To assess immunovirological response, safety and pharmacokinetic of NRTI-sparing regimen dual therapy of atazanavir (ATV) and raltegravir (RAL) in maintenance strategy. Methods A retrospective analysis was conducted on a cohort of HIV-infected adults followed in French centers (Dat'AIDS cohort), comparing the proportions of virological and therapeutic failures between ATV + RAL and ATV/ritonavir + RAL dual therapy regimens. Results 283 patients were assessed: 185 switched for ATV + RAL and 98 for ATV/ritonavir + RAL dual therapy. Virological failure rate at week 96 was 13.8% (95% CI, 9.8-17.8), without difference between the two groups (Log-rank Test, p = 0.87). The cumulative percentages of patients remaining free of therapeutic failure at week 24, 48 and 96 of dual therapy were 74.9% (95% CI, 69.9 +/- 80.0), 65.4% (95% CI, 59.8 +/- 70.9) and 53.4% (95% CI, 47.5 +/- 59.2), respectively. Four out of 39 confirmed virological failures developed RAL resistance. By multivariate analysis, virological failure was associated with high HIV-1 RNA zenith (p = 0.02), low CD4+ T-cell count at baseline (p<0.001) and short duration on antiretroviral therapy (p<0.001). Before week 96, dual therapy was discontinued in 44 patients (16%) because of various adverse events, with no difference between the two groups. Minimal plasma levels were targeted in 84% and 87% of patients for ATV and RAL, respectively, and both were significantly higher in ritonavir-boosted regimen. Conclusions Emerging RAL-resistance and discontinuations for adverse events resulted in moderate efficacy rates of ATV and RAL dual therapy in heavily pretreated patients.	[Gantner, Pierre; Rey, David] Hop Univ Strasbourg, Nouvel Hop Civil, HIV Infect Care Ctr, Le Trait Union, Strasbourg, France; [Bani-Sadr, Firouze] Ctr Hosp Univ Reims, Hop Robert Debre, Unite Malad Infect & Trop, Reims, France; [Garraffo, Rodolphe] Pasteur Univ Hosp, Pharmacol Clin, Nice, France; [Roger, Pierre-Marie; Pugliese, Pascal] CHU Nice, Infectiol, Nice, France; [Treger, Michele] Fac Med, Lab Biostat, Strasbourg, France; [Jovelin, Thomas] CHU Nantes, Hotel Dieu, Serv Infectiol, Serv Malad Infect & Trop, Nantes, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU Nice; CHU Nice; Nantes Universite; CHU de Nantes	Gantner, P (corresponding author), Hop Univ Strasbourg, Nouvel Hop Civil, HIV Infect Care Ctr, Le Trait Union, Strasbourg, France.	pierre.gantner@chru-strasbourg.fr	Hentzien, Maxime/H-8730-2019; Martin-Blondel, Guillaume/K-6762-2014	Hentzien, Maxime/0000-0003-2729-9420; BANI-SADR, Firouze/0000-0001-8268-866X; Gantner, Pierre/0000-0002-3984-883X; Martin-Blondel, Guillaume/0000-0002-8363-7028				Antinori A, 2015, AIDS, V29, P1811, DOI 10.1097/QAD.0000000000000778; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Avettand-Fenoel V, 2010, J ANTIMICROB CHEMOTH, V65, P1005, DOI 10.1093/jac/dkq084; Bavinger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059551; Burgard M, 2009, AIDS, V23, P2165, DOI 10.1097/QAD.0b013e32833032d4; Carey D, 2012, JAIDS-J ACQ IMM DEF, V60, P143, DOI 10.1097/QAI.0b013e318252f97e; Cattaneo D, 2010, THER DRUG MONIT, V32, P782, DOI 10.1097/FTD.0b013e3181fa53b7; Cordery DV, 2010, ANTIVIR THER, V15, P1035, DOI 10.3851/IMP1647; Duval X, 2008, ANTIVIR THER, V13, P389; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Eron JJ, 2010, LANCET, V375, P396, DOI 10.1016/S0140-6736(09)62041-9; Fabbiani M, 2014, J INT AIDS SOC, V17, P192, DOI 10.7448/IAS.17.4.19808; Fourati S, 2014, J ANTIMICROB CHEMOTH, V69, P753, DOI 10.1093/jac/dkt428; Gantner P, 2014, SCAND J INFECT DIS, V46, P838, DOI 10.3109/00365548.2014.947318; Gupta SK, 2013, JAIDS-J ACQ IMM DEF, V64, P279, DOI 10.1097/QAI.0b013e3182a97c39; Gupta Shaili, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P87, DOI 10.1177/1545109709332471; Hocqueloux L, 2013, J ANTIMICROB CHEMOTH, V68, P1169, DOI 10.1093/jac/dks533; Iwamoto M, 2008, CLIN INFECT DIS, V47, P137, DOI 10.1086/588794; Jansen A, 2013, HIV MED, V14, P449, DOI 10.1111/hiv.12029; Katlama C, 2014, J ANTIMICROB CHEMOTH, V69, P1648, DOI 10.1093/jac/dkt536; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; Kelesidis T, 2015, CLIN INFECT DIS, V61, P651, DOI 10.1093/cid/civ327; Kozal MJ, 2012, HIV CLIN TRIALS, V13, P119, DOI 10.1310/hct1303-119; Lake JE, 2014, HIV MED, V15, P431, DOI 10.1111/hiv.12128; Lambert-Niclot S, 2012, J ANTIMICROB CHEMOTH, V67, P1470, DOI 10.1093/jac/dks052; Lambert-Niclot S, 2011, J INFECT DIS, V204, P1211, DOI 10.1093/infdis/jir518; Martinez E, 2012, AIDS, V26, P2315, DOI 10.1097/QAD.0b013e328359f29c; McComsey GA, 2012, AIDS, V26, P1371, DOI 10.1097/QAD.0b013e328354f4fb; Monteiro P, 2014, J ANTIMICROB CHEMOTH, V69, P742, DOI 10.1093/jac/dkt406; Morlat P, UPDATE 2014 RAPPORT; Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222; Neely M, 2010, ANTIMICROB AGENTS CH, V54, P4619, DOI 10.1128/AAC.00712-10; Ofotokun I, 2015, CLIN INFECT DIS, V60, P1842, DOI 10.1093/cid/civ193; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Reinsch N, 2012, EUR J PREV CARDIOL, V19, P267, DOI 10.1177/1741826711398431; Santos JR, 2015, CLIN INFECT DIS, V61, P403, DOI 10.1093/cid/civ296; Silva EF, 2013, J INFECT DIS, V208, P892, DOI 10.1093/infdis/jit280; Soulie C, 2015, J ANTIMICRO IN PRESS; Squires KE, 2010, AIDS, V24, P2019, DOI 10.1097/QAD.0b013e32833bee1b; van Lunzen J, 2016, JAIDS-J ACQ IMM DEF, V71, P538, DOI 10.1097/QAI.0000000000000904; Xiang N, 2014, HIV MED, V15, P635, DOI 10.1111/hiv.12180; Zhu L, 2010, ANTIVIR THER, V15, P1107, DOI 10.3851/IMP1673	44	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0164240	10.1371/journal.pone.0164240	http://dx.doi.org/10.1371/journal.pone.0164240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798641	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100006
J	Johansen, KL; Stistrup, RD; Schjott, CS; Madsen, J; Vinther, A				Johansen, Katrine Lyders; Stistrup, Rikke Derby; Schjott, Camilla Skibdal; Madsen, Jacqueline; Vinther, Anders			Absolute and Relative Reliability of the Timed 'Up & Go' Test and '30second Chair-Stand' Test in Hospitalised Patients with Stroke	PLOS ONE			English	Article							FUNCTIONAL MOBILITY; PERFORMANCE TESTS; MUSCLE STRENGTH; HIP FRACTURE; OLDER-PEOPLE; OSTEOARTHRITIS; ADULTS	Objective The timed 'Up & Go' test and '30second Chair-Stand' test are simple clinical outcome measures widely used to assess functional performance. The reliability of both tests in hospitalised stroke patients is unknown. The purpose was to investigate the relative and absolute reliability of both tests in patients admitted to an acute stroke unit. Methods Sixty-two patients (men, n = 41) attended two test sessions separated by a one hours rest. Intraclass correlation coefficients (ICC2,1) were calculated to assess relative reliability. Absolute reliability was expressed as Standard Error of Measurement (with 95% certainty-SEM95) and Smallest Real Difference (SRD) and as percentage of their respective means if heteroscedasticity was observed in Bland Altman plots (SEM95% and SRD%). Results ICC values for interrater reliability were 0.97 and 0.99 for the timed 'Up & Go' test and 0.88 and 0.94 for '30second Chair-Stand' test, respectively. ICC values for intrarater reliability were 0.95 and 0.96 for the timed 'Up & Go' test and 0.87 and 0.91 for '30second ChairStand' test, respectively. Heteroscedasticity was observed in the timed 'Up & Go' test. Interrater SEM95% ranged from 9.8% to 14.2% with corresponding SRD% of 13.9-20.1%. Intrarater SEM95% ranged from 15.8% to 18.7% with corresponding SRD% of 22.3-26.5%. For '30second Chair-Stand' test interrater SEM95 ranged between 1.5 and 1.9 repetitions with corresponding SRD of 2 and 3 and intrarater SEM95 ranged between 1.8 and 2.0 repetitions with corresponding SRD values of 3. Conclusion Excellent reliability was observed for the timed 'Up & Go' test and the '30second ChairStand' test in hospitalised stroke patients. The thresholds to detect a real change in performance were 18.7% for the timed 'Up & Go' test and 2.0 repetitions for the '30second Chair-Stand' in groups of patients and 26.5% and 3 repetitions in individual patients, respectively.	[Johansen, Katrine Lyders; Stistrup, Rikke Derby; Schjott, Camilla Skibdal; Madsen, Jacqueline; Vinther, Anders] Herlev Gentofte Hosp, Copenhagen Univ Hosp, Dept Rehabil, Herlev, Denmark	University of Copenhagen	Johansen, KL (corresponding author), Herlev Gentofte Hosp, Copenhagen Univ Hosp, Dept Rehabil, Herlev, Denmark.	katrine.lyders.johansen@regionh.dk			Danish Association of Physical Therapists	Danish Association of Physical Therapists	This work was supported by the Danish Association of Physical Therapists with a grant for AV [https://fysio.dk/fafo/fonde/danske-fysioterapeuters-fond-for-forskning-uddannelse-og-praksisudvikling/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre TS, 2012, BRAZ J PHYS THER, V16, P381, DOI 10.1590/S1413-35552012000500008; Blankevoort CG, 2013, PHYS THER, V93, P69, DOI 10.2522/ptj.20110164; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; Dobson F, 2012, OSTEOARTHR CARTILAGE, V20, P1548, DOI 10.1016/j.joca.2012.08.015; Faria CDCM, 2013, DISABIL REHABIL, V35, P146, DOI 10.3109/09638288.2012.690497; Faria CDCM, 2012, CLIN REHABIL, V26, P460, DOI 10.1177/0269215511423849; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Gill S, 2008, PHYSIOTHER RES INT, V13, P141, DOI 10.1002/pri.411; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hafsteinsdottir TB, 2014, TOP STROKE REHABIL, V21, P197, DOI 10.1310/tsr2103-197; Hesseberg K, 2015, PHYSIOTHER RES INT, V20, P37, DOI 10.1002/pri.1594; Hiengkaew V, 2012, ARCH PHYS MED REHAB, V93, P1201, DOI 10.1016/j.apmr.2012.01.014; Holm B, 2011, PM&R, V3, P117, DOI 10.1016/j.pmrj.2010.10.019; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Jorgensen MG, 2013, J GERONTOL A-BIOL, V68, P845, DOI 10.1093/gerona/gls222; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Kristensen MT, 2010, ARCH PHYS MED REHAB, V91, P885, DOI 10.1016/j.apmr.2010.01.021; Kristensen MT, 2008, J REHABIL MED, V40, P589, DOI 10.2340/16501977-0217; Kristensen MT, 2011, J AM GERIATR SOC, V59, P565, DOI 10.1111/j.1532-5415.2010.03293.x; Ng SSM, 2010, AM J PHYS MED REHAB, V89, P497, DOI 10.1097/PHM.0b013e3181d3e90a; Ng SS, 2005, ARCH PHYS MED REHAB, V86, P1641, DOI 10.1016/j.apmr.2005.01.011; Paquet N, 2009, DISABIL REHABIL, V31, P1267, DOI 10.1080/09638280802621374; Persson CU, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-83; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Rikli RE, 2001, HUMAN KINETICS; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Silva PFS, 2014, BRAZ J PHYS THER, V18, P99, DOI 10.1590/S1413-35552012005000155; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Wright AA, 2011, J ORTHOP SPORT PHYS, V41, P319, DOI 10.2519/jospt.2011.3515	31	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165663	10.1371/journal.pone.0165663	http://dx.doi.org/10.1371/journal.pone.0165663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798686	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100053
J	Nair, NP; Chalmers, L; Connolly, M; Bereznicki, BJ; Peterson, GM; Curtain, C; Castelino, RL; Bereznicki, LR				Nair, Nibu Parameswaran; Chalmers, Leanne; Connolly, Michael; Bereznicki, Bonnie J.; Peterson, Gregory M.; Curtain, Colin; Castelino, Ronald L.; Bereznicki, Luke R.			Prediction of Hospitalization due to Adverse Drug Reactions in Elderly Community-Dwelling Patients (The PADR-EC Score)	PLOS ONE			English	Article							OLDER PATIENTS; ORTHOSTATIC HYPOTENSION; EMERGENCY-DEPARTMENT; MANAGING HYPERTENSION; COMBINATION THERAPY; RISK-FACTORS; ADMISSION; EVENTS; PREVALENCE; VALIDATION	Background Adverse drug reactions (ADRs) are the major cause of medication-related hospital admissions in older patients living in the community. This study aimed to develop and validate a score to predict ADR-related hospitalization in people aged >= 65 years. Methods ADR-related hospitalization and its risk factors were determined using a prospective, cross-sectional study in patients aged >= 65 years admitted to two hospitals. A predictive model was developed in the derivation cohort (n = 768) and the model was applied in the validation cohort (n = 240). ADR-related hospital admission was determined through expert consensus from comprehensive reviews of medical records and patient interviews. The causality and preventability of the ADR were assessed based on the Naranjo algorithm and modified Schumock and Thornton criteria, respectively. Results In the derivation sample (mean [+/-SD] age, 80.1+/-7.7 years), 115 (15%) patients were admitted due to a definite or probable ADR; 92.2% of these admissions were deemed preventable. The number of antihypertensives was the strongest predictor of an ADR followed by presence of dementia, renal failure, drug changes in the preceding 3 months and use of anticholinergic medications; these variables were used to derive the ADR prediction score. The predictive ability of the score, assessed from calculation of the area under the receiver operator characteristic (ROC) curve, was 0.70 (95% confidence interval (CI) 0.65-0.75). In the validation sample (mean [+/-SD] age, 79.6+/-7.6 years), 30 (12.5%) patients' admissions were related to definite or probable ADRs; 80% of these admissions were deemed preventable. The area under the ROC curve in this sample was 0.67 (95% CI 0.56-0.78). Conclusions This study proposes a practical and simple tool to identify elderly patients who are at an increased risk of preventable ADR-related hospital admission. Further refinement and testing of this tool is necessary to implement the score in clinical practice.	[Nair, Nibu Parameswaran; Chalmers, Leanne; Connolly, Michael; Bereznicki, Bonnie J.; Peterson, Gregory M.; Curtain, Colin; Castelino, Ronald L.; Bereznicki, Luke R.] Univ Tasmania, Sch Med, Fac Hlth, Unit Medicat Outcomes Res & Educ,Div Pharm, Hobart, Tas, Australia; [Connolly, Michael] Royal Hobart Hosp, Hobart, Tas, Australia	University of Tasmania; Royal Hobart Hospital	Nair, NP (corresponding author), Univ Tasmania, Sch Med, Fac Hlth, Unit Medicat Outcomes Res & Educ,Div Pharm, Hobart, Tas, Australia.		Nair, Nibu Parameswaran/F-3317-2017; Nair, Nibu Parameswaran/B-6347-2014	Nair, Nibu Parameswaran/0000-0002-0202-6453; Nair, Nibu Parameswaran/0000-0003-3503-8503; Chalmers, Leanne/0000-0002-2477-2190; Bereznicki, Bonnie/0000-0001-8463-4817				[Anonymous], 1968, TECHNICAL REPORT SER; [Anonymous], 2015, AUSTR MED HDB; Beijer HJM, 2002, PHARM WORLD SCI, V24, P46, DOI 10.1023/A:1015570104121; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Butt TF, 2010, J HUM HYPERTENS, V24, P514, DOI 10.1038/jhh.2009.116; Calderon-Ospina Carlos, 2010, Int J Pharm Pract, V18, P230, DOI 10.1111/j.2042-7174.2010.00039.x; Chan M, 2001, INTERN MED J, V31, P199, DOI 10.1046/j.1445-5994.2001.00044.x; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chen YC, 2014, EUR J INTERN MED, V25, P49, DOI 10.1016/j.ejim.2013.10.006; COCHRANE RA, 1992, BRIT MED J, V305, P694, DOI 10.1136/bmj.305.6855.694; Conforti A, 2012, DRUG HEALTHC PATIENT, V4, P75, DOI 10.2147/DHPS.S29287; Corsonello A, 2005, ARCH INTERN MED, V165, P790, DOI 10.1001/archinte.165.7.790; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Everett BM, 2008, CLIN THER, V30, P661, DOI 10.1016/j.clinthera.2008.04.013; FEINBERG M, 1993, DRUG AGING, V3, P335, DOI 10.2165/00002512-199303040-00004; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Franceschi M, 2008, DRUG SAFETY, V31, P545, DOI 10.2165/00002018-200831060-00009; Frank J, 2008, AM FAM PHYSICIAN, V77, P1279; Gurwitz JH, 2000, AM J MED, V109, P87, DOI 10.1016/S0002-9343(00)00451-4; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Gustafsson M, 2016, EUR J CLIN PHARM; Gustafsson M, 2016, EUR J CLIN PHARMACOL, V72, P1143, DOI 10.1007/s00228-016-2084-3; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; Hellden A, 2009, DRUG AGING, V26, P595, DOI 10.2165/11315790-000000000-00000; Hippisley-Cox J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003482; Jatau Abubakar Ibrahim, 2015, Drugs Real World Outcomes, V2, P387; Kaufmann CP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006376; Laroche ML, 2013, PHARMACOEPIDEM DR S, V22, P952, DOI 10.1002/pds.3471; Lavan AH, 2016, THER ADV DRUG SAF, V7, P11, DOI 10.1177/2042098615615472; Lee KI, 1997, COMMUN STAT-SIMUL C, V26, P559, DOI 10.1080/03610919708813397; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lyon D, 2007, FAM PRACT, V24, P158, DOI 10.1093/fampra/cml069; MAHONEY F I, 1965, Md State Med J, V14, P61; Mannesse CK, 2000, AGE AGEING, V29, P35, DOI 10.1093/ageing/29.1.35; Marcum ZA, 2012, J AM GERIATR SOC, V60, P34, DOI 10.1111/j.1532-5415.2011.03772.x; May S, 2008, J MAN MANIP THER, V16, P155, DOI 10.1179/jmt.2008.16.3.155; METS TF, 1995, DRUG AGING, V6, P219, DOI 10.2165/00002512-199506030-00005; Min SY, 2010, CIRC-CARDIOVASC INTE, V3, P127, DOI 10.1161/CIRCINTERVENTIONS.109.890053; Muir SW, 2010, PHYS THER, V90, P338, DOI 10.2522/ptj.20090163; Mussi C, 2009, J GERONTOL A-BIOL, V64, P801, DOI 10.1093/gerona/glp028; Nair NP, 2016, CLIN INTERV AGING, V11, P497, DOI 10.2147/CIA.S99097; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Ness Jose, 2006, Am J Geriatr Pharmacother, V4, P42, DOI 10.1016/j.amjopharm.2006.03.008; O'Connor MN, 2012, AGE AGEING, V41, P771, DOI 10.1093/ageing/afs046; Olsen H, 1999, BLOOD PRESSURE, V8, P94; Onder G, 2002, J AM GERIATR SOC, V50, P1962, DOI 10.1046/j.1532-5415.2002.50607.x; Onder G, 2013, AGE AGEING, V42, P284, DOI 10.1093/ageing/aft038; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Poon IO, 2005, J CLIN PHARM THER, V30, P173, DOI 10.1111/j.1365-2710.2005.00629.x; Rawlins MD, 1991, TXB ADVERSE DRUG REA, P18; Reeve E, 2015, BRIT J CLIN PHARMACO, V80, P1254, DOI 10.1111/bcp.12732; Rende P, 2013, J PHARMACOL PHARMACO, V4, pS47, DOI 10.4103/0976-500X.120954; Salahudeen MS, 2015, J AM GERIATR SOC, V63, P85, DOI 10.1111/jgs.13206; Schumock G T, 1992, Hosp Pharm, V27, P538; Shelton P, 2000, AM J MANAG CARE, V6, P925; Tangiisuran B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111254; The Society of Hospital Pharmacists of Australia (SHPA), 2005, J PHARM PRACT RES, V35, P122; Tune LE, 2001, J CLIN PSYCHIAT, V62, P11; UpToDate, COMPR CLIN DAT; Wawruch M, 2009, ARCH GERONTOL GERIAT, V48, P186, DOI 10.1016/j.archger.2008.01.004; *WICC, 1998, ICPC 2 INT CLASS PRI; World Health Organization, 1969, TECHNICAL REPORT SER, V425; Wu C, 2012, DRUG SAFETY, V35, P769, DOI 10.2165/11599540-000000000-00000	67	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165757	10.1371/journal.pone.0165757	http://dx.doi.org/10.1371/journal.pone.0165757			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6BX	27798708	Green Submitted, gold, Green Published			2022-12-26	WOS:000386711100062
J	Noble, JW; Hunter, DV; Roskelley, CD; Chan, EKL; Mills, J				Noble, Jake W.; Hunter, Diana V.; Roskelley, Calvin D.; Chan, Edward K. L.; Mills, Julia			Loukoumasomes Are Distinct Subcellular Structures from Rods and Rings and Are Structurally Associated with MAP2 and the Nuclear Envelope in Retinal Cells	PLOS ONE			English	Article							INOSINE MONOPHOSPHATE DEHYDROGENASE; DOMINANT RETINITIS-PIGMENTOSA; HUMAN IMP DEHYDROGENASE; INTEGRIN-LINKED KINASE; INTRANUCLEAR INCLUSIONS; PEGYLATED INTERFERON; BINDING-PROTEINS; CROSS-LINKING; MICROTUBULES; AUTOANTIBODIES	"Rods and rings " (RR) and loukoumasomes are similarly shaped, subcellular macromolecular structures with as yet unknown function. RR, so named because of their shape, are formed in response to inhibition in the GTP or CTP synthetic pathways and are highly enriched in the two key enzymes of the nucleotide synthetic pathway. Loukoumasomes also occur as linear and toroidal bodies and were initially inferred to be the same as RR, largely due to their shared shape and size and the fact that it was unclear if they shared the same subcomponents. In human retinoblastoma tissue and cells we have observed toroidal, perinuclear, macromolecular structures of similar size and antigenicity to those previously reported in neurons (neuronal-loukoumasomes). To further characterize the subcomponents of the retinal-loukoumasomes, confocal analysis following immunocytochemical staining for alpha-tubulin, beta-III tubulin and detyrosinated tubulin was performed. These studies indicate that retinal-loukoumasomes are enriched for beta-III tubulin and other tubulins associated with microtubules. Immunofluorescence together with the in situ proximity ligation assay (PLA), confirmed that beta-III tubulin colocalized with detyrosinated tubulin within loukoumasomes. Our results indicate that these tissues contain only loukoumasomes because these macromolecular structures are immunoreactive with an anti-tubulin antibody but are not recognized by the prototype anti-RR/inosine monophosphate dehydrogenase (IMPDH) antibody (It2006). To further compare the RR and retinal-loukoumasomes, retinoblastoma cells were exposed to the IMPDH-inhibitor ribavirin, a drug known to induce the formation of RR. In contrast to RR, the production of retinal-loukoumasomes was unaffected. Coimmunostaining of Y79 cells for beta-III tubulin and IMPDH indicate that these cells, when treated with ribavirin, can contain both retinal-loukoumasomes and RR and that these structures are antigenically distinct. Subcellular fractionation studies indicate that ribavirin increased the RR subcomponent, IMPDH, in the nuclear fraction of Y79 cells from 21.3 +/- 5.8% (0 mM ribavirin) to 122.8 +/- 7.9% (1 mM ribavirin) while the subcellular localization of the retinal-loukoumasome subcomponent tubulin went unaltered. Further characterization of retinal-loukoumasomes in retinoblastoma cells reveals that they are intimately associated with lamin folds within the nuclear envelope. Using immunofluorescence and the in situ PLA in this cell type, we have observed colocalization of beta-III tubulin with MAP2. As MAP2 is a microtubule-associated protein implicated in microtubule crosslinking, this supports a role for microtubule crosslinkers in the formation of retinal-loukoumasomes. Together, these results suggest that loukoumasomes and RR are distinct subcellular macromolecular structures, formed by different cellular processes and that there are other loukoumasome-like structures within retinal tissues and cells.	[Noble, Jake W.; Mills, Julia] Trinity Western Univ, Dept Biol, Langley, BC, Canada; [Hunter, Diana V.] Univ British Columbia, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Roskelley, Calvin D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada; [Chan, Edward K. L.] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Mills, Julia] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada	Trinity Western University; University of British Columbia; University of British Columbia; State University System of Florida; University of Florida; Simon Fraser University	Mills, J (corresponding author), Trinity Western Univ, Dept Biol, Langley, BC, Canada.; Mills, J (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada.	julia.mills@twu.ca	Chan, Edward K. L./B-5671-2009	Chan, Edward K. L./0000-0003-3938-9503	National Science and Engineering Research Council of Canada (NSERC); Trinity Western University; Murdock Trust	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Trinity Western University; Murdock Trust	Although the authors did not receive specific funding for this project, we did receive salary support for an undergraduate student in our laboratory. We gratefully acknowledge an Undergraduate Student Research Award (USRA) from the National Science and Engineering Research Council of Canada (NSERC) award and the student research award from Trinity Western University that provided summer salary support for Jake W. Noble. A Murdock General Science Grant as a match to the CFI Leaders Opportunity Fund Grant enabled the purchase of the Olympus DSU spinning disk confocal used in this study. The Molecular and Cell Biology laboratory and Cell Culture laboratory in which these studies took place were made possible by a grant from Murdock Trust as a match to the Industry Canada Knowledge Infrastructure Program Award. Dr. Valerie A. White, Department of Pathology and Laboratory Medicine, University of British Columbia is gratefully acknowledged for her provision of the retinoblastoma tissue for these studies. We also thank Dr. Gail M. Seigel, Department of Ophthalmology, University at Buffalo, for her provision of the retinal cell lines used in this study. Finally, we thank Joseph Goody and William K.A. Sikkema for the technical support they provided during the completion of this manuscript.; We gratefully acknowledge an Undergraduate Student Research Award (USRA) from the National Science and Engineering Research Council of Canada (NSERC) award and the student research award from Trinity Western University that provided summer salary support for Jake W Noble. A Murdock General Science Grant as a match to the CFI Leaders Opportunity Fund Grant enabled the purchase of the Olympus DSU spinning disk confocal used in this study. The Molecular and Cell Biology laboratory and Cell Culture laboratory in which these studies took place were made possible by a grant from Murdock Trust as a match to the Industry Canada Knowledge Infrastructure Program Award. Dr. Valerie A. White, Department of Pathology and Laboratory Medicine, University of British Columbia is gratefully acknowledged for her provision of the retinoblastoma tissue for these studies. We also thank Dr. Gail M. Seigel, Department of Ophthalmology, University at Buffalo, for her provision of the retinal cell lines used in this study. Finally, we thank Joseph Goody and William K.A. Sikkema for the technical support they provided during the completion of this manuscript.	Bicek AD, 2009, MOL BIOL CELL, V20, P2943, DOI 10.1091/mbc.E08-09-0909; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P3754, DOI 10.1167/iovs.06-0207; Bowne SJ, 2002, HUM MOL GENET, V11, P559, DOI 10.1093/hmg/11.5.559; Calise SJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00041; Calise SJ, 2014, CELL MOL LIFE SCI, V71, P2963, DOI 10.1007/s00018-014-1567-6; Carcamo WC, 2014, INT REV CEL MOL BIO, V308, P35, DOI 10.1016/B978-0-12-800097-7.00002-6; Carcamo WC, 2013, J CLIN IMMUNOL, V33, P420, DOI 10.1007/s10875-012-9827-4; Carcamo WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029690; CARR SF, 1993, J BIOL CHEM, V268, P27286; COLLART FR, 1988, J BIOL CHEM, V263, P15769; Covini G, 2012, ANTIVIR THER, V17, P805, DOI 10.3851/IMP1993; Duminuco R, 2015, CELL CYCLE, V14, P2924, DOI 10.1080/15384101.2015.1064205; Gunter JH, 2008, INT J BIOCHEM CELL B, V40, P1716, DOI 10.1016/j.biocel.2007.12.018; HAGER PW, 1995, BIOCHEM PHARMACOL, V49, P1323, DOI 10.1016/0006-2952(95)00026-V; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; HIROKAWA N, 1988, J NEUROSCI, V8, P2769; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; Ji YS, 2006, J BIOL CHEM, V281, P206, DOI 10.1074/jbc.M507056200; Jolly AL, 2010, P NATL ACAD SCI USA, V107, P12151, DOI 10.1073/pnas.1004736107; Juda P, 2014, J HISTOCHEM CYTOCHEM, V62, P739, DOI 10.1369/0022155414543853; Kennan A, 2002, HUM MOL GENET, V11, P547, DOI 10.1093/hmg/11.5.547; Kerman A, 2003, ADV EXP MED BIOL, V533, P13; Kulic IM, 2008, P NATL ACAD SCI USA, V105, P10011, DOI 10.1073/pnas.0800031105; MATUS A, 1994, TRENDS NEUROSCI, V17, P19, DOI 10.1016/0166-2236(94)90030-2; Mills J, 2006, J NEUROSCI, V26, P830, DOI 10.1523/JNEUROSCI.1852-05.2006; NATSUMEDA Y, 1990, J BIOL CHEM, V265, P5292; PAPANDRIKOPOULOU A, 1989, NATURE, V340, P650, DOI 10.1038/340650a0; PAYNE CM, 1983, ULTRASTRUCT PATHOL, V5, P1; Portran D, 2013, MOL BIOL CELL, V24, P1964, DOI 10.1091/mbc.E13-03-0141; Pringle J, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/37/374103; Ramer MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010872; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; ROBERTSON DM, 1965, ARCH NEUROL-CHICAGO, V13, P287, DOI 10.1001/archneur.1965.00470030067006; SCHREIBER E, 1990, NUCLEIC ACIDS RES, V18, P5495, DOI 10.1093/nar/18.18.5495; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seigel GM, 2014, MOL VIS, V20, P301; Seigel GM, 2005, MOL VIS, V11, P729; SEITE R, 1977, J ULTRA MOL STRUCT R, V61, P254, DOI 10.1016/S0022-5320(77)80050-6; SENDA M, 1994, LIFE SCI, V54, P1917, DOI 10.1016/0024-3205(94)90150-3; Sery T W, 1990, J Pediatr Ophthalmol Strabismus, V27, P212; Shaikh Y, 2013, J Prev Med Hyg, V54, P175; Shu QN, 2008, MED RES REV, V28, P219, DOI 10.1002/med.20104; SIEGESMUND KA, 1964, J ANAT, V98, P93; Sikkema WKA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098838; Steinberg G, 2001, J CELL SCI, V114, P609; Stinton LM, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-50; Straube A, 2006, MOL BIOL CELL, V17, P907, DOI 10.1091/mbc.E05-06-0542; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; TANI E, 1971, CANCER RES, V31, P1210; Thomas EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051096; Woulfe J, 2000, ACTA NEUROPATHOL, V100, P427, DOI 10.1007/s004010000191; Woulfe J, 2000, NEUROPATH APPL NEURO, V26, P161, DOI 10.1046/j.1365-2990.2000.026002161.x	52	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165162	10.1371/journal.pone.0165162	http://dx.doi.org/10.1371/journal.pone.0165162			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798680	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100020
J	Iida, R; Shinoda, K; Hayano, Y; Nagai, Y; Takatsu, K; Kouro, T				Iida, Ryuji; Shinoda, Kaori; Hayano, Yuki; Nagai, Yoshinori; Takatsu, Kiyoshi; Kouro, Taku			Fetal Lymphoid Progenitors Become Restricted to B-1 Fates Coincident with IL-7Ra Expression	PLOS ONE			English	Article							B-CELL DEVELOPMENT; HEMATOPOIETIC STEM-CELLS; ADULT BONE-MARROW; GENE-EXPRESSION; DEVELOPMENTAL SWITCH; PHOSPHATIDYL CHOLINE; YOLK-SAC; T-CELL; LINEAGE; LY-1	B-1 cells represent a sub-fraction of B lymphocytes that participate in T cell-independent antibody production and contribute to innate immunity. While the production of B-1 cells is favored during the fetal waves of lymphopoiesis, it has been unclear when and how that differentiation option is specified. To clarify this, lymphoid and hematopoietic progenitors of fetal liver (FL) and adult bone marrow (ABM) were examined for the B cell differentiation potential. Mouse common lymphoid progenitors (CLPs) and more primitive KSL fraction of FL and ABM were transferred to SCID mice and donor-derived B cell subsets were analyzed 4 weeks later. CLPs were also cultured on ST2 stromal cells for 6 days prior to transplantation. While Lin(-) IL-7R alpha(+) CLPs from ABM differentiated to B-1, B-2 and marginal zone B (MZB) cells, equivalent cells from d15 FL differentiated mostly to B-1a cells. We found that fetal CLPs had less ability to colonize the bone marrow than adult CLPs. However, the fetal/adult difference was already present when progenitors were cultured in an identical condition before transplantation. More primitive KSL fraction of FL could generate the same broad spectrum of B cells typical of adults, including splenic MZB cells. In conclusion, we argue that FL and ABM-CLPs are intrinsically different regarding B-1/B-2 fates and the difference is acquired just before or coincident with the acquisition of IL-7R alpha expression.	[Iida, Ryuji; Shinoda, Kaori; Hayano, Yuki; Kouro, Taku] Natl Inst Biomed Innovat Hlth & Nutr, Lab Immune Modulat, Ibaraki, Osaka, Japan; [Iida, Ryuji] Natl Inst Biomed Innovat Hlth & Nutr, Dept Cell Cultures, Ibaraki, Osaka, Japan; [Nagai, Yoshinori; Takatsu, Kiyoshi] Toyama Univ, Dept Immunobiol & Pharmacol Genet, Toyama, Japan; [Nagai, Yoshinori] JST, PRESTO, Kawaguchi, Saitama, Japan; [Takatsu, Kiyoshi] Toyama Prefectural Inst Pharmaceut Res, Imizu, Toyama, Japan	University of Toyama; Japan Science & Technology Agency (JST)	Iida, R (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Immune Modulat, Ibaraki, Osaka, Japan.; Iida, R (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Dept Cell Cultures, Ibaraki, Osaka, Japan.	r-iida@nibiohn.go.jp		Hayano, Yuki/0000-0003-0658-023X; Kouro, Taku/0000-0003-1526-575X	MEXT KAKENHI Grant [22590447]; Ministry of Education, Culture, Supports, Science and Technology of Japan	MEXT KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Supports, Science and Technology of Japan	This work was supported by MEXT KAKENHI Grant Number 22590447 to TK URL (http://www.mext.go.jp/english/), and also by grants-in-aid from the Ministry of Education, Culture, Supports, Science and Technology of Japan to (YN, KT and TK). This work was done in part as a vaccine adjuvant research project which is a collaboration of National Institute of Biomedical Innovation and four vaccine companies; The Chemo-Sero-Therapeutic Research Institute, DENKA SEIKEN CO., LTD, Kitasato Daiichi Sankyo Vaccine Co., Ltd. and The Research Foundation for Microbial Diseases of Osaka University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; Barber CL, 2011, P NATL ACAD SCI USA, V108, P13700, DOI 10.1073/pnas.1107172108; Duber S, 2009, BLOOD, V114, P4960, DOI 10.1182/blood-2009-04-218156; Esplin BL, 2009, P NATL ACAD SCI USA, V106, P5773, DOI 10.1073/pnas.0811632106; Ghosn EEB, 2012, P NATL ACAD SCI USA, V109, P5394, DOI 10.1073/pnas.1121632109; Ghosn EEB, 2011, P NATL ACAD SCI USA, V108, P2879, DOI 10.1073/pnas.1019764108; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; Hayakawa K, 2003, J EXP MED, V197, P87, DOI 10.1084/jem.20021459; HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; HITOSHI Y, 1990, J IMMUNOL, V144, P4218; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; JEONG HD, 1990, J IMMUNOL, V145, P2725; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Kawahara T, 2003, J IMMUNOL, V171, P5406, DOI 10.4049/jimmunol.171.10.5406; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kouro T, 2001, BLOOD, V97, P2708, DOI 10.1182/blood.V97.9.2708; Kristiansen TA, 2016, IMMUNITY, V45, P346, DOI 10.1016/j.immuni.2016.07.014; LAM KP, 1994, J EXP MED, V180, P507, DOI 10.1084/jem.180.2.507; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; MASMOUDI H, 1990, INT IMMUNOL, V2, P515, DOI 10.1093/intimm/2.6.515; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; MERCOLINO TJ, 1988, J EXP MED, V168, P687, DOI 10.1084/jem.168.2.687; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; MURAKAMI M, 1995, INT IMMUNOL, V7, P877, DOI 10.1093/intimm/7.5.877; OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x; PENNELL CA, 1989, EUR J IMMUNOL, V19, P1289, DOI 10.1002/eji.1830190721; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; STALL AM, 1992, ANN NY ACAD SCI, V651, P33; SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333; WALDSCHMIDT TJ, 1991, INT IMMUNOL, V3, P305, DOI 10.1093/intimm/3.4.305; Welner RS, 2008, NAT REV IMMUNOL, V8, P95, DOI 10.1038/nri2234; Yokota T, 2003, IMMUNITY, V19, P365, DOI 10.1016/S1074-7613(03)00231-0; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	44	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165676	10.1371/journal.pone.0165676	http://dx.doi.org/10.1371/journal.pone.0165676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792746	Green Submitted, gold, Green Published			2022-12-26	WOS:000389537000044
J	Cadol, D; Elmore, AJ; Guinn, SM; Engelhardt, KAM; Sanders, G				Cadol, Daniel; Elmore, Andrew J.; Guinn, Steven M.; Engelhardt, Katharina A. M.; Sanders, Geoffrey			Modeled Tradeoffs between Developed Land Protection and Tidal Habitat Maintenance during Rising Sea Levels	PLOS ONE			English	Article							FRESH-WATER MARSH; VERTICAL ACCRETION; RISE; SEDIMENTATION; COMPLEXITY; VEGETATION; INTRUSION; EXPANSION; RESPONSES; COLLAPSE	Tidal habitats host a diversity of species and provide hydrological services such as shoreline protection and nutrient attenuation. Accretion of sediment and biomass enables tidal marshes and swamps to grow vertically, providing a degree of resilience to rising sea levels. Even if accelerating sea level rise overcomes this vertical resilience, tidal habitats have the potential to migrate inland as they continue to occupy land that falls within the new tide range elevations. The existence of developed land inland of tidal habitats, however, may prevent this migration as efforts are often made to dyke and protect developments. To test the importance of inland migration to maintaining tidal habitat abundance under a range of potential rates of sea level rise, we developed a spatially explicit elevation tracking and habitat switching model, dubbed the Marsh Accretion and Inundation Model ( MAIM), which incorporates elevation-dependent net land surface elevation gain functions. We applied the model to the metropolitan Washington, DC region, finding that the abundance of small National Park Service units and other public open space along the tidal Potomac River system provides a refuge to which tidal habitats may retreat to maintain total habitat area even under moderate sea level rise scenarios (0.7 m and 1.1 m rise by 2100). Under a severe sea level rise scenario associated with ice sheet collapse (1.7 m by 2100) habitat area is maintained only if no development is protected from rising water. If all existing development is protected, then 5%, 10%, and 40% of the total tidal habitat area is lost by 2100 for the three sea level rise scenarios tested.	[Cadol, Daniel] New Mexico Inst Min & Technol, Earth & Environm Sci, Socorro, NM 87801 USA; [Elmore, Andrew J.; Guinn, Steven M.; Engelhardt, Katharina A. M.] Univ Maryland, Appalachian Lab, Ctr Environm Sci, Frostburg, MD 21532 USA; [Sanders, Geoffrey] Natl Pk Serv, Ctr Urban Ecol, Washington, DC 20240 USA	New Mexico Institute of Mining Technology; University System of Maryland; University of Maryland Center for Environmental Science; United States Department of the Interior	Cadol, D (corresponding author), New Mexico Inst Min & Technol, Earth & Environm Sci, Socorro, NM 87801 USA.	dcadol@nmt.edu	Engelhardt, Katharina AM/H-8755-2013; Elmore, Andrew James/D-4341-2012	Elmore, Andrew James/0000-0002-9697-9457; Cadol, Daniel/0000-0002-4408-8548	National Capital Region of the National Park Service [H3992060006]; University of Maryland Center for Environmental Science (UMCES) Appalachian Laboratory; National Science Foundation [DEB-0841394]	National Capital Region of the National Park Service; University of Maryland Center for Environmental Science (UMCES) Appalachian Laboratory; National Science Foundation(National Science Foundation (NSF))	This research was funded by the National Capital Region of the National Park Service through cooperative agreement #H3992060006 with the University of Maryland Center for Environmental Science (UMCES) Appalachian Laboratory (PI Andrew J. Elmore), and by the National Science Foundation through award DEB-0841394 (PI Katharina A. M. Engelhardt).	[Anonymous], 2011, 11652212 USACE DEP A; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Belliard JP, 2015, J GEOPHYS RES-EARTH, V120, P1040, DOI 10.1002/2015JF003445; BERTNESS MD, 1987, ECOL MONOGR, V57, P129, DOI 10.2307/1942621; Boesch Donald F., 2013, UPDATING MARYLANDS S; BRINSON MM, 1995, ESTUARIES, V18, P648, DOI 10.2307/1352383; Cadol D, 2014, LIMNOL OCEANOGR, V59, P1065, DOI 10.4319/lo.2014.59.3.1065; Callender E, 1984, 2233 USGS WAT SUPPL; Carson M, 2016, CLIMATIC CHANGE, V134, P269, DOI 10.1007/s10584-015-1520-1; Cornwell JC, 2016, J COASTAL RES, V32, P776, DOI [10.2112/JCOASTRES-D-15-00159.1, 10.2112/jcoastres-d-15-00159.1]; Costanza R, 1998, ECOL ECON, V25, P67, DOI 10.1016/S0921-8009(98)00019-6; COSTANZA R, 1990, BIOSCIENCE, V40, P91, DOI 10.2307/1311342; Craft C, 2007, LIMNOL OCEANOGR, V52, P1220, DOI 10.4319/lo.2007.52.3.1220; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Craft CB, 2012, GLOBAL CHANGE BIOL, V18, P3615, DOI 10.1111/gcb.12009; D'Alpaos A, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF002093; Dalrymple R. A., 2012, SEA LEVEL RISE COAST; Darrell LC, 1999, NUTR SUSPENDED SEDIM; DELAUNE RD, 1994, J COASTAL RES, V10, P1021; Dutton A, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4019; Elmore AJ, 2015, ECOLOGICAL APPL, DOI [10.1890/14-1970.1, DOI 10.1890/14-1970.1]; Ezer T, 2013, J GEOPHYS RES-OCEANS, V118, P685, DOI 10.1002/jgrc.20091; Fagherazzi S, 2013, OCEANOGRAPHY, V26, P70, DOI 10.5670/oceanog.2013.47; Feagin RA, 2010, ECOL SOC, V15; Harper JD, 1992, DYKE MARSH HYDROLOGI; Hazler KG, 2012, CARTOGRAPHE IN PRESS; Herman JD, 420 APPL MAR SCI OC; Hoeppner SS, 2011, ECOL MODEL, V222, P3541, DOI 10.1016/j.ecolmodel.2011.07.017; Jerolmack DJ, 2007, GEOMORPHOLOGY, V91, P259, DOI 10.1016/j.geomorph.2007.04.022; Kirwan ML, 2016, GEOPHYS RES LETT, V43, P4366, DOI 10.1002/2016GL068507; Kirwan ML, 2016, NAT CLIM CHANGE, V6, P253, DOI 10.1038/NCLIMATE2909; Kirwan ML, 2012, ECOSYSTEMS, V15, P140, DOI 10.1007/s10021-011-9498-7; Kirwan ML, 2011, GEOLOGY, V39, P507, DOI 10.1130/G31789.1; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Litwin RJ, 2011, 20101269 USGS, P80; Litwin RJ, 2013, WETLANDS, V33, P1037, DOI 10.1007/s13157-013-0461-6; Marani M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048995; Marani M, 2013, P NATL ACAD SCI USA, V110, P3259, DOI 10.1073/pnas.1218327110; Mariotti G, 2013, P NATL ACAD SCI USA, V110, P5353, DOI 10.1073/pnas.1219600110; Martin JF, 2002, BIOSCIENCE, V52, P357, DOI 10.1641/0006-3568(2002)052[0357:LMOTMD]2.0.CO;2; Moller I, 2014, NAT GEOSCI, V7, P848, DOI [10.1038/ngeo2251, 10.1038/NGEO2287, 10.1038/NGEO2251]; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Murray AB, 2007, GEOMORPHOLOGY, V90, P178, DOI 10.1016/j.geomorph.2006.10.020; Myrick RM, 1963, 442B US GEOL SURV; Neubauer SC, 2008, ESTUAR COAST SHELF S, V78, P78, DOI 10.1016/j.ecss.2007.11.011; Neubauer SC, 2013, ESTUAR COAST, V36, P491, DOI 10.1007/s12237-011-9455-x; Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Nyman JA, 2006, ESTUAR COAST SHELF S, V69, P370, DOI 10.1016/j.ecss.2006.05.041; ODUM WE, 1988, ANNU REV ECOL SYST, V19, P147, DOI 10.1146/annurev.es.19.110188.001051; Palinkas CM, 2016, LIMNOL OCEANOGR, V61, P132, DOI 10.1002/lno.10202; Palinkas CM, 2013, ESTUAR COAST SHELF S, V129, P152, DOI 10.1016/j.ecss.2013.05.022; Pasternack GB, 1998, ESTUARIES, V21, P407, DOI 10.2307/1352839; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; REDFIELD AC, 1972, ECOL MONOGR, V42, P201, DOI 10.2307/1942263; REED DJ, 1995, EARTH SURF PROC LAND, V20, P39, DOI 10.1002/esp.3290200105; Reyes E, 2000, ECOLOGY, V81, P2331, DOI 10.1890/0012-9658(2000)081[2331:LMOCHC]2.0.CO;2; Ritz C, 2015, NATURE, V528, P115, DOI 10.1038/nature16147; Sallenger AH, 2012, NAT CLIM CHANGE, V2, P884, DOI [10.1038/nclimate1597, 10.1038/NCLIMATE1597]; Schile LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088760; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Swanson KM, 2014, ESTUAR COAST, V37, P476, DOI 10.1007/s12237-013-9694-0; Temmerman S, 2004, MAR GEOL, V212, P1, DOI 10.1016/j.margeo.2004.10.021; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; Titus JG, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044008; Weston NB, 2011, BIOGEOCHEMISTRY, V102, P135, DOI 10.1007/s10533-010-9427-4; Whitehead A, 2011, P NATL ACAD SCI USA, V108, P6193, DOI 10.1073/pnas.1017542108; Yin JJ, 2009, NAT GEOSCI, V2, P262, DOI 10.1038/NGEO462; Zedler JB, 1999, ECOSYSTEMS, V2, P19, DOI 10.1007/s100219900055	69	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164875	10.1371/journal.pone.0164875	http://dx.doi.org/10.1371/journal.pone.0164875			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788209	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900033
J	Choi, YH; Jin, N; Kelly, F; Sakthivel, SK; Yu, TW				Choi, Youkyung H.; Jin, Nancy; Kelly, Fiona; Sakthivel, SenthilKumar K.; Yu, Tianwei			Elevation of Alanine Aminotransferase Activity Occurs after Activation of the Cell-Death Signaling Initiated by Pattern-Recognition Receptors but before Activation of Cytolytic Effectors in NK or CD8+T Cells in the Liver During Acute HCV Infection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INTERFERON REGULATORY FACTOR-3; ANTIVIRAL IMMUNITY; III INTERFERONS; APOPTOSIS; MECHANISMS; DISEASE; HEPATOCYTES; CHIMPANZEES; BIOMARKERS	Pattern-recognition receptors (PRRs) promote host defenses against HCV infection by binding to their corresponding adapter molecules leading to the initiation of innate immune responses including cell death. We investigated the expression of PRR genes, biomarkers of liver cell-death, and T cell and NK cell activation/inhibition-related genes in liver and serum obtained from three experimentally infected chimpanzees with acute HCV infection, and analyzed the correlation between gene expression levels and clinical profiles. Our results showed that expression of hepatic RIG-I, TLR3, TLR7, 2OAS1, and CXCL10 mRNAs was upregulated as early as 7 days post-inoculation and peaked 12 to 83 days post-inoculation. All of the three HCV infected chimpanzees exhibited significant elevations of serum alanine aminotransferase (ALT) activity between 70 and 95 days after inoculation. Elevated levels of serum cytokeratin 18 (CK-18) and caspases 3 and 7 activity coincided closely with the rise of ALT activity, and were preceded by significant increases in levels of caspase 3 and caspase 7 mRNAs in the liver. Particularly we found that significant positive auto-correlations were observed between RIG-I, TLR3, CXCL10, 2OAS1, and PD-L1 mRNA and ALT activity at 3 to 12 days before the peak of ALT activity. However, we observed substantial negative auto-correlations between T cell and NK cell activation/inhibition-related genes and ALT activity at 5 to 32 days after the peak of ALT activity. Our results indicated cell death signaling is preceded by early induction of RIG-I, TLR3, 2OAS1, and CXCL10 mRNAs which leads to elevation of ALT activity and this signaling pathway occurs before the activation of NK and T cells during acute HCV infection. Our study suggests that PRRs and type I IFN response may play a critical role in development of liver cell injury related to viral clearance during acute HCV infection.	[Choi, Youkyung H.; Kelly, Fiona; Sakthivel, SenthilKumar K.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA; [Jin, Nancy; Yu, Tianwei] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Choi, YH (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA.	brt5@cdc.gov		Yu, Tianwei/0000-0003-2502-1628	CDC	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for the study was provided by CDC.; We are very grateful to Dr. Kris Krawczynski (deceased) for his contribution of this study. We also thank Dr. Michael A. Purdy (Division of Viral Hepatitis, CDC) for critical reviews of the manuscript and helpful discussions. This study was funded by CDC. This information is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally disseminated by the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry. It does not represent and should not be construed to represent any agency determination or policy. Use of trade names is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services, the Public Health Service, or the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.	Ando K, 1997, J IMMUNOL, V158, P5283; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Brownell J, 2014, J VIROL, V88, P1582, DOI 10.1128/JVI.02007-13; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Calabrese F, 2000, HEPATOLOGY, V31, P1153, DOI 10.1053/he.2000.7123; Choi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076501; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Davis MA, 2014, FUTURE VIROL, V9, P537, DOI 10.2217/FVL.14.35; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Eguchi A, 2014, J HEPATOL, V60, P1063, DOI 10.1016/j.jhep.2013.12.026; Errett JS, 2015, VIROL SIN, V30, P163, DOI 10.1007/s12250-015-3604-5; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Feldstein AE, 2013, AM J GASTROENTEROL, V108, P1526, DOI 10.1038/ajg.2013.168; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guicciardi ME, 2010, SEMIN LIVER DIS, V30, P402, DOI 10.1055/s-0030-1267540; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Huang YF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004020; Knolle PA, 2014, GASTROENTEROLOGY, V146, P1193, DOI 10.1053/j.gastro.2013.12.036; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Major ME, 2004, HEPATOLOGY, V39, P1709, DOI 10.1002/hep.20239; Major ME, 1999, J VIROL, V73, P3317, DOI 10.1128/JVI.73.4.3317-3325.1999; Odendall C, 2015, CURR OPIN VIROL, V12, P47, DOI 10.1016/j.coviro.2015.02.003; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Park H, 2012, HEPATOLOGY, V56, P2060, DOI 10.1002/hep.25897; Rehermann B, 2015, CELL MOL GASTROENTER, V1, P578, DOI 10.1016/j.jcmgh.2015.09.004; Rosen HR, 2013, J CLIN INVEST, V123, P4121, DOI 10.1172/JCI67714; Rusch L, 2000, J INTERF CYTOK RES, V20, P1091, DOI 10.1089/107999000750053762; Sahin H, 2013, HEPATOLOGY, V57, P797, DOI 10.1002/hep.26069; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Tanner MS, 2002, CRIT REV CL LAB SCI, V39, P1, DOI 10.1080/10408360290795439; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Tsutsui M, 2010, J CLIN GASTROENTEROL, V44, P440, DOI 10.1097/MCG.0b013e3181bdefe2; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Yang ZH, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.15(5)2015.25328; Zeremski M, 2011, J HEPATOL, V55, P545, DOI 10.1016/j.jhep.2010.12.033; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	48	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165533	10.1371/journal.pone.0165533	http://dx.doi.org/10.1371/journal.pone.0165533			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788241	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900105
J	Gonzalez-Bengtsson, A; Asadi, A; Gao, H; Dahlman-Wright, K; Jacobsson, A				Gonzalez-Bengtsson, Amanda; Asadi, Abolfazl; Gao, Hui; Dahlman-Wright, Karin; Jacobsson, Anders			Estrogen Enhances the Expression of the Polyunsaturated Fatty Acid Elongase Elovl2 via ERa in Breast Cancer Cells	PLOS ONE			English	Article							RECEPTOR-ALPHA; BETA; BINDING; N-3; IDENTIFICATION; PROLIFERATION; BIOSYNTHESIS; TAMOXIFEN; APOPTOSIS; HORMONES	Endocrine therapy is the first-line targeted adjuvant therapy for hormone-sensitive breast cancer. In view of the potential anticancer property of the omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) together with chemotherapy in estrogen receptor alpha (ER alpha) positive mammary tumors, we have explored the regulation by estradiol of the fatty acid desaturation and elongation enzymes involved in DHA synthesis in the human breast cancer cell line MCF7, which expresses ER alpha but not ER beta. We demonstrate a robust up-regulation in the expression of the fatty acid elongases Elovl2 and Elovl5 upon estradiol stimulation in MCF7 cells, which was sustained for more than 24 hours. Exposure with the ER inhibitor tamoxifen abolished specifically the Elovl2 but not the Elovl5 expression. Similarly, knockdown of ER alpha eliminated almost fully the Elovl2 but not the Elovl5 expression. Furthermore, ER alpha binds to one specific ERE within the Elovl2 enhancer in a ligand dependent manner. The involvement of ER alpha in the control of especially Elovl2, which plays a crucial role in DHA synthesis, may have potential implications in the treatment of breast cancer.	[Gonzalez-Bengtsson, Amanda; Asadi, Abolfazl; Jacobsson, Anders] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Gao, Hui; Dahlman-Wright, Karin] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden	Stockholm University; Karolinska Institutet	Jacobsson, A (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden.	anders.jacobsson@su.se	Gao, Hui/AAF-9770-2019		Swedish Cancer Foundation [CAN 2011/574]	Swedish Cancer Foundation	This work was supported by grants from the Swedish Cancer Foundation (A.J.) CAN 2011/574.; This work was supported by grants from the Swedish Cancer Foundation (A.J.).	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Bardin A, 2004, ENDOCR-RELAT CANCER, V11, P537, DOI 10.1677/erc.1.00800; Bartsch H, 1999, CARCINOGENESIS, V20, P2209, DOI 10.1093/carcin/20.12.2209; Caizzi L, 2014, P NATL ACAD SCI USA, V111, P4892, DOI 10.1073/pnas.1315445111; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; Childs CE, 2012, PROSTAG LEUKOTR ESS, V86, P141, DOI 10.1016/j.plefa.2012.03.007; Corsetto PA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-73; Creighton CJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r28; Elledge RM, 2000, INT J CANCER, V89, P111, DOI 10.1002/(SICI)1097-0215(20000320)89:2<111::AID-IJC2>3.3.CO;2-N; Enmark E, 1997, J CLIN ENDOCR METAB, V82, P4258, DOI 10.1210/jc.82.12.4258; Fasano E, 2015, CRIT REV FOOD SCI NU; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; HULKA BS, 1994, CANCER, V74, P1111, DOI 10.1002/1097-0142(19940801)74:3+<1111::AID-CNCR2820741520>3.0.CO;2-L; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Javitt NB, 2015, STEROIDS; Kang KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010296; Koide A, 2007, MOL ENDOCRINOL, V21, P829, DOI 10.1210/me.2006-0203; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lai CF, 2013, NUCLEIC ACIDS RES, V41, P10228, DOI 10.1093/nar/gkt827; Laviano A, 2013, CURR OPIN CLIN NUTR, V16, P156, DOI 10.1097/MCO.0b013e32835d2d99; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Li XD, 2004, MOL CELL BIOL, V24, P7681, DOI 10.1128/MCB.24.17.7681-7694.2004; Liu Y, 2008, P NATL ACAD SCI USA, V105, P2604, DOI 10.1073/pnas.0712085105; Nilsson S, 2002, CRIT REV EUKAR GENE, V12, P237, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i4.10; Omoto Y, 2015, CANCER SCI, V106, P337, DOI 10.1111/cas.12613; Papoutsi Z, 2009, J MOL ENDOCRINOL, V43, P65, DOI 10.1677/JME-08-0177; Park HG, 2015, FASEB J, V29, P3911, DOI 10.1096/fj.15-271783; Park WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028186; Silva JDP, 2015, CLIN NUTR, V34, P359, DOI 10.1016/j.clnu.2014.11.005; Pauter AM, 2014, J LIPID RES; SACEDA M, 1991, J BIOL CHEM, V266, P17809; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Serini S, 2009, APOPTOSIS, V14, P135, DOI 10.1007/s10495-008-0298-2; Sibbons CM, 2014, PROSTAG LEUKOTR ESS, V90, P47, DOI 10.1016/j.plefa.2013.12.006; SPIELMANN D, 1988, JPEN-PARENTER ENTER, V12, pS111, DOI 10.1177/014860718801200618; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; Vega VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r82; VOSS A, 1991, J BIOL CHEM, V266, P19995; WHITE JO, 1987, BRIT J SURG, V74, P588, DOI 10.1002/bjs.1800740715; Wu SF, 2015, BIOCHEM BIOPH RES CO, V459, P294, DOI 10.1016/j.bbrc.2015.02.103; Zhao CY, 2003, ONCOGENE, V22, P7600, DOI 10.1038/sj.onc.1207100	43	29	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164241	10.1371/journal.pone.0164241	http://dx.doi.org/10.1371/journal.pone.0164241			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788154	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900014
J	Kaeslin, MA; Killer, HE; Fuhrer, CA; Zeleny, N; Huber, AR; Neutzner, A				Kaeslin, Martha Andrea; Killer, Hanspeter Ezriel; Fuhrer, Cyril Adrian; Zeleny, Nauke; Huber, Andreas Robert; Neutzner, Albert			Changes to the Aqueous Humor Proteome during Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OXIDATIVE STRESS; GENE ONTOLOGY; IDENTIFICATION; PATHOGENESIS; PREVALENCE; TOOL	Purpose To investigate the aqueous humor proteome in patients with glaucoma and a control group. Method Aqueous humor was obtained from five human donors diagnosed with primary open angle glaucoma (POAG) and five age- and sex-matched controls undergoing cataract surgery. Quantitative proteome analysis of the aqueous humor by hyper reaction monitoring mass spectrometry (HRM-MS) based on SWATH technology was performed. Results Expression levels of 87 proteins were found to be different between glaucomatous and control aqueous humor. Of the 87 proteins, 34 were significantly upregulated, whereas 53 proteins were downregulated in the aqueous humor from glaucoma patients compared to controls. Differentially expressed proteins were found to be involved in cholesterol-related, inflammatory, metabolic, antioxidant as well as proteolysis-related processes. Conclusion Glaucoma leads to profound changes to the aqueous humor proteome consistent with an altered metabolic state, an inflammatory response and impaired antioxidant defense.	[Kaeslin, Martha Andrea; Fuhrer, Cyril Adrian; Huber, Andreas Robert] Cantonal Hosp Aarau, Ctr Lab Med, Tellstr 25, CH-5001 Aarau, Switzerland; [Killer, Hanspeter Ezriel; Zeleny, Nauke] Cantonal Hosp Aarau, Dept Ophthalmol, Tellstr 25, CH-5001 Aarau, Switzerland; [Neutzner, Albert] Univ Basel, Dept Biomed, Basel, Switzerland; [Neutzner, Albert] Univ Basel, Dept Ophthalmol, Basel, Switzerland	Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA); University of Basel; University of Basel	Kaeslin, MA (corresponding author), Cantonal Hosp Aarau, Ctr Lab Med, Tellstr 25, CH-5001 Aarau, Switzerland.	martha.kaeslinmeyer@ksa.ch	Neutzner, Albert/ABC-4368-2020	Neutzner, Albert/0000-0001-9254-5558; Kaeslin, martha/0000-0002-7096-3078	Messerli Foundation, Zurich	Messerli Foundation, Zurich	This work was supported by grant from the Messerli Foundation, Zurich, to HEK.; This work was supported by grant from the Messerli Foundation, Zurich, to HEK. The authors also want to thank Biognosys AG, Zurich for the good collaboration on this project.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bagnis A, 2012, EXP EYE RES, V103, P55, DOI 10.1016/j.exer.2012.07.011; Bill A, 1989, Prog Clin Biol Res, V312, P417; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cedrone C, 2008, PROG BRAIN RES, V173, P3, DOI 10.1016/S0079-6123(08)01101-1; Charbonnier Frederic, 1997, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V191, P127; Chrysostomou V, 2013, CURR OPIN PHARMACOL, V13, P12, DOI 10.1016/j.coph.2012.09.008; COHENSOLAL M, 1994, BLOOD, V84, P898, DOI 10.1182/blood.V84.3.898.bloodjournal843898; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Gonzalez-Iglesias H, 2014, J PROTEOMICS, V98, P65, DOI 10.1016/j.jprot.2013.12.006; Izzotti A, 2010, J PROTEOME RES, V9, P4831, DOI 10.1021/pr1005372; Junk AK, 2010, MOL VIS, V16, P1286; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Killer Hanspeter Esriel, 2013, J Glaucoma, V22 Suppl 5, pS19, DOI 10.1097/IJG.0b013e3182934a0f; Kliuchnikova AA, 2016, PROTEOMICS, V16, P1938, DOI 10.1002/pmic.201500423; Konieczka K, 2014, EPMA J, V5, DOI 10.1186/1878-5085-5-11; Lin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029393; Madej A, 2010, UPSALA J MED SCI, V115, P249, DOI 10.3109/03009734.2010.487951; Marr HS, 2003, MATRIX BIOL, V22, P259, DOI 10.1016/S0945-053X(03)00036-2; Ojika K, 2000, PROG NEUROBIOL, V60, P37, DOI 10.1016/S0301-0082(99)00021-0; Osborne NN, 2013, CURR OPIN PHARMACOL, V13, P16, DOI 10.1016/j.coph.2012.09.002; Osborne NN, 2003, EUR J OPHTHALMOL, V13, pS19; STRUYK AF, 1995, J NEUROSCI, V15, P2141, DOI 10.1523/JNEUROSCI.15-03-02141.1995; Tezel G, 2005, INVEST OPHTH VIS SCI, V46, P3177, DOI 10.1167/iovs.05-0208; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Vohra R, 2013, SURV OPHTHALMOL, V58, P311, DOI 10.1016/j.survophthal.2012.08.010; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192	29	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165314	10.1371/journal.pone.0165314	http://dx.doi.org/10.1371/journal.pone.0165314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788204	gold, Green Submitted, Green Published			2022-12-26	WOS:000389604900061
J	Nobeyama, Y; Nakagawa, H				Nobeyama, Yoshimasa; Nakagawa, Hidemi			Aberrant DNA Methylation in Keratoacanthoma	PLoS One			English	Article							SQUAMOUS-CELL CARCINOMA; CANCER; TARGET	Background Keratoacanthoma (KA) is a self-limiting epidermal tumor for which histopathological examination sometimes suggests malignancy. Based on inconsistent clinical views, KA can be regarded as both a benign tumor and a variant of squamous cell carcinoma (SCC). Aberrant DNA methylation frequently occurs in malignant tumors but it scarcely occurs in benign tumors. Whether aberrant methylation occurs in KA has not been previously examined. Objective The aim is to elucidate whether aberrant methylation of CpG islands (CGI) containing a high density of cytosine-guanine dinucleotide (CpG) sites occurs in KA. Methods Five SCC cell lines, two cultured samples of normal human epidermal keratinocytes (NHEKs), 18 clinical SCC samples, and 21 clinical KA samples were analyzed with Infinium HumanMethylation450 BeadChips, quantitative real-time methylation-specific PCR (RTMSP) and/or bisulfite sequencing. Results Genome-wide analyses of NHEK, KA, and SCC indicated that there was a greater number of aberrantly hypermethylated CGIs in SCC than in KA and there were aberrantly hyper methylated CGIs which are common in both. Among the common hypermethylated CGIs, RT-MSP and bisulfite sequencing targeting CGIs located on CCDC1 7, PVR, and MAP3K1 1 gene bodies also showed that methylation levels were significantly higher in KA than in normal epidermis. Statistical analyses suggested that the methylation level of CGI located on PVR in SCC might be correlated to lymph node metastasis (P = 0.013, Mann Whitney U test) and that the methylation level of CGI in MAP3K1 1 in KA might be correlated to age (P= 0.031, linear regression analysis). Conclusion Aberrant DNA methylation occurs in KA.	[Nobeyama, Yoshimasa; Nakagawa, Hidemi] Jikei Univ, Dept Dermatol, Sch Med, Tokyo, Japan	Jikei University	Nobeyama, Y (corresponding author), Jikei Univ, Dept Dermatol, Sch Med, Tokyo, Japan.	nobederm@jikei.ac.jp		Nobeyama, Yoshimasa/0000-0002-0125-8930				Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beham A, 1998, Adv Anat Pathol, V5, P269, DOI 10.1097/00125480-199809000-00001; Brown VL, 2004, J INVEST DERMATOL, V122, P1284, DOI 10.1111/j.0022-202X.2004.22501.x; Calonje E, 2012, MCKEES PATHOLOGY SKI, P1115; Cribier B, 1999, DERMATOLOGY, V199, P208, DOI 10.1159/000018276; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hameetman L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-58; HODAK E, 1993, AM J DERMATOPATH, V15, P332, DOI 10.1097/00000372-199308000-00007; Iguchi-Manaka A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152982; Jones MJ, 2015, AGING CELL, V14, P924, DOI 10.1111/acel.12349; Joshi S, 2016, J CUTAN PATHOL; Knackmuss U, 2016, CELL DEATH DIFFER, V23, P242, DOI 10.1038/cdd.2015.87; Kwiek B, 2016, J AM ACAD DERMATOL; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Liang JQ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1650-x; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Rahimi S, 2013, CLIN TER, V164, P143, DOI 10.7417/CT.2013.1534; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Venza I, 2010, BRIT J DERMATOL, V162, P1093, DOI 10.1111/j.1365-2133.2009.09560.x; Weedon D, 2006, WORLD HLTH ORG CLASS; Weedon D, 2006, SQUAMOUS CELL CARCIN; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165370	10.1371/journal.pone.0165370	http://dx.doi.org/10.1371/journal.pone.0165370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788211	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900070
J	Zhao, HP; Sun, X; Xue, M; Zhang, X; Li, QL				Zhao, Haipeng; Sun, Xia; Xue, Ming; Zhang, Xiao; Li, Qingliang			Antioxidant Enzyme Responses Induced by Whiteflies in Tobacco Plants in Defense against Aphids: Catalase May Play a Dominant Role	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; PHLOEM-FEEDING INSECTS; TABACI BIOTYPE B; BEMISIA-TABACI; SALICYLIC-ACID; HEMIPTERA ALEYRODIDAE; SUPEROXIDE-DISMUTASE; ARABIDOPSIS-THALIANA; HYDROGEN-PEROXIDE; STRESS TOLERANCE	Background Bemisia tabaci MEAM1 (Middle East-Asia Minor 1) feeding alters antioxidative enzyme activity in some plant species. Infestation of B. tabaci nymphs decreases Myzus persicae performance on systemic, but not local leaves of tobacco plants. However, it is unclear if B. tabaci nymphs induced antioxidant activities contributing to the aphid resistance. Methodology/Principal Findings We investigated the relationship between antioxidants induced by nymphs of B. tabaci feeding on tobacco and aphid resistance. The activities of catalase (CAT), peroxidase (POD), superoxide dismutase (SOD) and the concentration of hydrogen peroxide (H2O2) were assayed in tobacco leaves at different feeding times following infestation of B. tabaci nymphs. The infestation altered the activities of CAT and POD, but had no significant effect on SOD activity. The highest CAT activity was observed at 15 d after infestation. This was 98.2% greater than control systemic leaves, but 32.6% lower than the control in local leaves. Higher POD activity was recorded in local vs. systemic leaves after 15 d of infestation. POD activity was 71.0% and 112.9% higher in local and systemic leaves, respectively, than in the controls. The changes of CAT, but not POD or SOD activity were correlated to levels of aphid resistance. H2O2 levels were higher in local than in systemic leaves in contrast to CAT activity. Tobacco curly shoot virus mediated virus-induced gene silencing was employed to determine if CAT activation was involved in the aphid resistance induced by B. tabaci nymphs. B. tabaci induced CAT activity decreased when the Cat1 expression was silenced. The performance assay indicated that Cat1 silencing made B. tabaci infested plants a more suitable host for aphids than infested control plants. The aphid survival rate was reduced by 40.4% in infested control plants, but reduced by only 26.1% in Cat1-silenced plants compared to uninfested controls. Also, qPCR results showed that silencing of Call led to the suppression of the B. tabaci mediated PR-2a expression. Conclusions/Significance Aphid resistance in plants infested with B. tabaci nymphs is associated with enhanced antioxidant activities in which CAT may play a dominant role. This resistance probably acted via interactions with SA-mediated defense responses.	[Zhao, Haipeng; Sun, Xia; Xue, Ming; Zhang, Xiao; Li, Qingliang] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China; [Li, Qingliang] Shanxi Acad Agr Sci, Jinzhong, Shanxi, Peoples R China	Shandong Agricultural University; Shanxi Agricultural University	Xue, M (corresponding author), Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China.	xueming@sdau.edu.cn			Nature Science Foundation of China [30971906]; Shandong modern agricultural industry technology system [SDAIT-05-022-08]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong modern agricultural industry technology system	This work was supported by the Nature Science Foundation of China (30971906) (http:// www.nsfc.gov.cn/) and Shandong modern agricultural industry technology system (SDAIT-05-022-08) (http://cyjstx.sdny.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abei H., 1984, CATALASE IN VITRO; Afiyanti M, 2014, J PLANT PHYSIOL, V171, P35, DOI 10.1016/j.jplph.2013.10.003; Allison SD, 2004, J CHEM ECOL, V30, P1363, DOI 10.1023/B:JOEC.0000037745.66972.3e; ANTONIW JF, 1980, J GEN VIROL, V47, P79, DOI 10.1099/0022-1317-47-1-79; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BI JL, 1995, J CHEM ECOL, V21, P1511, DOI 10.1007/BF02035149; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Cooper WC, 2004, J CHEM ECOL, V30, P2527, DOI 10.1007/s10886-004-7948-9; Dat JF, 2003, PLANT J, V33, P621, DOI 10.1046/j.1365-313X.2003.01655.x; De Vos M, 2006, PLANT PHYSIOL, V142, P352, DOI 10.1104/pp.106.083907; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; Denno RF, 2000, ECOLOGY, V81, P1814, DOI 10.1890/0012-9658(2000)081[1814:FICIPQ]2.0.CO;2; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Dicke M, 2009, NAT CHEM BIOL, V5, P317, DOI 10.1038/nchembio.169; DILLWITH JW, 1991, ARCH INSECT BIOCHEM, V17, P235, DOI 10.1002/arch.940170407; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; EISING R, 1990, ARCH BIOCHEM BIOPHYS, V278, P258, DOI 10.1016/0003-9861(90)90256-X; FELTON GW, 1994, J CHEM ECOL, V20, P639, DOI 10.1007/BF02059604; Frugoli JA, 1996, PLANT PHYSIOL, V112, P327, DOI 10.1104/pp.112.1.327; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GUAN LQ, 1995, P NATL ACAD SCI USA, V92, P5930, DOI 10.1073/pnas.92.13.5930; Havir EA, 1996, PHYTOCHEMISTRY, V41, P699, DOI 10.1016/0031-9422(95)00674-5; He JP, 2011, J PLANT PHYSIOL, V168, P687, DOI 10.1016/j.jplph.2010.10.009; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Inbar M, 1999, ENVIRON ENTOMOL, V28, P353, DOI 10.1093/ee/28.3.353; Ingham LM, 1998, PHYSIOL PLANTARUM, V102, P93, DOI 10.1034/j.1399-3054.1998.1020113.x; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Kaloshian I, 2004, J CHEM ECOL, V30, P2419, DOI 10.1007/s10886-004-7943-1; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; KAR M, 1976, PLANT PHYSIOL, V57, P315, DOI 10.1104/pp.57.2.315; Karban R., 2007, INDUCED RESPONSES HE; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kerchev PI, 2013, ANTIOXID REDOX SIGN, V18, P2091, DOI 10.1089/ars.2012.5097; Kornyeyev D, 2001, PHYSIOL PLANTARUM, V113, P323, DOI 10.1034/j.1399-3054.2001.1130304.x; Li Q, 2006, MOL PLANT MICROBE IN, V19, P655, DOI 10.1094/MPMI-19-0655; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Luan JB, 2013, ECOL LETT, V16, P390, DOI 10.1111/ele.12055; Maffei ME, 2006, PLANT PHYSIOL, V140, P1022, DOI 10.1104/pp.105.071993; Mayer RT, 2002, ARCH INSECT BIOCHEM, V51, P151, DOI 10.1002/arch.10065; Mhamdi A, 2012, ARCH BIOCHEM BIOPHYS, V525, P181, DOI 10.1016/j.abb.2012.04.015; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; NI WT, 1990, BIOCHIM BIOPHYS ACTA, V1049, P219, DOI 10.1016/0167-4781(90)90044-3; Nicholls P, 2012, ARCH BIOCHEM BIOPHYS, V525, P95, DOI 10.1016/j.abb.2012.01.015; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Peleg-Grossman S, 2010, PLANT SIGNAL BEHAV, V5, P1401, DOI 10.4161/psb.5.11.13209; Petrov VD, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls014; RAHBE Y, 1993, ENTOMOL EXP APPL, V67, P149, DOI 10.1007/BF02386520; Rostas M, 2008, CHEMOECOLOGY, V18, P29, DOI 10.1007/s00049-007-0390-z; Schaller A., 2008, INDUCED PLANT RESIST; Skadsen RW, 1995, PLANT MOL BIOL, V29, P1005, DOI 10.1007/BF00014973; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Taggar GK, 2012, PLANT SIGNAL BEHAV, V7, P1321, DOI 10.4161/psb.21435; Takahashi H, 1997, PLANT J, V11, P993, DOI 10.1046/j.1365-313X.1997.11050993.x; Tan XL, 2014, ENTOMOL EXP APPL, V151, P259, DOI 10.1111/eea.12190; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; Wang CX, 2010, ACTA ENTOMOL SINICA, V3; War AR, 2013, J PLANT GROWTH REGUL, V32, P259, DOI 10.1007/s00344-012-9294-4; War AR, 2011, PLANT SIGNAL BEHAV, V6, P1787, DOI 10.4161/psb.6.11.17685; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; WILLEKENS H, 1994, P NATL ACAD SCI USA, V91, P10450, DOI 10.1073/pnas.91.22.10450; Xue M, 2010, ENVIRON ENTOMOL, V39, P883, DOI 10.1603/EN09307; Yamaguchi T, 2000, PLANT CELL, V12, P817, DOI 10.1105/tpc.12.5.817; Yasur J, 2009, ALLELOPATHY J, V24, P131; Zhang GF, 2014, PEST MANAG SCI, V70, P1797, DOI 10.1002/ps.3713; Zhang LP, 2005, J APPL ENTOMOL, V129, P443, DOI 10.1111/j.1439-0418.2005.00991.x; Zhang PJ, 2013, J CHEM ECOL, V39, P612, DOI 10.1007/s10886-013-0283-2; Zhang SZ, 2013, ENTOMOL EXP APPL, V147, P293, DOI 10.1111/eea.12067; Zhang SZ, 2008, ARTHROPOD-PLANT INTE, V2, P209, DOI 10.1007/s11829-008-9044-5; Zhang X, 2015, ARTHROPOD-PLANT INTE, V9, P383, DOI 10.1007/s11829-015-9385-9; Zhao HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138584; Zhu F, 2014, NEW PHYTOL, V204, P315, DOI 10.1111/nph.12886; 김상아, 2014, [Journal of Life Science, 생명과학회지], V24, P227, DOI 10.5352/JLS.2014.24.3.227	84	15	17	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165454	10.1371/journal.pone.0165454	http://dx.doi.org/10.1371/journal.pone.0165454			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788203	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900086
J	Zhou, FB; Xu, XD; Wu, SJ; Cui, XB; Fan, L; Pan, WQ				Zhou, Fangbin; Xu, Xindong; Wu, Sijia; Cui, Xiaobing; Fan, Lin; Pan, Weiqing			Influence of HLA-DRB1 Alleles on the Variations of Antibody Response to Tuberculosis Serodiagnostic Antigens in Active Tuberculosis Patients	PLoS One			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; 16-KILODALTON ANTIGEN; IMMUNOGLOBULIN-G; DETECTION TESTS; HEPATITIS-B; HLA; IDENTIFICATION; METAANALYSIS; ASSOCIATION	Serology-based tests for tuberculosis (TB) diagnosis, though rapid, efficient and easily implemented, have so far shown unsatisfactory levels of sensitivity and specificity, probably due to variations of the antibody response in TB patients. The number and types of seropositive antigens vary from individual to individual. The person-to-person variations of antigen recognition may be linked to genetic polymorphisms of the human leukocyte antigen (HLA) class II alleles. In the present study, we find that there is a significant increase in the frequency of HLA-DRB1*14 (P = 2.5x10(-4)) among subjects with high antibody response levels compared to those with low antibody levels. HLA-DRB1*15, the most frequent allelic group in the studied active TB population, positively correlates with subjects with low antibody response levels rather than subjects with high antibody response levels (P = 0.005), which indicates the loss of relevant antigens for screening of patients with this allelic group. The potential association between HLA-DRB1 allelic group and individual antigens implies that TB diagnostic yield could be improved by the addition of antigens screened at the proteome scale in infected subjects from the HLA-DRB1*15 allelic group.	[Zhou, Fangbin; Xu, Xindong; Wu, Sijia; Cui, Xiaobing; Pan, Weiqing] Tongji Univ, Inst Infect Dis & Vaccine Dev, Sch Med, Shanghai, Peoples R China; [Fan, Lin] Tongji Univ, Shanghai Pulm Hosp, Shanghai Key Lab TB, Clin & Res Ctr TB,Sch Med, Shanghai, Peoples R China; [Pan, Weiqing] Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China	Tongji University; Tongji University; Naval Medical University	Pan, WQ (corresponding author), Tongji Univ, Inst Infect Dis & Vaccine Dev, Sch Med, Shanghai, Peoples R China.; Fan, L (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Shanghai Key Lab TB, Clin & Res Ctr TB,Sch Med, Shanghai, Peoples R China.; Pan, WQ (corresponding author), Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China.	fanlinsj@163.com; wqpan0912@aliyun.com			National S T Program [2013ZX10003007]	National S T Program	Support was provided by National S & T Program (2013ZX10003007) [http://www.nmp.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Ahmad S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-169; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Ben Selma W, 2010, INT J TUBERC LUNG D, V14, P841; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bigi F, 1997, MICROBIOL-SGM, V143, P3599, DOI 10.1099/00221287-143-11-3599; BOTHAMLEY GH, 1989, J INFECT DIS, V159, P549, DOI 10.1093/infdis/159.3.549; BOTHAMLEY GH, 1993, J INFECT DIS, V167, P992, DOI 10.1093/infdis/167.4.992; Carroll MV, 2010, PROTEIN CELL, V1, P859, DOI 10.1007/s13238-010-0101-3; Cheng Z, 2011, J CLIN LAB ANAL, V25, P344, DOI 10.1002/jcla.20483; Deenadayalan A, 2010, MOL CELL PROTEOMICS, V9, P538, DOI 10.1074/mcp.M900299-MCP200; Deodhar L, 1998, INDIAN J MED RES, V108, P75; Du KM, 2007, HUM IMMUNOL, V68, P854, DOI 10.1016/j.humimm.2007.04.006; Flores LL, 2011, CLIN VACCINE IMMUNOL, V18, P1616, DOI 10.1128/CVI.05205-11; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; He XY, 2011, CLIN VACCINE IMMUNOL, V18, P565, DOI 10.1128/CVI.00507-10; Imaz MS, 2001, INT J TUBERC LUNG D, V5, P1036; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kotsch K, 1999, TISSUE ANTIGENS, V53, P486, DOI 10.1034/j.1399-0039.1999.530505.x; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Li YQ, 2010, J PROTEOME RES, V9, P4812, DOI 10.1021/pr1005108; Lima JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036419; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; Pottumarthy S, 2000, J CLIN MICROBIOL, V38, P2227; Pukazhvanthen P, 2014, TUBERCULOSIS, V94, P622, DOI 10.1016/j.tube.2014.09.006; Raja A, 2002, CLIN DIAGN LAB IMMUN, V9, P308, DOI 10.1128/CDLI.9.2.308-312.2002; Shi GL, 2011, GENET MOL RES, V10, P1331, DOI 10.4238/vol10-3gmr1132; Steingart KR, 2007, POSTGRAD MED J, V83, P705, DOI 10.1136/thx.2006.075754; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Storti-Melo LM, 2012, ACTA TROP, V121, P152, DOI 10.1016/j.actatropica.2011.10.009; Tong X, 2015, LUNG, V193, P309, DOI 10.1007/s00408-015-9692-z; VERBON A, 1992, CLIN EXP IMMUNOL, V89, P395; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Wang CB, 2004, HEPATOLOGY, V39, P978, DOI 10.1002/hep.20142; Wang ZH, 2007, J MOL BIOL, V366, P375, DOI 10.1016/j.jmb.2006.11.039; Weldingh K, 2005, J CLIN MICROBIOL, V43, P57, DOI 10.1128/JCM.43.1.57-65.2005; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2009, GUID TREATM TUB; Xin P, 2014, AFRICAN J MICROBIOLO, V8, P776; Yin XM, 2013, J INFECTION, V67, P369, DOI 10.1016/j.jinf.2013.06.009; Zhang QF, 2009, J CLIN IMMUNOL, V29, P454, DOI 10.1007/s10875-009-9281-0; Zhang SL, 2009, TUBERCULOSIS, V89, P278, DOI 10.1016/j.tube.2009.05.005; Zhou FB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15349	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165291	10.1371/journal.pone.0165291	http://dx.doi.org/10.1371/journal.pone.0165291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788190	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900058
J	Cravens, PD; Hussain, RZ; Miller-Little, WA; Ben, LH; Segal, BM; Herndon, E; Stuve, O				Cravens, Petra D.; Hussain, Rehana Z.; Miller-Little, William A.; Ben, Li-Hong; Segal, Benjamin M.; Herndon, Emily; Stueve, Olaf			IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; T-CELLS; IN-VIVO; GM-CSF; CYTOKINE; MICE; TH1	Background Interleukin (IL)-12 and IL-23 are heterodimers that share the p40 subunit, and both cytokines are critical in the differentiation of T helper (Th) 1 and Th17 cells, respectively. Th1 and Th17 effector cells have been implicated in the pathogenesis of experimental autoimmune encephalitis (EAE), an animal model of the human central nervous system (CNS) autoimmune demyelinating disorder multiple sclerosis (MS). However, ustekinumab, a monoclonal antibody (mAb) against p40 failed to show efficacy over placebo in a phase II clinical trial in patients with MS. The role of p40 in initial T cell priming and maintenance in secondary lymphoid tissues is not yet well understood. Methods Active EAE was induced in the B6.129-IL12b strain of p40eYFP reporter mice (yet40 mice), and Th1 and Th17 polarized cells were adoptively transferred into p40-deficient mice. Cellular subsets were phenotyped by multi-parameter flow cytometry, and p40 tissue expression was identified by confocal microscopy. Results We show that yet40 mice are susceptible to EAE, and that p40 is highly expressed in secondary lymphoid organs and the CNS during all stages of the disease. Interestingly, p40 expression in the recipient is not required for EAE induction after adoptive transfer of activated and differentiated encephalitogenic Th1 and Th17 cells into p40-deficient mice. Peripheral antagonism of T helper cell trophic factors critical for the differentiation and maintenance of Th1 and Th17 cells ameliorates EAE, indicating that p40 may play a critical role in the induction of CNS autoimmunity but not in its perpetuation. Conclusion Our data may explain why ustekinumab did not ameliorate paraclinical and clinical disease in patients with MS. In patients with already established disease, activated antigen-specific encephalitogenic CD4(+) T cells are likely already differentiated, and are not dependent on p40 for maintenance. A clinical trial of longer duration with anti-p40 mAbs or other forms of pharmacological p40 antagonism, or sequential anti-p40 therapy following T cell depletion may show a benefit by affecting de novo generation of autoimmune T cells.	[Cravens, Petra D.; Hussain, Rehana Z.; Miller-Little, William A.; Ben, Li-Hong; Stueve, Olaf] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Segal, Benjamin M.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Herndon, Emily] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA; [Stueve, Olaf] VA North Texas Hlth Care Syst, Neurol Sect, Med Serv, Dallas, TX 75216 USA; [Stueve, Olaf] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Technical University of Munich	Stuve, O (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.; Stuve, O (corresponding author), VA North Texas Hlth Care Syst, Neurol Sect, Med Serv, Dallas, TX 75216 USA.; Stuve, O (corresponding author), Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany.	olaf.stuve@utsouthwestern.edu			Teva Pharmaceuticals; Opexa Therapeutics; Merit Review grant from the United States (U.S.) Department of Veterans Affairs, Biomedical Laboratory Research and Development [(FAIN)I016X001674]	Teva Pharmaceuticals(Teva Pharmaceutical Industries); Opexa Therapeutics; Merit Review grant from the United States (U.S.) Department of Veterans Affairs, Biomedical Laboratory Research and Development(US Department of Veterans Affairs)	Dr. Olaf Stive serves on the editorial boards of JAMA Neurology, Multiple Sclerosis Journal, and Therapeutic Advances in Neurological Disorders. Dr. Stive has served on data monitoring committees for Pfizer and Sanofi-Aventis without monetary compensation. Dr. Stive collaborated with Medscape on educational initiatives. Dr. Stive represented Novartis in front of a Scientific Advisory Group at the European Medicines Agency (EMA). Dr. Stive has advised Genentech and Genzyme. Dr. Stive has participated in a Teva-sponsored meeting. Dr. Stive has consulted for Navigant Consulting. Dr. Stive currently receives grant support from Teva Pharmaceuticals and Opexa Therapeutics. Dr. Stive received travel support from Pfizer. Dr. Stive is funded by a Merit Review grant (federal award document number (FAIN)I016X001674) from the United States (U.S.) Department of Veterans Affairs, Biomedical Laboratory Research and Development. The role of the funders is addressed, in that there is no role.	Baxi EG, 2015, J NEUROSCI, V35, P8626, DOI 10.1523/JNEUROSCI.3817-14.2015; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Cravens PD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-73; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gately MK, 1996, ANN NY ACAD SCI, V795, P1, DOI 10.1111/j.1749-6632.1996.tb52650.x; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Grifka-Walk HM, 2015, EUR J IMMUNOL, V45, P2780, DOI 10.1002/eji.201545800; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Hussain RZ, 2014, J NEUROIMMUNOL, V276, P9, DOI 10.1016/j.jneuroim.2014.08.622; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lehmann PV, 1998, IMMUNOL REV, V164, P53, DOI 10.1111/j.1600-065X.1998.tb01207.x; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Racke MK, 2001, CURR PROTOC NEUROSCI; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Schimpl A, 2002, CYTOKINE GROWTH F R, V13, P369, DOI 10.1016/S1359-6101(02)00022-9; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Slavin AJ, 2001, J CLIN INVEST, V108, P1133, DOI 10.1172/JCI200113360; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Wang GY, 2008, SCAND J IMMUNOL, V68, P589, DOI 10.1111/j.1365-3083.2008.02174.x; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165248	10.1371/journal.pone.0165248	http://dx.doi.org/10.1371/journal.pone.0165248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780253	Green Submitted, Green Published, gold			2022-12-26	WOS:000389046900038
J	Groeneveld, E; Lichtenberg, H				Groeneveld, Eildert; Lichtenberg, Helmut			TheSNPpit-D A High Performance Database System for Managing Large Scale SNP Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PHENOTYPE; GENOTYPE	The fast development of high throughput genotyping has opened up new possibilities in genetics while at the same time producing considerable data handling issues. TheSNPpit is a database system for managing large amounts of multi panel SNP genotype data from any genotyping platform. With an increasing rate of genotyping in areas like animal and plant breeding as well as human genetics, already now hundreds of thousand of individuals need to be managed. While the common database design with one row per SNP can manage hundreds of samples this approach becomes progressively slower as the size of the data sets increase until it finally fails completely once tens or even hundreds of thousands of individuals need to be managed. TheSNPpit has implemented three ideas to also accomodate such large scale experiments: highly compressed vector storage in a relational database, set based data manipulation, and a very fast export written in C with Perl as the base for the framework and PostgreSQL as the database backend. Its novel subset system allows the creation of named subsets based on the filtering of SNP (based on major allele frequency, no-calls, and chromosomes) and manually applied sample and SNP lists at negligible storage costs, thus avoiding the issue of proliferating file copies. The named subsets are exported for down stream analysis. PLINK ped and map files are processed as in-and outputs. TheSNPpit allows management of different panel sizes in the same population of individuals when higher density panels replace previous lower density versions as it occurs in animal and plant breeding programs. A completely generalized procedure allows storage of phenotypes. TheSNPpit only occupies 2 bits for storing a single SNP implying a capacity of 4 mio SNPs per 1MB of disk storage. To investigate performance scaling, a database with more than 18.5 mio samples has been created with 3.4 trillion SNPs from 12 panels ranging from 1000 through 20 mio SNPs resulting in a database of 850GB. The import and export performance scales linearly with the number of SNPs and is largely independent of panel and database size. Import speed is around 6 mio SNPs/sec, export between 60 and 120 mio SNPs/sec. Being command line based, imports and exports can easily be integrated into pipelines. TheSNPpit is available under the Open Source GNU General Public License (GPL) Version 2.	[Groeneveld, Eildert; Lichtenberg, Helmut] Friedrich Loeffler Inst, Inst Farm Anim Genet, D-31535 Mariensee, Germany	Friedrich Loeffler Institute	Groeneveld, E (corresponding author), Friedrich Loeffler Inst, Inst Farm Anim Genet, D-31535 Mariensee, Germany.	eildert.groeneveld@fli.de						Ameur A, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau098; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baron RV, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0505-4; Fong C, 2010, BIOINFORMATICS, V26, P560, DOI 10.1093/bioinformatics/btp714; Free Software Foundation, GNU GEN PUBL LIC VER; Groeneveld E, 2013, ARCH TIERZUCHT, V56, P1023, DOI 10.7482/0003-9438-56-103; Mitha F, 2011, WORKING PAPER SERIES, P19; Mitha Faheem, 2013, Methods Mol Biol, V1019, P99, DOI 10.1007/978-1-62703-447-0_4; Momjian B., 2001, POSTGRESQL INTRO CON; Neale B, PLINK TOOLSET WHOLE; Nelson SC, 2012, TRENDS GENET, V28, P361, DOI 10.1016/j.tig.2012.05.002; Nicolazzi EL, 2015, ANIM GENET, V46, P343, DOI 10.1111/age.12295; Orro A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S13; Perkel J, 2008, NAT METHODS, V5, P447, DOI 10.1038/nmeth0508-447; Rios D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-238	15	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164043	10.1371/journal.pone.0164043	http://dx.doi.org/10.1371/journal.pone.0164043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780248	gold, Green Published, Green Submitted			2022-12-26	WOS:000389046900007
J	Koul, A; Cavallo, A; Ansuini, C; Becchio, C				Koul, Atesh; Cavallo, Andrea; Ansuini, Caterina; Becchio, Cristina			Doing It Your Way: How Individual Movement Styles Affect Action Prediction	PLOS ONE			English	Article							STIMULUS PROBABILITY; DIFFUSION MODEL; MUSCLE-ACTIVITY; INTENTIONS; PERCEPTION; MIRROR; GOAL	Individuals show significant variations in performing a motor act. Previous studies in the action observation literature have largely ignored this ubiquitous, if often unwanted, characteristic of motor performance, assuming movement patterns to be highly similar across repetitions and individuals. In the present study, we examined the possibility that individual variations in motor style directly influence the ability to understand and predict others' actions. To this end, we first recorded grasping movements performed with different intents and used a two-step cluster analysis to identify quantitatively 'clusters' of movements performed with similar movement styles (Experiment 1). Next, using videos of the same movements, we proceeded to examine the influence of these styles on the ability to judge intention from action observation (Experiments 2 and 3). We found that motor styles directly influenced observers' ability to 'read' others' intention, with some styles always being less 'readable' than others. These results provide experimental support for the significance of motor variability for action prediction, suggesting that the ability to predict what another person is likely to do next directly depends on her individual movement style.	[Koul, Atesh; Ansuini, Caterina; Becchio, Cristina] Fdn Ist Italiano Tecnol, CMON Unit, Ctr Human Technol, I-16152 Genoa, Italy; [Cavallo, Andrea; Becchio, Cristina] Univ Turin, Dept Psychol, I-10123 Turin, Italy	Istituto Italiano di Tecnologia - IIT; University of Turin	Cavallo, A (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, Italy.	andrea.cavallo@unito.it	Koul, Atesh/I-2176-2019; Cavallo, Andrea/AAB-9615-2019	Koul, Atesh/0000-0002-0917-9583; Cavallo, Andrea/0000-0002-3717-3760	European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC grant [312919]	European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC grant(European Research Council (ERC))	This work received funding from European Research Council under the European Unions Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement n. 312919 (https://erc.europa.eu/projects-and-results/erc-funded-projects/Becchio?retain-filters=1) to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansuini C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120432; Ansuini C, 2015, NEUROSCIENTIST, V21, P126, DOI 10.1177/1073858414533827; Ansuini C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00815; Bacher J, 2001, U ERLANGEN NURNB, V1, P1; Calabrese RL, 2011, INTEGR COMP BIOL, V51, P845, DOI 10.1093/icb/icr074; Oliveira ASC, 2012, J NEUROPHYSIOL, V108, P1895, DOI 10.1152/jn.00217.2012; Catmur C, 2015, CONSCIOUS COGN, V36, P426, DOI 10.1016/j.concog.2015.03.012; Dunovan KE, 2014, NEUROPSYCHOLOGIA, V61, P210, DOI 10.1016/j.neuropsychologia.2014.06.024; Forstmann BU, 2015, MODEL BASED COGNITIV, P139, DOI [10.1007/978-1-4939-2236-9_7, DOI 10.1007/978-1-4939-2236-9_7]; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gentner R, 2010, CURR BIOL, V20, P1869, DOI 10.1016/j.cub.2010.09.045; GORDON IE, 1967, NATURE, V215, P895, DOI 10.1038/215895a0; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Macerollo A, 2015, SOC COGN AFFECT NEUR, V10, P1121, DOI 10.1093/scan/nsu161; Manera V, 2011, EXP BRAIN RES, V211, P547, DOI 10.1007/s00221-011-2649-4; Masciari E., 2013, ADV KNOWLEDGE DISCOV, P111, DOI [DOI 10.1007/978-3-642-37456-2_10, 10.1007/978-3-642-37456-2_10]; Naish KR, 2014, NEUROPSYCHOLOGIA, V64, P331, DOI 10.1016/j.neuropsychologia.2014.09.034; Naish KR, 2013, EXP BRAIN RES, V225, P261, DOI 10.1007/s00221-012-3367-2; PACHELLA RG, 1976, PERCEPT PSYCHOPHYS, V19, P29; Press C, 2011, J NEUROSCI, V31, P2792, DOI 10.1523/JNEUROSCI.1595-10.2011; Ramakrishnan R., 1996, P ACM SIGMOD INT C M, V1, P103, DOI [10.1145/233269.233324, DOI 10.1145/235968.233324]; Ratcliff R, 2002, PSYCHON B REV, V9, P278, DOI 10.3758/BF03196283; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Sartori L, 2011, COGNITION, V119, P242, DOI 10.1016/j.cognition.2011.01.014; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; STANOVICH KE, 1976, B PSYCHONOMIC SOC, V8, P281, DOI 10.3758/BF03335140; Stapel JC, 2012, PSYCHOL RES-PSYCH FO, V76, P434, DOI 10.1007/s00426-012-0423-2; Ting LH, 2015, NEURON, V86, P38, DOI 10.1016/j.neuron.2015.02.042; Ting LH, 2012, INT J NUMER METH BIO, V28, P1003, DOI 10.1002/cnm.2485; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P3, DOI 10.3758/BF03194023; Wagenmakers EJ, 2009, EUR J COGN PSYCHOL, V21, P641, DOI 10.1080/09541440802205067; Welch TDJ, 2008, J NEUROPHYSIOL, V99, P1032, DOI 10.1152/jn.01110.2007; Wiecki TV, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00014; Zhang T, 1997, DATA MIN KNOWL DISC, V1, P141, DOI 10.1023/A:1009783824328	35	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165297	10.1371/journal.pone.0165297	http://dx.doi.org/10.1371/journal.pone.0165297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED7LQ	27780259	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900044
J	Fuzzen, MLM; Bragg, LM; Tetreault, GR; Bahamonde, PA; Tenna, RN; Bennett, CJ; McMaster, ME; Servos, MR				Fuzzen, Meghan L. M.; Bragg, Leslie M.; Tetreault, Gerald R.; Bahamonde, Pauline A.; Tenna, Rajiv N.; Bennett, Charles J.; McMaster, Mark E.; Servos, Mark R.			An Assessment of the Spatial and Temporal Variability of Biological Responses to Municipal Wastewater Effluent in Rainbow Darter (Etheostoma caeruleum) Collected along an Urban Gradient	PLoS One			English	Article							PERSONAL CARE PRODUCTS; ENVIRONMENTAL MONITORING PROGRAMS; MINNOWS PIMEPHALES-PROMELAS; GRAND RIVER-BASIN; AQUATIC ENVIRONMENT; WILD FISH; ENDOCRINE DISRUPTION; REPRODUCTIVE DISRUPTION; SEXUAL DISRUPTION; FATHEAD MINNOWS	Municipal wastewater effluent (MWWE) and its constituents, such as chemicals of emerging concern, pose a potential threat to the sustainability of fish populations by disrupting key endocrine functions in aquatic organisms. While studies have demonstrated changes in biological markers of exposure of aquatic organisms to groups of chemicals of emerging concern, the variability of these markers over time has not been sufficiently described in wild fish species. The aim of this study was to assess the spatial and temporal variability of biological markers in response to MWWE exposure and to test the consistency of these responses between seasons and among years. Rainbow darter (Etheostoma caeruleum) were collected in spring and fall seasons over a 5-year period in the Grand River, Ontario, Canada. In addition to surface water chemistry (nutrients and selected pharmaceuticals), measures were taken across levels of biological organization in rainbow darter. The measurements of hormone production, gonad development, and intersex severity were temporally consistent and suggested impaired reproduction in male fish collected downstream of MWWE outfalls. In contrast, ovarian development and hormone production in females appeared to be influenced more by urbanization than MWWE. Measures of gene expression and somatic indices were highly variable between sites and years, respectively, and were inconclusive in terms of the impacts of MWWE overall. Robust biomonitoring programs must consider these factors in both the design and interpretation of results, especially when spatial and temporal sampling of biological endpoints is limited. Assessing the effects of contaminants and other stressors on fish in watersheds would be greatly enhanced by an approach that considers natural variability in the endpoints being measured.	[Fuzzen, Meghan L. M.; Bragg, Leslie M.; Tenna, Rajiv N.; Servos, Mark R.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada; [Tetreault, Gerald R.; Bennett, Charles J.; McMaster, Mark E.] Environm & Climate Change Canada, Canada Ctr Inland Waters, Water Sci Technol Directorate, Burlington, ON, Canada; [Bahamonde, Pauline A.] Univ New Brunswick, Canadian Rivers Inst, New Brunswick, NJ USA; [Bahamonde, Pauline A.] Univ New Brunswick, Dept Biol, New Brunswick, NJ USA	University of Waterloo; Environment & Climate Change Canada; Canada Centre for Inland Waters (CCIW)	Fuzzen, MLM (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON, Canada.	mfuzzen@uwaterloo.ca		Fuzzen, Meghan/0000-0003-3451-9380; Bahamonde, Paulina/0000-0002-8880-8463	NSERC [RGPIN-312050, CRDPJ 376338-08, STPSC 357028 - 07, STPGP-663331-14]; Canadian Water Network [2009-27-815, WSRG2001-1, CMWC-EC-2013]; Ontario Ministry of Environment and Climate Change; Canada Research Chairs Program [223146]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Water Network; Ontario Ministry of Environment and Climate Change; Canada Research Chairs Program(Canada Research Chairs)	This research was supported by grants from NSERC Discovery (RGPIN-312050), NSERC Strategic (CRDPJ 376338-08; STPSC 357028 - 07; STPGP-663331-14), Canadian Water Network (2009-27-815; WSRG2001-1; CMWC-EC-2013), Ontario Ministry of Environment and Climate Change, and Canada Research Chairs Program (223146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeogun AO, 2016, AQUAT TOXICOL, V174, P10, DOI 10.1016/j.aquatox.2016.02.002; Allen Y, 1999, ENVIRON TOXICOL CHEM, V18, P1791, DOI 10.1002/etc.5620180827; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Arlos MJ, 2015, WATER RES, V72, P40, DOI 10.1016/j.watres.2014.11.008; Arlos MJ, 2014, SCI TOTAL ENVIRON, V485, P193, DOI 10.1016/j.scitotenv.2014.03.092; Bahamonde PA, 2015, AQUAT TOXICOL, V159, P290, DOI 10.1016/j.aquatox.2014.11.023; Bahamonde PA, 2015, AQUAT TOXICOL, V159, P302, DOI 10.1016/j.aquatox.2014.11.022; Bahamonde PA, 2014, AQUAT TOXICOL, V148, P211, DOI 10.1016/j.aquatox.2014.01.010; Barrett TJ, 2010, ENVIRON REV, V18, P115, DOI 10.1139/A10-004; Baynes A, 2012, ENVIRON SCI TECHNOL, V46, P5565, DOI 10.1021/es204590d; Bizarro C, 2014, MAR ENVIRON RES, V96, P19, DOI 10.1016/j.marenvres.2013.10.009; Bjerregaard LB, 2006, ECOTOXICOLOGY, V15, P315, DOI 10.1007/s10646-006-0061-9; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Blazer VS, 2007, J AQUAT ANIM HEALTH, V19, P242, DOI 10.1577/H07-031.1; Blazer VS, 2012, ENVIRON MONIT ASSESS, V184, P4309, DOI 10.1007/s10661-011-2266-5; Brander SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074251; Clarke K.R., 2006, PRIMER V6 USER MANUA; Corcoran J, 2010, CRIT REV TOXICOL, V40, P287, DOI 10.3109/10408440903373590; Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Diamond J, 2015, ENVIRON TOXICOL CHEM, V34, P2671, DOI 10.1002/etc.3177; Feswick A, 2014, ENVIRON TOXICOL CHEM, V33, P847, DOI 10.1002/etc.2503; Filby AL, 2007, ENVIRON HEALTH PERSP, V115, P1704, DOI 10.1289/ehp.10443; Filby AL, 2010, ENVIRON SCI TECHNOL, V44, P4348, DOI 10.1021/es100602e; Fuzzen MLM, 2015, AQUAT TOXICOL, V160, P106, DOI 10.1016/j.aquatox.2015.01.009; Galloway BJ, 2006, J FISH BIOL, V69, P1788, DOI 10.1111/j.1095-8649.2006.01249.x; Halling-Sorensen B, 1998, CHEMOSPHERE, V36, P357, DOI 10.1016/S0045-6535(97)00354-8; Hamilton PB, 2016, FISH FISH, V17, P545, DOI 10.1111/faf.12125; Hanson N, 2010, ENVIRON TOXICOL CHEM, V29, P2616, DOI 10.1002/etc.300; Hanson N, 2009, ENVIRON TOXICOL CHEM, V28, P364, DOI 10.1897/08-259.1; Harries JE, 1996, ENVIRON TOXICOL CHEM, V15, P1993, DOI 10.1002/etc.5620151118; Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Holeton C, 2011, CAN J FISH AQUAT SCI, V68, P1836, DOI [10.1139/F2011-096, 10.1139/f2011-096]; Huang GY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20884; Jasinska EJ, 2015, SCI TOTAL ENVIRON, V530, P140, DOI 10.1016/j.scitotenv.2015.05.080; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Jobling S, 2003, AQUAT TOXICOL, V65, P205, DOI 10.1016/S0166-445X(03)00134-6; Jobling S, 2002, BIOL REPROD, V66, P272, DOI 10.1095/biolreprod66.2.272; Kasprzyk-Hordern B, 2009, WATER RES, V43, P363, DOI 10.1016/j.watres.2008.10.047; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kidd KA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0578; Kilgour BW, 2007, ENVIRON MONIT ASSESS, V130, P423, DOI 10.1007/s10661-006-9433-0; Kolok AS, 2007, SCI TOTAL ENVIRON, V388, P104, DOI 10.1016/j.scitotenv.2007.08.001; Lange A, 2009, ENVIRON SCI TECHNOL, V43, P1219, DOI 10.1021/es802661p; Lange A, 2008, TOXICOL SCI, V106, P113, DOI 10.1093/toxsci/kfn151; Lange A, 2011, ENVIRON SCI TECHNOL, V45, P1673, DOI 10.1021/es103232q; Liney KE, 2006, ENVIRON HEALTH PERSP, V114, P81, DOI 10.1289/ehp.8058; Liney KE, 2005, ENVIRON HEALTH PERSP, V113, P1299, DOI 10.1289/ehp.7921; Lister A, 2009, AQUAT TOXICOL, V95, P320, DOI 10.1016/j.aquatox.2009.04.011; Luo YL, 2014, SCI TOTAL ENVIRON, V473, P619, DOI 10.1016/j.scitotenv.2013.12.065; McMaster M. E., 1995, CANADIAN TECHNICAL R, P78; Miege C, 2009, ENVIRON POLLUT, V157, P1721, DOI 10.1016/j.envpol.2008.11.045; Munkittrick KR, 2009, ENVIRON TOXICOL CHEM, V28, P1361, DOI 10.1897/08-376.1; Naik KS, 2012, WATER SCI TECHNOL, V66, P644, DOI 10.2166/wst.2012.144; Overturf MD, 2015, AQUAT TOXICOL, V161, P33, DOI 10.1016/j.aquatox.2015.01.029; Pal A, 2010, SCI TOTAL ENVIRON, V408, P6062, DOI 10.1016/j.scitotenv.2010.09.026; Palace VP, 2002, WATER QUAL RES J CAN, V37, P637, DOI 10.2166/wqrj.2002.042; Park M, 2015, J AM WATER WORKS ASS, V107, pE174, DOI 10.5942/jawwa.2015.107.0015; Parrott JL, 2005, ENVIRON TOXICOL, V20, P131, DOI 10.1002/tox.20087; Prado PS, 2011, ECOTOX ENVIRON SAFE, V74, P1879, DOI 10.1016/j.ecoenv.2011.07.017; Prasse C, 2015, WATER RES, V87, P237, DOI 10.1016/j.watres.2015.09.023; Rose J, 2002, COMP BIOCHEM PHYS C, V131, P531, DOI 10.1016/S1532-0456(02)00035-2; Sanchez W, 2011, ENVIRON INT, V37, P1342, DOI 10.1016/j.envint.2011.06.002; Sumpter JP, 2013, ENVIRON TOXICOL CHEM, V32, P249, DOI 10.1002/etc.2084; Sumpter JP, 2005, ACTA HYDROCH HYDROB, V33, P9, DOI 10.1002/aheh.200400555; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; Tanna RN, 2013, ENVIRON TOXICOL CHEM, V32, P1981, DOI 10.1002/etc.2262; Ternes TA, 1999, SCI TOTAL ENVIRON, V225, P81, DOI 10.1016/S0048-9697(98)00334-9; Tetreault GR, 2013, INTEGR ENVIRON ASSES, V9, P456, DOI 10.1002/ieam.1364; Tetreault GR, 2012, AQUAT TOXICOL, V110, P149, DOI 10.1016/j.aquatox.2012.01.004; Tetreault GR, 2011, AQUAT TOXICOL, V104, P278, DOI 10.1016/j.aquatox.2011.05.008; Thorpe KL, 2009, ENVIRON SCI TECHNOL, V43, P2976, DOI 10.1021/es803103c; Vajda AM, 2008, ENVIRON SCI TECHNOL, V42, P3407, DOI 10.1021/es0720661; van Aerle R, 2001, ENVIRON TOXICOL CHEM, V20, P2841, DOI 10.1002/etc.5620201225; Verlicchi P, 2012, SCI TOTAL ENVIRON, V429, P123, DOI 10.1016/j.scitotenv.2012.04.028; Vethaak AD, 2005, CHEMOSPHERE, V59, P511, DOI 10.1016/j.chemosphere.2004.12.053; Waterloo Ro, 2012, WATER WASTEWATER MON; WINN HE, 1958, ECOL MONOGR, V28, P156, DOI 10.2307/1942207; Woodling JD, 2006, COMP BIOCHEM PHYS C, V144, P10, DOI 10.1016/j.cbpc.2006.04.019; Writer JH, 2010, SCI TOTAL ENVIRON, V409, P100, DOI 10.1016/j.scitotenv.2010.07.018	81	24	24	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0164879	10.1371/journal.pone.0164879	http://dx.doi.org/10.1371/journal.pone.0164879			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776151	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200026
J	Chhum, P; Yu, HT; An, B; Doyon, BR; Lin, YS; Brodsky, B				Chhum, Panharith; Yu, Hongtao; An, Bo; Doyon, Brian R.; Lin, Yu-Shan; Brodsky, Barbara			Consequences of Glycine Mutations in the Fibronectin-binding Sequence of Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I COLLAGEN; TRIPLE-HELIX; OSTEOGENESIS IMPERFECTA; MOLECULAR-DYNAMICS; STRUCTURAL-ANALYSIS; MUTANT COLLAGEN; MODEL PEPTIDES; FORCE-FIELD; PROTEIN; SITES	Collagen and fibronectin (Fn) are two key extracellular matrix proteins, which are known to interact and jointly shape matrix structure and function. Most proteins that interact with collagen bind only to the native triple-helical form, whereas Fn is unusual in binding strongly to denatured collagen and more weakly to native collagen. The consequences of replacing a Gly by Ser at each position in the required (Gly-Xaa-Yaa)(6) Fn-binding sequence are probed here, using model peptides and a recombinant bacterial collagen system. Fluorescence polarization and solid-state assays indicated that Gly replacements at four sites within the Fn-binding sequence led to decreased Fn binding to denatured collagen. Molecular dynamics simulations showed these Gly replacements interfered with the interaction of a collagen beta-strand with the beta-sheet structure of Fn modules seen in the high resolution crystal structure. Whereas previous studies showed that Gly to Ser mutations within an integrin-binding site caused no major structural perturbations, mutations within the Fn-binding site caused the triple helix to become highly sensitive to trypsin digestion. This trypsin susceptibility is consistent with the significant local unfolding and loss of hydrogen bonding seen in molecular dynamics simulations. Protease sensitivity resulting from mutations in the Fn-binding sequence could lead to degradation of type I collagen, early embryonic lethality, and the scarcity of reported osteogenesis imperfecta mutations in this region.	[Chhum, Panharith; Yu, Hongtao; An, Bo; Doyon, Brian R.; Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Yu, Hongtao; Lin, Yu-Shan] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [An, Bo] CSL Behring LLC, Res & Dev, Kankakee, IL 60901 USA; [Doyon, Brian R.] Novartis Inst Biomed Res Inc, 22 Windsor St, Cambridge, MA 02139 USA	Tufts University; Tufts University; CSL; Novartis	Brodsky, B (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.; Lin, YS (corresponding author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.	Yu-Shan.Lin@tufts.edu; Barbara.Brodsky@tufts.edu	Lin, Yu-Shan/E-2198-2013	Lin, Yu-Shan/0000-0001-6460-2877	National Institutes of Health [GM 60048]; Tufts start-up fund; Knez Family Faculty Investment Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts start-up fund; Knez Family Faculty Investment Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM 60048 (to B. B.), the Tufts start-up fund (to Y.-S. L.), and the Knez Family Faculty Investment Fund (to Y.-S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen M. P., 1987, COMPUTER SIMULATION, P64; An B, 2016, ADV DRUG DELIVER REV, V97, P69, DOI 10.1016/j.addr.2015.11.013; An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Brown AM, 2012, BIOCHEMISTRY-US, V51, P5041, DOI 10.1021/bi3002924; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Chellgren BW, 2004, BIOCHEMISTRY-US, V43, P5864, DOI 10.1021/bi049922v; Cheng AL, 1996, J PHYS CHEM-US, V100, P1927, DOI 10.1021/jp951968y; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; DESSAU W, 1978, BIOCHEM J, V169, P55, DOI 10.1042/bj1690055; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Erat MC, 2013, J BIOL CHEM, V288, P17441, DOI 10.1074/jbc.M113.469841; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forlino A, 2007, MATRIX BIOL, V26, P604, DOI 10.1016/j.matbio.2007.06.005; Gauba V, 2008, J AM CHEM SOC, V130, P7509, DOI 10.1021/ja801670v; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; INGHAM KC, 1988, J BIOL CHEM, V263, P4624; Ito H, 2005, J MOL BIOL, V352, P382, DOI 10.1016/j.jmb.2005.07.019; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KIM CWA, 1993, NATURE, V362, P267, DOI 10.1038/362267a0; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lingenheil M, 2008, J CHEM THEORY COMPUT, V4, P1293, DOI 10.1021/ct8000365; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Mooney SD, 2001, BIOPOLYMERS, V58, P347, DOI 10.1002/1097-0282(200103)58:3<347::AID-BIP1011>3.0.CO;2-M; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Park S, 2005, J COMPUT CHEM, V26, P1612, DOI 10.1002/jcc.20301; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickford AR, 2004, CHEM REV, V104, P3557, DOI 10.1021/cr0304018; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; Rainey JK, 2004, BIOINFORMATICS, V20, P2458, DOI 10.1093/bioinformatics/bth247; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; SCHNIEKE A, 1983, NATURE, V304, P315, DOI 10.1038/304315a0; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Squeglia F, 2014, J BIOL CHEM, V289, P5122, DOI 10.1074/jbc.M113.523597; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; TANGEMANN K, 1995, FEBS LETT, V358, P179, DOI 10.1016/0014-5793(94)01411-S; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yigit S, 2016, J BIOL CHEM, V291, P19196, DOI 10.1074/jbc.M116.726182; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134	54	15	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27073	27086		10.1074/jbc.M116.753566	http://dx.doi.org/10.1074/jbc.M116.753566			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27799304	Green Published, hybrid			2022-12-26	WOS:000391576300009
J	Yap, CC; Digilio, L; McMahon, L; Roszkowska, M; Bott, CJ; Kruczek, K; Winckler, B				Yap, Chan Choo; Digilio, Laura; McMahon, Lloyd; Roszkowska, Matylda; Bott, Christopher J.; Kruczek, Kamil; Winckler, Bettina			Different Doublecortin (DCX) Patient Alleles Show Distinct Phenotypes in Cultured Neurons EVIDENCE FOR DIVERGENT LOSS-OF-FUNCTION AND "OFF-PATHWAY" CELLULAR MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; FAMILY PROTEINS; MIGRATION; KINASE; MICE; MICROTUBULE; MUTATIONS; DOMAIN; DEPHOSPHORYLATION; NEUROFASCIN	Doublecortin on the X-chromosome (DCX) is a neuronal microtubule-binding protein with a multitude of roles in neuro-development. In humans, DCX is a major genetic locus for X-linked lissencephaly. The best studied defects are in neuronal migration during corticogenesis and in the hippocampus, as well as axon and dendrite growth defects. Much effort has been directed at understanding the molecular and cellular bases of DCX-linked lissencephaly. The focus has been in particular on defects in microtubule assembly and bundling, using knock-out mice and expression of WT and mutant Dcx in non-neuronal cells. Dcx also binds other proteins besides microtubules, such as spinophilin (abbreviated spn; gene name Ppp1r9b protein phosphatase 1 regulatory subunit 9b) and the clathrin adaptors AP-1 and AP-2. Even though many non-sense and missense mutations of Dcx are known, their molecular and cellular defects are still only incompletely understood. It is also largely unknown how neurons are affected by expression of DCX patient alleles. We have now characterized several patient DCX alleles (DCX-R89G, DCX-R59H, DCX-246X, DCX-272X, and DCX-303X) using a gain-of-function dendrite growth assay in cultured rat neurons in combination with the determination of molecular binding activities and subcellular localization in non-neuronal and neuronal cells. First, we find that several mutants (Dcx-R89G and Dcx-272X) were loss-of-function alleles (as had been postulated) but surprisingly acted via different cellular mechanisms. Second, one allele (Dcx-R59H) formed cytoplasmic aggregates, which contained Hspa1B (heat shock protein 1B hsp70) and ubiquitinated proteins, trapped other cytoskeletal proteins, including spinophilin, and led to increased autophagy. This allele could thus be categorized as "off-pathway"/possibly neomorph. Our findings thus suggested that distinct DCX alleles caused dysfunction by different mechanisms.	[Yap, Chan Choo; Digilio, Laura; McMahon, Lloyd; Roszkowska, Matylda; Bott, Christopher J.; Kruczek, Kamil; Winckler, Bettina] Univ Virginia, Dept Cell Biol, 3703B Pinn Hall,1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA	University of Virginia	Winckler, B (corresponding author), Univ Virginia, Dept Cell Biol, 3703B Pinn Hall,1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	bwinckler@virginia.edu	Roszkowska, Matylda/HGC-4112-2022	Roszkowska, Matylda/0000-0001-9280-8063; Winckler, Bettina/0000-0002-7924-9313	National Institutes of Health [R01NS081674]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS081674 (to B. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baek ST, 2014, NEURON, V82, P1255, DOI 10.1016/j.neuron.2014.04.036; Bahi-Buisson N, 2013, BRAIN, V136, P223, DOI 10.1093/brain/aws323; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bazelot M, 2012, EUR J NEUROSCI, V35, P244, DOI 10.1111/j.1460-9568.2011.07962.x; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Cohen D, 2008, DEV NEUROSCI-BASEL, V30, P187, DOI 10.1159/000109862; Corbo JC, 2002, J NEUROSCI, V22, P7548; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dixon-Salazar TJ, 2010, ANN NY ACAD SCI, V1214, P156, DOI 10.1111/j.1749-6632.2010.05819.x; Friocourt G, 2001, MOL CELL NEUROSCI, V18, P307, DOI 10.1006/mcne.2001.1022; Friocourt G, 2007, J NEUROSCI, V27, P3875, DOI 10.1523/JNEUROSCI.4530-06.2007; Friocourt G, 2011, ACTA NEUROPATHOL, V121, P149, DOI 10.1007/s00401-010-0768-9; Fu XQ, 2013, J NEUROSCI, V33, P709, DOI 10.1523/JNEUROSCI.4603-12.2013; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N; Jean DC, 2012, HUM MOL GENET, V21, P5511, DOI 10.1093/hmg/dds395; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Kerjan G, 2009, P NATL ACAD SCI USA, V106, P6766, DOI 10.1073/pnas.0812687106; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kizhatil K, 2002, J NEUROSCI, V22, P7948; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Liu JS, 2012, MOL CELL, V47, P707, DOI 10.1016/j.molcel.2012.06.025; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Nawabi H, 2015, NEURON, V88, P704, DOI 10.1016/j.neuron.2015.10.005; Pramparo T, 2010, J NEUROSCI, V30, P3002, DOI 10.1523/JNEUROSCI.4851-09.2010; Santra M, 2006, CANCER RES, V66, P11726, DOI 10.1158/0008-5472.CAN-06-1978; Sapir T, 2000, HUM MOL GENET, V9, P703, DOI 10.1093/hmg/9.5.703; Shin E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2443; Shmueli A, 2006, MOL CELL NEUROSCI, V32, P15, DOI 10.1016/j.mcn.2006.01.014; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2006, CEREB CORTEX, V16, pI69, DOI 10.1093/cercor/bhk005; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Toriyama M, 2012, J BIOL CHEM, V287, P12691, DOI 10.1074/jbc.M111.316307; Tsukada M, 2003, MECH DEVELOP, V120, P1033, DOI 10.1016/S0925-4773(03)00177-1; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Yap CC, 2012, J NEUROSCI, V32, P7439, DOI 10.1523/JNEUROSCI.5318-11.2012	37	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26613	26626		10.1074/jbc.M116.760777	http://dx.doi.org/10.1074/jbc.M116.760777			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27799303	Green Published, hybrid			2022-12-26	WOS:000391571400003
J	Boattini, A; Sarno, S; Bini, C; Pesci, V; Barbieri, C; De Fanti, S; Quagliariello, A; Pagani, L; Ayub, Q; Ferri, G; Pettener, D; Luiselli, D; Pelotti, S				Boattini, Alessio; Sarno, Stefania; Bini, Carla; Pesci, Valeria; Barbieri, Chiara; De Fanti, Sara; Quagliariello, Andrea; Pagani, Luca; Ayub, Qasim; Ferri, Gianmarco; Pettener, Davide; Luiselli, Donata; Pelotti, Susi			Mutation Rates and Discriminating Power for 13 Rapidly-Mutating Y-STRs between Related and Unrelated Individuals	PLOS ONE			English	Article							SHORT TANDEM REPEATS; CHROMOSOME; POPULATION	Rapidly Mutating Y-STRs (RM Y-STRs) were recently introduced in forensics in order to increase the differentiation of Y-chromosomal profiles even in case of close relatives. We estimate RM Y-STRs mutation rates and their power to discriminate between related individuals by using samples extracted from a wide set of paternal pedigrees and by comparing RM Y-STRs results with those obtained from the Y-filer set. In addition, we tested the ability of RM Y-STRs to discriminate between unrelated individuals carrying the same Y-filer haplotype, using the haplogroup R-M269 (reportedly characterised by a strong resemblance in Y-STR profiles) as a case study. Our results, despite confirming the high mutability of RM Y-STRs, show significantly lower mutation rates than reference germline ones. Consequently, their power to discriminate between related individuals, despite being higher than the one of Y-filer, does not seem to improve significantly the performance of the latter. On the contrary, when considering R-M269 unrelated individuals, RM Y-STRs reveal significant discriminatory power and retain some phylogenetic signal, allowing the correct classification of individuals for some R-M269-derived sub-lineages. These results have important implications not only for forensics, but also for molecular anthropology, suggesting that RM Y-STRs are useful tools for exploring subtle genetic variability within Y-chromosomal haplogroups.	[Boattini, Alessio; Sarno, Stefania; Barbieri, Chiara; De Fanti, Sara; Quagliariello, Andrea; Pettener, Davide; Luiselli, Donata] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali BiGeA, Bologna, Italy; [Bini, Carla; Pesci, Valeria; Pelotti, Susi] Univ Bologna, Dipartimento Sci Med & Chirurg, Bologna, Italy; [Pagani, Luca] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Ayub, Qasim] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Ferri, Gianmarco] Univ Modena & Reggio Emilia, Dipartimento Med Diagnost Clin & Sanita Pubbl, Modena, Italy	University of Bologna; University of Bologna; University of Cambridge; Wellcome Trust Sanger Institute; Universita di Modena e Reggio Emilia	Boattini, A; Sarno, S (corresponding author), Univ Bologna, Dipartimento Sci Biol Geol & Ambientali BiGeA, Bologna, Italy.	alessio.boattini2@unibo.it; stefania.sarno2@unibo.it	Pagani, Luca/G-8511-2017; Pettener, Davide/E-1576-2017; Quagliariello, Andrea/AAA-1710-2020; Quagliariello, Andrea/K-4955-2018	Pagani, Luca/0000-0002-6639-524X; Quagliariello, Andrea/0000-0002-3941-3684; Barbieri, Chiara/0000-0001-8827-5655	European Research Council [ERC-2011-AdG295733]	European Research Council(European Research Council (ERC)European Commission)	SS is supported by the European Research Council ERC-2011-AdG295733 grant (Langelin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne KN, 2014, HUM MUTAT, V35, P1021, DOI 10.1002/humu.22599; Ballantyne KN, 2012, FORENSIC SCI INT-GEN, V6, P208, DOI 10.1016/j.fsigen.2011.04.017; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Behar DM, 2004, HUM GENET, V114, P354, DOI 10.1007/s00439-003-1073-7; Boattini A, 2015, HEREDITY, V114, P155, DOI 10.1038/hdy.2014.77; Boattini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065441; Bosch E, 1999, AM J HUM GENET, V65, P1623, DOI 10.1086/302676; Busby GBJ, 2012, P ROY SOC B-BIOL SCI, V279, P884, DOI 10.1098/rspb.2011.1044; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jobling MA, 1997, INT J LEGAL MED, V110, P118, DOI 10.1007/s004140050050; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; King TE, 2009, MOL BIOL EVOL, V26, P1093, DOI 10.1093/molbev/msp022; Komsta L., 2011, OUTLIERS TESTS OUTLI; Larmuseau MHD, 2014, ANN HUM GENET, V78, P92, DOI 10.1111/ahg.12050; R Core Team, 2021, R LANGUAGE ENV STAT; Robino C, 2015, FORENSIC SCI INT-GEN, V15, P56, DOI 10.1016/j.fsigen.2014.10.008; Turrina S, 2016, TRANSFUSION, V56, P533, DOI 10.1111/trf.13368; Wei W, 2013, FORENSIC SCI INT-GEN, V7, P568, DOI 10.1016/j.fsigen.2013.03.014; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	21	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165678	10.1371/journal.pone.0165678	http://dx.doi.org/10.1371/journal.pone.0165678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802306	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200038
J	Flores, L; Bailey, RA; Elosegi, A; Larranaga, A; Reiss, J				Flores, Lorea; Bailey, R. A.; Elosegi, Arturo; Larranaga, Aitor; Reiss, Julia			Habitat Complexity in Aquatic Microcosms Affects Processes Driven by Detritivores	PLOS ONE			English	Article							FRESH-WATER MICROCOSMS; STRUCTURAL COMPLEXITY; ECOSYSTEM; BIODIVERSITY; MACROINVERTEBRATES; COMMUNITIES; METABOLISM; DIVERSITY; RICHNESS; IDENTITY	Habitat complexity can influence predation rates (e.g. by providing refuge) but other ecosystem processes and species interactions might also be modulated by the properties of habitat structure. Here, we focussed on how complexity of artificial habitat (plastic plants), in microcosms, influenced short-term processes driven by three aquatic detritivores. The effects of habitat complexity on leaf decomposition, production of fine organic matter and pH levels were explored by measuring complexity in three ways: 1. as the presence vs. absence of habitat structure; 2. as the amount of structure (3 or 4.5 g of plastic plants); and 3. as the spatial configuration of structures (measured as fractal dimension). The experiment also addressed potential interactions among the consumers by running all possible species combinations. In the experimental microcosms, habitat complexity influenced how species performed, especially when comparing structure present vs. structure absent. Treatments with structure showed higher fine particulate matter production and lower pH compared to treatments without structures and this was probably due to higher digestion and respiration when structures were present. When we explored the effects of the different complexity levels, we found that the amount of structure added explained more than the fractal dimension of the structures. We give a detailed overview of the experimental design, statistical models and R codes, because our statistical analysis can be applied to other study systems (and disciplines such as restoration ecology). We further make suggestions of how to optimise statistical power when artificially assembling, and analysing, 'habitat complexity' by not confounding complexity with the amount of structure added. In summary, this study highlights the importance of habitat complexity for energy flow and the maintenance of ecosystem processes in aquatic ecosystems.	[Flores, Lorea] INRA, UMR 1224, Ecol Comportementale & Biol Populat Poissons, Aquapole, F-64310 Quartier Ibarron, St Pee Sur Nive, France; [Bailey, R. A.] Queen Mary Univ London, Sch Math Sci, London E1 4NS, England; [Bailey, R. A.] Univ St Andrews, Sch Math & Stat, St Andrews KY16 9SS, Fife, Scotland; [Elosegi, Arturo; Larranaga, Aitor] Univ Basque Country, Dept Plant Biol & Ecol, Lab Stream Ecol, Fac Sci & Technol,UPV EHU, POB 644, Bilbao 48080, Spain; [Reiss, Julia] Univ Roehampton, Dept Life Sci, Whitelands Coll, London SW15 4JD, England	INRAE; Universite de Pau et des Pays de l'Adour; University of London; Queen Mary University London; University of St Andrews; University of Basque Country; Roehampton University	Flores, L (corresponding author), INRA, UMR 1224, Ecol Comportementale & Biol Populat Poissons, Aquapole, F-64310 Quartier Ibarron, St Pee Sur Nive, France.; Reiss, J (corresponding author), Univ Roehampton, Dept Life Sci, Whitelands Coll, London SW15 4JD, England.	lorea.flores@st-pee.inra.fr; julia.reiss@roehampton.ac.uk	Elosegi, Arturo/B-7796-2009; Larrañaga, Aitor/A-6185-2009	Elosegi, Arturo/0000-0001-8809-8484; Larrañaga, Aitor/0000-0002-0185-9154; Bailey, Rosemary/0000-0002-8990-2099; Reiss, Julia/0000-0002-3740-0046	Spanish Ministry of Economy and Competitiveness [Consolider-Ingenio CSD2009-00065]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness through the project SCARCE Consolider-Ingenio CSD2009-00065 (http://www.icra.cat/projects/consolider-ingenio-2010-scarce-assesing/1) to LF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LF was supported in part by the Spanish Ministry of Economy and Competitiveness through the project SCARCE Consolider-Ingenio CSD2009-00065.	Bailey RA, 2014, J STAT PLAN INFER, V144, P69, DOI 10.1016/j.jspi.2012.09.008; Barnes JB, 2013, FRESHWATER BIOL, V58, P2154, DOI 10.1111/fwb.12198; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cardinale BJ, 2002, ECOLOGY, V83, P412, DOI 10.1890/0012-9658(2002)083[0412:TIOSHO]2.0.CO;2; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; Duarte S, 2006, OECOLOGIA, V147, P658, DOI 10.1007/s00442-005-0300-4; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Friberg N, 2011, ADV ECOL RES, V44, P1, DOI 10.1016/B978-0-12-374794-5.00001-8; GEE JM, 1994, MAR ECOL PROG SER, V103, P141, DOI 10.3354/meps103141; Grafen A, 2002, J R STAT SOC D-STAT, V52, P368, DOI [10.1111/1467-9884.00369_10, DOI 10.1111/1467-9884.00369_10]; Gunn IDM, 2012, HYDROBIOLOGIA, V681, P59, DOI 10.1007/s10750-011-0926-7; Harrison SSC, 2004, J APPL ECOL, V41, P1140, DOI 10.1111/j.0021-8901.2004.00958.x; Hartley S., 1991, BIOCH SYST ECOL, V19, P526, DOI [10.1016/0305-1978(91)90076-C, DOI 10.1016/0305-1978(91)90076-C]; Hauzy C, 2010, OECOLOGIA, V163, P625, DOI 10.1007/s00442-010-1585-5; JEFFRIES M, 1993, OIKOS, V67, P142, DOI 10.2307/3545104; Kalinkat G, 2013, OECOLOGIA, V172, P877, DOI 10.1007/s00442-012-2530-6; Karperien A., FRACLAC IMAGEJ; Kirwan L, 2009, ECOLOGY, V90, P2032, DOI 10.1890/08-1684.1; Kovalenko KE, 2012, HYDROBIOLOGIA, V685, P1, DOI 10.1007/s10750-011-0974-z; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Pawar S, 2012, NATURE, V486, P485, DOI 10.1038/nature11131; Perkins DM, 2015, GLOBAL CHANGE BIOL, V21, P396, DOI 10.1111/gcb.12688; Perkins DM, 2012, GLOBAL CHANGE BIOL, V18, P1300, DOI 10.1111/j.1365-2486.2011.02597.x; Perkins DM, 2010, ADV ECOL RES, V43, P177, DOI 10.1016/S0065-2504(10)43005-6; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R. Core Team, 2013, R LANGUAGE ENV STAT; Rasband WS, 1997, IMAGEJ; Reiss J, 2011, J ANIM ECOL, V80, P1145, DOI 10.1111/j.1365-2656.2011.01857.x; Reiss J, 2011, FRESHWATER BIOL, V56, P1519, DOI 10.1111/j.1365-2427.2011.02590.x; Reiss J, 2010, ADV ECOL RES, V43, P151, DOI 10.1016/S0065-2504(10)43004-4; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Tokeshi M, 2012, HYDROBIOLOGIA, V685, P27, DOI 10.1007/s10750-011-0832-z; Warfe DM, 2006, OECOLOGIA, V150, P141, DOI 10.1007/s00442-006-0505-1; Williamson M, 2012, HABITAT STRUCTURE PH, P69; Wotton RS, 2001, BIOSCIENCE, V51, P537, DOI 10.1641/0006-3568(2001)051[0537:FIAE]2.0.CO;2	35	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165065	10.1371/journal.pone.0165065	http://dx.doi.org/10.1371/journal.pone.0165065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802267	Green Published, gold			2022-12-26	WOS:000386714200017
J	Lai, HTM; Koriyama, C; Tokudome, S; Tran, HH; Tran, LT; Nandakumar, A; Akiba, S; Le, NT				Hang Thi Minh Lai; Koriyama, Chihaya; Tokudome, Shinkan; Hoc Hieu Tran; Long Thanh Tran; Nandakumar, Athira; Akiba, Suminori; Ngoan Tran Le			Waterpipe Tobacco Smoking and Gastric Cancer Risk among Vietnamese Men	PLOS ONE			English	Article							STOMACH-CANCER; ALCOHOL-CONSUMPTION; CIGARETTE-SMOKING; LIFE-STYLE; HOOKAH; OPIUM	Background The association of waterpipe tobacco (WPT) smoking with gastric cancer (GC) risk was suggested. Methods A hospital-based case-control study was conducted to examine the association of WPT with GC risk among Vietnamese men, in Hanoi city, during the period of 2003-2011. Newly-diagnosed GC cases (n = 454) and control patients (n = 628) were matched by age (+/-5 years) and the year of hospitalization. Information on smoking and alcohol drinking habits and diet including salty food intake and fruits/vegetables consumption were obtained by the interview. Maximum likelihood estimates of odds ratios (ORs) and corresponding 95% confidence intervals (Cis) were obtained using conditional logistic regression models. Results The group with the highest consumption of citrus fruits showed a significantly low GC risk (OR = 0.6, 95% CI = 0.4-0.8, P for trend = 0.002). However, there was no association of raw vegetable consumption with GC risk. Referring to never smokers, GC risk was significantly higher in current WPT smokers (OR = 1.8, 95% CI = 1.3-2.4), and it was more evident in exclusively WPT smokers (OR = 2.7, 95% CI = 1.2-6.5). GC risk tended to be higher with daily frequency and longer duration of WPT smoking but these trends were not statistically significant (P for trend: 0.144 and 0.154, respectively). GC risk of those who started smoking WPT before the age of 25 was also significantly high (OR = 3.7, 95% CI = 1.2-11.3). Neither cigarette smoking nor alcohol drinking was related to GC risk. Conclusion The present findings revealed that WPT smoking was positively associated with GC risk in Vietnamese men.	[Hang Thi Minh Lai; Koriyama, Chihaya; Long Thanh Tran; Nandakumar, Athira; Akiba, Suminori] Kagoshima Univ, Dept Epidemiol & Prevent Med, Grad Sch Med & Dent Sci, Kagoshima, Japan; [Tokudome, Shinkan] Natl Inst Hlth & Nutr, Tokyo, Japan; [Hoc Hieu Tran] Hanoi Med Univ, Dept Surg, Hanoi, Vietnam; [Ngoan Tran Le] Hanoi Med Univ, Dept Occupat Hlth, Hanoi, Vietnam	Kagoshima University; National Institute of Health & Nutrition - Japan; Hanoi Medical University; Hanoi Medical University	Le, NT (corresponding author), Hanoi Med Univ, Dept Occupat Hlth, Hanoi, Vietnam.	letranngoan@yahoo.com		Nandakumar, Athira/0000-0001-5156-7304; TOKUDOME, SHINKAN/0000-0001-7311-2458; Akiba, Suminori/0000-0001-9004-3167; Le, Ngoan Tran/0000-0001-7862-492X	Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Science and Technology of Vietnam; UICC American Cancer Society Beginning Investigators Fellowship - American Cancer Society; UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant; Kodama Memorial Fund for Medical Research	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Science and Technology of Vietnam; UICC American Cancer Society Beginning Investigators Fellowship - American Cancer Society; UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant; Kodama Memorial Fund for Medical Research	The present study was supported by Grants-in-Aids for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology, Japan and Ministry of Science and Technology of Vietnam. This work has also been supported by a UICC American Cancer Society Beginning Investigators Fellowship funded by the American Cancer Society and by a UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant to N T Le. This study was supported by the Kodama Memorial Fund for Medical Research.	Akl EA, 2010, INT J EPIDEMIOL, V39, P834, DOI 10.1093/ije/dyq002; Al Rashidi M, 2008, FOOD CHEM TOXICOL, V46, P3546, DOI 10.1016/j.fct.2008.09.007; Anh PM, 2013, PRACTICAL MED, V876, P112; Bae JM, 2008, GASTRIC CANCER, V11, P23, DOI 10.1007/s10120-007-0447-2; Chen MJ, 2000, AM J GASTROENTEROL, V95, P3242; Chow WH, 1999, INT J CANCER, V81, P871, DOI 10.1002/(SICI)1097-0215(19990611)81:6&lt;871::AID-IJC6&gt;3.0.CO;2-#; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Duell EJ, 2013, GENES NUTR, V8, P549, DOI 10.1007/s12263-013-0346-6; Eissenberg T, 2009, AM J PREV MED, V37, P518, DOI 10.1016/j.amepre.2009.07.014; Gajalakshmi CK, 1996, INT J EPIDEMIOL, V25, P1146, DOI 10.1093/ije/25.6.1146; Inoue M, 1999, INT J CANCER, V81, P39; International agency for research on cancer, 2003, INT TERR LEG CHALL R, V8, P66; International agency for research on cancer, 2004, IARC MON EV CARC RIS, V83, p[68, 557]; Jacob P, 2011, CANCER EPIDEM BIOMAR, V20, P2345, DOI 10.1158/1055-9965.EPI-11-0545; Jayalekshmi PA, 2015, WORLD J GASTROENTERO, V21, P12676, DOI 10.3748/wjg.v21.i44.12676; La Torre G, 2009, TUMORI, V95, P13; Le GM, 2002, INT J CANCER, V102, P412, DOI 10.1002/ijc.10725; Xuan LTT, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120100; Maziak W, 2013, CANCER EPIDEMIOL, V37, P1, DOI 10.1016/j.canep.2012.10.013; Ministry of Health of Vietnam Ha Noi Medical University General Statistics Office Centers for Disease Control and Prevention and World Health Organization, 2010, GLOB AD TOB SURV GAT; Monzer B, 2008, FOOD CHEM TOXICOL, V46, P2991, DOI 10.1016/j.fct.2008.05.031; Park B, 2011, CANCER CAUSE CONTROL, V22, P1497, DOI 10.1007/s10552-011-9823-7; Ray CS, 2009, CURR SCI INDIA, V96, P1319; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Sadjadi A, 2014, INT J CANCER, V134, P181, DOI 10.1002/ijc.28344; Sasazuki S, 2002, INT J CANCER, V101, P560, DOI 10.1002/ijc.10649; Sepetdjian E, 2008, FOOD CHEM TOXICOL, V46, P1582, DOI 10.1016/j.fct.2007.12.028; Sepetdjian E, 2013, NICOTINE TOB RES, V15, P1107, DOI 10.1093/ntr/nts255; Shakeri R, 2013, INT J CANCER, V133, P455, DOI 10.1002/ijc.28018; She J, 2014, CHEST, V146, P924, DOI 10.1378/chest.13-1499; Siman JH, 2001, SCAND J GASTROENTERO, V36, P208, DOI 10.1080/003655201750065988; Sung NY, 2007, BRIT J CANCER, V97, P700, DOI 10.1038/sj.bjc.6603893; Tredaniel J, 1997, INT J CANCER, V72, P565, DOI 10.1002/(SICI)1097-0215(19970807)72:4<565::AID-IJC3>3.0.CO;2-O; World Health Organization, 2015, WHO STUD GROUP TOB P; Zaridze D, 2000, CANCER CAUSE CONTROL, V11, P363, DOI 10.1023/A:1008907924938	35	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165587	10.1371/journal.pone.0165587	http://dx.doi.org/10.1371/journal.pone.0165587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802311	Green Submitted, Green Published, gold			2022-12-26	WOS:000386714200028
J	Church, SR; Lux, T; Baker-Austin, C; Buddington, SP; Michell, SL				Church, Selina R.; Lux, Thomas; Baker-Austin, Craig; Buddington, Sam P.; Michell, Stephen Ll.			Vibrio vulnificus Type 6 Secretion System 1 Contains Anti-Bacterial Properties	PLOS ONE			English	Article							VI-SECRETION; PROTEIN SECRETION; IDENTIFICATION; VIRULENCE; REQUIRES	Vibrio vulnificus is a bacterium responsible for severe gastroenteritis, sepsis and wound infections. Gastroenteritis and sepsis are commonly associated with the consumption of raw oysters, whereas wound infection is often associated with the handling of contaminated fish. Although classical virulence factors of this emerging pathogen are well characterised, there remains a paucity of knowledge regarding the general biology of this species. To investigate the presence of previously unreported virulence factors, we applied whole genome sequencing to a panel of ten V. vulnificus strains with varying virulence potentials. This identified two novel type 6 secretion systems (T6SSs), systems that are known to have a role in bacterial virulence and population dynamics. By utilising a range of molecular techniques and assays we have demonstrated the functionality of one of these T6SSs. Furthermore, we have shown that this system is subject to thermoregulation and is negatively regulated by increasing salinity concentrations. This secretion system was also shown to be involved in the killing of V. vulnificus strains that did not possess this system and a model is proposed as to how this interaction may contribute to population dynamics within V. vulnificus strains. In addition to this intra-species killing, this system also contributes to the killing of inter bacterial species and may have a role in the general composition of Vibrio species in the environment.	[Church, Selina R.; Lux, Thomas; Buddington, Sam P.; Michell, Stephen Ll.] Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter, Devon, England; [Baker-Austin, Craig] Weymouth Lab, Ctr Environm Fisheries & Aquaculture Sci, Weymouth, Dorset, England	University of Exeter; Centre for Environment Fisheries & Aquaculture Science	Michell, SL (corresponding author), Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter, Devon, England.	S.L.Michell@exeter.ac.uk	Lux, Thomas/AAB-4452-2019	Lux, Thomas/0000-0002-5543-1911	CEFAS-Exeter University Alliance PhD Studentship	CEFAS-Exeter University Alliance PhD Studentship	This work was funded by a CEFAS-Exeter University Alliance PhD Studentship awarded to SRC and SLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baker-Austin C, 2012, FOOD MICROBIOL, V30, P17, DOI 10.1016/j.fm.2011.09.002; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bernard CS, 2011, J BACTERIOL, V193, P2158, DOI 10.1128/JB.00029-11; Bier N, 2013, APPL ENVIRON MICROB, V79, P3570, DOI 10.1128/AEM.00477-13; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Gerc AJ, 2015, CELL REP, V12, P2131, DOI 10.1016/j.celrep.2015.08.053; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hwang W, 2011, INFECT IMMUN, V79, P4068, DOI 10.1128/IAI.05351-11; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Jeong HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002581; Jiang F, 2014, CELL HOST MICROBE, V15, P600, DOI 10.1016/j.chom.2014.04.010; Kitaoka M, 2011, J BACTERIOL, V193, P6471, DOI 10.1128/JB.05414-11; Kwak JS, 2011, P NATL ACAD SCI USA, V108, P1645, DOI 10.1073/pnas.1014339108; Liang XY, 2015, P NATL ACAD SCI USA, V112, P9106, DOI 10.1073/pnas.1505317112; Lu X, 2014, APPL ENVIRON MICROB, V80, P2029, DOI 10.1128/AEM.03588-13; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2012, J BIOL CHEM, V287, P15610, DOI 10.1074/jbc.M111.301630; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Maugeri TL, 2000, J APPL MICROBIOL, V89, P261, DOI 10.1046/j.1365-2672.2000.01096.x; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Ramamurthy T, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00091; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Salomon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061086; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; Thiaville PC, 2011, INFECT IMMUN, V79, P1194, DOI 10.1128/IAI.01031-10; Tietze R, 2015, BIOCHEM BIOPH RES CO, V468, P463, DOI 10.1016/j.bbrc.2015.08.022; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Unterweger D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4549; Wietz M, 2010, MAR DRUGS, V8, P2946, DOI 10.3390/md8122946; WRIGHT AC, 1990, INFECT IMMUN, V58, P1769, DOI 10.1128/IAI.58.6.1769-1773.1990	38	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165500	10.1371/journal.pone.0165500	http://dx.doi.org/10.1371/journal.pone.0165500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798649	Green Submitted, Green Published, gold			2022-12-26	WOS:000386711100041
J	Mezaal, YS; Ali, JK				Mezaal, Yaqeen S.; Ali, Jawad K.			Investigation of Dual-Mode Microstrip Bandpass Filter Based on SIR Technique	PLOS ONE			English	Article							RESONATORS; FREQUENCY	In this paper, a new bandpass filter design has been presented using simple topology of stepped impedance square loop resonator. The proposed bandpass filter has been simulated and fabricated using a substrate with an insulation constant of 10.8, thickness of 1.27mm and loss tangent of 0.0023 at center frequency of 5.8 GHz. The simulation results have been evaluated using Sonnet simulator that is extensively adopted in microwave analysis and implementation. The output frequency results demonstrated that the proposed filter has high-quality frequency responses in addition to isolated second harmonic frequency. Besides, this filter has very small surface area and perceptible narrow band response features that represent the conditions of recent wireless communication systems. Various filter specifications have been compared with different magnitudes of perturbation element dimension. Furthermore, phase scattering response and current intensity distribution of the proposed filter have been discussed. The simulated and experimental results are well-matched. Lastly, the features of the proposed filter have been compared with other designed microstrip filters in the literature.	[Mezaal, Yaqeen S.] Cankaya Univ, Elect & Commun Engn Dept, Ankara, Turkey; [Mezaal, Yaqeen S.] Al Esraa Univ Coll, Comp Engn Tech Dept, Baghdad, Iraq; [Ali, Jawad K.] Univ Technol Baghdad, Dept Elect Engn, Microwave Res Grp, Baghdad, Iraq	Cankaya University; Al-Esraa University College; University of Technology- Iraq	Mezaal, YS (corresponding author), Cankaya Univ, Elect & Commun Engn Dept, Ankara, Turkey.; Mezaal, YS (corresponding author), Al Esraa Univ Coll, Comp Engn Tech Dept, Baghdad, Iraq.	yakeen_sbah@yahoo.com	Ali, Jawad K./C-6710-2009; Mezaal, Yaqeen Sabah/O-5095-2019	Ali, Jawad K./0000-0002-6900-6844; Mezaal, Yaqeen Sabah/0000-0002-9953-9975	Scientific and Technological Research Council of Turkey (TUBITAK) [21514107-115.02-188888]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work is supported by the Scientific and Technological Research Council of Turkey (TUBITAK) for Post-Doc Research Fellowship for Foreign Citizens Program under Fund Reference (21514107-115.02-188888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ES, 2012, RADIO ENG J, V1, P617; El-Shaarawy HB, 2008, IEEE MICROW WIREL CO, V18, P500, DOI 10.1109/LMWC.2008.2000998; Eryilmaz GM, 2008, IET MICROW ANTENNA P, V2, P839, DOI 10.1049/iet-map:20070360; Erylmaz GM, 2009, MICROW OPT TECHN LET, V51, P147; Gorur A, 2014, 44 EUR MICR C EUMC, P1060; Gorur AK, 2011, 41 EUR MICR C EUMC, P468; Hong J.-S., 2011, MICROSTRIP FILTERS R, V2nd, DOI DOI 10.1109/MMW.2002.1028365; Huang CY, 2010, PROG ELECTROMAGN RES, V100, P299, DOI 10.2528/PIER09112701; Karpuz C, 2015, MICROW OPT TECHN LET, V57, P639, DOI 10.1002/mop.28914; Karpuz C, 2013, MICROW OPT TECHN LET, V55, P143, DOI 10.1002/mop.27237; Lugo C, 2003, 33RD EUROPEAN MICROWAVE CONFERENCE, VOLS 1-3, CONFERENCE PROCEEDINGS, P923; Makimoto M., 2000, MICROWAVE RESONATORS; Mezaal YS, 2014, IETE J RES, V60, P257, DOI 10.1080/03772063.2014.922018; Mezaal YS, 2014, PLOS ONE, P1; Mezaal YS, 2016, PLOS ONE, P1; Othman MA, 2013, INT J ENG TECHNOLOGY, V5, P3227; Pozar DM, 2012, MICROWAVE ENG; Razalli MS, 2008, PROG ELECTROMAGN RES, V88, P91, DOI 10.2528/PIER08102303; Singhal P. K., 2010, Journal of Electromagnetic Analysis and Applications, V2, P98, DOI 10.4236/jemaa.2010.22014; Zhang L, 2016, IET IMAGE PROCESS, P1, DOI [10.1049/iet-ipr.2015.0844, DOI 10.1049/IET-IPR.2015.0844]; Zheng X, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/983601	21	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0164916	10.1371/journal.pone.0164916	http://dx.doi.org/10.1371/journal.pone.0164916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798675	Green Published, gold			2022-12-26	WOS:000386711100016
J	Cooper, JR; Abdullatif, MB; Burnett, EC; Kempsell, KE; Conforti, F; Tolley, H; Collins, JE; Davies, DE				Cooper, James Ross; Abdullatif, Muhammad Bilal; Burnett, Edward C.; Kempsell, Karen E.; Conforti, Franco; Tolley, Howard; Collins, Jane E.; Davies, Donna E.			Long Term Culture of the A549 Cancer Cell Line Promotes Multilamellar Body Formation and Differentiation towards an Alveolar Type II Pneumocyte Phenotype	PLOS ONE			English	Article							EPITHELIAL-CELLS; STEM-CELLS; LUNG INJURY; PHOSPHOLIPID BIOSYNTHESIS; LAMELLAR BODIES; PROTEIN; EXPRESSION; SECRETION; AUTOPHAGY; MODEL	Pulmonary research requires models that represent the physiology of alveolar epithelium but concerns with reproducibility, consistency and the technical and ethical challenges of using primary or stem cells has resulted in widespread use of continuous cancer or other immortalized cell lines. The A549 `alveolar' cell line has been available for over four decades but there is an inconsistent view as to its suitability as an appropriate model for primary alveolar type II (ATII) cells. Since most work with A549 cells involves short term culture of proliferating cells, we postulated that culture conditions that reduced proliferation of the cancer cells would promote a more differentiated ATII cell phenotype. We examined A549 cell growth in different media over long term culture and then used microarray analysis to investigate temporal regulation of pathways involved in cell cycle and ATII differentiation; we also made comparisons with gene expression in freshly isolated human ATII cells. Analyses indicated that long term culture in Ham's F12 resulted in substantial modulation of cell cycle genes to result in a quiescent population of cells with significant up-regulation of autophagic, differentiation and lipidogenic pathways. There were also increased numbers of up-and down-regulated genes shared with primary cells suggesting adoption of ATII characteristics and multilamellar body (MLB) development. Subsequent Oil Red-O staining and Transmission Electron Microscopy confirmed MLB expression in the differentiated A549 cells. This work defines a set of conditions for promoting ATII differentiation characteristics in A549 cells that may be advantageous for studies with this cell line.	[Cooper, James Ross; Burnett, Edward C.] Publ Hlth England, Culture Collect, Salisbury, Wilts, England; [Cooper, James Ross; Conforti, Franco; Collins, Jane E.; Davies, Donna E.] Univ Southampton, Southampton Univ Hosp, Sir Henry Wellcome Labs, Acad Unit Clin & Expt Sci,Fac Med, Southampton, Hants, England; [Abdullatif, Muhammad Bilal; Kempsell, Karen E.] Publ Hlth England, Diagnost Technol, Salisbury, Wilts, England; [Davies, Donna E.] Southampton Univ Hosp, Natl Inst Hlth Res, Resp Biomed Res Unit, Southampton, Hants, England; [Tolley, Howard] Publ Hlth England, Microbiol Serv, Salisbury, Wilts, England	Public Health England; University of Southampton; Public Health England; University of Southampton; Public Health England	Cooper, JR (corresponding author), Publ Hlth England, Culture Collect, Salisbury, Wilts, England.; Cooper, JR (corresponding author), Univ Southampton, Southampton Univ Hosp, Sir Henry Wellcome Labs, Acad Unit Clin & Expt Sci,Fac Med, Southampton, Hants, England.	jim.cooper@phe.gov.uk	Kempsell, Karen/ABA-4635-2021	Davies, Donna/0000-0002-5117-2991; Kempsell, Karen/0000-0002-3059-9718; Collins, Jane/0000-0002-9914-3890	Pipeline Funding Board of Public Health England (PHE); Department of Health (England); British Lung Foundation [IPFPG12-2]	Pipeline Funding Board of Public Health England (PHE); Department of Health (England); British Lung Foundation	This study was funded by the Pipeline Funding Board of Public Health England (PHE) (at that time the organization was known as the Health Protection Agency (HPA)) as part of its 2012/13 call to fund studies which had the potential to aid life science research. The original bid title was: "Use of microarray analysis in the characterisation of HPACC cell lines for the presence of cell biomarkers". PHE like its predecessor HPA is an executive agency sponsored by the Department of Health (England). The funding was awarded to Dr Edward Burnett of the Culture Collections of PHE; a not for profit Bio-Resource within the PHE National Infections Service (NIS). Five of the authors (James R Cooper, Muhammad Abdullatif, Edward C Burnett, Karen E Kempsell and Howard Tolley) were employed by HPA/PHE during the study but they were not and never have been members of the Pipeline Funding Board. The HPA/PHE Pipeline Funding Board had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr Franco Confort's contribution was funded by the British Lung Foundation reference number IPFPG12-2.	Agassandian M, 2013, BBA-MOL CELL BIOL L, V1831, P612, DOI 10.1016/j.bbalip.2012.09.010; Anversa P, 2011, NAT MED, V17, P1038, DOI 10.1038/nm.2463; BALIS JU, 1984, EXP LUNG RES, V6, P197, DOI 10.3109/01902148409109248; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Cerrada A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110195; Copland IB, 2002, AM J RESP CELL MOL, V26, P261, DOI 10.1165/ajrcmb.26.3.f231; Corbiere V, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-15; Drakopanagiotakis F, 2008, EUR RESPIR J, V32, P1631, DOI 10.1183/09031936.00176807; du Bois RM, 2010, NAT REV DRUG DISCOV, V9, P129, DOI 10.1038/nrd2958; Fehrenbach H, 2012, EUR RESPIR J, V39, P240, DOI 10.1183/09031936.00162111; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Geraghty RJ, 2014, BRIT J CANCER, V111, P1021, DOI 10.1038/bjc.2014.166; Ghaedi M, 2014, BIOMATERIALS, V35, P699, DOI 10.1016/j.biomaterials.2013.10.018; Ghaedi M, 2013, J CLIN INVEST, V123, P4950, DOI 10.1172/JCI68793; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; Heijink IH, 2010, EUR RESPIR J, V35, P894, DOI 10.1183/09031936.00065809; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kelder T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006447; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kotton DN, 2008, CELL TISSUE RES, V331, P145, DOI 10.1007/s00441-007-0479-2; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lajoie P, 2005, J CELL SCI, V118, P1991, DOI 10.1242/jcs.02324; Liang CY, 2010, CURR OPIN CELL BIOL, V22, P226, DOI 10.1016/j.ceb.2009.11.003; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marx V, 2014, NAT METHODS, V11, P483, DOI 10.1038/nmeth.2932; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; MASON RJ, 1980, BIOCHIM BIOPHYS ACTA, V617, P36, DOI 10.1016/0005-2760(80)90222-2; McElroy MC, 2004, EUR RESPIR J, V24, P664, DOI 10.1183/09031936.04.00096003; Miyake Y, 2007, J IMMUNOL, V178, P5001, DOI 10.4049/jimmunol.178.8.5001; Mulugeta S, 2002, J BIOL CHEM, V277, P22147, DOI 10.1074/jbc.M201812200; NARDONE LL, 1979, BIOCHIM BIOPHYS ACTA, V573, P276, DOI 10.1016/0005-2760(79)90061-4; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; PINTO M, 1983, BIOL CELL, V47, P323; Rennard Stephen I, 2011, Proc Am Thorac Soc, V8, P368, DOI 10.1513/pats.201102-019RM; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rogers DF, 2001, HUMAN AIRWAY INFLAMM; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; SCHMITZ G, 1991, J LIPID RES, V32, P1539; Seo DC, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-75; SHAPIRO DL, 1978, BIOCHIM BIOPHYS ACTA, V530, P197, DOI 10.1016/0005-2760(78)90005-X; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; STRUNK RC, 1988, J CLIN INVEST, V81, P1419, DOI 10.1172/JCI113472; Swain RJ, 2010, BIOPHYS J, V98, P1703, DOI 10.1016/j.bpj.2009.12.4289; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551	56	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0164438	10.1371/journal.pone.0164438	http://dx.doi.org/10.1371/journal.pone.0164438			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792742	Green Submitted, Green Published, gold			2022-12-26	WOS:000389537000007
J	Hang, CY; Moriya, S; Ogawa, S; Parhar, IS				Hang, Chong Yee; Moriya, Shogo; Ogawa, Satoshi; Parhar, Ishwar S.			Deep Brain Photoreceptor (val-opsin) Gene Knockout Using CRISPR/Cas Affects Chorion Formation and Embryonic Hatching in the Zebrafish	PLOS ONE			English	Article							GLUTAMIC-ACID-DECARBOXYLASE; GOLDFISH CARASSIUS-AURATUS; PRIMORDIAL GERM-CELLS; CRYSTAL-STRUCTURE; LIGHT RESPONSE; MESSENGER-RNA; SYSTEM; MUTATIONS; EFFICIENT; FISH	Non-rod non-cone photopigments in the eyes and the brain can directly mediate non-visual functions of light in non-mammals. This was supported by our recent findings on vertebrate ancient long (VAL)-opsin photopigments encoded by the val-opsinA (valopa) and val-opsinB (valopb) genes in zebrafish. However, the physiological functions of valop isoforms remain unknown. Here, we generated valop-mutant zebrafish using CRISPR/Cas genome editing, and examined the phenotypes of loss-of-function mutants. F0 mosaic mutations and germline transmission were confirmed via targeted insertions and/or deletions in the valopa or valopb gene in F1 mutants. Based on in silico analysis, frameshift mutations converted VAL-opsin proteins to non-functional truncated forms with pre-mature stop codons. Most F1 eggs or embryos from F0 female valopa/b mutants showed either no or only partial chorion elevation, and the eggs or embryos died within 26 hour-post-fertilization. However, most F1 embryos from F0 male valopa mutant developed but hatched late compared to wild-type embryos, which hatched at 4 day-post-fertilization. Late-hatched F1 offspring included wild-type and mutants, indicating the parental effects of valop knockout. This study shows valop gene knockout affects chorion formation and embryonic hatching in the zebrafish.	[Hang, Chong Yee; Moriya, Shogo; Ogawa, Satoshi; Parhar, Ishwar S.] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Brain Res Inst, Bandar Sunway, Selangor, Malaysia	Monash University; Monash University Sunway	Parhar, IS (corresponding author), Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Brain Res Inst, Bandar Sunway, Selangor, Malaysia.	ishwar@monash.edu	Hang, Chong Yee/I-9267-2018; Ogawa, Satoshi/AAX-2908-2021	Hang, Chong Yee/0000-0002-7969-0467; Ogawa, Satoshi/0000-0001-6664-4448	Monash University Malaysia [M-3-08, TK-10-0, M-NEU-RS-014]; Malaysian Ministry of Higher Education [FRGS/2/2010/SG/MUSM/02/2, ERGS/1/2011/STG/MUSM/02/6, FRGS/1/2016/STG03/MUSM/01/1]	Monash University Malaysia(Monash University); Malaysian Ministry of Higher Education	This work was supported in part by grants from the Monash University Malaysia M-3-08, TK-10-0, and M-NEU-RS-014 and the Malaysian Ministry of Higher Education, FRGS/2/2010/SG/MUSM/02/2, ERGS/1/2011/STG/MUSM/02/6 and FRGS/1/2016/STG03/MUSM/01/1.	Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; Edvardsen RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108622; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Fischer RM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001585; Friedmann D, 2015, CURR BIOL, V25, P69, DOI 10.1016/j.cub.2014.10.055; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; Hamamoto Akie, 2012, Front Endocrinol (Lausanne), V3, P147, DOI 10.3389/fendo.2012.00147; Han S, 2010, AQUAT TOXICOL, V98, P256, DOI 10.1016/j.aquatox.2010.02.013; Hang CY, 2015, J NEUROCHEM, V133, P501, DOI 10.1111/jnc.13084; Hang CY, 2014, J COMP NEUROL, V522, P3847, DOI 10.1002/cne.23645; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jenkins A, 2003, CURR BIOL, V13, P1269, DOI 10.1016/S0960-9822(03)00509-8; Ji K, 2013, J HAZARD MATER, V254, P242, DOI 10.1016/j.jhazmat.2013.03.036; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KAH O, 1992, NEUROENDOCRINOLOGY, V55, P396, DOI 10.1159/000126150; Khan IA, 1999, NEUROENDOCRINOLOGY, V69, P261, DOI 10.1159/000054427; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kojima D, 2000, J NEUROSCI, V20, P2845; Kojima D, 2008, J NEUROCHEM, V104, P1364, DOI 10.1111/j.1471-4159.2007.05093.x; Kokel D, 2013, J NEUROSCI, V33, P3834, DOI 10.1523/JNEUROSCI.3689-12.2013; Lariviere K, 2005, MOL BRAIN RES, V141, P1, DOI 10.1016/j.molbrainres.2005.06.005; Lee J, 2011, ECOTOX ENVIRON SAFE, V74, P1216, DOI 10.1016/j.ecoenv.2011.03.014; Li MH, 2014, GENETICS, V197, P591, DOI 10.1534/genetics.114.163667; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mananos EL, 1999, NEUROENDOCRINOLOGY, V69, P269, DOI 10.1159/000054428; Martyniuk CJ, 2007, J NEUROENDOCRINOL, V19, P390, DOI 10.1111/j.1365-2826.2007.01543.x; Mei WY, 2009, DEVELOPMENT, V136, P3007, DOI 10.1242/dev.037879; Migaud H, 2010, J FISH BIOL, V76, P27, DOI 10.1111/j.1095-8649.2009.02500.x; Minamoto T, 2002, BIOCHEM BIOPH RES CO, V290, P280, DOI 10.1006/bbrc.2001.6186; Moutsaki P, 2000, FEBS LETT, V473, P316, DOI 10.1016/S0014-5793(00)01550-7; Nakane Y, 2014, CURR BIOL, V24, pR596, DOI 10.1016/j.cub.2014.05.038; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parhar I, 2012, PROG NEUROBIOL, V98, P176, DOI 10.1016/j.pneurobio.2012.05.011; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Pelegri F, 2004, DEV DYNAM, V231, P324, DOI 10.1002/dvdy.20145; Philp AR, 2000, J EXP BIOL, V203, P1925; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Solin SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13745; Tokumoto T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025206; Villamizar N, 2014, ZEBRAFISH, V11, P173, DOI 10.1089/zeb.2013.0926; Villamizar N, 2013, CHRONOBIOL INT, V30, P889, DOI 10.3109/07420528.2013.784772; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	60	6	6	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165535	10.1371/journal.pone.0165535	http://dx.doi.org/10.1371/journal.pone.0165535			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	27792783	Green Submitted, Green Published, gold			2022-12-26	WOS:000389537000028
J	Abdulla, CP; Alsaafani, MA; Alraddadi, TM; Albarakati, AM				Abdulla, C. P.; Alsaafani, M. A.; Alraddadi, T. M.; Albarakati, A. M.			Estimation of Mixed Layer Depth in the Gulf of Aden: A New Approach	PLOS ONE			English	Article							OCEAN; PACIFIC; IMPACT; VARIABILITY	The mixed layer depth (MLD) in Gulf of Aden is analyzed using vertical high resolution (1m) profiles of both temperature and density. Firstly, we examined threshold and gradient methods for estimating the MLD. Close evaluation with individual profiles reveals the failure of both methods for most of the profiles. Furthermore, the curvature method, a relatively recent approach to define ocean MLDs, is established for open water profiles but for marginal seas, like the Gulf of Aden, it detects shallower depths than the actual MLD. These considerable differences motivated us to introduce a new approach of MLD identification, which is developed based on curvature method and is called segment method. Our segment method produces adequate MLD estimates for more than 95% of the profiles and overcomes major limitations of conventional methods. It is less biased and least scattered compared to other methods with a correlation coefficient > 0.95. The mixed layer in Gulf of Aden displays significant seasonal variability and is deeper in winter. Throughout the year, the western part of gulf experiences deeper mixed layer than the eastern part. Regional eddies dominate Gulf of Aden's MLD pattern during all seasons.	[Abdulla, C. P.; Alsaafani, M. A.; Alraddadi, T. M.; Albarakati, A. M.] King Abdulaziz Univ, Fac Marine Sci, Dept Marine Phys, Jeddah, Saudi Arabia; [Alsaafani, M. A.] Sanaa Univ, Dept Earth & Environm Sci, Fac Sci, Sanaa, Yemen	King Abdulaziz University	Abdulla, CP (corresponding author), King Abdulaziz Univ, Fac Marine Sci, Dept Marine Phys, Jeddah, Saudi Arabia.	acp@stu.kau.edu.sa	Alsaafani, mohammed/O-4940-2019; Abdulla, Cheriyeri Poyil/AAO-8417-2020; Albarakati, Alaa M/N-8592-2013; Alsaafani, Mohammed A/I-6557-2013; Alraddadi, Turki/AAS-4202-2021	Alsaafani, mohammed/0000-0002-0307-5353; Albarakati, Alaa M/0000-0003-1094-0197; Alsaafani, Mohammed A/0000-0002-0307-5353; Alraddadi, Turki/0000-0002-9433-7477; Abdulla, Cheriyeri Poyil/0000-0002-3388-0716	Deanship of Graduate Studies, King Abdulaziz University	Deanship of Graduate Studies, King Abdulaziz University	ACP is grateful to the Deanship of Graduate Studies, King Abdulaziz University for providing the Ph. D. Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Saafani MA, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004020; Al Saafani M. A., 2008, THESIS; Saafani MA, 2007, J OCEANOGR, V63, P1, DOI 10.1007/s10872-007-0001-1; Alexander MA, 2000, J GEOPHYS RES-OCEANS, V105, P16823, DOI 10.1029/2000JC900074; Bower AS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015342; BRAINERD KE, 1995, DEEP-SEA RES PT I, V42, P1521, DOI 10.1016/0967-0637(95)00068-H; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; D'Ortenzio F, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022463; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Dong S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC004051; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Holte J, 2009, J ATMOS OCEAN TECH, V26, P1920, DOI 10.1175/2009JTECHO543.1; Houpert L, 2014, GEOPH RES ABSTR, V16, P15100, DOI [10.1016/j.pocean.2014.11.004, DOI 10.1016/J.POCEAN.2014.11.004]; Johns W, 2001, TECH REP, P54; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Kara AB, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000736; Le Traon PY, 1999, J ATMOS OCEAN TECH, V16, P1208; Lim S, 2012, J MARINE SYST, V96-97, P1, DOI 10.1016/j.jmarsys.2012.01.003; Lorbacher K, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2003JC002157; Peters H, 2005, J PHYS OCEANOGR, V35, P584, DOI 10.1175/JPO2689.1; Polovina JJ, 1995, DEEP-SEA RES PT I, V42, P1701, DOI 10.1016/0967-0637(95)00075-H; ROBINSON CLK, 1993, J PLANKTON RES, V15, P161, DOI 10.1093/plankt/15.2.161; SUTTON PJ, 1993, J ACOUST SOC AM, V94, P1517, DOI 10.1121/1.408128; Thomson RE, 2003, J ATMOS OCEAN TECH, V20, P319, DOI 10.1175/1520-0426(2003)020<0319:EMLDFO>2.0.CO;2; Wijesekera HW, 1996, J GEOPHYS RES-OCEANS, V101, P977, DOI 10.1029/95JC02553; Zeng L, 2000, DYNAM ATMOS OCEANS, V47, P38; Zeng LL, 2017, CLIM DYNAM, V48, P1911, DOI 10.1007/s00382-016-3182-8	27	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165136	10.1371/journal.pone.0165136	http://dx.doi.org/10.1371/journal.pone.0165136			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788181	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900047
J	Cherrak, SA; Mokhtari-Soulimane, N; Berroukeche, F; Bensenane, B; Cherbonnel, A; Merzouk, H; Elhabiri, M				Cherrak, Sabri Ahmed; Mokhtari-Soulimane, Nassima; Berroukeche, Farid; Bensenane, Bachir; Cherbonnel, Angeline; Merzouk, Hafida; Elhabiri, Mourad			In Vitro Antioxidant versus Metal Ion Chelating Properties of Flavonoids: A Structure-Activity Investigation	PLOS ONE			English	Article							OXIDATIVE STRESS; DIETARY FLAVONOIDS; PHENOLIC-COMPOUNDS; HYDROGEN-PEROXIDE; MECHANISM; IRON; IRON(III); CHEMISTRY; COPPER; QUERCETIN	Natural flavonoids such as quercetin, (+) catechin and rutin as well as four methoxylated derivatives of quercetin used as models were investigated to elucidate their impact on the oxidant and antioxidant status of human red blood cells (RBCs). The impact of these compounds against metal toxicity was studied as well as their antiradical activities with DPPH assay. Antihemolytic experiments were conducted on quercetin, (+) catechin and rutin with excess of Fe, Cu and Zn (400 mu M), and the oxidant (malondialdehyde, carbonyl proteins) and antioxidant (reduced glutathione, catalase activity) markers were evaluated. The results showed that Fe and Zn have the highest prooxidant effect (37 and 33% of hemolysis, respectively). Quercetin, rutin and (+) catechin exhibited strong antioxidant properties toward Fe, but this effect was decreased with respect to Zn ions. However, the Cu showed a weak antioxidant effect at the highest flavonoid concentration (200 mu M), while a prooxidant effect was observed at the lowest flavonoid concentration (100 mu M). These results are in agreement with the physico-chemical and antiradical data which demonstrated that binding of the metal ions (for FeNTA: (+) Catechin, KLFeNTA = 1.0(7) x 10(6) M-1 > Rutin, KLFeNTA = 2.0(9) x 10(5) M-1 > Quercetin, K-LFeNTA = 1.0(7) x 10(5) M-1 > Q35OH, K-LFeNTA = 6.3(8.7) x 10(4) M-1 > Quercetin3'4'OH and Quercetin 3OH, K-LFeNTA similar to 2 x 10(4) M-1) reflects the (anti) oxidant status of the RBCs. This study reveals that flavonoids have both prooxidant and antioxidant activity depending on the nature and concentration of the flavonoids and metal ions.	[Cherrak, Sabri Ahmed; Mokhtari-Soulimane, Nassima; Berroukeche, Farid; Bensenane, Bachir; Merzouk, Hafida] Abou Bekr Belkaid Univ, Lab Physiol Pathophysiol & Biochem Nutr, Dept Biol, Fac Nat & Life Sci Earth & Universe, Tilimsen 13000, Algeria; [Cherbonnel, Angeline; Elhabiri, Mourad] ECPM, Lab Bioorgan & Med Chem, UMR 7509, CNRS, 25 Rue Becquerel, F-67200 Strasbourg, France	Universite Abou Bekr Belkaid; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mokhtari-Soulimane, N (corresponding author), Abou Bekr Belkaid Univ, Lab Physiol Pathophysiol & Biochem Nutr, Dept Biol, Fac Nat & Life Sci Earth & Universe, Tilimsen 13000, Algeria.; Elhabiri, M (corresponding author), ECPM, Lab Bioorgan & Med Chem, UMR 7509, CNRS, 25 Rue Becquerel, F-67200 Strasbourg, France.	nassima_amel@yahoo.fr; elhabiri@unistra.fr	Cherrak, Sabri Ahmed/ABD-6356-2020; Mourad, ELHABIRI/AAR-5501-2021; mokhtari, nassima/F-7775-2013	nassima, mokhtari soulimane/0000-0002-6934-5168; Farid, Berroukeche/0000-0003-4244-6871; Cherrak, Sabri Ahmed/0000-0002-5079-9661	French Algerian Cooperation Program PHC Tassili International Research Extension Grant [TASSI LI 13MDU892]; French Foreign Office (Campus France); CNRS [UMR 7509]; University of Tlemcen (University Abou Bekr Belkaid)	French Algerian Cooperation Program PHC Tassili International Research Extension Grant; French Foreign Office (Campus France); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Tlemcen (University Abou Bekr Belkaid)	This work was supported by the French Algerian Cooperation Program PHC Tassili International Research Extension Grant TASSI LI 13MDU892 and the French Foreign Office (Campus France). This work was partly supported by the CNRS (UMR 7509) and the University of Tlemcen (University Abou Bekr Belkaid).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Akahori A, 1999, BIOCHEM MOL BIOL INT, V47, P89; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Baccarin T, 2015, TOXICOL IN VITRO, V30, P421, DOI 10.1016/j.tiv.2015.09.020; Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; BASTIAN R, 1956, ANAL CHEM, V28, P459, DOI 10.1021/ac50161a014; Birt DF, 2001, PHARMACOL THERAPEUT, V90, P157, DOI 10.1016/S0163-7258(01)00137-1; Bourassa P, 2013, J PHOTOCH PHOTOBIO B, V128, P43, DOI 10.1016/j.jphotobiol.2013.07.021; Brandel J, 2012, DALTON T, V41, P2820, DOI 10.1039/c1dt11804h; Burda S, 2001, J AGR FOOD CHEM, V49, P2774, DOI 10.1021/jf001413m; Carroll Carlos, 2005, P1; Cesquini M, 2003, BIOMED PHARMACOTHER, V57, P124, DOI 10.1016/S0753-3322(03)00018-0; Chahine JME, 1996, J CHIM PHYS PCB, V93, P283; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chen K, 2003, FREE RADICAL BIO MED, V35, P117, DOI 10.1016/S0891-5849(03)00239-9; CHIMI H, 1995, TOXICOL IN VITRO, V9, P695, DOI 10.1016/0887-2333(95)00060-L; Chvatalova K, 2008, FOOD CHEM, V106, P650, DOI 10.1016/j.foodchem.2007.06.028; Correa JF, 2000, ALLELOPATHY J, V7, P225; DAS PK, 1989, J COORD CHEM, V19, P311, DOI 10.1080/00958978909408834; DAVIES IJT, 1968, J CLIN PATHOL, V21, P359, DOI 10.1136/jcp.21.3.359; Davis AL, 1996, MAGN RESON CHEM, V34, P887, DOI 10.1002/(SICI)1097-458X(199611)34:11<887::AID-OMR995>3.0.CO;2-U; Dehghan G, 2012, FOOD CHEM, V131, P422, DOI 10.1016/j.foodchem.2011.08.074; DELMASBEAUVIEUX MC, 1995, CLIN BIOCHEM, V28, P163, DOI 10.1016/0009-9120(94)00071-3; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; El Hajji H, 2006, FREE RADICAL RES, V40, P303, DOI 10.1080/10715760500484351; Elhabiri M, 2007, INORG CHIM ACTA, V360, P353, DOI 10.1016/j.ica.2006.07.110; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FALLER B, 1994, J AM CHEM SOC, V116, P3860, DOI 10.1021/ja00088a022; Florani M, 2003, FREE RADICAL RES, V37, P1331, DOI 10.1080/10715760310001615998; Gabricevic M, 2004, BIOCHEMISTRY-US, V43, P5811, DOI 10.1021/bi036217y; Gabricevic M, 2003, INORG CHEM, V42, P4098, DOI 10.1021/ic026281o; GAMPP H, 1985, TALANTA, V32, P257, DOI 10.1016/0039-9140(85)80077-1; Geoghegan F, 2010, PHYTOTHER RES, V24, P817, DOI 10.1002/ptr.3014; Ghavami S, 2008, J CELL MOL MED, V12, P1005, DOI 10.1111/j.1582-4934.2008.00129.x; Gil ES, 2013, REV BRAS FARMACOGN, V23, P542, DOI 10.1590/S0102-695X2013005000031; Goupy P, 2003, J AGR FOOD CHEM, V51, P615, DOI 10.1021/jf025938l; Haase H, 2015, METALLOMICS, V7, P97, DOI 10.1039/c4mt00206g; Han Y, 2015, EUR J MED CHEM, V92, P732, DOI 10.1016/j.ejmech.2015.01.017; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; Hayder N, 2008, TOXICOL IN VITRO, V22, P567, DOI 10.1016/j.tiv.2007.11.015; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Hippeli S, 1999, FEBS LETT, V443, P1, DOI 10.1016/S0014-5793(98)01665-2; Hosainzadeh A, 2012, J BIOMOL STRUCT DYN, V29, P1013, DOI 10.1080/073911012010525029; Ignat I, 2011, FOOD CHEM, V126, P1821, DOI 10.1016/j.foodchem.2010.12.026; Ilbert M, 2013, BBA-BIOENERGETICS, V1827, P161, DOI 10.1016/j.bbabio.2012.10.001; Iwasaki Y, 2011, TOXICOL IN VITRO, V25, P1320, DOI 10.1016/j.tiv.2011.04.024; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Jones-Lee A, 2005, REMEDIATION, V16, P33, DOI 10.1002/rem.20068; JURD L, 1962, J ORG CHEM, V27, P872, DOI 10.1021/jo01050a044; Kabel AM, 2014, WORLD J NUTR HLTH, V2, P35, DOI DOI 10.12691/JNH-2-3-2; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kim GN, 2011, TOXICOL IN VITRO, V25, P138, DOI 10.1016/j.tiv.2010.10.005; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Leopoldini M, 2011, FOOD CHEM, V125, P288, DOI 10.1016/j.foodchem.2010.08.012; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Liochev SI, 2002, REDOX REP, V7, P55, DOI 10.1179/135100002125000190; Lourenco RMDC, 2013, ANTIFUNGAL METABOLIT, P283; Mabile L, 2001, AM J CLIN NUTR, V74, P449; MAEDER M, 1990, ANAL CHEM, V62, P2220, DOI 10.1021/ac00219a013; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mehta R, 2011, TOXICOL IN VITRO, V25, P1114, DOI 10.1016/j.tiv.2011.03.015; Memarpoor-Yazdi M, 2012, J FUNCT FOODS, V4, P278, DOI 10.1016/j.jff.2011.12.004; Mira L, 2002, FREE RADICAL RES, V36, P1199, DOI 10.1080/1071576021000016463; Moon YJ, 2006, TOXICOL IN VITRO, V20, P187, DOI 10.1016/j.tiv.2005.06.048; Moosavi-Movahedi AA, 2003, BIOORGAN MED CHEM, V11, P4303, DOI 10.1016/S0968-0896(03)00524-8; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Nowack B, 2002, ENVIRON SCI TECHNOL, V36, P4009, DOI 10.1021/es025683s; Nowak D, 2010, STRUCT CHEM, V21, P323, DOI 10.1007/s11224-009-9531-z; Nygaard Sanne Bjorn, 2014, BMC Res Notes, V7, P84, DOI 10.1186/1756-0500-7-84; Palaniandavar M, 2006, J CHEM SCI, V118, P601, DOI 10.1007/BF02703959; Perron NR, 2011, J INORG BIOCHEM, V105, P745, DOI 10.1016/j.jinorgbio.2011.02.009; Perron NR, 2010, DALTON T, V39, P9982, DOI 10.1039/c0dt00752h; Pham AN, 2013, J CATAL, V301, P54, DOI 10.1016/j.jcat.2013.01.025; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040; Prochazkova D, 2011, FITOTERAPIA, V82, P513, DOI 10.1016/j.fitote.2011.01.018; Prousek J, 2007, PURE APPL CHEM, V79, P2325, DOI 10.1351/pac200779122325; Psotova Jitka, 2003, Biomedical Papers (Olomouc), V147, P147; Raymond K., 1983, TRAGIC CONSEQUENCE A, P4; Rice-Evans C., 1990, BLOOD CELL BIOCH, P429; ROBAK J, 1988, BIOCHEM PHARMACOL, V37, P837, DOI 10.1016/0006-2952(88)90169-4; Robbins MH, 1997, J CATAL, V170, P295, DOI 10.1006/jcat.1997.1754; Rodriguez-Mateos A, 2014, ARCH TOXICOL, V88, P1803, DOI 10.1007/s00204-014-1330-7; Salunke BK, 2005, CROP PROT, V24, P888, DOI 10.1016/j.cropro.2005.01.013; Sanchiz J, 1999, INORG CHIM ACTA, V291, P158, DOI 10.1016/S0020-1693(99)00125-5; Schneider HJ, 2009, ANGEW CHEM INT EDIT, V48, P3924, DOI 10.1002/anie.200802947; Shi ZH, 2012, EUR J MED CHEM, V54, P210, DOI 10.1016/j.ejmech.2012.04.044; Speisky H, 2009, BIOORGAN MED CHEM, V17, P1803, DOI 10.1016/j.bmc.2009.01.069; Symonowicz M., 2012, FOOD SCI BIOTECHNOL, V76, P35, DOI DOI 10.1016/0162-0134(89)84042-5; Tanzadehpanah H, 2012, FOOD RES INT, V49, P105, DOI 10.1016/j.foodres.2012.08.022; Wilms LC, 2008, TOXICOL IN VITRO, V22, P301, DOI 10.1016/j.tiv.2007.09.002; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	93	127	131	9	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165575	10.1371/journal.pone.0165575	http://dx.doi.org/10.1371/journal.pone.0165575			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788249	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900110
J	Ferrer, MD; Mestre-Alfaro, A; Martinez-Tome, M; Carrera-Quintanar, L; Capo, X; Jimenez-Monreal, AM; Garcia-Diz, L; Roche, E; Murcia, MA; Tur, JA; Pons, A				Ferrer, Miguel D.; Mestre-Alfaro, Antonia; Martinez-Tome, Magdalena; Carrera-Quintanar, Lucrecia; Capo, Xavier; Jimenez-Monreal, Antonia M.; Garcia-Diz, Luis; Roche, Enrique; Murcia, Maria A.; Tur, Josep A.; Pons, Antoni			Haem Biosynthesis and Antioxidant Enzymes in Circulating Cells of Acute Intermittent Porphyria Patients	PLoS One			English	Article							VARIEGATE PORPHYRIA; OXIDATIVE STRESS; HEPATIC PORPHYRIAS; NUTRITIONAL-STATUS; DEFENSES; SUPPLEMENTATION; NEUTROPHILS; EXERCISE; DAMAGE	The aims of the present study were to explore the expression pattern of haem biosynthesis enzymes in circulating cells of patients affected by two types of porphyria (acute intermittent, AIP, and variegate porphyria, VP), together with the antioxidant enzyme pattern in AIP in order to identify a possible situation of oxidative stress. Sixteen and twelve patients affected by AIP and VP, respectively, were analysed with the same numbers of healthy matched controls. Erythrocytes, neutrophils and peripheral blood mononuclear cells (PBMCs) were purified from blood, and RNA and proteins were extracted for quantitative real time PCR (qRT-PCR) and Western-blot analysis, respectively. Porhobilinogen deaminase (PBGD) and protoporphyrinogen oxidase (PPOX) gene and protein expression was analysed. Antioxidant enzyme activity and gene expression were additionally determined in blood cells, together with protein carbonyl content in plasma. PBMCs isolated from AIP patients presented low mRNA levels of PBGD when compared to controls, while PBMCs isolated from VP patients presented a decrease in PPOX mRNA. PPOX protein content was higher in AIP patients and lower in VP patients, compared to healthy controls. Regarding antioxidant enzymes, PBMCs and erythrocyte superoxide dismutase (SOD) presented statistically significant higher activity in AIP patients compared to controls, while catalase activity tended to be lower in these patients. No differences were observed regarding antioxidant gene expression in white blood cells. Circulating cells in AIP and VP patients present altered expression of haem biosynthetic enzymes, which could be useful for the differential diagnosis of these two types of porphyria in certain difficult cases. AIP patients present a condition of potential oxidative stress similar to VP patients, evidenced by the post-transcriptional activation of SOD and possible catalase impairment.	[Ferrer, Miguel D.; Mestre-Alfaro, Antonia; Capo, Xavier; Tur, Josep A.; Pons, Antoni] Univ Balearic Isl, Lab Phys Act Sci, Res Grp Community Nutr & Oxidat Stress, Dept Basic Biol & Hlth Sci,IUNICS, Palma De Mallorca, Spain; [Martinez-Tome, Magdalena; Jimenez-Monreal, Antonia M.; Murcia, Maria A.] Univ Murcia, Dept Nutr & Food Sci, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain; [Carrera-Quintanar, Lucrecia; Roche, Enrique] Univ Miguel Hernandez, Biochem & Cell Therapy Unit, Inst Bioengn, Elche, Spain; [Garcia-Diz, Luis] Univ Complutense Madrid, Dept Nutr 1, Madrid, Spain; [Ferrer, Miguel D.; Mestre-Alfaro, Antonia; Martinez-Tome, Magdalena; Capo, Xavier; Jimenez-Monreal, Antonia M.; Roche, Enrique; Murcia, Maria A.; Tur, Josep A.; Pons, Antoni] Inst Salud Carlos III, CIBEROBN Fisiopatol Obesidad & Nutr 03 30038 CB12, Madrid, Spain	Universitat de les Illes Balears; University of Murcia; Universidad Miguel Hernandez de Elche; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Pons, A (corresponding author), Univ Balearic Isl, Lab Phys Act Sci, Res Grp Community Nutr & Oxidat Stress, Dept Basic Biol & Hlth Sci,IUNICS, Palma De Mallorca, Spain.; Pons, A (corresponding author), Inst Salud Carlos III, CIBEROBN Fisiopatol Obesidad & Nutr 03 30038 CB12, Madrid, Spain.	antonipons@uib.es	Capó, Xavier/AAD-6322-2022; Tur, Josep/AAE-5748-2020; Reynés, Miguel David Ferrer/J-4206-2019; Pons, Antoni/L-4844-2014; Capò, Xavier/AAL-4246-2020; Carrera, Lucrecia/L-9168-2019; Roche, Enrique/V-5738-2017	Capó, Xavier/0000-0002-3499-5494; Tur, Josep/0000-0002-6940-0761; Reynés, Miguel David Ferrer/0000-0003-1924-7727; Pons, Antoni/0000-0003-2447-3868; Roche, Enrique/0000-0001-5128-1672; Jimenez Monreal, Antonia Maria/0000-0003-2543-0843; Martinez-Tome, Magdalena/0000-0003-2361-0170; Murcia, M. Antonia/0000-0001-5772-581X	Accion Estrategica en Salud del Ministro de Ciencia e Innovacion [DPS2008-07033-C03-03]; Programme of Promotion of Biomedical Research and Health Sciences [11/01791, Red Predimed-RETIC RD06/0045/1004, CIBERobn CB12/03/30038]; Balearic Island Government; FEDER funds [35/2011, 23/2012]; Generalitat Valenciana [PROMETEO/2012/007]; Institute de Salud Carlos III-FEDER [PS09/01093]; Fundacion Salud Merck Serono grants; CONACYT-Mexico [197139]	Accion Estrategica en Salud del Ministro de Ciencia e Innovacion; Programme of Promotion of Biomedical Research and Health Sciences; Balearic Island Government; FEDER funds(European Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Institute de Salud Carlos III-FEDER; Fundacion Salud Merck Serono grants; CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work has been granted by "Accion Estrategica en Salud del Ministro de Ciencia e Innovacion" (DPS2008-07033-C03-03), Programme of Promotion of Biomedical Research and Health Sciences, Projects 11/01791, Red Predimed-RETIC RD06/0045/1004, CIBERobn CB12/03/30038, Balearic Island Government and FEDER funds (35/2011 and 23/2012), PROMETEO/2012/007 from Generalitat Valenciana to ER. ER is recipient of Institute de Salud Carlos III-FEDER (PS09/01093) and Fundacion Salud 2000-Merck Serono grants. LC-Q was recipient of a CONACYT-Mexico (ref 197139) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been granted by "Accion Estrategica en Salud del Ministro de Ciencia e Innovacion" (DPS2008-07033-C03-03), Programme of Promotion of Biomedical Research and Health Sciences, Projects 11/01791, Red Predimed-RETIC RD06/0045/1004, CIBERobn CB12/03/30038, Balearic Island Government and FEDER funds (35/2011 and 23/2012), PROMETEO/2012/007 from Generalitat Valenciana to ER. ER is recipient of Instituto de Salud Carlos IIIFEDER (PS09/01093) and Fundacion Salud 2000-Merck Serono grants. LC-Q was recipient of a CONACYT-Mexico (ref 197139) fellowship.	Abiles J, 2008, NUTR HOSP, V23, P332; Aguilo A, 2005, PHYSIOL BEHAV, V84, P1, DOI 10.1016/j.physbeh.2004.07.034; Badminton MN, 2005, J INHERIT METAB DIS, V28, P277, DOI 10.1007/s10545-005-8050-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Diez B, 2009, CELL MOL BIOL, V55, P15, DOI 10.1170/T847; Dwyer BE, 2009, NEUROSCI LETT, V460, P180, DOI 10.1016/j.neulet.2009.05.058; Ferrer MD, 2007, FREE RADICAL RES, V41, P274, DOI 10.1080/10715760601080371; Ferrer MD, 2013, EUR J CLIN INVEST, V43, P668, DOI 10.1111/eci.12091; Ferrer MD, 2010, BRIT J HAEMATOL, V149, P759, DOI 10.1111/j.1365-2141.2010.08149.x; Ferrer MD, 2010, BRIT J NUTR, V103, P69, DOI 10.1017/S0007114509991413; Ferrer MD, 2009, REDOX REP, V14, P69, DOI 10.1179/135100009X392502; Garcia-Diz L, 2012, EUR J CLIN INVEST, V42, P943, DOI 10.1111/j.1365-2362.2012.02673.x; Gordon N, 1999, BRAIN DEV-JPN, V21, P373, DOI 10.1016/S0387-7604(99)00041-8; Ito S, 2009, FREE RADICAL RES, V43, P1214, DOI 10.3109/10715760903271249; Jimenez-Monreal AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001023; Tome MJM, 2011, NUTR HOSP, V26, P1175, DOI [10.1590/S0212-16112011000500038, 10.3305/nh.2011.26.5.5207]; MONTEIRO HP, 1989, ARCH BIOCHEM BIOPHYS, V271, P206, DOI 10.1016/0003-9861(89)90271-3; Nordmann Y, 2002, CLIN CHIM ACTA, V325, P17, DOI 10.1016/S0009-8981(02)00276-0; Romaguera D, 2006, ANN NUTR METAB, V50, P442, DOI 10.1159/000094719; SASSA S, 1990, INT J CELL CLONING, V8, P10, DOI 10.1002/stem.5530080104; Sassa S, 2000, INT J HEMATOL, V71, P1; Siegesmund M, 2010, BEST PRACT RES CL GA, V24, P593, DOI 10.1016/j.bpg.2010.08.010; Sureda A, 2004, FREE RADICAL BIO MED, V37, P1744, DOI 10.1016/j.freeradbiomed.2004.07.033; Tauler P, 2006, EUR J NUTR, V45, P187, DOI 10.1007/s00394-005-0582-7; THUNELL S, 1995, EUR J CLIN CHEM CLIN, V33, P179	25	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0164857	10.1371/journal.pone.0164857	http://dx.doi.org/10.1371/journal.pone.0164857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788171	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900030
J	Gross, M; Magar, V				Gross, Markus; Magar, Vanesa			Offshore Wind Energy Climate Projection Using UPSCALE Climate Data under the RCP8.5 Emission Scenario	PLoS One			English	Article							UNITED-STATES; POWER RESOURCES; MODEL	In previous work, the authors demonstrated how data from climate simulations can be utilized to estimate regional wind power densities. In particular, it was shown that the quality of wind power densities, estimated from the UPSCALE global dataset in offshore regions of Mexico, compared well with regional high resolution studies. Additionally, a link between surface temperature and moist air density in the estimates was presented. UPSCALE is an acronym for UK on PRACE (the Partnership for Advanced Computing in Europe) weather-resolving Simulations of Climate for globAL Environmental risk. The UPSCALE experiment was performed in 2012 by NCAS (National Centre for Atmospheric Science) Climate, at the University of Reading and the UK Met Office Hadley Centre. The study included a 25.6-year, five-member ensemble simulation of the HadGEM3 global atmosphere, at 25km resolution for present climate conditions. The initial conditions for the ensemble runs were taken from consecutive days of a test configuration. In the present paper, the emphasis is placed on the single climate run for a potential future climate scenario in the UPSCALE experiment dataset, using the Representation Concentrations Pathways (RCP) 8.5 climate change scenario. Firstly, some tests were performed to ensure that the results using only one instantiation of the current climate dataset are as robust as possible within the constraints of the available data. In order to achieve this, an artificial time series over a longer sampling period was created. Then, it was shown that these longer time series provided almost the same results than the short ones, thus leading to the argument that the short time series is sufficient to capture the climate. Finally, with the confidence that one instantiation is sufficient, the future climate dataset was analysed to provide, for the first time, a projection of future changes in wind power resources using the UPSCALE dataset. It is hoped that this, in turn, will provide some guidance for wind power developers and policy makers to prepare and adapt for climate change impacts on wind energy production. Although offshore locations around Mexico were used as a case study, the dataset is global and hence the methodology presented can be readily applied at any desired location.	[Gross, Markus; Magar, Vanesa] Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Fis, Ensenada, BC, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Gross, M (corresponding author), Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Fis, Ensenada, BC, Mexico.	mgross@cicese.mx	Magar, Vanesa/AEK-2907-2022; Gross, Markus/A-4665-2009; Magar, Vanesa/O-2103-2019	Gross, Markus/0000-0003-0802-8385; Magar, Vanesa/0000-0002-7897-1507	NERC; Met Office; PRACE Research Infrastructure resource HERMIT based in Germany at High Performance Computing Center Stuttgart (HLRS)	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Met Office; PRACE Research Infrastructure resource HERMIT based in Germany at High Performance Computing Center Stuttgart (HLRS)	This work is based on the UPSCALE dataset licensed from the University of Reading which includes material from Natural Environment Research Council (NERC) and the Controller of Her Majesty's Stationery Office (HMSO) & Queen's Printer. The UPSCALE dataset was created by P. L. Vidale, M. Roberts, M. Mizielinski, J. Strachan, M.E. Demory and R. Schiemann using the HadGEM3 model with support from NERC and the Met Office and the PRACE Research Infrastructure resource HERMIT based in Germany at High Performance Computing Center Stuttgart (HLRS).	Breslow PB, 2002, RENEW ENERG, V27, P585, DOI 10.1016/S0960-1481(01)00110-0; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Donlon CJ, 2012, REMOTE SENS ENVIRON, V116, P140, DOI 10.1016/j.rse.2010.10.017; Edenhofer O., 2011, IPCC SPECIAL REPORT; Gross MS, 2015, ENERGY SCI ENG, V3, P342, DOI 10.1002/ese3.76; Jones CD, 2011, GEOSCI MODEL DEV, V4, P543, DOI 10.5194/gmd-4-543-2011; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mizielinski MS, 2014, GEOSCI MODEL DEV, V7, P1629, DOI 10.5194/gmd-7-1629-2014; Moss R., 2008, NEW SCENARIOS ANAL E; Nebojsa N., 2000, EMISSIONS SCENARIOS; Pryor SC, 2011, P NATL ACAD SCI USA, V108, P8167, DOI 10.1073/pnas.1019388108; Pryor SC, 2010, RENEW SUST ENERG REV, V14, P430, DOI 10.1016/j.rser.2009.07.028; Pryor SC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026000; Pryor SC, 2005, CLIM DYNAM, V25, P815, DOI 10.1007/s00382-005-0072-x; Sailor DJ, 2008, RENEW ENERG, V33, P2393, DOI 10.1016/j.renene.2008.01.007; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Walters DN, 2011, GEOSCI MODEL DEV, V4, P919, DOI 10.5194/gmd-4-919-2011; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	18	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165423	10.1371/journal.pone.0165423	http://dx.doi.org/10.1371/journal.pone.0165423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788208	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900081
J	Kuniyoshi, Y; Maehara, K; Iwasaki, T; Hayashi, M; Semba, Y; Fujita, M; Sato, Y; Kimura, H; Harada, A; Ohkawa, Y				Kuniyoshi, Yuki; Maehara, Kazumitsu; Iwasaki, Takeshi; Hayashi, Masayasu; Semba, Yuichiro; Fujita, Masatoshi; Sato, Yuko; Kimura, Hiroshi; Harada, Akihito; Ohkawa, Yasuyuki			Identification of Immunoglobulin Gene Sequences from a Small Read Number of mRNA-Seq Using Hybridomas	PLoS One			English	Article							RAT MONOCLONAL-ANTIBODY; VARIABLE DOMAINS; CELL-LINES; MOUSE; PRIMERS; SYSTEM; CDNA	Identification of immunoglobulin genes in hybridomas is essential for producing antibodies for research and clinical applications. A couple of methods such as RACE and degenerative PCR have been developed for determination of the Igh and IgI/Igk coding sequences (CDSs) but it has been difficult to process a number of hybridomas both with accuracy and rapidness. Here, we propose a new strategy for antibody sequence determination by mRNA-seq of hybridomas. We demonstrated that hybridomas highly expressed the Igh and Igl/Igk genes and that de novo transcriptome assembly using mRNA-seq data enabled identification of the CDS of both Igh and IgI/Igk accurately. Furthermore, we estimated that only 30,000 sequenced reads are required to identify immunoglobulin sequences from four different hybridoma clones. Thus, our approach would facilitate determining variable CDSs drastically.	[Kuniyoshi, Yuki; Maehara, Kazumitsu; Iwasaki, Takeshi; Hayashi, Masayasu; Semba, Yuichiro; Harada, Akihito; Ohkawa, Yasuyuki] Kyushu Univ, Med Inst Bioregulat, Div Transcript, Fukuoka, Japan; [Kuniyoshi, Yuki; Fujita, Masatoshi] Kyushu Univ, Dept Cellular Biochem, Grad Sch Pharmaceut Sci, Fukuoka, Japan; [Sato, Yuko; Kimura, Hiroshi] Tokyo Inst Technol, Dept Biol Sci, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa, Japan	Kyushu University; Kyushu University; Tokyo Institute of Technology	Ohkawa, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Transcript, Fukuoka, Japan.	yohkawa@bioreg.kyushu-u.ac.jp	Ohkawa, Yasuyuki/C-4087-2016; Kimura, Hiroshi/B-9524-2015; 優子, 佐藤/GOH-1956-2022; Ohkawa, Yasuyuki/ABG-1839-2021	Ohkawa, Yasuyuki/0000-0001-6440-9954; Kimura, Hiroshi/0000-0003-0854-083X; Ohkawa, Yasuyuki/0000-0001-6440-9954; Fujita, Masatoshi/0000-0001-6617-2452; Maehara, Kazumitsu/0000-0002-2933-5176; Iwasaki, Takeshi/0000-0001-5277-2932	Core Research for Evolutional Science and Technology (CREST); Japan Society for the Promotion of Science (JSPS) KAKENHI [23310134, 25116010, 25132709, 25118518, 26290064]; JSPS KAKENHI [15K18457, 16H01219, 16K18479, 16H01577, 16H01550]; Grants-in-Aid for Scientific Research [16K18479] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology (CREST) (http://www.jst.go.jp/kisoken/crest/) and open access charge: Japan Society for the Promotion of Science (JSPS) KAKENHI [grant numbers 23310134, 25116010, 25132709, 25118518, 26290064] (https://www.jsps.go.jp). We have had the support from the updated grants (JSPS KAKENHI: 15K18457, 16H01219, 16K18479, 16H01577, 16H01550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doenecke A, 1997, LEUKEMIA, V11, P1787, DOI 10.1038/sj.leu.2400781; DUBEL S, 1994, J IMMUNOL METHODS, V175, P89, DOI 10.1016/0022-1759(94)90334-4; Elgert K.D., 1996, IMMUNOLOGY UNDERSTAN, P58; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gura T, 2002, NATURE, V417, P584, DOI 10.1038/417584a; Harada A, 2010, HYBRIDOMA, V29, P255, DOI 10.1089/hyb.2009.0117; Harada A, 2010, HYBRIDOMA, V29, P173, DOI 10.1089/hyb.2009.0090; Hayashi-Takanaka Y, 2011, NUCLEIC ACIDS RES, V39, P6475, DOI 10.1093/nar/gkr343; Honegger A, 2001, J MOL BIOL, V309, P687, DOI 10.1006/jmbi.2001.4664; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Nariai N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S10-S5; Ohkawa Y, 2009, HYBRIDOMA, V28, P463, DOI 10.1089/hyb.2009.0041; RUBERTI F, 1994, J IMMUNOL METHODS, V173, P33, DOI 10.1016/0022-1759(94)90280-1; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02436; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Xin H, 2006, INFECT IMMUN, V74, P4310, DOI 10.1128/IAI.00234-06; Yoshimura S, 2010, HYBRIDOMA, V29, P63, DOI 10.1089/hyb.2009.0069; ZHOU H, 1994, NUCLEIC ACIDS RES, V22, P888, DOI 10.1093/nar/22.5.888	18	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165473	10.1371/journal.pone.0165473	http://dx.doi.org/10.1371/journal.pone.0165473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788226	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900091
J	Meng, XB; Ezzati, P; Smolik, I; Bernstein, CN; Hitchon, CA; El-Gabalawy, HS				Meng, Xiaobo; Ezzati, Peyman; Smolik, Irene; Bernstein, Charles N.; Hitchon, Carol Ann; El-Gabalawy, Hani S.			Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; RHEUMATOID-ARTHRITIS; 1ST-DEGREE RELATIVES; PROTEIN/PEPTIDE ANTIBODIES; PEPTIDE ANTIBODIES; AUTOANTIBODIES; DISEASE; IDENTIFICATION; MECHANISMS; HEALTH	Anti-citrullinated protein antibodies (ACPA) have become an integral part of the clinical definition of rheumatoid arthritis, and are hypothesized to be important in the immunopathogenesis of this autoimmune disease. Several citrullinated proteins have been demonstrated to serve as candidate autoantigens for the ACPA, based on in vitro immune reactions between citrullinated peptides/proteins and RA sera. Yet it remains unclear whether the autoantigens identified in vitro are indeed directly and specifically targeted by the ACPA in vivo. Moreover, it is unclear whether ACPA present in RA sera are directed towards the same spectrum of autoantigens as the ACPA present within the synovial compartment. In this study, we isolated ACPA immune complexes from RA synovial fluids (SF) and sera by using immobilized cyclic citrullinated peptides (CCP3) based immune affinity, and characterized the proteins that are directly and specifically associated with them by mass spectrometry. The results demonstrate that four histone proteins are prominent ACPA autoantigens, with the frequency of detection being histone H4 (89%), H2B (63%), H3 (63%), and H2A (58%) in ACPA positive RA SF. We further demonstrate that a histone 4 peptide containing citrulline at position Cit39 was recognized by 100% of ACPA positive RA SF. An adjacent citrulline residue at Cit40 was recognized by 34% of ACPA positive RA SF. An H4 peptide containing Cit39-40 was recognized in the serum of 94% ACPA positive RA, 77% ACPA positive first-degree relatives (FDR) of RA patients, and 2.5% of healthy controls. The Cit39-40 peptide substantially blocked the ACPA reactivity in both SF and serum. Although the spectrum of ACPA we identified was limited to those isolated using immobilized CCP3 peptides, the findings indicate that H4 is a widely recognized RA autoantigen in both the synovial and serum compartments. The identification of this immunodominant ACPA epitope may be valuable in designing approaches to immune tolerance induction in RA.	[Meng, Xiaobo; Smolik, Irene; Hitchon, Carol Ann; El-Gabalawy, Hani S.] Univ Manitoba, Dept Internal Med, Arthrit Ctr, RR149,800 Sherbrook St, Winnipeg, MB R3A 1M4, Canada; [Meng, Xiaobo; Ezzati, Peyman; El-Gabalawy, Hani S.] Univ Manitoba, Manitoba Ctr Prote & Syst Biol, 799 JBRC,715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada; [Bernstein, Charles N.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	El-Gabalawy, HS (corresponding author), Univ Manitoba, Dept Internal Med, Arthrit Ctr, RR149,800 Sherbrook St, Winnipeg, MB R3A 1M4, Canada.; El-Gabalawy, HS (corresponding author), Univ Manitoba, Manitoba Ctr Prote & Syst Biol, 799 JBRC,715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada.	Hani.elgabalawy@umanitoba.ca		Hitchon, Carol/0000-0001-5547-3268; El-Gabalawy, Hani/0000-0002-0796-4422	Canadian Institutes of Health Research [MOP77700]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by Canadian Institutes of Health Research MOP77700, http://www.cihr-irsc.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; [Anonymous], 2013, J PROTEOM BIOINFORM, DOI DOI 10.4172/JPB.1000293; Anzilotti C, 2010, AUTOIMMUN REV, V9, P158, DOI 10.1016/j.autrev.2009.06.002; Bernstein CN, 2011, CAN J GASTROENTEROL, V25, P269, DOI 10.1155/2011/712350; Boiers U, 2008, EUR J IMMUNOL, V38, P2784, DOI 10.1002/eji.200838238; Catrina AI, 2016, IMMUNOL REV, V269, P162, DOI 10.1111/imr.12379; Deane KD, 2015, NAT REV RHEUMATOL, V11, DOI 10.1038/nrrheum.2015.134; Deane KD, 2014, NAT REV RHEUMATOL, V10, P212, DOI 10.1038/nrrheum.2014.6; El-Gabalawy HS, 2009, J RHEUMATOL, V36, P1130, DOI 10.3899/jrheum.080855; Fenyo D, 2010, METHODS MOL BIOL, V673, P189, DOI 10.1007/978-1-60761-842-3_11; Fernandes-Cerqueira C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0666-6; Ferucci ED, 2013, J RHEUMATOL, V40, P1523, DOI 10.3899/jrheum.130293; Haag S, 2014, ARTHRITIS RHEUMATOL, V66, P1440, DOI 10.1002/art.38383; Ho PP, 2010, J IMMUNOL, V184, P379, DOI 10.4049/jimmunol.0901639; Ioan-Facsinay A, 2008, ARTHRITIS RHEUM-US, V58, P3000, DOI 10.1002/art.23763; Ioan-Facsinay A, 2011, ANN RHEUM DIS, V70, P188, DOI 10.1136/ard.2010.131102; Johansson L, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1031-0; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Klareskog L, 2014, CURR OPIN RHEUMATOL, V26, P72, DOI 10.1097/BOR.0000000000000016; Koppejan H, 2016, ARTHRITIS RHEUMATOL, V68, P2090, DOI 10.1002/art.39664; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Mathsson L, 2008, ARTHRITIS RHEUM-US, V58, P36, DOI 10.1002/art.23188; Matsuo K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2085; Muller S, 2015, CLIN REV ALLERG IMMU, V49, P232, DOI 10.1007/s12016-014-8459-2; Ossipova E, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4683; Pratesi F, 2014, ANN RHEUM DIS, V73, P1414, DOI 10.1136/annrheumdis-2012-202765; Romero V, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006869; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Smolik I, 2013, J RHEUMATOL, V40, P818, DOI 10.3899/jrheum.121016; Snir O, 2010, ARTHRITIS RHEUM-US, V62, P44, DOI 10.1002/art.25036; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Swart A, 2012, CLIN CHIM ACTA, V414, P266, DOI 10.1016/j.cca.2012.09.015; Szekanecz Z, 2013, IMMUNOL RES, V56, P439, DOI 10.1007/s12026-013-8425-8; van Venrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391, DOI 10.1038/nrrheum.2011.76; Vorobjeva NV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1286, DOI 10.1134/S0006297914120025	39	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165501	10.1371/journal.pone.0165501	http://dx.doi.org/10.1371/journal.pone.0165501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788229	gold, Green Published, Green Submitted			2022-12-26	WOS:000389604900098
J	Paullada-Salmeron, JA; Cowan, M; Allaga-Guerrero, M; Lopez-Olmeda, JF; Mananos, EL; Zanuy, S; Munoz-Cueto, JA				Paullada-Salmeron, Jose A.; Cowan, Mairi; Allaga-Guerrero, Maria; Lopez-Olmeda, Jose F.; Mananos, Evaristo L.; Zanuy, Silvia; Munoz-Cueto, Jose A.			Testicular Steroidogenesis and Locomotor Activity Are Regulated by Gonadotropin-Inhibitory Hormone in Male European Sea Bass	PLoS One			English	Article							RFAMIDE-RELATED PEPTIDE-3; TROUT ONCORHYNCHUS-MYKISS; IN-SITU HYBRIDIZATION; LONG-TERM EXPOSURE; DICENTRARCHUS-LABRAX; LUTEINIZING-HORMONE; REPRODUCTIVE-CYCLE; HYPOPHYSIOTROPIC ROLE; RECEPTOR EXPRESSION; GONADAL DEVELOPMENT	Gonadotropin-inhibitory hormone (GnIH) is a neurohormone that suppresses reproduction by acting at both the brain and pituitary levels. In addition to the brain, GnIH may also be produced in gonads and can regulate steroidogenesis and gametogenesis. However, the function of GnIH in gonadal physiology has received little attention in fish. The main objective of this study was to evaluate the effects of peripheral sbGnih-1 and sbGnih-2 implants on gonadal development and steroidogenesis during the reproductive cycle of male sea bass (Dicentrarchus labrax). Both Gnihs decreased testosterone (T) and 11-ketotestosterone (11-KT) plasma levels in November and December (early-and mid-spermatogenesis) but did not affect plasma levels of the progestin 17,20 beta-dihydroxy-4-pregnen-3-one (DHP). In February (spermiation), fish treated with sbGnih-1 and sbGnih-2 exhibited testicles with abundant type A spermatogonia and partial spermatogenesis. In addition, we determined the effects of peripheral Gnih implants on plasma follicle-stimulating hormone (Fsh) and luteinizing hormone (Lh) levels, as well as on brain and pituitary expression of the main reproductive hormone genes and their receptors during the spermiation period (February). Treatment with sbGnih-2 increased brain gnrh2, gnih, kiss/rand gnihrtranscript levels. Whereas, both Gnihs decreased lhbeta expression and plasma Lh levels, and sbGnih-1 reduced plasmatic Fsh. Finally, through behavioral recording we showed that Gnih implanted animals exhibited a significant increase in diurnal activity from late spermatogenic to early spermiogenic stages. Our results indicate that Gnih may regulate the reproductive axis of sea bass acting not only on brain and pituitary hormones but also on gonadal physiology and behavior.	[Paullada-Salmeron, Jose A.; Cowan, Mairi; Allaga-Guerrero, Maria; Munoz-Cueto, Jose A.] Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Marine Campus Int Excellence CEIMAR, Puerto Real, Spain; [Paullada-Salmeron, Jose A.; Cowan, Mairi; Allaga-Guerrero, Maria; Munoz-Cueto, Jose A.] Agrifood Campus Int Excellence ceiA3, Puerto Real, Spain; [Lopez-Olmeda, Jose F.] Puerto Real Univ Campus, INMAR CACYTMAR Res Inst, Puerto Real, Spain; [Mananos, Evaristo L.; Zanuy, Silvia] Univ Murcia, Dept Physiol, Fac Biol, Murcia, Spain; [Mananos, Evaristo L.; Zanuy, Silvia] CSIC, Inst Aquaculture Torre Sal, Ribera De Cabanes, Castellon, Spain	Universidad de Cadiz; University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS)	Munoz-Cueto, JA (corresponding author), Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Marine Campus Int Excellence CEIMAR, Puerto Real, Spain.; Munoz-Cueto, JA (corresponding author), Agrifood Campus Int Excellence ceiA3, Puerto Real, Spain.	munoz.cueto@uca.es	Muñoz-Cueto, Jose A./E-1889-2014; Mañanós, Evaristo L/B-9708-2015; Cowan, Mairi/Q-7456-2018; Lopez-Olmeda, Jose Fernando/K-3848-2014; Salmerón, José Antonio Paullada/H-1920-2019	Muñoz-Cueto, Jose A./0000-0002-8597-5506; Mañanós, Evaristo L/0000-0001-5811-3882; Cowan, Mairi/0000-0002-0383-0814; Lopez-Olmeda, Jose Fernando/0000-0003-4920-5704; Salmerón, José Antonio Paullada/0000-0002-8211-4209	Junta de Andalucia [P10-AGR-05916]; European Union's Seventh Framework Programme (FP7) [331964]; GV (Prometeoll) [2014/051]; Junta de Andalucia; Marie Curie contract from EU	Junta de Andalucia(Junta de Andalucia); European Union's Seventh Framework Programme (FP7); GV (Prometeoll); Junta de Andalucia(Junta de Andalucia); Marie Curie contract from EU	This work was supported by grants from the Junta de Andalucia (grant no. P10-AGR-05916), the European Union's Seventh Framework Programme (FP7/2007-2013, grant no. 331964) to JAM-C and the GV (Prometeoll-2014/051) to SZ. JAP-S was a fellow FPI from the Junta de Andalucia. M.C. was a recipient of a Marie Curie contract from EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2006, J ENDOCRINOL, V188, P417, DOI 10.1677/joe.1.06494; Anjum S, 2014, J ENDOCRINOL, V223, P79, DOI 10.1530/JOE-14-0333; Asturiano JF, 2000, J FISH BIOL, V56, P1155, DOI 10.1111/j.1095-8649.2000.tb02131.x; Bayarri MJ, 2004, ZOOL SCI, V21, P427, DOI 10.2108/zsj.21.427; Begtashi I, 2004, AQUACULTURE, V241, P539, DOI 10.1016/j.aquaculture.2004.07.011; Bentley GE, 2008, GEN COMP ENDOCR, V156, P34, DOI 10.1016/j.ygcen.2007.10.003; Bentley GE, 2006, J EXP ZOOL PART A, V305A, P807, DOI 10.1002/jez.a.306; Biran J, 2014, ENDOCRINOLOGY, V155, P4391, DOI 10.1210/en.2013-2047; Blazquez M, 1998, COMP BIOCHEM PHYS C, V119, P345, DOI 10.1016/S0742-8413(98)00023-1; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Carrillo M, 2009, ANN NY ACAD SCI, V1163, P49, DOI 10.1111/j.1749-6632.2008.03645.x; Chang JP, 2009, GEN COMP ENDOCR, V161, P42, DOI 10.1016/j.ygcen.2008.09.005; Clarke IJ, 2008, ENDOCRINOLOGY, V149, P5811, DOI 10.1210/en.2008-0575; Di Yorio MP, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12377; Ekstrom P, 2003, PHILOS T R SOC B, V358, P1679, DOI 10.1098/rstb.2003.1303; Escobar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070177; Escobar S, 2013, J COMP NEUROL, V521, P933, DOI 10.1002/cne.23211; Espigares F, 2015, GEN COMP ENDOCR, V224, P176, DOI 10.1016/j.ygcen.2015.08.013; Espigares F, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125138; Falcon J, 2010, GEN COMP ENDOCR, V165, P469, DOI 10.1016/j.ygcen.2009.04.026; Falcon J, 2009, ANN NY ACAD SCI, V1163, P101, DOI 10.1111/j.1749-6632.2009.04435.x; Gonzalez-Martinez D, 2001, J COMP NEUROL, V429, P144, DOI 10.1002/1096-9861(20000101)429:1&lt;144::AID-CNE11&gt;3.0.CO;2-B; Gonzalez-Martinez D, 2004, BIOL REPROD, V70, P1380, DOI 10.1095/biolreprod.103.022624; Gonzalez-Martinez D, 2002, J COMP NEUROL, V446, P95, DOI 10.1002/cne.10190; Herrera-Perez P, 2010, J COMP NEUROL, V518, P3495, DOI 10.1002/cne.22408; Khan IA, 1999, BIOL REPROD, V61, P834, DOI 10.1095/biolreprod61.3.834; Klenke U, 2003, FISH PHYSIOL BIOCHEM, V28, P25, DOI 10.1023/B:FISH.0000030465.56876.97; KOBAYASHI M, 1990, ZOOL SCI, V7, P715; Kriegsfeld LJ, 2006, P NATL ACAD SCI USA, V103, P2410, DOI 10.1073/pnas.0511003103; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Maddineni S, 2008, J NEUROENDOCRINOL, V20, P1078, DOI 10.1111/j.1365-2826.2008.01765.x; Maddineni SR, 2008, REPRODUCTION, V135, P267, DOI 10.1530/REP-07-0369; Mananos E, 2002, J FISH BIOL, V60, P328, DOI 10.1006/jfbi.2001.1839; Mateos J, 2006, CIENC MAR, V32, P271, DOI 10.7773/cm.v32i21.1062; Mateos J, 2002, COMP BIOCHEM PHYS B, V132, P75, DOI 10.1016/S1096-4959(01)00535-8; McGuire NL, 2010, GEN COMP ENDOCR, V166, P565, DOI 10.1016/j.ygcen.2010.01.010; Moles G, 2012, GEN COMP ENDOCR, V176, P70, DOI 10.1016/j.ygcen.2011.12.029; Molnar CS, 2011, ENDOCRINOLOGY, V152, P1684, DOI 10.1210/en.2010-1418; Moussavi M, 2013, J NEUROENDOCRINOL, V25, P506, DOI 10.1111/jne.12024; Moussavi M, 2012, MOL CELL ENDOCRINOL, V350, P53, DOI 10.1016/j.mce.2011.11.020; Murakami M, 2008, J ENDOCRINOL, V199, P105, DOI 10.1677/JOE-08-0197; Nash JP, 2000, FISH PHYSIOL BIOCHEM, V22, P355, DOI 10.1023/A:1007850014021; Oishi H, 2012, ENDOCRINOLOGY, V153, P3435, DOI 10.1210/en.2012-1066; Osugi T, 2004, J ENDOCRINOL, V182, P33, DOI 10.1677/joe.0.1820033; Paullada-Salmeron JA, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.116.139022; Paullada-Salmeron JA, 2016, J COMP NEUROL, V524, P176, DOI 10.1002/cne.23833; Planas J. V., 2007, FISH REPROD, P37; Prat F, 1996, BIOL REPROD, V54, P1375, DOI 10.1095/biolreprod54.6.1375; Qi X, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105114; Qi X, 2013, MOL CELL ENDOCRINOL, V366, P9, DOI 10.1016/j.mce.2012.11.001; Rocha A, 2009, GEN COMP ENDOCR, V162, P265, DOI 10.1016/j.ygcen.2009.03.023; Rodriguez L, 2005, GEN COMP ENDOCR, V140, P116, DOI 10.1016/j.ygcen.2004.10.011; Rodriguez L, 2000, FISH PHYSIOL BIOCHEM, V23, P141, DOI 10.1023/A:1007871604795; Sanchez-Vazquez FJ, 1998, CHRONOBIOL INT, V15, P607, DOI 10.3109/07420529808993197; Sari IP, 2009, ENDOCRINOLOGY, V150, P5549, DOI 10.1210/en.2009-0775; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Schulz RW, 2002, FISH PHYSIOL BIOCHEM, V26, P43, DOI 10.1023/A:1023303427191; Servili A, 2013, INT J MOL SCI, V14, P7603, DOI 10.3390/ijms14047603; Servili A, 2010, ENDOCRINOLOGY, V151, P2265, DOI 10.1210/en.2009-1207; Shahjahan M, 2011, J NEUROENDOCRINOL, V23, P39, DOI 10.1111/j.1365-2826.2010.02081.x; Singh P, 2011, FERTIL STERIL, V95, P1397, DOI 10.1016/j.fertnstert.2010.03.052; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Tsutsui K, 2010, J NEUROENDOCRINOL, V22, P716, DOI 10.1111/j.1365-2826.2010.02018.x; Ubuka T, 2006, ENDOCRINOLOGY, V147, P1187, DOI 10.1210/en.2005-1178; Ubuka T, 2016, GEN COMP ENDOCR, V227, P27, DOI 10.1016/j.ygcen.2015.09.009; Umatani C, 2013, J NEUROPHYSIOL, V109, P2354, DOI 10.1152/jn.00712.2012; Villamizar N, 2012, AQUACULTURE, V354, P117, DOI 10.1016/j.aquaculture.2012.03.028; Wang QQ, 2015, GEN COMP ENDOCR, V216, P9, DOI 10.1016/j.ygcen.2015.04.016; Yamamoto N, 1997, NEUROENDOCRINOLOGY, V65, P403, DOI 10.1159/000127203; Yaron Z, 2003, INT REV CYTOL, V225, P131, DOI 10.1016/S0074-7696(05)25004-0; Zhang Y, 2010, PEPTIDES, V31, P1034, DOI 10.1016/j.peptides.2010.03.003; Zhao S, 2010, ENDOCRINOLOGY, V151, P617, DOI 10.1210/en.2009-0978; Zheng LC, 2015, ANIM REPROD SCI, V154, P113, DOI 10.1016/j.anireprosci.2015.01.004; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	76	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165494	10.1371/journal.pone.0165494	http://dx.doi.org/10.1371/journal.pone.0165494			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788270	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900096
J	Sohal, HS; Clowry, GJ; Jackson, A; O'Neill, A; Baker, SN				Sohal, Harbaljit S.; Clowry, Gavin J.; Jackson, Andrew; O'Neill, Anthony; Baker, Stuart N.			Mechanical Flexibility Reduces the Foreign Body Response to Long-Term Implanted Microelectrodes in Rabbit Cortex	PLoS One			English	Article							BRAIN-TISSUE; ARRAYS	Micromotion between the brain and implanted electrodes is a major contributor to the failure of invasive microelectrodes. Movements of the electrode tip cause recording instabilities while spike amplitudes decline over the weeks/months post-implantation due to glial cell activation caused by sustained mechanical trauma. We compared the glial response over a 26-96 week period following implantation in the rabbit cortex of microwires and a novel flexible electrode. Horizontal sections were used to obtain a depth profile of the radial distribution of microglia, astrocytes and neurofilament. We found that the flexible electrode was associated with decreased gliosis compared to the microwires over these long indwelling periods. This was in part due to a decrease in overall microgliosis and enhanced neuronal density around the flexible probe, especially at longer periods of implantation.	[Sohal, Harbaljit S.] Feinstein Inst Med Res, Ctr Bioelect Med, Manhassett, NY 11030 USA; [Sohal, Harbaljit S.; Clowry, Gavin J.; Jackson, Andrew; Baker, Stuart N.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [O'Neill, Anthony] Newcastle Univ, Sch Elect & Elect Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Northwell Health; Newcastle University - UK; Newcastle University - UK	Sohal, HS (corresponding author), Feinstein Inst Med Res, Ctr Bioelect Med, Manhassett, NY 11030 USA.; Sohal, HS (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	hsohal@northwell.edu	Clowry, Gavin John/A-4881-2009	Clowry, Gavin/0000-0002-6489-8329; O'Neill, Anthony/0000-0002-1141-2161; Baker, Stuart/0000-0001-8118-4048	Wellcome Trust; EPSRC; MRC	Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Wellcome Trust, EPSRC, and MRC.	Barrese JC, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026003; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Chung K, 2013, NATURE; Dickey AS, 2009, J NEUROPHYSIOL, V102, P1331, DOI 10.1152/jn.90920.2008; GOULD HJ, 1986, J COMP NEUROL, V243, P207, DOI 10.1002/cne.902430206; Ke M-T, 2013, NAT NEUROSCI; Kozai TDY, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046011; Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]; Kozai TDY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/066001; Kuo JTW, 2013, LAB CHIP, V13, P554, DOI 10.1039/c2lc40935f; Lee CD, 2016, J BIOMED MATER RES B, V104, P357, DOI 10.1002/jbm.b.33390; Loffler S, 2012, BIOMED TECH BERL; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Nolta NF, 2015, BIOMATERIALS, V53, P753, DOI 10.1016/j.biomaterials.2015.02.081; Perge JA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036004; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Potter KA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046020; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Seymour JP, 2011, BIOMED MICRODEVICES, V13, P441, DOI 10.1007/s10544-011-9512-z; Shih AY, 2013, NAT NEUROSCI, V16, P55, DOI 10.1038/nn.3278; Sohal HS, 2014, FRONT NEUROENG, V7; Subbaroyan J, 2005, J NEURAL ENG, V2, P103, DOI 10.1088/1741-2560/2/4/006; Swadlow HA, 1996, J NEUROPHYSIOL, V75, P1753, DOI 10.1152/jn.1996.75.4.1753; Takmakov P, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/2/026003; Winslow BD, 2010, BIOMATERIALS, V31, P9163, DOI 10.1016/j.biomaterials.2010.05.050; Winslow BD, 2010, BIOMATERIALS, V31, P1558, DOI 10.1016/j.biomaterials.2009.11.049	29	39	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165606	10.1371/journal.pone.0165606	http://dx.doi.org/10.1371/journal.pone.0165606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788240	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900113
J	Yeh, DM; Tsai, HY; Tyan, YS; Chang, YC; Pan, LK; Chen, TR				Yeh, Da-Ming; Tsai, Hui-Yu; Tyan, Yen-Sheng; Chang, Yu-Cheng; Pan, Lung-Kwang; Chen, Tou-Rong			The Population Effective Dose of Medical Computed Tomography Examinations in Taiwan for 2013	PLOS ONE			English	Article							CT; EXPOSURE	Purpose To evaluate the annual effective dose per capita attributed to computed tomography (CT) examinations in 2013 and to predict the population effective dose from 2000 to 2013 in Taiwan. Methods A CT examination database collected from 30 hospitals was divided into 22 procedures and classified into six regions: head, neck, chest, abdomen, pelvis, and other, respectively. The effective doses in different regions were evaluated by dose-length product (DLP) multiplied by conversion factors. Results The CT scan dose parameters were collected from 4,407 patients. For the six scanned regions, the percentages of patients scanned were: head (39.8%), neck (3.9%), chest (23.3%), abdomen (26.7%), pelvis (4.8%), and other (1.6%), respectively. The DLPs per patient (mGy-cm/patient) were head (1,071 +/- 225), neck (1,103 +/- 615), chest (724 +/- 509), abdomen (1,315 +/- 550), pelvis (1,231 +/- 620) and other (1,407 +/- 937), respectively. The number of CT examinations increased rapidly, with an average annual growth rate of 7.6%. The number of CT examinations in 2013 was 2.6 times that in 2000. The population effective dose was 0.30 mSv per capita in 2000 and increased to 0.74 mSv per capita in 2013, with an annual growth rate of 7.2%. The growth trend indicates that the effective dose will continue to rise in Taiwan. Conclusion Some strategies should be applied to cope with this growth. Defining the CT dose reference level stipulated in official recommendations and encouraging the use of iterative reconstruction imaging instead of filtered back -projection imaging could be a useful method for optimizing the effective dose and image quality.	[Yeh, Da-Ming; Tyan, Yen-Sheng; Chang, Yu-Cheng; Chen, Tou-Rong] Chung Shan Med Univ Hosp, Dept Med Image, Taichung, Taiwan; [Yeh, Da-Ming; Chen, Tou-Rong] Chung Shan Med Univ, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Yeh, Da-Ming; Pan, Lung-Kwang] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Tsai, Hui-Yu] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Tsai, Hui-Yu] Chang Gung Univ, Chang Gung Mem Hosp, Inst Radiol Res, Med Phys Res Ctr, Taoyuan, Taiwan; [Tsai, Hui-Yu] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Tyan, Yen-Sheng] Chung Shan Med Univ, Sch Med, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Central Taiwan University Science & Technology; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University	Chen, TR (corresponding author), Chung Shan Med Univ Hosp, Dept Med Image, Taichung, Taiwan.; Chen, TR (corresponding author), Chung Shan Med Univ, Dept Med Imaging & Radiol Sci, Taichung, Taiwan.	trchen@csmu.edu.tw		PAN, Lung-Kwang/0000-0002-9485-4722; Chen, Tou-Rong/0000-0002-7324-9312; Tsai, Hui-Yu/0000-0002-9661-5848	Atomic Energy Council [AEC10409031L]; Chung Shan Medical Hospital Research Program [CSH-2012-C-007]; Chang Gung Memorial Hospital [CMRPD1C0682, CIRPD1C0053, BMRPA61]	Atomic Energy Council; Chung Shan Medical Hospital Research Program; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the Atomic Energy Council (AEC10409031L) and the Chung Shan Medical Hospital Research Program (CSH-2012-C-007). Hui-Yu Tsai is a research scientist supported by Chang Gung Memorial Hospital (CMRPD1C0682, CIRPD1C0053, BMRPA61).	American Association of Physicists in Medicine (AAPM), 2007, 96 AAPM; [Anonymous], 1999, EUR16262 OFF OFF PUB; [Anonymous], 1991, ANN ICRP, V21, P1; Brix G, 2003, EUR RADIOL, V13, P1979, DOI 10.1007/s00330-003-1883-y; Chen TR, 2011, MED PHYS, V38, P3139, DOI 10.1118/1.3592936; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; ICRP (International Commission on Radiological Protection), 2007, ANN ICRP, V37; Karim MKA, 2016, RADIAT PHYS CHEM, V121, P69, DOI 10.1016/j.radphyschem.2015.12.020; Lin CL, 2008, J CHINESE ONCOL SOC, V24, P277; Lin P.H., 2000, P 10 IRPA SEM RAD SA, P1; National Council on Radiation Protection and Measurements, 2009, 160 NCRP; Origgi D, 2006, EUR RADIOL, V16, P227, DOI 10.1007/s00330-005-2682-4; Saltybaeva N, 2014, RADIOLOGY, V273, P153, DOI 10.1148/radiol.14132903; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wall BF, 2009, 160 NCRP, P1, DOI [10.1093/rpd/ncp162, DOI 10.1093/RPD/NCP162]	16	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165526	10.1371/journal.pone.0165526	http://dx.doi.org/10.1371/journal.pone.0165526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788231	Green Submitted, Green Published, gold			2022-12-26	WOS:000389604900103
J	Bouttell, J; Lewsey, J; Geue, C; Antony, G; Briggs, A; McCartney, G; Hutchinson, S; Graham, L; Heydtmann, M				Bouttell, Janet; Lewsey, James; Geue, Claudia; Antony, Grace; Briggs, Andrew; McCartney, Gerry; Hutchinson, Sharon; Graham, Lesley; Heydtmann, Mathis			The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011	PLOS ONE			English	Article							UNITED-STATES; MORTALITY; HEPATITIS; BURDEN; SURVIVAL	Studies assessing the costs of alcoholic liver disease are lacking. We aimed to calculate the costs of hospitalisations before and after diagnosis compared to population controls matched by age, sex and socio-economic deprivation. We aimed to use population level data to identify a cohort of individuals hospitalised for the first time with alcoholic liver disease in Scotland between 1991 and 2011. Incident cases were classified by disease severity, sex, age group, socio-economic deprivation and year of index admission. 5 matched controls for every incident case were identified from the Scottish population level primary care database. Hospital costs were calculated for both cases and controls using length of stay from morbidity records and hospital-specific daily rates by specialty. Remaining lifetime costs were estimated using parametric survival models and predicted annual costs. 35,208 incident alcoholic liver disease hospitalisations were identified. Mean annual hospital costs for cases were 2.3 times that of controls pre diagnosis ( pound 804 higher) and 10.2 times ( pound 12,774 higher) post diagnosis. Mean incident admission cost was pound 6,663. Remaining lifetime cost for a male, 50-59 years old, living in the most deprived area diagnosed with acoholic liver disease was estimated to be pound 65,999 higher than the matched controls ( pound 12,474 for 7.43 years remaining life compared to pound 1,224 for 21.8 years). In Scotland, alcoholic liver disease diagnosis is associated with significant increases in admissions to hospital both before and after diagnosis. Our results provide robust population level estimates of costs of alcoholic liver disease for the purposes of health-care delivery, planning and future cost-effectiveness analyses.	[Bouttell, Janet; Lewsey, James; Geue, Claudia; Antony, Grace; Briggs, Andrew] Univ Glasgow, Hlth Econ & Hlth Technol Assessment, Glasgow, Lanark, Scotland; [McCartney, Gerry] NHS Hlth Scotland, Glasgow, Lanark, Scotland; [Hutchinson, Sharon] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Graham, Lesley] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [Heydtmann, Mathis] Royal Alexandra Hosp, Dept Gastroenterol, Paisley, Renfrew, Scotland	University of Glasgow; Glasgow Caledonian University; NHS National Services Scotland	Lewsey, J (corresponding author), Univ Glasgow, Hlth Econ & Hlth Technol Assessment, Glasgow, Lanark, Scotland.	jim.lewsey@glasgow.ac.uk	Briggs, Andrew/ABA-9009-2020; Hutchinson, Sharon/Y-3949-2019	Briggs, Andrew/0000-0002-0777-1997; Hutchinson, Sharon/0000-0002-6891-6758; McCartney, Gerry/0000-0001-6341-3521	Chief Scientist Office [CZH/4/837]	Chief Scientist Office	This work was supported by the Chief Scientist Office grant number CZH/4/837.	Aljoudeh AN, 2013, GUT, V62, pA81, DOI [10.1136/gutjnl-2013-304907.177, DOI 10.1136/GUTJNL-2013-304907.177]; Bagust A, 2014, MED DECIS MAKING, V34, P343, DOI 10.1177/0272989X13497998; Beeston C., 2013, MONITORING EVALUATIN; Beeston C., 2016, MONITORING EVALUATIN; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Boylan JF, 2014, J CRITICAL CARE, V29, DOI [10.1016/j.jcrc.2014.06.002, DOI 10.1016/J.JCRC.2014.06.002]; Cortez-Pinto H, 2011, ALCOHOL ALCOHOLISM, V46, P8; Deleuran T, 2016, AM J GASTROENTEROL, V111, P817, DOI 10.1038/ajg.2016.107; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Heydtmann M, 2013, SCOT MED J, V58, P134, DOI 10.1177/0036933013490381; Hudson B, 2015, GUT, V64, pA252, DOI 10.1136/gutjnl-2015-309861.540; Jinjuvadia R, 2015, J CLIN GASTROENTEROL, V49, P506, DOI 10.1097/MCG.0000000000000161; Liangpunsakul S, 2011, J CLIN GASTROENTEROL, V45, P714, DOI 10.1097/MCG.0b013e3181fdef1d; Lloyd-Evans J, 2015, GUT, V64, pA258, DOI 10.1136/gutjnl-2015-309861.554; McDonnell T, 2014, J MED SCI, V1, pS51; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nick Sheron, 2016, J HEPATOL, V64.4, p957 , DOI [10.1016/j.jhep.2015.11.006, DOI 10.1016/J.JHEP.2015.11.006]; Ratib S, 2014, COMP NATL MORTALITY; Ratib S, 2014, J HEPATOL, V60, P282, DOI 10.1016/j.jhep.2013.09.027; Rhem J, 2013, J HEPATOL, V59, p160 , DOI [10.1016/j.jhep.2013.03.007, DOI 10.1016/J.JHEP.2013.03.007]; Ryder S, 2011, GUT, V60, pA50, DOI 10.1136/gutjnl-2011-300857b.1; Sandahl TD, 2011, J HEPATOL, V54, P760, DOI 10.1016/j.jhep.2010.07.016; Shinde AV, 2010, BIOMED RES-INDIA, V21, P321; Sjolander A, 2013, STAT MED, V32, P4696, DOI 10.1002/sim.5879; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9; Woodman K., 2013, PEER SUPP BREASTF GU; 2012, J HEPATOL, V57, P399, DOI DOI 10.1016/J.JHEP.2012.04.004	27	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0162980	10.1371/journal.pone.0162980	http://dx.doi.org/10.1371/journal.pone.0162980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783619	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000389602800013
J	Pryke, JS; Roets, F; Samways, MJ				Pryke, James S.; Roets, Francois; Samways, Michael J.			Wild Herbivore Grazing Enhances Insect Diversity over Livestock Grazing in an African Grassland System	PLOS ONE			English	Article							COLEOPTERA SCARABAEIDAE; ASSEMBLAGE STRUCTURE; DUNG; BIODIVERSITY; LAND; IMPACT; PLANT; UNGULATE; HETEROGENEITY; VEGETATION	Southern Africa's grassland biodiversity is threatened by habitat transformation such as commercial forestry. Ecological networks (ENs) have been instigated to alleviate the pressure of habitat transformation on local biodiversity. ENs are large scale webs of corridors and patches of natural vegetation criss-crossing production landscapes that can simulate conditions in protected areas (PAs). Many ENs have lost many native large mammal species, which have been replaced by domestic livestock to retain natural grazing dynamics, which could have an impact on the long-term value of ENs for insects. Here we compared dung beetle, butterfly and grasshopper diversity in ENs across a landscape mosaic of timber plantations, where 1) wild megaherbivores were maintained, 2) in ENs where these herbivores were replaced by livestock and, 3) in a nearby World Heritage PA which retained its natural complement of megaherbivores. Sites in the PA far from any plantation were similar in composition to those in the wild grazed EN. Presence of the wild grazers improved the alpha-and beta-diversity of all focal insect taxa when compared to domestic grazing. Furthermore, species composition shows significant differences between the two grazing systems indicating that an assemblage of native large mammals facilitates insect diversity conservation. We support the maintenance or introduction of large native mammals in ENs or similar conservation areas in production landscapes to simulate the ecological conditions and natural heterogeneity in nearby PAs.	[Pryke, James S.; Roets, Francois; Samways, Michael J.] Univ Stellenbosch, Dept Conservat Ecol & Entomol, Private Bag X1, ZA-7602 Matieland, South Africa	Stellenbosch University	Pryke, JS (corresponding author), Univ Stellenbosch, Dept Conservat Ecol & Entomol, Private Bag X1, ZA-7602 Matieland, South Africa.	JPryke@sun.ac.za	Pryke, James/A-6644-2008	Pryke, James/0000-0003-3148-5744; Samways, Michael J./0000-0003-4237-6025; Roets, Francois/0000-0003-3849-9057	Mondi Global; National Research Foundation	Mondi Global; National Research Foundation	This work was supported by Mondi Global (Dr James Stephen Pryke), and National Research Foundation (Dr James Stephen Pryke, Prof Michael Samways).	AGUIRRE AA, 1994, CONSERV BIOL, V8, P654, DOI 10.1046/j.1523-1739.1994.08030654.x; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bazelet CS, 2011, LANDSCAPE ECOL, V26, P341, DOI 10.1007/s10980-010-9557-z; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Cardoso P, 2015, METHODS ECOL EVOL, V6, P232, DOI 10.1111/2041-210X.12310; Cingolani AM, 2014, PERSPECT PLANT ECOL, V16, P143, DOI 10.1016/j.ppees.2014.04.002; Dave C, 2011, J TROP ECOL, V27, P239, DOI 10.1017/S0266467410000738; Davis A. L. V., 2008, AFRICAN DUNG BEETLE; Davis ALV, 2012, J INSECT CONSERV, V16, P399, DOI 10.1007/s10841-011-9426-3; DAVIS ALV, 1994, J NAT HIST, V28, P383, DOI 10.1080/00222939400770171; De Wet F., 2011, GRAZING ASSESSMENT M; Dennis P, 2008, J APPL ECOL, V45, P279, DOI 10.1111/j.1365-2664.2007.01378.x; Di Minin E, 2013, CONSERV BIOL, V27, P808, DOI 10.1111/cobi.12048; Dirsh VM, 1965, AFRICAN GENERA ACRID; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Dorrough J, 2007, AGR ECOSYST ENVIRON, V121, P222, DOI 10.1016/j.agee.2006.12.012; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; FLEISCHNER TL, 1994, CONSERV BIOL, V8, P629, DOI 10.1046/j.1523-1739.1994.08030629.x; Foster CN, 2014, J APPL ECOL, V51, P929, DOI 10.1111/1365-2664.12268; Gardiner Tim, 2002, Journal of Orthoptera Research, V11, P207, DOI 10.1665/1082-6467(2002)011[0207:TIOSHA]2.0.CO;2; Grau R, 2013, CURR OPIN ENV SUST, V5, P477, DOI 10.1016/j.cosust.2013.06.001; Henning GA, 1994, PENNINGTONS BUTTERFL; Jachowski DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031818; Jankielsohn A, 2001, ENVIRON ENTOMOL, V30, P474, DOI 10.1603/0046-225X-30.3.474; JONGMAN RHG, 1995, LANDSCAPE URBAN PLAN, V32, P169, DOI 10.1016/0169-2046(95)00197-O; Joubert L, 2016, INSECT CONSERV DIVER, V9, P290, DOI 10.1111/icad.12166; Joubert L, 2016, BIODIVERS CONSERV, V25, P725, DOI 10.1007/s10531-016-1088-8; Korosi A, 2012, INSECT CONSERV DIVER, V5, P57, DOI 10.1111/j.1752-4598.2011.00153.x; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Little IT, 2013, BIOL CONSERV, V158, P258, DOI 10.1016/j.biocon.2012.09.017; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; Moranz RA, 2012, BIODIVERS CONSERV, V21, P2719, DOI 10.1007/s10531-012-0330-2; Mucina L., 2006, VEGETATION S AFRICA; Mwendera EJ, 1997, AUST J EXP AGR, V37, P421, DOI 10.1071/EA96145; Negro M, 2011, ENVIRON ENTOMOL, V40, P1081, DOI 10.1603/EN11105; Nichols E, 2009, OIKOS, V118, P481, DOI 10.1111/j.1600-0706.2009.17268.x; Numa C, 2012, RANGELAND ECOL MANAG, V65, P137, DOI 10.2111/REM-D-10-00050.1; O'Connor TG, 2014, AFR J RANGE FOR SCI, V31, P67, DOI 10.2989/10220119.2014.939996; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Phalan B, 2011, FOOD POLICY, V36, pS62, DOI 10.1016/j.foodpol.2010.11.008; Pollitt E, 1993, Monogr Soc Res Child Dev, V58, P1; PRIMER E, 2008, PERMANOVA PRIMER 6; Pryke JS, 2015, LANDSCAPE ECOL, V30, P595, DOI 10.1007/s10980-014-0096-x; Pryke JS, 2012, J APPL ECOL, V49, P591, DOI 10.1111/j.1365-2664.2012.02142.x; Pryke JS, 2012, LANDSCAPE ECOL, V27, P73, DOI 10.1007/s10980-011-9668-1; RiversMoore NA, 1996, BIODIVERS CONSERV, V5, P1545, DOI 10.1007/BF00052115; Samways MJ, 2008, J INSECT CONSERV, V12, P493, DOI 10.1007/s10841-007-9089-2; Samways MJ, 2016, AMBIO, V45, P161, DOI 10.1007/s13280-015-0697-x; Samways MJ, 2001, BIODIVERS CONSERV, V10, P1963, DOI 10.1023/A:1013199621649; SKARPE C, 1991, AMBIO, V20, P351; Smith CC, 1940, ECOLOGY, V21, P381, DOI 10.2307/1930847; Spalinger LC, 2012, INSECT CONSERV DIVER, V5, P444, DOI 10.1111/j.1752-4598.2011.00180.x; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Toth E, 2018, LAND DEGRAD DEV, V29, P231, DOI 10.1002/ldr.2514; Tsbikae BP, 2008, ENVIRON ENTOMOL, V37, P431, DOI 10.1603/0046-225X(2008)37[431:TAOADB]2.0.CO;2; Tschope O, 2011, APPL VEG SCI, V14, P200, DOI 10.1111/j.1654-109X.2010.01119.x; Vanbergen AJ, 2014, FUNCT ECOL, V28, P178, DOI 10.1111/1365-2435.12191; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Whipple SD, 2012, ENVIRON ENTOMOL, V41, P238, DOI 10.1603/EN11285; Wilkerson ML, 2013, ECOL EVOL, V3, P3672, DOI 10.1002/ece3.744; Woodhall S., 2005, FIELD GUIDE BUTTERFL; Zhu H, 2012, J APPL ECOL, V49, P1075, DOI 10.1111/j.1365-2664.2012.02195.x	66	19	20	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164198	10.1371/journal.pone.0164198	http://dx.doi.org/10.1371/journal.pone.0164198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783685	Green Published, gold, Green Submitted			2022-12-26	WOS:000389602800031
J	Chiang, CF; Flint, M; Lin, JMS; Spiropoulou, CF				Chiang, Cheng-Feng; Flint, Mike; Lin, Jin-Mann S.; Spiropoulou, Christina F.			Endocytic Pathways Used by Andes Virus to Enter Primary Human Lung Endothelial Cells	PLOS ONE			English	Article							HANTAVIRUS PULMONARY SYNDROME; MEDIATED ENDOCYTOSIS; WORLD HANTAVIRUSES; HEMORRHAGIC-FEVER; ENTRY; MACROPINOCYTOSIS; NEUTRALIZATION; TRANSMISSION; PATHOGENESIS; REPLICATION	Andes virus (ANDV) is the major cause of hantavirus pulmonary syndrome (HPS) in South America. Despite a high fatality rate (up to 40%), no vaccines or antiviral therapies are approved to treat ANDV infection. To understand the role of endocytic pathways in ANDV infection, we used 3 complementary approaches to identify cellular factors required for ANDV entry into human lung microvascular endothelial cells. We screened an siRNA library targeting 140 genes involved in membrane trafficking, and identified 55 genes required for ANDV infection. These genes control the major endocytic pathways, endosomal transport, cell signaling, and cytoskeleton rearrangement. We then used infectious ANDV and retroviral pseudovirions to further characterize the possible involvement of 9 of these genes in the early steps of ANDV entry. In addition, we used markers of cellular endocytosis along with chemical inhibitors of known endocytic pathways to show that ANDV uses multiple routes of entry to infect target cells. These entry mechanisms are mainly clathrin-, dynamin-, and cholesterol-dependent, but can also occur via a clathrin-independent manner.	[Chiang, Cheng-Feng; Flint, Mike; Spiropoulou, Christina F.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA; [Lin, Jin-Mann S.] Ctr Dis Control & Prevent, Chron Viral Dis Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Spiropoulou, CF (corresponding author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.	css8@cdc.gov	Flint, Mike/L-8355-2019	Chiang, Cheng-Feng/0000-0002-3617-9124	Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by Centers for Disease Control and Prevention (CDC) core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borges AA, 2006, MICROBES INFECT, V8, P2324, DOI 10.1016/j.micinf.2006.04.019; Buranda T, 2010, ANAL BIOCHEM, V402, P151, DOI 10.1016/j.ab.2010.03.016; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Chiang CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099764; Choi Y, 2008, VIROLOGY, V381, P178, DOI 10.1016/j.virol.2008.08.035; De Franceschi N, 2015, J CELL SCI, V128, P839, DOI 10.1242/jcs.161653; Doyle TJ, 1998, INFECT DIS CLIN N AM, V12, P95, DOI 10.1016/S0891-5520(05)70411-6; Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799; Enria DA, 2001, CURR TOP MICROBIOL, V256, P117; Flint M, 2004, J VIROL, V78, P6875, DOI 10.1128/JVI.78.13.6875-6882.2004; Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074; Hetzenecker S, 2016, TRAFFIC, V17, P351, DOI 10.1111/tra.12355; Higa MM, 2012, VIROLOGY, V423, P134, DOI 10.1016/j.virol.2011.08.012; Hussein ITM, 2012, J VIROL, V86, P7520, DOI 10.1128/JVI.07204-11; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jin M, 2002, VIROLOGY, V294, P60, DOI 10.1006/viro.2001.1303; Kleinfelter LM, 2015, MBIO, V6, DOI 10.1128/mBio.00801-15; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Krautkramer E, 2008, J VIROL, V82, P4257, DOI 10.1128/JVI.02210-07; Krzyzaniak MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003309; Lagana A, 2000, J CELL SCI, V113, P3649; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Lozach PY, 2010, CELL HOST MICROBE, V7, P488, DOI 10.1016/j.chom.2010.05.007; Matthys VS, 2010, J VIROL, V84, P352, DOI 10.1128/JVI.01013-09; McNulty S, 2013, J VIROL, V87, P912, DOI 10.1128/JVI.02415-12; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Padula PJ, 1998, VIROLOGY, V241, P323, DOI 10.1006/viro.1997.8976; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; Popugaeva E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035587; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Raftery MJ, 2014, J EXP MED, V211, P1484, DOI 10.1084/jem.20131092; Raghu H, 2009, J VIROL, V83, P4895, DOI 10.1128/JVI.02498-08; Ramanathan HN, 2008, VIROLOGY, V374, P138, DOI 10.1016/j.virol.2007.12.030; Ray N, 2010, J VIROL METHODS, V163, P416, DOI 10.1016/j.jviromet.2009.11.004; Raymond T, 2005, P NATL ACAD SCI USA, V102, P1163, DOI 10.1073/pnas.0406743102; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Shin SY, 2013, CARCINOGENESIS, V34, P2080, DOI 10.1093/carcin/bgt169; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wells RM, 1997, EMERG INFECT DIS, V3, P361, DOI 10.3201/eid0303.970314; Yu DH, 2013, BIOMATERIALS, V34, P3925, DOI 10.1016/j.biomaterials.2013.02.017; ZAKI SR, 1995, AM J PATHOL, V146, P552; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	49	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164768	10.1371/journal.pone.0164768	http://dx.doi.org/10.1371/journal.pone.0164768			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780263	Green Submitted, Green Published, gold			2022-12-26	WOS:000389046900017
J	Baillet, A; Hograindleur, MA; El Benna, J; Grichine, A; Berthier, S; Morel, F; Paclet, MH				Baillet, Athan; Hograindleur, Marc-Andre; El Benna, Jamel; Grichine, Alexei; Berthier, Sylvie; Morel, Francoise; Paclet, Marie-Helene			Unexpected function of the phagocyte NADPH oxidase in supporting hyperglycolysis in stimulated neutrophils: key role of 6-phosphofructo-2-kinase	FASEB JOURNAL			English	Article						Nox2; PMN; PFK-2; reactive oxygen species; energetic metabolism	PROTEIN-KINASE-C; NUCLEOSIDE DIPHOSPHATE KINASE; RESPIRATORY BURST OXIDASE; CYTOCHROME B(558); LIPID RAFTS; ACTIVATION; PHOSPHORYLATION; COMPONENT; NOX; P67(PHOX)	The phagocyte NADPH oxidase 2 (Nox2) is an enzymatic complex that is involved in innate immunity, notably via its capacity to produce toxic reactive oxygen species. Recently, a proteomic analysis of the constitutively active Nox2 complex, isolated from neutrophil fractions, highlighted the presence of 6-phosphofructo-2-kinase (PFK-2). The purpose of this work was to study the relationship between PFK-2 and NADPH oxidase in neutrophils. Data have underlined a specific association of the active phosphorylated form of PFK-2 with Nox2 complex in stimulated neutrophils. In its active form, PFK-2 catalyzes the production of fructose-2,6-bisphosphate, which is the main allosteric activator of phosphofructo-1-kinase, the limiting enzyme in glycolysis. Pharmacologic inhibition of PFK-2 phosphorylation and cell depletion in PFK-2 by a small interfering RNA strategy led to a decrease in the glycolysis rate and a reduction in NADPH oxidase activity in stimulated cells. Surprisingly, alteration of Nox2 activity impacted the glycolysis rate, which indicated that Nox2 in neutrophils was not only required for reactive oxygen species production but was also involved in supporting the energetic metabolism increase that was induced by inflammatory conditions. PFK-2 seems to be a strategic element that links NADPH oxidase activation and glycolysis modulation, and, as such, is proposed as a potential therapeutic target in inflammatory diseases.	[Baillet, Athan; Hograindleur, Marc-Andre; Berthier, Sylvie; Morel, Francoise; Paclet, Marie-Helene] Univ Grenoble Alpes, GREPI, EA 7408, St Martin Dheres, France; [Baillet, Athan] Univ Grenoble Alpes, Dept Rheumatol, La Tronche, France; [Morel, Francoise; Paclet, Marie-Helene] Univ Grenoble Alpes, Ctr Hosp, La Tronche, France; [El Benna, Jamel] INSERM, Ctr Natl Rech Sci, Ctr Rech Inflammat, ERL8252,Unite 1149, Paris, France; [El Benna, Jamel] Univ Paris Diderot, Dept Hosp Univ Fibrosis,Site Xavier Bichat, Sorbonne Paris Cite,DHU FIRE,Fac Med, Inflammat Remodeling,Cardiovasc Resp & Renal Dis, Paris, France; [Grichine, Alexei] Univ Joseph Fourier, INSERM, Inst Albert Bonniot, Platform Opt Microscopy Cell Imaging,Unit 823, La Tronche, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Paclet, MH (corresponding author), Univ Grenoble Alpes, GREPI, EA 7408, St Martin Dheres, France.; Paclet, MH (corresponding author), Univ Grenoble Alpes, Grp Rech & Etude Proc Inflammatoire, EFS Site Grenoble, 29 Ave Maquis Gr Esivaudan,BP35, F-38701 La Tronche, France.	mhpaclet@chu-grenoble.fr	Grichine, Alexei/M-3923-2013; Paclet, Marie-Hélène/AAS-5029-2020; Grichine, Alexei/P-8377-2019	Grichine, Alexei/0000-0002-7335-9706; Grichine, Alexei/0000-0002-7335-9706	Ministere de l'Enseignement Superieur de la Recherche et Technologie (Paris, France); Societe Francaise de Rhumatologie; Etablissement Francais du Sang (Rhone-Alpes); Direction de la Recherche Clinique et de l'Innovation (Centre Hospitalier Universitaire de Grenoble)	Ministere de l'Enseignement Superieur de la Recherche et Technologie (Paris, France); Societe Francaise de Rhumatologie; Etablissement Francais du Sang (Rhone-Alpes)(Region Auvergne-Rhone-Alpes); Direction de la Recherche Clinique et de l'Innovation (Centre Hospitalier Universitaire de Grenoble)	The authors thank Edgar Pick (Tel Aviv University, Tel Aviv, Israel) for helpful discussions on NDPK. This study was supported by grants from the Ministere de l'Enseignement Superieur de la Recherche et Technologie (Paris, France), the Societe Francaise de Rhumatologie, the Etablissement Francais du Sang (Rhone-Alpes), and the Direction de la Recherche Clinique et de l'Innovation (Centre Hospitalier Universitaire de Grenoble). The authors declare no conflicts of interest.	Baillet A, 2011, FASEB J, V25, P2333, DOI 10.1096/fj.10-173807; BENGTSSON T, 1991, J LEUKOCYTE BIOL, V49, P236, DOI 10.1002/jlb.49.3.236; Bertrand L, 1999, J BIOL CHEM, V274, P30927, DOI 10.1074/jbc.274.43.30927; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Bouin AP, 1998, J BIOL CHEM, V273, P30097, DOI 10.1074/jbc.273.46.30097; Boussetta T, 2010, BLOOD, V116, P5795, DOI 10.1182/blood-2010-03-273094; Campion Y, 2007, BIOCHIMIE, V89, P1145, DOI 10.1016/j.biochi.2007.01.010; Campion Y, 2009, J INNATE IMMUN, V1, P556, DOI 10.1159/000231977; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Dang PMC, 2011, BIOCHEM PHARMACOL, V82, P1145, DOI 10.1016/j.bcp.2011.07.070; Dang PMC, 2001, J IMMUNOL, V166, P1206, DOI 10.4049/jimmunol.166.2.1206; David A, 2005, EXP CELL RES, V308, P156, DOI 10.1016/j.yexcr.2005.03.034; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; ELBENNA J, 1994, J BIOL CHEM, V269, P6729; ElBenna J, 1997, J BIOL CHEM, V272, P17204, DOI 10.1074/jbc.272.27.17204; Guichard C, 2005, J BIOL CHEM, V280, P37021, DOI 10.1074/jbc.M506594200; Guignard F, 1996, BIOCHEM J, V316, P233, DOI 10.1042/bj3160233; KLINGER E, 1992, BIOCHEM J, V285, P635, DOI 10.1042/bj2850635; Li JR, 1997, BIOCHEMISTRY-US, V36, P5529, DOI 10.1021/bi963013r; Li XJ, 2007, J LEUKOCYTE BIOL, V81, P238, DOI 10.1189/jlb.0905541; Lu W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001357; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; Mizrahi A, 2005, J BIOL CHEM, V280, P3802, DOI 10.1074/jbc.M410257200; Nauseef WM, 2008, SEMIN IMMUNOPATHOL, V30, P195, DOI 10.1007/s00281-008-0117-4; Nguyen MVC, 2015, M S-MED SCI, V31, P43, DOI 10.1051/medsci/20153101012; Paclet MH, 2007, FASEB J, V21, P1244, DOI 10.1096/fj.06-6852com; Paclet MH, 2000, BIOCHEMISTRY-US, V39, P9302, DOI 10.1021/bi000483j; PEVERI P, 1992, P NATL ACAD SCI USA, V89, P2494, DOI 10.1073/pnas.89.6.2494; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; RIDER MH, 1986, BIOCHEM J, V240, P57, DOI 10.1042/bj2400057; Rodriguez-Espinosa O, 2015, IMMUNOLOGY, V145, P213, DOI 10.1111/imm.12437; Shao DM, 2003, FEBS LETT, V550, P101, DOI 10.1016/S0014-5793(03)00845-7; SMOLEN JE, 1980, J CLIN INVEST, V65, P1077, DOI 10.1172/JCI109760; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096; Vergnaud S, 2000, EUR J BIOCHEM, V267, P1059, DOI 10.1046/j.1432-1327.2000.01097.x; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; WILSON PD, 1981, HISTOCHEM J, V13, P31, DOI 10.1007/BF01005837; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; ZUCKER-FRANKLIN DOROTHEA, 1968, SEMINAR HEMATOL, V5, P109	42	21	21	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					663	673		10.1096/fj.201600720R	http://dx.doi.org/10.1096/fj.201600720R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27799347				2022-12-26	WOS:000394235400019
J	Li, A; Li, JW; Johnson, KA				Li, An; Li, Jiawen; Johnson, Kenneth A.			HIV-1 Reverse Transcriptase Polymerase and RNase H (Ribonuclease H) Active Sites Work Simultaneously and Independently	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-POLYMERASE; SECONDARY STRUCTURE; AVIAN-MYELOBLASTOSIS; DRUG-RESISTANCE; RNA/DNA HYBRID; KINETIC-DATA; CLEAVAGE; DOMAIN; SPECIFICITY	HIV reverse transcriptase plays a central role in viral replication and requires coordination of both polymerase and RNase H activities. Although this coordination is crucial in viral replication, whether a DNA/RNA hybrid can simultaneously engage both active sites has yet to be determined as structural and kinetic analyses have provided contradictory results. Single nucleotide incorporation and RNase H cleavage were examined using presteady-state kinetics with global data analysis. The results revealed three interconverting reverse transcriptase-DNA/RNA species; 43% were active for both sites simultaneously, 27% showed only polymerase activity, and the remaining 30% were nonproductive. Our data clearly demonstrated that the DNA/RNA hybrid could contact both active sites simultaneously, although the single nucleotide incorporation (105 s(-1)) was similar to 5-fold faster than the cleavage (23 s(-1)). By using a series of primers with different lengths, we found that a string of at least 4-6 nucleotides downstream of the cleaving site was required for efficient RNA cleavage. This was corroborated by our observations that during processive nucleotide incorporation, sequential rounds of RNA cleavage occurred each time after similar to 6 nucleotides were incorporated. More importantly, during processive primer extension, pyrophosphate (PPi) release was ratelimiting so that the average rate of nucleotide incorporation (similar to 28 s(-1)) was comparable with that of net RNA cleavage (similar to 27 nucleotides(s)). Although polymerization is efficient and processive, RNase H is inefficient and periodic. This combination allows the two catalytic centers of HIVRT to work simultaneously at similar speeds without being tightly coupled.	[Li, An; Li, Jiawen; Johnson, Kenneth A.] Univ Texas Austin, Inst Cell & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), 2500 Speedway MBB3-122, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			National Institutes of Health [R01 GM084741]; Welch Foundation [F-1604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM084741. This work was also supported by a grant from the Welch Foundation (F-1604). K. A. J. is the president of KinTek Corp., which provided the AutoSF-200x stopped flow and RQF-3 quench-flow instruments and KinTek Explorer software used in this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Auerbach SD, 2005, J BIOL CHEM, V280, P37048, DOI 10.1074/jbc.M502984200; Beilhartz GL, 2010, VIRUSES-BASEL, V2, P900, DOI 10.3390/v2040900; Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Champoux JJ, 2009, FEBS J, V276, P1506, DOI 10.1111/j.1742-4658.2009.06909.x; Das K, 2014, NUCLEIC ACIDS RES, V42, P8125, DOI 10.1093/nar/gku487; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P7423; DESTEFANO JJ, 1994, NUCLEIC ACIDS RES, V22, P3793, DOI 10.1093/nar/22.18.3793; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P24295; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; EVANS DB, 1991, J BIOL CHEM, V266, P20583; FURFINE ES, 1991, J BIOL CHEM, V266, P406; Gao HQ, 1998, J MOL BIOL, V277, P559, DOI 10.1006/jmbi.1998.1624; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; Hanes JW, 2008, ANAL BIOCHEM, V372, P125, DOI 10.1016/j.ab.2007.08.004; HOSTOMSKY Z, 1991, P NATL ACAD SCI USA, V88, P1148, DOI 10.1073/pnas.88.4.1148; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KATI WM, 1992, J BIOL CHEM, V267, P25988; KECK JL, 1995, P NATL ACAD SCI USA, V92, P2740, DOI 10.1073/pnas.92.7.2740; Kellinger MW, 2011, BIOCHEMISTRY-US, V50, P5008, DOI 10.1021/bi200204m; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kerr SG, 1997, BIOCHEMISTRY-US, V36, P14056, DOI 10.1021/bi971385+; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; KRUG MS, 1989, P NATL ACAD SCI USA, V86, P3539, DOI 10.1073/pnas.86.10.3539; Lapkouski M, 2013, NAT STRUCT MOL BIOL, V20, P230, DOI 10.1038/nsmb.2485; Li A, 2016, J BIOL CHEM, V291, P26554, DOI 10.1074/jbc.M116.753152; Mandal D, 2006, NUCLEIC ACIDS RES, V34, P2853, DOI 10.1093/nar/gkl360; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Powell MD, 1999, J BIOL CHEM, V274, P19885, DOI 10.1074/jbc.274.28.19885; Purohit V, 2007, J BIOL CHEM, V282, P12598, DOI 10.1074/jbc.M700043200; Rausch JW, 2002, BIOCHEMISTRY-US, V41, P4856, DOI 10.1021/bi015970t; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Schultz SJ, 2010, J MOL BIOL, V397, P161, DOI 10.1016/j.jmb.2010.01.059; Shaw-Reid CA, 2005, BIOCHEMISTRY-US, V44, P1595, DOI 10.1021/bi0486740; SMITH JS, 1993, J VIROL, V67, P4037, DOI 10.1128/JVI.67.7.4037-4049.1993; STAHL SJ, 1994, PROTEIN ENG, V7, P1103, DOI 10.1093/protein/7.9.1103; STAMMERS DK, 1991, FEBS LETT, V283, P298, DOI 10.1016/0014-5793(91)80613-8; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12468, DOI 10.1021/bi971218+; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P14778, DOI 10.1021/bi971963m; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057	46	16	16	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26566	26585		10.1074/jbc.M116.753160	http://dx.doi.org/10.1074/jbc.M116.753160			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27777303	Green Published, hybrid			2022-12-26	WOS:000391568200028
J	Grabe, GJ; Zhang, Y; Przydacz, M; Rolhion, N; Yang, Y; Pruneda, JN; Komander, D; Holden, DW; Hare, SA				Grabe, Grzegorz J.; Zhang, Yue; Przydacz, Michal; Rolhion, Nathalie; Yang, Yi; Pruneda, Jonathan N.; Komander, David; Holden, David W.; Hare, Stephen A.			The Salmonella Effector SpvD Is a Cysteine Hydrolase with a Serovar-specific Polymorphism Influencing Catalytic Activity, Suppression of Immune Responses, and Bacterial Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECISION-MAKING; PLASMID; MECHANISM; UBIQUITIN; DUBLIN; PHENIX; TYPHIMURIUM; REFINEMENT; BINDING; SYSTEM	Many bacterial pathogens secrete virulence (effector) proteins that interfere with immune signaling in their host. SpvD is a Salmonella enterica effector protein that we previously demonstrated to negatively regulate the NF-kappa B signaling pathway and promote virulence of S. enterica serovar Typhimurium in mice. To shed light on the mechanistic basis for these observations, we determined the crystal structure of SpvD and show that it adopts a papa-in-like fold with a characteristic cysteine-histidine-aspartate catalytic triad comprising Cys-73, His-162, and Asp-182. SpvD possessed an in vitro deconjugative activity on aminoluciferin-linked peptide and protein substrates in vitro. A C73A mutation abolished SpvD activity, demonstrating that an intact catalytic triad is required for its function. Taken together, these results strongly suggest that SpvD is a cysteine protease. The amino acid sequence of SpvD is highly conserved across different S. enterica serovars, but residue 161, located close to the catalytic triad, is variable, with serovar Typhimurium SpvD havingan arginine and serovar Enteritidis a glycine at this position. This variation affected hydrolytic activity of the enzyme on artificial substrates and can be explained by substrate accessibility to the active site. Interestingly, the SpvD(G161) variant more potently inhibited NF-kappa B-mediated immune responses in cells in vitro and increased virulence of serovar Typhimurium in mice. In summary, our results explain the biochemical basis for the effect of virulence protein SpvD and demonstrate that a single amino acid polymorphism can affect the overall virulence of a bacterial pathogen in its host.	[Grabe, Grzegorz J.; Rolhion, Nathalie; Holden, David W.] Imperial Coll London, Microbiol Sect, London SW7 2AZ, England; [Zhang, Yue; Przydacz, Michal; Yang, Yi; Hare, Stephen A.] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, Dept Life Sci, London SW7 2AZ, England; [Pruneda, Jonathan N.; Komander, David] MRC Lab Mol Biol, Div Prot & Nucle Acid Chem, Cambridge CB2 OQH, England; [Zhang, Yue] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Rolhion, Nathalie] Inst Pasteur, Unite Interact Bacteries Cellules, F-75724 Paris, France	Imperial College London; Imperial College London; University of Cambridge; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Holden, DW (corresponding author), Imperial Coll London, Microbiol Sect, London SW7 2AZ, England.; Hare, SA (corresponding author), Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, Dept Life Sci, London SW7 2AZ, England.	d.holden@imperial.ac.uk; s.hare@imperial.ac.uk	Grabe, Grzegorz/CAG-9633-2022	Grabe, Grzegorz/0000-0002-0419-491X; Pruneda, Jonathan/0000-0002-0304-4418; Holden, David/0000-0002-8369-5105; Hare, Stephen/0000-0003-2951-1595; ROLHION, nathalie/0000-0002-2946-4808	Medical Research Council [MR/K027077/1, G1100332]; Wellcome Trust [095484/Z/11/Z, 093617/Z/10/Z]; Medical Research Council [MC_U105192732] Funding Source: researchfish; MRC [MR/K027077/1, MC_U105192732] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grants MR/K027077/1 (to D. H.) and G1100332 (to S. H.), Wellcome Trust Grant 095484/Z/11/Z (to D. H.), and Wellcome Trust Fellowship 093617/Z/10/Z (to G. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bauerfeind R, 2001, BERL MUNCH TIERARZTL, V114, P404; BENINGER PR, 1988, J CLIN INVEST, V81, P1341, DOI 10.1172/JCI113461; Bhaskaran SS, 2012, ACTA CRYSTALLOGR D, V68, P1613, DOI 10.1107/S0907444912039042; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Filipek R, 2005, J BIOL CHEM, V280, P14669, DOI 10.1074/jbc.M411792200; GULIG PA, 1988, INFECT IMMUN, V56, P3262, DOI 10.1128/IAI.56.12.3262-3271.1988; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; JONES GW, 1982, INFECT IMMUN, V38, P476, DOI 10.1128/IAI.38.2.476-486.1982; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KRAUSE M, 1992, J BACTERIOL, V174, P4482, DOI 10.1128/JB.174.13.4482-4489.1992; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; Libby SJ, 1997, INFECT IMMUN, V65, P1786, DOI 10.1128/IAI.65.5.1786-1792.1997; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; Mirkovic B, 2011, CHEMMEDCHEM, V6, P1351, DOI 10.1002/cmdc.201100098; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Nishide A, 2013, J MOL BIOL, V425, P2623, DOI 10.1016/j.jmb.2013.02.037; PICKERSGILL RW, 1992, ACTA CRYSTALLOGR B, V48, P59, DOI 10.1107/S0108768191006572; Pruneda JN, 2016, MOL CELL, V63, P261, DOI 10.1016/j.molcel.2016.06.015; Rolhion N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005653; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thornbrough JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045245; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wong CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10172; Yang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138529; Zhang Z, 2006, J APPL CRYSTALLOGR, V39, P112, DOI 10.1107/S0021889805040677; Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100; Zhu YQ, 2007, MOL CELL, V28, P899, DOI 10.1016/j.molcel.2007.11.011	41	21	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25853	25863		10.1074/jbc.M116.752782	http://dx.doi.org/10.1074/jbc.M116.752782			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27789710	Green Published, hybrid			2022-12-26	WOS:000390345200009
J	Rosati, R; Patki, M; Chari, V; Dakshnamurthy, S; McFall, T; Saxton, J; Kidder, BL; Shaw, PE; Ratnam, M				Rosati, Rayna; Patki, Mugdha; Chari, Venkatesh; Dakshnamurthy, Selvakumar; McFall, Thomas; Saxton, Janice; Kidder, Benjamin L.; Shaw, Peter E.; Ratnam, Manohar			The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX-FORMATION; TRANSCRIPTION FACTOR; MAP KINASES; PROGRESSION; TARGETS; BINDING; SURFACE; PHOSPHORYLATION; OVEREXPRESSION; PROLIFERATION	The ETS domain transcription factor ELK1 is in a repressive association with growth genes and is transiently activated through phosphorylation by ERK1/2. In prostate cancer (PCa) cells the androgen receptor (AR) is recruited by ELK1, via its amino-terminal domain (A/B), as a transcriptional co-activator, without ELK1 hyper-phosphorylation. Here we elucidate the structural basis of the interaction of AR with ELK1. The ELK1 polypeptide motifs required for co-activation by AR versus those required for activation of ELK1 by ERK were systematically mapped using a mammalian two-hybrid system and confirmed using a co-immunoprecipitation assay. The mapping precisely identified the two ERK-docking sites in ELK1, the D-box and the DEF (docking site for ERK, FXFP) motif, as the essential motifs for its cooperation with AR(A/B) or WTAR. In contrast, the transactivation domain in ELK1 was only required for activation by ERK. ELK1-mediated transcriptional activity of AR(A/B) was optimal in the absence of ELK1 binding partners, ERK1/2 and serum-response factor. Purified ELK1 and AR bound with a dissociation constant of 1.9 x 10(-8) M. A purified mutant ELK1 in which the D-box and DEF motifs were disrupted did not bind AR. An ELK1 mutant with deletion of the D-box region had a dominant-negative effect on androgen-dependent growth of PCa cells that were insensitive to MEK inhibition. This novel mechanism in which a nuclear receptor impinges on a signaling pathway by co-opting protein kinase docking sites to constitutively activate growth genes could enable rational design of a new class of targeted drug interventions.	[Rosati, Rayna; Patki, Mugdha; Chari, Venkatesh; Dakshnamurthy, Selvakumar; McFall, Thomas; Kidder, Benjamin L.; Ratnam, Manohar] Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Rosati, Rayna; Patki, Mugdha; Chari, Venkatesh; Dakshnamurthy, Selvakumar; McFall, Thomas; Kidder, Benjamin L.; Ratnam, Manohar] Dept Oncol, Detroit, MI 48201 USA; [Rosati, Rayna; Patki, Mugdha; McFall, Thomas; Kidder, Benjamin L.; Ratnam, Manohar] Wayne State Univ, Sch Med, Detroit, MI 48201 USA; [Saxton, Janice; Shaw, Peter E.] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England	Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Nottingham	Ratnam, M (corresponding author), 4100 John R,HWCRC840-1, Detroit, MI 48201 USA.	ratnamm@karmanos.org		SHAW, Peter/0000-0002-2598-4283	National Institutes of Health NRSA [5T32CA009531]; Biotechnology and Biological Sciences Research Council [BB/D019117/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA009531, P30CA022453] Funding Source: NIH RePORTER; BBSRC [BB/D019117/1] Funding Source: UKRI	National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Institutes of Health NRSA-T32 Training Grant 5T32CA009531 (to R. R.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barletta F, 2004, MOL ENDOCRINOL, V18, P1096, DOI 10.1210/me.2003-0335; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cai CM, 2011, CANCER RES, V71, P6503, DOI 10.1158/0008-5472.CAN-11-0532; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Criqui-Filipe P, 1999, EMBO J, V18, P3392, DOI 10.1093/emboj/18.12.3392; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Evans EL, 2011, NUCLEIC ACIDS RES, V39, P6390, DOI 10.1093/nar/gkr266; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Gonit M, 2011, MOL ENDOCRINOL, V25, P621, DOI 10.1210/me.2010-0409; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kawahara T, 2015, AM J CANCER RES, V5, P2959; Kawahara T, 2015, ONCOTARGET, V6, P29860, DOI 10.18632/oncotarget.5007; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Lamont KR, 2011, MOL ENDOCRINOL, V25, P897, DOI 10.1210/me.2010-0469; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Liao RS, 2013, TRANSL ANDROL UROL, V2, P187, DOI 10.3978/j.issn.2223-4683.2013.09.07; Linja MJ, 2001, CANCER RES, V61, P3550; Lonard DM, 2012, NAT REV ENDOCRINOL, V8, P598, DOI 10.1038/nrendo.2012.100; Massard C, 2011, CLIN CANCER RES, V17, P3876, DOI 10.1158/1078-0432.CCR-10-2815; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Patki M, 2013, J BIOL CHEM, V288, P11047, DOI 10.1074/jbc.M112.438473; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Ratnam M, 2013, ANDROGEN RESPONSIVE, P85; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Selvakumar D, 2013, J BIOL CHEM, V288, P7215, DOI 10.1074/jbc.M112.443226; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; SHAW PE, 1989, EMBO J, V8, P2567, DOI 10.1002/j.1460-2075.1989.tb08395.x; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tanoue T, 2002, J BIOL CHEM, V277, P22942, DOI 10.1074/jbc.M202096200; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Toren P, 2014, INT J ONCOL, V45, P1793, DOI 10.3892/ijo.2014.2601; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; Urbanucci A, 2012, ONCOGENE, V31, P2153, DOI 10.1038/onc.2011.401; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zarif JC, 2016, CELL SIGNAL, V28, P348, DOI 10.1016/j.cellsig.2016.01.013; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhang HM, 2008, NUCLEIC ACIDS RES, V36, P2594, DOI 10.1093/nar/gkn099; Zhang J, 2010, ONCOGENE, V29, P723, DOI 10.1038/onc.2009.373; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	63	10	10	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25983	25998		10.1074/jbc.M116.745596	http://dx.doi.org/10.1074/jbc.M116.745596			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27793987	Green Published, hybrid			2022-12-26	WOS:000390345200019
J	Sorrenson, B; Cognard, E; Lee, KL; Dissanayake, WC; Fu, YY; Han, WP; Hughes, WE; Shepherd, PR				Sorrenson, Brie; Cognard, Emmanuelle; Lee, Kathryn L.; Dissanayake, Waruni C.; Fu, Yanyun; Han, Weiping; Hughes, William E.; Shepherd, Peter R.			A Critical Role for beta-Catenin in Modulating Levels of Insulin Secretion from beta-Cells by Regulating Actin Cytoskeleton and Insulin Vesicle Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULE EXOCYTOSIS; SYNAPTIC VESICLES; SIGNALING PATHWAY; GLUCOSE; TCF7L2; MECHANISMS; CADHERIN; GENE; ASSOCIATION; ACTIVATION	The processes regulating glucose-stimulated insulin secretion (GSIS) and its modulation by incretins in pancreatic beta-cells are only partly understood. Here we investigate the involvement of beta-catenin in these processes. Reducing beta-catenin levels using siRNA knockdown attenuated GSIS in a range of beta-cell models and blocked the ability of GLP-1 agonists and the depolarizing agent KCl to potentiate this. This could be mimicked in both beta-cell models and isolated islets by short-term exposure to the beta-catenin inhibitory drug pyrvinium. In addition, short-term treatment with a drug that increases beta-catenin levels results in an increase in insulin secretion. The timing of these effects suggests that beta-catenin is required for the processes regulating trafficking and/or release of pre-existing insulin granules rather than for those regulated by gene expression. This was supported by the finding that the overexpression of the transcriptional coactivator of beta-catenin, transcription factor 7-like 2 (TCF7L2), attenuated insulin secretion, consistent with the extra TCF7L2 translocating beta-catenin from the plasma membrane pool to the nucleus. We show that beta-catenin depletion disrupts the intracellular actin cytoskeleton, and by using total internal reflectance fluorescence (TIRF) microscopy, we found that beta-catenin is required for the glucose-and incretin-induced depletion of insulin vesicles from near the plasma membrane. In conclusion, we find that beta-catenin levels modulate Ca2+-dependent insulin exocytosis under conditions of glucose, GLP-1, or KCl stimulation through a role in modulating insulin secretory vesicle localization and/or fusion via actin remodeling. These findings also provide insights as to how the overexpression of TCF7L2 may attenuate insulin secretion.	[Sorrenson, Brie; Cognard, Emmanuelle; Lee, Kathryn L.; Dissanayake, Waruni C.; Shepherd, Peter R.] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Private Bag 92019, Auckland 1142, New Zealand; [Sorrenson, Brie; Shepherd, Peter R.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1142, New Zealand; [Fu, Yanyun; Han, Weiping] ASTAR, Singapore Bioimaging Consortium, Singapore 138667, Singapore; [Hughes, William E.] St Vincents Hosp, Dept Med, Victoria St, Sydney, NSW 2010, Australia; [Hughes, William E.] Garvan Inst Med Res, 384 Victoria St, Sydney, NSW 2010, Australia	University of Auckland; University of Auckland; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); St Vincents Hospital Sydney; Garvan Institute of Medical Research	Shepherd, PR (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Private Bag 92019, Auckland 1142, New Zealand.; Shepherd, PR (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1142, New Zealand.	peter.shepherd@auckland.ac.nz		Hughes, William/0000-0002-7149-3987; Sorrenson, Brie/0000-0002-0938-7585	Health Research Council of New Zealand; University of Auckland; New Zealand Heart Foundation	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Auckland; New Zealand Heart Foundation	This work was supported by a project grant from the Health Research Council of New Zealand and a PJ Smith Traveling Fellowship from the University of Auckland. This work was also supported by a New Zealand Heart Foundation Research Fellowship (to B. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bertera S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/856386; Bian S., 2011, PLOS ONE, V6; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Cognard E, 2013, BIOCHEM J, V449, P803, DOI 10.1042/BJ20121454; Dabernat S, 2009, DIABETOLOGIA, V52, P1608, DOI 10.1007/s00125-009-1411-y; Dufer M, 2011, DIABETOLOGIA, V54, P423, DOI 10.1007/s00125-010-1936-0; Elghazi L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00693; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Gujral TS, 2013, CHEM BIOL, V20, P816, DOI 10.1016/j.chembiol.2013.04.021; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; He H, 2008, BBA-MOL CELL RES, V1783, P1943, DOI 10.1016/j.bbamcr.2008.04.016; Heaslip AT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109082; Hodgkin MN, 2007, PANCREAS, V34, P170, DOI 10.1097/01.mpa.0000240616.28098.55; Jacobson DA, 2010, J PHYSIOL-LONDON, V588, P3525, DOI 10.1113/jphysiol.2010.190207; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Jin T, 2008, DIABETOLOGIA, V51, P1771, DOI 10.1007/s00125-008-1084-y; Johansson JK, 2010, GENESIS, V48, P374, DOI 10.1002/dvg.20628; Kalwat MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.73; Kalwat MA, 2013, BIOCHEM PHARMACOL, V85, P808, DOI 10.1016/j.bcp.2012.12.003; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krutzfeldt J, 2010, DIABETOLOGIA, V53, P123, DOI 10.1007/s00125-009-1578-2; Lesage F, 2004, P NATL ACAD SCI USA, V101, P671, DOI 10.1073/pnas.0307681100; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; Meloni AR, 2013, DIABETES OBES METAB, V15, P15, DOI 10.1111/j.1463-1326.2012.01663.x; Mitchell RK, 2015, HUM MOL GENET, V24, P1390, DOI 10.1093/hmg/ddu553; Mourad NI, 2010, AM J PHYSIOL-CELL PH, V299, pC389, DOI 10.1152/ajpcell.00138.2010; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Parnaud G, 2015, DIABETES, V64, P887, DOI 10.2337/db14-0257; Rogers GJ, 2007, CELL PHYSIOL BIOCHEM, V20, P987, DOI 10.1159/000110459; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Rutter GA, 2014, DIABETIC MED, V31, P1480, DOI 10.1111/dme.12579; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Sun Y, 2011, J NEUROSCI, V31, P17123, DOI 10.1523/JNEUROSCI.2359-11.2011; Sun Y, 2009, MOL BIOL CELL, V20, P3390, DOI 10.1091/mbc.E08-12-1172; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tsang SW, 2010, MOL CELL ENDOCRINOL, V315, P263, DOI 10.1016/j.mce.2009.11.007; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Yang SY, 2016, BIOCHEM J, V473, P1791, DOI 10.1042/BCJ20160137; Zhu G, 2012, ONCOGENE, V31, P1001, DOI 10.1038/onc.2011.294	59	31	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25888	25900		10.1074/jbc.M116.758516	http://dx.doi.org/10.1074/jbc.M116.758516			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27777306	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000390345200012
J	Huang, SC; Zhou, AY; Nguyen, DT; Zhang, HS; Benz, EJ				Huang, Shu-Ching; Zhou, Anyu; Nguyen, Dan T.; Zhang, Henry S.; Benz, Edward J., Jr.			Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; myogenesis; protein degradation; protein stability; ubiquitylation (ubiquitination); myogenin; protein 4; 1R; von Hippel Lindau	TUMOR-SUPPRESSOR PROTEIN; MYOD MESSENGER-RNA; NONERYTHROID ISOFORM; EXPRESSION; GENE; IDENTIFICATION; DEGRADATION; CELLS; PATHOGENESIS; DISTINCT	Protein 4.1R (4.1R) isoforms are expressed in both cardiac and skeletal muscle. 4.1R is a component of the contractile apparatus. It is also associated with dystrophin at the sarcolemma in skeletal myofibers. However, the expression and function of 4.1R during myogenesis have not been characterized. We now report that 4.1R expression increases during C2C12 myoblast differentiation into myotubes. Depletion of 4.1R impairs skeletal muscle differentiation and is accompanied by a decrease in the levels of myosin heavy and light chains and caveolin-3. Furthermore, the expression of myogenin at the protein, but not mRNA, level is drastically decreased in 4.1R knockdown myocytes. Similar results were obtained using MyoD-induced differentiation of 4.1R(-/-) mouse embryonic fibroblast cells. von Hippel-Lindau (VHL) protein is known to destabilize myogenin via the ubiquitin-proteasome pathway. We show that 4.1R associates with VHL and, when overexpressed, reverses myogenin ubiquitination and stability. This suggests that 4.1R may influence myogenesis by preventing VHL-mediated myogenin degradation. Together, our results define a novel biological function for 4.1R in muscle differentiation and provide a molecular mechanism by which 4.1R promotes myogenic differentiation.	[Huang, Shu-Ching; Zhou, Anyu; Nguyen, Dan T.; Zhang, Henry S.; Benz, Edward J., Jr.] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA; [Huang, Shu-Ching; Benz, Edward J., Jr.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Huang, Shu-Ching; Benz, Edward J., Jr.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Benz, Edward J., Jr.] Dana Farber Harvard Canc Ctr, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Huang, SC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA.	shu-ching_huang@dfci.harvard.edu			National Institutes of Health [HL24385, HL44985, HL61295]; Claudia Barr Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024385, R29HL061295, R01HL061295, R01HL044985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claudia Barr Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL24385 and HL44985 (to E.J.B.) and National Institutes of Health Grant HL61295 and the Claudia Barr Award (to S.C.H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; AURADE F, 1994, DIFFERENTIATION, V55, P185, DOI 10.1046/j.1432-0436.1994.5530185.x; Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; Biederer CH, 2000, J BIOL CHEM, V275, P26245, DOI 10.1074/jbc.M001430200; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Braun T, 1996, EMBO J, V15, P310, DOI 10.1002/j.1460-2075.1996.tb00361.x; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Deguillien M, 2001, BLOOD, V98, P3809, DOI 10.1182/blood.V98.13.3809; Delhommeau F, 2005, CR BIOL, V328, P43, DOI 10.1016/j.crvi.2004.11.003; Doucet Christine, 2005, BMC Biochem, V6, P27, DOI 10.1186/1471-2091-6-27; EDMONDSON DG, 1991, J BIOL CHEM, V266, P21343; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Gutmann DH, 2000, HUM MOL GENET, V9, P1495, DOI 10.1093/hmg/9.10.1495; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Infante JP, 1999, MOL CELL BIOCHEM, V195, P155, DOI 10.1023/A:1006972315739; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jin DH, 2010, GENES CELLS, V15, P1158, DOI 10.1111/j.1365-2443.2010.01446.x; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kontrogianni-Konstantopoulos A, 2000, MOL BIOL CELL, V11, P3805, DOI 10.1091/mbc.11.11.3805; Krauss SW, 2003, P NATL ACAD SCI USA, V100, P10752, DOI 10.1073/pnas.1934680100; Kuns R, 2005, ONCOGENE, V24, P6502, DOI 10.1038/sj.onc.1208813; Lallena MJ, 1998, J CELL SCI, V111, P1963; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Lindon C, 2000, MOL CELL BIOL, V20, P8923, DOI 10.1128/MCB.20.23.8923-8932.2000; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Na X, 2003, EMBO J, V22, P4249, DOI 10.1093/emboj/cdg410; Noy T, 2012, BIOCHEM BIOPH RES CO, V418, P408, DOI 10.1016/j.bbrc.2012.01.045; Olguin HC, 2011, BIOL RES, V44, P323, DOI /S0716-97602011000400002; Pecina-Slaus N, 2013, PATHOL ONCOL RES, V19, P365, DOI 10.1007/s12253-013-9644-y; Perry A, 2004, J NEURO-ONCOL, V70, P183, DOI 10.1007/s11060-004-2749-0; Pinder JC, 2012, EXP CELL RES, V318, P1467, DOI 10.1016/j.yexcr.2012.03.003; Rajaram V, 2005, MODERN PATHOL, V18, P991, DOI 10.1038/modpathol.3800390; Reinstein E, 2006, ANN INTERN MED, V145, P676, DOI 10.7326/0003-4819-145-9-200611070-00010; Robb VA, 2003, NEUROBIOL DIS, V13, P191, DOI 10.1016/S0969-9961(03)00071-8; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Shiraishi S, 2007, J BIOL CHEM, V282, P9017, DOI 10.1074/jbc.M611513200; Stagg MA, 2008, CIRC RES, V103, P855, DOI 10.1161/CIRCRESAHA.108.176461; Sussman Michael, 2002, J Am Acad Orthop Surg, V10, P138; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Taylor-Harris PM, 2005, MAMM GENOME, V16, P137, DOI 10.1007/s00335-004-2436-7; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; Wong SY, 2007, P NATL ACAD SCI USA, V104, P12784, DOI 10.1073/pnas.0705499104; Yageta M, 2002, CANCER RES, V62, P5129; YAMAGUCHI A, 1995, SEMIN CELL BIOL, V6, P165, DOI 10.1006/scel.1995.0023; Yang SM, 2009, BBA-BIOMEMBRANES, V1788, P1458, DOI 10.1016/j.bbamem.2009.03.022; Young JA, 2011, J BIOL CHEM, V286, P6521, DOI 10.1074/jbc.M110.172288; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zatyka M, 2002, CANCER RES, V62, P3803	68	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25591	25607		10.1074/jbc.M116.761296	http://dx.doi.org/10.1074/jbc.M116.761296			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27780863	Green Published, hybrid			2022-12-26	WOS:000390095300026
J	Xie, J; Cai, K; Hu, HX; Jiang, YL; Yang, F; Hu, PF; Cao, DD; Li, WF; Chen, YX; Zhou, CZ				Xie, Jin; Cai, Kun; Hu, Hai-Xi; Jiang, Yong-Liang; Yang, Feng; Hu, Peng-Fei; Cao, Dong-Dong; Li, Wei-Fang; Chen, Yuxing; Zhou, Cong-Zhao			Structural Analysis of the Catalytic Mechanism and Substrate Specificity of Anabaena Alkaline Invertase InvA Reveals a Novel Glucosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; cyanobacteria; enzyme catalysis; glycoside hydrolase; substrate specificity; GH100; alkaline; neutral invertases; glucosidase; sucrose metabolism	NEUTRAL INVERTASE; CYTOSOLIC INVERTASE; SUCROSE METABOLISM; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; CELL-DEVELOPMENT; NORMAL GROWTH; SOLUBLE ACID; PURIFICATION; COMPLEX	Invertases catalyze the hydrolysis of sucrose to glucose and fructose, thereby playing a key role in primary metabolism and plant development. According to the optimum pH, invertases are classified into acid invertases (Ac-Invs) and alkaline/neutral invertases (A/N-Invs), which share no sequence homology. Compared with Ac-Invs that have been extensively studied, the structure and catalytic mechanism of A/N-Invs remain unknown. Here we report the crystal structures of Anabaena alkaline invertase InvA, which was proposed to be the ancestor of modern plant A/N-Invs. These structures are the first in the GH100 family. InvA exists as a hexamer in both crystal and solution. Each subunit consists of an (/)(6) barrel core structure in addition to an insertion of three helices. A couple of structures in complex with the substrate or products enabled us to assign the subsites -1 and +1 specifically binding glucose and fructose, respectively. Structural comparison combined with enzymatic assays indicated that Asp-188 and Glu-414 are putative catalytic residues. Further analysis of the substrate binding pocket demonstrated that InvA possesses a stringent substrate specificity toward the 1,2-glycosidic bond of sucrose. Together, we suggest that InvA and homologs represent a novel family of glucosidases.	[Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Chen, YX; Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	cyxing@ustc.edu.cn; zcz@ustc.edu.cn	Chen, Yuxing/P-4156-2014; Zhou, Cong-Zhao/E-9174-2011	Chen, Yuxing/0000-0002-7560-1922; Zhou, Cong-Zhao/0000-0002-6881-7151; Jiang, YongLiang/0000-0001-5441-4936; Cao, Dongdong/0000-0002-2031-9321	National Natural Science Foundation of China [31630001, 31370757, 31621002, 31500598]; Ministry of Education of China [20133402110023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grants 31630001 and 31370757, 31621002, and 31500598 and Ministry of Education of China Grant 20133402110023. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alberto F, 2006, BIOCHEM J, V395, P457, DOI [10.1042/BJ20051936, 10.1042/Bj20051936]; Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Aleshin AE, 2003, J MOL BIOL, V327, P61, DOI 10.1016/S0022-2836(03)00084-6; Alvaro-Benito M, 2010, J BIOL CHEM, V285, P13930, DOI 10.1074/jbc.M109.095430; Barker MK, 2013, J BIOL CHEM, V288, P13563, DOI 10.1074/jbc.M113.460436; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; CHEN JQ, 1992, ARCH BIOCHEM BIOPHYS, V295, P61, DOI 10.1016/0003-9861(92)90488-I; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coleman HD, 2009, P NATL ACAD SCI USA, V106, P13118, DOI 10.1073/pnas.0900188106; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallagher JA, 1998, J EXP BOT, V49, P789, DOI 10.1093/jexbot/49.322.789; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Guerin DMA, 2002, J MOL BIOL, V316, P1061, DOI 10.1006/jmbi.2001.5404; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; HAMAZAKI H, 1980, EUR J BIOCHEM, V111, P587, DOI 10.1111/j.1432-1033.1980.tb04975.x; Hertel S, 2000, CARBOHYD RES, V326, P264, DOI 10.1016/S0008-6215(00)00008-2; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hussain A, 2009, PLANT PHYSIOL BIOCH, V47, P188, DOI 10.1016/j.plaphy.2008.11.001; Jia LQ, 2008, PLANTA, V228, P51, DOI 10.1007/s00425-008-0718-0; Kim D, 2010, J INTEGR PLANT BIOL, V52, P536, DOI 10.1111/j.1744-7909.2010.00937.x; Kim HS, 2004, J BACTERIOL, V186, P411, DOI 10.1128/JB.186.2.411-418.2004; Kim MI, 2008, J MOL BIOL, V380, P636, DOI 10.1016/j.jmb.2008.05.046; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Kolman Maria A., 2015, Life-Basel, V5, P102, DOI 10.3390/life5010102; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurakata Y, 2008, J MOL BIOL, V381, P116, DOI 10.1016/j.jmb.2008.05.061; Lammens W, 2008, J MOL BIOL, V377, P378, DOI 10.1016/j.jmb.2007.12.074; Lee HS, 1996, PLANT PHYSIOL, V112, P1513, DOI 10.1104/pp.112.4.1513; Lin CL, 1999, NEW PHYTOL, V142, P427, DOI 10.1046/j.1469-8137.1999.00416.x; Liu CC, 2006, FOOD CHEM, V96, P621, DOI 10.1016/j.foodchem.2005.02.044; Liu SJ, 2015, NEW PHYTOL, V206, P709, DOI 10.1111/nph.13257; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lou Y, 2007, PLANT CELL, V19, P163, DOI 10.1105/tpc.106.045658; MASUDA H, 1987, AGR BIOL CHEM TOKYO, V51, P2309; MASUDA H, 1988, PLANT PHYSIOL, V86, P312, DOI 10.1104/pp.86.1.312; MITSUISHI Y, 1980, CARBOHYD RES, V83, P303, DOI 10.1016/S0008-6215(00)84542-5; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Omori T, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qi XP, 2007, PLANT MOL BIOL, V64, P575, DOI 10.1007/s11103-007-9177-4; Reca IB, 2008, BIOCHIMIE, V90, P1611, DOI 10.1016/j.biochi.2008.04.019; Reddy A, 1996, J BIOL CHEM, V271, P13953, DOI 10.1074/jbc.271.24.13953; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Salerno GL, 2003, TRENDS PLANT SCI, V8, P63, DOI 10.1016/S1360-1385(02)00029-8; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Sturm A, 1999, PHYSIOL PLANTARUM, V107, P159, DOI 10.1034/j.1399-3054.1999.100202.x; Sturm A, 1999, PLANT PHYSIOL, V121, P1, DOI 10.1104/pp.121.1.1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDENENDE W, 1995, PHYSIOL PLANTARUM, V93, P241, DOI 10.1111/j.1399-3054.1995.tb02223.x; Vargas W, 2003, PLANTA, V216, P951, DOI 10.1007/s00425-002-0943-x; Vargas WA, 2007, PLANTA, V226, P1535, DOI 10.1007/s00425-007-0590-3; Vargas WA, 2011, PLANTA, V233, P153, DOI 10.1007/s00425-010-1288-5; Vargas WA, 2010, PLANT SCI, V178, P1, DOI 10.1016/j.plantsci.2009.09.015; Walden H, 2010, ACTA CRYSTALLOGR D, V66, P352, DOI 10.1107/S0907444909038207; Wang LT, 2005, J AGR FOOD CHEM, V53, P3672, DOI 10.1021/jf0480851; Welham T, 2009, J EXP BOT, V60, P3353, DOI 10.1093/jxb/erp169; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069	67	20	21	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25667	25677		10.1074/jbc.M116.759290	http://dx.doi.org/10.1074/jbc.M116.759290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27777307	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000390095300032
J	Shin, SJ; Chung, S; Kim, SJ; Lee, EM; Yoo, YH; Kim, JW; Ahn, YB; Kim, ES; Moon, SD; Kim, MJ; Ko, SH				Shin, Seok Joon; Chung, Sungjin; Kim, Soo Jung; Lee, Eun-Mi; Yoo, Young-Hye; Kim, Ji-Won; Ahn, Yu-Bae; Kim, Eun-Sook; Moon, Sung-Dae; Kim, Myung-Jun; Ko, Seung-Hyun			Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes	PLOS ONE			English	Article							PROXIMAL TUBULAR CELLS; ACTIVATED RECEPTOR-ALPHA; PANCREATIC-FUNCTION; HYPERTENSIVE-RATS; SGLT2 INHIBITORS; OXIDATIVE STRESS; GENE-EXPRESSION; DB/DB MICE; NEPHROPATHY; KIDNEY	Background Renal renin-angiotensin system (RAS) activation is one of the important pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The aim of this study was to investigate the effects of a sodium-glucose co-transporter 2 (SGLT-2) inhibitor, dapagliflozin, on renal RAS in an animal model with type 2 diabetes. Methods Dapagliflozin (1.0 mg/kg, OL-DA) or voglibose (0.6 mg/kg, OL-VO, diabetic control) (n = 10 each) was administered to Otsuka Long-Evans Tokushima Fatty (OLETF) rats for 12 weeks. We used voglibose, an alpha-glucosidase inhibitor, as a comparable counterpart to SGLT2 inhibitor because of its postprandial glucose-lowering effect without proven renoprotective effects. Control Long-Evans Tokushima Otsuka (LT) and OLETF (OL-C) rats received saline (n = 10, each). Changes in blood glucose, urine albumin, creatinine clearance, and oxidative stress were measured. Inflammatory cell infiltration, mesangial widening, and interstitial fibrosis in the kidney were evaluated by histological analysis. The effects of dapagliflozin on renal expression of the RAS components were evaluated by quantitative RT-PCR in renal tissue. Results After treatment, hyperglycemia and urine microalbumin levels were attenuated in both OLDA and OL-VO rather than in the OL-C group (P < 0.05). The urine angiotensin II (Ang II) and angiotensinogen levels were significantly decreased following treatment with dapagliflozin or voglibose, but suppression of urine Ang II level was more prominent in the OL-DA than the OL-VO group (P < 0.05). The expressions of angiotensin type 1 receptor and tissue oxidative stress markers were markedly increased in OL-C rats, which were reversed by dapagliflozin or voglibose (P < 0.05, both). Inflammatory cell infiltration, mesangial widening, interstitial fibrosis, and total collagen content were significantly increased in OL-C rats, which were attenuated in OL-DA group (P < 0.05). Conclusion Dapagliflozin treatment showed beneficial effects on diabetic nephropathy, which might be via suppression of renal RAS component expression, oxidative stress and interstitial fibrosis in OLETF rats. We suggest that, in addition to control of hyperglycemia, partial suppression of renal RAS with an SGLT2 inhibitor would be a promising strategy for the prevention of treatment of diabetic nephropathy.	[Shin, Seok Joon; Chung, Sungjin; Kim, Soo Jung] Catholic Univ Korea, Div Nephrol, Dept Internal Med, Coll Med, Seoul, South Korea; [Lee, Eun-Mi; Yoo, Young-Hye; Kim, Ji-Won; Ahn, Yu-Bae; Kim, Eun-Sook; Moon, Sung-Dae; Ko, Seung-Hyun] Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Myung-Jun] Catholic Univ Korea, Dept Physiol, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Ko, SH (corresponding author), Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul, South Korea.	kosh@catholic.ac.kr			Korean Diabetes Association	Korean Diabetes Association	This work was supported by a grant from the Korean Diabetes Association (S.H.K 2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo S, 2015, J DIABETES METAB, V6, DOI 10.4172/2155-6156.1000547; ANDERSON S, 1993, AM J PHYSIOL, V265, pF477, DOI 10.1152/ajprenal.1993.265.4.F477; Barber MN, 1999, HYPERTENSION, V34, P1112, DOI 10.1161/01.HYP.34.5.1112; Barutta F, 2015, ENDOCRINE, V48, P730, DOI 10.1007/s12020-014-0437-1; Bouchie A, 2013, NAT BIOTECHNOL, V31, P469, DOI 10.1038/nbt0613-469; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Chen L, 2012, CURR MOL MED, V12, P995, DOI 10.2174/156652412802480970; DeFronzo RA, 2013, DIABETES CARE, V36, P3169, DOI 10.2337/dc13-0387; Durvasula RV, 2008, AM J PHYSIOL-RENAL, V294, pF830, DOI 10.1152/ajprenal.00266.2007; Fan YY, 2013, HORM METAB RES, V45, P338, DOI 10.1055/s-0032-1331256; Feliers D, 2010, MOL CELL ENDOCRINOL, V314, P136, DOI 10.1016/j.mce.2009.09.009; Fujimori Y, 2008, J PHARMACOL EXP THER, V327, P268, DOI 10.1124/jpet.108.140210; GOTO Y, 1995, DIABETES RES CLIN PR, V28, P81, DOI 10.1016/0168-8227(95)01065-L; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Gurley SB, 2007, SEMIN NEPHROL, V27, P144, DOI 10.1016/j.semnephrol.2007.01.009; Hsieh TJ, 2003, ENDOCRINOLOGY, V144, P4338, DOI 10.1210/en.2003-0220; Jones ES, 2008, PHARMACOL THERAPEUT, V120, P292, DOI 10.1016/j.pharmthera.2008.08.009; Jung CH, 2014, DIABETES METAB J, V38, P261, DOI 10.4093/dmj.2014.38.4.261; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Kim J, 2006, J BIOL CHEM, V281, P20349, DOI 10.1074/jbc.M512740200; Komala MG, 2013, CURR OPIN NEPHROL HY, V22, P113, DOI 10.1097/MNH.0b013e32835a17ae; Kreisberg JI, 1996, KIDNEY INT, V50, P805, DOI 10.1038/ki.1996.379; Macdonald FR, 2010, DIABETES OBES METAB, V12, P1004, DOI 10.1111/j.1463-1326.2010.01291.x; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; Moon JY, 2011, AM J PHYSIOL-RENAL, V300, pF1271, DOI 10.1152/ajprenal.00065.2010; Mori Y, 2004, ENDOCRINE, V23, P39, DOI 10.1385/ENDO:23:1:39; Nagata T, 2013, BRIT J PHARMACOL, V170, P519, DOI 10.1111/bph.12269; Nozako M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143979; Paisley AJ, 2013, EXPERT OPIN INV DRUG, V22, P131, DOI 10.1517/13543784.2013.740009; Park CW, 2014, DIABETES METAB J, V38, P252, DOI 10.4093/dmj.2014.38.4.252; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Plosker GL, 2012, DRUGS, V72, P2289, DOI 10.2165/11209910-000000000-00000; Raskin P, 2013, DIABETES-METAB RES, V29, P347, DOI 10.1002/dmrr.2403; Satirapoj B, 2014, KIDNEY RES CLIN PRAC, V33, P121, DOI 10.1016/j.krcp.2014.08.001; Shah NK, 2012, PHARMACOTHERAPY, V32, P80, DOI 10.1002/PHAR.1010; Shin SJ, 2009, HYPERTENS RES, V32, P835, DOI 10.1038/hr.2009.107; Singh R, 1999, DIABETES, V48, P2066, DOI 10.2337/diabetes.48.10.2066; Tahara A, 2013, EUR J PHARMACOL, V715, P246, DOI 10.1016/j.ejphar.2013.05.014; Terami N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100777; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Velez JCQ, 2009, NAT CLIN PRACT NEPHR, V5, P89, DOI 10.1038/ncpneph1015; Visavadiya NP, 2011, NEPHRON EXP NEPHROL, V117, pE62, DOI [10.1159/000320593, 10.1159/000320594]; Weibel ER., 1979, STEREOLOGICAL METHOD, P44; Wolf G, 1999, NEPHROL DIAL TRANSPL, V14, P42, DOI 10.1093/ndt/14.suppl_1.42; Wu J, 1998, BIOCHEM J, V329, P623, DOI 10.1042/bj3290623; Zaccardi F, 2016, DIABETES OBES METAB; Zhang SL, 2000, ENDOCRINOLOGY, V141, P4637, DOI 10.1210/endo.141.12.7844; Zhao FY, 2015, INT J CLIN EXP MED, V8, P22084	49	116	126	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165703	10.1371/journal.pone.0165703	http://dx.doi.org/10.1371/journal.pone.0165703			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802313	Green Published, Green Submitted, gold			2022-12-26	WOS:000386714200040
J	Arakawa, N; Kobayashi, H; Yonemoto, N; Masuishi, Y; Ino, Y; Shigetomi, H; Furukawa, N; Ohtake, N; Miyagi, Y; Hirahara, F; Hirano, H; Miyagi, E				Arakawa, Noriaki; Kobayashi, Hiroshi; Yonemoto, Naohiro; Masuishi, Yusuke; Ino, Yoko; Shigetomi, Hiroshi; Furukawa, Naoto; Ohtake, Norihisa; Miyagi, Yohei; Hirahara, Fumiki; Hirano, Hisashi; Miyagi, Etsuko			Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma	PLOS ONE			English	Article							TUMOR-MARKERS; PLACENTAL PROTEIN-5; MENSTRUAL-CYCLE; CA 125; CANCER; ADENOCARCINOMA; ENDOMETRIOSIS; PROGNOSIS; RISK; IDENTIFICATION	Background There is currently no reliable serum biomarker for ovarian clear cell carcinoma (CCC), a highly lethal histological subtype of epithelial ovarian cancer (EOC). Previously, using a proteome-based approach, we identified tissue factor pathway inhibitor 2 (TFPI2) as a candidate serum biomarker for CCC. In this study, we sought to evaluate the clinical diagnostic performance of TFPI2 in preoperative prediction of CCC. Methods Serum TFPI2 levels were measured in serum samples from a retrospective training set consisting of patients with benign and borderline ovarian tumors, EOC subtypes, and uterine diseases. Via receiver operating characteristic (ROC) analyses, we compared the diagnostic performance of TFPI2 with that of CA125 in discrimination of patients with ovarian CCC from other patient groups. The observed diagnostic performances were examined in a prospective validation set. Results The 268-patient training set included 29 patients with ovarian CCC. Unlike CA125, which was also elevated in patients with endometriosis and several EOC subtypes, serum TFPI2 levels were specifically elevated only in ovarian CCC patients, consistent with the mRNA expression pattern in tumor tissues. The area under the ROC curve (AUC) of serum TFPI2 was obviously higher than that of CA125 for discrimination of CCC from other ovarian diseases (AUC = 0.891 versus 0.595). Applying a cut-off value of 280 pg/mL, TFPI2 could distinguish early-stage ( FIGO I and II) CCC from endometriosis with 72.2% sensitivity, 93.3% specificity, and 88.8% accuracy. Similar results were confirmed in an independent 156-patient prospective validation set. Conclusions TFPI2 is a useful serum biomarker for preoperative clinical diagnosis of CCC.	[Arakawa, Noriaki; Masuishi, Yusuke; Ino, Yoko; Hirano, Hisashi] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Yokohama, Kanagawa, Japan; [Arakawa, Noriaki; Masuishi, Yusuke; Ino, Yoko; Hirano, Hisashi] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa, Japan; [Kobayashi, Hiroshi; Shigetomi, Hiroshi; Furukawa, Naoto] Nara Med Univ, Dept Obstet & Gynecol, Nara, Japan; [Yonemoto, Naohiro] Yokohama City Univ, Dept Biostat, Ctr Novel & Explanatory Clin Trials Y NEXT, Yokohama, Kanagawa, Japan; [Ohtake, Norihisa] Tosoh Corp, Reagent Dev Dept, Biosci Div, Ayase, Kanagawa, Japan; [Miyagi, Yohei] Kanagawa Canc Ctr, Res Inst, Yokohama, Kanagawa, Japan; [Hirahara, Fumiki; Miyagi, Etsuko] Yokohama City Univ Med, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan; [Yonemoto, Naohiro] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan	Yokohama City University; Yokohama City University; Nara Medical University; Yokohama City University; Tosoh Corporation; Kanagawa Prefectural Cancer Center; Yokohama City University; Kyoto University	Miyagi, E (corresponding author), Yokohama City Univ Med, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan.	emiyagi@yokohama-cu.ac.jp	Naohiro, Yonemoto/Y-3761-2019		Japan Society for the Promotion of Science [25460695, 16K07147]; Special Coordination Funds for Promoting Science and Technology; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology/Japan Science and Technology Agency; Tosoh Co., Ltd.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology/Japan Science and Technology Agency; Tosoh Co., Ltd.	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from Japan Society for the Promotion of Science (grant numbers 25460695 and 16K07147 to NA) and the Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, in the Project for Developing Innovation Systems from the Ministry of Education, Culture, Sports, Science and Technology/Japan Science and Technology Agency to HH, for which Tosoh Co., Ltd. has provided a matching fund in the form of salaries for NO and the research materials. However, the corporation and other funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa N, 2013, J PROTEOME RES, V12, P4340, DOI 10.1021/pr400282j; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Bast RC, 1998, INT J BIOL MARKER, V13, P179, DOI 10.1177/172460089801300402; BOHN H, 1977, ARCH GYNAKOL, V223, P179, DOI 10.1007/BF00667387; Bossuyt PM, 2003, CROAT MED J, V44, P635; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Cheng YM, 2002, OBSTET GYNECOL, V99, P375, DOI 10.1016/S0029-7844(01)01731-8; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; del Carmen MG, 2012, GYNECOL ONCOL, V126, P481, DOI 10.1016/j.ygyno.2012.04.021; Erbagci AB, 1999, DIS MARKERS, V15, P259, DOI 10.1155/1999/960934; Ferraresso S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092707; Haruta S, 2011, ONCOL REP, V26, P1347, DOI 10.3892/or.2011.1456; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Jiang XX, 1998, CANCER RES, V58, P1707; Kafali Hasan, 2007, Archives of Gynecology and Obstetrics, V275, P175, DOI 10.1007/s00404-006-0242-z; Kashiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087220; KISIEL W, 1994, BLOOD, V84, P4384, DOI 10.1182/blood.V84.12.4384.bloodjournal84124384; Kobayashi H, 2007, INT J GYNECOL CANCER, V17, P37, DOI 10.1111/j.1525-1438.2006.00754.x; Kobayashi H, 2015, ONCOL LETT, V10, P612, DOI 10.3892/ol.2015.3367; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kudoh K, 1999, GYNECOL OBSTET INVES, V47, P52, DOI 10.1159/000010062; Lai YH, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0237-7; Markman M, 1996, J CLIN ONCOL, V14, P1411, DOI 10.1200/JCO.1996.14.5.1411; Meyer T, 2000, BRIT J CANCER, V82, P1535; Mills GB, 2001, J NATL CANCER I, V93, P1437, DOI 10.1093/jnci/93.19.1437; MIYAGI Y, 1994, J BIOCHEM-TOKYO, V116, P939, DOI 10.1093/oxfordjournals.jbchem.a124648; Nagle CM, 2008, EUR J CANCER, V44, P2477, DOI 10.1016/j.ejca.2008.07.009; OBRIEN MER, 1993, GYNECOL ONCOL, V49, P250, DOI 10.1006/gyno.1993.1117; Ogawa S, 2000, GYNECOL ONCOL, V77, P298, DOI 10.1006/gyno.2000.5765; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Pectasides D, 2006, GYNECOL ONCOL, V102, P285, DOI 10.1016/j.ygyno.2005.12.038; Sato N, 2005, ONCOGENE, V24, P850, DOI 10.1038/sj.onc.1208050; Sierko E, 2007, SEMIN THROMB HEMOST, V33, P653, DOI 10.1055/s-2007-991532; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Suh KS, 2010, EXPERT REV MOL DIAGN, V10, P1069, DOI 10.1586/ERM.10.87; Takano M, 2006, BRIT J CANCER, V94, P1369, DOI 10.1038/sj.bjc.6603116; Tanase Y, 2012, EXP THER MED, V3, P18, DOI 10.3892/etm.2011.376; Wong CM, 2007, HEPATOLOGY, V45, P1129, DOI 10.1002/hep.21578; Yamamoto S, 2012, INT J GYNECOL PATHOL, V31, P116, DOI 10.1097/PGP.0b013e3182285c90	39	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2016	11	10							e0165609	10.1371/journal.pone.0165609	http://dx.doi.org/10.1371/journal.pone.0165609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6BX	27798689	Green Published, gold, Green Submitted			2022-12-26	WOS:000386711100049
J	Tham, DKL; Joshi, B; Moukhles, H				Tham, Daniel Kai Long; Joshi, Bharat; Moukhles, Hakima			Aquaporin-4 Cell-Surface Expression and Turnover Are Regulated by Dystroglycan, Dynamin, and the Extracellular Matrix in Astrocytes	PLoS One			English	Article							BLOOD-BRAIN-BARRIER; WATER CHANNEL; GENE DELETION; GLIAL-CELLS; RAT-BRAIN; MICE; EDEMA; AQP4; CLATHRIN; KIR4.1	The water-permeable channel aquaporin-4 (AQP4) is highly expressed in perivascular astrocytes of the mammalian brain and represents the major conduit for water across the blood-brain barrier. Within these cells, AQP4 is found in great quantities at perivascular endfoot sites but is detected in lesser amounts at the membrane domains within the brain parenchyma. We had previously established that this polarization was regulated by the interaction between dystroglycan (DG), an extracellular matrix receptor that is co expressed with AQP4, and the laminin that is contained within the perivascular basal lamina. In the present study, we have attempted to describe the mechanisms that underlie this regulation, using primary astrocyte cultures. Via biotinylation, we found that the cell-surface expression of AQP4 is DG-dependent and is potentiated by laminin. We also determined that this laminin-dependent increase occurs not through an upregulation of total AQP4 levels, but rather from a redirection of AQP4 from an intracellular, EEA-1-associated pool to the cell surface. We then demonstrated an association between DG and dynamin and showed that dynamin functioned in conjunction with clathrin to regulate surface AQP4 amounts. Furthermore, we observed that DG preferentially binds to the inactive forms of dynamin, suggesting that this interaction was inhibitory for AQP4 endocytosis. Finally, we showed that laminin selectively upregulates the cell-surface expression of the M23 isoform of AQP4. Our data therefore indicate that the dual interation of DG with laminin and dynamin is involved in the regulation of AQP4 internalization, leading to its asymmetric enrichment at perivascular astrocyte endfeet.	[Tham, Daniel Kai Long; Joshi, Bharat; Moukhles, Hakima] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada	University of British Columbia	Moukhles, H (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada.	moukhles@mail.ubc.ca			Canadian Institute of Health Research PG [20R47867]	Canadian Institute of Health Research PG	This project was supported by the Canadian Institute of Health Research PG#20R47867.	Amiry-Moghaddam M, 2004, FASEB J, V18, P542, DOI 10.1096/fj.03-0869fje; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Crane JM, 2010, NEUROSCIENCE, V168, P892, DOI 10.1016/j.neuroscience.2009.08.034; Frigeri A, 2001, FASEB J, V15, P1282, DOI 10.1096/fj.00-0525fje; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Guadagno E, 2004, GLIA, V47, P138, DOI 10.1002/glia.20039; Inoue M, 2002, TOHOKU J EXP MED, V197, P87, DOI 10.1620/tjem.197.87; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Lu DC, 2008, FASEB J, V22, P3216, DOI 10.1096/fj.07-104836; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; Nielsen S, 1997, J NEUROSCI, V17, P171; Noel G, 2005, J NEUROCHEM, V94, P691, DOI 10.1111/j.1471-4159.2005.03191.x; Noel G, 2009, J BIOL CHEM, V284, P19694, DOI 10.1074/jbc.M109.010090; Noell S, 2011, EUR J NEUROSCI, V33, P2179, DOI 10.1111/j.1460-9568.2011.07688.x; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Rurak J, 2007, J NEUROCHEM, V103, P1940, DOI 10.1111/j.1471-4159.2007.04886.x; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Sotgia F, 2000, J BIOL CHEM, V275, P38048, DOI 10.1074/jbc.M005321200; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Tham DKL, 2011, AM J PHYSIOL-RENAL, V301, pF396, DOI 10.1152/ajprenal.00315.2010; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Zhan YG, 2005, J BIOL CHEM, V280, P18015, DOI 10.1074/jbc.M409682200	34	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165439	10.1371/journal.pone.0165439	http://dx.doi.org/10.1371/journal.pone.0165439			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788222	Green Published, Green Submitted, gold			2022-12-26	WOS:000389604900085
J	White, MC; Horner, KC; Lai, PS				White, Michelle C.; Horner, Katherine C.; Lai, Peggy S.			Retrospective Review of the Anaesthetic Management of Maxillectomies and Mandibulectomies for Benign Tumours in Sub-Saharan Africa	PLOS ONE			English	Review							NATIONAL AUDIT PROJECT; DEVELOPING-COUNTRIES; MAJOR COMPLICATIONS; AIRWAY MANAGEMENT; ROYAL-COLLEGE; AMELOBLASTOMA; RISK	Background Safe anaesthesia is a crucial component of safe surgical care, yet anaesthetic complications are common in resource-limited settings. We describe differences in anaesthetic needs for Mandibulectomy vs. Maxillectomy in three sub-Saharan African countries. Materials and Methods Retrospective review of patients undergoing minor Mandibulectomy, major Mandibulectomy, or Maxillectomy in Togo, Guinea and Republic of the Congo. Surgeries were performed on the Africa Mercy, an international non-governmental hospital ship. Primary outcomes were need for advanced airway management and intra-operative blood loss. Secondary outcomes were time under general anaesthesia and hospital length of stay. Multivariate regression determined the association between operation type and each outcome measure. Results 105 patients were included (25 minor Mandibulectomy, 58 major Mandibulectomy, 22 Maxillectomy procedures). In-hospital mortality was 0%. 44/105 (41.9%) required an advanced airway management technique to achieve intubation, although in all cases this was anticipated prior to the procedure; no differences were noted between surgical procedure (p = 0.72). Operative procedure was a significant risk factor for intra-operative blood loss. Patients undergoing Maxillectomy lost on average 851.5 (413.3, 1289.8, p = 0.0003) mL more blood than patients undergoing minor Mandibulectomy, and 507.3 (150.3, 864.3, p = 0.007) mL more blood than patients undergoing major Mandibulectomy. Patients undergoing Maxillectomy had a significantly higher time under general anaesthesia than those undergoing minor Mandibulectomy. There was no significant difference in hospital length of stay between operation type. Conclusion Anaesthetic considerations for minor Mandibulectomy, major Mandibulectomy, and Maxillectomy differ with respect to intra-operative blood loss and time under general anaesthesia, but not need for advanced airway management or length of stay. Although advanced airway management was required in 41.9% of patients, there were no unanticipated difficult airways. With appropriate training and resources, safe anaesthesia can be delivered to patients from low-income countries requiring major head and neck surgery.	[White, Michelle C.; Horner, Katherine C.] Mercy Ships, Dept Anaesthesia, Reg 12, Port Au Toamasina, Madagascar; [Lai, Peggy S.] Massachusetts Gen Hosp, Div Pulm & Crit Care, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	White, MC (corresponding author), Mercy Ships, Dept Anaesthesia, Reg 12, Port Au Toamasina, Madagascar.	doctormcw@gmail.com			US National Institutes of Health [K23 ES023700]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K23ES023700] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors received no specific funding for this work. PSL reports receiving salary support from the US National Institutes of Health (K23 ES023700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassey GO, 2014, AFR HEALTH SCI, V14, P56, DOI 10.4314/ahs.v14i1.9; Chukwuneke FN, 2010, INT J ORAL MAX SURG, V39, P150, DOI 10.1016/j.ijom.2009.11.023; Cook TM, 2011, BRIT J ANAESTH, V106, P632, DOI 10.1093/bja/aer059; Cook TM, 2011, BRIT J ANAESTH, V106, P617, DOI 10.1093/bja/aer058; Crezoit G E, 2003, Rev Stomatol Chir Maxillofac, V104, P25; Glenshaw M, 2005, Cent Afr J Med, V51, P39; Hansen D, 2000, TROP DOCT, V30, P146, DOI 10.1177/004947550003000311; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Hodges SC, 2007, ANAESTHESIA, V62, P4, DOI 10.1111/j.1365-2044.2006.04907.x; Kalavrezos N, 2008, BRIT J ORAL MAX SURG, V46, P591, DOI 10.1016/j.bjoms.2008.02.001; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Maman AFOB, 2005, TROP DOCT, V35, P220, DOI 10.1258/004947505774938666; Ocean Health Index, 2015, IC SPEC; REICHART PA, 1995, ORAL ONCOL, V31B, P86; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; SHEAR M, 1978, COMMUNITY DENT ORAL, V6, P195, DOI 10.1111/j.1600-0528.1978.tb01149.x; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS38, DOI 10.1016/S2214-109X(15)70085-9; Steffner KR, 2014, CURR OPIN ANESTHESIO, V27, P623, DOI 10.1097/ACO.0000000000000121; Walker IA, 2008, LANCET, V371, P968, DOI 10.1016/S0140-6736(08)60432-8; Weber RS, 2010, ARCH OTOLARYNGOL, V136, P1212, DOI 10.1001/archoto.2010.215	20	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2016	11	10							e0165090	10.1371/journal.pone.0165090	http://dx.doi.org/10.1371/journal.pone.0165090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VY	27788172	Green Published, gold, Green Submitted			2022-12-26	WOS:000389604900042
J	Choi, H; Schoeni, RF; Martin, LG				Choi, HwaJung; Schoeni, Robert F.; Martin, Linda G.			Are Functional and Activity Limitations Becoming More Prevalent among 55 to 69-Year-Olds in the United States?	PLOS ONE			English	Article							DISABILITY; TRENDS; ADULTS; HEALTH	Objectives This study examines changes in functional and activity limitations 1998-2012 for individuals 55-69. Methods Logistic models are used to estimate trends in limitations in vision, hearing, physical and cognitive functioning, IADLs, and ADLs. Additional models assess the extent to which trends are associated with and differ by education, smoking, and BMI. Results Changes in prevalence of limitations in vision, hearing, cognitive functioning, and ADLs are not statistically significant. Limitations in physical functioning declined by 0.37% per year. IADL limitations increased by 1.33% per year, but most of the increase occurred between 2008 and 2010/2012, and are associated with economic hardship during the Great Recession. Increases in education are especially beneficially associated with trends in limitations, but reductions in smoking also appear to be advantageous for some outcomes. Increases in BMI are associated with trends in physical functioning, IADL, and ADL limitation. Discussion For Americans 55-69, functional and activity limitations were largely unchanged 1998-2012. Our results suggest that if educational attainment had not increased, most functional and activity limitations potentially could have worsened substantially. Future change in educational attainment is not expected to be so positive. Continued monitoring of trends in activity limitations might well include greater focus on the explanatory roles of environmental factors, including economic circumstances.	[Choi, HwaJung] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Schoeni, Robert F.] Univ Michigan, Dept Econ, Ann Arbor, MI USA; [Schoeni, Robert F.] Univ Michigan, G Ford Sch Publ Policy, Ann Arbor, MI USA; [Schoeni, Robert F.] Univ Michigan, Survey Res Ctr, Ann Arbor, MI USA; [Martin, Linda G.] RAND Corp, Arlington, VA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; RAND Corporation	Choi, H (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	hwajungc@umich.edu		Choi, Hwajung/0000-0001-6497-7679	Alfred P. Sloan Foundation [G-2014-13748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG012846] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	H. Choi, R. Schoeni, and L. Martin were supported by a grant (G-2014-13748) from the Alfred P. Sloan Foundation (http://www.sloan.org/) for their work on this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bound J, 2015, HEALTH AFFAIR, V34, P2167, DOI 10.1377/hlthaff.2015.0481; Bricker J., 2014, FEDERAL RESERVE B, V100; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Crimmins E., 2008, HRS DOC REP DR 011, V14, P47, DOI DOI 10.7826/ISR-UM.06.585031.001.05.0014.2008; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P162, DOI 10.1093/geronb/gbr048; Denavas-Walt C, 2015, INCOME POVERTY US 20; Freedman VA, 2004, DEMOGRAPHY, V41, P417, DOI 10.1353/dem.2004.0022; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Freedman VA, 2013, DEMOGRAPHY, V50, P661, DOI 10.1007/s13524-012-0167-z; HRS, 2011, SAMPL SIZ RESP RAT; HRS, 2008, SAMPL EV 1992 1998; Hummer Robert A, 2013, Popul Bull, V68, P1; Kaye HS, 2013, HEALTH AFFAIR, V32, P127, DOI 10.1377/hlthaff.2012.0533; Langa K, 2010, REPORT RACE COGNITIV, V12; Martin LG, 2014, DISABIL HEALTH J, V7, pS4, DOI 10.1016/j.dhjo.2013.06.007; Martin LG, 2010, DEMOGRAPHY, V47, pS17, DOI 10.1353/dem.2010.0003; Martin LG, 2010, HEALTH AFFAIR, V29, P725, DOI 10.1377/hlthaff.2008.0746; National Academies of Sciences E and Medicine, 2015, GROW GAP LIF EXP INC; Norton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304; Ofstedal MB, 2005, DR006 HRS U MICH SUR; Schoeni R. F., 2009, HLTH OLDER AGES CAUS, P75; Schoeni RF, 2005, AM J PUBLIC HEALTH, V95, P2065, DOI 10.2105/AJPH.2004.048744; Schoeni RF, 2008, MILBANK Q, V86, P47, DOI 10.1111/j.1468-0009.2007.00513.x; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Weir D., 2007, REDEFINING RETIREMEN, P95, DOI DOI 10.1093/ACPROF:OSO/9780199230778.003.0005	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0164565	10.1371/journal.pone.0164565	http://dx.doi.org/10.1371/journal.pone.0164565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4VE	27783638	gold, Green Published, Green Submitted			2022-12-26	WOS:000389602800044
J	van Lingen, HJ; Plugge, CM; Fadel, JG; Kebreab, E; Bannink, A; Dijkstra, J				van Lingen, Henk J.; Plugge, Caroline M.; Fadel, James G.; Kebreab, Ermias; Bannink, Andr; Dijkstra, Jan			Thermodynamic Driving Force of Hydrogen on Rumen Microbial Metabolism: A Theoretical Investigation	PLOS ONE			English	Article							FATTY-ACID PRODUCTION; PROPIONATE OXIDATION; SMITHELLA-PROPIONICA; METHANE PRODUCTION; DAIRY-COWS; BUTYRATE; CULTURE; FERMENTATION; ECOLOGY; ENERGY	Hydrogen is a key product of rumen fermentation and has been suggested to thermodynamically control the production of the various volatile fatty acids (VFA). Previous studies, however, have not accounted for the fact that only thermodynamic near-equilibrium conditions control the magnitude of reaction rate. Furthermore, the role of NAD, which is affected by hydrogen partial pressure (P-H2), has often not been considered. The aim of this study was to quantify the control of P-H2 on reaction rates of specific fermentation pathways, methanogenesis and NADH oxidation in rumen microbes. The control of P-H2 was quantified using the thermodynamic potential factor (F-T), which is a dimensionless factor that corrects a predicted kinetic reaction rate for the thermodynamic control exerted. Unity F-T was calculated for all glucose fermentation pathways considered, indicating no inhibition of P-H2 on the production of a specific type of VFA (e.g., acetate, propionate and butyrate) in the rumen. For NADH oxidation without ferredoxin oxidation, increasing P-H2 within the rumen physiological range decreased F-T from unity to zero for different NAD(+) to NADH ratios and pH of 6.2 and 7.0, which indicates thermodynamic control of P-H2. For NADH oxidation with ferredoxin oxidation, increasing P-H2 within the rumen physiological range decreased F-T from unity at pH of 7.0 only. For the acetate to propionate conversion, F-T increased from 0.65 to unity with increasing P-H2, which indicates thermodynamic control. For propionate to acetate and butyrate to acetate conversions, F-T decreased to zero below the rumen range of P-H2, indicating full thermodynamic suppression. For methanogenesis by archaea without cytochromes, F-T differed from unity only below the rumen range of P-H2, indicating no thermodynamic control. This theoretical investigation shows that thermodynamic control of P-H2 on individual VFA produced and associated yield of hydrogen and methane cannot be explained without considering NADH oxidation.	[van Lingen, Henk J.] TI Food & Nutr, Wageningen, Netherlands; [van Lingen, Henk J.; Dijkstra, Jan] Wageningen Univ, Anim Nutr Grp, NL-6700 AP Wageningen, Netherlands; [Plugge, Caroline M.; Kebreab, Ermias] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Fadel, James G.] Univ Calif Davis, Dept Anim Sci, Davis, CA USA; [Bannink, Andr] Wageningen UR Livestock Res, Anim Nutr, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; University of California System; University of California Davis; Wageningen University & Research	van Lingen, HJ (corresponding author), TI Food & Nutr, Wageningen, Netherlands.	henk.vanlingen@wur.nl	Kebreab, Ermias/E-9113-2012; DIJKSTRA, Jan/G-7680-2011	Kebreab, Ermias/0000-0002-0833-1352; DIJKSTRA, Jan/0000-0003-3728-6885; , Henk/0000-0002-3461-6503	Dutch Ministry of Economic Affairs (The Hague, the Netherlands); Product Board Animal Feed (Zoetermeer, the Netherlands); Dutch Dairy Board (Zoetermeer, the Netherlands)	Dutch Ministry of Economic Affairs (The Hague, the Netherlands)(Ministry of Economic Affairs, Netherlands); Product Board Animal Feed (Zoetermeer, the Netherlands)(Netherlands Government); Dutch Dairy Board (Zoetermeer, the Netherlands)(Netherlands Government)	AB and JD acknowledge support from the 'Low Emission Animal Feed' project that was financed by the Dutch Ministry of Economic Affairs (The Hague, the Netherlands), Product Board Animal Feed (Zoetermeer, the Netherlands) and the Dutch Dairy Board (Zoetermeer, the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AW, 2011, ANIM FEED SCI TECH, V166-67, P761, DOI 10.1016/j.anifeedsci.2011.04.054; Atkins P, 2006, ATKINS PHYS CHEM; BALDWIN RL, 1983, J ANIM SCI, V57, P461; Bannink A, 2006, J THEOR BIOL, V238, P36, DOI 10.1016/j.jtbi.2005.05.026; Bannink A, 2011, ANIM FEED SCI TECH, V166-67, P603, DOI 10.1016/j.anifeedsci.2011.04.043; Berrios-Rivera SJ, 2002, METAB ENG, V4, P230, DOI 10.1006/mben.2002.0228; BOONE DR, 1989, APPL ENVIRON MICROB, V55, P1735, DOI 10.1128/AEM.55.7.1735-1741.1989; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; COUNOTTE GHM, 1981, VET RES COMMUN, V5, P101, DOI 10.1007/BF02214975; de Bok FAM, 2001, APPL ENVIRON MICROB, V67, P1800, DOI 10.1128/AEM.67.4.1800-1804.2001; Dolfing J, 2013, APPL ENVIRON MICROB, V79, P4515, DOI 10.1128/AEM.00111-13; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; Ghimire S, 2014, J DAIRY SCI, V97, P354, DOI 10.3168/jds.2012-6199; Gould DH, 1997, J VET DIAGN INVEST, V9, P72, DOI 10.1177/104063879700900113; Hackmann TJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00622; Hatew B, 2015, J DAIRY SCI, V98, P486, DOI 10.3168/jds.2014-8427; Hegarty R. S., 1999, Recent Advances in Animal Nutrition in Australia, V12, P37; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; HINO T, 1985, APPL ENVIRON MICROB, V50, P1368, DOI 10.1128/AEM.50.6.1368-1374.1985; HOFMEISTER AEM, 1992, EUR J BIOCHEM, V206, P547, DOI 10.1111/j.1432-1033.1992.tb16958.x; Jackson BE, 2002, NATURE, V415, P454, DOI 10.1038/415454a; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Janssen PH, 2010, ANIM FEED SCI TECH, V160, P1, DOI 10.1016/j.anifeedsci.2010.07.002; Jin Q, 2007, AM J SCI, V307, P643, DOI 10.2475/04.2007.01; Kettle H, 2015, ENVIRON MICROBIOL, V17, P1615, DOI 10.1111/1462-2920.12599; Kleerebezem R, 2008, WATER SCI TECHNOL, V57, P493, DOI 10.2166/wst.2008.094; Kohn RA, 1998, J ANIM SCI, V76, P1702; Kraemer JT, 2006, BIOTECHNOL LETT, V28, P1485, DOI 10.1007/s10529-006-9114-7; LAANBROEK HJ, 1982, ARCH MICROBIOL, V133, P178, DOI 10.1007/BF00414998; Le Van TD, 1998, APPL ENVIRON MICROB, V64, P3429; Leng RA, 2014, ANIM PROD SCI, V54, P519, DOI 10.1071/AN13381; Liu YT, 1999, INT J SYST BACTERIOL, V49, P545, DOI 10.1099/00207713-49-2-545; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; MANES M, 1950, J CHEM PHYS, V18, P1355, DOI 10.1063/1.1747477; McInerney MJ, 2008, ANN NY ACAD SCI, V1125, P58, DOI 10.1196/annals.1419.005; Meier RR, 2016, FASEB J; Mller V., 2008, BACTERIAL FERMENTATI; Morvay Y, 2011, J DAIRY SCI, V94, P3063, DOI 10.3168/jds.2010-3995; MOSEY FE, 1983, WATER SCI TECHNOL, V15, P209, DOI 10.2166/wst.1983.0168; Peters JW, 2015, BBA-MOL CELL RES, V1853, P1350, DOI 10.1016/j.bbamcr.2014.11.021; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Rodriguez J, 2006, BIOTECHNOL BIOENG, V93, P592, DOI 10.1002/bit.20765; Russell J., 1997, RUMEN MICROBIAL ECOS, P246, DOI DOI 10.1007/978-94-009-1453-7_6; RUSSELL JB, 1987, APPL ENVIRON MICROB, V53, P2379, DOI 10.1128/AEM.53.10.2379-2383.1987; Salem JE, 2002, ANN BIOMED ENG, V30, P202, DOI 10.1114/1.1454133; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Song N, 2014, INORG CHEM, V53, P4100, DOI 10.1021/ic500072e; STAMS AJM, 1984, ARCH MICROBIOL, V139, P167, DOI 10.1007/BF00401994; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; Sutton JD, 2003, J DAIRY SCI, V86, P3620, DOI 10.3168/jds.S0022-0302(03)73968-X; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Ungerfeld E. M., 2006, P55; Ungerfeld EM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00319; van Zijderveld SM, 2011, J DAIRY SCI, V94, P4028, DOI 10.3168/jds.2011-4236; van Zijderveld SM, 2010, J DAIRY SCI, V93, P5856, DOI 10.3168/jds.2010-3281; Willquist K, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-111; Zhang F, 2013, BIOTECHNOL BIOENG, V110, P1884, DOI 10.1002/bit.24855; Zheng YN, 2014, J BACTERIOL, V196, P3840, DOI 10.1128/JB.02070-14	60	49	51	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2016	11	10							e0161362	10.1371/journal.pone.0161362	http://dx.doi.org/10.1371/journal.pone.0161362			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4VE	27783615	gold, Green Published, Green Submitted			2022-12-26	WOS:000389602800008
J	Haili, N; Louap, J; Canonge, M; Jagic, F; Louis-Mondesir, C; Chardot, T; Briozzo, P				Haili, Nawel; Louap, Julien; Canonge, Michel; Jagic, Franjo; Louis-Mondesir, Christelle; Chardot, Thierry; Briozzo, Pierre			Expression of Soluble Forms of Yeast Diacylglycerol Acyltransferase 2 That Integrate a Broad Range of Saturated Fatty Acids in Triacylglycerols	PLOS ONE			English	Article							ACYL-COADIACYLGLYCEROL ACYLTRANSFERASE; ENDOPLASMIC-RETICULUM; YARROWIA-LIPOLYTICA; OLEAGINOUS MICROORGANISMS; SACCHAROMYCES-CEREVISIAE; LIPID-ACCUMULATION; DGAT2; COA; PROTEIN; IDENTIFICATION	The membrane proteins acyl-CoA: diacylglycerol acyltransferases (DGAT) are essential actors for triglycerides (TG) biosynthesis in eukaryotic organisms. Microbial production of TG is of interest for producing biofuel and value-added novel oils. In the oleaginous yeast Yarrowia lipolytica, Dga1p enzyme from the DGAT2 family plays a major role in TG biosynthesis. Producing recombinant DGAT enzymes pure and catalytically active is difficult, hampering their detailed functional characterization. In this report, we expressed in Escherichia coli and purified two soluble and active forms of Y. lipolytica Dga1p as fusion proteins: the first one lacking the N-terminal hydrophilic segment (Dga1p Delta 19), the second one also devoid of the N-terminal putative transmembrane domain (Dga1p Delta 85). Most DGAT assays are performed on membrane fractions or microsomes, using radiolabeled substrates. We implemented a fluorescent assay in order to decipher the substrate specificity of purified Dga1p enzymes. Both enzyme versions prefer acyl-CoA saturated substrates to unsaturated ones. Dga1p Delta 85 preferentially uses long-chain saturated substrates. Dga1p activities are inhibited by niacin, a specific DGAT2 inhibitor. The N-terminal transmembrane domain appears important, but not essential, for TG biosynthesis. The soluble and active proteins described here could be useful tools for future functional and structural studies in order to better understand and optimize DGAT enzymes for biotechnological applications.	[Haili, Nawel; Louap, Julien; Canonge, Michel; Jagic, Franjo; Louis-Mondesir, Christelle; Chardot, Thierry; Briozzo, Pierre] Univ Paris Saclay, AgroParisTech, INRA, Inst Jean Pierre Bourgin, Versailles, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Briozzo, P (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, Inst Jean Pierre Bourgin, Versailles, France.	pierre.briozzo@versailles.inra.fr		Chardot, Thierry/0000-0001-6689-6151	Probio 3 project from French government [ANR-11-BTBR-*0003]; French government [ANR-11-BTBR-0003]	Probio 3 project from French government; French government	The work was supported by Probio 3 project from French government ANR-11-BTBR-*0003.; We thank Dr Jean-Marc Nicaud for providing pMal-c2X vector, Sebastien Baud for critical reading of the manuscript, and Laure Ayme for fruitful discussions. This work was carried out within Probio3 project ANR-11-BTBR-0003, with financial support from French government. NH and JL were supported by this project.	Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; Ayme L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092237; Beopoulos A, 2012, APPL MICROBIOL BIOT, V93, P1523, DOI 10.1007/s00253-011-3506-x; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Beopoulos A, 2008, APPL ENVIRON MICROB, V74, P7779, DOI 10.1128/AEM.01412-08; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; Brandt C, 2016, BIOCH J; Cao HP, 2012, APPL MICROBIOL BIOT, V96, P711, DOI 10.1007/s00253-012-3869-7; Cao Heping, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-249; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Daum G, 2007, BIOCHIMIE, V89, P243, DOI 10.1016/j.biochi.2006.06.018; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Durrett TP, 2010, P NATL ACAD SCI USA, V107, P9464, DOI 10.1073/pnas.1001707107; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ganji SH, 2004, J LIPID RES, V45, P1835, DOI 10.1194/jlr.M300403-JLR200; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Kamisaka Y, 2010, APPL MICROBIOL BIOT, V88, P105, DOI 10.1007/s00253-010-2725-x; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KENNEDY EP, 1957, FED PROC, V16, P847; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Ledesma-Amaro R, 2016, PROG LIPID RES, V61, P40, DOI 10.1016/j.plipres.2015.12.001; Liang MH, 2013, PROG LIPID RES, V52, P395, DOI 10.1016/j.plipres.2013.05.002; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; Liu Q, 2010, BIOCHEMISTRY-US, V49, P3237, DOI 10.1021/bi9020499; Liu QQ, 2012, APPL MATH LETT, V25, P1470, DOI 10.1016/j.aml.2011.12.026; Liu YM, 2013, BMB REP, V46, P575, DOI 10.5483/BMBRep.2013.46.12.271; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Peng ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061363; Ratledge C, 2002, ADV APPL MICROBIOL, V51, P1, DOI 10.1016/S0065-2164(02)51000-5; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sanderson MC, 2012, J PHYCOL, V48, P580, DOI 10.1111/j.1529-8817.2012.01137.x; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zammit VA, 2008, PHARMACOL THERAPEUT, V118, P295, DOI 10.1016/j.pharmthera.2008.03.010; Zhou XR, 2013, FEBS LETT, V587, P2371, DOI 10.1016/j.febslet.2013.06.003	47	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0165431	10.1371/journal.pone.0165431	http://dx.doi.org/10.1371/journal.pone.0165431			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780240	Green Published, Green Submitted, gold			2022-12-26	WOS:000389046900057
J	Zhao, MD; Wu, JQ; Gao, YH				Zhao, Mindi; Wu, Jianqiang; Gao, Youhe			The Specific alpha 1-Adrenergic Receptor Antagonist Prazosin Influences the Urine Proteome	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ALPHA-ADRENERGIC BLOCKERS; BLOOD-PRESSURE; ANGIOTENSIN-II; TRACT SYMPTOMS; BIOMARKER; PROTEINS; SODIUM; PLASMA; CANCER	Urine, reflecting many changes in the body, is a better source than blood for biomarker discovery. However, even under physiological conditions, the urine proteome often varies. Understanding how various regulating factors affect urine proteome helps link changes to urine proteome with urinary biomarkers of physiological conditions as well as corresponding diseases. To evaluate the possible impact of alpha 1-adrenergic receptor on urine proteome, this study investigated effects of the specific inhibitor prazosin on the urine proteome in a rat model by using tandem mass tagging and two-dimensional liquid chromatography-tandem mass spectrometry. A total of 775 proteins were identified, approximately half of which were influenced by prazosin treatment, indicating that the sympathetic nervous system exerts a significant impact on urine proteome. Eight significantly changed proteins were previously annotated as urinary candidate biomarkers. Angiotensinogen, haptoglobin, and beta-2 microglobulin, which were reported to be associated with blood pressure, were validated via Western blot. Prazosin is widely used in clinical practice; thus, these protein changes should be considered when studying corresponding diseases such as hypertension, post-traumatic stress disorder and benign prostatic hyperplasia. The related physiological activities of alpha 1-receptors, controlling blood pressure and fear response might significantly affect the urine proteome and warrant further biomarker studies.	[Zhao, Mindi; Wu, Jianqiang; Gao, Youhe] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Dept Pathophysiol,Inst Basic Med Sci,Sch Basic Me, Beijing, Peoples R China; [Gao, Youhe] Beijing Normal Univ, Gene Engn & Biotechnol Beijing Key Lab, Dept Biochem & Mol Biol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Beijing Normal University	Gao, YH (corresponding author), Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Dept Pathophysiol,Inst Basic Med Sci,Sch Basic Me, Beijing, Peoples R China.; Gao, YH (corresponding author), Beijing Normal Univ, Gene Engn & Biotechnol Beijing Key Lab, Dept Biochem & Mol Biol, Beijing, Peoples R China.	gaoyouhe@bnu.edu.cn	Wu, Jianqiang/GQH-5519-2022; Wu, Jianqiang/AAX-7995-2021	Wu, Jianqiang/0000-0001-6773-9289; Zhao, Mindi/0000-0003-2005-5140	National Key Research and Development Program of China [2016YFC1306300]; National Basic Research Program of China [2013CB530850]; Beijing Normal University [11100704, 10300-310421102]	National Key Research and Development Program of China; National Basic Research Program of China(National Basic Research Program of China); Beijing Normal University	This work was supported by the National Key Research and Development Program of China (2016YFC1306300), the National Basic Research Program of China (2013CB530850), and funds from Beijing Normal University (11100704,10300-310421102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUTLER E, 1985, J LAB CLIN MED, V105, P581; Boyd K, 2014, ANN PHARMACOTHER, V48, P711, DOI 10.1177/1060028014524174; Brogden R, 1979, ANTIHYPERTENSIVE DRU, P125; CASCINU S, 1995, J CLIN ONCOL, V13, P26, DOI 10.1200/JCO.1995.13.1.26; Cutillas PR, 2004, AM J PHYSIOL-RENAL, V287, pF353, DOI 10.1152/ajprenal.00018.2004; Fajardo N, 1998, J CARDIOVASC PHARM, V32, P913, DOI 10.1097/00005344-199812000-00007; Gao YH, 2013, SCI CHINA LIFE SCI, V56, P1145, DOI 10.1007/s11427-013-4574-1; Harrison-Bernard LM, 2009, ADV PHYSIOL EDUC, V33, P270, DOI 10.1152/advan.00049.2009; Holly MK, 2006, KIDNEY INT, V70, P496, DOI 10.1038/sj.ki.5001575; Kuroczycka-Saniutycz E, 2013, PEDIATR NEPHROL, V28, P1113, DOI 10.1007/s00467-013-2449-0; Lewen S, 2008, CANCER IMMUNOL IMMUN, V57, P507, DOI 10.1007/s00262-007-0389-x; Li ML, 2014, SCI CHINA LIFE SCI, V57, P649, DOI 10.1007/s11427-014-4661-y; Li Xundou, 2014, Genomics Proteomics & Bioinformatics, V12, P120, DOI 10.1016/j.gpb.2013.12.002; Lowe FC, 2004, CLIN THER, V26, P1701, DOI 10.1016/j.clinthera.2004.11.006; MCAREAVEY D, 1981, CLIN SCI, V61, pS457, DOI 10.1042/cs061457s; Musialik D, 1994, Pol Tyg Lek, V49, P239; NASH DT, 1990, CLIN CARDIOL, V13, P764, DOI 10.1002/clc.4960131104; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Rao PV, 2007, DIABETES CARE, V30, P629, DOI 10.2337/dc06-2056; ROMANKIEWICZ JA, 1983, DRUGS, V25, P6, DOI 10.2165/00003495-198325010-00002; Shao C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010975; SUBBARAO KV, 1991, J NEUROSCI RES, V28, P399, DOI 10.1002/jnr.490280312; Taylor F, 2002, J CLIN PSYCHOPHARM, V22, P82, DOI 10.1097/00004714-200202000-00013; Thongboonkerd V, 2003, AM J PHYSIOL-RENAL, V284, pF1155, DOI 10.1152/ajprenal.00140.2002; Togno J, 2015, AUST FAM PHYSICIAN, V44, P647; Urquidi V, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2012.01.016; Wang LN, 2012, J CELL BIOCHEM, V113, P2679, DOI 10.1002/jcb.24143; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; WEINBERGER MH, 1987, HYPERTENSION, V10, P443, DOI 10.1161/01.HYP.10.4.443; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu JQ, 2015, EXPERT REV PROTEOMIC, V12, P623, DOI 10.1586/14789450.2015.1094380; Yoo C, 2016, HEMATOL ONCOL, V34, P22, DOI 10.1002/hon.2188; Zhao MD, 2015, PEERJ, V3, DOI 10.7717/peerj.813	35	6	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2016	11	10							e0164796	10.1371/journal.pone.0164796	http://dx.doi.org/10.1371/journal.pone.0164796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7LQ	27780262	Green Submitted, Green Published, gold			2022-12-26	WOS:000389046900018
J	Hajiebrahimi, M; Montgomery, S; Burkill, S; Bahmanyar, S				Hajiebrahimi, Mohammadhossein; Montgomery, Scott; Burkill, Sarah; Bahmanyar, Shahram			Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients	PLoS One			English	Article							AUTOIMMUNE-DISEASE; SEX-DIFFERENCES; YOUNG; REGISTER; ESTROGEN; PROGESTERONE; SURVIVAL; COHORT; WOMEN	Objective To investigate risk of premenopausal and postmenopausal breast cancer among Multiple Sclerosis (MS) patients, considering tumor stage. Methods The Swedish Patient Register identified 19,330 women with MS between 1968 and 2012, matched individually with a cohort of 193,458 without MS. Matching variables were year of birth, sex, region of residence and vital status at the time of diagnosis. The cancer register identified 471 and 5,753 breast cancer cases among the MS and non-MS cohorts, respectively. Cox proportional hazard models estimated hazard ratios (HR) and 95% confidence intervals (CI) for premenopausal and postmenopausal breast cancer. Results Overall risk of postmenopausal breast cancer was 13% higher among MS patients compared with women without MS (HR = 1.13, 95% CI 1.02-1.26). Stratified analyses showed that the risk was statistically significantly increased in women diagnosed between 1968 and 1980 and those who were diagnosed at age 65 or older age. We observed a non-statistically significant risk only for stage 0-1 postmenopausal breast cancer (HR = 1.17, 95% CI 0.93-1.48). MS was not associated with premenopausal breast cancer. Conclusion The modest increased risk of postmenopausal breast cancer in women with MS may be due to surveillance bias, where contact with health services for one disease increases the risk of a second diagnosis being recorded.	[Hajiebrahimi, Mohammadhossein; Montgomery, Scott] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Montgomery, Scott] Univ Orebro, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden; [Montgomery, Scott] UCL, Dept Epidemiol & Publ Hlth, London, England; [Burkill, Sarah; Bahmanyar, Shahram] Karolinska Inst, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Burkill, Sarah; Bahmanyar, Shahram] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden; [Hajiebrahimi, Mohammadhossein; Bahmanyar, Shahram] Golestan Univ Med Sci, Dept Publ Hlth, Hlth Fac, Gorgan, Iran	Karolinska Institutet; Orebro University; University of London; University College London; Karolinska Institutet; Karolinska Institutet; Golestan University of Medical Sciences	Hajiebrahimi, M (corresponding author), Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden.; Hajiebrahimi, M (corresponding author), Golestan Univ Med Sci, Dept Publ Hlth, Hlth Fac, Gorgan, Iran.	Mohammadhossein.Hajiebrahimi@ki.se	Montgomery, Scott/AAN-2546-2020	Montgomery, Scott/0000-0001-6328-5494; Bahmanyar, Shahram/0000-0002-9205-6540; Hajiebrahimi, Mohammadhossein/0000-0001-8118-4988	Novartis Pharma AG; F. Hoffmann La Roche Ltd.; Novartis Pharma; F. Hoffmann; AsteraZeneca pharmaceutical company	Novartis Pharma AG; F. Hoffmann La Roche Ltd.(Hoffmann-La Roche); Novartis Pharma; F. Hoffmann; AsteraZeneca pharmaceutical company	The study was developed from a project funded by Novartis Pharma AG and F. Hoffmann La Roche Ltd. Professor Scott Montgomery received funding from Novartis Pharma and F. Hoffmann for this project and from AsteraZeneca pharmaceutical company for other projects. The funders had no role in study design, data collectio; The study was developed from a project funded by Novartis Pharma AG and F. Hoffmann La Roche Ltd. The companies did not participate in the design, analyses or interpretation of the results.n, analysis, interpretation of the results, preparation of the manuscript or decision to publish.	Anderson WF, 2001, J CLIN ONCOL, V19, P18, DOI 10.1200/JCO.2001.19.1.18; Bahmanyar S, 2009, NEUROLOGY, V72, P1170, DOI 10.1212/01.wnl.0000345366.10455.62; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Breslow NE, 1987, STAT METHODS CANC RE; Buttmann M, 2016, NEUROLOGY, V86, P2203, DOI 10.1212/WNL.0000000000002745; Colleoni M, 2002, ANN ONCOL, V13, P273, DOI 10.1093/annonc/mdf039; Do K-A, 1998, HUM BIOL, P1073; El Saghir NS, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-194; Fois AF, 2010, J NEUROL NEUROSUR PS, V81, P215, DOI 10.1136/jnnp.2009.175463; Group ECW, 2011, HUMAN REPROD UPDATE, V17, P706, DOI [10.1093/humupd/dmr020, DOI 10.1093/HUMUPD/DMR020]; Handel AE, 2010, J NEUROL NEUROSUR PS, V81, P1413, DOI 10.1136/jnnp.2009.195776; Kingwell E, 2010, J NEUROL SCI, V292, P57, DOI 10.1016/j.jns.2010.02.007; Lebrun C, 2011, J NEUROL, V258, P1304, DOI 10.1007/s00415-011-5929-9; Lockshin MD, 2006, ORTHOP CLIN N AM, V37, P629, DOI 10.1016/j.ocl.2006.08.002; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Maggard MA, 2003, J SURG RES, V113, P109, DOI 10.1016/S0022-4804(03)00179-3; Manouchehrinia A, 2013, BRAIN; Midgard R, 1996, ACTA NEUROL SCAND, V93, P411; MOLLER H, 1991, ACTA NEUROL SCAND, V84, P214, DOI 10.1111/j.1600-0404.1991.tb04941.x; Nielsen NM, 2006, INT J CANCER, V118, P979, DOI 10.1002/ijc.21437; POTTER JD, 1995, CANCER EPIDEM BIOMAR, V4, P319; Rapiti E, 2005, EUR J CANCER, V41, P1446, DOI 10.1016/j.ejca.2005.02.029; Sobin L, 2009, TNM CLASSIFICATION M; Socialstyrelsen, 2014, CANC SVER 2013; Suba Z, 2013, RECENT PAT ANTI-CANC, V8, P154; Sumelahti ML, 2004, NEUROEPIDEMIOLOGY, V23, P224, DOI 10.1159/000079947; Sun LM, 2014, EUR J NEUROL, V21, P238, DOI 10.1111/ene.12267; THORPE SM, 1988, ACTA ONCOL, V27, P1; Welfare NBoHa, 2011, CANC INC SWED 2011; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777	31	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165027	10.1371/journal.pone.0165027	http://dx.doi.org/10.1371/journal.pone.0165027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776164	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200035
J	Herberg, U; Linden, K; Dewald, O; Gatzweiler, E; Seehase, M; Duerr, GD; Dorner, J; Kleppe, S; Ladage, D; Breuer, J				Herberg, Ulrike; Linden, Katharina; Dewald, Oliver; Gatzweiler, Eva; Seehase, Matthias; Duerr, Georg Daniel; Doerner, Jonas; Kleppe, Stephanie; Ladage, Dennis; Breuer, Johannes			3D Real-Time Echocardiography Combined with Mini Pressure Wire Generate Reliable Pressure-Volume Loops in Small Hearts	PLOS ONE			English	Article							RIGHT-VENTRICULAR FUNCTION; SINGLE-BEAT ESTIMATION; 3-DIMENSIONAL ECHOCARDIOGRAPHY; VASCULAR-RESISTANCE; VALIDATION; INFANTS; CATHETERIZATION; QUANTIFICATION; FEASIBILITY; CHILDREN	Background Pressure-volume loops (PVL) provide vital information regarding ventricular performance and pathophysiology in cardiac disease. Unfortunately, acquisition of PVL by conductance technology is not feasible in neonates and small children due to the available human catheter size and resulting invasiveness. The aim of the study was to validate the accuracy of PVL in small hearts using volume data obtained by real-time three-dimensional echocardiography (3DE) and simultaneously acquired pressure data. Methods In 17 piglets (weight range: 3.6-8.0 kg) left ventricular PVL were generated by 3DE and simultaneous recordings of ventricular pressure using a mini pressure wire (PVL3D). PVL3D were compared to conductance catheter measurements (PVLCond) under various hemodynamic conditions (baseline, alpha-adrenergic stimulation with phenylephrine, beta-adrenoreceptor- blockage using esmolol). In order to validate the accuracy of 3D volumetric data, cardiac magnetic resonance imaging (CMR) was performed in another 8 piglets. Results Correlation between CMR-and 3DE-derived volumes was good (enddiastolic volume: mean bias -0.03ml +/- 1.34ml). Computation of PVL3D in small hearts was feasible and comparable to results obtained by conductance technology. Bland-Altman analysis showed a low bias between PVL3D and PVLCond. Systolic and diastolic parameters were closely associated (Intraclass-Correlation Coefficient for: systolic myocardial elastance 0.95, arterial elastance 0.93, diastolic relaxation constant tau 0.90, indexed end-diastolic volume 0.98). Hemodynamic changes under different conditions were well detected by both methods (ICC 0.82 to 0.98). Inter-and intra-observer coefficients of variation were below 5% for all parameters. Conclusions PVL3D generated from 3DE combined with mini pressure wire represent a novel, feasible and reliable method to assess different hemodynamic conditions of cardiac function in hearts comparable to neonate and infant size. This methodology may be integrated into clinical practice and cardiac catheterization programs and has the capability to contribute to clinical decision making even in small hearts.	[Herberg, Ulrike; Linden, Katharina; Gatzweiler, Eva; Seehase, Matthias; Kleppe, Stephanie; Breuer, Johannes] Univ Bonn, Pediat Heart Ctr, Dept Pediat Cardiol, Bonn, Germany; [Dewald, Oliver; Duerr, Georg Daniel] Univ Bonn, Pediat Heart Ctr, Dept Cardiac Surg, Bonn, Germany; [Doerner, Jonas] Univ Bonn, Dept Radiol, Bonn, Germany; [Ladage, Dennis] Univ Hosp Cologne, Ctr Heart, Dept Internal Med 3, Cologne, Germany; [Seehase, Matthias] Georg August Univ, Dept Pediat Cardiol & Intens Care Med Neonatol, Gottingen, Germany; [Doerner, Jonas] Univ Hosp Cologne, Inst Diagnost & Intervent Radiol, Cologne, Germany	University of Bonn; University of Bonn; University of Bonn; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; University of Cologne	Herberg, U (corresponding author), Univ Bonn, Pediat Heart Ctr, Dept Pediat Cardiol, Bonn, Germany.	Ulrike.Herberg@ukb.uni-bonn.de	Duerr, Georg Daniel/ABE-4511-2020; Herberg, Ulrike/AAY-2952-2021	Duerr, Georg Daniel/0000-0002-0310-6236; Herberg, Ulrike/0000-0002-9386-0258; Gatzweiler, Eva/0000-0002-2015-6673; Ladage, Dennis/0000-0002-4512-0917; Breuer, Judith/0000-0001-8246-0534	Deutsche Stiftung fur Herzforschung [F29/08]; Else Kroner-Fresenius-Stiftung [P15/06/A79/05]; Fordergemeinschaft Deutsche Kinderherzzentren [H-022.0039]	Deutsche Stiftung fur Herzforschung; Else Kroner-Fresenius-Stiftung; Fordergemeinschaft Deutsche Kinderherzzentren	Support was provided by: Deutsche Stiftung fur Herzforschung [http://www.dshf.de/sitemap.php] F29/08 (to SK and UH: financial support for conductance catheters, animals and salary for research position); Else Kroner-Fresenius-Stiftung [http://www.ekfs.de] P15/06/A79/05 (to UH); and Fordergemeinschaft Deutsche Kinderherzzentren [http://www.kinderherzen.de] H-022.0039 (to UH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsoufi B, 2007, EUR J CARDIO-THORAC, V31, P1013, DOI 10.1016/j.ejcts.2007.03.015; Apitz C, 2010, HEART, V96, P1837, DOI 10.1136/hrt.2010.203190; BAAN J, 1984, CIRCULATION, V70, P812, DOI 10.1161/01.CIR.70.5.812; Barkhausen J, 2001, RADIOLOGY, V219, P264, DOI 10.1148/radiology.219.1.r01ap12264; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Broscheit JA, 2007, J CARDIOTHOR VASC AN, V21, P8, DOI 10.1053/j.jvca.2006.03.005; Bulbul Ziad R, 2002, Asian Cardiovasc Thorac Ann, V10, P129; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; Cassidy SC, 1997, AM HEART J, V133, P174, DOI 10.1016/S0002-8703(97)70206-0; Chang SA, 2011, J AM SOC ECHOCARDIOG, V24, P853, DOI 10.1016/j.echo.2011.04.015; Daneshvar D, 2010, AM HEART J, V160, P394, DOI 10.1016/j.ahj.2010.06.040; Ding LD, 2016, CATHETER CARDIO INTE, V88, P1108, DOI 10.1002/ccd.26690; Emani SM, 2012, J AM COLL CARDIOL, V60, P1966, DOI 10.1016/j.jacc.2012.07.041; Friedberg MK, 2010, CIRC-CARDIOVASC IMAG, V3, P735, DOI 10.1161/CIRCIMAGING.109.928663; Gaemperli O, 2013, CIRCULATION, V127, P1018, DOI 10.1161/CIRCULATIONAHA.112.135061; Gayat E, 2011, AM J PHYSIOL-HEART C, V301, pH1916, DOI 10.1152/ajpheart.00760.2011; GRAHAM TP, 1991, CIRCULATION, V84, P2259, DOI 10.1161/01.CIR.84.6.2259; Hapfelmeier A, 2016, J CLIN MONIT COMPUT, V30, P149, DOI 10.1007/s10877-015-9711-x; Herberg U, 2013, CLIN RES CARDIOL, V102, P427, DOI 10.1007/s00392-013-0548-3; Herberg U, 2011, J ULTRAS MED, V30, P899, DOI 10.7863/jum.2011.30.7.899; Klotz S, 2006, AM J PHYSIOL-HEART C, V291, pH403, DOI 10.1152/ajpheart.01240.2005; Kutty S, 2014, ECHOCARDIOGR-J CARD, V31, P179, DOI 10.1111/echo.12326; Lang RM, 2012, J AM SOC ECHOCARDIOG, V25, P3, DOI 10.1016/j.echo.2011.11.010; Linden K, 2017, J CLIN MONIT COMPUT, V31, P353, DOI 10.1007/s10877-016-9843-7; Lionetti V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080591; Renella P, 2014, J AM SOC ECHOCARDIOG, V27, P903, DOI 10.1016/j.echo.2014.04.008; Rizzi M, 2015, LONG TERM OUTCOME CA, V170, DOI [10.1016/j.jpeds.2015.11.024, DOI 10.1016/J.JPEDS.2015.11.024]; Schlangen J, 2013, INT J CARDIOL, V167, P1305, DOI 10.1016/j.ijcard.2012.03.183; Schmitt B, 2010, CIRC-CARDIOVASC IMAG, V3, P623, DOI 10.1161/CIRCIMAGING.109.931592; Schmitt B, 2009, JACC-CARDIOVASC IMAG, V2, P1271, DOI 10.1016/j.jcmg.2009.09.007; Schranz D, 2013, J HEART LUNG TRANSPL, V32, P475, DOI 10.1016/j.healun.2013.01.988; Schwedler G, 2011, CLIN RES CARDIOL, V100, P1111, DOI 10.1007/s00392-011-0355-7; ten Brinke EA, 2010, HEART, V96, P213, DOI 10.1136/hrt.2009.176248; THOMPSON DS, 1983, BRIT HEART J, V49, P250; Tulner SAF, 2003, ANESTH ANALG, V97, P950, DOI 10.1213/01.ANE.0000078814.81889.B3; Tuo GL, 2013, PEDIATR CARDIOL, V34, P1567, DOI 10.1007/s00246-013-0685-5; Yang B, 2013, PLOS ONE, P8, DOI [DOI 10.1371/JOURNAL.PONE.0060580183, 10.1371/journal.pone.0060580183]; Yerebakan C, 2010, INTERACT CARDIOV TH, V10, P519, DOI 10.1510/icvts.2009.221234; Yotti R, 2014, CIRC-CARDIOVASC IMAG, V7, P164, DOI 10.1161/CIRCIMAGING.113.000722	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165397	10.1371/journal.pone.0165397	http://dx.doi.org/10.1371/journal.pone.0165397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776179	Green Published, gold, Green Submitted			2022-12-26	WOS:000389009200062
J	Merat, SJ; Molenkamp, R; Wagner, K; Koekkoek, SM; de Berg, DV; Yasuda, E; Bohne, M; Claassen, YB; Grady, BP; Prins, M; Bakker, AQ; de Jong, MD; Spits, H; Schinkel, J; Beaumont, T				Merat, Sabrina J.; Molenkamp, Richard; Wagner, Koen; Koekkoek, Sylvie M.; de Berg, Dorien van; Yasuda, Etsuko; Bohne, Martino; Claassen, Yvonne B.; Grady, Bart P.; Prins, Maria; Bakker, Arjen Q.; de Jong, Menno D.; Spits, Hergen; Schinkel, Janke; Beaumont, Tim			Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance	PLOS ONE			English	Article							SINGLE-SOURCE OUTBREAK; CHRONIC HCV; IMMUNE-RESPONSES; VIRAL CLEARANCE; DRUG-USERS; GLYCOPROTEIN; INFECTION; SOFOSBUVIR; EPITOPE; RIBAVIRIN	Hepatitis C virus (HCV) is world-wide a major cause of liver related morbidity and mortality. No vaccine is available to prevent HCV infection. To design an effective vaccine, understanding immunity against HCV is necessary. The memory B cell repertoire was characterized from an intravenous drug user who spontaneously cleared HCV infection 25 years ago. CD27+ IgG+ memory B cells were immortalized using BCL6 and Bcl-xL. These immortalized B cells were used to study antibody-mediated immunity against the HCV E1E2 glycoproteins. Five E1E2 broadly reactive antibodies were isolated: 3 antibodies showed potent neutralization of genotype 1 to 4 using HCV pseudotyped particles, whereas the other 2 antibodies neutralized genotype 1, 2 and 3 or 1 and 2 only. All antibodies recognized non-linear epitopes on E2. Finally, except for antibody AT12-011, which recognized an epitope consisting of antigenic domain C/AR2 and AR5, all other four antibodies recognized epitope II and domain B. These data show that a subject, who spontaneously cleared HCV infection 25 years ago, still has circulating memory B cells that are able to secrete broadly neutralizing antibodies. Presence of such memory B cells strengthens the argument for undertaking the development of an HCV vaccine.	[Merat, Sabrina J.; Wagner, Koen; de Berg, Dorien van; Yasuda, Etsuko; Bohne, Martino; Claassen, Yvonne B.; Bakker, Arjen Q.; Spits, Hergen; Beaumont, Tim] AIMM Therapeut, Amsterdam, Netherlands; [Molenkamp, Richard; Koekkoek, Sylvie M.; de Jong, Menno D.; Schinkel, Janke] Acad Med Ctr, Dept Med Microbiol, Sect Clin Virol, Amsterdam, Netherlands; [Grady, Bart P.; Prins, Maria] Publ Hlth Serv Amsterdam, Dept Infect Dis Res & Prevent, Cluster Infect Dis, Amsterdam, Netherlands; [Prins, Maria] Acad Med Ctr, Dept Infect Dis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Beaumont, T (corresponding author), AIMM Therapeut, Amsterdam, Netherlands.	tbeaumont@aimmtherapeutics.com	Spits, Hergen/N-2581-2019	Spits, Hergen/0000-0003-3269-8338	Virgo consortium - Dutch government [FES0908]	Virgo consortium - Dutch government	This study was supported by the Virgo consortium, funded by the Dutch government project number FES0908 (http://virgo/nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albecka A, 2011, J VIROL, V85, P1777, DOI 10.1128/JVI.02170-10; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Carlsen THR, 2014, HEPATOLOGY, V60, P1551, DOI 10.1002/hep.27298; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; de Jong YP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009512; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Desombere I, 2016, HEPATOLOGY, V63, P1120, DOI 10.1002/hep.28428; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Grebely J, 2014, HEPATOLOGY, V59, P109, DOI 10.1002/hep.26639; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Keck Z, 2013, J VIROL, V87, P37, DOI 10.1128/JVI.01941-12; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Sacks-Davis R, 2015, J INFECT DIS, V212, P1407, DOI 10.1093/infdis/jiv220; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Swann RE, 2016, J VIROL, V90, P4530, DOI 10.1128/JVI.02669-15; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Urbanowicz RA, 2015, J VIROL; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; van den Berg CHSB, 2009, J VIRAL HEPATITIS, V16, P568, DOI 10.1111/j.1365-2893.2009.01105.x; van den Berg CHBS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027555; van den Berg CHSB, 2007, EUR J EPIDEMIOL, V22, P183, DOI 10.1007/s10654-006-9089-7; VANDENHOEK JAR, 1988, AIDS, V2, P55, DOI 10.1097/00002030-198802000-00010; Wagner K, 2014, P NATL ACAD SCI USA, V111, P16820, DOI 10.1073/pnas.1408605111; Zhang P, 2007, P NATL ACAD SCI USA, V104, P8449, DOI 10.1073/pnas.0703039104; zur Wiesch JS, 2005, J IMMUNOL, V175, P3603, DOI 10.4049/jimmunol.175.6.3603	48	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2016	11	10							e0165047	10.1371/journal.pone.0165047	http://dx.doi.org/10.1371/journal.pone.0165047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED7AX	27776169	Green Published, Green Submitted, gold			2022-12-26	WOS:000389009200037
J	Perez, MF; Contreras, L; Garnica, NM; Fernandez-Zenoff, MV; Farias, ME; Sepulveda, M; Ramallo, J; Dib, JR				Florencia Perez, Maria; Contreras, Luciana; Mercedes Garnica, Nydia; Veronica Fernandez-Zenoff, Maria; Eugenia Farias, Maria; Sepulveda, Milena; Ramallo, Jacqueline; Rafael Dib, Julian			Native Killer Yeasts as Biocontrol Agents of Postharvest Fungal Diseases in Lemons	PLOS ONE			English	Article							PICHIA-MEMBRANIFACIENS; KLUYVEROMYCES-LACTIS; BIOLOGICAL-CONTROL; TOXIN; SACCHAROMYCES; MECHANISMS; PLASMIDS; FRUITS; APPLE; IDENTIFICATION	Economic losses caused by postharvest diseases represent one of the main problems of the citrus industry worldwide. The major diseases affecting citrus are the "green mold" and "blue mold", caused by Penicillium digitatum and P. italicum, respectively. To control them, synthetic fungicides are the most commonly used method. However, often the emergence of resistant strains occurs and their use is becoming more restricted because of toxic effects and environmental pollution they generate, combined with trade barriers to international markets. The aim of this work was to isolate indigenous killer yeasts with antagonistic activity against fungal postharvest diseases in lemons, and to determine their control efficiency in in vitro and in vivo assays. Among 437 yeast isolates, 8.5% show to have a killer phenotype. According to molecular identification, based on the 26S rDNA D1/D2 domain sequences analysis, strains were identified belonging to the genera Saccharomyces, Wickerhamomyces, Kazachstania, Pichia, Candida and Clavispora. Killers were challenged with pathogenic molds and strains that caused the maximum in vitro inhibition of P. digitatum were selected for in vivo assays. Two strains of Pichia and one strain of Wickerhamomyces depicted a significant protection (p < 0.05) from decay by P. digitatum in assays using wounded lemons. Thus, the native killer yeasts studied in this work showed to be an effective alternative for the biocontrol of postharvest fungal infections of lemons and could be promising agents for the development of commercial products for the biological control industry.	[Florencia Perez, Maria; Contreras, Luciana; Mercedes Garnica, Nydia; Eugenia Farias, Maria; Rafael Dib, Julian] Consejo Nacl Invest Cient & Tecn, Planta Piloto Proc Ind Microbiol, San Miguel De Tucuman, Argentina; [Veronica Fernandez-Zenoff, Maria; Rafael Dib, Julian] Univ Nacl Tucuman, Fac Bioquim Quim & Farm, Inst Microbiol, Ayacucho 471, RA-4000 San Miguel De Tucuman, Argentina; [Sepulveda, Milena; Ramallo, Jacqueline] SA San Miguel, Lab Desarrollo & Invest, Lavalle 4001,T4000BAB, San Miguel De Tucuman, Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman	Dib, JR (corresponding author), Consejo Nacl Invest Cient & Tecn, Planta Piloto Proc Ind Microbiol, San Miguel De Tucuman, Argentina.; Dib, JR (corresponding author), Univ Nacl Tucuman, Fac Bioquim Quim & Farm, Inst Microbiol, Ayacucho 471, RA-4000 San Miguel De Tucuman, Argentina.	jdib@proimi.org.ar	Shenoy, Vivek/ABD-5075-2021; Dib, Julian Rafael Dib/AAG-9240-2019; Cao, Xuan/AAI-6307-2020	Dib, Julian Rafael Dib/0000-0002-8965-8372; Farias, Maria Eugenia/0000-0002-2771-8915; Perez, Maria Florencia/0000-0002-7868-425X	Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE [U54CA193417] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK058123] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The financial support from the Alexander von Humboldt Foundation is gratefully acknowledged.; The financial support from the Alexander von Humboldt Foundation is gratefully acknowledged. We thank to Dr. John Paluszynski for manuscript editing. We also thank Ing. Gabriela Fogliata from "Estacion Experimental Obispo Colombres" for providing pure cultures of plant pathogens and to Nathalia Iriarte, Prof. Friedhelm Meinhardt and Dr. Alene Kast for providing reference yeast strains.	Bajaj BK, 2013, J BASIC MICROB, V53, P645, DOI 10.1002/jobm.201200187; Bocco A, 1998, J AGR FOOD CHEM, V46, P2123, DOI 10.1021/jf9709562; Chanchalchaovivat A, 2007, BIOL CONTROL, V42, P326, DOI 10.1016/j.biocontrol.2007.05.016; Ciani M, 2015, CURR OPIN FOOD SCI, V1, P1, DOI 10.1016/j.cofs.2014.07.001; Coelho AR, 2007, BRAZ ARCH BIOL TECHN, V50, P725, DOI 10.1590/S1516-89132007000400019; de Lima JR, 2013, J BASIC MICROB, V53, P590, DOI 10.1002/jobm.201200049; Di Rienzo J.A., 2015, INFOSTAT VERSI6N 201, DOI DOI 10.1111/j.1469-8137.2006.01787.x; Droby S, 2009, POSTHARVEST BIOL TEC, V52, P137, DOI 10.1016/j.postharvbio.2008.11.009; Druvefors UA, 2005, APPL ENVIRON MICROB, V71, P1865, DOI 10.1128/AEM.71.4.1865-1869.2005; El-Tarabily Khaled A., 2006, Mycoscience, V47, P25, DOI 10.1007/s10267-005-0268-2; ENTIAN KD, 1980, MOL GEN GENET, V178, P633, DOI 10.1007/BF00337871; Fan Q, 2000, PLANT DIS, V84, P1212, DOI 10.1094/PDIS.2000.84.11.1212; Federcitrus, 2015, ACT CITR ARG 2014; Fredericq P., 1948, REV BELGE PATH    S4, V4, P1; Giobbe S, 2007, FEMS YEAST RES, V7, P1389, DOI 10.1111/j.1567-1364.2007.00301.x; Golubev WI, 2013, MICROBIOLOGY+, V82, P290, DOI 10.1134/S0026261713030065; GRATIA A, 1946, CR SOC BIOL, V140, P1053; Grevesse C, 2003, PHYTOPATHOLOGY, V93, P1145, DOI 10.1094/PHYTO.2003.93.9.1145; GUNGE N, 1981, J BACTERIOL, V147, P155, DOI 10.1128/JB.147.1.155-160.1981; Hadacek F, 2000, PHYTOCHEM ANALYSIS, V11, P137, DOI 10.1002/(SICI)1099-1565(200005/06)11:3&lt;137::AID-PCA514&gt;3.0.CO;2-I; HAYMAN GT, 1991, CURR GENET, V19, P389, DOI 10.1007/BF00309600; Izgu DA, 2011, ANTON LEEUW INT J G, V99, P85, DOI 10.1007/s10482-010-9527-0; KAEMPER J, 1991, Current Genetics, V19, P109; Kaiser C., 1994, METHODS YEAST GENETI; Kishida M, 1996, BIOSCI BIOTECH BIOCH, V60, P798, DOI 10.1271/bbb.60.798; Klassen R, 2002, PLASMID, V48, P142, DOI 10.1016/S0147-619X(02)00101-4; Krcmery V, 1999, FEMS IMMUNOL MED MIC, V23, P75, DOI 10.1111/j.1574-695X.1999.tb01719.x; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Li BB, 2006, SEP PURIF TECHNOL, V48, P182, DOI 10.1016/j.seppur.2005.07.005; Liu GL, 2015, CRIT REV BIOTECHNOL, V35, P222, DOI 10.3109/07388551.2013.833582; Lopes CA, 2010, REV ARGENT MICROBIOL, V42, P298, DOI 10.1590/S0325-75412010000400011; Lopez-Garcia B, 2003, INT J FOOD MICROBIOL, V89, P163, DOI 10.1016/S0168-1605(03)00118-1; Makower M., 1963, 11 INT C GEN OXF; McGuire RG, 2000, PHYTOPATHOLOGY, V90, P1217, DOI 10.1094/PHYTO.2000.90.11.1217; Nakagawa Y, 2004, MED MYCOL, V42, P267, DOI 10.1080/13693780310001597674; Nantawanit N, 2010, BIOL CONTROL, V52, P145, DOI 10.1016/j.biocontrol.2009.10.011; Ochigava I, 2011, ANTON LEEUW INT J G, V99, P559, DOI 10.1007/s10482-010-9524-3; Palou L., 2007, REV ESPECIAL COMUNID, P82; Palou L., 2008, STEWART POSTHARVEST, V4, DOI DOI 10.2212/SPR.2008.2.2; PFEIFFER P, 1984, ARCH MICROBIOL, V137, P357, DOI 10.1007/BF00410734; Pimenta R.S., 2009, YEAST BIOTECHNOLOGY, P199, DOI [10.1007/978-1-4020-8292-4_10, DOI 10.1007/978-1-4020-8292-4_10]; Pitt J., 1985, FUNGI FOOD SPOILAGE; Platania C, 2012, FOOD MICROBIOL, V30, P219, DOI 10.1016/j.fm.2011.12.010; Radosavljevic M, 1999, J CLIN MICROBIOL, V37, P475, DOI 10.1128/JCM.37.2.475-477.1999; Robiglio A, 2011, INT J FOOD MICROBIOL, V147, P211, DOI 10.1016/j.ijfoodmicro.2011.04.007; ROGERS D, 1978, J GEN MICROBIOL, V105, P199, DOI 10.1099/00221287-105-2-199; Sanchez-Torres P, 2011, POSTHARVEST BIOL TEC, V59, P159; Sangorrin MP, 2007, INT J FOOD MICROBIOL, V119, P351, DOI 10.1016/j.ijfoodmicro.2007.04.010; Santos A, 2004, MICROBIOL-SGM, V150, P2527, DOI 10.1099/mic.0.27071-0; Santos A, 2004, YEAST, V21, P151, DOI 10.1002/yea.1069; Savastano G, 1929, J AGRIC RES, V39, P0163; Sepulveda M, 2015, SCI HORTIC-AMSTERDAM, V192, P387, DOI 10.1016/j.scienta.2015.06.021; SIEGEL MR, 1977, NETH J PLANT PATHOL, V83, P121, DOI 10.1007/BF03041427; STUMM C, 1977, A VAN LEEUW J MICROB, V43, P125, DOI 10.1007/BF00395667; Sugita T, 2003, J CLIN MICROBIOL, V41, P4695, DOI 10.1128/JCM.41.10.4695-4699.2003; Tripathi P, 2004, POSTHARVEST BIOL TEC, V32, P235, DOI 10.1016/j.postharvbio.2003.11.005; Tuset J. J., 1987, PODREDUMBRES FRUTOS; Vaudano E., 2014, IND MED ENV APPL MIC, P304; Vero S, 2013, FEMS YEAST RES, V13, P189, DOI 10.1111/1567-1364.12021; Wisniewski M, 2007, BIOLOGICAL CONTROL: A GLOBAL PERSPECTIVE, P262, DOI 10.1079/9781845932657.0262; WOODS DR, 1968, J GEN MICROBIOL, V51, P115, DOI 10.1099/00221287-51-1-115; Yao HJ, 2005, J APPL MICROBIOL, V98, P941, DOI 10.1111/j.1365-2672.2004.02531.x; YOUNG TW, 1978, A VAN LEEUW J MICROB, V44, P59, DOI 10.1007/BF00400077; Zenoff VF, 2006, APPL ENVIRON MICROB, V72, P7857, DOI 10.1128/AEM.01333-06; Zhao Y, 2008, POSTHARVEST BIOL TEC, V49, P113, DOI 10.1016/j.postharvbio.2008.01.001	66	125	125	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2016	11	10							e0165590	10.1371/journal.pone.0165590	http://dx.doi.org/10.1371/journal.pone.0165590			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3YA	26735954	Green Published, gold, Green Submitted			2022-12-26	WOS:000389537000035
J	Perepelyuk, M; Chin, LK; Cao, X; van Oosten, A; Shenoy, VB; Janmey, PA; Wells, RG				Perepelyuk, Maryna; Chin, LiKang; Cao, Xuan; van Oosten, Anne; Shenoy, Vivek B.; Janmey, Paul A.; Wells, Rebecca G.			Normal and Fibrotic Rat Livers Demonstrate Shear Strain Softening and Compression Stiffening: A Model for Soft Tissue Mechanics	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TRANSIENT ELASTOGRAPHY; EXTRACELLULAR-MATRIX; LATENT TGF-BETA-1; FIBROSIS; STIFFNESS; BEHAVIOR; CULTURE; DECELLULARIZATION; DIFFERENTIATION	Tissues including liver stiffen and acquire more extracellular matrix with fibrosis. The relationship between matrix content and stiffness, however, is non-linear, and stiffness is only one component of tissue mechanics. The mechanical response of tissues such as liver to physiological stresses is not well described, and models of tissue mechanics are limited. To better understand the mechanics of the normal and fibrotic rat liver, we carried out a series of studies using parallel plate rheometry, measuring the response to compressive, extensional, and shear strains. We found that the shear storage and loss moduli G' and G" and the apparent Young's moduli measured by uniaxial strain orthogonal to the shear direction increased markedly with both progressive fibrosis and increasing compression, that livers shear strain softened, and that significant increases in shear modulus with compressional stress occurred within a range consistent with increased sinusoidal pressures in liver disease. Proteoglycan content and integrin-matrix interactions were significant determinants of liver mechanics, particularly in compression. We propose a new non-linear constitutive model of the liver. A key feature of this model is that, while it assumes overall liver incompressibility, it takes into account water flow and solid phase compressibility. In sum, we report a detailed study of non-linear liver mechanics under physiological strains in the normal state, early fibrosis, and late fibrosis. We propose a constitutive model that captures compression stiffening, tension softening, and shear softening, and can be understood in terms of the cellular and matrix components of the liver.	[Perepelyuk, Maryna; Wells, Rebecca G.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chin, LiKang; van Oosten, Anne; Janmey, Paul A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Chin, LiKang; Janmey, Paul A.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chin, LiKang] Tokushima Univ Hosp, Clin Res Ctr Diabet, Tokushima, Japan; [Cao, Xuan; Shenoy, Vivek B.] Univ Penn, Sch Engn & Appl Sci, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [van Oosten, Anne] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Tokushima University; University of Pennsylvania; University of Pennsylvania	Janmey, PA (corresponding author), Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.	janmey@mail.med.upenn.edu; rgwells@mail.med.upenn.edu	Shenoy, Vivek/ABD-5075-2021; Dib, Julian Rafael Dib/AAG-9240-2019; Cao, Xuan/AAI-6307-2020	Dib, Julian Rafael Dib/0000-0002-8965-8372; Farias, Maria Eugenia/0000-0002-2771-8915; Perez, Maria Florencia/0000-0002-7868-425X	National Institutes of Health (University of Pennsylvania/National Institute for Diabetes Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases Molecular Pathology and Imaging Core) [R01 EB17753, R01 DK058123, T32 HL007954, P30 DK050306]; Fulbright Science and Technology Award; Prins Bernhard Cultuurfonds-Kuitse Fonds; NATIONAL CANCER INSTITUTE [U54CA193417] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK058123] Funding Source: NIH RePORTER	National Institutes of Health (University of Pennsylvania/National Institute for Diabetes Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases Molecular Pathology and Imaging Core); Fulbright Science and Technology Award; Prins Bernhard Cultuurfonds-Kuitse Fonds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01 EB17753 (to PAJ, VBS, and RGW), R01 DK058123 (to RGW), T32 HL007954 (for LC), P30 DK050306 (which supports the University of Pennsylvania/National Institute for Diabetes Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases Molecular Pathology and Imaging Core), Fulbright Science and Technology Award (to AvO) and the Prins Bernhard Cultuurfonds-Kuitse Fonds (to AvO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsebaey A, 2015, WORLD J HEPATOL, V7, P1149, DOI 10.4254/wjh.v7.i8.1149; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Buscemi L, 2011, CURR BIOL, V21, P2046, DOI 10.1016/j.cub.2011.11.037; Calvete JJ, 2003, BIOCHEM J, V372, P725, DOI 10.1042/BJ20021739; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; DUNN GD, 1973, AM J MED SCI, V265, P175, DOI 10.1097/00000441-197303000-00001; Evans DW, 2013, BIOMECH MODEL MECHAN, V12, P569, DOI 10.1007/s10237-012-0426-3; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Hansen LK, 2006, CURR TOP DEV BIOL, V72, P205, DOI 10.1016/S0070-2153(05)72004-4; Isgro G, 2013, J GASTROENTEROL, V48, P921, DOI 10.1007/s00535-012-0694-9; Lai VK, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024350; Lang R, 2011, BIOMATERIALS, V32, P7042, DOI 10.1016/j.biomaterials.2011.06.005; Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792; Liedtke C, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-19; Liu Z, 2000, BIORHEOLOGY, V37, P191; Liu ZZ, 2002, BIORHEOLOGY, V39, P735; Mattei G, 2014, ACTA BIOMATER, V10, P875, DOI 10.1016/j.actbio.2013.10.023; Mazza G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13079; Miller K, 2000, J BIOMECH, V33, P367, DOI 10.1016/S0021-9290(99)00196-7; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Mori M, 2011, HEPATOL RES, V41, P897, DOI 10.1111/j.1872-034X.2011.00842.x; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Parker KJ, 2014, PHYS MED BIOL, V59, P4443, DOI 10.1088/0031-9155/59/15/4443; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Pogoda K, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/075002; Poynard T, 2014, J HEPATOL, V60, P706, DOI 10.1016/j.jhep.2013.11.016; Ren HZ, 2013, LIVER INT, V33, P448, DOI 10.1111/liv.12088; SAITO M, 1987, AM J GASTROENTEROL, V82, P1057; Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328; Shupe T, 2010, ORGANOGENESIS, V6, P134, DOI 10.4161/org.6.2.11546; Simonetto DA, 2015, HEPATOLOGY, V61, P648, DOI 10.1002/hep.27387; Sparks JL, 2008, ANN BIOMED ENG, V36, P1883, DOI 10.1007/s10439-008-9555-3; Tan K, 2013, J BIOMECH, V46, P1060, DOI 10.1016/j.jbiomech.2013.01.028; Tang A, 2015, AM J ROENTGENOL, V205, P33, DOI 10.2214/AJR.15.14553; van Oosten ASG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19270; Wells R G., 2007, TXB HEPATOLOGY BASIC; Wilder J, 2014, MED DEVICES-EVID RES, V7, P107, DOI 10.2147/MDER.S46943; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Woo K, 2008, J PHYSIOL-LONDON, V586, P2779, DOI 10.1113/jphysiol.2008.153015; Wu FM, 2011, CONGENIT HEART DIS, V6, P190, DOI 10.1111/j.1747-0803.2011.00504.x; Yin M, 2016, RADIOLOGY, V278, P114, DOI 10.1148/radiol.2015142141; Yusko EC, 2014, MOL BIOL CELL, V25, P3717, DOI 10.1091/mbc.E13-12-0707; Zhu Y, 2014, J ZHEJIANG UNIV-SC B, V15, P375, DOI 10.1631/jzus.B1300121	47	125	125	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2016	11	1							e0146588	10.1371/journal.pone.0146588	http://dx.doi.org/10.1371/journal.pone.0146588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XE	26735954	Green Submitted, gold, Green Published			2022-12-26	WOS:000367805100054
